data_2mki_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mki _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.427 ' H ' ' HD3' ' A' ' 62' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -158.61 164.88 35.61 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 121.156 0.503 . . . . 0.0 110.543 -173.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.7 t -88.7 165.6 14.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.195 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.33 10.95 6.02 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.824 176.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -128.15 141.53 51.45 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 124.148 0.979 . . . . 0.0 109.977 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.63 134.58 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.613 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -79.63 140.68 37.03 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 m -127.63 114.48 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 173.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.9 163.12 25.55 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.368 -172.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.65 22.24 76.63 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 119.174 -0.792 . . . . 0.0 113.42 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.0 tp -47.11 123.38 8.14 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 118.629 1.214 . . . . 0.0 107.846 173.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 94.2 Cg_endo -75.67 157.53 39.94 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.705 2.27 . . . . 0.0 111.823 -172.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 39.7 Cg_exo -59.34 173.39 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.42 3.414 . . . . 0.0 112.873 173.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.9 t70 64.88 -78.94 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.6 pt -61.7 162.01 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 118.683 0.674 . . . . 0.0 111.699 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -143.54 -156.01 0.65 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.38 -174.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -43.09 -32.68 0.73 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.642 1.977 . . . . 0.0 114.847 -173.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -78.6 -34.74 46.54 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.615 1.098 . . . . 0.0 112.139 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -77.52 -27.92 51.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.149 -0.345 . . . . 0.0 110.51 -174.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 25.9 pt -84.26 -27.03 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 O-C-N 122.067 -0.396 . . . . 0.0 110.398 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.4 m -73.22 -12.97 61.05 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.16 -17.42 17.41 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.0 m -82.78 -42.51 17.85 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.93 0.787 . . . . 0.0 112.237 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -90.01 1.61 56.11 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -68.38 -14.64 63.14 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.838 0.455 . . . . 0.0 111.953 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -69.8 -10.0 56.76 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.014 0.525 . . . . 0.0 111.555 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -112.89 17.24 19.11 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.832 0.453 . . . . 0.0 110.46 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.54 167.89 21.03 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.78 146.45 72.51 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.448 2.765 . . . . 0.0 110.507 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.94 166.67 28.91 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.0 0.429 . . . . 0.0 111.646 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.9 pt -135.14 166.63 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.201 175.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.66 148.39 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 CA-C-O 120.722 0.296 . . . . 0.0 110.484 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -150.32 165.02 34.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.935 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.468 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 42.1 p90 -154.76 164.05 22.29 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.616 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 43.3 Cg_endo -73.04 -13.58 26.16 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 123.117 2.545 . . . . 0.0 110.927 -169.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.616 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 63.7 m-70 -101.75 7.48 41.85 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.763 0.825 . . . . 0.0 111.102 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.9 tptt -62.23 148.5 44.58 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.945 0.498 . . . . 0.0 110.395 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.291 0 C-N-CA 123.08 0.552 . . . . 0.0 111.117 -177.972 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.619 0 CA-C-O 119.53 -0.594 . . . . 0.0 113.7 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.76 147.59 31.08 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.168 0.984 . . . . 0.0 109.254 172.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.89 175.91 11.59 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 122.61 0.364 . . . . 0.0 110.931 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -136.1 129.39 31.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -90.32 149.18 22.43 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.549 0.69 . . . . 0.0 111.785 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.82 145.58 41.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.158 -1.383 . . . . 0.0 107.297 171.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -134.11 165.88 24.05 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 110.956 -176.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -105.03 -31.48 9.17 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.236 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -121.24 150.48 41.29 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.862 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -87.32 -5.83 58.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.322 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.2 p -93.72 -15.19 25.48 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.665 0.386 . . . . 0.0 111.437 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 75.3 m -73.19 -36.12 66.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 122.019 -0.426 . . . . 0.0 110.769 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.01 -20.43 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -77.42 -38.54 49.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.0 -35.97 66.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.257 0.48 . . . . 0.0 111.584 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -78.84 -15.59 58.18 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.199 0.454 . . . . 0.0 111.705 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.5 mt -99.33 -15.44 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 122.354 0.262 . . . . 0.0 111.209 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -103.34 -9.31 19.58 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.593 -0.692 . . . . 0.0 112.641 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -115.99 29.9 7.69 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.848 0.459 . . . . 0.0 111.96 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 32.0 p -140.48 -176.26 4.57 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.774 0.43 . . . . 0.0 111.659 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 32.2 mm -79.14 156.05 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 124.629 1.172 . . . . 0.0 109.007 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -138.84 155.5 48.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 111.972 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -144.15 70.77 1.3 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.374 0.607 . . . . 0.0 110.066 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 p30 47.44 12.92 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.72 2.008 . . . . 0.0 116.228 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 175.5 -20.47 0.05 OUTLIER Glycine 0 CA--C 1.526 0.779 0 CA-C-N 118.578 0.626 . . . . 0.0 112.446 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -134.63 170.96 15.02 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 117.759 0.779 . . . . 0.0 109.555 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 150' ' ' GLN . 4.6 mp -130.63 173.33 11.0 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.897 -176.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -139.75 147.69 41.21 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.2 mp -133.84 164.0 28.24 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 170.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.7 m -101.98 150.49 23.17 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.205 0.602 . . . . 0.0 110.659 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.6 m -142.6 -4.76 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.3 m 48.53 43.94 20.45 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.515 0.726 . . . . 0.0 112.842 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.6 p -73.55 153.62 89.71 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.71 8.95 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.635 1 C-N-CA 125.58 4.186 . . . . 0.0 117.296 -175.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.0 m -96.28 -18.42 20.02 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.677 1.126 . . . . 0.0 110.069 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -165.62 -172.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.342 1.457 . . . . 0.0 108.405 -171.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -69.5 -32.79 71.87 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.019 -0.426 . . . . 0.0 109.984 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -162.95 153.15 16.17 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.266 0.626 . . . . 0.0 111.0 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.515 ' HB2' ' HZ3' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -116.19 106.87 48.48 Favored Pre-proline 0 N--CA 1.457 -0.107 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 174.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.46 91.92 0.16 Allowed 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.866 2.378 . . . . 0.0 109.026 168.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.8 m -80.2 141.75 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 72.2 mt-30 -93.18 159.71 15.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.647 -177.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 50.0 mm -129.88 141.44 46.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.115 0.966 . . . . 0.0 109.761 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.29 101.62 1.54 Allowed Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.67 164.16 30.68 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.971 3.114 . . . . 0.0 111.91 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -88.08 148.7 24.35 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -109.28 150.31 28.15 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.851 0.46 . . . . 0.0 111.247 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.5 mp -96.74 78.1 2.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.128 0.571 . . . . 0.0 110.461 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.9 t -155.11 -32.66 0.1 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -134.56 28.06 3.66 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.2 m -60.71 -31.59 70.87 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.167 -0.333 . . . . 0.0 111.679 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -158.3 163.05 37.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.922 0.489 . . . . 0.0 110.877 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -156.1 156.61 34.6 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.494 0.318 . . . . 0.0 110.539 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.2 m -137.53 152.42 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 C-N-CA 123.273 0.629 . . . . 0.0 110.14 175.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 18.2 ttp -130.13 14.68 5.69 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.224 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -148.57 -170.95 3.74 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -73.02 25.77 0.8 Allowed Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.682 0.658 . . . . 0.0 112.949 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 44.7 m 53.67 52.17 13.69 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 117.945 0.873 . . . . 0.0 111.645 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -59.3 156.55 28.83 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 122.963 0.505 . . . . 0.0 110.349 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.15 140.64 60.52 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.179 2.586 . . . . 0.0 111.758 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 74.9 mt -114.38 153.61 29.54 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.777 0.431 . . . . 0.0 110.549 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -145.37 156.03 53.73 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.77 -5.76 17.57 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.033 2.488 . . . . 0.0 111.011 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -98.76 4.44 47.73 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.522 1.129 . . . . 0.0 111.455 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -129.01 16.6 6.22 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 122.693 0.397 . . . . 0.0 111.577 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 25.7 m -127.69 140.75 51.88 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.027 0.441 . . . . 0.0 112.018 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.9 tt -116.98 149.43 19.23 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.293 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -107.24 150.32 26.78 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 97.4 t -135.52 124.57 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 123.489 0.715 . . . . 0.0 109.278 -175.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -141.23 166.1 26.14 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 120.983 0.213 . . . . 0.0 112.585 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.6 17.79 61.35 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -170.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.0 m -72.19 154.85 92.08 Favored Pre-proline 0 CA--C 1.529 0.155 0 C-N-CA 122.965 0.506 . . . . 0.0 112.332 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.09 177.8 7.75 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.945 3.097 . . . . 0.0 108.963 169.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -66.39 -52.96 33.62 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.449 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.1 149.68 19.98 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.522 2.148 . . . . 0.0 111.069 175.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 43.1 mt -146.94 -43.54 0.18 Allowed 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 122.883 0.473 . . . . 0.0 110.964 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 52.76 102.71 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.43 1.492 . . . . 0.0 111.662 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -56.32 -24.28 42.62 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 30.9 t -63.27 -49.75 81.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 CA-C-N 117.979 0.354 . . . . 0.0 110.636 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -82.82 -21.12 34.57 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.814 -0.176 . . . . 0.0 110.773 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 40.7 tp -67.22 -37.31 83.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.68 -33.11 47.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.817 -0.135 . . . . 0.0 111.147 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.0 mmt -69.05 -37.17 78.42 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 117.873 0.306 . . . . 0.0 110.293 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.475 ' CG2' ' HA ' ' A' ' 239' ' ' LEU . 46.5 mt -69.6 -48.47 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 122.186 0.195 . . . . 0.0 110.535 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -58.94 -22.29 59.7 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.045 0.384 . . . . 0.0 111.453 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -84.18 -20.72 31.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.595 0.634 . . . . 0.0 111.546 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -89.32 -16.04 32.01 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 119.287 -0.387 . . . . 0.0 111.733 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -113.53 -18.36 11.97 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.36 0.527 . . . . 0.0 112.309 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -138.97 -30.37 0.74 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.851 0.75 . . . . 0.0 112.782 -177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.16 -177.92 18.57 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 68.99 11.66 63.81 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.586 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 15.6 t -69.09 149.11 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 118.323 1.061 . . . . 0.0 110.282 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 48.5 t -131.65 -35.3 1.29 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.163 0.185 . . . . 0.0 111.31 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -148.31 149.33 31.64 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.22 156.2 38.06 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.135 0.574 . . . . 0.0 109.803 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 169.39 -175.8 43.56 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.9 143.33 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -54.54 133.95 46.3 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.903 -0.135 . . . . 0.0 111.13 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 22.2 p -141.36 167.55 21.89 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 122.739 0.416 . . . . 0.0 110.363 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -129.34 131.51 23.69 Favored Pre-proline 0 N--CA 1.453 -0.299 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -80.19 -12.73 12.87 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.917 3.745 . . . . 0.0 113.728 -174.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -97.23 -27.06 14.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.701 0.682 . . . . 0.0 110.672 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 94.1 mt -108.75 -0.39 20.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.267 0.627 . . . . 0.0 110.534 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 46.59 48.41 14.24 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.707 1.203 . . . . 0.0 112.496 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.03 153.98 50.07 Favored Pre-proline 0 CA--C 1.53 0.182 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -176.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.85 153.92 29.71 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.78 2.32 . . . . 0.0 110.754 173.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -117.58 25.05 10.68 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.566 0.746 . . . . 0.0 110.563 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 68.01 -170.71 36.67 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 52.38 -166.51 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 117.521 0.661 . . . . 0.0 110.96 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -155.82 173.47 33.85 Favored Glycine 0 C--N 1.333 0.397 0 O-C-N 121.146 -0.972 . . . . 0.0 112.281 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -142.44 155.13 45.06 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 66.7 t -139.12 143.14 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.44 150.51 49.61 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.908 0.385 . . . . 0.0 110.197 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -125.81 152.72 45.06 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.899 -174.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 68.7 p -86.05 4.69 36.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.258 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -138.14 141.24 40.15 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.108 0.563 . . . . 0.0 110.448 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -75.13 -13.16 60.44 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.757 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -81.59 -37.48 27.59 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 20.0 m -75.58 -27.1 58.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -66.88 -51.8 51.08 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.448 -0.205 . . . . 0.0 110.448 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.0 pt -69.98 -15.67 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-N 118.002 0.365 . . . . 0.0 111.038 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.97 -23.91 35.8 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.786 0.267 . . . . 0.0 110.686 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -84.34 -31.34 24.87 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.705 0.229 . . . . 0.0 111.579 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.5 pt -98.77 24.57 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 122.621 0.368 . . . . 0.0 110.236 174.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.9 t -77.94 -17.7 56.92 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.024 0.53 . . . . 0.0 111.547 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.06 143.58 22.62 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -54.69 -32.29 59.17 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 122.716 0.406 . . . . 0.0 111.781 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -118.01 108.55 15.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.914 0.388 . . . . 0.0 110.195 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.4 m -78.03 161.3 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.599 176.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -93.55 135.77 34.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.475 ' HA ' ' CG2' ' A' ' 192' ' ' ILE . 2.7 mm? -123.3 28.03 7.26 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.795 0.331 . . . . 0.0 110.72 -175.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -76.5 147.37 37.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.643 0.377 . . . . 0.0 110.964 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -149.49 16.89 0.91 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.652 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 83.94 125.72 1.22 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -173.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 53.49 15.74 0.78 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.196 0.998 . . . . 0.0 113.128 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 73.6 mt -140.7 148.67 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.987 0.915 . . . . 0.0 109.241 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -158.8 134.42 8.73 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -144.91 166.19 25.98 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 124.492 1.117 . . . . 0.0 108.34 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.75 150.92 33.94 Favored 'General case' 0 CA--C 1.523 -0.061 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.5 p -158.97 157.13 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -82.81 145.16 29.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.088 0.555 . . . . 0.0 110.835 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.11 161.37 29.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 112.503 0.556 . . . . 0.0 112.503 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.57 159.29 25.83 Favored Pre-proline 0 N--CA 1.455 -0.176 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.911 170.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.09 135.98 73.89 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.559 2.173 . . . . 0.0 109.038 173.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -69.89 146.38 51.3 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.964 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.451 -0.382 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.922 -176.265 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.4 ppt_? . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -155.48 169.23 24.74 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.092 -171.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.6 t -89.73 19.97 4.37 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 54.13 18.94 1.92 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.578 0.751 . . . . 0.0 112.256 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -145.38 146.27 31.5 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.151 0.58 . . . . 0.0 109.866 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.36 142.05 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.208 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -90.26 139.35 30.74 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.5 m -125.72 99.04 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 122.033 0.92 . . . . 0.0 108.765 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.03 164.59 31.21 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.529 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.47 24.09 77.27 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 122.618 -0.342 . . . . 0.0 112.649 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.1 tp -60.41 128.67 88.31 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -69.72 131.02 20.42 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.886 1.724 . . . . 0.0 110.015 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -64.45 -8.48 17.15 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.735 2.957 . . . . 0.0 114.627 -176.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -88.07 -0.65 57.31 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -173.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 pp -136.67 -173.29 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.091 0 CA-C-N 118.636 0.653 . . . . 0.0 111.014 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -139.73 -166.78 2.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.541 0.736 . . . . 0.0 111.004 -175.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -45.93 -31.42 2.18 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.462 1.505 . . . . 0.0 113.213 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -65.94 -36.6 83.79 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -73.48 -38.17 65.51 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 122.095 -0.378 . . . . 0.0 110.403 -172.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.5 pt -84.05 -27.46 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 O-C-N 122.101 -0.374 . . . . 0.0 111.436 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 90.9 m -69.97 -16.41 63.19 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.14 -19.43 18.66 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.0 m -79.46 -26.68 41.68 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.902 0.774 . . . . 0.0 112.962 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -113.26 10.16 18.46 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.134 0.424 . . . . 0.0 111.743 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -68.9 -19.89 64.23 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 122.827 0.451 . . . . 0.0 111.762 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -72.18 -12.1 61.03 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.526 0.33 . . . . 0.0 111.102 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -105.2 20.5 18.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.744 0.418 . . . . 0.0 110.283 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.34 170.71 31.99 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.78 144.57 59.87 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.211 2.607 . . . . 0.0 110.425 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.61 168.33 23.86 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.862 0.363 . . . . 0.0 111.256 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.2 pt -140.53 166.49 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.46 149.73 24.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 121.147 0.498 . . . . 0.0 110.717 -176.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -147.18 163.32 36.71 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.222 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -158.62 161.75 27.85 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.555 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 32.8 Cg_endo -74.34 -9.59 21.8 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.5 2.134 . . . . 0.0 110.568 -170.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.555 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 8.2 m-70 -100.79 17.82 21.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.52 1.128 . . . . 0.0 110.98 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -50.15 146.1 5.29 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.322 0.649 . . . . 0.0 112.625 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.367 0 C-N-CA 124.495 1.118 . . . . 0.0 110.814 -177.164 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.66 0 N-CA-C 112.154 -0.379 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -141.42 145.66 35.59 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 117.799 0.799 . . . . 0.0 108.884 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.06 176.79 10.81 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.598 0.359 . . . . 0.0 110.875 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -139.54 126.97 21.5 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.5 mp -89.58 151.04 22.13 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.32 0.581 . . . . 0.0 111.524 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 mp -114.11 139.59 49.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -136.78 175.62 9.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.508 0.723 . . . . 0.0 109.946 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -115.95 -23.43 8.56 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 122.92 0.488 . . . . 0.0 111.783 -175.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -141.49 160.88 39.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.868 0.366 . . . . 0.0 111.228 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -82.14 -14.61 55.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.271 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 41.4 m -79.02 -16.96 56.14 Favored 'General case' 0 C--O 1.231 0.093 0 O-C-N 122.277 -0.265 . . . . 0.0 111.112 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 73.1 m -79.62 -42.73 24.28 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.331 -0.23 . . . . 0.0 110.599 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.96 -22.34 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -75.89 -33.63 59.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.87 -36.9 59.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 117.967 0.349 . . . . 0.0 111.086 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 pp -78.86 -14.6 59.15 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 117.993 0.36 . . . . 0.0 111.43 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.8 mt -98.76 -17.16 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 122.328 0.251 . . . . 0.0 111.43 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -100.55 -10.78 20.68 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.879 -0.513 . . . . 0.0 112.131 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -120.22 30.25 7.08 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.053 0.541 . . . . 0.0 111.719 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 23.4 p -127.55 -174.83 3.28 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.241 0.616 . . . . 0.0 111.216 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 43.2 mm -87.76 161.31 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.023 0.929 . . . . 0.0 109.074 -176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -127.14 154.25 44.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.611 0.243 . . . . 0.0 110.769 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -141.45 66.21 1.36 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.271 0.558 . . . . 0.0 110.402 176.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 52.31 9.57 0.1 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 172.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 171.11 -16.36 0.06 OUTLIER Glycine 0 CA--C 1.528 0.847 0 CA-C-N 118.59 0.632 . . . . 0.0 112.485 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -128.27 172.16 11.3 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-N 117.663 0.731 . . . . 0.0 109.726 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.8 161.63 15.25 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.343 0.257 . . . . 0.0 110.308 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.86 150.64 44.88 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.087 0.555 . . . . 0.0 109.784 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.8 tp -138.82 151.26 46.88 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 169.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 44.0 t -84.7 152.7 23.56 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -127.71 161.31 35.77 Favored 'Isoleucine or valine' 0 C--N 1.337 0.056 0 C-N-CA 122.972 0.509 . . . . 0.0 110.099 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 52.9 m -92.25 -13.94 29.68 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.3 m -142.9 65.25 15.78 Favored Pre-proline 0 CA--C 1.53 0.18 0 C-N-CA 123.073 0.549 . . . . 0.0 109.968 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -68.95 168.96 18.97 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.682 3.588 . . . . 0.0 111.849 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.4 t -84.31 160.31 20.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 174.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.9 mt 57.17 -108.49 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -148.85 132.24 16.6 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.465 0.706 . . . . 0.0 109.135 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.4 t0 41.79 78.78 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.754 1.222 . . . . 0.0 112.064 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 108.81 20.4 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 119.568 -0.253 . . . . 0.0 110.711 -174.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.59 165.31 32.91 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.399 3.4 . . . . 0.0 112.348 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.4 p -114.92 140.38 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.0 tm0? -94.94 151.89 18.81 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.483 0.713 . . . . 0.0 110.913 -174.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 32.4 mm -134.87 142.02 41.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 C-N-CA 123.408 0.683 . . . . 0.0 111.147 -177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -156.76 113.92 2.01 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 169.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -77.39 171.44 17.65 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 124.44 3.427 . . . . 0.0 112.464 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 -100.18 140.22 34.72 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -107.84 152.43 24.41 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.481 0.657 . . . . 0.0 111.663 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.7 mp -87.57 65.01 8.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.423 0.689 . . . . 0.0 110.544 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.4 t -133.76 -25.23 1.67 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.692 0.397 . . . . 0.0 111.151 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -153.81 138.3 16.8 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 67.2 m -157.79 -45.43 0.06 Allowed 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 117.907 0.321 . . . . 0.0 110.405 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -160.63 163.44 32.57 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.934 0.493 . . . . 0.0 110.617 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -157.37 160.24 38.25 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.2 m -138.69 150.39 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.559 0.744 . . . . 0.0 110.136 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 52.7 mtm -132.29 29.96 4.25 Favored 'General case' 0 C--N 1.335 -0.055 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.925 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -151.71 162.34 41.18 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -77.96 29.85 1.83 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 123.563 0.602 . . . . 0.0 112.141 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 m 57.42 52.1 9.03 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -61.92 163.51 12.86 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -47.03 128.05 13.32 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.171 2.58 . . . . 0.0 111.512 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.0 tp -136.45 136.41 39.47 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.648 0.779 . . . . 0.0 110.153 -172.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -150.95 159.99 32.9 Favored Pre-proline 0 N--CA 1.455 -0.215 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.88 -14.72 14.74 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.531 2.821 . . . . 0.0 113.151 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -79.74 -6.62 57.61 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.831 0.452 . . . . 0.0 111.286 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -126.75 23.23 6.74 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 122.744 0.417 . . . . 0.0 110.457 175.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 27.7 m -122.08 148.77 44.45 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.922 0.392 . . . . 0.0 111.075 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.27 147.86 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 123.306 0.643 . . . . 0.0 109.416 -176.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -112.32 154.34 25.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 10.9 m -140.14 146.16 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.077 0.551 . . . . 0.0 110.515 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -150.71 170.79 30.54 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.04 12.42 84.4 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.7 p -87.76 146.27 38.67 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 122.71 0.404 . . . . 0.0 111.009 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.64 161.91 7.21 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.247 2.632 . . . . 0.0 111.734 171.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -47.52 78.74 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.511 -0.757 . . . . 0.0 112.474 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.47 60.29 7.75 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.061 2.507 . . . . 0.0 111.429 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.02 -10.91 60.11 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.981 -0.449 . . . . 0.0 111.972 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.15 80.48 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.489 1.516 . . . . 0.0 112.242 172.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.39 -28.85 46.33 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -171.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.87 -44.37 88.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.068 0 CA-C-N 118.774 0.715 . . . . 0.0 110.167 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -85.86 -18.23 33.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.056 -175.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 29.9 tp -73.26 -30.31 63.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.85 -35.38 57.55 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.7 mmt -67.97 -33.5 74.77 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.417 ' CG2' ' HA ' ' A' ' 239' ' ' LEU . 34.8 mt -71.55 -46.99 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 122.613 0.365 . . . . 0.0 110.704 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -61.27 -23.18 65.49 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.31 0.505 . . . . 0.0 110.699 174.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -82.69 -18.65 40.17 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.969 -0.457 . . . . 0.0 111.272 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -93.4 -11.94 31.03 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 119.114 -0.47 . . . . 0.0 111.963 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -114.6 -20.75 10.59 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 118.673 0.669 . . . . 0.0 111.972 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -137.06 -33.6 0.75 Allowed 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.519 0.6 . . . . 0.0 112.578 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 68.08 179.1 15.97 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 70.82 13.89 72.46 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.428 -0.651 . . . . 0.0 113.133 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 22.6 t -68.78 140.66 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 118.269 1.034 . . . . 0.0 109.944 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.5 p -120.84 -30.13 4.5 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -153.39 149.37 27.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.639 0.256 . . . . 0.0 110.671 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -157.12 158.12 35.78 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.305 0.642 . . . . 0.0 109.739 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 157.41 -172.52 34.81 Favored Glycine 0 C--N 1.335 0.528 0 N-CA-C 111.974 -0.45 . . . . 0.0 111.974 177.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.01 140.15 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -53.67 106.01 0.16 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 14.4 t -152.56 146.27 25.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.238 0.542 . . . . 0.0 112.233 -175.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -152.79 135.44 9.26 Favored Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 170.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -75.89 3.09 6.37 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.022 3.148 . . . . 0.0 111.413 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -77.83 -45.73 23.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.5 pp -161.26 6.59 0.07 Allowed 'General case' 0 C--N 1.341 0.21 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -138.05 -29.77 0.82 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.463 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 34.3 m-85 54.18 -166.77 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.596 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.463 ' CD ' ' HB3' ' A' ' 213' ' ' TYR . 91.8 Cg_endo -75.19 144.35 29.52 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 CA-C-N 121.935 1.727 . . . . 0.0 112.778 -170.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -90.26 -168.76 2.2 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.583 0.753 . . . . 0.0 110.064 175.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -96.35 5.24 65.07 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -137.38 150.49 47.73 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.205 0.602 . . . . 0.0 110.85 -175.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -104.35 173.4 21.25 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.971 -173.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -148.31 153.51 38.75 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 88.7 t -138.25 148.85 24.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -136.65 156.87 47.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.422 0.63 . . . . 0.0 111.381 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -132.25 153.23 50.85 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.561 -175.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.1 p -84.63 0.48 50.04 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.956 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -132.83 141.18 48.32 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.068 0.547 . . . . 0.0 110.362 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.3 pm0 -74.41 -7.27 52.36 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.369 0.268 . . . . 0.0 111.268 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -83.52 -40.62 18.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 25.5 m -75.51 -24.98 56.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -63.91 -50.75 67.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -73.71 -11.78 14.91 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 CA-C-N 118.09 0.405 . . . . 0.0 111.144 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.43 -17.05 33.13 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.588 0.176 . . . . 0.0 111.149 174.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.76 -12.34 29.36 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 11.3 pt -120.39 23.25 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.354 0.662 . . . . 0.0 110.313 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.2 p -76.79 -19.03 58.05 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.23 0.612 . . . . 0.0 111.721 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.3 144.33 22.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -57.61 -31.61 66.4 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -122.94 110.14 15.01 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.0 m -82.36 154.89 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.205 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -84.07 138.45 33.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 173.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.417 ' HA ' ' CG2' ' A' ' 192' ' ' ILE . 3.1 mm? -120.88 36.77 4.49 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -81.63 147.29 29.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.945 0.402 . . . . 0.0 111.887 -173.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -136.48 16.33 3.16 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.27 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 85.55 -15.36 46.7 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.006 0.813 . . . . 0.0 112.523 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -140.68 1.83 1.75 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.707 0.753 . . . . 0.0 110.786 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.6 mt -141.18 153.45 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 123.751 0.82 . . . . 0.0 109.335 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -148.02 135.3 20.49 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -145.34 169.38 18.39 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 125.023 1.329 . . . . 0.0 108.415 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.15 151.65 33.46 Favored 'General case' 0 CA--C 1.523 -0.059 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 11.4 p -155.17 153.73 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -83.35 124.09 30.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.5 m -102.98 159.0 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.67 159.01 27.91 Favored Pre-proline 0 CA--C 1.528 0.113 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.665 169.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.33 142.72 94.95 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.769 2.312 . . . . 0.0 110.124 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -83.83 166.79 17.65 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.997 0.427 . . . . 0.0 110.641 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.454 -0.262 0 C-N-CA 123.282 0.633 . . . . 0.0 110.142 -170.894 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.439 ' HG3' ' H ' ' A' ' 63' ' ' TYR . 12.9 tpt180 . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.439 ' H ' ' HG3' ' A' ' 62' ' ' ARG . 15.6 m-85 -132.66 148.95 52.35 Favored 'General case' 0 N--CA 1.458 -0.044 0 CA-C-O 120.743 0.306 . . . . 0.0 111.106 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.2 m -88.41 24.86 1.81 Allowed 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.244 0.618 . . . . 0.0 111.847 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.19 28.02 6.61 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 122.867 0.467 . . . . 0.0 109.995 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -135.29 137.85 42.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.292 1.037 . . . . 0.0 110.447 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.4 p -151.39 137.96 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.732 174.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.427 ' CZ ' ' CA ' ' A' ' 70' ' ' GLY . 11.0 t80 -87.12 143.09 27.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.5 p -128.5 85.59 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 121.979 0.895 . . . . 0.0 108.96 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.427 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -80.84 165.05 47.18 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.094 -177.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.43 9.16 77.32 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 119.77 -0.461 . . . . 0.0 113.17 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.6 tp -49.47 137.08 16.9 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.0 136.57 45.24 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.959 1.773 . . . . 0.0 109.535 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.55 14.03 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 124.195 3.263 . . . . 0.0 115.593 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -140.55 32.31 1.86 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.961 0.801 . . . . 0.0 112.067 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.77 155.18 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -120.42 -178.45 3.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.443 0.697 . . . . 0.0 111.0 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -53.37 -31.48 44.9 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.753 0.821 . . . . 0.0 112.738 -175.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -78.18 -33.77 49.94 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -173.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -77.49 -24.98 50.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.867 -0.52 . . . . 0.0 110.583 -173.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.5 mt -80.53 -40.55 19.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.8 m -68.02 -8.71 39.83 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.593 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.43 -19.73 14.31 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 172.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.5 m -74.98 -26.96 59.96 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 118.856 0.753 . . . . 0.0 112.535 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -122.25 17.4 10.68 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -70.81 -17.08 62.77 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -80.62 4.94 16.96 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.044 -0.41 . . . . 0.0 111.79 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -116.66 24.87 10.98 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.566 0.346 . . . . 0.0 110.751 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.64 173.62 30.81 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.16 151.66 72.49 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.492 2.795 . . . . 0.0 110.846 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 0.6 OUTLIER -161.06 161.96 31.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.482 -170.294 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.9 pt -140.37 161.91 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.8 173.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.69 151.67 33.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -145.36 160.7 41.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.532 0.682 . . . . 0.0 112.299 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 30.3 p90 -155.75 158.77 31.86 Favored Pre-proline 0 N--CA 1.451 -0.386 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 169.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.606 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 28.5 Cg_endo -74.7 -7.98 19.93 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.447 2.765 . . . . 0.0 110.628 -169.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.606 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 75.4 m-70 -105.37 18.06 22.9 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.381 1.073 . . . . 0.0 111.182 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -50.86 155.04 1.26 Allowed 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.96 0.904 . . . . 0.0 112.387 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.279 0 C-N-CA 123.403 0.681 . . . . 0.0 111.1 -176.148 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.632 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.39 145.64 35.6 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.299 0.55 . . . . 0.0 110.625 175.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.5 -177.36 6.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.438 0.695 . . . . 0.0 109.72 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -144.21 144.23 31.43 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -97.56 146.01 25.69 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.407 0.622 . . . . 0.0 111.099 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.23 144.95 40.77 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -136.35 171.91 13.79 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.815 0.34 . . . . 0.0 111.088 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -108.39 -26.18 10.61 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.016 0.527 . . . . 0.0 109.969 -177.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -135.24 155.03 51.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.32 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -85.15 -11.34 55.29 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.069 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.4 m -81.29 -19.03 43.84 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.212 0.205 . . . . 0.0 111.235 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.3 m -76.2 -43.14 43.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.571 0.224 . . . . 0.0 110.846 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.6 p -75.74 -19.5 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -77.02 -29.03 55.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.06 -44.71 46.08 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 119.067 -0.492 . . . . 0.0 111.94 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -29.51 62.64 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 118.325 -1.35 . . . . 0.0 110.567 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.408 ' HA ' ' SG ' ' A' ' 128' ' ' CYS . 79.1 mt -78.42 -15.7 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 118.387 0.54 . . . . 0.0 111.111 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -92.09 -13.65 30.47 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.016 -0.427 . . . . 0.0 110.894 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -113.72 1.82 15.0 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.408 ' SG ' ' HA ' ' A' ' 125' ' ' ILE . 18.5 p -96.7 -176.07 3.49 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.159 0.504 . . . . 0.0 111.177 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.6 mm -81.66 155.91 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.534 1.134 . . . . 0.0 108.513 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -136.95 145.83 44.69 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.623 0.249 . . . . 0.0 110.375 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.99 176.18 9.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -57.66 -1.89 0.12 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -169.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -159.2 0.16 0.08 OUTLIER Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.415 1.007 . . . . 0.0 114.73 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -163.91 174.03 11.97 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.121 1.46 . . . . 0.0 111.6 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -117.68 161.75 19.16 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.884 0.874 . . . . 0.0 109.706 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.407 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 83.2 m-85 -144.63 158.22 43.86 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 176.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.4 tp -125.3 145.57 49.95 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 168.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 80.3 m -100.16 119.29 38.11 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.001 -0.437 . . . . 0.0 110.653 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.9 m -148.2 159.49 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.597 0.759 . . . . 0.0 110.17 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.2 p -91.11 160.38 15.6 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 97.0 p -150.58 163.78 22.8 Favored Pre-proline 0 N--CA 1.454 -0.265 0 O-C-N 122.112 -0.367 . . . . 0.0 111.895 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -66.35 -10.06 26.17 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.213 2.609 . . . . 0.0 112.641 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 54.8 m -93.59 -45.46 7.72 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.099 0.56 . . . . 0.0 110.741 -176.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.42 HG13 ' HE3' ' A' ' 147' ' ' LYS . 5.1 mm -135.51 158.21 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 C-N-CA 123.446 0.698 . . . . 0.0 109.22 -173.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -62.11 -24.31 67.06 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.974 -0.454 . . . . 0.0 109.971 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -157.35 141.05 15.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.244 1.018 . . . . 0.0 108.882 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.42 ' HE3' HG13 ' A' ' 144' ' ' ILE . 5.3 tppp? -132.46 115.51 14.86 Favored Pre-proline 0 N--CA 1.455 -0.182 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.407 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 89.7 Cg_endo -74.33 96.52 0.97 Allowed 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.409 2.073 . . . . 0.0 106.814 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.0 p -78.04 132.22 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -85.1 153.18 22.86 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.062 0.545 . . . . 0.0 110.67 -173.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.4 mm -136.98 143.35 35.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 123.505 0.722 . . . . 0.0 110.262 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 54.3 ttp85 -154.06 113.0 2.5 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 169.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.46 172.82 15.36 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.42 3.413 . . . . 0.0 112.655 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 19.7 t-105 -122.41 140.27 52.89 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.092 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -125.93 168.76 13.45 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.358 0.599 . . . . 0.0 111.021 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.438 ' N ' ' CD1' ' A' ' 156' ' ' LEU . 4.7 mp -104.59 99.01 8.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.373 -169.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.2 t -156.76 -32.97 0.08 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.999 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -138.86 26.25 2.5 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.7 m -70.14 -26.53 63.99 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -153.65 160.05 42.26 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.962 0.505 . . . . 0.0 110.941 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -154.69 162.34 41.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.455 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 1.6 p -154.04 147.46 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 122.63 0.372 . . . . 0.0 110.916 -175.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 66.2 mtm -140.79 22.51 2.29 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -147.21 13.07 1.09 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.947 0.794 . . . . 0.0 112.762 -174.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 83.33 23.05 55.56 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 121.77 -0.581 . . . . 0.0 112.848 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 31.6 m 56.91 44.14 23.59 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -65.71 159.31 69.61 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.72 147.31 31.91 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.725 2.95 . . . . 0.0 112.42 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 58.8 mt -118.57 161.95 19.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.481 0.713 . . . . 0.0 110.309 -176.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -149.74 140.42 14.08 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.76 -21.88 42.06 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.336 2.691 . . . . 0.0 113.777 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -83.86 -3.26 57.76 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.276 0.489 . . . . 0.0 110.826 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.88 22.4 7.43 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 122.81 0.444 . . . . 0.0 110.86 175.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.6 m -127.26 146.57 50.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.69 0.281 . . . . 0.0 110.803 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 9.7 tt -123.21 149.14 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 123.087 0.555 . . . . 0.0 110.551 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.442 ' CD1' ' HD3' ' A' ' 251' ' ' LYS . 5.4 t80 -111.28 143.74 41.57 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 172.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 8.6 m -138.99 136.71 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -145.43 171.45 26.48 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 77.86 11.18 85.67 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.6 p -67.22 146.41 98.9 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 122.728 0.411 . . . . 0.0 110.236 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.08 170.44 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.946 3.097 . . . . 0.0 112.789 173.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -55.08 -47.57 98.2 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.226 -0.892 . . . . 0.0 112.751 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.94 136.48 18.6 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.934 1.756 . . . . 0.0 110.375 173.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.669 ' CD1' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -145.7 -70.53 0.26 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 119.175 -0.441 . . . . 0.0 111.644 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.669 ' H ' ' CD1' ' A' ' 184' ' ' LEU . 81.3 mtp180 58.5 133.62 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.366 1.866 . . . . 0.0 112.912 -175.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.62 -26.3 64.36 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.557 -0.715 . . . . 0.0 110.076 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 51.1 t -68.73 -47.68 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-O 120.761 0.315 . . . . 0.0 110.662 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -81.05 -25.4 37.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.65 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 46.2 tp -71.67 -31.39 66.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.82 -34.59 45.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.284 -0.26 . . . . 0.0 111.317 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 23.3 mmt -68.99 -36.23 77.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 76.6 mt -72.45 -36.0 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.1 mmt -74.08 -14.88 61.05 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 122.09 -0.381 . . . . 0.0 110.194 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -95.19 -15.09 23.53 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 117.993 0.36 . . . . 0.0 110.978 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.31 -17.46 28.9 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.677 0.391 . . . . 0.0 111.339 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -118.12 -23.81 7.23 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 117.987 0.358 . . . . 0.0 111.215 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -139.89 45.21 1.9 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.688 0.395 . . . . 0.0 110.338 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -41.45 134.06 3.28 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.937 0.779 . . . . 0.0 112.618 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 132.07 6.77 3.07 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -175.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 46.5 t -65.59 147.39 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 123.335 0.654 . . . . 0.0 110.611 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 21.9 p -123.91 -28.84 3.74 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 119.216 -0.421 . . . . 0.0 112.121 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -154.19 154.42 33.49 Favored 'General case' 0 N--CA 1.458 -0.06 0 CA-C-N 118.626 0.648 . . . . 0.0 110.785 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.32 158.91 44.67 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.683 0.393 . . . . 0.0 110.57 175.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -177.29 177.66 48.29 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.6 mm -102.09 92.32 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.511 ' HB3' ' H ' ' A' ' 215' ' ' LYS . 27.7 t70 51.68 -58.3 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -169.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 69.3 p 46.04 71.5 0.29 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.552 0.741 . . . . 0.0 112.933 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -78.39 128.04 79.08 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.44 -6.91 20.02 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 124.294 3.329 . . . . 0.0 114.521 -174.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -73.36 -27.16 61.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.966 1.257 . . . . 0.0 111.575 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 78.0 mt -145.33 8.24 1.18 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.851 0.86 . . . . 0.0 110.592 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 54.02 50.08 17.47 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.745 0.818 . . . . 0.0 110.801 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -131.27 152.88 81.33 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 123.378 0.671 . . . . 0.0 110.228 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -84.77 140.52 8.11 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.741 2.294 . . . . 0.0 112.458 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.511 ' H ' ' HB3' ' A' ' 206' ' ' ASP . 37.4 mtmm -98.87 26.81 5.41 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 168.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.77 171.48 14.81 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 60.62 153.67 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.656 1.183 . . . . 0.0 113.746 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -88.19 160.63 30.91 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.58 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -149.55 150.28 32.01 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 60.2 t -142.49 149.93 18.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.06 148.8 50.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -123.22 153.24 40.39 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.895 -175.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 86.7 p -88.66 -0.74 57.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.637 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -130.84 144.67 51.63 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.798 0.439 . . . . 0.0 111.164 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 39.8 tp60 -74.27 -16.01 60.96 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.546 0.339 . . . . 0.0 110.195 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -85.21 -38.26 19.16 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 19.1 m -68.84 -29.65 68.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -66.98 -53.61 29.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.525 0.33 . . . . 0.0 110.944 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.6 pp -69.91 -12.26 15.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.08 0 CA-C-N 118.304 0.502 . . . . 0.0 111.686 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.79 -27.37 22.34 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.012 0.369 . . . . 0.0 111.102 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -82.92 -24.68 32.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.7 pt -108.67 27.22 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 123.153 0.581 . . . . 0.0 110.277 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.5 t -77.82 -15.34 59.15 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.299 0.639 . . . . 0.0 112.218 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -155.35 145.0 21.27 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -57.88 -32.45 67.71 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -124.49 111.84 16.18 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 30.0 m -98.2 159.27 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.55 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -81.88 143.14 31.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.4 mp -130.41 103.95 6.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -135.83 146.61 47.68 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.151 -177.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -146.91 8.64 0.97 Allowed 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.647 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.62 -139.25 5.48 Favored Glycine 0 C--N 1.336 0.537 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -175.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.82 4.34 14.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.986 0.393 . . . . 0.0 112.041 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 76.7 mt -104.2 136.28 38.2 Favored 'Isoleucine or valine' 0 C--N 1.338 0.106 0 C-N-CA 123.185 0.594 . . . . 0.0 110.541 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . 0.427 ' CG ' HH12 ' A' ' 247' ' ' ARG . 25.4 t70 -122.78 139.88 53.52 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.044 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -144.26 160.68 40.58 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.121 0.968 . . . . 0.0 109.851 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . 0.427 HH12 ' CG ' ' A' ' 245' ' ' ASP . 0.1 OUTLIER -134.81 160.43 38.24 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.195 0.598 . . . . 0.0 109.695 178.205 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.23 151.39 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -79.98 138.54 37.09 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -122.03 152.59 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.442 ' HD3' ' CD1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -159.03 158.62 29.05 Favored Pre-proline 0 C--O 1.231 0.13 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.775 169.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.52 141.2 90.51 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.177 2.585 . . . . 0.0 110.526 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -74.72 146.99 41.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.139 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -173.707 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.131 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -148.18 155.93 41.98 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.972 0.415 . . . . 0.0 111.159 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -91.14 22.77 3.58 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.412 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 53.86 21.95 3.04 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.633 0.773 . . . . 0.0 111.755 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -136.73 135.92 38.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.805 0.842 . . . . 0.0 109.525 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.11 137.91 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.314 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CZ ' ' CA ' ' A' ' 70' ' ' GLY . 7.9 t80 -81.61 140.43 34.44 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.0 96.54 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 122.02 0.914 . . . . 0.0 108.661 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.516 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -97.73 -171.43 32.98 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.831 -177.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.78 33.08 76.38 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-O 119.43 -0.65 . . . . 0.0 111.864 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.6 mt -100.92 135.45 19.99 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 118.201 1.001 . . . . 0.0 110.649 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.472 ' HD2' HG23 ' A' ' 76' ' ' ILE . 60.1 Cg_endo -65.3 171.41 9.22 Favored 'Trans proline' 0 N--CA 1.459 -0.532 1 C-N-CA 125.577 4.185 . . . . 0.0 113.23 -178.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.62 9.32 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.463 1 C-N-CA 126.161 4.574 . . . . 0.0 116.391 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -138.66 -114.56 0.15 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.472 HG23 ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER 44.6 67.91 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 122.623 1.201 . . . . 0.0 111.738 172.012 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -70.68 -176.22 1.25 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -46.48 -33.13 3.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.89 1.676 . . . . 0.0 113.382 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -80.17 -29.74 38.77 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.187 -0.32 . . . . 0.0 111.852 -173.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -78.81 -30.64 45.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.256 -0.278 . . . . 0.0 110.758 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 61.0 mt -74.01 -40.67 52.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.6 m -65.37 -22.0 66.75 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.654 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.91 -17.97 26.99 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -79.33 -25.73 42.26 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.723 0.692 . . . . 0.0 112.03 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -122.09 18.56 10.82 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -71.75 -20.28 61.91 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -75.76 -5.95 48.26 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 122.111 -0.368 . . . . 0.0 111.93 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -108.38 21.8 16.82 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.692 0.397 . . . . 0.0 110.301 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.81 165.17 32.9 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.469 -1.053 . . . . 0.0 110.469 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.98 141.29 93.9 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.532 2.822 . . . . 0.0 112.148 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.24 167.93 26.29 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.713 0.405 . . . . 0.0 110.697 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 mt -134.19 163.92 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.7 p -126.8 150.16 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -152.15 165.91 33.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -170.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.452 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 4.7 p90 -147.32 159.81 41.07 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 169.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.574 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 79.6 Cg_endo -64.51 -18.72 63.85 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 124.133 3.222 . . . . 0.0 111.912 -168.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.574 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 3.2 p80 -118.63 21.64 12.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.008 0.923 . . . . 0.0 111.396 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.564 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -58.59 115.71 3.21 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 173.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.246 0 C-N-CA 123.09 0.556 . . . . 0.0 109.953 179.553 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.703 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.82 139.54 53.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.548 0.674 . . . . 0.0 109.907 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -157.47 -162.42 1.19 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.607 0.763 . . . . 0.0 110.177 -170.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -137.18 141.31 42.16 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 122.59 0.356 . . . . 0.0 110.133 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.3 mp -96.84 149.51 21.77 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 mp -108.32 140.7 41.21 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 173.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -135.46 170.57 15.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.901 0.381 . . . . 0.0 110.559 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -111.25 -27.15 8.81 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.839 0.456 . . . . 0.0 110.487 -175.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -137.01 155.78 49.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.477 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -79.03 -18.86 52.82 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.487 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.9 m -77.9 -18.7 55.86 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.492 0.317 . . . . 0.0 111.528 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 63.3 m -75.36 -47.11 29.14 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.823 0.344 . . . . 0.0 110.678 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.4 p -76.78 -16.83 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -74.69 -32.69 62.27 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.46 -35.92 60.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.376 -0.345 . . . . 0.0 111.455 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 pp -76.38 -22.3 54.98 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.803 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.4 mt -87.27 -17.76 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 O-C-N 122.285 -0.259 . . . . 0.0 111.335 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -103.43 -5.87 22.45 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -122.9 10.26 9.5 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.8 m -122.76 -177.16 3.57 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.655 0.382 . . . . 0.0 110.456 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 38.2 mm -75.97 161.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 124.147 0.979 . . . . 0.0 110.136 -171.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -135.42 162.46 32.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.79 0.329 . . . . 0.0 110.722 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -140.22 77.4 1.61 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.318 0.58 . . . . 0.0 110.631 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 55.42 9.66 0.4 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 157.22 -10.92 0.26 Allowed Glycine 0 CA--C 1.526 0.745 0 CA-C-N 118.568 0.622 . . . . 0.0 113.053 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -124.08 176.51 6.33 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.22 160.55 19.6 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -172.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.35 161.87 39.4 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.405 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 27.2 tp -142.13 142.21 32.73 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 168.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 46.0 t -92.19 128.24 37.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.311 0.505 . . . . 0.0 110.866 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.2 m -145.83 172.04 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.879 0.871 . . . . 0.0 110.307 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.9 p -72.9 172.25 11.24 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.018 0.527 . . . . 0.0 110.127 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.9 t -140.3 137.03 17.34 Favored Pre-proline 0 N--CA 1.457 -0.123 0 O-C-N 122.177 -0.327 . . . . 0.0 111.777 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -80.74 -6.14 13.32 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 124.309 3.339 . . . . 0.0 112.662 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.8 t -125.38 -24.12 4.0 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.936 0.789 . . . . 0.0 112.458 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.577 HG23 ' H ' ' A' ' 145' ' ' LYS . 5.0 mm -124.09 -175.85 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.577 ' H ' HG23 ' A' ' 144' ' ' ILE . 54.4 mtmt -78.59 -21.33 48.73 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.684 -0.635 . . . . 0.0 111.356 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -158.9 166.45 31.83 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.62 0.768 . . . . 0.0 109.884 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.53 ' HZ1' ' HB2' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -151.23 119.37 3.4 Favored Pre-proline 0 N--CA 1.458 -0.071 0 O-C-N 122.192 -0.317 . . . . 0.0 110.987 178.246 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -81.08 101.87 1.31 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.617 2.212 . . . . 0.0 107.847 168.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.2 p -74.2 134.66 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -92.63 150.81 20.47 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.312 0.645 . . . . 0.0 110.785 -171.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 34.5 mm -137.32 141.19 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 122.545 0.338 . . . . 0.0 111.649 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -149.44 107.83 3.34 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 122.995 0.518 . . . . 0.0 109.649 174.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.36 165.0 31.65 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.744 2.963 . . . . 0.0 112.257 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -106.9 135.67 48.05 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-O 120.44 0.162 . . . . 0.0 110.678 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -102.26 156.41 17.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.693 0.797 . . . . 0.0 112.397 -175.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.6 mp -102.98 91.51 4.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 42.8 t -156.36 -32.85 0.09 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -141.67 31.65 1.65 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.1 m -71.15 -18.26 62.51 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -153.52 159.36 42.21 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.098 0.559 . . . . 0.0 110.664 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -153.35 153.2 32.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 17.3 t -130.76 141.0 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 33.1 ttm -127.92 -3.23 5.84 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.541 0.201 . . . . 0.0 111.541 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -159.69 -58.65 0.06 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.06 6.85 10.8 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.178 -0.79 . . . . 0.0 114.113 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 51.5 p -88.72 -11.79 44.12 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.853 1.326 . . . . 0.0 112.486 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -135.68 150.76 72.83 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 118.351 0.523 . . . . 0.0 111.479 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -70.43 167.76 24.39 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.196 3.264 . . . . 0.0 111.656 -177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.3 mt -107.25 160.48 15.57 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.454 0.701 . . . . 0.0 110.762 -175.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -151.41 142.95 15.68 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.0 -22.23 54.11 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.199 2.599 . . . . 0.0 113.648 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.6 mtp-105 -83.85 -2.97 57.49 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 122.942 0.497 . . . . 0.0 111.179 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -127.99 19.06 6.57 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.75 0.42 . . . . 0.0 111.095 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 21.1 m -127.42 140.75 51.96 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.541 0.21 . . . . 0.0 110.684 -177.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 9.7 tt -110.24 150.25 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.032 0 C-N-CA 123.015 0.526 . . . . 0.0 110.158 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -112.16 144.27 41.82 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 96.6 t -136.57 132.48 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -176.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -159.01 179.62 34.51 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 112.131 -0.387 . . . . 0.0 112.131 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 79.94 10.59 85.45 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.3 p -67.85 146.24 98.26 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 123.083 0.553 . . . . 0.0 109.911 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -53.66 -58.32 1.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.053 2.502 . . . . 0.0 113.657 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 25.7 mmm-85 -151.58 -68.01 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.319 -0.848 . . . . 0.0 112.312 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -79.23 162.89 25.41 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.083 2.522 . . . . 0.0 112.135 -176.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.3 mp -136.89 -49.97 0.64 Allowed 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 122.967 0.507 . . . . 0.0 109.633 173.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 47.9 102.83 0.0 OUTLIER 'General case' 0 C--N 1.341 0.207 0 C-N-CA 126.391 1.876 . . . . 0.0 112.829 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.54 -24.42 55.98 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 78.7 t -68.66 -51.76 42.64 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 CA-C-N 118.019 0.372 . . . . 0.0 110.866 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -84.51 -21.78 30.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 121.272 -0.171 . . . . 0.0 110.809 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 57.3 tp -68.01 -33.2 74.16 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.33 -36.18 46.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.407 -0.183 . . . . 0.0 111.361 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 25.2 mmt -70.02 -36.82 75.37 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 83.2 mt -70.0 -33.16 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.1 mmt -77.7 -9.78 59.17 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.119 -0.363 . . . . 0.0 111.024 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -109.53 -2.26 17.72 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.416 0.553 . . . . 0.0 112.448 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -108.08 -17.0 14.15 Favored 'General case' 0 C--N 1.34 0.193 0 O-C-N 121.969 -0.457 . . . . 0.0 111.454 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.47 -17.89 11.63 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.922 0.328 . . . . 0.0 110.554 175.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -142.69 40.39 1.55 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.188 0.595 . . . . 0.0 109.997 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -40.17 134.96 2.13 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.547 1.07 . . . . 0.0 113.502 -174.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 137.67 14.23 0.8 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.472 0.558 . . . . 0.0 112.046 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 42.4 t -73.73 149.2 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.244 1.022 . . . . 0.0 111.364 -176.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 25.7 p -124.85 -27.56 3.6 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.576 0.35 . . . . 0.0 111.014 175.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -155.15 156.82 36.43 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.655 0.264 . . . . 0.0 110.739 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -154.22 157.87 39.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.276 0.63 . . . . 0.0 109.977 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.43 -178.53 48.32 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.1 mm -95.35 143.51 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -59.67 122.71 14.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 16.9 p -141.73 163.41 32.99 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.119 0.485 . . . . 0.0 110.806 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -132.07 128.05 21.27 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 123.58 0.752 . . . . 0.0 109.16 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -80.31 -6.4 13.78 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 124.576 3.518 . . . . 0.0 113.196 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -92.79 -58.36 2.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.819 0.736 . . . . 0.0 111.459 -173.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -160.78 -5.06 0.05 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -96.24 -15.44 22.0 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 119.722 1.146 . . . . 0.0 113.117 -174.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.497 ' CB ' ' CD ' ' A' ' 214' ' ' PRO . 55.6 m-85 50.98 -146.89 0.01 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 117.219 -1.372 . . . . 0.0 110.044 177.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 213' ' ' TYR . 89.4 Cg_endo -72.06 150.33 54.07 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 CA-C-N 123.178 2.171 . . . . 0.0 112.405 -173.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -105.81 13.85 28.99 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.7 0.8 . . . . 0.0 112.158 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 68.15 14.54 66.29 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.615 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -133.07 154.66 50.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 117.908 0.854 . . . . 0.0 109.867 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -100.7 162.28 18.63 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 121.064 0.258 . . . . 0.0 112.537 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -151.04 146.64 26.33 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 94.9 t -141.44 145.82 24.18 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.059 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.98 142.62 51.0 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 110.86 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -118.76 156.54 29.2 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.638 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.7 m -84.19 -5.63 59.28 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.209 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -130.02 148.27 51.86 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.073 0.397 . . . . 0.0 111.919 -172.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -74.98 -15.45 60.66 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -84.98 -37.89 19.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 18.6 m -73.07 -28.04 62.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -67.91 -54.62 17.38 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.444 0.298 . . . . 0.0 110.531 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.1 pt -69.58 -14.84 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 CA-C-N 118.108 0.413 . . . . 0.0 111.345 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.66 -28.06 28.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.833 0.288 . . . . 0.0 110.794 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -82.89 -27.2 30.86 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.858 0.299 . . . . 0.0 111.759 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.2 pt -105.77 29.07 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.127 0.571 . . . . 0.0 110.181 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 21.9 t -78.38 -11.06 59.92 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.085 0.554 . . . . 0.0 111.925 -176.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -158.06 145.29 18.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -59.05 -29.91 67.65 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 122.416 0.287 . . . . 0.0 111.139 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -123.19 118.79 28.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.8 m -107.52 156.55 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.006 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -81.5 144.3 31.44 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.989 0.423 . . . . 0.0 110.275 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.99 105.86 7.67 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -133.25 147.42 51.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.216 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -144.62 11.87 1.47 Allowed 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.168 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.95 -140.16 5.91 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -175.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.65 14.8 1.94 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.961 0.504 . . . . 0.0 111.984 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 73.5 mt -116.57 141.42 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 123.619 0.768 . . . . 0.0 110.582 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -129.54 146.62 51.34 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.978 0.418 . . . . 0.0 111.548 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -144.39 163.99 32.15 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 124.582 1.153 . . . . 0.0 109.137 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.08 153.87 50.46 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.367 0.667 . . . . 0.0 109.709 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 12.1 p -154.53 157.87 4.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -85.11 138.47 32.38 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.476 -0.14 . . . . 0.0 110.757 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -121.28 159.75 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.06 0 CA-C-O 120.795 0.331 . . . . 0.0 111.527 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.41 159.9 26.12 Favored Pre-proline 0 N--CA 1.455 -0.187 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 171.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.3 131.69 46.43 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.726 2.284 . . . . 0.0 108.217 171.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -73.42 112.22 9.29 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.526 -173.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 CA--C 1.534 0.34 0 C-N-CA 125.534 1.534 . . . . 0.0 112.769 175.007 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -154.14 157.36 38.77 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 122.57 0.348 . . . . 0.0 110.823 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.8 t -94.25 -179.25 4.87 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.377 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.517 ' HA ' ' CE2' ' A' ' 115' ' ' PHE . 95.1 mtt180 -90.99 27.36 1.85 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.592 0.757 . . . . 0.0 111.305 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.561 ' HE2' ' CD1' ' A' ' 154' ' ' TRP . 16.5 pttm -146.93 141.78 26.87 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.02 0.928 . . . . 0.0 111.154 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 p -148.81 148.16 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.245 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.416 ' CZ ' ' CA ' ' A' ' 70' ' ' GLY . 6.4 t80 -100.57 143.08 31.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 171.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.7 m -127.31 103.7 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.927 0.87 . . . . 0.0 108.853 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.416 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -93.77 -164.03 36.59 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.13 13.82 29.52 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 119.461 -0.633 . . . . 0.0 112.708 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.0 mt -79.67 146.06 64.12 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 118.72 1.26 . . . . 0.0 109.676 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.492 ' HB3' ' HZ1' ' A' ' 147' ' ' LYS . 97.2 Cg_endo -76.68 161.23 34.02 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 124.355 3.37 . . . . 0.0 110.375 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -62.84 -11.61 25.08 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.777 2.985 . . . . 0.0 113.222 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -95.85 -39.47 9.81 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.4 mt -54.34 145.28 4.51 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 CA-C-O 121.735 0.779 . . . . 0.0 112.155 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -146.28 -170.45 3.5 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.768 1.227 . . . . 0.0 109.324 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -51.64 -27.0 10.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.604 0.762 . . . . 0.0 112.663 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -76.92 -45.02 29.35 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.721 -0.612 . . . . 0.0 111.446 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -78.4 -26.32 46.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.18 -173.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 84.6 mt -74.62 -47.27 39.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 87.4 m -67.94 -12.84 61.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.006 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.25 -15.11 20.97 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.6 m -82.38 -29.13 31.06 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.957 0.799 . . . . 0.0 112.032 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -118.46 14.64 13.73 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -66.32 -20.83 66.2 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.06 -0.4 . . . . 0.0 111.808 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -73.6 -5.1 38.26 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.512 0.325 . . . . 0.0 111.805 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -112.12 20.47 16.82 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.642 0.377 . . . . 0.0 111.083 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.23 176.2 25.35 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.92 154.29 67.25 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.677 2.918 . . . . 0.0 110.869 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.424 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 0.7 OUTLIER -164.54 162.09 21.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.187 -170.202 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.2 pt -140.91 167.59 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.276 173.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.7 p -134.69 155.54 38.74 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -150.32 165.29 33.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.992 0.425 . . . . 0.0 111.651 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.402 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 41.4 p90 -159.83 162.8 24.12 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 172.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.513 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 26.0 Cg_endo -75.51 -15.53 19.61 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.198 1.932 . . . . 0.0 110.513 -168.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.513 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 24.4 m-70 -91.41 2.17 56.6 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.653 0.781 . . . . 0.0 110.872 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -63.33 149.02 46.74 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 122.966 0.507 . . . . 0.0 110.765 -176.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.346 0 C-N-CA 123.707 0.803 . . . . 0.0 109.943 -178.715 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.918 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.472 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.28 138.47 58.54 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.269 1.534 . . . . 0.0 110.854 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -156.53 -170.24 3.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.85 -169.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -130.36 129.94 43.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.167 0.587 . . . . 0.0 109.49 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.7 mp -86.79 142.98 27.72 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.744 0.783 . . . . 0.0 111.816 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.57 138.08 51.09 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 113.262 -1.79 . . . . 0.0 107.106 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.517 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 29.3 p90 -159.83 166.0 31.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.64 -20.51 5.95 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -174.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -79.07 -14.11 59.35 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -169.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 52.95 14.48 0.46 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.4 m -128.38 -12.47 5.03 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.211 0.605 . . . . 0.0 110.956 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.2 t -69.23 -34.69 75.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.407 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 30.7 m -71.73 -26.23 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-N 116.857 -0.156 . . . . 0.0 111.007 177.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -70.63 -40.55 73.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -77.65 -32.41 53.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -82.56 -12.57 57.64 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 119.003 0.819 . . . . 0.0 111.587 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.4 mt -101.09 -19.81 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 O-C-N 122.174 -0.329 . . . . 0.0 110.745 178.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -101.84 -10.31 19.99 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -117.98 5.58 12.12 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 53.8 m -119.79 -159.92 0.8 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 75.5 mt -79.48 145.81 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.046 0.538 . . . . 0.0 109.756 -172.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -140.18 137.26 34.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -152.65 -175.61 5.37 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.077 0.465 . . . . 0.0 111.573 178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -61.18 108.72 0.95 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.581 0.705 . . . . 0.0 111.444 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.44 -3.69 66.7 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.009 -0.996 . . . . 0.0 115.051 171.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -156.54 166.9 32.09 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.962 1.381 . . . . 0.0 111.829 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 28.6 mt -129.46 160.49 32.99 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 124.324 1.05 . . . . 0.0 109.151 -174.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 149' ' ' VAL . 75.4 m-85 -147.87 170.28 17.99 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 177.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.411 HD12 ' H ' ' A' ' 138' ' ' CYS . 43.6 tp -146.31 147.06 30.97 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.397 -1.274 . . . . 0.0 107.695 170.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . 0.411 ' H ' HD12 ' A' ' 137' ' ' LEU . 70.9 m -84.29 138.38 32.95 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.983 0.421 . . . . 0.0 112.105 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.3 p -160.74 149.25 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.817 1.247 . . . . 0.0 107.986 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.7 t -122.29 144.7 48.84 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 118.249 0.477 . . . . 0.0 111.304 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.6 m -152.55 167.7 12.8 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.292 0.637 . . . . 0.0 110.945 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -59.12 24.57 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.71 1 C-N-CA 126.097 4.531 . . . . 0.0 117.604 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.7 m -117.38 -28.28 6.16 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 119.82 1.191 . . . . 0.0 109.843 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.431 HG12 ' HE3' ' A' ' 147' ' ' LYS . 0.5 OUTLIER -165.32 166.52 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.321 1.049 . . . . 0.0 110.455 -171.522 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -84.42 101.78 12.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 170.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.0 t70 61.44 144.83 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.268 1.427 . . . . 0.0 113.523 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.492 ' HZ1' ' HB3' ' A' ' 73' ' ' PRO . 27.6 ttmt -152.95 116.13 2.81 Favored Pre-proline 0 N--CA 1.455 -0.181 0 C-N-CA 124.232 1.013 . . . . 0.0 109.204 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.41 ' CB ' ' CD2' ' A' ' 136' ' ' TYR . 76.6 Cg_exo -54.94 125.08 17.96 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 124.416 3.411 . . . . 0.0 113.229 174.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 38.3 t -73.42 140.53 17.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 170.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.47 82.65 2.5 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.748 1.158 . . . . 0.0 110.284 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.9 mm -69.92 139.58 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.732 0.813 . . . . 0.0 112.313 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -155.14 105.28 2.25 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.834 172.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.56 164.97 29.75 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 124.123 3.216 . . . . 0.0 112.213 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.561 ' CD1' ' HE2' ' A' ' 66' ' ' LYS . 69.9 t-105 -86.16 145.75 26.87 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 175.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -105.83 152.25 23.48 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.108 0.48 . . . . 0.0 111.126 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.17 36.01 0.81 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.704 0.802 . . . . 0.0 111.715 -175.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.5 t -101.47 -30.5 11.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.097 -0.377 . . . . 0.0 110.771 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -159.93 144.92 15.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.9 m -152.4 -29.99 0.15 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.248 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -153.47 154.87 35.22 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.005 0.922 . . . . 0.0 109.431 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -157.1 155.57 31.3 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.603 0.24 . . . . 0.0 110.501 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.4 p -153.38 148.56 13.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -109.52 13.52 23.94 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -160.34 -47.56 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.532 0.606 . . . . 0.0 111.054 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.52 6.97 59.97 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.364 -0.686 . . . . 0.0 113.42 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.8 t -138.38 -2.6 1.79 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.285 1.043 . . . . 0.0 113.739 -177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -73.72 154.84 89.31 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 118.988 0.813 . . . . 0.0 109.958 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -53.79 140.93 66.93 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.239 2.626 . . . . 0.0 110.366 173.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 39.6 tp -150.25 135.29 17.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.535 0.207 . . . . 0.0 110.801 -175.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -148.68 155.36 41.5 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.089 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -65.31 -21.39 61.48 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.408 2.739 . . . . 0.0 111.897 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -85.27 3.86 37.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.89 0.876 . . . . 0.0 111.907 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -120.13 23.7 10.84 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.015 0.526 . . . . 0.0 109.715 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 17.0 m -117.17 146.38 43.24 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.016 0.436 . . . . 0.0 111.691 -173.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.4 tt -119.69 147.64 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.294 0.638 . . . . 0.0 109.735 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.405 ' HB2' ' CD1' ' A' ' 253' ' ' TYR . 6.3 t80 -105.24 136.5 44.65 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 99.5 t -130.9 113.31 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -141.91 -179.75 19.2 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 112.34 -0.304 . . . . 0.0 112.34 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.0 12.94 62.96 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -174.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.54 153.91 94.72 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -64.61 -68.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.027 2.485 . . . . 0.0 110.609 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.413 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 94.7 mtt-85 -146.59 -60.27 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.127 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' A' ' 182' ' ' ARG . 44.0 Cg_endo -80.09 162.28 23.25 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.904 2.403 . . . . 0.0 111.293 174.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -159.49 -26.94 0.07 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.403 0.681 . . . . 0.0 110.87 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 51.87 115.49 0.0 OUTLIER 'General case' 0 C--N 1.342 0.251 0 C-N-CA 127.686 2.394 . . . . 0.0 114.475 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.74 -29.18 69.95 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.6 t -69.73 -49.61 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-N 117.902 0.319 . . . . 0.0 111.043 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -80.84 -21.72 40.52 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 122.345 -0.222 . . . . 0.0 110.929 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 33.7 tp -70.11 -33.61 72.07 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -77.21 -35.25 55.78 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.4 mmt -69.17 -35.31 76.16 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 66.1 mt -69.75 -34.08 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.2 mmt -74.13 -17.42 60.93 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.859 -0.526 . . . . 0.0 111.009 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -90.5 -17.42 27.1 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.062 0.392 . . . . 0.0 111.965 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -100.37 -28.3 13.02 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 118.719 0.691 . . . . 0.0 112.777 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.37 -9.17 23.84 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.62 0.646 . . . . 0.0 111.592 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -141.7 -44.59 0.35 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.03 0.377 . . . . 0.0 111.102 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 70.3 162.11 3.85 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 86.55 13.17 68.17 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 222' ' ' PHE . 10.7 p -88.46 164.61 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.164 0.986 . . . . 0.0 109.3 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 41.7 t -139.84 -62.16 0.52 Allowed 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.067 -0.395 . . . . 0.0 111.356 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -108.32 151.07 26.48 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.128 0.49 . . . . 0.0 112.24 -172.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -152.36 163.64 39.07 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.434 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 175.04 -179.06 46.56 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 41.3 mm -92.34 138.08 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -59.22 118.57 6.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 24.9 p -144.73 153.59 41.85 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -116.95 130.32 24.68 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -78.68 -11.51 15.43 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 124.529 3.486 . . . . 0.0 112.393 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -101.32 -9.91 20.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.645 0.378 . . . . 0.0 111.335 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -118.23 -3.59 11.02 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.557 0.743 . . . . 0.0 109.477 171.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 49.35 36.64 10.03 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.924 0.89 . . . . 0.0 112.377 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.21 162.16 51.44 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -90.66 -179.07 1.52 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 124.502 3.468 . . . . 0.0 111.388 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -121.97 7.43 9.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.263 0.625 . . . . 0.0 111.339 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.01 13.48 66.77 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.92 -0.378 . . . . 0.0 112.851 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -146.54 164.54 32.24 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.503 0.651 . . . . 0.0 110.241 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -103.11 165.14 15.89 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 121.003 0.224 . . . . 0.0 112.941 -174.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -145.6 145.86 31.14 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 94.7 t -138.72 147.32 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.11 145.19 51.23 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.251 0.548 . . . . 0.0 111.344 -177.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 200' ' ' VAL . 9.9 m-85 -120.07 161.95 20.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.369 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 92.0 p -98.48 8.59 44.68 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -131.02 140.45 50.1 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.831 0.453 . . . . 0.0 110.213 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -75.06 -19.03 60.18 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -80.61 -38.21 29.73 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 25.1 m -75.77 -25.38 56.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -67.36 -50.34 60.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -73.66 -11.12 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-N 117.969 0.349 . . . . 0.0 111.176 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.63 -21.26 25.41 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 119.722 -0.18 . . . . 0.0 110.808 174.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -87.5 -27.3 22.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.965 0.348 . . . . 0.0 111.868 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 8.4 pt -105.38 28.75 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.162 0.585 . . . . 0.0 110.262 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.2 p -74.99 -17.0 60.6 Favored 'General case' 0 C--N 1.334 -0.079 0 C-N-CA 123.406 0.682 . . . . 0.0 112.112 -176.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -156.96 145.01 19.35 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -176.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -59.72 -30.56 68.9 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 122.406 0.282 . . . . 0.0 111.324 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -122.61 121.73 37.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 29.6 m -111.93 160.54 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.412 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -86.76 144.94 26.84 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.971 0.415 . . . . 0.0 110.138 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.4 mp -132.86 104.07 6.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -130.64 149.69 52.18 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.193 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -146.9 20.41 1.27 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.149 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.61 129.46 2.96 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -173.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 53.89 16.7 1.13 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.28 1.032 . . . . 0.0 113.121 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 76.2 mt -139.99 146.22 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.789 0.836 . . . . 0.0 109.601 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -156.32 129.61 8.12 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -148.55 162.27 39.99 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.493 0.717 . . . . 0.0 110.981 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.84 155.93 43.34 Favored 'General case' 0 C--N 1.338 0.068 0 C-N-CA 124.001 0.92 . . . . 0.0 109.388 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.4 p -156.8 156.72 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -86.06 138.76 31.71 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.19 158.94 32.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.103 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.63 161.86 24.13 Favored Pre-proline 0 N--CA 1.455 -0.197 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.338 169.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.93 132.63 50.82 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.589 2.193 . . . . 0.0 108.861 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . 0.405 ' CD1' ' HB2' ' A' ' 176' ' ' PHE . 3.2 t80 -78.11 167.49 21.34 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.242 -177.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.456 -0.17 0 C-N-CA 123.748 0.819 . . . . 0.0 111.106 -172.098 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.072 0 CA-C-O 121.075 0.465 . . . . 0.0 111.698 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -154.6 164.33 38.88 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.369 -174.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.9 t -96.0 165.51 12.22 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.584 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.89 11.01 2.88 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -123.33 139.79 53.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 p -155.59 151.08 10.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.79 -172.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -96.79 142.12 29.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 174.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 m -131.85 130.75 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.63 151.67 18.62 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 112.052 -0.419 . . . . 0.0 112.052 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.48 19.51 37.96 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.654 -0.526 . . . . 0.0 113.029 176.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 pp -80.93 153.3 72.49 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 118.556 1.178 . . . . 0.0 109.114 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.58 144.76 17.92 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.076 2.517 . . . . 0.0 112.46 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -80.55 -4.65 13.05 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 124.057 3.172 . . . . 0.0 111.461 174.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -73.79 -6.3 46.13 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -176.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 pp -141.68 -169.45 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -132.32 -170.62 2.46 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.918 0.487 . . . . 0.0 111.445 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -46.46 -30.3 2.12 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.461 1.504 . . . . 0.0 113.003 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.19 -34.23 77.08 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.399 0.545 . . . . 0.0 112.267 -176.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -80.26 -40.68 26.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.068 -0.395 . . . . 0.0 110.308 -174.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.7 pp -76.75 -23.76 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.366 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 78.3 m -70.84 -30.79 67.3 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.79 -16.95 60.03 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.056 -0.402 . . . . 0.0 110.8 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.7 m -86.28 -24.22 26.03 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -117.88 -18.18 9.59 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -176.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -68.26 -8.92 43.61 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.283 0.947 . . . . 0.0 112.176 -174.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -67.48 -6.7 20.75 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.983 -0.448 . . . . 0.0 111.617 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -111.98 -1.26 15.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.59 0.356 . . . . 0.0 111.545 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.41 165.73 11.43 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -68.17 137.31 40.14 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.368 2.712 . . . . 0.0 110.006 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 pp -160.09 174.47 14.25 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.833 -174.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.17 174.7 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.087 178.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.63 159.41 43.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 CA-C-O 120.777 0.322 . . . . 0.0 111.019 -177.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -150.87 160.62 43.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.41 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.416 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 38.8 p90 -160.23 159.24 26.59 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.613 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 17.5 Cg_endo -75.97 -8.76 19.15 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.119 2.546 . . . . 0.0 109.71 -169.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.613 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 23.3 m-70 -102.08 11.42 38.41 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.472 1.109 . . . . 0.0 111.614 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -53.51 159.05 1.58 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 123.95 0.9 . . . . 0.0 113.11 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 124.086 0.955 . . . . 0.0 110.212 -178.419 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.684 0 CA-C-O 119.748 -0.473 . . . . 0.0 113.026 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.59 147.36 34.27 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.035 0.918 . . . . 0.0 109.717 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.6 -177.26 6.24 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.077 0.551 . . . . 0.0 110.44 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -133.6 129.62 37.21 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mp -92.16 145.62 24.36 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.568 0.699 . . . . 0.0 111.997 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -115.21 136.2 53.36 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -128.51 177.91 6.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.442 0.697 . . . . 0.0 110.881 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -115.79 -32.28 5.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.079 0.552 . . . . 0.0 110.249 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -130.85 155.07 47.34 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.154 0.502 . . . . 0.0 111.523 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -81.52 -14.23 57.16 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.671 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.0 m -79.53 -14.9 58.55 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.173 -0.329 . . . . 0.0 111.034 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 52.8 m -79.93 -39.55 30.06 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.324 -0.235 . . . . 0.0 111.022 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.83 -19.3 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -79.71 -33.12 41.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.8 -34.57 57.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.072 0.396 . . . . 0.0 111.114 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.0 pp -79.86 -19.92 47.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.425 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 54.0 mt -92.66 -20.98 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 117.904 0.32 . . . . 0.0 111.328 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -95.43 -14.78 23.49 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.825 -0.547 . . . . 0.0 111.922 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -111.07 26.35 10.8 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.157 0.583 . . . . 0.0 111.418 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 16.7 p -130.73 -173.89 3.21 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.985 0.421 . . . . 0.0 111.771 -176.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.0 mp -86.49 155.54 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -128.78 152.45 48.44 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -139.6 67.6 1.38 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.405 0.621 . . . . 0.0 110.411 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 51.88 14.74 0.33 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 172.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 163.49 -14.16 0.1 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-N 118.671 0.669 . . . . 0.0 112.807 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -131.58 169.63 15.85 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 117.597 0.698 . . . . 0.0 109.319 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.71 162.74 14.15 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.401 0.143 . . . . 0.0 110.879 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.447 ' CE1' ' HG2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -143.31 136.96 28.46 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.3 mp -125.08 132.51 53.14 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 25.0 p -81.51 131.77 35.29 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.944 0.402 . . . . 0.0 112.036 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.0 m -153.25 173.58 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.298 1.439 . . . . 0.0 108.23 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.9 t -146.25 132.65 19.63 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.956 -0.465 . . . . 0.0 111.963 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.451 ' H ' ' HB ' ' A' ' 144' ' ' ILE . 15.1 m -158.65 172.69 5.81 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 125.996 1.718 . . . . 0.0 107.969 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.413 ' CD ' ' HB3' ' A' ' 141' ' ' SER . 62.2 Cg_exo -53.71 -40.31 80.26 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.623 2.882 . . . . 0.0 115.7 -172.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.8 m -91.82 -13.32 31.62 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.053 0.842 . . . . 0.0 110.816 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.492 ' CD1' ' HE3' ' A' ' 147' ' ' LYS . 37.5 mm -86.79 -37.6 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 122.769 0.428 . . . . 0.0 110.661 -171.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 59.0 mttm 46.07 51.6 10.82 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.613 0.365 . . . . 0.0 111.537 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 64.31 17.61 10.84 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.492 ' HE3' ' CD1' ' A' ' 144' ' ' ILE . 18.4 pttp -82.56 154.47 68.59 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 119.206 0.912 . . . . 0.0 109.749 174.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.447 ' HG2' ' CE1' ' A' ' 136' ' ' TYR . 90.0 Cg_endo -76.97 161.4 32.99 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.91 2.407 . . . . 0.0 112.625 172.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.6 m -114.7 151.45 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -98.13 149.96 21.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -169.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.3 mm -131.64 146.82 32.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 124.762 1.225 . . . . 0.0 110.612 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 60.4 ttp85 -158.1 101.59 1.75 Allowed Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 122.653 0.381 . . . . 0.0 110.275 172.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.58 170.79 5.13 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 124.594 3.529 . . . . 0.0 114.334 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -95.3 159.73 14.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.499 175.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -102.03 158.67 15.99 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.036 0.534 . . . . 0.0 112.013 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.3 mp -108.15 36.4 2.8 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.688 0.795 . . . . 0.0 111.562 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.6 t -137.15 -24.53 1.09 Allowed 'General case' 0 C--N 1.34 0.158 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -174.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -136.26 35.98 2.76 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.649 1.113 . . . . 0.0 113.53 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.6 m -74.02 -23.64 59.45 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.951 -0.468 . . . . 0.0 112.198 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -155.35 161.73 40.99 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 117.98 0.354 . . . . 0.0 111.395 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -155.72 153.62 30.22 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.021 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.4 m -140.3 155.91 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 121.249 0.547 . . . . 0.0 112.001 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 70.5 mtm -137.53 27.57 2.78 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.244 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 166' ' ' SER . 24.0 t70 -155.0 171.66 19.38 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -73.27 24.74 0.88 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 123.509 0.576 . . . . 0.0 112.411 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 164' ' ' ASP . 31.6 m 56.07 46.93 20.72 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 117.451 0.626 . . . . 0.0 112.431 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -61.1 157.79 39.91 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -53.31 148.76 31.58 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.776 2.984 . . . . 0.0 112.684 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 53.9 mt -118.06 163.34 16.76 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.623 0.769 . . . . 0.0 110.049 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -148.7 141.44 15.27 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.49 -22.01 48.73 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.438 2.759 . . . . 0.0 114.164 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -89.21 5.24 45.68 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.302 0.501 . . . . 0.0 110.948 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -130.06 18.42 5.52 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.877 0.471 . . . . 0.0 110.618 175.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 18.8 m -127.83 143.05 51.13 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.727 0.299 . . . . 0.0 110.851 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.8 tt -116.89 149.71 19.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 123.152 0.581 . . . . 0.0 110.795 -174.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.449 ' CD1' ' CE1' ' A' ' 253' ' ' TYR . 8.4 t80 -106.74 144.46 33.36 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 172.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 62.1 t -133.83 122.05 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -131.12 153.1 20.2 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.832 -0.223 . . . . 0.0 112.686 -176.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.81 39.53 4.61 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -171.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 26.9 m -118.1 54.72 1.97 Allowed Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.03 -11.63 27.44 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.71 2.273 . . . . 0.0 112.061 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.575 ' H ' ' CD ' ' A' ' 183' ' ' PRO . 0.0 OUTLIER -139.7 -37.75 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.575 ' CD ' ' H ' ' A' ' 182' ' ' ARG . 38.9 Cg_endo -83.57 22.16 0.96 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.807 2.338 . . . . 0.0 112.867 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.454 ' CD2' ' H ' ' A' ' 184' ' ' LEU . 1.6 pt? -80.61 -138.87 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.037 0.535 . . . . 0.0 112.062 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.415 ' H ' ' HG ' ' A' ' 184' ' ' LEU . 45.3 ttm-85 71.2 126.42 0.03 OUTLIER 'General case' 0 C--N 1.338 0.103 0 C-N-CA 125.881 1.672 . . . . 0.0 110.551 -172.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.57 -28.5 69.68 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 64.2 t -68.7 -48.07 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 CA-C-N 117.921 0.328 . . . . 0.0 110.757 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -77.96 -31.12 50.68 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 58.6 tp -73.14 -33.87 65.77 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.401 0.28 . . . . 0.0 110.37 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.27 -37.36 60.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.078 -0.389 . . . . 0.0 111.413 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 26.2 mmt -69.4 -40.59 77.27 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.5 mt -65.15 -36.95 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.2 mmt -73.05 -18.89 61.28 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.109 -0.37 . . . . 0.0 111.219 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -93.08 -13.52 28.45 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.436 0.562 . . . . 0.0 112.124 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -93.45 -19.66 21.06 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.392 0.542 . . . . 0.0 111.897 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.6 -19.14 10.7 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 118.273 0.488 . . . . 0.0 111.482 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -140.4 42.56 1.9 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.15 137.5 3.8 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 123.71 0.672 . . . . 0.0 112.331 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 124.85 9.81 5.09 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 58.5 t -69.61 144.78 13.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 117.47 0.635 . . . . 0.0 110.345 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 15.2 p -120.22 -32.62 4.1 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.124 0.169 . . . . 0.0 111.196 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -146.29 142.05 27.93 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -148.58 157.75 43.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 170.62 -167.27 40.43 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.43 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 43.5 mm -97.1 139.94 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -58.03 122.41 12.98 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.385 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.7 t -155.38 149.04 25.25 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -119.49 139.8 28.33 Favored Pre-proline 0 N--CA 1.455 -0.186 0 C-N-CA 122.726 0.41 . . . . 0.0 110.208 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -77.4 -8.58 17.34 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 124.223 3.282 . . . . 0.0 112.498 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.6 -22.4 62.56 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.44 0.564 . . . . 0.0 111.116 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.5 mt -140.38 5.87 2.08 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.146 0.978 . . . . 0.0 110.095 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt 49.22 40.46 18.01 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.896 1.279 . . . . 0.0 112.522 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -125.19 139.04 32.82 Favored Pre-proline 0 C--O 1.231 0.119 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.56 166.52 23.84 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 122.719 2.28 . . . . 0.0 111.383 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -120.27 24.2 10.53 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 64.5 15.89 60.01 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.605 -0.553 . . . . 0.0 114.109 170.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -131.01 161.94 30.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 117.877 0.838 . . . . 0.0 110.128 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -100.63 159.09 19.19 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 112.174 -0.37 . . . . 0.0 112.174 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -153.63 148.51 26.56 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 3.9 p -150.2 148.06 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -126.28 147.7 49.65 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.109 0.564 . . . . 0.0 110.186 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -119.41 155.29 32.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.183 -174.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 57.6 m -83.19 1.56 40.01 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.21 172.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -135.9 131.11 34.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.102 0.561 . . . . 0.0 110.192 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -73.2 -12.34 60.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.4 tp60 -76.24 -38.42 56.35 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 42.1 m -74.19 -30.29 62.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -64.3 -52.11 60.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.643 -0.217 . . . . 0.0 110.586 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.39 -14.65 17.94 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 CA-C-N 118.248 0.476 . . . . 0.0 111.355 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.39 -21.86 32.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 117.78 0.263 . . . . 0.0 110.382 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.21 -8.3 42.75 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 3.5 pt -125.16 40.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 118.781 0.718 . . . . 0.0 111.572 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 32.4 m -131.14 3.99 4.38 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -129.57 10.83 5.69 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 45.39 -89.61 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -83.64 90.34 7.26 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.8 m -81.94 140.9 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.684 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 247' ' ' ARG . 34.4 mt-30 -78.31 -12.71 60.02 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.109 0.964 . . . . 0.0 112.791 -174.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 10.3 mp 55.94 -77.13 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.947 0.899 . . . . 0.0 112.7 -175.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 58.49 132.09 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.172 1.789 . . . . 0.0 114.374 -177.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . 0.45 ' H ' HG23 ' A' ' 244' ' ' ILE . 7.4 t60 -160.83 129.17 4.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 58.79 34.74 78.94 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 64.35 17.9 11.02 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.033 1.333 . . . . 0.0 113.876 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.45 HG23 ' H ' ' A' ' 241' ' ' HIS . 3.9 tt -83.79 177.71 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 173.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -145.46 139.42 26.84 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -142.58 174.09 10.95 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 238' ' ' GLN . 0.5 OUTLIER -146.73 144.91 29.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.175 0.443 . . . . 0.0 110.631 173.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.8 p -158.91 154.6 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.31 144.51 25.25 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.357 0.263 . . . . 0.0 110.374 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 13.6 m -126.63 157.97 37.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 120.837 0.351 . . . . 0.0 111.123 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.95 162.28 24.77 Favored Pre-proline 0 N--CA 1.455 -0.225 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 173.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.57 133.38 57.64 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.733 2.289 . . . . 0.0 108.897 173.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . 0.449 ' CE1' ' CD1' ' A' ' 176' ' ' PHE . 2.0 t80 -75.5 166.88 22.91 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.927 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.456 -0.168 0 C-N-CA 123.934 0.894 . . . . 0.0 110.961 -171.169 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.485 ' HD3' ' H ' ' A' ' 63' ' ' TYR . 14.4 tpp180 . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.664 0.268 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.485 ' H ' ' HD3' ' A' ' 62' ' ' ARG . 8.1 m-85 -117.84 -173.87 2.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.396 -174.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.1 t -123.66 166.03 16.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.265 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 41.7 ptt85 -77.67 37.28 0.22 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.772 0.829 . . . . 0.0 112.096 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -138.91 135.58 34.59 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.143 0.977 . . . . 0.0 110.473 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -146.64 158.66 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.519 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -91.8 140.43 29.7 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 169.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.2 p -127.6 125.37 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.95 148.82 18.3 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 -169.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.07 108.99 0.04 OUTLIER Glycine 0 CA--C 1.524 0.646 0 C-N-CA 125.793 1.663 . . . . 0.0 114.369 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.2 mt -141.59 145.74 38.71 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 123.881 0.872 . . . . 0.0 108.675 172.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -76.78 172.65 15.82 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.702 2.935 . . . . 0.0 110.098 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.9 172.95 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.026 3.151 . . . . 0.0 113.103 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.2 t70 61.18 -91.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.2 pt -56.12 132.28 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.886 0.85 . . . . 0.0 112.121 -176.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -170.2 155.95 5.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.644 1.178 . . . . 0.0 108.003 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 61.65 -51.62 0.13 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.749 1.62 . . . . 0.0 114.046 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -80.87 -35.18 33.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.05 0.841 . . . . 0.0 111.567 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -76.02 -28.31 57.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.282 -0.261 . . . . 0.0 110.769 -174.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.6 pt -81.99 -27.17 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 O-C-N 121.978 -0.451 . . . . 0.0 110.067 173.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 94.4 m -72.8 -12.45 61.0 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.09 -19.53 16.45 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 173.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.9 m -76.78 -34.74 57.99 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.546 0.612 . . . . 0.0 111.921 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -105.41 7.07 33.04 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -65.18 -18.03 64.97 Favored 'General case' 0 CA--C 1.526 0.037 0 C-N-CA 122.767 0.427 . . . . 0.0 110.946 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -69.71 -12.21 61.45 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.362 0.665 . . . . 0.0 110.877 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -111.98 16.62 20.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.951 0.5 . . . . 0.0 109.939 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.51 163.12 30.41 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.63 148.57 63.7 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.63 2.887 . . . . 0.0 112.37 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.92 169.17 20.43 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.615 0.366 . . . . 0.0 111.048 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 pt -137.55 175.38 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.738 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.9 p -152.51 156.26 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 122.369 -0.207 . . . . 0.0 110.758 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -155.79 172.19 18.75 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.923 0.392 . . . . 0.0 111.127 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -160.14 162.65 23.76 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.471 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 68.1 Cg_endo -71.12 -16.96 31.88 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 CA-C-N 121.334 1.512 . . . . 0.0 110.468 -171.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.471 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 2.1 m-70 -88.38 1.34 54.87 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.848 0.859 . . . . 0.0 111.137 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.489 ' HE3' ' HA ' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -63.51 -29.11 70.43 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.718 0.807 . . . . 0.0 111.128 -176.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.299 0 C-N-CA 123.883 0.873 . . . . 0.0 112.894 179.292 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.105 0 CA-C-O 118.604 -1.109 . . . . 0.0 115.61 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.71 151.48 22.4 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 120.22 2.01 . . . . 0.0 108.906 174.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.68 -175.66 5.46 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.66 0.267 . . . . 0.0 110.964 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -132.19 118.57 19.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.8 tt -100.47 139.71 35.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.192 0.52 . . . . 0.0 111.515 -168.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.6 mp -119.9 153.46 35.85 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.976 -172.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -139.79 -176.26 4.51 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.359 1.064 . . . . 0.0 109.702 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -111.29 -26.66 9.04 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 122.634 0.373 . . . . 0.0 110.906 -176.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -140.63 161.71 37.11 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.5 0.32 . . . . 0.0 111.293 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -79.09 -13.41 59.77 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.424 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.5 p -75.04 -22.48 58.4 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.127 0.421 . . . . 0.0 110.523 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 57.0 m -79.25 -40.67 30.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.49 -0.131 . . . . 0.0 110.935 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.9 m -73.36 -20.21 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -72.64 -37.68 67.94 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.66 -32.48 62.25 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 119.329 -0.367 . . . . 0.0 111.735 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -82.07 -14.27 56.09 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.689 0.677 . . . . 0.0 111.933 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.6 mt -95.93 -20.9 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 122.008 -0.432 . . . . 0.0 110.258 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -101.84 -8.7 21.4 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -120.86 9.98 10.79 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 34.7 m -125.94 -178.53 4.32 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.191 0.596 . . . . 0.0 109.643 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.17 163.53 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 O-C-N 121.737 -0.602 . . . . 0.0 111.32 -170.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -143.44 157.62 44.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.541 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -146.84 173.29 12.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.76 3.94 0.32 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -171.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -148.22 -9.36 0.19 Allowed Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.016 -0.88 . . . . 0.0 114.224 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.421 ' HE2' ' CE2' ' A' ' 136' ' ' TYR . 24.8 pttm -167.14 -171.33 1.73 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.79 1.295 . . . . 0.0 110.963 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.28 170.22 10.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.077 0.951 . . . . 0.0 110.171 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.421 ' CE2' ' HE2' ' A' ' 134' ' ' LYS . 22.4 m-85 -150.64 165.05 34.56 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.992 0.425 . . . . 0.0 111.65 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.9 tp -141.37 134.61 29.43 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 167.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.2 p -78.21 141.42 38.62 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.1 m -141.05 162.77 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 122.882 0.473 . . . . 0.0 110.419 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.1 m -86.14 10.45 14.44 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.007 0.523 . . . . 0.0 110.978 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.0 t -67.08 118.87 59.81 Favored Pre-proline 0 N--CA 1.454 -0.271 0 C-N-CA 123.658 0.783 . . . . 0.0 110.478 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -79.83 113.02 2.97 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.4 2.733 . . . . 0.0 110.799 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.645 ' C ' ' H ' ' A' ' 145' ' ' LYS . 25.8 m -117.89 63.94 0.75 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.3 mp 64.38 -22.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.185 1.394 . . . . 0.0 110.889 -171.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.645 ' H ' ' C ' ' A' ' 143' ' ' THR . 39.2 ttpt -156.66 159.23 38.23 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 127.248 2.219 . . . . 0.0 106.025 169.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.58 139.83 58.48 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.68 0.673 . . . . 0.0 110.426 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -151.35 157.3 35.03 Favored Pre-proline 0 CA--C 1.529 0.153 0 C-N-CA 122.341 0.257 . . . . 0.0 111.203 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -79.41 163.29 24.69 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.808 3.005 . . . . 0.0 111.308 171.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.9 m -107.64 150.88 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.105 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -85.84 153.02 22.54 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 117.616 0.189 . . . . 0.0 111.081 -174.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.8 mm -137.63 143.27 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.802 0.841 . . . . 0.0 110.075 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -155.55 101.67 2.2 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -77.01 164.15 30.02 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.861 3.041 . . . . 0.0 112.218 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -97.99 150.01 21.83 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 46.2 p-10 -117.05 155.9 28.44 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.524 0.678 . . . . 0.0 111.955 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.3 mp -94.95 74.74 3.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.755 -175.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.2 t -141.35 -40.52 0.38 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.926 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -153.68 135.87 14.84 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.6 m -149.29 -30.15 0.25 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.252 0.221 . . . . 0.0 111.286 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -151.42 160.03 43.94 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.622 0.769 . . . . 0.0 109.815 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -149.85 158.55 44.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.5 t -130.63 138.4 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 51.6 tpp -100.34 -10.47 21.21 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -174.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -158.62 -47.39 0.06 Allowed 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.833 -0.542 . . . . 0.0 110.628 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.66 4.98 62.88 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.227 -0.763 . . . . 0.0 114.412 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.6 t -129.71 -13.8 4.16 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.726 1.263 . . . . 0.0 112.092 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -87.09 159.73 50.57 Favored Pre-proline 0 CA--C 1.533 0.294 0 O-C-N 122.066 -0.396 . . . . 0.0 110.464 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.65 163.59 6.84 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 124.278 3.318 . . . . 0.0 113.792 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.25 128.76 21.32 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -148.4 124.96 5.39 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-O 119.305 -0.379 . . . . 0.0 110.0 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -55.11 -20.17 23.08 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.617 2.878 . . . . 0.0 113.599 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -81.03 -3.25 51.18 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.123 0.419 . . . . 0.0 111.04 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -127.01 28.7 5.74 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 51.3 m -121.08 145.22 48.03 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.9 tt -115.9 149.52 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 123.085 0.554 . . . . 0.0 110.154 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.49 ' HB2' ' CD1' ' A' ' 253' ' ' TYR . 6.8 t80 -108.4 143.99 36.58 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 97.2 t -137.78 124.2 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -175.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -132.53 162.6 24.09 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 112.413 -0.275 . . . . 0.0 112.413 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.62 16.26 58.75 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -172.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.9 m -71.47 152.3 93.95 Favored Pre-proline 0 N--CA 1.456 -0.174 0 C-N-CA 122.706 0.402 . . . . 0.0 111.563 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -76.83 171.81 17.33 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 124.001 3.134 . . . . 0.0 109.965 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 48.5 tpt85 -73.51 -48.35 7.01 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -80.02 32.38 0.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.417 2.745 . . . . 0.0 112.634 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -61.37 -33.08 73.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.537 0.608 . . . . 0.0 112.319 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 54.23 122.01 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.704 2.002 . . . . 0.0 113.941 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.25 -29.06 70.17 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.777 -0.577 . . . . 0.0 111.783 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 65.7 t -68.36 -48.35 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 122.295 0.238 . . . . 0.0 111.167 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -82.89 -20.87 34.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.9 -0.137 . . . . 0.0 110.923 -174.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 42.1 tp -71.51 -33.24 69.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.45 -37.07 63.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.324 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 25.7 mmt -70.74 -34.04 71.45 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 62.4 mt -68.91 -37.31 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -71.58 -21.95 61.8 Favored 'General case' 0 N--CA 1.457 -0.106 0 O-C-N 121.856 -0.528 . . . . 0.0 110.339 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -86.7 -13.28 45.86 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 122.115 -0.366 . . . . 0.0 111.526 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -98.62 -21.21 16.58 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.36 -13.5 14.86 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.55 0.613 . . . . 0.0 111.954 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -140.44 -34.77 0.52 Allowed 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 118.673 0.67 . . . . 0.0 112.367 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.33 -178.33 18.12 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 69.6 10.96 64.67 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 119.411 -0.661 . . . . 0.0 112.899 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 22.1 t -72.77 147.02 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 118.248 1.024 . . . . 0.0 109.958 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.8 p -128.9 -24.97 2.86 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 119.625 -0.226 . . . . 0.0 111.455 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -150.46 149.98 30.71 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.007 0.367 . . . . 0.0 110.758 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -160.92 156.38 24.84 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.92 0.488 . . . . 0.0 110.332 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 158.55 -165.22 33.89 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 3.1 mp -100.65 130.58 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -56.2 114.91 2.16 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 89.6 m -143.71 157.48 44.36 Favored 'General case' 0 N--CA 1.458 -0.075 0 O-C-N 123.441 0.463 . . . . 0.0 110.279 -172.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -135.85 132.51 19.46 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.882 0.873 . . . . 0.0 108.916 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -80.86 -6.97 13.37 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 124.202 3.268 . . . . 0.0 114.558 -172.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -112.06 -41.02 4.05 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.993 1.27 . . . . 0.0 114.239 -172.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.5 pp -161.12 -15.88 0.05 OUTLIER 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -88.49 -26.51 22.02 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.759 1.163 . . . . 0.0 111.691 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.495 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 29.7 m-85 56.5 -178.7 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.83 0.852 . . . . 0.0 113.215 172.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.495 ' CD ' ' HB3' ' A' ' 213' ' ' TYR . 77.4 Cg_exo -54.26 153.16 22.81 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.026 2.484 . . . . 0.0 112.864 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 215' ' ' LYS . 34.0 ttmt -104.61 5.7 33.93 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.918 0.887 . . . . 0.0 111.169 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 66.81 10.67 55.97 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 112.19 -0.364 . . . . 0.0 112.19 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -141.39 149.2 40.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.262 0.625 . . . . 0.0 110.341 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -92.32 166.25 29.37 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.813 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -147.24 150.98 35.92 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 62.0 t -142.19 142.01 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.88 145.72 48.92 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -123.52 151.98 42.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.638 -176.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 54.4 m -84.25 2.8 38.3 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.075 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -137.82 138.13 38.86 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.955 0.502 . . . . 0.0 110.082 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -74.4 -14.9 60.92 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.4 tp60 -76.82 -38.44 53.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 31.7 m -75.16 -26.48 59.13 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -67.44 -50.33 59.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 119.545 -0.265 . . . . 0.0 110.37 176.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -72.32 -12.66 15.99 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 CA-C-N 118.163 0.438 . . . . 0.0 111.158 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.07 -23.55 28.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 174.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -85.94 -23.05 27.1 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 11.5 pt -106.6 25.25 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 C-N-CA 122.859 0.464 . . . . 0.0 110.311 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -79.64 -13.26 59.62 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.074 0.549 . . . . 0.0 112.033 -175.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -156.6 143.72 18.85 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -55.65 -36.07 66.64 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.692 0.397 . . . . 0.0 111.558 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -115.79 105.68 12.98 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 18.0 m -88.5 160.04 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.425 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -84.97 139.85 31.5 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.802 0.334 . . . . 0.0 110.249 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.49 104.2 6.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 172.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -137.67 153.0 49.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.371 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -146.51 20.08 1.34 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.187 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.29 130.17 3.01 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 52.85 17.82 0.94 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.425 1.09 . . . . 0.0 112.933 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 76.1 mt -140.52 149.33 21.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 123.97 0.908 . . . . 0.0 109.296 -178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -153.74 133.4 12.97 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -145.32 161.25 40.05 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.254 1.022 . . . . 0.0 109.025 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.86 155.17 44.73 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 123.361 0.664 . . . . 0.0 109.826 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.3 p -158.38 159.22 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 122.961 0.505 . . . . 0.0 109.981 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -83.68 141.35 31.55 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.112 0.565 . . . . 0.0 110.831 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.88 162.54 31.32 Favored 'Isoleucine or valine' 0 C--N 1.338 0.092 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.82 158.92 29.58 Favored Pre-proline 0 N--CA 1.455 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.823 170.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.76 134.74 62.5 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.461 2.108 . . . . 0.0 108.087 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . 0.49 ' CD1' ' HB2' ' A' ' 176' ' ' PHE . 0.7 OUTLIER -77.01 170.51 16.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.192 -175.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 CA--C 1.529 0.161 0 C-N-CA 123.669 0.788 . . . . 0.0 110.829 -170.43 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.767 0.317 . . . . 0.0 111.717 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -156.95 170.66 22.01 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.544 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.1 t -95.89 165.45 12.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.401 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -84.72 9.44 13.99 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.836 0.454 . . . . 0.0 111.005 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -128.83 141.46 51.29 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 121.14 0.495 . . . . 0.0 110.168 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 p -147.8 147.86 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.306 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -87.04 145.14 26.59 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.9 p -128.63 122.91 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -110.27 175.03 18.02 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-O 121.307 0.393 . . . . 0.0 112.175 -175.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.45 29.75 74.34 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.379 -0.41 . . . . 0.0 113.39 171.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.1 mt -69.15 142.44 92.85 Favored Pre-proline 0 N--CA 1.45 -0.462 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.11 174.88 11.69 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.233 2.622 . . . . 0.0 109.567 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -54.74 -9.38 1.79 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 124.742 3.628 . . . . 0.0 114.32 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.52 ' C ' ' H ' ' A' ' 77' ' ' ASP . 9.9 m-20 -125.5 -123.46 0.25 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER 63.55 -25.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 75' ' ' ASP . 4.2 p-10 39.26 -113.88 0.15 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.563 1.545 . . . . 0.0 113.114 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -127.27 -19.85 4.21 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.104 0.961 . . . . 0.0 110.487 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -80.95 -46.58 14.93 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.845 -0.535 . . . . 0.0 112.036 -174.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -68.03 -34.05 75.75 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.631 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.7 pt -84.25 -29.87 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 O-C-N 122.052 -0.405 . . . . 0.0 111.21 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 97.2 m -70.71 -12.93 61.86 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.49 0.586 . . . . 0.0 109.42 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.91 -15.45 15.14 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.6 m -82.18 -36.68 27.09 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.025 0.83 . . . . 0.0 112.461 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -98.08 1.56 47.77 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.4 ttt85 -78.43 -4.91 50.72 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -77.03 -11.09 59.76 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.737 0.415 . . . . 0.0 111.762 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -108.03 -19.12 13.61 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.443 0.297 . . . . 0.0 110.629 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.92 161.0 10.93 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.45 140.18 93.57 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.387 2.725 . . . . 0.0 111.906 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.77 164.53 36.81 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.274 0.23 . . . . 0.0 111.582 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.8 mm -134.48 164.08 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -128.24 146.44 33.74 Favored 'Isoleucine or valine' 0 C--O 1.23 0.079 0 CA-C-N 118.324 0.511 . . . . 0.0 110.243 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -150.0 166.78 28.65 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.085 0.469 . . . . 0.0 110.781 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.439 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 17.1 p90 -148.4 160.37 36.78 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.635 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 69.6 Cg_endo -70.0 -8.94 24.86 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 124.467 3.445 . . . . 0.0 111.72 -170.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.635 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 60.2 m-70 -101.47 5.15 41.84 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.091 0.556 . . . . 0.0 112.16 -176.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -70.17 161.22 30.66 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 121.659 0.742 . . . . 0.0 112.113 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.458 0 C-N-CA 124.829 1.251 . . . . 0.0 111.04 -175.56 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.615 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.31 148.65 33.66 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.346 1.073 . . . . 0.0 110.149 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.45 -176.46 5.6 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.965 0.506 . . . . 0.0 110.606 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -139.26 136.93 35.45 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -103.01 149.93 24.06 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 mp -111.23 143.01 42.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 171.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -130.62 162.87 28.39 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.202 0.525 . . . . 0.0 111.072 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -100.84 -32.3 10.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.693 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -113.53 151.51 31.47 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -88.65 -11.84 44.17 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.871 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.8 m -102.45 -7.02 22.29 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 122.932 0.493 . . . . 0.0 111.029 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.8 t -71.67 -35.14 70.22 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.0 m -73.71 -25.23 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -77.01 -29.5 55.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.405 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.5 -36.67 57.65 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.497 0.589 . . . . 0.0 110.899 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -76.72 -18.37 58.54 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.778 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 35.8 mt -91.97 -18.72 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 122.377 0.271 . . . . 0.0 111.203 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -100.98 -10.02 20.94 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.534 -0.728 . . . . 0.0 112.514 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.56 14.63 13.63 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 73.2 m -132.79 -171.38 2.65 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.959 0.345 . . . . 0.0 111.846 -175.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.5 mp -74.97 154.67 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.296 1.038 . . . . 0.0 109.159 -171.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 135' ' ' LEU . 12.7 pt-20 -133.24 161.64 33.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.494 0.188 . . . . 0.0 111.178 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.46 177.41 9.07 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -46.36 -24.74 0.53 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -169.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -153.67 5.2 0.34 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-N 119.184 0.902 . . . . 0.0 113.384 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -146.06 -171.75 3.78 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 117.949 0.874 . . . . 0.0 109.127 -175.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 4.5 mp -134.89 166.54 22.77 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.376 -0.202 . . . . 0.0 111.116 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 149' ' ' VAL . 17.4 m-85 -138.1 156.45 47.76 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.155 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.2 mp -134.04 157.45 46.07 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 73.5 m -100.28 135.11 42.21 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.182 0.447 . . . . 0.0 110.721 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.9 m -144.12 164.46 14.26 Favored 'Isoleucine or valine' 0 C--N 1.338 0.067 0 C-N-CA 123.694 0.798 . . . . 0.0 109.923 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.4 t -70.63 151.41 45.01 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 120.54 0.209 . . . . 0.0 110.559 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.3 t -156.02 139.05 10.77 Favored Pre-proline 0 N--CA 1.456 -0.151 0 C-N-CA 122.646 0.379 . . . . 0.0 110.408 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -79.13 -0.08 10.45 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.55 3.5 . . . . 0.0 114.046 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 49.2 m -93.97 -10.99 31.84 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.077 0.853 . . . . 0.0 108.998 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.97 -155.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 126.94 2.096 . . . . 0.0 106.668 -174.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -94.71 -36.94 11.52 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -162.07 154.63 19.76 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.896 1.279 . . . . 0.0 108.296 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.4 ttpp -143.5 138.6 15.56 Favored Pre-proline 0 CA--C 1.528 0.114 0 CA-C-N 118.171 0.441 . . . . 0.0 112.088 -179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -59.58 140.32 93.29 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.596 2.864 . . . . 0.0 111.678 169.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 33.0 m -126.33 143.07 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -87.74 150.74 23.41 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.9 mm -129.24 143.45 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 124.807 1.243 . . . . 0.0 110.419 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 47.8 ttp85 -159.13 97.68 1.65 Allowed Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -62.99 167.21 12.63 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 124.12 3.213 . . . . 0.0 113.497 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -87.2 147.37 25.62 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 172.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -107.35 147.95 29.67 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.349 0.595 . . . . 0.0 111.743 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.3 mp -98.42 93.54 6.23 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 t -158.18 -39.76 0.06 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.465 ' CG ' ' HE ' ' A' ' 185' ' ' ARG . 16.0 m-20 -143.91 39.58 1.36 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.3 m -67.53 -19.41 65.29 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -155.83 160.03 39.88 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.303 0.641 . . . . 0.0 110.835 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -154.11 151.88 29.78 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.09 143.39 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 90.0 mtp -129.41 3.19 5.1 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -175.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -156.17 -40.93 0.08 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.766 0.712 . . . . 0.0 112.322 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 155.81 12.14 0.06 OUTLIER Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.428 -0.651 . . . . 0.0 112.886 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.0 m 54.59 56.4 6.83 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 117.981 0.89 . . . . 0.0 112.167 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -57.8 159.41 10.06 Favored Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -59.45 145.44 97.94 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.692 2.261 . . . . 0.0 109.72 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 72.0 mt -121.09 166.84 13.34 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.101 0.477 . . . . 0.0 112.211 -171.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -141.3 155.35 67.84 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.26 -6.83 20.04 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.142 2.561 . . . . 0.0 111.026 -176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -101.96 5.56 40.83 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.107 0.963 . . . . 0.0 111.464 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -129.33 14.72 6.13 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.798 0.439 . . . . 0.0 111.088 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.6 m -132.45 142.56 49.3 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.178 0.191 . . . . 0.0 111.086 -174.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.4 tt -112.04 152.01 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 123.219 0.607 . . . . 0.0 110.343 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -121.16 143.23 49.22 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 35.3 m -139.01 149.68 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-O 120.663 0.268 . . . . 0.0 110.704 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -146.0 165.92 28.04 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 79.14 20.85 69.0 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -173.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 19.4 m -61.06 153.27 67.47 Favored Pre-proline 0 CA--C 1.529 0.171 0 C-N-CA 122.9 0.48 . . . . 0.0 111.956 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.14 168.76 21.14 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.755 2.97 . . . . 0.0 109.563 173.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -65.6 -47.44 67.38 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -173.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.52 -51.75 0.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 121.617 1.545 . . . . 0.0 112.254 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.1 tp 50.7 -72.48 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.537 1.935 . . . . 0.0 114.548 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.465 ' HE ' ' CG ' ' A' ' 158' ' ' ASP . 63.2 mtp180 61.97 127.66 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 127.521 2.328 . . . . 0.0 112.43 -174.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.46 -22.96 66.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.397 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 59.0 t -72.56 -47.83 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 122.341 0.256 . . . . 0.0 110.638 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -80.65 -32.89 36.03 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 55.6 tp -66.26 -34.0 77.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -86.73 -25.32 24.77 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -175.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 20.7 mmt -70.6 -33.83 71.49 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.4 mt -72.55 -39.76 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 20.1 mmt -60.08 -24.76 64.85 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 119.231 -0.414 . . . . 0.0 111.605 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -88.25 -20.17 25.83 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.923 0.783 . . . . 0.0 111.412 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.19 -18.73 33.18 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.871 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.38 -23.96 7.58 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 118.147 0.43 . . . . 0.0 111.042 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -135.29 45.3 2.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.893 0.477 . . . . 0.0 110.024 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -45.12 138.36 5.79 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.431 0.539 . . . . 0.0 112.117 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 123.52 9.87 5.72 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 5.2 p -71.02 160.46 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.847 0.859 . . . . 0.0 110.555 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 52.4 t -134.91 -35.64 0.85 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.638 0.606 . . . . 0.0 112.638 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -150.74 155.82 40.06 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.763 0.256 . . . . 0.0 110.766 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -154.2 159.42 41.35 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.025 0.441 . . . . 0.0 110.181 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 175.22 -175.67 47.17 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.7 mm -97.46 144.68 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -60.74 123.38 17.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 52.5 p -134.97 140.48 45.73 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -85.08 128.03 61.83 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -76.47 -10.88 18.94 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.263 3.309 . . . . 0.0 112.565 -174.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -69.23 -29.68 67.68 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.428 0.291 . . . . 0.0 110.53 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.13 6.71 1.76 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.453 0.701 . . . . 0.0 111.592 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 51.81 48.65 22.39 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.198 1.399 . . . . 0.0 113.904 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -123.15 152.18 63.17 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.965 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.55 171.72 16.58 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 124.206 3.271 . . . . 0.0 112.639 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 12.9 ttmt -134.69 19.31 3.56 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.68 0.792 . . . . 0.0 111.38 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 63.0 16.57 57.59 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 119.61 -0.55 . . . . 0.0 113.535 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -130.34 155.27 46.63 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.877 0.838 . . . . 0.0 109.982 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -105.98 160.56 14.7 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 112.426 -0.27 . . . . 0.0 112.426 -175.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -151.03 144.94 25.2 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 99.6 t -140.01 148.34 22.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -130.2 147.51 51.93 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.722 0.296 . . . . 0.0 110.845 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -128.05 156.7 42.35 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.598 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 74.1 m -77.84 -7.58 56.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -131.87 145.76 51.72 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.101 0.409 . . . . 0.0 111.085 -176.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -71.78 -22.55 61.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -70.22 -38.21 75.19 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 17.9 m -72.35 -29.91 64.24 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -70.09 -51.6 30.49 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 119.622 -0.228 . . . . 0.0 111.118 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.7 pt -69.11 -15.74 20.02 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 CA-C-N 118.289 0.495 . . . . 0.0 110.735 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.18 -27.52 29.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.17 -25.61 36.69 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 8.1 pt -105.09 24.98 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.022 0.529 . . . . 0.0 110.44 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -78.86 -11.38 59.99 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.247 0.619 . . . . 0.0 111.932 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.55 143.0 21.68 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -56.26 -33.23 65.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.778 0.431 . . . . 0.0 111.989 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -123.62 114.63 20.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.04 0.448 . . . . 0.0 110.633 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.5 m -87.55 147.61 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.136 173.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -83.21 134.12 34.98 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -121.61 21.25 10.93 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -66.86 149.35 50.71 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -147.0 8.58 0.95 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.624 0.25 . . . . 0.0 111.313 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 163.31 -137.36 4.74 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -176.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -74.63 -4.79 39.28 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.98 0.39 . . . . 0.0 110.502 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.9 mp -87.2 153.54 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.034 0.934 . . . . 0.0 108.963 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -134.68 135.73 42.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.893 0.378 . . . . 0.0 110.603 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -145.39 147.67 32.5 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.442 1.097 . . . . 0.0 109.199 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 161.63 42.33 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.271 0.628 . . . . 0.0 109.504 177.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.0 p -154.59 152.16 9.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -88.76 128.4 35.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.451 ' C ' ' HE2' ' A' ' 251' ' ' LYS . 1.5 m -104.56 156.34 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -174.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.451 ' HE2' ' C ' ' A' ' 250' ' ' VAL . 0.0 OUTLIER -156.15 158.48 31.6 Favored Pre-proline 0 N--CA 1.456 -0.147 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.891 170.205 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.91 140.56 92.28 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.777 2.318 . . . . 0.0 109.917 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -91.49 175.82 6.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.924 0.392 . . . . 0.0 110.505 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.451 -0.393 0 C-N-CA 123.375 0.67 . . . . 0.0 109.846 -170.859 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.801 0.334 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.435 ' HA ' ' HG ' ' A' ' 156' ' ' LEU . 0.3 OUTLIER -147.59 171.35 15.72 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.569 177.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.9 t -89.22 169.0 11.82 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.507 0.723 . . . . 0.0 111.666 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 49.1 ptt85 -77.42 5.57 8.56 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.709 0.804 . . . . 0.0 111.118 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -108.21 130.89 55.13 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.336 -0.986 . . . . 0.0 108.336 174.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.1 p -150.54 146.44 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.458 -170.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.425 ' CZ ' ' HA3' ' A' ' 70' ' ' GLY . 8.3 t80 -83.25 135.57 34.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.9 t -137.75 78.16 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 110' ' ' TYR . . . -120.28 159.62 15.11 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.946 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.45 5.92 33.86 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.526 HD21 ' H ' ' A' ' 72' ' ' LEU . 0.9 OUTLIER -73.69 173.4 6.36 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 171.228 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.502 ' C ' ' H ' ' A' ' 75' ' ' ASP . 50.2 Cg_endo -80.9 155.51 20.22 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 CA-C-N 120.677 1.277 . . . . 0.0 110.292 -174.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -64.95 13.39 0.1 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.92 3.08 . . . . 0.0 112.755 173.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 73' ' ' PRO . 12.2 m-20 -134.29 26.82 3.82 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -172.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 mt -123.93 152.05 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -126.11 -176.19 3.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.286 0.634 . . . . 0.0 110.933 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -51.4 -23.76 4.16 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.367 1.067 . . . . 0.0 113.139 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -79.64 -37.44 36.04 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.715 0.688 . . . . 0.0 112.472 -175.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -84.7 -25.45 28.37 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.41 0.55 . . . . 0.0 110.671 -174.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 52.9 mt -75.03 -42.71 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.9 m -66.51 -26.24 67.07 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.44 -20.77 46.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.234 -0.291 . . . . 0.0 111.541 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 m -85.34 -25.05 27.36 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.45 ' CE1' HD22 ' A' ' 137' ' ' LEU . 87.6 m-85 -117.58 1.98 12.31 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -174.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -80.6 -2.73 47.6 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.095 0.861 . . . . 0.0 112.09 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.525 ' HG3' ' CD2' ' A' ' 88' ' ' PHE . 12.7 ptp180 -77.12 -7.46 55.82 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.439 0.696 . . . . 0.0 112.149 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.525 ' CD2' ' HG3' ' A' ' 87' ' ' ARG . 71.3 m-85 -121.73 2.72 10.07 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.394 0.277 . . . . 0.0 111.699 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.45 162.37 9.31 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.0 139.24 46.4 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.072 2.515 . . . . 0.0 110.759 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.59 169.77 23.54 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.845 0.458 . . . . 0.0 111.333 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.5 pt -135.98 163.02 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 172.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.9 149.69 20.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -154.29 171.76 18.73 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.1 0.952 . . . . 0.0 112.494 -175.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.403 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 2.9 p90 -146.73 158.28 46.24 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 174.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.593 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 74.3 Cg_endo -63.14 -14.72 43.52 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 124.023 3.149 . . . . 0.0 112.996 -168.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.593 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 3.3 m170 -105.68 -34.29 7.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.927 0.331 . . . . 0.0 111.087 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.0 tptm 42.04 27.98 0.09 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.063 1.745 . . . . 0.0 113.634 -174.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.384 0 C-N-CA 124.585 1.154 . . . . 0.0 112.914 179.52 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 CA-C-O 119.923 -0.376 . . . . 0.0 113.853 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.429 ' HA ' ' HA2' ' A' ' 70' ' ' GLY . 0.4 OUTLIER -145.17 134.25 22.67 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 118.545 1.173 . . . . 0.0 111.079 170.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.31 -169.25 3.33 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.627 1.171 . . . . 0.0 109.37 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -134.8 151.02 50.6 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -176.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mp -108.24 151.04 26.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.585 0.707 . . . . 0.0 112.004 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.9 99.69 6.05 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -84.28 156.65 21.86 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.822 0.344 . . . . 0.0 110.232 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -86.35 -29.0 23.3 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.208 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -128.08 156.64 42.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -80.23 -19.86 45.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.218 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.0 m -90.44 -16.14 29.56 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.699 0.4 . . . . 0.0 111.14 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 18.8 m -72.67 -41.36 65.47 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.57 -13.97 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.849 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -78.4 -35.31 47.29 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.062 -0.398 . . . . 0.0 110.028 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.26 -37.5 57.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 117.83 0.287 . . . . 0.0 111.122 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.01 -38.16 87.75 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 52.3 mt -85.1 -10.73 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 121.422 -0.799 . . . . 0.0 111.925 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -102.26 -5.14 24.64 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.805 -0.559 . . . . 0.0 112.038 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -126.6 6.68 6.84 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 81.6 m -112.78 -179.48 3.67 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.865 0.757 . . . . 0.0 111.066 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.0 mp -68.72 147.98 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -171.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -130.69 151.91 50.62 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.545 0.212 . . . . 0.0 111.096 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.41 67.5 1.36 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.303 0.573 . . . . 0.0 110.26 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 52.72 12.23 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.45 -18.81 0.09 OUTLIER Glycine 0 CA--C 1.526 0.77 0 CA-C-N 118.682 0.673 . . . . 0.0 112.386 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -127.03 174.31 8.98 Favored 'General case' 0 C--N 1.338 0.07 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.4 167.95 20.1 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.032 0.378 . . . . 0.0 111.583 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 31.9 m-85 -139.09 159.17 42.78 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.795 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . 0.45 HD22 ' CE1' ' A' ' 85' ' ' PHE . 54.8 tp -150.47 158.58 44.32 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 169.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 84.7 m -95.26 167.97 11.03 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.891 -0.506 . . . . 0.0 111.954 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.15 164.78 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.933 0.893 . . . . 0.0 109.838 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.1 m -104.48 2.37 30.91 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.442 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 45.3 m -133.86 48.34 3.18 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 118.294 0.497 . . . . 0.0 111.546 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 141' ' ' SER . 62.0 Cg_endo -65.03 155.22 69.43 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.172 3.248 . . . . 0.0 111.905 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.8 t -89.12 -9.98 49.02 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.031 0.533 . . . . 0.0 111.513 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 64.7 mt -141.23 175.01 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -176.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -56.85 -24.82 54.17 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.998 -0.439 . . . . 0.0 111.284 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -141.97 150.3 41.2 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.873 0.869 . . . . 0.0 109.631 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.597 ' HZ1' ' HB2' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -158.95 70.0 3.5 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 122.703 0.401 . . . . 0.0 110.02 174.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.466 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 72.1 Cg_endo -68.76 124.0 11.03 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.077 1.851 . . . . 0.0 109.115 175.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.7 140.33 16.13 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -91.67 153.06 19.93 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.734 0.414 . . . . 0.0 110.857 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.9 mm -126.6 136.26 61.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.342 0.657 . . . . 0.0 110.303 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -147.83 96.85 4.01 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -78.7 165.07 25.17 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.614 2.876 . . . . 0.0 110.828 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.45 ' CD2' ' HG2' ' A' ' 214' ' ' PRO . 47.1 t-105 -82.15 111.41 18.24 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 121.9 -0.5 . . . . 0.0 111.001 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -70.62 148.91 47.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.435 ' HG ' ' HA ' ' A' ' 63' ' ' TYR . 35.7 mt -119.14 101.34 7.93 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.201 0.524 . . . . 0.0 111.076 -169.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.7 t -164.85 -32.23 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.737 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -140.5 42.47 1.88 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.384 0.274 . . . . 0.0 111.332 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.6 t -66.57 -32.46 73.81 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -176.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -151.44 158.27 43.45 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.004 0.522 . . . . 0.0 110.49 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.43 ' CD2' ' HA ' ' A' ' 187' ' ' VAL . 58.3 t80 -156.24 153.42 29.13 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.4 p -144.73 149.25 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 67.5 mtm -117.16 13.43 14.7 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -173.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.532 ' HB3' ' HG ' ' A' ' 201' ' ' CYS . 18.1 t70 -160.55 -41.63 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.32 7.4 38.87 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.302 -0.721 . . . . 0.0 113.335 175.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.9 m -133.72 -0.23 3.19 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -86.81 150.31 50.17 Favored Pre-proline 0 CA--C 1.529 0.148 0 CA-C-N 119.839 1.2 . . . . 0.0 110.448 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.36 148.64 49.26 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.093 2.529 . . . . 0.0 109.659 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 77.1 mt -133.75 152.27 51.83 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.161 0.584 . . . . 0.0 109.871 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -145.29 153.28 52.17 Favored Pre-proline 0 N--CA 1.455 -0.186 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -59.19 -20.12 53.18 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.318 2.679 . . . . 0.0 112.353 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.9 6.56 38.73 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.418 0.687 . . . . 0.0 110.741 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -129.72 19.42 5.63 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 122.833 0.453 . . . . 0.0 110.455 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 30.2 m -125.12 139.92 53.35 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.72 0.295 . . . . 0.0 111.133 -175.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.8 tt -110.92 150.78 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.17 0.588 . . . . 0.0 109.77 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -120.43 140.48 51.3 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.7 m -135.92 142.16 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -156.05 -173.86 25.15 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 118.454 0.57 . . . . 0.0 113.05 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 76.05 28.75 59.9 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.1 146.84 53.69 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.811 0.306 . . . . 0.0 111.24 -171.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.28 -172.35 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.536 2.824 . . . . 0.0 110.158 169.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.48 ' N ' ' CD ' ' A' ' 183' ' ' PRO . 0.0 OUTLIER -95.35 5.31 0.06 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 117.737 2.495 . . . . 0.0 117.737 -172.247 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 182' ' ' ARG . 66.4 Cg_endo -76.17 6.19 4.05 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 122.505 1.93 . . . . 0.0 112.64 -175.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 57.4 mt -64.49 -35.79 82.09 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.513 0.597 . . . . 0.0 110.881 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 59.36 125.11 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.091 1.356 . . . . 0.0 112.162 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.6 -30.17 70.51 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.548 -0.72 . . . . 0.0 111.56 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.43 ' HA ' ' CD2' ' A' ' 161' ' ' PHE . 54.3 t -67.74 -50.85 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 120.609 0.242 . . . . 0.0 110.847 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -79.53 -24.97 41.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.482 -0.137 . . . . 0.0 110.781 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.1 tp -67.2 -34.55 77.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.09 -35.88 59.16 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.212 -0.305 . . . . 0.0 111.473 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 57.7 mtt -73.11 -33.73 65.74 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.324 -0.235 . . . . 0.0 111.083 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.428 HG23 ' HA ' ' A' ' 239' ' ' LEU . 72.2 mt -78.11 -39.53 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 121.151 -0.219 . . . . 0.0 110.683 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.3 mmt -63.14 -26.44 68.82 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.592 0.633 . . . . 0.0 110.513 172.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -85.42 -16.92 38.16 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.816 -0.552 . . . . 0.0 111.677 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.63 -18.27 22.37 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.239 -0.41 . . . . 0.0 111.574 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -114.03 -14.49 12.4 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -137.62 -29.96 0.85 Allowed 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.651 0.659 . . . . 0.0 112.211 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.86 -176.47 25.25 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 71.42 7.54 64.35 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.372 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . 0.435 HG23 ' CE2' ' A' ' 222' ' ' PHE . 22.0 t -77.2 151.24 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 CA-C-N 118.127 0.963 . . . . 0.0 110.108 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . 0.532 ' HG ' ' HB3' ' A' ' 164' ' ' ASP . 44.3 t -133.12 -42.86 0.88 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 119.619 -0.229 . . . . 0.0 110.949 175.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -136.66 150.59 48.58 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -173.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.06 163.36 39.99 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.255 0.55 . . . . 0.0 111.988 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -178.34 169.46 41.16 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.1 mm -94.0 93.76 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 38.0 t70 41.61 -84.43 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -169.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.527 ' H ' ' HA ' ' A' ' 214' ' ' PRO . 16.2 m 52.79 50.46 18.03 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.444 0.64 . . . . 0.0 111.016 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.24 140.6 88.0 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.739 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -81.33 -16.18 9.68 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 124.263 3.309 . . . . 0.0 113.575 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -100.21 -36.66 9.22 Favored 'General case' 0 C--N 1.338 0.069 0 CA-C-N 118.613 0.642 . . . . 0.0 110.979 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.94 -3.89 53.72 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt 56.17 115.2 0.01 OUTLIER 'General case' 0 C--N 1.34 0.155 0 C-N-CA 126.798 2.039 . . . . 0.0 113.492 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.424 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 70.7 m-85 65.34 170.05 0.1 Allowed Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.338 1.055 . . . . 0.0 111.566 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.527 ' HA ' ' H ' ' A' ' 207' ' ' THR . 50.8 Cg_exo -56.62 163.07 7.46 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.701 2.934 . . . . 0.0 115.486 -170.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -123.63 35.09 4.92 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.556 176.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 64.35 26.06 70.36 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -145.12 164.94 29.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.527 0.731 . . . . 0.0 110.169 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -116.32 164.65 12.27 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -146.83 149.97 34.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 93.5 t -141.23 144.16 26.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -125.33 143.49 50.94 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.213 0.53 . . . . 0.0 110.336 -178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.435 ' CE2' HG23 ' A' ' 200' ' ' VAL . 55.4 m-85 -117.47 152.78 34.33 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.639 -175.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 71.1 p -84.36 2.24 41.39 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.77 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -137.42 139.13 40.49 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.325 0.65 . . . . 0.0 110.316 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 11.8 tm0? -73.98 -22.01 59.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -71.37 -38.95 71.51 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.5 m -73.25 -29.49 62.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -66.0 -48.93 69.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.635 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.4 pp -72.93 -10.7 14.22 Favored 'Isoleucine or valine' 0 C--N 1.338 0.084 0 CA-C-N 118.515 0.598 . . . . 0.0 111.139 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.42 -23.94 27.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 117.602 0.183 . . . . 0.0 110.52 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -85.01 -23.92 28.44 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 10.4 pt -102.98 26.27 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 123.092 0.557 . . . . 0.0 110.474 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.2 t -90.9 2.52 56.12 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.537 0.735 . . . . 0.0 111.564 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -139.83 -156.68 0.7 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -128.65 -35.76 1.89 Allowed 'General case' 0 C--O 1.227 -0.106 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -127.88 104.54 7.87 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.9 m -64.32 149.76 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.763 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -91.36 138.2 31.76 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.428 ' HA ' HG23 ' A' ' 192' ' ' ILE . 3.2 mm? -127.52 22.64 6.42 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -87.85 133.97 33.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.244 0.618 . . . . 0.0 111.69 -172.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -147.09 22.9 1.2 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.885 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.7 135.82 4.89 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 54.13 7.54 0.13 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.05 1.34 . . . . 0.0 113.82 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.4 mt -144.54 142.63 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 C-N-CA 123.486 0.715 . . . . 0.0 109.292 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -150.99 138.07 19.18 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -144.37 161.42 39.02 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -155.55 158.28 38.18 Favored 'General case' 0 N--CA 1.46 0.054 0 CA-C-N 118.117 0.417 . . . . 0.0 110.221 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 12.7 p -158.66 152.21 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -86.13 126.72 34.42 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.439 ' C ' ' HE2' ' A' ' 251' ' ' LYS . 4.3 m -97.46 155.01 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.439 ' HE2' ' C ' ' A' ' 250' ' ' VAL . 0.0 OUTLIER -155.48 157.47 31.62 Favored Pre-proline 0 C--O 1.231 0.103 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.591 170.151 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.01 138.23 84.9 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.816 2.344 . . . . 0.0 109.336 173.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -92.11 170.02 10.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.447 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.453 -0.3 0 C-N-CA 123.273 0.629 . . . . 0.0 110.128 -169.771 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 121.139 0.495 . . . . 0.0 111.298 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -97.05 161.26 13.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.3 t -92.25 27.86 2.08 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.129 0.972 . . . . 0.0 113.471 -169.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 54.34 23.52 4.45 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.373 0.533 . . . . 0.0 111.052 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -146.0 138.16 25.28 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.479 0.712 . . . . 0.0 109.945 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.7 m -138.91 152.36 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.921 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.443 ' CZ ' ' HA3' ' A' ' 70' ' ' GLY . 19.1 t80 -84.03 148.41 26.87 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.69 73.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 122.251 1.025 . . . . 0.0 109.028 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.443 ' HA3' ' CZ ' ' A' ' 68' ' ' PHE . . . -78.19 144.63 28.64 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.47 23.44 60.55 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-O 119.203 -0.776 . . . . 0.0 113.569 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 pp -62.04 148.92 87.59 Favored Pre-proline 0 CA--C 1.531 0.22 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 172.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 66.1 Cg_endo -66.15 143.82 72.92 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 121.585 1.524 . . . . 0.0 110.499 -169.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 31.2 Cg_exo -61.83 174.37 2.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.106 2.538 . . . . 0.0 113.669 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.8 t70 63.36 5.71 2.15 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 pp -134.01 171.41 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 171.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -143.31 -25.58 0.59 Allowed 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -154.25 -35.15 0.1 Allowed 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 119.199 0.908 . . . . 0.0 112.547 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -67.7 -45.7 74.39 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.716 0.689 . . . . 0.0 111.529 -175.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -72.34 -35.56 68.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.879 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.4 pt -83.89 -36.65 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 O-C-N 122.163 -0.336 . . . . 0.0 111.869 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 95.9 m -71.99 -15.41 62.06 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.44 0.564 . . . . 0.0 109.565 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.73 -21.29 20.05 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 172.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -84.2 -19.19 34.44 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.415 ' HB2' ' CD1' ' A' ' 91' ' ' LEU . 34.6 m-85 -113.02 5.84 17.39 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.338 0.517 . . . . 0.0 111.208 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -65.25 -21.75 66.78 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 123.811 0.845 . . . . 0.0 111.972 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -72.17 -3.37 22.97 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -113.06 15.48 19.55 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.467 0.307 . . . . 0.0 111.648 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.27 177.6 20.37 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.31 150.44 70.96 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.557 2.838 . . . . 0.0 110.675 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.415 ' CD1' ' HB2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -163.15 163.29 25.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.178 -169.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pt -142.71 168.11 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.017 172.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.9 p -128.34 157.0 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -148.05 155.88 42.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.002 0.429 . . . . 0.0 110.87 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -157.11 154.4 26.04 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 169.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.624 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 31.1 Cg_endo -75.61 -10.28 20.18 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.075 3.183 . . . . 0.0 110.77 -169.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.624 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 69.5 m-70 -102.37 9.92 39.44 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.872 0.869 . . . . 0.0 111.022 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.426 ' HE3' ' HA ' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -61.35 143.44 55.74 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.809 0.844 . . . . 0.0 109.914 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.224 0 C-N-CA 123.381 0.673 . . . . 0.0 110.118 179.813 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.817 0 CA-C-O 119.748 -0.473 . . . . 0.0 113.099 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -104.05 130.13 51.72 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.702 1.251 . . . . 0.0 108.543 172.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.98 -176.46 5.77 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.217 0.462 . . . . 0.0 110.657 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -141.62 144.35 34.14 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.773 0.429 . . . . 0.0 110.322 -176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -102.08 146.89 27.28 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.378 0.609 . . . . 0.0 111.769 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.4 mp -114.27 137.72 51.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -131.1 175.2 9.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.381 0.672 . . . . 0.0 110.004 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -115.6 -32.56 5.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.454 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -114.66 149.21 37.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.066 0.46 . . . . 0.0 111.327 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -77.97 -17.6 56.97 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.02 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.8 t -83.43 -16.39 45.99 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.264 -0.272 . . . . 0.0 111.476 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 67.5 m -74.93 -43.45 54.08 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.911 -0.493 . . . . 0.0 111.492 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 m -71.04 -22.99 23.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -80.29 -35.65 35.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.88 -33.02 65.79 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 119.442 -0.314 . . . . 0.0 111.382 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -80.26 -23.37 40.84 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.462 0.574 . . . . 0.0 110.955 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 54.5 mt -89.56 -20.91 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -100.98 -13.84 18.11 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.568 0.622 . . . . 0.0 112.619 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -108.62 11.07 26.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.06 0.391 . . . . 0.0 111.97 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 72.4 m -129.74 -166.41 1.66 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.852 0.461 . . . . 0.0 111.259 -176.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.8 mp -80.71 152.15 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 123.806 0.842 . . . . 0.0 109.353 -171.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -144.35 158.74 43.58 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.658 176.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 134' ' ' LYS . 1.9 pt-20 -145.62 174.79 10.88 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 175.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -59.8 -5.25 0.88 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -170.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -153.42 0.34 0.21 Allowed Glycine 0 CA--C 1.528 0.878 0 CA-C-N 119.164 0.893 . . . . 0.0 114.02 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.442 ' H ' ' HG3' ' A' ' 131' ' ' GLU . 3.4 mppt? -151.6 167.01 29.44 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 118.441 1.12 . . . . 0.0 110.618 -176.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -115.8 156.46 26.0 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -144.76 156.09 43.88 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.6 mp -135.55 164.02 28.78 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 169.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.2 m -108.13 141.09 40.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.76 150.4 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 C-N-CA 122.953 0.501 . . . . 0.0 110.344 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.9 m -66.63 161.76 22.57 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 122.902 0.481 . . . . 0.0 110.192 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.3 t -151.39 148.5 22.41 Favored Pre-proline 0 N--CA 1.455 -0.177 0 O-C-N 121.894 -0.504 . . . . 0.0 111.711 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -80.05 -7.76 14.23 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.768 2.979 . . . . 0.0 111.231 169.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 45.7 m -102.09 -32.69 10.01 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.872 0.869 . . . . 0.0 110.792 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 3.7 mm -140.09 170.81 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 124.191 0.996 . . . . 0.0 108.936 -175.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -70.16 -23.76 63.04 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -159.61 149.16 18.3 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.859 0.864 . . . . 0.0 109.912 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.535 ' HZ1' ' HB2' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -125.12 106.72 28.21 Favored Pre-proline 0 C--N 1.337 0.051 0 C-N-CA 123.269 0.627 . . . . 0.0 109.59 178.354 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.84 96.82 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.226 2.618 . . . . 0.0 109.193 169.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.8 p -84.98 137.96 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.24 146.77 24.78 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.22 0.608 . . . . 0.0 110.977 -173.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 37.4 mm -130.85 146.18 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 123.158 0.583 . . . . 0.0 111.218 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -148.37 109.76 3.66 Favored Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.85 165.11 26.97 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.51 2.806 . . . . 0.0 111.377 177.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -105.89 126.27 51.98 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 174.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -96.52 132.62 41.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.472 ' H ' HD12 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -92.6 118.13 30.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.767 0.794 . . . . 0.0 110.899 -178.222 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 34.5 t -172.62 -31.83 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.146 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -122.3 21.87 10.23 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.092 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 23.7 m -64.56 -27.77 69.18 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -160.4 160.95 32.88 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.569 0.348 . . . . 0.0 111.387 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.436 ' CD2' ' HA ' ' A' ' 187' ' ' VAL . 12.9 t80 -155.87 161.59 40.56 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.8 0.333 . . . . 0.0 110.711 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.9 m -136.95 148.76 26.36 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 C-N-CA 124.493 1.117 . . . . 0.0 109.878 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 29.3 mtm -139.49 12.31 2.54 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -137.88 24.07 2.84 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.041 0.837 . . . . 0.0 112.383 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 89.07 24.45 31.96 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 119.639 -0.534 . . . . 0.0 111.938 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 98.0 p 48.4 45.26 20.64 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -61.94 156.9 54.51 Favored Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -65.9 151.02 85.23 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.718 2.279 . . . . 0.0 110.688 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -108.66 172.49 6.81 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 121.259 0.552 . . . . 0.0 110.625 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -149.61 139.79 13.57 Favored Pre-proline 0 N--CA 1.452 -0.325 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.967 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.34 -12.19 31.79 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.213 2.608 . . . . 0.0 113.42 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -89.9 0.26 57.17 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.811 0.732 . . . . 0.0 110.383 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -127.01 25.11 6.3 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 122.959 0.504 . . . . 0.0 110.918 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 23.8 m -127.74 140.25 52.18 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.969 0.414 . . . . 0.0 111.486 -175.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.6 tt -113.24 150.23 15.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 C-N-CA 123.539 0.736 . . . . 0.0 109.726 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.445 ' CD1' ' CE1' ' A' ' 253' ' ' TYR . 10.9 t80 -109.55 147.82 32.31 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 48.1 t -137.13 138.72 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.317 0.647 . . . . 0.0 109.294 -175.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -141.89 146.84 18.17 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 112.065 -0.414 . . . . 0.0 112.065 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.42 15.23 48.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -172.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.6 m -70.04 146.7 95.28 Favored Pre-proline 0 C--O 1.231 0.108 0 CA-C-N 117.188 0.494 . . . . 0.0 111.298 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -79.64 160.0 25.09 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.579 2.853 . . . . 0.0 108.293 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.83 -43.81 6.6 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.903 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.29 20.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.118 3.212 . . . . 0.0 115.087 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.84 -27.63 69.01 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.511 1.05 . . . . 0.0 112.445 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 56.92 106.74 0.01 OUTLIER 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.602 1.561 . . . . 0.0 112.612 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.32 -23.2 47.18 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.436 ' HA ' ' CD2' ' A' ' 161' ' ' PHE . 41.8 t -68.27 -55.16 17.36 Favored 'Isoleucine or valine' 0 C--N 1.337 0.064 0 CA-C-N 118.691 0.678 . . . . 0.0 110.819 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.13 -20.09 38.71 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.363 -0.211 . . . . 0.0 110.977 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.06 -33.82 63.82 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.34 -35.29 63.6 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.789 -0.569 . . . . 0.0 110.538 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.4 mmt -69.1 -33.31 73.3 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 57.7 mt -75.31 -41.83 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -63.97 -20.71 66.08 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.07 0.395 . . . . 0.0 110.899 173.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -86.1 -20.46 28.68 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.586 0.63 . . . . 0.0 111.287 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -89.3 -16.45 31.1 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -115.75 -22.39 9.16 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.172 0.442 . . . . 0.0 110.909 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -137.78 43.79 2.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.201 0.6 . . . . 0.0 109.801 -176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -46.14 138.66 7.18 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 123.654 0.645 . . . . 0.0 112.549 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 120.46 12.03 6.38 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -175.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 9.1 p -77.69 161.09 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.952 0.901 . . . . 0.0 110.598 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 47.9 t -135.98 -27.16 1.13 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -153.22 140.88 19.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 117.83 0.286 . . . . 0.0 110.896 -173.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.37 157.5 43.12 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.569 0.347 . . . . 0.0 110.716 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 161.76 -161.33 33.18 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 44.9 mm -102.4 138.39 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -59.58 138.28 57.76 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.532 0.206 . . . . 0.0 110.577 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 26.5 p -141.73 160.01 41.05 Favored 'General case' 0 N--CA 1.458 -0.052 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.179 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -111.74 130.19 23.42 Favored Pre-proline 0 N--CA 1.455 -0.197 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -80.25 -17.07 10.59 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.385 3.39 . . . . 0.0 113.813 -174.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -88.61 -31.75 18.43 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.549 0.613 . . . . 0.0 110.95 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.53 -2.78 15.37 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.114 0.566 . . . . 0.0 110.478 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 62.6 mttp 48.12 61.89 2.77 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.043 1.337 . . . . 0.0 112.734 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -147.32 151.61 40.74 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 122.292 0.237 . . . . 0.0 111.105 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -82.54 155.92 16.22 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.347 2.698 . . . . 0.0 112.577 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -93.42 1.38 56.89 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.147 0.979 . . . . 0.0 109.492 173.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 65.86 7.74 37.62 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.19 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -117.86 146.16 44.09 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 117.462 0.631 . . . . 0.0 109.738 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -84.76 151.04 25.9 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 121.319 0.4 . . . . 0.0 112.547 -173.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.82 142.91 24.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 171.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.8 t -134.75 144.48 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -133.03 149.02 52.22 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.026 0.441 . . . . 0.0 110.056 -178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -126.13 153.66 44.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.481 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 63.2 p -84.15 4.51 30.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.732 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -134.98 136.68 42.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.391 0.677 . . . . 0.0 109.796 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -73.86 -20.28 60.47 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -70.99 -35.82 72.25 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 17.3 m -75.19 -29.96 60.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -66.93 -50.03 63.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.793 -0.146 . . . . 0.0 110.927 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.9 pt -70.09 -17.99 21.38 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 CA-C-N 118.061 0.392 . . . . 0.0 110.741 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.01 -24.55 37.86 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 117.582 0.174 . . . . 0.0 110.851 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.72 -31.06 32.25 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.981 0.355 . . . . 0.0 111.666 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.4 pt -95.78 23.54 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 122.712 0.405 . . . . 0.0 110.324 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.3 t -84.3 -13.81 51.44 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.004 0.522 . . . . 0.0 111.518 -176.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -149.62 135.81 18.97 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -53.54 -37.36 62.78 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.966 0.506 . . . . 0.0 112.019 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -113.84 105.06 12.82 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.905 0.383 . . . . 0.0 110.56 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.4 m -65.44 154.53 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.959 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -95.23 130.55 41.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -124.04 17.98 9.24 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.991 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -89.86 118.77 29.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -170.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -149.36 141.04 23.51 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 173.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.16 -131.61 50.11 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -98.98 7.5 45.94 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.942 0.497 . . . . 0.0 111.462 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.9 mp -88.1 149.41 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 122.841 0.456 . . . . 0.0 109.952 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -150.82 127.89 11.15 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -145.6 157.41 43.98 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.405 1.082 . . . . 0.0 108.652 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -153.36 152.02 30.61 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.9 p -159.93 158.49 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -85.86 145.61 27.11 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.363 0.665 . . . . 0.0 111.183 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.56 161.63 27.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.1 159.25 26.89 Favored Pre-proline 0 N--CA 1.455 -0.198 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.087 169.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.49 133.78 59.1 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.3 2.0 . . . . 0.0 108.731 173.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . 0.445 ' CE1' ' CD1' ' A' ' 176' ' ' PHE . 1.1 t80 -73.99 159.9 32.08 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.389 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.456 -0.163 0 C-N-CA 123.918 0.887 . . . . 0.0 111.331 -170.441 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 . . . . . 0 N--CA 1.456 -0.16 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -117.69 159.16 23.42 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.429 ' C ' ' H ' ' A' ' 66' ' ' LYS . 22.7 t -98.18 174.43 6.53 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.506 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -77.5 30.0 0.15 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.159 0.584 . . . . 0.0 110.992 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.429 ' H ' ' C ' ' A' ' 64' ' ' SER . 1.3 tmtp? -143.3 144.03 31.94 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.195 0.598 . . . . 0.0 110.701 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.0 m -141.66 155.0 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.801 176.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.409 ' CZ ' ' CA ' ' A' ' 70' ' ' GLY . 2.4 t80 -94.97 129.54 41.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 169.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 p -108.7 93.07 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 122.203 1.001 . . . . 0.0 108.455 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.409 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -86.49 155.81 28.58 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.005 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.76 26.86 73.71 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-O 119.045 -0.864 . . . . 0.0 113.912 171.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 pp -75.23 144.95 79.45 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 118.981 1.391 . . . . 0.0 108.208 173.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.22 120.07 7.47 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.822 2.348 . . . . 0.0 110.343 -172.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -54.84 -11.38 3.47 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.666 3.577 . . . . 0.0 115.238 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -82.89 -7.65 59.64 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.416 0.553 . . . . 0.0 112.307 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 pp -142.98 168.81 12.99 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -165.12 179.7 6.19 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 45.27 -99.42 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.144 1.777 . . . . 0.0 114.339 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -58.1 -28.32 64.52 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -80.38 -24.28 39.86 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.204 0.456 . . . . 0.0 110.29 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.1 mt -76.29 -46.05 33.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.1 m -63.25 -21.13 66.04 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.752 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.16 -18.37 24.58 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.1 m -79.15 -27.05 42.72 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.765 0.711 . . . . 0.0 112.139 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -114.99 11.87 16.6 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -64.85 -20.34 66.36 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.828 0.451 . . . . 0.0 112.189 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -75.24 -0.26 18.9 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -115.59 -4.48 12.24 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 141.86 177.34 16.89 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.24 146.05 50.27 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.475 2.784 . . . . 0.0 110.246 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.415 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -162.37 161.41 27.4 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.965 -169.744 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.9 mm -138.35 160.53 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.63 144.2 34.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -150.46 167.23 27.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.303 0.573 . . . . 0.0 110.826 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -157.77 162.74 26.6 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 175.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.541 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 39.2 Cg_endo -75.28 -15.64 20.03 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.304 2.002 . . . . 0.0 110.527 -169.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.541 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 20.8 m-70 -89.54 -0.49 57.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.829 0.851 . . . . 0.0 111.18 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.15 110.29 4.47 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.813 0.845 . . . . 0.0 109.108 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.305 0 C-N-CA 122.557 0.343 . . . . 0.0 111.049 -179.201 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.641 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.39 150.55 35.89 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.338 0.569 . . . . 0.0 109.494 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.93 -175.03 5.23 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.762 0.425 . . . . 0.0 110.344 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -137.93 142.45 40.56 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.8 151.38 25.8 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -113.82 146.45 39.94 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 169.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -134.69 168.11 19.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.873 0.469 . . . . 0.0 110.578 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -103.83 -25.31 13.13 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.572 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -122.38 152.54 40.09 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -84.36 -15.01 47.93 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.759 176.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.3 t -90.52 -14.95 31.63 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.707 0.403 . . . . 0.0 110.635 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.4 m -75.49 -39.34 58.68 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 122.037 -0.414 . . . . 0.0 110.078 177.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.2 -22.15 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -77.87 -29.9 50.59 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.71 -35.29 45.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.656 0.207 . . . . 0.0 111.148 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 pp -80.11 -16.31 55.25 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.252 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 79.5 mt -96.39 -17.4 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 122.282 0.233 . . . . 0.0 111.084 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -100.43 -10.95 20.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.464 0.574 . . . . 0.0 112.478 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -119.74 44.87 2.28 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.074 0.55 . . . . 0.0 110.825 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 31.4 p -141.48 179.92 6.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.741 0.416 . . . . 0.0 111.904 -175.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.7 mp -82.71 157.5 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -123.67 157.3 34.15 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.948 0.404 . . . . 0.0 111.199 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.98 -179.07 6.37 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -41.29 -23.44 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -161.04 4.82 0.09 OUTLIER Glycine 0 CA--C 1.529 0.946 0 CA-C-N 119.491 1.041 . . . . 0.0 113.47 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -146.28 -170.53 3.52 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.598 1.199 . . . . 0.0 111.096 -173.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -115.99 165.29 13.29 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.074 0.55 . . . . 0.0 111.815 -174.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -143.88 147.49 34.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.267 0.627 . . . . 0.0 109.404 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.6 mp -128.38 159.94 33.77 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 170.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.4 p -91.4 149.84 21.53 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 122.082 -0.386 . . . . 0.0 110.907 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.4 m -144.43 174.11 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 123.391 0.676 . . . . 0.0 109.944 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.4 p -67.71 -14.13 62.69 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.687 0.395 . . . . 0.0 111.669 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.403 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 39.0 t 47.24 57.38 17.62 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.313 1.045 . . . . 0.0 113.561 174.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.403 ' HD3' ' N ' ' A' ' 141' ' ' SER . 31.5 Cg_exo -61.9 -9.41 14.18 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.922 2.414 . . . . 0.0 113.945 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 55.3 m -82.37 -27.98 31.8 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.5 0.591 . . . . 0.0 109.6 178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.4 mt -150.31 -122.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -170.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -147.47 122.21 9.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.803 0.441 . . . . 0.0 110.311 174.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.6 t70 47.18 32.78 2.18 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 172.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.0 pttp -82.94 148.56 57.31 Favored Pre-proline 0 C--N 1.34 0.186 0 CA-C-N 119.786 1.176 . . . . 0.0 110.017 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -83.5 168.27 12.98 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.667 2.911 . . . . 0.0 112.245 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.9 m -128.3 146.78 33.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.486 HE21 ' C ' ' A' ' 150' ' ' GLN . 0.0 OUTLIER -93.02 149.52 21.16 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.601 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 45.0 mm -122.49 144.65 31.13 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 C-N-CA 124.246 1.018 . . . . 0.0 109.646 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.83 100.25 3.09 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.39 162.27 40.62 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.777 2.984 . . . . 0.0 111.799 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -89.82 149.54 22.63 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.935 -0.12 . . . . 0.0 110.799 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -109.04 115.23 29.66 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.683 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -83.85 12.09 6.61 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -169.634 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.2 t -96.2 -1.79 47.56 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -173.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -144.5 20.33 1.69 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.0 m -64.82 -21.06 66.71 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -175.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -153.74 156.29 37.5 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 118.014 0.37 . . . . 0.0 110.854 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -158.17 150.56 22.15 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.37 151.82 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 O-C-N 121.944 -0.473 . . . . 0.0 110.174 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 64.2 mtm -127.84 24.7 6.05 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 122.366 0.266 . . . . 0.0 111.409 -175.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -158.94 -49.91 0.06 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 64.95 11.64 51.67 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.98 -0.9 . . . . 0.0 113.939 172.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 26.3 t -138.75 -27.63 0.83 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.776 1.288 . . . . 0.0 114.332 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -77.08 147.34 76.68 Favored Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 119.115 0.871 . . . . 0.0 111.03 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.43 157.42 40.96 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.909 3.073 . . . . 0.0 110.969 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 10.6 mp -118.48 161.93 19.19 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.688 0.795 . . . . 0.0 109.85 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -137.5 152.89 73.87 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.68 -0.19 9.03 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.603 2.869 . . . . 0.0 111.432 -176.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -114.99 7.97 15.69 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 124.206 1.002 . . . . 0.0 111.494 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -123.33 19.72 9.74 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.825 0.45 . . . . 0.0 111.39 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.0 m -115.6 139.53 50.02 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.759 0.314 . . . . 0.0 111.079 -175.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.5 tt -118.32 149.57 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 C-N-CA 123.178 0.591 . . . . 0.0 109.934 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -109.97 147.28 33.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.2 t -134.9 132.25 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -177.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -152.39 167.16 31.33 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 87.1 11.82 69.13 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -170.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.8 m -65.93 156.21 84.49 Favored Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 122.919 0.488 . . . . 0.0 111.272 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -72.76 -171.98 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.941 3.094 . . . . 0.0 109.857 174.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -54.26 -50.92 82.07 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.874 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.42 139.32 23.12 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.143 1.895 . . . . 0.0 110.221 173.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.0 12.66 0.5 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 -42.14 140.07 1.21 Allowed 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.125 0.97 . . . . 0.0 112.209 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.47 -17.77 62.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.746 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.75 -50.45 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-O 120.699 0.285 . . . . 0.0 110.294 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -83.77 -25.93 30.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.562 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 26.0 tp -69.81 -32.97 71.71 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.68 -32.2 36.07 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 122.335 -0.228 . . . . 0.0 111.268 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.3 mmt -68.66 -31.58 70.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.6 mt -79.01 -33.26 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 O-C-N 122.231 -0.293 . . . . 0.0 110.49 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.7 mmt -73.36 -19.42 61.01 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.534 0.606 . . . . 0.0 109.984 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -83.62 -24.93 31.22 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.371 0.268 . . . . 0.0 111.224 175.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -87.76 -16.93 32.82 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -117.19 -17.01 10.34 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -134.68 23.06 3.64 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -173.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 73.87 -144.41 33.71 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 175.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -72.44 123.51 9.21 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 112.145 -0.382 . . . . 0.0 112.145 -173.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 90.8 t -111.57 137.74 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 124.745 1.218 . . . . 0.0 108.027 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.9 p -92.76 -41.44 10.13 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 118.364 0.529 . . . . 0.0 111.902 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -156.61 155.64 32.17 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.144 0.429 . . . . 0.0 111.676 -171.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -149.7 159.6 44.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.33 0.586 . . . . 0.0 111.006 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -174.67 170.48 43.6 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.7 mp -82.42 148.92 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -57.99 119.03 6.04 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 22.6 p -138.35 158.64 43.88 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -117.07 131.96 23.71 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.61 -16.1 15.07 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 124.503 3.469 . . . . 0.0 114.47 -172.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -110.97 -25.14 9.97 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.334 0.97 . . . . 0.0 111.381 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -86.86 -10.2 53.98 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 169.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 49.89 45.81 24.71 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.647 1.179 . . . . 0.0 111.839 175.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.32 156.22 39.66 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -80.69 157.25 21.47 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.527 2.818 . . . . 0.0 111.2 174.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -119.11 21.55 12.27 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.595 0.758 . . . . 0.0 111.04 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.23 -178.15 31.08 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 55.34 -173.98 0.05 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.334 0.567 . . . . 0.0 111.869 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -140.92 168.79 25.18 Favored Glycine 0 CA--C 1.524 0.632 0 O-C-N 121.608 -0.682 . . . . 0.0 112.979 -177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -146.58 149.8 34.26 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 97.1 t -136.68 151.09 27.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -124.38 145.72 49.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.916 0.486 . . . . 0.0 111.355 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -122.38 151.23 41.41 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.697 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 62.9 p -91.96 -0.64 57.49 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 116.78 -0.191 . . . . 0.0 111.242 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -132.5 144.83 50.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.901 0.48 . . . . 0.0 110.243 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -80.12 -9.36 59.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.244 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -85.09 -42.18 15.04 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 34.8 p -74.63 -24.6 58.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -68.45 -48.81 63.56 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 119.639 -0.22 . . . . 0.0 110.993 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.6 pp -71.95 -12.46 15.91 Favored 'Isoleucine or valine' 0 C--N 1.338 0.066 0 CA-C-N 118.372 0.533 . . . . 0.0 110.991 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.96 -27.83 30.22 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 173.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.59 -27.23 34.37 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.7 pt -106.92 29.58 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.039 0.536 . . . . 0.0 110.372 174.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.8 t -78.35 -14.57 59.34 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.29 0.636 . . . . 0.0 111.813 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -155.79 144.08 20.05 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -60.2 -33.12 71.8 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.409 -0.329 . . . . 0.0 111.584 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -119.67 116.26 25.62 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.738 0.304 . . . . 0.0 110.42 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -108.62 159.4 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.333 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -86.6 143.82 27.47 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.949 0.404 . . . . 0.0 111.155 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.85 103.97 6.09 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 173.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -135.44 153.31 51.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.226 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -138.73 11.88 2.7 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.123 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 175.17 -134.45 2.74 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -76.54 12.49 1.25 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.096 0.558 . . . . 0.0 111.381 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.1 mt -66.91 157.97 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.41 1.084 . . . . 0.0 110.112 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -145.82 21.02 1.46 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -67.87 160.48 28.35 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.054 0.542 . . . . 0.0 111.986 -173.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.16 161.99 35.4 Favored 'General case' 0 C--N 1.337 0.065 0 C-N-CA 124.353 1.061 . . . . 0.0 110.229 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.4 p -153.8 156.61 5.17 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -89.32 138.47 31.41 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 117.671 0.214 . . . . 0.0 110.624 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.97 158.46 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-O 120.828 0.347 . . . . 0.0 111.233 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.02 159.25 24.78 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 171.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.81 140.21 92.1 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.629 2.219 . . . . 0.0 109.78 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -78.41 168.24 20.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.244 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.452 -0.372 0 C-N-CA 123.067 0.547 . . . . 0.0 110.319 -170.548 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -75.33 170.83 15.32 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.153 0.501 . . . . 0.0 112.304 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.4 t -100.38 27.45 5.72 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -168.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.52 ' HA ' ' CE2' ' A' ' 115' ' ' PHE . 0.0 OUTLIER 55.33 17.41 2.1 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.122 0.419 . . . . 0.0 111.155 -176.414 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -147.82 140.24 24.47 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.247 0.619 . . . . 0.0 111.632 -177.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.5 m -136.06 148.52 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.704 169.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -85.22 140.45 30.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.9 p -122.98 98.55 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 121.779 0.8 . . . . 0.0 108.906 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.36 169.49 51.34 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.41 26.76 71.92 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 119.226 -0.763 . . . . 0.0 113.901 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.44 ' HB3' ' H ' ' A' ' 110' ' ' TYR . 18.5 tp -63.0 122.18 73.46 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 119.626 1.713 . . . . 0.0 107.352 173.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.65 170.07 20.86 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.164 2.576 . . . . 0.0 111.537 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.46 179.06 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 124.357 3.371 . . . . 0.0 112.753 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 61.45 -79.7 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 pp -65.2 164.8 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 118.288 0.494 . . . . 0.0 111.539 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -146.88 -24.67 0.41 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -154.28 -36.69 0.1 Allowed 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -174.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -67.48 -39.99 85.25 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.006 0.366 . . . . 0.0 111.944 -173.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -74.48 -35.33 63.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.179 -0.326 . . . . 0.0 111.37 -172.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.7 pt -83.91 -28.03 7.34 Favored 'Isoleucine or valine' 0 C--O 1.23 0.041 0 O-C-N 122.145 -0.347 . . . . 0.0 110.967 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.0 m -79.77 -5.63 55.68 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.15 -14.13 14.99 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 171.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 m -95.14 -17.79 21.49 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -120.65 0.74 10.49 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.374 0.534 . . . . 0.0 111.986 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.0 tpt85 -70.38 -21.4 62.87 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 122.716 0.406 . . . . 0.0 110.831 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -69.15 -5.71 24.16 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.674 0.789 . . . . 0.0 111.947 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -112.68 -13.34 13.27 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.239 0.215 . . . . 0.0 111.427 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.5 168.6 18.81 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -70.9 149.14 59.1 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.294 2.663 . . . . 0.0 110.804 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.404 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -164.77 158.73 17.86 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -170.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.2 mm -136.86 173.17 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 171.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.6 156.03 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 118.445 0.566 . . . . 0.0 110.606 178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -149.18 164.24 35.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.542 0.337 . . . . 0.0 111.039 -175.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.49 ' CZ2' ' HE3' ' A' ' 98' ' ' LYS . 24.2 p90 -155.46 156.32 30.75 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.637 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 25.5 Cg_endo -75.42 -11.66 20.72 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 124.026 3.151 . . . . 0.0 110.683 -169.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.637 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 89.9 m-70 -105.52 5.94 31.87 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.847 0.859 . . . . 0.0 111.363 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.49 ' HE3' ' CZ2' ' A' ' 95' ' ' TRP . 68.8 tttt -64.65 157.84 26.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.717 0.807 . . . . 0.0 112.568 -176.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.258 0 C-N-CA 125.037 1.335 . . . . 0.0 113.303 -178.795 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.778 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.44 ' H ' ' HB3' ' A' ' 72' ' ' LEU . 0.0 OUTLIER 60.54 147.7 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 113.859 -1.171 . . . . 0.0 113.991 -177.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.49 -173.45 3.99 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.185 0.594 . . . . 0.0 110.043 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.35 134.0 26.78 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.19 149.64 21.7 Favored 'General case' 0 CA--C 1.522 -0.108 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.8 mp -118.59 144.69 45.95 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 173.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.52 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.7 p90 -158.93 177.35 11.25 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -117.89 -12.74 10.12 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -129.29 142.66 50.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.973 0.416 . . . . 0.0 112.03 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -80.76 -6.05 57.97 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.831 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 75.1 p -82.73 -19.26 38.28 Favored 'General case' 0 N--CA 1.457 -0.113 0 O-C-N 122.137 -0.352 . . . . 0.0 111.075 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.5 t -72.58 -44.27 62.27 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.0 m -70.84 -26.2 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -69.94 -41.6 74.35 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.764 -0.585 . . . . 0.0 110.702 -176.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.54 -36.6 60.44 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.04 0.382 . . . . 0.0 111.792 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -76.86 -15.37 59.73 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.06 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 77.3 mt -95.42 -17.32 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.336 0.254 . . . . 0.0 110.467 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -90.84 -14.92 30.91 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.608 -0.682 . . . . 0.0 111.121 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.29 46.32 1.82 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.491 0.717 . . . . 0.0 111.437 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 22.5 p -138.27 176.7 8.47 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 39.5 mm -92.88 164.35 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 125.363 1.465 . . . . 0.0 108.351 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -133.46 150.63 51.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.778 0.323 . . . . 0.0 110.836 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.16 -179.86 5.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 175.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -55.84 -4.76 0.12 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -171.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -170.17 14.03 0.05 OUTLIER Glycine 0 CA--C 1.527 0.831 0 CA-C-N 118.854 0.752 . . . . 0.0 113.137 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 134' ' ' LYS . 21.4 ttmt -157.89 -178.05 7.02 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.596 1.198 . . . . 0.0 111.23 -174.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 150' ' ' GLN . 67.2 mt -112.24 169.56 8.78 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.078 0.551 . . . . 0.0 110.972 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.41 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 0.3 OUTLIER -145.81 139.53 26.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.27 0.628 . . . . 0.0 109.717 179.126 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.0 mp -136.8 149.71 47.91 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.346 0.521 . . . . 0.0 110.069 170.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.3 p -71.1 154.57 41.64 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.9 p -148.77 7.34 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 O-C-N 122.402 -0.187 . . . . 0.0 111.479 -177.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.2 m 53.16 46.99 25.44 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.847 -0.533 . . . . 0.0 110.799 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.9 t -47.6 139.83 8.27 Favored Pre-proline 0 CA--C 1.53 0.199 0 C-N-CA 124.351 1.06 . . . . 0.0 112.234 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -80.1 -15.14 11.79 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 124.142 3.228 . . . . 0.0 113.854 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.7 t -89.47 -24.0 21.95 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.841 1.201 . . . . 0.0 111.657 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.496 HG23 ' H ' ' A' ' 145' ' ' LYS . 2.4 mm -121.63 -174.95 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.496 ' H ' HG23 ' A' ' 144' ' ' ILE . 63.9 pttt -69.97 -32.67 71.0 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.346 -0.846 . . . . 0.0 109.139 171.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -165.58 150.14 8.59 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.781 1.633 . . . . 0.0 107.187 170.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.85 105.49 2.49 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.41 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 78.1 Cg_exo -53.39 145.11 47.17 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.031 3.154 . . . . 0.0 113.905 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.4 m -116.72 148.61 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.059 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 25.3 mp0 -82.03 157.33 24.21 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -174.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.0 mm -136.59 142.37 38.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.379 0.672 . . . . 0.0 109.36 171.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.6 ttp85 -157.66 104.4 1.8 Allowed Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 171.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -60.72 167.17 8.84 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 124.507 3.471 . . . . 0.0 114.819 175.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -111.1 136.43 50.15 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.348 171.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -103.18 150.12 23.99 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.478 0.711 . . . . 0.0 112.455 -176.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.6 mp -94.47 97.7 10.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.466 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.9 t -156.09 -33.1 0.09 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.803 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -138.78 22.36 2.67 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.7 m -68.62 -25.04 64.65 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -175.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -153.67 159.62 42.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.239 0.616 . . . . 0.0 110.518 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -151.77 154.26 35.91 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.6 t -136.42 144.29 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -174.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 63.8 mtm -141.74 15.36 2.14 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -151.38 10.79 0.59 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.336 0.516 . . . . 0.0 112.062 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.94 12.25 84.1 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 121.764 -0.585 . . . . 0.0 111.931 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.5 m 52.89 73.17 0.37 Allowed 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -70.85 173.55 4.65 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -54.44 133.97 59.07 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.208 1.938 . . . . 0.0 112.073 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.4 mp -106.66 160.87 15.12 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 123.603 0.761 . . . . 0.0 109.904 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -150.08 145.04 18.2 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.3 -20.84 33.78 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.425 2.75 . . . . 0.0 114.176 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -91.1 2.93 55.96 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.457 0.571 . . . . 0.0 111.126 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -131.07 15.96 5.14 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.655 0.382 . . . . 0.0 111.117 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 18.7 m -128.08 140.17 52.1 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 120.713 0.292 . . . . 0.0 110.805 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.4 tt -113.28 150.57 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 C-N-CA 123.204 0.602 . . . . 0.0 109.992 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -120.84 153.16 37.5 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 18.0 m -141.68 151.74 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.792 0.437 . . . . 0.0 110.422 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -164.34 171.48 39.87 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.47 11.04 80.95 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 11.9 p -63.26 138.62 97.39 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.18 -52.89 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.502 2.135 . . . . 0.0 112.218 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -162.78 -47.24 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.331 -0.842 . . . . 0.0 113.066 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -71.38 140.93 37.75 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.747 2.298 . . . . 0.0 111.778 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.716 ' CD1' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -151.88 -87.12 0.07 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 119.151 -0.452 . . . . 0.0 111.463 176.514 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.716 ' H ' ' CD1' ' A' ' 184' ' ' LEU . 71.2 mtp180 59.38 126.48 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 126.393 1.877 . . . . 0.0 112.181 -173.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.5 -20.23 65.42 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.896 -0.503 . . . . 0.0 110.364 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 68.1 t -69.43 -54.01 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 122.434 0.294 . . . . 0.0 110.616 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -81.71 -23.38 36.81 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.341 -0.224 . . . . 0.0 111.054 -174.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 53.1 tp -71.0 -33.6 70.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -79.49 -33.45 42.2 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.4 mmt -69.83 -38.63 76.61 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.877 0.308 . . . . 0.0 110.304 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 94.1 mt -73.1 -37.32 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.6 mmt -67.07 -20.08 65.76 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.975 -0.453 . . . . 0.0 110.695 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -86.3 -19.88 29.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.872 0.306 . . . . 0.0 111.784 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -96.58 -14.34 22.29 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.0 -13.45 10.02 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -136.66 21.22 3.1 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 81.83 -150.14 29.09 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 122.141 -0.349 . . . . 0.0 112.252 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.19 121.81 5.98 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 123.086 0.374 . . . . 0.0 112.221 -171.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 90.9 t -100.49 147.19 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 124.242 1.017 . . . . 0.0 109.612 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 46.7 t -102.12 -43.73 5.66 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -159.7 158.42 31.33 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.37 0.129 . . . . 0.0 111.105 -170.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -152.88 156.97 39.97 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.849 0.46 . . . . 0.0 110.648 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -178.16 -176.05 45.8 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 42.8 mm -113.58 90.81 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 14.1 t70 56.72 -63.57 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -169.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 55.3 p 45.67 56.41 5.88 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.87 130.59 94.89 Favored Pre-proline 0 N--CA 1.453 -0.307 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -78.32 -14.58 14.67 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.517 3.478 . . . . 0.0 113.681 -173.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -94.65 -36.82 11.61 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 118.643 0.656 . . . . 0.0 110.317 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 94.3 mt -96.44 -7.39 35.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.867 0.467 . . . . 0.0 109.925 176.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 50.16 44.55 26.07 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.792 1.237 . . . . 0.0 111.87 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.99 155.53 62.33 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -174.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -84.74 177.83 5.28 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 123.807 3.005 . . . . 0.0 111.073 174.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -138.73 22.81 2.67 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.113 0.565 . . . . 0.0 110.862 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 62.72 8.24 20.01 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.63 -0.539 . . . . 0.0 113.677 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -128.58 141.04 51.49 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.952 0.876 . . . . 0.0 109.274 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -86.16 161.64 34.55 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-O 121.526 0.515 . . . . 0.0 113.942 -171.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -149.53 148.51 29.47 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.9 t -141.64 154.82 19.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -135.69 150.48 49.59 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.619 0.247 . . . . 0.0 110.61 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -124.66 154.57 40.57 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 66.5 p -86.02 3.01 44.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.156 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -139.3 140.53 37.61 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.32 0.648 . . . . 0.0 110.005 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -74.2 -19.68 60.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.395 -0.191 . . . . 0.0 110.661 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -71.64 -37.0 70.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 44.2 m -72.49 -30.26 64.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -69.25 -49.97 51.31 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 119.484 -0.293 . . . . 0.0 111.041 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 41.8 pt -68.16 -18.31 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.032 0 CA-C-N 118.43 0.559 . . . . 0.0 110.79 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.55 -25.63 35.69 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -84.95 -23.23 28.87 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.6 pt -105.23 25.75 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 122.734 0.414 . . . . 0.0 110.833 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 20.0 t -84.54 -9.4 58.36 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.12 0.568 . . . . 0.0 112.271 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -156.65 143.97 18.98 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 249' ' ' GLU . 10.1 ptp180 -60.04 -52.57 64.81 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.214 -175.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -93.05 115.79 28.44 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.374 0.988 . . . . 0.0 110.139 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -83.52 147.24 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 171.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -81.99 127.19 32.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.84 17.25 6.82 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -84.15 130.34 34.85 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.165 0.586 . . . . 0.0 112.26 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -152.49 143.41 22.99 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 61.85 -144.31 48.93 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -177.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.1 8.73 31.27 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.086 0.554 . . . . 0.0 111.669 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 66.7 mt -96.62 153.81 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 123.442 0.697 . . . . 0.0 110.264 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -130.52 133.95 46.66 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -145.37 145.37 31.15 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 124.502 1.121 . . . . 0.0 108.576 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -158.93 155.31 27.4 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.29 0.636 . . . . 0.0 109.622 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 8.7 p -157.6 154.31 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 235' ' ' ARG . 42.8 mt-10 -94.13 136.4 34.46 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 117.786 0.266 . . . . 0.0 110.64 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.4 m -101.72 161.34 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.01 159.61 29.28 Favored Pre-proline 0 N--CA 1.454 -0.226 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.776 169.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.2 136.66 76.39 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.796 2.33 . . . . 0.0 109.27 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -87.28 167.55 13.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.052 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.451 -0.384 0 C-N-CA 123.626 0.771 . . . . 0.0 110.018 -170.455 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 . . . . . 0 N--CA 1.458 -0.026 0 CA-C-O 120.988 0.423 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -151.19 157.03 42.13 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.225 -171.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.0 t -94.01 161.24 14.37 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 50.1 mtm105 -81.96 24.32 0.64 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.32 0.248 . . . . 0.0 110.894 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -140.27 138.15 34.77 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.698 0.399 . . . . 0.0 110.804 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.36 155.78 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.866 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -86.97 139.04 30.99 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 171.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.23 115.48 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 174.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.73 137.98 19.55 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.47 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.49 158.61 6.17 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 121.985 0.77 . . . . 0.0 114.69 173.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.5 tp -160.09 126.37 2.44 Favored Pre-proline 0 N--CA 1.451 -0.385 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -73.74 142.23 31.84 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.622 1.548 . . . . 0.0 109.12 -178.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.54 -3.23 3.2 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.93 3.087 . . . . 0.0 115.165 -174.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -99.88 -21.27 15.77 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 pp -133.36 -171.89 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 119.459 1.027 . . . . 0.0 111.203 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -136.68 -163.24 1.38 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.465 0.706 . . . . 0.0 112.291 -172.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -40.62 -31.08 0.14 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.853 2.061 . . . . 0.0 113.459 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -64.61 -30.26 71.28 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -175.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -80.04 -33.99 38.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.083 -0.386 . . . . 0.0 111.133 -173.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.4 mt -73.78 -36.19 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 33.5 m -68.75 -21.77 64.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.76 -13.23 27.64 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.4 m -84.75 -29.54 25.41 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.285 0.493 . . . . 0.0 112.022 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -110.49 5.15 21.08 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -176.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.6 tpt85 -67.96 -14.0 62.62 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.973 -0.454 . . . . 0.0 110.365 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -64.78 -15.72 62.03 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.813 1.245 . . . . 0.0 111.81 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -120.83 -5.95 9.62 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.917 0.339 . . . . 0.0 111.917 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.04 163.82 10.31 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -57.93 139.04 88.97 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.141 2.56 . . . . 0.0 111.342 177.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.38 167.5 26.87 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.066 0.46 . . . . 0.0 111.096 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 pt -138.08 163.68 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.5 p -132.66 145.04 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -154.04 171.37 19.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.081 0.467 . . . . 0.0 110.395 -174.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.418 ' CH2' ' HE3' ' A' ' 98' ' ' LYS . 18.8 p90 -155.14 163.04 25.87 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 174.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.497 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 89.8 Cg_endo -71.31 -7.44 21.32 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 CA-C-N 121.232 1.476 . . . . 0.0 110.844 -170.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.497 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 3.4 m-70 -99.73 2.81 44.57 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.726 0.811 . . . . 0.0 111.491 -177.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.418 ' HE3' ' CH2' ' A' ' 95' ' ' TRP . 12.4 tptm -54.6 158.24 2.62 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.054 0.942 . . . . 0.0 112.693 -178.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.214 0 C-N-CA 124.078 0.951 . . . . 0.0 110.918 179.635 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.83 0 CA-C-O 119.364 -0.686 . . . . 0.0 114.173 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.75 153.61 45.95 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.519 1.159 . . . . 0.0 108.888 174.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.18 -178.63 6.74 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.274 0.488 . . . . 0.0 111.972 -174.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -141.11 140.51 34.16 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.5 mp -96.32 148.91 22.27 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 118.497 0.59 . . . . 0.0 112.326 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.9 mp -115.52 142.28 46.93 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 170.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -131.7 167.8 18.86 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.404 0.621 . . . . 0.0 111.93 -174.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -109.28 -29.85 8.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.932 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -121.8 153.17 38.66 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -85.97 -17.84 34.24 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.176 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.7 t -85.76 -17.67 35.19 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.128 -0.358 . . . . 0.0 110.198 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 41.9 t -72.36 -39.5 68.03 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.31 -26.71 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -71.05 -34.91 71.7 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.971 -0.455 . . . . 0.0 110.311 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -77.97 -35.17 50.55 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 122.176 -0.328 . . . . 0.0 111.654 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 pp -78.91 -16.7 56.66 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.43 0.559 . . . . 0.0 111.458 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.4 mt -92.33 -22.7 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 122.254 0.222 . . . . 0.0 110.454 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -97.9 -10.21 24.98 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -117.56 35.04 4.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.175 0.59 . . . . 0.0 111.269 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 26.8 p -136.76 -179.59 5.78 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.906 0.482 . . . . 0.0 111.331 -176.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.1 mm -87.4 159.44 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 124.391 1.077 . . . . 0.0 109.018 -177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.65 154.79 43.56 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.759 0.314 . . . . 0.0 110.791 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -146.39 85.11 1.64 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.516 0.675 . . . . 0.0 110.753 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 55.43 0.13 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.22 -12.18 0.07 OUTLIER Glycine 0 CA--C 1.527 0.841 0 CA-C-N 119.568 1.076 . . . . 0.0 114.072 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.1 170.84 15.06 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 118.195 0.998 . . . . 0.0 109.609 177.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.97 166.05 10.65 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -172.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.415 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -142.39 139.49 31.71 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.891 -177.52 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.1 tp -124.55 128.72 49.36 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 48.9 t -77.03 139.48 40.06 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.1 m -137.65 -0.97 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.116 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 29.7 t 45.68 60.38 3.15 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.265 0.626 . . . . 0.0 111.116 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.2 m -56.96 150.48 38.79 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.941 -175.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.82 11.91 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.795 2.996 . . . . 0.0 114.907 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.403 HG23 HG13 ' A' ' 144' ' ' ILE . 15.1 t -121.23 -15.39 8.17 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.595 1.089 . . . . 0.0 111.832 -174.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.403 HG13 HG23 ' A' ' 143' ' ' THR . 0.6 OUTLIER -168.25 -176.44 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 125.178 1.391 . . . . 0.0 109.635 -177.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -120.74 16.74 11.91 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.739 0.816 . . . . 0.0 110.953 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -141.38 34.35 1.67 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -173.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -129.16 80.1 73.16 Favored Pre-proline 0 C--N 1.34 0.179 0 CA-C-N 118.927 0.785 . . . . 0.0 111.193 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.415 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 19.8 Cg_exo -67.69 145.56 70.02 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.908 2.405 . . . . 0.0 108.765 169.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.8 m -75.65 133.92 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -86.27 150.28 24.47 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 26.3 mm -130.17 137.36 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 C-N-CA 122.743 0.417 . . . . 0.0 110.646 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -141.45 92.19 8.28 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.53 162.87 34.89 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 124.174 3.25 . . . . 0.0 112.742 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -93.47 142.69 27.04 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 172.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -101.52 157.1 17.06 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.219 0.533 . . . . 0.0 110.489 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.5 mp -90.33 178.99 5.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.518 0.675 . . . . 0.0 111.402 -176.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.7 m 65.12 4.43 2.56 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.501 1.92 . . . . 0.0 116.115 176.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 52.9 p30 -135.58 12.65 3.46 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 120.345 1.43 . . . . 0.0 113.317 172.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.8 m -66.13 -32.46 73.91 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -152.84 161.27 42.76 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 122.817 0.447 . . . . 0.0 111.015 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -152.97 152.89 31.94 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.956 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.97 140.66 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 28.3 ttp -132.44 13.7 4.55 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -159.66 -57.75 0.06 Allowed 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 61.33 11.64 28.18 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.409 -0.662 . . . . 0.0 113.54 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.4 t -109.36 -4.28 16.51 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.174 0.987 . . . . 0.0 112.184 -175.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -124.38 136.74 28.1 Favored Pre-proline 0 CA--C 1.531 0.218 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -68.3 160.52 48.62 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.146 2.564 . . . . 0.0 110.049 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 46.7 mt -113.04 153.31 28.31 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.51 0.324 . . . . 0.0 110.769 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -145.0 150.56 46.19 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.95 -5.43 13.43 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.442 2.761 . . . . 0.0 112.017 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -93.87 -1.22 55.13 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.028 0.531 . . . . 0.0 110.757 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.07 20.81 4.08 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.585 0.354 . . . . 0.0 111.444 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 13.6 m -119.99 143.17 48.18 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-O 120.987 0.422 . . . . 0.0 111.395 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.9 tt -113.05 141.3 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -106.92 152.36 24.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 76.1 t -137.97 144.98 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 123.633 0.773 . . . . 0.0 108.965 -173.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -148.02 149.55 21.64 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 112.04 -0.424 . . . . 0.0 112.04 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.4 22.1 54.97 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -172.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.6 m -60.94 144.91 89.86 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 116.913 0.356 . . . . 0.0 111.32 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.05 157.76 42.38 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.1 2.533 . . . . 0.0 108.715 170.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -66.73 -46.66 56.42 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.74 -176.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -78.48 27.08 0.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.452 2.768 . . . . 0.0 113.025 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.6 tp -64.96 -43.56 92.26 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.117 0.871 . . . . 0.0 110.38 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 59.35 129.64 0.01 OUTLIER 'General case' 0 C--N 1.341 0.223 0 C-N-CA 126.11 1.764 . . . . 0.0 112.955 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.86 -25.69 68.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 121.554 -0.716 . . . . 0.0 111.474 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 24.2 t -72.14 -47.85 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-O 120.662 0.268 . . . . 0.0 110.453 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -79.86 -24.64 41.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -176.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.8 tp -69.0 -33.85 74.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.78 -32.8 46.63 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.263 -0.273 . . . . 0.0 111.552 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.8 mmt -71.4 -35.99 71.23 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 122.305 -0.247 . . . . 0.0 110.475 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 71.5 mt -78.16 -40.51 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 22.5 mmt -60.67 -28.19 68.4 Favored 'General case' 0 C--N 1.334 -0.078 0 O-C-N 121.941 -0.474 . . . . 0.0 111.342 173.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -82.38 -21.51 35.83 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.419 0.554 . . . . 0.0 111.088 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.11 -19.69 26.67 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -110.1 -16.9 13.69 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.563 0.62 . . . . 0.0 111.875 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -135.1 -41.64 0.73 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.377 0.535 . . . . 0.0 111.587 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 69.19 162.76 3.08 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 121.474 0.486 . . . . 0.0 112.615 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 87.07 15.47 62.65 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 174.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.4 p -77.5 162.4 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.0 0.92 . . . . 0.0 110.597 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 51.5 t -137.28 -31.82 0.8 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -150.63 155.03 38.58 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.084 0.402 . . . . 0.0 111.814 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -156.27 156.85 34.76 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.346 0.658 . . . . 0.0 110.518 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 176.51 177.6 45.62 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.424 ' HA ' ' HA2' ' A' ' 218' ' ' GLY . 44.6 mm -103.83 87.05 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 26.2 t70 47.39 -86.85 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.927 -169.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.62 ' H ' ' HA ' ' A' ' 214' ' ' PRO . 12.6 m 49.72 65.16 1.49 Allowed 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.315 0.646 . . . . 0.0 111.091 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -59.75 133.46 89.27 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.74 -17.27 14.19 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 124.629 3.553 . . . . 0.0 114.282 -171.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -104.87 0.06 27.6 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.865 0.757 . . . . 0.0 111.282 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 97.5 mt -122.2 -13.21 8.16 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.807 0.843 . . . . 0.0 109.942 172.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt 52.97 38.11 26.29 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.534 1.134 . . . . 0.0 111.507 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -140.55 145.21 39.6 Favored Pre-proline 0 N--CA 1.461 0.12 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.62 ' HA ' ' H ' ' A' ' 207' ' ' THR . 64.6 Cg_endo -77.98 174.64 12.22 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.818 3.012 . . . . 0.0 110.769 173.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -132.16 21.07 4.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.417 0.687 . . . . 0.0 110.318 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 62.67 16.04 55.08 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 119.844 -0.42 . . . . 0.0 112.426 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -135.9 149.42 48.96 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.255 0.622 . . . . 0.0 110.273 -176.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 205' ' ' ILE . . . -95.11 162.0 23.66 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 116.629 -0.259 . . . . 0.0 112.773 -175.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -155.2 148.49 24.92 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 171.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.35 147.23 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -131.53 144.83 51.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.831 0.348 . . . . 0.0 110.301 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -128.88 165.66 20.59 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.027 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 78.5 p -94.66 -1.44 53.13 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -125.69 147.67 49.28 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 121.146 0.498 . . . . 0.0 111.62 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -78.5 -18.13 55.24 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.035 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -78.73 -37.14 42.15 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 58.6 p -80.14 -23.58 41.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -64.87 -41.67 95.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.722 0.409 . . . . 0.0 110.701 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.2 pt -84.21 -16.3 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 118.04 0.382 . . . . 0.0 111.592 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.66 -30.87 26.5 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 117.981 0.355 . . . . 0.0 110.86 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -77.04 -15.81 59.48 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.653 0.206 . . . . 0.0 111.38 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.79 24.51 4.78 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 C-N-CA 123.133 0.573 . . . . 0.0 110.523 177.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.0 t -77.53 -9.19 58.77 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.005 0.522 . . . . 0.0 111.037 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -152.29 145.66 24.79 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -56.84 -28.9 62.26 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.6 0.36 . . . . 0.0 111.664 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -121.7 122.19 39.01 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.4 m -82.79 151.85 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 C-N-CA 122.882 0.473 . . . . 0.0 109.961 174.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 11.1 mp0 -94.98 138.42 32.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -125.37 22.61 7.72 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.091 -175.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -88.3 132.37 34.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.851 0.46 . . . . 0.0 112.137 -172.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -150.18 12.42 0.75 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.206 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 176.19 -143.8 6.68 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 243' ' ' GLU . 0.4 OUTLIER -81.4 3.35 24.79 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.708 0.403 . . . . 0.0 111.273 178.163 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 77.1 mt -99.95 148.74 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.64 0.776 . . . . 0.0 109.719 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -147.57 140.86 25.24 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.755 0.312 . . . . 0.0 110.199 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -142.92 154.43 44.07 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.69 151.44 30.55 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.1 p -161.72 158.42 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -83.26 144.93 29.41 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.197 0.599 . . . . 0.0 111.206 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.1 m -123.75 163.72 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.4 ' C ' ' H ' ' A' ' 253' ' ' TYR . 0.0 OUTLIER -157.29 156.37 29.11 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.089 170.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -73.06 39.21 0.44 Allowed 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 125.052 3.835 . . . . 0.0 111.754 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . 0.4 ' H ' ' C ' ' A' ' 251' ' ' LYS . 0.3 OUTLIER 43.96 43.87 5.63 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.326 1.45 . . . . 0.0 111.331 -174.386 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 CA--C 1.537 0.48 0 C-N-CA 125.732 1.613 . . . . 0.0 113.723 177.533 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.115 0 N-CA-C 111.481 0.178 . . . . 0.0 111.481 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -153.33 159.34 42.46 Favored 'General case' 0 C--O 1.23 0.046 0 O-C-N 123.495 0.497 . . . . 0.0 110.219 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.9 t -93.26 20.56 6.88 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.168 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 70.1 mtm-85 55.97 21.03 4.64 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.423 0.689 . . . . 0.0 112.314 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.441 ' HZ2' ' HG2' ' A' ' 214' ' ' PRO . 4.1 ttpt -146.9 144.51 29.31 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.014 0.526 . . . . 0.0 110.068 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.2 m -138.34 152.39 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.155 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -88.63 140.9 28.99 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 170.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.61 138.47 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.57 -170.83 12.22 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -176.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.48 5.58 82.68 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.456 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.0 mt -70.86 148.79 94.88 Favored Pre-proline 0 N--CA 1.454 -0.245 0 CA-C-N 118.655 1.227 . . . . 0.0 108.823 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -62.38 160.53 31.0 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.328 2.019 . . . . 0.0 110.735 -177.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.64 -10.61 0.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 125.094 3.863 . . . . 0.0 114.781 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.47 ' CG ' ' H ' ' A' ' 76' ' ' ILE . 5.8 p-10 -105.0 -96.06 0.33 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 118.946 -0.55 . . . . 0.0 109.805 175.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.47 ' H ' ' CG ' ' A' ' 75' ' ' ASP . 3.1 tp 55.79 163.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -158.47 -179.28 7.94 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.863 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -59.14 -32.58 69.99 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.85 0.86 . . . . 0.0 112.633 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -91.09 -23.36 20.34 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 118.702 0.683 . . . . 0.0 112.629 -170.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -80.83 -27.16 36.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.3 mt -78.43 -40.53 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 97.0 m -63.31 -22.6 66.98 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.05 -21.25 24.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -72.94 -26.44 61.39 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.509 0.595 . . . . 0.0 111.88 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.494 ' CZ ' HD12 ' A' ' 151' ' ' ILE . 55.5 m-85 -124.31 13.17 8.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -17.29 64.39 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.992 -0.442 . . . . 0.0 111.269 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -68.41 -11.46 59.69 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.138 0.975 . . . . 0.0 111.466 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -123.61 36.15 4.69 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -173.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.1 175.46 34.74 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.11 151.83 61.74 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.9 3.066 . . . . 0.0 111.278 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 0.6 OUTLIER -166.89 163.34 16.19 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.872 -170.205 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.3 pt -141.42 169.55 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.0 p -135.38 150.12 29.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -152.91 174.11 14.52 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.419 0.628 . . . . 0.0 111.396 -177.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -160.41 157.94 24.89 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.496 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 37.8 Cg_endo -75.77 -17.97 17.49 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.237 1.958 . . . . 0.0 110.885 -169.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.496 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 22.6 m-70 -84.78 -7.57 59.15 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.561 0.744 . . . . 0.0 110.833 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -71.05 170.35 13.04 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.664 1.186 . . . . 0.0 112.997 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.297 0 C-N-CA 124.508 1.123 . . . . 0.0 109.655 178.07 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.599 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.13 140.59 51.48 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.51 -177.44 6.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.526 0.33 . . . . 0.0 110.591 -174.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -141.77 134.14 28.04 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.2 mp -92.28 150.83 20.64 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.245 0.545 . . . . 0.0 111.582 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.99 137.53 51.9 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 173.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -130.34 166.11 21.09 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.882 0.372 . . . . 0.0 111.117 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -113.03 -31.95 6.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.275 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -117.74 149.1 41.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.037 0.446 . . . . 0.0 111.074 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -83.91 -16.92 42.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.218 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.8 p -86.43 -17.61 33.85 Favored 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 122.16 -0.338 . . . . 0.0 111.549 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.3 m -71.94 -47.01 55.46 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.004 0.43 . . . . 0.0 110.584 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.0 p -72.58 -20.22 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.042 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -75.27 -32.28 61.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.66 -44.49 56.64 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.98 -28.79 62.6 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 118.388 -1.325 . . . . 0.0 110.994 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 83.4 mt -80.54 -16.65 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 118.292 0.496 . . . . 0.0 110.928 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -86.14 -17.83 33.91 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.731 -0.606 . . . . 0.0 110.364 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -112.11 14.12 20.67 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 20.0 p -98.99 171.56 7.96 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.168 0.508 . . . . 0.0 112.251 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 39.9 mm -90.17 167.96 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 125.522 1.529 . . . . 0.0 108.472 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -124.33 152.87 42.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.021 0.439 . . . . 0.0 112.004 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -145.61 -174.37 4.38 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 172.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.75 98.11 0.09 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.909 0.385 . . . . 0.0 111.342 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 78.06 -2.15 66.45 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.25 -0.75 . . . . 0.0 114.258 175.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -137.89 173.94 11.1 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.569 1.184 . . . . 0.0 110.372 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -110.19 174.8 5.7 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.479 0.712 . . . . 0.0 109.527 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.462 ' CE1' ' HB2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -144.07 149.21 36.26 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.2 0.6 . . . . 0.0 109.582 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.8 tp -132.22 146.32 51.93 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 169.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.1 m -89.25 133.72 34.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.793 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.1 p -156.18 154.11 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 124.32 1.048 . . . . 0.0 108.403 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.4 p -85.7 150.41 24.62 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.142 -0.349 . . . . 0.0 110.28 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.7 p -138.44 146.29 50.45 Favored Pre-proline 0 N--CA 1.456 -0.172 0 O-C-N 122.278 -0.264 . . . . 0.0 110.442 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.12 -8.85 20.3 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.214 2.609 . . . . 0.0 112.902 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.9 t -90.74 -18.21 25.38 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.239 0.927 . . . . 0.0 111.179 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.591 HG23 ' H ' ' A' ' 145' ' ' LYS . 2.3 mm -134.05 -144.72 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.591 ' H ' HG23 ' A' ' 144' ' ' ILE . 75.8 mmtt -119.41 -14.02 9.21 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.058 0.943 . . . . 0.0 109.158 169.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -156.99 157.35 34.57 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.612 1.165 . . . . 0.0 109.4 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.47 112.04 2.41 Favored Pre-proline 0 N--CA 1.457 -0.077 0 C-N-CA 122.54 0.336 . . . . 0.0 110.921 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.462 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 23.9 Cg_exo -67.68 133.98 31.32 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.894 2.396 . . . . 0.0 108.929 167.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.6 m -121.23 138.29 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 118.299 0.5 . . . . 0.0 110.354 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -74.56 154.77 38.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.494 HD12 ' CZ ' ' A' ' 85' ' ' PHE . 44.2 mm -138.55 141.32 37.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 124.886 1.274 . . . . 0.0 108.918 171.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.9 ttp85 -156.44 109.96 2.03 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 170.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -76.34 164.42 30.93 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.917 3.078 . . . . 0.0 111.356 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.413 ' CG ' ' HG3' ' A' ' 214' ' ' PRO . 55.0 t-105 -100.44 144.84 28.96 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.595 0.235 . . . . 0.0 111.209 176.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -107.02 156.85 18.31 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.494 0.718 . . . . 0.0 111.718 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.0 mp -100.89 15.41 28.61 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.091 0.556 . . . . 0.0 111.598 -175.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.4 t -90.86 -28.53 18.09 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -174.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -140.33 25.07 2.27 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.63 0.65 . . . . 0.0 112.631 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.0 t -70.74 -16.42 62.77 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -155.07 159.9 40.6 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.041 0.536 . . . . 0.0 110.524 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -156.86 156.74 33.67 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.587 0.232 . . . . 0.0 111.0 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.9 m -137.49 151.5 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 C-N-CA 123.152 0.581 . . . . 0.0 110.327 175.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 16.1 ttp -135.34 19.15 3.38 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.555 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 166' ' ' SER . 24.5 t0 -151.93 -179.66 7.67 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.86 18.75 0.61 Allowed Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.372 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 164' ' ' ASP . 9.0 t 54.6 50.46 15.92 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 117.736 0.768 . . . . 0.0 111.895 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -64.36 160.07 53.49 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 122.926 0.49 . . . . 0.0 109.962 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -52.19 147.55 27.38 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.72 2.947 . . . . 0.0 112.355 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 68.8 mt -122.09 162.04 21.97 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.357 0.663 . . . . 0.0 110.995 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -143.92 150.25 48.95 Favored Pre-proline 0 CA--C 1.529 0.168 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -68.28 -10.83 30.14 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.957 2.438 . . . . 0.0 111.508 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.78 2.48 56.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.149 0.58 . . . . 0.0 110.496 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -126.17 18.04 7.74 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.674 0.39 . . . . 0.0 111.09 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 16.4 m -127.55 139.74 52.58 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.722 0.296 . . . . 0.0 111.019 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.1 tt -111.62 152.07 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 C-N-CA 123.16 0.584 . . . . 0.0 110.474 -176.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.404 ' CD1' ' CE1' ' A' ' 253' ' ' TYR . 6.3 t80 -114.68 143.84 44.39 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.8 m -140.92 132.36 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 122.611 0.364 . . . . 0.0 110.287 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -142.44 179.95 19.8 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.99 10.12 83.37 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -171.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 28.9 m -72.82 155.42 90.71 Favored Pre-proline 0 N--CA 1.455 -0.177 0 C-N-CA 122.904 0.481 . . . . 0.0 110.891 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.74 -172.6 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.756 2.971 . . . . 0.0 109.785 175.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -55.8 -48.4 96.67 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.213 -0.898 . . . . 0.0 112.236 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.59 138.75 17.5 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.223 1.949 . . . . 0.0 110.939 174.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -155.52 16.32 0.39 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.371 0.668 . . . . 0.0 111.448 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -42.71 142.1 0.93 Allowed 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.963 1.305 . . . . 0.0 112.334 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.73 -21.57 61.74 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -171.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.5 t -60.75 -52.13 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-N 118.306 0.503 . . . . 0.0 110.838 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -83.54 -20.09 34.5 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.387 -0.196 . . . . 0.0 110.798 -175.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 25.2 tp -73.85 -32.9 63.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -77.63 -39.31 45.69 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 117.563 0.165 . . . . 0.0 111.046 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 25.5 mmt -64.88 -49.81 69.02 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -177.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.8 mt -65.87 -34.57 71.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -178.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.4 tpp -74.23 -13.09 60.73 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 122.469 -0.145 . . . . 0.0 110.966 -178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -102.26 -12.61 17.85 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.029 -0.42 . . . . 0.0 112.032 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -92.4 -18.06 23.78 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.241 0.473 . . . . 0.0 111.369 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.47 -20.79 10.63 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.18 0.445 . . . . 0.0 111.036 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -141.05 46.83 1.73 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.958 0.503 . . . . 0.0 109.97 -177.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.55 136.79 4.57 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.016 0.817 . . . . 0.0 113.395 -175.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 135.8 7.15 1.88 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.123 0.868 . . . . 0.0 111.747 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 40.9 t -72.31 149.3 9.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 117.617 0.709 . . . . 0.0 110.903 -177.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 23.5 p -134.2 -23.04 1.73 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -151.17 150.94 31.23 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -149.67 155.23 39.87 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.429 0.692 . . . . 0.0 109.285 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -177.27 -176.32 45.27 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 30.4 mm -100.23 152.81 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -53.34 132.03 38.6 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 33.4 p -144.2 167.66 21.9 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 122.584 0.353 . . . . 0.0 110.518 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . 0.422 ' HA ' ' HD3' ' A' ' 209' ' ' PRO . 12.6 t70 -132.97 136.57 27.87 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 119.392 -0.337 . . . . 0.0 110.212 174.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 208' ' ' ASP . 22.1 Cg_exo -68.61 -9.35 25.86 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 124.532 3.488 . . . . 0.0 115.809 -172.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.27 -26.24 68.41 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 119.737 1.153 . . . . 0.0 110.92 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 19.3 tp -150.35 3.83 0.51 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.971 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 55.11 39.67 31.58 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.208 1.003 . . . . 0.0 110.605 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -100.08 146.2 31.52 Favored Pre-proline 0 N--CA 1.457 -0.083 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.373 -176.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.441 ' HG2' ' HZ2' ' A' ' 66' ' ' LYS . 30.7 Cg_endo -82.1 164.91 17.32 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.289 2.659 . . . . 0.0 113.465 -177.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -128.39 -174.64 3.28 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.921 1.289 . . . . 0.0 108.372 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -71.45 164.25 53.98 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.0 173.47 0.07 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -135.21 177.38 19.41 Favored Glycine 0 CA--C 1.525 0.718 0 O-C-N 121.97 -0.457 . . . . 0.0 112.553 -173.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.02 155.18 42.03 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.173 0.511 . . . . 0.0 111.077 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 63.6 t -139.45 145.88 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.61 148.19 46.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.854 0.359 . . . . 0.0 110.274 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -122.79 150.24 43.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.416 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 68.5 m -83.32 2.6 35.41 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 111.389 0.144 . . . . 0.0 111.389 175.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -131.19 138.9 49.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.775 0.43 . . . . 0.0 110.559 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . 0.421 ' CD ' ' H ' ' A' ' 225' ' ' GLN . 0.0 OUTLIER -75.45 -12.83 60.32 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 176.601 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 -82.35 -37.11 26.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 19.9 m -73.26 -29.04 62.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -67.17 -53.04 34.11 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 119.687 -0.196 . . . . 0.0 110.749 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.2 pt -69.56 -16.59 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 CA-C-N 118.126 0.421 . . . . 0.0 111.092 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.9 -24.7 33.03 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.713 0.233 . . . . 0.0 110.821 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.74 -21.52 26.53 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.1 pt -110.43 27.49 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.071 0.548 . . . . 0.0 110.345 174.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 20.4 t -80.68 -9.99 59.76 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.257 0.623 . . . . 0.0 112.065 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -158.3 145.12 17.63 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 55.7 ttm-85 -57.06 -32.63 66.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.562 0.345 . . . . 0.0 111.665 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -122.54 115.92 23.01 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 23.5 m -99.36 161.3 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.119 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -85.18 142.34 29.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 110.463 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.31 105.44 7.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 173.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -131.73 148.01 52.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.434 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -141.76 20.62 2.16 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.452 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 95.75 131.04 6.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 54.73 4.31 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.52 1.528 . . . . 0.0 114.7 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.2 mt -145.09 136.33 20.12 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 CA-C-N 118.702 0.683 . . . . 0.0 109.937 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -129.16 147.44 51.01 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.825 0.345 . . . . 0.0 111.367 173.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -144.9 170.52 15.98 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.612 1.165 . . . . 0.0 109.648 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.88 160.41 39.37 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.635 0.774 . . . . 0.0 110.303 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.0 p -152.23 152.11 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -85.84 126.88 34.38 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.05 157.7 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 CA-C-O 121.039 0.447 . . . . 0.0 111.84 -176.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.46 158.41 27.82 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.57 169.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.64 133.28 57.02 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.564 2.176 . . . . 0.0 107.884 172.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . 0.404 ' CE1' ' CD1' ' A' ' 176' ' ' PHE . 2.3 t80 -75.28 118.88 18.68 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.087 -173.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.335 0 C-N-CA 127.434 2.293 . . . . 0.0 114.43 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.749 0.309 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.21 157.52 43.43 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -172.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.9 t -102.75 150.45 23.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.076 174.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -85.63 3.74 39.48 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.652 0.381 . . . . 0.0 110.281 174.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -100.02 135.96 40.66 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.85 0.86 . . . . 0.0 109.413 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 p -149.75 144.41 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.816 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -92.2 144.42 25.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 m -132.69 130.03 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -141.37 148.3 19.96 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.94 37.43 3.41 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -175.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.6 mt -85.96 159.63 54.05 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -70.71 153.79 64.34 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.959 2.439 . . . . 0.0 108.968 172.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.03 3.19 4.13 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.884 3.056 . . . . 0.0 112.354 -178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -94.0 -27.12 16.5 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 pp -136.39 174.81 11.61 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-N 118.524 0.602 . . . . 0.0 110.252 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -163.39 5.8 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -145.41 -45.71 0.22 Allowed 'General case' 0 C--N 1.341 0.21 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -174.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -84.62 -34.14 23.17 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.622 0.646 . . . . 0.0 112.371 -172.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -73.45 -27.11 61.24 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.725 0.298 . . . . 0.0 110.509 -176.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.7 pt -88.01 -30.35 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 122.465 0.306 . . . . 0.0 110.916 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 56.8 m -71.75 -14.87 62.13 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.94 -22.07 17.64 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.5 m -88.2 -15.53 35.71 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -123.29 10.21 9.25 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.852 0.751 . . . . 0.0 113.003 -174.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -83.63 -12.01 56.54 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.601 0.36 . . . . 0.0 111.945 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.498 ' HG3' ' CD2' ' A' ' 88' ' ' PHE . 15.9 ptm180 -72.79 -18.22 61.5 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.498 ' CD2' ' HG3' ' A' ' 87' ' ' ARG . 70.0 m-85 -105.61 1.84 27.7 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.339 0.256 . . . . 0.0 111.348 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.5 163.41 9.82 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.22 140.78 45.6 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.228 2.618 . . . . 0.0 110.237 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.04 166.15 33.33 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.257 0.551 . . . . 0.0 112.279 -177.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.8 pt -137.15 -179.95 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.597 173.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.0 p -132.4 157.75 43.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 O-C-N 122.283 -0.261 . . . . 0.0 110.349 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -148.32 161.72 40.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.296 0.569 . . . . 0.0 111.47 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.421 ' CZ2' ' HE3' ' A' ' 98' ' ' LYS . 27.7 p90 -157.1 158.75 31.26 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 105.539 -2.022 . . . . 0.0 105.539 169.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.572 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 59.8 Cg_endo -72.81 -10.05 24.46 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.494 1.463 . . . . 0.0 111.018 -169.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.572 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 17.1 m-70 -104.93 19.3 20.82 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.682 1.193 . . . . 0.0 110.444 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.51 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -36.39 -62.67 0.44 Allowed 'General case' 0 C--N 1.34 0.161 0 C-N-CA 125.571 1.549 . . . . 0.0 113.756 -171.133 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 124.02 0.928 . . . . 0.0 112.534 -173.613 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.787 0 CA-C-O 119.833 -0.426 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.39 141.7 32.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.719 0.759 . . . . 0.0 110.18 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.01 -179.1 7.19 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.985 0.514 . . . . 0.0 110.306 -176.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -129.24 121.12 26.93 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -176.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 mp -83.92 147.35 27.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.592 0.711 . . . . 0.0 111.292 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 mp -124.12 104.03 8.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -88.25 162.82 16.42 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.779 0.323 . . . . 0.0 110.249 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -90.26 -21.55 22.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.216 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -132.03 149.79 52.33 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.533 0.206 . . . . 0.0 111.534 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -77.49 -16.63 58.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.231 0.213 . . . . 0.0 110.629 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 59.0 m -93.64 -17.71 22.97 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 122.457 0.303 . . . . 0.0 111.305 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.0 m -70.59 -44.58 67.03 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.5 p -74.36 -15.66 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.997 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -78.3 -33.8 49.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 122.013 -0.429 . . . . 0.0 109.926 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.27 -36.74 61.17 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.25 0.477 . . . . 0.0 110.843 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.415 ' HB2' ' CD2' ' A' ' 88' ' ' PHE . 0.5 OUTLIER -65.32 -40.18 93.41 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 57.5 mt -85.81 -9.93 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 O-C-N 121.663 -0.648 . . . . 0.0 111.893 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -107.66 -3.72 18.94 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.98 -0.45 . . . . 0.0 112.163 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -122.57 6.59 9.49 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 74.9 m -113.75 -172.94 2.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.399 0.545 . . . . 0.0 110.516 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.2 mp -68.05 154.22 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.674 0.79 . . . . 0.0 108.904 -170.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -137.16 157.56 46.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -143.82 62.16 1.36 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.208 0.528 . . . . 0.0 110.895 175.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.2 t70 50.93 8.84 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.904 1.681 . . . . 0.0 115.534 171.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -179.51 -19.02 0.03 OUTLIER Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.558 -0.713 . . . . 0.0 111.895 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -129.94 162.67 28.1 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 117.642 0.721 . . . . 0.0 109.39 171.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.19 163.04 16.89 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -145.22 162.03 38.12 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.965 0.412 . . . . 0.0 111.186 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.4 tp -141.89 145.51 34.67 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 170.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 79.4 m -84.23 128.61 34.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.3 m -141.21 166.13 18.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 122.898 0.479 . . . . 0.0 110.616 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.0 t -65.91 149.4 50.27 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.2 t -151.64 91.33 3.82 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -176.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -55.24 -11.37 4.08 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.252 3.302 . . . . 0.0 115.645 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.5 t -95.98 -10.37 28.77 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.577 1.081 . . . . 0.0 111.353 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.652 HG23 ' H ' ' A' ' 145' ' ' LYS . 2.2 mm -132.96 -160.1 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.652 ' H ' HG23 ' A' ' 144' ' ' ILE . 49.9 mmtm -103.93 -23.42 13.36 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -163.04 152.58 15.35 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.981 1.313 . . . . 0.0 108.351 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -153.64 120.21 2.89 Favored Pre-proline 0 N--CA 1.457 -0.083 0 CA-C-N 118.062 0.392 . . . . 0.0 110.865 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -64.74 127.93 19.86 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.162 2.575 . . . . 0.0 110.105 168.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.4 p -100.79 136.03 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -85.03 146.88 26.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.579 0.352 . . . . 0.0 110.513 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 40.0 mm -125.12 143.03 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.882 0.873 . . . . 0.0 109.422 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.95 96.92 2.69 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -176.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.01 172.15 16.68 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.451 3.434 . . . . 0.0 111.897 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -109.24 150.48 27.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.776 0.322 . . . . 0.0 111.285 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -116.42 155.16 29.03 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.611 0.764 . . . . 0.0 111.234 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.9 mp -103.9 89.96 3.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 11.5 t -155.34 -36.25 0.09 Allowed 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -140.05 28.73 2.09 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.2 m -60.1 -35.92 76.3 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -154.24 161.51 41.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.78 0.432 . . . . 0.0 110.868 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -154.63 159.02 40.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.526 0.203 . . . . 0.0 110.62 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.9 m -138.95 149.98 23.45 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.016 0 C-N-CA 123.678 0.791 . . . . 0.0 109.585 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.2 mtm -137.83 8.71 2.8 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 -174.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.552 ' HB3' ' HG ' ' A' ' 201' ' ' CYS . 22.9 t0 -138.74 17.12 2.69 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.268 0.94 . . . . 0.0 112.936 -176.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.33 19.25 55.6 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 119.689 -0.506 . . . . 0.0 113.053 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 28.9 m 55.46 50.67 14.22 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 117.676 0.738 . . . . 0.0 112.327 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -62.11 165.75 7.83 Favored Pre-proline 0 CA--C 1.531 0.212 0 C-N-CA 123.748 0.819 . . . . 0.0 110.106 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.75 137.2 27.32 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.89 2.394 . . . . 0.0 110.534 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 12.8 tp -132.34 151.08 52.01 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 122.682 0.393 . . . . 0.0 110.483 -170.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 171' ' ' PRO . 13.2 t70 -147.7 140.66 14.93 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.901 -177.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 170' ' ' ASP . 50.7 Cg_exo -57.54 -21.6 47.07 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.569 2.846 . . . . 0.0 114.091 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -85.3 6.37 26.54 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.519 0.6 . . . . 0.0 110.787 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -125.03 28.14 6.49 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 31.4 m -129.66 152.29 49.33 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.088 -173.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.3 tt -123.95 148.21 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 C-N-CA 123.366 0.666 . . . . 0.0 109.288 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -114.42 144.18 43.73 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 13.7 m -135.97 130.13 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 122.87 0.468 . . . . 0.0 110.056 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -132.26 164.62 23.8 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 87.37 16.93 59.69 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -175.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 28.3 m -64.52 151.05 92.55 Favored Pre-proline 0 CA--C 1.53 0.181 0 C-N-CA 122.464 0.305 . . . . 0.0 111.257 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -75.83 -174.97 2.24 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.954 3.103 . . . . 0.0 110.065 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -56.03 -50.86 84.89 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.545 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.83 141.73 21.83 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.15 1.9 . . . . 0.0 110.928 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.683 ' CD1' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -148.02 -75.99 0.18 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.799 178.219 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.683 ' H ' ' CD1' ' A' ' 184' ' ' LEU . 5.8 ptm180 49.75 132.48 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 128.445 2.698 . . . . 0.0 115.073 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.87 -20.19 65.87 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 121.721 -0.612 . . . . 0.0 112.302 -175.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 96.7 t -67.91 -58.32 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-N 117.817 0.28 . . . . 0.0 111.187 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -82.73 -19.44 37.93 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.263 -0.273 . . . . 0.0 111.268 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.9 tp -70.09 -35.91 74.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.66 -35.47 57.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 122.387 -0.196 . . . . 0.0 111.406 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 23.5 mmt -69.78 -38.49 76.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -175.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 45.6 mt -71.85 -43.64 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.548 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -61.64 -21.27 64.25 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 118.31 0.505 . . . . 0.0 111.34 173.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.66 -11.58 36.58 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.659 0.663 . . . . 0.0 112.158 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -96.44 -15.75 21.58 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 122.033 -0.417 . . . . 0.0 111.861 175.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.08 -21.84 10.33 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 118.155 0.434 . . . . 0.0 110.793 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -139.86 44.21 1.93 Allowed 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.175 0.59 . . . . 0.0 109.444 -178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -42.47 135.93 3.74 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.168 0.889 . . . . 0.0 113.04 -174.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 131.45 12.59 2.0 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -176.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.03 148.42 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-N 117.541 0.671 . . . . 0.0 110.24 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . 0.552 ' HG ' ' HB3' ' A' ' 164' ' ' ASP . 51.5 t -125.64 -29.99 3.11 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.896 177.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -155.48 152.72 29.27 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.58 0.229 . . . . 0.0 110.893 -175.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.4 160.17 42.56 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.385 0.674 . . . . 0.0 110.761 175.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -178.58 173.55 45.88 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 176.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 3.4 mp -94.51 84.73 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 23.4 t70 53.66 -66.77 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -168.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' THR . . . . . 0.402 ' H ' ' HA ' ' A' ' 214' ' ' PRO . 38.8 p 43.0 54.14 4.9 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -60.65 132.31 91.27 Favored Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.19 -14.78 14.79 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.43 3.42 . . . . 0.0 113.886 -173.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -91.83 -39.68 11.62 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.616 0.644 . . . . 0.0 110.211 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.42 -7.8 34.02 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 65.8 mttm 52.02 46.34 26.77 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 124.618 1.167 . . . . 0.0 111.675 174.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.93 154.5 43.51 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -175.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.402 ' HA ' ' H ' ' A' ' 207' ' ' THR . 33.5 Cg_endo -83.58 173.21 9.69 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.918 3.079 . . . . 0.0 110.868 173.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -127.8 18.57 6.72 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.999 0.519 . . . . 0.0 111.621 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.07 10.27 56.03 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.886 -0.397 . . . . 0.0 112.27 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -134.91 148.7 50.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.45 0.625 . . . . 0.0 110.306 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -87.49 156.14 27.69 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 121.455 0.475 . . . . 0.0 113.146 -173.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -144.71 149.26 35.31 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 169.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 71.8 t -138.56 144.2 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -129.07 148.86 51.05 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.068 0.461 . . . . 0.0 110.39 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -120.62 154.14 35.86 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.101 -173.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 67.3 p -90.22 7.74 36.61 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.284 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -134.96 136.69 42.43 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.665 0.786 . . . . 0.0 109.655 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -75.9 -16.95 59.95 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.0 tp60 -77.71 -36.82 50.6 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 23.7 m -78.57 -24.65 45.42 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.287 -0.258 . . . . 0.0 110.38 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.46 -49.94 69.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.0 pt -75.09 -16.34 15.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.07 0 CA-C-N 117.744 0.247 . . . . 0.0 111.522 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.79 -25.59 37.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.83 0.286 . . . . 0.0 111.006 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -82.57 -22.23 34.95 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 21.8 pt -108.92 20.88 5.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.004 0.522 . . . . 0.0 110.538 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.3 t -77.41 -9.58 58.95 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.874 0.47 . . . . 0.0 111.659 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -152.12 144.12 23.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -53.69 -29.32 38.43 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -126.38 119.9 28.48 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.849 0.357 . . . . 0.0 110.415 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.7 m -84.37 159.19 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.207 175.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -94.86 138.53 32.52 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -129.83 14.39 5.85 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.908 -175.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.63 140.29 29.9 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -172.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -147.59 21.21 1.17 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.408 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 244' ' ' ILE . . . 87.59 139.74 6.32 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -177.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 54.85 3.28 0.05 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.186 1.394 . . . . 0.0 113.426 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . 0.411 ' H ' ' C ' ' A' ' 242' ' ' GLY . 62.0 mt -145.43 142.04 22.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 C-N-CA 124.23 1.012 . . . . 0.0 108.619 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -151.89 136.36 16.87 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 176.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -148.22 164.99 32.29 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.802 0.841 . . . . 0.0 109.62 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.57 155.92 38.31 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 8.5 p -155.88 152.32 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -82.68 143.58 30.85 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.2 m -116.73 153.82 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 121.631 0.729 . . . . 0.0 112.949 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -151.24 141.43 14.53 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.833 174.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -58.23 136.99 78.24 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.61 2.207 . . . . 0.0 108.364 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -70.07 132.65 46.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.266 -173.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.466 0 C-N-CA 127.111 2.164 . . . . 0.0 113.91 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.53 0.205 . . . . 0.0 111.324 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -134.27 160.79 36.8 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 121.135 0.493 . . . . 0.0 111.121 -174.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -88.51 31.88 0.81 Allowed 'General case' 0 C--N 1.334 -0.068 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.592 ' HA ' ' CE1' ' A' ' 115' ' ' PHE . 99.0 mtt180 54.62 18.42 2.04 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.192 0.597 . . . . 0.0 112.299 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -146.25 133.48 20.55 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 m -139.94 161.97 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -95.59 143.06 27.2 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 169.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.7 m -131.39 118.52 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 172.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.58 138.96 14.68 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.481 -172.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.57 145.44 4.85 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.446 0.546 . . . . 0.0 114.386 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.7 tp -164.96 132.79 2.47 Favored Pre-proline 0 N--CA 1.453 -0.283 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -77.19 156.04 33.34 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.937 1.758 . . . . 0.0 110.329 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -62.43 0.78 1.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 124.544 3.496 . . . . 0.0 114.913 -178.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -134.25 43.54 2.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.598 0.636 . . . . 0.0 111.552 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mt -141.32 151.5 19.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -135.99 -179.47 5.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.916 0.389 . . . . 0.0 111.595 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -45.76 -42.36 11.91 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.59 1.156 . . . . 0.0 112.075 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.94 -29.57 62.09 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.192 0.451 . . . . 0.0 111.92 -173.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -80.79 -29.83 36.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 122.29 -0.256 . . . . 0.0 110.823 -172.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.2 pt -86.41 -26.02 6.27 Favored 'Isoleucine or valine' 0 C--N 1.338 0.078 0 O-C-N 121.782 -0.574 . . . . 0.0 109.899 173.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 61.7 m -70.24 -14.15 62.49 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 172.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.26 -21.97 16.95 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.393 0.277 . . . . 0.0 111.606 173.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.4 m -77.06 -21.56 54.26 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.255 0.479 . . . . 0.0 111.885 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -111.89 4.57 18.36 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 117.825 0.284 . . . . 0.0 111.649 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -71.64 -5.9 37.0 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.966 -0.459 . . . . 0.0 111.964 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.4 tpt85 -67.1 -10.0 45.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.189 0.996 . . . . 0.0 110.627 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -126.56 33.03 5.06 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.47 0.308 . . . . 0.0 111.464 -174.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.68 178.45 38.07 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.948 -0.461 . . . . 0.0 111.948 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.38 141.74 35.81 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.882 3.055 . . . . 0.0 111.305 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.44 173.48 14.83 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.811 0.844 . . . . 0.0 110.088 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.89 167.27 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.147 -177.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.29 148.37 29.9 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -150.91 163.96 37.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.108 0.48 . . . . 0.0 110.827 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.464 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 33.7 p90 -153.5 162.98 25.22 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 176.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.624 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 40.3 Cg_endo -73.59 -10.19 23.39 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.644 2.896 . . . . 0.0 110.923 -169.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.624 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 74.4 m-70 -106.06 18.75 21.59 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.295 1.038 . . . . 0.0 111.257 -178.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -48.91 151.44 1.24 Allowed 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.895 0.878 . . . . 0.0 113.154 -176.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.302 0 C-N-CA 124.008 0.923 . . . . 0.0 110.319 -176.749 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.828 0 CA-C-O 119.332 -0.704 . . . . 0.0 113.831 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -113.93 142.53 46.01 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.968 1.384 . . . . 0.0 108.238 177.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.27 176.86 9.24 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.085 0.402 . . . . 0.0 111.754 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -142.95 137.15 29.2 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.77 148.7 23.11 Favored 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -174.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.2 mp -130.66 147.37 52.33 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.911 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.592 ' CE1' ' HA ' ' A' ' 65' ' ' ARG . 3.4 p90 -158.93 178.84 9.64 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.289 0.636 . . . . 0.0 109.297 175.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -107.76 -21.03 13.02 Favored 'General case' 0 N--CA 1.456 -0.128 0 O-C-N 122.187 -0.32 . . . . 0.0 111.782 -174.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -129.71 144.19 51.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.863 0.363 . . . . 0.0 111.335 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -74.68 -14.9 60.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.707 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 76.7 p -70.92 -21.65 62.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.354 -0.216 . . . . 0.0 110.902 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.4 t -75.35 -40.83 57.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.446 ' HB ' ' CZ ' ' A' ' 115' ' ' PHE . 4.7 p -82.8 -23.8 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -67.67 -37.83 82.9 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.108 -0.37 . . . . 0.0 110.004 177.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.4 -35.9 30.19 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.97 -18.25 60.41 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.58 0.627 . . . . 0.0 110.985 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.0 mt -93.82 -23.71 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 117.948 0.34 . . . . 0.0 110.748 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -83.94 -13.68 52.81 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.793 -0.567 . . . . 0.0 111.63 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -124.87 46.38 2.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.056 0.543 . . . . 0.0 111.125 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 18.6 p -137.75 -176.55 4.46 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 44.1 mt -86.29 154.98 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 125.168 1.387 . . . . 0.0 108.32 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.55 156.98 47.49 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.124 -0.36 . . . . 0.0 110.729 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.24 -176.64 5.37 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -42.75 -25.9 0.11 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -169.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.33 14.04 0.13 Allowed Glycine 0 CA--C 1.528 0.87 0 CA-C-N 119.163 0.892 . . . . 0.0 112.844 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -145.0 170.97 15.13 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 117.784 0.792 . . . . 0.0 111.05 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 75.1 mt -108.01 166.63 10.58 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -149.87 155.74 40.57 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.79 0.328 . . . . 0.0 110.739 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.6 mp -143.75 160.67 40.33 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 36.9 t -87.85 156.64 19.28 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.78 165.08 30.74 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-O 120.846 0.355 . . . . 0.0 111.109 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.4 t -115.62 179.33 4.0 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.562 0.745 . . . . 0.0 109.728 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.485 ' HB3' ' CD ' ' A' ' 142' ' ' PRO . 5.7 m 61.48 -172.77 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.321 0.648 . . . . 0.0 110.143 -176.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.485 ' CD ' ' HB3' ' A' ' 141' ' ' SER . 97.4 Cg_endo -74.07 135.96 21.75 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.703 1.602 . . . . 0.0 111.423 -169.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.7 m -147.29 42.85 1.11 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.619 0.768 . . . . 0.0 109.206 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 3.2 mp 63.4 -62.2 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.753 1.621 . . . . 0.0 111.167 -173.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -151.99 -62.09 0.17 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 174.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -160.55 130.46 5.15 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.897 0.479 . . . . 0.0 110.404 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -151.13 103.05 2.97 Favored Pre-proline 0 CA--C 1.53 0.174 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.97 135.29 58.3 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.402 2.735 . . . . 0.0 111.02 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.9 p -90.45 133.28 32.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -100.75 154.53 18.54 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -174.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.9 mm -131.08 147.64 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.946 0.898 . . . . 0.0 110.71 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -160.59 99.49 1.36 Allowed Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.009 0.524 . . . . 0.0 110.138 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.84 174.18 3.2 Favored 'Trans proline' 0 CA--C 1.531 0.356 1 C-N-CA 125.788 4.325 . . . . 0.0 115.969 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -108.18 156.48 19.28 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.539 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -102.58 125.22 49.23 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.515 0.674 . . . . 0.0 111.102 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.686 ' CD1' ' H ' ' A' ' 156' ' ' LEU . 1.9 mp -67.19 -19.77 65.61 Favored 'General case' 0 C--O 1.23 0.041 0 C-N-CA 125.102 1.361 . . . . 0.0 114.22 -172.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 81.1 p -87.11 -4.93 59.17 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -167.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -146.37 27.71 1.12 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.564 1.074 . . . . 0.0 113.318 -176.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.4 m -72.02 -20.98 61.61 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.8 -0.562 . . . . 0.0 112.377 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -150.49 155.36 39.34 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 122.801 0.44 . . . . 0.0 110.949 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -150.09 162.12 41.03 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 10.9 p -149.19 149.81 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.9 ttm -123.02 22.13 9.64 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -170.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -158.43 -41.16 0.06 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.22 10.26 59.2 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.723 173.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.5 t -141.79 -24.2 0.7 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.573 1.186 . . . . 0.0 114.163 -176.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -80.32 130.51 65.25 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 119.625 1.102 . . . . 0.0 110.615 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.11 159.49 29.97 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.667 2.912 . . . . 0.0 111.457 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.7 mt -108.71 154.36 22.14 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.514 0.326 . . . . 0.0 110.122 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -151.58 138.44 11.96 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.51 -14.09 42.38 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.143 2.562 . . . . 0.0 113.182 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -86.32 -6.6 58.92 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.711 0.687 . . . . 0.0 110.491 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -125.65 15.71 8.14 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.665 0.386 . . . . 0.0 111.355 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 46.4 m -119.5 143.64 47.45 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 121.131 0.491 . . . . 0.0 110.905 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.47 148.7 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.088 -177.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -115.96 151.9 34.51 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.47 111.44 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.291 0.637 . . . . 0.0 109.911 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -82.92 126.58 7.54 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 118.2 -110.87 2.05 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.4 p 36.68 63.95 2.69 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.407 0.683 . . . . 0.0 111.573 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.22 176.75 3.66 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.251 3.301 . . . . 0.0 112.731 -174.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.435 ' N ' ' CD ' ' A' ' 183' ' ' PRO . 9.8 ptm180 -59.81 -21.14 0.71 Allowed Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -173.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 182' ' ' ARG . 46.9 Cg_exo -60.35 -12.1 18.98 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.926 1.751 . . . . 0.0 112.882 172.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 89.2 mt -104.71 174.24 5.96 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.976 0.51 . . . . 0.0 110.605 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -152.46 153.33 33.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.244 1.017 . . . . 0.0 109.376 -170.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.21 -26.37 65.69 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.27 -48.68 80.31 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 CA-C-N 118.418 0.554 . . . . 0.0 111.291 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -84.17 -20.8 31.79 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.94 -40.13 79.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 174.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.04 -38.08 78.93 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 122.323 -0.235 . . . . 0.0 111.567 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 24.4 mmt -69.45 -32.47 71.44 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.235 -0.29 . . . . 0.0 111.069 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 88.7 mt -71.8 -32.19 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.2 mmt -73.18 -23.23 60.39 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.943 -0.473 . . . . 0.0 110.642 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -82.19 -23.59 35.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 122.146 -0.346 . . . . 0.0 111.213 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -86.14 -19.58 29.91 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.94 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -116.25 -16.16 10.96 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -133.33 19.04 3.99 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -173.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.03 -144.68 38.34 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -70.72 113.36 4.76 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 112.256 -0.338 . . . . 0.0 112.256 -174.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 40.4 t -98.51 154.41 3.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 C-N-CA 124.143 0.977 . . . . 0.0 108.614 174.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.7 p -114.79 -31.45 6.13 Favored 'General case' 0 C--O 1.227 -0.084 0 CA-C-N 118.397 0.544 . . . . 0.0 111.324 175.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -148.19 144.44 27.73 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-N 118.492 0.587 . . . . 0.0 110.589 175.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -159.29 147.52 17.75 Favored 'General case' 0 N--CA 1.458 -0.03 0 CA-C-O 120.851 0.358 . . . . 0.0 111.075 177.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 163.41 -158.94 31.48 Favored Glycine 0 CA--C 1.522 0.481 0 O-C-N 121.924 -0.485 . . . . 0.0 112.289 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 44.0 mm -96.14 140.99 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -66.36 139.03 58.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.98 0.419 . . . . 0.0 110.8 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 55.0 p -136.31 155.7 49.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.277 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -80.88 126.59 77.28 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 171.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.2 -10.56 17.75 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.842 3.695 . . . . 0.0 113.405 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -103.73 -27.37 12.31 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.731 0.696 . . . . 0.0 110.398 -177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 81.7 mt -105.08 -7.34 19.21 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.775 0.43 . . . . 0.0 110.894 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm 53.06 40.74 31.7 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.048 0.939 . . . . 0.0 112.443 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.417 ' CE1' ' HB2' ' A' ' 65' ' ' ARG . 21.2 m-85 -127.82 155.55 77.23 Favored Pre-proline 0 N--CA 1.467 0.425 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.558 -175.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.7 146.56 92.37 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.272 1.982 . . . . 0.0 110.735 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . 0.534 ' HB3' ' HZ1' ' A' ' 215' ' ' LYS . 0.0 OUTLIER -130.98 31.25 4.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.031 0.932 . . . . 0.0 109.557 -176.128 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.53 156.93 2.62 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.231 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 54.59 -175.42 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.6 0.76 . . . . 0.0 111.999 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -139.36 174.09 22.41 Favored Glycine 0 CA--C 1.521 0.466 0 O-C-N 121.734 -0.604 . . . . 0.0 111.96 -176.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -148.93 154.32 39.26 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 62.8 t -140.27 145.84 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.45 150.37 52.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.119 0.485 . . . . 0.0 110.936 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -131.54 159.97 36.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.112 -175.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 77.3 p -92.95 -5.76 50.01 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.261 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -124.35 144.39 50.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.105 0.562 . . . . 0.0 111.061 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -78.33 -9.61 59.33 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.095 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -82.92 -38.92 22.17 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.2 m -75.91 -26.49 57.01 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -64.24 -50.94 66.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 175.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.45 -14.23 16.49 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 CA-C-N 118.051 0.387 . . . . 0.0 111.309 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.47 -21.16 32.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 117.708 0.231 . . . . 0.0 111.065 175.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.56 -14.91 36.48 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.0 pt -119.31 23.78 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.315 0.646 . . . . 0.0 110.567 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 88.7 p -76.2 -20.12 57.78 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.222 0.609 . . . . 0.0 112.544 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -149.77 133.01 16.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -54.88 -37.53 66.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -175.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -122.01 116.61 24.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.154 0.434 . . . . 0.0 110.615 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.5 m -97.95 158.41 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.311 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -89.75 144.19 26.18 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.931 0.395 . . . . 0.0 110.727 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.0 mp -138.22 98.73 3.68 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -138.54 76.19 1.56 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.928 -172.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -137.24 152.18 49.54 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 66.71 25.27 72.91 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 63.06 21.85 13.11 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.284 1.034 . . . . 0.0 112.21 -175.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 68.7 mt -92.34 163.99 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -152.43 110.02 3.6 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -146.1 164.11 33.21 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.824 0.45 . . . . 0.0 110.841 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.01 157.8 44.32 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 123.818 0.847 . . . . 0.0 109.188 178.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.58 149.54 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -87.42 121.87 30.42 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.4 m -95.6 150.45 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 CA-C-N 118.139 0.427 . . . . 0.0 111.286 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.27 160.21 29.74 Favored Pre-proline 0 N--CA 1.457 -0.096 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 171.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.03 135.18 69.21 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.725 2.283 . . . . 0.0 109.139 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -73.64 112.92 10.2 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 119.221 -0.992 . . . . 0.0 111.421 -176.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.536 0.408 0 C-N-CA 125.554 1.542 . . . . 0.0 113.051 174.091 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.293 0.092 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -166.2 164.98 17.82 Favored 'General case' 0 CA--C 1.52 -0.193 0 O-C-N 123.552 0.533 . . . . 0.0 109.699 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 66' ' ' LYS . 25.5 t -108.37 156.95 18.84 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 171.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.493 ' H ' ' CD ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -76.6 26.77 0.13 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.497 0.719 . . . . 0.0 112.086 179.235 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 64' ' ' SER . 47.7 pttt -136.44 141.61 43.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.048 0.939 . . . . 0.0 109.627 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 m -147.25 160.87 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.055 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.767 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -100.49 143.43 30.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.2 132.66 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.21 -163.59 9.57 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.3 21.37 66.28 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.001 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.471 ' H ' HD21 ' A' ' 72' ' ' LEU . 2.1 pt? -118.44 150.02 47.16 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 118.179 0.989 . . . . 0.0 109.954 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.4 168.98 21.97 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 124.09 3.194 . . . . 0.0 113.706 -169.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -83.36 0.31 9.55 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 124.116 3.211 . . . . 0.0 111.65 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -100.89 11.47 39.52 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -173.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.39 177.65 3.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -142.65 -175.58 4.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.921 0.391 . . . . 0.0 111.578 -175.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -50.03 -31.88 14.04 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.356 1.062 . . . . 0.0 112.258 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -71.45 -29.77 65.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 117.894 0.316 . . . . 0.0 111.542 -176.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -82.21 -31.78 30.15 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 122.184 -0.323 . . . . 0.0 110.42 -174.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 66.0 mt -77.49 -42.42 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.2 m -66.9 -22.97 65.95 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.67 -18.3 28.2 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.9 m -77.57 -27.61 51.51 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 118.424 0.557 . . . . 0.0 111.685 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -120.98 12.71 11.24 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.49 -18.05 64.44 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.293 0.497 . . . . 0.0 112.249 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -75.6 -10.18 59.22 Favored 'General case' 0 C--N 1.338 0.093 0 O-C-N 122.033 -0.417 . . . . 0.0 111.944 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -103.8 23.21 13.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.559 0.344 . . . . 0.0 111.319 -176.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.93 179.21 31.81 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.59 150.2 68.95 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.369 2.713 . . . . 0.0 110.772 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -162.77 164.6 26.18 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.02 -170.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.63 164.55 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.752 174.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -129.58 151.05 35.24 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -143.23 159.07 43.0 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.487 0.66 . . . . 0.0 112.02 -174.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.459 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 30.2 p90 -151.88 159.52 32.96 Favored Pre-proline 0 N--CA 1.452 -0.349 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 170.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.53 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 94.2 Cg_endo -65.68 -13.99 42.55 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 123.525 2.816 . . . . 0.0 112.505 -169.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.53 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 21.0 m170 -106.59 13.72 27.9 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.066 0.546 . . . . 0.0 111.549 -176.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.7 tptm -49.81 151.51 1.78 Allowed 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.844 0.858 . . . . 0.0 112.739 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.301 0 C-N-CA 123.587 0.755 . . . . 0.0 110.487 -177.749 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.735 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.05 150.12 37.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.69 -176.7 5.61 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.961 0.41 . . . . 0.0 111.427 -174.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -140.27 128.82 22.85 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -89.98 149.54 22.52 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.656 0.741 . . . . 0.0 112.372 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.2 mp -113.09 138.6 49.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -134.62 170.64 15.5 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.047 0.539 . . . . 0.0 110.388 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -101.87 -24.17 14.06 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.705 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -135.83 153.57 51.46 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -75.48 -15.51 60.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.735 171.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 m -78.91 -20.04 50.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 176.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.6 m -76.87 -42.3 40.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.7 m -74.15 -20.18 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -72.1 -41.33 67.4 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.71 -34.52 62.62 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 122.168 -0.333 . . . . 0.0 111.557 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 pp -77.41 -17.9 57.73 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.372 0.533 . . . . 0.0 111.613 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.9 mt -95.46 -17.48 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 122.39 0.276 . . . . 0.0 111.014 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -99.41 -11.2 21.36 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.864 -0.523 . . . . 0.0 112.273 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -114.84 29.34 8.09 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.811 0.444 . . . . 0.0 111.921 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 17.6 p -137.41 -173.8 3.58 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.994 0.426 . . . . 0.0 111.647 -176.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.2 mm -84.67 160.53 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 124.596 1.158 . . . . 0.0 109.427 -175.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -132.23 158.45 41.75 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.681 0.276 . . . . 0.0 110.821 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.3 74.52 1.33 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.436 0.636 . . . . 0.0 110.671 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 51.97 9.39 0.09 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.16 -9.87 0.06 OUTLIER Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.115 0.87 . . . . 0.0 113.289 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.6 pttt -146.34 178.25 8.39 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 174.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.6 mp -125.33 169.69 12.07 Favored 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -171.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.434 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 0.3 OUTLIER -140.87 156.01 46.2 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.591 -175.744 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.4 tp -137.06 142.89 42.41 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 47.4 t -82.97 132.58 35.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.518 0.599 . . . . 0.0 109.99 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 19.9 m -137.38 -10.42 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.4 m 46.3 46.1 13.41 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.531 0.732 . . . . 0.0 112.786 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.7 m -57.17 156.15 15.18 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.399 0.68 . . . . 0.0 111.785 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.13 20.08 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 125.008 3.805 . . . . 0.0 114.19 -176.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.7 m -133.13 138.62 46.71 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 55.31 -149.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -170.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -139.12 145.7 39.76 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.449 0.568 . . . . 0.0 110.554 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 49.62 39.46 17.36 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.417 1.087 . . . . 0.0 112.969 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -55.63 118.27 18.8 Favored Pre-proline 0 CA--C 1.53 0.195 0 C-N-CA 123.637 0.775 . . . . 0.0 111.964 -177.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.434 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 25.8 Cg_endo -93.8 129.53 0.66 Allowed 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 124.252 3.301 . . . . 0.0 109.765 169.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.3 131.53 38.18 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -89.23 151.15 22.3 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.605 0.762 . . . . 0.0 111.503 -173.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 48.5 mm -134.94 144.48 34.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 123.967 0.907 . . . . 0.0 111.344 -177.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.0 ttp85 -152.57 116.11 2.89 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 168.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.59 165.01 33.45 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.877 3.051 . . . . 0.0 111.908 177.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.417 ' CD1' ' HE3' ' A' ' 66' ' ' LYS . 34.5 t-105 -100.66 152.5 20.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.351 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -104.98 153.75 21.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.676 0.791 . . . . 0.0 112.209 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.3 mp -94.63 -2.56 51.13 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -172.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.4 m -79.52 -10.38 59.79 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -173.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 160' ' ' ASP . 5.3 m-20 -136.17 -110.44 0.2 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.733 0.697 . . . . 0.0 111.738 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 m 64.03 -33.4 0.14 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.541 1.937 . . . . 0.0 113.951 -173.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 158' ' ' ASP . 4.5 p30 -153.49 151.82 30.27 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.101 0.56 . . . . 0.0 110.07 176.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -157.63 153.84 27.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.58 152.68 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 121.887 -0.508 . . . . 0.0 109.744 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 71.4 mtm -128.96 29.92 5.13 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -159.72 -44.5 0.05 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.54 3.93 59.68 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.102 -0.832 . . . . 0.0 113.635 174.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.3 m -138.53 -0.8 1.93 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -176.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -79.17 141.36 57.9 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 120.076 1.307 . . . . 0.0 110.261 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.11 153.21 41.08 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.369 2.713 . . . . 0.0 108.815 173.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 63.9 mt -121.46 150.12 42.04 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.631 0.253 . . . . 0.0 110.961 -177.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -144.22 139.02 15.37 Favored Pre-proline 0 N--CA 1.456 -0.157 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -68.34 -9.23 25.3 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.681 2.921 . . . . 0.0 112.613 -173.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -88.5 -1.68 58.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.715 0.406 . . . . 0.0 110.771 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -128.44 33.2 4.72 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.891 0.476 . . . . 0.0 109.733 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 11.5 m -126.14 153.45 44.55 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.077 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.6 tt -121.84 151.61 25.43 Favored 'Isoleucine or valine' 0 C--O 1.229 0.024 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -116.36 148.22 40.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 172.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.39 117.71 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.497 ' HA2' ' CB ' ' A' ' 217' ' ' ALA . . . -119.83 159.65 14.86 Favored Glycine 0 C--N 1.336 0.564 0 O-C-N 123.202 0.314 . . . . 0.0 113.586 -171.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.84 24.77 12.57 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.24 107.57 57.79 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 117.197 0.498 . . . . 0.0 110.969 -176.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.88 -33.61 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.759 2.306 . . . . 0.0 112.66 176.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.658 ' H ' ' CD ' ' A' ' 183' ' ' PRO . 71.7 mtt180 -149.81 -38.12 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -177.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.658 ' CD ' ' H ' ' A' ' 182' ' ' ARG . 51.8 Cg_exo -59.29 -168.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 124.029 3.153 . . . . 0.0 114.857 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 48.0 mt 65.35 -53.65 0.34 Allowed 'General case' 0 C--O 1.23 0.064 0 C-N-CA 126.963 2.105 . . . . 0.0 114.224 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 54.18 -163.43 0.11 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.947 0.794 . . . . 0.0 109.382 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -103.85 -37.2 7.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.964 -0.46 . . . . 0.0 110.806 172.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 69.0 t -67.16 -56.45 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 C-N-CA 122.391 0.276 . . . . 0.0 111.183 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -74.34 -22.29 59.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.856 -0.156 . . . . 0.0 110.961 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.6 tp -68.47 -35.94 78.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.39 -28.75 61.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.311 -0.243 . . . . 0.0 111.346 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 26.3 mmt -70.7 -35.2 72.64 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 117.704 0.229 . . . . 0.0 111.614 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.62 -32.17 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 O-C-N 121.64 -0.663 . . . . 0.0 109.683 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.6 mmt -76.66 -15.82 59.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 121.897 -0.502 . . . . 0.0 111.894 -177.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -97.9 -24.31 15.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.697 0.681 . . . . 0.0 111.553 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -86.43 -16.36 37.42 Favored 'General case' 0 C--N 1.34 0.165 0 O-C-N 121.872 -0.517 . . . . 0.0 112.334 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -117.49 -20.19 9.15 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.355 0.525 . . . . 0.0 111.082 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -140.03 42.65 1.94 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.928 0.491 . . . . 0.0 109.752 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.51 137.15 4.38 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.032 0.825 . . . . 0.0 112.782 -175.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 122.7 1.38 9.85 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.48 157.16 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 123.837 0.855 . . . . 0.0 109.889 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.9 p -129.41 -32.15 1.99 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -147.15 152.0 37.71 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.217 0.917 . . . . 0.0 111.891 -177.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -149.6 160.91 43.1 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.481 0.312 . . . . 0.0 111.176 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 168.39 -170.21 42.01 Favored Glycine 0 C--N 1.336 0.534 0 O-C-N 121.909 -0.494 . . . . 0.0 112.122 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.9 mp -105.08 146.02 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -65.81 117.88 8.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.552 0.215 . . . . 0.0 110.434 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 76.4 p -140.49 162.59 34.99 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 122.759 0.424 . . . . 0.0 110.266 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -115.98 130.75 24.16 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.28 -1.98 10.97 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 124.811 3.674 . . . . 0.0 114.335 -170.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -68.0 -32.42 72.79 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 119.025 0.829 . . . . 0.0 110.104 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.31 8.33 1.19 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.512 0.725 . . . . 0.0 109.853 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt 53.03 39.89 30.26 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.219 1.008 . . . . 0.0 111.434 -174.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -94.25 151.92 39.86 Favored Pre-proline 0 N--CA 1.455 -0.178 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.719 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.9 141.93 37.95 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.559 2.173 . . . . 0.0 110.821 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.67 14.67 6.48 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.867 0.867 . . . . 0.0 109.92 -178.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 165.69 -165.09 37.78 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.497 ' CB ' ' HA2' ' A' ' 178' ' ' GLY . . . -86.08 -160.21 0.53 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.349 1.06 . . . . 0.0 110.829 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -74.56 158.87 51.92 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 122.189 -0.32 . . . . 0.0 112.777 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.06 153.26 38.69 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 50.1 t -145.27 146.12 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.06 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.39 145.33 50.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.547 0.339 . . . . 0.0 110.405 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -128.84 -23.09 3.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.312 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 46.0 m 56.28 25.18 9.01 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -178.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -128.05 151.84 48.69 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -73.43 -30.99 63.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -176.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -85.12 -39.83 17.46 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 111.373 0.138 . . . . 0.0 111.373 -172.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 65.7 p -77.54 -23.07 50.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.16 -0.337 . . . . 0.0 110.249 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -67.6 -52.75 34.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 175.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 32.7 pt -73.08 -18.04 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.63 -29.38 30.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.159 0.436 . . . . 0.0 111.491 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -77.62 -23.77 49.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.931 0.332 . . . . 0.0 111.691 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.9 pt -108.89 25.14 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.525 0.73 . . . . 0.0 110.561 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.0 t -77.06 -12.51 59.95 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.136 0.574 . . . . 0.0 112.12 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -152.67 140.83 20.41 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -55.3 -30.26 59.84 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -128.15 130.24 47.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.295 0.569 . . . . 0.0 111.135 177.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.2 m -100.8 177.34 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.294 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -109.01 138.66 45.0 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.451 0.3 . . . . 0.0 110.346 172.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.2 mp -134.76 84.41 2.1 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -119.55 -66.93 1.02 Allowed 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -172.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 48.34 24.14 0.67 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -174.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 168.95 -151.28 17.47 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -80.3 6.18 12.71 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.022 0.529 . . . . 0.0 111.717 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.53 157.05 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.597 0.759 . . . . 0.0 108.971 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -141.58 25.63 1.99 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.906 0.384 . . . . 0.0 111.257 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -90.12 154.73 19.56 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.128 0.571 . . . . 0.0 111.093 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -160.26 -179.93 8.14 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.61 157.94 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.854 0.862 . . . . 0.0 110.187 -174.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -85.19 129.48 34.8 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 122.678 0.391 . . . . 0.0 110.009 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -100.28 158.23 3.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.0 156.95 27.65 Favored Pre-proline 0 N--CA 1.456 -0.135 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.677 169.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.31 146.0 96.11 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.844 2.363 . . . . 0.0 109.863 174.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -79.83 166.03 22.12 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.489 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.452 -0.37 0 C-N-CA 123.059 0.544 . . . . 0.0 110.245 -171.23 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.274 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.415 ' HA ' HD11 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -142.22 -153.13 0.44 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -174.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.2 m 64.75 5.89 3.02 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 126.133 1.773 . . . . 0.0 113.069 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -65.03 118.49 9.2 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 173.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 63.47 143.58 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.767 1.227 . . . . 0.0 111.071 -168.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -156.11 146.43 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.337 -172.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.467 ' CZ ' ' HA2' ' A' ' 70' ' ' GLY . 9.3 t80 -89.69 140.01 30.0 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 p -118.76 117.88 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.467 ' HA2' ' CZ ' ' A' ' 68' ' ' PHE . . . -89.45 125.1 7.67 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 116.348 -0.387 . . . . 0.0 113.141 -170.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.37 146.67 11.1 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.222 0.915 . . . . 0.0 112.522 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.6 tp -153.94 122.62 3.09 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.17 164.07 31.71 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.217 2.611 . . . . 0.0 111.781 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.15 175.43 9.24 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.39 3.393 . . . . 0.0 111.426 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.1 t70 60.9 -85.86 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.237 0.615 . . . . 0.0 112.332 -175.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.0 pt -56.38 157.24 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 121.278 0.561 . . . . 0.0 111.333 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -149.63 -121.76 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.029 0.531 . . . . 0.0 110.256 -177.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -54.07 -22.9 11.97 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.091 1.357 . . . . 0.0 111.974 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -77.83 -36.96 49.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -173.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -86.41 -30.42 22.12 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.911 -0.493 . . . . 0.0 111.343 -173.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.8 pt -78.57 -33.3 16.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 O-C-N 121.935 -0.478 . . . . 0.0 109.968 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.3 m -70.47 -23.74 62.74 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 175.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.32 -17.07 40.76 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.4 m -76.66 -37.4 56.29 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.557 0.617 . . . . 0.0 111.695 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.44 ' CZ ' HD11 ' A' ' 151' ' ' ILE . 81.2 m-85 -108.25 6.66 26.82 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -176.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.89 -18.34 64.09 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.709 0.404 . . . . 0.0 110.941 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -72.09 -8.92 57.37 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.557 0.743 . . . . 0.0 112.031 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -110.23 5.72 22.02 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.335 0.254 . . . . 0.0 111.427 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.78 177.58 15.11 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -70.5 150.79 64.26 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.69 2.927 . . . . 0.0 110.835 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.41 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 0.5 OUTLIER -164.53 164.41 21.76 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.747 -170.771 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 pt -142.22 170.82 11.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.295 174.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.09 155.15 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 122.449 0.299 . . . . 0.0 110.351 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -153.25 170.27 21.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.67 0.271 . . . . 0.0 111.608 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 33.7 p90 -159.27 158.14 28.03 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -75.36 -9.18 20.18 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.892 1.728 . . . . 0.0 110.74 -169.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -95.37 6.71 48.29 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.723 0.809 . . . . 0.0 111.349 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -50.19 152.02 1.87 Allowed 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.778 0.831 . . . . 0.0 112.911 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.336 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.088 -177.153 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.566 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -147.77 143.12 27.31 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 167.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.35 172.89 12.31 Favored 'General case' 0 C--N 1.335 -0.057 0 CA-C-N 119.896 1.225 . . . . 0.0 113.489 -169.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -136.08 125.47 24.95 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.218 0.607 . . . . 0.0 109.515 -177.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 mp -84.8 141.97 30.11 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.345 0.593 . . . . 0.0 110.72 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.7 mp -104.99 136.48 44.38 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -140.28 163.93 31.45 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.049 0.539 . . . . 0.0 110.68 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -123.53 -29.36 3.78 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.087 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -102.23 159.91 14.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.827 0.346 . . . . 0.0 111.53 -175.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -111.29 5.0 19.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.236 -178.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.8 p -105.3 -22.22 13.09 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.904 0.482 . . . . 0.0 110.921 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 76.8 p -76.16 -31.43 58.54 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.84 -22.26 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 173.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -80.29 -36.92 33.73 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -174.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.87 -35.11 62.32 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 119.684 -0.198 . . . . 0.0 111.52 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -80.42 -18.51 48.62 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.313 0.506 . . . . 0.0 111.916 -176.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.1 mt -97.8 -14.47 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 117.843 0.292 . . . . 0.0 110.557 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -91.91 -16.54 26.5 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.312 -0.868 . . . . 0.0 111.238 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -108.74 26.9 10.01 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.457 0.703 . . . . 0.0 111.794 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 136' ' ' TYR . 17.2 p -124.98 166.77 15.74 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.043 0.537 . . . . 0.0 111.105 -176.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.56 172.4 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -137.31 157.95 45.49 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.021 0.438 . . . . 0.0 111.558 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.52 -172.7 4.09 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -30.1 -39.57 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.1 1.76 . . . . 0.0 115.253 -173.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.0 15.72 0.15 Allowed Glycine 0 CA--C 1.527 0.814 0 CA-C-N 118.595 0.634 . . . . 0.0 112.089 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -141.16 177.35 8.14 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 117.577 0.688 . . . . 0.0 110.56 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.22 170.76 9.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.439 0.696 . . . . 0.0 110.186 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.423 ' CE1' ' HG2' ' A' ' 148' ' ' PRO . 6.3 m-85 -146.76 151.59 37.42 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.857 0.463 . . . . 0.0 111.084 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 45.4 tp -132.46 145.73 51.4 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 170.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 85.0 m -80.33 141.88 35.02 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.745 -0.597 . . . . 0.0 110.893 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.2 175.43 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.324 0.65 . . . . 0.0 109.681 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.8 m -138.51 117.32 12.33 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 122.674 0.39 . . . . 0.0 110.759 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.455 ' HB3' ' HD2' ' A' ' 142' ' ' PRO . 52.7 m -155.21 162.15 27.89 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.688 1.195 . . . . 0.0 108.828 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 60.7 Cg_endo -66.1 -15.72 49.56 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.203 2.602 . . . . 0.0 114.088 -175.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.6 m -105.12 -2.93 23.67 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.44 0.564 . . . . 0.0 110.169 175.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.2 mp -98.97 -52.42 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.177 0.591 . . . . 0.0 111.026 -172.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 87.6 tttt 58.2 -57.96 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.729 1.612 . . . . 0.0 113.194 -172.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -149.83 12.72 0.79 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.391 1.076 . . . . 0.0 110.678 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -67.99 137.38 92.18 Favored Pre-proline 0 C--N 1.338 0.1 0 C-N-CA 123.607 0.763 . . . . 0.0 111.532 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.423 ' HG2' ' CE1' ' A' ' 136' ' ' TYR . 37.8 Cg_endo -86.96 146.79 7.91 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 123.685 2.923 . . . . 0.0 110.632 168.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.9 p -98.88 142.37 14.94 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -83.37 158.78 22.01 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.786 0.721 . . . . 0.0 112.464 -174.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.44 HD11 ' CZ ' ' A' ' 85' ' ' PHE . 29.6 mm -137.13 142.79 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.051 1.341 . . . . 0.0 108.759 177.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 44.8 ttt-85 -146.08 88.52 6.31 Favored Pre-proline 0 CA--C 1.529 0.152 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.78 145.37 72.42 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.495 3.463 . . . . 0.0 112.857 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -92.86 153.02 19.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 173.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -119.48 134.1 55.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.653 0.739 . . . . 0.0 110.883 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.457 ' N ' ' CD1' ' A' ' 156' ' ' LEU . 4.7 mp -87.87 8.21 27.13 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.473 -169.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.7 t -91.1 -12.65 34.95 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -175.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -135.51 20.12 3.35 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -175.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.6 m -69.89 -20.98 63.36 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.433 0.56 . . . . 0.0 112.448 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -158.19 158.09 33.91 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.275 0.488 . . . . 0.0 111.04 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -158.35 157.34 32.2 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.987 0.422 . . . . 0.0 111.054 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.0 m -140.35 149.34 21.69 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 C-N-CA 124.353 1.061 . . . . 0.0 109.722 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 58.3 mtm -140.62 10.42 2.25 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -140.3 16.64 2.41 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.243 0.929 . . . . 0.0 112.971 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 91.09 22.8 31.54 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.519 -0.6 . . . . 0.0 113.016 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.4 m 56.29 47.03 20.02 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 117.722 0.761 . . . . 0.0 112.544 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -61.88 158.21 44.82 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 123.259 0.624 . . . . 0.0 110.602 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.0 154.54 69.67 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.184 2.589 . . . . 0.0 110.67 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 61.2 mt -135.57 167.67 20.68 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.605 0.762 . . . . 0.0 110.666 -173.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -141.49 149.57 54.71 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.01 -19.84 57.72 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.217 2.611 . . . . 0.0 112.516 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -88.1 5.93 38.78 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.46 0.704 . . . . 0.0 110.837 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -131.07 18.96 4.97 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.903 0.481 . . . . 0.0 110.875 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 24.2 m -126.35 139.9 52.93 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.88 0.371 . . . . 0.0 111.153 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.7 tt -112.0 149.2 14.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.913 -177.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -116.15 148.73 40.03 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.19 139.01 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 122.632 0.373 . . . . 0.0 110.207 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -148.48 173.56 28.42 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.67 20.96 62.68 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -174.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.0 m -56.38 142.48 68.55 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 122.751 0.42 . . . . 0.0 110.372 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.06 -49.39 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.944 2.429 . . . . 0.0 112.21 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -161.11 -59.2 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.435 -0.793 . . . . 0.0 111.257 176.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -76.01 156.53 38.57 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.871 2.381 . . . . 0.0 111.394 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.59 0.68 0.11 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.155 0.582 . . . . 0.0 112.296 175.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . 0.406 ' HG2' ' H ' ' A' ' 188' ' ' GLU . 16.7 ttp-105 -28.46 120.56 0.12 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.864 1.666 . . . . 0.0 111.582 175.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.4 -21.14 63.79 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 94.3 t -67.21 -50.16 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 118.154 0.434 . . . . 0.0 110.62 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.406 ' H ' ' HG2' ' A' ' 185' ' ' ARG . 59.6 mt-10 -84.87 -22.57 29.34 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.61 -0.144 . . . . 0.0 110.61 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.94 -30.91 68.41 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -83.4 -31.6 26.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 119.503 -0.284 . . . . 0.0 111.713 -177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.3 mmt -70.46 -37.05 74.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.318 0.508 . . . . 0.0 109.656 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 64.5 mt -72.55 -40.42 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.6 mmt -63.39 -25.37 68.26 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.941 -0.474 . . . . 0.0 110.929 172.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.59 -18.13 49.22 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.105 0.411 . . . . 0.0 111.836 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -98.53 -16.21 19.24 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.59 -13.11 11.53 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.184 0.902 . . . . 0.0 113.221 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -135.9 26.59 3.3 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.839 0.745 . . . . 0.0 112.657 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 76.18 -150.55 39.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -76.27 141.29 26.69 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -174.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.84 143.89 31.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 124.248 1.019 . . . . 0.0 108.56 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 61.4 m -109.48 -33.53 6.78 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -151.9 149.77 29.32 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.0 0.428 . . . . 0.0 110.964 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.28 155.61 40.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.465 0.706 . . . . 0.0 109.143 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.85 -174.97 47.27 Favored Glycine 0 C--N 1.333 0.363 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.2 mm -104.95 145.01 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -54.91 118.23 4.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.013 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 12.2 p -144.23 158.94 43.45 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.63 0.372 . . . . 0.0 110.267 -176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -135.1 135.54 23.06 Favored Pre-proline 0 N--CA 1.455 -0.216 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.68 -5.97 15.04 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.225 3.283 . . . . 0.0 112.824 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -73.74 -39.63 64.11 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.311 0.505 . . . . 0.0 110.688 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.11 0.68 12.41 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.35 0.66 . . . . 0.0 109.602 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm 48.26 59.35 4.35 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.281 1.032 . . . . 0.0 111.386 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -133.49 147.33 64.29 Favored Pre-proline 0 CA--C 1.529 0.149 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -176.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -81.96 165.65 17.27 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 124.238 3.292 . . . . 0.0 110.546 174.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -125.63 23.25 7.44 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 61.59 13.33 37.79 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 119.373 -0.682 . . . . 0.0 114.684 170.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -132.81 146.09 51.53 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 118.235 1.017 . . . . 0.0 109.569 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -93.18 162.31 25.92 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 121.445 0.469 . . . . 0.0 113.326 -172.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -149.64 145.21 26.62 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 173.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 95.2 t -136.57 147.77 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -133.51 154.03 51.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.396 0.617 . . . . 0.0 111.33 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -132.22 154.95 49.09 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.05 -176.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.9 m -97.3 10.08 40.53 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 173.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -132.17 134.22 45.14 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.631 0.773 . . . . 0.0 109.799 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -72.92 -12.86 61.12 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 116.859 -0.155 . . . . 0.0 111.145 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -82.1 -39.04 23.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.9 m -75.06 -28.95 60.57 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -64.52 -51.78 61.16 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 119.649 -0.215 . . . . 0.0 110.568 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.3 pt -71.42 -14.71 17.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 CA-C-N 118.111 0.414 . . . . 0.0 111.181 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.03 -22.01 33.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.799 0.272 . . . . 0.0 110.734 175.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -87.99 -27.84 21.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.5 pt -103.41 24.85 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 122.917 0.487 . . . . 0.0 110.547 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 86.6 p -75.15 -18.07 60.28 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.172 0.589 . . . . 0.0 111.96 -177.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.98 146.04 23.66 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -55.15 -31.4 61.29 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -123.05 121.94 37.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.899 0.381 . . . . 0.0 110.489 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.8 m -82.68 153.98 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.594 172.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -95.62 140.58 30.24 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.82 27.23 5.76 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -91.96 136.52 33.1 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.909 0.484 . . . . 0.0 112.138 -171.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -148.71 19.26 1.02 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.918 177.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 84.79 138.54 4.2 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -176.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 55.86 7.39 0.27 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.389 1.076 . . . . 0.0 112.63 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.4 mt -142.71 141.61 27.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 C-N-CA 124.046 0.938 . . . . 0.0 108.991 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -157.41 123.97 4.95 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -144.34 161.27 39.4 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.98 155.21 36.51 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.0 p -154.92 151.43 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -84.97 126.71 33.75 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.5 m -102.03 158.52 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.23 157.43 27.49 Favored Pre-proline 0 N--CA 1.456 -0.148 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.733 169.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.86 130.73 41.43 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.55 2.167 . . . . 0.0 107.733 171.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -71.56 110.34 6.08 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.462 -172.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 CA--C 1.534 0.363 0 C-N-CA 125.473 1.509 . . . . 0.0 112.751 174.929 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.0 ppt_? . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.68 0.276 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.406 ' CD1' ' HA ' ' A' ' 155' ' ' ASN . 54.1 m-85 -168.96 -172.98 1.69 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -169.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.8 t -141.01 36.37 1.75 Allowed 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.02 -0.425 . . . . 0.0 112.04 173.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.78 36.36 2.73 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.329 1.451 . . . . 0.0 114.487 176.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.4 pttm -141.71 153.48 44.68 Favored 'General case' 0 N--CA 1.46 0.064 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 171.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 p -153.54 146.29 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-O 120.62 0.247 . . . . 0.0 111.025 -176.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -89.41 144.15 26.28 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.78 115.0 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.724 0.773 . . . . 0.0 109.315 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.23 -165.17 37.4 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.87 -104.67 1.51 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.1 tp 54.97 101.5 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 125.366 1.466 . . . . 0.0 112.547 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -67.2 148.23 80.22 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.905 1.737 . . . . 0.0 108.572 174.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.8 20.14 0.63 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.883 3.055 . . . . 0.0 112.574 -174.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -138.5 28.72 2.44 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.1 pt -133.66 175.55 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 119.012 0.824 . . . . 0.0 109.049 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -138.17 -175.97 4.29 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -49.88 -34.88 21.52 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.764 1.226 . . . . 0.0 112.261 -175.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -72.15 -29.85 64.43 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -175.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -79.13 -36.95 39.74 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -174.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.5 mt -73.72 -39.31 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 90.0 m -65.31 -22.94 66.9 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.1 -17.89 28.35 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -79.55 -26.72 41.35 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.383 0.538 . . . . 0.0 112.363 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -114.47 10.2 16.89 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -59.41 -19.83 50.27 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -172.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -73.63 -11.89 60.57 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.22 0.464 . . . . 0.0 112.236 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -99.46 16.44 23.19 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.45 0.3 . . . . 0.0 111.713 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.03 -175.33 29.7 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.95 137.28 37.45 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.49 2.793 . . . . 0.0 110.536 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.9 pp -160.25 166.69 29.1 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.519 0.728 . . . . 0.0 109.909 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mt -136.01 164.78 31.15 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.44 147.06 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -148.36 166.98 26.42 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -174.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -156.51 159.15 31.58 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 176.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.619 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 63.8 Cg_endo -71.36 -10.89 27.83 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.482 2.788 . . . . 0.0 110.976 -171.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.619 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 54.0 m-70 -100.28 17.09 22.27 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.955 0.902 . . . . 0.0 111.39 -178.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -54.02 160.56 1.47 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.004 0.922 . . . . 0.0 112.987 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.223 0 C-N-CA 124.079 0.952 . . . . 0.0 110.499 -178.02 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.892 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 54.89 -177.25 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.068 0.547 . . . . 0.0 111.29 -175.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.54 175.38 12.38 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 121.356 -0.84 . . . . 0.0 112.672 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -139.59 143.49 37.32 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.9 mp -102.78 149.2 24.71 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-O 121.387 0.613 . . . . 0.0 112.267 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.9 mp -107.9 143.11 36.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.362 -1.29 . . . . 0.0 107.658 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -139.44 154.41 47.76 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.136 0.494 . . . . 0.0 110.346 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -101.18 -23.86 14.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.139 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -111.93 153.38 26.82 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.257 0.223 . . . . 0.0 110.438 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -97.58 1.71 49.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.559 0.219 . . . . 0.0 111.086 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.3 t -115.08 -13.93 11.82 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.509 0.724 . . . . 0.0 110.884 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.5 m -68.27 -32.53 72.76 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 121.507 -0.746 . . . . 0.0 109.227 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.78 -22.93 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -80.56 -26.37 38.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.832 -0.543 . . . . 0.0 109.639 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.51 -36.28 68.32 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.926 -0.484 . . . . 0.0 110.569 176.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -79.51 -16.3 56.26 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.312 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 97.0 mt -94.17 -10.77 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 122.439 0.295 . . . . 0.0 110.85 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -108.19 -10.72 15.36 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.709 -0.619 . . . . 0.0 112.225 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -116.37 42.2 2.46 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.482 0.713 . . . . 0.0 110.293 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 136' ' ' TYR . 31.1 p -142.67 174.97 10.17 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.45 0.7 . . . . 0.0 110.974 -172.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.95 165.89 2.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.02 157.27 44.56 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.995 0.426 . . . . 0.0 111.613 177.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -143.08 75.82 1.5 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.436 0.636 . . . . 0.0 109.654 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.7 t70 54.52 12.45 0.54 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.196 1.399 . . . . 0.0 114.703 175.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 154.71 -8.73 0.36 Allowed Glycine 0 CA--C 1.528 0.888 0 O-C-N 121.526 -0.734 . . . . 0.0 113.384 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -129.78 171.04 13.11 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 118.136 0.968 . . . . 0.0 109.328 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -122.44 164.95 17.12 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -170.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.431 ' O ' ' HB2' ' A' ' 128' ' ' CYS . 9.7 m-85 -143.69 150.36 38.57 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.028 176.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.8 mp -127.21 159.47 34.2 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.2 p -94.08 128.58 40.54 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.931 -0.48 . . . . 0.0 111.067 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.4 m -148.43 166.12 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 123.651 0.78 . . . . 0.0 109.838 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.8 m -96.68 155.4 16.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.615 0.366 . . . . 0.0 110.738 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.4 m -146.35 144.49 21.27 Favored Pre-proline 0 CA--C 1.528 0.132 0 C-N-CA 123.338 0.655 . . . . 0.0 109.436 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.86 -14.52 13.79 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.41 2.74 . . . . 0.0 111.338 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.4 m -76.71 -24.53 53.1 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 123.934 0.893 . . . . 0.0 110.668 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 145' ' ' LYS . 0.2 OUTLIER -137.83 -172.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.371 1.068 . . . . 0.0 108.804 -170.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.441 ' H ' HG22 ' A' ' 144' ' ' ILE . 22.1 ptmt -91.41 -23.38 20.05 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 169.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -165.42 154.04 11.79 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.087 1.355 . . . . 0.0 108.462 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 22.2 ttmt -151.13 117.69 3.29 Favored Pre-proline 0 N--CA 1.457 -0.083 0 CA-C-N 118.276 0.489 . . . . 0.0 111.139 175.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -63.8 120.53 7.94 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 122.295 1.997 . . . . 0.0 108.654 168.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.6 p -84.25 132.0 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.1 tm0? -90.3 147.69 23.35 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.38 0.272 . . . . 0.0 110.787 -170.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 26.4 mm -135.18 142.76 39.03 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 C-N-CA 123.006 0.522 . . . . 0.0 111.501 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -144.33 106.83 4.79 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 173.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -71.43 161.03 46.86 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.826 3.017 . . . . 0.0 113.79 -176.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -93.92 94.5 8.51 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.406 ' HA ' ' CD1' ' A' ' 63' ' ' TYR . 3.3 m120 -69.31 0.84 4.41 Favored 'General case' 0 C--O 1.228 -0.054 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -168.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.519 HD22 ' H ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -156.09 175.85 13.43 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.499 1.5 . . . . 0.0 114.464 -169.192 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 54.4 m -108.49 24.6 12.8 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.904 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.519 ' H ' HD22 ' A' ' 156' ' ' LEU . 80.5 m-20 -94.84 31.72 1.78 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.408 0.283 . . . . 0.0 110.497 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 m -75.47 -20.02 59.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -153.29 154.01 33.76 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.06 0.391 . . . . 0.0 111.356 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -157.88 153.25 26.01 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.935 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.8 m -139.21 155.75 26.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 122.803 0.441 . . . . 0.0 110.254 177.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 64.1 mtm -135.23 28.19 3.43 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.318 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.45 ' HB3' ' HG ' ' A' ' 201' ' ' CYS . 4.6 t0 -155.37 168.72 26.18 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -77.65 41.03 1.86 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.672 0.653 . . . . 0.0 112.793 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.9 m 55.89 60.56 3.19 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 117.414 0.607 . . . . 0.0 111.51 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -63.43 161.72 31.77 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 123.532 0.733 . . . . 0.0 109.745 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -56.01 124.02 15.26 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.518 2.145 . . . . 0.0 109.396 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.5 tp -127.07 138.31 53.18 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.748 0.819 . . . . 0.0 110.391 -171.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -144.78 156.3 55.87 Favored Pre-proline 0 N--CA 1.454 -0.261 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.63 -12.42 31.21 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.877 2.385 . . . . 0.0 111.203 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -83.61 -5.03 59.07 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.665 0.786 . . . . 0.0 111.563 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -118.35 24.51 10.9 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.853 0.461 . . . . 0.0 110.127 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 44.8 m -122.09 154.0 37.92 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.603 0.361 . . . . 0.0 111.001 -174.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.61 146.24 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -99.3 129.06 45.49 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 45.5 t -104.8 78.66 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 125.02 1.328 . . . . 0.0 108.447 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.44 ' HA2' ' CB ' ' A' ' 217' ' ' ALA . . . -96.09 153.42 20.55 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 116.355 -0.384 . . . . 0.0 113.44 -174.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 109.21 11.79 21.31 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.9 m -73.63 152.88 89.54 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 117.255 0.527 . . . . 0.0 110.298 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.32 -45.9 2.42 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.63 2.22 . . . . 0.0 110.099 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.482 ' HB3' ' CD ' ' A' ' 183' ' ' PRO . 29.5 ttp-105 -159.8 -75.32 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 118.019 -0.991 . . . . 0.0 108.664 172.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.482 ' CD ' ' HB3' ' A' ' 182' ' ' ARG . 14.4 Cg_endo -87.66 177.11 3.78 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.765 2.31 . . . . 0.0 109.81 169.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 19.3 tp -136.58 -0.34 2.4 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 169.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 57.53 95.38 0.02 OUTLIER 'General case' 0 C--N 1.341 0.217 0 C-N-CA 126.941 2.096 . . . . 0.0 111.702 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.89 -27.44 63.29 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -173.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 62.5 t -62.8 -56.41 17.7 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 CA-C-N 118.515 0.598 . . . . 0.0 111.183 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -82.46 -23.03 34.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 122.454 -0.153 . . . . 0.0 110.721 -175.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.88 -38.87 66.82 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.52 -37.56 74.15 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 121.923 -0.486 . . . . 0.0 110.426 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.2 mmt -68.33 -35.64 78.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.376 -0.202 . . . . 0.0 110.818 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 56.5 mt -76.95 -35.95 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 117.594 0.179 . . . . 0.0 111.317 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.3 mmt -64.56 -23.43 67.26 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.891 -0.505 . . . . 0.0 109.998 172.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -78.68 -24.26 45.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.022 0.374 . . . . 0.0 110.735 174.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -83.43 -17.7 41.24 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 119.129 -0.462 . . . . 0.0 112.134 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -118.48 -17.07 9.46 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -177.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -133.24 19.03 4.02 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -174.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.19 -144.41 37.64 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -69.3 118.38 8.56 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 60.2 t -109.3 142.35 22.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 124.08 0.952 . . . . 0.0 108.612 174.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . 0.45 ' HG ' ' HB3' ' A' ' 164' ' ' ASP . 42.9 t -99.9 -39.78 8.0 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.687 0.221 . . . . 0.0 110.84 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -150.09 146.29 26.85 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.727 0.298 . . . . 0.0 110.964 -176.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -154.49 153.04 30.83 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.312 0.645 . . . . 0.0 109.844 175.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 162.75 -158.25 30.42 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.651 -0.579 . . . . 0.0 111.651 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . 0.453 ' HA ' ' HA2' ' A' ' 218' ' ' GLY . 48.8 mm -108.51 145.33 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -60.3 102.68 0.18 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 40.7 p -145.51 166.76 24.75 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.944 0.498 . . . . 0.0 109.802 -176.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -138.26 131.61 16.51 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -80.11 -16.42 11.12 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.458 3.439 . . . . 0.0 113.587 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -91.12 -31.65 16.15 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.527 0.603 . . . . 0.0 110.476 -176.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.04 -1.88 30.76 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.208 0.603 . . . . 0.0 110.291 176.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 49.86 45.2 25.1 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.103 0.961 . . . . 0.0 112.551 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.37 155.25 53.93 Favored Pre-proline 0 CA--C 1.528 0.104 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -84.41 153.85 12.21 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.411 2.741 . . . . 0.0 109.586 170.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.58 6.59 6.25 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.856 0.463 . . . . 0.0 110.502 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 165.46 -163.07 36.35 Favored Glycine 0 CA--C 1.524 0.609 0 O-C-N 121.919 -0.488 . . . . 0.0 112.08 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . 0.44 ' CB ' ' HA2' ' A' ' 178' ' ' GLY . . . -80.09 -162.36 0.44 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.223 1.009 . . . . 0.0 111.401 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 205' ' ' ILE . . . -71.05 166.58 52.31 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 116.427 -0.351 . . . . 0.0 112.97 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -155.56 154.68 32.09 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 87.6 t -140.6 147.09 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -137.56 154.04 49.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.355 0.597 . . . . 0.0 111.846 -177.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -129.48 158.25 39.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.035 -173.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 34.3 m -84.58 -10.49 57.34 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.311 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -124.67 149.15 47.48 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.166 0.587 . . . . 0.0 111.03 -174.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -78.07 -16.33 58.12 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.92 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -80.87 -35.42 32.69 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 15.1 m -77.51 -26.89 51.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -64.59 -48.03 76.48 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.629 0.372 . . . . 0.0 110.481 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 35.5 pt -72.95 -24.49 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 CA-C-N 117.937 0.335 . . . . 0.0 111.039 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -73.62 -24.72 60.06 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.018 0.372 . . . . 0.0 110.804 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -83.74 -8.52 59.24 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.4 pt -120.0 19.42 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 123.035 0.534 . . . . 0.0 110.791 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 21.1 m -89.32 -11.51 43.2 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.899 0.48 . . . . 0.0 112.129 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -142.41 122.94 14.09 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -50.75 -41.14 56.33 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -115.44 107.29 15.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.098 0.408 . . . . 0.0 111.104 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 10.6 m -67.24 151.21 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.418 172.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -100.23 139.93 35.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.276 0.56 . . . . 0.0 109.678 174.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -118.94 21.41 12.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.522 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -84.04 121.85 27.98 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.709 0.803 . . . . 0.0 112.041 -170.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -147.58 24.68 1.09 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.36 142.47 7.58 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 56.22 10.86 0.68 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.259 1.024 . . . . 0.0 112.85 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.7 mt -140.87 142.29 30.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 C-N-CA 123.742 0.817 . . . . 0.0 109.213 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -142.8 18.56 1.98 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.542 0.337 . . . . 0.0 111.343 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -55.36 151.36 10.07 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 124.2 1.0 . . . . 0.0 111.385 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.61 154.21 37.1 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.826 1.25 . . . . 0.0 108.975 176.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 7.2 p -161.12 158.32 2.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -89.66 150.28 22.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.463 0.305 . . . . 0.0 111.739 -175.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.2 m -118.69 155.98 20.72 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-O 120.775 0.322 . . . . 0.0 111.683 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.45 157.56 30.18 Favored Pre-proline 0 CA--C 1.528 0.118 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.73 137.6 74.63 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.349 2.033 . . . . 0.0 108.578 173.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -72.08 120.81 18.21 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 119.04 -1.064 . . . . 0.0 112.009 -175.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 CA--C 1.533 0.309 0 C-N-CA 126.17 1.788 . . . . 0.0 113.403 172.994 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? . . . . . 0 CA--C 1.531 0.217 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 53.85 172.16 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -175.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.3 t -107.46 21.47 17.42 Favored 'General case' 0 C--O 1.23 0.043 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.652 -173.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . 0.467 ' HA ' ' CE1' ' A' ' 115' ' ' PHE . 96.4 mtt180 54.23 20.87 2.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.507 0.723 . . . . 0.0 112.784 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -145.96 146.87 31.19 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.074 0.549 . . . . 0.0 110.73 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -139.07 153.5 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.468 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -88.44 142.68 27.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 170.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.6 m -129.28 100.61 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.994 0.902 . . . . 0.0 109.017 175.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.26 -174.77 50.3 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.26 11.24 85.71 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.715 -0.491 . . . . 0.0 112.72 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.0 tp -67.87 127.04 93.33 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 118.112 0.956 . . . . 0.0 110.965 -177.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.31 163.25 30.34 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.581 2.854 . . . . 0.0 110.257 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -83.64 3.17 7.87 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.123 3.215 . . . . 0.0 113.666 -173.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -129.67 22.41 5.46 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -170.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.0 pt -124.2 171.08 13.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 118.791 0.723 . . . . 0.0 109.958 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -140.35 -173.88 3.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.128 0.49 . . . . 0.0 112.201 -173.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -51.33 -29.41 15.09 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.317 1.447 . . . . 0.0 113.091 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.78 -32.28 35.51 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.501 0.591 . . . . 0.0 111.585 -175.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -76.81 -39.25 52.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.374 0.131 . . . . 0.0 110.848 -173.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.0 pt -83.95 -36.15 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 119.652 -0.213 . . . . 0.0 110.971 -177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.8 m -65.54 -26.52 67.93 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.01 -22.58 31.29 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.647 -0.216 . . . . 0.0 111.408 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 m -78.58 -12.88 60.04 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.213 0.461 . . . . 0.0 112.099 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -118.45 4.44 11.78 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.175 0.443 . . . . 0.0 112.145 175.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 47.9 tpt85 -67.8 -18.55 64.89 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -72.05 -5.34 34.51 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.415 0.552 . . . . 0.0 112.398 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -106.67 6.3 29.65 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.449 0.3 . . . . 0.0 111.619 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.31 179.59 17.54 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.57 134.89 25.16 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.548 2.832 . . . . 0.0 110.662 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.0 pp -159.85 164.93 33.21 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.919 0.888 . . . . 0.0 109.753 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.4 mm -128.45 163.79 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.17 153.67 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -145.47 157.07 44.07 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.214 0.53 . . . . 0.0 111.049 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.416 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 44.8 p90 -156.5 158.77 31.57 Favored Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 169.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.629 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 38.4 Cg_endo -74.15 -10.62 22.79 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.389 2.726 . . . . 0.0 110.459 -169.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.629 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 50.1 m-70 -103.88 10.4 36.4 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.157 0.983 . . . . 0.0 110.927 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -63.92 -24.2 67.64 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.866 0.866 . . . . 0.0 110.927 -178.748 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.255 0 C-N-CA 123.736 0.814 . . . . 0.0 111.473 178.719 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.99 0 CA-C-O 119.656 -0.525 . . . . 0.0 112.165 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 60.64 166.12 0.08 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.324 0.65 . . . . 0.0 111.757 -177.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.82 175.34 9.9 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 121.153 -0.967 . . . . 0.0 113.126 -171.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -145.95 141.71 28.0 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.702 0.801 . . . . 0.0 109.504 -178.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.0 mp -98.94 144.89 27.61 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.23 139.15 52.35 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.467 ' CE1' ' HA ' ' A' ' 65' ' ' ARG . 8.1 p90 -152.19 177.4 10.57 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -117.69 -30.36 5.48 Favored 'General case' 0 CA--C 1.521 -0.148 0 O-C-N 122.188 -0.32 . . . . 0.0 110.88 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -93.31 124.72 37.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -69.15 -19.36 64.01 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.73 0.3 . . . . 0.0 110.324 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.9 m -77.02 -13.27 59.98 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.854 0.462 . . . . 0.0 111.245 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.3 t -75.53 -38.28 59.46 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.9 p -83.64 -21.54 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -67.08 -40.16 86.94 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.28 -37.99 60.62 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.64 -20.47 59.88 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.536 0.607 . . . . 0.0 111.708 -176.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 76.8 mt -92.07 -22.55 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 118.014 0.37 . . . . 0.0 111.437 176.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -91.24 -12.65 34.6 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.889 -0.507 . . . . 0.0 112.225 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -127.04 46.0 2.59 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.885 0.474 . . . . 0.0 111.458 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 27.6 p -139.42 -177.9 5.14 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.775 0.43 . . . . 0.0 111.57 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.9 mp -81.8 159.86 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -139.9 160.52 39.73 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.819 -0.551 . . . . 0.0 112.324 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -143.56 176.69 9.01 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -61.34 3.34 0.12 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -171.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.6 1.89 0.06 OUTLIER Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.006 -0.885 . . . . 0.0 114.0 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -154.1 177.02 11.54 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.713 1.256 . . . . 0.0 110.642 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -116.34 163.33 16.18 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.444 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 6.3 m-85 -139.46 148.16 42.33 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.009 0.433 . . . . 0.0 112.008 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.6 mp -139.56 -171.02 3.05 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 172.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 72.1 m -133.61 162.51 31.73 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.82 0.736 . . . . 0.0 112.138 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.09 167.72 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.674 1.19 . . . . 0.0 109.403 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.7 m -119.47 11.92 12.26 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -170.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.518 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 6.1 t -141.68 32.6 0.16 Allowed Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 176.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 141' ' ' SER . 85.5 Cg_endo -71.28 172.16 14.62 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.631 2.888 . . . . 0.0 113.533 -174.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.9 t -79.89 -20.54 45.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.728 0.811 . . . . 0.0 112.727 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.8 mm -117.21 165.1 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -62.82 121.1 12.62 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 57.5 159.47 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.875 1.27 . . . . 0.0 112.582 -172.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.587 ' HZ1' ' HB2' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -160.05 108.53 1.41 Allowed Pre-proline 0 CA--C 1.522 -0.129 0 O-C-N 121.679 -0.638 . . . . 0.0 110.66 178.472 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.444 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 58.9 Cg_endo -79.77 139.92 14.31 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.636 2.224 . . . . 0.0 108.506 169.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.6 m -124.3 144.85 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.046 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -85.38 158.74 20.17 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 43.4 mm -133.32 140.73 46.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.586 1.154 . . . . 0.0 108.943 172.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -154.92 91.84 2.91 Favored Pre-proline 0 CA--C 1.535 0.375 0 O-C-N 123.345 0.403 . . . . 0.0 110.244 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -61.23 169.93 5.72 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 124.758 3.639 . . . . 0.0 114.853 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' TRP . . . . . 0.428 ' CD2' ' HG2' ' A' ' 214' ' ' PRO . 19.6 t-105 -113.73 141.5 47.18 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.786 174.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -118.22 153.22 34.25 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.703 0.801 . . . . 0.0 110.957 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.66 12.45 16.84 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -170.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.4 t -75.51 -24.0 56.79 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -173.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -143.97 29.55 1.34 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.499 0.59 . . . . 0.0 112.578 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 49.3 m -65.51 -22.24 66.7 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.848 -0.532 . . . . 0.0 112.122 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -153.66 157.42 39.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.782 0.433 . . . . 0.0 110.851 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -155.82 152.83 28.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.33 150.3 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 O-C-N 121.935 -0.478 . . . . 0.0 109.85 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 65.2 mtm -125.14 18.9 8.35 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.252 0.221 . . . . 0.0 111.568 -175.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -154.38 -48.52 0.09 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 67.97 11.09 60.27 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 119.115 -0.825 . . . . 0.0 114.296 172.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 61.3 p -141.08 -16.51 0.85 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -176.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 48.4 mm-40 -82.9 139.18 42.99 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 119.548 1.067 . . . . 0.0 110.926 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 167' ' ' GLN . 37.7 Cg_exo -62.92 156.18 55.81 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.675 2.917 . . . . 0.0 112.238 174.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.5 mp -120.32 162.23 19.8 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.519 0.728 . . . . 0.0 110.719 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -150.01 138.79 12.64 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.17 -11.24 31.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.26 2.64 . . . . 0.0 113.322 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.2 6.14 46.29 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.558 0.617 . . . . 0.0 110.174 175.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -128.28 25.08 5.85 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.93 0.492 . . . . 0.0 110.832 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.7 m -123.75 144.48 49.66 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.77 0.319 . . . . 0.0 110.549 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.5 tt -118.8 151.25 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 123.076 0.55 . . . . 0.0 110.726 -173.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -109.61 143.43 39.34 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 172.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.1 m -139.72 134.39 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 122.974 0.509 . . . . 0.0 109.664 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -150.09 -177.74 24.36 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 -176.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.65 7.19 84.71 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.93 128.37 86.69 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -79.55 -34.5 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.842 2.361 . . . . 0.0 114.376 -172.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ARG . . . . . 0.556 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 71.4 ttp85 -160.92 -38.32 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 116.841 2.163 . . . . 0.0 116.841 -174.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.556 ' HD2' ' H ' ' A' ' 182' ' ' ARG . 84.8 Cg_endo -76.98 -45.76 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 121.609 1.61 . . . . 0.0 113.989 -169.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 30.2 -106.74 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.734 1.214 . . . . 0.0 112.858 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 64.47 136.39 0.02 OUTLIER 'General case' 0 C--N 1.343 0.284 0 C-N-CA 126.222 1.809 . . . . 0.0 112.488 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.15 -32.13 56.1 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.005 -0.434 . . . . 0.0 112.022 -175.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.44 -54.18 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-N 117.674 0.215 . . . . 0.0 111.155 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -75.4 -23.54 57.06 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.68 -173.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 51.8 tp -72.98 -30.49 63.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.02 -41.38 35.97 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 122.171 -0.331 . . . . 0.0 111.768 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 17.3 ptp -75.08 -26.48 59.37 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.217 -0.302 . . . . 0.0 110.713 -177.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.5 mt -72.04 -37.74 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.1 mmt -72.68 -15.75 61.69 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.969 -0.457 . . . . 0.0 110.076 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -89.65 -17.72 27.86 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.862 0.301 . . . . 0.0 110.95 175.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -88.83 -18.27 28.01 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 119.341 -0.362 . . . . 0.0 111.874 177.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.36 -24.86 8.22 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.284 0.493 . . . . 0.0 111.377 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -140.01 47.7 1.81 Allowed 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.794 0.438 . . . . 0.0 110.501 -175.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.13 136.12 4.33 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 123.276 0.465 . . . . 0.0 112.097 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 128.55 8.96 3.75 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -174.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.08 147.94 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 123.65 0.78 . . . . 0.0 110.146 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.2 p -118.24 -37.45 3.35 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 119.504 -0.284 . . . . 0.0 111.49 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -157.43 153.06 26.56 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.775 0.261 . . . . 0.0 110.936 -172.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -147.99 162.04 40.14 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.308 0.575 . . . . 0.0 111.839 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 178.0 -178.36 48.49 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 8.5 tp -87.73 155.59 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ASP . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 219' ' ' ARG . 15.0 p-10 -70.76 38.68 0.05 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.2 t -74.2 152.4 39.78 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.105 -0.372 . . . . 0.0 110.325 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -134.18 146.23 58.81 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 122.604 0.362 . . . . 0.0 110.31 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' PRO . . . . . 0.409 ' C ' ' H ' ' A' ' 211' ' ' LEU . 84.3 Cg_endo -76.01 -7.43 18.23 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 124.533 3.489 . . . . 0.0 111.989 -176.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.24 40.55 0.49 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.952 0.501 . . . . 0.0 110.347 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.409 ' H ' ' C ' ' A' ' 209' ' ' PRO . 0.8 OUTLIER 51.68 21.94 1.49 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.263 1.825 . . . . 0.0 114.316 179.743 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -86.74 -24.15 25.23 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 119.24 -0.41 . . . . 0.0 110.261 174.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.489 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 37.6 m-85 56.28 -169.6 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.624 -0.703 . . . . 0.0 109.811 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.489 ' CD ' ' HB3' ' A' ' 213' ' ' TYR . 52.0 Cg_exo -56.15 151.2 44.35 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.063 1.842 . . . . 0.0 113.102 -177.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -120.9 25.1 9.87 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.739 0.415 . . . . 0.0 110.485 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.66 12.28 73.83 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.28 -0.733 . . . . 0.0 114.152 171.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -132.2 155.03 48.97 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.236 1.018 . . . . 0.0 110.64 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -97.68 160.23 21.04 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 121.45 0.472 . . . . 0.0 112.998 -173.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' ARG . . . . . 0.428 ' CZ ' ' HA ' ' A' ' 206' ' ' ASP . 4.0 ptp85 -142.83 147.31 35.22 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 172.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 3.5 p -150.08 150.42 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.25 150.62 43.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.535 0.734 . . . . 0.0 111.175 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -125.96 149.26 48.91 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.47 0.708 . . . . 0.0 110.816 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 69.1 m -82.05 -0.52 44.78 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 122.257 0.223 . . . . 0.0 110.879 173.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -132.68 133.66 43.82 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.01 0.524 . . . . 0.0 109.943 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -73.34 -21.95 60.42 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -70.42 -38.8 74.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.6 m -76.66 -25.05 53.3 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.239 -0.288 . . . . 0.0 110.239 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -69.21 -51.24 39.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 41.9 pt -69.48 -17.33 21.43 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 118.095 0.407 . . . . 0.0 110.969 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.04 -28.48 39.3 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.48 -17.06 49.99 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 13.5 pt -113.92 24.54 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 123.331 0.653 . . . . 0.0 110.329 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -81.0 -9.89 59.78 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.268 0.627 . . . . 0.0 111.669 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.45 141.78 20.6 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -56.23 -35.47 67.4 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.283 0.233 . . . . 0.0 111.403 -177.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -126.15 114.66 18.65 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.08 0.467 . . . . 0.0 110.306 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 28.7 m -97.81 161.22 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.888 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' GLN . . . . . 0.436 ' H ' ' CD ' ' A' ' 238' ' ' GLN . 0.1 OUTLIER -87.19 142.23 28.06 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.028 0.442 . . . . 0.0 109.833 176.39 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 7.2 mp -117.47 19.2 14.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.667 0.746 . . . . 0.0 109.62 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -55.13 138.83 43.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.243 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -146.09 18.25 1.4 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.472 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 88.08 -9.53 74.41 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 123.703 0.668 . . . . 0.0 111.817 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -141.74 10.31 2.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.64 0.776 . . . . 0.0 110.884 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 35.5 mm -133.54 153.9 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.587 0.755 . . . . 0.0 109.71 -174.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -146.96 12.44 1.1 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.695 0.398 . . . . 0.0 111.019 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -80.11 173.51 12.52 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 123.579 0.752 . . . . 0.0 112.191 -172.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.6 163.01 31.56 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.818 1.247 . . . . 0.0 109.565 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 5.7 p -149.07 150.42 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -85.51 132.46 34.19 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -117.32 155.19 19.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -175.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -157.73 160.31 30.15 Favored Pre-proline 0 C--O 1.232 0.142 0 CA-C-O 119.548 -0.263 . . . . 0.0 110.548 168.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.48 124.8 14.88 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.244 1.962 . . . . 0.0 107.323 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -66.16 117.96 9.21 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.911 -169.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 125.914 1.686 . . . . 0.0 113.292 174.56 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.1 m . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 120.455 0.169 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -146.83 169.51 18.95 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.232 0.613 . . . . 0.0 109.905 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -142.22 166.89 23.46 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.954 0.502 . . . . 0.0 111.134 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -128.5 19.19 6.28 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.535 0.734 . . . . 0.0 111.624 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.92 166.97 16.95 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 57.39 10.81 1.0 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.379 1.072 . . . . 0.0 113.222 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -136.21 -1.85 2.34 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.297 0.639 . . . . 0.0 111.753 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.47 12.53 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 C-N-CA 123.302 0.641 . . . . 0.0 111.24 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -117.2 11.39 14.1 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.581 0.752 . . . . 0.0 111.629 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.427 ' H ' ' HD3' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -80.7 141.47 34.84 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -158.61 164.88 35.61 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 121.156 0.503 . . . . 0.0 110.543 -173.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.7 t -88.7 165.6 14.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.195 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.33 10.95 6.02 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.824 176.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -128.15 141.53 51.45 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 124.148 0.979 . . . . 0.0 109.977 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.63 134.58 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.613 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.455 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 7.8 t80 -79.63 140.68 37.03 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.3 m -127.63 114.48 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 173.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.9 163.12 25.55 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.368 -172.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.65 22.24 76.63 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 119.174 -0.792 . . . . 0.0 113.42 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.0 tp -47.11 123.38 8.14 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 118.629 1.214 . . . . 0.0 107.846 173.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 94.2 Cg_endo -75.67 157.53 39.94 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.705 2.27 . . . . 0.0 111.823 -172.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 39.7 Cg_exo -59.34 173.39 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.42 3.414 . . . . 0.0 112.873 173.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.9 t70 64.88 -78.94 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.6 pt -61.7 162.01 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 118.683 0.674 . . . . 0.0 111.699 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -143.54 -156.01 0.65 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.38 -174.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -43.09 -32.68 0.73 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.642 1.977 . . . . 0.0 114.847 -173.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -78.6 -34.74 46.54 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.615 1.098 . . . . 0.0 112.139 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -77.52 -27.92 51.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.149 -0.345 . . . . 0.0 110.51 -174.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 25.9 pt -84.26 -27.03 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 O-C-N 122.067 -0.396 . . . . 0.0 110.398 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.4 m -73.22 -12.97 61.05 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.16 -17.42 17.41 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.0 m -82.78 -42.51 17.85 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.93 0.787 . . . . 0.0 112.237 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -90.01 1.61 56.11 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -68.38 -14.64 63.14 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.838 0.455 . . . . 0.0 111.953 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -69.8 -10.0 56.76 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.014 0.525 . . . . 0.0 111.555 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -112.89 17.24 19.11 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.832 0.453 . . . . 0.0 110.46 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.54 167.89 21.03 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.78 146.45 72.51 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.448 2.765 . . . . 0.0 110.507 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.94 166.67 28.91 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.0 0.429 . . . . 0.0 111.646 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.9 pt -135.14 166.63 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.201 175.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.66 148.39 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 CA-C-O 120.722 0.296 . . . . 0.0 110.484 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -150.32 165.02 34.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.935 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.468 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 42.1 p90 -154.76 164.05 22.29 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.616 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 43.3 Cg_endo -73.04 -13.58 26.16 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 123.117 2.545 . . . . 0.0 110.927 -169.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.616 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 63.7 m-70 -101.75 7.48 41.85 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.763 0.825 . . . . 0.0 111.102 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.9 tptt -62.23 148.5 44.58 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.945 0.498 . . . . 0.0 110.395 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.43 166.58 27.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.08 0.552 . . . . 0.0 111.117 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -89.47 9.2 27.35 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.212 0.605 . . . . 0.0 110.947 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 84.4 p -79.02 -0.57 31.78 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.398 0.679 . . . . 0.0 112.044 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt 52.76 31.7 10.92 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.817 0.847 . . . . 0.0 112.346 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.1 t -82.09 -25.48 34.46 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.133 0.173 . . . . 0.0 110.974 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 53.02 -171.42 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.764 1.225 . . . . 0.0 113.422 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 48.9 t80 57.48 110.54 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 126.435 1.894 . . . . 0.0 113.975 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.9 166.81 3.56 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 124.373 3.382 . . . . 0.0 112.778 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -47.98 -29.85 12.73 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 124.892 3.728 . . . . 0.0 115.633 -177.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -151.35 -68.23 0.18 Allowed 'General case' 0 C--N 1.34 0.156 0 CA-C-N 119.239 0.927 . . . . 0.0 111.649 177.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.73 41.34 0.14 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.7 -171.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.76 147.59 31.08 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.168 0.984 . . . . 0.0 109.254 172.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.89 175.91 11.59 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 122.61 0.364 . . . . 0.0 110.931 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -136.1 129.39 31.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -90.32 149.18 22.43 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.549 0.69 . . . . 0.0 111.785 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.82 145.58 41.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.158 -1.383 . . . . 0.0 107.297 171.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -134.11 165.88 24.05 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 110.956 -176.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -105.03 -31.48 9.17 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.236 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -121.24 150.48 41.29 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.862 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -87.32 -5.83 58.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.322 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.2 p -93.72 -15.19 25.48 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.665 0.386 . . . . 0.0 111.437 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 75.3 m -73.19 -36.12 66.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 122.019 -0.426 . . . . 0.0 110.769 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.01 -20.43 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -77.42 -38.54 49.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.0 -35.97 66.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.257 0.48 . . . . 0.0 111.584 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -78.84 -15.59 58.18 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.199 0.454 . . . . 0.0 111.705 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.5 mt -99.33 -15.44 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 122.354 0.262 . . . . 0.0 111.209 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -103.34 -9.31 19.58 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.593 -0.692 . . . . 0.0 112.641 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -115.99 29.9 7.69 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.848 0.459 . . . . 0.0 111.96 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 32.0 p -140.48 -176.26 4.57 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.774 0.43 . . . . 0.0 111.659 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 32.2 mm -79.14 156.05 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 124.629 1.172 . . . . 0.0 109.007 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -138.84 155.5 48.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 111.972 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -144.15 70.77 1.3 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.374 0.607 . . . . 0.0 110.066 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 p30 47.44 12.92 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.72 2.008 . . . . 0.0 116.228 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 175.5 -20.47 0.05 OUTLIER Glycine 0 CA--C 1.526 0.779 0 CA-C-N 118.578 0.626 . . . . 0.0 112.446 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -134.63 170.96 15.02 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 117.759 0.779 . . . . 0.0 109.555 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 150' ' ' GLN . 4.6 mp -130.63 173.33 11.0 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.897 -176.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -139.75 147.69 41.21 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.2 mp -133.84 164.0 28.24 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 170.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.7 m -101.98 150.49 23.17 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.205 0.602 . . . . 0.0 110.659 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.6 m -142.6 -4.76 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.3 m 48.53 43.94 20.45 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.515 0.726 . . . . 0.0 112.842 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.6 p -73.55 153.62 89.71 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.71 8.95 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.635 1 C-N-CA 125.58 4.186 . . . . 0.0 117.296 -175.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.0 m -96.28 -18.42 20.02 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.677 1.126 . . . . 0.0 110.069 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.447 HG22 ' H42' ' B' ' 1' ' ' ' C' . 0.3 OUTLIER -165.62 -172.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.342 1.457 . . . . 0.0 108.405 -171.537 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -69.5 -32.79 71.87 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.019 -0.426 . . . . 0.0 109.984 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -162.95 153.15 16.17 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.266 0.626 . . . . 0.0 111.0 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.515 ' HB2' ' HZ3' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -116.19 106.87 48.48 Favored Pre-proline 0 N--CA 1.457 -0.107 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 174.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.46 91.92 0.16 Allowed 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.866 2.378 . . . . 0.0 109.026 168.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.8 m -80.2 141.75 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 72.2 mt-30 -93.18 159.71 15.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.647 -177.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 50.0 mm -129.88 141.44 46.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.115 0.966 . . . . 0.0 109.761 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.29 101.62 1.54 Allowed Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.67 164.16 30.68 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.971 3.114 . . . . 0.0 111.91 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -88.08 148.7 24.35 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -109.28 150.31 28.15 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.851 0.46 . . . . 0.0 111.247 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.5 mp -96.74 78.1 2.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.128 0.571 . . . . 0.0 110.461 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.9 t -155.11 -32.66 0.1 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -134.56 28.06 3.66 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.2 m -60.71 -31.59 70.87 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.167 -0.333 . . . . 0.0 111.679 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -158.3 163.05 37.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.922 0.489 . . . . 0.0 110.877 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -156.1 156.61 34.6 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.494 0.318 . . . . 0.0 110.539 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.2 m -137.53 152.42 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 C-N-CA 123.273 0.629 . . . . 0.0 110.14 175.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 18.2 ttp -130.13 14.68 5.69 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.224 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -148.57 -170.95 3.74 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -73.02 25.77 0.8 Allowed Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.682 0.658 . . . . 0.0 112.949 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 44.7 m 53.67 52.17 13.69 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 117.945 0.873 . . . . 0.0 111.645 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -59.3 156.55 28.83 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 122.963 0.505 . . . . 0.0 110.349 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.15 140.64 60.52 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.179 2.586 . . . . 0.0 111.758 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 74.9 mt -114.38 153.61 29.54 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.777 0.431 . . . . 0.0 110.549 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -145.37 156.03 53.73 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.77 -5.76 17.57 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.033 2.488 . . . . 0.0 111.011 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -98.76 4.44 47.73 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.522 1.129 . . . . 0.0 111.455 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -129.01 16.6 6.22 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 122.693 0.397 . . . . 0.0 111.577 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 25.7 m -127.69 140.75 51.88 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.027 0.441 . . . . 0.0 112.018 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.9 tt -116.98 149.43 19.23 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.293 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -107.24 150.32 26.78 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 97.4 t -135.52 124.57 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 123.489 0.715 . . . . 0.0 109.278 -175.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -141.23 166.1 26.14 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 120.983 0.213 . . . . 0.0 112.585 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.6 17.79 61.35 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -170.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.0 m -72.19 154.85 92.08 Favored Pre-proline 0 CA--C 1.529 0.155 0 C-N-CA 122.965 0.506 . . . . 0.0 112.332 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.09 177.8 7.75 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.945 3.097 . . . . 0.0 108.963 169.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -66.39 -52.96 33.62 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.449 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.1 149.68 19.98 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.522 2.148 . . . . 0.0 111.069 175.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 43.1 mt -146.94 -43.54 0.18 Allowed 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 122.883 0.473 . . . . 0.0 110.964 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 52.76 102.71 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.43 1.492 . . . . 0.0 111.662 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -56.32 -24.28 42.62 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 30.9 t -63.27 -49.75 81.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 CA-C-N 117.979 0.354 . . . . 0.0 110.636 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -82.82 -21.12 34.57 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.814 -0.176 . . . . 0.0 110.773 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 40.7 tp -67.22 -37.31 83.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.68 -33.11 47.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.817 -0.135 . . . . 0.0 111.147 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.0 mmt -69.05 -37.17 78.42 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 117.873 0.306 . . . . 0.0 110.293 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.475 ' CG2' ' HA ' ' A' ' 239' ' ' LEU . 46.5 mt -69.6 -48.47 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 122.186 0.195 . . . . 0.0 110.535 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -58.94 -22.29 59.7 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.045 0.384 . . . . 0.0 111.453 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -84.18 -20.72 31.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.595 0.634 . . . . 0.0 111.546 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -89.32 -16.04 32.01 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 119.287 -0.387 . . . . 0.0 111.733 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -113.53 -18.36 11.97 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.36 0.527 . . . . 0.0 112.309 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -138.97 -30.37 0.74 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.851 0.75 . . . . 0.0 112.782 -177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.16 -177.92 18.57 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 68.99 11.66 63.81 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.586 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 15.6 t -69.09 149.11 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 118.323 1.061 . . . . 0.0 110.282 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 48.5 t -131.65 -35.3 1.29 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.163 0.185 . . . . 0.0 111.31 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -148.31 149.33 31.64 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.22 156.2 38.06 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.135 0.574 . . . . 0.0 109.803 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 169.39 -175.8 43.56 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.9 143.33 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -54.54 133.95 46.3 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.903 -0.135 . . . . 0.0 111.13 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 22.2 p -141.36 167.55 21.89 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 122.739 0.416 . . . . 0.0 110.363 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -129.34 131.51 23.69 Favored Pre-proline 0 N--CA 1.453 -0.299 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -80.19 -12.73 12.87 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.917 3.745 . . . . 0.0 113.728 -174.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -97.23 -27.06 14.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.701 0.682 . . . . 0.0 110.672 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 94.1 mt -108.75 -0.39 20.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.267 0.627 . . . . 0.0 110.534 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 46.59 48.41 14.24 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.707 1.203 . . . . 0.0 112.496 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.03 153.98 50.07 Favored Pre-proline 0 CA--C 1.53 0.182 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -176.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.85 153.92 29.71 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.78 2.32 . . . . 0.0 110.754 173.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -117.58 25.05 10.68 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.566 0.746 . . . . 0.0 110.563 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 68.01 -170.71 36.67 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 52.38 -166.51 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 117.521 0.661 . . . . 0.0 110.96 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -155.82 173.47 33.85 Favored Glycine 0 C--N 1.333 0.397 0 O-C-N 121.146 -0.972 . . . . 0.0 112.281 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -142.44 155.13 45.06 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 66.7 t -139.12 143.14 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.44 150.51 49.61 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.908 0.385 . . . . 0.0 110.197 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -125.81 152.72 45.06 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.899 -174.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 68.7 p -86.05 4.69 36.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.258 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -138.14 141.24 40.15 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.108 0.563 . . . . 0.0 110.448 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -75.13 -13.16 60.44 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.757 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -81.59 -37.48 27.59 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 20.0 m -75.58 -27.1 58.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -66.88 -51.8 51.08 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.448 -0.205 . . . . 0.0 110.448 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.0 pt -69.98 -15.67 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-N 118.002 0.365 . . . . 0.0 111.038 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.97 -23.91 35.8 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.786 0.267 . . . . 0.0 110.686 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -84.34 -31.34 24.87 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.705 0.229 . . . . 0.0 111.579 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.5 pt -98.77 24.57 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 122.621 0.368 . . . . 0.0 110.236 174.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.9 t -77.94 -17.7 56.92 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.024 0.53 . . . . 0.0 111.547 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.06 143.58 22.62 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -54.69 -32.29 59.17 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 122.716 0.406 . . . . 0.0 111.781 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -118.01 108.55 15.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.914 0.388 . . . . 0.0 110.195 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.4 m -78.03 161.3 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.599 176.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 7.4 mp0 -93.55 135.77 34.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.475 ' HA ' ' CG2' ' A' ' 192' ' ' ILE . 2.7 mm? -123.3 28.03 7.26 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.795 0.331 . . . . 0.0 110.72 -175.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -76.5 147.37 37.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.643 0.377 . . . . 0.0 110.964 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -149.49 16.89 0.91 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.652 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 83.94 125.72 1.22 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -173.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 53.49 15.74 0.78 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.196 0.998 . . . . 0.0 113.128 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 73.6 mt -140.7 148.67 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.987 0.915 . . . . 0.0 109.241 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -158.8 134.42 8.73 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -144.91 166.19 25.98 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 124.492 1.117 . . . . 0.0 108.34 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.75 150.92 33.94 Favored 'General case' 0 CA--C 1.523 -0.061 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.5 p -158.97 157.13 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -82.81 145.16 29.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.088 0.555 . . . . 0.0 110.835 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.11 161.37 29.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 112.503 0.556 . . . . 0.0 112.503 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.57 159.29 25.83 Favored Pre-proline 0 N--CA 1.455 -0.176 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.911 170.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.09 135.98 73.89 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.559 2.173 . . . . 0.0 109.038 173.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -69.89 146.38 51.3 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.964 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.5 p -154.3 146.21 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.922 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 C--O 1.251 1.176 0 CA-C-O 117.776 -1.107 . . . . 0.0 110.926 -179.809 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.447 ' H42' HG22 ' A' ' 144' ' ' ILE . . . . . . . . 0 O4'--C4' 1.418 -2.898 1 O4'-C1'-N19 113.936 5.736 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.171 2 C3'-C2'-C1' 105.735 4.706 OUTLIER-DELTA 0.378 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.455 ' C6 ' ' CE2' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.417 -3.02 2 O4'-C1'-N19 114.191 5.991 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.539 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.417 -2.965 0 C5'-C4'-C3' 110.825 -3.117 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.549 ' C8 ' H5'' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.059 0 O4'-C1'-N19 111.445 3.245 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.5 p . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 120.0 -0.048 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -146.26 162.31 38.37 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.283 0.633 . . . . 0.0 110.075 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -137.68 164.79 27.97 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.708 0.803 . . . . 0.0 110.188 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -142.09 161.13 38.78 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.823 0.449 . . . . 0.0 110.882 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.89 -173.88 47.9 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -138.79 152.77 48.18 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.626 0.771 . . . . 0.0 109.231 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -137.76 166.99 22.64 Favored 'General case' 0 C--O 1.228 -0.042 0 C-N-CA 123.365 0.666 . . . . 0.0 110.116 -177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.26 9.6 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 123.034 0.534 . . . . 0.0 111.49 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -81.93 -8.65 59.69 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.729 0.412 . . . . 0.0 111.195 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.4 ppt_? -86.95 145.93 26.34 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 110.692 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -155.48 169.23 24.74 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.092 -171.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.6 t -89.73 19.97 4.37 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 54.13 18.94 1.92 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.578 0.751 . . . . 0.0 112.256 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -145.38 146.27 31.5 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.151 0.58 . . . . 0.0 109.866 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.36 142.05 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.208 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.497 ' CZ ' ' C6 ' ' B' ' 3' ' ' ' U' . 3.7 t80 -90.26 139.35 30.74 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.5 m -125.72 99.04 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 122.033 0.92 . . . . 0.0 108.765 177.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.03 164.59 31.21 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.529 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.47 24.09 77.27 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 122.618 -0.342 . . . . 0.0 112.649 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.1 tp -60.41 128.67 88.31 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -69.72 131.02 20.42 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.886 1.724 . . . . 0.0 110.015 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -64.45 -8.48 17.15 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.735 2.957 . . . . 0.0 114.627 -176.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -88.07 -0.65 57.31 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -173.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 pp -136.67 -173.29 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.091 0 CA-C-N 118.636 0.653 . . . . 0.0 111.014 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -139.73 -166.78 2.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.541 0.736 . . . . 0.0 111.004 -175.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -45.93 -31.42 2.18 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.462 1.505 . . . . 0.0 113.213 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -65.94 -36.6 83.79 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -73.48 -38.17 65.51 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 122.095 -0.378 . . . . 0.0 110.403 -172.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.5 pt -84.05 -27.46 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 O-C-N 122.101 -0.374 . . . . 0.0 111.436 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 90.9 m -69.97 -16.41 63.19 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.14 -19.43 18.66 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.0 m -79.46 -26.68 41.68 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.902 0.774 . . . . 0.0 112.962 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -113.26 10.16 18.46 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.134 0.424 . . . . 0.0 111.743 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -68.9 -19.89 64.23 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 122.827 0.451 . . . . 0.0 111.762 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -72.18 -12.1 61.03 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.526 0.33 . . . . 0.0 111.102 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -105.2 20.5 18.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.744 0.418 . . . . 0.0 110.283 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.34 170.71 31.99 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.78 144.57 59.87 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.211 2.607 . . . . 0.0 110.425 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -149.61 168.33 23.86 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.862 0.363 . . . . 0.0 111.256 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.2 pt -140.53 166.49 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.46 149.73 24.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 121.147 0.498 . . . . 0.0 110.717 -176.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -147.18 163.32 36.71 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.222 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 28.8 p90 -158.62 161.75 27.85 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 174.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.555 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 32.8 Cg_endo -74.34 -9.59 21.8 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.5 2.134 . . . . 0.0 110.568 -170.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.555 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 8.2 m-70 -100.79 17.82 21.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.52 1.128 . . . . 0.0 110.98 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -50.15 146.1 5.29 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.322 0.649 . . . . 0.0 112.625 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -108.42 -172.24 2.02 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.495 1.118 . . . . 0.0 110.814 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.413 ' C ' ' H ' ' A' ' 102' ' ' LYS . 60.2 mt-10 -68.35 -178.99 1.19 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.32 0.648 . . . . 0.0 110.536 176.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.9 m -70.24 9.12 0.63 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.087 0.555 . . . . 0.0 111.712 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 100' ' ' GLU . 22.8 pttp -147.6 160.97 42.06 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.305 1.042 . . . . 0.0 110.052 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.3 t 52.97 32.45 12.73 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.589 0.756 . . . . 0.0 112.811 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -80.01 138.57 37.07 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.6 0.36 . . . . 0.0 111.146 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -153.14 150.46 23.97 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 124.096 0.958 . . . . 0.0 109.296 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -62.86 156.62 52.79 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.28 3.32 . . . . 0.0 111.976 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.66 -29.09 16.43 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.784 2.989 . . . . 0.0 112.149 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -156.74 -68.53 0.1 Allowed 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 123.419 0.687 . . . . 0.0 109.454 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.3 31.5 0.07 OUTLIER Glycine 0 CA--C 1.525 0.66 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.154 -172.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.448 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.4 OUTLIER -141.42 145.66 35.59 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 117.799 0.799 . . . . 0.0 108.884 174.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.06 176.79 10.81 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.598 0.359 . . . . 0.0 110.875 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.495 ' CE1' ' C5 ' ' B' ' 4' ' ' ' U' . 1.6 m-85 -139.54 126.97 21.5 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -177.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.5 mp -89.58 151.04 22.13 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.32 0.581 . . . . 0.0 111.524 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 mp -114.11 139.59 49.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -136.78 175.62 9.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.508 0.723 . . . . 0.0 109.946 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -115.95 -23.43 8.56 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 122.92 0.488 . . . . 0.0 111.783 -175.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -141.49 160.88 39.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.868 0.366 . . . . 0.0 111.228 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -82.14 -14.61 55.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.271 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 41.4 m -79.02 -16.96 56.14 Favored 'General case' 0 C--O 1.231 0.093 0 O-C-N 122.277 -0.265 . . . . 0.0 111.112 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 73.1 m -79.62 -42.73 24.28 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.331 -0.23 . . . . 0.0 110.599 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.96 -22.34 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -75.89 -33.63 59.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.87 -36.9 59.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 117.967 0.349 . . . . 0.0 111.086 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 pp -78.86 -14.6 59.15 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 117.993 0.36 . . . . 0.0 111.43 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.8 mt -98.76 -17.16 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 122.328 0.251 . . . . 0.0 111.43 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -100.55 -10.78 20.68 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.879 -0.513 . . . . 0.0 112.131 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -120.22 30.25 7.08 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.053 0.541 . . . . 0.0 111.719 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 23.4 p -127.55 -174.83 3.28 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.241 0.616 . . . . 0.0 111.216 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 43.2 mm -87.76 161.31 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.023 0.929 . . . . 0.0 109.074 -176.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -127.14 154.25 44.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.611 0.243 . . . . 0.0 110.769 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -141.45 66.21 1.36 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.271 0.558 . . . . 0.0 110.402 176.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 52.31 9.57 0.1 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 172.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 171.11 -16.36 0.06 OUTLIER Glycine 0 CA--C 1.528 0.847 0 CA-C-N 118.59 0.632 . . . . 0.0 112.485 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -128.27 172.16 11.3 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-N 117.663 0.731 . . . . 0.0 109.726 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.8 161.63 15.25 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.343 0.257 . . . . 0.0 110.308 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -139.86 150.64 44.88 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.087 0.555 . . . . 0.0 109.784 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.8 tp -138.82 151.26 46.88 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 169.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 44.0 t -84.7 152.7 23.56 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -127.71 161.31 35.77 Favored 'Isoleucine or valine' 0 C--N 1.337 0.056 0 C-N-CA 122.972 0.509 . . . . 0.0 110.099 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 52.9 m -92.25 -13.94 29.68 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.3 m -142.9 65.25 15.78 Favored Pre-proline 0 CA--C 1.53 0.18 0 C-N-CA 123.073 0.549 . . . . 0.0 109.968 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -68.95 168.96 18.97 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.682 3.588 . . . . 0.0 111.849 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 13.4 t -84.31 160.31 20.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 174.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.9 mt 57.17 -108.49 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -148.85 132.24 16.6 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.465 0.706 . . . . 0.0 109.135 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.4 t0 41.79 78.78 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.754 1.222 . . . . 0.0 112.064 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 108.81 20.4 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 119.568 -0.253 . . . . 0.0 110.711 -174.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -71.59 165.31 32.91 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.399 3.4 . . . . 0.0 112.348 -178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.4 p -114.92 140.38 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.0 tm0? -94.94 151.89 18.81 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.483 0.713 . . . . 0.0 110.913 -174.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 32.4 mm -134.87 142.02 41.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 C-N-CA 123.408 0.683 . . . . 0.0 111.147 -177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -156.76 113.92 2.01 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 169.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -77.39 171.44 17.65 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 124.44 3.427 . . . . 0.0 112.464 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 -100.18 140.22 34.72 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -107.84 152.43 24.41 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.481 0.657 . . . . 0.0 111.663 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.7 mp -87.57 65.01 8.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.423 0.689 . . . . 0.0 110.544 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.4 t -133.76 -25.23 1.67 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.692 0.397 . . . . 0.0 111.151 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -153.81 138.3 16.8 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 67.2 m -157.79 -45.43 0.06 Allowed 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 117.907 0.321 . . . . 0.0 110.405 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -160.63 163.44 32.57 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.934 0.493 . . . . 0.0 110.617 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -157.37 160.24 38.25 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.2 m -138.69 150.39 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.559 0.744 . . . . 0.0 110.136 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 52.7 mtm -132.29 29.96 4.25 Favored 'General case' 0 C--N 1.335 -0.055 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.925 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -151.71 162.34 41.18 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -77.96 29.85 1.83 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 123.563 0.602 . . . . 0.0 112.141 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 m 57.42 52.1 9.03 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -61.92 163.51 12.86 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -47.03 128.05 13.32 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.171 2.58 . . . . 0.0 111.512 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.0 tp -136.45 136.41 39.47 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.648 0.779 . . . . 0.0 110.153 -172.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -150.95 159.99 32.9 Favored Pre-proline 0 N--CA 1.455 -0.215 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.88 -14.72 14.74 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.531 2.821 . . . . 0.0 113.151 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -79.74 -6.62 57.61 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.831 0.452 . . . . 0.0 111.286 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -126.75 23.23 6.74 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 122.744 0.417 . . . . 0.0 110.457 175.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 27.7 m -122.08 148.77 44.45 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.922 0.392 . . . . 0.0 111.075 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.27 147.86 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 123.306 0.643 . . . . 0.0 109.416 -176.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -112.32 154.34 25.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 10.9 m -140.14 146.16 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.077 0.551 . . . . 0.0 110.515 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -150.71 170.79 30.54 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.04 12.42 84.4 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.7 p -87.76 146.27 38.67 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 122.71 0.404 . . . . 0.0 111.009 -176.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.64 161.91 7.21 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.247 2.632 . . . . 0.0 111.734 171.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -47.52 78.74 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.511 -0.757 . . . . 0.0 112.474 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.47 60.29 7.75 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.061 2.507 . . . . 0.0 111.429 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 4.1 pp -74.02 -10.91 60.11 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.981 -0.449 . . . . 0.0 111.972 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.15 80.48 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.489 1.516 . . . . 0.0 112.242 172.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.39 -28.85 46.33 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -171.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.87 -44.37 88.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.068 0 CA-C-N 118.774 0.715 . . . . 0.0 110.167 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -85.86 -18.23 33.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.056 -175.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 29.9 tp -73.26 -30.31 63.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.85 -35.38 57.55 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.7 mmt -67.97 -33.5 74.77 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.417 ' CG2' ' HA ' ' A' ' 239' ' ' LEU . 34.8 mt -71.55 -46.99 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 122.613 0.365 . . . . 0.0 110.704 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -61.27 -23.18 65.49 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.31 0.505 . . . . 0.0 110.699 174.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -82.69 -18.65 40.17 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.969 -0.457 . . . . 0.0 111.272 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -93.4 -11.94 31.03 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 119.114 -0.47 . . . . 0.0 111.963 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -114.6 -20.75 10.59 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 118.673 0.669 . . . . 0.0 111.972 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -137.06 -33.6 0.75 Allowed 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.519 0.6 . . . . 0.0 112.578 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 68.08 179.1 15.97 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 70.82 13.89 72.46 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.428 -0.651 . . . . 0.0 113.133 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 22.6 t -68.78 140.66 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 118.269 1.034 . . . . 0.0 109.944 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.5 p -120.84 -30.13 4.5 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -153.39 149.37 27.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.639 0.256 . . . . 0.0 110.671 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -157.12 158.12 35.78 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.305 0.642 . . . . 0.0 109.739 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 157.41 -172.52 34.81 Favored Glycine 0 C--N 1.335 0.528 0 N-CA-C 111.974 -0.45 . . . . 0.0 111.974 177.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.01 140.15 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 174.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -53.67 106.01 0.16 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 14.4 t -152.56 146.27 25.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.238 0.542 . . . . 0.0 112.233 -175.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -152.79 135.44 9.26 Favored Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 170.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -75.89 3.09 6.37 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.022 3.148 . . . . 0.0 111.413 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -77.83 -45.73 23.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.5 pp -161.26 6.59 0.07 Allowed 'General case' 0 C--N 1.341 0.21 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -138.05 -29.77 0.82 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -177.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.463 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 34.3 m-85 54.18 -166.77 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.596 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.463 ' CD ' ' HB3' ' A' ' 213' ' ' TYR . 91.8 Cg_endo -75.19 144.35 29.52 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 CA-C-N 121.935 1.727 . . . . 0.0 112.778 -170.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.462 ' HA ' ' C4 ' ' B' ' 4' ' ' ' U' . 88.3 mttt -90.26 -168.76 2.2 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.583 0.753 . . . . 0.0 110.064 175.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.408 ' N ' ' C5 ' ' B' ' 4' ' ' ' U' . . . -96.35 5.24 65.07 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -137.38 150.49 47.73 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.205 0.602 . . . . 0.0 110.85 -175.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -104.35 173.4 21.25 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.971 -173.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -148.31 153.51 38.75 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 88.7 t -138.25 148.85 24.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -136.65 156.87 47.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.422 0.63 . . . . 0.0 111.381 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -132.25 153.23 50.85 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.561 -175.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.1 p -84.63 0.48 50.04 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.956 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -132.83 141.18 48.32 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.068 0.547 . . . . 0.0 110.362 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.3 pm0 -74.41 -7.27 52.36 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.369 0.268 . . . . 0.0 111.268 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -83.52 -40.62 18.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 25.5 m -75.51 -24.98 56.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -63.91 -50.75 67.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -73.71 -11.78 14.91 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 CA-C-N 118.09 0.405 . . . . 0.0 111.144 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.43 -17.05 33.13 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.588 0.176 . . . . 0.0 111.149 174.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.76 -12.34 29.36 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 11.3 pt -120.39 23.25 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.354 0.662 . . . . 0.0 110.313 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.2 p -76.79 -19.03 58.05 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.23 0.612 . . . . 0.0 111.721 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.3 144.33 22.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -57.61 -31.61 66.4 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -122.94 110.14 15.01 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.0 m -82.36 154.89 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.205 175.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -84.07 138.45 33.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 173.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.417 ' HA ' ' CG2' ' A' ' 192' ' ' ILE . 3.1 mm? -120.88 36.77 4.49 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -81.63 147.29 29.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.945 0.402 . . . . 0.0 111.887 -173.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -136.48 16.33 3.16 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.27 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 85.55 -15.36 46.7 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.006 0.813 . . . . 0.0 112.523 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -140.68 1.83 1.75 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.707 0.753 . . . . 0.0 110.786 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.6 mt -141.18 153.45 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 123.751 0.82 . . . . 0.0 109.335 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -148.02 135.3 20.49 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -145.34 169.38 18.39 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 125.023 1.329 . . . . 0.0 108.415 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.15 151.65 33.46 Favored 'General case' 0 CA--C 1.523 -0.059 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 11.4 p -155.17 153.73 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -83.35 124.09 30.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.5 m -102.98 159.0 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.536 ' HG3' ' H61' ' B' ' 5' ' ' ' A' . 0.0 OUTLIER -159.67 159.01 27.91 Favored Pre-proline 0 CA--C 1.528 0.113 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.665 169.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.33 142.72 94.95 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.769 2.312 . . . . 0.0 110.124 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -83.83 166.79 17.65 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.997 0.427 . . . . 0.0 110.641 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 6.7 p -151.78 155.37 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 123.282 0.633 . . . . 0.0 110.142 -170.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 61.8 tp . . . . . 0 C--O 1.249 1.035 0 CA-C-O 117.245 -1.359 . . . . 0.0 110.064 179.56 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.77 1 C5'-C4'-C3' 108.76 -4.493 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.94 1 C3'-C2'-C1' 105.15 4.056 . 0.095 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.497 ' C6 ' ' CZ ' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.691 2 O4'-C1'-N19 114.062 5.862 OUTLIER-DELTA 0.308 4b . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.495 ' C5 ' ' CE1' ' A' ' 112' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.732 0 C5'-C4'-C3' 111.32 -2.787 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.536 ' H61' ' HG3' ' A' ' 251' ' ' LYS . . . . . . . . 0 O4'--C4' 1.412 -3.395 1 C5'-C4'-C3' 108.711 -4.526 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 120.487 0.184 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -145.93 14.21 1.33 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.944 0.498 . . . . 0.0 111.243 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -138.87 168.86 18.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.723 0.809 . . . . 0.0 110.485 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -142.15 157.25 45.09 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.887 0.475 . . . . 0.0 109.803 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.87 167.83 27.75 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -153.67 154.74 34.71 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.277 0.631 . . . . 0.0 109.682 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -138.42 120.75 15.92 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.765 0.426 . . . . 0.0 109.914 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.2 t -149.2 127.45 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -158.35 170.99 20.99 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.703 0.287 . . . . 0.0 110.687 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.439 ' HG3' ' H ' ' A' ' 63' ' ' TYR . 12.9 tpt180 -130.42 174.34 9.96 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.737 0.815 . . . . 0.0 109.257 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.439 ' H ' ' HG3' ' A' ' 62' ' ' ARG . 15.6 m-85 -132.66 148.95 52.35 Favored 'General case' 0 N--CA 1.458 -0.044 0 CA-C-O 120.743 0.306 . . . . 0.0 111.106 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.2 m -88.41 24.86 1.81 Allowed 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.244 0.618 . . . . 0.0 111.847 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.19 28.02 6.61 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 122.867 0.467 . . . . 0.0 109.995 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -135.29 137.85 42.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.292 1.037 . . . . 0.0 110.447 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.4 p -151.39 137.96 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.732 174.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.498 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 11.0 t80 -87.12 143.09 27.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.5 p -128.5 85.59 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 121.979 0.895 . . . . 0.0 108.96 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.427 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -80.84 165.05 47.18 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.094 -177.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.433 ' HA2' " H4'" ' B' ' 1' ' ' ' C' . . . 73.43 9.16 77.32 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 119.77 -0.461 . . . . 0.0 113.17 177.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.6 tp -49.47 137.08 16.9 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -66.0 136.57 45.24 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.959 1.773 . . . . 0.0 109.535 178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.55 14.03 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 124.195 3.263 . . . . 0.0 115.593 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -140.55 32.31 1.86 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.961 0.801 . . . . 0.0 112.067 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.77 155.18 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -120.42 -178.45 3.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.443 0.697 . . . . 0.0 111.0 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -53.37 -31.48 44.9 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.753 0.821 . . . . 0.0 112.738 -175.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -78.18 -33.77 49.94 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -173.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -77.49 -24.98 50.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.867 -0.52 . . . . 0.0 110.583 -173.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.5 mt -80.53 -40.55 19.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.8 m -68.02 -8.71 39.83 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.593 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.43 -19.73 14.31 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 172.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.5 m -74.98 -26.96 59.96 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 118.856 0.753 . . . . 0.0 112.535 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -122.25 17.4 10.68 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -70.81 -17.08 62.77 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -80.62 4.94 16.96 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.044 -0.41 . . . . 0.0 111.79 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -116.66 24.87 10.98 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.566 0.346 . . . . 0.0 110.751 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.64 173.62 30.81 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.16 151.66 72.49 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.492 2.795 . . . . 0.0 110.846 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 0.6 OUTLIER -161.06 161.96 31.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.482 -170.294 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.9 pt -140.37 161.91 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.8 173.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.69 151.67 33.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -145.36 160.7 41.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.532 0.682 . . . . 0.0 112.299 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 30.3 p90 -155.75 158.77 31.86 Favored Pre-proline 0 N--CA 1.451 -0.386 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 169.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.606 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 28.5 Cg_endo -74.7 -7.98 19.93 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.447 2.765 . . . . 0.0 110.628 -169.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.606 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 75.4 m-70 -105.37 18.06 22.9 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.381 1.073 . . . . 0.0 111.182 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -50.86 155.04 1.26 Allowed 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.96 0.904 . . . . 0.0 112.387 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -136.74 169.47 17.69 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.403 0.681 . . . . 0.0 111.1 -176.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -141.23 150.81 43.13 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.36 0.664 . . . . 0.0 109.544 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.6 m 55.56 18.63 2.82 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.737 0.815 . . . . 0.0 112.767 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -142.46 170.92 14.8 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.429 1.092 . . . . 0.0 109.438 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.3 p -67.63 159.4 30.01 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.685 0.278 . . . . 0.0 110.727 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -98.02 142.36 29.83 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.651 0.38 . . . . 0.0 110.903 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -159.19 115.82 1.61 Allowed Pre-proline 0 N--CA 1.454 -0.264 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.69 158.29 24.91 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.933 3.089 . . . . 0.0 110.815 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.14 133.63 31.4 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.378 2.719 . . . . 0.0 110.305 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.6 tptm 40.03 -93.3 0.01 OUTLIER 'General case' 0 C--N 1.341 0.215 0 C-N-CA 125.574 1.55 . . . . 0.0 111.917 -177.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -157.87 40.13 0.53 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -172.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.456 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.0 OUTLIER -141.39 145.64 35.6 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.299 0.55 . . . . 0.0 110.625 175.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.5 -177.36 6.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.438 0.695 . . . . 0.0 109.72 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -144.21 144.23 31.43 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -97.56 146.01 25.69 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.407 0.622 . . . . 0.0 111.099 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.23 144.95 40.77 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -136.35 171.91 13.79 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.815 0.34 . . . . 0.0 111.088 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -108.39 -26.18 10.61 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.016 0.527 . . . . 0.0 109.969 -177.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -135.24 155.03 51.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.32 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -85.15 -11.34 55.29 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.069 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.4 m -81.29 -19.03 43.84 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.212 0.205 . . . . 0.0 111.235 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.3 m -76.2 -43.14 43.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.571 0.224 . . . . 0.0 110.846 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 8.6 p -75.74 -19.5 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -77.02 -29.03 55.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.06 -44.71 46.08 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 119.067 -0.492 . . . . 0.0 111.94 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.41 -29.51 62.64 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 118.325 -1.35 . . . . 0.0 110.567 -179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.408 ' HA ' ' SG ' ' A' ' 128' ' ' CYS . 79.1 mt -78.42 -15.7 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 118.387 0.54 . . . . 0.0 111.111 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -92.09 -13.65 30.47 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.016 -0.427 . . . . 0.0 110.894 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -113.72 1.82 15.0 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.408 ' SG ' ' HA ' ' A' ' 125' ' ' ILE . 18.5 p -96.7 -176.07 3.49 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.159 0.504 . . . . 0.0 111.177 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.6 mm -81.66 155.91 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.534 1.134 . . . . 0.0 108.513 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -136.95 145.83 44.69 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.623 0.249 . . . . 0.0 110.375 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.99 176.18 9.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -57.66 -1.89 0.12 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -169.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -159.2 0.16 0.08 OUTLIER Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.415 1.007 . . . . 0.0 114.73 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -163.91 174.03 11.97 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.121 1.46 . . . . 0.0 111.6 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -117.68 161.75 19.16 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.884 0.874 . . . . 0.0 109.706 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.407 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 83.2 m-85 -144.63 158.22 43.86 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 176.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.4 tp -125.3 145.57 49.95 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 168.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 80.3 m -100.16 119.29 38.11 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.001 -0.437 . . . . 0.0 110.653 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.9 m -148.2 159.49 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.597 0.759 . . . . 0.0 110.17 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.2 p -91.11 160.38 15.6 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 97.0 p -150.58 163.78 22.8 Favored Pre-proline 0 N--CA 1.454 -0.265 0 O-C-N 122.112 -0.367 . . . . 0.0 111.895 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -66.35 -10.06 26.17 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.213 2.609 . . . . 0.0 112.641 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 54.8 m -93.59 -45.46 7.72 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.099 0.56 . . . . 0.0 110.741 -176.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.42 HG13 ' HE3' ' A' ' 147' ' ' LYS . 5.1 mm -135.51 158.21 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 C-N-CA 123.446 0.698 . . . . 0.0 109.22 -173.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -62.11 -24.31 67.06 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.974 -0.454 . . . . 0.0 109.971 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -157.35 141.05 15.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.244 1.018 . . . . 0.0 108.882 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.42 ' HE3' HG13 ' A' ' 144' ' ' ILE . 5.3 tppp? -132.46 115.51 14.86 Favored Pre-proline 0 N--CA 1.455 -0.182 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.407 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 89.7 Cg_endo -74.33 96.52 0.97 Allowed 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.409 2.073 . . . . 0.0 106.814 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.0 p -78.04 132.22 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -85.1 153.18 22.86 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.062 0.545 . . . . 0.0 110.67 -173.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.4 mm -136.98 143.35 35.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 123.505 0.722 . . . . 0.0 110.262 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 54.3 ttp85 -154.06 113.0 2.5 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 169.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.46 172.82 15.36 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.42 3.413 . . . . 0.0 112.655 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 19.7 t-105 -122.41 140.27 52.89 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.092 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -125.93 168.76 13.45 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.358 0.599 . . . . 0.0 111.021 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.438 ' CD1' ' N ' ' A' ' 156' ' ' LEU . 4.7 mp -104.59 99.01 8.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.373 -169.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.2 t -156.76 -32.97 0.08 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.999 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -138.86 26.25 2.5 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.7 m -70.14 -26.53 63.99 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -153.65 160.05 42.26 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.962 0.505 . . . . 0.0 110.941 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -154.69 162.34 41.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.455 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 1.6 p -154.04 147.46 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 122.63 0.372 . . . . 0.0 110.916 -175.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 66.2 mtm -140.79 22.51 2.29 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -147.21 13.07 1.09 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.947 0.794 . . . . 0.0 112.762 -174.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 83.33 23.05 55.56 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 121.77 -0.581 . . . . 0.0 112.848 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 31.6 m 56.91 44.14 23.59 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -65.71 159.31 69.61 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.72 147.31 31.91 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.725 2.95 . . . . 0.0 112.42 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 58.8 mt -118.57 161.95 19.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.481 0.713 . . . . 0.0 110.309 -176.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -149.74 140.42 14.08 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -56.76 -21.88 42.06 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.336 2.691 . . . . 0.0 113.777 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -83.86 -3.26 57.76 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.276 0.489 . . . . 0.0 110.826 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.88 22.4 7.43 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 122.81 0.444 . . . . 0.0 110.86 175.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.6 m -127.26 146.57 50.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.69 0.281 . . . . 0.0 110.803 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 9.7 tt -123.21 149.14 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 123.087 0.555 . . . . 0.0 110.551 -177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.442 ' CD1' ' HD3' ' A' ' 251' ' ' LYS . 5.4 t80 -111.28 143.74 41.57 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 172.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 8.6 m -138.99 136.71 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -145.43 171.45 26.48 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 77.86 11.18 85.67 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.6 p -67.22 146.41 98.9 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 122.728 0.411 . . . . 0.0 110.236 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.08 170.44 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.946 3.097 . . . . 0.0 112.789 173.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -55.08 -47.57 98.2 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.226 -0.892 . . . . 0.0 112.751 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.94 136.48 18.6 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.934 1.756 . . . . 0.0 110.375 173.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.669 ' CD1' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -145.7 -70.53 0.26 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 119.175 -0.441 . . . . 0.0 111.644 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.669 ' H ' ' CD1' ' A' ' 184' ' ' LEU . 81.3 mtp180 58.5 133.62 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.366 1.866 . . . . 0.0 112.912 -175.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.62 -26.3 64.36 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.557 -0.715 . . . . 0.0 110.076 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 51.1 t -68.73 -47.68 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-O 120.761 0.315 . . . . 0.0 110.662 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -81.05 -25.4 37.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.65 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 46.2 tp -71.67 -31.39 66.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.82 -34.59 45.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.284 -0.26 . . . . 0.0 111.317 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 23.3 mmt -68.99 -36.23 77.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 76.6 mt -72.45 -36.0 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.1 mmt -74.08 -14.88 61.05 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 122.09 -0.381 . . . . 0.0 110.194 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -95.19 -15.09 23.53 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 117.993 0.36 . . . . 0.0 110.978 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.31 -17.46 28.9 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.677 0.391 . . . . 0.0 111.339 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -118.12 -23.81 7.23 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 117.987 0.358 . . . . 0.0 111.215 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -139.89 45.21 1.9 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.688 0.395 . . . . 0.0 110.338 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -41.45 134.06 3.28 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.937 0.779 . . . . 0.0 112.618 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 132.07 6.77 3.07 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -175.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 46.5 t -65.59 147.39 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 123.335 0.654 . . . . 0.0 110.611 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 21.9 p -123.91 -28.84 3.74 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 119.216 -0.421 . . . . 0.0 112.121 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -154.19 154.42 33.49 Favored 'General case' 0 N--CA 1.458 -0.06 0 CA-C-N 118.626 0.648 . . . . 0.0 110.785 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.32 158.91 44.67 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.683 0.393 . . . . 0.0 110.57 175.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -177.29 177.66 48.29 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.6 mm -102.09 92.32 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.511 ' HB3' ' H ' ' A' ' 215' ' ' LYS . 27.7 t70 51.68 -58.3 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -169.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 69.3 p 46.04 71.5 0.29 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.552 0.741 . . . . 0.0 112.933 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -78.39 128.04 79.08 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.44 -6.91 20.02 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 124.294 3.329 . . . . 0.0 114.521 -174.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -73.36 -27.16 61.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.966 1.257 . . . . 0.0 111.575 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 78.0 mt -145.33 8.24 1.18 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.851 0.86 . . . . 0.0 110.592 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 54.02 50.08 17.47 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.745 0.818 . . . . 0.0 110.801 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -131.27 152.88 81.33 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 123.378 0.671 . . . . 0.0 110.228 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -84.77 140.52 8.11 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.741 2.294 . . . . 0.0 112.458 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.511 ' H ' ' HB3' ' A' ' 206' ' ' ASP . 37.4 mtmm -98.87 26.81 5.41 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 168.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.77 171.48 14.81 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 60.62 153.67 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.656 1.183 . . . . 0.0 113.746 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -88.19 160.63 30.91 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.58 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -149.55 150.28 32.01 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 60.2 t -142.49 149.93 18.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.06 148.8 50.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -123.22 153.24 40.39 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.895 -175.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 86.7 p -88.66 -0.74 57.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.637 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -130.84 144.67 51.63 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.798 0.439 . . . . 0.0 111.164 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 39.8 tp60 -74.27 -16.01 60.96 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.546 0.339 . . . . 0.0 110.195 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -85.21 -38.26 19.16 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 19.1 m -68.84 -29.65 68.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -66.98 -53.61 29.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.525 0.33 . . . . 0.0 110.944 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.6 pp -69.91 -12.26 15.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.08 0 CA-C-N 118.304 0.502 . . . . 0.0 111.686 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.79 -27.37 22.34 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.012 0.369 . . . . 0.0 111.102 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -82.92 -24.68 32.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.7 pt -108.67 27.22 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 123.153 0.581 . . . . 0.0 110.277 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.5 t -77.82 -15.34 59.15 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.299 0.639 . . . . 0.0 112.218 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -155.35 145.0 21.27 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -57.88 -32.45 67.71 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -124.49 111.84 16.18 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 30.0 m -98.2 159.27 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.55 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -81.88 143.14 31.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.4 mp -130.41 103.95 6.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -135.83 146.61 47.68 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.151 -177.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -146.91 8.64 0.97 Allowed 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.647 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.62 -139.25 5.48 Favored Glycine 0 C--N 1.336 0.537 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -175.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.82 4.34 14.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.986 0.393 . . . . 0.0 112.041 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 76.7 mt -104.2 136.28 38.2 Favored 'Isoleucine or valine' 0 C--N 1.338 0.106 0 C-N-CA 123.185 0.594 . . . . 0.0 110.541 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . 0.427 ' CG ' HH12 ' A' ' 247' ' ' ARG . 25.4 t70 -122.78 139.88 53.52 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.044 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -144.26 160.68 40.58 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.121 0.968 . . . . 0.0 109.851 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . 0.427 HH12 ' CG ' ' A' ' 245' ' ' ASP . 0.1 OUTLIER -134.81 160.43 38.24 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.195 0.598 . . . . 0.0 109.695 178.205 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.23 151.39 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -79.98 138.54 37.09 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -122.03 152.59 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.442 ' HD3' ' CD1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -159.03 158.62 29.05 Favored Pre-proline 0 C--O 1.231 0.13 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.775 169.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.52 141.2 90.51 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.177 2.585 . . . . 0.0 110.526 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -74.72 146.99 41.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.139 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.7 p -158.35 165.88 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -173.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 78.5 mt . . . . . 0 C--O 1.251 1.151 0 C-N-CA 124.342 1.057 . . . . 0.0 111.087 -175.815 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.433 " H4'" ' HA2' ' A' ' 71' ' ' GLY . . . . . . . . 0 O4'--C4' 1.419 -2.872 1 O4'-C1'-N19 112.92 4.72 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.913 0 C3'-C2'-C1' 104.598 3.442 . 0.332 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.498 ' C6 ' ' CE2' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.738 1 O4'-C1'-N19 112.793 4.593 . 0.376 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.552 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.42 -2.761 0 O4'-C4'-C3' 109.343 2.745 . 0.096 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.505 ' C8 ' H5'' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.415 -3.134 0 P-O3'-C3' 123.321 3.017 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.8 t . . . . . 0 N--CA 1.474 0.76 0 CA-C-O 120.329 0.109 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -149.47 165.15 33.02 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.039 0.536 . . . . 0.0 110.537 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -138.51 167.32 22.18 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.326 0.65 . . . . 0.0 110.249 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -110.49 161.67 15.45 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.286 0.634 . . . . 0.0 109.887 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.27 160.38 51.04 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -150.38 154.51 37.91 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.115 0.566 . . . . 0.0 109.82 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -135.46 162.89 31.37 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 123.366 0.667 . . . . 0.0 110.373 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.0 m 49.77 -178.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 126.366 1.866 . . . . 0.0 113.42 -177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -134.65 162.03 33.45 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 121.293 0.568 . . . . 0.0 111.545 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.16 150.6 24.72 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.37 1.068 . . . . 0.0 110.024 177.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -148.18 155.93 41.98 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.972 0.415 . . . . 0.0 111.159 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -91.14 22.77 3.58 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.412 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 53.86 21.95 3.04 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.633 0.773 . . . . 0.0 111.755 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -136.73 135.92 38.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.805 0.842 . . . . 0.0 109.525 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.11 137.91 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.314 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CZ ' ' CA ' ' A' ' 70' ' ' GLY . 7.9 t80 -81.61 140.43 34.44 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.0 96.54 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 122.02 0.914 . . . . 0.0 108.661 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.516 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -97.73 -171.43 32.98 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.831 -177.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.78 33.08 76.38 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-O 119.43 -0.65 . . . . 0.0 111.864 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 43.6 mt -100.92 135.45 19.99 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 118.201 1.001 . . . . 0.0 110.649 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.472 ' HD2' HG23 ' A' ' 76' ' ' ILE . 60.1 Cg_endo -65.3 171.41 9.22 Favored 'Trans proline' 0 N--CA 1.459 -0.532 1 C-N-CA 125.577 4.185 . . . . 0.0 113.23 -178.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.62 9.32 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.463 1 C-N-CA 126.161 4.574 . . . . 0.0 116.391 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -138.66 -114.56 0.15 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.472 HG23 ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER 44.6 67.91 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 122.623 1.201 . . . . 0.0 111.738 172.012 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -70.68 -176.22 1.25 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -46.48 -33.13 3.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.89 1.676 . . . . 0.0 113.382 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -80.17 -29.74 38.77 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.187 -0.32 . . . . 0.0 111.852 -173.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -78.81 -30.64 45.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.256 -0.278 . . . . 0.0 110.758 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 61.0 mt -74.01 -40.67 52.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.6 m -65.37 -22.0 66.75 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.654 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.91 -17.97 26.99 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -79.33 -25.73 42.26 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.723 0.692 . . . . 0.0 112.03 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -122.09 18.56 10.82 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -71.75 -20.28 61.91 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -75.76 -5.95 48.26 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 122.111 -0.368 . . . . 0.0 111.93 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -108.38 21.8 16.82 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.692 0.397 . . . . 0.0 110.301 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.81 165.17 32.9 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.469 -1.053 . . . . 0.0 110.469 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.98 141.29 93.9 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.532 2.822 . . . . 0.0 112.148 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.24 167.93 26.29 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.713 0.405 . . . . 0.0 110.697 177.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 mt -134.19 163.92 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.7 p -126.8 150.16 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -152.15 165.91 33.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -170.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.452 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 4.7 p90 -147.32 159.81 41.07 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 169.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.574 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 79.6 Cg_endo -64.51 -18.72 63.85 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 124.133 3.222 . . . . 0.0 111.912 -168.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.574 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 3.2 p80 -118.63 21.64 12.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.008 0.923 . . . . 0.0 111.396 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.564 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -58.59 115.71 3.21 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 173.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -154.19 167.33 30.23 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.09 0.556 . . . . 0.0 109.953 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -76.23 -8.58 57.38 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.069 0.148 . . . . 0.0 110.875 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.5 p -86.24 -4.86 59.25 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.249 0.62 . . . . 0.0 111.158 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -128.12 9.42 6.24 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.777 0.831 . . . . 0.0 110.817 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.6 t 56.07 -170.35 0.08 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.059 0.944 . . . . 0.0 112.066 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -87.87 22.96 2.16 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.936 0.894 . . . . 0.0 111.173 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -102.35 121.83 48.7 Favored Pre-proline 0 N--CA 1.451 -0.405 0 C-N-CA 123.491 0.716 . . . . 0.0 110.088 -176.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.52 163.38 13.01 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.593 3.529 . . . . 0.0 112.522 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -60.96 -24.08 78.72 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.489 2.793 . . . . 0.0 111.595 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -153.41 -51.8 0.1 Allowed 'General case' 0 C--O 1.227 -0.095 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 170.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 174.21 -38.42 0.12 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.82 139.54 53.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.548 0.674 . . . . 0.0 109.907 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -157.47 -162.42 1.19 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.607 0.763 . . . . 0.0 110.177 -170.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -137.18 141.31 42.16 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 122.59 0.356 . . . . 0.0 110.133 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.3 mp -96.84 149.51 21.77 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 mp -108.32 140.7 41.21 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 173.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -135.46 170.57 15.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.901 0.381 . . . . 0.0 110.559 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -111.25 -27.15 8.81 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.839 0.456 . . . . 0.0 110.487 -175.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -137.01 155.78 49.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.477 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -79.03 -18.86 52.82 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.487 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.9 m -77.9 -18.7 55.86 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.492 0.317 . . . . 0.0 111.528 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 63.3 m -75.36 -47.11 29.14 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.823 0.344 . . . . 0.0 110.678 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.4 p -76.78 -16.83 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -74.69 -32.69 62.27 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.46 -35.92 60.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.376 -0.345 . . . . 0.0 111.455 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 pp -76.38 -22.3 54.98 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.803 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.4 mt -87.27 -17.76 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 O-C-N 122.285 -0.259 . . . . 0.0 111.335 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -103.43 -5.87 22.45 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -122.9 10.26 9.5 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.8 m -122.76 -177.16 3.57 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.655 0.382 . . . . 0.0 110.456 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 38.2 mm -75.97 161.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 124.147 0.979 . . . . 0.0 110.136 -171.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -135.42 162.46 32.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.79 0.329 . . . . 0.0 110.722 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -140.22 77.4 1.61 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.318 0.58 . . . . 0.0 110.631 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 55.42 9.66 0.4 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 157.22 -10.92 0.26 Allowed Glycine 0 CA--C 1.526 0.745 0 CA-C-N 118.568 0.622 . . . . 0.0 113.053 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -124.08 176.51 6.33 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.22 160.55 19.6 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -172.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.35 161.87 39.4 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.405 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 27.2 tp -142.13 142.21 32.73 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 168.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 46.0 t -92.19 128.24 37.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.311 0.505 . . . . 0.0 110.866 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.2 m -145.83 172.04 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.879 0.871 . . . . 0.0 110.307 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.9 p -72.9 172.25 11.24 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.018 0.527 . . . . 0.0 110.127 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.9 t -140.3 137.03 17.34 Favored Pre-proline 0 N--CA 1.457 -0.123 0 O-C-N 122.177 -0.327 . . . . 0.0 111.777 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -80.74 -6.14 13.32 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 124.309 3.339 . . . . 0.0 112.662 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 3.8 t -125.38 -24.12 4.0 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.936 0.789 . . . . 0.0 112.458 -178.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.577 HG23 ' H ' ' A' ' 145' ' ' LYS . 5.0 mm -124.09 -175.85 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.577 ' H ' HG23 ' A' ' 144' ' ' ILE . 54.4 mtmt -78.59 -21.33 48.73 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.684 -0.635 . . . . 0.0 111.356 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -158.9 166.45 31.83 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.62 0.768 . . . . 0.0 109.884 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.53 ' HZ1' ' HB2' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -151.23 119.37 3.4 Favored Pre-proline 0 N--CA 1.458 -0.071 0 O-C-N 122.192 -0.317 . . . . 0.0 110.987 178.246 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -81.08 101.87 1.31 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.617 2.212 . . . . 0.0 107.847 168.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.2 p -74.2 134.66 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -92.63 150.81 20.47 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.312 0.645 . . . . 0.0 110.785 -171.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 34.5 mm -137.32 141.19 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 122.545 0.338 . . . . 0.0 111.649 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -149.44 107.83 3.34 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 122.995 0.518 . . . . 0.0 109.649 174.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.36 165.0 31.65 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.744 2.963 . . . . 0.0 112.257 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -106.9 135.67 48.05 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-O 120.44 0.162 . . . . 0.0 110.678 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -102.26 156.41 17.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.693 0.797 . . . . 0.0 112.397 -175.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.6 mp -102.98 91.51 4.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 42.8 t -156.36 -32.85 0.09 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -141.67 31.65 1.65 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.1 m -71.15 -18.26 62.51 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -153.52 159.36 42.21 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.098 0.559 . . . . 0.0 110.664 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -153.35 153.2 32.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 17.3 t -130.76 141.0 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 33.1 ttm -127.92 -3.23 5.84 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.541 0.201 . . . . 0.0 111.541 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -159.69 -58.65 0.06 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.06 6.85 10.8 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.178 -0.79 . . . . 0.0 114.113 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 51.5 p -88.72 -11.79 44.12 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.853 1.326 . . . . 0.0 112.486 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -135.68 150.76 72.83 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 118.351 0.523 . . . . 0.0 111.479 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -70.43 167.76 24.39 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.196 3.264 . . . . 0.0 111.656 -177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.3 mt -107.25 160.48 15.57 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.454 0.701 . . . . 0.0 110.762 -175.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -151.41 142.95 15.68 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.0 -22.23 54.11 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.199 2.599 . . . . 0.0 113.648 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.6 mtp-105 -83.85 -2.97 57.49 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 122.942 0.497 . . . . 0.0 111.179 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -127.99 19.06 6.57 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.75 0.42 . . . . 0.0 111.095 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 21.1 m -127.42 140.75 51.96 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.541 0.21 . . . . 0.0 110.684 -177.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 9.7 tt -110.24 150.25 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.032 0 C-N-CA 123.015 0.526 . . . . 0.0 110.158 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -112.16 144.27 41.82 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 96.6 t -136.57 132.48 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -176.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -159.01 179.62 34.51 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 112.131 -0.387 . . . . 0.0 112.131 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 79.94 10.59 85.45 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.3 p -67.85 146.24 98.26 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 123.083 0.553 . . . . 0.0 109.911 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -53.66 -58.32 1.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.053 2.502 . . . . 0.0 113.657 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 25.7 mmm-85 -151.58 -68.01 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.319 -0.848 . . . . 0.0 112.312 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -79.23 162.89 25.41 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.083 2.522 . . . . 0.0 112.135 -176.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.3 mp -136.89 -49.97 0.64 Allowed 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 122.967 0.507 . . . . 0.0 109.633 173.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 47.9 102.83 0.0 OUTLIER 'General case' 0 C--N 1.341 0.207 0 C-N-CA 126.391 1.876 . . . . 0.0 112.829 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.54 -24.42 55.98 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 78.7 t -68.66 -51.76 42.64 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 CA-C-N 118.019 0.372 . . . . 0.0 110.866 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -84.51 -21.78 30.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 121.272 -0.171 . . . . 0.0 110.809 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 57.3 tp -68.01 -33.2 74.16 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.33 -36.18 46.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.407 -0.183 . . . . 0.0 111.361 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 25.2 mmt -70.02 -36.82 75.37 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 83.2 mt -70.0 -33.16 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.1 mmt -77.7 -9.78 59.17 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.119 -0.363 . . . . 0.0 111.024 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -109.53 -2.26 17.72 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.416 0.553 . . . . 0.0 112.448 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -108.08 -17.0 14.15 Favored 'General case' 0 C--N 1.34 0.193 0 O-C-N 121.969 -0.457 . . . . 0.0 111.454 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.47 -17.89 11.63 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.922 0.328 . . . . 0.0 110.554 175.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -142.69 40.39 1.55 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.188 0.595 . . . . 0.0 109.997 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -40.17 134.96 2.13 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.547 1.07 . . . . 0.0 113.502 -174.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 137.67 14.23 0.8 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.472 0.558 . . . . 0.0 112.046 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 42.4 t -73.73 149.2 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.244 1.022 . . . . 0.0 111.364 -176.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 25.7 p -124.85 -27.56 3.6 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.576 0.35 . . . . 0.0 111.014 175.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -155.15 156.82 36.43 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.655 0.264 . . . . 0.0 110.739 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -154.22 157.87 39.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.276 0.63 . . . . 0.0 109.977 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.43 -178.53 48.32 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.1 mm -95.35 143.51 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -59.67 122.71 14.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 16.9 p -141.73 163.41 32.99 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.119 0.485 . . . . 0.0 110.806 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -132.07 128.05 21.27 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 123.58 0.752 . . . . 0.0 109.16 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -80.31 -6.4 13.78 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 124.576 3.518 . . . . 0.0 113.196 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -92.79 -58.36 2.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.819 0.736 . . . . 0.0 111.459 -173.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -160.78 -5.06 0.05 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -96.24 -15.44 22.0 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 119.722 1.146 . . . . 0.0 113.117 -174.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.497 ' CB ' ' CD ' ' A' ' 214' ' ' PRO . 55.6 m-85 50.98 -146.89 0.01 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 117.219 -1.372 . . . . 0.0 110.044 177.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.497 ' CD ' ' CB ' ' A' ' 213' ' ' TYR . 89.4 Cg_endo -72.06 150.33 54.07 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 CA-C-N 123.178 2.171 . . . . 0.0 112.405 -173.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -105.81 13.85 28.99 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.7 0.8 . . . . 0.0 112.158 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 68.15 14.54 66.29 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.615 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -133.07 154.66 50.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 117.908 0.854 . . . . 0.0 109.867 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -100.7 162.28 18.63 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 121.064 0.258 . . . . 0.0 112.537 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -151.04 146.64 26.33 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 94.9 t -141.44 145.82 24.18 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.059 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.98 142.62 51.0 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 110.86 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -118.76 156.54 29.2 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.638 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.7 m -84.19 -5.63 59.28 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.209 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -130.02 148.27 51.86 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.073 0.397 . . . . 0.0 111.919 -172.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -74.98 -15.45 60.66 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -84.98 -37.89 19.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 18.6 m -73.07 -28.04 62.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -67.91 -54.62 17.38 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.444 0.298 . . . . 0.0 110.531 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.1 pt -69.58 -14.84 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 CA-C-N 118.108 0.413 . . . . 0.0 111.345 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.66 -28.06 28.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.833 0.288 . . . . 0.0 110.794 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -82.89 -27.2 30.86 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.858 0.299 . . . . 0.0 111.759 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.2 pt -105.77 29.07 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.127 0.571 . . . . 0.0 110.181 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 21.9 t -78.38 -11.06 59.92 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.085 0.554 . . . . 0.0 111.925 -176.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -158.06 145.29 18.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -59.05 -29.91 67.65 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 122.416 0.287 . . . . 0.0 111.139 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -123.19 118.79 28.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.8 m -107.52 156.55 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.006 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -81.5 144.3 31.44 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.989 0.423 . . . . 0.0 110.275 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.99 105.86 7.67 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -133.25 147.42 51.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.216 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -144.62 11.87 1.47 Allowed 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.168 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.95 -140.16 5.91 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -175.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.65 14.8 1.94 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.961 0.504 . . . . 0.0 111.984 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 73.5 mt -116.57 141.42 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 123.619 0.768 . . . . 0.0 110.582 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -129.54 146.62 51.34 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.978 0.418 . . . . 0.0 111.548 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -144.39 163.99 32.15 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 124.582 1.153 . . . . 0.0 109.137 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.08 153.87 50.46 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.367 0.667 . . . . 0.0 109.709 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 12.1 p -154.53 157.87 4.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -85.11 138.47 32.38 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.476 -0.14 . . . . 0.0 110.757 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -121.28 159.75 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.06 0 CA-C-O 120.795 0.331 . . . . 0.0 111.527 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.41 159.9 26.12 Favored Pre-proline 0 N--CA 1.455 -0.187 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 171.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.3 131.69 46.43 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.726 2.284 . . . . 0.0 108.217 171.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -73.42 112.22 9.29 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.526 -173.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 8.2 p 45.3 35.39 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.534 1.534 . . . . 0.0 112.769 175.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 63.0 tp . . . . . 0 C--O 1.25 1.106 0 CA-C-O 117.622 -1.18 . . . . 0.0 110.417 -178.004 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.812 1 O4'-C1'-N19 113.599 5.399 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.647 1 O4'-C1'-N19 113.096 4.896 . 0.382 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.479 " O4'" ' CZ ' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.415 -3.186 0 O4'-C1'-N19 111.927 3.727 . 0.597 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.566 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.417 -2.999 0 C5'-C4'-C3' 111.822 -2.452 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.847 1 C5'-C4'-C3' 108.457 -4.695 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 120.583 0.23 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -148.54 161.01 42.52 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.157 0.583 . . . . 0.0 110.105 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -148.58 163.03 38.46 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.047 0.539 . . . . 0.0 110.911 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -96.39 37.91 1.23 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.355 0.662 . . . . 0.0 111.153 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.46 -179.12 36.86 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -151.44 167.83 26.76 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.333 0.653 . . . . 0.0 110.447 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -147.55 148.71 31.45 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.857 0.463 . . . . 0.0 110.115 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.9 p -149.68 154.61 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 123.564 0.745 . . . . 0.0 109.313 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -89.57 161.62 16.08 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.659 0.384 . . . . 0.0 110.938 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.63 145.26 26.66 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 123.325 0.65 . . . . 0.0 110.128 -179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -154.14 157.36 38.77 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 122.57 0.348 . . . . 0.0 110.823 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.8 t -94.25 -179.25 4.87 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.377 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.517 ' HA ' ' CE2' ' A' ' 115' ' ' PHE . 95.1 mtt180 -90.99 27.36 1.85 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.592 0.757 . . . . 0.0 111.305 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.561 ' HE2' ' CD1' ' A' ' 154' ' ' TRP . 16.5 pttm -146.93 141.78 26.87 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.02 0.928 . . . . 0.0 111.154 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 p -148.81 148.16 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.245 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.434 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 6.4 t80 -100.57 143.08 31.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 171.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.7 m -127.31 103.7 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.927 0.87 . . . . 0.0 108.853 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.416 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -93.77 -164.03 36.59 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.13 13.82 29.52 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 119.461 -0.633 . . . . 0.0 112.708 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 27.0 mt -79.67 146.06 64.12 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 118.72 1.26 . . . . 0.0 109.676 177.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.492 ' HB3' ' HZ1' ' A' ' 147' ' ' LYS . 97.2 Cg_endo -76.68 161.23 34.02 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 124.355 3.37 . . . . 0.0 110.375 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -62.84 -11.61 25.08 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.777 2.985 . . . . 0.0 113.222 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -95.85 -39.47 9.81 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.4 mt -54.34 145.28 4.51 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 CA-C-O 121.735 0.779 . . . . 0.0 112.155 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -146.28 -170.45 3.5 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.768 1.227 . . . . 0.0 109.324 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -51.64 -27.0 10.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.604 0.762 . . . . 0.0 112.663 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -76.92 -45.02 29.35 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.721 -0.612 . . . . 0.0 111.446 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -78.4 -26.32 46.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.18 -173.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 84.6 mt -74.62 -47.27 39.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 87.4 m -67.94 -12.84 61.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.006 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.25 -15.11 20.97 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.6 m -82.38 -29.13 31.06 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.957 0.799 . . . . 0.0 112.032 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -118.46 14.64 13.73 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -66.32 -20.83 66.2 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.06 -0.4 . . . . 0.0 111.808 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -73.6 -5.1 38.26 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.512 0.325 . . . . 0.0 111.805 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -112.12 20.47 16.82 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.642 0.377 . . . . 0.0 111.083 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.23 176.2 25.35 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.92 154.29 67.25 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.677 2.918 . . . . 0.0 110.869 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.424 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 0.7 OUTLIER -164.54 162.09 21.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.187 -170.202 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.2 pt -140.91 167.59 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.276 173.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.7 p -134.69 155.54 38.74 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -150.32 165.29 33.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.992 0.425 . . . . 0.0 111.651 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.402 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 41.4 p90 -159.83 162.8 24.12 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 172.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.513 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 26.0 Cg_endo -75.51 -15.53 19.61 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.198 1.932 . . . . 0.0 110.513 -168.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.513 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 24.4 m-70 -91.41 2.17 56.6 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.653 0.781 . . . . 0.0 110.872 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -63.33 149.02 46.74 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 122.966 0.507 . . . . 0.0 110.765 -176.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.5 179.11 8.22 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.707 0.803 . . . . 0.0 109.943 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -76.25 6.56 5.32 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.729 0.411 . . . . 0.0 111.12 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.4 t -72.17 166.22 22.8 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.604 0.761 . . . . 0.0 110.952 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -129.11 17.51 6.1 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.881 0.873 . . . . 0.0 110.571 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.6 m -77.84 -6.67 54.96 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.993 0.517 . . . . 0.0 112.368 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 51.68 -157.32 0.13 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.97 0.908 . . . . 0.0 112.588 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 54.72 86.41 0.17 Allowed Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 125.685 1.594 . . . . 0.0 113.544 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.16 171.82 2.09 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 124.449 3.433 . . . . 0.0 111.016 171.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -46.96 -38.59 23.96 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.778 2.986 . . . . 0.0 113.801 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 110' ' ' TYR . 42.6 tttp -155.99 22.09 0.38 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.829 0.451 . . . . 0.0 110.568 173.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.29 -35.87 3.61 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.472 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.43 ' CZ ' ' HB3' ' A' ' 108' ' ' LYS . 0.3 OUTLIER -63.28 138.47 58.54 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.269 1.534 . . . . 0.0 110.854 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -156.53 -170.24 3.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.85 -169.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -130.36 129.94 43.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.167 0.587 . . . . 0.0 109.49 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.7 mp -86.79 142.98 27.72 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.744 0.783 . . . . 0.0 111.816 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.57 138.08 51.09 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 113.262 -1.79 . . . . 0.0 107.106 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.517 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 29.3 p90 -159.83 166.0 31.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.64 -20.51 5.95 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -174.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -79.07 -14.11 59.35 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -169.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 52.95 14.48 0.46 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.4 m -128.38 -12.47 5.03 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.211 0.605 . . . . 0.0 110.956 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.2 t -69.23 -34.69 75.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.407 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 30.7 m -71.73 -26.23 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-N 116.857 -0.156 . . . . 0.0 111.007 177.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -70.63 -40.55 73.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -77.65 -32.41 53.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -82.56 -12.57 57.64 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 119.003 0.819 . . . . 0.0 111.587 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.4 mt -101.09 -19.81 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 O-C-N 122.174 -0.329 . . . . 0.0 110.745 178.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -101.84 -10.31 19.99 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -117.98 5.58 12.12 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 53.8 m -119.79 -159.92 0.8 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 75.5 mt -79.48 145.81 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.046 0.538 . . . . 0.0 109.756 -172.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -140.18 137.26 34.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -152.65 -175.61 5.37 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.077 0.465 . . . . 0.0 111.573 178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -61.18 108.72 0.95 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.581 0.705 . . . . 0.0 111.444 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.44 -3.69 66.7 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.009 -0.996 . . . . 0.0 115.051 171.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -156.54 166.9 32.09 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.962 1.381 . . . . 0.0 111.829 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 28.6 mt -129.46 160.49 32.99 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 124.324 1.05 . . . . 0.0 109.151 -174.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 149' ' ' VAL . 75.4 m-85 -147.87 170.28 17.99 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 177.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.411 HD12 ' H ' ' A' ' 138' ' ' CYS . 43.6 tp -146.31 147.06 30.97 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.397 -1.274 . . . . 0.0 107.695 170.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . 0.411 ' H ' HD12 ' A' ' 137' ' ' LEU . 70.9 m -84.29 138.38 32.95 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.983 0.421 . . . . 0.0 112.105 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.3 p -160.74 149.25 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.817 1.247 . . . . 0.0 107.986 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.7 t -122.29 144.7 48.84 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 118.249 0.477 . . . . 0.0 111.304 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.6 m -152.55 167.7 12.8 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.292 0.637 . . . . 0.0 110.945 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -59.12 24.57 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.71 1 C-N-CA 126.097 4.531 . . . . 0.0 117.604 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.7 m -117.38 -28.28 6.16 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 119.82 1.191 . . . . 0.0 109.843 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.431 HG12 ' HE3' ' A' ' 147' ' ' LYS . 0.5 OUTLIER -165.32 166.52 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.321 1.049 . . . . 0.0 110.455 -171.522 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -84.42 101.78 12.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 170.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.0 t70 61.44 144.83 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.268 1.427 . . . . 0.0 113.523 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.692 ' HE2' ' C6 ' ' B' ' 1' ' ' ' C' . 27.6 ttmt -152.95 116.13 2.81 Favored Pre-proline 0 N--CA 1.455 -0.181 0 C-N-CA 124.232 1.013 . . . . 0.0 109.204 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.41 ' CB ' ' CD2' ' A' ' 136' ' ' TYR . 76.6 Cg_exo -54.94 125.08 17.96 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 124.416 3.411 . . . . 0.0 113.229 174.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 38.3 t -73.42 140.53 17.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 170.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.47 82.65 2.5 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.748 1.158 . . . . 0.0 110.284 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.9 mm -69.92 139.58 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.732 0.813 . . . . 0.0 112.313 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -155.14 105.28 2.25 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.834 172.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.56 164.97 29.75 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 124.123 3.216 . . . . 0.0 112.213 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.561 ' CD1' ' HE2' ' A' ' 66' ' ' LYS . 69.9 t-105 -86.16 145.75 26.87 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 175.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -105.83 152.25 23.48 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.108 0.48 . . . . 0.0 111.126 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.17 36.01 0.81 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.704 0.802 . . . . 0.0 111.715 -175.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.5 t -101.47 -30.5 11.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.097 -0.377 . . . . 0.0 110.771 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -159.93 144.92 15.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.9 m -152.4 -29.99 0.15 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.248 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -153.47 154.87 35.22 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.005 0.922 . . . . 0.0 109.431 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -157.1 155.57 31.3 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.603 0.24 . . . . 0.0 110.501 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.4 p -153.38 148.56 13.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -109.52 13.52 23.94 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -160.34 -47.56 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.532 0.606 . . . . 0.0 111.054 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.52 6.97 59.97 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.364 -0.686 . . . . 0.0 113.42 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.8 t -138.38 -2.6 1.79 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.285 1.043 . . . . 0.0 113.739 -177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -73.72 154.84 89.31 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 118.988 0.813 . . . . 0.0 109.958 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -53.79 140.93 66.93 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.239 2.626 . . . . 0.0 110.366 173.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 39.6 tp -150.25 135.29 17.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.535 0.207 . . . . 0.0 110.801 -175.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -148.68 155.36 41.5 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.089 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -65.31 -21.39 61.48 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.408 2.739 . . . . 0.0 111.897 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -85.27 3.86 37.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.89 0.876 . . . . 0.0 111.907 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -120.13 23.7 10.84 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.015 0.526 . . . . 0.0 109.715 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 17.0 m -117.17 146.38 43.24 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.016 0.436 . . . . 0.0 111.691 -173.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.4 tt -119.69 147.64 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.294 0.638 . . . . 0.0 109.735 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.405 ' HB2' ' CD1' ' A' ' 253' ' ' TYR . 6.3 t80 -105.24 136.5 44.65 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 99.5 t -130.9 113.31 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -141.91 -179.75 19.2 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 112.34 -0.304 . . . . 0.0 112.34 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.0 12.94 62.96 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -174.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.54 153.91 94.72 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -64.61 -68.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.027 2.485 . . . . 0.0 110.609 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.413 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 94.7 mtt-85 -146.59 -60.27 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.127 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.413 ' HD3' ' HB2' ' A' ' 182' ' ' ARG . 44.0 Cg_endo -80.09 162.28 23.25 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.904 2.403 . . . . 0.0 111.293 174.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -159.49 -26.94 0.07 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.403 0.681 . . . . 0.0 110.87 173.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 51.87 115.49 0.0 OUTLIER 'General case' 0 C--N 1.342 0.251 0 C-N-CA 127.686 2.394 . . . . 0.0 114.475 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.74 -29.18 69.95 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.6 t -69.73 -49.61 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-N 117.902 0.319 . . . . 0.0 111.043 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -80.84 -21.72 40.52 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 122.345 -0.222 . . . . 0.0 110.929 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 33.7 tp -70.11 -33.61 72.07 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -77.21 -35.25 55.78 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.4 mmt -69.17 -35.31 76.16 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 66.1 mt -69.75 -34.08 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.2 mmt -74.13 -17.42 60.93 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.859 -0.526 . . . . 0.0 111.009 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -90.5 -17.42 27.1 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.062 0.392 . . . . 0.0 111.965 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -100.37 -28.3 13.02 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 118.719 0.691 . . . . 0.0 112.777 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.37 -9.17 23.84 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.62 0.646 . . . . 0.0 111.592 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -141.7 -44.59 0.35 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.03 0.377 . . . . 0.0 111.102 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 70.3 162.11 3.85 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 86.55 13.17 68.17 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 222' ' ' PHE . 10.7 p -88.46 164.61 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.164 0.986 . . . . 0.0 109.3 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 41.7 t -139.84 -62.16 0.52 Allowed 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.067 -0.395 . . . . 0.0 111.356 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -108.32 151.07 26.48 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.128 0.49 . . . . 0.0 112.24 -172.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -152.36 163.64 39.07 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.434 176.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 175.04 -179.06 46.56 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 41.3 mm -92.34 138.08 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -59.22 118.57 6.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 24.9 p -144.73 153.59 41.85 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -116.95 130.32 24.68 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -78.68 -11.51 15.43 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 124.529 3.486 . . . . 0.0 112.393 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -101.32 -9.91 20.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.645 0.378 . . . . 0.0 111.335 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -118.23 -3.59 11.02 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.557 0.743 . . . . 0.0 109.477 171.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 49.35 36.64 10.03 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.924 0.89 . . . . 0.0 112.377 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.21 162.16 51.44 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -90.66 -179.07 1.52 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 124.502 3.468 . . . . 0.0 111.388 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -121.97 7.43 9.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.263 0.625 . . . . 0.0 111.339 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.01 13.48 66.77 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.92 -0.378 . . . . 0.0 112.851 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -146.54 164.54 32.24 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.503 0.651 . . . . 0.0 110.241 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -103.11 165.14 15.89 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 121.003 0.224 . . . . 0.0 112.941 -174.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -145.6 145.86 31.14 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 94.7 t -138.72 147.32 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.11 145.19 51.23 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.251 0.548 . . . . 0.0 111.344 -177.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.405 ' HA ' ' HA ' ' A' ' 200' ' ' VAL . 9.9 m-85 -120.07 161.95 20.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.369 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 92.0 p -98.48 8.59 44.68 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -131.02 140.45 50.1 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.831 0.453 . . . . 0.0 110.213 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -75.06 -19.03 60.18 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -80.61 -38.21 29.73 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 25.1 m -75.77 -25.38 56.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -67.36 -50.34 60.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -73.66 -11.12 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-N 117.969 0.349 . . . . 0.0 111.176 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.63 -21.26 25.41 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 119.722 -0.18 . . . . 0.0 110.808 174.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -87.5 -27.3 22.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.965 0.348 . . . . 0.0 111.868 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 8.4 pt -105.38 28.75 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.162 0.585 . . . . 0.0 110.262 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.2 p -74.99 -17.0 60.6 Favored 'General case' 0 C--N 1.334 -0.079 0 C-N-CA 123.406 0.682 . . . . 0.0 112.112 -176.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -156.96 145.01 19.35 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -176.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -59.72 -30.56 68.9 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 122.406 0.282 . . . . 0.0 111.324 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -122.61 121.73 37.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 29.6 m -111.93 160.54 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.412 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -86.76 144.94 26.84 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.971 0.415 . . . . 0.0 110.138 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.4 mp -132.86 104.07 6.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -130.64 149.69 52.18 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.193 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -146.9 20.41 1.27 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.149 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.61 129.46 2.96 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -173.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 53.89 16.7 1.13 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.28 1.032 . . . . 0.0 113.121 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 76.2 mt -139.99 146.22 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.789 0.836 . . . . 0.0 109.601 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -156.32 129.61 8.12 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -148.55 162.27 39.99 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.493 0.717 . . . . 0.0 110.981 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.84 155.93 43.34 Favored 'General case' 0 C--N 1.338 0.068 0 C-N-CA 124.001 0.92 . . . . 0.0 109.388 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.4 p -156.8 156.72 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -86.06 138.76 31.71 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.19 158.94 32.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.103 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.461 ' HG3' ' H61' ' B' ' 5' ' ' ' A' . 0.0 OUTLIER -160.63 161.86 24.13 Favored Pre-proline 0 N--CA 1.455 -0.197 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.338 169.412 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.93 132.63 50.82 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.589 2.193 . . . . 0.0 108.861 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . 0.405 ' CD1' ' HB2' ' A' ' 176' ' ' PHE . 3.2 t80 -78.11 167.49 21.34 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.242 -177.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.71 162.73 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.748 0.819 . . . . 0.0 111.106 -172.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 C--O 1.251 1.135 0 CA-C-O 117.209 -1.377 . . . . 0.0 108.998 -179.871 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.692 ' C6 ' ' HE2' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.422 -2.553 0 O4'-C1'-N19 112.183 3.983 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.665 1 O4'-C1'-N19 112.412 4.212 . 0.71 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.434 ' C6 ' ' CE2' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.416 -3.046 0 O4'-C1'-N19 111.635 3.435 . 0.413 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.486 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.418 -2.89 0 O5'-C5'-C4' 106.572 -2.592 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.461 ' H61' ' HG3' ' A' ' 251' ' ' LYS . . . . . . . . 0 O4'--C4' 1.411 -3.474 1 C5'-C4'-C3' 109.204 -4.197 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.4 m . . . . . 0 N--CA 1.475 0.822 0 CA-C-O 120.387 0.137 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -131.8 7.24 4.39 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.125 0.57 . . . . 0.0 111.679 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -147.59 152.42 37.9 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.133 0.573 . . . . 0.0 109.625 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -143.19 173.06 11.92 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.419 0.688 . . . . 0.0 110.707 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.87 5.1 0.11 Allowed Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.499 -0.612 . . . . 0.0 112.685 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 60.66 161.61 0.05 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.896 1.278 . . . . 0.0 112.823 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -144.62 146.56 32.35 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.341 0.656 . . . . 0.0 109.905 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.1 t -138.81 153.28 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.83 0.852 . . . . 0.0 109.061 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -141.69 149.86 41.12 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.27 150.8 20.66 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-O 121.075 0.465 . . . . 0.0 111.698 -177.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -154.6 164.33 38.88 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.369 -174.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.9 t -96.0 165.51 12.22 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.584 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.89 11.01 2.88 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -123.33 139.79 53.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 p -155.59 151.08 10.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.79 -172.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -96.79 142.12 29.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 174.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 m -131.85 130.75 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.63 151.67 18.62 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 112.052 -0.419 . . . . 0.0 112.052 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.48 19.51 37.96 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.654 -0.526 . . . . 0.0 113.029 176.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 pp -80.93 153.3 72.49 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 118.556 1.178 . . . . 0.0 109.114 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.58 144.76 17.92 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.076 2.517 . . . . 0.0 112.46 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -80.55 -4.65 13.05 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 124.057 3.172 . . . . 0.0 111.461 174.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -73.79 -6.3 46.13 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -176.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 pp -141.68 -169.45 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -132.32 -170.62 2.46 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.918 0.487 . . . . 0.0 111.445 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -46.46 -30.3 2.12 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.461 1.504 . . . . 0.0 113.003 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.19 -34.23 77.08 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.399 0.545 . . . . 0.0 112.267 -176.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -80.26 -40.68 26.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.068 -0.395 . . . . 0.0 110.308 -174.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.7 pp -76.75 -23.76 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.366 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 78.3 m -70.84 -30.79 67.3 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.79 -16.95 60.03 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.056 -0.402 . . . . 0.0 110.8 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.7 m -86.28 -24.22 26.03 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -117.88 -18.18 9.59 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -176.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -68.26 -8.92 43.61 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.283 0.947 . . . . 0.0 112.176 -174.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -67.48 -6.7 20.75 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.983 -0.448 . . . . 0.0 111.617 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -111.98 -1.26 15.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.59 0.356 . . . . 0.0 111.545 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.41 165.73 11.43 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -68.17 137.31 40.14 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.368 2.712 . . . . 0.0 110.006 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.3 pp -160.09 174.47 14.25 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.833 -174.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.17 174.7 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.087 178.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.63 159.41 43.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 CA-C-O 120.777 0.322 . . . . 0.0 111.019 -177.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -150.87 160.62 43.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.41 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.416 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 38.8 p90 -160.23 159.24 26.59 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.613 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 17.5 Cg_endo -75.97 -8.76 19.15 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.119 2.546 . . . . 0.0 109.71 -169.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.613 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 23.3 m-70 -102.08 11.42 38.41 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.472 1.109 . . . . 0.0 111.614 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -53.51 159.05 1.58 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 123.95 0.9 . . . . 0.0 113.11 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -136.43 168.51 19.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.086 0.955 . . . . 0.0 110.212 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -127.64 14.2 7.0 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.166 0.586 . . . . 0.0 111.187 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.5 m -78.8 36.42 0.27 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.975 0.91 . . . . 0.0 111.861 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 55.74 19.1 3.22 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.348 1.059 . . . . 0.0 112.276 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.7 t -153.63 161.64 41.99 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.027 0.931 . . . . 0.0 108.873 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -137.58 155.5 49.14 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.297 0.239 . . . . 0.0 110.425 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -156.09 126.75 3.47 Favored Pre-proline 0 N--CA 1.453 -0.324 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.68 159.92 41.76 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.838 3.026 . . . . 0.0 110.41 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.59 -28.73 44.74 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.273 2.649 . . . . 0.0 111.881 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -160.41 -54.23 0.05 Allowed 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.214 0.605 . . . . 0.0 109.532 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 176.16 34.77 0.05 OUTLIER Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.059 -0.591 . . . . 0.0 113.026 -176.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.508 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -143.59 147.36 34.27 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.035 0.918 . . . . 0.0 109.717 178.491 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.6 -177.26 6.24 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.077 0.551 . . . . 0.0 110.44 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.431 ' CE1' ' C4 ' ' B' ' 4' ' ' ' U' . 2.4 m-85 -133.6 129.62 37.21 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -177.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mp -92.16 145.62 24.36 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.568 0.699 . . . . 0.0 111.997 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -115.21 136.2 53.36 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -128.51 177.91 6.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.442 0.697 . . . . 0.0 110.881 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -115.79 -32.28 5.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.079 0.552 . . . . 0.0 110.249 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -130.85 155.07 47.34 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.154 0.502 . . . . 0.0 111.523 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -81.52 -14.23 57.16 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.671 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.0 m -79.53 -14.9 58.55 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.173 -0.329 . . . . 0.0 111.034 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 52.8 m -79.93 -39.55 30.06 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.324 -0.235 . . . . 0.0 111.022 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.83 -19.3 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -79.71 -33.12 41.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.8 -34.57 57.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.072 0.396 . . . . 0.0 111.114 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.0 pp -79.86 -19.92 47.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.425 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 54.0 mt -92.66 -20.98 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 117.904 0.32 . . . . 0.0 111.328 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -95.43 -14.78 23.49 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.825 -0.547 . . . . 0.0 111.922 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -111.07 26.35 10.8 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.157 0.583 . . . . 0.0 111.418 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 16.7 p -130.73 -173.89 3.21 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.985 0.421 . . . . 0.0 111.771 -176.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.0 mp -86.49 155.54 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -128.78 152.45 48.44 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -139.6 67.6 1.38 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.405 0.621 . . . . 0.0 110.411 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 51.88 14.74 0.33 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 172.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 163.49 -14.16 0.1 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-N 118.671 0.669 . . . . 0.0 112.807 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -131.58 169.63 15.85 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 117.597 0.698 . . . . 0.0 109.319 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.71 162.74 14.15 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.401 0.143 . . . . 0.0 110.879 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.447 ' CE1' ' HG2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -143.31 136.96 28.46 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.3 mp -125.08 132.51 53.14 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 25.0 p -81.51 131.77 35.29 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.944 0.402 . . . . 0.0 112.036 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.0 m -153.25 173.58 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.298 1.439 . . . . 0.0 108.23 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.9 t -146.25 132.65 19.63 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.956 -0.465 . . . . 0.0 111.963 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.451 ' H ' ' HB ' ' A' ' 144' ' ' ILE . 15.1 m -158.65 172.69 5.81 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 125.996 1.718 . . . . 0.0 107.969 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.413 ' CD ' ' HB3' ' A' ' 141' ' ' SER . 62.2 Cg_exo -53.71 -40.31 80.26 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.623 2.882 . . . . 0.0 115.7 -172.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.8 m -91.82 -13.32 31.62 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.053 0.842 . . . . 0.0 110.816 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.492 ' CD1' ' HE3' ' A' ' 147' ' ' LYS . 37.5 mm -86.79 -37.6 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 122.769 0.428 . . . . 0.0 110.661 -171.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 59.0 mttm 46.07 51.6 10.82 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.613 0.365 . . . . 0.0 111.537 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 64.31 17.61 10.84 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.492 ' HE3' ' CD1' ' A' ' 144' ' ' ILE . 18.4 pttp -82.56 154.47 68.59 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 119.206 0.912 . . . . 0.0 109.749 174.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.447 ' HG2' ' CE1' ' A' ' 136' ' ' TYR . 90.0 Cg_endo -76.97 161.4 32.99 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.91 2.407 . . . . 0.0 112.625 172.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.6 m -114.7 151.45 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -98.13 149.96 21.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -169.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.3 mm -131.64 146.82 32.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 124.762 1.225 . . . . 0.0 110.612 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 60.4 ttp85 -158.1 101.59 1.75 Allowed Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 122.653 0.381 . . . . 0.0 110.275 172.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.58 170.79 5.13 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 124.594 3.529 . . . . 0.0 114.334 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -95.3 159.73 14.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.499 175.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -102.03 158.67 15.99 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.036 0.534 . . . . 0.0 112.013 -176.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.3 mp -108.15 36.4 2.8 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.688 0.795 . . . . 0.0 111.562 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.6 t -137.15 -24.53 1.09 Allowed 'General case' 0 C--N 1.34 0.158 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -174.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -136.26 35.98 2.76 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.649 1.113 . . . . 0.0 113.53 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.6 m -74.02 -23.64 59.45 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.951 -0.468 . . . . 0.0 112.198 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -155.35 161.73 40.99 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 117.98 0.354 . . . . 0.0 111.395 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -155.72 153.62 30.22 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.021 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.4 m -140.3 155.91 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 121.249 0.547 . . . . 0.0 112.001 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 70.5 mtm -137.53 27.57 2.78 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.244 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 166' ' ' SER . 24.0 t70 -155.0 171.66 19.38 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -174.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -73.27 24.74 0.88 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 123.509 0.576 . . . . 0.0 112.411 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 164' ' ' ASP . 31.6 m 56.07 46.93 20.72 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 117.451 0.626 . . . . 0.0 112.431 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -61.1 157.79 39.91 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -53.31 148.76 31.58 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.776 2.984 . . . . 0.0 112.684 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 53.9 mt -118.06 163.34 16.76 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.623 0.769 . . . . 0.0 110.049 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -148.7 141.44 15.27 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.49 -22.01 48.73 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.438 2.759 . . . . 0.0 114.164 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -89.21 5.24 45.68 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.302 0.501 . . . . 0.0 110.948 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -130.06 18.42 5.52 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.877 0.471 . . . . 0.0 110.618 175.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 18.8 m -127.83 143.05 51.13 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.727 0.299 . . . . 0.0 110.851 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.8 tt -116.89 149.71 19.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 123.152 0.581 . . . . 0.0 110.795 -174.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.449 ' CD1' ' CE1' ' A' ' 253' ' ' TYR . 8.4 t80 -106.74 144.46 33.36 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 172.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 62.1 t -133.83 122.05 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -131.12 153.1 20.2 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.832 -0.223 . . . . 0.0 112.686 -176.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.81 39.53 4.61 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -171.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 26.9 m -118.1 54.72 1.97 Allowed Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.03 -11.63 27.44 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.71 2.273 . . . . 0.0 112.061 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.575 ' H ' ' CD ' ' A' ' 183' ' ' PRO . 0.0 OUTLIER -139.7 -37.75 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.575 ' CD ' ' H ' ' A' ' 182' ' ' ARG . 38.9 Cg_endo -83.57 22.16 0.96 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.807 2.338 . . . . 0.0 112.867 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.454 ' H ' ' CD2' ' A' ' 184' ' ' LEU . 1.6 pt? -80.61 -138.87 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.037 0.535 . . . . 0.0 112.062 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.415 ' H ' ' HG ' ' A' ' 184' ' ' LEU . 45.3 ttm-85 71.2 126.42 0.03 OUTLIER 'General case' 0 C--N 1.338 0.103 0 C-N-CA 125.881 1.672 . . . . 0.0 110.551 -172.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.57 -28.5 69.68 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 64.2 t -68.7 -48.07 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 CA-C-N 117.921 0.328 . . . . 0.0 110.757 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -77.96 -31.12 50.68 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 58.6 tp -73.14 -33.87 65.77 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.401 0.28 . . . . 0.0 110.37 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.27 -37.36 60.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.078 -0.389 . . . . 0.0 111.413 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 26.2 mmt -69.4 -40.59 77.27 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.5 mt -65.15 -36.95 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.2 mmt -73.05 -18.89 61.28 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.109 -0.37 . . . . 0.0 111.219 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -93.08 -13.52 28.45 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.436 0.562 . . . . 0.0 112.124 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -93.45 -19.66 21.06 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.392 0.542 . . . . 0.0 111.897 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.6 -19.14 10.7 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 118.273 0.488 . . . . 0.0 111.482 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -140.4 42.56 1.9 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.15 137.5 3.8 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 123.71 0.672 . . . . 0.0 112.331 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 124.85 9.81 5.09 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 58.5 t -69.61 144.78 13.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 117.47 0.635 . . . . 0.0 110.345 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 15.2 p -120.22 -32.62 4.1 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.124 0.169 . . . . 0.0 111.196 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -146.29 142.05 27.93 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -148.58 157.75 43.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 170.62 -167.27 40.43 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.43 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 43.5 mm -97.1 139.94 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -58.03 122.41 12.98 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.385 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.7 t -155.38 149.04 25.25 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -119.49 139.8 28.33 Favored Pre-proline 0 N--CA 1.455 -0.186 0 C-N-CA 122.726 0.41 . . . . 0.0 110.208 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -77.4 -8.58 17.34 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 124.223 3.282 . . . . 0.0 112.498 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.6 -22.4 62.56 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.44 0.564 . . . . 0.0 111.116 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.5 mt -140.38 5.87 2.08 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.146 0.978 . . . . 0.0 110.095 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt 49.22 40.46 18.01 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.896 1.279 . . . . 0.0 112.522 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -125.19 139.04 32.82 Favored Pre-proline 0 C--O 1.231 0.119 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.56 166.52 23.84 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 122.719 2.28 . . . . 0.0 111.383 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.499 ' HA ' ' C4 ' ' B' ' 4' ' ' ' U' . 33.5 mtmm -120.27 24.2 10.53 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 64.5 15.89 60.01 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.605 -0.553 . . . . 0.0 114.109 170.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -131.01 161.94 30.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 117.877 0.838 . . . . 0.0 110.128 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -100.63 159.09 19.19 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 112.174 -0.37 . . . . 0.0 112.174 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -153.63 148.51 26.56 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 3.9 p -150.2 148.06 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -126.28 147.7 49.65 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.109 0.564 . . . . 0.0 110.186 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -119.41 155.29 32.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.183 -174.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 57.6 m -83.19 1.56 40.01 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.21 172.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -135.9 131.11 34.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.102 0.561 . . . . 0.0 110.192 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -73.2 -12.34 60.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.4 tp60 -76.24 -38.42 56.35 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 42.1 m -74.19 -30.29 62.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -64.3 -52.11 60.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.643 -0.217 . . . . 0.0 110.586 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.39 -14.65 17.94 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 CA-C-N 118.248 0.476 . . . . 0.0 111.355 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.39 -21.86 32.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 117.78 0.263 . . . . 0.0 110.382 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.21 -8.3 42.75 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 3.5 pt -125.16 40.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 118.781 0.718 . . . . 0.0 111.572 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 32.4 m -131.14 3.99 4.38 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -129.57 10.83 5.69 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 45.39 -89.61 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -83.64 90.34 7.26 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 3.8 m -81.94 140.9 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.684 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 247' ' ' ARG . 34.4 mt-30 -78.31 -12.71 60.02 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.109 0.964 . . . . 0.0 112.791 -174.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 10.3 mp 55.94 -77.13 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.947 0.899 . . . . 0.0 112.7 -175.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 58.49 132.09 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.172 1.789 . . . . 0.0 114.374 -177.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . 0.45 ' H ' HG23 ' A' ' 244' ' ' ILE . 7.4 t60 -160.83 129.17 4.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 58.79 34.74 78.94 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 64.35 17.9 11.02 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.033 1.333 . . . . 0.0 113.876 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.45 HG23 ' H ' ' A' ' 241' ' ' HIS . 3.9 tt -83.79 177.71 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 173.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -145.46 139.42 26.84 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -142.58 174.09 10.95 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . 0.425 ' HD3' ' HA ' ' A' ' 238' ' ' GLN . 0.5 OUTLIER -146.73 144.91 29.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.175 0.443 . . . . 0.0 110.631 173.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.8 p -158.91 154.6 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.31 144.51 25.25 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.357 0.263 . . . . 0.0 110.374 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 13.6 m -126.63 157.97 37.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 120.837 0.351 . . . . 0.0 111.123 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.95 162.28 24.77 Favored Pre-proline 0 N--CA 1.455 -0.225 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 173.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.57 133.38 57.64 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.733 2.289 . . . . 0.0 108.897 173.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . 0.449 ' CE1' ' CD1' ' A' ' 176' ' ' PHE . 2.0 t80 -75.5 166.88 22.91 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.927 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.89 163.94 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 123.934 0.894 . . . . 0.0 110.961 -171.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.1 tm? . . . . . 0 C--O 1.251 1.173 0 CA-C-O 117.582 -1.199 . . . . 0.0 109.093 179.903 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.027 1 C5'-C4'-C3' 108.148 -4.901 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.915 2 C3'-C2'-C1' 105.809 4.788 OUTLIER-DELTA 0.06 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.508 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.72 2 O4'-C1'-N19 113.677 5.477 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.499 ' C4 ' ' HA ' ' A' ' 215' ' ' LYS . . . . . . . . 0 O4'--C4' 1.419 -2.85 1 C5'-C4'-C3' 108.999 -4.334 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.512 " H4'" ' HB2' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.41 -3.618 0 C5'-C4'-C3' 110.363 -3.425 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.4 t . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.502 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 9.5 t60 57.78 178.46 0.06 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.502 1.121 . . . . 0.0 112.293 -177.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.502 ' H ' ' CG ' ' A' ' 54' ' ' HIS . 21.7 pt20 -144.97 165.23 28.76 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.034 0.533 . . . . 0.0 110.759 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -107.92 19.08 20.5 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.338 0.655 . . . . 0.0 110.948 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.65 4.91 82.38 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 53.86 20.98 2.55 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.578 1.151 . . . . 0.0 113.11 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -145.94 144.92 30.46 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 123.236 0.614 . . . . 0.0 109.408 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.6 p -145.45 160.92 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 123.217 0.607 . . . . 0.0 110.188 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -133.3 153.05 51.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.485 ' HD3' ' H ' ' A' ' 63' ' ' TYR . 14.4 tpp180 -118.22 154.02 32.92 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.527 0.331 . . . . 0.0 110.623 -176.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.485 ' H ' ' HD3' ' A' ' 62' ' ' ARG . 8.1 m-85 -117.84 -173.87 2.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.396 -174.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.1 t -123.66 166.03 16.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.265 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 41.7 ptt85 -77.67 37.28 0.22 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.772 0.829 . . . . 0.0 112.096 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -138.91 135.58 34.59 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.143 0.977 . . . . 0.0 110.473 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -146.64 158.66 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.519 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.449 ' CZ ' ' C6 ' ' B' ' 3' ' ' ' U' . 5.1 t80 -91.8 140.43 29.7 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 169.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.2 p -127.6 125.37 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.95 148.82 18.3 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 -169.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.07 108.99 0.04 OUTLIER Glycine 0 CA--C 1.524 0.646 0 C-N-CA 125.793 1.663 . . . . 0.0 114.369 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.2 mt -141.59 145.74 38.71 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 123.881 0.872 . . . . 0.0 108.675 172.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -76.78 172.65 15.82 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.702 2.935 . . . . 0.0 110.098 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.9 172.95 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.026 3.151 . . . . 0.0 113.103 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.2 t70 61.18 -91.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.2 pt -56.12 132.28 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.886 0.85 . . . . 0.0 112.121 -176.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -170.2 155.95 5.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.644 1.178 . . . . 0.0 108.003 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 61.65 -51.62 0.13 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.749 1.62 . . . . 0.0 114.046 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -80.87 -35.18 33.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.05 0.841 . . . . 0.0 111.567 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -76.02 -28.31 57.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.282 -0.261 . . . . 0.0 110.769 -174.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.6 pt -81.99 -27.17 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 O-C-N 121.978 -0.451 . . . . 0.0 110.067 173.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 94.4 m -72.8 -12.45 61.0 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.09 -19.53 16.45 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 173.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.9 m -76.78 -34.74 57.99 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.546 0.612 . . . . 0.0 111.921 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -105.41 7.07 33.04 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -65.18 -18.03 64.97 Favored 'General case' 0 CA--C 1.526 0.037 0 C-N-CA 122.767 0.427 . . . . 0.0 110.946 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -69.71 -12.21 61.45 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.362 0.665 . . . . 0.0 110.877 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -111.98 16.62 20.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.951 0.5 . . . . 0.0 109.939 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.51 163.12 30.41 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.63 148.57 63.7 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.63 2.887 . . . . 0.0 112.37 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.92 169.17 20.43 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.615 0.366 . . . . 0.0 111.048 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 pt -137.55 175.38 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.738 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.9 p -152.51 156.26 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 122.369 -0.207 . . . . 0.0 110.758 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -155.79 172.19 18.75 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.923 0.392 . . . . 0.0 111.127 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -160.14 162.65 23.76 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.498 ' HG3' " H1'" ' B' ' 4' ' ' ' U' . 68.1 Cg_endo -71.12 -16.96 31.88 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 CA-C-N 121.334 1.512 . . . . 0.0 110.468 -171.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.471 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 2.1 m-70 -88.38 1.34 54.87 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.848 0.859 . . . . 0.0 111.137 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.489 ' HE3' ' HA ' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -63.51 -29.11 70.43 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.718 0.807 . . . . 0.0 111.128 -176.064 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 50.0 27.03 2.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.883 0.873 . . . . 0.0 112.894 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 53.17 23.96 3.38 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.707 0.803 . . . . 0.0 112.116 -176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.7 t -101.72 165.84 11.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.785 0.834 . . . . 0.0 111.17 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.625 ' HA ' ' HE2' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -86.83 4.69 40.11 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.692 0.797 . . . . 0.0 110.709 -179.421 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.0 p -58.89 162.82 3.84 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.689 0.795 . . . . 0.0 111.935 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -126.25 166.58 16.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.219 0.607 . . . . 0.0 111.502 -177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 60.9 t80 56.18 102.33 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 126.975 2.11 . . . . 0.0 113.679 178.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -70.75 167.6 25.26 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.58 2.853 . . . . 0.0 109.467 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -45.36 -25.96 2.34 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 124.835 3.69 . . . . 0.0 116.486 -172.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.503 ' HB3' ' CE2' ' A' ' 110' ' ' TYR . 3.6 tmtm? -151.26 22.37 0.74 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.396 0.998 . . . . 0.0 112.144 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.54 2.17 87.51 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 118.604 -1.109 . . . . 0.0 115.61 172.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.508 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -88.71 151.48 22.4 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 120.22 2.01 . . . . 0.0 108.906 174.503 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.68 -175.66 5.46 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.66 0.267 . . . . 0.0 110.964 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -132.19 118.57 19.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.8 tt -100.47 139.71 35.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.192 0.52 . . . . 0.0 111.515 -168.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.6 mp -119.9 153.46 35.85 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.976 -172.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -139.79 -176.26 4.51 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.359 1.064 . . . . 0.0 109.702 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -111.29 -26.66 9.04 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 122.634 0.373 . . . . 0.0 110.906 -176.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -140.63 161.71 37.11 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.5 0.32 . . . . 0.0 111.293 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -79.09 -13.41 59.77 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.424 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.5 p -75.04 -22.48 58.4 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.127 0.421 . . . . 0.0 110.523 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 57.0 m -79.25 -40.67 30.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.49 -0.131 . . . . 0.0 110.935 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.9 m -73.36 -20.21 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -72.64 -37.68 67.94 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.66 -32.48 62.25 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 119.329 -0.367 . . . . 0.0 111.735 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -82.07 -14.27 56.09 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.689 0.677 . . . . 0.0 111.933 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.6 mt -95.93 -20.9 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 122.008 -0.432 . . . . 0.0 110.258 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -101.84 -8.7 21.4 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -120.86 9.98 10.79 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 34.7 m -125.94 -178.53 4.32 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.191 0.596 . . . . 0.0 109.643 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -80.17 163.53 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 O-C-N 121.737 -0.602 . . . . 0.0 111.32 -170.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -143.44 157.62 44.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.541 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -146.84 173.29 12.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.76 3.94 0.32 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -171.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -148.22 -9.36 0.19 Allowed Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.016 -0.88 . . . . 0.0 114.224 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.421 ' HE2' ' CE2' ' A' ' 136' ' ' TYR . 24.8 pttm -167.14 -171.33 1.73 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.79 1.295 . . . . 0.0 110.963 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.28 170.22 10.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.077 0.951 . . . . 0.0 110.171 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.421 ' CE2' ' HE2' ' A' ' 134' ' ' LYS . 22.4 m-85 -150.64 165.05 34.56 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.992 0.425 . . . . 0.0 111.65 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.9 tp -141.37 134.61 29.43 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 167.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.2 p -78.21 141.42 38.62 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.1 m -141.05 162.77 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 122.882 0.473 . . . . 0.0 110.419 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.1 m -86.14 10.45 14.44 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.007 0.523 . . . . 0.0 110.978 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.0 t -67.08 118.87 59.81 Favored Pre-proline 0 N--CA 1.454 -0.271 0 C-N-CA 123.658 0.783 . . . . 0.0 110.478 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -79.83 113.02 2.97 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.4 2.733 . . . . 0.0 110.799 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.645 ' C ' ' H ' ' A' ' 145' ' ' LYS . 25.8 m -117.89 63.94 0.75 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.3 mp 64.38 -22.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.185 1.394 . . . . 0.0 110.889 -171.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.645 ' H ' ' C ' ' A' ' 143' ' ' THR . 39.2 ttpt -156.66 159.23 38.23 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 127.248 2.219 . . . . 0.0 106.025 169.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.58 139.83 58.48 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.68 0.673 . . . . 0.0 110.426 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -151.35 157.3 35.03 Favored Pre-proline 0 CA--C 1.529 0.153 0 C-N-CA 122.341 0.257 . . . . 0.0 111.203 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -79.41 163.29 24.69 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.808 3.005 . . . . 0.0 111.308 171.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.9 m -107.64 150.88 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.105 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -85.84 153.02 22.54 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 117.616 0.189 . . . . 0.0 111.081 -174.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.8 mm -137.63 143.27 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.802 0.841 . . . . 0.0 110.075 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -155.55 101.67 2.2 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -77.01 164.15 30.02 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.861 3.041 . . . . 0.0 112.218 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -97.99 150.01 21.83 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 46.2 p-10 -117.05 155.9 28.44 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.524 0.678 . . . . 0.0 111.955 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.3 mp -94.95 74.74 3.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.755 -175.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.2 t -141.35 -40.52 0.38 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.926 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -153.68 135.87 14.84 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.6 m -149.29 -30.15 0.25 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.252 0.221 . . . . 0.0 111.286 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -151.42 160.03 43.94 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.622 0.769 . . . . 0.0 109.815 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -149.85 158.55 44.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.5 t -130.63 138.4 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 51.6 tpp -100.34 -10.47 21.21 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -174.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -158.62 -47.39 0.06 Allowed 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.833 -0.542 . . . . 0.0 110.628 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.66 4.98 62.88 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.227 -0.763 . . . . 0.0 114.412 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.6 t -129.71 -13.8 4.16 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.726 1.263 . . . . 0.0 112.092 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -87.09 159.73 50.57 Favored Pre-proline 0 CA--C 1.533 0.294 0 O-C-N 122.066 -0.396 . . . . 0.0 110.464 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.65 163.59 6.84 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 124.278 3.318 . . . . 0.0 113.792 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.25 128.76 21.32 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -148.4 124.96 5.39 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-O 119.305 -0.379 . . . . 0.0 110.0 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -55.11 -20.17 23.08 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.617 2.878 . . . . 0.0 113.599 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -81.03 -3.25 51.18 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.123 0.419 . . . . 0.0 111.04 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -127.01 28.7 5.74 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 51.3 m -121.08 145.22 48.03 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.9 tt -115.9 149.52 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 123.085 0.554 . . . . 0.0 110.154 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.49 ' HB2' ' CD1' ' A' ' 253' ' ' TYR . 6.8 t80 -108.4 143.99 36.58 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 97.2 t -137.78 124.2 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -175.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -132.53 162.6 24.09 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 112.413 -0.275 . . . . 0.0 112.413 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.62 16.26 58.75 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -172.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.9 m -71.47 152.3 93.95 Favored Pre-proline 0 N--CA 1.456 -0.174 0 C-N-CA 122.706 0.402 . . . . 0.0 111.563 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -76.83 171.81 17.33 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 124.001 3.134 . . . . 0.0 109.965 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 48.5 tpt85 -73.51 -48.35 7.01 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -80.02 32.38 0.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.417 2.745 . . . . 0.0 112.634 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -61.37 -33.08 73.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.537 0.608 . . . . 0.0 112.319 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 54.23 122.01 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.704 2.002 . . . . 0.0 113.941 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.25 -29.06 70.17 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.777 -0.577 . . . . 0.0 111.783 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 65.7 t -68.36 -48.35 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 122.295 0.238 . . . . 0.0 111.167 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -82.89 -20.87 34.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.9 -0.137 . . . . 0.0 110.923 -174.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 42.1 tp -71.51 -33.24 69.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.45 -37.07 63.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.324 -178.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 25.7 mmt -70.74 -34.04 71.45 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 62.4 mt -68.91 -37.31 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -71.58 -21.95 61.8 Favored 'General case' 0 N--CA 1.457 -0.106 0 O-C-N 121.856 -0.528 . . . . 0.0 110.339 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -86.7 -13.28 45.86 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 122.115 -0.366 . . . . 0.0 111.526 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -98.62 -21.21 16.58 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.36 -13.5 14.86 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.55 0.613 . . . . 0.0 111.954 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -140.44 -34.77 0.52 Allowed 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 118.673 0.67 . . . . 0.0 112.367 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.33 -178.33 18.12 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 69.6 10.96 64.67 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 119.411 -0.661 . . . . 0.0 112.899 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 22.1 t -72.77 147.02 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 118.248 1.024 . . . . 0.0 109.958 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.8 p -128.9 -24.97 2.86 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 119.625 -0.226 . . . . 0.0 111.455 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -150.46 149.98 30.71 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.007 0.367 . . . . 0.0 110.758 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -160.92 156.38 24.84 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.92 0.488 . . . . 0.0 110.332 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 158.55 -165.22 33.89 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 3.1 mp -100.65 130.58 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -56.2 114.91 2.16 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 89.6 m -143.71 157.48 44.36 Favored 'General case' 0 N--CA 1.458 -0.075 0 O-C-N 123.441 0.463 . . . . 0.0 110.279 -172.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -135.85 132.51 19.46 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.882 0.873 . . . . 0.0 108.916 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -80.86 -6.97 13.37 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 124.202 3.268 . . . . 0.0 114.558 -172.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -112.06 -41.02 4.05 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.993 1.27 . . . . 0.0 114.239 -172.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.5 pp -161.12 -15.88 0.05 OUTLIER 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -88.49 -26.51 22.02 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.759 1.163 . . . . 0.0 111.691 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.495 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 29.7 m-85 56.5 -178.7 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.83 0.852 . . . . 0.0 113.215 172.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.495 ' CD ' ' HB3' ' A' ' 213' ' ' TYR . 77.4 Cg_exo -54.26 153.16 22.81 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.026 2.484 . . . . 0.0 112.864 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 215' ' ' LYS . 34.0 ttmt -104.61 5.7 33.93 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.918 0.887 . . . . 0.0 111.169 -178.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 66.81 10.67 55.97 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 112.19 -0.364 . . . . 0.0 112.19 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -141.39 149.2 40.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.262 0.625 . . . . 0.0 110.341 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -92.32 166.25 29.37 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.813 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -147.24 150.98 35.92 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 62.0 t -142.19 142.01 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.88 145.72 48.92 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -123.52 151.98 42.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.638 -176.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 54.4 m -84.25 2.8 38.3 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.075 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -137.82 138.13 38.86 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.955 0.502 . . . . 0.0 110.082 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -74.4 -14.9 60.92 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.4 tp60 -76.82 -38.44 53.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 31.7 m -75.16 -26.48 59.13 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -67.44 -50.33 59.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 119.545 -0.265 . . . . 0.0 110.37 176.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -72.32 -12.66 15.99 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 CA-C-N 118.163 0.438 . . . . 0.0 111.158 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.07 -23.55 28.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 174.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -85.94 -23.05 27.1 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 11.5 pt -106.6 25.25 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 C-N-CA 122.859 0.464 . . . . 0.0 110.311 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -79.64 -13.26 59.62 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.074 0.549 . . . . 0.0 112.033 -175.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -156.6 143.72 18.85 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -55.65 -36.07 66.64 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.692 0.397 . . . . 0.0 111.558 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -115.79 105.68 12.98 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 18.0 m -88.5 160.04 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.425 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -84.97 139.85 31.5 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.802 0.334 . . . . 0.0 110.249 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.49 104.2 6.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 172.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -137.67 153.0 49.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.371 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -146.51 20.08 1.34 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.187 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.29 130.17 3.01 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 52.85 17.82 0.94 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.425 1.09 . . . . 0.0 112.933 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 76.1 mt -140.52 149.33 21.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 123.97 0.908 . . . . 0.0 109.296 -178.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -153.74 133.4 12.97 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -145.32 161.25 40.05 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.254 1.022 . . . . 0.0 109.025 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.86 155.17 44.73 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 123.361 0.664 . . . . 0.0 109.826 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.3 p -158.38 159.22 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 122.961 0.505 . . . . 0.0 109.981 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -83.68 141.35 31.55 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.112 0.565 . . . . 0.0 110.831 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.88 162.54 31.32 Favored 'Isoleucine or valine' 0 C--N 1.338 0.092 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.82 158.92 29.58 Favored Pre-proline 0 N--CA 1.455 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.823 170.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.76 134.74 62.5 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.461 2.108 . . . . 0.0 108.087 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . 0.49 ' CD1' ' HB2' ' A' ' 176' ' ' PHE . 0.7 OUTLIER -77.01 170.51 16.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.192 -175.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.51 163.58 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.669 0.788 . . . . 0.0 110.829 -170.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 3.9 tt . . . . . 0 C--O 1.251 1.157 0 CA-C-O 117.228 -1.368 . . . . 0.0 109.255 -179.825 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.916 0 C5'-C4'-C3' 110.108 -3.595 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.416 -3.056 2 O4'-C1'-N19 113.123 4.923 OUTLIER-DELTA 0.165 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.508 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.709 1 O4'-C1'-N19 112.363 4.163 . 0.054 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.498 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.421 -2.705 0 O5'-C5'-C4' 106.03 -2.978 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.431 " H4'" ' HB2' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.415 -3.164 0 C5'-C4'-C3' 112.045 -2.303 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 110.522 -0.177 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -140.54 161.59 37.38 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.341 0.657 . . . . 0.0 110.402 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -78.01 159.93 28.46 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.537 0.335 . . . . 0.0 110.578 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -88.23 -4.62 58.69 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.514 0.325 . . . . 0.0 111.283 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.92 -175.24 46.3 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -136.05 165.95 24.5 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.077 0.551 . . . . 0.0 110.562 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.17 166.71 22.95 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.046 0.538 . . . . 0.0 111.664 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 m 47.54 28.8 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.405 1.482 . . . . 0.0 113.473 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -65.68 147.68 52.99 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.64 154.09 21.93 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 120.767 0.317 . . . . 0.0 111.717 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -156.95 170.66 22.01 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.544 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.1 t -95.89 165.45 12.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.401 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -84.72 9.44 13.99 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.836 0.454 . . . . 0.0 111.005 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -128.83 141.46 51.29 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 121.14 0.495 . . . . 0.0 110.168 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 p -147.8 147.86 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.306 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.532 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 8.1 t80 -87.04 145.14 26.59 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.9 p -128.63 122.91 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -110.27 175.03 18.02 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-O 121.307 0.393 . . . . 0.0 112.175 -175.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.45 29.75 74.34 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.379 -0.41 . . . . 0.0 113.39 171.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.1 mt -69.15 142.44 92.85 Favored Pre-proline 0 N--CA 1.45 -0.462 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.11 174.88 11.69 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.233 2.622 . . . . 0.0 109.567 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -54.74 -9.38 1.79 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 124.742 3.628 . . . . 0.0 114.32 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.52 ' C ' ' H ' ' A' ' 77' ' ' ASP . 9.9 m-20 -125.5 -123.46 0.25 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER 63.55 -25.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.52 ' H ' ' C ' ' A' ' 75' ' ' ASP . 4.2 p-10 39.26 -113.88 0.15 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.563 1.545 . . . . 0.0 113.114 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -127.27 -19.85 4.21 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.104 0.961 . . . . 0.0 110.487 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -80.95 -46.58 14.93 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.845 -0.535 . . . . 0.0 112.036 -174.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -68.03 -34.05 75.75 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.631 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.7 pt -84.25 -29.87 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 O-C-N 122.052 -0.405 . . . . 0.0 111.21 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 97.2 m -70.71 -12.93 61.86 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.49 0.586 . . . . 0.0 109.42 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.91 -15.45 15.14 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.6 m -82.18 -36.68 27.09 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.025 0.83 . . . . 0.0 112.461 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -98.08 1.56 47.77 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.4 ttt85 -78.43 -4.91 50.72 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -77.03 -11.09 59.76 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.737 0.415 . . . . 0.0 111.762 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -108.03 -19.12 13.61 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.443 0.297 . . . . 0.0 110.629 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.92 161.0 10.93 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.45 140.18 93.57 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.387 2.725 . . . . 0.0 111.906 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.77 164.53 36.81 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.274 0.23 . . . . 0.0 111.582 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.8 mm -134.48 164.08 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.5 p -128.24 146.44 33.74 Favored 'Isoleucine or valine' 0 C--O 1.23 0.079 0 CA-C-N 118.324 0.511 . . . . 0.0 110.243 177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -150.0 166.78 28.65 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.085 0.469 . . . . 0.0 110.781 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.439 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 17.1 p90 -148.4 160.37 36.78 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.635 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 69.6 Cg_endo -70.0 -8.94 24.86 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 124.467 3.445 . . . . 0.0 111.72 -170.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.635 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 60.2 m-70 -101.47 5.15 41.84 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.091 0.556 . . . . 0.0 112.16 -176.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -70.17 161.22 30.66 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 121.659 0.742 . . . . 0.0 112.113 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -101.04 36.31 2.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.829 1.251 . . . . 0.0 111.04 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 59.21 14.3 3.5 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.74 0.816 . . . . 0.0 111.228 -173.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.6 t -155.54 173.91 16.02 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.764 1.226 . . . . 0.0 108.284 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -64.06 150.98 44.26 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.77 0.319 . . . . 0.0 110.778 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -149.69 -8.19 0.32 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.251 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 56.8 177.84 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.435 1.094 . . . . 0.0 112.716 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 44.72 77.85 0.43 Allowed Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 124.815 1.246 . . . . 0.0 113.138 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.99 162.23 42.52 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.588 2.859 . . . . 0.0 110.583 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -47.83 128.82 16.69 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.342 3.361 . . . . 0.0 113.02 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? 44.05 -83.42 0.0 OUTLIER 'General case' 0 C--N 1.34 0.177 0 C-N-CA 126.904 2.082 . . . . 0.0 112.629 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.82 34.75 0.24 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -174.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.533 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -145.31 148.65 33.66 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.346 1.073 . . . . 0.0 110.149 176.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.45 -176.46 5.6 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.965 0.506 . . . . 0.0 110.606 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -139.26 136.93 35.45 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -103.01 149.93 24.06 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 mp -111.23 143.01 42.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 171.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -130.62 162.87 28.39 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.202 0.525 . . . . 0.0 111.072 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -100.84 -32.3 10.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.693 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -113.53 151.51 31.47 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -88.65 -11.84 44.17 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.871 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.8 m -102.45 -7.02 22.29 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 122.932 0.493 . . . . 0.0 111.029 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.8 t -71.67 -35.14 70.22 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.0 m -73.71 -25.23 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -77.01 -29.5 55.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.405 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.5 -36.67 57.65 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.497 0.589 . . . . 0.0 110.899 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -76.72 -18.37 58.54 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.778 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 35.8 mt -91.97 -18.72 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 122.377 0.271 . . . . 0.0 111.203 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -100.98 -10.02 20.94 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.534 -0.728 . . . . 0.0 112.514 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.56 14.63 13.63 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 73.2 m -132.79 -171.38 2.65 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.959 0.345 . . . . 0.0 111.846 -175.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.5 mp -74.97 154.67 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.296 1.038 . . . . 0.0 109.159 -171.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 135' ' ' LEU . 12.7 pt-20 -133.24 161.64 33.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.494 0.188 . . . . 0.0 111.178 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.46 177.41 9.07 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -46.36 -24.74 0.53 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -169.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -153.67 5.2 0.34 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-N 119.184 0.902 . . . . 0.0 113.384 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -146.06 -171.75 3.78 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 117.949 0.874 . . . . 0.0 109.127 -175.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 130' ' ' GLU . 4.5 mp -134.89 166.54 22.77 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.376 -0.202 . . . . 0.0 111.116 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 149' ' ' VAL . 17.4 m-85 -138.1 156.45 47.76 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.155 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.2 mp -134.04 157.45 46.07 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 73.5 m -100.28 135.11 42.21 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.182 0.447 . . . . 0.0 110.721 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.9 m -144.12 164.46 14.26 Favored 'Isoleucine or valine' 0 C--N 1.338 0.067 0 C-N-CA 123.694 0.798 . . . . 0.0 109.923 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.4 t -70.63 151.41 45.01 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 120.54 0.209 . . . . 0.0 110.559 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.3 t -156.02 139.05 10.77 Favored Pre-proline 0 N--CA 1.456 -0.151 0 C-N-CA 122.646 0.379 . . . . 0.0 110.408 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -79.13 -0.08 10.45 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.55 3.5 . . . . 0.0 114.046 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 49.2 m -93.97 -10.99 31.84 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.077 0.853 . . . . 0.0 108.998 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.97 -155.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 126.94 2.096 . . . . 0.0 106.668 -174.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -94.71 -36.94 11.52 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -162.07 154.63 19.76 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.896 1.279 . . . . 0.0 108.296 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.43 ' HD2' ' N1 ' ' B' ' 1' ' ' ' C' . 23.4 ttpp -143.5 138.6 15.56 Favored Pre-proline 0 CA--C 1.528 0.114 0 CA-C-N 118.171 0.441 . . . . 0.0 112.088 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -59.58 140.32 93.29 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.596 2.864 . . . . 0.0 111.678 169.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 33.0 m -126.33 143.07 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -87.74 150.74 23.41 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.9 mm -129.24 143.45 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 124.807 1.243 . . . . 0.0 110.419 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 47.8 ttp85 -159.13 97.68 1.65 Allowed Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -62.99 167.21 12.63 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 124.12 3.213 . . . . 0.0 113.497 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -87.2 147.37 25.62 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 172.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -107.35 147.95 29.67 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.349 0.595 . . . . 0.0 111.743 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.3 mp -98.42 93.54 6.23 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 t -158.18 -39.76 0.06 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.465 ' CG ' ' HE ' ' A' ' 185' ' ' ARG . 16.0 m-20 -143.91 39.58 1.36 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.3 m -67.53 -19.41 65.29 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -155.83 160.03 39.88 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.303 0.641 . . . . 0.0 110.835 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -154.11 151.88 29.78 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.09 143.39 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 90.0 mtp -129.41 3.19 5.1 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -175.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -156.17 -40.93 0.08 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.766 0.712 . . . . 0.0 112.322 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 155.81 12.14 0.06 OUTLIER Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.428 -0.651 . . . . 0.0 112.886 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.0 m 54.59 56.4 6.83 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 117.981 0.89 . . . . 0.0 112.167 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -57.8 159.41 10.06 Favored Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -59.45 145.44 97.94 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.692 2.261 . . . . 0.0 109.72 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 72.0 mt -121.09 166.84 13.34 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.101 0.477 . . . . 0.0 112.211 -171.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -141.3 155.35 67.84 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.26 -6.83 20.04 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.142 2.561 . . . . 0.0 111.026 -176.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -101.96 5.56 40.83 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.107 0.963 . . . . 0.0 111.464 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -129.33 14.72 6.13 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.798 0.439 . . . . 0.0 111.088 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.6 m -132.45 142.56 49.3 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.178 0.191 . . . . 0.0 111.086 -174.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.4 tt -112.04 152.01 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 123.219 0.607 . . . . 0.0 110.343 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -121.16 143.23 49.22 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 35.3 m -139.01 149.68 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-O 120.663 0.268 . . . . 0.0 110.704 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -146.0 165.92 28.04 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 79.14 20.85 69.0 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -173.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 19.4 m -61.06 153.27 67.47 Favored Pre-proline 0 CA--C 1.529 0.171 0 C-N-CA 122.9 0.48 . . . . 0.0 111.956 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.14 168.76 21.14 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.755 2.97 . . . . 0.0 109.563 173.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -65.6 -47.44 67.38 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -173.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.52 -51.75 0.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 121.617 1.545 . . . . 0.0 112.254 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.1 tp 50.7 -72.48 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.537 1.935 . . . . 0.0 114.548 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.465 ' HE ' ' CG ' ' A' ' 158' ' ' ASP . 63.2 mtp180 61.97 127.66 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 127.521 2.328 . . . . 0.0 112.43 -174.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.46 -22.96 66.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.397 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 59.0 t -72.56 -47.83 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 122.341 0.256 . . . . 0.0 110.638 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -80.65 -32.89 36.03 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 55.6 tp -66.26 -34.0 77.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -86.73 -25.32 24.77 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -175.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 20.7 mmt -70.6 -33.83 71.49 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.4 mt -72.55 -39.76 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 20.1 mmt -60.08 -24.76 64.85 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 119.231 -0.414 . . . . 0.0 111.605 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -88.25 -20.17 25.83 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.923 0.783 . . . . 0.0 111.412 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.19 -18.73 33.18 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.871 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.38 -23.96 7.58 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 118.147 0.43 . . . . 0.0 111.042 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -135.29 45.3 2.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.893 0.477 . . . . 0.0 110.024 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -45.12 138.36 5.79 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.431 0.539 . . . . 0.0 112.117 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 123.52 9.87 5.72 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 5.2 p -71.02 160.46 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.847 0.859 . . . . 0.0 110.555 -179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 52.4 t -134.91 -35.64 0.85 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.638 0.606 . . . . 0.0 112.638 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -150.74 155.82 40.06 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.763 0.256 . . . . 0.0 110.766 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -154.2 159.42 41.35 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.025 0.441 . . . . 0.0 110.181 177.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 175.22 -175.67 47.17 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.7 mm -97.46 144.68 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -60.74 123.38 17.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 52.5 p -134.97 140.48 45.73 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -85.08 128.03 61.83 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -76.47 -10.88 18.94 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.263 3.309 . . . . 0.0 112.565 -174.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -69.23 -29.68 67.68 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.428 0.291 . . . . 0.0 110.53 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.13 6.71 1.76 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.453 0.701 . . . . 0.0 111.592 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 51.81 48.65 22.39 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.198 1.399 . . . . 0.0 113.904 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -123.15 152.18 63.17 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.965 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.55 171.72 16.58 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 124.206 3.271 . . . . 0.0 112.639 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 12.9 ttmt -134.69 19.31 3.56 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.68 0.792 . . . . 0.0 111.38 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 63.0 16.57 57.59 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 119.61 -0.55 . . . . 0.0 113.535 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -130.34 155.27 46.63 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.877 0.838 . . . . 0.0 109.982 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -105.98 160.56 14.7 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 112.426 -0.27 . . . . 0.0 112.426 -175.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -151.03 144.94 25.2 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 99.6 t -140.01 148.34 22.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -130.2 147.51 51.93 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.722 0.296 . . . . 0.0 110.845 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 14.0 m-85 -128.05 156.7 42.35 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.598 -176.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 74.1 m -77.84 -7.58 56.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -131.87 145.76 51.72 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.101 0.409 . . . . 0.0 111.085 -176.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -71.78 -22.55 61.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -70.22 -38.21 75.19 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 17.9 m -72.35 -29.91 64.24 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -70.09 -51.6 30.49 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 119.622 -0.228 . . . . 0.0 111.118 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.7 pt -69.11 -15.74 20.02 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 CA-C-N 118.289 0.495 . . . . 0.0 110.735 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.18 -27.52 29.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.17 -25.61 36.69 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 8.1 pt -105.09 24.98 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.022 0.529 . . . . 0.0 110.44 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -78.86 -11.38 59.99 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.247 0.619 . . . . 0.0 111.932 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.55 143.0 21.68 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -56.26 -33.23 65.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.778 0.431 . . . . 0.0 111.989 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -123.62 114.63 20.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.04 0.448 . . . . 0.0 110.633 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.5 m -87.55 147.61 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.136 173.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -83.21 134.12 34.98 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -121.61 21.25 10.93 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -66.86 149.35 50.71 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -147.0 8.58 0.95 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.624 0.25 . . . . 0.0 111.313 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 163.31 -137.36 4.74 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -176.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -74.63 -4.79 39.28 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.98 0.39 . . . . 0.0 110.502 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.9 mp -87.2 153.54 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.034 0.934 . . . . 0.0 108.963 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -134.68 135.73 42.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.893 0.378 . . . . 0.0 110.603 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -145.39 147.67 32.5 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.442 1.097 . . . . 0.0 109.199 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 161.63 42.33 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.271 0.628 . . . . 0.0 109.504 177.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.0 p -154.59 152.16 9.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -88.76 128.4 35.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.451 ' C ' ' HE2' ' A' ' 251' ' ' LYS . 1.5 m -104.56 156.34 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -174.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.451 ' HE2' ' C ' ' A' ' 250' ' ' VAL . 0.0 OUTLIER -156.15 158.48 31.6 Favored Pre-proline 0 N--CA 1.456 -0.147 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.891 170.205 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.91 140.56 92.28 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.777 2.318 . . . . 0.0 109.917 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -91.49 175.82 6.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.924 0.392 . . . . 0.0 110.505 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.1 p -151.11 152.8 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 123.375 0.67 . . . . 0.0 109.846 -170.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.441 ' H ' ' CD2' ' A' ' 255' ' ' LEU . 1.9 pt? . . . . . 0 C--O 1.252 1.188 0 CA-C-O 116.823 -1.56 . . . . 0.0 112.256 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.43 ' N1 ' ' HD2' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.93 1 C5'-C4'-C3' 109.002 -4.332 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.221 0 C5'-C4'-C3' 110.514 -3.324 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.533 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.418 -2.948 1 O4'-C1'-N19 113.277 5.077 . 0.356 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.548 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.417 -3.031 0 O4'-C4'-C3' 109.863 3.116 . 0.01 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.496 ' C8 ' H5'' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.414 -3.289 0 P-O3'-C3' 123.01 2.758 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.2 p . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 119.876 -0.106 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -138.15 167.3 22.11 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.28 0.632 . . . . 0.0 110.619 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -143.58 164.81 29.33 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.331 0.653 . . . . 0.0 110.36 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -76.28 160.37 29.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.897 0.379 . . . . 0.0 110.723 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.28 8.54 0.32 Allowed Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.14 0.51 40.47 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.55 0.675 . . . . 0.0 111.749 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -144.07 150.56 38.35 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.673 0.789 . . . . 0.0 109.442 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 p -148.39 156.15 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.367 0.667 . . . . 0.0 109.654 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -129.73 166.44 19.85 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.333 0.653 . . . . 0.0 109.881 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -135.91 124.45 23.6 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.801 0.334 . . . . 0.0 110.461 -178.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.435 ' HA ' ' HG ' ' A' ' 156' ' ' LEU . 0.3 OUTLIER -147.59 171.35 15.72 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.569 177.493 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.9 t -89.22 169.0 11.82 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.507 0.723 . . . . 0.0 111.666 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 49.1 ptt85 -77.42 5.57 8.56 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.709 0.804 . . . . 0.0 111.118 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -108.21 130.89 55.13 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.336 -0.986 . . . . 0.0 108.336 174.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.1 p -150.54 146.44 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.458 -170.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.425 ' CZ ' ' HA3' ' A' ' 70' ' ' GLY . 8.3 t80 -83.25 135.57 34.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.9 t -137.75 78.16 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 110' ' ' TYR . . . -120.28 159.62 15.11 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.946 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.45 5.92 33.86 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.526 HD21 ' H ' ' A' ' 72' ' ' LEU . 0.9 OUTLIER -73.69 173.4 6.36 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 171.228 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.502 ' C ' ' H ' ' A' ' 75' ' ' ASP . 50.2 Cg_endo -80.9 155.51 20.22 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 CA-C-N 120.677 1.277 . . . . 0.0 110.292 -174.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -64.95 13.39 0.1 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.92 3.08 . . . . 0.0 112.755 173.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 73' ' ' PRO . 12.2 m-20 -134.29 26.82 3.82 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -172.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 mt -123.93 152.05 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -126.11 -176.19 3.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.286 0.634 . . . . 0.0 110.933 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -51.4 -23.76 4.16 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.367 1.067 . . . . 0.0 113.139 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -79.64 -37.44 36.04 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.715 0.688 . . . . 0.0 112.472 -175.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -84.7 -25.45 28.37 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.41 0.55 . . . . 0.0 110.671 -174.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 52.9 mt -75.03 -42.71 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.9 m -66.51 -26.24 67.07 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.44 -20.77 46.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.234 -0.291 . . . . 0.0 111.541 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 m -85.34 -25.05 27.36 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.45 ' CE1' HD22 ' A' ' 137' ' ' LEU . 87.6 m-85 -117.58 1.98 12.31 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -174.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -80.6 -2.73 47.6 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.095 0.861 . . . . 0.0 112.09 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.525 ' HG3' ' CD2' ' A' ' 88' ' ' PHE . 12.7 ptp180 -77.12 -7.46 55.82 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.439 0.696 . . . . 0.0 112.149 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.525 ' CD2' ' HG3' ' A' ' 87' ' ' ARG . 71.3 m-85 -121.73 2.72 10.07 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.394 0.277 . . . . 0.0 111.699 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.45 162.37 9.31 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.0 139.24 46.4 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.072 2.515 . . . . 0.0 110.759 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.59 169.77 23.54 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.845 0.458 . . . . 0.0 111.333 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.5 pt -135.98 163.02 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 172.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.9 149.69 20.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -154.29 171.76 18.73 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.1 0.952 . . . . 0.0 112.494 -175.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.403 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 2.9 p90 -146.73 158.28 46.24 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 174.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.593 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 74.3 Cg_endo -63.14 -14.72 43.52 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 124.023 3.149 . . . . 0.0 112.996 -168.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.593 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 3.3 m170 -105.68 -34.29 7.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.927 0.331 . . . . 0.0 111.087 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.0 tptm 42.04 27.98 0.09 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.063 1.745 . . . . 0.0 113.634 -174.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 53.13 -169.24 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.585 1.154 . . . . 0.0 112.914 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -83.84 26.68 0.69 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.621 0.769 . . . . 0.0 111.104 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.6 m 59.43 24.19 12.8 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.985 0.914 . . . . 0.0 112.699 -175.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -113.77 3.73 15.65 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.446 0.699 . . . . 0.0 111.162 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.8 p -150.13 167.96 25.32 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.211 0.604 . . . . 0.0 110.358 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -141.41 33.0 1.67 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.5 0.72 . . . . 0.0 110.897 -176.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -129.54 125.54 22.43 Favored Pre-proline 0 N--CA 1.45 -0.475 0 C-N-CA 124.21 1.004 . . . . 0.0 108.885 -175.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.21 157.7 49.87 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.169 3.246 . . . . 0.0 111.144 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -71.06 -16.07 32.19 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.839 3.026 . . . . 0.0 112.827 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.69 ' CD ' ' H ' ' A' ' 109' ' ' GLY . 1.9 tmtm? -154.46 169.99 22.45 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.69 ' H ' ' CD ' ' A' ' 108' ' ' LYS . . . -71.69 34.27 0.59 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.923 1.725 . . . . 0.0 113.853 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.429 ' HA ' ' HA2' ' A' ' 70' ' ' GLY . 0.4 OUTLIER -145.17 134.25 22.67 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 118.545 1.173 . . . . 0.0 111.079 170.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.31 -169.25 3.33 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.627 1.171 . . . . 0.0 109.37 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.509 ' CE1' ' C5 ' ' B' ' 4' ' ' ' U' . 1.9 m-85 -134.8 151.02 50.6 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -176.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mp -108.24 151.04 26.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.585 0.707 . . . . 0.0 112.004 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.9 99.69 6.05 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -84.28 156.65 21.86 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.822 0.344 . . . . 0.0 110.232 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -86.35 -29.0 23.3 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.208 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -128.08 156.64 42.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -80.23 -19.86 45.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.218 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.0 m -90.44 -16.14 29.56 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.699 0.4 . . . . 0.0 111.14 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 18.8 m -72.67 -41.36 65.47 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.57 -13.97 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.849 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -78.4 -35.31 47.29 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.062 -0.398 . . . . 0.0 110.028 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.26 -37.5 57.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 117.83 0.287 . . . . 0.0 111.122 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.01 -38.16 87.75 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 52.3 mt -85.1 -10.73 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 121.422 -0.799 . . . . 0.0 111.925 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -102.26 -5.14 24.64 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.805 -0.559 . . . . 0.0 112.038 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -126.6 6.68 6.84 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 81.6 m -112.78 -179.48 3.67 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.865 0.757 . . . . 0.0 111.066 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.0 mp -68.72 147.98 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -171.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -130.69 151.91 50.62 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.545 0.212 . . . . 0.0 111.096 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.41 67.5 1.36 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.303 0.573 . . . . 0.0 110.26 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 52.72 12.23 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.45 -18.81 0.09 OUTLIER Glycine 0 CA--C 1.526 0.77 0 CA-C-N 118.682 0.673 . . . . 0.0 112.386 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -127.03 174.31 8.98 Favored 'General case' 0 C--N 1.338 0.07 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.4 167.95 20.1 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.032 0.378 . . . . 0.0 111.583 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.466 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 31.9 m-85 -139.09 159.17 42.78 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.795 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . 0.45 HD22 ' CE1' ' A' ' 85' ' ' PHE . 54.8 tp -150.47 158.58 44.32 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 169.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 84.7 m -95.26 167.97 11.03 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.891 -0.506 . . . . 0.0 111.954 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.15 164.78 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.933 0.893 . . . . 0.0 109.838 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.1 m -104.48 2.37 30.91 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.442 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 45.3 m -133.86 48.34 3.18 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 118.294 0.497 . . . . 0.0 111.546 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 141' ' ' SER . 62.0 Cg_endo -65.03 155.22 69.43 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.172 3.248 . . . . 0.0 111.905 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.8 t -89.12 -9.98 49.02 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.031 0.533 . . . . 0.0 111.513 -179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 64.7 mt -141.23 175.01 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -176.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -56.85 -24.82 54.17 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.998 -0.439 . . . . 0.0 111.284 -176.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -141.97 150.3 41.2 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.873 0.869 . . . . 0.0 109.631 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.597 ' HZ1' ' HB2' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -158.95 70.0 3.5 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 122.703 0.401 . . . . 0.0 110.02 174.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.466 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 72.1 Cg_endo -68.76 124.0 11.03 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.077 1.851 . . . . 0.0 109.115 175.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.7 140.33 16.13 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -91.67 153.06 19.93 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.734 0.414 . . . . 0.0 110.857 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.9 mm -126.6 136.26 61.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.342 0.657 . . . . 0.0 110.303 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -147.83 96.85 4.01 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -78.7 165.07 25.17 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.614 2.876 . . . . 0.0 110.828 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.45 ' CD2' ' HG2' ' A' ' 214' ' ' PRO . 47.1 t-105 -82.15 111.41 18.24 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 121.9 -0.5 . . . . 0.0 111.001 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -70.62 148.91 47.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.435 ' HG ' ' HA ' ' A' ' 63' ' ' TYR . 35.7 mt -119.14 101.34 7.93 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.201 0.524 . . . . 0.0 111.076 -169.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.7 t -164.85 -32.23 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.737 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -140.5 42.47 1.88 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.384 0.274 . . . . 0.0 111.332 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.6 t -66.57 -32.46 73.81 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -176.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -151.44 158.27 43.45 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.004 0.522 . . . . 0.0 110.49 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.43 ' CD2' ' HA ' ' A' ' 187' ' ' VAL . 58.3 t80 -156.24 153.42 29.13 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.4 p -144.73 149.25 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 67.5 mtm -117.16 13.43 14.7 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -173.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.532 ' HB3' ' HG ' ' A' ' 201' ' ' CYS . 18.1 t70 -160.55 -41.63 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.32 7.4 38.87 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.302 -0.721 . . . . 0.0 113.335 175.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.9 m -133.72 -0.23 3.19 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -86.81 150.31 50.17 Favored Pre-proline 0 CA--C 1.529 0.148 0 CA-C-N 119.839 1.2 . . . . 0.0 110.448 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.36 148.64 49.26 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.093 2.529 . . . . 0.0 109.659 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 77.1 mt -133.75 152.27 51.83 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.161 0.584 . . . . 0.0 109.871 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -145.29 153.28 52.17 Favored Pre-proline 0 N--CA 1.455 -0.186 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -59.19 -20.12 53.18 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.318 2.679 . . . . 0.0 112.353 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.9 6.56 38.73 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.418 0.687 . . . . 0.0 110.741 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -129.72 19.42 5.63 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 122.833 0.453 . . . . 0.0 110.455 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 30.2 m -125.12 139.92 53.35 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.72 0.295 . . . . 0.0 111.133 -175.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.8 tt -110.92 150.78 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.17 0.588 . . . . 0.0 109.77 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -120.43 140.48 51.3 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.7 m -135.92 142.16 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -156.05 -173.86 25.15 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 118.454 0.57 . . . . 0.0 113.05 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 76.05 28.75 59.9 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.1 146.84 53.69 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.811 0.306 . . . . 0.0 111.24 -171.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -68.28 -172.35 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.536 2.824 . . . . 0.0 110.158 169.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.48 ' N ' ' CD ' ' A' ' 183' ' ' PRO . 0.0 OUTLIER -95.35 5.31 0.06 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 117.737 2.495 . . . . 0.0 117.737 -172.247 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 182' ' ' ARG . 66.4 Cg_endo -76.17 6.19 4.05 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 122.505 1.93 . . . . 0.0 112.64 -175.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 57.4 mt -64.49 -35.79 82.09 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.513 0.597 . . . . 0.0 110.881 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 59.36 125.11 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.091 1.356 . . . . 0.0 112.162 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.6 -30.17 70.51 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.548 -0.72 . . . . 0.0 111.56 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.43 ' HA ' ' CD2' ' A' ' 161' ' ' PHE . 54.3 t -67.74 -50.85 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 120.609 0.242 . . . . 0.0 110.847 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -79.53 -24.97 41.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.482 -0.137 . . . . 0.0 110.781 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.1 tp -67.2 -34.55 77.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.09 -35.88 59.16 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.212 -0.305 . . . . 0.0 111.473 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 57.7 mtt -73.11 -33.73 65.74 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.324 -0.235 . . . . 0.0 111.083 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.428 HG23 ' HA ' ' A' ' 239' ' ' LEU . 72.2 mt -78.11 -39.53 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 121.151 -0.219 . . . . 0.0 110.683 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.3 mmt -63.14 -26.44 68.82 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.592 0.633 . . . . 0.0 110.513 172.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -85.42 -16.92 38.16 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.816 -0.552 . . . . 0.0 111.677 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.63 -18.27 22.37 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.239 -0.41 . . . . 0.0 111.574 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -114.03 -14.49 12.4 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -137.62 -29.96 0.85 Allowed 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.651 0.659 . . . . 0.0 112.211 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.86 -176.47 25.25 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 71.42 7.54 64.35 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.372 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . 0.435 HG23 ' CE2' ' A' ' 222' ' ' PHE . 22.0 t -77.2 151.24 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 CA-C-N 118.127 0.963 . . . . 0.0 110.108 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . 0.532 ' HG ' ' HB3' ' A' ' 164' ' ' ASP . 44.3 t -133.12 -42.86 0.88 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 119.619 -0.229 . . . . 0.0 110.949 175.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -136.66 150.59 48.58 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -173.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.06 163.36 39.99 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.255 0.55 . . . . 0.0 111.988 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -178.34 169.46 41.16 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.1 mm -94.0 93.76 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 38.0 t70 41.61 -84.43 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -169.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.527 ' H ' ' HA ' ' A' ' 214' ' ' PRO . 16.2 m 52.79 50.46 18.03 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.444 0.64 . . . . 0.0 111.016 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.24 140.6 88.0 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.739 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -81.33 -16.18 9.68 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 124.263 3.309 . . . . 0.0 113.575 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -100.21 -36.66 9.22 Favored 'General case' 0 C--N 1.338 0.069 0 CA-C-N 118.613 0.642 . . . . 0.0 110.979 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.94 -3.89 53.72 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt 56.17 115.2 0.01 OUTLIER 'General case' 0 C--N 1.34 0.155 0 C-N-CA 126.798 2.039 . . . . 0.0 113.492 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.424 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 70.7 m-85 65.34 170.05 0.1 Allowed Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.338 1.055 . . . . 0.0 111.566 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.527 ' HA ' ' H ' ' A' ' 207' ' ' THR . 50.8 Cg_exo -56.62 163.07 7.46 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.701 2.934 . . . . 0.0 115.486 -170.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.536 ' HA ' ' C4 ' ' B' ' 4' ' ' ' U' . 36.9 mtmm -123.63 35.09 4.92 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.556 176.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 64.35 26.06 70.36 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -145.12 164.94 29.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.527 0.731 . . . . 0.0 110.169 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -116.32 164.65 12.27 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -146.83 149.97 34.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 93.5 t -141.23 144.16 26.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -125.33 143.49 50.94 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.213 0.53 . . . . 0.0 110.336 -178.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.435 ' CE2' HG23 ' A' ' 200' ' ' VAL . 55.4 m-85 -117.47 152.78 34.33 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.639 -175.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 71.1 p -84.36 2.24 41.39 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.77 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -137.42 139.13 40.49 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.325 0.65 . . . . 0.0 110.316 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 11.8 tm0? -73.98 -22.01 59.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -71.37 -38.95 71.51 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.5 m -73.25 -29.49 62.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -66.0 -48.93 69.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.635 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.4 pp -72.93 -10.7 14.22 Favored 'Isoleucine or valine' 0 C--N 1.338 0.084 0 CA-C-N 118.515 0.598 . . . . 0.0 111.139 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.42 -23.94 27.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 117.602 0.183 . . . . 0.0 110.52 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -85.01 -23.92 28.44 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 10.4 pt -102.98 26.27 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 123.092 0.557 . . . . 0.0 110.474 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.2 t -90.9 2.52 56.12 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.537 0.735 . . . . 0.0 111.564 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -139.83 -156.68 0.7 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -128.65 -35.76 1.89 Allowed 'General case' 0 C--O 1.227 -0.106 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -127.88 104.54 7.87 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.9 m -64.32 149.76 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.763 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 17.8 mm-40 -91.36 138.2 31.76 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.428 ' HA ' HG23 ' A' ' 192' ' ' ILE . 3.2 mm? -127.52 22.64 6.42 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -87.85 133.97 33.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.244 0.618 . . . . 0.0 111.69 -172.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -147.09 22.9 1.2 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.885 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.7 135.82 4.89 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 54.13 7.54 0.13 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.05 1.34 . . . . 0.0 113.82 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.4 mt -144.54 142.63 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 C-N-CA 123.486 0.715 . . . . 0.0 109.292 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -150.99 138.07 19.18 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -144.37 161.42 39.02 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -155.55 158.28 38.18 Favored 'General case' 0 N--CA 1.46 0.054 0 CA-C-N 118.117 0.417 . . . . 0.0 110.221 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 12.7 p -158.66 152.21 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -86.13 126.72 34.42 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.439 ' C ' ' HE2' ' A' ' 251' ' ' LYS . 4.3 m -97.46 155.01 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.439 ' HE2' ' C ' ' A' ' 250' ' ' VAL . 0.0 OUTLIER -155.48 157.47 31.62 Favored Pre-proline 0 C--O 1.231 0.103 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.591 170.151 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.01 138.23 84.9 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.816 2.344 . . . . 0.0 109.336 173.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -92.11 170.02 10.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.447 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.8 p -150.53 153.81 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.273 0.629 . . . . 0.0 110.128 -169.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 4.6 tt . . . . . 0 C--O 1.25 1.122 0 CA-C-O 117.733 -1.127 . . . . 0.0 108.923 178.937 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.573 1 O4'-C1'-N19 114.456 6.256 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.86 0 C3'-C2'-C1' 105.065 3.961 . 0.141 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.408 " H4'" ' CD1' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.417 -3.01 1 O4'-C1'-N19 112.622 4.422 . 0.195 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.536 ' C4 ' ' HA ' ' A' ' 215' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.769 0 C5'-C4'-C3' 111.071 -2.952 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.254 0 C5'-C4'-C3' 111.283 -2.811 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.7 m . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 120.594 0.235 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -148.58 154.02 39.17 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.916 0.487 . . . . 0.0 110.436 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -143.16 154.38 43.83 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.621 0.768 . . . . 0.0 109.597 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -96.94 -7.57 32.87 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.407 0.283 . . . . 0.0 111.625 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.99 151.29 31.63 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -155.41 -27.0 0.11 Allowed 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.66 -0.318 . . . . 0.0 111.362 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -139.8 19.74 2.49 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.788 0.435 . . . . 0.0 111.826 -173.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.7 9.95 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.43 -1.73 2.82 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.996 0.518 . . . . 0.0 111.878 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.82 67.67 5.67 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.647 0.779 . . . . 0.0 111.298 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -97.05 161.26 13.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.3 t -92.25 27.86 2.08 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.129 0.972 . . . . 0.0 113.471 -169.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 54.34 23.52 4.45 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.373 0.533 . . . . 0.0 111.052 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -146.0 138.16 25.28 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.479 0.712 . . . . 0.0 109.945 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.7 m -138.91 152.36 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.921 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.443 ' CZ ' ' HA3' ' A' ' 70' ' ' GLY . 19.1 t80 -84.03 148.41 26.87 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.69 73.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 122.251 1.025 . . . . 0.0 109.028 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.443 ' HA3' ' CZ ' ' A' ' 68' ' ' PHE . . . -78.19 144.63 28.64 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.47 23.44 60.55 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-O 119.203 -0.776 . . . . 0.0 113.569 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 pp -62.04 148.92 87.59 Favored Pre-proline 0 CA--C 1.531 0.22 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 172.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.426 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 66.1 Cg_endo -66.15 143.82 72.92 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 121.585 1.524 . . . . 0.0 110.499 -169.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 31.2 Cg_exo -61.83 174.37 2.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.106 2.538 . . . . 0.0 113.669 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.8 t70 63.36 5.71 2.15 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.5 pp -134.01 171.41 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 171.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -143.31 -25.58 0.59 Allowed 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -154.25 -35.15 0.1 Allowed 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 119.199 0.908 . . . . 0.0 112.547 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -67.7 -45.7 74.39 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.716 0.689 . . . . 0.0 111.529 -175.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -72.34 -35.56 68.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.879 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.4 pt -83.89 -36.65 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 O-C-N 122.163 -0.336 . . . . 0.0 111.869 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 95.9 m -71.99 -15.41 62.06 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.44 0.564 . . . . 0.0 109.565 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.73 -21.29 20.05 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 172.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -84.2 -19.19 34.44 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.415 ' HB2' ' CD1' ' A' ' 91' ' ' LEU . 34.6 m-85 -113.02 5.84 17.39 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.338 0.517 . . . . 0.0 111.208 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -65.25 -21.75 66.78 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 123.811 0.845 . . . . 0.0 111.972 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -72.17 -3.37 22.97 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -113.06 15.48 19.55 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.467 0.307 . . . . 0.0 111.648 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.27 177.6 20.37 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.31 150.44 70.96 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.557 2.838 . . . . 0.0 110.675 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.415 ' CD1' ' HB2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -163.15 163.29 25.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.178 -169.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pt -142.71 168.11 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.017 172.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.9 p -128.34 157.0 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -148.05 155.88 42.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.002 0.429 . . . . 0.0 110.87 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -157.11 154.4 26.04 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 169.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.624 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 31.1 Cg_endo -75.61 -10.28 20.18 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.075 3.183 . . . . 0.0 110.77 -169.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.624 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 69.5 m-70 -102.37 9.92 39.44 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.872 0.869 . . . . 0.0 111.022 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.426 ' HA ' ' HE3' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -61.35 143.44 55.74 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.809 0.844 . . . . 0.0 109.914 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -146.21 172.55 13.29 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.381 0.673 . . . . 0.0 110.118 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -80.38 0.98 30.86 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.679 0.392 . . . . 0.0 111.664 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 82.0 p -81.16 165.88 21.15 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.991 0.516 . . . . 0.0 111.234 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -95.61 41.91 1.1 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.37 0.668 . . . . 0.0 110.592 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.7 p -75.56 169.93 17.13 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.071 0.548 . . . . 0.0 111.287 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -137.95 170.55 15.86 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.335 0.654 . . . . 0.0 110.373 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 14.2 t80 52.6 94.21 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 125.533 1.533 . . . . 0.0 113.6 177.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -71.85 164.65 34.99 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.425 2.75 . . . . 0.0 109.105 175.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -43.41 107.02 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 124.272 3.315 . . . . 0.0 113.196 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.3 tptt 47.14 21.23 0.16 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.15 1.78 . . . . 0.0 113.632 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.01 33.98 39.32 Favored Glycine 0 CA--C 1.527 0.817 0 O-C-N 121.187 -0.946 . . . . 0.0 113.099 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.577 ' CE1' " H4'" ' B' ' 2' ' ' ' U' . 1.1 m-30 -104.05 130.13 51.72 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.702 1.251 . . . . 0.0 108.543 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.98 -176.46 5.77 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.217 0.462 . . . . 0.0 110.657 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -141.62 144.35 34.14 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.773 0.429 . . . . 0.0 110.322 -176.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -102.08 146.89 27.28 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.378 0.609 . . . . 0.0 111.769 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.4 mp -114.27 137.72 51.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -131.1 175.2 9.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.381 0.672 . . . . 0.0 110.004 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -115.6 -32.56 5.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.454 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -114.66 149.21 37.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.066 0.46 . . . . 0.0 111.327 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -77.97 -17.6 56.97 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.02 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.8 t -83.43 -16.39 45.99 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.264 -0.272 . . . . 0.0 111.476 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 67.5 m -74.93 -43.45 54.08 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.911 -0.493 . . . . 0.0 111.492 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 m -71.04 -22.99 23.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -80.29 -35.65 35.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.88 -33.02 65.79 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 119.442 -0.314 . . . . 0.0 111.382 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -80.26 -23.37 40.84 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.462 0.574 . . . . 0.0 110.955 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 54.5 mt -89.56 -20.91 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -100.98 -13.84 18.11 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.568 0.622 . . . . 0.0 112.619 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -108.62 11.07 26.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.06 0.391 . . . . 0.0 111.97 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 72.4 m -129.74 -166.41 1.66 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.852 0.461 . . . . 0.0 111.259 -176.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.8 mp -80.71 152.15 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 123.806 0.842 . . . . 0.0 109.353 -171.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -144.35 158.74 43.58 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.658 176.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.442 ' HG3' ' H ' ' A' ' 134' ' ' LYS . 1.9 pt-20 -145.62 174.79 10.88 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 175.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -59.8 -5.25 0.88 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -170.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -153.42 0.34 0.21 Allowed Glycine 0 CA--C 1.528 0.878 0 CA-C-N 119.164 0.893 . . . . 0.0 114.02 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.442 ' H ' ' HG3' ' A' ' 131' ' ' GLU . 3.4 mppt? -151.6 167.01 29.44 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 118.441 1.12 . . . . 0.0 110.618 -176.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -115.8 156.46 26.0 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -144.76 156.09 43.88 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.6 mp -135.55 164.02 28.78 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 169.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.2 m -108.13 141.09 40.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.76 150.4 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 C-N-CA 122.953 0.501 . . . . 0.0 110.344 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.9 m -66.63 161.76 22.57 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 122.902 0.481 . . . . 0.0 110.192 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.3 t -151.39 148.5 22.41 Favored Pre-proline 0 N--CA 1.455 -0.177 0 O-C-N 121.894 -0.504 . . . . 0.0 111.711 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -80.05 -7.76 14.23 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.768 2.979 . . . . 0.0 111.231 169.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 45.7 m -102.09 -32.69 10.01 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.872 0.869 . . . . 0.0 110.792 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 3.7 mm -140.09 170.81 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 124.191 0.996 . . . . 0.0 108.936 -175.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -70.16 -23.76 63.04 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -159.61 149.16 18.3 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.859 0.864 . . . . 0.0 109.912 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.535 ' HZ1' ' HB2' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -125.12 106.72 28.21 Favored Pre-proline 0 C--N 1.337 0.051 0 C-N-CA 123.269 0.627 . . . . 0.0 109.59 178.354 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.84 96.82 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.226 2.618 . . . . 0.0 109.193 169.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.8 p -84.98 137.96 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.24 146.77 24.78 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.22 0.608 . . . . 0.0 110.977 -173.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 37.4 mm -130.85 146.18 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 123.158 0.583 . . . . 0.0 111.218 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -148.37 109.76 3.66 Favored Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.85 165.11 26.97 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.51 2.806 . . . . 0.0 111.377 177.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -105.89 126.27 51.98 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 174.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -96.52 132.62 41.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.472 ' H ' HD12 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -92.6 118.13 30.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.767 0.794 . . . . 0.0 110.899 -178.222 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 34.5 t -172.62 -31.83 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.146 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -122.3 21.87 10.23 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.092 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 23.7 m -64.56 -27.77 69.18 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -160.4 160.95 32.88 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.569 0.348 . . . . 0.0 111.387 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.436 ' CD2' ' HA ' ' A' ' 187' ' ' VAL . 12.9 t80 -155.87 161.59 40.56 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.8 0.333 . . . . 0.0 110.711 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.9 m -136.95 148.76 26.36 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 C-N-CA 124.493 1.117 . . . . 0.0 109.878 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 29.3 mtm -139.49 12.31 2.54 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -137.88 24.07 2.84 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.041 0.837 . . . . 0.0 112.383 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 89.07 24.45 31.96 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 119.639 -0.534 . . . . 0.0 111.938 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 98.0 p 48.4 45.26 20.64 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -61.94 156.9 54.51 Favored Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -65.9 151.02 85.23 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.718 2.279 . . . . 0.0 110.688 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -108.66 172.49 6.81 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 121.259 0.552 . . . . 0.0 110.625 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -149.61 139.79 13.57 Favored Pre-proline 0 N--CA 1.452 -0.325 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.967 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.34 -12.19 31.79 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.213 2.608 . . . . 0.0 113.42 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -89.9 0.26 57.17 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.811 0.732 . . . . 0.0 110.383 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -127.01 25.11 6.3 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 122.959 0.504 . . . . 0.0 110.918 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 23.8 m -127.74 140.25 52.18 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.969 0.414 . . . . 0.0 111.486 -175.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.6 tt -113.24 150.23 15.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 C-N-CA 123.539 0.736 . . . . 0.0 109.726 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.445 ' CD1' ' CE1' ' A' ' 253' ' ' TYR . 10.9 t80 -109.55 147.82 32.31 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 48.1 t -137.13 138.72 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.317 0.647 . . . . 0.0 109.294 -175.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -141.89 146.84 18.17 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 112.065 -0.414 . . . . 0.0 112.065 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.42 15.23 48.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -172.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.6 m -70.04 146.7 95.28 Favored Pre-proline 0 C--O 1.231 0.108 0 CA-C-N 117.188 0.494 . . . . 0.0 111.298 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -79.64 160.0 25.09 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.579 2.853 . . . . 0.0 108.293 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.83 -43.81 6.6 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.903 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.29 20.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.118 3.212 . . . . 0.0 115.087 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.84 -27.63 69.01 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.511 1.05 . . . . 0.0 112.445 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 56.92 106.74 0.01 OUTLIER 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.602 1.561 . . . . 0.0 112.612 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.32 -23.2 47.18 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.436 ' HA ' ' CD2' ' A' ' 161' ' ' PHE . 41.8 t -68.27 -55.16 17.36 Favored 'Isoleucine or valine' 0 C--N 1.337 0.064 0 CA-C-N 118.691 0.678 . . . . 0.0 110.819 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.13 -20.09 38.71 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.363 -0.211 . . . . 0.0 110.977 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.06 -33.82 63.82 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.34 -35.29 63.6 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.789 -0.569 . . . . 0.0 110.538 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.4 mmt -69.1 -33.31 73.3 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 57.7 mt -75.31 -41.83 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -63.97 -20.71 66.08 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.07 0.395 . . . . 0.0 110.899 173.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -86.1 -20.46 28.68 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.586 0.63 . . . . 0.0 111.287 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -89.3 -16.45 31.1 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -115.75 -22.39 9.16 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.172 0.442 . . . . 0.0 110.909 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -137.78 43.79 2.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.201 0.6 . . . . 0.0 109.801 -176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -46.14 138.66 7.18 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 123.654 0.645 . . . . 0.0 112.549 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 120.46 12.03 6.38 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -175.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 9.1 p -77.69 161.09 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.952 0.901 . . . . 0.0 110.598 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 47.9 t -135.98 -27.16 1.13 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -153.22 140.88 19.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 117.83 0.286 . . . . 0.0 110.896 -173.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.37 157.5 43.12 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.569 0.347 . . . . 0.0 110.716 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 161.76 -161.33 33.18 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 44.9 mm -102.4 138.39 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -59.58 138.28 57.76 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.532 0.206 . . . . 0.0 110.577 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 26.5 p -141.73 160.01 41.05 Favored 'General case' 0 N--CA 1.458 -0.052 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.179 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -111.74 130.19 23.42 Favored Pre-proline 0 N--CA 1.455 -0.197 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -80.25 -17.07 10.59 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.385 3.39 . . . . 0.0 113.813 -174.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -88.61 -31.75 18.43 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.549 0.613 . . . . 0.0 110.95 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.53 -2.78 15.37 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.114 0.566 . . . . 0.0 110.478 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 62.6 mttp 48.12 61.89 2.77 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.043 1.337 . . . . 0.0 112.734 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -147.32 151.61 40.74 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 122.292 0.237 . . . . 0.0 111.105 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -82.54 155.92 16.22 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.347 2.698 . . . . 0.0 112.577 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -93.42 1.38 56.89 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.147 0.979 . . . . 0.0 109.492 173.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 65.86 7.74 37.62 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.19 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -117.86 146.16 44.09 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 117.462 0.631 . . . . 0.0 109.738 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -84.76 151.04 25.9 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 121.319 0.4 . . . . 0.0 112.547 -173.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.82 142.91 24.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 171.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.8 t -134.75 144.48 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -133.03 149.02 52.22 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.026 0.441 . . . . 0.0 110.056 -178.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -126.13 153.66 44.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.481 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 63.2 p -84.15 4.51 30.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.732 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -134.98 136.68 42.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.391 0.677 . . . . 0.0 109.796 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -73.86 -20.28 60.47 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -70.99 -35.82 72.25 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 17.3 m -75.19 -29.96 60.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -66.93 -50.03 63.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.793 -0.146 . . . . 0.0 110.927 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.9 pt -70.09 -17.99 21.38 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 CA-C-N 118.061 0.392 . . . . 0.0 110.741 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.01 -24.55 37.86 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 117.582 0.174 . . . . 0.0 110.851 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.72 -31.06 32.25 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.981 0.355 . . . . 0.0 111.666 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.4 pt -95.78 23.54 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 122.712 0.405 . . . . 0.0 110.324 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.3 t -84.3 -13.81 51.44 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.004 0.522 . . . . 0.0 111.518 -176.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -149.62 135.81 18.97 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -53.54 -37.36 62.78 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.966 0.506 . . . . 0.0 112.019 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -113.84 105.06 12.82 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.905 0.383 . . . . 0.0 110.56 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.4 m -65.44 154.53 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.959 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -95.23 130.55 41.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -124.04 17.98 9.24 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.991 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -89.86 118.77 29.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -170.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -149.36 141.04 23.51 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 173.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.16 -131.61 50.11 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -98.98 7.5 45.94 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.942 0.497 . . . . 0.0 111.462 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.9 mp -88.1 149.41 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 122.841 0.456 . . . . 0.0 109.952 -177.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -150.82 127.89 11.15 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -145.6 157.41 43.98 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.405 1.082 . . . . 0.0 108.652 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -153.36 152.02 30.61 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.9 p -159.93 158.49 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -85.86 145.61 27.11 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.363 0.665 . . . . 0.0 111.183 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.56 161.63 27.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.1 159.25 26.89 Favored Pre-proline 0 N--CA 1.455 -0.198 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.087 169.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.49 133.78 59.1 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.3 2.0 . . . . 0.0 108.731 173.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . 0.445 ' CE1' ' CD1' ' A' ' 176' ' ' PHE . 1.1 t80 -73.99 159.9 32.08 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.389 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 34.0 m -107.24 165.05 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 123.918 0.887 . . . . 0.0 111.331 -170.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 3.9 tt . . . . . 0 C--O 1.251 1.152 0 CA-C-O 117.167 -1.397 . . . . 0.0 109.235 -178.314 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.795 1 O4'-C1'-N19 114.423 6.223 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . 0.577 " H4'" ' CE1' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.414 -3.229 1 C3'-C2'-C1' 105.714 4.683 OUTLIER-DELTA 0.193 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.404 " O4'" ' CZ ' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.414 -3.264 2 O4'-C1'-N19 113.932 5.732 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.542 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.419 -2.847 0 O4'-C4'-C3' 109.07 2.55 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.466 ' C8 ' H5'' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.414 -3.259 0 P-O3'-C3' 123.437 3.114 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 120.164 0.031 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -133.48 5.92 3.76 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.038 0.535 . . . . 0.0 111.801 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -99.2 2.66 45.96 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.186 0.594 . . . . 0.0 110.698 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -139.39 174.91 10.03 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.725 0.81 . . . . 0.0 110.56 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.8 10.13 85.49 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -140.27 153.09 46.39 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.466 0.706 . . . . 0.0 109.782 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -72.78 136.85 45.53 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.695 0.398 . . . . 0.0 110.402 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.06 172.28 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 123.889 0.876 . . . . 0.0 109.934 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -129.82 168.75 16.1 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.185 0.594 . . . . 0.0 109.887 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -124.96 161.35 26.87 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.876 0.47 . . . . 0.0 109.861 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -117.69 159.16 23.42 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.429 ' C ' ' H ' ' A' ' 66' ' ' LYS . 22.7 t -98.18 174.43 6.53 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.506 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -77.5 30.0 0.15 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.159 0.584 . . . . 0.0 110.992 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.429 ' H ' ' C ' ' A' ' 64' ' ' SER . 1.3 tmtp? -143.3 144.03 31.94 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.195 0.598 . . . . 0.0 110.701 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.0 m -141.66 155.0 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.801 176.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.409 ' CZ ' ' CA ' ' A' ' 70' ' ' GLY . 2.4 t80 -94.97 129.54 41.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 169.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 p -108.7 93.07 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 122.203 1.001 . . . . 0.0 108.455 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.409 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -86.49 155.81 28.58 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.005 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.76 26.86 73.71 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-O 119.045 -0.864 . . . . 0.0 113.912 171.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 pp -75.23 144.95 79.45 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 118.981 1.391 . . . . 0.0 108.208 173.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.22 120.07 7.47 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.822 2.348 . . . . 0.0 110.343 -172.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -54.84 -11.38 3.47 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.666 3.577 . . . . 0.0 115.238 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -82.89 -7.65 59.64 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.416 0.553 . . . . 0.0 112.307 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 pp -142.98 168.81 12.99 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -165.12 179.7 6.19 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 45.27 -99.42 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.144 1.777 . . . . 0.0 114.339 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -58.1 -28.32 64.52 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -80.38 -24.28 39.86 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.204 0.456 . . . . 0.0 110.29 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.1 mt -76.29 -46.05 33.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.1 m -63.25 -21.13 66.04 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.752 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.16 -18.37 24.58 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.1 m -79.15 -27.05 42.72 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.765 0.711 . . . . 0.0 112.139 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -114.99 11.87 16.6 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -64.85 -20.34 66.36 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.828 0.451 . . . . 0.0 112.189 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -75.24 -0.26 18.9 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -115.59 -4.48 12.24 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 141.86 177.34 16.89 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.24 146.05 50.27 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.475 2.784 . . . . 0.0 110.246 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.415 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -162.37 161.41 27.4 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.965 -169.744 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.9 mm -138.35 160.53 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.63 144.2 34.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -150.46 167.23 27.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.303 0.573 . . . . 0.0 110.826 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -157.77 162.74 26.6 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 175.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.541 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 39.2 Cg_endo -75.28 -15.64 20.03 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.304 2.002 . . . . 0.0 110.527 -169.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.541 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 20.8 m-70 -89.54 -0.49 57.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.829 0.851 . . . . 0.0 111.18 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.15 110.29 4.47 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.813 0.845 . . . . 0.0 109.108 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -156.51 161.24 40.03 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.557 0.343 . . . . 0.0 111.049 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 58.88 -5.78 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.842 1.657 . . . . 0.0 114.262 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.0 t 54.8 27.31 8.72 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.816 0.847 . . . . 0.0 112.684 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -129.38 17.11 5.99 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.367 0.667 . . . . 0.0 111.696 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.5 t -135.27 146.15 48.26 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.075 0.55 . . . . 0.0 109.611 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -142.72 -1.06 1.15 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -174.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.514 ' N ' ' CD ' ' A' ' 106' ' ' PRO . 83.6 m-85 -136.54 29.05 0.13 Allowed Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 105' ' ' PHE . 46.8 Cg_endo -66.33 -29.91 45.57 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 CA-C-N 120.839 1.335 . . . . 0.0 114.457 177.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -81.19 168.41 16.92 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 CA-C-N 122.321 1.865 . . . . 0.0 110.29 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -79.42 -50.22 11.14 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.73 36.77 0.11 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 -175.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.465 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.0 OUTLIER -146.39 150.55 35.89 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.338 0.569 . . . . 0.0 109.494 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.93 -175.03 5.23 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.762 0.425 . . . . 0.0 110.344 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -137.93 142.45 40.56 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.8 151.38 25.8 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -113.82 146.45 39.94 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 169.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -134.69 168.11 19.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.873 0.469 . . . . 0.0 110.578 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -103.83 -25.31 13.13 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.572 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -122.38 152.54 40.09 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -84.36 -15.01 47.93 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.759 176.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.3 t -90.52 -14.95 31.63 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.707 0.403 . . . . 0.0 110.635 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.4 m -75.49 -39.34 58.68 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 122.037 -0.414 . . . . 0.0 110.078 177.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.2 -22.15 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -77.87 -29.9 50.59 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.71 -35.29 45.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.656 0.207 . . . . 0.0 111.148 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 pp -80.11 -16.31 55.25 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.252 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 79.5 mt -96.39 -17.4 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 122.282 0.233 . . . . 0.0 111.084 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -100.43 -10.95 20.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.464 0.574 . . . . 0.0 112.478 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -119.74 44.87 2.28 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.074 0.55 . . . . 0.0 110.825 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 31.4 p -141.48 179.92 6.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.741 0.416 . . . . 0.0 111.904 -175.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.7 mp -82.71 157.5 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -123.67 157.3 34.15 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.948 0.404 . . . . 0.0 111.199 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.98 -179.07 6.37 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -41.29 -23.44 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -161.04 4.82 0.09 OUTLIER Glycine 0 CA--C 1.529 0.946 0 CA-C-N 119.491 1.041 . . . . 0.0 113.47 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -146.28 -170.53 3.52 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.598 1.199 . . . . 0.0 111.096 -173.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -115.99 165.29 13.29 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.074 0.55 . . . . 0.0 111.815 -174.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -143.88 147.49 34.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.267 0.627 . . . . 0.0 109.404 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.6 mp -128.38 159.94 33.77 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 170.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.4 p -91.4 149.84 21.53 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 122.082 -0.386 . . . . 0.0 110.907 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.4 m -144.43 174.11 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 123.391 0.676 . . . . 0.0 109.944 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.4 p -67.71 -14.13 62.69 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.687 0.395 . . . . 0.0 111.669 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.403 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 39.0 t 47.24 57.38 17.62 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.313 1.045 . . . . 0.0 113.561 174.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.403 ' HD3' ' N ' ' A' ' 141' ' ' SER . 31.5 Cg_exo -61.9 -9.41 14.18 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.922 2.414 . . . . 0.0 113.945 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 55.3 m -82.37 -27.98 31.8 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.5 0.591 . . . . 0.0 109.6 178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.45 ' CD1' ' C5 ' ' B' ' 1' ' ' ' C' . 4.4 mt -150.31 -122.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -170.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -147.47 122.21 9.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.803 0.441 . . . . 0.0 110.311 174.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.6 t70 47.18 32.78 2.18 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 172.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.0 pttp -82.94 148.56 57.31 Favored Pre-proline 0 C--N 1.34 0.186 0 CA-C-N 119.786 1.176 . . . . 0.0 110.017 176.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -83.5 168.27 12.98 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.667 2.911 . . . . 0.0 112.245 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.9 m -128.3 146.78 33.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.486 HE21 ' C ' ' A' ' 150' ' ' GLN . 0.0 OUTLIER -93.02 149.52 21.16 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.601 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 45.0 mm -122.49 144.65 31.13 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 C-N-CA 124.246 1.018 . . . . 0.0 109.646 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.83 100.25 3.09 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.39 162.27 40.62 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.777 2.984 . . . . 0.0 111.799 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -89.82 149.54 22.63 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.935 -0.12 . . . . 0.0 110.799 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -109.04 115.23 29.66 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.683 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -83.85 12.09 6.61 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -169.634 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.2 t -96.2 -1.79 47.56 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -173.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -144.5 20.33 1.69 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.0 m -64.82 -21.06 66.71 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -175.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -153.74 156.29 37.5 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 118.014 0.37 . . . . 0.0 110.854 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -158.17 150.56 22.15 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.37 151.82 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 O-C-N 121.944 -0.473 . . . . 0.0 110.174 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 64.2 mtm -127.84 24.7 6.05 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 122.366 0.266 . . . . 0.0 111.409 -175.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -158.94 -49.91 0.06 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 64.95 11.64 51.67 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.98 -0.9 . . . . 0.0 113.939 172.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 26.3 t -138.75 -27.63 0.83 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.776 1.288 . . . . 0.0 114.332 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -77.08 147.34 76.68 Favored Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 119.115 0.871 . . . . 0.0 111.03 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.43 157.42 40.96 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.909 3.073 . . . . 0.0 110.969 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 10.6 mp -118.48 161.93 19.19 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.688 0.795 . . . . 0.0 109.85 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -137.5 152.89 73.87 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.68 -0.19 9.03 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.603 2.869 . . . . 0.0 111.432 -176.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -114.99 7.97 15.69 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 124.206 1.002 . . . . 0.0 111.494 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -123.33 19.72 9.74 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.825 0.45 . . . . 0.0 111.39 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.0 m -115.6 139.53 50.02 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.759 0.314 . . . . 0.0 111.079 -175.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.5 tt -118.32 149.57 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 C-N-CA 123.178 0.591 . . . . 0.0 109.934 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -109.97 147.28 33.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.2 t -134.9 132.25 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -177.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -152.39 167.16 31.33 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 87.1 11.82 69.13 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -170.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.8 m -65.93 156.21 84.49 Favored Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 122.919 0.488 . . . . 0.0 111.272 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -72.76 -171.98 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.941 3.094 . . . . 0.0 109.857 174.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -54.26 -50.92 82.07 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.874 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.42 139.32 23.12 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.143 1.895 . . . . 0.0 110.221 173.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.0 12.66 0.5 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 -42.14 140.07 1.21 Allowed 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.125 0.97 . . . . 0.0 112.209 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.47 -17.77 62.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.746 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.75 -50.45 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-O 120.699 0.285 . . . . 0.0 110.294 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -83.77 -25.93 30.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.562 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 26.0 tp -69.81 -32.97 71.71 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.68 -32.2 36.07 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 122.335 -0.228 . . . . 0.0 111.268 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.3 mmt -68.66 -31.58 70.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.6 mt -79.01 -33.26 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 O-C-N 122.231 -0.293 . . . . 0.0 110.49 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.7 mmt -73.36 -19.42 61.01 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.534 0.606 . . . . 0.0 109.984 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -83.62 -24.93 31.22 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.371 0.268 . . . . 0.0 111.224 175.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -87.76 -16.93 32.82 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -117.19 -17.01 10.34 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -134.68 23.06 3.64 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -173.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 73.87 -144.41 33.71 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 175.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -72.44 123.51 9.21 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 112.145 -0.382 . . . . 0.0 112.145 -173.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 90.8 t -111.57 137.74 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 124.745 1.218 . . . . 0.0 108.027 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.9 p -92.76 -41.44 10.13 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 118.364 0.529 . . . . 0.0 111.902 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -156.61 155.64 32.17 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.144 0.429 . . . . 0.0 111.676 -171.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -149.7 159.6 44.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.33 0.586 . . . . 0.0 111.006 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -174.67 170.48 43.6 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.7 mp -82.42 148.92 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -57.99 119.03 6.04 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 22.6 p -138.35 158.64 43.88 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -117.07 131.96 23.71 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.61 -16.1 15.07 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 124.503 3.469 . . . . 0.0 114.47 -172.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -110.97 -25.14 9.97 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.334 0.97 . . . . 0.0 111.381 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -86.86 -10.2 53.98 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 169.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 49.89 45.81 24.71 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.647 1.179 . . . . 0.0 111.839 175.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.32 156.22 39.66 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -80.69 157.25 21.47 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.527 2.818 . . . . 0.0 111.2 174.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.41 ' HA ' ' N3 ' ' B' ' 4' ' ' ' U' . 35.2 mtmm -119.11 21.55 12.27 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.595 0.758 . . . . 0.0 111.04 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.23 -178.15 31.08 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 55.34 -173.98 0.05 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.334 0.567 . . . . 0.0 111.869 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -140.92 168.79 25.18 Favored Glycine 0 CA--C 1.524 0.632 0 O-C-N 121.608 -0.682 . . . . 0.0 112.979 -177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -146.58 149.8 34.26 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 97.1 t -136.68 151.09 27.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -124.38 145.72 49.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.916 0.486 . . . . 0.0 111.355 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -122.38 151.23 41.41 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.697 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 62.9 p -91.96 -0.64 57.49 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 116.78 -0.191 . . . . 0.0 111.242 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -132.5 144.83 50.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.901 0.48 . . . . 0.0 110.243 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -80.12 -9.36 59.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.244 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -85.09 -42.18 15.04 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 34.8 p -74.63 -24.6 58.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -68.45 -48.81 63.56 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 119.639 -0.22 . . . . 0.0 110.993 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.6 pp -71.95 -12.46 15.91 Favored 'Isoleucine or valine' 0 C--N 1.338 0.066 0 CA-C-N 118.372 0.533 . . . . 0.0 110.991 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.96 -27.83 30.22 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 173.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.59 -27.23 34.37 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.7 pt -106.92 29.58 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.039 0.536 . . . . 0.0 110.372 174.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.8 t -78.35 -14.57 59.34 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.29 0.636 . . . . 0.0 111.813 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -155.79 144.08 20.05 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -60.2 -33.12 71.8 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.409 -0.329 . . . . 0.0 111.584 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -119.67 116.26 25.62 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.738 0.304 . . . . 0.0 110.42 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -108.62 159.4 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.333 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -86.6 143.82 27.47 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.949 0.404 . . . . 0.0 111.155 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.85 103.97 6.09 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 173.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -135.44 153.31 51.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.226 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -138.73 11.88 2.7 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.123 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 175.17 -134.45 2.74 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -76.54 12.49 1.25 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.096 0.558 . . . . 0.0 111.381 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.1 mt -66.91 157.97 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.41 1.084 . . . . 0.0 110.112 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -145.82 21.02 1.46 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -67.87 160.48 28.35 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.054 0.542 . . . . 0.0 111.986 -173.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.16 161.99 35.4 Favored 'General case' 0 C--N 1.337 0.065 0 C-N-CA 124.353 1.061 . . . . 0.0 110.229 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.4 p -153.8 156.61 5.17 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -89.32 138.47 31.41 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 117.671 0.214 . . . . 0.0 110.624 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.97 158.46 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-O 120.828 0.347 . . . . 0.0 111.233 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.433 ' HG3' ' H61' ' B' ' 5' ' ' ' A' . 0.0 OUTLIER -161.02 159.25 24.78 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 171.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.81 140.21 92.1 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.629 2.219 . . . . 0.0 109.78 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -78.41 168.24 20.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.244 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.4 p -149.7 153.27 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.067 0.547 . . . . 0.0 110.319 -170.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.0 pt? . . . . . 0 C--O 1.251 1.14 0 CA-C-O 116.995 -1.478 . . . . 0.0 111.203 -179.916 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.45 ' C5 ' ' CD1' ' A' ' 144' ' ' ILE . . . . . . . . 0 O4'--C4' 1.425 -2.324 5 O4'-C1'-N19 115.888 7.688 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . 0.446 ' C6 ' ' P ' ' B' ' 2' ' ' ' U' . . . . . . . . 0 P--O5' 1.622 2.877 0 O4'-C1'-N19 111.896 3.696 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.465 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.425 -2.336 2 O4'-C1'-N19 113.477 5.277 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.467 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.419 -2.792 0 O5'-C5'-C4' 106.319 -2.772 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.452 " H4'" ' HB2' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.414 -3.233 1 C5'-C4'-C3' 108.399 -4.734 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 120.45 0.167 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -146.34 169.04 19.65 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.216 0.606 . . . . 0.0 110.437 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.404 ' H ' ' CD ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -94.67 10.78 33.58 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.261 0.624 . . . . 0.0 112.567 -175.909 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -105.45 9.63 33.54 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.883 0.473 . . . . 0.0 111.278 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.55 172.04 46.07 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 123.049 0.357 . . . . 0.0 112.36 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -147.56 159.76 43.39 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.487 0.715 . . . . 0.0 109.352 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -65.71 -23.76 66.83 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.873 0.469 . . . . 0.0 111.485 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.4 m -143.74 157.56 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.048 0 C-N-CA 123.865 0.866 . . . . 0.0 109.569 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.417 ' HB3' ' CE2' ' A' ' 63' ' ' TYR . 14.4 mp0 -91.2 6.96 43.05 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.292 0.237 . . . . 0.0 111.428 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.89 37.6 3.74 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.236 1.414 . . . . 0.0 114.479 175.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 61' ' ' GLU . 29.7 m-85 -75.33 170.83 15.32 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.153 0.501 . . . . 0.0 112.304 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.4 t -100.38 27.45 5.72 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -168.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.52 ' HA ' ' CE2' ' A' ' 115' ' ' PHE . 0.0 OUTLIER 55.33 17.41 2.1 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.122 0.419 . . . . 0.0 111.155 -176.414 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -147.82 140.24 24.47 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.247 0.619 . . . . 0.0 111.632 -177.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.5 m -136.06 148.52 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.704 169.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.422 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 4.3 t80 -85.22 140.45 30.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 174.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.9 p -122.98 98.55 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 121.779 0.8 . . . . 0.0 108.906 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.36 169.49 51.34 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.41 26.76 71.92 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 119.226 -0.763 . . . . 0.0 113.901 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.44 ' HB3' ' H ' ' A' ' 110' ' ' TYR . 18.5 tp -63.0 122.18 73.46 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 119.626 1.713 . . . . 0.0 107.352 173.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.65 170.07 20.86 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.164 2.576 . . . . 0.0 111.537 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.46 179.06 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 124.357 3.371 . . . . 0.0 112.753 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 61.45 -79.7 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 pp -65.2 164.8 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 118.288 0.494 . . . . 0.0 111.539 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -146.88 -24.67 0.41 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -154.28 -36.69 0.1 Allowed 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -174.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -67.48 -39.99 85.25 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.006 0.366 . . . . 0.0 111.944 -173.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -74.48 -35.33 63.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.179 -0.326 . . . . 0.0 111.37 -172.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.7 pt -83.91 -28.03 7.34 Favored 'Isoleucine or valine' 0 C--O 1.23 0.041 0 O-C-N 122.145 -0.347 . . . . 0.0 110.967 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.0 m -79.77 -5.63 55.68 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.15 -14.13 14.99 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 171.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 m -95.14 -17.79 21.49 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -120.65 0.74 10.49 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.374 0.534 . . . . 0.0 111.986 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.0 tpt85 -70.38 -21.4 62.87 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 122.716 0.406 . . . . 0.0 110.831 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -69.15 -5.71 24.16 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.674 0.789 . . . . 0.0 111.947 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -112.68 -13.34 13.27 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.239 0.215 . . . . 0.0 111.427 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.5 168.6 18.81 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -70.9 149.14 59.1 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.294 2.663 . . . . 0.0 110.804 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.404 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -164.77 158.73 17.86 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -170.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 12.2 mm -136.86 173.17 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 171.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.6 156.03 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 118.445 0.566 . . . . 0.0 110.606 178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -149.18 164.24 35.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.542 0.337 . . . . 0.0 111.039 -175.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.49 ' CZ2' ' HE3' ' A' ' 98' ' ' LYS . 24.2 p90 -155.46 156.32 30.75 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.637 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 25.5 Cg_endo -75.42 -11.66 20.72 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 124.026 3.151 . . . . 0.0 110.683 -169.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.637 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 89.9 m-70 -105.52 5.94 31.87 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.847 0.859 . . . . 0.0 111.363 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.49 ' HE3' ' CZ2' ' A' ' 95' ' ' TRP . 68.8 tttt -64.65 157.84 26.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.717 0.807 . . . . 0.0 112.568 -176.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 60.45 173.38 0.09 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.037 1.335 . . . . 0.0 113.303 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 53.54 82.77 0.08 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.797 1.239 . . . . 0.0 111.796 -178.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.9 m 56.72 19.66 4.53 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.554 1.142 . . . . 0.0 113.908 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -134.8 26.84 3.64 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.412 0.685 . . . . 0.0 110.893 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.2 m -86.61 163.49 17.39 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.085 0.554 . . . . 0.0 111.037 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 26.6 t80 57.16 9.59 0.7 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.925 1.29 . . . . 0.0 114.129 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.421 ' CD1' ' HD2' ' A' ' 106' ' ' PRO . 44.2 t80 -162.3 130.0 2.72 Favored Pre-proline 0 CA--C 1.534 0.349 0 O-C-N 121.567 -0.708 . . . . 0.0 109.85 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.421 ' HD2' ' CD1' ' A' ' 105' ' ' PHE . 83.2 Cg_endo -73.84 168.35 25.0 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 124.094 3.196 . . . . 0.0 109.945 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -62.21 -28.18 79.09 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.71 2.273 . . . . 0.0 111.099 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -162.14 -41.83 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 171.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 176.54 -163.81 33.15 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.44 ' H ' ' HB3' ' A' ' 72' ' ' LEU . 0.0 OUTLIER 60.54 147.7 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 113.859 -1.171 . . . . 0.0 113.991 -177.411 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.49 -173.45 3.99 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.185 0.594 . . . . 0.0 110.043 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.35 134.0 26.78 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.19 149.64 21.7 Favored 'General case' 0 CA--C 1.522 -0.108 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -176.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.8 mp -118.59 144.69 45.95 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 173.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.52 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.7 p90 -158.93 177.35 11.25 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -117.89 -12.74 10.12 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -129.29 142.66 50.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.973 0.416 . . . . 0.0 112.03 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -80.76 -6.05 57.97 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.831 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 75.1 p -82.73 -19.26 38.28 Favored 'General case' 0 N--CA 1.457 -0.113 0 O-C-N 122.137 -0.352 . . . . 0.0 111.075 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.5 t -72.58 -44.27 62.27 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.0 m -70.84 -26.2 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -69.94 -41.6 74.35 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.764 -0.585 . . . . 0.0 110.702 -176.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.54 -36.6 60.44 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.04 0.382 . . . . 0.0 111.792 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -76.86 -15.37 59.73 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.06 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 77.3 mt -95.42 -17.32 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.336 0.254 . . . . 0.0 110.467 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -90.84 -14.92 30.91 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.608 -0.682 . . . . 0.0 111.121 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.29 46.32 1.82 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.491 0.717 . . . . 0.0 111.437 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 22.5 p -138.27 176.7 8.47 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 39.5 mm -92.88 164.35 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 125.363 1.465 . . . . 0.0 108.351 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -133.46 150.63 51.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.778 0.323 . . . . 0.0 110.836 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.16 -179.86 5.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 175.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -55.84 -4.76 0.12 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -171.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -170.17 14.03 0.05 OUTLIER Glycine 0 CA--C 1.527 0.831 0 CA-C-N 118.854 0.752 . . . . 0.0 113.137 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 134' ' ' LYS . 21.4 ttmt -157.89 -178.05 7.02 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.596 1.198 . . . . 0.0 111.23 -174.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 150' ' ' GLN . 67.2 mt -112.24 169.56 8.78 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.078 0.551 . . . . 0.0 110.972 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.41 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 0.3 OUTLIER -145.81 139.53 26.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.27 0.628 . . . . 0.0 109.717 179.126 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.0 mp -136.8 149.71 47.91 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.346 0.521 . . . . 0.0 110.069 170.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.3 p -71.1 154.57 41.64 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.9 p -148.77 7.34 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 O-C-N 122.402 -0.187 . . . . 0.0 111.479 -177.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.2 m 53.16 46.99 25.44 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.847 -0.533 . . . . 0.0 110.799 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.9 t -47.6 139.83 8.27 Favored Pre-proline 0 CA--C 1.53 0.199 0 C-N-CA 124.351 1.06 . . . . 0.0 112.234 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -80.1 -15.14 11.79 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 124.142 3.228 . . . . 0.0 113.854 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.7 t -89.47 -24.0 21.95 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.841 1.201 . . . . 0.0 111.657 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.496 HG23 ' H ' ' A' ' 145' ' ' LYS . 2.4 mm -121.63 -174.95 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.496 ' H ' HG23 ' A' ' 144' ' ' ILE . 63.9 pttt -69.97 -32.67 71.0 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.346 -0.846 . . . . 0.0 109.139 171.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -165.58 150.14 8.59 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.781 1.633 . . . . 0.0 107.187 170.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.85 105.49 2.49 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.41 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 78.1 Cg_exo -53.39 145.11 47.17 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.031 3.154 . . . . 0.0 113.905 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.4 m -116.72 148.61 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.059 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 25.3 mp0 -82.03 157.33 24.21 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -174.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.0 mm -136.59 142.37 38.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.379 0.672 . . . . 0.0 109.36 171.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.6 ttp85 -157.66 104.4 1.8 Allowed Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 171.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -60.72 167.17 8.84 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 124.507 3.471 . . . . 0.0 114.819 175.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -111.1 136.43 50.15 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.348 171.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -103.18 150.12 23.99 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.478 0.711 . . . . 0.0 112.455 -176.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.6 mp -94.47 97.7 10.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.466 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.9 t -156.09 -33.1 0.09 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.803 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -138.78 22.36 2.67 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.7 m -68.62 -25.04 64.65 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -175.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -153.67 159.62 42.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.239 0.616 . . . . 0.0 110.518 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -151.77 154.26 35.91 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.6 t -136.42 144.29 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -174.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 63.8 mtm -141.74 15.36 2.14 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -151.38 10.79 0.59 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.336 0.516 . . . . 0.0 112.062 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.94 12.25 84.1 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 121.764 -0.585 . . . . 0.0 111.931 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.5 m 52.89 73.17 0.37 Allowed 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -70.85 173.55 4.65 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -54.44 133.97 59.07 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.208 1.938 . . . . 0.0 112.073 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.4 mp -106.66 160.87 15.12 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 123.603 0.761 . . . . 0.0 109.904 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -150.08 145.04 18.2 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.3 -20.84 33.78 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.425 2.75 . . . . 0.0 114.176 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -91.1 2.93 55.96 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.457 0.571 . . . . 0.0 111.126 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -131.07 15.96 5.14 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.655 0.382 . . . . 0.0 111.117 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 18.7 m -128.08 140.17 52.1 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 120.713 0.292 . . . . 0.0 110.805 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.4 tt -113.28 150.57 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 C-N-CA 123.204 0.602 . . . . 0.0 109.992 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -120.84 153.16 37.5 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 18.0 m -141.68 151.74 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.792 0.437 . . . . 0.0 110.422 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -164.34 171.48 39.87 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.47 11.04 80.95 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 11.9 p -63.26 138.62 97.39 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.18 -52.89 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.502 2.135 . . . . 0.0 112.218 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 24.5 tpt180 -162.78 -47.24 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.331 -0.842 . . . . 0.0 113.066 176.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -71.38 140.93 37.75 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.747 2.298 . . . . 0.0 111.778 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.716 ' CD1' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -151.88 -87.12 0.07 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 119.151 -0.452 . . . . 0.0 111.463 176.514 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.716 ' H ' ' CD1' ' A' ' 184' ' ' LEU . 71.2 mtp180 59.38 126.48 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 126.393 1.877 . . . . 0.0 112.181 -173.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.5 -20.23 65.42 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.896 -0.503 . . . . 0.0 110.364 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 68.1 t -69.43 -54.01 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 122.434 0.294 . . . . 0.0 110.616 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -81.71 -23.38 36.81 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.341 -0.224 . . . . 0.0 111.054 -174.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 53.1 tp -71.0 -33.6 70.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -79.49 -33.45 42.2 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.4 mmt -69.83 -38.63 76.61 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.877 0.308 . . . . 0.0 110.304 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 94.1 mt -73.1 -37.32 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.6 mmt -67.07 -20.08 65.76 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.975 -0.453 . . . . 0.0 110.695 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -86.3 -19.88 29.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.872 0.306 . . . . 0.0 111.784 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -96.58 -14.34 22.29 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.0 -13.45 10.02 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -136.66 21.22 3.1 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 81.83 -150.14 29.09 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 122.141 -0.349 . . . . 0.0 112.252 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.19 121.81 5.98 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 123.086 0.374 . . . . 0.0 112.221 -171.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 90.9 t -100.49 147.19 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 124.242 1.017 . . . . 0.0 109.612 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 46.7 t -102.12 -43.73 5.66 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -159.7 158.42 31.33 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.37 0.129 . . . . 0.0 111.105 -170.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -152.88 156.97 39.97 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.849 0.46 . . . . 0.0 110.648 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -178.16 -176.05 45.8 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 42.8 mm -113.58 90.81 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 14.1 t70 56.72 -63.57 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -169.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 55.3 p 45.67 56.41 5.88 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.87 130.59 94.89 Favored Pre-proline 0 N--CA 1.453 -0.307 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -78.32 -14.58 14.67 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.517 3.478 . . . . 0.0 113.681 -173.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -94.65 -36.82 11.61 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 118.643 0.656 . . . . 0.0 110.317 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 94.3 mt -96.44 -7.39 35.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.867 0.467 . . . . 0.0 109.925 176.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 50.16 44.55 26.07 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.792 1.237 . . . . 0.0 111.87 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.99 155.53 62.33 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -174.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -84.74 177.83 5.28 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 123.807 3.005 . . . . 0.0 111.073 174.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -138.73 22.81 2.67 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.113 0.565 . . . . 0.0 110.862 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 62.72 8.24 20.01 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.63 -0.539 . . . . 0.0 113.677 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -128.58 141.04 51.49 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.952 0.876 . . . . 0.0 109.274 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -86.16 161.64 34.55 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-O 121.526 0.515 . . . . 0.0 113.942 -171.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -149.53 148.51 29.47 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.9 t -141.64 154.82 19.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -135.69 150.48 49.59 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.619 0.247 . . . . 0.0 110.61 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -124.66 154.57 40.57 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 66.5 p -86.02 3.01 44.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.156 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -139.3 140.53 37.61 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.32 0.648 . . . . 0.0 110.005 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -74.2 -19.68 60.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.395 -0.191 . . . . 0.0 110.661 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -71.64 -37.0 70.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 44.2 m -72.49 -30.26 64.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -69.25 -49.97 51.31 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 119.484 -0.293 . . . . 0.0 111.041 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 41.8 pt -68.16 -18.31 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.032 0 CA-C-N 118.43 0.559 . . . . 0.0 110.79 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.55 -25.63 35.69 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -84.95 -23.23 28.87 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.6 pt -105.23 25.75 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 122.734 0.414 . . . . 0.0 110.833 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 20.0 t -84.54 -9.4 58.36 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.12 0.568 . . . . 0.0 112.271 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -156.65 143.97 18.98 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 249' ' ' GLU . 10.1 ptp180 -60.04 -52.57 64.81 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.214 -175.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -93.05 115.79 28.44 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.374 0.988 . . . . 0.0 110.139 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -83.52 147.24 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 171.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -81.99 127.19 32.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.84 17.25 6.82 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -84.15 130.34 34.85 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.165 0.586 . . . . 0.0 112.26 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -152.49 143.41 22.99 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 61.85 -144.31 48.93 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -177.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.1 8.73 31.27 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.086 0.554 . . . . 0.0 111.669 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 66.7 mt -96.62 153.81 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 123.442 0.697 . . . . 0.0 110.264 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -130.52 133.95 46.66 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -145.37 145.37 31.15 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 124.502 1.121 . . . . 0.0 108.576 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -158.93 155.31 27.4 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.29 0.636 . . . . 0.0 109.622 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 8.7 p -157.6 154.31 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 235' ' ' ARG . 42.8 mt-10 -94.13 136.4 34.46 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 117.786 0.266 . . . . 0.0 110.64 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.4 m -101.72 161.34 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.433 ' HG3' ' H61' ' B' ' 5' ' ' ' A' . 0.0 OUTLIER -159.01 159.61 29.28 Favored Pre-proline 0 N--CA 1.454 -0.226 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.776 169.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.2 136.66 76.39 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.796 2.33 . . . . 0.0 109.27 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -87.28 167.55 13.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.052 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.3 p -153.44 149.44 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.626 0.771 . . . . 0.0 110.018 -170.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 89.7 mt . . . . . 0 C--O 1.253 1.253 0 CA-C-O 117.568 -1.206 . . . . 0.0 109.625 178.866 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.683 2 O4'-C1'-N19 113.141 4.941 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.804 1 O4'-C1'-N19 112.653 4.453 . 0.36 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.423 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.423 -2.5 1 O4'-C1'-N19 113.887 5.687 . 0.01 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.471 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.418 -2.902 0 C5'-C4'-C3' 109.595 -3.937 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.441 " H2'" ' N3 ' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.411 -3.521 0 O4'-C1'-N19 110.847 2.647 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.1 m . . . . . 0 N--CA 1.475 0.805 0 CA-C-O 120.347 0.118 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 53.25 30.48 10.08 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.04 0.936 . . . . 0.0 113.189 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -73.56 161.85 29.89 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.723 0.297 . . . . 0.0 110.817 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -135.6 14.59 3.42 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.402 0.681 . . . . 0.0 111.483 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.74 -171.74 24.04 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -127.39 162.55 26.07 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.149 0.58 . . . . 0.0 110.515 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -93.86 171.5 8.83 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 121.151 0.5 . . . . 0.0 111.451 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 p -68.57 158.73 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.816 0.847 . . . . 0.0 110.535 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -126.09 153.94 43.78 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.489 0.715 . . . . 0.0 109.46 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -122.75 164.8 17.67 Favored 'General case' 0 C--N 1.337 0.063 0 C-N-CA 123.051 0.54 . . . . 0.0 111.238 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -151.19 157.03 42.13 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.225 -171.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.0 t -94.01 161.24 14.37 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 50.1 mtm105 -81.96 24.32 0.64 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.32 0.248 . . . . 0.0 110.894 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -140.27 138.15 34.77 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.698 0.399 . . . . 0.0 110.804 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.36 155.78 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.866 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.419 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 5.8 t80 -86.97 139.04 30.99 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 171.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.23 115.48 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 174.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -79.73 137.98 19.55 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.47 -175.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.49 158.61 6.17 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 121.985 0.77 . . . . 0.0 114.69 173.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.5 tp -160.09 126.37 2.44 Favored Pre-proline 0 N--CA 1.451 -0.385 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -73.74 142.23 31.84 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.622 1.548 . . . . 0.0 109.12 -178.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.54 -3.23 3.2 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.93 3.087 . . . . 0.0 115.165 -174.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -99.88 -21.27 15.77 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.8 pp -133.36 -171.89 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 119.459 1.027 . . . . 0.0 111.203 -177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -136.68 -163.24 1.38 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.465 0.706 . . . . 0.0 112.291 -172.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -40.62 -31.08 0.14 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.853 2.061 . . . . 0.0 113.459 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -64.61 -30.26 71.28 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -175.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -80.04 -33.99 38.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.083 -0.386 . . . . 0.0 111.133 -173.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.4 mt -73.78 -36.19 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 33.5 m -68.75 -21.77 64.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.76 -13.23 27.64 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.4 m -84.75 -29.54 25.41 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.285 0.493 . . . . 0.0 112.022 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -110.49 5.15 21.08 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -176.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.6 tpt85 -67.96 -14.0 62.62 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.973 -0.454 . . . . 0.0 110.365 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -64.78 -15.72 62.03 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.813 1.245 . . . . 0.0 111.81 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -120.83 -5.95 9.62 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.917 0.339 . . . . 0.0 111.917 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.04 163.82 10.31 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -57.93 139.04 88.97 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.141 2.56 . . . . 0.0 111.342 177.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.38 167.5 26.87 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.066 0.46 . . . . 0.0 111.096 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 pt -138.08 163.68 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.5 p -132.66 145.04 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -154.04 171.37 19.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.081 0.467 . . . . 0.0 110.395 -174.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.418 ' CH2' ' HE3' ' A' ' 98' ' ' LYS . 18.8 p90 -155.14 163.04 25.87 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 174.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.504 ' HG3' " H1'" ' B' ' 4' ' ' ' U' . 89.8 Cg_endo -71.31 -7.44 21.32 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 CA-C-N 121.232 1.476 . . . . 0.0 110.844 -170.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.497 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 3.4 m-70 -99.73 2.81 44.57 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.726 0.811 . . . . 0.0 111.491 -177.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.418 ' HE3' ' CH2' ' A' ' 95' ' ' TRP . 12.4 tptm -54.6 158.24 2.62 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.054 0.942 . . . . 0.0 112.693 -178.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -126.47 18.32 7.52 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.078 0.951 . . . . 0.0 110.918 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 59.95 -25.08 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.99 2.116 . . . . 0.0 115.394 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.0 t -163.07 -21.36 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.162 0.892 . . . . 0.0 112.143 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.515 ' HZ3' ' HB3' ' A' ' 102' ' ' LYS . 2.6 mmmp? -87.71 1.17 54.49 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.2 m -141.37 149.62 41.35 Favored 'General case' 0 N--CA 1.458 -0.073 0 CA-C-N 118.063 0.392 . . . . 0.0 110.849 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -137.44 -2.91 1.95 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.789 0.835 . . . . 0.0 111.331 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -126.51 127.76 24.48 Favored Pre-proline 0 N--CA 1.453 -0.316 0 CA-C-N 118.03 0.377 . . . . 0.0 110.324 -175.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -59.76 165.76 9.42 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.917 3.078 . . . . 0.0 111.512 171.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -52.05 -24.39 19.58 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.039 3.159 . . . . 0.0 113.734 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -146.98 -61.31 0.29 Allowed 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.149 0.432 . . . . 0.0 110.643 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.02 42.55 0.04 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.282 -0.961 . . . . 0.0 114.173 -177.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.535 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -140.75 153.61 45.95 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.519 1.159 . . . . 0.0 108.888 174.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.18 -178.63 6.74 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.274 0.488 . . . . 0.0 111.972 -174.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -141.11 140.51 34.16 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.5 mp -96.32 148.91 22.27 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 118.497 0.59 . . . . 0.0 112.326 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.9 mp -115.52 142.28 46.93 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 170.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -131.7 167.8 18.86 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.404 0.621 . . . . 0.0 111.93 -174.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -109.28 -29.85 8.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.932 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -121.8 153.17 38.66 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -85.97 -17.84 34.24 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.176 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.7 t -85.76 -17.67 35.19 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.128 -0.358 . . . . 0.0 110.198 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 41.9 t -72.36 -39.5 68.03 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.31 -26.71 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -71.05 -34.91 71.7 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.971 -0.455 . . . . 0.0 110.311 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -77.97 -35.17 50.55 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 122.176 -0.328 . . . . 0.0 111.654 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 pp -78.91 -16.7 56.66 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.43 0.559 . . . . 0.0 111.458 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.4 mt -92.33 -22.7 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 122.254 0.222 . . . . 0.0 110.454 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -97.9 -10.21 24.98 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -117.56 35.04 4.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.175 0.59 . . . . 0.0 111.269 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 26.8 p -136.76 -179.59 5.78 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.906 0.482 . . . . 0.0 111.331 -176.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.1 mm -87.4 159.44 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 124.391 1.077 . . . . 0.0 109.018 -177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.65 154.79 43.56 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.759 0.314 . . . . 0.0 110.791 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -146.39 85.11 1.64 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.516 0.675 . . . . 0.0 110.753 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 55.43 0.13 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.22 -12.18 0.07 OUTLIER Glycine 0 CA--C 1.527 0.841 0 CA-C-N 119.568 1.076 . . . . 0.0 114.072 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.1 170.84 15.06 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 118.195 0.998 . . . . 0.0 109.609 177.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.97 166.05 10.65 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -172.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.415 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -142.39 139.49 31.71 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.891 -177.52 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.1 tp -124.55 128.72 49.36 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 48.9 t -77.03 139.48 40.06 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.1 m -137.65 -0.97 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.116 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 29.7 t 45.68 60.38 3.15 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.265 0.626 . . . . 0.0 111.116 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.2 m -56.96 150.48 38.79 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.941 -175.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.82 11.91 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.795 2.996 . . . . 0.0 114.907 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.403 HG23 HG13 ' A' ' 144' ' ' ILE . 15.1 t -121.23 -15.39 8.17 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.595 1.089 . . . . 0.0 111.832 -174.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.403 HG13 HG23 ' A' ' 143' ' ' THR . 0.6 OUTLIER -168.25 -176.44 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 125.178 1.391 . . . . 0.0 109.635 -177.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -120.74 16.74 11.91 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.739 0.816 . . . . 0.0 110.953 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -141.38 34.35 1.67 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -173.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.628 ' HD3' " H2'" ' B' ' 1' ' ' ' C' . 50.2 mttp -129.16 80.1 73.16 Favored Pre-proline 0 C--N 1.34 0.179 0 CA-C-N 118.927 0.785 . . . . 0.0 111.193 177.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.415 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 19.8 Cg_exo -67.69 145.56 70.02 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.908 2.405 . . . . 0.0 108.765 169.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.8 m -75.65 133.92 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -86.27 150.28 24.47 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 26.3 mm -130.17 137.36 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 C-N-CA 122.743 0.417 . . . . 0.0 110.646 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -141.45 92.19 8.28 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.53 162.87 34.89 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 124.174 3.25 . . . . 0.0 112.742 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -93.47 142.69 27.04 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 172.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -101.52 157.1 17.06 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.219 0.533 . . . . 0.0 110.489 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.5 mp -90.33 178.99 5.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.518 0.675 . . . . 0.0 111.402 -176.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.7 m 65.12 4.43 2.56 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.501 1.92 . . . . 0.0 116.115 176.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 52.9 p30 -135.58 12.65 3.46 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 120.345 1.43 . . . . 0.0 113.317 172.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.8 m -66.13 -32.46 73.91 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -152.84 161.27 42.76 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 122.817 0.447 . . . . 0.0 111.015 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -152.97 152.89 31.94 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.956 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.97 140.66 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 28.3 ttp -132.44 13.7 4.55 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -159.66 -57.75 0.06 Allowed 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 61.33 11.64 28.18 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.409 -0.662 . . . . 0.0 113.54 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.4 t -109.36 -4.28 16.51 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.174 0.987 . . . . 0.0 112.184 -175.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -124.38 136.74 28.1 Favored Pre-proline 0 CA--C 1.531 0.218 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -68.3 160.52 48.62 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.146 2.564 . . . . 0.0 110.049 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 46.7 mt -113.04 153.31 28.31 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.51 0.324 . . . . 0.0 110.769 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -145.0 150.56 46.19 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.95 -5.43 13.43 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.442 2.761 . . . . 0.0 112.017 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -93.87 -1.22 55.13 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.028 0.531 . . . . 0.0 110.757 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.07 20.81 4.08 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.585 0.354 . . . . 0.0 111.444 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 13.6 m -119.99 143.17 48.18 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-O 120.987 0.422 . . . . 0.0 111.395 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.9 tt -113.05 141.3 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -106.92 152.36 24.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 76.1 t -137.97 144.98 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 123.633 0.773 . . . . 0.0 108.965 -173.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -148.02 149.55 21.64 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 112.04 -0.424 . . . . 0.0 112.04 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.4 22.1 54.97 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -172.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.6 m -60.94 144.91 89.86 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 116.913 0.356 . . . . 0.0 111.32 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.05 157.76 42.38 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.1 2.533 . . . . 0.0 108.715 170.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -66.73 -46.66 56.42 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.74 -176.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -78.48 27.08 0.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.452 2.768 . . . . 0.0 113.025 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.6 tp -64.96 -43.56 92.26 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.117 0.871 . . . . 0.0 110.38 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 59.35 129.64 0.01 OUTLIER 'General case' 0 C--N 1.341 0.223 0 C-N-CA 126.11 1.764 . . . . 0.0 112.955 179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.86 -25.69 68.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 121.554 -0.716 . . . . 0.0 111.474 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 24.2 t -72.14 -47.85 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-O 120.662 0.268 . . . . 0.0 110.453 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -79.86 -24.64 41.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -176.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.8 tp -69.0 -33.85 74.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.78 -32.8 46.63 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.263 -0.273 . . . . 0.0 111.552 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.8 mmt -71.4 -35.99 71.23 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 122.305 -0.247 . . . . 0.0 110.475 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 71.5 mt -78.16 -40.51 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 22.5 mmt -60.67 -28.19 68.4 Favored 'General case' 0 C--N 1.334 -0.078 0 O-C-N 121.941 -0.474 . . . . 0.0 111.342 173.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -82.38 -21.51 35.83 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.419 0.554 . . . . 0.0 111.088 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.11 -19.69 26.67 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -110.1 -16.9 13.69 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.563 0.62 . . . . 0.0 111.875 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -135.1 -41.64 0.73 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.377 0.535 . . . . 0.0 111.587 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 69.19 162.76 3.08 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 121.474 0.486 . . . . 0.0 112.615 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 87.07 15.47 62.65 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 174.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.4 p -77.5 162.4 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.0 0.92 . . . . 0.0 110.597 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 51.5 t -137.28 -31.82 0.8 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -150.63 155.03 38.58 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.084 0.402 . . . . 0.0 111.814 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -156.27 156.85 34.76 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.346 0.658 . . . . 0.0 110.518 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 176.51 177.6 45.62 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.424 ' HA ' ' HA2' ' A' ' 218' ' ' GLY . 44.6 mm -103.83 87.05 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 26.2 t70 47.39 -86.85 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.927 -169.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.62 ' H ' ' HA ' ' A' ' 214' ' ' PRO . 12.6 m 49.72 65.16 1.49 Allowed 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.315 0.646 . . . . 0.0 111.091 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -59.75 133.46 89.27 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.74 -17.27 14.19 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 124.629 3.553 . . . . 0.0 114.282 -171.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -104.87 0.06 27.6 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.865 0.757 . . . . 0.0 111.282 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 97.5 mt -122.2 -13.21 8.16 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.807 0.843 . . . . 0.0 109.942 172.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt 52.97 38.11 26.29 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.534 1.134 . . . . 0.0 111.507 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -140.55 145.21 39.6 Favored Pre-proline 0 N--CA 1.461 0.12 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.62 ' HA ' ' H ' ' A' ' 207' ' ' THR . 64.6 Cg_endo -77.98 174.64 12.22 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.818 3.012 . . . . 0.0 110.769 173.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -132.16 21.07 4.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.417 0.687 . . . . 0.0 110.318 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 62.67 16.04 55.08 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 119.844 -0.42 . . . . 0.0 112.426 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -135.9 149.42 48.96 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.255 0.622 . . . . 0.0 110.273 -176.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.424 ' HA2' ' HA ' ' A' ' 205' ' ' ILE . . . -95.11 162.0 23.66 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 116.629 -0.259 . . . . 0.0 112.773 -175.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -155.2 148.49 24.92 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 171.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.35 147.23 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -131.53 144.83 51.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.831 0.348 . . . . 0.0 110.301 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -128.88 165.66 20.59 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.027 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 78.5 p -94.66 -1.44 53.13 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -125.69 147.67 49.28 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 121.146 0.498 . . . . 0.0 111.62 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -78.5 -18.13 55.24 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.035 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -78.73 -37.14 42.15 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 58.6 p -80.14 -23.58 41.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -64.87 -41.67 95.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.722 0.409 . . . . 0.0 110.701 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.2 pt -84.21 -16.3 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 118.04 0.382 . . . . 0.0 111.592 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.66 -30.87 26.5 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 117.981 0.355 . . . . 0.0 110.86 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -77.04 -15.81 59.48 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.653 0.206 . . . . 0.0 111.38 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 1.6 pp -117.79 24.51 4.78 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 C-N-CA 123.133 0.573 . . . . 0.0 110.523 177.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.0 t -77.53 -9.19 58.77 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.005 0.522 . . . . 0.0 111.037 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -152.29 145.66 24.79 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -56.84 -28.9 62.26 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.6 0.36 . . . . 0.0 111.664 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -121.7 122.19 39.01 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.4 m -82.79 151.85 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 C-N-CA 122.882 0.473 . . . . 0.0 109.961 174.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 11.1 mp0 -94.98 138.42 32.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -125.37 22.61 7.72 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.091 -175.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -88.3 132.37 34.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.851 0.46 . . . . 0.0 112.137 -172.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -150.18 12.42 0.75 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.206 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 176.19 -143.8 6.68 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 243' ' ' GLU . 0.4 OUTLIER -81.4 3.35 24.79 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.708 0.403 . . . . 0.0 111.273 178.163 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 77.1 mt -99.95 148.74 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.64 0.776 . . . . 0.0 109.719 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -147.57 140.86 25.24 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.755 0.312 . . . . 0.0 110.199 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -142.92 154.43 44.07 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.69 151.44 30.55 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.1 p -161.72 158.42 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -83.26 144.93 29.41 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.197 0.599 . . . . 0.0 111.206 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.1 m -123.75 163.72 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.4 ' C ' ' H ' ' A' ' 253' ' ' TYR . 0.0 OUTLIER -157.29 156.37 29.11 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.089 170.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -73.06 39.21 0.44 Allowed 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 125.052 3.835 . . . . 0.0 111.754 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . 0.4 ' H ' ' C ' ' A' ' 251' ' ' LYS . 0.3 OUTLIER 43.96 43.87 5.63 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.326 1.45 . . . . 0.0 111.331 -174.386 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 9.8 p 49.73 18.75 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.732 1.613 . . . . 0.0 113.723 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.497 1.919 . . . . 0.0 114.237 178.274 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.628 " H2'" ' HD3' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -2.977 0 C4'-C3'-C2' 99.638 -3.062 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.836 1 O4'-C1'-N19 113.969 5.769 . 0.128 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.535 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.422 -2.592 1 O4'-C1'-N19 113.33 5.13 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.504 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.422 -2.581 0 O4'-C1'-N19 111.664 3.464 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.489 " H2'" ' N3 ' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.576 0 O5'-C5'-C4' 113.286 2.204 . 0.07 4a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 111.308 0.114 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -140.73 7.61 2.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.139 0.575 . . . . 0.0 111.05 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -74.97 162.19 28.81 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.342 0.657 . . . . 0.0 110.416 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -143.83 142.93 31.1 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.984 0.514 . . . . 0.0 109.821 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.08 -4.35 88.43 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.904 -0.478 . . . . 0.0 111.904 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -119.59 167.69 11.75 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.474 0.71 . . . . 0.0 110.806 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -139.85 168.51 19.64 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.522 0.729 . . . . 0.0 110.877 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.6 t 63.43 146.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 125.762 1.625 . . . . 0.0 112.345 -176.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -134.22 160.8 36.76 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.409 0.683 . . . . 0.0 110.266 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.65 142.2 58.18 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.067 0.547 . . . . 0.0 111.481 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -153.33 159.34 42.46 Favored 'General case' 0 C--O 1.23 0.046 0 O-C-N 123.495 0.497 . . . . 0.0 110.219 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.9 t -93.26 20.56 6.88 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.168 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 70.1 mtm-85 55.97 21.03 4.64 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.423 0.689 . . . . 0.0 112.314 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.441 ' HZ2' ' HG2' ' A' ' 214' ' ' PRO . 4.1 ttpt -146.9 144.51 29.31 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.014 0.526 . . . . 0.0 110.068 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.2 m -138.34 152.39 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.155 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.434 ' CZ ' ' C6 ' ' B' ' 3' ' ' ' U' . 2.9 t80 -88.63 140.9 28.99 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 170.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.5 m -134.61 138.47 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.57 -170.83 12.22 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -176.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.429 ' HA2' " H4'" ' B' ' 1' ' ' ' C' . . . 76.48 5.58 82.68 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.456 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.0 mt -70.86 148.79 94.88 Favored Pre-proline 0 N--CA 1.454 -0.245 0 CA-C-N 118.655 1.227 . . . . 0.0 108.823 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -62.38 160.53 31.0 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.328 2.019 . . . . 0.0 110.735 -177.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.64 -10.61 0.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 125.094 3.863 . . . . 0.0 114.781 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.47 ' CG ' ' H ' ' A' ' 76' ' ' ILE . 5.8 p-10 -105.0 -96.06 0.33 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 118.946 -0.55 . . . . 0.0 109.805 175.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.47 ' H ' ' CG ' ' A' ' 75' ' ' ASP . 3.1 tp 55.79 163.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -158.47 -179.28 7.94 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.863 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -59.14 -32.58 69.99 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.85 0.86 . . . . 0.0 112.633 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -91.09 -23.36 20.34 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 118.702 0.683 . . . . 0.0 112.629 -170.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -80.83 -27.16 36.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.3 mt -78.43 -40.53 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 97.0 m -63.31 -22.6 66.98 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.05 -21.25 24.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -72.94 -26.44 61.39 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.509 0.595 . . . . 0.0 111.88 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.494 ' CZ ' HD12 ' A' ' 151' ' ' ILE . 55.5 m-85 -124.31 13.17 8.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -17.29 64.39 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.992 -0.442 . . . . 0.0 111.269 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -68.41 -11.46 59.69 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.138 0.975 . . . . 0.0 111.466 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -123.61 36.15 4.69 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -173.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.1 175.46 34.74 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.11 151.83 61.74 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.9 3.066 . . . . 0.0 111.278 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 0.6 OUTLIER -166.89 163.34 16.19 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.872 -170.205 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.3 pt -141.42 169.55 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.0 p -135.38 150.12 29.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -152.91 174.11 14.52 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.419 0.628 . . . . 0.0 111.396 -177.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -160.41 157.94 24.89 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.496 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 37.8 Cg_endo -75.77 -17.97 17.49 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.237 1.958 . . . . 0.0 110.885 -169.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.496 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 22.6 m-70 -84.78 -7.57 59.15 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.561 0.744 . . . . 0.0 110.833 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -71.05 170.35 13.04 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.664 1.186 . . . . 0.0 112.997 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -124.61 167.0 15.1 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.508 1.123 . . . . 0.0 109.655 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -88.77 -7.76 55.66 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.6 t -155.02 17.2 0.43 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.214 0.461 . . . . 0.0 112.166 -178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.9 tptp -144.62 144.16 31.13 Favored 'General case' 0 C--N 1.339 0.146 0 O-C-N 121.719 -0.613 . . . . 0.0 111.705 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 70.9 m 58.01 163.2 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.844 1.658 . . . . 0.0 114.762 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -142.9 10.97 1.8 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.762 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -106.22 116.05 60.04 Favored Pre-proline 0 CA--C 1.531 0.225 0 C-N-CA 123.846 0.858 . . . . 0.0 110.983 -172.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.13 159.79 24.97 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 124.093 3.195 . . . . 0.0 111.7 172.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.74 -32.2 35.63 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.25 3.3 . . . . 0.0 114.788 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -159.29 -59.62 0.07 Allowed 'General case' 0 C--N 1.34 0.162 0 CA-C-N 118.505 0.593 . . . . 0.0 111.752 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -179.89 23.02 0.04 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 -174.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.523 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.2 OUTLIER -129.13 140.59 51.48 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.199 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.51 -177.44 6.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.526 0.33 . . . . 0.0 110.591 -174.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.402 ' CE1' ' C5 ' ' B' ' 4' ' ' ' U' . 1.2 m-85 -141.77 134.14 28.04 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 11.2 mp -92.28 150.83 20.64 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.245 0.545 . . . . 0.0 111.582 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.99 137.53 51.9 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 173.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -130.34 166.11 21.09 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.882 0.372 . . . . 0.0 111.117 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -113.03 -31.95 6.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.275 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -117.74 149.1 41.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.037 0.446 . . . . 0.0 111.074 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -83.91 -16.92 42.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.218 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.8 p -86.43 -17.61 33.85 Favored 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 122.16 -0.338 . . . . 0.0 111.549 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.3 m -71.94 -47.01 55.46 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.004 0.43 . . . . 0.0 110.584 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 5.0 p -72.58 -20.22 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.042 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -75.27 -32.28 61.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.66 -44.49 56.64 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -72.98 -28.79 62.6 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 118.388 -1.325 . . . . 0.0 110.994 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 83.4 mt -80.54 -16.65 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 118.292 0.496 . . . . 0.0 110.928 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -86.14 -17.83 33.91 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.731 -0.606 . . . . 0.0 110.364 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -112.11 14.12 20.67 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 20.0 p -98.99 171.56 7.96 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.168 0.508 . . . . 0.0 112.251 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 39.9 mm -90.17 167.96 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 125.522 1.529 . . . . 0.0 108.472 179.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -124.33 152.87 42.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.021 0.439 . . . . 0.0 112.004 -178.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -145.61 -174.37 4.38 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 172.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.75 98.11 0.09 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.909 0.385 . . . . 0.0 111.342 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 78.06 -2.15 66.45 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.25 -0.75 . . . . 0.0 114.258 175.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -137.89 173.94 11.1 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.569 1.184 . . . . 0.0 110.372 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -110.19 174.8 5.7 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.479 0.712 . . . . 0.0 109.527 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.462 ' CE1' ' HB2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -144.07 149.21 36.26 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.2 0.6 . . . . 0.0 109.582 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.8 tp -132.22 146.32 51.93 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 169.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.1 m -89.25 133.72 34.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.793 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.1 p -156.18 154.11 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 124.32 1.048 . . . . 0.0 108.403 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.4 p -85.7 150.41 24.62 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.142 -0.349 . . . . 0.0 110.28 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.7 p -138.44 146.29 50.45 Favored Pre-proline 0 N--CA 1.456 -0.172 0 O-C-N 122.278 -0.264 . . . . 0.0 110.442 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.12 -8.85 20.3 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.214 2.609 . . . . 0.0 112.902 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.9 t -90.74 -18.21 25.38 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.239 0.927 . . . . 0.0 111.179 178.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.591 HG23 ' H ' ' A' ' 145' ' ' LYS . 2.3 mm -134.05 -144.72 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.591 ' H ' HG23 ' A' ' 144' ' ' ILE . 75.8 mmtt -119.41 -14.02 9.21 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.058 0.943 . . . . 0.0 109.158 169.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -156.99 157.35 34.57 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.612 1.165 . . . . 0.0 109.4 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.56 ' HE3' ' C6 ' ' B' ' 1' ' ' ' C' . 0.0 OUTLIER -154.47 112.04 2.41 Favored Pre-proline 0 N--CA 1.457 -0.077 0 C-N-CA 122.54 0.336 . . . . 0.0 110.921 178.846 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.462 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 23.9 Cg_exo -67.68 133.98 31.32 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.894 2.396 . . . . 0.0 108.929 167.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.6 m -121.23 138.29 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 118.299 0.5 . . . . 0.0 110.354 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -74.56 154.77 38.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.494 HD12 ' CZ ' ' A' ' 85' ' ' PHE . 44.2 mm -138.55 141.32 37.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 124.886 1.274 . . . . 0.0 108.918 171.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.9 ttp85 -156.44 109.96 2.03 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 170.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -76.34 164.42 30.93 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.917 3.078 . . . . 0.0 111.356 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.413 ' CG ' ' HG3' ' A' ' 214' ' ' PRO . 55.0 t-105 -100.44 144.84 28.96 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.595 0.235 . . . . 0.0 111.209 176.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -107.02 156.85 18.31 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.494 0.718 . . . . 0.0 111.718 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.0 mp -100.89 15.41 28.61 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.091 0.556 . . . . 0.0 111.598 -175.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.4 t -90.86 -28.53 18.09 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -174.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -140.33 25.07 2.27 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.63 0.65 . . . . 0.0 112.631 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.0 t -70.74 -16.42 62.77 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -155.07 159.9 40.6 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.041 0.536 . . . . 0.0 110.524 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -156.86 156.74 33.67 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.587 0.232 . . . . 0.0 111.0 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.9 m -137.49 151.5 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 C-N-CA 123.152 0.581 . . . . 0.0 110.327 175.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 16.1 ttp -135.34 19.15 3.38 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.555 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 166' ' ' SER . 24.5 t0 -151.93 -179.66 7.67 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -178.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.86 18.75 0.61 Allowed Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.372 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 164' ' ' ASP . 9.0 t 54.6 50.46 15.92 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 117.736 0.768 . . . . 0.0 111.895 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -64.36 160.07 53.49 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 122.926 0.49 . . . . 0.0 109.962 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -52.19 147.55 27.38 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.72 2.947 . . . . 0.0 112.355 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 68.8 mt -122.09 162.04 21.97 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.357 0.663 . . . . 0.0 110.995 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -143.92 150.25 48.95 Favored Pre-proline 0 CA--C 1.529 0.168 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -68.28 -10.83 30.14 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.957 2.438 . . . . 0.0 111.508 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.78 2.48 56.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.149 0.58 . . . . 0.0 110.496 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -126.17 18.04 7.74 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.674 0.39 . . . . 0.0 111.09 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 16.4 m -127.55 139.74 52.58 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.722 0.296 . . . . 0.0 111.019 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.1 tt -111.62 152.07 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 C-N-CA 123.16 0.584 . . . . 0.0 110.474 -176.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.404 ' CD1' ' CE1' ' A' ' 253' ' ' TYR . 6.3 t80 -114.68 143.84 44.39 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.8 m -140.92 132.36 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 122.611 0.364 . . . . 0.0 110.287 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -142.44 179.95 19.8 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.99 10.12 83.37 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -171.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 28.9 m -72.82 155.42 90.71 Favored Pre-proline 0 N--CA 1.455 -0.177 0 C-N-CA 122.904 0.481 . . . . 0.0 110.891 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.74 -172.6 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.756 2.971 . . . . 0.0 109.785 175.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -55.8 -48.4 96.67 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.213 -0.898 . . . . 0.0 112.236 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.59 138.75 17.5 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.223 1.949 . . . . 0.0 110.939 174.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -155.52 16.32 0.39 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.371 0.668 . . . . 0.0 111.448 178.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -42.71 142.1 0.93 Allowed 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.963 1.305 . . . . 0.0 112.334 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.73 -21.57 61.74 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -171.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.5 t -60.75 -52.13 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-N 118.306 0.503 . . . . 0.0 110.838 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -83.54 -20.09 34.5 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.387 -0.196 . . . . 0.0 110.798 -175.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 25.2 tp -73.85 -32.9 63.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -77.63 -39.31 45.69 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 117.563 0.165 . . . . 0.0 111.046 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 25.5 mmt -64.88 -49.81 69.02 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -177.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.8 mt -65.87 -34.57 71.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -178.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.4 tpp -74.23 -13.09 60.73 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 122.469 -0.145 . . . . 0.0 110.966 -178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -102.26 -12.61 17.85 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.029 -0.42 . . . . 0.0 112.032 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -92.4 -18.06 23.78 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.241 0.473 . . . . 0.0 111.369 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.47 -20.79 10.63 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.18 0.445 . . . . 0.0 111.036 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -141.05 46.83 1.73 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.958 0.503 . . . . 0.0 109.97 -177.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.55 136.79 4.57 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.016 0.817 . . . . 0.0 113.395 -175.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 135.8 7.15 1.88 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.123 0.868 . . . . 0.0 111.747 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 40.9 t -72.31 149.3 9.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 117.617 0.709 . . . . 0.0 110.903 -177.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 23.5 p -134.2 -23.04 1.73 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -151.17 150.94 31.23 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -149.67 155.23 39.87 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.429 0.692 . . . . 0.0 109.285 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -177.27 -176.32 45.27 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 30.4 mm -100.23 152.81 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -53.34 132.03 38.6 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 33.4 p -144.2 167.66 21.9 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 122.584 0.353 . . . . 0.0 110.518 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . 0.422 ' HA ' ' HD3' ' A' ' 209' ' ' PRO . 12.6 t70 -132.97 136.57 27.87 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 119.392 -0.337 . . . . 0.0 110.212 174.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 208' ' ' ASP . 22.1 Cg_exo -68.61 -9.35 25.86 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 124.532 3.488 . . . . 0.0 115.809 -172.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.27 -26.24 68.41 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 119.737 1.153 . . . . 0.0 110.92 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 19.3 tp -150.35 3.83 0.51 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.971 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 55.11 39.67 31.58 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.208 1.003 . . . . 0.0 110.605 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -100.08 146.2 31.52 Favored Pre-proline 0 N--CA 1.457 -0.083 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.373 -176.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.441 ' HG2' ' HZ2' ' A' ' 66' ' ' LYS . 30.7 Cg_endo -82.1 164.91 17.32 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.289 2.659 . . . . 0.0 113.465 -177.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -128.39 -174.64 3.28 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.921 1.289 . . . . 0.0 108.372 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -71.45 164.25 53.98 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.0 173.47 0.07 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -135.21 177.38 19.41 Favored Glycine 0 CA--C 1.525 0.718 0 O-C-N 121.97 -0.457 . . . . 0.0 112.553 -173.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.02 155.18 42.03 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.173 0.511 . . . . 0.0 111.077 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 63.6 t -139.45 145.88 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.61 148.19 46.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.854 0.359 . . . . 0.0 110.274 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -122.79 150.24 43.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.416 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 68.5 m -83.32 2.6 35.41 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 111.389 0.144 . . . . 0.0 111.389 175.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -131.19 138.9 49.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.775 0.43 . . . . 0.0 110.559 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . 0.421 ' H ' ' CD ' ' A' ' 225' ' ' GLN . 0.0 OUTLIER -75.45 -12.83 60.32 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 176.601 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 -82.35 -37.11 26.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 19.9 m -73.26 -29.04 62.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -67.17 -53.04 34.11 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 119.687 -0.196 . . . . 0.0 110.749 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.2 pt -69.56 -16.59 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 CA-C-N 118.126 0.421 . . . . 0.0 111.092 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.9 -24.7 33.03 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.713 0.233 . . . . 0.0 110.821 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.74 -21.52 26.53 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.1 pt -110.43 27.49 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.071 0.548 . . . . 0.0 110.345 174.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 20.4 t -80.68 -9.99 59.76 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.257 0.623 . . . . 0.0 112.065 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -158.3 145.12 17.63 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 55.7 ttm-85 -57.06 -32.63 66.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.562 0.345 . . . . 0.0 111.665 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -122.54 115.92 23.01 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 23.5 m -99.36 161.3 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.119 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -85.18 142.34 29.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 110.463 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.31 105.44 7.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 173.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -131.73 148.01 52.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.434 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -141.76 20.62 2.16 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.452 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 95.75 131.04 6.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 54.73 4.31 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.52 1.528 . . . . 0.0 114.7 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.2 mt -145.09 136.33 20.12 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 CA-C-N 118.702 0.683 . . . . 0.0 109.937 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -129.16 147.44 51.01 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.825 0.345 . . . . 0.0 111.367 173.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -144.9 170.52 15.98 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.612 1.165 . . . . 0.0 109.648 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.88 160.41 39.37 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.635 0.774 . . . . 0.0 110.303 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.0 p -152.23 152.11 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -85.84 126.88 34.38 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.05 157.7 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 CA-C-O 121.039 0.447 . . . . 0.0 111.84 -176.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.46 158.41 27.82 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.57 169.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.64 133.28 57.02 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.564 2.176 . . . . 0.0 107.884 172.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . 0.404 ' CE1' ' CD1' ' A' ' 176' ' ' PHE . 2.3 t80 -75.28 118.88 18.68 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.087 -173.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.439 HG23 ' H ' ' A' ' 255' ' ' LEU . 0.8 OUTLIER 53.7 168.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 127.434 2.293 . . . . 0.0 114.43 177.345 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.439 ' H ' HG23 ' A' ' 254' ' ' VAL . 34.2 tp . . . . . 0 C--O 1.25 1.116 0 C-N-CA 124.956 1.302 . . . . 0.0 111.726 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.56 ' C6 ' ' HE3' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.424 -2.451 1 O4'-C1'-N19 114.274 6.074 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.694 0 O4'-C1'-N19 112.137 3.937 . 0.258 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.523 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.713 2 C5'-C4'-C3' 109.252 -4.166 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.49 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.42 -2.75 0 O5'-C5'-C4' 106.675 -2.518 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.478 " H4'" ' HB2' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.414 -3.288 1 C5'-C4'-C3' 107.857 -5.095 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.3 t . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 120.365 0.126 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -134.08 8.23 3.74 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.339 0.656 . . . . 0.0 111.129 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 53.4 24.81 4.15 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.065 0.946 . . . . 0.0 112.106 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -148.38 155.83 41.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.261 0.624 . . . . 0.0 109.569 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.4 -179.56 45.66 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -147.17 166.49 26.81 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.15 0.58 . . . . 0.0 110.307 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.9 ptt-85 -148.76 172.9 13.87 Favored 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 123.122 0.569 . . . . 0.0 110.979 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 t 52.05 48.4 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 123.966 0.906 . . . . 0.0 111.092 178.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -73.52 -179.89 3.73 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.177 0.513 . . . . 0.0 110.813 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.68 134.68 7.24 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.082 0.953 . . . . 0.0 110.487 173.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.21 157.52 43.43 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -172.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.9 t -102.75 150.45 23.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.076 174.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -85.63 3.74 39.48 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.652 0.381 . . . . 0.0 110.281 174.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -100.02 135.96 40.66 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.85 0.86 . . . . 0.0 109.413 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 p -149.75 144.41 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.816 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.446 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 14.7 t80 -92.2 144.42 25.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 m -132.69 130.03 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -141.37 148.3 19.96 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.94 37.43 3.41 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -175.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.6 mt -85.96 159.63 54.05 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -70.71 153.79 64.34 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.959 2.439 . . . . 0.0 108.968 172.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.03 3.19 4.13 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.884 3.056 . . . . 0.0 112.354 -178.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -94.0 -27.12 16.5 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.3 pp -136.39 174.81 11.61 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-N 118.524 0.602 . . . . 0.0 110.252 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -163.39 5.8 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -145.41 -45.71 0.22 Allowed 'General case' 0 C--N 1.341 0.21 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -174.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -84.62 -34.14 23.17 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.622 0.646 . . . . 0.0 112.371 -172.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -73.45 -27.11 61.24 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.725 0.298 . . . . 0.0 110.509 -176.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.7 pt -88.01 -30.35 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 122.465 0.306 . . . . 0.0 110.916 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 56.8 m -71.75 -14.87 62.13 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.94 -22.07 17.64 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.5 m -88.2 -15.53 35.71 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -123.29 10.21 9.25 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.852 0.751 . . . . 0.0 113.003 -174.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -83.63 -12.01 56.54 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.601 0.36 . . . . 0.0 111.945 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.498 ' HG3' ' CD2' ' A' ' 88' ' ' PHE . 15.9 ptm180 -72.79 -18.22 61.5 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.498 ' CD2' ' HG3' ' A' ' 87' ' ' ARG . 70.0 m-85 -105.61 1.84 27.7 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.339 0.256 . . . . 0.0 111.348 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.5 163.41 9.82 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.22 140.78 45.6 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.228 2.618 . . . . 0.0 110.237 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.04 166.15 33.33 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.257 0.551 . . . . 0.0 112.279 -177.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.8 pt -137.15 -179.95 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.597 173.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.0 p -132.4 157.75 43.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 O-C-N 122.283 -0.261 . . . . 0.0 110.349 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -148.32 161.72 40.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.296 0.569 . . . . 0.0 111.47 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.421 ' CZ2' ' HE3' ' A' ' 98' ' ' LYS . 27.7 p90 -157.1 158.75 31.26 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 105.539 -2.022 . . . . 0.0 105.539 169.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.572 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 59.8 Cg_endo -72.81 -10.05 24.46 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.494 1.463 . . . . 0.0 111.018 -169.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.572 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 17.1 m-70 -104.93 19.3 20.82 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.682 1.193 . . . . 0.0 110.444 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.51 ' HE2' ' HA ' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -36.39 -62.67 0.44 Allowed 'General case' 0 C--N 1.34 0.161 0 C-N-CA 125.571 1.549 . . . . 0.0 113.756 -171.133 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 55.81 167.44 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.02 0.928 . . . . 0.0 112.534 -173.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -137.42 11.42 2.99 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.808 -0.558 . . . . 0.0 111.373 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 85.8 p -141.9 -3.09 1.13 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -142.61 142.61 32.15 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.323 0.511 . . . . 0.0 111.029 -178.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.4 t 55.68 171.06 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.867 1.667 . . . . 0.0 114.545 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -138.33 -7.69 1.53 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.881 1.273 . . . . 0.0 110.326 176.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.28 59.47 2.0 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -175.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.38 -42.18 67.34 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.187 1.924 . . . . 0.0 113.455 175.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -64.39 163.66 25.89 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.293 2.662 . . . . 0.0 112.48 173.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -79.66 -29.82 41.03 Favored 'General case' 0 C--N 1.339 0.125 0 O-C-N 122.25 -0.281 . . . . 0.0 111.315 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 171.45 29.19 0.02 OUTLIER Glycine 0 CA--C 1.527 0.787 0 CA-C-O 119.833 -0.426 . . . . 0.0 112.264 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.409 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.0 OUTLIER -142.39 141.7 32.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.719 0.759 . . . . 0.0 110.18 -179.547 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.01 -179.1 7.19 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.985 0.514 . . . . 0.0 110.306 -176.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.471 ' CZ ' ' C6 ' ' B' ' 4' ' ' ' U' . 4.4 m-85 -129.24 121.12 26.93 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -176.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 mp -83.92 147.35 27.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.592 0.711 . . . . 0.0 111.292 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 mp -124.12 104.03 8.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -88.25 162.82 16.42 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.779 0.323 . . . . 0.0 110.249 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -90.26 -21.55 22.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.216 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -132.03 149.79 52.33 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.533 0.206 . . . . 0.0 111.534 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -77.49 -16.63 58.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.231 0.213 . . . . 0.0 110.629 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 59.0 m -93.64 -17.71 22.97 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 122.457 0.303 . . . . 0.0 111.305 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.0 m -70.59 -44.58 67.03 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.5 p -74.36 -15.66 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.997 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -78.3 -33.8 49.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 122.013 -0.429 . . . . 0.0 109.926 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.27 -36.74 61.17 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.25 0.477 . . . . 0.0 110.843 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.415 ' HB2' ' CD2' ' A' ' 88' ' ' PHE . 0.5 OUTLIER -65.32 -40.18 93.41 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 57.5 mt -85.81 -9.93 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 O-C-N 121.663 -0.648 . . . . 0.0 111.893 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -107.66 -3.72 18.94 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.98 -0.45 . . . . 0.0 112.163 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -122.57 6.59 9.49 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 74.9 m -113.75 -172.94 2.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.399 0.545 . . . . 0.0 110.516 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 3.2 mp -68.05 154.22 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.674 0.79 . . . . 0.0 108.904 -170.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -137.16 157.56 46.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -143.82 62.16 1.36 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.208 0.528 . . . . 0.0 110.895 175.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.2 t70 50.93 8.84 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.904 1.681 . . . . 0.0 115.534 171.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -179.51 -19.02 0.03 OUTLIER Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.558 -0.713 . . . . 0.0 111.895 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -129.94 162.67 28.1 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 117.642 0.721 . . . . 0.0 109.39 171.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.19 163.04 16.89 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -145.22 162.03 38.12 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.965 0.412 . . . . 0.0 111.186 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.4 tp -141.89 145.51 34.67 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 170.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 79.4 m -84.23 128.61 34.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.3 m -141.21 166.13 18.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 122.898 0.479 . . . . 0.0 110.616 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.0 t -65.91 149.4 50.27 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.2 t -151.64 91.33 3.82 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -176.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -55.24 -11.37 4.08 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.252 3.302 . . . . 0.0 115.645 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.5 t -95.98 -10.37 28.77 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.577 1.081 . . . . 0.0 111.353 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.652 HG23 ' H ' ' A' ' 145' ' ' LYS . 2.2 mm -132.96 -160.1 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.652 ' H ' HG23 ' A' ' 144' ' ' ILE . 49.9 mmtm -103.93 -23.42 13.36 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -163.04 152.58 15.35 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.981 1.313 . . . . 0.0 108.351 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.636 ' HE2' ' C6 ' ' B' ' 1' ' ' ' C' . 21.6 ttmt -153.64 120.21 2.89 Favored Pre-proline 0 N--CA 1.457 -0.083 0 CA-C-N 118.062 0.392 . . . . 0.0 110.865 177.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -64.74 127.93 19.86 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.162 2.575 . . . . 0.0 110.105 168.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.4 p -100.79 136.03 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -85.03 146.88 26.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.579 0.352 . . . . 0.0 110.513 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 40.0 mm -125.12 143.03 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.882 0.873 . . . . 0.0 109.422 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.95 96.92 2.69 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -176.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.01 172.15 16.68 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.451 3.434 . . . . 0.0 111.897 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -109.24 150.48 27.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.776 0.322 . . . . 0.0 111.285 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -116.42 155.16 29.03 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.611 0.764 . . . . 0.0 111.234 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.9 mp -103.9 89.96 3.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 11.5 t -155.34 -36.25 0.09 Allowed 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -140.05 28.73 2.09 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.2 m -60.1 -35.92 76.3 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -154.24 161.51 41.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.78 0.432 . . . . 0.0 110.868 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -154.63 159.02 40.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.526 0.203 . . . . 0.0 110.62 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.9 m -138.95 149.98 23.45 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.016 0 C-N-CA 123.678 0.791 . . . . 0.0 109.585 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.2 mtm -137.83 8.71 2.8 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 -174.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.552 ' HB3' ' HG ' ' A' ' 201' ' ' CYS . 22.9 t0 -138.74 17.12 2.69 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.268 0.94 . . . . 0.0 112.936 -176.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.33 19.25 55.6 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 119.689 -0.506 . . . . 0.0 113.053 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 28.9 m 55.46 50.67 14.22 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 117.676 0.738 . . . . 0.0 112.327 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -62.11 165.75 7.83 Favored Pre-proline 0 CA--C 1.531 0.212 0 C-N-CA 123.748 0.819 . . . . 0.0 110.106 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.75 137.2 27.32 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.89 2.394 . . . . 0.0 110.534 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 12.8 tp -132.34 151.08 52.01 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 122.682 0.393 . . . . 0.0 110.483 -170.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 171' ' ' PRO . 13.2 t70 -147.7 140.66 14.93 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.901 -177.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 170' ' ' ASP . 50.7 Cg_exo -57.54 -21.6 47.07 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.569 2.846 . . . . 0.0 114.091 179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -85.3 6.37 26.54 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.519 0.6 . . . . 0.0 110.787 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -125.03 28.14 6.49 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 31.4 m -129.66 152.29 49.33 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.088 -173.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.3 tt -123.95 148.21 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 C-N-CA 123.366 0.666 . . . . 0.0 109.288 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.473 ' CD1' ' N6 ' ' B' ' 5' ' ' ' A' . 10.1 t80 -114.42 144.18 43.73 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 13.7 m -135.97 130.13 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 122.87 0.468 . . . . 0.0 110.056 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -132.26 164.62 23.8 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 87.37 16.93 59.69 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -175.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 28.3 m -64.52 151.05 92.55 Favored Pre-proline 0 CA--C 1.53 0.181 0 C-N-CA 122.464 0.305 . . . . 0.0 111.257 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -75.83 -174.97 2.24 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.954 3.103 . . . . 0.0 110.065 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -56.03 -50.86 84.89 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.545 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.83 141.73 21.83 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.15 1.9 . . . . 0.0 110.928 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.683 ' CD1' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -148.02 -75.99 0.18 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.799 178.219 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.683 ' H ' ' CD1' ' A' ' 184' ' ' LEU . 5.8 ptm180 49.75 132.48 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 128.445 2.698 . . . . 0.0 115.073 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.87 -20.19 65.87 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 121.721 -0.612 . . . . 0.0 112.302 -175.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 96.7 t -67.91 -58.32 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-N 117.817 0.28 . . . . 0.0 111.187 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -82.73 -19.44 37.93 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.263 -0.273 . . . . 0.0 111.268 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.9 tp -70.09 -35.91 74.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.66 -35.47 57.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 122.387 -0.196 . . . . 0.0 111.406 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 23.5 mmt -69.78 -38.49 76.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -175.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 45.6 mt -71.85 -43.64 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.548 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -61.64 -21.27 64.25 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 118.31 0.505 . . . . 0.0 111.34 173.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.66 -11.58 36.58 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.659 0.663 . . . . 0.0 112.158 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -96.44 -15.75 21.58 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 122.033 -0.417 . . . . 0.0 111.861 175.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.08 -21.84 10.33 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 118.155 0.434 . . . . 0.0 110.793 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -139.86 44.21 1.93 Allowed 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.175 0.59 . . . . 0.0 109.444 -178.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -42.47 135.93 3.74 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.168 0.889 . . . . 0.0 113.04 -174.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 131.45 12.59 2.0 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -176.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.03 148.42 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-N 117.541 0.671 . . . . 0.0 110.24 -178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . 0.552 ' HG ' ' HB3' ' A' ' 164' ' ' ASP . 51.5 t -125.64 -29.99 3.11 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.896 177.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -155.48 152.72 29.27 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.58 0.229 . . . . 0.0 110.893 -175.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.4 160.17 42.56 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.385 0.674 . . . . 0.0 110.761 175.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -178.58 173.55 45.88 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 176.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 3.4 mp -94.51 84.73 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 23.4 t70 53.66 -66.77 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -168.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' THR . . . . . 0.402 ' H ' ' HA ' ' A' ' 214' ' ' PRO . 38.8 p 43.0 54.14 4.9 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -60.65 132.31 91.27 Favored Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.19 -14.78 14.79 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.43 3.42 . . . . 0.0 113.886 -173.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -91.83 -39.68 11.62 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.616 0.644 . . . . 0.0 110.211 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.42 -7.8 34.02 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 65.8 mttm 52.02 46.34 26.77 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 124.618 1.167 . . . . 0.0 111.675 174.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.93 154.5 43.51 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -175.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.402 ' HA ' ' H ' ' A' ' 207' ' ' THR . 33.5 Cg_endo -83.58 173.21 9.69 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.918 3.079 . . . . 0.0 110.868 173.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.524 ' HA ' ' C4 ' ' B' ' 4' ' ' ' U' . 60.9 mttp -127.8 18.57 6.72 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.999 0.519 . . . . 0.0 111.621 176.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.07 10.27 56.03 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.886 -0.397 . . . . 0.0 112.27 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -134.91 148.7 50.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.45 0.625 . . . . 0.0 110.306 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -87.49 156.14 27.69 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 121.455 0.475 . . . . 0.0 113.146 -173.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -144.71 149.26 35.31 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 169.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 71.8 t -138.56 144.2 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -129.07 148.86 51.05 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.068 0.461 . . . . 0.0 110.39 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -120.62 154.14 35.86 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.101 -173.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 67.3 p -90.22 7.74 36.61 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.284 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -134.96 136.69 42.43 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.665 0.786 . . . . 0.0 109.655 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -75.9 -16.95 59.95 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.0 tp60 -77.71 -36.82 50.6 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 23.7 m -78.57 -24.65 45.42 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.287 -0.258 . . . . 0.0 110.38 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.46 -49.94 69.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.0 pt -75.09 -16.34 15.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.07 0 CA-C-N 117.744 0.247 . . . . 0.0 111.522 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.79 -25.59 37.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.83 0.286 . . . . 0.0 111.006 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -82.57 -22.23 34.95 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 21.8 pt -108.92 20.88 5.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.004 0.522 . . . . 0.0 110.538 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.3 t -77.41 -9.58 58.95 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.874 0.47 . . . . 0.0 111.659 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -152.12 144.12 23.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -53.69 -29.32 38.43 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -126.38 119.9 28.48 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.849 0.357 . . . . 0.0 110.415 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 2.7 m -84.37 159.19 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.207 175.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -94.86 138.53 32.52 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -129.83 14.39 5.85 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.908 -175.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.63 140.29 29.9 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -172.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -147.59 21.21 1.17 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.408 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 244' ' ' ILE . . . 87.59 139.74 6.32 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -177.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 54.85 3.28 0.05 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.186 1.394 . . . . 0.0 113.426 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . 0.411 ' H ' ' C ' ' A' ' 242' ' ' GLY . 62.0 mt -145.43 142.04 22.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 C-N-CA 124.23 1.012 . . . . 0.0 108.619 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -151.89 136.36 16.87 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 176.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -148.22 164.99 32.29 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.802 0.841 . . . . 0.0 109.62 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.57 155.92 38.31 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 8.5 p -155.88 152.32 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -82.68 143.58 30.85 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.2 m -116.73 153.82 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 121.631 0.729 . . . . 0.0 112.949 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.46 ' HD2' ' N6 ' ' B' ' 5' ' ' ' A' . 32.4 ttmt -151.24 141.43 14.53 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.833 174.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -58.23 136.99 78.24 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.61 2.207 . . . . 0.0 108.364 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -70.07 132.65 46.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.266 -173.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . 0.417 HG23 ' H ' ' A' ' 255' ' ' LEU . 0.3 OUTLIER 53.17 172.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 127.111 2.164 . . . . 0.0 113.91 178.078 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.417 ' H ' HG23 ' A' ' 254' ' ' VAL . 1.8 pt? . . . . . 0 C--O 1.25 1.085 0 CA-C-O 117.005 -1.474 . . . . 0.0 112.37 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.636 ' C6 ' ' HE2' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.421 -2.679 1 O4'-C1'-N19 112.305 4.105 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.201 0 C3'-C2'-C1' 104.799 3.665 . 0.639 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.446 ' C6 ' ' CE2' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.934 1 O4'-C1'-N19 112.948 4.748 . 0.155 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.524 ' C4 ' ' HA ' ' A' ' 215' ' ' LYS . . . . . . . . 0 O4'--C4' 1.421 -2.662 0 O4'-C1'-N19 111.595 3.395 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.473 ' N6 ' ' CD1' ' A' ' 176' ' ' PHE . . . . . . . . 0 O4'--C4' 1.417 -3.005 0 C5'-C4'-C3' 110.258 -3.494 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 111.271 0.101 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 58.0 t60 -147.85 161.57 41.02 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.981 0.513 . . . . 0.0 110.256 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -149.18 164.59 34.3 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 122.907 0.483 . . . . 0.0 110.818 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -77.0 166.8 22.84 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.827 0.451 . . . . 0.0 110.332 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.62 -164.36 20.9 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.69 157.92 45.65 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.377 0.671 . . . . 0.0 110.477 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? 53.22 30.2 9.58 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.138 0.575 . . . . 0.0 111.254 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.6 m -88.6 8.39 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 123.614 0.765 . . . . 0.0 111.904 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -70.98 157.45 38.18 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.987 0.422 . . . . 0.0 111.222 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.77 157.55 19.0 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.202 0.601 . . . . 0.0 111.324 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -134.27 160.79 36.8 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 121.135 0.493 . . . . 0.0 111.121 -174.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -88.51 31.88 0.81 Allowed 'General case' 0 C--N 1.334 -0.068 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.592 ' HA ' ' CE1' ' A' ' 115' ' ' PHE . 99.0 mtt180 54.62 18.42 2.04 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.192 0.597 . . . . 0.0 112.299 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -146.25 133.48 20.55 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 m -139.94 161.97 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -95.59 143.06 27.2 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 169.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.7 m -131.39 118.52 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 172.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.58 138.96 14.68 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.481 -172.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.57 145.44 4.85 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.446 0.546 . . . . 0.0 114.386 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.7 tp -164.96 132.79 2.47 Favored Pre-proline 0 N--CA 1.453 -0.283 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -77.19 156.04 33.34 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.937 1.758 . . . . 0.0 110.329 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -62.43 0.78 1.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 124.544 3.496 . . . . 0.0 114.913 -178.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -134.25 43.54 2.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.598 0.636 . . . . 0.0 111.552 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mt -141.32 151.5 19.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -135.99 -179.47 5.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.916 0.389 . . . . 0.0 111.595 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -45.76 -42.36 11.91 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.59 1.156 . . . . 0.0 112.075 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.94 -29.57 62.09 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.192 0.451 . . . . 0.0 111.92 -173.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -80.79 -29.83 36.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 122.29 -0.256 . . . . 0.0 110.823 -172.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.2 pt -86.41 -26.02 6.27 Favored 'Isoleucine or valine' 0 C--N 1.338 0.078 0 O-C-N 121.782 -0.574 . . . . 0.0 109.899 173.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 61.7 m -70.24 -14.15 62.49 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 172.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.26 -21.97 16.95 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.393 0.277 . . . . 0.0 111.606 173.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.4 m -77.06 -21.56 54.26 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.255 0.479 . . . . 0.0 111.885 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -111.89 4.57 18.36 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 117.825 0.284 . . . . 0.0 111.649 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -71.64 -5.9 37.0 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.966 -0.459 . . . . 0.0 111.964 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.4 tpt85 -67.1 -10.0 45.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.189 0.996 . . . . 0.0 110.627 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -126.56 33.03 5.06 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.47 0.308 . . . . 0.0 111.464 -174.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.68 178.45 38.07 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.948 -0.461 . . . . 0.0 111.948 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.38 141.74 35.81 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.882 3.055 . . . . 0.0 111.305 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.44 173.48 14.83 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.811 0.844 . . . . 0.0 110.088 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.89 167.27 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.147 -177.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.29 148.37 29.9 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -150.91 163.96 37.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.108 0.48 . . . . 0.0 110.827 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.464 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 33.7 p90 -153.5 162.98 25.22 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 176.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.624 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 40.3 Cg_endo -73.59 -10.19 23.39 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.644 2.896 . . . . 0.0 110.923 -169.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.624 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 74.4 m-70 -106.06 18.75 21.59 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.295 1.038 . . . . 0.0 111.257 -178.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -48.91 151.44 1.24 Allowed 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.895 0.878 . . . . 0.0 113.154 -176.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.82 169.99 16.55 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.008 0.923 . . . . 0.0 110.319 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -105.92 -3.85 21.32 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.978 0.511 . . . . 0.0 110.896 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.7 t -78.06 160.03 28.35 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.656 0.383 . . . . 0.0 111.212 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -66.96 161.38 24.33 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.567 0.747 . . . . 0.0 110.592 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.1 m 55.02 53.17 10.67 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.501 0.72 . . . . 0.0 111.652 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -49.68 133.49 21.18 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.927 0.891 . . . . 0.0 110.519 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -158.62 131.51 4.54 Favored Pre-proline 0 N--CA 1.453 -0.313 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -71.1 158.54 54.79 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.73 2.953 . . . . 0.0 110.686 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.76 -15.63 4.69 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 124.667 3.578 . . . . 0.0 115.977 -178.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -142.76 -58.18 0.44 Allowed 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.288 0.949 . . . . 0.0 111.979 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 154.53 21.98 0.04 OUTLIER Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.831 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -113.93 142.53 46.01 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.968 1.384 . . . . 0.0 108.238 177.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.27 176.86 9.24 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.085 0.402 . . . . 0.0 111.754 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -142.95 137.15 29.2 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -177.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.77 148.7 23.11 Favored 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -174.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.2 mp -130.66 147.37 52.33 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.911 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.592 ' CE1' ' HA ' ' A' ' 65' ' ' ARG . 3.4 p90 -158.93 178.84 9.64 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.289 0.636 . . . . 0.0 109.297 175.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -107.76 -21.03 13.02 Favored 'General case' 0 N--CA 1.456 -0.128 0 O-C-N 122.187 -0.32 . . . . 0.0 111.782 -174.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -129.71 144.19 51.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.863 0.363 . . . . 0.0 111.335 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -74.68 -14.9 60.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.707 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 76.7 p -70.92 -21.65 62.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.354 -0.216 . . . . 0.0 110.902 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.4 t -75.35 -40.83 57.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.446 ' HB ' ' CZ ' ' A' ' 115' ' ' PHE . 4.7 p -82.8 -23.8 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -67.67 -37.83 82.9 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.108 -0.37 . . . . 0.0 110.004 177.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.4 -35.9 30.19 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.97 -18.25 60.41 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.58 0.627 . . . . 0.0 110.985 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.0 mt -93.82 -23.71 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 117.948 0.34 . . . . 0.0 110.748 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -83.94 -13.68 52.81 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.793 -0.567 . . . . 0.0 111.63 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -124.87 46.38 2.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.056 0.543 . . . . 0.0 111.125 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 18.6 p -137.75 -176.55 4.46 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 44.1 mt -86.29 154.98 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 125.168 1.387 . . . . 0.0 108.32 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.55 156.98 47.49 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.124 -0.36 . . . . 0.0 110.729 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.24 -176.64 5.37 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -42.75 -25.9 0.11 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -169.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.33 14.04 0.13 Allowed Glycine 0 CA--C 1.528 0.87 0 CA-C-N 119.163 0.892 . . . . 0.0 112.844 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -145.0 170.97 15.13 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 117.784 0.792 . . . . 0.0 111.05 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 75.1 mt -108.01 166.63 10.58 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -149.87 155.74 40.57 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.79 0.328 . . . . 0.0 110.739 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.6 mp -143.75 160.67 40.33 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 36.9 t -87.85 156.64 19.28 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.78 165.08 30.74 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-O 120.846 0.355 . . . . 0.0 111.109 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.4 t -115.62 179.33 4.0 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.562 0.745 . . . . 0.0 109.728 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.485 ' HB3' ' CD ' ' A' ' 142' ' ' PRO . 5.7 m 61.48 -172.77 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.321 0.648 . . . . 0.0 110.143 -176.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.485 ' CD ' ' HB3' ' A' ' 141' ' ' SER . 97.4 Cg_endo -74.07 135.96 21.75 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.703 1.602 . . . . 0.0 111.423 -169.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.7 m -147.29 42.85 1.11 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.619 0.768 . . . . 0.0 109.206 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 3.2 mp 63.4 -62.2 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.753 1.621 . . . . 0.0 111.167 -173.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -151.99 -62.09 0.17 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 174.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -160.55 130.46 5.15 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.897 0.479 . . . . 0.0 110.404 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.638 ' HD3' ' C6 ' ' B' ' 1' ' ' ' C' . 37.3 mttp -151.13 103.05 2.97 Favored Pre-proline 0 CA--C 1.53 0.174 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.97 135.29 58.3 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.402 2.735 . . . . 0.0 111.02 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.9 p -90.45 133.28 32.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -100.75 154.53 18.54 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -174.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.9 mm -131.08 147.64 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.946 0.898 . . . . 0.0 110.71 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -160.59 99.49 1.36 Allowed Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.009 0.524 . . . . 0.0 110.138 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.84 174.18 3.2 Favored 'Trans proline' 0 CA--C 1.531 0.356 1 C-N-CA 125.788 4.325 . . . . 0.0 115.969 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -108.18 156.48 19.28 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.539 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -102.58 125.22 49.23 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.515 0.674 . . . . 0.0 111.102 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.686 ' H ' ' CD1' ' A' ' 156' ' ' LEU . 1.9 mp -67.19 -19.77 65.61 Favored 'General case' 0 C--O 1.23 0.041 0 C-N-CA 125.102 1.361 . . . . 0.0 114.22 -172.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 81.1 p -87.11 -4.93 59.17 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -167.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -146.37 27.71 1.12 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.564 1.074 . . . . 0.0 113.318 -176.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.4 m -72.02 -20.98 61.61 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.8 -0.562 . . . . 0.0 112.377 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -150.49 155.36 39.34 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 122.801 0.44 . . . . 0.0 110.949 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -150.09 162.12 41.03 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 10.9 p -149.19 149.81 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.9 ttm -123.02 22.13 9.64 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -170.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -158.43 -41.16 0.06 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.22 10.26 59.2 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.723 173.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.5 t -141.79 -24.2 0.7 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.573 1.186 . . . . 0.0 114.163 -176.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -80.32 130.51 65.25 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 119.625 1.102 . . . . 0.0 110.615 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -61.11 159.49 29.97 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.667 2.912 . . . . 0.0 111.457 173.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.7 mt -108.71 154.36 22.14 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.514 0.326 . . . . 0.0 110.122 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -151.58 138.44 11.96 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.51 -14.09 42.38 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.143 2.562 . . . . 0.0 113.182 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -86.32 -6.6 58.92 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.711 0.687 . . . . 0.0 110.491 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -125.65 15.71 8.14 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.665 0.386 . . . . 0.0 111.355 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 46.4 m -119.5 143.64 47.45 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 121.131 0.491 . . . . 0.0 110.905 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.47 148.7 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.088 -177.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -115.96 151.9 34.51 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.47 111.44 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.291 0.637 . . . . 0.0 109.911 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -82.92 126.58 7.54 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 118.2 -110.87 2.05 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.4 p 36.68 63.95 2.69 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.407 0.683 . . . . 0.0 111.573 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.22 176.75 3.66 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.251 3.301 . . . . 0.0 112.731 -174.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.435 ' N ' ' CD ' ' A' ' 183' ' ' PRO . 9.8 ptm180 -59.81 -21.14 0.71 Allowed Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -173.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 182' ' ' ARG . 46.9 Cg_exo -60.35 -12.1 18.98 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.926 1.751 . . . . 0.0 112.882 172.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 89.2 mt -104.71 174.24 5.96 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.976 0.51 . . . . 0.0 110.605 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -152.46 153.33 33.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.244 1.017 . . . . 0.0 109.376 -170.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.21 -26.37 65.69 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.27 -48.68 80.31 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 CA-C-N 118.418 0.554 . . . . 0.0 111.291 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -84.17 -20.8 31.79 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.94 -40.13 79.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 174.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.04 -38.08 78.93 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 122.323 -0.235 . . . . 0.0 111.567 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 24.4 mmt -69.45 -32.47 71.44 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.235 -0.29 . . . . 0.0 111.069 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 88.7 mt -71.8 -32.19 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.2 mmt -73.18 -23.23 60.39 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.943 -0.473 . . . . 0.0 110.642 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -82.19 -23.59 35.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 122.146 -0.346 . . . . 0.0 111.213 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -86.14 -19.58 29.91 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.94 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -116.25 -16.16 10.96 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -133.33 19.04 3.99 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -173.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.03 -144.68 38.34 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -70.72 113.36 4.76 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 112.256 -0.338 . . . . 0.0 112.256 -174.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 40.4 t -98.51 154.41 3.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 C-N-CA 124.143 0.977 . . . . 0.0 108.614 174.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.7 p -114.79 -31.45 6.13 Favored 'General case' 0 C--O 1.227 -0.084 0 CA-C-N 118.397 0.544 . . . . 0.0 111.324 175.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -148.19 144.44 27.73 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-N 118.492 0.587 . . . . 0.0 110.589 175.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -159.29 147.52 17.75 Favored 'General case' 0 N--CA 1.458 -0.03 0 CA-C-O 120.851 0.358 . . . . 0.0 111.075 177.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 163.41 -158.94 31.48 Favored Glycine 0 CA--C 1.522 0.481 0 O-C-N 121.924 -0.485 . . . . 0.0 112.289 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 44.0 mm -96.14 140.99 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -66.36 139.03 58.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.98 0.419 . . . . 0.0 110.8 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 55.0 p -136.31 155.7 49.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.277 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -80.88 126.59 77.28 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 171.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.2 -10.56 17.75 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.842 3.695 . . . . 0.0 113.405 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -103.73 -27.37 12.31 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.731 0.696 . . . . 0.0 110.398 -177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 81.7 mt -105.08 -7.34 19.21 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.775 0.43 . . . . 0.0 110.894 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm 53.06 40.74 31.7 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.048 0.939 . . . . 0.0 112.443 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.417 ' CE1' ' HB2' ' A' ' 65' ' ' ARG . 21.2 m-85 -127.82 155.55 77.23 Favored Pre-proline 0 N--CA 1.467 0.425 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.558 -175.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.7 146.56 92.37 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.272 1.982 . . . . 0.0 110.735 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . 0.534 ' HZ1' ' HB3' ' A' ' 215' ' ' LYS . 0.0 OUTLIER -130.98 31.25 4.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.031 0.932 . . . . 0.0 109.557 -176.128 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.53 156.93 2.62 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.231 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 54.59 -175.42 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.6 0.76 . . . . 0.0 111.999 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -139.36 174.09 22.41 Favored Glycine 0 CA--C 1.521 0.466 0 O-C-N 121.734 -0.604 . . . . 0.0 111.96 -176.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -148.93 154.32 39.26 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 62.8 t -140.27 145.84 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.45 150.37 52.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.119 0.485 . . . . 0.0 110.936 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -131.54 159.97 36.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.112 -175.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 77.3 p -92.95 -5.76 50.01 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.261 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -124.35 144.39 50.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.105 0.562 . . . . 0.0 111.061 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -78.33 -9.61 59.33 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.095 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -82.92 -38.92 22.17 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.2 m -75.91 -26.49 57.01 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -64.24 -50.94 66.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 175.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.45 -14.23 16.49 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 CA-C-N 118.051 0.387 . . . . 0.0 111.309 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.47 -21.16 32.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 117.708 0.231 . . . . 0.0 111.065 175.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.56 -14.91 36.48 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.0 pt -119.31 23.78 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.315 0.646 . . . . 0.0 110.567 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 88.7 p -76.2 -20.12 57.78 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.222 0.609 . . . . 0.0 112.544 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -149.77 133.01 16.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -54.88 -37.53 66.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -175.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -122.01 116.61 24.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.154 0.434 . . . . 0.0 110.615 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.5 m -97.95 158.41 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.311 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -89.75 144.19 26.18 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.931 0.395 . . . . 0.0 110.727 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.0 mp -138.22 98.73 3.68 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -138.54 76.19 1.56 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.928 -172.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -137.24 152.18 49.54 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 66.71 25.27 72.91 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 63.06 21.85 13.11 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.284 1.034 . . . . 0.0 112.21 -175.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 68.7 mt -92.34 163.99 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -152.43 110.02 3.6 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -146.1 164.11 33.21 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.824 0.45 . . . . 0.0 110.841 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.01 157.8 44.32 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 123.818 0.847 . . . . 0.0 109.188 178.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.58 149.54 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -87.42 121.87 30.42 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.4 m -95.6 150.45 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 CA-C-N 118.139 0.427 . . . . 0.0 111.286 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.468 ' HG3' ' H61' ' B' ' 5' ' ' ' A' . 0.0 OUTLIER -158.27 160.21 29.74 Favored Pre-proline 0 N--CA 1.457 -0.096 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 171.024 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.03 135.18 69.21 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.725 2.283 . . . . 0.0 109.139 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -73.64 112.92 10.2 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 119.221 -0.992 . . . . 0.0 111.421 -176.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.6 p 44.25 34.81 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.554 1.542 . . . . 0.0 113.051 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 60.4 tp . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.187 -1.387 . . . . 0.0 110.433 -178.209 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.638 ' C6 ' ' HD3' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.411 -3.492 0 O5'-C5'-C4' 113.577 2.412 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . 0.483 " C5'" " H4'" ' B' ' 1' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.416 -3.066 2 O4'-C1'-N19 113.871 5.671 OUTLIER-DELTA 0.0 OUTLIER '7D dist 0b' 0.0 . . . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.184 1 O4'-C1'-N19 113.236 5.036 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.515 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.416 -3.062 0 C5'-C4'-C3' 110.409 -3.394 . 0.01 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.498 ' C8 ' H5'' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.414 -3.275 0 O4'-C1'-N19 111.671 3.471 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 120.688 0.28 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -149.69 164.84 34.12 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.153 0.581 . . . . 0.0 110.523 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.53 12.22 1.91 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.109 0.564 . . . . 0.0 111.496 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -140.58 173.07 11.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.317 0.647 . . . . 0.0 111.002 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.11 -179.52 52.83 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -147.76 171.52 15.55 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.173 0.589 . . . . 0.0 110.556 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.3 ttp85 -136.2 -19.02 1.5 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.889 0.476 . . . . 0.0 111.385 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.3 p -153.52 153.58 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 122.905 0.482 . . . . 0.0 109.915 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -146.16 152.81 39.85 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.25 148.82 37.35 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 122.356 -0.215 . . . . 0.0 110.927 -178.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -166.2 164.98 17.82 Favored 'General case' 0 CA--C 1.52 -0.193 0 O-C-N 123.552 0.533 . . . . 0.0 109.699 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.427 ' C ' ' H ' ' A' ' 66' ' ' LYS . 25.5 t -108.37 156.95 18.84 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 171.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.493 ' CD ' ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -76.6 26.77 0.13 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.497 0.719 . . . . 0.0 112.086 179.235 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 64' ' ' SER . 47.7 pttt -136.44 141.61 43.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.048 0.939 . . . . 0.0 109.627 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 m -147.25 160.87 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.055 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.767 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.461 ' CZ ' ' C6 ' ' B' ' 3' ' ' ' U' . 3.4 t80 -100.49 143.43 30.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.2 m -134.2 132.66 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 173.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.21 -163.59 9.57 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.3 21.37 66.28 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.001 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.471 HD21 ' H ' ' A' ' 72' ' ' LEU . 2.1 pt? -118.44 150.02 47.16 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 118.179 0.989 . . . . 0.0 109.954 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.4 168.98 21.97 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 124.09 3.194 . . . . 0.0 113.706 -169.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -83.36 0.31 9.55 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 124.116 3.211 . . . . 0.0 111.65 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -100.89 11.47 39.52 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -173.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.9 pp -122.39 177.65 3.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -142.65 -175.58 4.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.921 0.391 . . . . 0.0 111.578 -175.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -50.03 -31.88 14.04 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.356 1.062 . . . . 0.0 112.258 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -71.45 -29.77 65.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 117.894 0.316 . . . . 0.0 111.542 -176.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -82.21 -31.78 30.15 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 122.184 -0.323 . . . . 0.0 110.42 -174.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 66.0 mt -77.49 -42.42 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.2 m -66.9 -22.97 65.95 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.67 -18.3 28.2 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.9 m -77.57 -27.61 51.51 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 118.424 0.557 . . . . 0.0 111.685 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -120.98 12.71 11.24 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -177.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.49 -18.05 64.44 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.293 0.497 . . . . 0.0 112.249 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -75.6 -10.18 59.22 Favored 'General case' 0 C--N 1.338 0.093 0 O-C-N 122.033 -0.417 . . . . 0.0 111.944 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -103.8 23.21 13.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.559 0.344 . . . . 0.0 111.319 -176.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.93 179.21 31.81 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.59 150.2 68.95 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.369 2.713 . . . . 0.0 110.772 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -162.77 164.6 26.18 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.02 -170.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.63 164.55 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.752 174.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -129.58 151.05 35.24 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -143.23 159.07 43.0 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.487 0.66 . . . . 0.0 112.02 -174.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.459 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 30.2 p90 -151.88 159.52 32.96 Favored Pre-proline 0 N--CA 1.452 -0.349 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 170.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.53 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 94.2 Cg_endo -65.68 -13.99 42.55 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 123.525 2.816 . . . . 0.0 112.505 -169.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.53 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 21.0 m170 -106.59 13.72 27.9 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.066 0.546 . . . . 0.0 111.549 -176.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.7 tptm -49.81 151.51 1.78 Allowed 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.844 0.858 . . . . 0.0 112.739 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -146.4 165.67 28.64 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.587 0.755 . . . . 0.0 110.487 -177.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -86.23 -9.76 55.92 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.932 0.493 . . . . 0.0 110.382 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 94.5 p -82.19 -178.19 6.93 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.601 0.76 . . . . 0.0 110.986 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -74.78 15.06 0.41 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.504 0.721 . . . . 0.0 111.559 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.8 m -77.93 58.64 1.97 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.595 0.758 . . . . 0.0 110.635 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -75.16 24.29 0.1 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.144 0.977 . . . . 0.0 112.191 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -118.62 123.2 29.33 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 118.132 0.424 . . . . 0.0 110.75 -175.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.94 166.68 8.26 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.343 3.362 . . . . 0.0 111.728 173.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.73 -17.12 47.99 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.493 2.795 . . . . 0.0 112.227 176.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -141.16 -69.96 0.37 Allowed 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 175.78 -17.02 0.04 OUTLIER Glycine 0 CA--C 1.526 0.735 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.101 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.437 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.2 OUTLIER -76.05 150.12 37.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.025 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.69 -176.7 5.61 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.961 0.41 . . . . 0.0 111.427 -174.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -140.27 128.82 22.85 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -89.98 149.54 22.52 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.656 0.741 . . . . 0.0 112.372 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.2 mp -113.09 138.6 49.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -134.62 170.64 15.5 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.047 0.539 . . . . 0.0 110.388 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -101.87 -24.17 14.06 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.705 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -135.83 153.57 51.46 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -75.48 -15.51 60.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.735 171.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 m -78.91 -20.04 50.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 176.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.6 m -76.87 -42.3 40.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.7 m -74.15 -20.18 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -72.1 -41.33 67.4 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.71 -34.52 62.62 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 122.168 -0.333 . . . . 0.0 111.557 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 pp -77.41 -17.9 57.73 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.372 0.533 . . . . 0.0 111.613 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.9 mt -95.46 -17.48 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 122.39 0.276 . . . . 0.0 111.014 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -99.41 -11.2 21.36 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.864 -0.523 . . . . 0.0 112.273 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -114.84 29.34 8.09 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.811 0.444 . . . . 0.0 111.921 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 17.6 p -137.41 -173.8 3.58 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.994 0.426 . . . . 0.0 111.647 -176.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.2 mm -84.67 160.53 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 124.596 1.158 . . . . 0.0 109.427 -175.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -132.23 158.45 41.75 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.681 0.276 . . . . 0.0 110.821 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.3 74.52 1.33 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.436 0.636 . . . . 0.0 110.671 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 51.97 9.39 0.09 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.16 -9.87 0.06 OUTLIER Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.115 0.87 . . . . 0.0 113.289 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.6 pttt -146.34 178.25 8.39 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 174.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.6 mp -125.33 169.69 12.07 Favored 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -171.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.434 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 0.3 OUTLIER -140.87 156.01 46.2 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.591 -175.744 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.4 tp -137.06 142.89 42.41 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 47.4 t -82.97 132.58 35.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.518 0.599 . . . . 0.0 109.99 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 19.9 m -137.38 -10.42 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.4 m 46.3 46.1 13.41 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.531 0.732 . . . . 0.0 112.786 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.7 m -57.17 156.15 15.18 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.399 0.68 . . . . 0.0 111.785 -178.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -72.13 20.08 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 125.008 3.805 . . . . 0.0 114.19 -176.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 21.7 m -133.13 138.62 46.71 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER 55.31 -149.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -170.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -139.12 145.7 39.76 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.449 0.568 . . . . 0.0 110.554 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 49.62 39.46 17.36 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.417 1.087 . . . . 0.0 112.969 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.471 ' CE ' ' C6 ' ' B' ' 1' ' ' ' C' . 2.6 tppp? -55.63 118.27 18.8 Favored Pre-proline 0 CA--C 1.53 0.195 0 C-N-CA 123.637 0.775 . . . . 0.0 111.964 -177.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.434 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 25.8 Cg_endo -93.8 129.53 0.66 Allowed 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 124.252 3.301 . . . . 0.0 109.765 169.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.3 131.53 38.18 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -89.23 151.15 22.3 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.605 0.762 . . . . 0.0 111.503 -173.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 48.5 mm -134.94 144.48 34.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 123.967 0.907 . . . . 0.0 111.344 -177.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.0 ttp85 -152.57 116.11 2.89 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 168.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.59 165.01 33.45 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.877 3.051 . . . . 0.0 111.908 177.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.417 ' CD1' ' HE3' ' A' ' 66' ' ' LYS . 34.5 t-105 -100.66 152.5 20.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.351 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -104.98 153.75 21.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.676 0.791 . . . . 0.0 112.209 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.3 mp -94.63 -2.56 51.13 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -172.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.4 m -79.52 -10.38 59.79 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -173.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 160' ' ' ASP . 5.3 m-20 -136.17 -110.44 0.2 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.733 0.697 . . . . 0.0 111.738 -179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 m 64.03 -33.4 0.14 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.541 1.937 . . . . 0.0 113.951 -173.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 158' ' ' ASP . 4.5 p30 -153.49 151.82 30.27 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.101 0.56 . . . . 0.0 110.07 176.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -157.63 153.84 27.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.58 152.68 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 121.887 -0.508 . . . . 0.0 109.744 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 71.4 mtm -128.96 29.92 5.13 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -159.72 -44.5 0.05 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.54 3.93 59.68 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.102 -0.832 . . . . 0.0 113.635 174.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.3 m -138.53 -0.8 1.93 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -176.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -79.17 141.36 57.9 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 120.076 1.307 . . . . 0.0 110.261 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.11 153.21 41.08 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.369 2.713 . . . . 0.0 108.815 173.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 63.9 mt -121.46 150.12 42.04 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.631 0.253 . . . . 0.0 110.961 -177.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -144.22 139.02 15.37 Favored Pre-proline 0 N--CA 1.456 -0.157 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -68.34 -9.23 25.3 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.681 2.921 . . . . 0.0 112.613 -173.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -88.5 -1.68 58.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.715 0.406 . . . . 0.0 110.771 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -128.44 33.2 4.72 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.891 0.476 . . . . 0.0 109.733 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 11.5 m -126.14 153.45 44.55 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.077 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.6 tt -121.84 151.61 25.43 Favored 'Isoleucine or valine' 0 C--O 1.229 0.024 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -116.36 148.22 40.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 172.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.39 117.71 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.497 ' HA2' ' CB ' ' A' ' 217' ' ' ALA . . . -119.83 159.65 14.86 Favored Glycine 0 C--N 1.336 0.564 0 O-C-N 123.202 0.314 . . . . 0.0 113.586 -171.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.84 24.77 12.57 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.24 107.57 57.79 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 117.197 0.498 . . . . 0.0 110.969 -176.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.88 -33.61 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.759 2.306 . . . . 0.0 112.66 176.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.658 ' H ' ' CD ' ' A' ' 183' ' ' PRO . 71.7 mtt180 -149.81 -38.12 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -177.178 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.658 ' CD ' ' H ' ' A' ' 182' ' ' ARG . 51.8 Cg_exo -59.29 -168.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 124.029 3.153 . . . . 0.0 114.857 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 48.0 mt 65.35 -53.65 0.34 Allowed 'General case' 0 C--O 1.23 0.064 0 C-N-CA 126.963 2.105 . . . . 0.0 114.224 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 54.18 -163.43 0.11 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.947 0.794 . . . . 0.0 109.382 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -103.85 -37.2 7.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.964 -0.46 . . . . 0.0 110.806 172.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 69.0 t -67.16 -56.45 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 C-N-CA 122.391 0.276 . . . . 0.0 111.183 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -74.34 -22.29 59.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.856 -0.156 . . . . 0.0 110.961 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.6 tp -68.47 -35.94 78.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.39 -28.75 61.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.311 -0.243 . . . . 0.0 111.346 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 26.3 mmt -70.7 -35.2 72.64 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 117.704 0.229 . . . . 0.0 111.614 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.62 -32.17 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 O-C-N 121.64 -0.663 . . . . 0.0 109.683 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.6 mmt -76.66 -15.82 59.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 121.897 -0.502 . . . . 0.0 111.894 -177.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -97.9 -24.31 15.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.697 0.681 . . . . 0.0 111.553 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -86.43 -16.36 37.42 Favored 'General case' 0 C--N 1.34 0.165 0 O-C-N 121.872 -0.517 . . . . 0.0 112.334 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -117.49 -20.19 9.15 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.355 0.525 . . . . 0.0 111.082 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -140.03 42.65 1.94 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.928 0.491 . . . . 0.0 109.752 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.51 137.15 4.38 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.032 0.825 . . . . 0.0 112.782 -175.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 122.7 1.38 9.85 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.48 157.16 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 123.837 0.855 . . . . 0.0 109.889 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.9 p -129.41 -32.15 1.99 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -147.15 152.0 37.71 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.217 0.917 . . . . 0.0 111.891 -177.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -149.6 160.91 43.1 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.481 0.312 . . . . 0.0 111.176 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 168.39 -170.21 42.01 Favored Glycine 0 C--N 1.336 0.534 0 O-C-N 121.909 -0.494 . . . . 0.0 112.122 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.9 mp -105.08 146.02 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -65.81 117.88 8.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.552 0.215 . . . . 0.0 110.434 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 76.4 p -140.49 162.59 34.99 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 122.759 0.424 . . . . 0.0 110.266 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -115.98 130.75 24.16 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.28 -1.98 10.97 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 124.811 3.674 . . . . 0.0 114.335 -170.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -68.0 -32.42 72.79 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 119.025 0.829 . . . . 0.0 110.104 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.31 8.33 1.19 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.512 0.725 . . . . 0.0 109.853 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt 53.03 39.89 30.26 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.219 1.008 . . . . 0.0 111.434 -174.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -94.25 151.92 39.86 Favored Pre-proline 0 N--CA 1.455 -0.178 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.719 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.9 141.93 37.95 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.559 2.173 . . . . 0.0 110.821 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.67 14.67 6.48 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.867 0.867 . . . . 0.0 109.92 -178.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 165.69 -165.09 37.78 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.497 ' CB ' ' HA2' ' A' ' 178' ' ' GLY . . . -86.08 -160.21 0.53 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.349 1.06 . . . . 0.0 110.829 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -74.56 158.87 51.92 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 122.189 -0.32 . . . . 0.0 112.777 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.06 153.26 38.69 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 50.1 t -145.27 146.12 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.06 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.39 145.33 50.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.547 0.339 . . . . 0.0 110.405 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -128.84 -23.09 3.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.312 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 46.0 m 56.28 25.18 9.01 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -178.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -128.05 151.84 48.69 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -73.43 -30.99 63.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -176.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -85.12 -39.83 17.46 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 111.373 0.138 . . . . 0.0 111.373 -172.387 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 65.7 p -77.54 -23.07 50.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.16 -0.337 . . . . 0.0 110.249 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -67.6 -52.75 34.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 175.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 32.7 pt -73.08 -18.04 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.63 -29.38 30.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.159 0.436 . . . . 0.0 111.491 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -77.62 -23.77 49.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.931 0.332 . . . . 0.0 111.691 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.9 pt -108.89 25.14 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.525 0.73 . . . . 0.0 110.561 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.0 t -77.06 -12.51 59.95 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.136 0.574 . . . . 0.0 112.12 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -152.67 140.83 20.41 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -55.3 -30.26 59.84 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -128.15 130.24 47.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.295 0.569 . . . . 0.0 111.135 177.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.2 m -100.8 177.34 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.294 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -109.01 138.66 45.0 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.451 0.3 . . . . 0.0 110.346 172.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.2 mp -134.76 84.41 2.1 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -119.55 -66.93 1.02 Allowed 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -172.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 48.34 24.14 0.67 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -174.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 168.95 -151.28 17.47 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -80.3 6.18 12.71 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.022 0.529 . . . . 0.0 111.717 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.53 157.05 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.597 0.759 . . . . 0.0 108.971 179.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -141.58 25.63 1.99 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.906 0.384 . . . . 0.0 111.257 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -90.12 154.73 19.56 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.128 0.571 . . . . 0.0 111.093 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -160.26 -179.93 8.14 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.61 157.94 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.854 0.862 . . . . 0.0 110.187 -174.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -85.19 129.48 34.8 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 122.678 0.391 . . . . 0.0 110.009 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -100.28 158.23 3.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.0 156.95 27.65 Favored Pre-proline 0 N--CA 1.456 -0.135 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.677 169.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.31 146.0 96.11 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.844 2.363 . . . . 0.0 109.863 174.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -79.83 166.03 22.12 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.489 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.7 152.84 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 123.059 0.544 . . . . 0.0 110.245 -171.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 62.2 tp . . . . . 0 C--O 1.251 1.149 0 CA-C-O 117.158 -1.401 . . . . 0.0 109.973 179.267 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.471 ' C6 ' ' CE ' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.921 1 O4'-C1'-N19 112.871 4.671 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.829 0 O4'-C1'-N19 111.842 3.642 . 0.271 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.461 ' C6 ' ' CZ ' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.756 1 O4'-C1'-N19 113.034 4.834 . 0.053 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.53 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 C5'-C4'-C3' 111.287 -2.809 . 0.063 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.471 " H2'" ' N3 ' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.107 0 P-O3'-C3' 122.915 2.679 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 77.6 p . . . . . 0 N--CA 1.475 0.805 0 CA-C-O 120.418 0.152 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -138.39 10.26 2.73 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.097 0.559 . . . . 0.0 111.614 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -138.6 167.89 20.96 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 123.464 0.706 . . . . 0.0 110.241 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -141.52 177.91 7.81 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.285 0.634 . . . . 0.0 110.781 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.84 11.06 74.56 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 112.14 -0.384 . . . . 0.0 112.14 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -70.29 168.94 14.82 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.467 0.633 . . . . 0.0 111.618 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -137.11 145.54 44.0 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.185 0.594 . . . . 0.0 109.731 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.9 t -131.2 150.86 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 123.538 0.735 . . . . 0.0 109.475 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -77.15 149.88 35.59 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 111.465 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.9 31.14 0.71 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.456 1.102 . . . . 0.0 113.49 -174.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.415 ' HA ' HD11 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -142.22 -153.13 0.44 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -174.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.2 m 64.75 5.89 3.02 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 126.133 1.773 . . . . 0.0 113.069 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -65.03 118.49 9.2 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 173.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 63.47 143.58 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.767 1.227 . . . . 0.0 111.071 -168.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -156.11 146.43 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.337 -172.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.494 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 9.3 t80 -89.69 140.01 30.0 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 p -118.76 117.88 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.467 ' HA2' ' CZ ' ' A' ' 68' ' ' PHE . . . -89.45 125.1 7.67 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 116.348 -0.387 . . . . 0.0 113.141 -170.191 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.37 146.67 11.1 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.222 0.915 . . . . 0.0 112.522 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.6 tp -153.94 122.62 3.09 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.17 164.07 31.71 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.217 2.611 . . . . 0.0 111.781 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.15 175.43 9.24 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.39 3.393 . . . . 0.0 111.426 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.1 t70 60.9 -85.86 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.237 0.615 . . . . 0.0 112.332 -175.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.0 pt -56.38 157.24 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 121.278 0.561 . . . . 0.0 111.333 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -149.63 -121.76 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.029 0.531 . . . . 0.0 110.256 -177.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -54.07 -22.9 11.97 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.091 1.357 . . . . 0.0 111.974 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -77.83 -36.96 49.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -173.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -86.41 -30.42 22.12 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.911 -0.493 . . . . 0.0 111.343 -173.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.8 pt -78.57 -33.3 16.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 O-C-N 121.935 -0.478 . . . . 0.0 109.968 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.3 m -70.47 -23.74 62.74 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 175.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.32 -17.07 40.76 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.4 m -76.66 -37.4 56.29 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.557 0.617 . . . . 0.0 111.695 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.44 ' CZ ' HD11 ' A' ' 151' ' ' ILE . 81.2 m-85 -108.25 6.66 26.82 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -176.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.89 -18.34 64.09 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.709 0.404 . . . . 0.0 110.941 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -72.09 -8.92 57.37 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.557 0.743 . . . . 0.0 112.031 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -110.23 5.72 22.02 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.335 0.254 . . . . 0.0 111.427 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.78 177.58 15.11 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -70.5 150.79 64.26 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.69 2.927 . . . . 0.0 110.835 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.41 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 0.5 OUTLIER -164.53 164.41 21.76 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.747 -170.771 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 pt -142.22 170.82 11.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.295 174.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.09 155.15 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 122.449 0.299 . . . . 0.0 110.351 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -153.25 170.27 21.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.67 0.271 . . . . 0.0 111.608 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 33.7 p90 -159.27 158.14 28.03 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.51 ' HG3' " H1'" ' B' ' 4' ' ' ' U' . 34.6 Cg_endo -75.36 -9.18 20.18 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.892 1.728 . . . . 0.0 110.74 -169.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -95.37 6.71 48.29 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.723 0.809 . . . . 0.0 111.349 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -50.19 152.02 1.87 Allowed 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.778 0.831 . . . . 0.0 112.911 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.37 161.6 37.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.088 -177.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -142.24 152.33 42.96 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.162 0.585 . . . . 0.0 110.37 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 93.3 p 47.51 19.13 0.13 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.964 1.705 . . . . 0.0 115.106 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -152.94 -35.82 0.11 Allowed 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 118.348 0.522 . . . . 0.0 111.16 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.6 m -149.09 156.68 42.57 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 123.399 0.68 . . . . 0.0 110.025 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -153.78 22.7 0.52 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.766 0.426 . . . . 0.0 111.052 178.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -139.17 125.5 12.43 Favored Pre-proline 0 N--CA 1.451 -0.406 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.72 164.82 33.81 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.716 3.61 . . . . 0.0 111.675 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.1 -26.06 65.62 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.955 3.103 . . . . 0.0 112.873 -178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -152.28 -38.72 0.11 Allowed 'General case' 0 C--O 1.227 -0.112 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.48 123.12 3.2 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 168.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.511 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 14.3 m-85 -147.77 143.12 27.31 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 167.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.35 172.89 12.31 Favored 'General case' 0 C--N 1.335 -0.057 0 CA-C-N 119.896 1.225 . . . . 0.0 113.489 -169.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.4 ' CE1' ' C5 ' ' B' ' 4' ' ' ' U' . 1.3 m-85 -136.08 125.47 24.95 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.218 0.607 . . . . 0.0 109.515 -177.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 mp -84.8 141.97 30.11 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.345 0.593 . . . . 0.0 110.72 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.7 mp -104.99 136.48 44.38 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -140.28 163.93 31.45 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.049 0.539 . . . . 0.0 110.68 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -123.53 -29.36 3.78 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.087 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -102.23 159.91 14.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.827 0.346 . . . . 0.0 111.53 -175.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -111.29 5.0 19.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.236 -178.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.8 p -105.3 -22.22 13.09 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.904 0.482 . . . . 0.0 110.921 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 76.8 p -76.16 -31.43 58.54 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.84 -22.26 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 173.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -80.29 -36.92 33.73 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -174.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.87 -35.11 62.32 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 119.684 -0.198 . . . . 0.0 111.52 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -80.42 -18.51 48.62 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.313 0.506 . . . . 0.0 111.916 -176.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.1 mt -97.8 -14.47 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 117.843 0.292 . . . . 0.0 110.557 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -91.91 -16.54 26.5 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.312 -0.868 . . . . 0.0 111.238 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -108.74 26.9 10.01 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.457 0.703 . . . . 0.0 111.794 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 136' ' ' TYR . 17.2 p -124.98 166.77 15.74 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.043 0.537 . . . . 0.0 111.105 -176.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.56 172.4 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -137.31 157.95 45.49 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.021 0.438 . . . . 0.0 111.558 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.52 -172.7 4.09 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -30.1 -39.57 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.1 1.76 . . . . 0.0 115.253 -173.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.0 15.72 0.15 Allowed Glycine 0 CA--C 1.527 0.814 0 CA-C-N 118.595 0.634 . . . . 0.0 112.089 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -141.16 177.35 8.14 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 117.577 0.688 . . . . 0.0 110.56 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.22 170.76 9.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.439 0.696 . . . . 0.0 110.186 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.423 ' CE1' ' HG2' ' A' ' 148' ' ' PRO . 6.3 m-85 -146.76 151.59 37.42 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.857 0.463 . . . . 0.0 111.084 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 45.4 tp -132.46 145.73 51.4 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 170.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 85.0 m -80.33 141.88 35.02 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.745 -0.597 . . . . 0.0 110.893 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.2 175.43 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.324 0.65 . . . . 0.0 109.681 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.8 m -138.51 117.32 12.33 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 122.674 0.39 . . . . 0.0 110.759 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.455 ' HB3' ' HD2' ' A' ' 142' ' ' PRO . 52.7 m -155.21 162.15 27.89 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.688 1.195 . . . . 0.0 108.828 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 60.7 Cg_endo -66.1 -15.72 49.56 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.203 2.602 . . . . 0.0 114.088 -175.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.6 m -105.12 -2.93 23.67 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.44 0.564 . . . . 0.0 110.169 175.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.2 mp -98.97 -52.42 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.177 0.591 . . . . 0.0 111.026 -172.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 87.6 tttt 58.2 -57.96 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.729 1.612 . . . . 0.0 113.194 -172.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -149.83 12.72 0.79 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.391 1.076 . . . . 0.0 110.678 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.498 ' HD2' ' C6 ' ' B' ' 1' ' ' ' C' . 14.0 tttm -67.99 137.38 92.18 Favored Pre-proline 0 C--N 1.338 0.1 0 C-N-CA 123.607 0.763 . . . . 0.0 111.532 -177.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.423 ' HG2' ' CE1' ' A' ' 136' ' ' TYR . 37.8 Cg_endo -86.96 146.79 7.91 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 123.685 2.923 . . . . 0.0 110.632 168.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.9 p -98.88 142.37 14.94 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -83.37 158.78 22.01 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.786 0.721 . . . . 0.0 112.464 -174.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.44 HD11 ' CZ ' ' A' ' 85' ' ' PHE . 29.6 mm -137.13 142.79 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.051 1.341 . . . . 0.0 108.759 177.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 44.8 ttt-85 -146.08 88.52 6.31 Favored Pre-proline 0 CA--C 1.529 0.152 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.78 145.37 72.42 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.495 3.463 . . . . 0.0 112.857 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -92.86 153.02 19.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 173.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -119.48 134.1 55.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.653 0.739 . . . . 0.0 110.883 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.457 ' N ' ' CD1' ' A' ' 156' ' ' LEU . 4.7 mp -87.87 8.21 27.13 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.473 -169.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.7 t -91.1 -12.65 34.95 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -175.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -135.51 20.12 3.35 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -175.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.6 m -69.89 -20.98 63.36 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.433 0.56 . . . . 0.0 112.448 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -158.19 158.09 33.91 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.275 0.488 . . . . 0.0 111.04 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -158.35 157.34 32.2 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.987 0.422 . . . . 0.0 111.054 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.0 m -140.35 149.34 21.69 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 C-N-CA 124.353 1.061 . . . . 0.0 109.722 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 58.3 mtm -140.62 10.42 2.25 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -140.3 16.64 2.41 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.243 0.929 . . . . 0.0 112.971 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 91.09 22.8 31.54 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.519 -0.6 . . . . 0.0 113.016 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.4 m 56.29 47.03 20.02 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 117.722 0.761 . . . . 0.0 112.544 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -61.88 158.21 44.82 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 123.259 0.624 . . . . 0.0 110.602 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.0 154.54 69.67 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.184 2.589 . . . . 0.0 110.67 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 61.2 mt -135.57 167.67 20.68 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.605 0.762 . . . . 0.0 110.666 -173.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -141.49 149.57 54.71 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.01 -19.84 57.72 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.217 2.611 . . . . 0.0 112.516 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -88.1 5.93 38.78 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.46 0.704 . . . . 0.0 110.837 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -131.07 18.96 4.97 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.903 0.481 . . . . 0.0 110.875 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 24.2 m -126.35 139.9 52.93 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.88 0.371 . . . . 0.0 111.153 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.7 tt -112.0 149.2 14.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.913 -177.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -116.15 148.73 40.03 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.19 139.01 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 122.632 0.373 . . . . 0.0 110.207 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -148.48 173.56 28.42 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.67 20.96 62.68 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -174.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.0 m -56.38 142.48 68.55 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 122.751 0.42 . . . . 0.0 110.372 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.06 -49.39 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.944 2.429 . . . . 0.0 112.21 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -161.11 -59.2 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.435 -0.793 . . . . 0.0 111.257 176.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -76.01 156.53 38.57 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.871 2.381 . . . . 0.0 111.394 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.59 0.68 0.11 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.155 0.582 . . . . 0.0 112.296 175.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . 0.406 ' HG2' ' H ' ' A' ' 188' ' ' GLU . 16.7 ttp-105 -28.46 120.56 0.12 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.864 1.666 . . . . 0.0 111.582 175.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.4 -21.14 63.79 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 94.3 t -67.21 -50.16 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 118.154 0.434 . . . . 0.0 110.62 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.406 ' H ' ' HG2' ' A' ' 185' ' ' ARG . 59.6 mt-10 -84.87 -22.57 29.34 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.61 -0.144 . . . . 0.0 110.61 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.94 -30.91 68.41 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -83.4 -31.6 26.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 119.503 -0.284 . . . . 0.0 111.713 -177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.3 mmt -70.46 -37.05 74.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.318 0.508 . . . . 0.0 109.656 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 64.5 mt -72.55 -40.42 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.6 mmt -63.39 -25.37 68.26 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.941 -0.474 . . . . 0.0 110.929 172.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.59 -18.13 49.22 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.105 0.411 . . . . 0.0 111.836 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -98.53 -16.21 19.24 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.59 -13.11 11.53 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.184 0.902 . . . . 0.0 113.221 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -135.9 26.59 3.3 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.839 0.745 . . . . 0.0 112.657 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 76.18 -150.55 39.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -76.27 141.29 26.69 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -174.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.84 143.89 31.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 124.248 1.019 . . . . 0.0 108.56 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 61.4 m -109.48 -33.53 6.78 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -151.9 149.77 29.32 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.0 0.428 . . . . 0.0 110.964 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.28 155.61 40.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.465 0.706 . . . . 0.0 109.143 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.85 -174.97 47.27 Favored Glycine 0 C--N 1.333 0.363 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.2 mm -104.95 145.01 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -54.91 118.23 4.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.013 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 12.2 p -144.23 158.94 43.45 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.63 0.372 . . . . 0.0 110.267 -176.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -135.1 135.54 23.06 Favored Pre-proline 0 N--CA 1.455 -0.216 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.68 -5.97 15.04 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.225 3.283 . . . . 0.0 112.824 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -73.74 -39.63 64.11 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.311 0.505 . . . . 0.0 110.688 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.11 0.68 12.41 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.35 0.66 . . . . 0.0 109.602 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm 48.26 59.35 4.35 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.281 1.032 . . . . 0.0 111.386 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -133.49 147.33 64.29 Favored Pre-proline 0 CA--C 1.529 0.149 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -176.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -81.96 165.65 17.27 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 124.238 3.292 . . . . 0.0 110.546 174.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -125.63 23.25 7.44 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 61.59 13.33 37.79 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 119.373 -0.682 . . . . 0.0 114.684 170.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -132.81 146.09 51.53 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 118.235 1.017 . . . . 0.0 109.569 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -93.18 162.31 25.92 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 121.445 0.469 . . . . 0.0 113.326 -172.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -149.64 145.21 26.62 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 173.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 95.2 t -136.57 147.77 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -133.51 154.03 51.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.396 0.617 . . . . 0.0 111.33 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -132.22 154.95 49.09 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.05 -176.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.9 m -97.3 10.08 40.53 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 173.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -132.17 134.22 45.14 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.631 0.773 . . . . 0.0 109.799 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -72.92 -12.86 61.12 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 116.859 -0.155 . . . . 0.0 111.145 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -82.1 -39.04 23.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.9 m -75.06 -28.95 60.57 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -64.52 -51.78 61.16 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 119.649 -0.215 . . . . 0.0 110.568 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.3 pt -71.42 -14.71 17.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 CA-C-N 118.111 0.414 . . . . 0.0 111.181 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.03 -22.01 33.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.799 0.272 . . . . 0.0 110.734 175.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -87.99 -27.84 21.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.5 pt -103.41 24.85 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 122.917 0.487 . . . . 0.0 110.547 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 86.6 p -75.15 -18.07 60.28 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.172 0.589 . . . . 0.0 111.96 -177.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.98 146.04 23.66 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -55.15 -31.4 61.29 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -123.05 121.94 37.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.899 0.381 . . . . 0.0 110.489 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.8 m -82.68 153.98 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.594 172.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -95.62 140.58 30.24 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.82 27.23 5.76 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -91.96 136.52 33.1 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.909 0.484 . . . . 0.0 112.138 -171.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -148.71 19.26 1.02 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.918 177.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 84.79 138.54 4.2 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -176.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 55.86 7.39 0.27 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.389 1.076 . . . . 0.0 112.63 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.4 mt -142.71 141.61 27.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 C-N-CA 124.046 0.938 . . . . 0.0 108.991 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -157.41 123.97 4.95 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -144.34 161.27 39.4 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.98 155.21 36.51 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.0 p -154.92 151.43 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -84.97 126.71 33.75 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.5 m -102.03 158.52 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.23 157.43 27.49 Favored Pre-proline 0 N--CA 1.456 -0.148 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.733 169.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.86 130.73 41.43 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.55 2.167 . . . . 0.0 107.733 171.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -71.56 110.34 6.08 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.462 -172.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 8.6 p 45.2 34.87 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.473 1.509 . . . . 0.0 112.751 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 62.9 tp . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.107 -1.425 . . . . 0.0 110.357 -177.711 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.498 ' C6 ' ' HD2' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.415 -3.128 1 C5'-C4'-C3' 107.874 -5.084 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . 0.457 ' O2 ' " H2'" ' B' ' 2' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.774 2 C3'-C2'-C1' 105.947 4.941 OUTLIER-DELTA 0.061 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.511 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.421 -2.638 1 O4'-C1'-N19 113.849 5.649 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.51 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.422 -2.623 0 O4'-C1'-N19 111.215 3.015 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.489 ' N3 ' " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.459 0 O3'-P-O5' 99.647 -2.291 . 0.013 4a . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -142.3 163.32 33.17 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.089 0.556 . . . . 0.0 110.481 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -82.24 163.77 21.64 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.832 0.453 . . . . 0.0 110.538 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -142.53 179.83 6.73 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.574 0.75 . . . . 0.0 110.45 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.32 -149.94 23.24 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -61.6 156.71 19.14 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.214 0.605 . . . . 0.0 112.013 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -100.77 -10.25 20.97 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.17 0.588 . . . . 0.0 111.864 -177.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.48 160.2 31.43 Favored 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 122.93 0.492 . . . . 0.0 110.866 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -97.72 171.68 8.17 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.4 0.68 . . . . 0.0 110.228 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.0 ppt_? -127.76 156.12 42.94 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.359 0.664 . . . . 0.0 110.789 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.406 ' CD1' ' HA ' ' A' ' 155' ' ' ASN . 54.1 m-85 -168.96 -172.98 1.69 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -169.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.8 t -141.01 36.37 1.75 Allowed 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.02 -0.425 . . . . 0.0 112.04 173.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.78 36.36 2.73 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.329 1.451 . . . . 0.0 114.487 176.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.4 pttm -141.71 153.48 44.68 Favored 'General case' 0 N--CA 1.46 0.064 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 171.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 p -153.54 146.29 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-O 120.62 0.247 . . . . 0.0 111.025 -176.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -89.41 144.15 26.28 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.78 115.0 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.724 0.773 . . . . 0.0 109.315 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.23 -165.17 37.4 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.87 -104.67 1.51 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.1 tp 54.97 101.5 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 125.366 1.466 . . . . 0.0 112.547 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -67.2 148.23 80.22 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.905 1.737 . . . . 0.0 108.572 174.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.8 20.14 0.63 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.883 3.055 . . . . 0.0 112.574 -174.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -138.5 28.72 2.44 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.1 pt -133.66 175.55 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 119.012 0.824 . . . . 0.0 109.049 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -138.17 -175.97 4.29 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -49.88 -34.88 21.52 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.764 1.226 . . . . 0.0 112.261 -175.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -72.15 -29.85 64.43 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -175.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -79.13 -36.95 39.74 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -174.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.5 mt -73.72 -39.31 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 90.0 m -65.31 -22.94 66.9 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.1 -17.89 28.35 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -79.55 -26.72 41.35 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.383 0.538 . . . . 0.0 112.363 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -114.47 10.2 16.89 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -59.41 -19.83 50.27 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -172.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -73.63 -11.89 60.57 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.22 0.464 . . . . 0.0 112.236 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -99.46 16.44 23.19 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.45 0.3 . . . . 0.0 111.713 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.03 -175.33 29.7 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.95 137.28 37.45 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.49 2.793 . . . . 0.0 110.536 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.9 pp -160.25 166.69 29.1 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.519 0.728 . . . . 0.0 109.909 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mt -136.01 164.78 31.15 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.44 147.06 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -148.36 166.98 26.42 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -174.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -156.51 159.15 31.58 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 176.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.619 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 63.8 Cg_endo -71.36 -10.89 27.83 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.482 2.788 . . . . 0.0 110.976 -171.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.619 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 54.0 m-70 -100.28 17.09 22.27 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.955 0.902 . . . . 0.0 111.39 -178.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -54.02 160.56 1.47 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.004 0.922 . . . . 0.0 112.987 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.83 167.34 19.07 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.079 0.952 . . . . 0.0 110.499 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -143.73 150.12 38.16 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.274 0.63 . . . . 0.0 109.804 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.5 m 53.13 23.6 3.14 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.711 0.804 . . . . 0.0 112.503 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -150.88 162.86 39.98 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.719 0.808 . . . . 0.0 109.381 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.0 m -62.41 161.66 11.34 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.744 0.418 . . . . 0.0 110.683 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -131.39 135.68 47.4 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.038 0.447 . . . . 0.0 111.097 -177.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -159.79 99.01 1.5 Allowed Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.17 146.8 32.49 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.637 2.891 . . . . 0.0 111.946 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.471 ' C ' ' H ' ' A' ' 109' ' ' GLY . 48.9 Cg_endo -80.3 -166.71 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.633 3.555 . . . . 0.0 109.217 172.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -75.93 33.7 0.12 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.874 0.368 . . . . 0.0 110.568 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.471 ' H ' ' C ' ' A' ' 107' ' ' PRO . . . -80.28 9.32 48.74 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.562 0.601 . . . . 0.0 111.703 178.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.463 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 3.1 m-85 54.89 -177.25 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.068 0.547 . . . . 0.0 111.29 -175.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.54 175.38 12.38 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 121.356 -0.84 . . . . 0.0 112.672 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -139.59 143.49 37.32 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.9 mp -102.78 149.2 24.71 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-O 121.387 0.613 . . . . 0.0 112.267 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.9 mp -107.9 143.11 36.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.362 -1.29 . . . . 0.0 107.658 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -139.44 154.41 47.76 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.136 0.494 . . . . 0.0 110.346 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -101.18 -23.86 14.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.139 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -111.93 153.38 26.82 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.257 0.223 . . . . 0.0 110.438 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -97.58 1.71 49.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.559 0.219 . . . . 0.0 111.086 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.3 t -115.08 -13.93 11.82 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.509 0.724 . . . . 0.0 110.884 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.5 m -68.27 -32.53 72.76 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 121.507 -0.746 . . . . 0.0 109.227 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.78 -22.93 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -80.56 -26.37 38.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.832 -0.543 . . . . 0.0 109.639 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.51 -36.28 68.32 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.926 -0.484 . . . . 0.0 110.569 176.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -79.51 -16.3 56.26 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.312 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 97.0 mt -94.17 -10.77 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 122.439 0.295 . . . . 0.0 110.85 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -108.19 -10.72 15.36 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.709 -0.619 . . . . 0.0 112.225 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -116.37 42.2 2.46 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.482 0.713 . . . . 0.0 110.293 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 136' ' ' TYR . 31.1 p -142.67 174.97 10.17 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.45 0.7 . . . . 0.0 110.974 -172.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.95 165.89 2.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.02 157.27 44.56 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.995 0.426 . . . . 0.0 111.613 177.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -143.08 75.82 1.5 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.436 0.636 . . . . 0.0 109.654 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.7 t70 54.52 12.45 0.54 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.196 1.399 . . . . 0.0 114.703 175.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 154.71 -8.73 0.36 Allowed Glycine 0 CA--C 1.528 0.888 0 O-C-N 121.526 -0.734 . . . . 0.0 113.384 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -129.78 171.04 13.11 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 118.136 0.968 . . . . 0.0 109.328 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -122.44 164.95 17.12 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -170.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.431 ' O ' ' HB2' ' A' ' 128' ' ' CYS . 9.7 m-85 -143.69 150.36 38.57 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.028 176.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.8 mp -127.21 159.47 34.2 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.2 p -94.08 128.58 40.54 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.931 -0.48 . . . . 0.0 111.067 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.4 m -148.43 166.12 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 123.651 0.78 . . . . 0.0 109.838 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.8 m -96.68 155.4 16.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.615 0.366 . . . . 0.0 110.738 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.4 m -146.35 144.49 21.27 Favored Pre-proline 0 CA--C 1.528 0.132 0 C-N-CA 123.338 0.655 . . . . 0.0 109.436 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.86 -14.52 13.79 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.41 2.74 . . . . 0.0 111.338 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.4 m -76.71 -24.53 53.1 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 123.934 0.893 . . . . 0.0 110.668 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.441 HG22 ' H ' ' A' ' 145' ' ' LYS . 0.2 OUTLIER -137.83 -172.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.371 1.068 . . . . 0.0 108.804 -170.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.441 ' H ' HG22 ' A' ' 144' ' ' ILE . 22.1 ptmt -91.41 -23.38 20.05 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 169.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -165.42 154.04 11.79 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.087 1.355 . . . . 0.0 108.462 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.489 ' HE2' ' C6 ' ' B' ' 1' ' ' ' C' . 22.2 ttmt -151.13 117.69 3.29 Favored Pre-proline 0 N--CA 1.457 -0.083 0 CA-C-N 118.276 0.489 . . . . 0.0 111.139 175.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -63.8 120.53 7.94 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 122.295 1.997 . . . . 0.0 108.654 168.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.6 p -84.25 132.0 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.1 tm0? -90.3 147.69 23.35 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.38 0.272 . . . . 0.0 110.787 -170.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 26.4 mm -135.18 142.76 39.03 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 C-N-CA 123.006 0.522 . . . . 0.0 111.501 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.412 ' HD2' ' C4 ' ' B' ' 3' ' ' ' U' . 72.1 mtt180 -144.33 106.83 4.79 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 173.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -71.43 161.03 46.86 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.826 3.017 . . . . 0.0 113.79 -176.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -93.92 94.5 8.51 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.406 ' HA ' ' CD1' ' A' ' 63' ' ' TYR . 3.3 m120 -69.31 0.84 4.41 Favored 'General case' 0 C--O 1.228 -0.054 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -168.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.519 HD22 ' H ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -156.09 175.85 13.43 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.499 1.5 . . . . 0.0 114.464 -169.192 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 54.4 m -108.49 24.6 12.8 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.904 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.519 ' H ' HD22 ' A' ' 156' ' ' LEU . 80.5 m-20 -94.84 31.72 1.78 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.408 0.283 . . . . 0.0 110.497 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 m -75.47 -20.02 59.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -153.29 154.01 33.76 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.06 0.391 . . . . 0.0 111.356 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -157.88 153.25 26.01 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.935 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.8 m -139.21 155.75 26.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 122.803 0.441 . . . . 0.0 110.254 177.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 64.1 mtm -135.23 28.19 3.43 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.318 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.45 ' HB3' ' HG ' ' A' ' 201' ' ' CYS . 4.6 t0 -155.37 168.72 26.18 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -77.65 41.03 1.86 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.672 0.653 . . . . 0.0 112.793 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.9 m 55.89 60.56 3.19 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 117.414 0.607 . . . . 0.0 111.51 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -63.43 161.72 31.77 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 123.532 0.733 . . . . 0.0 109.745 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -56.01 124.02 15.26 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.518 2.145 . . . . 0.0 109.396 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.5 tp -127.07 138.31 53.18 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.748 0.819 . . . . 0.0 110.391 -171.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -144.78 156.3 55.87 Favored Pre-proline 0 N--CA 1.454 -0.261 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.63 -12.42 31.21 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.877 2.385 . . . . 0.0 111.203 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -83.61 -5.03 59.07 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.665 0.786 . . . . 0.0 111.563 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -118.35 24.51 10.9 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.853 0.461 . . . . 0.0 110.127 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 44.8 m -122.09 154.0 37.92 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.603 0.361 . . . . 0.0 111.001 -174.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.61 146.24 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -99.3 129.06 45.49 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 45.5 t -104.8 78.66 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 125.02 1.328 . . . . 0.0 108.447 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.44 ' HA2' ' CB ' ' A' ' 217' ' ' ALA . . . -96.09 153.42 20.55 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 116.355 -0.384 . . . . 0.0 113.44 -174.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 109.21 11.79 21.31 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.9 m -73.63 152.88 89.54 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 117.255 0.527 . . . . 0.0 110.298 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.32 -45.9 2.42 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.63 2.22 . . . . 0.0 110.099 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.482 ' HB3' ' CD ' ' A' ' 183' ' ' PRO . 29.5 ttp-105 -159.8 -75.32 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 118.019 -0.991 . . . . 0.0 108.664 172.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.482 ' CD ' ' HB3' ' A' ' 182' ' ' ARG . 14.4 Cg_endo -87.66 177.11 3.78 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.765 2.31 . . . . 0.0 109.81 169.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 19.3 tp -136.58 -0.34 2.4 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 169.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 57.53 95.38 0.02 OUTLIER 'General case' 0 C--N 1.341 0.217 0 C-N-CA 126.941 2.096 . . . . 0.0 111.702 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.89 -27.44 63.29 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -173.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 62.5 t -62.8 -56.41 17.7 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 CA-C-N 118.515 0.598 . . . . 0.0 111.183 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -82.46 -23.03 34.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 122.454 -0.153 . . . . 0.0 110.721 -175.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.88 -38.87 66.82 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.52 -37.56 74.15 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 121.923 -0.486 . . . . 0.0 110.426 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.2 mmt -68.33 -35.64 78.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.376 -0.202 . . . . 0.0 110.818 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 56.5 mt -76.95 -35.95 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 117.594 0.179 . . . . 0.0 111.317 -176.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.3 mmt -64.56 -23.43 67.26 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.891 -0.505 . . . . 0.0 109.998 172.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -78.68 -24.26 45.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.022 0.374 . . . . 0.0 110.735 174.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -83.43 -17.7 41.24 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 119.129 -0.462 . . . . 0.0 112.134 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -118.48 -17.07 9.46 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -177.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -133.24 19.03 4.02 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -174.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.19 -144.41 37.64 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -69.3 118.38 8.56 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 60.2 t -109.3 142.35 22.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 124.08 0.952 . . . . 0.0 108.612 174.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . 0.45 ' HG ' ' HB3' ' A' ' 164' ' ' ASP . 42.9 t -99.9 -39.78 8.0 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.687 0.221 . . . . 0.0 110.84 -178.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -150.09 146.29 26.85 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.727 0.298 . . . . 0.0 110.964 -176.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -154.49 153.04 30.83 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.312 0.645 . . . . 0.0 109.844 175.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 162.75 -158.25 30.42 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.651 -0.579 . . . . 0.0 111.651 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . 0.453 ' HA ' ' HA2' ' A' ' 218' ' ' GLY . 48.8 mm -108.51 145.33 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -60.3 102.68 0.18 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 40.7 p -145.51 166.76 24.75 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.944 0.498 . . . . 0.0 109.802 -176.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -138.26 131.61 16.51 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -80.11 -16.42 11.12 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.458 3.439 . . . . 0.0 113.587 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -91.12 -31.65 16.15 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.527 0.603 . . . . 0.0 110.476 -176.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.04 -1.88 30.76 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.208 0.603 . . . . 0.0 110.291 176.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 49.86 45.2 25.1 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.103 0.961 . . . . 0.0 112.551 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.37 155.25 53.93 Favored Pre-proline 0 CA--C 1.528 0.104 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -84.41 153.85 12.21 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.411 2.741 . . . . 0.0 109.586 170.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.58 6.59 6.25 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.856 0.463 . . . . 0.0 110.502 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 165.46 -163.07 36.35 Favored Glycine 0 CA--C 1.524 0.609 0 O-C-N 121.919 -0.488 . . . . 0.0 112.08 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . 0.44 ' CB ' ' HA2' ' A' ' 178' ' ' GLY . . . -80.09 -162.36 0.44 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.223 1.009 . . . . 0.0 111.401 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 205' ' ' ILE . . . -71.05 166.58 52.31 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 116.427 -0.351 . . . . 0.0 112.97 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -155.56 154.68 32.09 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 87.6 t -140.6 147.09 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -137.56 154.04 49.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.355 0.597 . . . . 0.0 111.846 -177.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -129.48 158.25 39.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.035 -173.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 34.3 m -84.58 -10.49 57.34 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.311 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -124.67 149.15 47.48 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.166 0.587 . . . . 0.0 111.03 -174.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -78.07 -16.33 58.12 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.92 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -80.87 -35.42 32.69 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 15.1 m -77.51 -26.89 51.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -64.59 -48.03 76.48 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.629 0.372 . . . . 0.0 110.481 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 35.5 pt -72.95 -24.49 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 CA-C-N 117.937 0.335 . . . . 0.0 111.039 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -73.62 -24.72 60.06 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.018 0.372 . . . . 0.0 110.804 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -83.74 -8.52 59.24 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.4 pt -120.0 19.42 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 123.035 0.534 . . . . 0.0 110.791 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 21.1 m -89.32 -11.51 43.2 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.899 0.48 . . . . 0.0 112.129 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -142.41 122.94 14.09 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -50.75 -41.14 56.33 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -115.44 107.29 15.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.098 0.408 . . . . 0.0 111.104 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 10.6 m -67.24 151.21 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.418 172.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -100.23 139.93 35.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.276 0.56 . . . . 0.0 109.678 174.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -118.94 21.41 12.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.522 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -84.04 121.85 27.98 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.709 0.803 . . . . 0.0 112.041 -170.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -147.58 24.68 1.09 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.36 142.47 7.58 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 56.22 10.86 0.68 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.259 1.024 . . . . 0.0 112.85 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.7 mt -140.87 142.29 30.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 C-N-CA 123.742 0.817 . . . . 0.0 109.213 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -142.8 18.56 1.98 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.542 0.337 . . . . 0.0 111.343 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -55.36 151.36 10.07 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 124.2 1.0 . . . . 0.0 111.385 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.61 154.21 37.1 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.826 1.25 . . . . 0.0 108.975 176.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 7.2 p -161.12 158.32 2.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -89.66 150.28 22.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.463 0.305 . . . . 0.0 111.739 -175.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.2 m -118.69 155.98 20.72 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-O 120.775 0.322 . . . . 0.0 111.683 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.45 157.56 30.18 Favored Pre-proline 0 CA--C 1.528 0.118 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.73 137.6 74.63 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.349 2.033 . . . . 0.0 108.578 173.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -72.08 120.81 18.21 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 119.04 -1.064 . . . . 0.0 112.009 -175.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.7 p 42.84 42.48 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 126.17 1.788 . . . . 0.0 113.403 172.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.098 -0.953 . . . . 0.0 112.085 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.489 ' C6 ' ' HE2' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.947 1 O4'-C1'-N19 112.788 4.588 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . 0.438 HO2' ' P ' ' B' ' 3' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.419 -2.837 2 O4'-C1'-N19 112.935 4.735 . 0.673 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.463 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.416 -3.111 1 O4'-C1'-N19 113.176 4.976 . 0.01 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.544 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.42 -2.777 0 O4'-C4'-C3' 109.619 2.942 . 0.073 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.557 ' C8 ' H5'' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -3.001 0 C3'-C2'-C1' 104.159 2.955 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 110.872 -0.047 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -133.19 4.79 3.77 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.896 0.479 . . . . 0.0 111.841 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 51.53 41.15 28.34 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.793 0.837 . . . . 0.0 111.954 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -66.39 -10.99 49.05 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 122.023 -0.423 . . . . 0.0 111.489 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.03 -9.65 86.79 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 119.58 -0.567 . . . . 0.0 111.739 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.576 ' HG2' ' H ' ' A' ' 59' ' ' ARG . 21.0 tt0 57.31 -175.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.261 1.024 . . . . 0.0 111.798 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.576 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 30.9 ttt180 -135.99 171.78 13.97 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.317 0.647 . . . . 0.0 109.752 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.509 ' H ' ' HG2' ' A' ' 59' ' ' ARG . 73.6 t -54.46 122.61 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 123.554 0.741 . . . . 0.0 110.125 177.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -160.36 149.55 17.32 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? 57.19 -80.66 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.439 1.496 . . . . 0.0 112.064 -173.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 53.85 172.16 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -175.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.3 t -107.46 21.47 17.42 Favored 'General case' 0 C--O 1.23 0.043 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.652 -173.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.467 ' HA ' ' CE1' ' A' ' 115' ' ' PHE . 96.4 mtt180 54.23 20.87 2.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.507 0.723 . . . . 0.0 112.784 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -145.96 146.87 31.19 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.074 0.549 . . . . 0.0 110.73 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -139.07 153.5 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.468 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 6.8 t80 -88.44 142.68 27.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 170.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.6 m -129.28 100.61 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.994 0.902 . . . . 0.0 109.017 175.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.26 -174.77 50.3 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.489 ' HA2' " H4'" ' B' ' 1' ' ' ' C' . . . 77.26 11.24 85.71 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.715 -0.491 . . . . 0.0 112.72 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.0 tp -67.87 127.04 93.33 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 118.112 0.956 . . . . 0.0 110.965 -177.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.31 163.25 30.34 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.581 2.854 . . . . 0.0 110.257 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -83.64 3.17 7.87 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.123 3.215 . . . . 0.0 113.666 -173.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -129.67 22.41 5.46 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -170.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.0 pt -124.2 171.08 13.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 118.791 0.723 . . . . 0.0 109.958 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -140.35 -173.88 3.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.128 0.49 . . . . 0.0 112.201 -173.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -51.33 -29.41 15.09 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.317 1.447 . . . . 0.0 113.091 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.78 -32.28 35.51 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.501 0.591 . . . . 0.0 111.585 -175.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -76.81 -39.25 52.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.374 0.131 . . . . 0.0 110.848 -173.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 5.0 pt -83.95 -36.15 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 119.652 -0.213 . . . . 0.0 110.971 -177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.8 m -65.54 -26.52 67.93 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.01 -22.58 31.29 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.647 -0.216 . . . . 0.0 111.408 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 m -78.58 -12.88 60.04 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.213 0.461 . . . . 0.0 112.099 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -118.45 4.44 11.78 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.175 0.443 . . . . 0.0 112.145 175.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 47.9 tpt85 -67.8 -18.55 64.89 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -72.05 -5.34 34.51 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.415 0.552 . . . . 0.0 112.398 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -106.67 6.3 29.65 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.449 0.3 . . . . 0.0 111.619 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.31 179.59 17.54 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.57 134.89 25.16 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.548 2.832 . . . . 0.0 110.662 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.0 pp -159.85 164.93 33.21 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.919 0.888 . . . . 0.0 109.753 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.4 mm -128.45 163.79 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.17 153.67 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -145.47 157.07 44.07 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.214 0.53 . . . . 0.0 111.049 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.416 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 44.8 p90 -156.5 158.77 31.57 Favored Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 169.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.629 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 38.4 Cg_endo -74.15 -10.62 22.79 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.389 2.726 . . . . 0.0 110.459 -169.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.629 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 50.1 m-70 -103.88 10.4 36.4 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.157 0.983 . . . . 0.0 110.927 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.471 ' HA ' ' HE3' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -63.92 -24.2 67.64 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.866 0.866 . . . . 0.0 110.927 -178.748 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 49.34 -151.76 0.15 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.736 0.814 . . . . 0.0 111.473 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -77.37 39.88 0.27 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.642 0.777 . . . . 0.0 111.036 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.7 t 57.41 27.5 13.98 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.882 0.873 . . . . 0.0 111.775 -177.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -88.11 11.52 15.99 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.561 0.744 . . . . 0.0 112.095 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.2 t -130.05 143.75 50.96 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.074 0.55 . . . . 0.0 110.211 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -142.28 14.92 2.03 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.379 0.672 . . . . 0.0 111.107 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -151.9 71.99 7.95 Favored Pre-proline 0 CA--C 1.532 0.265 0 O-C-N 122.017 -0.427 . . . . 0.0 110.139 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.93 156.72 47.79 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.478 2.785 . . . . 0.0 111.352 -178.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 109' ' ' GLY . 67.7 Cg_endo -77.68 -173.47 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 124.409 3.406 . . . . 0.0 110.027 175.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.404 ' C ' ' H ' ' A' ' 110' ' ' TYR . 21.9 ptmt -75.62 37.54 0.14 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.975 0.51 . . . . 0.0 111.524 177.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 107' ' ' PRO . . . -70.94 8.17 4.84 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 123.714 0.673 . . . . 0.0 112.165 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.581 ' CE1' " H4'" ' B' ' 2' ' ' ' U' . 3.1 m-85 60.64 166.12 0.08 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.324 0.65 . . . . 0.0 111.757 -177.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.82 175.34 9.9 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 121.153 -0.967 . . . . 0.0 113.126 -171.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.417 ' CE1' ' C4 ' ' B' ' 4' ' ' ' U' . 0.7 OUTLIER -145.95 141.71 28.0 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.702 0.801 . . . . 0.0 109.504 -178.01 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.0 mp -98.94 144.89 27.61 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.23 139.15 52.35 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.467 ' CE1' ' HA ' ' A' ' 65' ' ' ARG . 8.1 p90 -152.19 177.4 10.57 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -117.69 -30.36 5.48 Favored 'General case' 0 CA--C 1.521 -0.148 0 O-C-N 122.188 -0.32 . . . . 0.0 110.88 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -93.31 124.72 37.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -69.15 -19.36 64.01 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.73 0.3 . . . . 0.0 110.324 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.9 m -77.02 -13.27 59.98 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.854 0.462 . . . . 0.0 111.245 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.3 t -75.53 -38.28 59.46 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.9 p -83.64 -21.54 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -67.08 -40.16 86.94 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.28 -37.99 60.62 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.64 -20.47 59.88 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.536 0.607 . . . . 0.0 111.708 -176.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 76.8 mt -92.07 -22.55 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 118.014 0.37 . . . . 0.0 111.437 176.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -91.24 -12.65 34.6 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.889 -0.507 . . . . 0.0 112.225 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -127.04 46.0 2.59 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.885 0.474 . . . . 0.0 111.458 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 27.6 p -139.42 -177.9 5.14 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.775 0.43 . . . . 0.0 111.57 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 2.9 mp -81.8 159.86 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -139.9 160.52 39.73 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.819 -0.551 . . . . 0.0 112.324 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -143.56 176.69 9.01 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -61.34 3.34 0.12 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -171.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.6 1.89 0.06 OUTLIER Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.006 -0.885 . . . . 0.0 114.0 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -154.1 177.02 11.54 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.713 1.256 . . . . 0.0 110.642 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -116.34 163.33 16.18 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.444 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 6.3 m-85 -139.46 148.16 42.33 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.009 0.433 . . . . 0.0 112.008 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.6 mp -139.56 -171.02 3.05 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 172.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 72.1 m -133.61 162.51 31.73 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.82 0.736 . . . . 0.0 112.138 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.09 167.72 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.674 1.19 . . . . 0.0 109.403 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.7 m -119.47 11.92 12.26 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -170.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.518 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 6.1 t -141.68 32.6 0.16 Allowed Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 176.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 141' ' ' SER . 85.5 Cg_endo -71.28 172.16 14.62 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.631 2.888 . . . . 0.0 113.533 -174.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.9 t -79.89 -20.54 45.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.728 0.811 . . . . 0.0 112.727 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.8 mm -117.21 165.1 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -62.82 121.1 12.62 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 57.5 159.47 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.875 1.27 . . . . 0.0 112.582 -172.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.587 ' HZ1' ' HB2' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -160.05 108.53 1.41 Allowed Pre-proline 0 CA--C 1.522 -0.129 0 O-C-N 121.679 -0.638 . . . . 0.0 110.66 178.472 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.444 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 58.9 Cg_endo -79.77 139.92 14.31 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.636 2.224 . . . . 0.0 108.506 169.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.6 m -124.3 144.85 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.046 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -85.38 158.74 20.17 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 43.4 mm -133.32 140.73 46.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.586 1.154 . . . . 0.0 108.943 172.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -154.92 91.84 2.91 Favored Pre-proline 0 CA--C 1.535 0.375 0 O-C-N 123.345 0.403 . . . . 0.0 110.244 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_exo -61.23 169.93 5.72 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 124.758 3.639 . . . . 0.0 114.853 178.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . 0.428 ' CD2' ' HG2' ' A' ' 214' ' ' PRO . 19.6 t-105 -113.73 141.5 47.18 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.786 174.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -118.22 153.22 34.25 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.703 0.801 . . . . 0.0 110.957 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.66 12.45 16.84 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -170.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.4 t -75.51 -24.0 56.79 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -173.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -143.97 29.55 1.34 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.499 0.59 . . . . 0.0 112.578 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 49.3 m -65.51 -22.24 66.7 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.848 -0.532 . . . . 0.0 112.122 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -153.66 157.42 39.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.782 0.433 . . . . 0.0 110.851 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -155.82 152.83 28.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.33 150.3 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 O-C-N 121.935 -0.478 . . . . 0.0 109.85 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 65.2 mtm -125.14 18.9 8.35 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.252 0.221 . . . . 0.0 111.568 -175.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -154.38 -48.52 0.09 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 67.97 11.09 60.27 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 119.115 -0.825 . . . . 0.0 114.296 172.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 61.3 p -141.08 -16.51 0.85 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -176.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.421 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 48.4 mm-40 -82.9 139.18 42.99 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 119.548 1.067 . . . . 0.0 110.926 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 167' ' ' GLN . 37.7 Cg_exo -62.92 156.18 55.81 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.675 2.917 . . . . 0.0 112.238 174.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.5 mp -120.32 162.23 19.8 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.519 0.728 . . . . 0.0 110.719 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -150.01 138.79 12.64 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.17 -11.24 31.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.26 2.64 . . . . 0.0 113.322 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.2 6.14 46.29 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.558 0.617 . . . . 0.0 110.174 175.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -128.28 25.08 5.85 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.93 0.492 . . . . 0.0 110.832 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.7 m -123.75 144.48 49.66 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.77 0.319 . . . . 0.0 110.549 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.5 tt -118.8 151.25 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 123.076 0.55 . . . . 0.0 110.726 -173.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.498 ' CZ ' ' N7 ' ' B' ' 5' ' ' ' A' . 7.8 t80 -109.61 143.43 39.34 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 172.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.1 m -139.72 134.39 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 122.974 0.509 . . . . 0.0 109.664 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -150.09 -177.74 24.36 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 -176.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.65 7.19 84.71 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.93 128.37 86.69 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -79.55 -34.5 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.842 2.361 . . . . 0.0 114.376 -172.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.556 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 71.4 ttp85 -160.92 -38.32 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 116.841 2.163 . . . . 0.0 116.841 -174.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.556 ' HD2' ' H ' ' A' ' 182' ' ' ARG . 84.8 Cg_endo -76.98 -45.76 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 121.609 1.61 . . . . 0.0 113.989 -169.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 30.2 -106.74 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.734 1.214 . . . . 0.0 112.858 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 64.47 136.39 0.02 OUTLIER 'General case' 0 C--N 1.343 0.284 0 C-N-CA 126.222 1.809 . . . . 0.0 112.488 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.15 -32.13 56.1 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.005 -0.434 . . . . 0.0 112.022 -175.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.44 -54.18 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-N 117.674 0.215 . . . . 0.0 111.155 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -75.4 -23.54 57.06 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.68 -173.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 51.8 tp -72.98 -30.49 63.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.02 -41.38 35.97 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 122.171 -0.331 . . . . 0.0 111.768 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 17.3 ptp -75.08 -26.48 59.37 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.217 -0.302 . . . . 0.0 110.713 -177.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.5 mt -72.04 -37.74 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.1 mmt -72.68 -15.75 61.69 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.969 -0.457 . . . . 0.0 110.076 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -89.65 -17.72 27.86 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.862 0.301 . . . . 0.0 110.95 175.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -88.83 -18.27 28.01 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 119.341 -0.362 . . . . 0.0 111.874 177.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.36 -24.86 8.22 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.284 0.493 . . . . 0.0 111.377 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -140.01 47.7 1.81 Allowed 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.794 0.438 . . . . 0.0 110.501 -175.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.13 136.12 4.33 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 123.276 0.465 . . . . 0.0 112.097 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 128.55 8.96 3.75 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -174.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.08 147.94 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 123.65 0.78 . . . . 0.0 110.146 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.2 p -118.24 -37.45 3.35 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 119.504 -0.284 . . . . 0.0 111.49 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -157.43 153.06 26.56 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.775 0.261 . . . . 0.0 110.936 -172.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -147.99 162.04 40.14 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.308 0.575 . . . . 0.0 111.839 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 178.0 -178.36 48.49 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 8.5 tp -87.73 155.59 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ASP . . . . . 0.428 ' HA ' ' CZ ' ' A' ' 219' ' ' ARG . 15.0 p-10 -70.76 38.68 0.05 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.2 t -74.2 152.4 39.78 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.105 -0.372 . . . . 0.0 110.325 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -134.18 146.23 58.81 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 122.604 0.362 . . . . 0.0 110.31 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' PRO . . . . . 0.409 ' C ' ' H ' ' A' ' 211' ' ' LEU . 84.3 Cg_endo -76.01 -7.43 18.23 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 124.533 3.489 . . . . 0.0 111.989 -176.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.24 40.55 0.49 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.952 0.501 . . . . 0.0 110.347 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.409 ' H ' ' C ' ' A' ' 209' ' ' PRO . 0.8 OUTLIER 51.68 21.94 1.49 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.263 1.825 . . . . 0.0 114.316 179.743 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -86.74 -24.15 25.23 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 119.24 -0.41 . . . . 0.0 110.261 174.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.489 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 37.6 m-85 56.28 -169.6 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.624 -0.703 . . . . 0.0 109.811 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.489 ' CD ' ' HB3' ' A' ' 213' ' ' TYR . 52.0 Cg_exo -56.15 151.2 44.35 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.063 1.842 . . . . 0.0 113.102 -177.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -120.9 25.1 9.87 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.739 0.415 . . . . 0.0 110.485 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.66 12.28 73.83 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.28 -0.733 . . . . 0.0 114.152 171.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -132.2 155.03 48.97 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.236 1.018 . . . . 0.0 110.64 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -97.68 160.23 21.04 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 121.45 0.472 . . . . 0.0 112.998 -173.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . 0.428 ' CZ ' ' HA ' ' A' ' 206' ' ' ASP . 4.0 ptp85 -142.83 147.31 35.22 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 172.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 3.5 p -150.08 150.42 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.25 150.62 43.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.535 0.734 . . . . 0.0 111.175 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -125.96 149.26 48.91 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.47 0.708 . . . . 0.0 110.816 -177.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 69.1 m -82.05 -0.52 44.78 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 122.257 0.223 . . . . 0.0 110.879 173.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -132.68 133.66 43.82 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.01 0.524 . . . . 0.0 109.943 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -73.34 -21.95 60.42 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -70.42 -38.8 74.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.6 m -76.66 -25.05 53.3 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.239 -0.288 . . . . 0.0 110.239 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -69.21 -51.24 39.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 41.9 pt -69.48 -17.33 21.43 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 118.095 0.407 . . . . 0.0 110.969 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.04 -28.48 39.3 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.48 -17.06 49.99 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 13.5 pt -113.92 24.54 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 123.331 0.653 . . . . 0.0 110.329 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -81.0 -9.89 59.78 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.268 0.627 . . . . 0.0 111.669 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.45 141.78 20.6 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -56.23 -35.47 67.4 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.283 0.233 . . . . 0.0 111.403 -177.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -126.15 114.66 18.65 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.08 0.467 . . . . 0.0 110.306 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 28.7 m -97.81 161.22 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.888 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' GLN . . . . . 0.436 ' CD ' ' H ' ' A' ' 238' ' ' GLN . 0.1 OUTLIER -87.19 142.23 28.06 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.028 0.442 . . . . 0.0 109.833 176.39 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 7.2 mp -117.47 19.2 14.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.667 0.746 . . . . 0.0 109.62 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -55.13 138.83 43.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.243 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -146.09 18.25 1.4 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.472 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 88.08 -9.53 74.41 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 123.703 0.668 . . . . 0.0 111.817 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -141.74 10.31 2.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.64 0.776 . . . . 0.0 110.884 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 35.5 mm -133.54 153.9 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.587 0.755 . . . . 0.0 109.71 -174.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -146.96 12.44 1.1 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.695 0.398 . . . . 0.0 111.019 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -80.11 173.51 12.52 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 123.579 0.752 . . . . 0.0 112.191 -172.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.6 163.01 31.56 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.818 1.247 . . . . 0.0 109.565 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 5.7 p -149.07 150.42 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -85.51 132.46 34.19 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -117.32 155.19 19.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -175.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -157.73 160.31 30.15 Favored Pre-proline 0 C--O 1.232 0.142 0 CA-C-O 119.548 -0.263 . . . . 0.0 110.548 168.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.48 124.8 14.88 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.244 1.962 . . . . 0.0 107.323 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -66.16 117.96 9.21 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.911 -169.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.7 p 45.76 29.01 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.914 1.686 . . . . 0.0 113.292 174.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 1.9 tm? . . . . . 0 C--O 1.252 1.187 0 CA-C-O 117.726 -1.131 . . . . 0.0 109.656 -179.901 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' ' C' . . . . . 0.489 " H4'" ' HA2' ' A' ' 71' ' ' GLY . . . . . . . . 0 O4'--C4' 1.419 -2.802 1 O4'-C1'-N19 113.572 5.372 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ' U' . . . . . 0.581 " H4'" ' CE1' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.415 -3.205 1 C3'-C2'-C1' 105.818 4.798 OUTLIER-DELTA 0.058 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.511 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.41 -3.557 3 O4'-C1'-N19 113.548 5.348 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ' U' . . . . . 0.535 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.418 -2.909 0 O4'-C4'-C3' 109.695 2.996 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ' A' . . . . . 0.498 ' N7 ' ' CZ ' ' A' ' 176' ' ' PHE . . . . . . . . 0 O4'--C4' 1.415 -3.147 0 P-O3'-C3' 123.336 3.03 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -158.61 164.88 35.61 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 121.156 0.503 . . . . 0.0 110.543 -173.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.7 t -88.7 165.6 14.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.195 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.33 10.95 6.02 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.824 176.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -128.15 141.53 51.45 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 124.148 0.979 . . . . 0.0 109.977 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.63 134.58 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.613 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -79.63 140.68 37.03 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 3.3 m -127.63 114.48 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 173.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.9 163.12 25.55 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.368 -172.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.65 22.24 76.63 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 119.174 -0.792 . . . . 0.0 113.42 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.0 tp -47.11 123.38 8.14 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 118.629 1.214 . . . . 0.0 107.846 173.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.67 157.53 39.94 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.705 2.27 . . . . 0.0 111.823 -172.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.34 173.39 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.42 3.414 . . . . 0.0 112.873 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.9 t70 64.88 -78.94 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.6 pt -61.7 162.01 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 118.683 0.674 . . . . 0.0 111.699 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -143.54 -156.01 0.65 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.38 -174.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -43.09 -32.68 0.73 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.642 1.977 . . . . 0.0 114.847 -173.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -78.6 -34.74 46.54 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.615 1.098 . . . . 0.0 112.139 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -77.52 -27.92 51.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.149 -0.345 . . . . 0.0 110.51 -174.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 25.9 pt -84.26 -27.03 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 O-C-N 122.067 -0.396 . . . . 0.0 110.398 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.4 m -73.22 -12.97 61.05 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.16 -17.42 17.41 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.0 m -82.78 -42.51 17.85 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.93 0.787 . . . . 0.0 112.237 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -90.01 1.61 56.11 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -68.38 -14.64 63.14 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.838 0.455 . . . . 0.0 111.953 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -69.8 -10.0 56.76 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.014 0.525 . . . . 0.0 111.555 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -112.89 17.24 19.11 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.832 0.453 . . . . 0.0 110.46 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.54 167.89 21.03 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.78 146.45 72.51 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.448 2.765 . . . . 0.0 110.507 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.5 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -149.94 166.67 28.91 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.0 0.429 . . . . 0.0 111.646 -178.776 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.9 pt -135.14 166.63 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.201 175.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.66 148.39 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 CA-C-O 120.722 0.296 . . . . 0.0 110.484 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -150.32 165.02 34.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.935 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.524 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 42.1 p90 -154.76 164.05 22.29 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.524 ' HD2' ' HB2' ' A' ' 95' ' ' TRP . 43.3 Cg_endo -73.04 -13.58 26.16 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 123.117 2.545 . . . . 0.0 110.927 -169.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.446 ' ND1' ' HG2' ' A' ' 96' ' ' PRO . 44.0 m80 -101.75 7.48 41.85 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.763 0.825 . . . . 0.0 111.102 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.9 tptt -62.23 148.5 44.58 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.945 0.498 . . . . 0.0 110.395 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.291 0 C-N-CA 123.08 0.552 . . . . 0.0 111.117 -177.972 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.619 0 CA-C-O 119.53 -0.594 . . . . 0.0 113.7 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.76 147.59 31.08 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.168 0.984 . . . . 0.0 109.254 172.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.89 175.91 11.59 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 122.61 0.364 . . . . 0.0 110.931 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -136.1 129.39 31.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -90.32 149.18 22.43 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.549 0.69 . . . . 0.0 111.785 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.82 145.58 41.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.158 -1.383 . . . . 0.0 107.297 171.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -134.11 165.88 24.05 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 110.956 -176.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -105.03 -31.48 9.17 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.236 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -121.24 150.48 41.29 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.862 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -87.32 -5.83 58.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.322 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.2 p -93.72 -15.19 25.48 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.665 0.386 . . . . 0.0 111.437 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 75.3 m -73.19 -36.12 66.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 122.019 -0.426 . . . . 0.0 110.769 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.01 -20.43 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -77.42 -38.54 49.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.0 -35.97 66.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.257 0.48 . . . . 0.0 111.584 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -78.84 -15.59 58.18 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.199 0.454 . . . . 0.0 111.705 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.5 mt -99.33 -15.44 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 122.354 0.262 . . . . 0.0 111.209 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -103.34 -9.31 19.58 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.593 -0.692 . . . . 0.0 112.641 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -115.99 29.9 7.69 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.848 0.459 . . . . 0.0 111.96 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 32.0 p -140.48 -176.26 4.57 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.774 0.43 . . . . 0.0 111.659 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 32.2 mm -79.14 156.05 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 124.629 1.172 . . . . 0.0 109.007 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -138.84 155.5 48.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 111.972 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -144.15 70.77 1.3 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.374 0.607 . . . . 0.0 110.066 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 p30 47.44 12.92 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.72 2.008 . . . . 0.0 116.228 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 175.5 -20.47 0.05 OUTLIER Glycine 0 CA--C 1.526 0.779 0 CA-C-N 118.578 0.626 . . . . 0.0 112.446 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -134.63 170.96 15.02 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 117.759 0.779 . . . . 0.0 109.555 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 150' ' ' GLN . 4.6 mp -130.63 173.33 11.0 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.897 -176.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -139.75 147.69 41.21 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.2 mp -133.84 164.0 28.24 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 170.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.7 m -101.98 150.49 23.17 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.205 0.602 . . . . 0.0 110.659 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.6 m -142.6 -4.76 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.3 m 48.53 43.94 20.45 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.515 0.726 . . . . 0.0 112.842 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.6 p -73.55 153.62 89.71 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.71 8.95 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.635 1 C-N-CA 125.58 4.186 . . . . 0.0 117.296 -175.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.0 m -96.28 -18.42 20.02 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.677 1.126 . . . . 0.0 110.069 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.533 ' N ' HD12 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -165.62 -172.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.342 1.457 . . . . 0.0 108.405 -171.537 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -69.5 -32.79 71.87 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.019 -0.426 . . . . 0.0 109.984 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.49 ' C ' HD13 ' A' ' 144' ' ' ILE . 24.3 t70 -162.95 153.15 16.17 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.266 0.626 . . . . 0.0 111.0 176.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.19 106.87 48.48 Favored Pre-proline 0 N--CA 1.457 -0.107 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 174.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.46 91.92 0.16 Allowed 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.866 2.378 . . . . 0.0 109.026 168.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.8 m -80.2 141.75 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.428 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 72.2 mt-30 -93.18 159.71 15.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.647 -177.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 50.0 mm -129.88 141.44 46.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.115 0.966 . . . . 0.0 109.761 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.29 101.62 1.54 Allowed Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.67 164.16 30.68 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.971 3.114 . . . . 0.0 111.91 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -88.08 148.7 24.35 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -109.28 150.31 28.15 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.851 0.46 . . . . 0.0 111.247 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.5 mp -96.74 78.1 2.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.128 0.571 . . . . 0.0 110.461 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.9 t -155.11 -32.66 0.1 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -134.56 28.06 3.66 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.2 m -60.71 -31.59 70.87 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.167 -0.333 . . . . 0.0 111.679 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -158.3 163.05 37.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.922 0.489 . . . . 0.0 110.877 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -156.1 156.61 34.6 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.494 0.318 . . . . 0.0 110.539 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.2 m -137.53 152.42 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 C-N-CA 123.273 0.629 . . . . 0.0 110.14 175.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 18.2 ttp -130.13 14.68 5.69 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.224 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -148.57 -170.95 3.74 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -73.02 25.77 0.8 Allowed Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.682 0.658 . . . . 0.0 112.949 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 44.7 m 53.67 52.17 13.69 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 117.945 0.873 . . . . 0.0 111.645 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -59.3 156.55 28.83 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 122.963 0.505 . . . . 0.0 110.349 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.15 140.64 60.52 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.179 2.586 . . . . 0.0 111.758 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 74.9 mt -114.38 153.61 29.54 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.777 0.431 . . . . 0.0 110.549 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -145.37 156.03 53.73 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.77 -5.76 17.57 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.033 2.488 . . . . 0.0 111.011 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -98.76 4.44 47.73 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.522 1.129 . . . . 0.0 111.455 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -129.01 16.6 6.22 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 122.693 0.397 . . . . 0.0 111.577 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 25.7 m -127.69 140.75 51.88 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.027 0.441 . . . . 0.0 112.018 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.9 tt -116.98 149.43 19.23 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.293 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -107.24 150.32 26.78 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 97.4 t -135.52 124.57 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 123.489 0.715 . . . . 0.0 109.278 -175.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -141.23 166.1 26.14 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 120.983 0.213 . . . . 0.0 112.585 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.6 17.79 61.35 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -170.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.0 m -72.19 154.85 92.08 Favored Pre-proline 0 CA--C 1.529 0.155 0 C-N-CA 122.965 0.506 . . . . 0.0 112.332 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.09 177.8 7.75 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.945 3.097 . . . . 0.0 108.963 169.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -66.39 -52.96 33.62 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.449 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.1 149.68 19.98 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.522 2.148 . . . . 0.0 111.069 175.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 43.1 mt -146.94 -43.54 0.18 Allowed 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 122.883 0.473 . . . . 0.0 110.964 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 52.76 102.71 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.43 1.492 . . . . 0.0 111.662 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -56.32 -24.28 42.62 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 30.9 t -63.27 -49.75 81.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 CA-C-N 117.979 0.354 . . . . 0.0 110.636 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -82.82 -21.12 34.57 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.814 -0.176 . . . . 0.0 110.773 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 40.7 tp -67.22 -37.31 83.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.68 -33.11 47.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.817 -0.135 . . . . 0.0 111.147 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.0 mmt -69.05 -37.17 78.42 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 117.873 0.306 . . . . 0.0 110.293 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.475 ' CG2' ' HA ' ' A' ' 239' ' ' LEU . 46.5 mt -69.6 -48.47 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 122.186 0.195 . . . . 0.0 110.535 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -58.94 -22.29 59.7 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.045 0.384 . . . . 0.0 111.453 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -84.18 -20.72 31.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.595 0.634 . . . . 0.0 111.546 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -89.32 -16.04 32.01 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 119.287 -0.387 . . . . 0.0 111.733 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -113.53 -18.36 11.97 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.36 0.527 . . . . 0.0 112.309 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -138.97 -30.37 0.74 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.851 0.75 . . . . 0.0 112.782 -177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.16 -177.92 18.57 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 68.99 11.66 63.81 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.586 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 15.6 t -69.09 149.11 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 118.323 1.061 . . . . 0.0 110.282 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 48.5 t -131.65 -35.3 1.29 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.163 0.185 . . . . 0.0 111.31 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -148.31 149.33 31.64 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.22 156.2 38.06 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.135 0.574 . . . . 0.0 109.803 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 169.39 -175.8 43.56 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.9 143.33 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -54.54 133.95 46.3 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.903 -0.135 . . . . 0.0 111.13 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 22.2 p -141.36 167.55 21.89 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 122.739 0.416 . . . . 0.0 110.363 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -129.34 131.51 23.69 Favored Pre-proline 0 N--CA 1.453 -0.299 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -80.19 -12.73 12.87 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.917 3.745 . . . . 0.0 113.728 -174.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -97.23 -27.06 14.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.701 0.682 . . . . 0.0 110.672 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 94.1 mt -108.75 -0.39 20.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.267 0.627 . . . . 0.0 110.534 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 46.59 48.41 14.24 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.707 1.203 . . . . 0.0 112.496 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.03 153.98 50.07 Favored Pre-proline 0 CA--C 1.53 0.182 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -176.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.85 153.92 29.71 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.78 2.32 . . . . 0.0 110.754 173.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -117.58 25.05 10.68 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.566 0.746 . . . . 0.0 110.563 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 68.01 -170.71 36.67 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 52.38 -166.51 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 117.521 0.661 . . . . 0.0 110.96 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -155.82 173.47 33.85 Favored Glycine 0 C--N 1.333 0.397 0 O-C-N 121.146 -0.972 . . . . 0.0 112.281 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -142.44 155.13 45.06 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 66.7 t -139.12 143.14 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.44 150.51 49.61 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.908 0.385 . . . . 0.0 110.197 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -125.81 152.72 45.06 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.899 -174.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 68.7 p -86.05 4.69 36.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.258 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -138.14 141.24 40.15 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.108 0.563 . . . . 0.0 110.448 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -75.13 -13.16 60.44 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.757 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -81.59 -37.48 27.59 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 20.0 m -75.58 -27.1 58.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -66.88 -51.8 51.08 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.448 -0.205 . . . . 0.0 110.448 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.0 pt -69.98 -15.67 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-N 118.002 0.365 . . . . 0.0 111.038 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.97 -23.91 35.8 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.786 0.267 . . . . 0.0 110.686 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -84.34 -31.34 24.87 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.705 0.229 . . . . 0.0 111.579 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.5 pt -98.77 24.57 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 122.621 0.368 . . . . 0.0 110.236 174.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.9 t -77.94 -17.7 56.92 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.024 0.53 . . . . 0.0 111.547 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.06 143.58 22.62 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -54.69 -32.29 59.17 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 122.716 0.406 . . . . 0.0 111.781 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -118.01 108.55 15.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.914 0.388 . . . . 0.0 110.195 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.53 HG23 HD21 ' A' ' 239' ' ' LEU . 2.4 m -78.03 161.3 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.599 176.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.61 ' C ' HD22 ' A' ' 239' ' ' LEU . 7.4 mp0 -93.55 135.77 34.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.61 HD22 ' C ' ' A' ' 238' ' ' GLN . 2.7 mm? -123.3 28.03 7.26 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.795 0.331 . . . . 0.0 110.72 -175.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -76.5 147.37 37.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.643 0.377 . . . . 0.0 110.964 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -149.49 16.89 0.91 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.652 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 83.94 125.72 1.22 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -173.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 53.49 15.74 0.78 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.196 0.998 . . . . 0.0 113.128 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 73.6 mt -140.7 148.67 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.987 0.915 . . . . 0.0 109.241 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -158.8 134.42 8.73 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -144.91 166.19 25.98 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 124.492 1.117 . . . . 0.0 108.34 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.75 150.92 33.94 Favored 'General case' 0 CA--C 1.523 -0.061 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.5 p -158.97 157.13 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -82.81 145.16 29.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.088 0.555 . . . . 0.0 110.835 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.11 161.37 29.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 112.503 0.556 . . . . 0.0 112.503 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.57 159.29 25.83 Favored Pre-proline 0 N--CA 1.455 -0.176 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.911 170.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.09 135.98 73.89 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.559 2.173 . . . . 0.0 109.038 173.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -69.89 146.38 51.3 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.964 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.451 -0.382 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.922 -176.265 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.4 ppt_? . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -155.48 169.23 24.74 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.092 -171.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.6 t -89.73 19.97 4.37 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 54.13 18.94 1.92 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.578 0.751 . . . . 0.0 112.256 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -145.38 146.27 31.5 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.151 0.58 . . . . 0.0 109.866 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.36 142.05 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.208 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -90.26 139.35 30.74 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.462 HG12 ' CD1' ' A' ' 151' ' ' ILE . 5.5 m -125.72 99.04 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 122.033 0.92 . . . . 0.0 108.765 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.03 164.59 31.21 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.529 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.47 24.09 77.27 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 122.618 -0.342 . . . . 0.0 112.649 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.1 tp -60.41 128.67 88.31 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 69.4 Cg_endo -69.72 131.02 20.42 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.886 1.724 . . . . 0.0 110.015 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 35.9 Cg_exo -64.45 -8.48 17.15 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.735 2.957 . . . . 0.0 114.627 -176.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -88.07 -0.65 57.31 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -173.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.404 HD12 ' C ' ' A' ' 76' ' ' ILE . 2.1 pp -136.67 -173.29 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.091 0 CA-C-N 118.636 0.653 . . . . 0.0 111.014 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -139.73 -166.78 2.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.541 0.736 . . . . 0.0 111.004 -175.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -45.93 -31.42 2.18 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.462 1.505 . . . . 0.0 113.213 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -65.94 -36.6 83.79 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -73.48 -38.17 65.51 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 122.095 -0.378 . . . . 0.0 110.403 -172.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.5 pt -84.05 -27.46 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 O-C-N 122.101 -0.374 . . . . 0.0 111.436 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 90.9 m -69.97 -16.41 63.19 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.14 -19.43 18.66 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.0 m -79.46 -26.68 41.68 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.902 0.774 . . . . 0.0 112.962 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -113.26 10.16 18.46 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.134 0.424 . . . . 0.0 111.743 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -68.9 -19.89 64.23 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 122.827 0.451 . . . . 0.0 111.762 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -72.18 -12.1 61.03 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.526 0.33 . . . . 0.0 111.102 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -105.2 20.5 18.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.744 0.418 . . . . 0.0 110.283 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.34 170.71 31.99 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.78 144.57 59.87 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.211 2.607 . . . . 0.0 110.425 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.511 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -149.61 168.33 23.86 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.862 0.363 . . . . 0.0 111.256 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.2 pt -140.53 166.49 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.46 149.73 24.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 121.147 0.498 . . . . 0.0 110.717 -176.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -147.18 163.32 36.71 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.222 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.409 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 28.8 p90 -158.62 161.75 27.85 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 174.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 95' ' ' TRP . 32.8 Cg_endo -74.34 -9.59 21.8 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.5 2.134 . . . . 0.0 110.568 -170.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -100.79 17.82 21.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.52 1.128 . . . . 0.0 110.98 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -50.15 146.1 5.29 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.322 0.649 . . . . 0.0 112.625 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.367 0 C-N-CA 124.495 1.118 . . . . 0.0 110.814 -177.164 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.66 0 N-CA-C 112.154 -0.379 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -141.42 145.66 35.59 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 117.799 0.799 . . . . 0.0 108.884 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.06 176.79 10.81 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.598 0.359 . . . . 0.0 110.875 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -139.54 126.97 21.5 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.5 mp -89.58 151.04 22.13 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.32 0.581 . . . . 0.0 111.524 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 mp -114.11 139.59 49.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -136.78 175.62 9.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.508 0.723 . . . . 0.0 109.946 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -115.95 -23.43 8.56 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 122.92 0.488 . . . . 0.0 111.783 -175.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -141.49 160.88 39.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.868 0.366 . . . . 0.0 111.228 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -82.14 -14.61 55.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.271 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 41.4 m -79.02 -16.96 56.14 Favored 'General case' 0 C--O 1.231 0.093 0 O-C-N 122.277 -0.265 . . . . 0.0 111.112 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 73.1 m -79.62 -42.73 24.28 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.331 -0.23 . . . . 0.0 110.599 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.96 -22.34 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -75.89 -33.63 59.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.87 -36.9 59.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 117.967 0.349 . . . . 0.0 111.086 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 pp -78.86 -14.6 59.15 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 117.993 0.36 . . . . 0.0 111.43 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.8 mt -98.76 -17.16 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 122.328 0.251 . . . . 0.0 111.43 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -100.55 -10.78 20.68 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.879 -0.513 . . . . 0.0 112.131 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -120.22 30.25 7.08 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.053 0.541 . . . . 0.0 111.719 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 23.4 p -127.55 -174.83 3.28 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.241 0.616 . . . . 0.0 111.216 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 43.2 mm -87.76 161.31 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.023 0.929 . . . . 0.0 109.074 -176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -127.14 154.25 44.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.611 0.243 . . . . 0.0 110.769 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -141.45 66.21 1.36 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.271 0.558 . . . . 0.0 110.402 176.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 52.31 9.57 0.1 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 172.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 171.11 -16.36 0.06 OUTLIER Glycine 0 CA--C 1.528 0.847 0 CA-C-N 118.59 0.632 . . . . 0.0 112.485 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -128.27 172.16 11.3 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-N 117.663 0.731 . . . . 0.0 109.726 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.8 161.63 15.25 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.343 0.257 . . . . 0.0 110.308 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.413 ' CE1' ' HG2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -139.86 150.64 44.88 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.087 0.555 . . . . 0.0 109.784 -178.882 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.8 tp -138.82 151.26 46.88 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 169.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 44.0 t -84.7 152.7 23.56 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -127.71 161.31 35.77 Favored 'Isoleucine or valine' 0 C--N 1.337 0.056 0 C-N-CA 122.972 0.509 . . . . 0.0 110.099 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 52.9 m -92.25 -13.94 29.68 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.3 m -142.9 65.25 15.78 Favored Pre-proline 0 CA--C 1.53 0.18 0 C-N-CA 123.073 0.549 . . . . 0.0 109.968 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -68.95 168.96 18.97 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.682 3.588 . . . . 0.0 111.849 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.422 ' HB ' ' CB ' ' A' ' 73' ' ' PRO . 13.4 t -84.31 160.31 20.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 174.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.9 mt 57.17 -108.49 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -148.85 132.24 16.6 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.465 0.706 . . . . 0.0 109.135 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.4 t0 41.79 78.78 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.754 1.222 . . . . 0.0 112.064 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 108.81 20.4 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 119.568 -0.253 . . . . 0.0 110.711 -174.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.413 ' HG2' ' CE1' ' A' ' 136' ' ' TYR . 91.1 Cg_endo -71.59 165.31 32.91 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.399 3.4 . . . . 0.0 112.348 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.4 p -114.92 140.38 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.0 tm0? -94.94 151.89 18.81 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.483 0.713 . . . . 0.0 110.913 -174.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.462 ' CD1' HG12 ' A' ' 69' ' ' VAL . 32.4 mm -134.87 142.02 41.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 C-N-CA 123.408 0.683 . . . . 0.0 111.147 -177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -156.76 113.92 2.01 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 169.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -77.39 171.44 17.65 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 124.44 3.427 . . . . 0.0 112.464 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 -100.18 140.22 34.72 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -107.84 152.43 24.41 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.481 0.657 . . . . 0.0 111.663 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.7 mp -87.57 65.01 8.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.423 0.689 . . . . 0.0 110.544 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.4 t -133.76 -25.23 1.67 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.692 0.397 . . . . 0.0 111.151 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -153.81 138.3 16.8 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 67.2 m -157.79 -45.43 0.06 Allowed 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 117.907 0.321 . . . . 0.0 110.405 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -160.63 163.44 32.57 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.934 0.493 . . . . 0.0 110.617 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -157.37 160.24 38.25 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.2 m -138.69 150.39 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.559 0.744 . . . . 0.0 110.136 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 52.7 mtm -132.29 29.96 4.25 Favored 'General case' 0 C--N 1.335 -0.055 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.925 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -151.71 162.34 41.18 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -77.96 29.85 1.83 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 123.563 0.602 . . . . 0.0 112.141 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 m 57.42 52.1 9.03 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -61.92 163.51 12.86 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -47.03 128.05 13.32 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.171 2.58 . . . . 0.0 111.512 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.0 tp -136.45 136.41 39.47 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.648 0.779 . . . . 0.0 110.153 -172.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -150.95 159.99 32.9 Favored Pre-proline 0 N--CA 1.455 -0.215 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.88 -14.72 14.74 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.531 2.821 . . . . 0.0 113.151 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -79.74 -6.62 57.61 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.831 0.452 . . . . 0.0 111.286 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -126.75 23.23 6.74 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 122.744 0.417 . . . . 0.0 110.457 175.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 27.7 m -122.08 148.77 44.45 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.922 0.392 . . . . 0.0 111.075 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.27 147.86 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 123.306 0.643 . . . . 0.0 109.416 -176.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -112.32 154.34 25.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 10.9 m -140.14 146.16 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.077 0.551 . . . . 0.0 110.515 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -150.71 170.79 30.54 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.04 12.42 84.4 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . 10.7 p -87.76 146.27 38.67 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 122.71 0.404 . . . . 0.0 111.009 -176.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 180' ' ' VAL . 53.1 Cg_exo -55.64 161.91 7.21 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.247 2.632 . . . . 0.0 111.734 171.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -47.52 78.74 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.511 -0.757 . . . . 0.0 112.474 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.47 60.29 7.75 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.061 2.507 . . . . 0.0 111.429 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.408 ' C ' HD12 ' A' ' 184' ' ' LEU . 4.1 pp -74.02 -10.91 60.11 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.981 -0.449 . . . . 0.0 111.972 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.15 80.48 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.489 1.516 . . . . 0.0 112.242 172.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.39 -28.85 46.33 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -171.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.87 -44.37 88.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.068 0 CA-C-N 118.774 0.715 . . . . 0.0 110.167 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -85.86 -18.23 33.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.056 -175.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 29.9 tp -73.26 -30.31 63.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.85 -35.38 57.55 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.7 mmt -67.97 -33.5 74.77 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.425 ' CG2' ' HA ' ' A' ' 239' ' ' LEU . 34.8 mt -71.55 -46.99 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 122.613 0.365 . . . . 0.0 110.704 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -61.27 -23.18 65.49 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.31 0.505 . . . . 0.0 110.699 174.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -82.69 -18.65 40.17 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.969 -0.457 . . . . 0.0 111.272 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -93.4 -11.94 31.03 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 119.114 -0.47 . . . . 0.0 111.963 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -114.6 -20.75 10.59 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 118.673 0.669 . . . . 0.0 111.972 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -137.06 -33.6 0.75 Allowed 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.519 0.6 . . . . 0.0 112.578 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 68.08 179.1 15.97 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 70.82 13.89 72.46 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.428 -0.651 . . . . 0.0 113.133 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.41 HG22 ' CE2' ' A' ' 222' ' ' PHE . 22.6 t -68.78 140.66 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 118.269 1.034 . . . . 0.0 109.944 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.5 p -120.84 -30.13 4.5 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -153.39 149.37 27.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.639 0.256 . . . . 0.0 110.671 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -157.12 158.12 35.78 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.305 0.642 . . . . 0.0 109.739 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 157.41 -172.52 34.81 Favored Glycine 0 C--N 1.335 0.528 0 N-CA-C 111.974 -0.45 . . . . 0.0 111.974 177.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 205' ' ' ILE . 4.2 mp -88.01 140.15 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 174.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -53.67 106.01 0.16 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 14.4 t -152.56 146.27 25.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.238 0.542 . . . . 0.0 112.233 -175.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -152.79 135.44 9.26 Favored Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 170.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -75.89 3.09 6.37 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.022 3.148 . . . . 0.0 111.413 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -77.83 -45.73 23.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.5 pp -161.26 6.59 0.07 Allowed 'General case' 0 C--N 1.341 0.21 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -138.05 -29.77 0.82 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.501 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 34.3 m-85 54.18 -166.77 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.596 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.501 ' CD ' ' HB3' ' A' ' 213' ' ' TYR . 91.8 Cg_endo -75.19 144.35 29.52 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 CA-C-N 121.935 1.727 . . . . 0.0 112.778 -170.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -90.26 -168.76 2.2 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.583 0.753 . . . . 0.0 110.064 175.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -96.35 5.24 65.07 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -137.38 150.49 47.73 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.205 0.602 . . . . 0.0 110.85 -175.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -104.35 173.4 21.25 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.971 -173.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -148.31 153.51 38.75 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 88.7 t -138.25 148.85 24.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -136.65 156.87 47.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.422 0.63 . . . . 0.0 111.381 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.41 ' CE2' HG22 ' A' ' 200' ' ' VAL . 81.5 m-85 -132.25 153.23 50.85 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.561 -175.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.1 p -84.63 0.48 50.04 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.956 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -132.83 141.18 48.32 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.068 0.547 . . . . 0.0 110.362 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.3 pm0 -74.41 -7.27 52.36 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.369 0.268 . . . . 0.0 111.268 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -83.52 -40.62 18.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 25.5 m -75.51 -24.98 56.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -63.91 -50.75 67.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -73.71 -11.78 14.91 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 CA-C-N 118.09 0.405 . . . . 0.0 111.144 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.43 -17.05 33.13 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.588 0.176 . . . . 0.0 111.149 174.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.76 -12.34 29.36 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 11.3 pt -120.39 23.25 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.354 0.662 . . . . 0.0 110.313 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.2 p -76.79 -19.03 58.05 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.23 0.612 . . . . 0.0 111.721 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.3 144.33 22.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -57.61 -31.61 66.4 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -122.94 110.14 15.01 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.466 HG23 HD21 ' A' ' 239' ' ' LEU . 4.0 m -82.36 154.89 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.205 175.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.533 ' C ' HD22 ' A' ' 239' ' ' LEU . 24.8 mm100 -84.07 138.45 33.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 173.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.533 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.1 mm? -120.88 36.77 4.49 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -81.63 147.29 29.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.945 0.402 . . . . 0.0 111.887 -173.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -136.48 16.33 3.16 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.27 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 85.55 -15.36 46.7 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.006 0.813 . . . . 0.0 112.523 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -140.68 1.83 1.75 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.707 0.753 . . . . 0.0 110.786 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.6 mt -141.18 153.45 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 123.751 0.82 . . . . 0.0 109.335 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -148.02 135.3 20.49 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -145.34 169.38 18.39 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 125.023 1.329 . . . . 0.0 108.415 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' ARG . . . . . 0.456 ' HA ' HD23 ' A' ' 239' ' ' LEU . 0.1 OUTLIER -150.15 151.65 33.46 Favored 'General case' 0 CA--C 1.523 -0.059 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.47 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 11.4 p -155.17 153.73 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -83.35 124.09 30.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.5 m -102.98 159.0 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.67 159.01 27.91 Favored Pre-proline 0 CA--C 1.528 0.113 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.665 169.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.33 142.72 94.95 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.769 2.312 . . . . 0.0 110.124 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -83.83 166.79 17.65 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.997 0.427 . . . . 0.0 110.641 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.454 -0.262 0 C-N-CA 123.282 0.633 . . . . 0.0 110.142 -170.894 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.431 ' HG3' ' H ' ' A' ' 63' ' ' TYR . 12.9 tpt180 . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.431 ' H ' ' HG3' ' A' ' 62' ' ' ARG . 15.6 m-85 -132.66 148.95 52.35 Favored 'General case' 0 N--CA 1.458 -0.044 0 CA-C-O 120.743 0.306 . . . . 0.0 111.106 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.2 m -88.41 24.86 1.81 Allowed 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.244 0.618 . . . . 0.0 111.847 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.19 28.02 6.61 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 122.867 0.467 . . . . 0.0 109.995 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -135.29 137.85 42.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.292 1.037 . . . . 0.0 110.447 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.4 p -151.39 137.96 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.732 174.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.427 ' CZ ' ' CA ' ' A' ' 70' ' ' GLY . 11.0 t80 -87.12 143.09 27.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.5 p -128.5 85.59 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 121.979 0.895 . . . . 0.0 108.96 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.427 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -80.84 165.05 47.18 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.094 -177.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.43 9.16 77.32 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 119.77 -0.461 . . . . 0.0 113.17 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.6 tp -49.47 137.08 16.9 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.477 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 58.3 Cg_endo -66.0 136.57 45.24 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.959 1.773 . . . . 0.0 109.535 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 31.8 Cg_exo -61.55 14.03 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 124.195 3.263 . . . . 0.0 115.593 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -140.55 32.31 1.86 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.961 0.801 . . . . 0.0 112.067 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.77 155.18 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -120.42 -178.45 3.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.443 0.697 . . . . 0.0 111.0 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -53.37 -31.48 44.9 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.753 0.821 . . . . 0.0 112.738 -175.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -78.18 -33.77 49.94 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -173.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -77.49 -24.98 50.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.867 -0.52 . . . . 0.0 110.583 -173.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.5 mt -80.53 -40.55 19.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.8 m -68.02 -8.71 39.83 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.593 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.43 -19.73 14.31 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 172.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.5 m -74.98 -26.96 59.96 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 118.856 0.753 . . . . 0.0 112.535 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -122.25 17.4 10.68 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -70.81 -17.08 62.77 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -80.62 4.94 16.96 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.044 -0.41 . . . . 0.0 111.79 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -116.66 24.87 10.98 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.566 0.346 . . . . 0.0 110.751 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.64 173.62 30.81 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.16 151.66 72.49 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.492 2.795 . . . . 0.0 110.846 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.464 HD23 ' N ' ' A' ' 91' ' ' LEU . 0.6 OUTLIER -161.06 161.96 31.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.482 -170.294 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.9 pt -140.37 161.91 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.8 173.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.69 151.67 33.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -145.36 160.7 41.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.532 0.682 . . . . 0.0 112.299 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.418 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 30.3 p90 -155.75 158.77 31.86 Favored Pre-proline 0 N--CA 1.451 -0.386 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 169.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.431 ' HG2' ' ND1' ' A' ' 97' ' ' HIS . 28.5 Cg_endo -74.7 -7.98 19.93 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.447 2.765 . . . . 0.0 110.628 -169.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.431 ' ND1' ' HG2' ' A' ' 96' ' ' PRO . 51.5 m80 -105.37 18.06 22.9 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.381 1.073 . . . . 0.0 111.182 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -50.86 155.04 1.26 Allowed 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.96 0.904 . . . . 0.0 112.387 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.279 0 C-N-CA 123.403 0.681 . . . . 0.0 111.1 -176.148 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.632 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.39 145.64 35.6 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.299 0.55 . . . . 0.0 110.625 175.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.5 -177.36 6.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.438 0.695 . . . . 0.0 109.72 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -144.21 144.23 31.43 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -97.56 146.01 25.69 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.407 0.622 . . . . 0.0 111.099 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.23 144.95 40.77 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -136.35 171.91 13.79 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.815 0.34 . . . . 0.0 111.088 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -108.39 -26.18 10.61 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.016 0.527 . . . . 0.0 109.969 -177.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -135.24 155.03 51.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.32 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -85.15 -11.34 55.29 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.069 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.4 m -81.29 -19.03 43.84 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.212 0.205 . . . . 0.0 111.235 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.3 m -76.2 -43.14 43.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.571 0.224 . . . . 0.0 110.846 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.4 ' HA ' HD12 ' A' ' 124' ' ' LEU . 8.6 p -75.74 -19.5 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -77.02 -29.03 55.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.06 -44.71 46.08 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 119.067 -0.492 . . . . 0.0 111.94 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.555 ' C ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -73.41 -29.51 62.64 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 118.325 -1.35 . . . . 0.0 110.567 -179.029 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.419 ' HA ' ' SG ' ' A' ' 128' ' ' CYS . 79.1 mt -78.42 -15.7 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 118.387 0.54 . . . . 0.0 111.111 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -92.09 -13.65 30.47 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.016 -0.427 . . . . 0.0 110.894 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -113.72 1.82 15.0 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.419 ' SG ' ' HA ' ' A' ' 125' ' ' ILE . 18.5 p -96.7 -176.07 3.49 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.159 0.504 . . . . 0.0 111.177 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.6 mm -81.66 155.91 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.534 1.134 . . . . 0.0 108.513 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -136.95 145.83 44.69 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.623 0.249 . . . . 0.0 110.375 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.99 176.18 9.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -57.66 -1.89 0.12 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -169.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -159.2 0.16 0.08 OUTLIER Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.415 1.007 . . . . 0.0 114.73 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -163.91 174.03 11.97 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.121 1.46 . . . . 0.0 111.6 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 135' ' ' LEU . 2.5 mm? -117.68 161.75 19.16 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.884 0.874 . . . . 0.0 109.706 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 83.2 m-85 -144.63 158.22 43.86 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 176.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.4 tp -125.3 145.57 49.95 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 168.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 80.3 m -100.16 119.29 38.11 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.001 -0.437 . . . . 0.0 110.653 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.9 m -148.2 159.49 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.597 0.759 . . . . 0.0 110.17 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.2 p -91.11 160.38 15.6 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 97.0 p -150.58 163.78 22.8 Favored Pre-proline 0 N--CA 1.454 -0.265 0 O-C-N 122.112 -0.367 . . . . 0.0 111.895 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -66.35 -10.06 26.17 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.213 2.609 . . . . 0.0 112.641 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.417 HG22 ' CD1' ' A' ' 144' ' ' ILE . 54.8 m -93.59 -45.46 7.72 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.099 0.56 . . . . 0.0 110.741 -176.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.451 HG13 ' HE3' ' A' ' 147' ' ' LYS . 5.1 mm -135.51 158.21 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 C-N-CA 123.446 0.698 . . . . 0.0 109.22 -173.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -62.11 -24.31 67.06 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.974 -0.454 . . . . 0.0 109.971 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -157.35 141.05 15.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.244 1.018 . . . . 0.0 108.882 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.451 ' HE3' HG13 ' A' ' 144' ' ' ILE . 5.3 tppp? -132.46 115.51 14.86 Favored Pre-proline 0 N--CA 1.455 -0.182 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.414 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 89.7 Cg_endo -74.33 96.52 0.97 Allowed 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.409 2.073 . . . . 0.0 106.814 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.0 p -78.04 132.22 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -85.1 153.18 22.86 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.062 0.545 . . . . 0.0 110.67 -173.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.4 mm -136.98 143.35 35.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 123.505 0.722 . . . . 0.0 110.262 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 54.3 ttp85 -154.06 113.0 2.5 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 169.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.46 172.82 15.36 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.42 3.413 . . . . 0.0 112.655 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 19.7 t-105 -122.41 140.27 52.89 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.092 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.477 ' C ' HD12 ' A' ' 156' ' ' LEU . 17.9 m120 -125.93 168.76 13.45 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.358 0.599 . . . . 0.0 111.021 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 155' ' ' ASN . 4.7 mp -104.59 99.01 8.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.373 -169.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.2 t -156.76 -32.97 0.08 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.999 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -138.86 26.25 2.5 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.7 m -70.14 -26.53 63.99 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -153.65 160.05 42.26 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.962 0.505 . . . . 0.0 110.941 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -154.69 162.34 41.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.455 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 1.6 p -154.04 147.46 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 122.63 0.372 . . . . 0.0 110.916 -175.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 66.2 mtm -140.79 22.51 2.29 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -147.21 13.07 1.09 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.947 0.794 . . . . 0.0 112.762 -174.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 83.33 23.05 55.56 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 121.77 -0.581 . . . . 0.0 112.848 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 31.6 m 56.91 44.14 23.59 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -65.71 159.31 69.61 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.72 147.31 31.91 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.725 2.95 . . . . 0.0 112.42 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 58.8 mt -118.57 161.95 19.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.481 0.713 . . . . 0.0 110.309 -176.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 171' ' ' PRO . 13.7 t70 -149.74 140.42 14.08 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 170' ' ' ASP . 50.1 Cg_exo -56.76 -21.88 42.06 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.336 2.691 . . . . 0.0 113.777 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -83.86 -3.26 57.76 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.276 0.489 . . . . 0.0 110.826 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.88 22.4 7.43 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 122.81 0.444 . . . . 0.0 110.86 175.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.6 m -127.26 146.57 50.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.69 0.281 . . . . 0.0 110.803 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 175' ' ' ILE . 9.7 tt -123.21 149.14 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 123.087 0.555 . . . . 0.0 110.551 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.449 ' CD1' ' HD3' ' A' ' 251' ' ' LYS . 5.4 t80 -111.28 143.74 41.57 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 172.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 8.6 m -138.99 136.71 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -145.43 171.45 26.48 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 77.86 11.18 85.67 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.6 p -67.22 146.41 98.9 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 122.728 0.411 . . . . 0.0 110.236 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.08 170.44 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.946 3.097 . . . . 0.0 112.789 173.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -55.08 -47.57 98.2 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.226 -0.892 . . . . 0.0 112.751 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.94 136.48 18.6 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.934 1.756 . . . . 0.0 110.375 173.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.653 ' CD1' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -145.7 -70.53 0.26 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 119.175 -0.441 . . . . 0.0 111.644 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.653 ' H ' ' CD1' ' A' ' 184' ' ' LEU . 81.3 mtp180 58.5 133.62 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.366 1.866 . . . . 0.0 112.912 -175.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.62 -26.3 64.36 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.557 -0.715 . . . . 0.0 110.076 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 51.1 t -68.73 -47.68 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-O 120.761 0.315 . . . . 0.0 110.662 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -81.05 -25.4 37.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.65 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 46.2 tp -71.67 -31.39 66.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.82 -34.59 45.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.284 -0.26 . . . . 0.0 111.317 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 23.3 mmt -68.99 -36.23 77.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 76.6 mt -72.45 -36.0 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.1 mmt -74.08 -14.88 61.05 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 122.09 -0.381 . . . . 0.0 110.194 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -95.19 -15.09 23.53 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 117.993 0.36 . . . . 0.0 110.978 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.31 -17.46 28.9 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.677 0.391 . . . . 0.0 111.339 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -118.12 -23.81 7.23 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 117.987 0.358 . . . . 0.0 111.215 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -139.89 45.21 1.9 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.688 0.395 . . . . 0.0 110.338 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -41.45 134.06 3.28 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.937 0.779 . . . . 0.0 112.618 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 132.07 6.77 3.07 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -175.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.422 HG22 ' CE2' ' A' ' 222' ' ' PHE . 46.5 t -65.59 147.39 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 123.335 0.654 . . . . 0.0 110.611 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 21.9 p -123.91 -28.84 3.74 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 119.216 -0.421 . . . . 0.0 112.121 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -154.19 154.42 33.49 Favored 'General case' 0 N--CA 1.458 -0.06 0 CA-C-N 118.626 0.648 . . . . 0.0 110.785 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.32 158.91 44.67 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.683 0.393 . . . . 0.0 110.57 175.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -177.29 177.66 48.29 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.6 mm -102.09 92.32 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.507 ' HB3' ' H ' ' A' ' 215' ' ' LYS . 27.7 t70 51.68 -58.3 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -169.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 69.3 p 46.04 71.5 0.29 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.552 0.741 . . . . 0.0 112.933 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -78.39 128.04 79.08 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.44 -6.91 20.02 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 124.294 3.329 . . . . 0.0 114.521 -174.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -73.36 -27.16 61.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.966 1.257 . . . . 0.0 111.575 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 78.0 mt -145.33 8.24 1.18 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.851 0.86 . . . . 0.0 110.592 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 54.02 50.08 17.47 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.745 0.818 . . . . 0.0 110.801 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -131.27 152.88 81.33 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 123.378 0.671 . . . . 0.0 110.228 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -84.77 140.52 8.11 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.741 2.294 . . . . 0.0 112.458 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' LYS . . . . . 0.507 ' H ' ' HB3' ' A' ' 206' ' ' ASP . 37.4 mtmm -98.87 26.81 5.41 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 168.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.77 171.48 14.81 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 60.62 153.67 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.656 1.183 . . . . 0.0 113.746 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -88.19 160.63 30.91 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.58 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -149.55 150.28 32.01 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 60.2 t -142.49 149.93 18.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.06 148.8 50.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.422 ' CE2' HG22 ' A' ' 200' ' ' VAL . 82.0 m-85 -123.22 153.24 40.39 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.895 -175.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 86.7 p -88.66 -0.74 57.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.637 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -130.84 144.67 51.63 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.798 0.439 . . . . 0.0 111.164 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 39.8 tp60 -74.27 -16.01 60.96 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.546 0.339 . . . . 0.0 110.195 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -85.21 -38.26 19.16 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 19.1 m -68.84 -29.65 68.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -66.98 -53.61 29.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.525 0.33 . . . . 0.0 110.944 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.6 pp -69.91 -12.26 15.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.08 0 CA-C-N 118.304 0.502 . . . . 0.0 111.686 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.79 -27.37 22.34 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.012 0.369 . . . . 0.0 111.102 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -82.92 -24.68 32.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.7 pt -108.67 27.22 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 123.153 0.581 . . . . 0.0 110.277 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.5 t -77.82 -15.34 59.15 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.299 0.639 . . . . 0.0 112.218 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -155.35 145.0 21.27 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -57.88 -32.45 67.71 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -124.49 111.84 16.18 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 30.0 m -98.2 159.27 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.55 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -81.88 143.14 31.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.4 mp -130.41 103.95 6.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -135.83 146.61 47.68 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.151 -177.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -146.91 8.64 0.97 Allowed 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.647 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.62 -139.25 5.48 Favored Glycine 0 C--N 1.336 0.537 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -175.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.82 4.34 14.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.986 0.393 . . . . 0.0 112.041 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 76.7 mt -104.2 136.28 38.2 Favored 'Isoleucine or valine' 0 C--N 1.338 0.106 0 C-N-CA 123.185 0.594 . . . . 0.0 110.541 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ASP . . . . . 0.446 ' CG ' HH12 ' A' ' 247' ' ' ARG . 25.4 t70 -122.78 139.88 53.52 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.044 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -144.26 160.68 40.58 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.121 0.968 . . . . 0.0 109.851 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' ARG . . . . . 0.446 HH12 ' CG ' ' A' ' 245' ' ' ASP . 0.1 OUTLIER -134.81 160.43 38.24 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.195 0.598 . . . . 0.0 109.695 178.205 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.23 151.39 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -79.98 138.54 37.09 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -122.03 152.59 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.449 ' HD3' ' CD1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -159.03 158.62 29.05 Favored Pre-proline 0 C--O 1.231 0.13 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.775 169.72 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.52 141.2 90.51 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.177 2.585 . . . . 0.0 110.526 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -74.72 146.99 41.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.139 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -173.707 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.131 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -148.18 155.93 41.98 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.972 0.415 . . . . 0.0 111.159 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -91.14 22.77 3.58 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.412 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 53.86 21.95 3.04 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.633 0.773 . . . . 0.0 111.755 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -136.73 135.92 38.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.805 0.842 . . . . 0.0 109.525 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.11 137.91 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.314 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CZ ' ' CA ' ' A' ' 70' ' ' GLY . 7.9 t80 -81.61 140.43 34.44 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.0 96.54 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 122.02 0.914 . . . . 0.0 108.661 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.516 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -97.73 -171.43 32.98 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.831 -177.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.78 33.08 76.38 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-O 119.43 -0.65 . . . . 0.0 111.864 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 72' ' ' LEU . 43.6 mt -100.92 135.45 19.99 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 118.201 1.001 . . . . 0.0 110.649 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.488 ' HD2' HG21 ' A' ' 76' ' ' ILE . 60.1 Cg_endo -65.3 171.41 9.22 Favored 'Trans proline' 0 N--CA 1.459 -0.532 1 C-N-CA 125.577 4.185 . . . . 0.0 113.23 -178.649 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.62 9.32 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.463 1 C-N-CA 126.161 4.574 . . . . 0.0 116.391 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -138.66 -114.56 0.15 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.488 HG21 ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER 44.6 67.91 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 122.623 1.201 . . . . 0.0 111.738 172.012 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -70.68 -176.22 1.25 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -46.48 -33.13 3.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.89 1.676 . . . . 0.0 113.382 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -80.17 -29.74 38.77 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.187 -0.32 . . . . 0.0 111.852 -173.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -78.81 -30.64 45.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.256 -0.278 . . . . 0.0 110.758 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 61.0 mt -74.01 -40.67 52.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.6 m -65.37 -22.0 66.75 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.654 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.91 -17.97 26.99 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -79.33 -25.73 42.26 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.723 0.692 . . . . 0.0 112.03 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -122.09 18.56 10.82 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -71.75 -20.28 61.91 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -75.76 -5.95 48.26 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 122.111 -0.368 . . . . 0.0 111.93 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -108.38 21.8 16.82 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.692 0.397 . . . . 0.0 110.301 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.81 165.17 32.9 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.469 -1.053 . . . . 0.0 110.469 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.98 141.29 93.9 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.532 2.822 . . . . 0.0 112.148 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.513 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -151.24 167.93 26.29 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.713 0.405 . . . . 0.0 110.697 177.702 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 mt -134.19 163.92 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.7 p -126.8 150.16 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -152.15 165.91 33.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -170.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.475 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 4.7 p90 -147.32 159.81 41.07 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 169.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 95' ' ' TRP . 79.6 Cg_endo -64.51 -18.72 63.85 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 124.133 3.222 . . . . 0.0 111.912 -168.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -118.63 21.64 12.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.008 0.923 . . . . 0.0 111.396 -177.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -58.59 115.71 3.21 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 173.622 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.246 0 C-N-CA 123.09 0.556 . . . . 0.0 109.953 179.553 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.703 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.82 139.54 53.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.548 0.674 . . . . 0.0 109.907 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -157.47 -162.42 1.19 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.607 0.763 . . . . 0.0 110.177 -170.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -137.18 141.31 42.16 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 122.59 0.356 . . . . 0.0 110.133 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.3 mp -96.84 149.51 21.77 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 mp -108.32 140.7 41.21 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 173.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -135.46 170.57 15.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.901 0.381 . . . . 0.0 110.559 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -111.25 -27.15 8.81 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.839 0.456 . . . . 0.0 110.487 -175.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -137.01 155.78 49.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.477 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -79.03 -18.86 52.82 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.487 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.9 m -77.9 -18.7 55.86 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.492 0.317 . . . . 0.0 111.528 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 63.3 m -75.36 -47.11 29.14 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.823 0.344 . . . . 0.0 110.678 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.4 p -76.78 -16.83 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -74.69 -32.69 62.27 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.46 -35.92 60.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.376 -0.345 . . . . 0.0 111.455 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 pp -76.38 -22.3 54.98 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.803 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.4 mt -87.27 -17.76 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 O-C-N 122.285 -0.259 . . . . 0.0 111.335 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -103.43 -5.87 22.45 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -122.9 10.26 9.5 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.8 m -122.76 -177.16 3.57 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.655 0.382 . . . . 0.0 110.456 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 38.2 mm -75.97 161.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 124.147 0.979 . . . . 0.0 110.136 -171.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -135.42 162.46 32.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.79 0.329 . . . . 0.0 110.722 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -140.22 77.4 1.61 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.318 0.58 . . . . 0.0 110.631 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 55.42 9.66 0.4 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 157.22 -10.92 0.26 Allowed Glycine 0 CA--C 1.526 0.745 0 CA-C-N 118.568 0.622 . . . . 0.0 113.053 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.42 ' HB2' ' HE2' ' A' ' 134' ' ' LYS . 1.6 mppt? -124.08 176.51 6.33 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.22 160.55 19.6 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -172.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.35 161.87 39.4 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.405 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 27.2 tp -142.13 142.21 32.73 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 168.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 46.0 t -92.19 128.24 37.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.311 0.505 . . . . 0.0 110.866 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.2 m -145.83 172.04 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.879 0.871 . . . . 0.0 110.307 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.9 p -72.9 172.25 11.24 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.018 0.527 . . . . 0.0 110.127 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.9 t -140.3 137.03 17.34 Favored Pre-proline 0 N--CA 1.457 -0.123 0 O-C-N 122.177 -0.327 . . . . 0.0 111.777 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -80.74 -6.14 13.32 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 124.309 3.339 . . . . 0.0 112.662 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.465 HG23 HG12 ' A' ' 144' ' ' ILE . 3.8 t -125.38 -24.12 4.0 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.936 0.789 . . . . 0.0 112.458 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.638 HG22 ' H ' ' A' ' 145' ' ' LYS . 5.0 mm -124.09 -175.85 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.638 ' H ' HG22 ' A' ' 144' ' ' ILE . 54.4 mtmt -78.59 -21.33 48.73 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.684 -0.635 . . . . 0.0 111.356 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -158.9 166.45 31.83 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.62 0.768 . . . . 0.0 109.884 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.426 ' HZ3' ' HB2' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -151.23 119.37 3.4 Favored Pre-proline 0 N--CA 1.458 -0.071 0 O-C-N 122.192 -0.317 . . . . 0.0 110.987 178.246 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -81.08 101.87 1.31 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.617 2.212 . . . . 0.0 107.847 168.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.2 p -74.2 134.66 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -92.63 150.81 20.47 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.312 0.645 . . . . 0.0 110.785 -171.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 34.5 mm -137.32 141.19 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 122.545 0.338 . . . . 0.0 111.649 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -149.44 107.83 3.34 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 122.995 0.518 . . . . 0.0 109.649 174.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.36 165.0 31.65 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.744 2.963 . . . . 0.0 112.257 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -106.9 135.67 48.05 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-O 120.44 0.162 . . . . 0.0 110.678 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -102.26 156.41 17.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.693 0.797 . . . . 0.0 112.397 -175.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.6 mp -102.98 91.51 4.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 42.8 t -156.36 -32.85 0.09 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -141.67 31.65 1.65 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.1 m -71.15 -18.26 62.51 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -153.52 159.36 42.21 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.098 0.559 . . . . 0.0 110.664 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -153.35 153.2 32.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 17.3 t -130.76 141.0 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 33.1 ttm -127.92 -3.23 5.84 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.541 0.201 . . . . 0.0 111.541 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -159.69 -58.65 0.06 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.06 6.85 10.8 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.178 -0.79 . . . . 0.0 114.113 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 51.5 p -88.72 -11.79 44.12 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.853 1.326 . . . . 0.0 112.486 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -135.68 150.76 72.83 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 118.351 0.523 . . . . 0.0 111.479 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -70.43 167.76 24.39 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.196 3.264 . . . . 0.0 111.656 -177.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.3 mt -107.25 160.48 15.57 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.454 0.701 . . . . 0.0 110.762 -175.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -151.41 142.95 15.68 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.0 -22.23 54.11 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.199 2.599 . . . . 0.0 113.648 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.6 mtp-105 -83.85 -2.97 57.49 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 122.942 0.497 . . . . 0.0 111.179 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -127.99 19.06 6.57 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.75 0.42 . . . . 0.0 111.095 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 21.1 m -127.42 140.75 51.96 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.541 0.21 . . . . 0.0 110.684 -177.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 9.7 tt -110.24 150.25 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.032 0 C-N-CA 123.015 0.526 . . . . 0.0 110.158 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -112.16 144.27 41.82 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 96.6 t -136.57 132.48 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -176.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -159.01 179.62 34.51 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 112.131 -0.387 . . . . 0.0 112.131 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 79.94 10.59 85.45 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.3 p -67.85 146.24 98.26 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 123.083 0.553 . . . . 0.0 109.911 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -53.66 -58.32 1.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.053 2.502 . . . . 0.0 113.657 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.426 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 25.7 mmm-85 -151.58 -68.01 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.319 -0.848 . . . . 0.0 112.312 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 182' ' ' ARG . 50.1 Cg_endo -79.23 162.89 25.41 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.083 2.522 . . . . 0.0 112.135 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.3 mp -136.89 -49.97 0.64 Allowed 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 122.967 0.507 . . . . 0.0 109.633 173.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 47.9 102.83 0.0 OUTLIER 'General case' 0 C--N 1.341 0.207 0 C-N-CA 126.391 1.876 . . . . 0.0 112.829 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.54 -24.42 55.98 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 78.7 t -68.66 -51.76 42.64 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 CA-C-N 118.019 0.372 . . . . 0.0 110.866 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -84.51 -21.78 30.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 121.272 -0.171 . . . . 0.0 110.809 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 57.3 tp -68.01 -33.2 74.16 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.401 ' HB2' ' CB ' ' A' ' 203' ' ' ALA . . . -78.33 -36.18 46.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.407 -0.183 . . . . 0.0 111.361 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 25.2 mmt -70.02 -36.82 75.37 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 83.2 mt -70.0 -33.16 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.1 mmt -77.7 -9.78 59.17 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.119 -0.363 . . . . 0.0 111.024 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -109.53 -2.26 17.72 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.416 0.553 . . . . 0.0 112.448 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -108.08 -17.0 14.15 Favored 'General case' 0 C--N 1.34 0.193 0 O-C-N 121.969 -0.457 . . . . 0.0 111.454 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.47 -17.89 11.63 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.922 0.328 . . . . 0.0 110.554 175.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -142.69 40.39 1.55 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.188 0.595 . . . . 0.0 109.997 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -40.17 134.96 2.13 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.547 1.07 . . . . 0.0 113.502 -174.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 137.67 14.23 0.8 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.472 0.558 . . . . 0.0 112.046 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 42.4 t -73.73 149.2 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.244 1.022 . . . . 0.0 111.364 -176.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 25.7 p -124.85 -27.56 3.6 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.576 0.35 . . . . 0.0 111.014 175.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -155.15 156.82 36.43 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.655 0.264 . . . . 0.0 110.739 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.401 ' CB ' ' HB2' ' A' ' 190' ' ' ALA . . . -154.22 157.87 39.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.276 0.63 . . . . 0.0 109.977 176.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.43 -178.53 48.32 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.1 mm -95.35 143.51 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -59.67 122.71 14.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 16.9 p -141.73 163.41 32.99 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.119 0.485 . . . . 0.0 110.806 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -132.07 128.05 21.27 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 123.58 0.752 . . . . 0.0 109.16 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -80.31 -6.4 13.78 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 124.576 3.518 . . . . 0.0 113.196 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -92.79 -58.36 2.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.819 0.736 . . . . 0.0 111.459 -173.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -160.78 -5.06 0.05 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -96.24 -15.44 22.0 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 119.722 1.146 . . . . 0.0 113.117 -174.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.517 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 55.6 m-85 50.98 -146.89 0.01 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 117.219 -1.372 . . . . 0.0 110.044 177.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.517 ' CD ' ' HB3' ' A' ' 213' ' ' TYR . 89.4 Cg_endo -72.06 150.33 54.07 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 CA-C-N 123.178 2.171 . . . . 0.0 112.405 -173.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -105.81 13.85 28.99 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.7 0.8 . . . . 0.0 112.158 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 68.15 14.54 66.29 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.615 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -133.07 154.66 50.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 117.908 0.854 . . . . 0.0 109.867 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -100.7 162.28 18.63 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 121.064 0.258 . . . . 0.0 112.537 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -151.04 146.64 26.33 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 94.9 t -141.44 145.82 24.18 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.059 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.98 142.62 51.0 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 110.86 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -118.76 156.54 29.2 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.638 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.7 m -84.19 -5.63 59.28 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.209 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -130.02 148.27 51.86 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.073 0.397 . . . . 0.0 111.919 -172.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -74.98 -15.45 60.66 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -84.98 -37.89 19.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 18.6 m -73.07 -28.04 62.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -67.91 -54.62 17.38 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.444 0.298 . . . . 0.0 110.531 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.1 pt -69.58 -14.84 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 CA-C-N 118.108 0.413 . . . . 0.0 111.345 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.66 -28.06 28.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.833 0.288 . . . . 0.0 110.794 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -82.89 -27.2 30.86 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.858 0.299 . . . . 0.0 111.759 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.2 pt -105.77 29.07 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.127 0.571 . . . . 0.0 110.181 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 21.9 t -78.38 -11.06 59.92 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.085 0.554 . . . . 0.0 111.925 -176.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -158.06 145.29 18.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -59.05 -29.91 67.65 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 122.416 0.287 . . . . 0.0 111.139 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -123.19 118.79 28.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.8 m -107.52 156.55 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.006 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -81.5 144.3 31.44 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.989 0.423 . . . . 0.0 110.275 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.99 105.86 7.67 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -133.25 147.42 51.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.216 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -144.62 11.87 1.47 Allowed 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.168 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.95 -140.16 5.91 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -175.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.65 14.8 1.94 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.961 0.504 . . . . 0.0 111.984 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 73.5 mt -116.57 141.42 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 123.619 0.768 . . . . 0.0 110.582 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -129.54 146.62 51.34 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.978 0.418 . . . . 0.0 111.548 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -144.39 163.99 32.15 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 124.582 1.153 . . . . 0.0 109.137 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.08 153.87 50.46 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.367 0.667 . . . . 0.0 109.709 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 12.1 p -154.53 157.87 4.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -85.11 138.47 32.38 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.476 -0.14 . . . . 0.0 110.757 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -121.28 159.75 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.06 0 CA-C-O 120.795 0.331 . . . . 0.0 111.527 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.41 159.9 26.12 Favored Pre-proline 0 N--CA 1.455 -0.187 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 171.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.3 131.69 46.43 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.726 2.284 . . . . 0.0 108.217 171.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -73.42 112.22 9.29 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.526 -173.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 CA--C 1.534 0.34 0 C-N-CA 125.534 1.534 . . . . 0.0 112.769 175.007 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -154.14 157.36 38.77 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 122.57 0.348 . . . . 0.0 110.823 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.8 t -94.25 -179.25 4.87 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.377 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.53 ' HA ' ' CE2' ' A' ' 115' ' ' PHE . 95.1 mtt180 -90.99 27.36 1.85 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.592 0.757 . . . . 0.0 111.305 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.563 ' HE2' ' CD1' ' A' ' 154' ' ' TRP . 16.5 pttm -146.93 141.78 26.87 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.02 0.928 . . . . 0.0 111.154 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 p -148.81 148.16 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.245 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.416 ' CZ ' ' CA ' ' A' ' 70' ' ' GLY . 6.4 t80 -100.57 143.08 31.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 171.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.403 HG11 HD13 ' A' ' 113' ' ' LEU . 2.7 m -127.31 103.7 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.927 0.87 . . . . 0.0 108.853 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.416 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -93.77 -164.03 36.59 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.13 13.82 29.52 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 119.461 -0.633 . . . . 0.0 112.708 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 72' ' ' LEU . 27.0 mt -79.67 146.06 64.12 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 118.72 1.26 . . . . 0.0 109.676 177.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 97.2 Cg_endo -76.68 161.23 34.02 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 124.355 3.37 . . . . 0.0 110.375 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 33.1 Cg_exo -62.84 -11.61 25.08 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.777 2.985 . . . . 0.0 113.222 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -95.85 -39.47 9.81 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.4 mt -54.34 145.28 4.51 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 CA-C-O 121.735 0.779 . . . . 0.0 112.155 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -146.28 -170.45 3.5 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.768 1.227 . . . . 0.0 109.324 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -51.64 -27.0 10.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.604 0.762 . . . . 0.0 112.663 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -76.92 -45.02 29.35 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.721 -0.612 . . . . 0.0 111.446 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -78.4 -26.32 46.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.18 -173.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.411 ' CG2' HD11 ' A' ' 113' ' ' LEU . 84.6 mt -74.62 -47.27 39.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 87.4 m -67.94 -12.84 61.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.006 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.25 -15.11 20.97 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.6 m -82.38 -29.13 31.06 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.957 0.799 . . . . 0.0 112.032 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -118.46 14.64 13.73 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -66.32 -20.83 66.2 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.06 -0.4 . . . . 0.0 111.808 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -73.6 -5.1 38.26 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.512 0.325 . . . . 0.0 111.805 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -112.12 20.47 16.82 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.642 0.377 . . . . 0.0 111.083 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.23 176.2 25.35 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.92 154.29 67.25 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.677 2.918 . . . . 0.0 110.869 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.479 HD23 ' N ' ' A' ' 91' ' ' LEU . 0.7 OUTLIER -164.54 162.09 21.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.187 -170.202 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.2 pt -140.91 167.59 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.276 173.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.7 p -134.69 155.54 38.74 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -150.32 165.29 33.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.992 0.425 . . . . 0.0 111.651 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.443 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 41.4 p90 -159.83 162.8 24.12 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 172.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.443 ' HD2' ' HB2' ' A' ' 95' ' ' TRP . 26.0 Cg_endo -75.51 -15.53 19.61 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.198 1.932 . . . . 0.0 110.513 -168.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.5 m80 -91.41 2.17 56.6 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.653 0.781 . . . . 0.0 110.872 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -63.33 149.02 46.74 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 122.966 0.507 . . . . 0.0 110.765 -176.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.346 0 C-N-CA 123.707 0.803 . . . . 0.0 109.943 -178.715 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.918 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.472 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.28 138.47 58.54 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.269 1.534 . . . . 0.0 110.854 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -156.53 -170.24 3.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.85 -169.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -130.36 129.94 43.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.167 0.587 . . . . 0.0 109.49 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.411 HD11 ' CG2' ' A' ' 81' ' ' ILE . 10.7 mp -86.79 142.98 27.72 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.744 0.783 . . . . 0.0 111.816 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.57 138.08 51.09 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 113.262 -1.79 . . . . 0.0 107.106 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 29.3 p90 -159.83 166.0 31.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.64 -20.51 5.95 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -174.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -79.07 -14.11 59.35 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -169.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 52.95 14.48 0.46 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.4 m -128.38 -12.47 5.03 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.211 0.605 . . . . 0.0 110.956 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.2 t -69.23 -34.69 75.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.477 HG11 ' CZ ' ' A' ' 115' ' ' PHE . 30.7 m -71.73 -26.23 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-N 116.857 -0.156 . . . . 0.0 111.007 177.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -70.63 -40.55 73.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -77.65 -32.41 53.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -82.56 -12.57 57.64 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 119.003 0.819 . . . . 0.0 111.587 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.467 HG23 HD13 ' A' ' 135' ' ' LEU . 61.4 mt -101.09 -19.81 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 O-C-N 122.174 -0.329 . . . . 0.0 110.745 178.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -101.84 -10.31 19.99 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -117.98 5.58 12.12 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 53.8 m -119.79 -159.92 0.8 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' A' ' 136' ' ' TYR . 75.5 mt -79.48 145.81 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.046 0.538 . . . . 0.0 109.756 -172.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -140.18 137.26 34.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -152.65 -175.61 5.37 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.077 0.465 . . . . 0.0 111.573 178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -61.18 108.72 0.95 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.581 0.705 . . . . 0.0 111.444 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.44 -3.69 66.7 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.009 -0.996 . . . . 0.0 115.051 171.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -156.54 166.9 32.09 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.962 1.381 . . . . 0.0 111.829 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.467 HD13 HG23 ' A' ' 125' ' ' ILE . 28.6 mt -129.46 160.49 32.99 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 124.324 1.05 . . . . 0.0 109.151 -174.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 149' ' ' VAL . 75.4 m-85 -147.87 170.28 17.99 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 177.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.405 HD12 ' H ' ' A' ' 138' ' ' CYS . 43.6 tp -146.31 147.06 30.97 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.397 -1.274 . . . . 0.0 107.695 170.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' CYS . . . . . 0.405 ' H ' HD12 ' A' ' 137' ' ' LEU . 70.9 m -84.29 138.38 32.95 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.983 0.421 . . . . 0.0 112.105 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.3 p -160.74 149.25 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.817 1.247 . . . . 0.0 107.986 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.7 t -122.29 144.7 48.84 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 118.249 0.477 . . . . 0.0 111.304 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.6 m -152.55 167.7 12.8 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.292 0.637 . . . . 0.0 110.945 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -59.12 24.57 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.71 1 C-N-CA 126.097 4.531 . . . . 0.0 117.604 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.7 m -117.38 -28.28 6.16 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 119.82 1.191 . . . . 0.0 109.843 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.443 HG12 ' HE3' ' A' ' 147' ' ' LYS . 0.5 OUTLIER -165.32 166.52 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.321 1.049 . . . . 0.0 110.455 -171.522 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -84.42 101.78 12.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 170.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.0 t70 61.44 144.83 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.268 1.427 . . . . 0.0 113.523 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.443 ' HE3' HG12 ' A' ' 144' ' ' ILE . 27.6 ttmt -152.95 116.13 2.81 Favored Pre-proline 0 N--CA 1.455 -0.181 0 C-N-CA 124.232 1.013 . . . . 0.0 109.204 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.465 ' HB2' ' CD2' ' A' ' 136' ' ' TYR . 76.6 Cg_exo -54.94 125.08 17.96 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 124.416 3.411 . . . . 0.0 113.229 174.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 38.3 t -73.42 140.53 17.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 170.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.47 82.65 2.5 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.748 1.158 . . . . 0.0 110.284 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.9 mm -69.92 139.58 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.732 0.813 . . . . 0.0 112.313 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -155.14 105.28 2.25 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.834 172.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.56 164.97 29.75 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 124.123 3.216 . . . . 0.0 112.213 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.563 ' CD1' ' HE2' ' A' ' 66' ' ' LYS . 69.9 t-105 -86.16 145.75 26.87 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 175.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -105.83 152.25 23.48 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.108 0.48 . . . . 0.0 111.126 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.17 36.01 0.81 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.704 0.802 . . . . 0.0 111.715 -175.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.5 t -101.47 -30.5 11.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.097 -0.377 . . . . 0.0 110.771 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -159.93 144.92 15.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.9 m -152.4 -29.99 0.15 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.248 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -153.47 154.87 35.22 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.005 0.922 . . . . 0.0 109.431 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -157.1 155.57 31.3 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.603 0.24 . . . . 0.0 110.501 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.4 p -153.38 148.56 13.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -109.52 13.52 23.94 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -160.34 -47.56 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.532 0.606 . . . . 0.0 111.054 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.52 6.97 59.97 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.364 -0.686 . . . . 0.0 113.42 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.8 t -138.38 -2.6 1.79 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.285 1.043 . . . . 0.0 113.739 -177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -73.72 154.84 89.31 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 118.988 0.813 . . . . 0.0 109.958 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -53.79 140.93 66.93 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.239 2.626 . . . . 0.0 110.366 173.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 39.6 tp -150.25 135.29 17.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.535 0.207 . . . . 0.0 110.801 -175.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -148.68 155.36 41.5 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.089 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -65.31 -21.39 61.48 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.408 2.739 . . . . 0.0 111.897 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -85.27 3.86 37.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.89 0.876 . . . . 0.0 111.907 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -120.13 23.7 10.84 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.015 0.526 . . . . 0.0 109.715 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 17.0 m -117.17 146.38 43.24 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.016 0.436 . . . . 0.0 111.691 -173.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.4 tt -119.69 147.64 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.294 0.638 . . . . 0.0 109.735 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.4 ' HB2' ' CD1' ' A' ' 253' ' ' TYR . 6.3 t80 -105.24 136.5 44.65 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 99.5 t -130.9 113.31 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -141.91 -179.75 19.2 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 112.34 -0.304 . . . . 0.0 112.34 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.0 12.94 62.96 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -174.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.54 153.91 94.72 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -64.61 -68.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.027 2.485 . . . . 0.0 110.609 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.5 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 94.7 mtt-85 -146.59 -60.27 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.127 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' A' ' 182' ' ' ARG . 44.0 Cg_endo -80.09 162.28 23.25 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.904 2.403 . . . . 0.0 111.293 174.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.421 HD23 ' N ' ' A' ' 184' ' ' LEU . 2.1 pt? -159.49 -26.94 0.07 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.403 0.681 . . . . 0.0 110.87 173.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 51.87 115.49 0.0 OUTLIER 'General case' 0 C--N 1.342 0.251 0 C-N-CA 127.686 2.394 . . . . 0.0 114.475 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.74 -29.18 69.95 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.6 t -69.73 -49.61 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-N 117.902 0.319 . . . . 0.0 111.043 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -80.84 -21.72 40.52 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 122.345 -0.222 . . . . 0.0 110.929 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 33.7 tp -70.11 -33.61 72.07 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.433 ' HB2' ' CB ' ' A' ' 203' ' ' ALA . . . -77.21 -35.25 55.78 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.4 mmt -69.17 -35.31 76.16 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 66.1 mt -69.75 -34.08 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.2 mmt -74.13 -17.42 60.93 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.859 -0.526 . . . . 0.0 111.009 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -90.5 -17.42 27.1 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.062 0.392 . . . . 0.0 111.965 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -100.37 -28.3 13.02 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 118.719 0.691 . . . . 0.0 112.777 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.37 -9.17 23.84 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.62 0.646 . . . . 0.0 111.592 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -141.7 -44.59 0.35 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.03 0.377 . . . . 0.0 111.102 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 70.3 162.11 3.85 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 86.55 13.17 68.17 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 222' ' ' PHE . 10.7 p -88.46 164.61 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.164 0.986 . . . . 0.0 109.3 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 41.7 t -139.84 -62.16 0.52 Allowed 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.067 -0.395 . . . . 0.0 111.356 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -108.32 151.07 26.48 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.128 0.49 . . . . 0.0 112.24 -172.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' A' ' 190' ' ' ALA . . . -152.36 163.64 39.07 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.434 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 175.04 -179.06 46.56 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 41.3 mm -92.34 138.08 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -59.22 118.57 6.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 24.9 p -144.73 153.59 41.85 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -116.95 130.32 24.68 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -78.68 -11.51 15.43 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 124.529 3.486 . . . . 0.0 112.393 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -101.32 -9.91 20.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.645 0.378 . . . . 0.0 111.335 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -118.23 -3.59 11.02 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.557 0.743 . . . . 0.0 109.477 171.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 49.35 36.64 10.03 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.924 0.89 . . . . 0.0 112.377 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.21 162.16 51.44 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -90.66 -179.07 1.52 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 124.502 3.468 . . . . 0.0 111.388 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -121.97 7.43 9.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.263 0.625 . . . . 0.0 111.339 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.01 13.48 66.77 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.92 -0.378 . . . . 0.0 112.851 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -146.54 164.54 32.24 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.503 0.651 . . . . 0.0 110.241 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -103.11 165.14 15.89 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 121.003 0.224 . . . . 0.0 112.941 -174.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -145.6 145.86 31.14 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 94.7 t -138.72 147.32 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.11 145.19 51.23 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.251 0.548 . . . . 0.0 111.344 -177.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 200' ' ' VAL . 9.9 m-85 -120.07 161.95 20.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.369 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 92.0 p -98.48 8.59 44.68 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -131.02 140.45 50.1 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.831 0.453 . . . . 0.0 110.213 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -75.06 -19.03 60.18 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -80.61 -38.21 29.73 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 25.1 m -75.77 -25.38 56.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -67.36 -50.34 60.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -73.66 -11.12 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-N 117.969 0.349 . . . . 0.0 111.176 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.63 -21.26 25.41 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 119.722 -0.18 . . . . 0.0 110.808 174.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -87.5 -27.3 22.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.965 0.348 . . . . 0.0 111.868 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 8.4 pt -105.38 28.75 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.162 0.585 . . . . 0.0 110.262 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.2 p -74.99 -17.0 60.6 Favored 'General case' 0 C--N 1.334 -0.079 0 C-N-CA 123.406 0.682 . . . . 0.0 112.112 -176.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -156.96 145.01 19.35 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -176.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -59.72 -30.56 68.9 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 122.406 0.282 . . . . 0.0 111.324 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -122.61 121.73 37.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 29.6 m -111.93 160.54 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.412 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -86.76 144.94 26.84 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.971 0.415 . . . . 0.0 110.138 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.4 mp -132.86 104.07 6.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -130.64 149.69 52.18 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.193 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -146.9 20.41 1.27 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.149 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.61 129.46 2.96 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -173.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 53.89 16.7 1.13 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.28 1.032 . . . . 0.0 113.121 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 76.2 mt -139.99 146.22 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.789 0.836 . . . . 0.0 109.601 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -156.32 129.61 8.12 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -148.55 162.27 39.99 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.493 0.717 . . . . 0.0 110.981 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.84 155.93 43.34 Favored 'General case' 0 C--N 1.338 0.068 0 C-N-CA 124.001 0.92 . . . . 0.0 109.388 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.4 p -156.8 156.72 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -86.06 138.76 31.71 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.19 158.94 32.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.103 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.63 161.86 24.13 Favored Pre-proline 0 N--CA 1.455 -0.197 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.338 169.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.93 132.63 50.82 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.589 2.193 . . . . 0.0 108.861 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' TYR . . . . . 0.4 ' CD1' ' HB2' ' A' ' 176' ' ' PHE . 3.2 t80 -78.11 167.49 21.34 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.242 -177.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.456 -0.17 0 C-N-CA 123.748 0.819 . . . . 0.0 111.106 -172.098 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.072 0 CA-C-O 121.075 0.465 . . . . 0.0 111.698 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -154.6 164.33 38.88 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.369 -174.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.9 t -96.0 165.51 12.22 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.584 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.89 11.01 2.88 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -123.33 139.79 53.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 p -155.59 151.08 10.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.79 -172.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -96.79 142.12 29.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 174.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 m -131.85 130.75 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.63 151.67 18.62 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 112.052 -0.419 . . . . 0.0 112.052 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.48 19.51 37.96 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.654 -0.526 . . . . 0.0 113.029 176.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 pp -80.93 153.3 72.49 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 118.556 1.178 . . . . 0.0 109.114 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.58 144.76 17.92 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.076 2.517 . . . . 0.0 112.46 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -80.55 -4.65 13.05 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 124.057 3.172 . . . . 0.0 111.461 174.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -73.79 -6.3 46.13 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -176.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.404 ' C ' HD12 ' A' ' 76' ' ' ILE . 1.9 pp -141.68 -169.45 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -132.32 -170.62 2.46 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.918 0.487 . . . . 0.0 111.445 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -46.46 -30.3 2.12 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.461 1.504 . . . . 0.0 113.003 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.19 -34.23 77.08 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.399 0.545 . . . . 0.0 112.267 -176.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -80.26 -40.68 26.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.068 -0.395 . . . . 0.0 110.308 -174.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.7 pp -76.75 -23.76 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.366 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 78.3 m -70.84 -30.79 67.3 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.79 -16.95 60.03 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.056 -0.402 . . . . 0.0 110.8 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.7 m -86.28 -24.22 26.03 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -117.88 -18.18 9.59 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -176.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -68.26 -8.92 43.61 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.283 0.947 . . . . 0.0 112.176 -174.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -67.48 -6.7 20.75 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.983 -0.448 . . . . 0.0 111.617 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -111.98 -1.26 15.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.59 0.356 . . . . 0.0 111.545 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.41 165.73 11.43 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -68.17 137.31 40.14 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.368 2.712 . . . . 0.0 110.006 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.407 ' C ' HD12 ' A' ' 91' ' ' LEU . 3.3 pp -160.09 174.47 14.25 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.833 -174.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.17 174.7 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.087 178.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.63 159.41 43.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 CA-C-O 120.777 0.322 . . . . 0.0 111.019 -177.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -150.87 160.62 43.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.41 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.456 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 38.8 p90 -160.23 159.24 26.59 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 95' ' ' TRP . 17.5 Cg_endo -75.97 -8.76 19.15 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.119 2.546 . . . . 0.0 109.71 -169.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.453 ' ND1' ' HG2' ' A' ' 96' ' ' PRO . 16.0 m80 -102.08 11.42 38.41 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.472 1.109 . . . . 0.0 111.614 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -53.51 159.05 1.58 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 123.95 0.9 . . . . 0.0 113.11 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 124.086 0.955 . . . . 0.0 110.212 -178.419 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.684 0 CA-C-O 119.748 -0.473 . . . . 0.0 113.026 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.59 147.36 34.27 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.035 0.918 . . . . 0.0 109.717 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.6 -177.26 6.24 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.077 0.551 . . . . 0.0 110.44 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -133.6 129.62 37.21 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mp -92.16 145.62 24.36 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.568 0.699 . . . . 0.0 111.997 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -115.21 136.2 53.36 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -128.51 177.91 6.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.442 0.697 . . . . 0.0 110.881 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -115.79 -32.28 5.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.079 0.552 . . . . 0.0 110.249 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -130.85 155.07 47.34 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.154 0.502 . . . . 0.0 111.523 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -81.52 -14.23 57.16 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.671 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.0 m -79.53 -14.9 58.55 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.173 -0.329 . . . . 0.0 111.034 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 52.8 m -79.93 -39.55 30.06 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.324 -0.235 . . . . 0.0 111.022 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.83 -19.3 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -79.71 -33.12 41.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.8 -34.57 57.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.072 0.396 . . . . 0.0 111.114 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.0 pp -79.86 -19.92 47.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.425 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 54.0 mt -92.66 -20.98 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 117.904 0.32 . . . . 0.0 111.328 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -95.43 -14.78 23.49 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.825 -0.547 . . . . 0.0 111.922 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -111.07 26.35 10.8 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.157 0.583 . . . . 0.0 111.418 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 16.7 p -130.73 -173.89 3.21 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.985 0.421 . . . . 0.0 111.771 -176.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 129' ' ' ILE . 2.0 mp -86.49 155.54 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -128.78 152.45 48.44 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -139.6 67.6 1.38 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.405 0.621 . . . . 0.0 110.411 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 51.88 14.74 0.33 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 172.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 163.49 -14.16 0.1 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-N 118.671 0.669 . . . . 0.0 112.807 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -131.58 169.63 15.85 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 117.597 0.698 . . . . 0.0 109.319 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.71 162.74 14.15 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.401 0.143 . . . . 0.0 110.879 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.445 ' CE1' ' HG2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -143.31 136.96 28.46 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.3 mp -125.08 132.51 53.14 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 25.0 p -81.51 131.77 35.29 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.944 0.402 . . . . 0.0 112.036 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.0 m -153.25 173.58 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.298 1.439 . . . . 0.0 108.23 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.9 t -146.25 132.65 19.63 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.956 -0.465 . . . . 0.0 111.963 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.469 ' H ' ' HB ' ' A' ' 144' ' ' ILE . 15.1 m -158.65 172.69 5.81 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 125.996 1.718 . . . . 0.0 107.969 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.423 ' CD ' ' HB3' ' A' ' 141' ' ' SER . 62.2 Cg_exo -53.71 -40.31 80.26 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.623 2.882 . . . . 0.0 115.7 -172.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.8 m -91.82 -13.32 31.62 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.053 0.842 . . . . 0.0 110.816 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.497 ' CD1' ' HE3' ' A' ' 147' ' ' LYS . 37.5 mm -86.79 -37.6 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 122.769 0.428 . . . . 0.0 110.661 -171.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 59.0 mttm 46.07 51.6 10.82 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.613 0.365 . . . . 0.0 111.537 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 64.31 17.61 10.84 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.497 ' HE3' ' CD1' ' A' ' 144' ' ' ILE . 18.4 pttp -82.56 154.47 68.59 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 119.206 0.912 . . . . 0.0 109.749 174.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.445 ' HG2' ' CE1' ' A' ' 136' ' ' TYR . 90.0 Cg_endo -76.97 161.4 32.99 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.91 2.407 . . . . 0.0 112.625 172.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.6 m -114.7 151.45 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -98.13 149.96 21.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -169.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.3 mm -131.64 146.82 32.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 124.762 1.225 . . . . 0.0 110.612 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 60.4 ttp85 -158.1 101.59 1.75 Allowed Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 122.653 0.381 . . . . 0.0 110.275 172.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.58 170.79 5.13 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 124.594 3.529 . . . . 0.0 114.334 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -95.3 159.73 14.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.499 175.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.411 ' C ' HD12 ' A' ' 156' ' ' LEU . 10.0 p30 -102.03 158.67 15.99 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.036 0.534 . . . . 0.0 112.013 -176.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.411 HD12 ' C ' ' A' ' 155' ' ' ASN . 8.3 mp -108.15 36.4 2.8 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.688 0.795 . . . . 0.0 111.562 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.6 t -137.15 -24.53 1.09 Allowed 'General case' 0 C--N 1.34 0.158 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -174.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -136.26 35.98 2.76 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.649 1.113 . . . . 0.0 113.53 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.6 m -74.02 -23.64 59.45 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.951 -0.468 . . . . 0.0 112.198 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -155.35 161.73 40.99 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 117.98 0.354 . . . . 0.0 111.395 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -155.72 153.62 30.22 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.021 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.4 m -140.3 155.91 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 121.249 0.547 . . . . 0.0 112.001 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 70.5 mtm -137.53 27.57 2.78 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.244 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -155.0 171.66 19.38 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -174.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -73.27 24.74 0.88 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 123.509 0.576 . . . . 0.0 112.411 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 31.6 m 56.07 46.93 20.72 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 117.451 0.626 . . . . 0.0 112.431 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -61.1 157.79 39.91 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -53.31 148.76 31.58 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.776 2.984 . . . . 0.0 112.684 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 53.9 mt -118.06 163.34 16.76 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.623 0.769 . . . . 0.0 110.049 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -148.7 141.44 15.27 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.49 -22.01 48.73 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.438 2.759 . . . . 0.0 114.164 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -89.21 5.24 45.68 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.302 0.501 . . . . 0.0 110.948 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -130.06 18.42 5.52 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.877 0.471 . . . . 0.0 110.618 175.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 18.8 m -127.83 143.05 51.13 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.727 0.299 . . . . 0.0 110.851 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.8 tt -116.89 149.71 19.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 123.152 0.581 . . . . 0.0 110.795 -174.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.449 ' CD1' ' CE1' ' A' ' 253' ' ' TYR . 8.4 t80 -106.74 144.46 33.36 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 172.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 62.1 t -133.83 122.05 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -131.12 153.1 20.2 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.832 -0.223 . . . . 0.0 112.686 -176.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.81 39.53 4.61 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -171.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 26.9 m -118.1 54.72 1.97 Allowed Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.03 -11.63 27.44 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.71 2.273 . . . . 0.0 112.061 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.656 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 0.0 OUTLIER -139.7 -37.75 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.656 ' HD2' ' H ' ' A' ' 182' ' ' ARG . 38.9 Cg_endo -83.57 22.16 0.96 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.807 2.338 . . . . 0.0 112.867 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.607 HD23 ' H ' ' A' ' 184' ' ' LEU . 1.6 pt? -80.61 -138.87 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.037 0.535 . . . . 0.0 112.062 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.428 ' H ' ' HG ' ' A' ' 184' ' ' LEU . 45.3 ttm-85 71.2 126.42 0.03 OUTLIER 'General case' 0 C--N 1.338 0.103 0 C-N-CA 125.881 1.672 . . . . 0.0 110.551 -172.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.57 -28.5 69.68 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 64.2 t -68.7 -48.07 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 CA-C-N 117.921 0.328 . . . . 0.0 110.757 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -77.96 -31.12 50.68 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 58.6 tp -73.14 -33.87 65.77 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.401 0.28 . . . . 0.0 110.37 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.27 -37.36 60.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.078 -0.389 . . . . 0.0 111.413 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 26.2 mmt -69.4 -40.59 77.27 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.5 mt -65.15 -36.95 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.2 mmt -73.05 -18.89 61.28 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.109 -0.37 . . . . 0.0 111.219 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -93.08 -13.52 28.45 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.436 0.562 . . . . 0.0 112.124 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -93.45 -19.66 21.06 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.392 0.542 . . . . 0.0 111.897 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.6 -19.14 10.7 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 118.273 0.488 . . . . 0.0 111.482 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -140.4 42.56 1.9 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.15 137.5 3.8 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 123.71 0.672 . . . . 0.0 112.331 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 124.85 9.81 5.09 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 58.5 t -69.61 144.78 13.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 117.47 0.635 . . . . 0.0 110.345 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 15.2 p -120.22 -32.62 4.1 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.124 0.169 . . . . 0.0 111.196 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -146.29 142.05 27.93 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -148.58 157.75 43.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 170.62 -167.27 40.43 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.43 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 43.5 mm -97.1 139.94 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -58.03 122.41 12.98 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.385 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.7 t -155.38 149.04 25.25 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -119.49 139.8 28.33 Favored Pre-proline 0 N--CA 1.455 -0.186 0 C-N-CA 122.726 0.41 . . . . 0.0 110.208 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -77.4 -8.58 17.34 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 124.223 3.282 . . . . 0.0 112.498 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.6 -22.4 62.56 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.44 0.564 . . . . 0.0 111.116 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.5 mt -140.38 5.87 2.08 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.146 0.978 . . . . 0.0 110.095 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt 49.22 40.46 18.01 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.896 1.279 . . . . 0.0 112.522 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -125.19 139.04 32.82 Favored Pre-proline 0 C--O 1.231 0.119 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.56 166.52 23.84 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 122.719 2.28 . . . . 0.0 111.383 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -120.27 24.2 10.53 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 64.5 15.89 60.01 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.605 -0.553 . . . . 0.0 114.109 170.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -131.01 161.94 30.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 117.877 0.838 . . . . 0.0 110.128 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -100.63 159.09 19.19 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 112.174 -0.37 . . . . 0.0 112.174 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -153.63 148.51 26.56 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 3.9 p -150.2 148.06 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -126.28 147.7 49.65 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.109 0.564 . . . . 0.0 110.186 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -119.41 155.29 32.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.183 -174.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 57.6 m -83.19 1.56 40.01 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.21 172.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -135.9 131.11 34.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.102 0.561 . . . . 0.0 110.192 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -73.2 -12.34 60.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.4 tp60 -76.24 -38.42 56.35 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 42.1 m -74.19 -30.29 62.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -64.3 -52.11 60.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.643 -0.217 . . . . 0.0 110.586 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.39 -14.65 17.94 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 CA-C-N 118.248 0.476 . . . . 0.0 111.355 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.39 -21.86 32.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 117.78 0.263 . . . . 0.0 110.382 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.21 -8.3 42.75 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 3.5 pt -125.16 40.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 118.781 0.718 . . . . 0.0 111.572 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 32.4 m -131.14 3.99 4.38 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -129.57 10.83 5.69 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 45.39 -89.61 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -83.64 90.34 7.26 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.482 HG23 ' CD1' ' A' ' 239' ' ' LEU . 3.8 m -81.94 140.9 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.684 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 247' ' ' ARG . 34.4 mt-30 -78.31 -12.71 60.02 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.109 0.964 . . . . 0.0 112.791 -174.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.482 ' CD1' HG23 ' A' ' 237' ' ' VAL . 10.3 mp 55.94 -77.13 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.947 0.899 . . . . 0.0 112.7 -175.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 58.49 132.09 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.172 1.789 . . . . 0.0 114.374 -177.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' HIS . . . . . 0.424 ' H ' HG22 ' A' ' 244' ' ' ILE . 7.4 t60 -160.83 129.17 4.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 58.79 34.74 78.94 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 64.35 17.9 11.02 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.033 1.333 . . . . 0.0 113.876 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.424 HG22 ' H ' ' A' ' 241' ' ' HIS . 3.9 tt -83.79 177.71 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 173.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -145.46 139.42 26.84 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -142.58 174.09 10.95 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' ARG . . . . . 0.449 ' HD3' ' HA ' ' A' ' 238' ' ' GLN . 0.5 OUTLIER -146.73 144.91 29.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.175 0.443 . . . . 0.0 110.631 173.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.8 p -158.91 154.6 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.31 144.51 25.25 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.357 0.263 . . . . 0.0 110.374 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 13.6 m -126.63 157.97 37.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 120.837 0.351 . . . . 0.0 111.123 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.95 162.28 24.77 Favored Pre-proline 0 N--CA 1.455 -0.225 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 173.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.57 133.38 57.64 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.733 2.289 . . . . 0.0 108.897 173.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' TYR . . . . . 0.449 ' CE1' ' CD1' ' A' ' 176' ' ' PHE . 2.0 t80 -75.5 166.88 22.91 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.927 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.456 -0.168 0 C-N-CA 123.934 0.894 . . . . 0.0 110.961 -171.169 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.449 ' HD3' ' H ' ' A' ' 63' ' ' TYR . 14.4 tpp180 . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.664 0.268 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.449 ' H ' ' HD3' ' A' ' 62' ' ' ARG . 8.1 m-85 -117.84 -173.87 2.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.396 -174.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.1 t -123.66 166.03 16.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.265 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 41.7 ptt85 -77.67 37.28 0.22 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.772 0.829 . . . . 0.0 112.096 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -138.91 135.58 34.59 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.143 0.977 . . . . 0.0 110.473 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -146.64 158.66 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.519 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -91.8 140.43 29.7 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 169.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.2 p -127.6 125.37 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.95 148.82 18.3 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 -169.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.07 108.99 0.04 OUTLIER Glycine 0 CA--C 1.524 0.646 0 C-N-CA 125.793 1.663 . . . . 0.0 114.369 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.2 mt -141.59 145.74 38.71 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 123.881 0.872 . . . . 0.0 108.675 172.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -76.78 172.65 15.82 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.702 2.935 . . . . 0.0 110.098 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.9 172.95 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.026 3.151 . . . . 0.0 113.103 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.2 t70 61.18 -91.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.2 pt -56.12 132.28 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.886 0.85 . . . . 0.0 112.121 -176.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -170.2 155.95 5.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.644 1.178 . . . . 0.0 108.003 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 61.65 -51.62 0.13 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.749 1.62 . . . . 0.0 114.046 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -80.87 -35.18 33.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.05 0.841 . . . . 0.0 111.567 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -76.02 -28.31 57.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.282 -0.261 . . . . 0.0 110.769 -174.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.6 pt -81.99 -27.17 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 O-C-N 121.978 -0.451 . . . . 0.0 110.067 173.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.413 ' HA ' HD21 ' A' ' 91' ' ' LEU . 94.4 m -72.8 -12.45 61.0 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.09 -19.53 16.45 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 173.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.9 m -76.78 -34.74 57.99 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.546 0.612 . . . . 0.0 111.921 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -105.41 7.07 33.04 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -65.18 -18.03 64.97 Favored 'General case' 0 CA--C 1.526 0.037 0 C-N-CA 122.767 0.427 . . . . 0.0 110.946 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -69.71 -12.21 61.45 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.362 0.665 . . . . 0.0 110.877 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -111.98 16.62 20.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.951 0.5 . . . . 0.0 109.939 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.51 163.12 30.41 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.63 148.57 63.7 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.63 2.887 . . . . 0.0 112.37 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.484 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -147.92 169.17 20.43 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.615 0.366 . . . . 0.0 111.048 179.128 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 pt -137.55 175.38 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.738 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.9 p -152.51 156.26 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 122.369 -0.207 . . . . 0.0 110.758 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -155.79 172.19 18.75 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.923 0.392 . . . . 0.0 111.127 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -160.14 162.65 23.76 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -71.12 -16.96 31.88 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 CA-C-N 121.334 1.512 . . . . 0.0 110.468 -171.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -88.38 1.34 54.87 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.848 0.859 . . . . 0.0 111.137 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.498 ' HA ' ' HE3' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -63.51 -29.11 70.43 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.718 0.807 . . . . 0.0 111.128 -176.064 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.299 0 C-N-CA 123.883 0.873 . . . . 0.0 112.894 179.292 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.105 0 CA-C-O 118.604 -1.109 . . . . 0.0 115.61 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.71 151.48 22.4 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 120.22 2.01 . . . . 0.0 108.906 174.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.68 -175.66 5.46 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.66 0.267 . . . . 0.0 110.964 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -132.19 118.57 19.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.8 tt -100.47 139.71 35.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.192 0.52 . . . . 0.0 111.515 -168.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.6 mp -119.9 153.46 35.85 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.976 -172.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -139.79 -176.26 4.51 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.359 1.064 . . . . 0.0 109.702 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -111.29 -26.66 9.04 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 122.634 0.373 . . . . 0.0 110.906 -176.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -140.63 161.71 37.11 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.5 0.32 . . . . 0.0 111.293 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -79.09 -13.41 59.77 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.424 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.5 p -75.04 -22.48 58.4 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.127 0.421 . . . . 0.0 110.523 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 57.0 m -79.25 -40.67 30.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.49 -0.131 . . . . 0.0 110.935 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.9 m -73.36 -20.21 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -72.64 -37.68 67.94 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.66 -32.48 62.25 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 119.329 -0.367 . . . . 0.0 111.735 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -82.07 -14.27 56.09 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.689 0.677 . . . . 0.0 111.933 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.6 mt -95.93 -20.9 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 122.008 -0.432 . . . . 0.0 110.258 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -101.84 -8.7 21.4 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -120.86 9.98 10.79 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 34.7 m -125.94 -178.53 4.32 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.191 0.596 . . . . 0.0 109.643 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -80.17 163.53 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 O-C-N 121.737 -0.602 . . . . 0.0 111.32 -170.241 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -143.44 157.62 44.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.541 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -146.84 173.29 12.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.76 3.94 0.32 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -171.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -148.22 -9.36 0.19 Allowed Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.016 -0.88 . . . . 0.0 114.224 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.42 ' HE2' ' CE2' ' A' ' 136' ' ' TYR . 24.8 pttm -167.14 -171.33 1.73 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.79 1.295 . . . . 0.0 110.963 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.28 170.22 10.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.077 0.951 . . . . 0.0 110.171 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.42 ' CE2' ' HE2' ' A' ' 134' ' ' LYS . 22.4 m-85 -150.64 165.05 34.56 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.992 0.425 . . . . 0.0 111.65 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.9 tp -141.37 134.61 29.43 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 167.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.2 p -78.21 141.42 38.62 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.1 m -141.05 162.77 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 122.882 0.473 . . . . 0.0 110.419 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.1 m -86.14 10.45 14.44 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.007 0.523 . . . . 0.0 110.978 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.0 t -67.08 118.87 59.81 Favored Pre-proline 0 N--CA 1.454 -0.271 0 C-N-CA 123.658 0.783 . . . . 0.0 110.478 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -79.83 113.02 2.97 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.4 2.733 . . . . 0.0 110.799 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.601 ' C ' ' H ' ' A' ' 145' ' ' LYS . 25.8 m -117.89 63.94 0.75 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.3 mp 64.38 -22.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.185 1.394 . . . . 0.0 110.889 -171.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.601 ' H ' ' C ' ' A' ' 143' ' ' THR . 39.2 ttpt -156.66 159.23 38.23 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 127.248 2.219 . . . . 0.0 106.025 169.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.58 139.83 58.48 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.68 0.673 . . . . 0.0 110.426 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -151.35 157.3 35.03 Favored Pre-proline 0 CA--C 1.529 0.153 0 C-N-CA 122.341 0.257 . . . . 0.0 111.203 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -79.41 163.29 24.69 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.808 3.005 . . . . 0.0 111.308 171.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.9 m -107.64 150.88 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.105 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -85.84 153.02 22.54 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 117.616 0.189 . . . . 0.0 111.081 -174.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.8 mm -137.63 143.27 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.802 0.841 . . . . 0.0 110.075 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -155.55 101.67 2.2 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -77.01 164.15 30.02 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.861 3.041 . . . . 0.0 112.218 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -97.99 150.01 21.83 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 46.2 p-10 -117.05 155.9 28.44 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.524 0.678 . . . . 0.0 111.955 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.3 mp -94.95 74.74 3.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.755 -175.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.2 t -141.35 -40.52 0.38 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.926 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -153.68 135.87 14.84 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.6 m -149.29 -30.15 0.25 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.252 0.221 . . . . 0.0 111.286 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -151.42 160.03 43.94 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.622 0.769 . . . . 0.0 109.815 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -149.85 158.55 44.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.5 t -130.63 138.4 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 51.6 tpp -100.34 -10.47 21.21 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -174.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -158.62 -47.39 0.06 Allowed 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.833 -0.542 . . . . 0.0 110.628 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.66 4.98 62.88 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.227 -0.763 . . . . 0.0 114.412 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.6 t -129.71 -13.8 4.16 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.726 1.263 . . . . 0.0 112.092 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -87.09 159.73 50.57 Favored Pre-proline 0 CA--C 1.533 0.294 0 O-C-N 122.066 -0.396 . . . . 0.0 110.464 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.65 163.59 6.84 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 124.278 3.318 . . . . 0.0 113.792 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.25 128.76 21.32 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -148.4 124.96 5.39 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-O 119.305 -0.379 . . . . 0.0 110.0 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -55.11 -20.17 23.08 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.617 2.878 . . . . 0.0 113.599 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -81.03 -3.25 51.18 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.123 0.419 . . . . 0.0 111.04 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -127.01 28.7 5.74 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 51.3 m -121.08 145.22 48.03 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.9 tt -115.9 149.52 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 123.085 0.554 . . . . 0.0 110.154 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.483 ' HB2' ' CD1' ' A' ' 253' ' ' TYR . 6.8 t80 -108.4 143.99 36.58 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 97.2 t -137.78 124.2 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -175.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -132.53 162.6 24.09 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 112.413 -0.275 . . . . 0.0 112.413 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.62 16.26 58.75 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -172.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.9 m -71.47 152.3 93.95 Favored Pre-proline 0 N--CA 1.456 -0.174 0 C-N-CA 122.706 0.402 . . . . 0.0 111.563 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -76.83 171.81 17.33 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 124.001 3.134 . . . . 0.0 109.965 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 48.5 tpt85 -73.51 -48.35 7.01 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -80.02 32.38 0.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.417 2.745 . . . . 0.0 112.634 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -61.37 -33.08 73.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.537 0.608 . . . . 0.0 112.319 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 54.23 122.01 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.704 2.002 . . . . 0.0 113.941 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.25 -29.06 70.17 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.777 -0.577 . . . . 0.0 111.783 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 65.7 t -68.36 -48.35 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 122.295 0.238 . . . . 0.0 111.167 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -82.89 -20.87 34.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.9 -0.137 . . . . 0.0 110.923 -174.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 42.1 tp -71.51 -33.24 69.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' A' ' 203' ' ' ALA . . . -74.45 -37.07 63.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.324 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 25.7 mmt -70.74 -34.04 71.45 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 62.4 mt -68.91 -37.31 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -71.58 -21.95 61.8 Favored 'General case' 0 N--CA 1.457 -0.106 0 O-C-N 121.856 -0.528 . . . . 0.0 110.339 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -86.7 -13.28 45.86 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 122.115 -0.366 . . . . 0.0 111.526 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -98.62 -21.21 16.58 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.36 -13.5 14.86 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.55 0.613 . . . . 0.0 111.954 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -140.44 -34.77 0.52 Allowed 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 118.673 0.67 . . . . 0.0 112.367 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.33 -178.33 18.12 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 69.6 10.96 64.67 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 119.411 -0.661 . . . . 0.0 112.899 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 22.1 t -72.77 147.02 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 118.248 1.024 . . . . 0.0 109.958 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.8 p -128.9 -24.97 2.86 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 119.625 -0.226 . . . . 0.0 111.455 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -150.46 149.98 30.71 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.007 0.367 . . . . 0.0 110.758 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 190' ' ' ALA . . . -160.92 156.38 24.84 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.92 0.488 . . . . 0.0 110.332 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 158.55 -165.22 33.89 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 205' ' ' ILE . 3.1 mp -100.65 130.58 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -56.2 114.91 2.16 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 89.6 m -143.71 157.48 44.36 Favored 'General case' 0 N--CA 1.458 -0.075 0 O-C-N 123.441 0.463 . . . . 0.0 110.279 -172.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -135.85 132.51 19.46 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.882 0.873 . . . . 0.0 108.916 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -80.86 -6.97 13.37 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 124.202 3.268 . . . . 0.0 114.558 -172.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -112.06 -41.02 4.05 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.993 1.27 . . . . 0.0 114.239 -172.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.5 pp -161.12 -15.88 0.05 OUTLIER 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -88.49 -26.51 22.02 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.759 1.163 . . . . 0.0 111.691 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.517 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 29.7 m-85 56.5 -178.7 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.83 0.852 . . . . 0.0 113.215 172.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.517 ' CD ' ' HB3' ' A' ' 213' ' ' TYR . 77.4 Cg_exo -54.26 153.16 22.81 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.026 2.484 . . . . 0.0 112.864 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -104.61 5.7 33.93 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.918 0.887 . . . . 0.0 111.169 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 66.81 10.67 55.97 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 112.19 -0.364 . . . . 0.0 112.19 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -141.39 149.2 40.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.262 0.625 . . . . 0.0 110.341 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -92.32 166.25 29.37 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.813 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -147.24 150.98 35.92 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 62.0 t -142.19 142.01 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.88 145.72 48.92 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -123.52 151.98 42.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.638 -176.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 54.4 m -84.25 2.8 38.3 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.075 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -137.82 138.13 38.86 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.955 0.502 . . . . 0.0 110.082 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -74.4 -14.9 60.92 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.4 tp60 -76.82 -38.44 53.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 31.7 m -75.16 -26.48 59.13 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -67.44 -50.33 59.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 119.545 -0.265 . . . . 0.0 110.37 176.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -72.32 -12.66 15.99 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 CA-C-N 118.163 0.438 . . . . 0.0 111.158 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.07 -23.55 28.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 174.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -85.94 -23.05 27.1 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 11.5 pt -106.6 25.25 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 C-N-CA 122.859 0.464 . . . . 0.0 110.311 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -79.64 -13.26 59.62 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.074 0.549 . . . . 0.0 112.033 -175.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -156.6 143.72 18.85 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -55.65 -36.07 66.64 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.692 0.397 . . . . 0.0 111.558 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -115.79 105.68 12.98 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 18.0 m -88.5 160.04 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.425 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -84.97 139.85 31.5 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.802 0.334 . . . . 0.0 110.249 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.49 104.2 6.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 172.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -137.67 153.0 49.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.371 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -146.51 20.08 1.34 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.187 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.29 130.17 3.01 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 52.85 17.82 0.94 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.425 1.09 . . . . 0.0 112.933 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 76.1 mt -140.52 149.33 21.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 123.97 0.908 . . . . 0.0 109.296 -178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -153.74 133.4 12.97 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -145.32 161.25 40.05 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.254 1.022 . . . . 0.0 109.025 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.86 155.17 44.73 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 123.361 0.664 . . . . 0.0 109.826 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.3 p -158.38 159.22 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 122.961 0.505 . . . . 0.0 109.981 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -83.68 141.35 31.55 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.112 0.565 . . . . 0.0 110.831 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.88 162.54 31.32 Favored 'Isoleucine or valine' 0 C--N 1.338 0.092 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.82 158.92 29.58 Favored Pre-proline 0 N--CA 1.455 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.823 170.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.76 134.74 62.5 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.461 2.108 . . . . 0.0 108.087 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' TYR . . . . . 0.483 ' CD1' ' HB2' ' A' ' 176' ' ' PHE . 0.7 OUTLIER -77.01 170.51 16.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.192 -175.636 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 CA--C 1.529 0.161 0 C-N-CA 123.669 0.788 . . . . 0.0 110.829 -170.43 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.767 0.317 . . . . 0.0 111.717 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -156.95 170.66 22.01 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.544 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.1 t -95.89 165.45 12.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.401 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -84.72 9.44 13.99 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.836 0.454 . . . . 0.0 111.005 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -128.83 141.46 51.29 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 121.14 0.495 . . . . 0.0 110.168 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 p -147.8 147.86 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.306 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -87.04 145.14 26.59 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.9 p -128.63 122.91 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -110.27 175.03 18.02 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-O 121.307 0.393 . . . . 0.0 112.175 -175.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.45 29.75 74.34 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.379 -0.41 . . . . 0.0 113.39 171.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.1 mt -69.15 142.44 92.85 Favored Pre-proline 0 N--CA 1.45 -0.462 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.11 174.88 11.69 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.233 2.622 . . . . 0.0 109.567 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -54.74 -9.38 1.79 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 124.742 3.628 . . . . 0.0 114.32 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 77' ' ' ASP . 9.9 m-20 -125.5 -123.46 0.25 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER 63.55 -25.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 75' ' ' ASP . 4.2 p-10 39.26 -113.88 0.15 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.563 1.545 . . . . 0.0 113.114 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -127.27 -19.85 4.21 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.104 0.961 . . . . 0.0 110.487 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -80.95 -46.58 14.93 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.845 -0.535 . . . . 0.0 112.036 -174.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -68.03 -34.05 75.75 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.631 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.7 pt -84.25 -29.87 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 O-C-N 122.052 -0.405 . . . . 0.0 111.21 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 97.2 m -70.71 -12.93 61.86 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.49 0.586 . . . . 0.0 109.42 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.91 -15.45 15.14 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.6 m -82.18 -36.68 27.09 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.025 0.83 . . . . 0.0 112.461 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -98.08 1.56 47.77 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.4 ttt85 -78.43 -4.91 50.72 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -77.03 -11.09 59.76 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.737 0.415 . . . . 0.0 111.762 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -108.03 -19.12 13.61 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.443 0.297 . . . . 0.0 110.629 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.92 161.0 10.93 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.45 140.18 93.57 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.387 2.725 . . . . 0.0 111.906 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.532 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -151.77 164.53 36.81 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.274 0.23 . . . . 0.0 111.582 178.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 93' ' ' VAL . 26.8 mm -134.48 164.08 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.403 ' N ' HG22 ' A' ' 92' ' ' ILE . 7.5 p -128.24 146.44 33.74 Favored 'Isoleucine or valine' 0 C--O 1.23 0.079 0 CA-C-N 118.324 0.511 . . . . 0.0 110.243 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -150.0 166.78 28.65 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.085 0.469 . . . . 0.0 110.781 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.479 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 17.1 p90 -148.4 160.37 36.78 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 95' ' ' TRP . 69.6 Cg_endo -70.0 -8.94 24.86 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 124.467 3.445 . . . . 0.0 111.72 -170.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.451 ' ND1' ' HG2' ' A' ' 96' ' ' PRO . 53.1 m80 -101.47 5.15 41.84 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.091 0.556 . . . . 0.0 112.16 -176.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.412 ' HG3' ' CD1' ' A' ' 95' ' ' TRP . 50.9 mtpt -70.17 161.22 30.66 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 121.659 0.742 . . . . 0.0 112.113 -177.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.458 0 C-N-CA 124.829 1.251 . . . . 0.0 111.04 -175.56 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.615 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.31 148.65 33.66 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.346 1.073 . . . . 0.0 110.149 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.45 -176.46 5.6 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.965 0.506 . . . . 0.0 110.606 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -139.26 136.93 35.45 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -103.01 149.93 24.06 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 mp -111.23 143.01 42.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 171.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -130.62 162.87 28.39 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.202 0.525 . . . . 0.0 111.072 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -100.84 -32.3 10.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.693 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -113.53 151.51 31.47 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -88.65 -11.84 44.17 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.871 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.8 m -102.45 -7.02 22.29 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 122.932 0.493 . . . . 0.0 111.029 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.8 t -71.67 -35.14 70.22 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.0 m -73.71 -25.23 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -77.01 -29.5 55.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.405 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.5 -36.67 57.65 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.497 0.589 . . . . 0.0 110.899 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -76.72 -18.37 58.54 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.778 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.405 HG23 HD22 ' A' ' 135' ' ' LEU . 35.8 mt -91.97 -18.72 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 122.377 0.271 . . . . 0.0 111.203 177.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -100.98 -10.02 20.94 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.534 -0.728 . . . . 0.0 112.514 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.56 14.63 13.63 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 73.2 m -132.79 -171.38 2.65 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.959 0.345 . . . . 0.0 111.846 -175.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.46 ' N ' HD12 ' A' ' 129' ' ' ILE . 3.5 mp -74.97 154.67 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.296 1.038 . . . . 0.0 109.159 -171.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 135' ' ' LEU . 12.7 pt-20 -133.24 161.64 33.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.494 0.188 . . . . 0.0 111.178 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.46 177.41 9.07 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -46.36 -24.74 0.53 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -169.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -153.67 5.2 0.34 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-N 119.184 0.902 . . . . 0.0 113.384 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -146.06 -171.75 3.78 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 117.949 0.874 . . . . 0.0 109.127 -175.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.405 HD22 HG23 ' A' ' 125' ' ' ILE . 4.5 mp -134.89 166.54 22.77 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.376 -0.202 . . . . 0.0 111.116 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 149' ' ' VAL . 17.4 m-85 -138.1 156.45 47.76 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.155 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.2 mp -134.04 157.45 46.07 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 73.5 m -100.28 135.11 42.21 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.182 0.447 . . . . 0.0 110.721 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.9 m -144.12 164.46 14.26 Favored 'Isoleucine or valine' 0 C--N 1.338 0.067 0 C-N-CA 123.694 0.798 . . . . 0.0 109.923 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.4 t -70.63 151.41 45.01 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 120.54 0.209 . . . . 0.0 110.559 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.3 t -156.02 139.05 10.77 Favored Pre-proline 0 N--CA 1.456 -0.151 0 C-N-CA 122.646 0.379 . . . . 0.0 110.408 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -79.13 -0.08 10.45 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.55 3.5 . . . . 0.0 114.046 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.443 ' HB ' HD13 ' A' ' 144' ' ' ILE . 49.2 m -93.97 -10.99 31.84 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.077 0.853 . . . . 0.0 108.998 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.443 HD13 ' HB ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -154.97 -155.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 126.94 2.096 . . . . 0.0 106.668 -174.083 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -94.71 -36.94 11.52 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -162.07 154.63 19.76 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.896 1.279 . . . . 0.0 108.296 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 23.4 ttpp -143.5 138.6 15.56 Favored Pre-proline 0 CA--C 1.528 0.114 0 CA-C-N 118.171 0.441 . . . . 0.0 112.088 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 147' ' ' LYS . 46.8 Cg_exo -59.58 140.32 93.29 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.596 2.864 . . . . 0.0 111.678 169.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 33.0 m -126.33 143.07 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -87.74 150.74 23.41 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.9 mm -129.24 143.45 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 124.807 1.243 . . . . 0.0 110.419 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 47.8 ttp85 -159.13 97.68 1.65 Allowed Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -62.99 167.21 12.63 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 124.12 3.213 . . . . 0.0 113.497 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -87.2 147.37 25.62 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 172.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -107.35 147.95 29.67 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.349 0.595 . . . . 0.0 111.743 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 156' ' ' LEU . 6.3 mp -98.42 93.54 6.23 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 t -158.18 -39.76 0.06 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.475 ' CG ' ' HE ' ' A' ' 185' ' ' ARG . 16.0 m-20 -143.91 39.58 1.36 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.3 m -67.53 -19.41 65.29 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -155.83 160.03 39.88 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.303 0.641 . . . . 0.0 110.835 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -154.11 151.88 29.78 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.09 143.39 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' MET . . . . . 0.466 ' SD ' ' HB1' ' A' ' 190' ' ' ALA . 90.0 mtp -129.41 3.19 5.1 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -175.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -156.17 -40.93 0.08 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.766 0.712 . . . . 0.0 112.322 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 155.81 12.14 0.06 OUTLIER Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.428 -0.651 . . . . 0.0 112.886 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.0 m 54.59 56.4 6.83 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 117.981 0.89 . . . . 0.0 112.167 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -57.8 159.41 10.06 Favored Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -59.45 145.44 97.94 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.692 2.261 . . . . 0.0 109.72 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 72.0 mt -121.09 166.84 13.34 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.101 0.477 . . . . 0.0 112.211 -171.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -141.3 155.35 67.84 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.26 -6.83 20.04 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.142 2.561 . . . . 0.0 111.026 -176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -101.96 5.56 40.83 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.107 0.963 . . . . 0.0 111.464 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -129.33 14.72 6.13 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.798 0.439 . . . . 0.0 111.088 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.6 m -132.45 142.56 49.3 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.178 0.191 . . . . 0.0 111.086 -174.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.4 tt -112.04 152.01 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 123.219 0.607 . . . . 0.0 110.343 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -121.16 143.23 49.22 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 35.3 m -139.01 149.68 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-O 120.663 0.268 . . . . 0.0 110.704 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -146.0 165.92 28.04 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 79.14 20.85 69.0 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -173.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 19.4 m -61.06 153.27 67.47 Favored Pre-proline 0 CA--C 1.529 0.171 0 C-N-CA 122.9 0.48 . . . . 0.0 111.956 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.14 168.76 21.14 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.755 2.97 . . . . 0.0 109.563 173.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -65.6 -47.44 67.38 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -173.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.52 -51.75 0.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 121.617 1.545 . . . . 0.0 112.254 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.1 tp 50.7 -72.48 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.537 1.935 . . . . 0.0 114.548 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.475 ' HE ' ' CG ' ' A' ' 158' ' ' ASP . 63.2 mtp180 61.97 127.66 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 127.521 2.328 . . . . 0.0 112.43 -174.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.46 -22.96 66.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.397 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 59.0 t -72.56 -47.83 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 122.341 0.256 . . . . 0.0 110.638 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -80.65 -32.89 36.03 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 55.6 tp -66.26 -34.0 77.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.468 ' HB2' ' CB ' ' A' ' 203' ' ' ALA . . . -86.73 -25.32 24.77 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -175.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 20.7 mmt -70.6 -33.83 71.49 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.4 mt -72.55 -39.76 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 20.1 mmt -60.08 -24.76 64.85 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 119.231 -0.414 . . . . 0.0 111.605 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -88.25 -20.17 25.83 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.923 0.783 . . . . 0.0 111.412 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.19 -18.73 33.18 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.871 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.38 -23.96 7.58 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 118.147 0.43 . . . . 0.0 111.042 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -135.29 45.3 2.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.893 0.477 . . . . 0.0 110.024 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -45.12 138.36 5.79 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.431 0.539 . . . . 0.0 112.117 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 123.52 9.87 5.72 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 222' ' ' PHE . 5.2 p -71.02 160.46 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.847 0.859 . . . . 0.0 110.555 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 52.4 t -134.91 -35.64 0.85 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.638 0.606 . . . . 0.0 112.638 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -150.74 155.82 40.06 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.763 0.256 . . . . 0.0 110.766 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ALA . . . . . 0.468 ' CB ' ' HB2' ' A' ' 190' ' ' ALA . . . -154.2 159.42 41.35 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.025 0.441 . . . . 0.0 110.181 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 175.22 -175.67 47.17 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.7 mm -97.46 144.68 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -60.74 123.38 17.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 52.5 p -134.97 140.48 45.73 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -85.08 128.03 61.83 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -76.47 -10.88 18.94 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.263 3.309 . . . . 0.0 112.565 -174.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -69.23 -29.68 67.68 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.428 0.291 . . . . 0.0 110.53 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.13 6.71 1.76 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.453 0.701 . . . . 0.0 111.592 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 51.81 48.65 22.39 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.198 1.399 . . . . 0.0 113.904 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -123.15 152.18 63.17 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.965 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.55 171.72 16.58 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 124.206 3.271 . . . . 0.0 112.639 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 12.9 ttmt -134.69 19.31 3.56 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.68 0.792 . . . . 0.0 111.38 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 63.0 16.57 57.59 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 119.61 -0.55 . . . . 0.0 113.535 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -130.34 155.27 46.63 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.877 0.838 . . . . 0.0 109.982 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -105.98 160.56 14.7 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 112.426 -0.27 . . . . 0.0 112.426 -175.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -151.03 144.94 25.2 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 99.6 t -140.01 148.34 22.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -130.2 147.51 51.93 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.722 0.296 . . . . 0.0 110.845 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 200' ' ' VAL . 14.0 m-85 -128.05 156.7 42.35 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.598 -176.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 74.1 m -77.84 -7.58 56.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -131.87 145.76 51.72 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.101 0.409 . . . . 0.0 111.085 -176.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -71.78 -22.55 61.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -70.22 -38.21 75.19 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 17.9 m -72.35 -29.91 64.24 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -70.09 -51.6 30.49 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 119.622 -0.228 . . . . 0.0 111.118 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.7 pt -69.11 -15.74 20.02 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 CA-C-N 118.289 0.495 . . . . 0.0 110.735 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.18 -27.52 29.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.17 -25.61 36.69 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 8.1 pt -105.09 24.98 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.022 0.529 . . . . 0.0 110.44 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -78.86 -11.38 59.99 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.247 0.619 . . . . 0.0 111.932 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.55 143.0 21.68 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -56.26 -33.23 65.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.778 0.431 . . . . 0.0 111.989 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -123.62 114.63 20.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.04 0.448 . . . . 0.0 110.633 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.5 m -87.55 147.61 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.136 173.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -83.21 134.12 34.98 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -121.61 21.25 10.93 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -66.86 149.35 50.71 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -147.0 8.58 0.95 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.624 0.25 . . . . 0.0 111.313 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 163.31 -137.36 4.74 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -176.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -74.63 -4.79 39.28 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.98 0.39 . . . . 0.0 110.502 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 244' ' ' ILE . 1.9 mp -87.2 153.54 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.034 0.934 . . . . 0.0 108.963 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -134.68 135.73 42.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.893 0.378 . . . . 0.0 110.603 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -145.39 147.67 32.5 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.442 1.097 . . . . 0.0 109.199 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 161.63 42.33 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.271 0.628 . . . . 0.0 109.504 177.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.0 p -154.59 152.16 9.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -88.76 128.4 35.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.469 ' C ' ' HE2' ' A' ' 251' ' ' LYS . 1.5 m -104.56 156.34 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -174.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.469 ' HE2' ' C ' ' A' ' 250' ' ' VAL . 0.0 OUTLIER -156.15 158.48 31.6 Favored Pre-proline 0 N--CA 1.456 -0.147 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.891 170.205 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.91 140.56 92.28 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.777 2.318 . . . . 0.0 109.917 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -91.49 175.82 6.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.924 0.392 . . . . 0.0 110.505 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.451 -0.393 0 C-N-CA 123.375 0.67 . . . . 0.0 109.846 -170.859 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.801 0.334 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.413 ' HA ' ' HG ' ' A' ' 156' ' ' LEU . 0.3 OUTLIER -147.59 171.35 15.72 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.569 177.493 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.9 t -89.22 169.0 11.82 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.507 0.723 . . . . 0.0 111.666 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 49.1 ptt85 -77.42 5.57 8.56 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.709 0.804 . . . . 0.0 111.118 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -108.21 130.89 55.13 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.336 -0.986 . . . . 0.0 108.336 174.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.1 p -150.54 146.44 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.458 -170.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.427 ' CZ ' ' HA3' ' A' ' 70' ' ' GLY . 8.3 t80 -83.25 135.57 34.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.9 t -137.75 78.16 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 110' ' ' TYR . . . -120.28 159.62 15.11 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.946 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.45 5.92 33.86 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.579 HD23 ' H ' ' A' ' 72' ' ' LEU . 0.9 OUTLIER -73.69 173.4 6.36 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 171.228 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 72' ' ' LEU . 50.2 Cg_endo -80.9 155.51 20.22 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 CA-C-N 120.677 1.277 . . . . 0.0 110.292 -174.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 27.0 Cg_exo -64.95 13.39 0.1 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.92 3.08 . . . . 0.0 112.755 173.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 73' ' ' PRO . 12.2 m-20 -134.29 26.82 3.82 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -172.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 mt -123.93 152.05 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -126.11 -176.19 3.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.286 0.634 . . . . 0.0 110.933 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -51.4 -23.76 4.16 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.367 1.067 . . . . 0.0 113.139 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -79.64 -37.44 36.04 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.715 0.688 . . . . 0.0 112.472 -175.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -84.7 -25.45 28.37 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.41 0.55 . . . . 0.0 110.671 -174.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 52.9 mt -75.03 -42.71 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.9 m -66.51 -26.24 67.07 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.44 -20.77 46.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.234 -0.291 . . . . 0.0 111.541 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 m -85.34 -25.05 27.36 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.561 ' CE1' HD23 ' A' ' 137' ' ' LEU . 87.6 m-85 -117.58 1.98 12.31 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -174.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -80.6 -2.73 47.6 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.095 0.861 . . . . 0.0 112.09 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.529 ' HG3' ' CD2' ' A' ' 88' ' ' PHE . 12.7 ptp180 -77.12 -7.46 55.82 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.439 0.696 . . . . 0.0 112.149 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.529 ' CD2' ' HG3' ' A' ' 87' ' ' ARG . 71.3 m-85 -121.73 2.72 10.07 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.394 0.277 . . . . 0.0 111.699 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.45 162.37 9.31 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.0 139.24 46.4 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.072 2.515 . . . . 0.0 110.759 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.502 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -155.59 169.77 23.54 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.845 0.458 . . . . 0.0 111.333 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.5 pt -135.98 163.02 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 172.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.9 149.69 20.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -154.29 171.76 18.73 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.1 0.952 . . . . 0.0 112.494 -175.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.422 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 2.9 p90 -146.73 158.28 46.24 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 174.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.49 ' HG2' ' CE1' ' A' ' 97' ' ' HIS . 74.3 Cg_endo -63.14 -14.72 43.52 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 124.023 3.149 . . . . 0.0 112.996 -168.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.49 ' CE1' ' HG2' ' A' ' 96' ' ' PRO . 2.2 m-70 -105.68 -34.29 7.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.927 0.331 . . . . 0.0 111.087 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 98' ' ' LYS . 12.0 tptm 42.04 27.98 0.09 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.063 1.745 . . . . 0.0 113.634 -174.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.384 0 C-N-CA 124.585 1.154 . . . . 0.0 112.914 179.52 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 CA-C-O 119.923 -0.376 . . . . 0.0 113.853 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.457 ' HA ' ' HA2' ' A' ' 70' ' ' GLY . 0.4 OUTLIER -145.17 134.25 22.67 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 118.545 1.173 . . . . 0.0 111.079 170.575 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.31 -169.25 3.33 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.627 1.171 . . . . 0.0 109.37 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -134.8 151.02 50.6 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -176.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mp -108.24 151.04 26.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.585 0.707 . . . . 0.0 112.004 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.9 99.69 6.05 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -84.28 156.65 21.86 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.822 0.344 . . . . 0.0 110.232 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -86.35 -29.0 23.3 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.208 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -128.08 156.64 42.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -80.23 -19.86 45.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.218 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.0 m -90.44 -16.14 29.56 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.699 0.4 . . . . 0.0 111.14 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 18.8 m -72.67 -41.36 65.47 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.57 -13.97 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.849 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -78.4 -35.31 47.29 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.062 -0.398 . . . . 0.0 110.028 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.26 -37.5 57.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 117.83 0.287 . . . . 0.0 111.122 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.404 ' CD1' HG13 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -66.01 -38.16 87.75 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.415 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.404 HG13 ' CD1' ' A' ' 124' ' ' LEU . 52.3 mt -85.1 -10.73 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 121.422 -0.799 . . . . 0.0 111.925 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -102.26 -5.14 24.64 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.805 -0.559 . . . . 0.0 112.038 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -126.6 6.68 6.84 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 81.6 m -112.78 -179.48 3.67 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.865 0.757 . . . . 0.0 111.066 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.472 HD12 ' N ' ' A' ' 129' ' ' ILE . 3.0 mp -68.72 147.98 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -171.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -130.69 151.91 50.62 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.545 0.212 . . . . 0.0 111.096 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.41 67.5 1.36 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.303 0.573 . . . . 0.0 110.26 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 52.72 12.23 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.45 -18.81 0.09 OUTLIER Glycine 0 CA--C 1.526 0.77 0 CA-C-N 118.682 0.673 . . . . 0.0 112.386 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -127.03 174.31 8.98 Favored 'General case' 0 C--N 1.338 0.07 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.4 167.95 20.1 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.032 0.378 . . . . 0.0 111.583 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.475 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 31.9 m-85 -139.09 159.17 42.78 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.795 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.561 HD23 ' CE1' ' A' ' 85' ' ' PHE . 54.8 tp -150.47 158.58 44.32 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 169.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 84.7 m -95.26 167.97 11.03 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.891 -0.506 . . . . 0.0 111.954 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.15 164.78 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.933 0.893 . . . . 0.0 109.838 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.1 m -104.48 2.37 30.91 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.442 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 45.3 m -133.86 48.34 3.18 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 118.294 0.497 . . . . 0.0 111.546 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 141' ' ' SER . 62.0 Cg_endo -65.03 155.22 69.43 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.172 3.248 . . . . 0.0 111.905 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.805 HG23 HG13 ' A' ' 144' ' ' ILE . 14.8 t -89.12 -9.98 49.02 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.031 0.533 . . . . 0.0 111.513 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.805 HG13 HG23 ' A' ' 143' ' ' THR . 64.7 mt -141.23 175.01 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -176.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.474 ' H ' HG22 ' A' ' 144' ' ' ILE . 1.7 tmmt? -56.85 -24.82 54.17 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.998 -0.439 . . . . 0.0 111.284 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -141.97 150.3 41.2 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.873 0.869 . . . . 0.0 109.631 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.477 ' HE2' HG22 ' A' ' 143' ' ' THR . 0.1 OUTLIER -158.95 70.0 3.5 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 122.703 0.401 . . . . 0.0 110.02 174.337 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.475 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 72.1 Cg_endo -68.76 124.0 11.03 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.077 1.851 . . . . 0.0 109.115 175.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.7 140.33 16.13 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -91.67 153.06 19.93 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.734 0.414 . . . . 0.0 110.857 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.9 mm -126.6 136.26 61.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.342 0.657 . . . . 0.0 110.303 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -147.83 96.85 4.01 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -78.7 165.07 25.17 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.614 2.876 . . . . 0.0 110.828 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.45 ' CD2' ' HG2' ' A' ' 214' ' ' PRO . 47.1 t-105 -82.15 111.41 18.24 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 121.9 -0.5 . . . . 0.0 111.001 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -70.62 148.91 47.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.413 ' HG ' ' HA ' ' A' ' 63' ' ' TYR . 35.7 mt -119.14 101.34 7.93 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.201 0.524 . . . . 0.0 111.076 -169.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.7 t -164.85 -32.23 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.737 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -140.5 42.47 1.88 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.384 0.274 . . . . 0.0 111.332 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.6 t -66.57 -32.46 73.81 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -176.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -151.44 158.27 43.45 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.004 0.522 . . . . 0.0 110.49 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.43 ' CD2' ' HA ' ' A' ' 187' ' ' VAL . 58.3 t80 -156.24 153.42 29.13 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.4 p -144.73 149.25 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 67.5 mtm -117.16 13.43 14.7 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -173.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -160.55 -41.63 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.32 7.4 38.87 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.302 -0.721 . . . . 0.0 113.335 175.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.9 m -133.72 -0.23 3.19 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -86.81 150.31 50.17 Favored Pre-proline 0 CA--C 1.529 0.148 0 CA-C-N 119.839 1.2 . . . . 0.0 110.448 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.36 148.64 49.26 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.093 2.529 . . . . 0.0 109.659 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 77.1 mt -133.75 152.27 51.83 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.161 0.584 . . . . 0.0 109.871 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -145.29 153.28 52.17 Favored Pre-proline 0 N--CA 1.455 -0.186 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -59.19 -20.12 53.18 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.318 2.679 . . . . 0.0 112.353 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.9 6.56 38.73 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.418 0.687 . . . . 0.0 110.741 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -129.72 19.42 5.63 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 122.833 0.453 . . . . 0.0 110.455 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 30.2 m -125.12 139.92 53.35 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.72 0.295 . . . . 0.0 111.133 -175.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.8 tt -110.92 150.78 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.17 0.588 . . . . 0.0 109.77 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -120.43 140.48 51.3 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.7 m -135.92 142.16 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -156.05 -173.86 25.15 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 118.454 0.57 . . . . 0.0 113.05 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 76.05 28.75 59.9 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.1 146.84 53.69 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.811 0.306 . . . . 0.0 111.24 -171.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.414 ' C ' ' HD2' ' A' ' 183' ' ' PRO . 73.4 Cg_endo -68.28 -172.35 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.536 2.824 . . . . 0.0 110.158 169.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.48 ' N ' ' CD ' ' A' ' 183' ' ' PRO . 0.0 OUTLIER -95.35 5.31 0.06 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 117.737 2.495 . . . . 0.0 117.737 -172.247 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 182' ' ' ARG . 66.4 Cg_endo -76.17 6.19 4.05 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 122.505 1.93 . . . . 0.0 112.64 -175.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 57.4 mt -64.49 -35.79 82.09 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.513 0.597 . . . . 0.0 110.881 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 59.36 125.11 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.091 1.356 . . . . 0.0 112.162 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.6 -30.17 70.51 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.548 -0.72 . . . . 0.0 111.56 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.43 ' HA ' ' CD2' ' A' ' 161' ' ' PHE . 54.3 t -67.74 -50.85 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 120.609 0.242 . . . . 0.0 110.847 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -79.53 -24.97 41.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.482 -0.137 . . . . 0.0 110.781 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.1 tp -67.2 -34.55 77.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.09 -35.88 59.16 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.212 -0.305 . . . . 0.0 111.473 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 57.7 mtt -73.11 -33.73 65.74 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.324 -0.235 . . . . 0.0 111.083 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.436 HG21 ' HA ' ' A' ' 239' ' ' LEU . 72.2 mt -78.11 -39.53 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 121.151 -0.219 . . . . 0.0 110.683 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.3 mmt -63.14 -26.44 68.82 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.592 0.633 . . . . 0.0 110.513 172.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -85.42 -16.92 38.16 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.816 -0.552 . . . . 0.0 111.677 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.63 -18.27 22.37 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.239 -0.41 . . . . 0.0 111.574 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -114.03 -14.49 12.4 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -137.62 -29.96 0.85 Allowed 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.651 0.659 . . . . 0.0 112.211 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.86 -176.47 25.25 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 71.42 7.54 64.35 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.372 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.462 HG22 ' CE2' ' A' ' 222' ' ' PHE . 22.0 t -77.2 151.24 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 CA-C-N 118.127 0.963 . . . . 0.0 110.108 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 44.3 t -133.12 -42.86 0.88 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 119.619 -0.229 . . . . 0.0 110.949 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -136.66 150.59 48.58 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -173.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.06 163.36 39.99 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.255 0.55 . . . . 0.0 111.988 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -178.34 169.46 41.16 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.1 mm -94.0 93.76 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 38.0 t70 41.61 -84.43 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -169.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.48 ' H ' ' HA ' ' A' ' 214' ' ' PRO . 16.2 m 52.79 50.46 18.03 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.444 0.64 . . . . 0.0 111.016 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.24 140.6 88.0 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.739 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -81.33 -16.18 9.68 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 124.263 3.309 . . . . 0.0 113.575 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -100.21 -36.66 9.22 Favored 'General case' 0 C--N 1.338 0.069 0 CA-C-N 118.613 0.642 . . . . 0.0 110.979 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.94 -3.89 53.72 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt 56.17 115.2 0.01 OUTLIER 'General case' 0 C--N 1.34 0.155 0 C-N-CA 126.798 2.039 . . . . 0.0 113.492 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.44 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 70.7 m-85 65.34 170.05 0.1 Allowed Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.338 1.055 . . . . 0.0 111.566 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.48 ' HA ' ' H ' ' A' ' 207' ' ' THR . 50.8 Cg_exo -56.62 163.07 7.46 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.701 2.934 . . . . 0.0 115.486 -170.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -123.63 35.09 4.92 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.556 176.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 64.35 26.06 70.36 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -145.12 164.94 29.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.527 0.731 . . . . 0.0 110.169 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -116.32 164.65 12.27 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -146.83 149.97 34.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 93.5 t -141.23 144.16 26.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -125.33 143.49 50.94 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.213 0.53 . . . . 0.0 110.336 -178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.462 ' CE2' HG22 ' A' ' 200' ' ' VAL . 55.4 m-85 -117.47 152.78 34.33 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.639 -175.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 71.1 p -84.36 2.24 41.39 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.77 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -137.42 139.13 40.49 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.325 0.65 . . . . 0.0 110.316 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 11.8 tm0? -73.98 -22.01 59.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -71.37 -38.95 71.51 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.5 m -73.25 -29.49 62.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -66.0 -48.93 69.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.635 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.4 pp -72.93 -10.7 14.22 Favored 'Isoleucine or valine' 0 C--N 1.338 0.084 0 CA-C-N 118.515 0.598 . . . . 0.0 111.139 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.42 -23.94 27.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 117.602 0.183 . . . . 0.0 110.52 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -85.01 -23.92 28.44 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 10.4 pt -102.98 26.27 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 123.092 0.557 . . . . 0.0 110.474 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.2 t -90.9 2.52 56.12 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.537 0.735 . . . . 0.0 111.564 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -139.83 -156.68 0.7 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -128.65 -35.76 1.89 Allowed 'General case' 0 C--O 1.227 -0.106 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -127.88 104.54 7.87 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.9 m -64.32 149.76 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.763 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.526 ' C ' HD22 ' A' ' 239' ' ' LEU . 14.0 mm100 -91.36 138.2 31.76 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.526 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.2 mm? -127.52 22.64 6.42 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -87.85 133.97 33.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.244 0.618 . . . . 0.0 111.69 -172.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -147.09 22.9 1.2 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.885 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.7 135.82 4.89 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 54.13 7.54 0.13 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.05 1.34 . . . . 0.0 113.82 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.4 mt -144.54 142.63 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 C-N-CA 123.486 0.715 . . . . 0.0 109.292 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -150.99 138.07 19.18 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -144.37 161.42 39.02 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -155.55 158.28 38.18 Favored 'General case' 0 N--CA 1.46 0.054 0 CA-C-N 118.117 0.417 . . . . 0.0 110.221 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 12.7 p -158.66 152.21 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -86.13 126.72 34.42 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.46 ' C ' ' HE2' ' A' ' 251' ' ' LYS . 4.3 m -97.46 155.01 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.46 ' HE2' ' C ' ' A' ' 250' ' ' VAL . 0.0 OUTLIER -155.48 157.47 31.62 Favored Pre-proline 0 C--O 1.231 0.103 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.591 170.151 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.01 138.23 84.9 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.816 2.344 . . . . 0.0 109.336 173.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -92.11 170.02 10.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.447 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.453 -0.3 0 C-N-CA 123.273 0.629 . . . . 0.0 110.128 -169.771 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 121.139 0.495 . . . . 0.0 111.298 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -97.05 161.26 13.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.3 t -92.25 27.86 2.08 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.129 0.972 . . . . 0.0 113.471 -169.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 54.34 23.52 4.45 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.373 0.533 . . . . 0.0 111.052 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -146.0 138.16 25.28 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.479 0.712 . . . . 0.0 109.945 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.7 m -138.91 152.36 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.921 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.467 ' CZ ' ' HA3' ' A' ' 70' ' ' GLY . 19.1 t80 -84.03 148.41 26.87 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.69 73.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 122.251 1.025 . . . . 0.0 109.028 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.467 ' HA3' ' CZ ' ' A' ' 68' ' ' PHE . . . -78.19 144.63 28.64 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.47 23.44 60.55 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-O 119.203 -0.776 . . . . 0.0 113.569 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 pp -62.04 148.92 87.59 Favored Pre-proline 0 CA--C 1.531 0.22 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 172.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 66.1 Cg_endo -66.15 143.82 72.92 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 121.585 1.524 . . . . 0.0 110.499 -169.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 31.2 Cg_exo -61.83 174.37 2.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.106 2.538 . . . . 0.0 113.669 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.8 t70 63.36 5.71 2.15 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.434 HD12 ' C ' ' A' ' 76' ' ' ILE . 2.5 pp -134.01 171.41 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 171.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -143.31 -25.58 0.59 Allowed 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -154.25 -35.15 0.1 Allowed 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 119.199 0.908 . . . . 0.0 112.547 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -67.7 -45.7 74.39 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.716 0.689 . . . . 0.0 111.529 -175.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -72.34 -35.56 68.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.879 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.4 pt -83.89 -36.65 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 O-C-N 122.163 -0.336 . . . . 0.0 111.869 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 95.9 m -71.99 -15.41 62.06 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.44 0.564 . . . . 0.0 109.565 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.73 -21.29 20.05 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 172.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -84.2 -19.19 34.44 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.433 ' HB2' ' CD1' ' A' ' 91' ' ' LEU . 34.6 m-85 -113.02 5.84 17.39 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.338 0.517 . . . . 0.0 111.208 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -65.25 -21.75 66.78 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 123.811 0.845 . . . . 0.0 111.972 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -72.17 -3.37 22.97 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -113.06 15.48 19.55 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.467 0.307 . . . . 0.0 111.648 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.27 177.6 20.37 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.31 150.44 70.96 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.557 2.838 . . . . 0.0 110.675 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.433 ' CD1' ' HB2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -163.15 163.29 25.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.178 -169.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pt -142.71 168.11 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.017 172.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.9 p -128.34 157.0 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -148.05 155.88 42.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.002 0.429 . . . . 0.0 110.87 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.42 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 45.8 p90 -157.11 154.4 26.04 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 169.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.458 ' HG2' ' ND1' ' A' ' 97' ' ' HIS . 31.1 Cg_endo -75.61 -10.28 20.18 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.075 3.183 . . . . 0.0 110.77 -169.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.458 ' ND1' ' HG2' ' A' ' 96' ' ' PRO . 46.8 m80 -102.37 9.92 39.44 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.872 0.869 . . . . 0.0 111.022 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.449 ' HA ' ' HE3' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -61.35 143.44 55.74 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.809 0.844 . . . . 0.0 109.914 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.224 0 C-N-CA 123.381 0.673 . . . . 0.0 110.118 179.813 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.817 0 CA-C-O 119.748 -0.473 . . . . 0.0 113.099 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -104.05 130.13 51.72 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.702 1.251 . . . . 0.0 108.543 172.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.98 -176.46 5.77 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.217 0.462 . . . . 0.0 110.657 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -141.62 144.35 34.14 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.773 0.429 . . . . 0.0 110.322 -176.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -102.08 146.89 27.28 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.378 0.609 . . . . 0.0 111.769 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.4 mp -114.27 137.72 51.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -131.1 175.2 9.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.381 0.672 . . . . 0.0 110.004 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -115.6 -32.56 5.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.454 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -114.66 149.21 37.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.066 0.46 . . . . 0.0 111.327 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -77.97 -17.6 56.97 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.02 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.8 t -83.43 -16.39 45.99 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.264 -0.272 . . . . 0.0 111.476 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 67.5 m -74.93 -43.45 54.08 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.911 -0.493 . . . . 0.0 111.492 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 m -71.04 -22.99 23.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -80.29 -35.65 35.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.88 -33.02 65.79 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 119.442 -0.314 . . . . 0.0 111.382 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -80.26 -23.37 40.84 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.462 0.574 . . . . 0.0 110.955 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 54.5 mt -89.56 -20.91 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -100.98 -13.84 18.11 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.568 0.622 . . . . 0.0 112.619 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -108.62 11.07 26.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.06 0.391 . . . . 0.0 111.97 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 72.4 m -129.74 -166.41 1.66 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.852 0.461 . . . . 0.0 111.259 -176.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 129' ' ' ILE . 3.8 mp -80.71 152.15 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 123.806 0.842 . . . . 0.0 109.353 -171.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -144.35 158.74 43.58 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.658 176.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 134' ' ' LYS . 1.9 pt-20 -145.62 174.79 10.88 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 175.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -59.8 -5.25 0.88 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -170.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -153.42 0.34 0.21 Allowed Glycine 0 CA--C 1.528 0.878 0 CA-C-N 119.164 0.893 . . . . 0.0 114.02 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.478 ' H ' ' HG3' ' A' ' 131' ' ' GLU . 3.4 mppt? -151.6 167.01 29.44 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 118.441 1.12 . . . . 0.0 110.618 -176.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -115.8 156.46 26.0 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -144.76 156.09 43.88 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.6 mp -135.55 164.02 28.78 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 169.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.2 m -108.13 141.09 40.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.76 150.4 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 C-N-CA 122.953 0.501 . . . . 0.0 110.344 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.9 m -66.63 161.76 22.57 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 122.902 0.481 . . . . 0.0 110.192 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.3 t -151.39 148.5 22.41 Favored Pre-proline 0 N--CA 1.455 -0.177 0 O-C-N 121.894 -0.504 . . . . 0.0 111.711 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -80.05 -7.76 14.23 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.768 2.979 . . . . 0.0 111.231 169.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 45.7 m -102.09 -32.69 10.01 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.872 0.869 . . . . 0.0 110.792 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 3.7 mm -140.09 170.81 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 124.191 0.996 . . . . 0.0 108.936 -175.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -70.16 -23.76 63.04 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -159.61 149.16 18.3 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.859 0.864 . . . . 0.0 109.912 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.12 106.72 28.21 Favored Pre-proline 0 C--N 1.337 0.051 0 C-N-CA 123.269 0.627 . . . . 0.0 109.59 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.84 96.82 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.226 2.618 . . . . 0.0 109.193 169.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.8 p -84.98 137.96 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.24 146.77 24.78 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.22 0.608 . . . . 0.0 110.977 -173.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 37.4 mm -130.85 146.18 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 123.158 0.583 . . . . 0.0 111.218 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -148.37 109.76 3.66 Favored Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.85 165.11 26.97 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.51 2.806 . . . . 0.0 111.377 177.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -105.89 126.27 51.98 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 174.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -96.52 132.62 41.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.495 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -92.6 118.13 30.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.767 0.794 . . . . 0.0 110.899 -178.222 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 34.5 t -172.62 -31.83 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.146 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -122.3 21.87 10.23 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.092 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 23.7 m -64.56 -27.77 69.18 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -160.4 160.95 32.88 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.569 0.348 . . . . 0.0 111.387 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.437 ' CD2' ' HA ' ' A' ' 187' ' ' VAL . 12.9 t80 -155.87 161.59 40.56 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.8 0.333 . . . . 0.0 110.711 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.9 m -136.95 148.76 26.36 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 C-N-CA 124.493 1.117 . . . . 0.0 109.878 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 29.3 mtm -139.49 12.31 2.54 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -137.88 24.07 2.84 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.041 0.837 . . . . 0.0 112.383 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 89.07 24.45 31.96 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 119.639 -0.534 . . . . 0.0 111.938 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 98.0 p 48.4 45.26 20.64 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -61.94 156.9 54.51 Favored Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -65.9 151.02 85.23 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.718 2.279 . . . . 0.0 110.688 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.481 HD12 ' HB1' ' A' ' 221' ' ' ALA . 3.0 mm? -108.66 172.49 6.81 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 121.259 0.552 . . . . 0.0 110.625 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -149.61 139.79 13.57 Favored Pre-proline 0 N--CA 1.452 -0.325 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.967 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.34 -12.19 31.79 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.213 2.608 . . . . 0.0 113.42 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -89.9 0.26 57.17 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.811 0.732 . . . . 0.0 110.383 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -127.01 25.11 6.3 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 122.959 0.504 . . . . 0.0 110.918 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 23.8 m -127.74 140.25 52.18 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.969 0.414 . . . . 0.0 111.486 -175.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.6 tt -113.24 150.23 15.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 C-N-CA 123.539 0.736 . . . . 0.0 109.726 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.445 ' CD1' ' CE1' ' A' ' 253' ' ' TYR . 10.9 t80 -109.55 147.82 32.31 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 48.1 t -137.13 138.72 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.317 0.647 . . . . 0.0 109.294 -175.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -141.89 146.84 18.17 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 112.065 -0.414 . . . . 0.0 112.065 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.42 15.23 48.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -172.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.6 m -70.04 146.7 95.28 Favored Pre-proline 0 C--O 1.231 0.108 0 CA-C-N 117.188 0.494 . . . . 0.0 111.298 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -79.64 160.0 25.09 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.579 2.853 . . . . 0.0 108.293 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.83 -43.81 6.6 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.903 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.29 20.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.118 3.212 . . . . 0.0 115.087 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.84 -27.63 69.01 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.511 1.05 . . . . 0.0 112.445 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 56.92 106.74 0.01 OUTLIER 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.602 1.561 . . . . 0.0 112.612 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.32 -23.2 47.18 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.437 ' HA ' ' CD2' ' A' ' 161' ' ' PHE . 41.8 t -68.27 -55.16 17.36 Favored 'Isoleucine or valine' 0 C--N 1.337 0.064 0 CA-C-N 118.691 0.678 . . . . 0.0 110.819 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.13 -20.09 38.71 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.363 -0.211 . . . . 0.0 110.977 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.06 -33.82 63.82 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.34 -35.29 63.6 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.789 -0.569 . . . . 0.0 110.538 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.4 mmt -69.1 -33.31 73.3 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 57.7 mt -75.31 -41.83 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -63.97 -20.71 66.08 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.07 0.395 . . . . 0.0 110.899 173.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -86.1 -20.46 28.68 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.586 0.63 . . . . 0.0 111.287 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -89.3 -16.45 31.1 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -115.75 -22.39 9.16 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.172 0.442 . . . . 0.0 110.909 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -137.78 43.79 2.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.201 0.6 . . . . 0.0 109.801 -176.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -46.14 138.66 7.18 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 123.654 0.645 . . . . 0.0 112.549 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 120.46 12.03 6.38 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -175.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 9.1 p -77.69 161.09 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.952 0.901 . . . . 0.0 110.598 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 47.9 t -135.98 -27.16 1.13 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -153.22 140.88 19.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 117.83 0.286 . . . . 0.0 110.896 -173.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.37 157.5 43.12 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.569 0.347 . . . . 0.0 110.716 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 161.76 -161.33 33.18 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 44.9 mm -102.4 138.39 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -59.58 138.28 57.76 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.532 0.206 . . . . 0.0 110.577 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 26.5 p -141.73 160.01 41.05 Favored 'General case' 0 N--CA 1.458 -0.052 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.179 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -111.74 130.19 23.42 Favored Pre-proline 0 N--CA 1.455 -0.197 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -80.25 -17.07 10.59 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.385 3.39 . . . . 0.0 113.813 -174.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -88.61 -31.75 18.43 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.549 0.613 . . . . 0.0 110.95 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.53 -2.78 15.37 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.114 0.566 . . . . 0.0 110.478 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 62.6 mttp 48.12 61.89 2.77 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.043 1.337 . . . . 0.0 112.734 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -147.32 151.61 40.74 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 122.292 0.237 . . . . 0.0 111.105 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -82.54 155.92 16.22 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.347 2.698 . . . . 0.0 112.577 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -93.42 1.38 56.89 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.147 0.979 . . . . 0.0 109.492 173.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 65.86 7.74 37.62 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.19 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -117.86 146.16 44.09 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 117.462 0.631 . . . . 0.0 109.738 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -84.76 151.04 25.9 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 121.319 0.4 . . . . 0.0 112.547 -173.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.82 142.91 24.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 171.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.8 t -134.75 144.48 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.481 ' HB1' HD12 ' A' ' 169' ' ' LEU . . . -133.03 149.02 52.22 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.026 0.441 . . . . 0.0 110.056 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -126.13 153.66 44.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.481 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 63.2 p -84.15 4.51 30.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.732 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -134.98 136.68 42.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.391 0.677 . . . . 0.0 109.796 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -73.86 -20.28 60.47 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -70.99 -35.82 72.25 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 17.3 m -75.19 -29.96 60.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -66.93 -50.03 63.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.793 -0.146 . . . . 0.0 110.927 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.9 pt -70.09 -17.99 21.38 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 CA-C-N 118.061 0.392 . . . . 0.0 110.741 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.01 -24.55 37.86 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 117.582 0.174 . . . . 0.0 110.851 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.72 -31.06 32.25 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.981 0.355 . . . . 0.0 111.666 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.4 pt -95.78 23.54 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 122.712 0.405 . . . . 0.0 110.324 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.3 t -84.3 -13.81 51.44 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.004 0.522 . . . . 0.0 111.518 -176.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -149.62 135.81 18.97 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -53.54 -37.36 62.78 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.966 0.506 . . . . 0.0 112.019 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -113.84 105.06 12.82 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.905 0.383 . . . . 0.0 110.56 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.4 HG23 HD21 ' A' ' 239' ' ' LEU . 1.4 m -65.44 154.53 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.959 174.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.519 ' C ' HD22 ' A' ' 239' ' ' LEU . 44.3 mm-40 -95.23 130.55 41.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.519 HD22 ' C ' ' A' ' 238' ' ' GLN . 2.3 mm? -124.04 17.98 9.24 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.991 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -89.86 118.77 29.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -170.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -149.36 141.04 23.51 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 173.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.16 -131.61 50.11 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -98.98 7.5 45.94 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.942 0.497 . . . . 0.0 111.462 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 244' ' ' ILE . 1.9 mp -88.1 149.41 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 122.841 0.456 . . . . 0.0 109.952 -177.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -150.82 127.89 11.15 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -145.6 157.41 43.98 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.405 1.082 . . . . 0.0 108.652 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -153.36 152.02 30.61 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.9 p -159.93 158.49 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -85.86 145.61 27.11 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.363 0.665 . . . . 0.0 111.183 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.56 161.63 27.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.1 159.25 26.89 Favored Pre-proline 0 N--CA 1.455 -0.198 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.087 169.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.49 133.78 59.1 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.3 2.0 . . . . 0.0 108.731 173.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' TYR . . . . . 0.445 ' CE1' ' CD1' ' A' ' 176' ' ' PHE . 1.1 t80 -73.99 159.9 32.08 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.389 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.456 -0.163 0 C-N-CA 123.918 0.887 . . . . 0.0 111.331 -170.441 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 . . . . . 0 N--CA 1.456 -0.16 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -117.69 159.16 23.42 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t -98.18 174.43 6.53 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.506 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -77.5 30.0 0.15 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.159 0.584 . . . . 0.0 110.992 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -143.3 144.03 31.94 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.195 0.598 . . . . 0.0 110.701 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.0 m -141.66 155.0 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.801 176.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.409 ' CZ ' ' CA ' ' A' ' 70' ' ' GLY . 2.4 t80 -94.97 129.54 41.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 169.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 p -108.7 93.07 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 122.203 1.001 . . . . 0.0 108.455 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.409 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -86.49 155.81 28.58 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.005 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.76 26.86 73.71 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-O 119.045 -0.864 . . . . 0.0 113.912 171.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 pp -75.23 144.95 79.45 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 118.981 1.391 . . . . 0.0 108.208 173.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 39.9 Cg_endo -62.22 120.07 7.47 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.822 2.348 . . . . 0.0 110.343 -172.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 85.8 Cg_exo -54.84 -11.38 3.47 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.666 3.577 . . . . 0.0 115.238 -178.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -82.89 -7.65 59.64 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.416 0.553 . . . . 0.0 112.307 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.439 HD12 ' C ' ' A' ' 76' ' ' ILE . 2.2 pp -142.98 168.81 12.99 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -165.12 179.7 6.19 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 45.27 -99.42 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.144 1.777 . . . . 0.0 114.339 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -58.1 -28.32 64.52 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -80.38 -24.28 39.86 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.204 0.456 . . . . 0.0 110.29 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.1 mt -76.29 -46.05 33.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.1 m -63.25 -21.13 66.04 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.752 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.16 -18.37 24.58 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.1 m -79.15 -27.05 42.72 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.765 0.711 . . . . 0.0 112.139 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -114.99 11.87 16.6 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -64.85 -20.34 66.36 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.828 0.451 . . . . 0.0 112.189 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -75.24 -0.26 18.9 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -115.59 -4.48 12.24 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 141.86 177.34 16.89 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.24 146.05 50.27 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.475 2.784 . . . . 0.0 110.246 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.415 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -162.37 161.41 27.4 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.965 -169.744 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.9 mm -138.35 160.53 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.63 144.2 34.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -150.46 167.23 27.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.303 0.573 . . . . 0.0 110.826 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.431 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 35.7 p90 -157.77 162.74 26.6 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 175.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.431 ' HD2' ' HB2' ' A' ' 95' ' ' TRP . 39.2 Cg_endo -75.28 -15.64 20.03 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.304 2.002 . . . . 0.0 110.527 -169.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.5 m80 -89.54 -0.49 57.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.829 0.851 . . . . 0.0 111.18 -179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.15 110.29 4.47 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.813 0.845 . . . . 0.0 109.108 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.305 0 C-N-CA 122.557 0.343 . . . . 0.0 111.049 -179.201 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.641 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.39 150.55 35.89 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.338 0.569 . . . . 0.0 109.494 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.93 -175.03 5.23 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.762 0.425 . . . . 0.0 110.344 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -137.93 142.45 40.56 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.8 151.38 25.8 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -113.82 146.45 39.94 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 169.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -134.69 168.11 19.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.873 0.469 . . . . 0.0 110.578 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -103.83 -25.31 13.13 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.572 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -122.38 152.54 40.09 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -84.36 -15.01 47.93 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.759 176.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.3 t -90.52 -14.95 31.63 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.707 0.403 . . . . 0.0 110.635 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.4 m -75.49 -39.34 58.68 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 122.037 -0.414 . . . . 0.0 110.078 177.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.2 -22.15 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -77.87 -29.9 50.59 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.71 -35.29 45.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.656 0.207 . . . . 0.0 111.148 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 pp -80.11 -16.31 55.25 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.252 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 79.5 mt -96.39 -17.4 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 122.282 0.233 . . . . 0.0 111.084 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -100.43 -10.95 20.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.464 0.574 . . . . 0.0 112.478 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -119.74 44.87 2.28 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.074 0.55 . . . . 0.0 110.825 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 31.4 p -141.48 179.92 6.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.741 0.416 . . . . 0.0 111.904 -175.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.462 ' N ' HD12 ' A' ' 129' ' ' ILE . 2.7 mp -82.71 157.5 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -123.67 157.3 34.15 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.948 0.404 . . . . 0.0 111.199 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.98 -179.07 6.37 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -41.29 -23.44 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -161.04 4.82 0.09 OUTLIER Glycine 0 CA--C 1.529 0.946 0 CA-C-N 119.491 1.041 . . . . 0.0 113.47 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -146.28 -170.53 3.52 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.598 1.199 . . . . 0.0 111.096 -173.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -115.99 165.29 13.29 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.074 0.55 . . . . 0.0 111.815 -174.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -143.88 147.49 34.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.267 0.627 . . . . 0.0 109.404 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.6 mp -128.38 159.94 33.77 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 170.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.4 p -91.4 149.84 21.53 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 122.082 -0.386 . . . . 0.0 110.907 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.4 m -144.43 174.11 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 123.391 0.676 . . . . 0.0 109.944 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.4 p -67.71 -14.13 62.69 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.687 0.395 . . . . 0.0 111.669 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.425 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 39.0 t 47.24 57.38 17.62 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.313 1.045 . . . . 0.0 113.561 174.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 141' ' ' SER . 31.5 Cg_exo -61.9 -9.41 14.18 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.922 2.414 . . . . 0.0 113.945 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.442 HG21 ' HD2' ' A' ' 74' ' ' PRO . 55.3 m -82.37 -27.98 31.8 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.5 0.591 . . . . 0.0 109.6 178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.475 HD12 ' HD3' ' A' ' 147' ' ' LYS . 4.4 mt -150.31 -122.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -170.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -147.47 122.21 9.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.803 0.441 . . . . 0.0 110.311 174.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.6 t70 47.18 32.78 2.18 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 172.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.475 ' HD3' HD12 ' A' ' 144' ' ' ILE . 14.0 pttp -82.94 148.56 57.31 Favored Pre-proline 0 C--N 1.34 0.186 0 CA-C-N 119.786 1.176 . . . . 0.0 110.017 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -83.5 168.27 12.98 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.667 2.911 . . . . 0.0 112.245 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.9 m -128.3 146.78 33.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.501 HE21 ' C ' ' A' ' 150' ' ' GLN . 0.0 OUTLIER -93.02 149.52 21.16 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.601 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 45.0 mm -122.49 144.65 31.13 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 C-N-CA 124.246 1.018 . . . . 0.0 109.646 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.83 100.25 3.09 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.39 162.27 40.62 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.777 2.984 . . . . 0.0 111.799 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -89.82 149.54 22.63 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.935 -0.12 . . . . 0.0 110.799 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -109.04 115.23 29.66 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.768 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -83.85 12.09 6.61 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -169.634 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.2 t -96.2 -1.79 47.56 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -173.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -144.5 20.33 1.69 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.0 m -64.82 -21.06 66.71 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -175.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -153.74 156.29 37.5 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 118.014 0.37 . . . . 0.0 110.854 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -158.17 150.56 22.15 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.37 151.82 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 O-C-N 121.944 -0.473 . . . . 0.0 110.174 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 64.2 mtm -127.84 24.7 6.05 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 122.366 0.266 . . . . 0.0 111.409 -175.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -158.94 -49.91 0.06 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 64.95 11.64 51.67 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.98 -0.9 . . . . 0.0 113.939 172.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 26.3 t -138.75 -27.63 0.83 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.776 1.288 . . . . 0.0 114.332 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -77.08 147.34 76.68 Favored Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 119.115 0.871 . . . . 0.0 111.03 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.43 157.42 40.96 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.909 3.073 . . . . 0.0 110.969 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 10.6 mp -118.48 161.93 19.19 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.688 0.795 . . . . 0.0 109.85 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -137.5 152.89 73.87 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.68 -0.19 9.03 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.603 2.869 . . . . 0.0 111.432 -176.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -114.99 7.97 15.69 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 124.206 1.002 . . . . 0.0 111.494 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -123.33 19.72 9.74 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.825 0.45 . . . . 0.0 111.39 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.0 m -115.6 139.53 50.02 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.759 0.314 . . . . 0.0 111.079 -175.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.5 tt -118.32 149.57 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 C-N-CA 123.178 0.591 . . . . 0.0 109.934 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -109.97 147.28 33.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.2 t -134.9 132.25 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -177.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -152.39 167.16 31.33 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 87.1 11.82 69.13 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -170.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.8 m -65.93 156.21 84.49 Favored Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 122.919 0.488 . . . . 0.0 111.272 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -72.76 -171.98 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.941 3.094 . . . . 0.0 109.857 174.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -54.26 -50.92 82.07 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.874 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.42 139.32 23.12 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.143 1.895 . . . . 0.0 110.221 173.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.0 12.66 0.5 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 -42.14 140.07 1.21 Allowed 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.125 0.97 . . . . 0.0 112.209 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.47 -17.77 62.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.746 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.75 -50.45 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-O 120.699 0.285 . . . . 0.0 110.294 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -83.77 -25.93 30.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.562 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 26.0 tp -69.81 -32.97 71.71 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.68 -32.2 36.07 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 122.335 -0.228 . . . . 0.0 111.268 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.3 mmt -68.66 -31.58 70.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.6 mt -79.01 -33.26 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 O-C-N 122.231 -0.293 . . . . 0.0 110.49 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.7 mmt -73.36 -19.42 61.01 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.534 0.606 . . . . 0.0 109.984 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -83.62 -24.93 31.22 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.371 0.268 . . . . 0.0 111.224 175.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -87.76 -16.93 32.82 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -117.19 -17.01 10.34 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -134.68 23.06 3.64 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -173.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 73.87 -144.41 33.71 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 175.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -72.44 123.51 9.21 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 112.145 -0.382 . . . . 0.0 112.145 -173.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 90.8 t -111.57 137.74 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 124.745 1.218 . . . . 0.0 108.027 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.9 p -92.76 -41.44 10.13 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 118.364 0.529 . . . . 0.0 111.902 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -156.61 155.64 32.17 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.144 0.429 . . . . 0.0 111.676 -171.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -149.7 159.6 44.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.33 0.586 . . . . 0.0 111.006 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -174.67 170.48 43.6 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.7 mp -82.42 148.92 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -57.99 119.03 6.04 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 22.6 p -138.35 158.64 43.88 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -117.07 131.96 23.71 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.61 -16.1 15.07 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 124.503 3.469 . . . . 0.0 114.47 -172.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -110.97 -25.14 9.97 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.334 0.97 . . . . 0.0 111.381 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -86.86 -10.2 53.98 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 169.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 49.89 45.81 24.71 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.647 1.179 . . . . 0.0 111.839 175.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.32 156.22 39.66 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -80.69 157.25 21.47 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.527 2.818 . . . . 0.0 111.2 174.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -119.11 21.55 12.27 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.595 0.758 . . . . 0.0 111.04 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.23 -178.15 31.08 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 55.34 -173.98 0.05 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.334 0.567 . . . . 0.0 111.869 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -140.92 168.79 25.18 Favored Glycine 0 CA--C 1.524 0.632 0 O-C-N 121.608 -0.682 . . . . 0.0 112.979 -177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -146.58 149.8 34.26 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 97.1 t -136.68 151.09 27.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -124.38 145.72 49.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.916 0.486 . . . . 0.0 111.355 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -122.38 151.23 41.41 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.697 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 62.9 p -91.96 -0.64 57.49 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 116.78 -0.191 . . . . 0.0 111.242 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -132.5 144.83 50.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.901 0.48 . . . . 0.0 110.243 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -80.12 -9.36 59.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.244 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -85.09 -42.18 15.04 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 34.8 p -74.63 -24.6 58.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -68.45 -48.81 63.56 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 119.639 -0.22 . . . . 0.0 110.993 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.6 pp -71.95 -12.46 15.91 Favored 'Isoleucine or valine' 0 C--N 1.338 0.066 0 CA-C-N 118.372 0.533 . . . . 0.0 110.991 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.96 -27.83 30.22 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 173.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.59 -27.23 34.37 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.7 pt -106.92 29.58 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.039 0.536 . . . . 0.0 110.372 174.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.8 t -78.35 -14.57 59.34 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.29 0.636 . . . . 0.0 111.813 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -155.79 144.08 20.05 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -60.2 -33.12 71.8 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.409 -0.329 . . . . 0.0 111.584 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -119.67 116.26 25.62 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.738 0.304 . . . . 0.0 110.42 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -108.62 159.4 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.333 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -86.6 143.82 27.47 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.949 0.404 . . . . 0.0 111.155 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.85 103.97 6.09 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 173.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -135.44 153.31 51.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.226 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -138.73 11.88 2.7 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.123 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 175.17 -134.45 2.74 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -76.54 12.49 1.25 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.096 0.558 . . . . 0.0 111.381 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.1 mt -66.91 157.97 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.41 1.084 . . . . 0.0 110.112 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -145.82 21.02 1.46 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -67.87 160.48 28.35 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.054 0.542 . . . . 0.0 111.986 -173.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.16 161.99 35.4 Favored 'General case' 0 C--N 1.337 0.065 0 C-N-CA 124.353 1.061 . . . . 0.0 110.229 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.4 p -153.8 156.61 5.17 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -89.32 138.47 31.41 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 117.671 0.214 . . . . 0.0 110.624 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.97 158.46 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-O 120.828 0.347 . . . . 0.0 111.233 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.02 159.25 24.78 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 171.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.81 140.21 92.1 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.629 2.219 . . . . 0.0 109.78 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -78.41 168.24 20.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.244 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.452 -0.372 0 C-N-CA 123.067 0.547 . . . . 0.0 110.319 -170.548 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -75.33 170.83 15.32 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.153 0.501 . . . . 0.0 112.304 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.4 t -100.38 27.45 5.72 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -168.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.517 ' HA ' ' CE2' ' A' ' 115' ' ' PHE . 0.0 OUTLIER 55.33 17.41 2.1 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.122 0.419 . . . . 0.0 111.155 -176.414 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -147.82 140.24 24.47 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.247 0.619 . . . . 0.0 111.632 -177.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.5 m -136.06 148.52 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.704 169.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -85.22 140.45 30.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.9 p -122.98 98.55 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 121.779 0.8 . . . . 0.0 108.906 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.36 169.49 51.34 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.41 26.76 71.92 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 119.226 -0.763 . . . . 0.0 113.901 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.457 ' HB3' ' H ' ' A' ' 110' ' ' TYR . 18.5 tp -63.0 122.18 73.46 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 119.626 1.713 . . . . 0.0 107.352 173.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.65 170.07 20.86 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.164 2.576 . . . . 0.0 111.537 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.46 179.06 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 124.357 3.371 . . . . 0.0 112.753 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 61.45 -79.7 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.411 HD12 ' C ' ' A' ' 76' ' ' ILE . 2.3 pp -65.2 164.8 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 118.288 0.494 . . . . 0.0 111.539 -177.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -146.88 -24.67 0.41 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -154.28 -36.69 0.1 Allowed 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -174.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -67.48 -39.99 85.25 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.006 0.366 . . . . 0.0 111.944 -173.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -74.48 -35.33 63.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.179 -0.326 . . . . 0.0 111.37 -172.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.7 pt -83.91 -28.03 7.34 Favored 'Isoleucine or valine' 0 C--O 1.23 0.041 0 O-C-N 122.145 -0.347 . . . . 0.0 110.967 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.0 m -79.77 -5.63 55.68 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.15 -14.13 14.99 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 171.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 m -95.14 -17.79 21.49 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -120.65 0.74 10.49 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.374 0.534 . . . . 0.0 111.986 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.0 tpt85 -70.38 -21.4 62.87 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 122.716 0.406 . . . . 0.0 110.831 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -69.15 -5.71 24.16 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.674 0.789 . . . . 0.0 111.947 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -112.68 -13.34 13.27 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.239 0.215 . . . . 0.0 111.427 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.5 168.6 18.81 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -70.9 149.14 59.1 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.294 2.663 . . . . 0.0 110.804 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.404 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -164.77 158.73 17.86 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -170.728 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.489 HG22 ' H ' ' A' ' 93' ' ' VAL . 12.2 mm -136.86 173.17 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 171.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.489 ' H ' HG22 ' A' ' 92' ' ' ILE . 7.3 p -137.6 156.03 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 118.445 0.566 . . . . 0.0 110.606 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -149.18 164.24 35.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.542 0.337 . . . . 0.0 111.039 -175.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.461 ' CZ2' ' HE3' ' A' ' 98' ' ' LYS . 24.2 p90 -155.46 156.32 30.75 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.477 ' HG2' ' ND1' ' A' ' 97' ' ' HIS . 25.5 Cg_endo -75.42 -11.66 20.72 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 124.026 3.151 . . . . 0.0 110.683 -169.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.477 ' ND1' ' HG2' ' A' ' 96' ' ' PRO . 61.6 m80 -105.52 5.94 31.87 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.847 0.859 . . . . 0.0 111.363 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.461 ' HE3' ' CZ2' ' A' ' 95' ' ' TRP . 68.8 tttt -64.65 157.84 26.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.717 0.807 . . . . 0.0 112.568 -176.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.258 0 C-N-CA 125.037 1.335 . . . . 0.0 113.303 -178.795 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.778 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.457 ' H ' ' HB3' ' A' ' 72' ' ' LEU . 0.0 OUTLIER 60.54 147.7 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 113.859 -1.171 . . . . 0.0 113.991 -177.411 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.49 -173.45 3.99 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.185 0.594 . . . . 0.0 110.043 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.35 134.0 26.78 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.424 ' C ' HD12 ' A' ' 114' ' ' LEU . 10.6 mp -91.19 149.64 21.7 Favored 'General case' 0 CA--C 1.522 -0.108 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -176.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.424 HD12 ' C ' ' A' ' 113' ' ' LEU . 9.8 mp -118.59 144.69 45.95 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 173.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.517 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.7 p90 -158.93 177.35 11.25 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -117.89 -12.74 10.12 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -129.29 142.66 50.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.973 0.416 . . . . 0.0 112.03 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -80.76 -6.05 57.97 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.831 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 75.1 p -82.73 -19.26 38.28 Favored 'General case' 0 N--CA 1.457 -0.113 0 O-C-N 122.137 -0.352 . . . . 0.0 111.075 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.5 t -72.58 -44.27 62.27 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.0 m -70.84 -26.2 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -69.94 -41.6 74.35 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.764 -0.585 . . . . 0.0 110.702 -176.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.54 -36.6 60.44 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.04 0.382 . . . . 0.0 111.792 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -76.86 -15.37 59.73 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.06 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 77.3 mt -95.42 -17.32 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.336 0.254 . . . . 0.0 110.467 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -90.84 -14.92 30.91 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.608 -0.682 . . . . 0.0 111.121 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.29 46.32 1.82 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.491 0.717 . . . . 0.0 111.437 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 22.5 p -138.27 176.7 8.47 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 39.5 mm -92.88 164.35 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 125.363 1.465 . . . . 0.0 108.351 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -133.46 150.63 51.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.778 0.323 . . . . 0.0 110.836 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.16 -179.86 5.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 175.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -55.84 -4.76 0.12 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -171.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -170.17 14.03 0.05 OUTLIER Glycine 0 CA--C 1.527 0.831 0 CA-C-N 118.854 0.752 . . . . 0.0 113.137 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' A' ' 134' ' ' LYS . 21.4 ttmt -157.89 -178.05 7.02 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.596 1.198 . . . . 0.0 111.23 -174.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 150' ' ' GLN . 67.2 mt -112.24 169.56 8.78 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.078 0.551 . . . . 0.0 110.972 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.472 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 0.3 OUTLIER -145.81 139.53 26.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.27 0.628 . . . . 0.0 109.717 179.126 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.0 mp -136.8 149.71 47.91 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.346 0.521 . . . . 0.0 110.069 170.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.3 p -71.1 154.57 41.64 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.9 p -148.77 7.34 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 O-C-N 122.402 -0.187 . . . . 0.0 111.479 -177.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.2 m 53.16 46.99 25.44 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.847 -0.533 . . . . 0.0 110.799 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.9 t -47.6 139.83 8.27 Favored Pre-proline 0 CA--C 1.53 0.199 0 C-N-CA 124.351 1.06 . . . . 0.0 112.234 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -80.1 -15.14 11.79 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 124.142 3.228 . . . . 0.0 113.854 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.7 t -89.47 -24.0 21.95 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.841 1.201 . . . . 0.0 111.657 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.49 HG22 ' H ' ' A' ' 145' ' ' LYS . 2.4 mm -121.63 -174.95 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.077 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.49 ' H ' HG22 ' A' ' 144' ' ' ILE . 63.9 pttt -69.97 -32.67 71.0 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.346 -0.846 . . . . 0.0 109.139 171.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -165.58 150.14 8.59 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.781 1.633 . . . . 0.0 107.187 170.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.85 105.49 2.49 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.472 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 78.1 Cg_exo -53.39 145.11 47.17 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.031 3.154 . . . . 0.0 113.905 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.4 m -116.72 148.61 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.059 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 25.3 mp0 -82.03 157.33 24.21 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -174.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.0 mm -136.59 142.37 38.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.379 0.672 . . . . 0.0 109.36 171.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.6 ttp85 -157.66 104.4 1.8 Allowed Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 171.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -60.72 167.17 8.84 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 124.507 3.471 . . . . 0.0 114.819 175.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -111.1 136.43 50.15 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.348 171.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -103.18 150.12 23.99 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.478 0.711 . . . . 0.0 112.455 -176.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.6 mp -94.47 97.7 10.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.466 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.9 t -156.09 -33.1 0.09 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.803 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -138.78 22.36 2.67 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.7 m -68.62 -25.04 64.65 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -175.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -153.67 159.62 42.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.239 0.616 . . . . 0.0 110.518 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -151.77 154.26 35.91 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.6 t -136.42 144.29 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -174.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 63.8 mtm -141.74 15.36 2.14 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -151.38 10.79 0.59 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.336 0.516 . . . . 0.0 112.062 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.94 12.25 84.1 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 121.764 -0.585 . . . . 0.0 111.931 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.5 m 52.89 73.17 0.37 Allowed 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -70.85 173.55 4.65 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -54.44 133.97 59.07 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.208 1.938 . . . . 0.0 112.073 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.4 mp -106.66 160.87 15.12 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 123.603 0.761 . . . . 0.0 109.904 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -150.08 145.04 18.2 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.3 -20.84 33.78 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.425 2.75 . . . . 0.0 114.176 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -91.1 2.93 55.96 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.457 0.571 . . . . 0.0 111.126 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -131.07 15.96 5.14 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.655 0.382 . . . . 0.0 111.117 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 18.7 m -128.08 140.17 52.1 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 120.713 0.292 . . . . 0.0 110.805 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.4 tt -113.28 150.57 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 C-N-CA 123.204 0.602 . . . . 0.0 109.992 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -120.84 153.16 37.5 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 18.0 m -141.68 151.74 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.792 0.437 . . . . 0.0 110.422 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -164.34 171.48 39.87 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.47 11.04 80.95 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 11.9 p -63.26 138.62 97.39 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.18 -52.89 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.502 2.135 . . . . 0.0 112.218 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.428 ' H ' ' CD ' ' A' ' 183' ' ' PRO . 24.5 tpt180 -162.78 -47.24 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.331 -0.842 . . . . 0.0 113.066 176.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.428 ' CD ' ' H ' ' A' ' 182' ' ' ARG . 16.3 Cg_exo -71.38 140.93 37.75 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.747 2.298 . . . . 0.0 111.778 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.696 ' CD1' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -151.88 -87.12 0.07 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 119.151 -0.452 . . . . 0.0 111.463 176.514 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.696 ' H ' ' CD1' ' A' ' 184' ' ' LEU . 71.2 mtp180 59.38 126.48 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 126.393 1.877 . . . . 0.0 112.181 -173.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.5 -20.23 65.42 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.896 -0.503 . . . . 0.0 110.364 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 68.1 t -69.43 -54.01 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 122.434 0.294 . . . . 0.0 110.616 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -81.71 -23.38 36.81 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.341 -0.224 . . . . 0.0 111.054 -174.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 53.1 tp -71.0 -33.6 70.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -79.49 -33.45 42.2 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.4 mmt -69.83 -38.63 76.61 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.877 0.308 . . . . 0.0 110.304 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 94.1 mt -73.1 -37.32 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.6 mmt -67.07 -20.08 65.76 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.975 -0.453 . . . . 0.0 110.695 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -86.3 -19.88 29.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.872 0.306 . . . . 0.0 111.784 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -96.58 -14.34 22.29 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.0 -13.45 10.02 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -136.66 21.22 3.1 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 81.83 -150.14 29.09 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 122.141 -0.349 . . . . 0.0 112.252 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.19 121.81 5.98 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 123.086 0.374 . . . . 0.0 112.221 -171.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 90.9 t -100.49 147.19 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 124.242 1.017 . . . . 0.0 109.612 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 46.7 t -102.12 -43.73 5.66 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -159.7 158.42 31.33 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.37 0.129 . . . . 0.0 111.105 -170.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -152.88 156.97 39.97 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.849 0.46 . . . . 0.0 110.648 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -178.16 -176.05 45.8 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 42.8 mm -113.58 90.81 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 14.1 t70 56.72 -63.57 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -169.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 55.3 p 45.67 56.41 5.88 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.87 130.59 94.89 Favored Pre-proline 0 N--CA 1.453 -0.307 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -78.32 -14.58 14.67 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.517 3.478 . . . . 0.0 113.681 -173.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -94.65 -36.82 11.61 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 118.643 0.656 . . . . 0.0 110.317 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 94.3 mt -96.44 -7.39 35.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.867 0.467 . . . . 0.0 109.925 176.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 50.16 44.55 26.07 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.792 1.237 . . . . 0.0 111.87 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.99 155.53 62.33 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -174.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -84.74 177.83 5.28 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 123.807 3.005 . . . . 0.0 111.073 174.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -138.73 22.81 2.67 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.113 0.565 . . . . 0.0 110.862 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 62.72 8.24 20.01 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.63 -0.539 . . . . 0.0 113.677 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -128.58 141.04 51.49 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.952 0.876 . . . . 0.0 109.274 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -86.16 161.64 34.55 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-O 121.526 0.515 . . . . 0.0 113.942 -171.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -149.53 148.51 29.47 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.9 t -141.64 154.82 19.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -135.69 150.48 49.59 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.619 0.247 . . . . 0.0 110.61 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -124.66 154.57 40.57 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 66.5 p -86.02 3.01 44.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.156 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -139.3 140.53 37.61 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.32 0.648 . . . . 0.0 110.005 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -74.2 -19.68 60.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.395 -0.191 . . . . 0.0 110.661 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -71.64 -37.0 70.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 44.2 m -72.49 -30.26 64.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -69.25 -49.97 51.31 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 119.484 -0.293 . . . . 0.0 111.041 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 41.8 pt -68.16 -18.31 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.032 0 CA-C-N 118.43 0.559 . . . . 0.0 110.79 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.55 -25.63 35.69 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -84.95 -23.23 28.87 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.6 pt -105.23 25.75 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 122.734 0.414 . . . . 0.0 110.833 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 20.0 t -84.54 -9.4 58.36 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.12 0.568 . . . . 0.0 112.271 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -156.65 143.97 18.98 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 249' ' ' GLU . 10.1 ptp180 -60.04 -52.57 64.81 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.214 -175.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -93.05 115.79 28.44 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.374 0.988 . . . . 0.0 110.139 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 237' ' ' VAL . 0.6 OUTLIER -83.52 147.24 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 171.858 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -81.99 127.19 32.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.84 17.25 6.82 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -84.15 130.34 34.85 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.165 0.586 . . . . 0.0 112.26 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -152.49 143.41 22.99 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 61.85 -144.31 48.93 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -177.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.1 8.73 31.27 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.086 0.554 . . . . 0.0 111.669 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 66.7 mt -96.62 153.81 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 123.442 0.697 . . . . 0.0 110.264 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -130.52 133.95 46.66 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -145.37 145.37 31.15 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 124.502 1.121 . . . . 0.0 108.576 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -158.93 155.31 27.4 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.29 0.636 . . . . 0.0 109.622 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 8.7 p -157.6 154.31 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 235' ' ' ARG . 42.8 mt-10 -94.13 136.4 34.46 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 117.786 0.266 . . . . 0.0 110.64 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.4 m -101.72 161.34 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.01 159.61 29.28 Favored Pre-proline 0 N--CA 1.454 -0.226 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.776 169.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.2 136.66 76.39 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.796 2.33 . . . . 0.0 109.27 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -87.28 167.55 13.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.052 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.451 -0.384 0 C-N-CA 123.626 0.771 . . . . 0.0 110.018 -170.455 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 . . . . . 0 N--CA 1.458 -0.026 0 CA-C-O 120.988 0.423 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -151.19 157.03 42.13 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.225 -171.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.0 t -94.01 161.24 14.37 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 50.1 mtm105 -81.96 24.32 0.64 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.32 0.248 . . . . 0.0 110.894 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -140.27 138.15 34.77 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.698 0.399 . . . . 0.0 110.804 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.36 155.78 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.866 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CZ ' ' HA2' ' A' ' 70' ' ' GLY . 5.8 t80 -86.97 139.04 30.99 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 171.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.23 115.48 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 174.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.414 ' HA2' ' CZ ' ' A' ' 68' ' ' PHE . . . -79.73 137.98 19.55 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.47 -175.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.49 158.61 6.17 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 121.985 0.77 . . . . 0.0 114.69 173.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.5 tp -160.09 126.37 2.44 Favored Pre-proline 0 N--CA 1.451 -0.385 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.465 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 98.0 Cg_endo -73.74 142.23 31.84 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.622 1.548 . . . . 0.0 109.12 -178.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 32.1 Cg_exo -61.54 -3.23 3.2 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.93 3.087 . . . . 0.0 115.165 -174.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -99.88 -21.27 15.77 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.432 HD12 ' C ' ' A' ' 76' ' ' ILE . 1.8 pp -133.36 -171.89 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 119.459 1.027 . . . . 0.0 111.203 -177.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -136.68 -163.24 1.38 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.465 0.706 . . . . 0.0 112.291 -172.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -40.62 -31.08 0.14 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.853 2.061 . . . . 0.0 113.459 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -64.61 -30.26 71.28 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -175.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -80.04 -33.99 38.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.083 -0.386 . . . . 0.0 111.133 -173.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.4 mt -73.78 -36.19 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 33.5 m -68.75 -21.77 64.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.76 -13.23 27.64 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.4 m -84.75 -29.54 25.41 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.285 0.493 . . . . 0.0 112.022 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -110.49 5.15 21.08 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -176.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.6 tpt85 -67.96 -14.0 62.62 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.973 -0.454 . . . . 0.0 110.365 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -64.78 -15.72 62.03 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.813 1.245 . . . . 0.0 111.81 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -120.83 -5.95 9.62 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.917 0.339 . . . . 0.0 111.917 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.04 163.82 10.31 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -57.93 139.04 88.97 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.141 2.56 . . . . 0.0 111.342 177.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.516 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -150.38 167.5 26.87 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.066 0.46 . . . . 0.0 111.096 178.229 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 pt -138.08 163.68 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.5 p -132.66 145.04 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -154.04 171.37 19.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.081 0.467 . . . . 0.0 110.395 -174.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.4 ' CH2' ' HE3' ' A' ' 98' ' ' LYS . 18.8 p90 -155.14 163.04 25.87 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 174.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.433 ' HG2' ' CE1' ' A' ' 97' ' ' HIS . 89.8 Cg_endo -71.31 -7.44 21.32 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 CA-C-N 121.232 1.476 . . . . 0.0 110.844 -170.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.433 ' CE1' ' HG2' ' A' ' 96' ' ' PRO . 2.5 m80 -99.73 2.81 44.57 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.726 0.811 . . . . 0.0 111.491 -177.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.4 ' HE3' ' CH2' ' A' ' 95' ' ' TRP . 12.4 tptm -54.6 158.24 2.62 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.054 0.942 . . . . 0.0 112.693 -178.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.214 0 C-N-CA 124.078 0.951 . . . . 0.0 110.918 179.635 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.83 0 CA-C-O 119.364 -0.686 . . . . 0.0 114.173 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.75 153.61 45.95 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.519 1.159 . . . . 0.0 108.888 174.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.18 -178.63 6.74 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.274 0.488 . . . . 0.0 111.972 -174.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -141.11 140.51 34.16 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.5 mp -96.32 148.91 22.27 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 118.497 0.59 . . . . 0.0 112.326 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.9 mp -115.52 142.28 46.93 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 170.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -131.7 167.8 18.86 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.404 0.621 . . . . 0.0 111.93 -174.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -109.28 -29.85 8.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.932 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -121.8 153.17 38.66 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -85.97 -17.84 34.24 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.176 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.7 t -85.76 -17.67 35.19 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.128 -0.358 . . . . 0.0 110.198 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 41.9 t -72.36 -39.5 68.03 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.31 -26.71 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -71.05 -34.91 71.7 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.971 -0.455 . . . . 0.0 110.311 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -77.97 -35.17 50.55 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 122.176 -0.328 . . . . 0.0 111.654 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 pp -78.91 -16.7 56.66 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.43 0.559 . . . . 0.0 111.458 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.4 mt -92.33 -22.7 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 122.254 0.222 . . . . 0.0 110.454 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -97.9 -10.21 24.98 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -117.56 35.04 4.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.175 0.59 . . . . 0.0 111.269 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 26.8 p -136.76 -179.59 5.78 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.906 0.482 . . . . 0.0 111.331 -176.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.1 mm -87.4 159.44 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 124.391 1.077 . . . . 0.0 109.018 -177.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.65 154.79 43.56 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.759 0.314 . . . . 0.0 110.791 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -146.39 85.11 1.64 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.516 0.675 . . . . 0.0 110.753 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 55.43 0.13 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.22 -12.18 0.07 OUTLIER Glycine 0 CA--C 1.527 0.841 0 CA-C-N 119.568 1.076 . . . . 0.0 114.072 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.1 170.84 15.06 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 118.195 0.998 . . . . 0.0 109.609 177.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.97 166.05 10.65 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -172.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.406 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -142.39 139.49 31.71 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.891 -177.52 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.1 tp -124.55 128.72 49.36 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 48.9 t -77.03 139.48 40.06 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.1 m -137.65 -0.97 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.116 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 29.7 t 45.68 60.38 3.15 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.265 0.626 . . . . 0.0 111.116 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 142' ' ' PRO . 75.2 m -56.96 150.48 38.79 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.941 -175.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 141' ' ' SER . 19.8 Cg_exo -67.82 11.91 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.795 2.996 . . . . 0.0 114.907 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.743 HG23 HG13 ' A' ' 144' ' ' ILE . 15.1 t -121.23 -15.39 8.17 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.595 1.089 . . . . 0.0 111.832 -174.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.743 HG13 HG23 ' A' ' 143' ' ' THR . 0.6 OUTLIER -168.25 -176.44 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 125.178 1.391 . . . . 0.0 109.635 -177.799 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -120.74 16.74 11.91 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.739 0.816 . . . . 0.0 110.953 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -141.38 34.35 1.67 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -173.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -129.16 80.1 73.16 Favored Pre-proline 0 C--N 1.34 0.179 0 CA-C-N 118.927 0.785 . . . . 0.0 111.193 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.406 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 19.8 Cg_exo -67.69 145.56 70.02 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.908 2.405 . . . . 0.0 108.765 169.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.8 m -75.65 133.92 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -86.27 150.28 24.47 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 26.3 mm -130.17 137.36 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 C-N-CA 122.743 0.417 . . . . 0.0 110.646 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -141.45 92.19 8.28 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.53 162.87 34.89 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 124.174 3.25 . . . . 0.0 112.742 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -93.47 142.69 27.04 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 172.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -101.52 157.1 17.06 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.219 0.533 . . . . 0.0 110.489 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 156' ' ' LEU . 8.5 mp -90.33 178.99 5.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.518 0.675 . . . . 0.0 111.402 -176.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.7 m 65.12 4.43 2.56 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.501 1.92 . . . . 0.0 116.115 176.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 52.9 p30 -135.58 12.65 3.46 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 120.345 1.43 . . . . 0.0 113.317 172.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.8 m -66.13 -32.46 73.91 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -152.84 161.27 42.76 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 122.817 0.447 . . . . 0.0 111.015 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -152.97 152.89 31.94 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.956 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.97 140.66 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 28.3 ttp -132.44 13.7 4.55 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -159.66 -57.75 0.06 Allowed 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 61.33 11.64 28.18 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.409 -0.662 . . . . 0.0 113.54 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.4 t -109.36 -4.28 16.51 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.174 0.987 . . . . 0.0 112.184 -175.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -124.38 136.74 28.1 Favored Pre-proline 0 CA--C 1.531 0.218 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -68.3 160.52 48.62 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.146 2.564 . . . . 0.0 110.049 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 46.7 mt -113.04 153.31 28.31 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.51 0.324 . . . . 0.0 110.769 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -145.0 150.56 46.19 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.95 -5.43 13.43 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.442 2.761 . . . . 0.0 112.017 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -93.87 -1.22 55.13 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.028 0.531 . . . . 0.0 110.757 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.07 20.81 4.08 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.585 0.354 . . . . 0.0 111.444 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 13.6 m -119.99 143.17 48.18 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-O 120.987 0.422 . . . . 0.0 111.395 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.9 tt -113.05 141.3 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -106.92 152.36 24.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 76.1 t -137.97 144.98 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 123.633 0.773 . . . . 0.0 108.965 -173.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -148.02 149.55 21.64 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 112.04 -0.424 . . . . 0.0 112.04 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.4 22.1 54.97 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -172.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.6 m -60.94 144.91 89.86 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 116.913 0.356 . . . . 0.0 111.32 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.05 157.76 42.38 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.1 2.533 . . . . 0.0 108.715 170.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.419 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 10.7 tpt180 -66.73 -46.66 56.42 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.74 -176.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 182' ' ' ARG . 45.1 Cg_endo -78.48 27.08 0.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.452 2.768 . . . . 0.0 113.025 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.6 tp -64.96 -43.56 92.26 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.117 0.871 . . . . 0.0 110.38 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.427 ' HG2' ' H ' ' A' ' 187' ' ' VAL . 59.7 ttm-85 59.35 129.64 0.01 OUTLIER 'General case' 0 C--N 1.341 0.223 0 C-N-CA 126.11 1.764 . . . . 0.0 112.955 179.019 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.86 -25.69 68.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 121.554 -0.716 . . . . 0.0 111.474 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.427 ' H ' ' HG2' ' A' ' 185' ' ' ARG . 24.2 t -72.14 -47.85 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-O 120.662 0.268 . . . . 0.0 110.453 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -79.86 -24.64 41.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -176.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.8 tp -69.0 -33.85 74.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.78 -32.8 46.63 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.263 -0.273 . . . . 0.0 111.552 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.8 mmt -71.4 -35.99 71.23 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 122.305 -0.247 . . . . 0.0 110.475 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 71.5 mt -78.16 -40.51 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 22.5 mmt -60.67 -28.19 68.4 Favored 'General case' 0 C--N 1.334 -0.078 0 O-C-N 121.941 -0.474 . . . . 0.0 111.342 173.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -82.38 -21.51 35.83 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.419 0.554 . . . . 0.0 111.088 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.11 -19.69 26.67 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -110.1 -16.9 13.69 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.563 0.62 . . . . 0.0 111.875 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -135.1 -41.64 0.73 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.377 0.535 . . . . 0.0 111.587 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 69.19 162.76 3.08 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 121.474 0.486 . . . . 0.0 112.615 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 87.07 15.47 62.65 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 174.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.4 p -77.5 162.4 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.0 0.92 . . . . 0.0 110.597 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 51.5 t -137.28 -31.82 0.8 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -150.63 155.03 38.58 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.084 0.402 . . . . 0.0 111.814 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -156.27 156.85 34.76 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.346 0.658 . . . . 0.0 110.518 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 176.51 177.6 45.62 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.417 ' HA ' ' HA2' ' A' ' 218' ' ' GLY . 44.6 mm -103.83 87.05 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 26.2 t70 47.39 -86.85 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.927 -169.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.659 ' H ' ' HA ' ' A' ' 214' ' ' PRO . 12.6 m 49.72 65.16 1.49 Allowed 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.315 0.646 . . . . 0.0 111.091 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -59.75 133.46 89.27 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.74 -17.27 14.19 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 124.629 3.553 . . . . 0.0 114.282 -171.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -104.87 0.06 27.6 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.865 0.757 . . . . 0.0 111.282 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 97.5 mt -122.2 -13.21 8.16 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.807 0.843 . . . . 0.0 109.942 172.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt 52.97 38.11 26.29 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.534 1.134 . . . . 0.0 111.507 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -140.55 145.21 39.6 Favored Pre-proline 0 N--CA 1.461 0.12 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.659 ' HA ' ' H ' ' A' ' 207' ' ' THR . 64.6 Cg_endo -77.98 174.64 12.22 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.818 3.012 . . . . 0.0 110.769 173.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -132.16 21.07 4.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.417 0.687 . . . . 0.0 110.318 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 62.67 16.04 55.08 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 119.844 -0.42 . . . . 0.0 112.426 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -135.9 149.42 48.96 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.255 0.622 . . . . 0.0 110.273 -176.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 205' ' ' ILE . . . -95.11 162.0 23.66 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 116.629 -0.259 . . . . 0.0 112.773 -175.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -155.2 148.49 24.92 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 171.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.35 147.23 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -131.53 144.83 51.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.831 0.348 . . . . 0.0 110.301 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -128.88 165.66 20.59 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.027 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 78.5 p -94.66 -1.44 53.13 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -125.69 147.67 49.28 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 121.146 0.498 . . . . 0.0 111.62 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -78.5 -18.13 55.24 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.035 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -78.73 -37.14 42.15 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 58.6 p -80.14 -23.58 41.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -64.87 -41.67 95.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.722 0.409 . . . . 0.0 110.701 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.2 pt -84.21 -16.3 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 118.04 0.382 . . . . 0.0 111.592 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.66 -30.87 26.5 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 117.981 0.355 . . . . 0.0 110.86 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -77.04 -15.81 59.48 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.653 0.206 . . . . 0.0 111.38 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.409 ' HA ' HG21 ' A' ' 250' ' ' VAL . 1.6 pp -117.79 24.51 4.78 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 C-N-CA 123.133 0.573 . . . . 0.0 110.523 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.0 t -77.53 -9.19 58.77 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.005 0.522 . . . . 0.0 111.037 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -152.29 145.66 24.79 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -56.84 -28.9 62.26 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.6 0.36 . . . . 0.0 111.664 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -121.7 122.19 39.01 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 237' ' ' VAL . 2.4 m -82.79 151.85 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 C-N-CA 122.882 0.473 . . . . 0.0 109.961 174.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.521 ' C ' HD22 ' A' ' 239' ' ' LEU . 11.1 mp0 -94.98 138.42 32.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.521 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.5 mm? -125.37 22.61 7.72 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.091 -175.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -88.3 132.37 34.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.851 0.46 . . . . 0.0 112.137 -172.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -150.18 12.42 0.75 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.206 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 176.19 -143.8 6.68 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 243' ' ' GLU . 0.4 OUTLIER -81.4 3.35 24.79 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.708 0.403 . . . . 0.0 111.273 178.163 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 77.1 mt -99.95 148.74 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.64 0.776 . . . . 0.0 109.719 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -147.57 140.86 25.24 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.755 0.312 . . . . 0.0 110.199 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -142.92 154.43 44.07 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.69 151.44 30.55 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.1 p -161.72 158.42 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -83.26 144.93 29.41 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.197 0.599 . . . . 0.0 111.206 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 232' ' ' ILE . 2.1 m -123.75 163.72 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 252' ' ' PRO . 0.0 OUTLIER -157.29 156.37 29.11 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.089 170.498 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 252' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 251' ' ' LYS . 96.8 Cg_endo -73.06 39.21 0.44 Allowed 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 125.052 3.835 . . . . 0.0 111.754 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 43.96 43.87 5.63 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.326 1.45 . . . . 0.0 111.331 -174.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 CA--C 1.537 0.48 0 C-N-CA 125.732 1.613 . . . . 0.0 113.723 177.533 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.401 ' N ' ' HD3' ' A' ' 62' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.115 0 N-CA-C 111.481 0.178 . . . . 0.0 111.481 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -153.33 159.34 42.46 Favored 'General case' 0 C--O 1.23 0.046 0 O-C-N 123.495 0.497 . . . . 0.0 110.219 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.9 t -93.26 20.56 6.88 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.168 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 70.1 mtm-85 55.97 21.03 4.64 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.423 0.689 . . . . 0.0 112.314 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -146.9 144.51 29.31 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.014 0.526 . . . . 0.0 110.068 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.2 m -138.34 152.39 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.155 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -88.63 140.9 28.99 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 170.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 113' ' ' LEU . 1.5 m -134.61 138.47 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.57 -170.83 12.22 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -176.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.48 5.58 82.68 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.456 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.0 mt -70.86 148.79 94.88 Favored Pre-proline 0 N--CA 1.454 -0.245 0 CA-C-N 118.655 1.227 . . . . 0.0 108.823 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -62.38 160.53 31.0 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.328 2.019 . . . . 0.0 110.735 -177.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.64 -10.61 0.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 125.094 3.863 . . . . 0.0 114.781 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 76' ' ' ILE . 5.8 p-10 -105.0 -96.06 0.33 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 118.946 -0.55 . . . . 0.0 109.805 175.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.424 ' H ' ' CG ' ' A' ' 75' ' ' ASP . 3.1 tp 55.79 163.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -158.47 -179.28 7.94 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.863 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -59.14 -32.58 69.99 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.85 0.86 . . . . 0.0 112.633 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -91.09 -23.36 20.34 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 118.702 0.683 . . . . 0.0 112.629 -170.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -80.83 -27.16 36.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.3 mt -78.43 -40.53 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 97.0 m -63.31 -22.6 66.98 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.05 -21.25 24.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -72.94 -26.44 61.39 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.509 0.595 . . . . 0.0 111.88 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.519 ' CZ ' HD11 ' A' ' 151' ' ' ILE . 55.5 m-85 -124.31 13.17 8.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -17.29 64.39 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.992 -0.442 . . . . 0.0 111.269 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -68.41 -11.46 59.69 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.138 0.975 . . . . 0.0 111.466 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -123.61 36.15 4.69 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -173.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.1 175.46 34.74 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.11 151.83 61.74 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.9 3.066 . . . . 0.0 111.278 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.452 ' N ' HD23 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -166.89 163.34 16.19 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.872 -170.205 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.3 pt -141.42 169.55 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.0 p -135.38 150.12 29.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -152.91 174.11 14.52 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.419 0.628 . . . . 0.0 111.396 -177.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -160.41 157.94 24.89 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -75.77 -17.97 17.49 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.237 1.958 . . . . 0.0 110.885 -169.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -84.78 -7.57 59.15 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.561 0.744 . . . . 0.0 110.833 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -71.05 170.35 13.04 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.664 1.186 . . . . 0.0 112.997 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.297 0 C-N-CA 124.508 1.123 . . . . 0.0 109.655 178.07 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.599 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.13 140.59 51.48 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.51 -177.44 6.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.526 0.33 . . . . 0.0 110.591 -174.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -141.77 134.14 28.04 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.538 HD13 HG11 ' A' ' 69' ' ' VAL . 11.2 mp -92.28 150.83 20.64 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.245 0.545 . . . . 0.0 111.582 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.99 137.53 51.9 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 173.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -130.34 166.11 21.09 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.882 0.372 . . . . 0.0 111.117 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -113.03 -31.95 6.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.275 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -117.74 149.1 41.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.037 0.446 . . . . 0.0 111.074 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -83.91 -16.92 42.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.218 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.8 p -86.43 -17.61 33.85 Favored 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 122.16 -0.338 . . . . 0.0 111.549 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.3 m -71.94 -47.01 55.46 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.004 0.43 . . . . 0.0 110.584 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.428 ' HA ' HD12 ' A' ' 124' ' ' LEU . 5.0 p -72.58 -20.22 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.042 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -75.27 -32.28 61.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.66 -44.49 56.64 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.547 HD22 ' C ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -72.98 -28.79 62.6 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 118.388 -1.325 . . . . 0.0 110.994 -178.367 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 83.4 mt -80.54 -16.65 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 118.292 0.496 . . . . 0.0 110.928 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -86.14 -17.83 33.91 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.731 -0.606 . . . . 0.0 110.364 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -112.11 14.12 20.67 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 20.0 p -98.99 171.56 7.96 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.168 0.508 . . . . 0.0 112.251 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 130' ' ' GLU . 39.9 mm -90.17 167.96 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 125.522 1.529 . . . . 0.0 108.472 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.414 ' N ' HG22 ' A' ' 129' ' ' ILE . 42.2 mt-10 -124.33 152.87 42.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.021 0.439 . . . . 0.0 112.004 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -145.61 -174.37 4.38 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 172.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.75 98.11 0.09 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.909 0.385 . . . . 0.0 111.342 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 78.06 -2.15 66.45 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.25 -0.75 . . . . 0.0 114.258 175.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -137.89 173.94 11.1 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.569 1.184 . . . . 0.0 110.372 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -110.19 174.8 5.7 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.479 0.712 . . . . 0.0 109.527 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -144.07 149.21 36.26 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.2 0.6 . . . . 0.0 109.582 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.8 tp -132.22 146.32 51.93 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 169.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.1 m -89.25 133.72 34.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.793 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.1 p -156.18 154.11 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 124.32 1.048 . . . . 0.0 108.403 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.4 p -85.7 150.41 24.62 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.142 -0.349 . . . . 0.0 110.28 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.7 p -138.44 146.29 50.45 Favored Pre-proline 0 N--CA 1.456 -0.172 0 O-C-N 122.278 -0.264 . . . . 0.0 110.442 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.12 -8.85 20.3 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.214 2.609 . . . . 0.0 112.902 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.42 HG23 HG12 ' A' ' 144' ' ' ILE . 1.9 t -90.74 -18.21 25.38 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.239 0.927 . . . . 0.0 111.179 178.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.597 HG22 ' H ' ' A' ' 145' ' ' LYS . 2.3 mm -134.05 -144.72 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.597 ' H ' HG22 ' A' ' 144' ' ' ILE . 75.8 mmtt -119.41 -14.02 9.21 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.058 0.943 . . . . 0.0 109.158 169.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -156.99 157.35 34.57 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.612 1.165 . . . . 0.0 109.4 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.47 112.04 2.41 Favored Pre-proline 0 N--CA 1.457 -0.077 0 C-N-CA 122.54 0.336 . . . . 0.0 110.921 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.508 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 23.9 Cg_exo -67.68 133.98 31.32 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.894 2.396 . . . . 0.0 108.929 167.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.6 m -121.23 138.29 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 118.299 0.5 . . . . 0.0 110.354 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -74.56 154.77 38.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.519 HD11 ' CZ ' ' A' ' 85' ' ' PHE . 44.2 mm -138.55 141.32 37.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 124.886 1.274 . . . . 0.0 108.918 171.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.9 ttp85 -156.44 109.96 2.03 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 170.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -76.34 164.42 30.93 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.917 3.078 . . . . 0.0 111.356 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.413 ' CG ' ' HG3' ' A' ' 214' ' ' PRO . 55.0 t-105 -100.44 144.84 28.96 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.595 0.235 . . . . 0.0 111.209 176.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -107.02 156.85 18.31 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.494 0.718 . . . . 0.0 111.718 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.0 mp -100.89 15.41 28.61 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.091 0.556 . . . . 0.0 111.598 -175.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.4 t -90.86 -28.53 18.09 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -174.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -140.33 25.07 2.27 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.63 0.65 . . . . 0.0 112.631 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.0 t -70.74 -16.42 62.77 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -155.07 159.9 40.6 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.041 0.536 . . . . 0.0 110.524 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -156.86 156.74 33.67 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.587 0.232 . . . . 0.0 111.0 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.9 m -137.49 151.5 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 C-N-CA 123.152 0.581 . . . . 0.0 110.327 175.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 16.1 ttp -135.34 19.15 3.38 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.555 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -151.93 -179.66 7.67 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.86 18.75 0.61 Allowed Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.372 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.0 t 54.6 50.46 15.92 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 117.736 0.768 . . . . 0.0 111.895 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -64.36 160.07 53.49 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 122.926 0.49 . . . . 0.0 109.962 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -52.19 147.55 27.38 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.72 2.947 . . . . 0.0 112.355 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 68.8 mt -122.09 162.04 21.97 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.357 0.663 . . . . 0.0 110.995 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -143.92 150.25 48.95 Favored Pre-proline 0 CA--C 1.529 0.168 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -68.28 -10.83 30.14 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.957 2.438 . . . . 0.0 111.508 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.78 2.48 56.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.149 0.58 . . . . 0.0 110.496 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -126.17 18.04 7.74 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.674 0.39 . . . . 0.0 111.09 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 16.4 m -127.55 139.74 52.58 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.722 0.296 . . . . 0.0 111.019 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.1 tt -111.62 152.07 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 C-N-CA 123.16 0.584 . . . . 0.0 110.474 -176.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.404 ' CD1' ' CE1' ' A' ' 253' ' ' TYR . 6.3 t80 -114.68 143.84 44.39 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.8 m -140.92 132.36 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 122.611 0.364 . . . . 0.0 110.287 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -142.44 179.95 19.8 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.99 10.12 83.37 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -171.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 28.9 m -72.82 155.42 90.71 Favored Pre-proline 0 N--CA 1.455 -0.177 0 C-N-CA 122.904 0.481 . . . . 0.0 110.891 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.74 -172.6 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.756 2.971 . . . . 0.0 109.785 175.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -55.8 -48.4 96.67 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.213 -0.898 . . . . 0.0 112.236 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.59 138.75 17.5 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.223 1.949 . . . . 0.0 110.939 174.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 184' ' ' LEU . 2.4 pt? -155.52 16.32 0.39 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.371 0.668 . . . . 0.0 111.448 178.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -42.71 142.1 0.93 Allowed 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.963 1.305 . . . . 0.0 112.334 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.73 -21.57 61.74 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -171.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.5 t -60.75 -52.13 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-N 118.306 0.503 . . . . 0.0 110.838 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -83.54 -20.09 34.5 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.387 -0.196 . . . . 0.0 110.798 -175.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 25.2 tp -73.85 -32.9 63.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -77.63 -39.31 45.69 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 117.563 0.165 . . . . 0.0 111.046 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 25.5 mmt -64.88 -49.81 69.02 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -177.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.8 mt -65.87 -34.57 71.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -178.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.4 tpp -74.23 -13.09 60.73 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 122.469 -0.145 . . . . 0.0 110.966 -178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -102.26 -12.61 17.85 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.029 -0.42 . . . . 0.0 112.032 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -92.4 -18.06 23.78 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.241 0.473 . . . . 0.0 111.369 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.47 -20.79 10.63 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.18 0.445 . . . . 0.0 111.036 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -141.05 46.83 1.73 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.958 0.503 . . . . 0.0 109.97 -177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.55 136.79 4.57 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.016 0.817 . . . . 0.0 113.395 -175.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 135.8 7.15 1.88 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.123 0.868 . . . . 0.0 111.747 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 40.9 t -72.31 149.3 9.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 117.617 0.709 . . . . 0.0 110.903 -177.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 23.5 p -134.2 -23.04 1.73 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -151.17 150.94 31.23 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -149.67 155.23 39.87 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.429 0.692 . . . . 0.0 109.285 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -177.27 -176.32 45.27 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 30.4 mm -100.23 152.81 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 9.8 t70 -53.34 132.03 38.6 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 33.4 p -144.2 167.66 21.9 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 122.584 0.353 . . . . 0.0 110.518 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' ASP . . . . . 0.479 ' HA ' ' HD3' ' A' ' 209' ' ' PRO . 12.6 t70 -132.97 136.57 27.87 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 119.392 -0.337 . . . . 0.0 110.212 174.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 208' ' ' ASP . 22.1 Cg_exo -68.61 -9.35 25.86 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 124.532 3.488 . . . . 0.0 115.809 -172.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.27 -26.24 68.41 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 119.737 1.153 . . . . 0.0 110.92 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 19.3 tp -150.35 3.83 0.51 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.971 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 55.11 39.67 31.58 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.208 1.003 . . . . 0.0 110.605 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -100.08 146.2 31.52 Favored Pre-proline 0 N--CA 1.457 -0.083 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.373 -176.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.413 ' HG3' ' CG ' ' A' ' 154' ' ' TRP . 30.7 Cg_endo -82.1 164.91 17.32 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.289 2.659 . . . . 0.0 113.465 -177.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -128.39 -174.64 3.28 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.921 1.289 . . . . 0.0 108.372 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -71.45 164.25 53.98 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.0 173.47 0.07 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -135.21 177.38 19.41 Favored Glycine 0 CA--C 1.525 0.718 0 O-C-N 121.97 -0.457 . . . . 0.0 112.553 -173.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.02 155.18 42.03 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.173 0.511 . . . . 0.0 111.077 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 63.6 t -139.45 145.88 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.61 148.19 46.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.854 0.359 . . . . 0.0 110.274 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -122.79 150.24 43.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.416 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 68.5 m -83.32 2.6 35.41 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 111.389 0.144 . . . . 0.0 111.389 175.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -131.19 138.9 49.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.775 0.43 . . . . 0.0 110.559 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' GLN . . . . . 0.473 ' H ' ' CD ' ' A' ' 225' ' ' GLN . 0.0 OUTLIER -75.45 -12.83 60.32 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 176.601 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 -82.35 -37.11 26.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 19.9 m -73.26 -29.04 62.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -67.17 -53.04 34.11 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 119.687 -0.196 . . . . 0.0 110.749 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.2 pt -69.56 -16.59 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 CA-C-N 118.126 0.421 . . . . 0.0 111.092 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.9 -24.7 33.03 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.713 0.233 . . . . 0.0 110.821 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.74 -21.52 26.53 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.1 pt -110.43 27.49 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.071 0.548 . . . . 0.0 110.345 174.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 20.4 t -80.68 -9.99 59.76 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.257 0.623 . . . . 0.0 112.065 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -158.3 145.12 17.63 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 55.7 ttm-85 -57.06 -32.63 66.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.562 0.345 . . . . 0.0 111.665 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -122.54 115.92 23.01 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 23.5 m -99.36 161.3 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.119 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -85.18 142.34 29.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 110.463 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.31 105.44 7.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 173.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -131.73 148.01 52.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.434 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -141.76 20.62 2.16 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.452 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 95.75 131.04 6.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 54.73 4.31 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.52 1.528 . . . . 0.0 114.7 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.2 mt -145.09 136.33 20.12 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 CA-C-N 118.702 0.683 . . . . 0.0 109.937 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -129.16 147.44 51.01 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.825 0.345 . . . . 0.0 111.367 173.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -144.9 170.52 15.98 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.612 1.165 . . . . 0.0 109.648 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.88 160.41 39.37 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.635 0.774 . . . . 0.0 110.303 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.0 p -152.23 152.11 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -85.84 126.88 34.38 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.05 157.7 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 CA-C-O 121.039 0.447 . . . . 0.0 111.84 -176.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.46 158.41 27.82 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.57 169.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.64 133.28 57.02 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.564 2.176 . . . . 0.0 107.884 172.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' TYR . . . . . 0.404 ' CE1' ' CD1' ' A' ' 176' ' ' PHE . 2.3 t80 -75.28 118.88 18.68 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.087 -173.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.335 0 C-N-CA 127.434 2.293 . . . . 0.0 114.43 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.749 0.309 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.21 157.52 43.43 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -172.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.9 t -102.75 150.45 23.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.076 174.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -85.63 3.74 39.48 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.652 0.381 . . . . 0.0 110.281 174.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -100.02 135.96 40.66 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.85 0.86 . . . . 0.0 109.413 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 p -149.75 144.41 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.816 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -92.2 144.42 25.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 m -132.69 130.03 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -141.37 148.3 19.96 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.94 37.43 3.41 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -175.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.6 mt -85.96 159.63 54.05 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -70.71 153.79 64.34 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.959 2.439 . . . . 0.0 108.968 172.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.03 3.19 4.13 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.884 3.056 . . . . 0.0 112.354 -178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -94.0 -27.12 16.5 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.465 ' C ' HD12 ' A' ' 76' ' ' ILE . 2.3 pp -136.39 174.81 11.61 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-N 118.524 0.602 . . . . 0.0 110.252 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -163.39 5.8 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -145.41 -45.71 0.22 Allowed 'General case' 0 C--N 1.341 0.21 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -174.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -84.62 -34.14 23.17 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.622 0.646 . . . . 0.0 112.371 -172.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -73.45 -27.11 61.24 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.725 0.298 . . . . 0.0 110.509 -176.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.7 pt -88.01 -30.35 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 122.465 0.306 . . . . 0.0 110.916 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 56.8 m -71.75 -14.87 62.13 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.94 -22.07 17.64 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.5 m -88.2 -15.53 35.71 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.451 ' CE1' HD23 ' A' ' 137' ' ' LEU . 68.2 m-85 -123.29 10.21 9.25 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.852 0.751 . . . . 0.0 113.003 -174.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -83.63 -12.01 56.54 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.601 0.36 . . . . 0.0 111.945 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.493 ' HG3' ' CD2' ' A' ' 88' ' ' PHE . 15.9 ptm180 -72.79 -18.22 61.5 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.493 ' CD2' ' HG3' ' A' ' 87' ' ' ARG . 70.0 m-85 -105.61 1.84 27.7 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.339 0.256 . . . . 0.0 111.348 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.5 163.41 9.82 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.22 140.78 45.6 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.228 2.618 . . . . 0.0 110.237 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.513 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -153.04 166.15 33.33 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.257 0.551 . . . . 0.0 112.279 -177.87 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.8 pt -137.15 -179.95 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.597 173.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.0 p -132.4 157.75 43.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 O-C-N 122.283 -0.261 . . . . 0.0 110.349 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -148.32 161.72 40.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.296 0.569 . . . . 0.0 111.47 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.451 ' CZ2' ' HE3' ' A' ' 98' ' ' LYS . 27.7 p90 -157.1 158.75 31.26 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 105.539 -2.022 . . . . 0.0 105.539 169.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.589 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 59.8 Cg_endo -72.81 -10.05 24.46 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.494 1.463 . . . . 0.0 111.018 -169.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.589 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 17.1 m-70 -104.93 19.3 20.82 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.682 1.193 . . . . 0.0 110.444 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.536 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -36.39 -62.67 0.44 Allowed 'General case' 0 C--N 1.34 0.161 0 C-N-CA 125.571 1.549 . . . . 0.0 113.756 -171.133 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 124.02 0.928 . . . . 0.0 112.534 -173.613 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.787 0 CA-C-O 119.833 -0.426 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.39 141.7 32.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.719 0.759 . . . . 0.0 110.18 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.01 -179.1 7.19 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.985 0.514 . . . . 0.0 110.306 -176.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -129.24 121.12 26.93 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -176.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 mp -83.92 147.35 27.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.592 0.711 . . . . 0.0 111.292 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 mp -124.12 104.03 8.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -88.25 162.82 16.42 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.779 0.323 . . . . 0.0 110.249 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -90.26 -21.55 22.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.216 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -132.03 149.79 52.33 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.533 0.206 . . . . 0.0 111.534 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -77.49 -16.63 58.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.231 0.213 . . . . 0.0 110.629 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 59.0 m -93.64 -17.71 22.97 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 122.457 0.303 . . . . 0.0 111.305 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.0 m -70.59 -44.58 67.03 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.5 p -74.36 -15.66 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.997 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -78.3 -33.8 49.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 122.013 -0.429 . . . . 0.0 109.926 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.27 -36.74 61.17 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.25 0.477 . . . . 0.0 110.843 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.32 -40.18 93.41 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 57.5 mt -85.81 -9.93 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 O-C-N 121.663 -0.648 . . . . 0.0 111.893 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -107.66 -3.72 18.94 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.98 -0.45 . . . . 0.0 112.163 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -122.57 6.59 9.49 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 74.9 m -113.75 -172.94 2.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.399 0.545 . . . . 0.0 110.516 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.449 HD12 ' N ' ' A' ' 129' ' ' ILE . 3.2 mp -68.05 154.22 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.674 0.79 . . . . 0.0 108.904 -170.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -137.16 157.56 46.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -143.82 62.16 1.36 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.208 0.528 . . . . 0.0 110.895 175.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.2 t70 50.93 8.84 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.904 1.681 . . . . 0.0 115.534 171.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -179.51 -19.02 0.03 OUTLIER Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.558 -0.713 . . . . 0.0 111.895 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -129.94 162.67 28.1 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 117.642 0.721 . . . . 0.0 109.39 171.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.19 163.04 16.89 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -145.22 162.03 38.12 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.965 0.412 . . . . 0.0 111.186 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.451 HD23 ' CE1' ' A' ' 85' ' ' PHE . 56.4 tp -141.89 145.51 34.67 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 170.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 79.4 m -84.23 128.61 34.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.3 m -141.21 166.13 18.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 122.898 0.479 . . . . 0.0 110.616 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.0 t -65.91 149.4 50.27 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.2 t -151.64 91.33 3.82 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -176.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -55.24 -11.37 4.08 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.252 3.302 . . . . 0.0 115.645 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.401 HG23 ' CD1' ' A' ' 144' ' ' ILE . 5.5 t -95.98 -10.37 28.77 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.577 1.081 . . . . 0.0 111.353 178.115 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.654 HG22 ' H ' ' A' ' 145' ' ' LYS . 2.2 mm -132.96 -160.1 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.654 ' H ' HG22 ' A' ' 144' ' ' ILE . 49.9 mmtm -103.93 -23.42 13.36 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -163.04 152.58 15.35 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.981 1.313 . . . . 0.0 108.351 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -153.64 120.21 2.89 Favored Pre-proline 0 N--CA 1.457 -0.083 0 CA-C-N 118.062 0.392 . . . . 0.0 110.865 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -64.74 127.93 19.86 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.162 2.575 . . . . 0.0 110.105 168.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.4 p -100.79 136.03 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -85.03 146.88 26.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.579 0.352 . . . . 0.0 110.513 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 40.0 mm -125.12 143.03 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.882 0.873 . . . . 0.0 109.422 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.95 96.92 2.69 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -176.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.01 172.15 16.68 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.451 3.434 . . . . 0.0 111.897 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -109.24 150.48 27.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.776 0.322 . . . . 0.0 111.285 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -116.42 155.16 29.03 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.611 0.764 . . . . 0.0 111.234 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.419 HD12 ' N ' ' A' ' 156' ' ' LEU . 6.9 mp -103.9 89.96 3.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -177.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 11.5 t -155.34 -36.25 0.09 Allowed 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -140.05 28.73 2.09 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.2 m -60.1 -35.92 76.3 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -154.24 161.51 41.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.78 0.432 . . . . 0.0 110.868 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -154.63 159.02 40.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.526 0.203 . . . . 0.0 110.62 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.9 m -138.95 149.98 23.45 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.016 0 C-N-CA 123.678 0.791 . . . . 0.0 109.585 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.2 mtm -137.83 8.71 2.8 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 -174.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -138.74 17.12 2.69 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.268 0.94 . . . . 0.0 112.936 -176.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.33 19.25 55.6 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 119.689 -0.506 . . . . 0.0 113.053 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 28.9 m 55.46 50.67 14.22 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 117.676 0.738 . . . . 0.0 112.327 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -62.11 165.75 7.83 Favored Pre-proline 0 CA--C 1.531 0.212 0 C-N-CA 123.748 0.819 . . . . 0.0 110.106 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.75 137.2 27.32 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.89 2.394 . . . . 0.0 110.534 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.442 HD11 ' HB1' ' A' ' 221' ' ' ALA . 12.8 tp -132.34 151.08 52.01 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 122.682 0.393 . . . . 0.0 110.483 -170.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -147.7 140.66 14.93 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.901 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.54 -21.6 47.07 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.569 2.846 . . . . 0.0 114.091 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -85.3 6.37 26.54 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.519 0.6 . . . . 0.0 110.787 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -125.03 28.14 6.49 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 31.4 m -129.66 152.29 49.33 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.088 -173.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.3 tt -123.95 148.21 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 C-N-CA 123.366 0.666 . . . . 0.0 109.288 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -114.42 144.18 43.73 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 13.7 m -135.97 130.13 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 122.87 0.468 . . . . 0.0 110.056 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -132.26 164.62 23.8 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 87.37 16.93 59.69 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -175.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 28.3 m -64.52 151.05 92.55 Favored Pre-proline 0 CA--C 1.53 0.181 0 C-N-CA 122.464 0.305 . . . . 0.0 111.257 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -75.83 -174.97 2.24 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.954 3.103 . . . . 0.0 110.065 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -56.03 -50.86 84.89 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.545 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.83 141.73 21.83 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.15 1.9 . . . . 0.0 110.928 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.675 ' CD1' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -148.02 -75.99 0.18 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.799 178.219 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.675 ' H ' ' CD1' ' A' ' 184' ' ' LEU . 5.8 ptm180 49.75 132.48 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 128.445 2.698 . . . . 0.0 115.073 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.87 -20.19 65.87 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 121.721 -0.612 . . . . 0.0 112.302 -175.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 96.7 t -67.91 -58.32 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-N 117.817 0.28 . . . . 0.0 111.187 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -82.73 -19.44 37.93 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.263 -0.273 . . . . 0.0 111.268 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.9 tp -70.09 -35.91 74.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.66 -35.47 57.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 122.387 -0.196 . . . . 0.0 111.406 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 23.5 mmt -69.78 -38.49 76.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -175.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 45.6 mt -71.85 -43.64 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.548 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -61.64 -21.27 64.25 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 118.31 0.505 . . . . 0.0 111.34 173.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.66 -11.58 36.58 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.659 0.663 . . . . 0.0 112.158 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -96.44 -15.75 21.58 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 122.033 -0.417 . . . . 0.0 111.861 175.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.08 -21.84 10.33 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 118.155 0.434 . . . . 0.0 110.793 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -139.86 44.21 1.93 Allowed 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.175 0.59 . . . . 0.0 109.444 -178.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -42.47 135.93 3.74 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.168 0.889 . . . . 0.0 113.04 -174.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 131.45 12.59 2.0 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -176.166 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.404 HG22 ' CE2' ' A' ' 222' ' ' PHE . 49.1 t -70.03 148.42 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-N 117.541 0.671 . . . . 0.0 110.24 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 51.5 t -125.64 -29.99 3.11 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.896 177.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -155.48 152.72 29.27 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.58 0.229 . . . . 0.0 110.893 -175.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.4 160.17 42.56 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.385 0.674 . . . . 0.0 110.761 175.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -178.58 173.55 45.88 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 176.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 205' ' ' ILE . 3.4 mp -94.51 84.73 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 23.4 t70 53.66 -66.77 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -168.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 38.8 p 43.0 54.14 4.9 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -60.65 132.31 91.27 Favored Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.19 -14.78 14.79 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.43 3.42 . . . . 0.0 113.886 -173.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -91.83 -39.68 11.62 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.616 0.644 . . . . 0.0 110.211 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.42 -7.8 34.02 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 65.8 mttm 52.02 46.34 26.77 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 124.618 1.167 . . . . 0.0 111.675 174.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.93 154.5 43.51 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -175.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -83.58 173.21 9.69 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.918 3.079 . . . . 0.0 110.868 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -127.8 18.57 6.72 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.999 0.519 . . . . 0.0 111.621 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.07 10.27 56.03 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.886 -0.397 . . . . 0.0 112.27 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -134.91 148.7 50.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.45 0.625 . . . . 0.0 110.306 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -87.49 156.14 27.69 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 121.455 0.475 . . . . 0.0 113.146 -173.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -144.71 149.26 35.31 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 169.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 71.8 t -138.56 144.2 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.442 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -129.07 148.86 51.05 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.068 0.461 . . . . 0.0 110.39 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.404 ' CE2' HG22 ' A' ' 200' ' ' VAL . 69.0 m-85 -120.62 154.14 35.86 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.101 -173.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 67.3 p -90.22 7.74 36.61 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.284 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -134.96 136.69 42.43 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.665 0.786 . . . . 0.0 109.655 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -75.9 -16.95 59.95 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.0 tp60 -77.71 -36.82 50.6 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 23.7 m -78.57 -24.65 45.42 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.287 -0.258 . . . . 0.0 110.38 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.46 -49.94 69.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.0 pt -75.09 -16.34 15.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.07 0 CA-C-N 117.744 0.247 . . . . 0.0 111.522 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.79 -25.59 37.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.83 0.286 . . . . 0.0 111.006 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -82.57 -22.23 34.95 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 21.8 pt -108.92 20.88 5.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.004 0.522 . . . . 0.0 110.538 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.3 t -77.41 -9.58 58.95 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.874 0.47 . . . . 0.0 111.659 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -152.12 144.12 23.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -53.69 -29.32 38.43 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -126.38 119.9 28.48 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.849 0.357 . . . . 0.0 110.415 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.431 HG23 HD21 ' A' ' 239' ' ' LEU . 2.7 m -84.37 159.19 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.207 175.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.606 ' C ' HD22 ' A' ' 239' ' ' LEU . 3.6 mp0 -94.86 138.53 32.52 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.606 HD22 ' C ' ' A' ' 238' ' ' GLN . 2.5 mm? -129.83 14.39 5.85 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.908 -175.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.63 140.29 29.9 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -172.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -147.59 21.21 1.17 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.408 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.59 139.74 6.32 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 54.85 3.28 0.05 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.186 1.394 . . . . 0.0 113.426 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 62.0 mt -145.43 142.04 22.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 C-N-CA 124.23 1.012 . . . . 0.0 108.619 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -151.89 136.36 16.87 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 176.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -148.22 164.99 32.29 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.802 0.841 . . . . 0.0 109.62 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.57 155.92 38.31 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 8.5 p -155.88 152.32 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -82.68 143.58 30.85 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.2 m -116.73 153.82 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 121.631 0.729 . . . . 0.0 112.949 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 251' ' ' LYS . 32.4 ttmt -151.24 141.43 14.53 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.833 174.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' PRO . . . . . 0.409 ' HD2' ' HG3' ' A' ' 251' ' ' LYS . 24.9 Cg_endo -58.23 136.99 78.24 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.61 2.207 . . . . 0.0 108.364 176.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -70.07 132.65 46.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.266 -173.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.466 0 C-N-CA 127.111 2.164 . . . . 0.0 113.91 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.637 ' HD3' HD13 ' A' ' 156' ' ' LEU . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.53 0.205 . . . . 0.0 111.324 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.704 ' C ' HD11 ' A' ' 156' ' ' LEU . 26.1 m-85 -134.27 160.79 36.8 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 121.135 0.493 . . . . 0.0 111.121 -174.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -88.51 31.88 0.81 Allowed 'General case' 0 C--N 1.334 -0.068 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.597 ' HA ' ' CE1' ' A' ' 115' ' ' PHE . 99.0 mtt180 54.62 18.42 2.04 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.192 0.597 . . . . 0.0 112.299 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -146.25 133.48 20.55 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 m -139.94 161.97 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -95.59 143.06 27.2 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 169.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.7 m -131.39 118.52 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 172.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.58 138.96 14.68 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.481 -172.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.57 145.44 4.85 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.446 0.546 . . . . 0.0 114.386 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.7 tp -164.96 132.79 2.47 Favored Pre-proline 0 N--CA 1.453 -0.283 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 81.9 Cg_endo -77.19 156.04 33.34 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.937 1.758 . . . . 0.0 110.329 178.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 33.0 Cg_exo -62.43 0.78 1.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 124.544 3.496 . . . . 0.0 114.913 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -134.25 43.54 2.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.598 0.636 . . . . 0.0 111.552 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mt -141.32 151.5 19.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -135.99 -179.47 5.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.916 0.389 . . . . 0.0 111.595 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -45.76 -42.36 11.91 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.59 1.156 . . . . 0.0 112.075 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.94 -29.57 62.09 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.192 0.451 . . . . 0.0 111.92 -173.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -80.79 -29.83 36.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 122.29 -0.256 . . . . 0.0 110.823 -172.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.2 pt -86.41 -26.02 6.27 Favored 'Isoleucine or valine' 0 C--N 1.338 0.078 0 O-C-N 121.782 -0.574 . . . . 0.0 109.899 173.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 61.7 m -70.24 -14.15 62.49 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 172.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.26 -21.97 16.95 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.393 0.277 . . . . 0.0 111.606 173.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.4 m -77.06 -21.56 54.26 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.255 0.479 . . . . 0.0 111.885 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -111.89 4.57 18.36 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 117.825 0.284 . . . . 0.0 111.649 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -71.64 -5.9 37.0 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.966 -0.459 . . . . 0.0 111.964 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.4 tpt85 -67.1 -10.0 45.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.189 0.996 . . . . 0.0 110.627 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -126.56 33.03 5.06 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.47 0.308 . . . . 0.0 111.464 -174.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.68 178.45 38.07 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.948 -0.461 . . . . 0.0 111.948 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.38 141.74 35.81 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.882 3.055 . . . . 0.0 111.305 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.44 173.48 14.83 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.811 0.844 . . . . 0.0 110.088 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.89 167.27 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.147 -177.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.29 148.37 29.9 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -150.91 163.96 37.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.108 0.48 . . . . 0.0 110.827 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.512 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 33.7 p90 -153.5 162.98 25.22 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 176.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.512 ' HD2' ' HB2' ' A' ' 95' ' ' TRP . 40.3 Cg_endo -73.59 -10.19 23.39 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.644 2.896 . . . . 0.0 110.923 -169.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.461 ' ND1' ' HG2' ' A' ' 96' ' ' PRO . 51.4 m80 -106.06 18.75 21.59 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.295 1.038 . . . . 0.0 111.257 -178.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -48.91 151.44 1.24 Allowed 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.895 0.878 . . . . 0.0 113.154 -176.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.302 0 C-N-CA 124.008 0.923 . . . . 0.0 110.319 -176.749 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.828 0 CA-C-O 119.332 -0.704 . . . . 0.0 113.831 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -113.93 142.53 46.01 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.968 1.384 . . . . 0.0 108.238 177.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.27 176.86 9.24 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.085 0.402 . . . . 0.0 111.754 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -142.95 137.15 29.2 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -177.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.77 148.7 23.11 Favored 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -174.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.2 mp -130.66 147.37 52.33 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.911 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.597 ' CE1' ' HA ' ' A' ' 65' ' ' ARG . 3.4 p90 -158.93 178.84 9.64 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.289 0.636 . . . . 0.0 109.297 175.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -107.76 -21.03 13.02 Favored 'General case' 0 N--CA 1.456 -0.128 0 O-C-N 122.187 -0.32 . . . . 0.0 111.782 -174.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -129.71 144.19 51.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.863 0.363 . . . . 0.0 111.335 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -74.68 -14.9 60.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.707 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 76.7 p -70.92 -21.65 62.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.354 -0.216 . . . . 0.0 110.902 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.4 t -75.35 -40.83 57.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.431 ' HB ' ' CZ ' ' A' ' 115' ' ' PHE . 4.7 p -82.8 -23.8 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -67.67 -37.83 82.9 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.108 -0.37 . . . . 0.0 110.004 177.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.4 -35.9 30.19 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.97 -18.25 60.41 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.58 0.627 . . . . 0.0 110.985 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.0 mt -93.82 -23.71 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 117.948 0.34 . . . . 0.0 110.748 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -83.94 -13.68 52.81 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.793 -0.567 . . . . 0.0 111.63 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -124.87 46.38 2.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.056 0.543 . . . . 0.0 111.125 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 18.6 p -137.75 -176.55 4.46 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 44.1 mt -86.29 154.98 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 125.168 1.387 . . . . 0.0 108.32 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.55 156.98 47.49 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.124 -0.36 . . . . 0.0 110.729 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.24 -176.64 5.37 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -42.75 -25.9 0.11 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -169.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.33 14.04 0.13 Allowed Glycine 0 CA--C 1.528 0.87 0 CA-C-N 119.163 0.892 . . . . 0.0 112.844 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -145.0 170.97 15.13 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 117.784 0.792 . . . . 0.0 111.05 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 75.1 mt -108.01 166.63 10.58 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -149.87 155.74 40.57 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.79 0.328 . . . . 0.0 110.739 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.6 mp -143.75 160.67 40.33 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 36.9 t -87.85 156.64 19.28 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.78 165.08 30.74 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-O 120.846 0.355 . . . . 0.0 111.109 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.4 t -115.62 179.33 4.0 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.562 0.745 . . . . 0.0 109.728 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.541 ' HB3' ' HD2' ' A' ' 142' ' ' PRO . 5.7 m 61.48 -172.77 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.321 0.648 . . . . 0.0 110.143 -176.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 97.4 Cg_endo -74.07 135.96 21.75 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.703 1.602 . . . . 0.0 111.423 -169.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.7 m -147.29 42.85 1.11 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.619 0.768 . . . . 0.0 109.206 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 144' ' ' ILE . 3.2 mp 63.4 -62.2 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.753 1.621 . . . . 0.0 111.167 -173.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -151.99 -62.09 0.17 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 174.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -160.55 130.46 5.15 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.897 0.479 . . . . 0.0 110.404 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -151.13 103.05 2.97 Favored Pre-proline 0 CA--C 1.53 0.174 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.97 135.29 58.3 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.402 2.735 . . . . 0.0 111.02 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.9 p -90.45 133.28 32.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -100.75 154.53 18.54 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -174.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.9 mm -131.08 147.64 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.946 0.898 . . . . 0.0 110.71 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -160.59 99.49 1.36 Allowed Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.009 0.524 . . . . 0.0 110.138 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.84 174.18 3.2 Favored 'Trans proline' 0 CA--C 1.531 0.356 1 C-N-CA 125.788 4.325 . . . . 0.0 115.969 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -108.18 156.48 19.28 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.539 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -102.58 125.22 49.23 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.515 0.674 . . . . 0.0 111.102 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.707 ' H ' ' CD1' ' A' ' 156' ' ' LEU . 1.9 mp -67.19 -19.77 65.61 Favored 'General case' 0 C--O 1.23 0.041 0 C-N-CA 125.102 1.361 . . . . 0.0 114.22 -172.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 81.1 p -87.11 -4.93 59.17 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -167.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -146.37 27.71 1.12 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.564 1.074 . . . . 0.0 113.318 -176.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.4 m -72.02 -20.98 61.61 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.8 -0.562 . . . . 0.0 112.377 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -150.49 155.36 39.34 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 122.801 0.44 . . . . 0.0 110.949 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -150.09 162.12 41.03 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 10.9 p -149.19 149.81 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.9 ttm -123.02 22.13 9.64 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -170.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -158.43 -41.16 0.06 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.22 10.26 59.2 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.723 173.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.5 t -141.79 -24.2 0.7 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.573 1.186 . . . . 0.0 114.163 -176.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 24.0 mm100 -80.32 130.51 65.25 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 119.625 1.102 . . . . 0.0 110.615 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 167' ' ' GLN . 32.4 Cg_exo -61.11 159.49 29.97 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.667 2.912 . . . . 0.0 111.457 173.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.7 mt -108.71 154.36 22.14 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.514 0.326 . . . . 0.0 110.122 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -151.58 138.44 11.96 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.51 -14.09 42.38 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.143 2.562 . . . . 0.0 113.182 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -86.32 -6.6 58.92 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.711 0.687 . . . . 0.0 110.491 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -125.65 15.71 8.14 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.665 0.386 . . . . 0.0 111.355 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 46.4 m -119.5 143.64 47.45 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 121.131 0.491 . . . . 0.0 110.905 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.47 148.7 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.088 -177.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -115.96 151.9 34.51 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.47 111.44 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.291 0.637 . . . . 0.0 109.911 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -82.92 126.58 7.54 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 118.2 -110.87 2.05 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.4 p 36.68 63.95 2.69 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.407 0.683 . . . . 0.0 111.573 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.22 176.75 3.66 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.251 3.301 . . . . 0.0 112.731 -174.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.435 ' N ' ' CD ' ' A' ' 183' ' ' PRO . 9.8 ptm180 -59.81 -21.14 0.71 Allowed Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -173.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 182' ' ' ARG . 46.9 Cg_exo -60.35 -12.1 18.98 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.926 1.751 . . . . 0.0 112.882 172.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 89.2 mt -104.71 174.24 5.96 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.976 0.51 . . . . 0.0 110.605 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -152.46 153.33 33.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.244 1.017 . . . . 0.0 109.376 -170.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.21 -26.37 65.69 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.27 -48.68 80.31 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 CA-C-N 118.418 0.554 . . . . 0.0 111.291 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -84.17 -20.8 31.79 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.94 -40.13 79.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 174.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.04 -38.08 78.93 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 122.323 -0.235 . . . . 0.0 111.567 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 24.4 mmt -69.45 -32.47 71.44 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.235 -0.29 . . . . 0.0 111.069 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 88.7 mt -71.8 -32.19 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.2 mmt -73.18 -23.23 60.39 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.943 -0.473 . . . . 0.0 110.642 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -82.19 -23.59 35.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 122.146 -0.346 . . . . 0.0 111.213 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -86.14 -19.58 29.91 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.94 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -116.25 -16.16 10.96 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -133.33 19.04 3.99 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -173.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.03 -144.68 38.34 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -70.72 113.36 4.76 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 112.256 -0.338 . . . . 0.0 112.256 -174.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 40.4 t -98.51 154.41 3.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 C-N-CA 124.143 0.977 . . . . 0.0 108.614 174.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.7 p -114.79 -31.45 6.13 Favored 'General case' 0 C--O 1.227 -0.084 0 CA-C-N 118.397 0.544 . . . . 0.0 111.324 175.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -148.19 144.44 27.73 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-N 118.492 0.587 . . . . 0.0 110.589 175.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -159.29 147.52 17.75 Favored 'General case' 0 N--CA 1.458 -0.03 0 CA-C-O 120.851 0.358 . . . . 0.0 111.075 177.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 163.41 -158.94 31.48 Favored Glycine 0 CA--C 1.522 0.481 0 O-C-N 121.924 -0.485 . . . . 0.0 112.289 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 44.0 mm -96.14 140.99 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -66.36 139.03 58.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.98 0.419 . . . . 0.0 110.8 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 55.0 p -136.31 155.7 49.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.277 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -80.88 126.59 77.28 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 171.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.2 -10.56 17.75 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.842 3.695 . . . . 0.0 113.405 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -103.73 -27.37 12.31 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.731 0.696 . . . . 0.0 110.398 -177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 81.7 mt -105.08 -7.34 19.21 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.775 0.43 . . . . 0.0 110.894 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm 53.06 40.74 31.7 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.048 0.939 . . . . 0.0 112.443 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.424 ' CE1' ' HB2' ' A' ' 65' ' ' ARG . 21.2 m-85 -127.82 155.55 77.23 Favored Pre-proline 0 N--CA 1.467 0.425 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.558 -175.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.7 146.56 92.37 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.272 1.982 . . . . 0.0 110.735 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.98 31.25 4.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.031 0.932 . . . . 0.0 109.557 -176.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.53 156.93 2.62 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.231 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 54.59 -175.42 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.6 0.76 . . . . 0.0 111.999 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -139.36 174.09 22.41 Favored Glycine 0 CA--C 1.521 0.466 0 O-C-N 121.734 -0.604 . . . . 0.0 111.96 -176.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -148.93 154.32 39.26 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 62.8 t -140.27 145.84 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.45 150.37 52.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.119 0.485 . . . . 0.0 110.936 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -131.54 159.97 36.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.112 -175.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 77.3 p -92.95 -5.76 50.01 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.261 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -124.35 144.39 50.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.105 0.562 . . . . 0.0 111.061 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -78.33 -9.61 59.33 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.095 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -82.92 -38.92 22.17 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.2 m -75.91 -26.49 57.01 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -64.24 -50.94 66.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 175.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.45 -14.23 16.49 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 CA-C-N 118.051 0.387 . . . . 0.0 111.309 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.47 -21.16 32.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 117.708 0.231 . . . . 0.0 111.065 175.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.56 -14.91 36.48 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.0 pt -119.31 23.78 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.315 0.646 . . . . 0.0 110.567 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 88.7 p -76.2 -20.12 57.78 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.222 0.609 . . . . 0.0 112.544 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -149.77 133.01 16.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -54.88 -37.53 66.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -175.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -122.01 116.61 24.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.154 0.434 . . . . 0.0 110.615 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.5 m -97.95 158.41 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.311 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -89.75 144.19 26.18 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.931 0.395 . . . . 0.0 110.727 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.0 mp -138.22 98.73 3.68 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -138.54 76.19 1.56 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.928 -172.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -137.24 152.18 49.54 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 66.71 25.27 72.91 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 63.06 21.85 13.11 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.284 1.034 . . . . 0.0 112.21 -175.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 68.7 mt -92.34 163.99 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -152.43 110.02 3.6 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -146.1 164.11 33.21 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.824 0.45 . . . . 0.0 110.841 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.01 157.8 44.32 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 123.818 0.847 . . . . 0.0 109.188 178.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.58 149.54 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -87.42 121.87 30.42 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.4 m -95.6 150.45 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 CA-C-N 118.139 0.427 . . . . 0.0 111.286 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.27 160.21 29.74 Favored Pre-proline 0 N--CA 1.457 -0.096 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 171.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.03 135.18 69.21 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.725 2.283 . . . . 0.0 109.139 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -73.64 112.92 10.2 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 119.221 -0.992 . . . . 0.0 111.421 -176.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.536 0.408 0 C-N-CA 125.554 1.542 . . . . 0.0 113.051 174.091 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.293 0.092 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -166.2 164.98 17.82 Favored 'General case' 0 CA--C 1.52 -0.193 0 O-C-N 123.552 0.533 . . . . 0.0 109.699 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.5 t -108.37 156.95 18.84 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 171.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.553 ' H ' ' CD ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -76.6 26.77 0.13 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.497 0.719 . . . . 0.0 112.086 179.235 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.432 ' HE3' ' CD1' ' A' ' 154' ' ' TRP . 47.7 pttt -136.44 141.61 43.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.048 0.939 . . . . 0.0 109.627 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 m -147.25 160.87 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.055 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.767 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -100.49 143.43 30.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.44 HG11 HD13 ' A' ' 113' ' ' LEU . 3.2 m -134.2 132.66 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 173.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.21 -163.59 9.57 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.3 21.37 66.28 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.001 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.676 ' H ' HD23 ' A' ' 72' ' ' LEU . 2.1 pt? -118.44 150.02 47.16 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 118.179 0.989 . . . . 0.0 109.954 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.4 168.98 21.97 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 124.09 3.194 . . . . 0.0 113.706 -169.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -83.36 0.31 9.55 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 124.116 3.211 . . . . 0.0 111.65 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -100.89 11.47 39.52 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -173.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.444 HD12 ' C ' ' A' ' 76' ' ' ILE . 1.9 pp -122.39 177.65 3.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -142.65 -175.58 4.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.921 0.391 . . . . 0.0 111.578 -175.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -50.03 -31.88 14.04 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.356 1.062 . . . . 0.0 112.258 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -71.45 -29.77 65.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 117.894 0.316 . . . . 0.0 111.542 -176.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -82.21 -31.78 30.15 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 122.184 -0.323 . . . . 0.0 110.42 -174.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 66.0 mt -77.49 -42.42 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.2 m -66.9 -22.97 65.95 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.67 -18.3 28.2 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.9 m -77.57 -27.61 51.51 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 118.424 0.557 . . . . 0.0 111.685 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.41 ' CZ ' HD11 ' A' ' 151' ' ' ILE . 74.6 m-85 -120.98 12.71 11.24 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.49 -18.05 64.44 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.293 0.497 . . . . 0.0 112.249 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -75.6 -10.18 59.22 Favored 'General case' 0 C--N 1.338 0.093 0 O-C-N 122.033 -0.417 . . . . 0.0 111.944 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -103.8 23.21 13.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.559 0.344 . . . . 0.0 111.319 -176.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.93 179.21 31.81 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.59 150.2 68.95 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.369 2.713 . . . . 0.0 110.772 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.417 ' N ' HD23 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -162.77 164.6 26.18 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.02 -170.141 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.63 164.55 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.752 174.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -129.58 151.05 35.24 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -143.23 159.07 43.0 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.487 0.66 . . . . 0.0 112.02 -174.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.499 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 30.2 p90 -151.88 159.52 32.96 Favored Pre-proline 0 N--CA 1.452 -0.349 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 170.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 95' ' ' TRP . 94.2 Cg_endo -65.68 -13.99 42.55 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 123.525 2.816 . . . . 0.0 112.505 -169.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -106.59 13.72 27.9 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.066 0.546 . . . . 0.0 111.549 -176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.7 tptm -49.81 151.51 1.78 Allowed 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.844 0.858 . . . . 0.0 112.739 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.301 0 C-N-CA 123.587 0.755 . . . . 0.0 110.487 -177.749 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.735 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.472 ' HA ' HD21 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -76.05 150.12 37.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.025 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.69 -176.7 5.61 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.961 0.41 . . . . 0.0 111.427 -174.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -140.27 128.82 22.85 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.44 HD13 HG11 ' A' ' 69' ' ' VAL . 10.6 mp -89.98 149.54 22.52 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.656 0.741 . . . . 0.0 112.372 -177.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.2 mp -113.09 138.6 49.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -134.62 170.64 15.5 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.047 0.539 . . . . 0.0 110.388 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -101.87 -24.17 14.06 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.705 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -135.83 153.57 51.46 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -75.48 -15.51 60.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.735 171.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 m -78.91 -20.04 50.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 176.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.6 m -76.87 -42.3 40.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.7 m -74.15 -20.18 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -72.1 -41.33 67.4 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.71 -34.52 62.62 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 122.168 -0.333 . . . . 0.0 111.557 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 pp -77.41 -17.9 57.73 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.372 0.533 . . . . 0.0 111.613 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.9 mt -95.46 -17.48 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 122.39 0.276 . . . . 0.0 111.014 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -99.41 -11.2 21.36 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.864 -0.523 . . . . 0.0 112.273 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -114.84 29.34 8.09 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.811 0.444 . . . . 0.0 111.921 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 17.6 p -137.41 -173.8 3.58 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.994 0.426 . . . . 0.0 111.647 -176.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.2 mm -84.67 160.53 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 124.596 1.158 . . . . 0.0 109.427 -175.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -132.23 158.45 41.75 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.681 0.276 . . . . 0.0 110.821 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.3 74.52 1.33 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.436 0.636 . . . . 0.0 110.671 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 51.97 9.39 0.09 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.16 -9.87 0.06 OUTLIER Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.115 0.87 . . . . 0.0 113.289 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.6 pttt -146.34 178.25 8.39 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 174.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.6 mp -125.33 169.69 12.07 Favored 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -171.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 0.3 OUTLIER -140.87 156.01 46.2 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.591 -175.744 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.4 tp -137.06 142.89 42.41 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 47.4 t -82.97 132.58 35.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.518 0.599 . . . . 0.0 109.99 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 19.9 m -137.38 -10.42 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.4 m 46.3 46.1 13.41 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.531 0.732 . . . . 0.0 112.786 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.407 ' HB3' ' HD2' ' A' ' 142' ' ' PRO . 18.7 m -57.17 156.15 15.18 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.399 0.68 . . . . 0.0 111.785 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 97.1 Cg_endo -72.13 20.08 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 125.008 3.805 . . . . 0.0 114.19 -176.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.42 HG22 HG12 ' A' ' 144' ' ' ILE . 21.7 m -133.13 138.62 46.71 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.42 HG12 HG22 ' A' ' 143' ' ' THR . 0.9 OUTLIER 55.31 -149.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -170.352 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -139.12 145.7 39.76 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.449 0.568 . . . . 0.0 110.554 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 49.62 39.46 17.36 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.417 1.087 . . . . 0.0 112.969 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -55.63 118.27 18.8 Favored Pre-proline 0 CA--C 1.53 0.195 0 C-N-CA 123.637 0.775 . . . . 0.0 111.964 -177.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.44 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 25.8 Cg_endo -93.8 129.53 0.66 Allowed 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 124.252 3.301 . . . . 0.0 109.765 169.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.3 131.53 38.18 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -89.23 151.15 22.3 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.605 0.762 . . . . 0.0 111.503 -173.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.41 HD11 ' CZ ' ' A' ' 85' ' ' PHE . 48.5 mm -134.94 144.48 34.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 123.967 0.907 . . . . 0.0 111.344 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.0 ttp85 -152.57 116.11 2.89 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 168.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.59 165.01 33.45 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.877 3.051 . . . . 0.0 111.908 177.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.432 ' CD1' ' HE3' ' A' ' 66' ' ' LYS . 34.5 t-105 -100.66 152.5 20.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.351 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -104.98 153.75 21.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.676 0.791 . . . . 0.0 112.209 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.3 mp -94.63 -2.56 51.13 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -172.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.4 m -79.52 -10.38 59.79 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -173.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -136.17 -110.44 0.2 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.733 0.697 . . . . 0.0 111.738 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 m 64.03 -33.4 0.14 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.541 1.937 . . . . 0.0 113.951 -173.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -153.49 151.82 30.27 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.101 0.56 . . . . 0.0 110.07 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -157.63 153.84 27.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.58 152.68 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 121.887 -0.508 . . . . 0.0 109.744 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 71.4 mtm -128.96 29.92 5.13 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -159.72 -44.5 0.05 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.54 3.93 59.68 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.102 -0.832 . . . . 0.0 113.635 174.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.3 m -138.53 -0.8 1.93 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -176.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -79.17 141.36 57.9 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 120.076 1.307 . . . . 0.0 110.261 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.11 153.21 41.08 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.369 2.713 . . . . 0.0 108.815 173.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 63.9 mt -121.46 150.12 42.04 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.631 0.253 . . . . 0.0 110.961 -177.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -144.22 139.02 15.37 Favored Pre-proline 0 N--CA 1.456 -0.157 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -68.34 -9.23 25.3 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.681 2.921 . . . . 0.0 112.613 -173.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -88.5 -1.68 58.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.715 0.406 . . . . 0.0 110.771 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -128.44 33.2 4.72 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.891 0.476 . . . . 0.0 109.733 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 11.5 m -126.14 153.45 44.55 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.077 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.6 tt -121.84 151.61 25.43 Favored 'Isoleucine or valine' 0 C--O 1.229 0.024 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -116.36 148.22 40.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 172.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.39 117.71 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.504 ' HA2' ' CB ' ' A' ' 217' ' ' ALA . . . -119.83 159.65 14.86 Favored Glycine 0 C--N 1.336 0.564 0 O-C-N 123.202 0.314 . . . . 0.0 113.586 -171.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.84 24.77 12.57 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.24 107.57 57.79 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 117.197 0.498 . . . . 0.0 110.969 -176.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.88 -33.61 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.759 2.306 . . . . 0.0 112.66 176.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.724 ' H ' ' CD ' ' A' ' 183' ' ' PRO . 71.7 mtt180 -149.81 -38.12 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -177.178 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.724 ' CD ' ' H ' ' A' ' 182' ' ' ARG . 51.8 Cg_exo -59.29 -168.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 124.029 3.153 . . . . 0.0 114.857 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 48.0 mt 65.35 -53.65 0.34 Allowed 'General case' 0 C--O 1.23 0.064 0 C-N-CA 126.963 2.105 . . . . 0.0 114.224 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 54.18 -163.43 0.11 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.947 0.794 . . . . 0.0 109.382 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -103.85 -37.2 7.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.964 -0.46 . . . . 0.0 110.806 172.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 69.0 t -67.16 -56.45 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 C-N-CA 122.391 0.276 . . . . 0.0 111.183 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -74.34 -22.29 59.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.856 -0.156 . . . . 0.0 110.961 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.6 tp -68.47 -35.94 78.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.39 -28.75 61.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.311 -0.243 . . . . 0.0 111.346 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 26.3 mmt -70.7 -35.2 72.64 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 117.704 0.229 . . . . 0.0 111.614 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.62 -32.17 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 O-C-N 121.64 -0.663 . . . . 0.0 109.683 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.6 mmt -76.66 -15.82 59.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 121.897 -0.502 . . . . 0.0 111.894 -177.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -97.9 -24.31 15.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.697 0.681 . . . . 0.0 111.553 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -86.43 -16.36 37.42 Favored 'General case' 0 C--N 1.34 0.165 0 O-C-N 121.872 -0.517 . . . . 0.0 112.334 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -117.49 -20.19 9.15 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.355 0.525 . . . . 0.0 111.082 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -140.03 42.65 1.94 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.928 0.491 . . . . 0.0 109.752 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.51 137.15 4.38 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.032 0.825 . . . . 0.0 112.782 -175.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 122.7 1.38 9.85 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.48 157.16 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 123.837 0.855 . . . . 0.0 109.889 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.9 p -129.41 -32.15 1.99 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -147.15 152.0 37.71 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.217 0.917 . . . . 0.0 111.891 -177.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -149.6 160.91 43.1 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.481 0.312 . . . . 0.0 111.176 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 168.39 -170.21 42.01 Favored Glycine 0 C--N 1.336 0.534 0 O-C-N 121.909 -0.494 . . . . 0.0 112.122 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.9 mp -105.08 146.02 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -65.81 117.88 8.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.552 0.215 . . . . 0.0 110.434 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 76.4 p -140.49 162.59 34.99 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 122.759 0.424 . . . . 0.0 110.266 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -115.98 130.75 24.16 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.28 -1.98 10.97 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 124.811 3.674 . . . . 0.0 114.335 -170.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -68.0 -32.42 72.79 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 119.025 0.829 . . . . 0.0 110.104 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.31 8.33 1.19 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.512 0.725 . . . . 0.0 109.853 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt 53.03 39.89 30.26 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.219 1.008 . . . . 0.0 111.434 -174.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -94.25 151.92 39.86 Favored Pre-proline 0 N--CA 1.455 -0.178 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.719 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.9 141.93 37.95 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.559 2.173 . . . . 0.0 110.821 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.67 14.67 6.48 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.867 0.867 . . . . 0.0 109.92 -178.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 165.69 -165.09 37.78 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.504 ' CB ' ' HA2' ' A' ' 178' ' ' GLY . . . -86.08 -160.21 0.53 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.349 1.06 . . . . 0.0 110.829 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -74.56 158.87 51.92 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 122.189 -0.32 . . . . 0.0 112.777 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.06 153.26 38.69 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 50.1 t -145.27 146.12 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.06 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.39 145.33 50.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.547 0.339 . . . . 0.0 110.405 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -128.84 -23.09 3.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.312 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 46.0 m 56.28 25.18 9.01 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -178.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -128.05 151.84 48.69 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -73.43 -30.99 63.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -176.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -85.12 -39.83 17.46 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 111.373 0.138 . . . . 0.0 111.373 -172.387 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 65.7 p -77.54 -23.07 50.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.16 -0.337 . . . . 0.0 110.249 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -67.6 -52.75 34.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 175.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 32.7 pt -73.08 -18.04 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.63 -29.38 30.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.159 0.436 . . . . 0.0 111.491 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -77.62 -23.77 49.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.931 0.332 . . . . 0.0 111.691 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.9 pt -108.89 25.14 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.525 0.73 . . . . 0.0 110.561 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.0 t -77.06 -12.51 59.95 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.136 0.574 . . . . 0.0 112.12 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -152.67 140.83 20.41 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -55.3 -30.26 59.84 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -128.15 130.24 47.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.295 0.569 . . . . 0.0 111.135 177.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.2 m -100.8 177.34 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.294 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -109.01 138.66 45.0 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.451 0.3 . . . . 0.0 110.346 172.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.2 mp -134.76 84.41 2.1 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -119.55 -66.93 1.02 Allowed 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -172.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 48.34 24.14 0.67 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -174.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 168.95 -151.28 17.47 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -80.3 6.18 12.71 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.022 0.529 . . . . 0.0 111.717 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 244' ' ' ILE . 1.8 mp -71.53 157.05 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.597 0.759 . . . . 0.0 108.971 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -141.58 25.63 1.99 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.906 0.384 . . . . 0.0 111.257 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' LYS . . . . . 0.425 ' H ' HG22 ' A' ' 244' ' ' ILE . 99.1 mttt -90.12 154.73 19.56 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.128 0.571 . . . . 0.0 111.093 -177.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -160.26 -179.93 8.14 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.61 157.94 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.854 0.862 . . . . 0.0 110.187 -174.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -85.19 129.48 34.8 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 122.678 0.391 . . . . 0.0 110.009 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -100.28 158.23 3.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.432 ' HE3' ' HB3' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -159.0 156.95 27.65 Favored Pre-proline 0 N--CA 1.456 -0.135 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.677 169.831 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.31 146.0 96.11 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.844 2.363 . . . . 0.0 109.863 174.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -79.83 166.03 22.12 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.489 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.452 -0.37 0 C-N-CA 123.059 0.544 . . . . 0.0 110.245 -171.23 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.274 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.586 ' HA ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -142.22 -153.13 0.44 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -174.662 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.2 m 64.75 5.89 3.02 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 126.133 1.773 . . . . 0.0 113.069 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -65.03 118.49 9.2 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 173.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 63.47 143.58 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.767 1.227 . . . . 0.0 111.071 -168.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -156.11 146.43 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.337 -172.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.482 ' CZ ' ' HA2' ' A' ' 70' ' ' GLY . 9.3 t80 -89.69 140.01 30.0 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 p -118.76 117.88 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.482 ' HA2' ' CZ ' ' A' ' 68' ' ' PHE . . . -89.45 125.1 7.67 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 116.348 -0.387 . . . . 0.0 113.141 -170.191 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.37 146.67 11.1 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.222 0.915 . . . . 0.0 112.522 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.6 tp -153.94 122.62 3.09 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.17 164.07 31.71 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.217 2.611 . . . . 0.0 111.781 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.15 175.43 9.24 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.39 3.393 . . . . 0.0 111.426 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.1 t70 60.9 -85.86 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.237 0.615 . . . . 0.0 112.332 -175.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.0 pt -56.38 157.24 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 121.278 0.561 . . . . 0.0 111.333 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -149.63 -121.76 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.029 0.531 . . . . 0.0 110.256 -177.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -54.07 -22.9 11.97 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.091 1.357 . . . . 0.0 111.974 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -77.83 -36.96 49.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -173.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -86.41 -30.42 22.12 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.911 -0.493 . . . . 0.0 111.343 -173.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.8 pt -78.57 -33.3 16.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 O-C-N 121.935 -0.478 . . . . 0.0 109.968 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.3 m -70.47 -23.74 62.74 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 175.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.32 -17.07 40.76 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.4 m -76.66 -37.4 56.29 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.557 0.617 . . . . 0.0 111.695 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.455 ' CZ ' HD11 ' A' ' 151' ' ' ILE . 81.2 m-85 -108.25 6.66 26.82 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -176.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.89 -18.34 64.09 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.709 0.404 . . . . 0.0 110.941 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -72.09 -8.92 57.37 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.557 0.743 . . . . 0.0 112.031 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -110.23 5.72 22.02 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.335 0.254 . . . . 0.0 111.427 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.78 177.58 15.11 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -70.5 150.79 64.26 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.69 2.927 . . . . 0.0 110.835 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.421 ' N ' HD23 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -164.53 164.41 21.76 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.747 -170.771 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 pt -142.22 170.82 11.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.295 174.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.09 155.15 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 122.449 0.299 . . . . 0.0 110.351 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -153.25 170.27 21.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.67 0.271 . . . . 0.0 111.608 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 33.7 p90 -159.27 158.14 28.03 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -75.36 -9.18 20.18 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.892 1.728 . . . . 0.0 110.74 -169.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -95.37 6.71 48.29 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.723 0.809 . . . . 0.0 111.349 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -50.19 152.02 1.87 Allowed 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.778 0.831 . . . . 0.0 112.911 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.336 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.088 -177.153 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.566 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -147.77 143.12 27.31 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 167.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.35 172.89 12.31 Favored 'General case' 0 C--N 1.335 -0.057 0 CA-C-N 119.896 1.225 . . . . 0.0 113.489 -169.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -136.08 125.47 24.95 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.218 0.607 . . . . 0.0 109.515 -177.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 mp -84.8 141.97 30.11 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.345 0.593 . . . . 0.0 110.72 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.7 mp -104.99 136.48 44.38 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -140.28 163.93 31.45 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.049 0.539 . . . . 0.0 110.68 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -123.53 -29.36 3.78 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.087 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -102.23 159.91 14.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.827 0.346 . . . . 0.0 111.53 -175.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -111.29 5.0 19.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.236 -178.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.8 p -105.3 -22.22 13.09 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.904 0.482 . . . . 0.0 110.921 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 76.8 p -76.16 -31.43 58.54 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.84 -22.26 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 173.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -80.29 -36.92 33.73 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -174.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.87 -35.11 62.32 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 119.684 -0.198 . . . . 0.0 111.52 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -80.42 -18.51 48.62 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.313 0.506 . . . . 0.0 111.916 -176.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.1 mt -97.8 -14.47 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 117.843 0.292 . . . . 0.0 110.557 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -91.91 -16.54 26.5 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.312 -0.868 . . . . 0.0 111.238 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -108.74 26.9 10.01 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.457 0.703 . . . . 0.0 111.794 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 136' ' ' TYR . 17.2 p -124.98 166.77 15.74 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.043 0.537 . . . . 0.0 111.105 -176.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.56 172.4 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -137.31 157.95 45.49 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.021 0.438 . . . . 0.0 111.558 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.52 -172.7 4.09 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -30.1 -39.57 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.1 1.76 . . . . 0.0 115.253 -173.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.0 15.72 0.15 Allowed Glycine 0 CA--C 1.527 0.814 0 CA-C-N 118.595 0.634 . . . . 0.0 112.089 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -141.16 177.35 8.14 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 117.577 0.688 . . . . 0.0 110.56 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.22 170.76 9.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.439 0.696 . . . . 0.0 110.186 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.431 ' O ' ' HB2' ' A' ' 128' ' ' CYS . 6.3 m-85 -146.76 151.59 37.42 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.857 0.463 . . . . 0.0 111.084 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 45.4 tp -132.46 145.73 51.4 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 170.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 85.0 m -80.33 141.88 35.02 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.745 -0.597 . . . . 0.0 110.893 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.2 175.43 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.324 0.65 . . . . 0.0 109.681 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.8 m -138.51 117.32 12.33 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 122.674 0.39 . . . . 0.0 110.759 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.479 ' HB3' ' HD2' ' A' ' 142' ' ' PRO . 52.7 m -155.21 162.15 27.89 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.688 1.195 . . . . 0.0 108.828 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 60.7 Cg_endo -66.1 -15.72 49.56 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.203 2.602 . . . . 0.0 114.088 -175.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.6 m -105.12 -2.93 23.67 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.44 0.564 . . . . 0.0 110.169 175.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.2 mp -98.97 -52.42 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.177 0.591 . . . . 0.0 111.026 -172.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 87.6 tttt 58.2 -57.96 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.729 1.612 . . . . 0.0 113.194 -172.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -149.83 12.72 0.79 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.391 1.076 . . . . 0.0 110.678 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -67.99 137.38 92.18 Favored Pre-proline 0 C--N 1.338 0.1 0 C-N-CA 123.607 0.763 . . . . 0.0 111.532 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.428 ' HG2' ' CE1' ' A' ' 136' ' ' TYR . 37.8 Cg_endo -86.96 146.79 7.91 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 123.685 2.923 . . . . 0.0 110.632 168.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.9 p -98.88 142.37 14.94 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -83.37 158.78 22.01 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.786 0.721 . . . . 0.0 112.464 -174.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.455 HD11 ' CZ ' ' A' ' 85' ' ' PHE . 29.6 mm -137.13 142.79 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.051 1.341 . . . . 0.0 108.759 177.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 44.8 ttt-85 -146.08 88.52 6.31 Favored Pre-proline 0 CA--C 1.529 0.152 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.78 145.37 72.42 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.495 3.463 . . . . 0.0 112.857 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -92.86 153.02 19.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 173.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -119.48 134.1 55.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.653 0.739 . . . . 0.0 110.883 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.586 HD13 ' HA ' ' A' ' 63' ' ' TYR . 4.7 mp -87.87 8.21 27.13 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.473 -169.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.7 t -91.1 -12.65 34.95 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -175.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -135.51 20.12 3.35 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -175.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.6 m -69.89 -20.98 63.36 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.433 0.56 . . . . 0.0 112.448 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -158.19 158.09 33.91 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.275 0.488 . . . . 0.0 111.04 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -158.35 157.34 32.2 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.987 0.422 . . . . 0.0 111.054 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.0 m -140.35 149.34 21.69 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 C-N-CA 124.353 1.061 . . . . 0.0 109.722 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 58.3 mtm -140.62 10.42 2.25 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -140.3 16.64 2.41 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.243 0.929 . . . . 0.0 112.971 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 91.09 22.8 31.54 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.519 -0.6 . . . . 0.0 113.016 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.4 m 56.29 47.03 20.02 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 117.722 0.761 . . . . 0.0 112.544 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -61.88 158.21 44.82 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 123.259 0.624 . . . . 0.0 110.602 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.0 154.54 69.67 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.184 2.589 . . . . 0.0 110.67 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 61.2 mt -135.57 167.67 20.68 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.605 0.762 . . . . 0.0 110.666 -173.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -141.49 149.57 54.71 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.01 -19.84 57.72 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.217 2.611 . . . . 0.0 112.516 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -88.1 5.93 38.78 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.46 0.704 . . . . 0.0 110.837 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -131.07 18.96 4.97 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.903 0.481 . . . . 0.0 110.875 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 24.2 m -126.35 139.9 52.93 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.88 0.371 . . . . 0.0 111.153 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.7 tt -112.0 149.2 14.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.913 -177.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -116.15 148.73 40.03 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.19 139.01 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 122.632 0.373 . . . . 0.0 110.207 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -148.48 173.56 28.42 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.67 20.96 62.68 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -174.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.0 m -56.38 142.48 68.55 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 122.751 0.42 . . . . 0.0 110.372 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.06 -49.39 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.944 2.429 . . . . 0.0 112.21 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.412 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 41.7 ttm180 -161.11 -59.2 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.435 -0.793 . . . . 0.0 111.257 176.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 182' ' ' ARG . 77.3 Cg_endo -76.01 156.53 38.57 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.871 2.381 . . . . 0.0 111.394 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.59 0.68 0.11 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.155 0.582 . . . . 0.0 112.296 175.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ARG . . . . . 0.423 ' HG2' ' H ' ' A' ' 188' ' ' GLU . 16.7 ttp-105 -28.46 120.56 0.12 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.864 1.666 . . . . 0.0 111.582 175.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.4 -21.14 63.79 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 94.3 t -67.21 -50.16 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 118.154 0.434 . . . . 0.0 110.62 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 185' ' ' ARG . 59.6 mt-10 -84.87 -22.57 29.34 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.61 -0.144 . . . . 0.0 110.61 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.94 -30.91 68.41 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -83.4 -31.6 26.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 119.503 -0.284 . . . . 0.0 111.713 -177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.3 mmt -70.46 -37.05 74.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.318 0.508 . . . . 0.0 109.656 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.408 HG21 ' HA ' ' A' ' 239' ' ' LEU . 64.5 mt -72.55 -40.42 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.6 mmt -63.39 -25.37 68.26 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.941 -0.474 . . . . 0.0 110.929 172.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.59 -18.13 49.22 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.105 0.411 . . . . 0.0 111.836 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -98.53 -16.21 19.24 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.59 -13.11 11.53 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.184 0.902 . . . . 0.0 113.221 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -135.9 26.59 3.3 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.839 0.745 . . . . 0.0 112.657 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 76.18 -150.55 39.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -76.27 141.29 26.69 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -174.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.84 143.89 31.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 124.248 1.019 . . . . 0.0 108.56 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 61.4 m -109.48 -33.53 6.78 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -151.9 149.77 29.32 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.0 0.428 . . . . 0.0 110.964 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.28 155.61 40.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.465 0.706 . . . . 0.0 109.143 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.85 -174.97 47.27 Favored Glycine 0 C--N 1.333 0.363 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.2 mm -104.95 145.01 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -54.91 118.23 4.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.013 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 214' ' ' PRO . 12.2 p -144.23 158.94 43.45 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.63 0.372 . . . . 0.0 110.267 -176.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -135.1 135.54 23.06 Favored Pre-proline 0 N--CA 1.455 -0.216 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.68 -5.97 15.04 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.225 3.283 . . . . 0.0 112.824 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -73.74 -39.63 64.11 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.311 0.505 . . . . 0.0 110.688 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.11 0.68 12.41 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.35 0.66 . . . . 0.0 109.602 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm 48.26 59.35 4.35 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.281 1.032 . . . . 0.0 111.386 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -133.49 147.33 64.29 Favored Pre-proline 0 CA--C 1.529 0.149 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -176.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.413 ' HA ' HG22 ' A' ' 207' ' ' THR . 43.7 Cg_endo -81.96 165.65 17.27 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 124.238 3.292 . . . . 0.0 110.546 174.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -125.63 23.25 7.44 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 61.59 13.33 37.79 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 119.373 -0.682 . . . . 0.0 114.684 170.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -132.81 146.09 51.53 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 118.235 1.017 . . . . 0.0 109.569 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -93.18 162.31 25.92 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 121.445 0.469 . . . . 0.0 113.326 -172.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -149.64 145.21 26.62 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 173.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 95.2 t -136.57 147.77 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -133.51 154.03 51.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.396 0.617 . . . . 0.0 111.33 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -132.22 154.95 49.09 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.05 -176.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.9 m -97.3 10.08 40.53 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 173.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -132.17 134.22 45.14 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.631 0.773 . . . . 0.0 109.799 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -72.92 -12.86 61.12 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 116.859 -0.155 . . . . 0.0 111.145 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -82.1 -39.04 23.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.9 m -75.06 -28.95 60.57 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -64.52 -51.78 61.16 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 119.649 -0.215 . . . . 0.0 110.568 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.3 pt -71.42 -14.71 17.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 CA-C-N 118.111 0.414 . . . . 0.0 111.181 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.03 -22.01 33.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.799 0.272 . . . . 0.0 110.734 175.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -87.99 -27.84 21.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.5 pt -103.41 24.85 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 122.917 0.487 . . . . 0.0 110.547 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 86.6 p -75.15 -18.07 60.28 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.172 0.589 . . . . 0.0 111.96 -177.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.98 146.04 23.66 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -55.15 -31.4 61.29 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -123.05 121.94 37.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.899 0.381 . . . . 0.0 110.489 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.441 ' H ' HG22 ' A' ' 237' ' ' VAL . 1.8 m -82.68 153.98 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.594 172.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.566 ' C ' HD22 ' A' ' 239' ' ' LEU . 9.8 mp0 -95.62 140.58 30.24 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.566 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.0 mm? -127.82 27.23 5.76 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -91.96 136.52 33.1 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.909 0.484 . . . . 0.0 112.138 -171.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -148.71 19.26 1.02 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.918 177.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 84.79 138.54 4.2 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -176.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 55.86 7.39 0.27 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.389 1.076 . . . . 0.0 112.63 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.4 mt -142.71 141.61 27.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 C-N-CA 124.046 0.938 . . . . 0.0 108.991 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -157.41 123.97 4.95 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -144.34 161.27 39.4 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.98 155.21 36.51 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.0 p -154.92 151.43 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -84.97 126.71 33.75 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.5 m -102.03 158.52 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.23 157.43 27.49 Favored Pre-proline 0 N--CA 1.456 -0.148 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.733 169.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.86 130.73 41.43 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.55 2.167 . . . . 0.0 107.733 171.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -71.56 110.34 6.08 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.462 -172.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 CA--C 1.534 0.363 0 C-N-CA 125.473 1.509 . . . . 0.0 112.751 174.929 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.0 ppt_? . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.68 0.276 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.448 ' CD1' ' HA ' ' A' ' 155' ' ' ASN . 54.1 m-85 -168.96 -172.98 1.69 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -169.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.8 t -141.01 36.37 1.75 Allowed 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.02 -0.425 . . . . 0.0 112.04 173.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.78 36.36 2.73 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.329 1.451 . . . . 0.0 114.487 176.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.4 pttm -141.71 153.48 44.68 Favored 'General case' 0 N--CA 1.46 0.064 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 171.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 p -153.54 146.29 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-O 120.62 0.247 . . . . 0.0 111.025 -176.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -89.41 144.15 26.28 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.78 115.0 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.724 0.773 . . . . 0.0 109.315 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.23 -165.17 37.4 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.87 -104.67 1.51 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.1 tp 54.97 101.5 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 125.366 1.466 . . . . 0.0 112.547 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -67.2 148.23 80.22 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.905 1.737 . . . . 0.0 108.572 174.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.8 20.14 0.63 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.883 3.055 . . . . 0.0 112.574 -174.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -138.5 28.72 2.44 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.1 pt -133.66 175.55 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 119.012 0.824 . . . . 0.0 109.049 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -138.17 -175.97 4.29 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -49.88 -34.88 21.52 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.764 1.226 . . . . 0.0 112.261 -175.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -72.15 -29.85 64.43 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -175.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -79.13 -36.95 39.74 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -174.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.5 mt -73.72 -39.31 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 90.0 m -65.31 -22.94 66.9 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.1 -17.89 28.35 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -79.55 -26.72 41.35 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.383 0.538 . . . . 0.0 112.363 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -114.47 10.2 16.89 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -59.41 -19.83 50.27 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -172.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -73.63 -11.89 60.57 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.22 0.464 . . . . 0.0 112.236 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -99.46 16.44 23.19 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.45 0.3 . . . . 0.0 111.713 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.03 -175.33 29.7 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.95 137.28 37.45 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.49 2.793 . . . . 0.0 110.536 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.9 pp -160.25 166.69 29.1 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.519 0.728 . . . . 0.0 109.909 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mt -136.01 164.78 31.15 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.44 147.06 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -148.36 166.98 26.42 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -174.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -156.51 159.15 31.58 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 176.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.442 ' HG2' ' ND1' ' A' ' 97' ' ' HIS . 63.8 Cg_endo -71.36 -10.89 27.83 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.482 2.788 . . . . 0.0 110.976 -171.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.442 ' ND1' ' HG2' ' A' ' 96' ' ' PRO . 39.0 m80 -100.28 17.09 22.27 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.955 0.902 . . . . 0.0 111.39 -178.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -54.02 160.56 1.47 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.004 0.922 . . . . 0.0 112.987 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.223 0 C-N-CA 124.079 0.952 . . . . 0.0 110.499 -178.02 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.892 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 54.89 -177.25 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.068 0.547 . . . . 0.0 111.29 -175.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.54 175.38 12.38 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 121.356 -0.84 . . . . 0.0 112.672 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -139.59 143.49 37.32 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.9 mp -102.78 149.2 24.71 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-O 121.387 0.613 . . . . 0.0 112.267 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.9 mp -107.9 143.11 36.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.362 -1.29 . . . . 0.0 107.658 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -139.44 154.41 47.76 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.136 0.494 . . . . 0.0 110.346 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -101.18 -23.86 14.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.139 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -111.93 153.38 26.82 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.257 0.223 . . . . 0.0 110.438 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -97.58 1.71 49.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.559 0.219 . . . . 0.0 111.086 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.3 t -115.08 -13.93 11.82 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.509 0.724 . . . . 0.0 110.884 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.5 m -68.27 -32.53 72.76 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 121.507 -0.746 . . . . 0.0 109.227 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.78 -22.93 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -80.56 -26.37 38.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.832 -0.543 . . . . 0.0 109.639 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.51 -36.28 68.32 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.926 -0.484 . . . . 0.0 110.569 176.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -79.51 -16.3 56.26 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.312 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.51 HD11 ' HB3' ' A' ' 153' ' ' PRO . 97.0 mt -94.17 -10.77 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 122.439 0.295 . . . . 0.0 110.85 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -108.19 -10.72 15.36 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.709 -0.619 . . . . 0.0 112.225 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -116.37 42.2 2.46 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.482 0.713 . . . . 0.0 110.293 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 136' ' ' TYR . 31.1 p -142.67 174.97 10.17 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.45 0.7 . . . . 0.0 110.974 -172.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.95 165.89 2.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.02 157.27 44.56 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.995 0.426 . . . . 0.0 111.613 177.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -143.08 75.82 1.5 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.436 0.636 . . . . 0.0 109.654 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.7 t70 54.52 12.45 0.54 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.196 1.399 . . . . 0.0 114.703 175.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 154.71 -8.73 0.36 Allowed Glycine 0 CA--C 1.528 0.888 0 O-C-N 121.526 -0.734 . . . . 0.0 113.384 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -129.78 171.04 13.11 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 118.136 0.968 . . . . 0.0 109.328 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -122.44 164.95 17.12 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -170.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.433 ' O ' ' HB2' ' A' ' 128' ' ' CYS . 9.7 m-85 -143.69 150.36 38.57 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.028 176.006 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.8 mp -127.21 159.47 34.2 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.2 p -94.08 128.58 40.54 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.931 -0.48 . . . . 0.0 111.067 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.4 m -148.43 166.12 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 123.651 0.78 . . . . 0.0 109.838 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.8 m -96.68 155.4 16.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.615 0.366 . . . . 0.0 110.738 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.4 m -146.35 144.49 21.27 Favored Pre-proline 0 CA--C 1.528 0.132 0 C-N-CA 123.338 0.655 . . . . 0.0 109.436 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.86 -14.52 13.79 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.41 2.74 . . . . 0.0 111.338 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.4 m -76.71 -24.53 53.1 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 123.934 0.893 . . . . 0.0 110.668 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.417 HG22 ' H ' ' A' ' 145' ' ' LYS . 0.2 OUTLIER -137.83 -172.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.371 1.068 . . . . 0.0 108.804 -170.712 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.417 ' H ' HG22 ' A' ' 144' ' ' ILE . 22.1 ptmt -91.41 -23.38 20.05 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 169.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -165.42 154.04 11.79 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.087 1.355 . . . . 0.0 108.462 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' A' ' 147' ' ' LYS . 22.2 ttmt -151.13 117.69 3.29 Favored Pre-proline 0 N--CA 1.457 -0.083 0 CA-C-N 118.276 0.489 . . . . 0.0 111.139 175.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.402 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 38.4 Cg_exo -63.8 120.53 7.94 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 122.295 1.997 . . . . 0.0 108.654 168.023 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.6 p -84.25 132.0 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.1 tm0? -90.3 147.69 23.35 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.38 0.272 . . . . 0.0 110.787 -170.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 26.4 mm -135.18 142.76 39.03 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 C-N-CA 123.006 0.522 . . . . 0.0 111.501 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -144.33 106.83 4.79 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 173.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.51 ' HB3' HD11 ' A' ' 125' ' ' ILE . 84.1 Cg_endo -71.43 161.03 46.86 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.826 3.017 . . . . 0.0 113.79 -176.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -93.92 94.5 8.51 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.448 ' HA ' ' CD1' ' A' ' 63' ' ' TYR . 3.3 m120 -69.31 0.84 4.41 Favored 'General case' 0 C--O 1.228 -0.054 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -168.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.538 HD23 ' H ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -156.09 175.85 13.43 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.499 1.5 . . . . 0.0 114.464 -169.192 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 54.4 m -108.49 24.6 12.8 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.904 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.538 ' H ' HD23 ' A' ' 156' ' ' LEU . 80.5 m-20 -94.84 31.72 1.78 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.408 0.283 . . . . 0.0 110.497 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 m -75.47 -20.02 59.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -153.29 154.01 33.76 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.06 0.391 . . . . 0.0 111.356 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -157.88 153.25 26.01 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.935 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.8 m -139.21 155.75 26.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 122.803 0.441 . . . . 0.0 110.254 177.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 64.1 mtm -135.23 28.19 3.43 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.318 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -155.37 168.72 26.18 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -77.65 41.03 1.86 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.672 0.653 . . . . 0.0 112.793 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.9 m 55.89 60.56 3.19 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 117.414 0.607 . . . . 0.0 111.51 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -63.43 161.72 31.77 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 123.532 0.733 . . . . 0.0 109.745 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -56.01 124.02 15.26 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.518 2.145 . . . . 0.0 109.396 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.5 tp -127.07 138.31 53.18 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.748 0.819 . . . . 0.0 110.391 -171.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -144.78 156.3 55.87 Favored Pre-proline 0 N--CA 1.454 -0.261 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.63 -12.42 31.21 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.877 2.385 . . . . 0.0 111.203 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -83.61 -5.03 59.07 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.665 0.786 . . . . 0.0 111.563 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -118.35 24.51 10.9 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.853 0.461 . . . . 0.0 110.127 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 44.8 m -122.09 154.0 37.92 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.603 0.361 . . . . 0.0 111.001 -174.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.61 146.24 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -99.3 129.06 45.49 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.431 HG12 HG21 ' A' ' 248' ' ' VAL . 45.5 t -104.8 78.66 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 125.02 1.328 . . . . 0.0 108.447 -177.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.451 ' HA2' ' CB ' ' A' ' 217' ' ' ALA . . . -96.09 153.42 20.55 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 116.355 -0.384 . . . . 0.0 113.44 -174.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 109.21 11.79 21.31 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.9 m -73.63 152.88 89.54 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 117.255 0.527 . . . . 0.0 110.298 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.32 -45.9 2.42 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.63 2.22 . . . . 0.0 110.099 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.531 ' HB3' ' CD ' ' A' ' 183' ' ' PRO . 29.5 ttp-105 -159.8 -75.32 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 118.019 -0.991 . . . . 0.0 108.664 172.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 182' ' ' ARG . 14.4 Cg_endo -87.66 177.11 3.78 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.765 2.31 . . . . 0.0 109.81 169.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 184' ' ' LEU . 19.3 tp -136.58 -0.34 2.4 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 169.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 57.53 95.38 0.02 OUTLIER 'General case' 0 C--N 1.341 0.217 0 C-N-CA 126.941 2.096 . . . . 0.0 111.702 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.89 -27.44 63.29 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -173.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 62.5 t -62.8 -56.41 17.7 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 CA-C-N 118.515 0.598 . . . . 0.0 111.183 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -82.46 -23.03 34.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 122.454 -0.153 . . . . 0.0 110.721 -175.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.88 -38.87 66.82 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.52 -37.56 74.15 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 121.923 -0.486 . . . . 0.0 110.426 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.2 mmt -68.33 -35.64 78.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.376 -0.202 . . . . 0.0 110.818 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.41 HG21 ' HA ' ' A' ' 239' ' ' LEU . 56.5 mt -76.95 -35.95 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 117.594 0.179 . . . . 0.0 111.317 -176.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.3 mmt -64.56 -23.43 67.26 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.891 -0.505 . . . . 0.0 109.998 172.39 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -78.68 -24.26 45.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.022 0.374 . . . . 0.0 110.735 174.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -83.43 -17.7 41.24 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 119.129 -0.462 . . . . 0.0 112.134 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -118.48 -17.07 9.46 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -177.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -133.24 19.03 4.02 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -174.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.19 -144.41 37.64 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -69.3 118.38 8.56 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 60.2 t -109.3 142.35 22.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 124.08 0.952 . . . . 0.0 108.612 174.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 42.9 t -99.9 -39.78 8.0 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.687 0.221 . . . . 0.0 110.84 -178.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -150.09 146.29 26.85 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.727 0.298 . . . . 0.0 110.964 -176.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -154.49 153.04 30.83 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.312 0.645 . . . . 0.0 109.844 175.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 162.75 -158.25 30.42 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.651 -0.579 . . . . 0.0 111.651 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ILE . . . . . 0.454 ' HA ' ' HA2' ' A' ' 218' ' ' GLY . 48.8 mm -108.51 145.33 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -60.3 102.68 0.18 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 40.7 p -145.51 166.76 24.75 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.944 0.498 . . . . 0.0 109.802 -176.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -138.26 131.61 16.51 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -80.11 -16.42 11.12 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.458 3.439 . . . . 0.0 113.587 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -91.12 -31.65 16.15 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.527 0.603 . . . . 0.0 110.476 -176.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.04 -1.88 30.76 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.208 0.603 . . . . 0.0 110.291 176.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 49.86 45.2 25.1 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.103 0.961 . . . . 0.0 112.551 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.37 155.25 53.93 Favored Pre-proline 0 CA--C 1.528 0.104 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -84.41 153.85 12.21 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.411 2.741 . . . . 0.0 109.586 170.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.58 6.59 6.25 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.856 0.463 . . . . 0.0 110.502 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 165.46 -163.07 36.35 Favored Glycine 0 CA--C 1.524 0.609 0 O-C-N 121.919 -0.488 . . . . 0.0 112.08 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' ALA . . . . . 0.451 ' CB ' ' HA2' ' A' ' 178' ' ' GLY . . . -80.09 -162.36 0.44 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.223 1.009 . . . . 0.0 111.401 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 205' ' ' ILE . . . -71.05 166.58 52.31 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 116.427 -0.351 . . . . 0.0 112.97 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -155.56 154.68 32.09 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 87.6 t -140.6 147.09 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -137.56 154.04 49.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.355 0.597 . . . . 0.0 111.846 -177.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -129.48 158.25 39.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.035 -173.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 34.3 m -84.58 -10.49 57.34 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.311 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -124.67 149.15 47.48 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.166 0.587 . . . . 0.0 111.03 -174.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -78.07 -16.33 58.12 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.92 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -80.87 -35.42 32.69 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 15.1 m -77.51 -26.89 51.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -64.59 -48.03 76.48 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.629 0.372 . . . . 0.0 110.481 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 35.5 pt -72.95 -24.49 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 CA-C-N 117.937 0.335 . . . . 0.0 111.039 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -73.62 -24.72 60.06 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.018 0.372 . . . . 0.0 110.804 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -83.74 -8.52 59.24 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.4 pt -120.0 19.42 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 123.035 0.534 . . . . 0.0 110.791 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 21.1 m -89.32 -11.51 43.2 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.899 0.48 . . . . 0.0 112.129 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -142.41 122.94 14.09 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -50.75 -41.14 56.33 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -115.44 107.29 15.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.098 0.408 . . . . 0.0 111.104 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 237' ' ' VAL . 10.6 m -67.24 151.21 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.418 172.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.461 ' C ' HD22 ' A' ' 239' ' ' LEU . 0.3 OUTLIER -100.23 139.93 35.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.276 0.56 . . . . 0.0 109.678 174.043 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.461 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.1 mm? -118.94 21.41 12.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.522 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -84.04 121.85 27.98 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.709 0.803 . . . . 0.0 112.041 -170.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -147.58 24.68 1.09 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.36 142.47 7.58 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 56.22 10.86 0.68 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.259 1.024 . . . . 0.0 112.85 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.7 mt -140.87 142.29 30.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 C-N-CA 123.742 0.817 . . . . 0.0 109.213 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -142.8 18.56 1.98 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.542 0.337 . . . . 0.0 111.343 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -55.36 151.36 10.07 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 124.2 1.0 . . . . 0.0 111.385 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.61 154.21 37.1 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.826 1.25 . . . . 0.0 108.975 176.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' VAL . . . . . 0.431 HG21 HG12 ' A' ' 177' ' ' VAL . 7.2 p -161.12 158.32 2.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -89.66 150.28 22.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.463 0.305 . . . . 0.0 111.739 -175.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.2 m -118.69 155.98 20.72 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-O 120.775 0.322 . . . . 0.0 111.683 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.45 157.56 30.18 Favored Pre-proline 0 CA--C 1.528 0.118 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.73 137.6 74.63 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.349 2.033 . . . . 0.0 108.578 173.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -72.08 120.81 18.21 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 119.04 -1.064 . . . . 0.0 112.009 -175.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 CA--C 1.533 0.309 0 C-N-CA 126.17 1.788 . . . . 0.0 113.403 172.994 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? . . . . . 0 CA--C 1.531 0.217 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 53.85 172.16 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -175.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.3 t -107.46 21.47 17.42 Favored 'General case' 0 C--O 1.23 0.043 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.652 -173.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.484 ' HA ' ' CE1' ' A' ' 115' ' ' PHE . 96.4 mtt180 54.23 20.87 2.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.507 0.723 . . . . 0.0 112.784 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -145.96 146.87 31.19 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.074 0.549 . . . . 0.0 110.73 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -139.07 153.5 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.468 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -88.44 142.68 27.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 170.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.505 HG11 HD13 ' A' ' 113' ' ' LEU . 3.6 m -129.28 100.61 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.994 0.902 . . . . 0.0 109.017 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.26 -174.77 50.3 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.26 11.24 85.71 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.715 -0.491 . . . . 0.0 112.72 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.0 tp -67.87 127.04 93.33 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 118.112 0.956 . . . . 0.0 110.965 -177.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.31 163.25 30.34 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.581 2.854 . . . . 0.0 110.257 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -83.64 3.17 7.87 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.123 3.215 . . . . 0.0 113.666 -173.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -129.67 22.41 5.46 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -170.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.0 pt -124.2 171.08 13.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 118.791 0.723 . . . . 0.0 109.958 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -140.35 -173.88 3.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.128 0.49 . . . . 0.0 112.201 -173.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -51.33 -29.41 15.09 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.317 1.447 . . . . 0.0 113.091 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.78 -32.28 35.51 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.501 0.591 . . . . 0.0 111.585 -175.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -76.81 -39.25 52.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.374 0.131 . . . . 0.0 110.848 -173.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.417 ' H ' HG12 ' A' ' 81' ' ' ILE . 5.0 pt -83.95 -36.15 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 119.652 -0.213 . . . . 0.0 110.971 -177.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.8 m -65.54 -26.52 67.93 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.01 -22.58 31.29 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.647 -0.216 . . . . 0.0 111.408 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 m -78.58 -12.88 60.04 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.213 0.461 . . . . 0.0 112.099 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -118.45 4.44 11.78 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.175 0.443 . . . . 0.0 112.145 175.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 47.9 tpt85 -67.8 -18.55 64.89 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -72.05 -5.34 34.51 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.415 0.552 . . . . 0.0 112.398 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -106.67 6.3 29.65 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.449 0.3 . . . . 0.0 111.619 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.31 179.59 17.54 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.57 134.89 25.16 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.548 2.832 . . . . 0.0 110.662 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.0 pp -159.85 164.93 33.21 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.919 0.888 . . . . 0.0 109.753 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.4 mm -128.45 163.79 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.17 153.67 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -145.47 157.07 44.07 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.214 0.53 . . . . 0.0 111.049 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.454 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 44.8 p90 -156.5 158.77 31.57 Favored Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 169.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 95' ' ' TRP . 38.4 Cg_endo -74.15 -10.62 22.79 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.389 2.726 . . . . 0.0 110.459 -169.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.454 ' ND1' ' HG2' ' A' ' 96' ' ' PRO . 31.9 m80 -103.88 10.4 36.4 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.157 0.983 . . . . 0.0 110.927 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.493 ' HA ' ' HE3' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -63.92 -24.2 67.64 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.866 0.866 . . . . 0.0 110.927 -178.748 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.255 0 C-N-CA 123.736 0.814 . . . . 0.0 111.473 178.719 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.99 0 CA-C-O 119.656 -0.525 . . . . 0.0 112.165 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 60.64 166.12 0.08 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.324 0.65 . . . . 0.0 111.757 -177.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.82 175.34 9.9 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 121.153 -0.967 . . . . 0.0 113.126 -171.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -145.95 141.71 28.0 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.702 0.801 . . . . 0.0 109.504 -178.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.505 HD13 HG11 ' A' ' 69' ' ' VAL . 9.0 mp -98.94 144.89 27.61 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.23 139.15 52.35 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.484 ' CE1' ' HA ' ' A' ' 65' ' ' ARG . 8.1 p90 -152.19 177.4 10.57 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -117.69 -30.36 5.48 Favored 'General case' 0 CA--C 1.521 -0.148 0 O-C-N 122.188 -0.32 . . . . 0.0 110.88 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -93.31 124.72 37.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -69.15 -19.36 64.01 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.73 0.3 . . . . 0.0 110.324 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.9 m -77.02 -13.27 59.98 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.854 0.462 . . . . 0.0 111.245 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.3 t -75.53 -38.28 59.46 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.9 p -83.64 -21.54 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -67.08 -40.16 86.94 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.28 -37.99 60.62 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.64 -20.47 59.88 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.536 0.607 . . . . 0.0 111.708 -176.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.412 HD11 ' HG3' ' A' ' 153' ' ' PRO . 76.8 mt -92.07 -22.55 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 118.014 0.37 . . . . 0.0 111.437 176.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -91.24 -12.65 34.6 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.889 -0.507 . . . . 0.0 112.225 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -127.04 46.0 2.59 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.885 0.474 . . . . 0.0 111.458 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 27.6 p -139.42 -177.9 5.14 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.775 0.43 . . . . 0.0 111.57 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.471 ' N ' HD12 ' A' ' 129' ' ' ILE . 2.9 mp -81.8 159.86 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -139.9 160.52 39.73 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.819 -0.551 . . . . 0.0 112.324 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -143.56 176.69 9.01 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -61.34 3.34 0.12 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -171.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.6 1.89 0.06 OUTLIER Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.006 -0.885 . . . . 0.0 114.0 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -154.1 177.02 11.54 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.713 1.256 . . . . 0.0 110.642 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -116.34 163.33 16.18 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.449 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 6.3 m-85 -139.46 148.16 42.33 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.009 0.433 . . . . 0.0 112.008 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.6 mp -139.56 -171.02 3.05 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 172.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 72.1 m -133.61 162.51 31.73 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.82 0.736 . . . . 0.0 112.138 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.09 167.72 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.674 1.19 . . . . 0.0 109.403 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.7 m -119.47 11.92 12.26 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -170.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.518 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 6.1 t -141.68 32.6 0.16 Allowed Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 176.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 141' ' ' SER . 85.5 Cg_endo -71.28 172.16 14.62 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.631 2.888 . . . . 0.0 113.533 -174.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.9 t -79.89 -20.54 45.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.728 0.811 . . . . 0.0 112.727 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.8 mm -117.21 165.1 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -62.82 121.1 12.62 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 57.5 159.47 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.875 1.27 . . . . 0.0 112.582 -172.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.05 108.53 1.41 Allowed Pre-proline 0 CA--C 1.522 -0.129 0 O-C-N 121.679 -0.638 . . . . 0.0 110.66 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.449 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 58.9 Cg_endo -79.77 139.92 14.31 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.636 2.224 . . . . 0.0 108.506 169.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.6 m -124.3 144.85 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.046 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -85.38 158.74 20.17 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 43.4 mm -133.32 140.73 46.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.586 1.154 . . . . 0.0 108.943 172.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -154.92 91.84 2.91 Favored Pre-proline 0 CA--C 1.535 0.375 0 O-C-N 123.345 0.403 . . . . 0.0 110.244 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.412 ' HG3' HD11 ' A' ' 125' ' ' ILE . 36.7 Cg_exo -61.23 169.93 5.72 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 124.758 3.639 . . . . 0.0 114.853 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' TRP . . . . . 0.434 ' CD2' ' HG2' ' A' ' 214' ' ' PRO . 19.6 t-105 -113.73 141.5 47.18 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.786 174.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -118.22 153.22 34.25 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.703 0.801 . . . . 0.0 110.957 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.66 12.45 16.84 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -170.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.4 t -75.51 -24.0 56.79 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -173.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -143.97 29.55 1.34 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.499 0.59 . . . . 0.0 112.578 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 49.3 m -65.51 -22.24 66.7 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.848 -0.532 . . . . 0.0 112.122 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -153.66 157.42 39.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.782 0.433 . . . . 0.0 110.851 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -155.82 152.83 28.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.33 150.3 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 O-C-N 121.935 -0.478 . . . . 0.0 109.85 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 65.2 mtm -125.14 18.9 8.35 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.252 0.221 . . . . 0.0 111.568 -175.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -154.38 -48.52 0.09 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 67.97 11.09 60.27 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 119.115 -0.825 . . . . 0.0 114.296 172.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 61.3 p -141.08 -16.51 0.85 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -176.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -82.9 139.18 42.99 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 119.548 1.067 . . . . 0.0 110.926 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -62.92 156.18 55.81 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.675 2.917 . . . . 0.0 112.238 174.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.5 mp -120.32 162.23 19.8 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.519 0.728 . . . . 0.0 110.719 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -150.01 138.79 12.64 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.17 -11.24 31.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.26 2.64 . . . . 0.0 113.322 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.2 6.14 46.29 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.558 0.617 . . . . 0.0 110.174 175.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -128.28 25.08 5.85 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.93 0.492 . . . . 0.0 110.832 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.7 m -123.75 144.48 49.66 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.77 0.319 . . . . 0.0 110.549 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.5 tt -118.8 151.25 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 123.076 0.55 . . . . 0.0 110.726 -173.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -109.61 143.43 39.34 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 172.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.1 m -139.72 134.39 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 122.974 0.509 . . . . 0.0 109.664 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -150.09 -177.74 24.36 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 -176.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.65 7.19 84.71 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.93 128.37 86.69 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -79.55 -34.5 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.842 2.361 . . . . 0.0 114.376 -172.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ARG . . . . . 0.641 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 71.4 ttp85 -160.92 -38.32 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 116.841 2.163 . . . . 0.0 116.841 -174.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.641 ' HD2' ' H ' ' A' ' 182' ' ' ARG . 84.8 Cg_endo -76.98 -45.76 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 121.609 1.61 . . . . 0.0 113.989 -169.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 30.2 -106.74 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.734 1.214 . . . . 0.0 112.858 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 64.47 136.39 0.02 OUTLIER 'General case' 0 C--N 1.343 0.284 0 C-N-CA 126.222 1.809 . . . . 0.0 112.488 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.15 -32.13 56.1 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.005 -0.434 . . . . 0.0 112.022 -175.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.44 -54.18 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-N 117.674 0.215 . . . . 0.0 111.155 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -75.4 -23.54 57.06 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.68 -173.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 51.8 tp -72.98 -30.49 63.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.02 -41.38 35.97 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 122.171 -0.331 . . . . 0.0 111.768 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 17.3 ptp -75.08 -26.48 59.37 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.217 -0.302 . . . . 0.0 110.713 -177.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.5 mt -72.04 -37.74 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.1 mmt -72.68 -15.75 61.69 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.969 -0.457 . . . . 0.0 110.076 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -89.65 -17.72 27.86 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.862 0.301 . . . . 0.0 110.95 175.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -88.83 -18.27 28.01 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 119.341 -0.362 . . . . 0.0 111.874 177.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.36 -24.86 8.22 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.284 0.493 . . . . 0.0 111.377 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -140.01 47.7 1.81 Allowed 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.794 0.438 . . . . 0.0 110.501 -175.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.13 136.12 4.33 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 123.276 0.465 . . . . 0.0 112.097 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 128.55 8.96 3.75 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -174.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' VAL . . . . . 0.414 HG22 ' CE2' ' A' ' 222' ' ' PHE . 53.9 t -66.08 147.94 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 123.65 0.78 . . . . 0.0 110.146 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.2 p -118.24 -37.45 3.35 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 119.504 -0.284 . . . . 0.0 111.49 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -157.43 153.06 26.56 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.775 0.261 . . . . 0.0 110.936 -172.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -147.99 162.04 40.14 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.308 0.575 . . . . 0.0 111.839 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 178.0 -178.36 48.49 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 8.5 tp -87.73 155.59 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ASP . . . . . 0.446 ' HA ' ' CZ ' ' A' ' 219' ' ' ARG . 15.0 p-10 -70.76 38.68 0.05 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.2 t -74.2 152.4 39.78 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.105 -0.372 . . . . 0.0 110.325 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -134.18 146.23 58.81 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 122.604 0.362 . . . . 0.0 110.31 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.01 -7.43 18.23 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 124.533 3.489 . . . . 0.0 111.989 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.24 40.55 0.49 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.952 0.501 . . . . 0.0 110.347 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 51.68 21.94 1.49 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.263 1.825 . . . . 0.0 114.316 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -86.74 -24.15 25.23 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 119.24 -0.41 . . . . 0.0 110.261 174.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.52 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 37.6 m-85 56.28 -169.6 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.624 -0.703 . . . . 0.0 109.811 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.52 ' CD ' ' HB3' ' A' ' 213' ' ' TYR . 52.0 Cg_exo -56.15 151.2 44.35 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.063 1.842 . . . . 0.0 113.102 -177.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -120.9 25.1 9.87 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.739 0.415 . . . . 0.0 110.485 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.66 12.28 73.83 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.28 -0.733 . . . . 0.0 114.152 171.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -132.2 155.03 48.97 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.236 1.018 . . . . 0.0 110.64 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -97.68 160.23 21.04 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 121.45 0.472 . . . . 0.0 112.998 -173.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' ARG . . . . . 0.446 ' CZ ' ' HA ' ' A' ' 206' ' ' ASP . 4.0 ptp85 -142.83 147.31 35.22 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 172.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 3.5 p -150.08 150.42 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.25 150.62 43.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.535 0.734 . . . . 0.0 111.175 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.414 ' CE2' HG22 ' A' ' 200' ' ' VAL . 74.8 m-85 -125.96 149.26 48.91 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.47 0.708 . . . . 0.0 110.816 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 69.1 m -82.05 -0.52 44.78 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 122.257 0.223 . . . . 0.0 110.879 173.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -132.68 133.66 43.82 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.01 0.524 . . . . 0.0 109.943 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -73.34 -21.95 60.42 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -70.42 -38.8 74.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.6 m -76.66 -25.05 53.3 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.239 -0.288 . . . . 0.0 110.239 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -69.21 -51.24 39.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 41.9 pt -69.48 -17.33 21.43 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 118.095 0.407 . . . . 0.0 110.969 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.04 -28.48 39.3 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.48 -17.06 49.99 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 13.5 pt -113.92 24.54 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 123.331 0.653 . . . . 0.0 110.329 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -81.0 -9.89 59.78 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.268 0.627 . . . . 0.0 111.669 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.45 141.78 20.6 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -56.23 -35.47 67.4 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.283 0.233 . . . . 0.0 111.403 -177.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -126.15 114.66 18.65 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.08 0.467 . . . . 0.0 110.306 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 28.7 m -97.81 161.22 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.888 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' GLN . . . . . 0.499 ' H ' ' CD ' ' A' ' 238' ' ' GLN . 0.1 OUTLIER -87.19 142.23 28.06 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.028 0.442 . . . . 0.0 109.833 176.39 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.432 HD12 ' C ' ' A' ' 238' ' ' GLN . 7.2 mp -117.47 19.2 14.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.667 0.746 . . . . 0.0 109.62 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -55.13 138.83 43.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.243 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -146.09 18.25 1.4 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.472 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 88.08 -9.53 74.41 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 123.703 0.668 . . . . 0.0 111.817 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -141.74 10.31 2.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.64 0.776 . . . . 0.0 110.884 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 35.5 mm -133.54 153.9 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.587 0.755 . . . . 0.0 109.71 -174.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -146.96 12.44 1.1 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.695 0.398 . . . . 0.0 111.019 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -80.11 173.51 12.52 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 123.579 0.752 . . . . 0.0 112.191 -172.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.6 163.01 31.56 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.818 1.247 . . . . 0.0 109.565 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 5.7 p -149.07 150.42 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -85.51 132.46 34.19 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -117.32 155.19 19.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -175.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -157.73 160.31 30.15 Favored Pre-proline 0 C--O 1.232 0.142 0 CA-C-O 119.548 -0.263 . . . . 0.0 110.548 168.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.48 124.8 14.88 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.244 1.962 . . . . 0.0 107.323 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -66.16 117.96 9.21 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.911 -169.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 125.914 1.686 . . . . 0.0 113.292 174.56 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.1 m . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 120.455 0.169 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -146.83 169.51 18.95 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.232 0.613 . . . . 0.0 109.905 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -142.22 166.89 23.46 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.954 0.502 . . . . 0.0 111.134 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -128.5 19.19 6.28 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.535 0.734 . . . . 0.0 111.624 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.92 166.97 16.95 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 57.39 10.81 1.0 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.379 1.072 . . . . 0.0 113.222 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -136.21 -1.85 2.34 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.297 0.639 . . . . 0.0 111.753 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.47 12.53 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 C-N-CA 123.302 0.641 . . . . 0.0 111.24 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -117.2 11.39 14.1 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.581 0.752 . . . . 0.0 111.629 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.5 ' HD3' ' H ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -80.7 141.47 34.84 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.441 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -158.61 164.88 35.61 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 121.156 0.503 . . . . 0.0 110.543 -173.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.7 t -88.7 165.6 14.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.195 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.33 10.95 6.02 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.824 176.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -128.15 141.53 51.45 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 124.148 0.979 . . . . 0.0 109.977 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.63 134.58 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.613 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.455 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 7.8 t80 -79.63 140.68 37.03 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 3.3 m -127.63 114.48 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 173.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.9 163.12 25.55 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.368 -172.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.65 22.24 76.63 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 119.174 -0.792 . . . . 0.0 113.42 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.0 tp -47.11 123.38 8.14 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 118.629 1.214 . . . . 0.0 107.846 173.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.67 157.53 39.94 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.705 2.27 . . . . 0.0 111.823 -172.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.34 173.39 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.42 3.414 . . . . 0.0 112.873 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.9 t70 64.88 -78.94 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.6 pt -61.7 162.01 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 118.683 0.674 . . . . 0.0 111.699 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -143.54 -156.01 0.65 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.38 -174.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -43.09 -32.68 0.73 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.642 1.977 . . . . 0.0 114.847 -173.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -78.6 -34.74 46.54 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.615 1.098 . . . . 0.0 112.139 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -77.52 -27.92 51.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.149 -0.345 . . . . 0.0 110.51 -174.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 25.9 pt -84.26 -27.03 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 O-C-N 122.067 -0.396 . . . . 0.0 110.398 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.4 m -73.22 -12.97 61.05 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.16 -17.42 17.41 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.0 m -82.78 -42.51 17.85 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.93 0.787 . . . . 0.0 112.237 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -90.01 1.61 56.11 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -68.38 -14.64 63.14 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.838 0.455 . . . . 0.0 111.953 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -69.8 -10.0 56.76 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.014 0.525 . . . . 0.0 111.555 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -112.89 17.24 19.11 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.832 0.453 . . . . 0.0 110.46 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.54 167.89 21.03 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.78 146.45 72.51 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.448 2.765 . . . . 0.0 110.507 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.5 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -149.94 166.67 28.91 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.0 0.429 . . . . 0.0 111.646 -178.776 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.9 pt -135.14 166.63 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.201 175.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.66 148.39 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 CA-C-O 120.722 0.296 . . . . 0.0 110.484 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -150.32 165.02 34.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.935 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.524 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 42.1 p90 -154.76 164.05 22.29 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.524 ' HD2' ' HB2' ' A' ' 95' ' ' TRP . 43.3 Cg_endo -73.04 -13.58 26.16 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 123.117 2.545 . . . . 0.0 110.927 -169.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.446 ' ND1' ' HG2' ' A' ' 96' ' ' PRO . 44.0 m80 -101.75 7.48 41.85 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.763 0.825 . . . . 0.0 111.102 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.9 tptt -62.23 148.5 44.58 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.945 0.498 . . . . 0.0 110.395 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.43 166.58 27.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.08 0.552 . . . . 0.0 111.117 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -89.47 9.2 27.35 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.212 0.605 . . . . 0.0 110.947 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 84.4 p -79.02 -0.57 31.78 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.398 0.679 . . . . 0.0 112.044 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt 52.76 31.7 10.92 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.817 0.847 . . . . 0.0 112.346 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.1 t -82.09 -25.48 34.46 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.133 0.173 . . . . 0.0 110.974 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 53.02 -171.42 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.764 1.225 . . . . 0.0 113.422 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 48.9 t80 57.48 110.54 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 126.435 1.894 . . . . 0.0 113.975 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.9 166.81 3.56 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 124.373 3.382 . . . . 0.0 112.778 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -47.98 -29.85 12.73 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 124.892 3.728 . . . . 0.0 115.633 -177.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -151.35 -68.23 0.18 Allowed 'General case' 0 C--N 1.34 0.156 0 CA-C-N 119.239 0.927 . . . . 0.0 111.649 177.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.73 41.34 0.14 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.7 -171.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.76 147.59 31.08 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.168 0.984 . . . . 0.0 109.254 172.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.89 175.91 11.59 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 122.61 0.364 . . . . 0.0 110.931 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -136.1 129.39 31.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -90.32 149.18 22.43 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.549 0.69 . . . . 0.0 111.785 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.82 145.58 41.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.158 -1.383 . . . . 0.0 107.297 171.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -134.11 165.88 24.05 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 110.956 -176.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -105.03 -31.48 9.17 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.236 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -121.24 150.48 41.29 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.862 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -87.32 -5.83 58.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.322 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.2 p -93.72 -15.19 25.48 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.665 0.386 . . . . 0.0 111.437 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 75.3 m -73.19 -36.12 66.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 122.019 -0.426 . . . . 0.0 110.769 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.01 -20.43 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -77.42 -38.54 49.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.0 -35.97 66.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.257 0.48 . . . . 0.0 111.584 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -78.84 -15.59 58.18 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.199 0.454 . . . . 0.0 111.705 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.5 mt -99.33 -15.44 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 122.354 0.262 . . . . 0.0 111.209 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -103.34 -9.31 19.58 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.593 -0.692 . . . . 0.0 112.641 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -115.99 29.9 7.69 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.848 0.459 . . . . 0.0 111.96 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 32.0 p -140.48 -176.26 4.57 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.774 0.43 . . . . 0.0 111.659 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 32.2 mm -79.14 156.05 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 124.629 1.172 . . . . 0.0 109.007 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -138.84 155.5 48.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 111.972 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -144.15 70.77 1.3 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.374 0.607 . . . . 0.0 110.066 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 p30 47.44 12.92 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.72 2.008 . . . . 0.0 116.228 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 175.5 -20.47 0.05 OUTLIER Glycine 0 CA--C 1.526 0.779 0 CA-C-N 118.578 0.626 . . . . 0.0 112.446 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -134.63 170.96 15.02 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 117.759 0.779 . . . . 0.0 109.555 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 150' ' ' GLN . 4.6 mp -130.63 173.33 11.0 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.897 -176.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -139.75 147.69 41.21 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.2 mp -133.84 164.0 28.24 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 170.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.7 m -101.98 150.49 23.17 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.205 0.602 . . . . 0.0 110.659 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.6 m -142.6 -4.76 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.3 m 48.53 43.94 20.45 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.515 0.726 . . . . 0.0 112.842 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.6 p -73.55 153.62 89.71 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.71 8.95 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.635 1 C-N-CA 125.58 4.186 . . . . 0.0 117.296 -175.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.0 m -96.28 -18.42 20.02 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.677 1.126 . . . . 0.0 110.069 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.533 ' N ' HD12 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -165.62 -172.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.342 1.457 . . . . 0.0 108.405 -171.537 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -69.5 -32.79 71.87 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.019 -0.426 . . . . 0.0 109.984 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.49 ' C ' HD13 ' A' ' 144' ' ' ILE . 24.3 t70 -162.95 153.15 16.17 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.266 0.626 . . . . 0.0 111.0 176.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.472 ' HE3' " O5'" ' B' ' 1' ' ' ' C' . 0.0 OUTLIER -116.19 106.87 48.48 Favored Pre-proline 0 N--CA 1.457 -0.107 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 174.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.407 ' HD2' ' C2 ' ' B' ' 1' ' ' ' C' . 35.5 Cg_exo -63.46 91.92 0.16 Allowed 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.866 2.378 . . . . 0.0 109.026 168.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.8 m -80.2 141.75 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.428 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 72.2 mt-30 -93.18 159.71 15.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.647 -177.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 50.0 mm -129.88 141.44 46.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.115 0.966 . . . . 0.0 109.761 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.29 101.62 1.54 Allowed Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.67 164.16 30.68 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.971 3.114 . . . . 0.0 111.91 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -88.08 148.7 24.35 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -109.28 150.31 28.15 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.851 0.46 . . . . 0.0 111.247 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.5 mp -96.74 78.1 2.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.128 0.571 . . . . 0.0 110.461 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.9 t -155.11 -32.66 0.1 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -134.56 28.06 3.66 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.2 m -60.71 -31.59 70.87 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.167 -0.333 . . . . 0.0 111.679 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -158.3 163.05 37.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.922 0.489 . . . . 0.0 110.877 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -156.1 156.61 34.6 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.494 0.318 . . . . 0.0 110.539 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.2 m -137.53 152.42 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 C-N-CA 123.273 0.629 . . . . 0.0 110.14 175.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 18.2 ttp -130.13 14.68 5.69 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.224 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -148.57 -170.95 3.74 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -73.02 25.77 0.8 Allowed Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.682 0.658 . . . . 0.0 112.949 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 44.7 m 53.67 52.17 13.69 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 117.945 0.873 . . . . 0.0 111.645 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -59.3 156.55 28.83 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 122.963 0.505 . . . . 0.0 110.349 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.15 140.64 60.52 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.179 2.586 . . . . 0.0 111.758 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 74.9 mt -114.38 153.61 29.54 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.777 0.431 . . . . 0.0 110.549 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -145.37 156.03 53.73 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.77 -5.76 17.57 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.033 2.488 . . . . 0.0 111.011 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -98.76 4.44 47.73 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.522 1.129 . . . . 0.0 111.455 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -129.01 16.6 6.22 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 122.693 0.397 . . . . 0.0 111.577 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 25.7 m -127.69 140.75 51.88 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.027 0.441 . . . . 0.0 112.018 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.9 tt -116.98 149.43 19.23 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.293 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -107.24 150.32 26.78 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 97.4 t -135.52 124.57 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 123.489 0.715 . . . . 0.0 109.278 -175.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -141.23 166.1 26.14 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 120.983 0.213 . . . . 0.0 112.585 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.6 17.79 61.35 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -170.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.0 m -72.19 154.85 92.08 Favored Pre-proline 0 CA--C 1.529 0.155 0 C-N-CA 122.965 0.506 . . . . 0.0 112.332 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.09 177.8 7.75 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.945 3.097 . . . . 0.0 108.963 169.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -66.39 -52.96 33.62 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.449 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.1 149.68 19.98 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.522 2.148 . . . . 0.0 111.069 175.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 43.1 mt -146.94 -43.54 0.18 Allowed 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 122.883 0.473 . . . . 0.0 110.964 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 52.76 102.71 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.43 1.492 . . . . 0.0 111.662 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -56.32 -24.28 42.62 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 30.9 t -63.27 -49.75 81.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 CA-C-N 117.979 0.354 . . . . 0.0 110.636 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -82.82 -21.12 34.57 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.814 -0.176 . . . . 0.0 110.773 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 40.7 tp -67.22 -37.31 83.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.68 -33.11 47.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.817 -0.135 . . . . 0.0 111.147 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.0 mmt -69.05 -37.17 78.42 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 117.873 0.306 . . . . 0.0 110.293 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.475 ' CG2' ' HA ' ' A' ' 239' ' ' LEU . 46.5 mt -69.6 -48.47 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 122.186 0.195 . . . . 0.0 110.535 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -58.94 -22.29 59.7 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.045 0.384 . . . . 0.0 111.453 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -84.18 -20.72 31.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.595 0.634 . . . . 0.0 111.546 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -89.32 -16.04 32.01 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 119.287 -0.387 . . . . 0.0 111.733 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -113.53 -18.36 11.97 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.36 0.527 . . . . 0.0 112.309 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -138.97 -30.37 0.74 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.851 0.75 . . . . 0.0 112.782 -177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.16 -177.92 18.57 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 68.99 11.66 63.81 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.586 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 15.6 t -69.09 149.11 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 118.323 1.061 . . . . 0.0 110.282 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 48.5 t -131.65 -35.3 1.29 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.163 0.185 . . . . 0.0 111.31 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -148.31 149.33 31.64 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.22 156.2 38.06 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.135 0.574 . . . . 0.0 109.803 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 169.39 -175.8 43.56 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.9 143.33 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -54.54 133.95 46.3 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.903 -0.135 . . . . 0.0 111.13 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 22.2 p -141.36 167.55 21.89 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 122.739 0.416 . . . . 0.0 110.363 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -129.34 131.51 23.69 Favored Pre-proline 0 N--CA 1.453 -0.299 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -80.19 -12.73 12.87 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.917 3.745 . . . . 0.0 113.728 -174.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -97.23 -27.06 14.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.701 0.682 . . . . 0.0 110.672 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 94.1 mt -108.75 -0.39 20.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.267 0.627 . . . . 0.0 110.534 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 46.59 48.41 14.24 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.707 1.203 . . . . 0.0 112.496 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.03 153.98 50.07 Favored Pre-proline 0 CA--C 1.53 0.182 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -176.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.85 153.92 29.71 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.78 2.32 . . . . 0.0 110.754 173.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -117.58 25.05 10.68 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.566 0.746 . . . . 0.0 110.563 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.41 ' HA3' ' C5 ' ' B' ' 4' ' ' ' U' . . . 68.01 -170.71 36.67 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -176.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 52.38 -166.51 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 117.521 0.661 . . . . 0.0 110.96 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -155.82 173.47 33.85 Favored Glycine 0 C--N 1.333 0.397 0 O-C-N 121.146 -0.972 . . . . 0.0 112.281 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -142.44 155.13 45.06 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 66.7 t -139.12 143.14 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.44 150.51 49.61 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.908 0.385 . . . . 0.0 110.197 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -125.81 152.72 45.06 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.899 -174.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 68.7 p -86.05 4.69 36.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.258 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -138.14 141.24 40.15 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.108 0.563 . . . . 0.0 110.448 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -75.13 -13.16 60.44 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.757 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -81.59 -37.48 27.59 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 20.0 m -75.58 -27.1 58.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -66.88 -51.8 51.08 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.448 -0.205 . . . . 0.0 110.448 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.0 pt -69.98 -15.67 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-N 118.002 0.365 . . . . 0.0 111.038 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.97 -23.91 35.8 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.786 0.267 . . . . 0.0 110.686 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -84.34 -31.34 24.87 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.705 0.229 . . . . 0.0 111.579 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.5 pt -98.77 24.57 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 122.621 0.368 . . . . 0.0 110.236 174.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.9 t -77.94 -17.7 56.92 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.024 0.53 . . . . 0.0 111.547 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.06 143.58 22.62 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -54.69 -32.29 59.17 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 122.716 0.406 . . . . 0.0 111.781 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -118.01 108.55 15.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.914 0.388 . . . . 0.0 110.195 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.53 HG23 HD21 ' A' ' 239' ' ' LEU . 2.4 m -78.03 161.3 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.599 176.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.61 ' C ' HD22 ' A' ' 239' ' ' LEU . 7.4 mp0 -93.55 135.77 34.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.61 HD22 ' C ' ' A' ' 238' ' ' GLN . 2.7 mm? -123.3 28.03 7.26 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.795 0.331 . . . . 0.0 110.72 -175.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -76.5 147.37 37.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.643 0.377 . . . . 0.0 110.964 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -149.49 16.89 0.91 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.652 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 83.94 125.72 1.22 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -173.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 53.49 15.74 0.78 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.196 0.998 . . . . 0.0 113.128 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 73.6 mt -140.7 148.67 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.987 0.915 . . . . 0.0 109.241 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -158.8 134.42 8.73 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -144.91 166.19 25.98 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 124.492 1.117 . . . . 0.0 108.34 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.75 150.92 33.94 Favored 'General case' 0 CA--C 1.523 -0.061 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.5 p -158.97 157.13 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -82.81 145.16 29.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.088 0.555 . . . . 0.0 110.835 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.11 161.37 29.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 112.503 0.556 . . . . 0.0 112.503 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.57 159.29 25.83 Favored Pre-proline 0 N--CA 1.455 -0.176 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.911 170.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.09 135.98 73.89 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.559 2.173 . . . . 0.0 109.038 173.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -69.89 146.38 51.3 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.964 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.5 p -154.3 146.21 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.922 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 C--O 1.251 1.176 0 CA-C-O 117.776 -1.107 . . . . 0.0 110.926 -179.809 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.472 " O5'" ' HE3' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.898 1 O4'-C1'-N19 113.936 5.736 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.171 2 C3'-C2'-C1' 105.735 4.706 OUTLIER-DELTA 0.378 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.455 ' C6 ' ' CE2' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.417 -3.02 2 O4'-C1'-N19 114.191 5.991 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.5 " C1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.417 -2.965 0 C5'-C4'-C3' 110.825 -3.117 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.54 H5'' ' C8 ' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.059 0 O4'-C1'-N19 111.445 3.245 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.5 p . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 120.0 -0.048 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -146.26 162.31 38.37 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.283 0.633 . . . . 0.0 110.075 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -137.68 164.79 27.97 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.708 0.803 . . . . 0.0 110.188 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -142.09 161.13 38.78 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.823 0.449 . . . . 0.0 110.882 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.89 -173.88 47.9 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -138.79 152.77 48.18 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.626 0.771 . . . . 0.0 109.231 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -137.76 166.99 22.64 Favored 'General case' 0 C--O 1.228 -0.042 0 C-N-CA 123.365 0.666 . . . . 0.0 110.116 -177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.26 9.6 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 123.034 0.534 . . . . 0.0 111.49 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -81.93 -8.65 59.69 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.729 0.412 . . . . 0.0 111.195 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.4 ppt_? -86.95 145.93 26.34 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 110.692 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -155.48 169.23 24.74 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.092 -171.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.6 t -89.73 19.97 4.37 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 54.13 18.94 1.92 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.578 0.751 . . . . 0.0 112.256 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -145.38 146.27 31.5 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.151 0.58 . . . . 0.0 109.866 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.36 142.05 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.208 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.497 ' CZ ' ' C6 ' ' B' ' 3' ' ' ' U' . 3.7 t80 -90.26 139.35 30.74 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.462 HG12 ' CD1' ' A' ' 151' ' ' ILE . 5.5 m -125.72 99.04 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 122.033 0.92 . . . . 0.0 108.765 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.03 164.59 31.21 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.529 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.47 24.09 77.27 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 122.618 -0.342 . . . . 0.0 112.649 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.1 tp -60.41 128.67 88.31 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 69.4 Cg_endo -69.72 131.02 20.42 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.886 1.724 . . . . 0.0 110.015 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 35.9 Cg_exo -64.45 -8.48 17.15 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.735 2.957 . . . . 0.0 114.627 -176.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -88.07 -0.65 57.31 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -173.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.404 HD12 ' C ' ' A' ' 76' ' ' ILE . 2.1 pp -136.67 -173.29 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.091 0 CA-C-N 118.636 0.653 . . . . 0.0 111.014 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -139.73 -166.78 2.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.541 0.736 . . . . 0.0 111.004 -175.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -45.93 -31.42 2.18 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.462 1.505 . . . . 0.0 113.213 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -65.94 -36.6 83.79 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -73.48 -38.17 65.51 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 122.095 -0.378 . . . . 0.0 110.403 -172.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.5 pt -84.05 -27.46 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 O-C-N 122.101 -0.374 . . . . 0.0 111.436 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 90.9 m -69.97 -16.41 63.19 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.14 -19.43 18.66 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.0 m -79.46 -26.68 41.68 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.902 0.774 . . . . 0.0 112.962 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -113.26 10.16 18.46 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.134 0.424 . . . . 0.0 111.743 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -68.9 -19.89 64.23 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 122.827 0.451 . . . . 0.0 111.762 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -72.18 -12.1 61.03 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.526 0.33 . . . . 0.0 111.102 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -105.2 20.5 18.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.744 0.418 . . . . 0.0 110.283 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.34 170.71 31.99 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.78 144.57 59.87 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.211 2.607 . . . . 0.0 110.425 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.511 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -149.61 168.33 23.86 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.862 0.363 . . . . 0.0 111.256 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.2 pt -140.53 166.49 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.46 149.73 24.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 121.147 0.498 . . . . 0.0 110.717 -176.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -147.18 163.32 36.71 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.222 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.409 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 28.8 p90 -158.62 161.75 27.85 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 174.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.5 ' HB2' " H4'" ' B' ' 5' ' ' ' A' . 32.8 Cg_endo -74.34 -9.59 21.8 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.5 2.134 . . . . 0.0 110.568 -170.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -100.79 17.82 21.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.52 1.128 . . . . 0.0 110.98 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -50.15 146.1 5.29 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.322 0.649 . . . . 0.0 112.625 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -108.42 -172.24 2.02 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.495 1.118 . . . . 0.0 110.814 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -68.35 -178.99 1.19 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.32 0.648 . . . . 0.0 110.536 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.9 m -70.24 9.12 0.63 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.087 0.555 . . . . 0.0 111.712 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -147.6 160.97 42.06 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.305 1.042 . . . . 0.0 110.052 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.3 t 52.97 32.45 12.73 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.589 0.756 . . . . 0.0 112.811 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -80.01 138.57 37.07 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.6 0.36 . . . . 0.0 111.146 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -153.14 150.46 23.97 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 124.096 0.958 . . . . 0.0 109.296 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -62.86 156.62 52.79 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.28 3.32 . . . . 0.0 111.976 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.66 -29.09 16.43 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.784 2.989 . . . . 0.0 112.149 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.407 ' HD3' ' C ' ' A' ' 108' ' ' LYS . 4.4 tmtm? -156.74 -68.53 0.1 Allowed 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 123.419 0.687 . . . . 0.0 109.454 176.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.3 31.5 0.07 OUTLIER Glycine 0 CA--C 1.525 0.66 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.154 -172.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.436 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.4 OUTLIER -141.42 145.66 35.59 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 117.799 0.799 . . . . 0.0 108.884 174.687 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.06 176.79 10.81 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.598 0.359 . . . . 0.0 110.875 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.495 ' CE1' ' C5 ' ' B' ' 4' ' ' ' U' . 1.6 m-85 -139.54 126.97 21.5 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -177.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.5 mp -89.58 151.04 22.13 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.32 0.581 . . . . 0.0 111.524 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 mp -114.11 139.59 49.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -136.78 175.62 9.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.508 0.723 . . . . 0.0 109.946 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -115.95 -23.43 8.56 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 122.92 0.488 . . . . 0.0 111.783 -175.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -141.49 160.88 39.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.868 0.366 . . . . 0.0 111.228 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -82.14 -14.61 55.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.271 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 41.4 m -79.02 -16.96 56.14 Favored 'General case' 0 C--O 1.231 0.093 0 O-C-N 122.277 -0.265 . . . . 0.0 111.112 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 73.1 m -79.62 -42.73 24.28 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.331 -0.23 . . . . 0.0 110.599 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.96 -22.34 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -75.89 -33.63 59.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.87 -36.9 59.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 117.967 0.349 . . . . 0.0 111.086 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 pp -78.86 -14.6 59.15 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 117.993 0.36 . . . . 0.0 111.43 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.8 mt -98.76 -17.16 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 122.328 0.251 . . . . 0.0 111.43 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -100.55 -10.78 20.68 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.879 -0.513 . . . . 0.0 112.131 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -120.22 30.25 7.08 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.053 0.541 . . . . 0.0 111.719 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 23.4 p -127.55 -174.83 3.28 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.241 0.616 . . . . 0.0 111.216 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 43.2 mm -87.76 161.31 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.023 0.929 . . . . 0.0 109.074 -176.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -127.14 154.25 44.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.611 0.243 . . . . 0.0 110.769 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -141.45 66.21 1.36 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.271 0.558 . . . . 0.0 110.402 176.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 52.31 9.57 0.1 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 172.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 171.11 -16.36 0.06 OUTLIER Glycine 0 CA--C 1.528 0.847 0 CA-C-N 118.59 0.632 . . . . 0.0 112.485 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -128.27 172.16 11.3 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-N 117.663 0.731 . . . . 0.0 109.726 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.8 161.63 15.25 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.343 0.257 . . . . 0.0 110.308 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.413 ' CE1' ' HG2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -139.86 150.64 44.88 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.087 0.555 . . . . 0.0 109.784 -178.882 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.8 tp -138.82 151.26 46.88 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 169.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 44.0 t -84.7 152.7 23.56 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -127.71 161.31 35.77 Favored 'Isoleucine or valine' 0 C--N 1.337 0.056 0 C-N-CA 122.972 0.509 . . . . 0.0 110.099 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 52.9 m -92.25 -13.94 29.68 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.3 m -142.9 65.25 15.78 Favored Pre-proline 0 CA--C 1.53 0.18 0 C-N-CA 123.073 0.549 . . . . 0.0 109.968 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -68.95 168.96 18.97 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.682 3.588 . . . . 0.0 111.849 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.422 ' HB ' ' CB ' ' A' ' 73' ' ' PRO . 13.4 t -84.31 160.31 20.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 174.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.9 mt 57.17 -108.49 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -148.85 132.24 16.6 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.465 0.706 . . . . 0.0 109.135 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.4 t0 41.79 78.78 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.754 1.222 . . . . 0.0 112.064 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 108.81 20.4 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 119.568 -0.253 . . . . 0.0 110.711 -174.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.413 ' HG2' ' CE1' ' A' ' 136' ' ' TYR . 91.1 Cg_endo -71.59 165.31 32.91 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.399 3.4 . . . . 0.0 112.348 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.4 p -114.92 140.38 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.0 tm0? -94.94 151.89 18.81 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.483 0.713 . . . . 0.0 110.913 -174.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.462 ' CD1' HG12 ' A' ' 69' ' ' VAL . 32.4 mm -134.87 142.02 41.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 C-N-CA 123.408 0.683 . . . . 0.0 111.147 -177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -156.76 113.92 2.01 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 169.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -77.39 171.44 17.65 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 124.44 3.427 . . . . 0.0 112.464 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 -100.18 140.22 34.72 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -107.84 152.43 24.41 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.481 0.657 . . . . 0.0 111.663 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.7 mp -87.57 65.01 8.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.423 0.689 . . . . 0.0 110.544 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.4 t -133.76 -25.23 1.67 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.692 0.397 . . . . 0.0 111.151 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -153.81 138.3 16.8 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 67.2 m -157.79 -45.43 0.06 Allowed 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 117.907 0.321 . . . . 0.0 110.405 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -160.63 163.44 32.57 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.934 0.493 . . . . 0.0 110.617 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -157.37 160.24 38.25 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.2 m -138.69 150.39 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.559 0.744 . . . . 0.0 110.136 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 52.7 mtm -132.29 29.96 4.25 Favored 'General case' 0 C--N 1.335 -0.055 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.925 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -151.71 162.34 41.18 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -77.96 29.85 1.83 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 123.563 0.602 . . . . 0.0 112.141 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 m 57.42 52.1 9.03 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -61.92 163.51 12.86 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -47.03 128.05 13.32 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.171 2.58 . . . . 0.0 111.512 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.0 tp -136.45 136.41 39.47 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.648 0.779 . . . . 0.0 110.153 -172.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -150.95 159.99 32.9 Favored Pre-proline 0 N--CA 1.455 -0.215 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.88 -14.72 14.74 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.531 2.821 . . . . 0.0 113.151 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -79.74 -6.62 57.61 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.831 0.452 . . . . 0.0 111.286 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -126.75 23.23 6.74 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 122.744 0.417 . . . . 0.0 110.457 175.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 27.7 m -122.08 148.77 44.45 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.922 0.392 . . . . 0.0 111.075 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.27 147.86 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 123.306 0.643 . . . . 0.0 109.416 -176.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -112.32 154.34 25.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 10.9 m -140.14 146.16 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.077 0.551 . . . . 0.0 110.515 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -150.71 170.79 30.54 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.04 12.42 84.4 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . 10.7 p -87.76 146.27 38.67 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 122.71 0.404 . . . . 0.0 111.009 -176.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 180' ' ' VAL . 53.1 Cg_exo -55.64 161.91 7.21 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.247 2.632 . . . . 0.0 111.734 171.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -47.52 78.74 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.511 -0.757 . . . . 0.0 112.474 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.47 60.29 7.75 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.061 2.507 . . . . 0.0 111.429 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.408 ' C ' HD12 ' A' ' 184' ' ' LEU . 4.1 pp -74.02 -10.91 60.11 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.981 -0.449 . . . . 0.0 111.972 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.15 80.48 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.489 1.516 . . . . 0.0 112.242 172.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.39 -28.85 46.33 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -171.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.87 -44.37 88.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.068 0 CA-C-N 118.774 0.715 . . . . 0.0 110.167 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -85.86 -18.23 33.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.056 -175.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 29.9 tp -73.26 -30.31 63.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.85 -35.38 57.55 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.7 mmt -67.97 -33.5 74.77 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.425 ' CG2' ' HA ' ' A' ' 239' ' ' LEU . 34.8 mt -71.55 -46.99 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 122.613 0.365 . . . . 0.0 110.704 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -61.27 -23.18 65.49 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.31 0.505 . . . . 0.0 110.699 174.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -82.69 -18.65 40.17 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.969 -0.457 . . . . 0.0 111.272 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -93.4 -11.94 31.03 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 119.114 -0.47 . . . . 0.0 111.963 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -114.6 -20.75 10.59 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 118.673 0.669 . . . . 0.0 111.972 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -137.06 -33.6 0.75 Allowed 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.519 0.6 . . . . 0.0 112.578 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 68.08 179.1 15.97 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 70.82 13.89 72.46 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.428 -0.651 . . . . 0.0 113.133 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.41 HG22 ' CE2' ' A' ' 222' ' ' PHE . 22.6 t -68.78 140.66 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 118.269 1.034 . . . . 0.0 109.944 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.5 p -120.84 -30.13 4.5 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -153.39 149.37 27.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.639 0.256 . . . . 0.0 110.671 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -157.12 158.12 35.78 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.305 0.642 . . . . 0.0 109.739 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 157.41 -172.52 34.81 Favored Glycine 0 C--N 1.335 0.528 0 N-CA-C 111.974 -0.45 . . . . 0.0 111.974 177.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 205' ' ' ILE . 4.2 mp -88.01 140.15 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 174.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -53.67 106.01 0.16 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 14.4 t -152.56 146.27 25.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.238 0.542 . . . . 0.0 112.233 -175.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -152.79 135.44 9.26 Favored Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 170.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -75.89 3.09 6.37 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.022 3.148 . . . . 0.0 111.413 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -77.83 -45.73 23.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.5 pp -161.26 6.59 0.07 Allowed 'General case' 0 C--N 1.341 0.21 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -138.05 -29.77 0.82 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -177.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.501 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 34.3 m-85 54.18 -166.77 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.596 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.501 ' CD ' ' HB3' ' A' ' 213' ' ' TYR . 91.8 Cg_endo -75.19 144.35 29.52 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 CA-C-N 121.935 1.727 . . . . 0.0 112.778 -170.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.472 ' HA ' ' C4 ' ' B' ' 4' ' ' ' U' . 88.3 mttt -90.26 -168.76 2.2 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.583 0.753 . . . . 0.0 110.064 175.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.408 ' N ' ' C5 ' ' B' ' 4' ' ' ' U' . . . -96.35 5.24 65.07 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -137.38 150.49 47.73 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.205 0.602 . . . . 0.0 110.85 -175.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -104.35 173.4 21.25 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.971 -173.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -148.31 153.51 38.75 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 88.7 t -138.25 148.85 24.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -136.65 156.87 47.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.422 0.63 . . . . 0.0 111.381 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.41 ' CE2' HG22 ' A' ' 200' ' ' VAL . 81.5 m-85 -132.25 153.23 50.85 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.561 -175.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.1 p -84.63 0.48 50.04 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.956 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -132.83 141.18 48.32 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.068 0.547 . . . . 0.0 110.362 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.3 pm0 -74.41 -7.27 52.36 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.369 0.268 . . . . 0.0 111.268 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -83.52 -40.62 18.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 25.5 m -75.51 -24.98 56.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -63.91 -50.75 67.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -73.71 -11.78 14.91 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 CA-C-N 118.09 0.405 . . . . 0.0 111.144 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.43 -17.05 33.13 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.588 0.176 . . . . 0.0 111.149 174.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.76 -12.34 29.36 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 11.3 pt -120.39 23.25 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.354 0.662 . . . . 0.0 110.313 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.2 p -76.79 -19.03 58.05 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.23 0.612 . . . . 0.0 111.721 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.3 144.33 22.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -57.61 -31.61 66.4 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -122.94 110.14 15.01 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.466 HG23 HD21 ' A' ' 239' ' ' LEU . 4.0 m -82.36 154.89 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.205 175.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.533 ' C ' HD22 ' A' ' 239' ' ' LEU . 24.8 mm100 -84.07 138.45 33.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 173.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.533 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.1 mm? -120.88 36.77 4.49 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -81.63 147.29 29.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.945 0.402 . . . . 0.0 111.887 -173.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -136.48 16.33 3.16 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.27 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 85.55 -15.36 46.7 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.006 0.813 . . . . 0.0 112.523 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -140.68 1.83 1.75 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.707 0.753 . . . . 0.0 110.786 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.6 mt -141.18 153.45 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 123.751 0.82 . . . . 0.0 109.335 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -148.02 135.3 20.49 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -145.34 169.38 18.39 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 125.023 1.329 . . . . 0.0 108.415 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ARG . . . . . 0.456 ' HA ' HD23 ' A' ' 239' ' ' LEU . 0.1 OUTLIER -150.15 151.65 33.46 Favored 'General case' 0 CA--C 1.523 -0.059 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.47 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 11.4 p -155.17 153.73 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -83.35 124.09 30.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.5 m -102.98 159.0 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.547 ' HG3' ' H61' ' B' ' 5' ' ' ' A' . 0.0 OUTLIER -159.67 159.01 27.91 Favored Pre-proline 0 CA--C 1.528 0.113 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.665 169.45 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.33 142.72 94.95 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.769 2.312 . . . . 0.0 110.124 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -83.83 166.79 17.65 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.997 0.427 . . . . 0.0 110.641 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 6.7 p -151.78 155.37 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 123.282 0.633 . . . . 0.0 110.142 -170.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 61.8 tp . . . . . 0 C--O 1.249 1.035 0 CA-C-O 117.245 -1.359 . . . . 0.0 110.064 179.56 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.77 1 C5'-C4'-C3' 108.76 -4.493 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.94 1 C3'-C2'-C1' 105.15 4.056 . 0.095 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.497 ' C6 ' ' CZ ' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.691 2 O4'-C1'-N19 114.062 5.862 OUTLIER-DELTA 0.308 4b . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.495 ' C5 ' ' CE1' ' A' ' 112' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.732 0 C5'-C4'-C3' 111.32 -2.787 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.547 ' H61' ' HG3' ' A' ' 251' ' ' LYS . . . . . . . . 0 O4'--C4' 1.412 -3.395 1 C5'-C4'-C3' 108.711 -4.526 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 120.487 0.184 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -145.93 14.21 1.33 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.944 0.498 . . . . 0.0 111.243 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -138.87 168.86 18.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.723 0.809 . . . . 0.0 110.485 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -142.15 157.25 45.09 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.887 0.475 . . . . 0.0 109.803 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.87 167.83 27.75 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -153.67 154.74 34.71 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.277 0.631 . . . . 0.0 109.682 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -138.42 120.75 15.92 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.765 0.426 . . . . 0.0 109.914 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.2 t -149.2 127.45 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -158.35 170.99 20.99 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.703 0.287 . . . . 0.0 110.687 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.431 ' HG3' ' H ' ' A' ' 63' ' ' TYR . 12.9 tpt180 -130.42 174.34 9.96 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.737 0.815 . . . . 0.0 109.257 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.431 ' H ' ' HG3' ' A' ' 62' ' ' ARG . 15.6 m-85 -132.66 148.95 52.35 Favored 'General case' 0 N--CA 1.458 -0.044 0 CA-C-O 120.743 0.306 . . . . 0.0 111.106 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.2 m -88.41 24.86 1.81 Allowed 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.244 0.618 . . . . 0.0 111.847 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.19 28.02 6.61 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 122.867 0.467 . . . . 0.0 109.995 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -135.29 137.85 42.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.292 1.037 . . . . 0.0 110.447 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.4 p -151.39 137.96 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.732 174.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.498 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 11.0 t80 -87.12 143.09 27.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.5 p -128.5 85.59 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 121.979 0.895 . . . . 0.0 108.96 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.427 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -80.84 165.05 47.18 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.094 -177.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.526 ' HA2' " H4'" ' B' ' 1' ' ' ' C' . . . 73.43 9.16 77.32 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 119.77 -0.461 . . . . 0.0 113.17 177.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.6 tp -49.47 137.08 16.9 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.477 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 58.3 Cg_endo -66.0 136.57 45.24 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.959 1.773 . . . . 0.0 109.535 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 31.8 Cg_exo -61.55 14.03 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 124.195 3.263 . . . . 0.0 115.593 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -140.55 32.31 1.86 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.961 0.801 . . . . 0.0 112.067 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.77 155.18 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -120.42 -178.45 3.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.443 0.697 . . . . 0.0 111.0 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -53.37 -31.48 44.9 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.753 0.821 . . . . 0.0 112.738 -175.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -78.18 -33.77 49.94 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -173.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -77.49 -24.98 50.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.867 -0.52 . . . . 0.0 110.583 -173.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.5 mt -80.53 -40.55 19.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.8 m -68.02 -8.71 39.83 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.593 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.43 -19.73 14.31 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 172.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.5 m -74.98 -26.96 59.96 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 118.856 0.753 . . . . 0.0 112.535 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -122.25 17.4 10.68 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -70.81 -17.08 62.77 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -80.62 4.94 16.96 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.044 -0.41 . . . . 0.0 111.79 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -116.66 24.87 10.98 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.566 0.346 . . . . 0.0 110.751 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.64 173.62 30.81 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.16 151.66 72.49 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.492 2.795 . . . . 0.0 110.846 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.464 HD23 ' N ' ' A' ' 91' ' ' LEU . 0.6 OUTLIER -161.06 161.96 31.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.482 -170.294 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.9 pt -140.37 161.91 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.8 173.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.69 151.67 33.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -145.36 160.7 41.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.532 0.682 . . . . 0.0 112.299 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.418 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 30.3 p90 -155.75 158.77 31.86 Favored Pre-proline 0 N--CA 1.451 -0.386 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 169.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.472 ' HG3' " C1'" ' B' ' 4' ' ' ' U' . 28.5 Cg_endo -74.7 -7.98 19.93 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.447 2.765 . . . . 0.0 110.628 -169.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.431 ' ND1' ' HG2' ' A' ' 96' ' ' PRO . 51.5 m80 -105.37 18.06 22.9 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.381 1.073 . . . . 0.0 111.182 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -50.86 155.04 1.26 Allowed 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.96 0.904 . . . . 0.0 112.387 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -136.74 169.47 17.69 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.403 0.681 . . . . 0.0 111.1 -176.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -141.23 150.81 43.13 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.36 0.664 . . . . 0.0 109.544 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.6 m 55.56 18.63 2.82 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.737 0.815 . . . . 0.0 112.767 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -142.46 170.92 14.8 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.429 1.092 . . . . 0.0 109.438 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.3 p -67.63 159.4 30.01 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.685 0.278 . . . . 0.0 110.727 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -98.02 142.36 29.83 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.651 0.38 . . . . 0.0 110.903 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -159.19 115.82 1.61 Allowed Pre-proline 0 N--CA 1.454 -0.264 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.69 158.29 24.91 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.933 3.089 . . . . 0.0 110.815 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.14 133.63 31.4 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.378 2.719 . . . . 0.0 110.305 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.6 tptm 40.03 -93.3 0.01 OUTLIER 'General case' 0 C--N 1.341 0.215 0 C-N-CA 125.574 1.55 . . . . 0.0 111.917 -177.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -157.87 40.13 0.53 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -172.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.459 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.0 OUTLIER -141.39 145.64 35.6 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.299 0.55 . . . . 0.0 110.625 175.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.5 -177.36 6.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.438 0.695 . . . . 0.0 109.72 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -144.21 144.23 31.43 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -97.56 146.01 25.69 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.407 0.622 . . . . 0.0 111.099 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.23 144.95 40.77 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -136.35 171.91 13.79 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.815 0.34 . . . . 0.0 111.088 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -108.39 -26.18 10.61 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.016 0.527 . . . . 0.0 109.969 -177.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -135.24 155.03 51.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.32 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -85.15 -11.34 55.29 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.069 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.4 m -81.29 -19.03 43.84 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.212 0.205 . . . . 0.0 111.235 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.3 m -76.2 -43.14 43.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.571 0.224 . . . . 0.0 110.846 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.4 ' HA ' HD12 ' A' ' 124' ' ' LEU . 8.6 p -75.74 -19.5 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -77.02 -29.03 55.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.06 -44.71 46.08 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 119.067 -0.492 . . . . 0.0 111.94 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.555 ' C ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -73.41 -29.51 62.64 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 118.325 -1.35 . . . . 0.0 110.567 -179.029 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.419 ' HA ' ' SG ' ' A' ' 128' ' ' CYS . 79.1 mt -78.42 -15.7 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 118.387 0.54 . . . . 0.0 111.111 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -92.09 -13.65 30.47 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.016 -0.427 . . . . 0.0 110.894 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -113.72 1.82 15.0 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.419 ' SG ' ' HA ' ' A' ' 125' ' ' ILE . 18.5 p -96.7 -176.07 3.49 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.159 0.504 . . . . 0.0 111.177 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.6 mm -81.66 155.91 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.534 1.134 . . . . 0.0 108.513 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -136.95 145.83 44.69 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.623 0.249 . . . . 0.0 110.375 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.99 176.18 9.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -57.66 -1.89 0.12 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -169.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -159.2 0.16 0.08 OUTLIER Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.415 1.007 . . . . 0.0 114.73 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -163.91 174.03 11.97 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.121 1.46 . . . . 0.0 111.6 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 135' ' ' LEU . 2.5 mm? -117.68 161.75 19.16 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.884 0.874 . . . . 0.0 109.706 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 83.2 m-85 -144.63 158.22 43.86 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 176.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.4 tp -125.3 145.57 49.95 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 168.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 80.3 m -100.16 119.29 38.11 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.001 -0.437 . . . . 0.0 110.653 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.9 m -148.2 159.49 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.597 0.759 . . . . 0.0 110.17 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.2 p -91.11 160.38 15.6 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 97.0 p -150.58 163.78 22.8 Favored Pre-proline 0 N--CA 1.454 -0.265 0 O-C-N 122.112 -0.367 . . . . 0.0 111.895 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -66.35 -10.06 26.17 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.213 2.609 . . . . 0.0 112.641 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.417 HG22 ' CD1' ' A' ' 144' ' ' ILE . 54.8 m -93.59 -45.46 7.72 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.099 0.56 . . . . 0.0 110.741 -176.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.451 HG13 ' HE3' ' A' ' 147' ' ' LYS . 5.1 mm -135.51 158.21 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 C-N-CA 123.446 0.698 . . . . 0.0 109.22 -173.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -62.11 -24.31 67.06 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.974 -0.454 . . . . 0.0 109.971 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -157.35 141.05 15.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.244 1.018 . . . . 0.0 108.882 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.451 ' HE3' HG13 ' A' ' 144' ' ' ILE . 5.3 tppp? -132.46 115.51 14.86 Favored Pre-proline 0 N--CA 1.455 -0.182 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.414 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 89.7 Cg_endo -74.33 96.52 0.97 Allowed 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.409 2.073 . . . . 0.0 106.814 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.0 p -78.04 132.22 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -85.1 153.18 22.86 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.062 0.545 . . . . 0.0 110.67 -173.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.4 mm -136.98 143.35 35.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 123.505 0.722 . . . . 0.0 110.262 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 54.3 ttp85 -154.06 113.0 2.5 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 169.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.46 172.82 15.36 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.42 3.413 . . . . 0.0 112.655 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 19.7 t-105 -122.41 140.27 52.89 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.092 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.477 ' C ' HD12 ' A' ' 156' ' ' LEU . 17.9 m120 -125.93 168.76 13.45 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.358 0.599 . . . . 0.0 111.021 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 155' ' ' ASN . 4.7 mp -104.59 99.01 8.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.373 -169.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.2 t -156.76 -32.97 0.08 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.999 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -138.86 26.25 2.5 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.7 m -70.14 -26.53 63.99 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -153.65 160.05 42.26 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.962 0.505 . . . . 0.0 110.941 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -154.69 162.34 41.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.455 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 1.6 p -154.04 147.46 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 122.63 0.372 . . . . 0.0 110.916 -175.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 66.2 mtm -140.79 22.51 2.29 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -147.21 13.07 1.09 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.947 0.794 . . . . 0.0 112.762 -174.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 83.33 23.05 55.56 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 121.77 -0.581 . . . . 0.0 112.848 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 31.6 m 56.91 44.14 23.59 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -65.71 159.31 69.61 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.72 147.31 31.91 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.725 2.95 . . . . 0.0 112.42 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 58.8 mt -118.57 161.95 19.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.481 0.713 . . . . 0.0 110.309 -176.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 171' ' ' PRO . 13.7 t70 -149.74 140.42 14.08 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 170' ' ' ASP . 50.1 Cg_exo -56.76 -21.88 42.06 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.336 2.691 . . . . 0.0 113.777 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -83.86 -3.26 57.76 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.276 0.489 . . . . 0.0 110.826 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.88 22.4 7.43 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 122.81 0.444 . . . . 0.0 110.86 175.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.6 m -127.26 146.57 50.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.69 0.281 . . . . 0.0 110.803 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 175' ' ' ILE . 9.7 tt -123.21 149.14 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 123.087 0.555 . . . . 0.0 110.551 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.449 ' CD1' ' HD3' ' A' ' 251' ' ' LYS . 5.4 t80 -111.28 143.74 41.57 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 172.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 8.6 m -138.99 136.71 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -145.43 171.45 26.48 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 77.86 11.18 85.67 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.6 p -67.22 146.41 98.9 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 122.728 0.411 . . . . 0.0 110.236 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.08 170.44 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.946 3.097 . . . . 0.0 112.789 173.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -55.08 -47.57 98.2 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.226 -0.892 . . . . 0.0 112.751 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.94 136.48 18.6 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.934 1.756 . . . . 0.0 110.375 173.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.653 ' CD1' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -145.7 -70.53 0.26 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 119.175 -0.441 . . . . 0.0 111.644 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.653 ' H ' ' CD1' ' A' ' 184' ' ' LEU . 81.3 mtp180 58.5 133.62 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.366 1.866 . . . . 0.0 112.912 -175.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.62 -26.3 64.36 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.557 -0.715 . . . . 0.0 110.076 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 51.1 t -68.73 -47.68 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-O 120.761 0.315 . . . . 0.0 110.662 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -81.05 -25.4 37.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.65 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 46.2 tp -71.67 -31.39 66.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.82 -34.59 45.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.284 -0.26 . . . . 0.0 111.317 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 23.3 mmt -68.99 -36.23 77.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 76.6 mt -72.45 -36.0 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.1 mmt -74.08 -14.88 61.05 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 122.09 -0.381 . . . . 0.0 110.194 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -95.19 -15.09 23.53 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 117.993 0.36 . . . . 0.0 110.978 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.31 -17.46 28.9 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.677 0.391 . . . . 0.0 111.339 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -118.12 -23.81 7.23 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 117.987 0.358 . . . . 0.0 111.215 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -139.89 45.21 1.9 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.688 0.395 . . . . 0.0 110.338 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -41.45 134.06 3.28 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.937 0.779 . . . . 0.0 112.618 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 132.07 6.77 3.07 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -175.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.422 HG22 ' CE2' ' A' ' 222' ' ' PHE . 46.5 t -65.59 147.39 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 123.335 0.654 . . . . 0.0 110.611 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 21.9 p -123.91 -28.84 3.74 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 119.216 -0.421 . . . . 0.0 112.121 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -154.19 154.42 33.49 Favored 'General case' 0 N--CA 1.458 -0.06 0 CA-C-N 118.626 0.648 . . . . 0.0 110.785 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.32 158.91 44.67 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.683 0.393 . . . . 0.0 110.57 175.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -177.29 177.66 48.29 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.6 mm -102.09 92.32 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.507 ' HB3' ' H ' ' A' ' 215' ' ' LYS . 27.7 t70 51.68 -58.3 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -169.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 69.3 p 46.04 71.5 0.29 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.552 0.741 . . . . 0.0 112.933 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -78.39 128.04 79.08 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.44 -6.91 20.02 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 124.294 3.329 . . . . 0.0 114.521 -174.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -73.36 -27.16 61.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.966 1.257 . . . . 0.0 111.575 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 78.0 mt -145.33 8.24 1.18 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.851 0.86 . . . . 0.0 110.592 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 54.02 50.08 17.47 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.745 0.818 . . . . 0.0 110.801 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -131.27 152.88 81.33 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 123.378 0.671 . . . . 0.0 110.228 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -84.77 140.52 8.11 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.741 2.294 . . . . 0.0 112.458 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.507 ' H ' ' HB3' ' A' ' 206' ' ' ASP . 37.4 mtmm -98.87 26.81 5.41 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 168.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.77 171.48 14.81 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 60.62 153.67 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.656 1.183 . . . . 0.0 113.746 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -88.19 160.63 30.91 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.58 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -149.55 150.28 32.01 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 60.2 t -142.49 149.93 18.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.06 148.8 50.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.422 ' CE2' HG22 ' A' ' 200' ' ' VAL . 82.0 m-85 -123.22 153.24 40.39 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.895 -175.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 86.7 p -88.66 -0.74 57.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.637 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -130.84 144.67 51.63 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.798 0.439 . . . . 0.0 111.164 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 39.8 tp60 -74.27 -16.01 60.96 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.546 0.339 . . . . 0.0 110.195 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -85.21 -38.26 19.16 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 19.1 m -68.84 -29.65 68.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -66.98 -53.61 29.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.525 0.33 . . . . 0.0 110.944 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.6 pp -69.91 -12.26 15.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.08 0 CA-C-N 118.304 0.502 . . . . 0.0 111.686 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.79 -27.37 22.34 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.012 0.369 . . . . 0.0 111.102 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -82.92 -24.68 32.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.7 pt -108.67 27.22 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 123.153 0.581 . . . . 0.0 110.277 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.5 t -77.82 -15.34 59.15 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.299 0.639 . . . . 0.0 112.218 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -155.35 145.0 21.27 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -57.88 -32.45 67.71 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -124.49 111.84 16.18 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 30.0 m -98.2 159.27 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.55 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -81.88 143.14 31.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.4 mp -130.41 103.95 6.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -135.83 146.61 47.68 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.151 -177.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -146.91 8.64 0.97 Allowed 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.647 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.62 -139.25 5.48 Favored Glycine 0 C--N 1.336 0.537 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -175.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.82 4.34 14.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.986 0.393 . . . . 0.0 112.041 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 76.7 mt -104.2 136.28 38.2 Favored 'Isoleucine or valine' 0 C--N 1.338 0.106 0 C-N-CA 123.185 0.594 . . . . 0.0 110.541 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ASP . . . . . 0.446 ' CG ' HH12 ' A' ' 247' ' ' ARG . 25.4 t70 -122.78 139.88 53.52 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.044 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -144.26 160.68 40.58 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.121 0.968 . . . . 0.0 109.851 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ARG . . . . . 0.446 HH12 ' CG ' ' A' ' 245' ' ' ASP . 0.1 OUTLIER -134.81 160.43 38.24 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.195 0.598 . . . . 0.0 109.695 178.205 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.23 151.39 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -79.98 138.54 37.09 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -122.03 152.59 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.471 ' HG3' ' H61' ' B' ' 5' ' ' ' A' . 0.0 OUTLIER -159.03 158.62 29.05 Favored Pre-proline 0 C--O 1.231 0.13 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.775 169.72 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.52 141.2 90.51 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.177 2.585 . . . . 0.0 110.526 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -74.72 146.99 41.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.139 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.7 p -158.35 165.88 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -173.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 78.5 mt . . . . . 0 C--O 1.251 1.151 0 C-N-CA 124.342 1.057 . . . . 0.0 111.087 -175.815 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.526 " H4'" ' HA2' ' A' ' 71' ' ' GLY . . . . . . . . 0 O4'--C4' 1.419 -2.872 1 O4'-C1'-N19 112.92 4.72 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.913 0 C3'-C2'-C1' 104.598 3.442 . 0.332 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.498 ' C6 ' ' CE2' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.738 1 O4'-C1'-N19 112.793 4.593 . 0.376 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.472 " C1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.42 -2.761 0 O4'-C4'-C3' 109.343 2.745 . 0.096 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.503 H5'' ' C8 ' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.415 -3.134 0 P-O3'-C3' 123.321 3.017 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.8 t . . . . . 0 N--CA 1.474 0.76 0 CA-C-O 120.329 0.109 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -149.47 165.15 33.02 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.039 0.536 . . . . 0.0 110.537 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -138.51 167.32 22.18 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.326 0.65 . . . . 0.0 110.249 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -110.49 161.67 15.45 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.286 0.634 . . . . 0.0 109.887 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.27 160.38 51.04 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -150.38 154.51 37.91 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.115 0.566 . . . . 0.0 109.82 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -135.46 162.89 31.37 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 123.366 0.667 . . . . 0.0 110.373 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.0 m 49.77 -178.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 126.366 1.866 . . . . 0.0 113.42 -177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -134.65 162.03 33.45 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 121.293 0.568 . . . . 0.0 111.545 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.16 150.6 24.72 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.37 1.068 . . . . 0.0 110.024 177.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -148.18 155.93 41.98 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.972 0.415 . . . . 0.0 111.159 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -91.14 22.77 3.58 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.412 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 53.86 21.95 3.04 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.633 0.773 . . . . 0.0 111.755 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -136.73 135.92 38.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.805 0.842 . . . . 0.0 109.525 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.11 137.91 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.314 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CZ ' ' CA ' ' A' ' 70' ' ' GLY . 7.9 t80 -81.61 140.43 34.44 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.0 96.54 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 122.02 0.914 . . . . 0.0 108.661 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.516 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -97.73 -171.43 32.98 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.831 -177.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.78 33.08 76.38 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-O 119.43 -0.65 . . . . 0.0 111.864 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 72' ' ' LEU . 43.6 mt -100.92 135.45 19.99 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 118.201 1.001 . . . . 0.0 110.649 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.488 ' HD2' HG21 ' A' ' 76' ' ' ILE . 60.1 Cg_endo -65.3 171.41 9.22 Favored 'Trans proline' 0 N--CA 1.459 -0.532 1 C-N-CA 125.577 4.185 . . . . 0.0 113.23 -178.649 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.62 9.32 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.463 1 C-N-CA 126.161 4.574 . . . . 0.0 116.391 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -138.66 -114.56 0.15 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.488 HG21 ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER 44.6 67.91 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 122.623 1.201 . . . . 0.0 111.738 172.012 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -70.68 -176.22 1.25 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -46.48 -33.13 3.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.89 1.676 . . . . 0.0 113.382 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -80.17 -29.74 38.77 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.187 -0.32 . . . . 0.0 111.852 -173.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -78.81 -30.64 45.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.256 -0.278 . . . . 0.0 110.758 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 61.0 mt -74.01 -40.67 52.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.6 m -65.37 -22.0 66.75 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.654 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.91 -17.97 26.99 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -79.33 -25.73 42.26 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.723 0.692 . . . . 0.0 112.03 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -122.09 18.56 10.82 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -176.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -71.75 -20.28 61.91 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -75.76 -5.95 48.26 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 122.111 -0.368 . . . . 0.0 111.93 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -108.38 21.8 16.82 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.692 0.397 . . . . 0.0 110.301 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.81 165.17 32.9 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.469 -1.053 . . . . 0.0 110.469 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.98 141.29 93.9 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.532 2.822 . . . . 0.0 112.148 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.513 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -151.24 167.93 26.29 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.713 0.405 . . . . 0.0 110.697 177.702 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 mt -134.19 163.92 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.7 p -126.8 150.16 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -152.15 165.91 33.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -170.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.475 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 4.7 p90 -147.32 159.81 41.07 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 169.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.595 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 79.6 Cg_endo -64.51 -18.72 63.85 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 124.133 3.222 . . . . 0.0 111.912 -168.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.595 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 3.2 p80 -118.63 21.64 12.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.008 0.923 . . . . 0.0 111.396 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -58.59 115.71 3.21 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 173.622 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -154.19 167.33 30.23 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.09 0.556 . . . . 0.0 109.953 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -76.23 -8.58 57.38 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.069 0.148 . . . . 0.0 110.875 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.5 p -86.24 -4.86 59.25 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.249 0.62 . . . . 0.0 111.158 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -128.12 9.42 6.24 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.777 0.831 . . . . 0.0 110.817 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.6 t 56.07 -170.35 0.08 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.059 0.944 . . . . 0.0 112.066 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -87.87 22.96 2.16 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.936 0.894 . . . . 0.0 111.173 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -102.35 121.83 48.7 Favored Pre-proline 0 N--CA 1.451 -0.405 0 C-N-CA 123.491 0.716 . . . . 0.0 110.088 -176.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.52 163.38 13.01 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.593 3.529 . . . . 0.0 112.522 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -60.96 -24.08 78.72 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.489 2.793 . . . . 0.0 111.595 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -153.41 -51.8 0.1 Allowed 'General case' 0 C--O 1.227 -0.095 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 170.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 174.21 -38.42 0.12 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.41 ' CE1' H5'' ' B' ' 3' ' ' ' U' . 0.6 OUTLIER -69.82 139.54 53.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.548 0.674 . . . . 0.0 109.907 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -157.47 -162.42 1.19 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.607 0.763 . . . . 0.0 110.177 -170.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -137.18 141.31 42.16 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 122.59 0.356 . . . . 0.0 110.133 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.3 mp -96.84 149.51 21.77 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 mp -108.32 140.7 41.21 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 173.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -135.46 170.57 15.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.901 0.381 . . . . 0.0 110.559 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -111.25 -27.15 8.81 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.839 0.456 . . . . 0.0 110.487 -175.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -137.01 155.78 49.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.477 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -79.03 -18.86 52.82 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.487 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.9 m -77.9 -18.7 55.86 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.492 0.317 . . . . 0.0 111.528 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 63.3 m -75.36 -47.11 29.14 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.823 0.344 . . . . 0.0 110.678 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.4 p -76.78 -16.83 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -74.69 -32.69 62.27 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.46 -35.92 60.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.376 -0.345 . . . . 0.0 111.455 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 pp -76.38 -22.3 54.98 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.803 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.4 mt -87.27 -17.76 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 O-C-N 122.285 -0.259 . . . . 0.0 111.335 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -103.43 -5.87 22.45 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -122.9 10.26 9.5 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.8 m -122.76 -177.16 3.57 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.655 0.382 . . . . 0.0 110.456 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 38.2 mm -75.97 161.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 124.147 0.979 . . . . 0.0 110.136 -171.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -135.42 162.46 32.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.79 0.329 . . . . 0.0 110.722 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -140.22 77.4 1.61 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.318 0.58 . . . . 0.0 110.631 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 55.42 9.66 0.4 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 157.22 -10.92 0.26 Allowed Glycine 0 CA--C 1.526 0.745 0 CA-C-N 118.568 0.622 . . . . 0.0 113.053 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.42 ' HB2' ' HE2' ' A' ' 134' ' ' LYS . 1.6 mppt? -124.08 176.51 6.33 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.22 160.55 19.6 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -172.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.35 161.87 39.4 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.405 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 27.2 tp -142.13 142.21 32.73 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 168.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 46.0 t -92.19 128.24 37.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.311 0.505 . . . . 0.0 110.866 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.2 m -145.83 172.04 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.879 0.871 . . . . 0.0 110.307 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.9 p -72.9 172.25 11.24 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.018 0.527 . . . . 0.0 110.127 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.9 t -140.3 137.03 17.34 Favored Pre-proline 0 N--CA 1.457 -0.123 0 O-C-N 122.177 -0.327 . . . . 0.0 111.777 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -80.74 -6.14 13.32 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 124.309 3.339 . . . . 0.0 112.662 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.465 HG23 HG12 ' A' ' 144' ' ' ILE . 3.8 t -125.38 -24.12 4.0 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.936 0.789 . . . . 0.0 112.458 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.638 HG22 ' H ' ' A' ' 145' ' ' LYS . 5.0 mm -124.09 -175.85 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.638 ' H ' HG22 ' A' ' 144' ' ' ILE . 54.4 mtmt -78.59 -21.33 48.73 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.684 -0.635 . . . . 0.0 111.356 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -158.9 166.45 31.83 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.62 0.768 . . . . 0.0 109.884 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.426 ' HZ3' ' HB2' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -151.23 119.37 3.4 Favored Pre-proline 0 N--CA 1.458 -0.071 0 O-C-N 122.192 -0.317 . . . . 0.0 110.987 178.246 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -81.08 101.87 1.31 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.617 2.212 . . . . 0.0 107.847 168.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.2 p -74.2 134.66 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -92.63 150.81 20.47 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.312 0.645 . . . . 0.0 110.785 -171.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 34.5 mm -137.32 141.19 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 122.545 0.338 . . . . 0.0 111.649 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -149.44 107.83 3.34 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 122.995 0.518 . . . . 0.0 109.649 174.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.36 165.0 31.65 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.744 2.963 . . . . 0.0 112.257 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -106.9 135.67 48.05 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-O 120.44 0.162 . . . . 0.0 110.678 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -102.26 156.41 17.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.693 0.797 . . . . 0.0 112.397 -175.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.6 mp -102.98 91.51 4.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 42.8 t -156.36 -32.85 0.09 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -141.67 31.65 1.65 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.1 m -71.15 -18.26 62.51 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -153.52 159.36 42.21 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.098 0.559 . . . . 0.0 110.664 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -153.35 153.2 32.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 17.3 t -130.76 141.0 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 33.1 ttm -127.92 -3.23 5.84 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.541 0.201 . . . . 0.0 111.541 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -159.69 -58.65 0.06 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.06 6.85 10.8 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.178 -0.79 . . . . 0.0 114.113 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 51.5 p -88.72 -11.79 44.12 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.853 1.326 . . . . 0.0 112.486 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -135.68 150.76 72.83 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 118.351 0.523 . . . . 0.0 111.479 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -70.43 167.76 24.39 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.196 3.264 . . . . 0.0 111.656 -177.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.3 mt -107.25 160.48 15.57 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.454 0.701 . . . . 0.0 110.762 -175.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -151.41 142.95 15.68 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.0 -22.23 54.11 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.199 2.599 . . . . 0.0 113.648 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.6 mtp-105 -83.85 -2.97 57.49 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 122.942 0.497 . . . . 0.0 111.179 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -127.99 19.06 6.57 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.75 0.42 . . . . 0.0 111.095 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 21.1 m -127.42 140.75 51.96 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.541 0.21 . . . . 0.0 110.684 -177.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 9.7 tt -110.24 150.25 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.032 0 C-N-CA 123.015 0.526 . . . . 0.0 110.158 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -112.16 144.27 41.82 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 96.6 t -136.57 132.48 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -176.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -159.01 179.62 34.51 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 112.131 -0.387 . . . . 0.0 112.131 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 79.94 10.59 85.45 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.3 p -67.85 146.24 98.26 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 123.083 0.553 . . . . 0.0 109.911 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -53.66 -58.32 1.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.053 2.502 . . . . 0.0 113.657 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.426 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 25.7 mmm-85 -151.58 -68.01 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.319 -0.848 . . . . 0.0 112.312 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 182' ' ' ARG . 50.1 Cg_endo -79.23 162.89 25.41 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.083 2.522 . . . . 0.0 112.135 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.3 mp -136.89 -49.97 0.64 Allowed 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 122.967 0.507 . . . . 0.0 109.633 173.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 47.9 102.83 0.0 OUTLIER 'General case' 0 C--N 1.341 0.207 0 C-N-CA 126.391 1.876 . . . . 0.0 112.829 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.54 -24.42 55.98 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 78.7 t -68.66 -51.76 42.64 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 CA-C-N 118.019 0.372 . . . . 0.0 110.866 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -84.51 -21.78 30.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 121.272 -0.171 . . . . 0.0 110.809 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 57.3 tp -68.01 -33.2 74.16 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.401 ' HB2' ' CB ' ' A' ' 203' ' ' ALA . . . -78.33 -36.18 46.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.407 -0.183 . . . . 0.0 111.361 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 25.2 mmt -70.02 -36.82 75.37 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 83.2 mt -70.0 -33.16 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.1 mmt -77.7 -9.78 59.17 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.119 -0.363 . . . . 0.0 111.024 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -109.53 -2.26 17.72 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.416 0.553 . . . . 0.0 112.448 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -108.08 -17.0 14.15 Favored 'General case' 0 C--N 1.34 0.193 0 O-C-N 121.969 -0.457 . . . . 0.0 111.454 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.47 -17.89 11.63 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.922 0.328 . . . . 0.0 110.554 175.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -142.69 40.39 1.55 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.188 0.595 . . . . 0.0 109.997 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -40.17 134.96 2.13 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.547 1.07 . . . . 0.0 113.502 -174.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 137.67 14.23 0.8 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.472 0.558 . . . . 0.0 112.046 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 42.4 t -73.73 149.2 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.244 1.022 . . . . 0.0 111.364 -176.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 25.7 p -124.85 -27.56 3.6 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.576 0.35 . . . . 0.0 111.014 175.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -155.15 156.82 36.43 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.655 0.264 . . . . 0.0 110.739 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.401 ' CB ' ' HB2' ' A' ' 190' ' ' ALA . . . -154.22 157.87 39.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.276 0.63 . . . . 0.0 109.977 176.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.43 -178.53 48.32 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.1 mm -95.35 143.51 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -59.67 122.71 14.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 16.9 p -141.73 163.41 32.99 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.119 0.485 . . . . 0.0 110.806 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -132.07 128.05 21.27 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 123.58 0.752 . . . . 0.0 109.16 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -80.31 -6.4 13.78 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 124.576 3.518 . . . . 0.0 113.196 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -92.79 -58.36 2.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.819 0.736 . . . . 0.0 111.459 -173.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -160.78 -5.06 0.05 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -96.24 -15.44 22.0 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 119.722 1.146 . . . . 0.0 113.117 -174.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.517 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 55.6 m-85 50.98 -146.89 0.01 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 117.219 -1.372 . . . . 0.0 110.044 177.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.517 ' CD ' ' HB3' ' A' ' 213' ' ' TYR . 89.4 Cg_endo -72.06 150.33 54.07 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 CA-C-N 123.178 2.171 . . . . 0.0 112.405 -173.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -105.81 13.85 28.99 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.7 0.8 . . . . 0.0 112.158 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 68.15 14.54 66.29 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.615 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -133.07 154.66 50.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 117.908 0.854 . . . . 0.0 109.867 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -100.7 162.28 18.63 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 121.064 0.258 . . . . 0.0 112.537 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -151.04 146.64 26.33 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 94.9 t -141.44 145.82 24.18 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.059 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.98 142.62 51.0 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 110.86 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -118.76 156.54 29.2 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.638 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.7 m -84.19 -5.63 59.28 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.209 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -130.02 148.27 51.86 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.073 0.397 . . . . 0.0 111.919 -172.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -74.98 -15.45 60.66 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -84.98 -37.89 19.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 18.6 m -73.07 -28.04 62.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -67.91 -54.62 17.38 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.444 0.298 . . . . 0.0 110.531 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.1 pt -69.58 -14.84 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 CA-C-N 118.108 0.413 . . . . 0.0 111.345 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.66 -28.06 28.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.833 0.288 . . . . 0.0 110.794 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -82.89 -27.2 30.86 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.858 0.299 . . . . 0.0 111.759 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.2 pt -105.77 29.07 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.127 0.571 . . . . 0.0 110.181 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 21.9 t -78.38 -11.06 59.92 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.085 0.554 . . . . 0.0 111.925 -176.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -158.06 145.29 18.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -59.05 -29.91 67.65 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 122.416 0.287 . . . . 0.0 111.139 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -123.19 118.79 28.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.8 m -107.52 156.55 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.006 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -81.5 144.3 31.44 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.989 0.423 . . . . 0.0 110.275 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.99 105.86 7.67 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -133.25 147.42 51.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.216 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -144.62 11.87 1.47 Allowed 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.168 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.95 -140.16 5.91 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -175.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.65 14.8 1.94 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.961 0.504 . . . . 0.0 111.984 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 73.5 mt -116.57 141.42 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 123.619 0.768 . . . . 0.0 110.582 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -129.54 146.62 51.34 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.978 0.418 . . . . 0.0 111.548 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -144.39 163.99 32.15 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 124.582 1.153 . . . . 0.0 109.137 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.08 153.87 50.46 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.367 0.667 . . . . 0.0 109.709 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 12.1 p -154.53 157.87 4.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -85.11 138.47 32.38 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.476 -0.14 . . . . 0.0 110.757 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -121.28 159.75 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.06 0 CA-C-O 120.795 0.331 . . . . 0.0 111.527 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.41 159.9 26.12 Favored Pre-proline 0 N--CA 1.455 -0.187 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 171.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.3 131.69 46.43 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.726 2.284 . . . . 0.0 108.217 171.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -73.42 112.22 9.29 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.526 -173.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 8.2 p 45.3 35.39 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.534 1.534 . . . . 0.0 112.769 175.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 63.0 tp . . . . . 0 C--O 1.25 1.106 0 CA-C-O 117.622 -1.18 . . . . 0.0 110.417 -178.004 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.812 1 O4'-C1'-N19 113.599 5.399 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.647 1 O4'-C1'-N19 113.096 4.896 . 0.382 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.479 " O4'" ' CZ ' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.415 -3.186 0 O4'-C1'-N19 111.927 3.727 . 0.597 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.471 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.417 -2.999 0 C5'-C4'-C3' 111.822 -2.452 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.847 1 C5'-C4'-C3' 108.457 -4.695 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 120.583 0.23 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -148.54 161.01 42.52 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.157 0.583 . . . . 0.0 110.105 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -148.58 163.03 38.46 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.047 0.539 . . . . 0.0 110.911 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -96.39 37.91 1.23 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.355 0.662 . . . . 0.0 111.153 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.46 -179.12 36.86 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -151.44 167.83 26.76 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.333 0.653 . . . . 0.0 110.447 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -147.55 148.71 31.45 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.857 0.463 . . . . 0.0 110.115 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.9 p -149.68 154.61 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 123.564 0.745 . . . . 0.0 109.313 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -89.57 161.62 16.08 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.659 0.384 . . . . 0.0 110.938 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.4 ' H ' ' HD3' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -149.63 145.26 26.66 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 123.325 0.65 . . . . 0.0 110.128 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -154.14 157.36 38.77 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 122.57 0.348 . . . . 0.0 110.823 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.8 t -94.25 -179.25 4.87 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.377 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.53 ' HA ' ' CE2' ' A' ' 115' ' ' PHE . 95.1 mtt180 -90.99 27.36 1.85 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.592 0.757 . . . . 0.0 111.305 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.563 ' HE2' ' CD1' ' A' ' 154' ' ' TRP . 16.5 pttm -146.93 141.78 26.87 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.02 0.928 . . . . 0.0 111.154 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 p -148.81 148.16 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.245 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.434 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 6.4 t80 -100.57 143.08 31.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 171.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.403 HG11 HD13 ' A' ' 113' ' ' LEU . 2.7 m -127.31 103.7 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.927 0.87 . . . . 0.0 108.853 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.416 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -93.77 -164.03 36.59 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.13 13.82 29.52 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 119.461 -0.633 . . . . 0.0 112.708 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 72' ' ' LEU . 27.0 mt -79.67 146.06 64.12 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 118.72 1.26 . . . . 0.0 109.676 177.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 97.2 Cg_endo -76.68 161.23 34.02 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 124.355 3.37 . . . . 0.0 110.375 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 33.1 Cg_exo -62.84 -11.61 25.08 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.777 2.985 . . . . 0.0 113.222 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -95.85 -39.47 9.81 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.4 mt -54.34 145.28 4.51 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 CA-C-O 121.735 0.779 . . . . 0.0 112.155 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -146.28 -170.45 3.5 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.768 1.227 . . . . 0.0 109.324 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -51.64 -27.0 10.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.604 0.762 . . . . 0.0 112.663 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -76.92 -45.02 29.35 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.721 -0.612 . . . . 0.0 111.446 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -78.4 -26.32 46.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.18 -173.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.411 ' CG2' HD11 ' A' ' 113' ' ' LEU . 84.6 mt -74.62 -47.27 39.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 87.4 m -67.94 -12.84 61.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.006 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.25 -15.11 20.97 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.6 m -82.38 -29.13 31.06 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.957 0.799 . . . . 0.0 112.032 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -118.46 14.64 13.73 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -66.32 -20.83 66.2 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.06 -0.4 . . . . 0.0 111.808 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -73.6 -5.1 38.26 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.512 0.325 . . . . 0.0 111.805 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -112.12 20.47 16.82 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.642 0.377 . . . . 0.0 111.083 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.23 176.2 25.35 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.92 154.29 67.25 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.677 2.918 . . . . 0.0 110.869 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.479 HD23 ' N ' ' A' ' 91' ' ' LEU . 0.7 OUTLIER -164.54 162.09 21.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.187 -170.202 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.2 pt -140.91 167.59 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.276 173.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.7 p -134.69 155.54 38.74 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -150.32 165.29 33.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.992 0.425 . . . . 0.0 111.651 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.443 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 41.4 p90 -159.83 162.8 24.12 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 172.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.538 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 26.0 Cg_endo -75.51 -15.53 19.61 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.198 1.932 . . . . 0.0 110.513 -168.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.538 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 24.4 m-70 -91.41 2.17 56.6 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.653 0.781 . . . . 0.0 110.872 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -63.33 149.02 46.74 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 122.966 0.507 . . . . 0.0 110.765 -176.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.5 179.11 8.22 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.707 0.803 . . . . 0.0 109.943 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -76.25 6.56 5.32 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.729 0.411 . . . . 0.0 111.12 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.4 t -72.17 166.22 22.8 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.604 0.761 . . . . 0.0 110.952 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -129.11 17.51 6.1 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.881 0.873 . . . . 0.0 110.571 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.6 m -77.84 -6.67 54.96 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.993 0.517 . . . . 0.0 112.368 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 51.68 -157.32 0.13 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.97 0.908 . . . . 0.0 112.588 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 54.72 86.41 0.17 Allowed Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 125.685 1.594 . . . . 0.0 113.544 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.16 171.82 2.09 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 124.449 3.433 . . . . 0.0 111.016 171.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -46.96 -38.59 23.96 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.778 2.986 . . . . 0.0 113.801 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 110' ' ' TYR . 42.6 tttp -155.99 22.09 0.38 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.829 0.451 . . . . 0.0 110.568 173.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.29 -35.87 3.61 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.472 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 108' ' ' LYS . 0.3 OUTLIER -63.28 138.47 58.54 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.269 1.534 . . . . 0.0 110.854 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -156.53 -170.24 3.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.85 -169.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -130.36 129.94 43.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.167 0.587 . . . . 0.0 109.49 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.411 HD11 ' CG2' ' A' ' 81' ' ' ILE . 10.7 mp -86.79 142.98 27.72 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.744 0.783 . . . . 0.0 111.816 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.57 138.08 51.09 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 113.262 -1.79 . . . . 0.0 107.106 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 29.3 p90 -159.83 166.0 31.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.64 -20.51 5.95 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -174.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -79.07 -14.11 59.35 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -169.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 52.95 14.48 0.46 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.4 m -128.38 -12.47 5.03 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.211 0.605 . . . . 0.0 110.956 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.2 t -69.23 -34.69 75.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.477 HG11 ' CZ ' ' A' ' 115' ' ' PHE . 30.7 m -71.73 -26.23 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-N 116.857 -0.156 . . . . 0.0 111.007 177.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -70.63 -40.55 73.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -77.65 -32.41 53.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -82.56 -12.57 57.64 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 119.003 0.819 . . . . 0.0 111.587 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.467 HG23 HD13 ' A' ' 135' ' ' LEU . 61.4 mt -101.09 -19.81 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 O-C-N 122.174 -0.329 . . . . 0.0 110.745 178.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -101.84 -10.31 19.99 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -117.98 5.58 12.12 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 53.8 m -119.79 -159.92 0.8 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' A' ' 136' ' ' TYR . 75.5 mt -79.48 145.81 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.046 0.538 . . . . 0.0 109.756 -172.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -140.18 137.26 34.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -152.65 -175.61 5.37 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.077 0.465 . . . . 0.0 111.573 178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -61.18 108.72 0.95 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.581 0.705 . . . . 0.0 111.444 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.44 -3.69 66.7 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.009 -0.996 . . . . 0.0 115.051 171.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -156.54 166.9 32.09 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.962 1.381 . . . . 0.0 111.829 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.467 HD13 HG23 ' A' ' 125' ' ' ILE . 28.6 mt -129.46 160.49 32.99 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 124.324 1.05 . . . . 0.0 109.151 -174.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 149' ' ' VAL . 75.4 m-85 -147.87 170.28 17.99 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 177.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.405 HD12 ' H ' ' A' ' 138' ' ' CYS . 43.6 tp -146.31 147.06 30.97 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.397 -1.274 . . . . 0.0 107.695 170.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' CYS . . . . . 0.405 ' H ' HD12 ' A' ' 137' ' ' LEU . 70.9 m -84.29 138.38 32.95 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.983 0.421 . . . . 0.0 112.105 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.3 p -160.74 149.25 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.817 1.247 . . . . 0.0 107.986 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.7 t -122.29 144.7 48.84 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 118.249 0.477 . . . . 0.0 111.304 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.6 m -152.55 167.7 12.8 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.292 0.637 . . . . 0.0 110.945 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -59.12 24.57 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.71 1 C-N-CA 126.097 4.531 . . . . 0.0 117.604 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.7 m -117.38 -28.28 6.16 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 119.82 1.191 . . . . 0.0 109.843 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.443 HG12 ' HE3' ' A' ' 147' ' ' LYS . 0.5 OUTLIER -165.32 166.52 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.321 1.049 . . . . 0.0 110.455 -171.522 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -84.42 101.78 12.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 170.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.0 t70 61.44 144.83 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.268 1.427 . . . . 0.0 113.523 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.729 ' HE2' ' C6 ' ' B' ' 1' ' ' ' C' . 27.6 ttmt -152.95 116.13 2.81 Favored Pre-proline 0 N--CA 1.455 -0.181 0 C-N-CA 124.232 1.013 . . . . 0.0 109.204 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.465 ' HB2' ' CD2' ' A' ' 136' ' ' TYR . 76.6 Cg_exo -54.94 125.08 17.96 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 124.416 3.411 . . . . 0.0 113.229 174.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 38.3 t -73.42 140.53 17.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 170.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.47 82.65 2.5 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.748 1.158 . . . . 0.0 110.284 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.9 mm -69.92 139.58 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.732 0.813 . . . . 0.0 112.313 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -155.14 105.28 2.25 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.834 172.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.56 164.97 29.75 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 124.123 3.216 . . . . 0.0 112.213 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.563 ' CD1' ' HE2' ' A' ' 66' ' ' LYS . 69.9 t-105 -86.16 145.75 26.87 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 175.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -105.83 152.25 23.48 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.108 0.48 . . . . 0.0 111.126 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.17 36.01 0.81 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.704 0.802 . . . . 0.0 111.715 -175.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.5 t -101.47 -30.5 11.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.097 -0.377 . . . . 0.0 110.771 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -159.93 144.92 15.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.9 m -152.4 -29.99 0.15 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.248 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -153.47 154.87 35.22 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.005 0.922 . . . . 0.0 109.431 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -157.1 155.57 31.3 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.603 0.24 . . . . 0.0 110.501 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.4 p -153.38 148.56 13.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -109.52 13.52 23.94 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -160.34 -47.56 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.532 0.606 . . . . 0.0 111.054 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.52 6.97 59.97 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.364 -0.686 . . . . 0.0 113.42 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.8 t -138.38 -2.6 1.79 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.285 1.043 . . . . 0.0 113.739 -177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -73.72 154.84 89.31 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 118.988 0.813 . . . . 0.0 109.958 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -53.79 140.93 66.93 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.239 2.626 . . . . 0.0 110.366 173.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 39.6 tp -150.25 135.29 17.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.535 0.207 . . . . 0.0 110.801 -175.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -148.68 155.36 41.5 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.089 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -65.31 -21.39 61.48 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.408 2.739 . . . . 0.0 111.897 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -85.27 3.86 37.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.89 0.876 . . . . 0.0 111.907 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -120.13 23.7 10.84 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.015 0.526 . . . . 0.0 109.715 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 17.0 m -117.17 146.38 43.24 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.016 0.436 . . . . 0.0 111.691 -173.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.4 tt -119.69 147.64 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.294 0.638 . . . . 0.0 109.735 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.4 ' HB2' ' CD1' ' A' ' 253' ' ' TYR . 6.3 t80 -105.24 136.5 44.65 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 99.5 t -130.9 113.31 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -141.91 -179.75 19.2 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 112.34 -0.304 . . . . 0.0 112.34 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.0 12.94 62.96 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -174.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.54 153.91 94.72 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -64.61 -68.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.027 2.485 . . . . 0.0 110.609 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.5 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 94.7 mtt-85 -146.59 -60.27 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.127 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' A' ' 182' ' ' ARG . 44.0 Cg_endo -80.09 162.28 23.25 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.904 2.403 . . . . 0.0 111.293 174.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.421 HD23 ' N ' ' A' ' 184' ' ' LEU . 2.1 pt? -159.49 -26.94 0.07 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.403 0.681 . . . . 0.0 110.87 173.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 51.87 115.49 0.0 OUTLIER 'General case' 0 C--N 1.342 0.251 0 C-N-CA 127.686 2.394 . . . . 0.0 114.475 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.74 -29.18 69.95 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.6 t -69.73 -49.61 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-N 117.902 0.319 . . . . 0.0 111.043 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -80.84 -21.72 40.52 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 122.345 -0.222 . . . . 0.0 110.929 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 33.7 tp -70.11 -33.61 72.07 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.433 ' HB2' ' CB ' ' A' ' 203' ' ' ALA . . . -77.21 -35.25 55.78 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.4 mmt -69.17 -35.31 76.16 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 66.1 mt -69.75 -34.08 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.2 mmt -74.13 -17.42 60.93 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.859 -0.526 . . . . 0.0 111.009 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -90.5 -17.42 27.1 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.062 0.392 . . . . 0.0 111.965 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -100.37 -28.3 13.02 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 118.719 0.691 . . . . 0.0 112.777 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.37 -9.17 23.84 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.62 0.646 . . . . 0.0 111.592 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -141.7 -44.59 0.35 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.03 0.377 . . . . 0.0 111.102 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 70.3 162.11 3.85 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 86.55 13.17 68.17 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 222' ' ' PHE . 10.7 p -88.46 164.61 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.164 0.986 . . . . 0.0 109.3 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 41.7 t -139.84 -62.16 0.52 Allowed 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.067 -0.395 . . . . 0.0 111.356 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -108.32 151.07 26.48 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.128 0.49 . . . . 0.0 112.24 -172.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' A' ' 190' ' ' ALA . . . -152.36 163.64 39.07 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.434 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 175.04 -179.06 46.56 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 41.3 mm -92.34 138.08 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -59.22 118.57 6.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 24.9 p -144.73 153.59 41.85 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -116.95 130.32 24.68 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -78.68 -11.51 15.43 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 124.529 3.486 . . . . 0.0 112.393 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -101.32 -9.91 20.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.645 0.378 . . . . 0.0 111.335 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -118.23 -3.59 11.02 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.557 0.743 . . . . 0.0 109.477 171.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 49.35 36.64 10.03 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.924 0.89 . . . . 0.0 112.377 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.21 162.16 51.44 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -90.66 -179.07 1.52 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 124.502 3.468 . . . . 0.0 111.388 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -121.97 7.43 9.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.263 0.625 . . . . 0.0 111.339 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.01 13.48 66.77 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.92 -0.378 . . . . 0.0 112.851 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -146.54 164.54 32.24 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.503 0.651 . . . . 0.0 110.241 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -103.11 165.14 15.89 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 121.003 0.224 . . . . 0.0 112.941 -174.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -145.6 145.86 31.14 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 94.7 t -138.72 147.32 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.11 145.19 51.23 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.251 0.548 . . . . 0.0 111.344 -177.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 200' ' ' VAL . 9.9 m-85 -120.07 161.95 20.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.369 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 92.0 p -98.48 8.59 44.68 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -131.02 140.45 50.1 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.831 0.453 . . . . 0.0 110.213 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -75.06 -19.03 60.18 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -80.61 -38.21 29.73 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 25.1 m -75.77 -25.38 56.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -67.36 -50.34 60.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -73.66 -11.12 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-N 117.969 0.349 . . . . 0.0 111.176 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.63 -21.26 25.41 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 119.722 -0.18 . . . . 0.0 110.808 174.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -87.5 -27.3 22.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.965 0.348 . . . . 0.0 111.868 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 8.4 pt -105.38 28.75 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.162 0.585 . . . . 0.0 110.262 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.2 p -74.99 -17.0 60.6 Favored 'General case' 0 C--N 1.334 -0.079 0 C-N-CA 123.406 0.682 . . . . 0.0 112.112 -176.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -156.96 145.01 19.35 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -176.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -59.72 -30.56 68.9 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 122.406 0.282 . . . . 0.0 111.324 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -122.61 121.73 37.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 29.6 m -111.93 160.54 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.412 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -86.76 144.94 26.84 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.971 0.415 . . . . 0.0 110.138 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.4 mp -132.86 104.07 6.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -130.64 149.69 52.18 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.193 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -146.9 20.41 1.27 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.149 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.61 129.46 2.96 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -173.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 53.89 16.7 1.13 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.28 1.032 . . . . 0.0 113.121 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 76.2 mt -139.99 146.22 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.789 0.836 . . . . 0.0 109.601 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -156.32 129.61 8.12 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -148.55 162.27 39.99 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.493 0.717 . . . . 0.0 110.981 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.84 155.93 43.34 Favored 'General case' 0 C--N 1.338 0.068 0 C-N-CA 124.001 0.92 . . . . 0.0 109.388 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.4 p -156.8 156.72 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -86.06 138.76 31.71 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.19 158.94 32.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.103 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.457 ' HG3' ' H61' ' B' ' 5' ' ' ' A' . 0.0 OUTLIER -160.63 161.86 24.13 Favored Pre-proline 0 N--CA 1.455 -0.197 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.338 169.412 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.93 132.63 50.82 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.589 2.193 . . . . 0.0 108.861 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' TYR . . . . . 0.4 ' CD1' ' HB2' ' A' ' 176' ' ' PHE . 3.2 t80 -78.11 167.49 21.34 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.242 -177.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.71 162.73 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.748 0.819 . . . . 0.0 111.106 -172.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 C--O 1.251 1.135 0 CA-C-O 117.209 -1.377 . . . . 0.0 108.998 -179.871 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.729 ' C6 ' ' HE2' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.422 -2.553 0 O4'-C1'-N19 112.183 3.983 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.665 1 O4'-C1'-N19 112.412 4.212 . 0.71 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.434 ' C6 ' ' CE2' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.416 -3.046 0 O4'-C1'-N19 111.635 3.435 . 0.413 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.43 " C4'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.418 -2.89 0 O5'-C5'-C4' 106.572 -2.592 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.457 ' H61' ' HG3' ' A' ' 251' ' ' LYS . . . . . . . . 0 O4'--C4' 1.411 -3.474 1 C5'-C4'-C3' 109.204 -4.197 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.4 m . . . . . 0 N--CA 1.475 0.822 0 CA-C-O 120.387 0.137 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -131.8 7.24 4.39 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.125 0.57 . . . . 0.0 111.679 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -147.59 152.42 37.9 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.133 0.573 . . . . 0.0 109.625 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -143.19 173.06 11.92 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.419 0.688 . . . . 0.0 110.707 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.87 5.1 0.11 Allowed Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.499 -0.612 . . . . 0.0 112.685 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 60.66 161.61 0.05 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.896 1.278 . . . . 0.0 112.823 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -144.62 146.56 32.35 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.341 0.656 . . . . 0.0 109.905 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.1 t -138.81 153.28 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.83 0.852 . . . . 0.0 109.061 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -141.69 149.86 41.12 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.27 150.8 20.66 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-O 121.075 0.465 . . . . 0.0 111.698 -177.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -154.6 164.33 38.88 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.369 -174.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.9 t -96.0 165.51 12.22 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.584 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.89 11.01 2.88 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -123.33 139.79 53.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 p -155.59 151.08 10.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.79 -172.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -96.79 142.12 29.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 174.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 m -131.85 130.75 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.63 151.67 18.62 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 112.052 -0.419 . . . . 0.0 112.052 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.48 19.51 37.96 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.654 -0.526 . . . . 0.0 113.029 176.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 pp -80.93 153.3 72.49 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 118.556 1.178 . . . . 0.0 109.114 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.58 144.76 17.92 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.076 2.517 . . . . 0.0 112.46 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -80.55 -4.65 13.05 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 124.057 3.172 . . . . 0.0 111.461 174.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -73.79 -6.3 46.13 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -176.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.404 ' C ' HD12 ' A' ' 76' ' ' ILE . 1.9 pp -141.68 -169.45 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -132.32 -170.62 2.46 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.918 0.487 . . . . 0.0 111.445 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -46.46 -30.3 2.12 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.461 1.504 . . . . 0.0 113.003 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.19 -34.23 77.08 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.399 0.545 . . . . 0.0 112.267 -176.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -80.26 -40.68 26.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.068 -0.395 . . . . 0.0 110.308 -174.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.7 pp -76.75 -23.76 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.366 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 78.3 m -70.84 -30.79 67.3 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.79 -16.95 60.03 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.056 -0.402 . . . . 0.0 110.8 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.7 m -86.28 -24.22 26.03 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -117.88 -18.18 9.59 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -176.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -68.26 -8.92 43.61 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.283 0.947 . . . . 0.0 112.176 -174.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -67.48 -6.7 20.75 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.983 -0.448 . . . . 0.0 111.617 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -111.98 -1.26 15.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.59 0.356 . . . . 0.0 111.545 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.41 165.73 11.43 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -68.17 137.31 40.14 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.368 2.712 . . . . 0.0 110.006 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.407 ' C ' HD12 ' A' ' 91' ' ' LEU . 3.3 pp -160.09 174.47 14.25 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.833 -174.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.17 174.7 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.087 178.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.63 159.41 43.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 CA-C-O 120.777 0.322 . . . . 0.0 111.019 -177.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -150.87 160.62 43.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.41 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.456 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 38.8 p90 -160.23 159.24 26.59 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.645 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 17.5 Cg_endo -75.97 -8.76 19.15 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.119 2.546 . . . . 0.0 109.71 -169.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.645 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 23.3 m-70 -102.08 11.42 38.41 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.472 1.109 . . . . 0.0 111.614 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -53.51 159.05 1.58 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 123.95 0.9 . . . . 0.0 113.11 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -136.43 168.51 19.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.086 0.955 . . . . 0.0 110.212 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -127.64 14.2 7.0 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.166 0.586 . . . . 0.0 111.187 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.5 m -78.8 36.42 0.27 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.975 0.91 . . . . 0.0 111.861 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 55.74 19.1 3.22 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.348 1.059 . . . . 0.0 112.276 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.7 t -153.63 161.64 41.99 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.027 0.931 . . . . 0.0 108.873 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -137.58 155.5 49.14 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.297 0.239 . . . . 0.0 110.425 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -156.09 126.75 3.47 Favored Pre-proline 0 N--CA 1.453 -0.324 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.68 159.92 41.76 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.838 3.026 . . . . 0.0 110.41 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.59 -28.73 44.74 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.273 2.649 . . . . 0.0 111.881 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -160.41 -54.23 0.05 Allowed 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.214 0.605 . . . . 0.0 109.532 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 176.16 34.77 0.05 OUTLIER Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.059 -0.591 . . . . 0.0 113.026 -176.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.511 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -143.59 147.36 34.27 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.035 0.918 . . . . 0.0 109.717 178.491 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.6 -177.26 6.24 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.077 0.551 . . . . 0.0 110.44 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.431 ' CE1' ' C4 ' ' B' ' 4' ' ' ' U' . 2.4 m-85 -133.6 129.62 37.21 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -177.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mp -92.16 145.62 24.36 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.568 0.699 . . . . 0.0 111.997 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -115.21 136.2 53.36 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -128.51 177.91 6.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.442 0.697 . . . . 0.0 110.881 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -115.79 -32.28 5.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.079 0.552 . . . . 0.0 110.249 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -130.85 155.07 47.34 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.154 0.502 . . . . 0.0 111.523 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -81.52 -14.23 57.16 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.671 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.0 m -79.53 -14.9 58.55 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.173 -0.329 . . . . 0.0 111.034 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 52.8 m -79.93 -39.55 30.06 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.324 -0.235 . . . . 0.0 111.022 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.83 -19.3 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -79.71 -33.12 41.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.8 -34.57 57.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.072 0.396 . . . . 0.0 111.114 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.0 pp -79.86 -19.92 47.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.425 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 54.0 mt -92.66 -20.98 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 117.904 0.32 . . . . 0.0 111.328 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -95.43 -14.78 23.49 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.825 -0.547 . . . . 0.0 111.922 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -111.07 26.35 10.8 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.157 0.583 . . . . 0.0 111.418 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 16.7 p -130.73 -173.89 3.21 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.985 0.421 . . . . 0.0 111.771 -176.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.506 HD12 ' N ' ' A' ' 129' ' ' ILE . 2.0 mp -86.49 155.54 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -128.78 152.45 48.44 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -139.6 67.6 1.38 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.405 0.621 . . . . 0.0 110.411 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 51.88 14.74 0.33 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 172.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 163.49 -14.16 0.1 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-N 118.671 0.669 . . . . 0.0 112.807 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -131.58 169.63 15.85 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 117.597 0.698 . . . . 0.0 109.319 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.71 162.74 14.15 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.401 0.143 . . . . 0.0 110.879 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.445 ' CE1' ' HG2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -143.31 136.96 28.46 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.3 mp -125.08 132.51 53.14 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 25.0 p -81.51 131.77 35.29 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.944 0.402 . . . . 0.0 112.036 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.0 m -153.25 173.58 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.298 1.439 . . . . 0.0 108.23 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.9 t -146.25 132.65 19.63 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.956 -0.465 . . . . 0.0 111.963 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.469 ' H ' ' HB ' ' A' ' 144' ' ' ILE . 15.1 m -158.65 172.69 5.81 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 125.996 1.718 . . . . 0.0 107.969 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.423 ' CD ' ' HB3' ' A' ' 141' ' ' SER . 62.2 Cg_exo -53.71 -40.31 80.26 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.623 2.882 . . . . 0.0 115.7 -172.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.8 m -91.82 -13.32 31.62 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.053 0.842 . . . . 0.0 110.816 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.497 ' CD1' ' HE3' ' A' ' 147' ' ' LYS . 37.5 mm -86.79 -37.6 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 122.769 0.428 . . . . 0.0 110.661 -171.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 59.0 mttm 46.07 51.6 10.82 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.613 0.365 . . . . 0.0 111.537 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 64.31 17.61 10.84 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.497 ' HE3' ' CD1' ' A' ' 144' ' ' ILE . 18.4 pttp -82.56 154.47 68.59 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 119.206 0.912 . . . . 0.0 109.749 174.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.445 ' HG2' ' CE1' ' A' ' 136' ' ' TYR . 90.0 Cg_endo -76.97 161.4 32.99 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.91 2.407 . . . . 0.0 112.625 172.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.6 m -114.7 151.45 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -98.13 149.96 21.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -169.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.3 mm -131.64 146.82 32.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 124.762 1.225 . . . . 0.0 110.612 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 60.4 ttp85 -158.1 101.59 1.75 Allowed Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 122.653 0.381 . . . . 0.0 110.275 172.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.58 170.79 5.13 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 124.594 3.529 . . . . 0.0 114.334 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -95.3 159.73 14.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.499 175.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.411 ' C ' HD12 ' A' ' 156' ' ' LEU . 10.0 p30 -102.03 158.67 15.99 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.036 0.534 . . . . 0.0 112.013 -176.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.411 HD12 ' C ' ' A' ' 155' ' ' ASN . 8.3 mp -108.15 36.4 2.8 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.688 0.795 . . . . 0.0 111.562 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.6 t -137.15 -24.53 1.09 Allowed 'General case' 0 C--N 1.34 0.158 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -174.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -136.26 35.98 2.76 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.649 1.113 . . . . 0.0 113.53 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.6 m -74.02 -23.64 59.45 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.951 -0.468 . . . . 0.0 112.198 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -155.35 161.73 40.99 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 117.98 0.354 . . . . 0.0 111.395 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -155.72 153.62 30.22 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.021 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.4 m -140.3 155.91 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 121.249 0.547 . . . . 0.0 112.001 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 70.5 mtm -137.53 27.57 2.78 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.244 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -155.0 171.66 19.38 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -174.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -73.27 24.74 0.88 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 123.509 0.576 . . . . 0.0 112.411 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 31.6 m 56.07 46.93 20.72 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 117.451 0.626 . . . . 0.0 112.431 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -61.1 157.79 39.91 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -53.31 148.76 31.58 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.776 2.984 . . . . 0.0 112.684 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 53.9 mt -118.06 163.34 16.76 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.623 0.769 . . . . 0.0 110.049 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -148.7 141.44 15.27 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.49 -22.01 48.73 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.438 2.759 . . . . 0.0 114.164 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -89.21 5.24 45.68 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.302 0.501 . . . . 0.0 110.948 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -130.06 18.42 5.52 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.877 0.471 . . . . 0.0 110.618 175.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 18.8 m -127.83 143.05 51.13 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.727 0.299 . . . . 0.0 110.851 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.8 tt -116.89 149.71 19.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 123.152 0.581 . . . . 0.0 110.795 -174.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.449 ' CD1' ' CE1' ' A' ' 253' ' ' TYR . 8.4 t80 -106.74 144.46 33.36 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 172.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 62.1 t -133.83 122.05 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -131.12 153.1 20.2 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.832 -0.223 . . . . 0.0 112.686 -176.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.81 39.53 4.61 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -171.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 26.9 m -118.1 54.72 1.97 Allowed Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.03 -11.63 27.44 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.71 2.273 . . . . 0.0 112.061 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.656 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 0.0 OUTLIER -139.7 -37.75 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.656 ' HD2' ' H ' ' A' ' 182' ' ' ARG . 38.9 Cg_endo -83.57 22.16 0.96 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.807 2.338 . . . . 0.0 112.867 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.607 HD23 ' H ' ' A' ' 184' ' ' LEU . 1.6 pt? -80.61 -138.87 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.037 0.535 . . . . 0.0 112.062 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.428 ' H ' ' HG ' ' A' ' 184' ' ' LEU . 45.3 ttm-85 71.2 126.42 0.03 OUTLIER 'General case' 0 C--N 1.338 0.103 0 C-N-CA 125.881 1.672 . . . . 0.0 110.551 -172.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.57 -28.5 69.68 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 64.2 t -68.7 -48.07 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 CA-C-N 117.921 0.328 . . . . 0.0 110.757 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -77.96 -31.12 50.68 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 58.6 tp -73.14 -33.87 65.77 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.401 0.28 . . . . 0.0 110.37 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.27 -37.36 60.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.078 -0.389 . . . . 0.0 111.413 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 26.2 mmt -69.4 -40.59 77.27 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.5 mt -65.15 -36.95 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.2 mmt -73.05 -18.89 61.28 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.109 -0.37 . . . . 0.0 111.219 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -93.08 -13.52 28.45 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.436 0.562 . . . . 0.0 112.124 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -93.45 -19.66 21.06 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.392 0.542 . . . . 0.0 111.897 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.6 -19.14 10.7 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 118.273 0.488 . . . . 0.0 111.482 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -140.4 42.56 1.9 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.15 137.5 3.8 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 123.71 0.672 . . . . 0.0 112.331 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 124.85 9.81 5.09 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 58.5 t -69.61 144.78 13.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 117.47 0.635 . . . . 0.0 110.345 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 15.2 p -120.22 -32.62 4.1 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.124 0.169 . . . . 0.0 111.196 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -146.29 142.05 27.93 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -148.58 157.75 43.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 170.62 -167.27 40.43 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.43 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 43.5 mm -97.1 139.94 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -58.03 122.41 12.98 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.385 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.7 t -155.38 149.04 25.25 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -119.49 139.8 28.33 Favored Pre-proline 0 N--CA 1.455 -0.186 0 C-N-CA 122.726 0.41 . . . . 0.0 110.208 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -77.4 -8.58 17.34 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 124.223 3.282 . . . . 0.0 112.498 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.6 -22.4 62.56 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.44 0.564 . . . . 0.0 111.116 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.5 mt -140.38 5.87 2.08 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.146 0.978 . . . . 0.0 110.095 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt 49.22 40.46 18.01 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.896 1.279 . . . . 0.0 112.522 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -125.19 139.04 32.82 Favored Pre-proline 0 C--O 1.231 0.119 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.56 166.52 23.84 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 122.719 2.28 . . . . 0.0 111.383 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.503 ' HA ' ' C4 ' ' B' ' 4' ' ' ' U' . 33.5 mtmm -120.27 24.2 10.53 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 64.5 15.89 60.01 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.605 -0.553 . . . . 0.0 114.109 170.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -131.01 161.94 30.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 117.877 0.838 . . . . 0.0 110.128 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -100.63 159.09 19.19 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 112.174 -0.37 . . . . 0.0 112.174 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -153.63 148.51 26.56 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 3.9 p -150.2 148.06 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -126.28 147.7 49.65 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.109 0.564 . . . . 0.0 110.186 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -119.41 155.29 32.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.183 -174.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 57.6 m -83.19 1.56 40.01 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.21 172.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -135.9 131.11 34.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.102 0.561 . . . . 0.0 110.192 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -73.2 -12.34 60.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.4 tp60 -76.24 -38.42 56.35 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 42.1 m -74.19 -30.29 62.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -64.3 -52.11 60.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.643 -0.217 . . . . 0.0 110.586 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.39 -14.65 17.94 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 CA-C-N 118.248 0.476 . . . . 0.0 111.355 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.39 -21.86 32.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 117.78 0.263 . . . . 0.0 110.382 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.21 -8.3 42.75 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 3.5 pt -125.16 40.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 118.781 0.718 . . . . 0.0 111.572 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 32.4 m -131.14 3.99 4.38 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -129.57 10.83 5.69 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 45.39 -89.61 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -83.64 90.34 7.26 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.482 HG23 ' CD1' ' A' ' 239' ' ' LEU . 3.8 m -81.94 140.9 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.684 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 247' ' ' ARG . 34.4 mt-30 -78.31 -12.71 60.02 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.109 0.964 . . . . 0.0 112.791 -174.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.482 ' CD1' HG23 ' A' ' 237' ' ' VAL . 10.3 mp 55.94 -77.13 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.947 0.899 . . . . 0.0 112.7 -175.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 58.49 132.09 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.172 1.789 . . . . 0.0 114.374 -177.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' HIS . . . . . 0.424 ' H ' HG22 ' A' ' 244' ' ' ILE . 7.4 t60 -160.83 129.17 4.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 58.79 34.74 78.94 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 64.35 17.9 11.02 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.033 1.333 . . . . 0.0 113.876 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.424 HG22 ' H ' ' A' ' 241' ' ' HIS . 3.9 tt -83.79 177.71 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 173.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -145.46 139.42 26.84 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -142.58 174.09 10.95 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ARG . . . . . 0.449 ' HD3' ' HA ' ' A' ' 238' ' ' GLN . 0.5 OUTLIER -146.73 144.91 29.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.175 0.443 . . . . 0.0 110.631 173.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.8 p -158.91 154.6 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.31 144.51 25.25 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.357 0.263 . . . . 0.0 110.374 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 13.6 m -126.63 157.97 37.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 120.837 0.351 . . . . 0.0 111.123 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.95 162.28 24.77 Favored Pre-proline 0 N--CA 1.455 -0.225 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 173.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.57 133.38 57.64 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.733 2.289 . . . . 0.0 108.897 173.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' TYR . . . . . 0.449 ' CE1' ' CD1' ' A' ' 176' ' ' PHE . 2.0 t80 -75.5 166.88 22.91 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.927 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.89 163.94 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 123.934 0.894 . . . . 0.0 110.961 -171.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.1 tm? . . . . . 0 C--O 1.251 1.173 0 CA-C-O 117.582 -1.199 . . . . 0.0 109.093 179.903 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.027 1 C5'-C4'-C3' 108.148 -4.901 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.915 2 C3'-C2'-C1' 105.809 4.788 OUTLIER-DELTA 0.06 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.511 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.72 2 O4'-C1'-N19 113.677 5.477 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.503 ' C4 ' ' HA ' ' A' ' 215' ' ' LYS . . . . . . . . 0 O4'--C4' 1.419 -2.85 1 C5'-C4'-C3' 108.999 -4.334 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.468 " H4'" ' HB2' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.41 -3.618 0 C5'-C4'-C3' 110.363 -3.425 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.4 t . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.459 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 9.5 t60 57.78 178.46 0.06 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.502 1.121 . . . . 0.0 112.293 -177.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.459 ' H ' ' CG ' ' A' ' 54' ' ' HIS . 21.7 pt20 -144.97 165.23 28.76 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.034 0.533 . . . . 0.0 110.759 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -107.92 19.08 20.5 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.338 0.655 . . . . 0.0 110.948 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.65 4.91 82.38 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 53.86 20.98 2.55 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.578 1.151 . . . . 0.0 113.11 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -145.94 144.92 30.46 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 123.236 0.614 . . . . 0.0 109.408 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.6 p -145.45 160.92 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 123.217 0.607 . . . . 0.0 110.188 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -133.3 153.05 51.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.449 ' HD3' ' H ' ' A' ' 63' ' ' TYR . 14.4 tpp180 -118.22 154.02 32.92 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.527 0.331 . . . . 0.0 110.623 -176.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.449 ' H ' ' HD3' ' A' ' 62' ' ' ARG . 8.1 m-85 -117.84 -173.87 2.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.396 -174.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.1 t -123.66 166.03 16.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.265 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 41.7 ptt85 -77.67 37.28 0.22 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.772 0.829 . . . . 0.0 112.096 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -138.91 135.58 34.59 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.143 0.977 . . . . 0.0 110.473 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -146.64 158.66 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.519 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.449 ' CZ ' ' C6 ' ' B' ' 3' ' ' ' U' . 5.1 t80 -91.8 140.43 29.7 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 169.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.2 p -127.6 125.37 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.95 148.82 18.3 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 -169.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.07 108.99 0.04 OUTLIER Glycine 0 CA--C 1.524 0.646 0 C-N-CA 125.793 1.663 . . . . 0.0 114.369 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.2 mt -141.59 145.74 38.71 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 123.881 0.872 . . . . 0.0 108.675 172.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -76.78 172.65 15.82 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.702 2.935 . . . . 0.0 110.098 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.9 172.95 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.026 3.151 . . . . 0.0 113.103 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.2 t70 61.18 -91.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.2 pt -56.12 132.28 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.886 0.85 . . . . 0.0 112.121 -176.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -170.2 155.95 5.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.644 1.178 . . . . 0.0 108.003 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 61.65 -51.62 0.13 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.749 1.62 . . . . 0.0 114.046 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -80.87 -35.18 33.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.05 0.841 . . . . 0.0 111.567 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -76.02 -28.31 57.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.282 -0.261 . . . . 0.0 110.769 -174.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.6 pt -81.99 -27.17 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 O-C-N 121.978 -0.451 . . . . 0.0 110.067 173.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.413 ' HA ' HD21 ' A' ' 91' ' ' LEU . 94.4 m -72.8 -12.45 61.0 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.09 -19.53 16.45 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 173.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.9 m -76.78 -34.74 57.99 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.546 0.612 . . . . 0.0 111.921 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -105.41 7.07 33.04 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -65.18 -18.03 64.97 Favored 'General case' 0 CA--C 1.526 0.037 0 C-N-CA 122.767 0.427 . . . . 0.0 110.946 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -69.71 -12.21 61.45 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.362 0.665 . . . . 0.0 110.877 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -111.98 16.62 20.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.951 0.5 . . . . 0.0 109.939 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.51 163.12 30.41 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.63 148.57 63.7 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.63 2.887 . . . . 0.0 112.37 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.484 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -147.92 169.17 20.43 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.615 0.366 . . . . 0.0 111.048 179.128 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 pt -137.55 175.38 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.738 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.9 p -152.51 156.26 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 122.369 -0.207 . . . . 0.0 110.758 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -155.79 172.19 18.75 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.923 0.392 . . . . 0.0 111.127 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -160.14 162.65 23.76 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.478 ' HB2' " H4'" ' B' ' 5' ' ' ' A' . 68.1 Cg_endo -71.12 -16.96 31.88 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 CA-C-N 121.334 1.512 . . . . 0.0 110.468 -171.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -88.38 1.34 54.87 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.848 0.859 . . . . 0.0 111.137 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.498 ' HA ' ' HE3' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -63.51 -29.11 70.43 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.718 0.807 . . . . 0.0 111.128 -176.064 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 50.0 27.03 2.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.883 0.873 . . . . 0.0 112.894 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 53.17 23.96 3.38 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.707 0.803 . . . . 0.0 112.116 -176.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.7 t -101.72 165.84 11.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.785 0.834 . . . . 0.0 111.17 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.656 ' HE2' ' HA ' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -86.83 4.69 40.11 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.692 0.797 . . . . 0.0 110.709 -179.421 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.0 p -58.89 162.82 3.84 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.689 0.795 . . . . 0.0 111.935 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -126.25 166.58 16.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.219 0.607 . . . . 0.0 111.502 -177.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.432 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 60.9 t80 56.18 102.33 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 126.975 2.11 . . . . 0.0 113.679 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 105' ' ' PHE . 69.9 Cg_endo -70.75 167.6 25.26 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.58 2.853 . . . . 0.0 109.467 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -45.36 -25.96 2.34 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 124.835 3.69 . . . . 0.0 116.486 -172.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.501 ' HB3' ' CE2' ' A' ' 110' ' ' TYR . 3.6 tmtm? -151.26 22.37 0.74 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.396 0.998 . . . . 0.0 112.144 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.54 2.17 87.51 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 118.604 -1.109 . . . . 0.0 115.61 172.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.517 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -88.71 151.48 22.4 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 120.22 2.01 . . . . 0.0 108.906 174.503 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.68 -175.66 5.46 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.66 0.267 . . . . 0.0 110.964 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -132.19 118.57 19.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.8 tt -100.47 139.71 35.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.192 0.52 . . . . 0.0 111.515 -168.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.6 mp -119.9 153.46 35.85 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.976 -172.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -139.79 -176.26 4.51 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.359 1.064 . . . . 0.0 109.702 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -111.29 -26.66 9.04 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 122.634 0.373 . . . . 0.0 110.906 -176.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -140.63 161.71 37.11 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.5 0.32 . . . . 0.0 111.293 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -79.09 -13.41 59.77 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.424 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.5 p -75.04 -22.48 58.4 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.127 0.421 . . . . 0.0 110.523 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 57.0 m -79.25 -40.67 30.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.49 -0.131 . . . . 0.0 110.935 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.9 m -73.36 -20.21 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -72.64 -37.68 67.94 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.66 -32.48 62.25 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 119.329 -0.367 . . . . 0.0 111.735 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -82.07 -14.27 56.09 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.689 0.677 . . . . 0.0 111.933 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.6 mt -95.93 -20.9 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 122.008 -0.432 . . . . 0.0 110.258 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -101.84 -8.7 21.4 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -120.86 9.98 10.79 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 34.7 m -125.94 -178.53 4.32 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.191 0.596 . . . . 0.0 109.643 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -80.17 163.53 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 O-C-N 121.737 -0.602 . . . . 0.0 111.32 -170.241 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -143.44 157.62 44.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.541 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -146.84 173.29 12.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.76 3.94 0.32 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -171.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -148.22 -9.36 0.19 Allowed Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.016 -0.88 . . . . 0.0 114.224 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.42 ' HE2' ' CE2' ' A' ' 136' ' ' TYR . 24.8 pttm -167.14 -171.33 1.73 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.79 1.295 . . . . 0.0 110.963 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.28 170.22 10.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.077 0.951 . . . . 0.0 110.171 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.42 ' CE2' ' HE2' ' A' ' 134' ' ' LYS . 22.4 m-85 -150.64 165.05 34.56 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.992 0.425 . . . . 0.0 111.65 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.9 tp -141.37 134.61 29.43 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 167.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.2 p -78.21 141.42 38.62 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.1 m -141.05 162.77 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 122.882 0.473 . . . . 0.0 110.419 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.1 m -86.14 10.45 14.44 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.007 0.523 . . . . 0.0 110.978 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.0 t -67.08 118.87 59.81 Favored Pre-proline 0 N--CA 1.454 -0.271 0 C-N-CA 123.658 0.783 . . . . 0.0 110.478 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -79.83 113.02 2.97 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.4 2.733 . . . . 0.0 110.799 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.601 ' C ' ' H ' ' A' ' 145' ' ' LYS . 25.8 m -117.89 63.94 0.75 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.3 mp 64.38 -22.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.185 1.394 . . . . 0.0 110.889 -171.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.601 ' H ' ' C ' ' A' ' 143' ' ' THR . 39.2 ttpt -156.66 159.23 38.23 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 127.248 2.219 . . . . 0.0 106.025 169.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.58 139.83 58.48 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.68 0.673 . . . . 0.0 110.426 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -151.35 157.3 35.03 Favored Pre-proline 0 CA--C 1.529 0.153 0 C-N-CA 122.341 0.257 . . . . 0.0 111.203 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -79.41 163.29 24.69 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.808 3.005 . . . . 0.0 111.308 171.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.9 m -107.64 150.88 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.105 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -85.84 153.02 22.54 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 117.616 0.189 . . . . 0.0 111.081 -174.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.8 mm -137.63 143.27 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.802 0.841 . . . . 0.0 110.075 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -155.55 101.67 2.2 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -77.01 164.15 30.02 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.861 3.041 . . . . 0.0 112.218 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -97.99 150.01 21.83 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 46.2 p-10 -117.05 155.9 28.44 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.524 0.678 . . . . 0.0 111.955 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.3 mp -94.95 74.74 3.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.755 -175.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.2 t -141.35 -40.52 0.38 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.926 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -153.68 135.87 14.84 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.6 m -149.29 -30.15 0.25 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.252 0.221 . . . . 0.0 111.286 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -151.42 160.03 43.94 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.622 0.769 . . . . 0.0 109.815 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -149.85 158.55 44.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.5 t -130.63 138.4 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 51.6 tpp -100.34 -10.47 21.21 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -174.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -158.62 -47.39 0.06 Allowed 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.833 -0.542 . . . . 0.0 110.628 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.66 4.98 62.88 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.227 -0.763 . . . . 0.0 114.412 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.6 t -129.71 -13.8 4.16 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.726 1.263 . . . . 0.0 112.092 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -87.09 159.73 50.57 Favored Pre-proline 0 CA--C 1.533 0.294 0 O-C-N 122.066 -0.396 . . . . 0.0 110.464 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.65 163.59 6.84 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 124.278 3.318 . . . . 0.0 113.792 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.25 128.76 21.32 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -148.4 124.96 5.39 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-O 119.305 -0.379 . . . . 0.0 110.0 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -55.11 -20.17 23.08 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.617 2.878 . . . . 0.0 113.599 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -81.03 -3.25 51.18 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.123 0.419 . . . . 0.0 111.04 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -127.01 28.7 5.74 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 51.3 m -121.08 145.22 48.03 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.9 tt -115.9 149.52 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 123.085 0.554 . . . . 0.0 110.154 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.483 ' HB2' ' CD1' ' A' ' 253' ' ' TYR . 6.8 t80 -108.4 143.99 36.58 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 97.2 t -137.78 124.2 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -175.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -132.53 162.6 24.09 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 112.413 -0.275 . . . . 0.0 112.413 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.62 16.26 58.75 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -172.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.9 m -71.47 152.3 93.95 Favored Pre-proline 0 N--CA 1.456 -0.174 0 C-N-CA 122.706 0.402 . . . . 0.0 111.563 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -76.83 171.81 17.33 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 124.001 3.134 . . . . 0.0 109.965 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 48.5 tpt85 -73.51 -48.35 7.01 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -80.02 32.38 0.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.417 2.745 . . . . 0.0 112.634 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -61.37 -33.08 73.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.537 0.608 . . . . 0.0 112.319 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 54.23 122.01 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.704 2.002 . . . . 0.0 113.941 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.25 -29.06 70.17 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.777 -0.577 . . . . 0.0 111.783 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 65.7 t -68.36 -48.35 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 122.295 0.238 . . . . 0.0 111.167 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -82.89 -20.87 34.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.9 -0.137 . . . . 0.0 110.923 -174.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 42.1 tp -71.51 -33.24 69.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' A' ' 203' ' ' ALA . . . -74.45 -37.07 63.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.324 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 25.7 mmt -70.74 -34.04 71.45 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 62.4 mt -68.91 -37.31 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -71.58 -21.95 61.8 Favored 'General case' 0 N--CA 1.457 -0.106 0 O-C-N 121.856 -0.528 . . . . 0.0 110.339 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -86.7 -13.28 45.86 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 122.115 -0.366 . . . . 0.0 111.526 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -98.62 -21.21 16.58 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.36 -13.5 14.86 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.55 0.613 . . . . 0.0 111.954 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -140.44 -34.77 0.52 Allowed 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 118.673 0.67 . . . . 0.0 112.367 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.33 -178.33 18.12 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 69.6 10.96 64.67 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 119.411 -0.661 . . . . 0.0 112.899 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 22.1 t -72.77 147.02 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 118.248 1.024 . . . . 0.0 109.958 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.8 p -128.9 -24.97 2.86 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 119.625 -0.226 . . . . 0.0 111.455 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -150.46 149.98 30.71 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.007 0.367 . . . . 0.0 110.758 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 190' ' ' ALA . . . -160.92 156.38 24.84 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.92 0.488 . . . . 0.0 110.332 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 158.55 -165.22 33.89 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 205' ' ' ILE . 3.1 mp -100.65 130.58 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -56.2 114.91 2.16 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 89.6 m -143.71 157.48 44.36 Favored 'General case' 0 N--CA 1.458 -0.075 0 O-C-N 123.441 0.463 . . . . 0.0 110.279 -172.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -135.85 132.51 19.46 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.882 0.873 . . . . 0.0 108.916 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -80.86 -6.97 13.37 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 124.202 3.268 . . . . 0.0 114.558 -172.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -112.06 -41.02 4.05 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.993 1.27 . . . . 0.0 114.239 -172.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.5 pp -161.12 -15.88 0.05 OUTLIER 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -88.49 -26.51 22.02 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.759 1.163 . . . . 0.0 111.691 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.517 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 29.7 m-85 56.5 -178.7 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.83 0.852 . . . . 0.0 113.215 172.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.517 ' CD ' ' HB3' ' A' ' 213' ' ' TYR . 77.4 Cg_exo -54.26 153.16 22.81 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.026 2.484 . . . . 0.0 112.864 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -104.61 5.7 33.93 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.918 0.887 . . . . 0.0 111.169 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 66.81 10.67 55.97 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 112.19 -0.364 . . . . 0.0 112.19 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -141.39 149.2 40.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.262 0.625 . . . . 0.0 110.341 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -92.32 166.25 29.37 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.813 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -147.24 150.98 35.92 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 62.0 t -142.19 142.01 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.88 145.72 48.92 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -123.52 151.98 42.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.638 -176.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 54.4 m -84.25 2.8 38.3 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.075 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -137.82 138.13 38.86 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.955 0.502 . . . . 0.0 110.082 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -74.4 -14.9 60.92 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.4 tp60 -76.82 -38.44 53.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 31.7 m -75.16 -26.48 59.13 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -67.44 -50.33 59.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 119.545 -0.265 . . . . 0.0 110.37 176.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -72.32 -12.66 15.99 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 CA-C-N 118.163 0.438 . . . . 0.0 111.158 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.07 -23.55 28.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 174.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -85.94 -23.05 27.1 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 11.5 pt -106.6 25.25 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 C-N-CA 122.859 0.464 . . . . 0.0 110.311 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -79.64 -13.26 59.62 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.074 0.549 . . . . 0.0 112.033 -175.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -156.6 143.72 18.85 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -55.65 -36.07 66.64 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.692 0.397 . . . . 0.0 111.558 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -115.79 105.68 12.98 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 18.0 m -88.5 160.04 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.425 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -84.97 139.85 31.5 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.802 0.334 . . . . 0.0 110.249 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.49 104.2 6.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 172.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -137.67 153.0 49.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.371 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -146.51 20.08 1.34 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.187 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.29 130.17 3.01 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 52.85 17.82 0.94 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.425 1.09 . . . . 0.0 112.933 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 76.1 mt -140.52 149.33 21.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 123.97 0.908 . . . . 0.0 109.296 -178.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -153.74 133.4 12.97 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -145.32 161.25 40.05 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.254 1.022 . . . . 0.0 109.025 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.86 155.17 44.73 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 123.361 0.664 . . . . 0.0 109.826 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.3 p -158.38 159.22 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 122.961 0.505 . . . . 0.0 109.981 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -83.68 141.35 31.55 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.112 0.565 . . . . 0.0 110.831 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.88 162.54 31.32 Favored 'Isoleucine or valine' 0 C--N 1.338 0.092 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.82 158.92 29.58 Favored Pre-proline 0 N--CA 1.455 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.823 170.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.76 134.74 62.5 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.461 2.108 . . . . 0.0 108.087 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' TYR . . . . . 0.483 ' CD1' ' HB2' ' A' ' 176' ' ' PHE . 0.7 OUTLIER -77.01 170.51 16.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.192 -175.636 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.51 163.58 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.669 0.788 . . . . 0.0 110.829 -170.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 3.9 tt . . . . . 0 C--O 1.251 1.157 0 CA-C-O 117.228 -1.368 . . . . 0.0 109.255 -179.825 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.916 0 C5'-C4'-C3' 110.108 -3.595 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . 0.411 " H4'" ' CE1' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.416 -3.056 2 O4'-C1'-N19 113.123 4.923 OUTLIER-DELTA 0.165 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.517 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.709 1 O4'-C1'-N19 112.363 4.163 . 0.054 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.417 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.421 -2.705 0 O5'-C5'-C4' 106.03 -2.978 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.478 " H4'" ' HB2' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.415 -3.164 0 C5'-C4'-C3' 112.045 -2.303 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 110.522 -0.177 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -140.54 161.59 37.38 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.341 0.657 . . . . 0.0 110.402 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -78.01 159.93 28.46 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.537 0.335 . . . . 0.0 110.578 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -88.23 -4.62 58.69 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.514 0.325 . . . . 0.0 111.283 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.92 -175.24 46.3 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -136.05 165.95 24.5 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.077 0.551 . . . . 0.0 110.562 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.17 166.71 22.95 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.046 0.538 . . . . 0.0 111.664 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 m 47.54 28.8 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.405 1.482 . . . . 0.0 113.473 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -65.68 147.68 52.99 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.64 154.09 21.93 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 120.767 0.317 . . . . 0.0 111.717 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -156.95 170.66 22.01 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.544 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.1 t -95.89 165.45 12.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.401 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -84.72 9.44 13.99 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.836 0.454 . . . . 0.0 111.005 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -128.83 141.46 51.29 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 121.14 0.495 . . . . 0.0 110.168 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 p -147.8 147.86 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.306 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.532 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 8.1 t80 -87.04 145.14 26.59 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.9 p -128.63 122.91 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -110.27 175.03 18.02 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-O 121.307 0.393 . . . . 0.0 112.175 -175.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.45 29.75 74.34 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.379 -0.41 . . . . 0.0 113.39 171.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.1 mt -69.15 142.44 92.85 Favored Pre-proline 0 N--CA 1.45 -0.462 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.11 174.88 11.69 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.233 2.622 . . . . 0.0 109.567 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -54.74 -9.38 1.79 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 124.742 3.628 . . . . 0.0 114.32 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 77' ' ' ASP . 9.9 m-20 -125.5 -123.46 0.25 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER 63.55 -25.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 75' ' ' ASP . 4.2 p-10 39.26 -113.88 0.15 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.563 1.545 . . . . 0.0 113.114 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -127.27 -19.85 4.21 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.104 0.961 . . . . 0.0 110.487 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -80.95 -46.58 14.93 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.845 -0.535 . . . . 0.0 112.036 -174.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -68.03 -34.05 75.75 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.631 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.7 pt -84.25 -29.87 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 O-C-N 122.052 -0.405 . . . . 0.0 111.21 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 97.2 m -70.71 -12.93 61.86 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.49 0.586 . . . . 0.0 109.42 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.91 -15.45 15.14 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.6 m -82.18 -36.68 27.09 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.025 0.83 . . . . 0.0 112.461 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -98.08 1.56 47.77 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.4 ttt85 -78.43 -4.91 50.72 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -77.03 -11.09 59.76 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.737 0.415 . . . . 0.0 111.762 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -108.03 -19.12 13.61 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.443 0.297 . . . . 0.0 110.629 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.92 161.0 10.93 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.45 140.18 93.57 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.387 2.725 . . . . 0.0 111.906 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.532 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -151.77 164.53 36.81 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.274 0.23 . . . . 0.0 111.582 178.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 93' ' ' VAL . 26.8 mm -134.48 164.08 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.403 ' N ' HG22 ' A' ' 92' ' ' ILE . 7.5 p -128.24 146.44 33.74 Favored 'Isoleucine or valine' 0 C--O 1.23 0.079 0 CA-C-N 118.324 0.511 . . . . 0.0 110.243 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -150.0 166.78 28.65 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.085 0.469 . . . . 0.0 110.781 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.479 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 17.1 p90 -148.4 160.37 36.78 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.5 ' HG3' " C1'" ' B' ' 4' ' ' ' U' . 69.6 Cg_endo -70.0 -8.94 24.86 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 124.467 3.445 . . . . 0.0 111.72 -170.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.451 ' ND1' ' HG2' ' A' ' 96' ' ' PRO . 53.1 m80 -101.47 5.15 41.84 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.091 0.556 . . . . 0.0 112.16 -176.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.412 ' HG3' ' CD1' ' A' ' 95' ' ' TRP . 50.9 mtpt -70.17 161.22 30.66 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 121.659 0.742 . . . . 0.0 112.113 -177.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -101.04 36.31 2.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.829 1.251 . . . . 0.0 111.04 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 59.21 14.3 3.5 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.74 0.816 . . . . 0.0 111.228 -173.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.6 t -155.54 173.91 16.02 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.764 1.226 . . . . 0.0 108.284 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -64.06 150.98 44.26 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.77 0.319 . . . . 0.0 110.778 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -149.69 -8.19 0.32 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.251 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 56.8 177.84 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.435 1.094 . . . . 0.0 112.716 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 44.72 77.85 0.43 Allowed Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 124.815 1.246 . . . . 0.0 113.138 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.99 162.23 42.52 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.588 2.859 . . . . 0.0 110.583 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -47.83 128.82 16.69 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.342 3.361 . . . . 0.0 113.02 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? 44.05 -83.42 0.0 OUTLIER 'General case' 0 C--N 1.34 0.177 0 C-N-CA 126.904 2.082 . . . . 0.0 112.629 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.82 34.75 0.24 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -174.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.533 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -145.31 148.65 33.66 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.346 1.073 . . . . 0.0 110.149 176.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.45 -176.46 5.6 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.965 0.506 . . . . 0.0 110.606 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -139.26 136.93 35.45 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -103.01 149.93 24.06 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 mp -111.23 143.01 42.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 171.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -130.62 162.87 28.39 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.202 0.525 . . . . 0.0 111.072 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -100.84 -32.3 10.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.693 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -113.53 151.51 31.47 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -88.65 -11.84 44.17 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.871 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.8 m -102.45 -7.02 22.29 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 122.932 0.493 . . . . 0.0 111.029 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.8 t -71.67 -35.14 70.22 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.0 m -73.71 -25.23 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -77.01 -29.5 55.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.405 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.5 -36.67 57.65 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.497 0.589 . . . . 0.0 110.899 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -76.72 -18.37 58.54 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.778 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.405 HG23 HD22 ' A' ' 135' ' ' LEU . 35.8 mt -91.97 -18.72 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 122.377 0.271 . . . . 0.0 111.203 177.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -100.98 -10.02 20.94 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.534 -0.728 . . . . 0.0 112.514 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.56 14.63 13.63 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 73.2 m -132.79 -171.38 2.65 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.959 0.345 . . . . 0.0 111.846 -175.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.46 HD12 ' N ' ' A' ' 129' ' ' ILE . 3.5 mp -74.97 154.67 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.296 1.038 . . . . 0.0 109.159 -171.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 135' ' ' LEU . 12.7 pt-20 -133.24 161.64 33.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.494 0.188 . . . . 0.0 111.178 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.46 177.41 9.07 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -46.36 -24.74 0.53 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -169.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -153.67 5.2 0.34 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-N 119.184 0.902 . . . . 0.0 113.384 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -146.06 -171.75 3.78 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 117.949 0.874 . . . . 0.0 109.127 -175.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.405 HD22 HG23 ' A' ' 125' ' ' ILE . 4.5 mp -134.89 166.54 22.77 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.376 -0.202 . . . . 0.0 111.116 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 149' ' ' VAL . 17.4 m-85 -138.1 156.45 47.76 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.155 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.2 mp -134.04 157.45 46.07 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 73.5 m -100.28 135.11 42.21 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.182 0.447 . . . . 0.0 110.721 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.9 m -144.12 164.46 14.26 Favored 'Isoleucine or valine' 0 C--N 1.338 0.067 0 C-N-CA 123.694 0.798 . . . . 0.0 109.923 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.4 t -70.63 151.41 45.01 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 120.54 0.209 . . . . 0.0 110.559 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.3 t -156.02 139.05 10.77 Favored Pre-proline 0 N--CA 1.456 -0.151 0 C-N-CA 122.646 0.379 . . . . 0.0 110.408 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -79.13 -0.08 10.45 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.55 3.5 . . . . 0.0 114.046 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.443 ' HB ' HD13 ' A' ' 144' ' ' ILE . 49.2 m -93.97 -10.99 31.84 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.077 0.853 . . . . 0.0 108.998 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.443 HD13 ' HB ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -154.97 -155.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 126.94 2.096 . . . . 0.0 106.668 -174.083 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -94.71 -36.94 11.52 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -162.07 154.63 19.76 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.896 1.279 . . . . 0.0 108.296 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.45 ' HD2' ' N1 ' ' B' ' 1' ' ' ' C' . 23.4 ttpp -143.5 138.6 15.56 Favored Pre-proline 0 CA--C 1.528 0.114 0 CA-C-N 118.171 0.441 . . . . 0.0 112.088 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 147' ' ' LYS . 46.8 Cg_exo -59.58 140.32 93.29 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.596 2.864 . . . . 0.0 111.678 169.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 33.0 m -126.33 143.07 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -87.74 150.74 23.41 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.9 mm -129.24 143.45 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 124.807 1.243 . . . . 0.0 110.419 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 47.8 ttp85 -159.13 97.68 1.65 Allowed Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -62.99 167.21 12.63 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 124.12 3.213 . . . . 0.0 113.497 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -87.2 147.37 25.62 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 172.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -107.35 147.95 29.67 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.349 0.595 . . . . 0.0 111.743 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.402 HD12 ' N ' ' A' ' 156' ' ' LEU . 6.3 mp -98.42 93.54 6.23 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 t -158.18 -39.76 0.06 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.475 ' CG ' ' HE ' ' A' ' 185' ' ' ARG . 16.0 m-20 -143.91 39.58 1.36 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.3 m -67.53 -19.41 65.29 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -155.83 160.03 39.88 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.303 0.641 . . . . 0.0 110.835 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -154.11 151.88 29.78 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.09 143.39 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' MET . . . . . 0.466 ' SD ' ' HB1' ' A' ' 190' ' ' ALA . 90.0 mtp -129.41 3.19 5.1 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -175.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -156.17 -40.93 0.08 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.766 0.712 . . . . 0.0 112.322 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 155.81 12.14 0.06 OUTLIER Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.428 -0.651 . . . . 0.0 112.886 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.0 m 54.59 56.4 6.83 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 117.981 0.89 . . . . 0.0 112.167 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -57.8 159.41 10.06 Favored Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -59.45 145.44 97.94 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.692 2.261 . . . . 0.0 109.72 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 72.0 mt -121.09 166.84 13.34 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.101 0.477 . . . . 0.0 112.211 -171.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -141.3 155.35 67.84 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.26 -6.83 20.04 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.142 2.561 . . . . 0.0 111.026 -176.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -101.96 5.56 40.83 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.107 0.963 . . . . 0.0 111.464 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -129.33 14.72 6.13 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.798 0.439 . . . . 0.0 111.088 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.6 m -132.45 142.56 49.3 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.178 0.191 . . . . 0.0 111.086 -174.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.4 tt -112.04 152.01 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 123.219 0.607 . . . . 0.0 110.343 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -121.16 143.23 49.22 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 35.3 m -139.01 149.68 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-O 120.663 0.268 . . . . 0.0 110.704 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -146.0 165.92 28.04 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 79.14 20.85 69.0 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -173.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 19.4 m -61.06 153.27 67.47 Favored Pre-proline 0 CA--C 1.529 0.171 0 C-N-CA 122.9 0.48 . . . . 0.0 111.956 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.14 168.76 21.14 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.755 2.97 . . . . 0.0 109.563 173.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -65.6 -47.44 67.38 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -173.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.52 -51.75 0.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 121.617 1.545 . . . . 0.0 112.254 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.1 tp 50.7 -72.48 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.537 1.935 . . . . 0.0 114.548 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.475 ' HE ' ' CG ' ' A' ' 158' ' ' ASP . 63.2 mtp180 61.97 127.66 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 127.521 2.328 . . . . 0.0 112.43 -174.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.46 -22.96 66.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.397 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 59.0 t -72.56 -47.83 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 122.341 0.256 . . . . 0.0 110.638 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -80.65 -32.89 36.03 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 55.6 tp -66.26 -34.0 77.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.468 ' HB2' ' CB ' ' A' ' 203' ' ' ALA . . . -86.73 -25.32 24.77 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -175.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 20.7 mmt -70.6 -33.83 71.49 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.4 mt -72.55 -39.76 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 20.1 mmt -60.08 -24.76 64.85 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 119.231 -0.414 . . . . 0.0 111.605 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -88.25 -20.17 25.83 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.923 0.783 . . . . 0.0 111.412 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.19 -18.73 33.18 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.871 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.38 -23.96 7.58 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 118.147 0.43 . . . . 0.0 111.042 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -135.29 45.3 2.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.893 0.477 . . . . 0.0 110.024 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -45.12 138.36 5.79 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.431 0.539 . . . . 0.0 112.117 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 123.52 9.87 5.72 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 222' ' ' PHE . 5.2 p -71.02 160.46 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.847 0.859 . . . . 0.0 110.555 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 52.4 t -134.91 -35.64 0.85 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.638 0.606 . . . . 0.0 112.638 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -150.74 155.82 40.06 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.763 0.256 . . . . 0.0 110.766 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ALA . . . . . 0.468 ' CB ' ' HB2' ' A' ' 190' ' ' ALA . . . -154.2 159.42 41.35 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.025 0.441 . . . . 0.0 110.181 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 175.22 -175.67 47.17 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.7 mm -97.46 144.68 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -60.74 123.38 17.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 52.5 p -134.97 140.48 45.73 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -85.08 128.03 61.83 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -76.47 -10.88 18.94 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.263 3.309 . . . . 0.0 112.565 -174.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -69.23 -29.68 67.68 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.428 0.291 . . . . 0.0 110.53 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.13 6.71 1.76 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.453 0.701 . . . . 0.0 111.592 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 51.81 48.65 22.39 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.198 1.399 . . . . 0.0 113.904 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -123.15 152.18 63.17 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.965 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.55 171.72 16.58 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 124.206 3.271 . . . . 0.0 112.639 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 12.9 ttmt -134.69 19.31 3.56 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.68 0.792 . . . . 0.0 111.38 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 63.0 16.57 57.59 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 119.61 -0.55 . . . . 0.0 113.535 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -130.34 155.27 46.63 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.877 0.838 . . . . 0.0 109.982 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -105.98 160.56 14.7 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 112.426 -0.27 . . . . 0.0 112.426 -175.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -151.03 144.94 25.2 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 99.6 t -140.01 148.34 22.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -130.2 147.51 51.93 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.722 0.296 . . . . 0.0 110.845 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 200' ' ' VAL . 14.0 m-85 -128.05 156.7 42.35 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.598 -176.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 74.1 m -77.84 -7.58 56.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -131.87 145.76 51.72 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.101 0.409 . . . . 0.0 111.085 -176.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -71.78 -22.55 61.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -70.22 -38.21 75.19 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 17.9 m -72.35 -29.91 64.24 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -70.09 -51.6 30.49 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 119.622 -0.228 . . . . 0.0 111.118 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.7 pt -69.11 -15.74 20.02 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 CA-C-N 118.289 0.495 . . . . 0.0 110.735 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.18 -27.52 29.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.17 -25.61 36.69 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 8.1 pt -105.09 24.98 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.022 0.529 . . . . 0.0 110.44 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -78.86 -11.38 59.99 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.247 0.619 . . . . 0.0 111.932 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.55 143.0 21.68 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -56.26 -33.23 65.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.778 0.431 . . . . 0.0 111.989 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -123.62 114.63 20.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.04 0.448 . . . . 0.0 110.633 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.5 m -87.55 147.61 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.136 173.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -83.21 134.12 34.98 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -121.61 21.25 10.93 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -66.86 149.35 50.71 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -147.0 8.58 0.95 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.624 0.25 . . . . 0.0 111.313 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 163.31 -137.36 4.74 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -176.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -74.63 -4.79 39.28 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.98 0.39 . . . . 0.0 110.502 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 244' ' ' ILE . 1.9 mp -87.2 153.54 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.034 0.934 . . . . 0.0 108.963 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -134.68 135.73 42.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.893 0.378 . . . . 0.0 110.603 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -145.39 147.67 32.5 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.442 1.097 . . . . 0.0 109.199 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 161.63 42.33 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.271 0.628 . . . . 0.0 109.504 177.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.0 p -154.59 152.16 9.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -88.76 128.4 35.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.469 ' C ' ' HE2' ' A' ' 251' ' ' LYS . 1.5 m -104.56 156.34 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -174.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.469 ' HE2' ' C ' ' A' ' 250' ' ' VAL . 0.0 OUTLIER -156.15 158.48 31.6 Favored Pre-proline 0 N--CA 1.456 -0.147 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.891 170.205 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.91 140.56 92.28 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.777 2.318 . . . . 0.0 109.917 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -91.49 175.82 6.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.924 0.392 . . . . 0.0 110.505 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.1 p -151.11 152.8 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 123.375 0.67 . . . . 0.0 109.846 -170.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.612 HD23 ' H ' ' A' ' 255' ' ' LEU . 1.9 pt? . . . . . 0 C--O 1.252 1.188 0 CA-C-O 116.823 -1.56 . . . . 0.0 112.256 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.45 ' N1 ' ' HD2' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.93 1 C5'-C4'-C3' 109.002 -4.332 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.221 0 C5'-C4'-C3' 110.514 -3.324 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.533 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.418 -2.948 1 O4'-C1'-N19 113.277 5.077 . 0.356 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.5 " C1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.417 -3.031 0 O4'-C4'-C3' 109.863 3.116 . 0.01 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.476 H5'' ' C8 ' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.414 -3.289 0 P-O3'-C3' 123.01 2.758 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.2 p . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 119.876 -0.106 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -138.15 167.3 22.11 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.28 0.632 . . . . 0.0 110.619 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -143.58 164.81 29.33 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.331 0.653 . . . . 0.0 110.36 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -76.28 160.37 29.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.897 0.379 . . . . 0.0 110.723 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.28 8.54 0.32 Allowed Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.14 0.51 40.47 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.55 0.675 . . . . 0.0 111.749 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -144.07 150.56 38.35 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.673 0.789 . . . . 0.0 109.442 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 p -148.39 156.15 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.367 0.667 . . . . 0.0 109.654 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -129.73 166.44 19.85 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.333 0.653 . . . . 0.0 109.881 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -135.91 124.45 23.6 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.801 0.334 . . . . 0.0 110.461 -178.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.413 ' HA ' ' HG ' ' A' ' 156' ' ' LEU . 0.3 OUTLIER -147.59 171.35 15.72 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.569 177.493 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.9 t -89.22 169.0 11.82 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.507 0.723 . . . . 0.0 111.666 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 49.1 ptt85 -77.42 5.57 8.56 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.709 0.804 . . . . 0.0 111.118 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -108.21 130.89 55.13 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.336 -0.986 . . . . 0.0 108.336 174.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.1 p -150.54 146.44 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.458 -170.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.427 ' CZ ' ' HA3' ' A' ' 70' ' ' GLY . 8.3 t80 -83.25 135.57 34.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.9 t -137.75 78.16 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 110' ' ' TYR . . . -120.28 159.62 15.11 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.946 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.45 5.92 33.86 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.579 HD23 ' H ' ' A' ' 72' ' ' LEU . 0.9 OUTLIER -73.69 173.4 6.36 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 171.228 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 72' ' ' LEU . 50.2 Cg_endo -80.9 155.51 20.22 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 CA-C-N 120.677 1.277 . . . . 0.0 110.292 -174.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 27.0 Cg_exo -64.95 13.39 0.1 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.92 3.08 . . . . 0.0 112.755 173.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 73' ' ' PRO . 12.2 m-20 -134.29 26.82 3.82 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -172.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 mt -123.93 152.05 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -126.11 -176.19 3.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.286 0.634 . . . . 0.0 110.933 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -51.4 -23.76 4.16 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.367 1.067 . . . . 0.0 113.139 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -79.64 -37.44 36.04 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.715 0.688 . . . . 0.0 112.472 -175.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -84.7 -25.45 28.37 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.41 0.55 . . . . 0.0 110.671 -174.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 52.9 mt -75.03 -42.71 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.9 m -66.51 -26.24 67.07 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.44 -20.77 46.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.234 -0.291 . . . . 0.0 111.541 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 m -85.34 -25.05 27.36 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.561 ' CE1' HD23 ' A' ' 137' ' ' LEU . 87.6 m-85 -117.58 1.98 12.31 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -174.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -80.6 -2.73 47.6 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.095 0.861 . . . . 0.0 112.09 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.529 ' HG3' ' CD2' ' A' ' 88' ' ' PHE . 12.7 ptp180 -77.12 -7.46 55.82 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.439 0.696 . . . . 0.0 112.149 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.529 ' CD2' ' HG3' ' A' ' 87' ' ' ARG . 71.3 m-85 -121.73 2.72 10.07 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.394 0.277 . . . . 0.0 111.699 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.45 162.37 9.31 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.0 139.24 46.4 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.072 2.515 . . . . 0.0 110.759 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.502 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -155.59 169.77 23.54 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.845 0.458 . . . . 0.0 111.333 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.5 pt -135.98 163.02 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 172.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.9 149.69 20.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -154.29 171.76 18.73 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.1 0.952 . . . . 0.0 112.494 -175.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.422 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 2.9 p90 -146.73 158.28 46.24 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 174.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.611 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 74.3 Cg_endo -63.14 -14.72 43.52 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 124.023 3.149 . . . . 0.0 112.996 -168.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.611 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 3.3 m170 -105.68 -34.29 7.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.927 0.331 . . . . 0.0 111.087 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.414 ' HD2' ' HA ' ' A' ' 98' ' ' LYS . 12.0 tptm 42.04 27.98 0.09 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.063 1.745 . . . . 0.0 113.634 -174.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 53.13 -169.24 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.585 1.154 . . . . 0.0 112.914 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -83.84 26.68 0.69 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.621 0.769 . . . . 0.0 111.104 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.6 m 59.43 24.19 12.8 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.985 0.914 . . . . 0.0 112.699 -175.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -113.77 3.73 15.65 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.446 0.699 . . . . 0.0 111.162 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.8 p -150.13 167.96 25.32 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.211 0.604 . . . . 0.0 110.358 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -141.41 33.0 1.67 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.5 0.72 . . . . 0.0 110.897 -176.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -129.54 125.54 22.43 Favored Pre-proline 0 N--CA 1.45 -0.475 0 C-N-CA 124.21 1.004 . . . . 0.0 108.885 -175.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.21 157.7 49.87 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.169 3.246 . . . . 0.0 111.144 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -71.06 -16.07 32.19 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.839 3.026 . . . . 0.0 112.827 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.673 ' CD ' ' H ' ' A' ' 109' ' ' GLY . 1.9 tmtm? -154.46 169.99 22.45 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.673 ' H ' ' CD ' ' A' ' 108' ' ' LYS . . . -71.69 34.27 0.59 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.923 1.725 . . . . 0.0 113.853 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.457 ' HA ' ' HA2' ' A' ' 70' ' ' GLY . 0.4 OUTLIER -145.17 134.25 22.67 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 118.545 1.173 . . . . 0.0 111.079 170.575 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.31 -169.25 3.33 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.627 1.171 . . . . 0.0 109.37 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.509 ' CE1' ' C5 ' ' B' ' 4' ' ' ' U' . 1.9 m-85 -134.8 151.02 50.6 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -176.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mp -108.24 151.04 26.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.585 0.707 . . . . 0.0 112.004 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.9 99.69 6.05 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -84.28 156.65 21.86 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.822 0.344 . . . . 0.0 110.232 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -86.35 -29.0 23.3 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.208 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -128.08 156.64 42.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -80.23 -19.86 45.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.218 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.0 m -90.44 -16.14 29.56 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.699 0.4 . . . . 0.0 111.14 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 18.8 m -72.67 -41.36 65.47 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.57 -13.97 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.849 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -78.4 -35.31 47.29 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.062 -0.398 . . . . 0.0 110.028 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.26 -37.5 57.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 117.83 0.287 . . . . 0.0 111.122 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.404 ' CD1' HG13 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -66.01 -38.16 87.75 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.415 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.404 HG13 ' CD1' ' A' ' 124' ' ' LEU . 52.3 mt -85.1 -10.73 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 121.422 -0.799 . . . . 0.0 111.925 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -102.26 -5.14 24.64 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.805 -0.559 . . . . 0.0 112.038 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -126.6 6.68 6.84 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 81.6 m -112.78 -179.48 3.67 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.865 0.757 . . . . 0.0 111.066 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.472 HD12 ' N ' ' A' ' 129' ' ' ILE . 3.0 mp -68.72 147.98 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -171.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -130.69 151.91 50.62 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.545 0.212 . . . . 0.0 111.096 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.41 67.5 1.36 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.303 0.573 . . . . 0.0 110.26 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 52.72 12.23 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.45 -18.81 0.09 OUTLIER Glycine 0 CA--C 1.526 0.77 0 CA-C-N 118.682 0.673 . . . . 0.0 112.386 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -127.03 174.31 8.98 Favored 'General case' 0 C--N 1.338 0.07 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.4 167.95 20.1 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.032 0.378 . . . . 0.0 111.583 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.475 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 31.9 m-85 -139.09 159.17 42.78 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.795 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.561 HD23 ' CE1' ' A' ' 85' ' ' PHE . 54.8 tp -150.47 158.58 44.32 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 169.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 84.7 m -95.26 167.97 11.03 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.891 -0.506 . . . . 0.0 111.954 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.15 164.78 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.933 0.893 . . . . 0.0 109.838 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.1 m -104.48 2.37 30.91 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.442 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 45.3 m -133.86 48.34 3.18 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 118.294 0.497 . . . . 0.0 111.546 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 141' ' ' SER . 62.0 Cg_endo -65.03 155.22 69.43 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.172 3.248 . . . . 0.0 111.905 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.805 HG23 HG13 ' A' ' 144' ' ' ILE . 14.8 t -89.12 -9.98 49.02 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.031 0.533 . . . . 0.0 111.513 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.805 HG13 HG23 ' A' ' 143' ' ' THR . 64.7 mt -141.23 175.01 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -176.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.474 ' H ' HG22 ' A' ' 144' ' ' ILE . 1.7 tmmt? -56.85 -24.82 54.17 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.998 -0.439 . . . . 0.0 111.284 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -141.97 150.3 41.2 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.873 0.869 . . . . 0.0 109.631 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.477 ' HE2' HG22 ' A' ' 143' ' ' THR . 0.1 OUTLIER -158.95 70.0 3.5 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 122.703 0.401 . . . . 0.0 110.02 174.337 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.475 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 72.1 Cg_endo -68.76 124.0 11.03 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.077 1.851 . . . . 0.0 109.115 175.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.7 140.33 16.13 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -91.67 153.06 19.93 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.734 0.414 . . . . 0.0 110.857 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.9 mm -126.6 136.26 61.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.342 0.657 . . . . 0.0 110.303 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -147.83 96.85 4.01 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -78.7 165.07 25.17 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.614 2.876 . . . . 0.0 110.828 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.45 ' CD2' ' HG2' ' A' ' 214' ' ' PRO . 47.1 t-105 -82.15 111.41 18.24 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 121.9 -0.5 . . . . 0.0 111.001 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -70.62 148.91 47.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.413 ' HG ' ' HA ' ' A' ' 63' ' ' TYR . 35.7 mt -119.14 101.34 7.93 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.201 0.524 . . . . 0.0 111.076 -169.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.7 t -164.85 -32.23 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.737 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -140.5 42.47 1.88 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.384 0.274 . . . . 0.0 111.332 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.6 t -66.57 -32.46 73.81 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -176.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -151.44 158.27 43.45 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.004 0.522 . . . . 0.0 110.49 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.43 ' CD2' ' HA ' ' A' ' 187' ' ' VAL . 58.3 t80 -156.24 153.42 29.13 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.4 p -144.73 149.25 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 67.5 mtm -117.16 13.43 14.7 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -173.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -160.55 -41.63 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.32 7.4 38.87 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.302 -0.721 . . . . 0.0 113.335 175.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.9 m -133.72 -0.23 3.19 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -86.81 150.31 50.17 Favored Pre-proline 0 CA--C 1.529 0.148 0 CA-C-N 119.839 1.2 . . . . 0.0 110.448 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.36 148.64 49.26 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.093 2.529 . . . . 0.0 109.659 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 77.1 mt -133.75 152.27 51.83 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.161 0.584 . . . . 0.0 109.871 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -145.29 153.28 52.17 Favored Pre-proline 0 N--CA 1.455 -0.186 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -59.19 -20.12 53.18 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.318 2.679 . . . . 0.0 112.353 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.9 6.56 38.73 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.418 0.687 . . . . 0.0 110.741 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -129.72 19.42 5.63 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 122.833 0.453 . . . . 0.0 110.455 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 30.2 m -125.12 139.92 53.35 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.72 0.295 . . . . 0.0 111.133 -175.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.8 tt -110.92 150.78 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.17 0.588 . . . . 0.0 109.77 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -120.43 140.48 51.3 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.7 m -135.92 142.16 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -156.05 -173.86 25.15 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 118.454 0.57 . . . . 0.0 113.05 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 76.05 28.75 59.9 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.1 146.84 53.69 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.811 0.306 . . . . 0.0 111.24 -171.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.414 ' C ' ' HD2' ' A' ' 183' ' ' PRO . 73.4 Cg_endo -68.28 -172.35 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.536 2.824 . . . . 0.0 110.158 169.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.48 ' N ' ' CD ' ' A' ' 183' ' ' PRO . 0.0 OUTLIER -95.35 5.31 0.06 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 117.737 2.495 . . . . 0.0 117.737 -172.247 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 182' ' ' ARG . 66.4 Cg_endo -76.17 6.19 4.05 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 122.505 1.93 . . . . 0.0 112.64 -175.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 57.4 mt -64.49 -35.79 82.09 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.513 0.597 . . . . 0.0 110.881 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 59.36 125.11 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.091 1.356 . . . . 0.0 112.162 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.6 -30.17 70.51 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.548 -0.72 . . . . 0.0 111.56 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.43 ' HA ' ' CD2' ' A' ' 161' ' ' PHE . 54.3 t -67.74 -50.85 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 120.609 0.242 . . . . 0.0 110.847 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -79.53 -24.97 41.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.482 -0.137 . . . . 0.0 110.781 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.1 tp -67.2 -34.55 77.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.09 -35.88 59.16 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.212 -0.305 . . . . 0.0 111.473 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 57.7 mtt -73.11 -33.73 65.74 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.324 -0.235 . . . . 0.0 111.083 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.436 HG21 ' HA ' ' A' ' 239' ' ' LEU . 72.2 mt -78.11 -39.53 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 121.151 -0.219 . . . . 0.0 110.683 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.3 mmt -63.14 -26.44 68.82 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.592 0.633 . . . . 0.0 110.513 172.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -85.42 -16.92 38.16 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.816 -0.552 . . . . 0.0 111.677 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.63 -18.27 22.37 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.239 -0.41 . . . . 0.0 111.574 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -114.03 -14.49 12.4 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -137.62 -29.96 0.85 Allowed 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.651 0.659 . . . . 0.0 112.211 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.86 -176.47 25.25 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 71.42 7.54 64.35 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.372 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.462 HG22 ' CE2' ' A' ' 222' ' ' PHE . 22.0 t -77.2 151.24 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 CA-C-N 118.127 0.963 . . . . 0.0 110.108 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 44.3 t -133.12 -42.86 0.88 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 119.619 -0.229 . . . . 0.0 110.949 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -136.66 150.59 48.58 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -173.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.06 163.36 39.99 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.255 0.55 . . . . 0.0 111.988 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -178.34 169.46 41.16 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.1 mm -94.0 93.76 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 38.0 t70 41.61 -84.43 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -169.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.48 ' H ' ' HA ' ' A' ' 214' ' ' PRO . 16.2 m 52.79 50.46 18.03 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.444 0.64 . . . . 0.0 111.016 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.24 140.6 88.0 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.739 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -81.33 -16.18 9.68 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 124.263 3.309 . . . . 0.0 113.575 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -100.21 -36.66 9.22 Favored 'General case' 0 C--N 1.338 0.069 0 CA-C-N 118.613 0.642 . . . . 0.0 110.979 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.94 -3.89 53.72 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt 56.17 115.2 0.01 OUTLIER 'General case' 0 C--N 1.34 0.155 0 C-N-CA 126.798 2.039 . . . . 0.0 113.492 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.44 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 70.7 m-85 65.34 170.05 0.1 Allowed Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.338 1.055 . . . . 0.0 111.566 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.48 ' HA ' ' H ' ' A' ' 207' ' ' THR . 50.8 Cg_exo -56.62 163.07 7.46 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.701 2.934 . . . . 0.0 115.486 -170.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.542 ' HA ' ' C4 ' ' B' ' 4' ' ' ' U' . 36.9 mtmm -123.63 35.09 4.92 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.556 176.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 64.35 26.06 70.36 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -145.12 164.94 29.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.527 0.731 . . . . 0.0 110.169 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -116.32 164.65 12.27 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -146.83 149.97 34.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 93.5 t -141.23 144.16 26.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -125.33 143.49 50.94 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.213 0.53 . . . . 0.0 110.336 -178.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.462 ' CE2' HG22 ' A' ' 200' ' ' VAL . 55.4 m-85 -117.47 152.78 34.33 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.639 -175.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 71.1 p -84.36 2.24 41.39 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.77 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -137.42 139.13 40.49 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.325 0.65 . . . . 0.0 110.316 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 11.8 tm0? -73.98 -22.01 59.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -71.37 -38.95 71.51 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.5 m -73.25 -29.49 62.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -66.0 -48.93 69.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.635 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.4 pp -72.93 -10.7 14.22 Favored 'Isoleucine or valine' 0 C--N 1.338 0.084 0 CA-C-N 118.515 0.598 . . . . 0.0 111.139 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.42 -23.94 27.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 117.602 0.183 . . . . 0.0 110.52 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -85.01 -23.92 28.44 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 10.4 pt -102.98 26.27 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 123.092 0.557 . . . . 0.0 110.474 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.2 t -90.9 2.52 56.12 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.537 0.735 . . . . 0.0 111.564 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -139.83 -156.68 0.7 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -128.65 -35.76 1.89 Allowed 'General case' 0 C--O 1.227 -0.106 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -127.88 104.54 7.87 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.9 m -64.32 149.76 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.763 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.526 ' C ' HD22 ' A' ' 239' ' ' LEU . 14.0 mm100 -91.36 138.2 31.76 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.526 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.2 mm? -127.52 22.64 6.42 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -87.85 133.97 33.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.244 0.618 . . . . 0.0 111.69 -172.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -147.09 22.9 1.2 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.885 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.7 135.82 4.89 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 54.13 7.54 0.13 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.05 1.34 . . . . 0.0 113.82 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.4 mt -144.54 142.63 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 C-N-CA 123.486 0.715 . . . . 0.0 109.292 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -150.99 138.07 19.18 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -144.37 161.42 39.02 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -155.55 158.28 38.18 Favored 'General case' 0 N--CA 1.46 0.054 0 CA-C-N 118.117 0.417 . . . . 0.0 110.221 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 12.7 p -158.66 152.21 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -86.13 126.72 34.42 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.46 ' C ' ' HE2' ' A' ' 251' ' ' LYS . 4.3 m -97.46 155.01 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.46 ' HE2' ' C ' ' A' ' 250' ' ' VAL . 0.0 OUTLIER -155.48 157.47 31.62 Favored Pre-proline 0 C--O 1.231 0.103 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.591 170.151 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.01 138.23 84.9 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.816 2.344 . . . . 0.0 109.336 173.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -92.11 170.02 10.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.447 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.8 p -150.53 153.81 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.273 0.629 . . . . 0.0 110.128 -169.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 4.6 tt . . . . . 0 C--O 1.25 1.122 0 CA-C-O 117.733 -1.127 . . . . 0.0 108.923 178.937 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.573 1 O4'-C1'-N19 114.456 6.256 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.86 0 C3'-C2'-C1' 105.065 3.961 . 0.141 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.406 ' C6 ' ' CE2' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.417 -3.01 1 O4'-C1'-N19 112.622 4.422 . 0.195 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.542 ' C4 ' ' HA ' ' A' ' 215' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.769 0 C5'-C4'-C3' 111.071 -2.952 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.41 ' N3 ' " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.414 -3.254 0 C5'-C4'-C3' 111.283 -2.811 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.7 m . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 120.594 0.235 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -148.58 154.02 39.17 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.916 0.487 . . . . 0.0 110.436 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -143.16 154.38 43.83 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.621 0.768 . . . . 0.0 109.597 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -96.94 -7.57 32.87 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.407 0.283 . . . . 0.0 111.625 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.99 151.29 31.63 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -155.41 -27.0 0.11 Allowed 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.66 -0.318 . . . . 0.0 111.362 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -139.8 19.74 2.49 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.788 0.435 . . . . 0.0 111.826 -173.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.7 9.95 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.43 -1.73 2.82 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.996 0.518 . . . . 0.0 111.878 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.82 67.67 5.67 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.647 0.779 . . . . 0.0 111.298 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -97.05 161.26 13.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.3 t -92.25 27.86 2.08 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.129 0.972 . . . . 0.0 113.471 -169.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 54.34 23.52 4.45 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.373 0.533 . . . . 0.0 111.052 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -146.0 138.16 25.28 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.479 0.712 . . . . 0.0 109.945 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.7 m -138.91 152.36 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.921 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.467 ' CZ ' ' HA3' ' A' ' 70' ' ' GLY . 19.1 t80 -84.03 148.41 26.87 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.69 73.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 122.251 1.025 . . . . 0.0 109.028 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.467 ' HA3' ' CZ ' ' A' ' 68' ' ' PHE . . . -78.19 144.63 28.64 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.47 23.44 60.55 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-O 119.203 -0.776 . . . . 0.0 113.569 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 pp -62.04 148.92 87.59 Favored Pre-proline 0 CA--C 1.531 0.22 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 172.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 66.1 Cg_endo -66.15 143.82 72.92 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 121.585 1.524 . . . . 0.0 110.499 -169.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 31.2 Cg_exo -61.83 174.37 2.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.106 2.538 . . . . 0.0 113.669 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.8 t70 63.36 5.71 2.15 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.434 ' C ' HD12 ' A' ' 76' ' ' ILE . 2.5 pp -134.01 171.41 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 171.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -143.31 -25.58 0.59 Allowed 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -154.25 -35.15 0.1 Allowed 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 119.199 0.908 . . . . 0.0 112.547 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -67.7 -45.7 74.39 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.716 0.689 . . . . 0.0 111.529 -175.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -72.34 -35.56 68.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.879 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.4 pt -83.89 -36.65 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 O-C-N 122.163 -0.336 . . . . 0.0 111.869 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 95.9 m -71.99 -15.41 62.06 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.44 0.564 . . . . 0.0 109.565 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.73 -21.29 20.05 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 172.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -84.2 -19.19 34.44 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.433 ' HB2' ' CD1' ' A' ' 91' ' ' LEU . 34.6 m-85 -113.02 5.84 17.39 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.338 0.517 . . . . 0.0 111.208 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -65.25 -21.75 66.78 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 123.811 0.845 . . . . 0.0 111.972 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -72.17 -3.37 22.97 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -113.06 15.48 19.55 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.467 0.307 . . . . 0.0 111.648 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.27 177.6 20.37 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.31 150.44 70.96 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.557 2.838 . . . . 0.0 110.675 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.433 ' CD1' ' HB2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -163.15 163.29 25.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.178 -169.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pt -142.71 168.11 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.017 172.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.9 p -128.34 157.0 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -148.05 155.88 42.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.002 0.429 . . . . 0.0 110.87 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.42 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 45.8 p90 -157.11 154.4 26.04 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 169.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.462 ' HB2' " H4'" ' B' ' 5' ' ' ' A' . 31.1 Cg_endo -75.61 -10.28 20.18 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.075 3.183 . . . . 0.0 110.77 -169.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.458 ' ND1' ' HG2' ' A' ' 96' ' ' PRO . 46.8 m80 -102.37 9.92 39.44 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.872 0.869 . . . . 0.0 111.022 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.449 ' HA ' ' HE3' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -61.35 143.44 55.74 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.809 0.844 . . . . 0.0 109.914 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -146.21 172.55 13.29 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.381 0.673 . . . . 0.0 110.118 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -80.38 0.98 30.86 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.679 0.392 . . . . 0.0 111.664 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 82.0 p -81.16 165.88 21.15 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.991 0.516 . . . . 0.0 111.234 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -95.61 41.91 1.1 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.37 0.668 . . . . 0.0 110.592 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.7 p -75.56 169.93 17.13 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.071 0.548 . . . . 0.0 111.287 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -137.95 170.55 15.86 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.335 0.654 . . . . 0.0 110.373 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.41 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 14.2 t80 52.6 94.21 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 125.533 1.533 . . . . 0.0 113.6 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 105' ' ' PHE . 76.6 Cg_endo -71.85 164.65 34.99 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.425 2.75 . . . . 0.0 109.105 175.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -43.41 107.02 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 124.272 3.315 . . . . 0.0 113.196 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.3 tptt 47.14 21.23 0.16 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.15 1.78 . . . . 0.0 113.632 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.01 33.98 39.32 Favored Glycine 0 CA--C 1.527 0.817 0 O-C-N 121.187 -0.946 . . . . 0.0 113.099 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.602 ' CE1' " H4'" ' B' ' 2' ' ' ' U' . 1.1 m-30 -104.05 130.13 51.72 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.702 1.251 . . . . 0.0 108.543 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.98 -176.46 5.77 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.217 0.462 . . . . 0.0 110.657 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -141.62 144.35 34.14 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.773 0.429 . . . . 0.0 110.322 -176.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -102.08 146.89 27.28 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.378 0.609 . . . . 0.0 111.769 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.4 mp -114.27 137.72 51.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -131.1 175.2 9.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.381 0.672 . . . . 0.0 110.004 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -115.6 -32.56 5.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.454 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -114.66 149.21 37.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.066 0.46 . . . . 0.0 111.327 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -77.97 -17.6 56.97 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.02 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.8 t -83.43 -16.39 45.99 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.264 -0.272 . . . . 0.0 111.476 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 67.5 m -74.93 -43.45 54.08 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.911 -0.493 . . . . 0.0 111.492 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 m -71.04 -22.99 23.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -80.29 -35.65 35.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.88 -33.02 65.79 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 119.442 -0.314 . . . . 0.0 111.382 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -80.26 -23.37 40.84 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.462 0.574 . . . . 0.0 110.955 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 54.5 mt -89.56 -20.91 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -100.98 -13.84 18.11 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.568 0.622 . . . . 0.0 112.619 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -108.62 11.07 26.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.06 0.391 . . . . 0.0 111.97 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 72.4 m -129.74 -166.41 1.66 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.852 0.461 . . . . 0.0 111.259 -176.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 129' ' ' ILE . 3.8 mp -80.71 152.15 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 123.806 0.842 . . . . 0.0 109.353 -171.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -144.35 158.74 43.58 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.658 176.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 134' ' ' LYS . 1.9 pt-20 -145.62 174.79 10.88 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 175.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -59.8 -5.25 0.88 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -170.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -153.42 0.34 0.21 Allowed Glycine 0 CA--C 1.528 0.878 0 CA-C-N 119.164 0.893 . . . . 0.0 114.02 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.478 ' H ' ' HG3' ' A' ' 131' ' ' GLU . 3.4 mppt? -151.6 167.01 29.44 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 118.441 1.12 . . . . 0.0 110.618 -176.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -115.8 156.46 26.0 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -144.76 156.09 43.88 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.6 mp -135.55 164.02 28.78 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 169.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.2 m -108.13 141.09 40.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.76 150.4 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 C-N-CA 122.953 0.501 . . . . 0.0 110.344 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.9 m -66.63 161.76 22.57 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 122.902 0.481 . . . . 0.0 110.192 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.3 t -151.39 148.5 22.41 Favored Pre-proline 0 N--CA 1.455 -0.177 0 O-C-N 121.894 -0.504 . . . . 0.0 111.711 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -80.05 -7.76 14.23 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.768 2.979 . . . . 0.0 111.231 169.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 45.7 m -102.09 -32.69 10.01 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.872 0.869 . . . . 0.0 110.792 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 3.7 mm -140.09 170.81 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 124.191 0.996 . . . . 0.0 108.936 -175.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -70.16 -23.76 63.04 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -159.61 149.16 18.3 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.859 0.864 . . . . 0.0 109.912 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.438 ' HD2' " O4'" ' B' ' 1' ' ' ' C' . 0.0 OUTLIER -125.12 106.72 28.21 Favored Pre-proline 0 C--N 1.337 0.051 0 C-N-CA 123.269 0.627 . . . . 0.0 109.59 178.354 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.84 96.82 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.226 2.618 . . . . 0.0 109.193 169.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.8 p -84.98 137.96 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.24 146.77 24.78 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.22 0.608 . . . . 0.0 110.977 -173.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 37.4 mm -130.85 146.18 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 123.158 0.583 . . . . 0.0 111.218 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -148.37 109.76 3.66 Favored Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.85 165.11 26.97 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.51 2.806 . . . . 0.0 111.377 177.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -105.89 126.27 51.98 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 174.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -96.52 132.62 41.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.495 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -92.6 118.13 30.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.767 0.794 . . . . 0.0 110.899 -178.222 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 34.5 t -172.62 -31.83 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.146 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -122.3 21.87 10.23 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.092 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 23.7 m -64.56 -27.77 69.18 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -160.4 160.95 32.88 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.569 0.348 . . . . 0.0 111.387 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.437 ' CD2' ' HA ' ' A' ' 187' ' ' VAL . 12.9 t80 -155.87 161.59 40.56 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.8 0.333 . . . . 0.0 110.711 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.9 m -136.95 148.76 26.36 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 C-N-CA 124.493 1.117 . . . . 0.0 109.878 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 29.3 mtm -139.49 12.31 2.54 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -137.88 24.07 2.84 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.041 0.837 . . . . 0.0 112.383 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 89.07 24.45 31.96 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 119.639 -0.534 . . . . 0.0 111.938 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 98.0 p 48.4 45.26 20.64 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -61.94 156.9 54.51 Favored Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -65.9 151.02 85.23 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.718 2.279 . . . . 0.0 110.688 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.481 HD12 ' HB1' ' A' ' 221' ' ' ALA . 3.0 mm? -108.66 172.49 6.81 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 121.259 0.552 . . . . 0.0 110.625 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -149.61 139.79 13.57 Favored Pre-proline 0 N--CA 1.452 -0.325 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.967 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.34 -12.19 31.79 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.213 2.608 . . . . 0.0 113.42 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -89.9 0.26 57.17 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.811 0.732 . . . . 0.0 110.383 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -127.01 25.11 6.3 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 122.959 0.504 . . . . 0.0 110.918 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 23.8 m -127.74 140.25 52.18 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.969 0.414 . . . . 0.0 111.486 -175.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.6 tt -113.24 150.23 15.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 C-N-CA 123.539 0.736 . . . . 0.0 109.726 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.445 ' CD1' ' CE1' ' A' ' 253' ' ' TYR . 10.9 t80 -109.55 147.82 32.31 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 48.1 t -137.13 138.72 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.317 0.647 . . . . 0.0 109.294 -175.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -141.89 146.84 18.17 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 112.065 -0.414 . . . . 0.0 112.065 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.42 15.23 48.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -172.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.6 m -70.04 146.7 95.28 Favored Pre-proline 0 C--O 1.231 0.108 0 CA-C-N 117.188 0.494 . . . . 0.0 111.298 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -79.64 160.0 25.09 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.579 2.853 . . . . 0.0 108.293 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.83 -43.81 6.6 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.903 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.29 20.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.118 3.212 . . . . 0.0 115.087 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.84 -27.63 69.01 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.511 1.05 . . . . 0.0 112.445 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 56.92 106.74 0.01 OUTLIER 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.602 1.561 . . . . 0.0 112.612 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.32 -23.2 47.18 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.437 ' HA ' ' CD2' ' A' ' 161' ' ' PHE . 41.8 t -68.27 -55.16 17.36 Favored 'Isoleucine or valine' 0 C--N 1.337 0.064 0 CA-C-N 118.691 0.678 . . . . 0.0 110.819 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.13 -20.09 38.71 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.363 -0.211 . . . . 0.0 110.977 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.06 -33.82 63.82 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.34 -35.29 63.6 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.789 -0.569 . . . . 0.0 110.538 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.4 mmt -69.1 -33.31 73.3 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 57.7 mt -75.31 -41.83 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -63.97 -20.71 66.08 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.07 0.395 . . . . 0.0 110.899 173.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -86.1 -20.46 28.68 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.586 0.63 . . . . 0.0 111.287 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -89.3 -16.45 31.1 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -115.75 -22.39 9.16 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.172 0.442 . . . . 0.0 110.909 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -137.78 43.79 2.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.201 0.6 . . . . 0.0 109.801 -176.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -46.14 138.66 7.18 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 123.654 0.645 . . . . 0.0 112.549 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 120.46 12.03 6.38 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -175.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 9.1 p -77.69 161.09 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.952 0.901 . . . . 0.0 110.598 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 47.9 t -135.98 -27.16 1.13 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -153.22 140.88 19.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 117.83 0.286 . . . . 0.0 110.896 -173.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.37 157.5 43.12 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.569 0.347 . . . . 0.0 110.716 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 161.76 -161.33 33.18 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 44.9 mm -102.4 138.39 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -59.58 138.28 57.76 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.532 0.206 . . . . 0.0 110.577 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 26.5 p -141.73 160.01 41.05 Favored 'General case' 0 N--CA 1.458 -0.052 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.179 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -111.74 130.19 23.42 Favored Pre-proline 0 N--CA 1.455 -0.197 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -80.25 -17.07 10.59 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.385 3.39 . . . . 0.0 113.813 -174.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -88.61 -31.75 18.43 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.549 0.613 . . . . 0.0 110.95 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.53 -2.78 15.37 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.114 0.566 . . . . 0.0 110.478 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 62.6 mttp 48.12 61.89 2.77 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.043 1.337 . . . . 0.0 112.734 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -147.32 151.61 40.74 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 122.292 0.237 . . . . 0.0 111.105 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -82.54 155.92 16.22 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.347 2.698 . . . . 0.0 112.577 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -93.42 1.38 56.89 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.147 0.979 . . . . 0.0 109.492 173.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 65.86 7.74 37.62 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.19 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -117.86 146.16 44.09 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 117.462 0.631 . . . . 0.0 109.738 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -84.76 151.04 25.9 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 121.319 0.4 . . . . 0.0 112.547 -173.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.82 142.91 24.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 171.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.8 t -134.75 144.48 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.481 ' HB1' HD12 ' A' ' 169' ' ' LEU . . . -133.03 149.02 52.22 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.026 0.441 . . . . 0.0 110.056 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -126.13 153.66 44.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.481 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 63.2 p -84.15 4.51 30.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.732 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -134.98 136.68 42.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.391 0.677 . . . . 0.0 109.796 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -73.86 -20.28 60.47 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -70.99 -35.82 72.25 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 17.3 m -75.19 -29.96 60.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -66.93 -50.03 63.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.793 -0.146 . . . . 0.0 110.927 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.9 pt -70.09 -17.99 21.38 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 CA-C-N 118.061 0.392 . . . . 0.0 110.741 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.01 -24.55 37.86 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 117.582 0.174 . . . . 0.0 110.851 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.72 -31.06 32.25 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.981 0.355 . . . . 0.0 111.666 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.4 pt -95.78 23.54 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 122.712 0.405 . . . . 0.0 110.324 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.3 t -84.3 -13.81 51.44 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.004 0.522 . . . . 0.0 111.518 -176.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -149.62 135.81 18.97 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -53.54 -37.36 62.78 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.966 0.506 . . . . 0.0 112.019 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -113.84 105.06 12.82 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.905 0.383 . . . . 0.0 110.56 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.4 HG23 HD21 ' A' ' 239' ' ' LEU . 1.4 m -65.44 154.53 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.959 174.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.519 ' C ' HD22 ' A' ' 239' ' ' LEU . 44.3 mm-40 -95.23 130.55 41.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.519 HD22 ' C ' ' A' ' 238' ' ' GLN . 2.3 mm? -124.04 17.98 9.24 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.991 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -89.86 118.77 29.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -170.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -149.36 141.04 23.51 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 173.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.16 -131.61 50.11 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -98.98 7.5 45.94 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.942 0.497 . . . . 0.0 111.462 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 244' ' ' ILE . 1.9 mp -88.1 149.41 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 122.841 0.456 . . . . 0.0 109.952 -177.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -150.82 127.89 11.15 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -145.6 157.41 43.98 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.405 1.082 . . . . 0.0 108.652 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -153.36 152.02 30.61 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.9 p -159.93 158.49 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -85.86 145.61 27.11 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.363 0.665 . . . . 0.0 111.183 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.56 161.63 27.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.1 159.25 26.89 Favored Pre-proline 0 N--CA 1.455 -0.198 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.087 169.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.49 133.78 59.1 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.3 2.0 . . . . 0.0 108.731 173.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' TYR . . . . . 0.445 ' CE1' ' CD1' ' A' ' 176' ' ' PHE . 1.1 t80 -73.99 159.9 32.08 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.389 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 34.0 m -107.24 165.05 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 123.918 0.887 . . . . 0.0 111.331 -170.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 3.9 tt . . . . . 0 C--O 1.251 1.152 0 CA-C-O 117.167 -1.397 . . . . 0.0 109.235 -178.314 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.438 " O4'" ' HD2' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.419 -2.795 1 O4'-C1'-N19 114.423 6.223 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . 0.602 " H4'" ' CE1' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.414 -3.229 1 C3'-C2'-C1' 105.714 4.683 OUTLIER-DELTA 0.193 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.404 " O4'" ' CZ ' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.414 -3.264 2 O4'-C1'-N19 113.932 5.732 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.455 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.419 -2.847 0 O4'-C4'-C3' 109.07 2.55 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.462 " H4'" ' HB2' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.414 -3.259 0 P-O3'-C3' 123.437 3.114 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 120.164 0.031 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -133.48 5.92 3.76 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.038 0.535 . . . . 0.0 111.801 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -99.2 2.66 45.96 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.186 0.594 . . . . 0.0 110.698 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -139.39 174.91 10.03 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.725 0.81 . . . . 0.0 110.56 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.8 10.13 85.49 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -140.27 153.09 46.39 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.466 0.706 . . . . 0.0 109.782 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -72.78 136.85 45.53 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.695 0.398 . . . . 0.0 110.402 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.06 172.28 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 123.889 0.876 . . . . 0.0 109.934 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -129.82 168.75 16.1 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.185 0.594 . . . . 0.0 109.887 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -124.96 161.35 26.87 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.876 0.47 . . . . 0.0 109.861 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -117.69 159.16 23.42 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t -98.18 174.43 6.53 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.506 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -77.5 30.0 0.15 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.159 0.584 . . . . 0.0 110.992 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -143.3 144.03 31.94 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.195 0.598 . . . . 0.0 110.701 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.0 m -141.66 155.0 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.801 176.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.409 ' CZ ' ' CA ' ' A' ' 70' ' ' GLY . 2.4 t80 -94.97 129.54 41.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 169.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 p -108.7 93.07 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 122.203 1.001 . . . . 0.0 108.455 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.409 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -86.49 155.81 28.58 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.005 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.76 26.86 73.71 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-O 119.045 -0.864 . . . . 0.0 113.912 171.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 pp -75.23 144.95 79.45 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 118.981 1.391 . . . . 0.0 108.208 173.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 39.9 Cg_endo -62.22 120.07 7.47 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.822 2.348 . . . . 0.0 110.343 -172.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 85.8 Cg_exo -54.84 -11.38 3.47 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.666 3.577 . . . . 0.0 115.238 -178.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -82.89 -7.65 59.64 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.416 0.553 . . . . 0.0 112.307 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.439 HD12 ' C ' ' A' ' 76' ' ' ILE . 2.2 pp -142.98 168.81 12.99 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -165.12 179.7 6.19 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 45.27 -99.42 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.144 1.777 . . . . 0.0 114.339 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -58.1 -28.32 64.52 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -80.38 -24.28 39.86 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.204 0.456 . . . . 0.0 110.29 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.1 mt -76.29 -46.05 33.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.1 m -63.25 -21.13 66.04 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.752 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.16 -18.37 24.58 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.1 m -79.15 -27.05 42.72 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.765 0.711 . . . . 0.0 112.139 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -114.99 11.87 16.6 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -64.85 -20.34 66.36 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.828 0.451 . . . . 0.0 112.189 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -75.24 -0.26 18.9 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -115.59 -4.48 12.24 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 141.86 177.34 16.89 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.24 146.05 50.27 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.475 2.784 . . . . 0.0 110.246 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.415 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -162.37 161.41 27.4 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.965 -169.744 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.9 mm -138.35 160.53 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.63 144.2 34.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -150.46 167.23 27.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.303 0.573 . . . . 0.0 110.826 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.431 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 35.7 p90 -157.77 162.74 26.6 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 175.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.562 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 39.2 Cg_endo -75.28 -15.64 20.03 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.304 2.002 . . . . 0.0 110.527 -169.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.562 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 20.8 m-70 -89.54 -0.49 57.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.829 0.851 . . . . 0.0 111.18 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.15 110.29 4.47 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.813 0.845 . . . . 0.0 109.108 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -156.51 161.24 40.03 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.557 0.343 . . . . 0.0 111.049 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 58.88 -5.78 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.842 1.657 . . . . 0.0 114.262 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.0 t 54.8 27.31 8.72 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.816 0.847 . . . . 0.0 112.684 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -129.38 17.11 5.99 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.367 0.667 . . . . 0.0 111.696 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.5 t -135.27 146.15 48.26 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.075 0.55 . . . . 0.0 109.611 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -142.72 -1.06 1.15 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -174.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.514 ' N ' ' CD ' ' A' ' 106' ' ' PRO . 83.6 m-85 -136.54 29.05 0.13 Allowed Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 105' ' ' PHE . 46.8 Cg_endo -66.33 -29.91 45.57 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 CA-C-N 120.839 1.335 . . . . 0.0 114.457 177.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -81.19 168.41 16.92 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 CA-C-N 122.321 1.865 . . . . 0.0 110.29 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -79.42 -50.22 11.14 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.73 36.77 0.11 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 -175.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.474 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.0 OUTLIER -146.39 150.55 35.89 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.338 0.569 . . . . 0.0 109.494 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.93 -175.03 5.23 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.762 0.425 . . . . 0.0 110.344 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -137.93 142.45 40.56 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.8 151.38 25.8 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -113.82 146.45 39.94 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 169.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -134.69 168.11 19.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.873 0.469 . . . . 0.0 110.578 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -103.83 -25.31 13.13 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.572 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -122.38 152.54 40.09 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -84.36 -15.01 47.93 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.759 176.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.3 t -90.52 -14.95 31.63 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.707 0.403 . . . . 0.0 110.635 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.4 m -75.49 -39.34 58.68 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 122.037 -0.414 . . . . 0.0 110.078 177.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.2 -22.15 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -77.87 -29.9 50.59 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.71 -35.29 45.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.656 0.207 . . . . 0.0 111.148 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 pp -80.11 -16.31 55.25 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.252 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 79.5 mt -96.39 -17.4 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 122.282 0.233 . . . . 0.0 111.084 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -100.43 -10.95 20.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.464 0.574 . . . . 0.0 112.478 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -119.74 44.87 2.28 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.074 0.55 . . . . 0.0 110.825 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 31.4 p -141.48 179.92 6.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.741 0.416 . . . . 0.0 111.904 -175.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.462 ' N ' HD12 ' A' ' 129' ' ' ILE . 2.7 mp -82.71 157.5 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -123.67 157.3 34.15 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.948 0.404 . . . . 0.0 111.199 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.98 -179.07 6.37 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -41.29 -23.44 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -161.04 4.82 0.09 OUTLIER Glycine 0 CA--C 1.529 0.946 0 CA-C-N 119.491 1.041 . . . . 0.0 113.47 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -146.28 -170.53 3.52 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.598 1.199 . . . . 0.0 111.096 -173.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -115.99 165.29 13.29 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.074 0.55 . . . . 0.0 111.815 -174.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -143.88 147.49 34.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.267 0.627 . . . . 0.0 109.404 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.6 mp -128.38 159.94 33.77 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 170.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.4 p -91.4 149.84 21.53 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 122.082 -0.386 . . . . 0.0 110.907 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.4 m -144.43 174.11 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 123.391 0.676 . . . . 0.0 109.944 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.4 p -67.71 -14.13 62.69 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.687 0.395 . . . . 0.0 111.669 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.425 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 39.0 t 47.24 57.38 17.62 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.313 1.045 . . . . 0.0 113.561 174.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 141' ' ' SER . 31.5 Cg_exo -61.9 -9.41 14.18 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.922 2.414 . . . . 0.0 113.945 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.442 HG21 ' HD2' ' A' ' 74' ' ' PRO . 55.3 m -82.37 -27.98 31.8 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.5 0.591 . . . . 0.0 109.6 178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.475 HD12 ' HD3' ' A' ' 147' ' ' LYS . 4.4 mt -150.31 -122.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -170.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -147.47 122.21 9.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.803 0.441 . . . . 0.0 110.311 174.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.6 t70 47.18 32.78 2.18 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 172.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.475 ' HD3' HD12 ' A' ' 144' ' ' ILE . 14.0 pttp -82.94 148.56 57.31 Favored Pre-proline 0 C--N 1.34 0.186 0 CA-C-N 119.786 1.176 . . . . 0.0 110.017 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -83.5 168.27 12.98 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.667 2.911 . . . . 0.0 112.245 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.9 m -128.3 146.78 33.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.501 HE21 ' C ' ' A' ' 150' ' ' GLN . 0.0 OUTLIER -93.02 149.52 21.16 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.601 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 45.0 mm -122.49 144.65 31.13 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 C-N-CA 124.246 1.018 . . . . 0.0 109.646 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.83 100.25 3.09 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.39 162.27 40.62 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.777 2.984 . . . . 0.0 111.799 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -89.82 149.54 22.63 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.935 -0.12 . . . . 0.0 110.799 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -109.04 115.23 29.66 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.768 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -83.85 12.09 6.61 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -169.634 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.2 t -96.2 -1.79 47.56 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -173.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -144.5 20.33 1.69 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.0 m -64.82 -21.06 66.71 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -175.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -153.74 156.29 37.5 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 118.014 0.37 . . . . 0.0 110.854 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -158.17 150.56 22.15 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.37 151.82 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 O-C-N 121.944 -0.473 . . . . 0.0 110.174 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 64.2 mtm -127.84 24.7 6.05 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 122.366 0.266 . . . . 0.0 111.409 -175.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -158.94 -49.91 0.06 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 64.95 11.64 51.67 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.98 -0.9 . . . . 0.0 113.939 172.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 26.3 t -138.75 -27.63 0.83 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.776 1.288 . . . . 0.0 114.332 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -77.08 147.34 76.68 Favored Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 119.115 0.871 . . . . 0.0 111.03 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.43 157.42 40.96 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.909 3.073 . . . . 0.0 110.969 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 10.6 mp -118.48 161.93 19.19 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.688 0.795 . . . . 0.0 109.85 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -137.5 152.89 73.87 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.68 -0.19 9.03 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.603 2.869 . . . . 0.0 111.432 -176.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -114.99 7.97 15.69 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 124.206 1.002 . . . . 0.0 111.494 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -123.33 19.72 9.74 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.825 0.45 . . . . 0.0 111.39 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.0 m -115.6 139.53 50.02 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.759 0.314 . . . . 0.0 111.079 -175.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.5 tt -118.32 149.57 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 C-N-CA 123.178 0.591 . . . . 0.0 109.934 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -109.97 147.28 33.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.2 t -134.9 132.25 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -177.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -152.39 167.16 31.33 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 87.1 11.82 69.13 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -170.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.8 m -65.93 156.21 84.49 Favored Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 122.919 0.488 . . . . 0.0 111.272 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -72.76 -171.98 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.941 3.094 . . . . 0.0 109.857 174.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -54.26 -50.92 82.07 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.874 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.42 139.32 23.12 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.143 1.895 . . . . 0.0 110.221 173.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.0 12.66 0.5 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 -42.14 140.07 1.21 Allowed 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.125 0.97 . . . . 0.0 112.209 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.47 -17.77 62.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.746 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.75 -50.45 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-O 120.699 0.285 . . . . 0.0 110.294 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -83.77 -25.93 30.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.562 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 26.0 tp -69.81 -32.97 71.71 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.68 -32.2 36.07 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 122.335 -0.228 . . . . 0.0 111.268 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.3 mmt -68.66 -31.58 70.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.6 mt -79.01 -33.26 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 O-C-N 122.231 -0.293 . . . . 0.0 110.49 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.7 mmt -73.36 -19.42 61.01 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.534 0.606 . . . . 0.0 109.984 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -83.62 -24.93 31.22 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.371 0.268 . . . . 0.0 111.224 175.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -87.76 -16.93 32.82 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -117.19 -17.01 10.34 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -134.68 23.06 3.64 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -173.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 73.87 -144.41 33.71 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 175.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -72.44 123.51 9.21 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 112.145 -0.382 . . . . 0.0 112.145 -173.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 90.8 t -111.57 137.74 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 124.745 1.218 . . . . 0.0 108.027 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.9 p -92.76 -41.44 10.13 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 118.364 0.529 . . . . 0.0 111.902 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -156.61 155.64 32.17 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.144 0.429 . . . . 0.0 111.676 -171.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -149.7 159.6 44.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.33 0.586 . . . . 0.0 111.006 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -174.67 170.48 43.6 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.7 mp -82.42 148.92 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -57.99 119.03 6.04 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 22.6 p -138.35 158.64 43.88 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -117.07 131.96 23.71 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.61 -16.1 15.07 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 124.503 3.469 . . . . 0.0 114.47 -172.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -110.97 -25.14 9.97 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.334 0.97 . . . . 0.0 111.381 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -86.86 -10.2 53.98 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 169.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 49.89 45.81 24.71 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.647 1.179 . . . . 0.0 111.839 175.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.32 156.22 39.66 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -80.69 157.25 21.47 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.527 2.818 . . . . 0.0 111.2 174.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.41 ' HA ' ' N3 ' ' B' ' 4' ' ' ' U' . 35.2 mtmm -119.11 21.55 12.27 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.595 0.758 . . . . 0.0 111.04 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.23 -178.15 31.08 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 55.34 -173.98 0.05 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.334 0.567 . . . . 0.0 111.869 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -140.92 168.79 25.18 Favored Glycine 0 CA--C 1.524 0.632 0 O-C-N 121.608 -0.682 . . . . 0.0 112.979 -177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -146.58 149.8 34.26 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 97.1 t -136.68 151.09 27.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -124.38 145.72 49.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.916 0.486 . . . . 0.0 111.355 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -122.38 151.23 41.41 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.697 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 62.9 p -91.96 -0.64 57.49 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 116.78 -0.191 . . . . 0.0 111.242 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -132.5 144.83 50.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.901 0.48 . . . . 0.0 110.243 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -80.12 -9.36 59.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.244 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -85.09 -42.18 15.04 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 34.8 p -74.63 -24.6 58.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -68.45 -48.81 63.56 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 119.639 -0.22 . . . . 0.0 110.993 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.6 pp -71.95 -12.46 15.91 Favored 'Isoleucine or valine' 0 C--N 1.338 0.066 0 CA-C-N 118.372 0.533 . . . . 0.0 110.991 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.96 -27.83 30.22 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 173.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.59 -27.23 34.37 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.7 pt -106.92 29.58 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.039 0.536 . . . . 0.0 110.372 174.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.8 t -78.35 -14.57 59.34 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.29 0.636 . . . . 0.0 111.813 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -155.79 144.08 20.05 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -60.2 -33.12 71.8 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.409 -0.329 . . . . 0.0 111.584 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -119.67 116.26 25.62 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.738 0.304 . . . . 0.0 110.42 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -108.62 159.4 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.333 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -86.6 143.82 27.47 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.949 0.404 . . . . 0.0 111.155 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.85 103.97 6.09 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 173.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -135.44 153.31 51.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.226 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -138.73 11.88 2.7 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.123 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 175.17 -134.45 2.74 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -76.54 12.49 1.25 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.096 0.558 . . . . 0.0 111.381 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.1 mt -66.91 157.97 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.41 1.084 . . . . 0.0 110.112 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -145.82 21.02 1.46 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -67.87 160.48 28.35 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.054 0.542 . . . . 0.0 111.986 -173.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.16 161.99 35.4 Favored 'General case' 0 C--N 1.337 0.065 0 C-N-CA 124.353 1.061 . . . . 0.0 110.229 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.4 p -153.8 156.61 5.17 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -89.32 138.47 31.41 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 117.671 0.214 . . . . 0.0 110.624 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.97 158.46 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-O 120.828 0.347 . . . . 0.0 111.233 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.424 ' HG3' ' H61' ' B' ' 5' ' ' ' A' . 0.0 OUTLIER -161.02 159.25 24.78 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 171.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.81 140.21 92.1 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.629 2.219 . . . . 0.0 109.78 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -78.41 168.24 20.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.244 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.4 p -149.7 153.27 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.067 0.547 . . . . 0.0 110.319 -170.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.403 ' H ' HD23 ' A' ' 255' ' ' LEU . 2.0 pt? . . . . . 0 C--O 1.251 1.14 0 CA-C-O 116.995 -1.478 . . . . 0.0 111.203 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.45 ' C5 ' ' CD1' ' A' ' 144' ' ' ILE . . . . . . . . 0 O4'--C4' 1.425 -2.324 5 O4'-C1'-N19 115.888 7.688 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . 0.446 ' P ' ' C6 ' ' B' ' 2' ' ' ' U' . . . . . . . . 0 P--O5' 1.622 2.877 0 O4'-C1'-N19 111.896 3.696 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.474 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.425 -2.336 2 O4'-C1'-N19 113.477 5.277 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.41 ' N3 ' ' HA ' ' A' ' 215' ' ' LYS . . . . . . . . 0 O4'--C4' 1.419 -2.792 0 O5'-C5'-C4' 106.319 -2.772 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.424 ' H61' ' HG3' ' A' ' 251' ' ' LYS . . . . . . . . 0 O4'--C4' 1.414 -3.233 1 C5'-C4'-C3' 108.399 -4.734 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 120.45 0.167 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -146.34 169.04 19.65 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.216 0.606 . . . . 0.0 110.437 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.457 ' H ' ' CD ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -94.67 10.78 33.58 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.261 0.624 . . . . 0.0 112.567 -175.909 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -105.45 9.63 33.54 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.883 0.473 . . . . 0.0 111.278 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.55 172.04 46.07 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 123.049 0.357 . . . . 0.0 112.36 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -147.56 159.76 43.39 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.487 0.715 . . . . 0.0 109.352 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -65.71 -23.76 66.83 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.873 0.469 . . . . 0.0 111.485 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.4 m -143.74 157.56 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.048 0 C-N-CA 123.865 0.866 . . . . 0.0 109.569 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.461 ' HB3' ' CE2' ' A' ' 63' ' ' TYR . 14.4 mp0 -91.2 6.96 43.05 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.292 0.237 . . . . 0.0 111.428 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.89 37.6 3.74 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.236 1.414 . . . . 0.0 114.479 175.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.461 ' CE2' ' HB3' ' A' ' 61' ' ' GLU . 29.7 m-85 -75.33 170.83 15.32 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.153 0.501 . . . . 0.0 112.304 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.4 t -100.38 27.45 5.72 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -168.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.517 ' HA ' ' CE2' ' A' ' 115' ' ' PHE . 0.0 OUTLIER 55.33 17.41 2.1 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.122 0.419 . . . . 0.0 111.155 -176.414 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -147.82 140.24 24.47 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.247 0.619 . . . . 0.0 111.632 -177.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.5 m -136.06 148.52 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.704 169.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.422 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 4.3 t80 -85.22 140.45 30.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 174.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.9 p -122.98 98.55 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 121.779 0.8 . . . . 0.0 108.906 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.36 169.49 51.34 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.41 26.76 71.92 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 119.226 -0.763 . . . . 0.0 113.901 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.457 ' HB3' ' H ' ' A' ' 110' ' ' TYR . 18.5 tp -63.0 122.18 73.46 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 119.626 1.713 . . . . 0.0 107.352 173.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.65 170.07 20.86 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.164 2.576 . . . . 0.0 111.537 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.46 179.06 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 124.357 3.371 . . . . 0.0 112.753 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 61.45 -79.7 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.411 ' C ' HD12 ' A' ' 76' ' ' ILE . 2.3 pp -65.2 164.8 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 118.288 0.494 . . . . 0.0 111.539 -177.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -146.88 -24.67 0.41 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -154.28 -36.69 0.1 Allowed 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -174.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -67.48 -39.99 85.25 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.006 0.366 . . . . 0.0 111.944 -173.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -74.48 -35.33 63.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.179 -0.326 . . . . 0.0 111.37 -172.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.7 pt -83.91 -28.03 7.34 Favored 'Isoleucine or valine' 0 C--O 1.23 0.041 0 O-C-N 122.145 -0.347 . . . . 0.0 110.967 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.0 m -79.77 -5.63 55.68 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.15 -14.13 14.99 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 171.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 m -95.14 -17.79 21.49 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -120.65 0.74 10.49 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.374 0.534 . . . . 0.0 111.986 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.0 tpt85 -70.38 -21.4 62.87 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 122.716 0.406 . . . . 0.0 110.831 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -69.15 -5.71 24.16 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.674 0.789 . . . . 0.0 111.947 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -112.68 -13.34 13.27 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.239 0.215 . . . . 0.0 111.427 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.5 168.6 18.81 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -70.9 149.14 59.1 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.294 2.663 . . . . 0.0 110.804 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.404 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -164.77 158.73 17.86 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -170.728 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.489 HG22 ' H ' ' A' ' 93' ' ' VAL . 12.2 mm -136.86 173.17 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 171.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.489 ' H ' HG22 ' A' ' 92' ' ' ILE . 7.3 p -137.6 156.03 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 118.445 0.566 . . . . 0.0 110.606 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -149.18 164.24 35.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.542 0.337 . . . . 0.0 111.039 -175.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.461 ' CZ2' ' HE3' ' A' ' 98' ' ' LYS . 24.2 p90 -155.46 156.32 30.75 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.477 ' HG2' ' ND1' ' A' ' 97' ' ' HIS . 25.5 Cg_endo -75.42 -11.66 20.72 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 124.026 3.151 . . . . 0.0 110.683 -169.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.477 ' ND1' ' HG2' ' A' ' 96' ' ' PRO . 61.6 m80 -105.52 5.94 31.87 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.847 0.859 . . . . 0.0 111.363 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.461 ' HE3' ' CZ2' ' A' ' 95' ' ' TRP . 68.8 tttt -64.65 157.84 26.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.717 0.807 . . . . 0.0 112.568 -176.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 60.45 173.38 0.09 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.037 1.335 . . . . 0.0 113.303 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 53.54 82.77 0.08 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.797 1.239 . . . . 0.0 111.796 -178.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.9 m 56.72 19.66 4.53 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.554 1.142 . . . . 0.0 113.908 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -134.8 26.84 3.64 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.412 0.685 . . . . 0.0 110.893 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.2 m -86.61 163.49 17.39 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.085 0.554 . . . . 0.0 111.037 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 26.6 t80 57.16 9.59 0.7 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.925 1.29 . . . . 0.0 114.129 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.422 ' CD1' ' HD2' ' A' ' 106' ' ' PRO . 44.2 t80 -162.3 130.0 2.72 Favored Pre-proline 0 CA--C 1.534 0.349 0 O-C-N 121.567 -0.708 . . . . 0.0 109.85 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.422 ' HD2' ' CD1' ' A' ' 105' ' ' PHE . 83.2 Cg_endo -73.84 168.35 25.0 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 124.094 3.196 . . . . 0.0 109.945 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -62.21 -28.18 79.09 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.71 2.273 . . . . 0.0 111.099 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -162.14 -41.83 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 171.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 176.54 -163.81 33.15 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.457 ' H ' ' HB3' ' A' ' 72' ' ' LEU . 0.0 OUTLIER 60.54 147.7 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 113.859 -1.171 . . . . 0.0 113.991 -177.411 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.49 -173.45 3.99 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.185 0.594 . . . . 0.0 110.043 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.35 134.0 26.78 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.424 ' C ' HD12 ' A' ' 114' ' ' LEU . 10.6 mp -91.19 149.64 21.7 Favored 'General case' 0 CA--C 1.522 -0.108 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -176.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.424 HD12 ' C ' ' A' ' 113' ' ' LEU . 9.8 mp -118.59 144.69 45.95 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 173.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.517 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.7 p90 -158.93 177.35 11.25 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -117.89 -12.74 10.12 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -129.29 142.66 50.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.973 0.416 . . . . 0.0 112.03 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -80.76 -6.05 57.97 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.831 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 75.1 p -82.73 -19.26 38.28 Favored 'General case' 0 N--CA 1.457 -0.113 0 O-C-N 122.137 -0.352 . . . . 0.0 111.075 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.5 t -72.58 -44.27 62.27 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.0 m -70.84 -26.2 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -69.94 -41.6 74.35 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.764 -0.585 . . . . 0.0 110.702 -176.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.54 -36.6 60.44 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.04 0.382 . . . . 0.0 111.792 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -76.86 -15.37 59.73 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.06 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 77.3 mt -95.42 -17.32 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.336 0.254 . . . . 0.0 110.467 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -90.84 -14.92 30.91 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.608 -0.682 . . . . 0.0 111.121 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.29 46.32 1.82 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.491 0.717 . . . . 0.0 111.437 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 22.5 p -138.27 176.7 8.47 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 39.5 mm -92.88 164.35 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 125.363 1.465 . . . . 0.0 108.351 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -133.46 150.63 51.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.778 0.323 . . . . 0.0 110.836 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.16 -179.86 5.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 175.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -55.84 -4.76 0.12 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -171.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -170.17 14.03 0.05 OUTLIER Glycine 0 CA--C 1.527 0.831 0 CA-C-N 118.854 0.752 . . . . 0.0 113.137 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' A' ' 134' ' ' LYS . 21.4 ttmt -157.89 -178.05 7.02 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.596 1.198 . . . . 0.0 111.23 -174.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 150' ' ' GLN . 67.2 mt -112.24 169.56 8.78 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.078 0.551 . . . . 0.0 110.972 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.472 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 0.3 OUTLIER -145.81 139.53 26.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.27 0.628 . . . . 0.0 109.717 179.126 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.0 mp -136.8 149.71 47.91 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.346 0.521 . . . . 0.0 110.069 170.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.3 p -71.1 154.57 41.64 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.9 p -148.77 7.34 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 O-C-N 122.402 -0.187 . . . . 0.0 111.479 -177.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.2 m 53.16 46.99 25.44 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.847 -0.533 . . . . 0.0 110.799 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.9 t -47.6 139.83 8.27 Favored Pre-proline 0 CA--C 1.53 0.199 0 C-N-CA 124.351 1.06 . . . . 0.0 112.234 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -80.1 -15.14 11.79 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 124.142 3.228 . . . . 0.0 113.854 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.7 t -89.47 -24.0 21.95 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.841 1.201 . . . . 0.0 111.657 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.49 HG22 ' H ' ' A' ' 145' ' ' LYS . 2.4 mm -121.63 -174.95 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.077 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.49 ' H ' HG22 ' A' ' 144' ' ' ILE . 63.9 pttt -69.97 -32.67 71.0 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.346 -0.846 . . . . 0.0 109.139 171.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -165.58 150.14 8.59 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.781 1.633 . . . . 0.0 107.187 170.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.85 105.49 2.49 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.472 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 78.1 Cg_exo -53.39 145.11 47.17 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.031 3.154 . . . . 0.0 113.905 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.4 m -116.72 148.61 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.059 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 25.3 mp0 -82.03 157.33 24.21 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -174.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.0 mm -136.59 142.37 38.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.379 0.672 . . . . 0.0 109.36 171.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.6 ttp85 -157.66 104.4 1.8 Allowed Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 171.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -60.72 167.17 8.84 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 124.507 3.471 . . . . 0.0 114.819 175.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -111.1 136.43 50.15 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.348 171.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -103.18 150.12 23.99 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.478 0.711 . . . . 0.0 112.455 -176.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.6 mp -94.47 97.7 10.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.466 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.9 t -156.09 -33.1 0.09 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.803 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -138.78 22.36 2.67 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.7 m -68.62 -25.04 64.65 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -175.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -153.67 159.62 42.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.239 0.616 . . . . 0.0 110.518 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -151.77 154.26 35.91 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.6 t -136.42 144.29 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -174.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 63.8 mtm -141.74 15.36 2.14 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -151.38 10.79 0.59 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.336 0.516 . . . . 0.0 112.062 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.94 12.25 84.1 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 121.764 -0.585 . . . . 0.0 111.931 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.5 m 52.89 73.17 0.37 Allowed 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -70.85 173.55 4.65 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -54.44 133.97 59.07 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.208 1.938 . . . . 0.0 112.073 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.4 mp -106.66 160.87 15.12 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 123.603 0.761 . . . . 0.0 109.904 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -150.08 145.04 18.2 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.3 -20.84 33.78 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.425 2.75 . . . . 0.0 114.176 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -91.1 2.93 55.96 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.457 0.571 . . . . 0.0 111.126 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -131.07 15.96 5.14 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.655 0.382 . . . . 0.0 111.117 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 18.7 m -128.08 140.17 52.1 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 120.713 0.292 . . . . 0.0 110.805 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.4 tt -113.28 150.57 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 C-N-CA 123.204 0.602 . . . . 0.0 109.992 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -120.84 153.16 37.5 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 18.0 m -141.68 151.74 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.792 0.437 . . . . 0.0 110.422 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -164.34 171.48 39.87 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.47 11.04 80.95 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 11.9 p -63.26 138.62 97.39 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.18 -52.89 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.502 2.135 . . . . 0.0 112.218 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.428 ' H ' ' CD ' ' A' ' 183' ' ' PRO . 24.5 tpt180 -162.78 -47.24 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.331 -0.842 . . . . 0.0 113.066 176.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.428 ' CD ' ' H ' ' A' ' 182' ' ' ARG . 16.3 Cg_exo -71.38 140.93 37.75 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.747 2.298 . . . . 0.0 111.778 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.696 ' CD1' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -151.88 -87.12 0.07 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 119.151 -0.452 . . . . 0.0 111.463 176.514 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.696 ' H ' ' CD1' ' A' ' 184' ' ' LEU . 71.2 mtp180 59.38 126.48 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 126.393 1.877 . . . . 0.0 112.181 -173.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.5 -20.23 65.42 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.896 -0.503 . . . . 0.0 110.364 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 68.1 t -69.43 -54.01 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 122.434 0.294 . . . . 0.0 110.616 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -81.71 -23.38 36.81 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.341 -0.224 . . . . 0.0 111.054 -174.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 53.1 tp -71.0 -33.6 70.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -79.49 -33.45 42.2 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.4 mmt -69.83 -38.63 76.61 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.877 0.308 . . . . 0.0 110.304 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 94.1 mt -73.1 -37.32 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.6 mmt -67.07 -20.08 65.76 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.975 -0.453 . . . . 0.0 110.695 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -86.3 -19.88 29.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.872 0.306 . . . . 0.0 111.784 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -96.58 -14.34 22.29 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.0 -13.45 10.02 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -136.66 21.22 3.1 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 81.83 -150.14 29.09 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 122.141 -0.349 . . . . 0.0 112.252 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.19 121.81 5.98 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 123.086 0.374 . . . . 0.0 112.221 -171.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 90.9 t -100.49 147.19 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 124.242 1.017 . . . . 0.0 109.612 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 46.7 t -102.12 -43.73 5.66 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -159.7 158.42 31.33 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.37 0.129 . . . . 0.0 111.105 -170.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -152.88 156.97 39.97 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.849 0.46 . . . . 0.0 110.648 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -178.16 -176.05 45.8 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 42.8 mm -113.58 90.81 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 14.1 t70 56.72 -63.57 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -169.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 55.3 p 45.67 56.41 5.88 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.87 130.59 94.89 Favored Pre-proline 0 N--CA 1.453 -0.307 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -78.32 -14.58 14.67 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.517 3.478 . . . . 0.0 113.681 -173.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -94.65 -36.82 11.61 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 118.643 0.656 . . . . 0.0 110.317 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 94.3 mt -96.44 -7.39 35.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.867 0.467 . . . . 0.0 109.925 176.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 50.16 44.55 26.07 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.792 1.237 . . . . 0.0 111.87 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.99 155.53 62.33 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -174.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -84.74 177.83 5.28 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 123.807 3.005 . . . . 0.0 111.073 174.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -138.73 22.81 2.67 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.113 0.565 . . . . 0.0 110.862 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 62.72 8.24 20.01 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.63 -0.539 . . . . 0.0 113.677 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -128.58 141.04 51.49 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.952 0.876 . . . . 0.0 109.274 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -86.16 161.64 34.55 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-O 121.526 0.515 . . . . 0.0 113.942 -171.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -149.53 148.51 29.47 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.9 t -141.64 154.82 19.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -135.69 150.48 49.59 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.619 0.247 . . . . 0.0 110.61 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -124.66 154.57 40.57 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 66.5 p -86.02 3.01 44.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.156 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -139.3 140.53 37.61 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.32 0.648 . . . . 0.0 110.005 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -74.2 -19.68 60.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.395 -0.191 . . . . 0.0 110.661 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -71.64 -37.0 70.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 44.2 m -72.49 -30.26 64.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -69.25 -49.97 51.31 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 119.484 -0.293 . . . . 0.0 111.041 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 41.8 pt -68.16 -18.31 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.032 0 CA-C-N 118.43 0.559 . . . . 0.0 110.79 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.55 -25.63 35.69 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -84.95 -23.23 28.87 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.6 pt -105.23 25.75 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 122.734 0.414 . . . . 0.0 110.833 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 20.0 t -84.54 -9.4 58.36 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.12 0.568 . . . . 0.0 112.271 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -156.65 143.97 18.98 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 249' ' ' GLU . 10.1 ptp180 -60.04 -52.57 64.81 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.214 -175.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -93.05 115.79 28.44 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.374 0.988 . . . . 0.0 110.139 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 237' ' ' VAL . 0.6 OUTLIER -83.52 147.24 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 171.858 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -81.99 127.19 32.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.84 17.25 6.82 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -84.15 130.34 34.85 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.165 0.586 . . . . 0.0 112.26 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -152.49 143.41 22.99 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 61.85 -144.31 48.93 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -177.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.1 8.73 31.27 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.086 0.554 . . . . 0.0 111.669 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 66.7 mt -96.62 153.81 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 123.442 0.697 . . . . 0.0 110.264 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -130.52 133.95 46.66 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -145.37 145.37 31.15 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 124.502 1.121 . . . . 0.0 108.576 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -158.93 155.31 27.4 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.29 0.636 . . . . 0.0 109.622 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 8.7 p -157.6 154.31 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 235' ' ' ARG . 42.8 mt-10 -94.13 136.4 34.46 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 117.786 0.266 . . . . 0.0 110.64 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.4 m -101.72 161.34 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.432 ' HG3' ' H61' ' B' ' 5' ' ' ' A' . 0.0 OUTLIER -159.01 159.61 29.28 Favored Pre-proline 0 N--CA 1.454 -0.226 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.776 169.449 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.2 136.66 76.39 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.796 2.33 . . . . 0.0 109.27 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -87.28 167.55 13.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.052 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.3 p -153.44 149.44 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.626 0.771 . . . . 0.0 110.018 -170.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 89.7 mt . . . . . 0 C--O 1.253 1.253 0 CA-C-O 117.568 -1.206 . . . . 0.0 109.625 178.866 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.683 2 O4'-C1'-N19 113.141 4.941 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.804 1 O4'-C1'-N19 112.653 4.453 . 0.36 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.422 ' C6 ' ' CE2' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.5 1 O4'-C1'-N19 113.887 5.687 . 0.01 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.43 " C1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.418 -2.902 0 C5'-C4'-C3' 109.595 -3.937 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.432 ' H61' ' HG3' ' A' ' 251' ' ' LYS . . . . . . . . 0 O4'--C4' 1.411 -3.521 0 O4'-C1'-N19 110.847 2.647 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.1 m . . . . . 0 N--CA 1.475 0.805 0 CA-C-O 120.347 0.118 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 53.25 30.48 10.08 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.04 0.936 . . . . 0.0 113.189 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -73.56 161.85 29.89 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.723 0.297 . . . . 0.0 110.817 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -135.6 14.59 3.42 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.402 0.681 . . . . 0.0 111.483 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.74 -171.74 24.04 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -127.39 162.55 26.07 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.149 0.58 . . . . 0.0 110.515 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -93.86 171.5 8.83 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 121.151 0.5 . . . . 0.0 111.451 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 p -68.57 158.73 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.816 0.847 . . . . 0.0 110.535 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -126.09 153.94 43.78 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.489 0.715 . . . . 0.0 109.46 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -122.75 164.8 17.67 Favored 'General case' 0 C--N 1.337 0.063 0 C-N-CA 123.051 0.54 . . . . 0.0 111.238 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -151.19 157.03 42.13 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.225 -171.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.0 t -94.01 161.24 14.37 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 50.1 mtm105 -81.96 24.32 0.64 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.32 0.248 . . . . 0.0 110.894 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -140.27 138.15 34.77 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.698 0.399 . . . . 0.0 110.804 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.36 155.78 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.866 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.419 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 5.8 t80 -86.97 139.04 30.99 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 171.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.23 115.48 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 174.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.414 ' HA2' ' CZ ' ' A' ' 68' ' ' PHE . . . -79.73 137.98 19.55 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.47 -175.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.49 158.61 6.17 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 121.985 0.77 . . . . 0.0 114.69 173.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.5 tp -160.09 126.37 2.44 Favored Pre-proline 0 N--CA 1.451 -0.385 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.465 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 98.0 Cg_endo -73.74 142.23 31.84 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.622 1.548 . . . . 0.0 109.12 -178.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 32.1 Cg_exo -61.54 -3.23 3.2 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.93 3.087 . . . . 0.0 115.165 -174.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -99.88 -21.27 15.77 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.432 ' C ' HD12 ' A' ' 76' ' ' ILE . 1.8 pp -133.36 -171.89 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 119.459 1.027 . . . . 0.0 111.203 -177.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -136.68 -163.24 1.38 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.465 0.706 . . . . 0.0 112.291 -172.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -40.62 -31.08 0.14 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.853 2.061 . . . . 0.0 113.459 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -64.61 -30.26 71.28 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -175.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -80.04 -33.99 38.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.083 -0.386 . . . . 0.0 111.133 -173.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.4 mt -73.78 -36.19 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 33.5 m -68.75 -21.77 64.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.76 -13.23 27.64 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.4 m -84.75 -29.54 25.41 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.285 0.493 . . . . 0.0 112.022 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -110.49 5.15 21.08 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -176.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.6 tpt85 -67.96 -14.0 62.62 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.973 -0.454 . . . . 0.0 110.365 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -64.78 -15.72 62.03 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.813 1.245 . . . . 0.0 111.81 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -120.83 -5.95 9.62 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.917 0.339 . . . . 0.0 111.917 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.04 163.82 10.31 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -57.93 139.04 88.97 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.141 2.56 . . . . 0.0 111.342 177.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.516 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -150.38 167.5 26.87 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.066 0.46 . . . . 0.0 111.096 178.229 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 pt -138.08 163.68 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.5 p -132.66 145.04 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -154.04 171.37 19.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.081 0.467 . . . . 0.0 110.395 -174.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.4 ' CH2' ' HE3' ' A' ' 98' ' ' LYS . 18.8 p90 -155.14 163.04 25.87 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 174.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.487 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 89.8 Cg_endo -71.31 -7.44 21.32 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 CA-C-N 121.232 1.476 . . . . 0.0 110.844 -170.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.487 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 3.4 m-70 -99.73 2.81 44.57 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.726 0.811 . . . . 0.0 111.491 -177.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.4 ' HE3' ' CH2' ' A' ' 95' ' ' TRP . 12.4 tptm -54.6 158.24 2.62 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.054 0.942 . . . . 0.0 112.693 -178.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -126.47 18.32 7.52 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.078 0.951 . . . . 0.0 110.918 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 59.95 -25.08 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.99 2.116 . . . . 0.0 115.394 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.0 t -163.07 -21.36 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.162 0.892 . . . . 0.0 112.143 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -87.71 1.17 54.49 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.2 m -141.37 149.62 41.35 Favored 'General case' 0 N--CA 1.458 -0.073 0 CA-C-N 118.063 0.392 . . . . 0.0 110.849 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -137.44 -2.91 1.95 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.789 0.835 . . . . 0.0 111.331 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 91.9 m-85 -126.51 127.76 24.48 Favored Pre-proline 0 N--CA 1.453 -0.316 0 CA-C-N 118.03 0.377 . . . . 0.0 110.324 -175.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 105' ' ' PHE . 39.1 Cg_exo -59.76 165.76 9.42 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.917 3.078 . . . . 0.0 111.512 171.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -52.05 -24.39 19.58 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.039 3.159 . . . . 0.0 113.734 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -146.98 -61.31 0.29 Allowed 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.149 0.432 . . . . 0.0 110.643 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.02 42.55 0.04 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.282 -0.961 . . . . 0.0 114.173 -177.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.542 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -140.75 153.61 45.95 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.519 1.159 . . . . 0.0 108.888 174.864 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.18 -178.63 6.74 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.274 0.488 . . . . 0.0 111.972 -174.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -141.11 140.51 34.16 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.5 mp -96.32 148.91 22.27 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 118.497 0.59 . . . . 0.0 112.326 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.9 mp -115.52 142.28 46.93 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 170.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -131.7 167.8 18.86 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.404 0.621 . . . . 0.0 111.93 -174.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -109.28 -29.85 8.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.932 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -121.8 153.17 38.66 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -85.97 -17.84 34.24 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.176 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.7 t -85.76 -17.67 35.19 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.128 -0.358 . . . . 0.0 110.198 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 41.9 t -72.36 -39.5 68.03 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.31 -26.71 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -71.05 -34.91 71.7 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.971 -0.455 . . . . 0.0 110.311 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -77.97 -35.17 50.55 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 122.176 -0.328 . . . . 0.0 111.654 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 pp -78.91 -16.7 56.66 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.43 0.559 . . . . 0.0 111.458 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.4 mt -92.33 -22.7 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 122.254 0.222 . . . . 0.0 110.454 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -97.9 -10.21 24.98 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -117.56 35.04 4.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.175 0.59 . . . . 0.0 111.269 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 26.8 p -136.76 -179.59 5.78 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.906 0.482 . . . . 0.0 111.331 -176.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.1 mm -87.4 159.44 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 124.391 1.077 . . . . 0.0 109.018 -177.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.65 154.79 43.56 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.759 0.314 . . . . 0.0 110.791 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -146.39 85.11 1.64 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.516 0.675 . . . . 0.0 110.753 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 55.43 0.13 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.22 -12.18 0.07 OUTLIER Glycine 0 CA--C 1.527 0.841 0 CA-C-N 119.568 1.076 . . . . 0.0 114.072 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.1 170.84 15.06 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 118.195 0.998 . . . . 0.0 109.609 177.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.97 166.05 10.65 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -172.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.406 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -142.39 139.49 31.71 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.891 -177.52 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.1 tp -124.55 128.72 49.36 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 48.9 t -77.03 139.48 40.06 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.1 m -137.65 -0.97 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.116 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 29.7 t 45.68 60.38 3.15 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.265 0.626 . . . . 0.0 111.116 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 142' ' ' PRO . 75.2 m -56.96 150.48 38.79 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.941 -175.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 141' ' ' SER . 19.8 Cg_exo -67.82 11.91 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.795 2.996 . . . . 0.0 114.907 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.743 HG23 HG13 ' A' ' 144' ' ' ILE . 15.1 t -121.23 -15.39 8.17 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.595 1.089 . . . . 0.0 111.832 -174.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.743 HG13 HG23 ' A' ' 143' ' ' THR . 0.6 OUTLIER -168.25 -176.44 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 125.178 1.391 . . . . 0.0 109.635 -177.799 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -120.74 16.74 11.91 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.739 0.816 . . . . 0.0 110.953 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -141.38 34.35 1.67 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -173.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.638 ' CD ' " H2'" ' B' ' 1' ' ' ' C' . 50.2 mttp -129.16 80.1 73.16 Favored Pre-proline 0 C--N 1.34 0.179 0 CA-C-N 118.927 0.785 . . . . 0.0 111.193 177.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.406 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 19.8 Cg_exo -67.69 145.56 70.02 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.908 2.405 . . . . 0.0 108.765 169.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.8 m -75.65 133.92 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -86.27 150.28 24.47 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 26.3 mm -130.17 137.36 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 C-N-CA 122.743 0.417 . . . . 0.0 110.646 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -141.45 92.19 8.28 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.53 162.87 34.89 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 124.174 3.25 . . . . 0.0 112.742 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -93.47 142.69 27.04 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 172.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -101.52 157.1 17.06 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.219 0.533 . . . . 0.0 110.489 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.419 HD12 ' N ' ' A' ' 156' ' ' LEU . 8.5 mp -90.33 178.99 5.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.518 0.675 . . . . 0.0 111.402 -176.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.7 m 65.12 4.43 2.56 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.501 1.92 . . . . 0.0 116.115 176.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 52.9 p30 -135.58 12.65 3.46 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 120.345 1.43 . . . . 0.0 113.317 172.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.8 m -66.13 -32.46 73.91 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -152.84 161.27 42.76 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 122.817 0.447 . . . . 0.0 111.015 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -152.97 152.89 31.94 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.956 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.97 140.66 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 28.3 ttp -132.44 13.7 4.55 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -159.66 -57.75 0.06 Allowed 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 61.33 11.64 28.18 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.409 -0.662 . . . . 0.0 113.54 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.4 t -109.36 -4.28 16.51 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.174 0.987 . . . . 0.0 112.184 -175.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -124.38 136.74 28.1 Favored Pre-proline 0 CA--C 1.531 0.218 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -68.3 160.52 48.62 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.146 2.564 . . . . 0.0 110.049 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 46.7 mt -113.04 153.31 28.31 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.51 0.324 . . . . 0.0 110.769 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -145.0 150.56 46.19 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.95 -5.43 13.43 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.442 2.761 . . . . 0.0 112.017 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -93.87 -1.22 55.13 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.028 0.531 . . . . 0.0 110.757 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.07 20.81 4.08 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.585 0.354 . . . . 0.0 111.444 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 13.6 m -119.99 143.17 48.18 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-O 120.987 0.422 . . . . 0.0 111.395 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.9 tt -113.05 141.3 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -106.92 152.36 24.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 76.1 t -137.97 144.98 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 123.633 0.773 . . . . 0.0 108.965 -173.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -148.02 149.55 21.64 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 112.04 -0.424 . . . . 0.0 112.04 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.4 22.1 54.97 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -172.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.6 m -60.94 144.91 89.86 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 116.913 0.356 . . . . 0.0 111.32 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.05 157.76 42.38 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.1 2.533 . . . . 0.0 108.715 170.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.419 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 10.7 tpt180 -66.73 -46.66 56.42 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.74 -176.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 182' ' ' ARG . 45.1 Cg_endo -78.48 27.08 0.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.452 2.768 . . . . 0.0 113.025 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.6 tp -64.96 -43.56 92.26 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.117 0.871 . . . . 0.0 110.38 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.427 ' HG2' ' H ' ' A' ' 187' ' ' VAL . 59.7 ttm-85 59.35 129.64 0.01 OUTLIER 'General case' 0 C--N 1.341 0.223 0 C-N-CA 126.11 1.764 . . . . 0.0 112.955 179.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.86 -25.69 68.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 121.554 -0.716 . . . . 0.0 111.474 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.427 ' H ' ' HG2' ' A' ' 185' ' ' ARG . 24.2 t -72.14 -47.85 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-O 120.662 0.268 . . . . 0.0 110.453 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -79.86 -24.64 41.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -176.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.8 tp -69.0 -33.85 74.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.78 -32.8 46.63 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.263 -0.273 . . . . 0.0 111.552 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.8 mmt -71.4 -35.99 71.23 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 122.305 -0.247 . . . . 0.0 110.475 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 71.5 mt -78.16 -40.51 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 22.5 mmt -60.67 -28.19 68.4 Favored 'General case' 0 C--N 1.334 -0.078 0 O-C-N 121.941 -0.474 . . . . 0.0 111.342 173.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -82.38 -21.51 35.83 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.419 0.554 . . . . 0.0 111.088 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.11 -19.69 26.67 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -110.1 -16.9 13.69 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.563 0.62 . . . . 0.0 111.875 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -135.1 -41.64 0.73 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.377 0.535 . . . . 0.0 111.587 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 69.19 162.76 3.08 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 121.474 0.486 . . . . 0.0 112.615 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 87.07 15.47 62.65 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 174.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.4 p -77.5 162.4 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.0 0.92 . . . . 0.0 110.597 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 51.5 t -137.28 -31.82 0.8 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -150.63 155.03 38.58 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.084 0.402 . . . . 0.0 111.814 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -156.27 156.85 34.76 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.346 0.658 . . . . 0.0 110.518 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 176.51 177.6 45.62 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.417 ' HA ' ' HA2' ' A' ' 218' ' ' GLY . 44.6 mm -103.83 87.05 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 26.2 t70 47.39 -86.85 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.927 -169.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.659 ' H ' ' HA ' ' A' ' 214' ' ' PRO . 12.6 m 49.72 65.16 1.49 Allowed 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.315 0.646 . . . . 0.0 111.091 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -59.75 133.46 89.27 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.74 -17.27 14.19 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 124.629 3.553 . . . . 0.0 114.282 -171.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -104.87 0.06 27.6 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.865 0.757 . . . . 0.0 111.282 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 97.5 mt -122.2 -13.21 8.16 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.807 0.843 . . . . 0.0 109.942 172.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt 52.97 38.11 26.29 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.534 1.134 . . . . 0.0 111.507 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -140.55 145.21 39.6 Favored Pre-proline 0 N--CA 1.461 0.12 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.659 ' HA ' ' H ' ' A' ' 207' ' ' THR . 64.6 Cg_endo -77.98 174.64 12.22 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.818 3.012 . . . . 0.0 110.769 173.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -132.16 21.07 4.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.417 0.687 . . . . 0.0 110.318 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 62.67 16.04 55.08 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 119.844 -0.42 . . . . 0.0 112.426 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -135.9 149.42 48.96 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.255 0.622 . . . . 0.0 110.273 -176.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 205' ' ' ILE . . . -95.11 162.0 23.66 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 116.629 -0.259 . . . . 0.0 112.773 -175.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -155.2 148.49 24.92 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 171.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.35 147.23 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -131.53 144.83 51.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.831 0.348 . . . . 0.0 110.301 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -128.88 165.66 20.59 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.027 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 78.5 p -94.66 -1.44 53.13 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -125.69 147.67 49.28 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 121.146 0.498 . . . . 0.0 111.62 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -78.5 -18.13 55.24 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.035 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -78.73 -37.14 42.15 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 58.6 p -80.14 -23.58 41.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -64.87 -41.67 95.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.722 0.409 . . . . 0.0 110.701 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.2 pt -84.21 -16.3 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 118.04 0.382 . . . . 0.0 111.592 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.66 -30.87 26.5 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 117.981 0.355 . . . . 0.0 110.86 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -77.04 -15.81 59.48 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.653 0.206 . . . . 0.0 111.38 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.409 ' HA ' HG21 ' A' ' 250' ' ' VAL . 1.6 pp -117.79 24.51 4.78 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 C-N-CA 123.133 0.573 . . . . 0.0 110.523 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.0 t -77.53 -9.19 58.77 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.005 0.522 . . . . 0.0 111.037 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -152.29 145.66 24.79 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -56.84 -28.9 62.26 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.6 0.36 . . . . 0.0 111.664 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -121.7 122.19 39.01 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 237' ' ' VAL . 2.4 m -82.79 151.85 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 C-N-CA 122.882 0.473 . . . . 0.0 109.961 174.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.521 ' C ' HD22 ' A' ' 239' ' ' LEU . 11.1 mp0 -94.98 138.42 32.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.521 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.5 mm? -125.37 22.61 7.72 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.091 -175.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -88.3 132.37 34.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.851 0.46 . . . . 0.0 112.137 -172.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -150.18 12.42 0.75 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.206 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 176.19 -143.8 6.68 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' GLU . . . . . 0.49 ' H ' ' CD ' ' A' ' 243' ' ' GLU . 0.4 OUTLIER -81.4 3.35 24.79 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.708 0.403 . . . . 0.0 111.273 178.163 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 77.1 mt -99.95 148.74 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.64 0.776 . . . . 0.0 109.719 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -147.57 140.86 25.24 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.755 0.312 . . . . 0.0 110.199 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -142.92 154.43 44.07 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.69 151.44 30.55 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.1 p -161.72 158.42 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -83.26 144.93 29.41 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.197 0.599 . . . . 0.0 111.206 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 232' ' ' ILE . 2.1 m -123.75 163.72 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 252' ' ' PRO . 0.0 OUTLIER -157.29 156.37 29.11 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.089 170.498 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 252' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 251' ' ' LYS . 96.8 Cg_endo -73.06 39.21 0.44 Allowed 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 125.052 3.835 . . . . 0.0 111.754 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 43.96 43.87 5.63 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.326 1.45 . . . . 0.0 111.331 -174.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 9.8 p 49.73 18.75 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.732 1.613 . . . . 0.0 113.723 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.497 1.919 . . . . 0.0 114.237 178.274 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.638 " H2'" ' CD ' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -2.977 0 C4'-C3'-C2' 99.638 -3.062 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.836 1 O4'-C1'-N19 113.969 5.769 . 0.128 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.542 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.422 -2.592 1 O4'-C1'-N19 113.33 5.13 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.417 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.422 -2.581 0 O4'-C1'-N19 111.664 3.464 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.447 ' N3 ' " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.576 0 O5'-C5'-C4' 113.286 2.204 . 0.07 4a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 111.308 0.114 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -140.73 7.61 2.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.139 0.575 . . . . 0.0 111.05 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -74.97 162.19 28.81 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.342 0.657 . . . . 0.0 110.416 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -143.83 142.93 31.1 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.984 0.514 . . . . 0.0 109.821 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.08 -4.35 88.43 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.904 -0.478 . . . . 0.0 111.904 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -119.59 167.69 11.75 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.474 0.71 . . . . 0.0 110.806 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -139.85 168.51 19.64 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.522 0.729 . . . . 0.0 110.877 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.6 t 63.43 146.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 125.762 1.625 . . . . 0.0 112.345 -176.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -134.22 160.8 36.76 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.409 0.683 . . . . 0.0 110.266 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.401 ' N ' ' HD3' ' A' ' 62' ' ' ARG . 0.1 OUTLIER -62.65 142.2 58.18 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.067 0.547 . . . . 0.0 111.481 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -153.33 159.34 42.46 Favored 'General case' 0 C--O 1.23 0.046 0 O-C-N 123.495 0.497 . . . . 0.0 110.219 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.9 t -93.26 20.56 6.88 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.168 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 70.1 mtm-85 55.97 21.03 4.64 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.423 0.689 . . . . 0.0 112.314 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -146.9 144.51 29.31 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.014 0.526 . . . . 0.0 110.068 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.2 m -138.34 152.39 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.155 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.434 ' CZ ' ' C6 ' ' B' ' 3' ' ' ' U' . 2.9 t80 -88.63 140.9 28.99 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 170.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 113' ' ' LEU . 1.5 m -134.61 138.47 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.57 -170.83 12.22 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -176.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.431 ' HA2' " H4'" ' B' ' 1' ' ' ' C' . . . 76.48 5.58 82.68 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.456 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.0 mt -70.86 148.79 94.88 Favored Pre-proline 0 N--CA 1.454 -0.245 0 CA-C-N 118.655 1.227 . . . . 0.0 108.823 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -62.38 160.53 31.0 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.328 2.019 . . . . 0.0 110.735 -177.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.64 -10.61 0.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 125.094 3.863 . . . . 0.0 114.781 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 76' ' ' ILE . 5.8 p-10 -105.0 -96.06 0.33 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 118.946 -0.55 . . . . 0.0 109.805 175.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.424 ' H ' ' CG ' ' A' ' 75' ' ' ASP . 3.1 tp 55.79 163.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -158.47 -179.28 7.94 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.863 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -59.14 -32.58 69.99 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.85 0.86 . . . . 0.0 112.633 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -91.09 -23.36 20.34 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 118.702 0.683 . . . . 0.0 112.629 -170.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -80.83 -27.16 36.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.3 mt -78.43 -40.53 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 97.0 m -63.31 -22.6 66.98 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.05 -21.25 24.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -72.94 -26.44 61.39 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.509 0.595 . . . . 0.0 111.88 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.519 ' CZ ' HD11 ' A' ' 151' ' ' ILE . 55.5 m-85 -124.31 13.17 8.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -17.29 64.39 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.992 -0.442 . . . . 0.0 111.269 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -68.41 -11.46 59.69 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.138 0.975 . . . . 0.0 111.466 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -123.61 36.15 4.69 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -173.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.1 175.46 34.74 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.11 151.83 61.74 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.9 3.066 . . . . 0.0 111.278 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.452 HD23 ' N ' ' A' ' 91' ' ' LEU . 0.6 OUTLIER -166.89 163.34 16.19 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.872 -170.205 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.3 pt -141.42 169.55 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.0 p -135.38 150.12 29.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -152.91 174.11 14.52 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.419 0.628 . . . . 0.0 111.396 -177.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -160.41 157.94 24.89 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.417 ' HB2' " H4'" ' B' ' 5' ' ' ' A' . 37.8 Cg_endo -75.77 -17.97 17.49 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.237 1.958 . . . . 0.0 110.885 -169.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.4 m80 -84.78 -7.57 59.15 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.561 0.744 . . . . 0.0 110.833 -178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -71.05 170.35 13.04 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.664 1.186 . . . . 0.0 112.997 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -124.61 167.0 15.1 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.508 1.123 . . . . 0.0 109.655 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -88.77 -7.76 55.66 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.6 t -155.02 17.2 0.43 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.214 0.461 . . . . 0.0 112.166 -178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.9 tptp -144.62 144.16 31.13 Favored 'General case' 0 C--N 1.339 0.146 0 O-C-N 121.719 -0.613 . . . . 0.0 111.705 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 70.9 m 58.01 163.2 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.844 1.658 . . . . 0.0 114.762 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -142.9 10.97 1.8 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.762 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -106.22 116.05 60.04 Favored Pre-proline 0 CA--C 1.531 0.225 0 C-N-CA 123.846 0.858 . . . . 0.0 110.983 -172.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.13 159.79 24.97 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 124.093 3.195 . . . . 0.0 111.7 172.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.74 -32.2 35.63 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.25 3.3 . . . . 0.0 114.788 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -159.29 -59.62 0.07 Allowed 'General case' 0 C--N 1.34 0.162 0 CA-C-N 118.505 0.593 . . . . 0.0 111.752 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -179.89 23.02 0.04 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 -174.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.523 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.2 OUTLIER -129.13 140.59 51.48 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.199 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.51 -177.44 6.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.526 0.33 . . . . 0.0 110.591 -174.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.402 ' CE1' ' C5 ' ' B' ' 4' ' ' ' U' . 1.2 m-85 -141.77 134.14 28.04 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.538 HD13 HG11 ' A' ' 69' ' ' VAL . 11.2 mp -92.28 150.83 20.64 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.245 0.545 . . . . 0.0 111.582 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.99 137.53 51.9 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 173.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -130.34 166.11 21.09 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.882 0.372 . . . . 0.0 111.117 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -113.03 -31.95 6.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.275 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -117.74 149.1 41.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.037 0.446 . . . . 0.0 111.074 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -83.91 -16.92 42.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.218 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.8 p -86.43 -17.61 33.85 Favored 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 122.16 -0.338 . . . . 0.0 111.549 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.3 m -71.94 -47.01 55.46 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.004 0.43 . . . . 0.0 110.584 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.428 ' HA ' HD12 ' A' ' 124' ' ' LEU . 5.0 p -72.58 -20.22 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.042 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -75.27 -32.28 61.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.66 -44.49 56.64 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.547 ' C ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -72.98 -28.79 62.6 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 118.388 -1.325 . . . . 0.0 110.994 -178.367 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 83.4 mt -80.54 -16.65 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 118.292 0.496 . . . . 0.0 110.928 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -86.14 -17.83 33.91 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.731 -0.606 . . . . 0.0 110.364 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -112.11 14.12 20.67 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 20.0 p -98.99 171.56 7.96 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.168 0.508 . . . . 0.0 112.251 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 130' ' ' GLU . 39.9 mm -90.17 167.96 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 125.522 1.529 . . . . 0.0 108.472 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.414 ' N ' HG22 ' A' ' 129' ' ' ILE . 42.2 mt-10 -124.33 152.87 42.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.021 0.439 . . . . 0.0 112.004 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -145.61 -174.37 4.38 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 172.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.75 98.11 0.09 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.909 0.385 . . . . 0.0 111.342 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 78.06 -2.15 66.45 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.25 -0.75 . . . . 0.0 114.258 175.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -137.89 173.94 11.1 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.569 1.184 . . . . 0.0 110.372 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -110.19 174.8 5.7 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.479 0.712 . . . . 0.0 109.527 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -144.07 149.21 36.26 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.2 0.6 . . . . 0.0 109.582 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.8 tp -132.22 146.32 51.93 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 169.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.1 m -89.25 133.72 34.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.793 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.1 p -156.18 154.11 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 124.32 1.048 . . . . 0.0 108.403 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.4 p -85.7 150.41 24.62 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.142 -0.349 . . . . 0.0 110.28 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.7 p -138.44 146.29 50.45 Favored Pre-proline 0 N--CA 1.456 -0.172 0 O-C-N 122.278 -0.264 . . . . 0.0 110.442 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.12 -8.85 20.3 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.214 2.609 . . . . 0.0 112.902 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.42 HG23 HG12 ' A' ' 144' ' ' ILE . 1.9 t -90.74 -18.21 25.38 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.239 0.927 . . . . 0.0 111.179 178.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.597 HG22 ' H ' ' A' ' 145' ' ' LYS . 2.3 mm -134.05 -144.72 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.597 ' H ' HG22 ' A' ' 144' ' ' ILE . 75.8 mmtt -119.41 -14.02 9.21 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.058 0.943 . . . . 0.0 109.158 169.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -156.99 157.35 34.57 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.612 1.165 . . . . 0.0 109.4 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.545 ' HE3' ' C6 ' ' B' ' 1' ' ' ' C' . 0.0 OUTLIER -154.47 112.04 2.41 Favored Pre-proline 0 N--CA 1.457 -0.077 0 C-N-CA 122.54 0.336 . . . . 0.0 110.921 178.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.508 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 23.9 Cg_exo -67.68 133.98 31.32 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.894 2.396 . . . . 0.0 108.929 167.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.6 m -121.23 138.29 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 118.299 0.5 . . . . 0.0 110.354 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -74.56 154.77 38.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.519 HD11 ' CZ ' ' A' ' 85' ' ' PHE . 44.2 mm -138.55 141.32 37.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 124.886 1.274 . . . . 0.0 108.918 171.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.9 ttp85 -156.44 109.96 2.03 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 170.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -76.34 164.42 30.93 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.917 3.078 . . . . 0.0 111.356 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.413 ' CG ' ' HG3' ' A' ' 214' ' ' PRO . 55.0 t-105 -100.44 144.84 28.96 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.595 0.235 . . . . 0.0 111.209 176.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -107.02 156.85 18.31 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.494 0.718 . . . . 0.0 111.718 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.0 mp -100.89 15.41 28.61 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.091 0.556 . . . . 0.0 111.598 -175.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.4 t -90.86 -28.53 18.09 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -174.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -140.33 25.07 2.27 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.63 0.65 . . . . 0.0 112.631 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.0 t -70.74 -16.42 62.77 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -155.07 159.9 40.6 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.041 0.536 . . . . 0.0 110.524 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -156.86 156.74 33.67 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.587 0.232 . . . . 0.0 111.0 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.9 m -137.49 151.5 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 C-N-CA 123.152 0.581 . . . . 0.0 110.327 175.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 16.1 ttp -135.34 19.15 3.38 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.555 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -151.93 -179.66 7.67 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.86 18.75 0.61 Allowed Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.372 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.0 t 54.6 50.46 15.92 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 117.736 0.768 . . . . 0.0 111.895 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -64.36 160.07 53.49 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 122.926 0.49 . . . . 0.0 109.962 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -52.19 147.55 27.38 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.72 2.947 . . . . 0.0 112.355 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 68.8 mt -122.09 162.04 21.97 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.357 0.663 . . . . 0.0 110.995 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -143.92 150.25 48.95 Favored Pre-proline 0 CA--C 1.529 0.168 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -68.28 -10.83 30.14 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.957 2.438 . . . . 0.0 111.508 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.78 2.48 56.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.149 0.58 . . . . 0.0 110.496 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -126.17 18.04 7.74 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.674 0.39 . . . . 0.0 111.09 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 16.4 m -127.55 139.74 52.58 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.722 0.296 . . . . 0.0 111.019 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.1 tt -111.62 152.07 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 C-N-CA 123.16 0.584 . . . . 0.0 110.474 -176.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.404 ' CD1' ' CE1' ' A' ' 253' ' ' TYR . 6.3 t80 -114.68 143.84 44.39 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.8 m -140.92 132.36 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 122.611 0.364 . . . . 0.0 110.287 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -142.44 179.95 19.8 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.99 10.12 83.37 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -171.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 28.9 m -72.82 155.42 90.71 Favored Pre-proline 0 N--CA 1.455 -0.177 0 C-N-CA 122.904 0.481 . . . . 0.0 110.891 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.74 -172.6 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.756 2.971 . . . . 0.0 109.785 175.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -55.8 -48.4 96.67 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.213 -0.898 . . . . 0.0 112.236 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.59 138.75 17.5 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.223 1.949 . . . . 0.0 110.939 174.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 184' ' ' LEU . 2.4 pt? -155.52 16.32 0.39 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.371 0.668 . . . . 0.0 111.448 178.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -42.71 142.1 0.93 Allowed 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.963 1.305 . . . . 0.0 112.334 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.73 -21.57 61.74 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -171.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.5 t -60.75 -52.13 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-N 118.306 0.503 . . . . 0.0 110.838 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -83.54 -20.09 34.5 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.387 -0.196 . . . . 0.0 110.798 -175.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 25.2 tp -73.85 -32.9 63.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -77.63 -39.31 45.69 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 117.563 0.165 . . . . 0.0 111.046 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 25.5 mmt -64.88 -49.81 69.02 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -177.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.8 mt -65.87 -34.57 71.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -178.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.4 tpp -74.23 -13.09 60.73 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 122.469 -0.145 . . . . 0.0 110.966 -178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -102.26 -12.61 17.85 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.029 -0.42 . . . . 0.0 112.032 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -92.4 -18.06 23.78 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.241 0.473 . . . . 0.0 111.369 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.47 -20.79 10.63 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.18 0.445 . . . . 0.0 111.036 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -141.05 46.83 1.73 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.958 0.503 . . . . 0.0 109.97 -177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.55 136.79 4.57 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.016 0.817 . . . . 0.0 113.395 -175.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 135.8 7.15 1.88 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.123 0.868 . . . . 0.0 111.747 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 40.9 t -72.31 149.3 9.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 117.617 0.709 . . . . 0.0 110.903 -177.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 23.5 p -134.2 -23.04 1.73 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -151.17 150.94 31.23 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -149.67 155.23 39.87 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.429 0.692 . . . . 0.0 109.285 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -177.27 -176.32 45.27 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 30.4 mm -100.23 152.81 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 9.8 t70 -53.34 132.03 38.6 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 33.4 p -144.2 167.66 21.9 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 122.584 0.353 . . . . 0.0 110.518 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ASP . . . . . 0.479 ' HA ' ' HD3' ' A' ' 209' ' ' PRO . 12.6 t70 -132.97 136.57 27.87 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 119.392 -0.337 . . . . 0.0 110.212 174.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 208' ' ' ASP . 22.1 Cg_exo -68.61 -9.35 25.86 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 124.532 3.488 . . . . 0.0 115.809 -172.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.27 -26.24 68.41 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 119.737 1.153 . . . . 0.0 110.92 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 19.3 tp -150.35 3.83 0.51 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.971 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 55.11 39.67 31.58 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.208 1.003 . . . . 0.0 110.605 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -100.08 146.2 31.52 Favored Pre-proline 0 N--CA 1.457 -0.083 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.373 -176.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.413 ' HG3' ' CG ' ' A' ' 154' ' ' TRP . 30.7 Cg_endo -82.1 164.91 17.32 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.289 2.659 . . . . 0.0 113.465 -177.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -128.39 -174.64 3.28 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.921 1.289 . . . . 0.0 108.372 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -71.45 164.25 53.98 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.0 173.47 0.07 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -135.21 177.38 19.41 Favored Glycine 0 CA--C 1.525 0.718 0 O-C-N 121.97 -0.457 . . . . 0.0 112.553 -173.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.02 155.18 42.03 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.173 0.511 . . . . 0.0 111.077 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 63.6 t -139.45 145.88 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.61 148.19 46.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.854 0.359 . . . . 0.0 110.274 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -122.79 150.24 43.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.416 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 68.5 m -83.32 2.6 35.41 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 111.389 0.144 . . . . 0.0 111.389 175.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -131.19 138.9 49.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.775 0.43 . . . . 0.0 110.559 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.473 ' H ' ' CD ' ' A' ' 225' ' ' GLN . 0.0 OUTLIER -75.45 -12.83 60.32 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 176.601 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 -82.35 -37.11 26.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 19.9 m -73.26 -29.04 62.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -67.17 -53.04 34.11 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 119.687 -0.196 . . . . 0.0 110.749 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.2 pt -69.56 -16.59 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 CA-C-N 118.126 0.421 . . . . 0.0 111.092 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.9 -24.7 33.03 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.713 0.233 . . . . 0.0 110.821 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.74 -21.52 26.53 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.1 pt -110.43 27.49 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.071 0.548 . . . . 0.0 110.345 174.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 20.4 t -80.68 -9.99 59.76 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.257 0.623 . . . . 0.0 112.065 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -158.3 145.12 17.63 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 55.7 ttm-85 -57.06 -32.63 66.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.562 0.345 . . . . 0.0 111.665 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -122.54 115.92 23.01 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 23.5 m -99.36 161.3 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.119 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -85.18 142.34 29.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 110.463 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.31 105.44 7.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 173.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -131.73 148.01 52.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.434 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -141.76 20.62 2.16 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.452 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 95.75 131.04 6.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 54.73 4.31 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.52 1.528 . . . . 0.0 114.7 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.2 mt -145.09 136.33 20.12 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 CA-C-N 118.702 0.683 . . . . 0.0 109.937 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -129.16 147.44 51.01 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.825 0.345 . . . . 0.0 111.367 173.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -144.9 170.52 15.98 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.612 1.165 . . . . 0.0 109.648 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.88 160.41 39.37 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.635 0.774 . . . . 0.0 110.303 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.0 p -152.23 152.11 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -85.84 126.88 34.38 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.05 157.7 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 CA-C-O 121.039 0.447 . . . . 0.0 111.84 -176.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.46 158.41 27.82 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.57 169.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.64 133.28 57.02 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.564 2.176 . . . . 0.0 107.884 172.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' TYR . . . . . 0.404 ' CE1' ' CD1' ' A' ' 176' ' ' PHE . 2.3 t80 -75.28 118.88 18.68 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.087 -173.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.5 HG22 ' H ' ' A' ' 255' ' ' LEU . 0.8 OUTLIER 53.7 168.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 127.434 2.293 . . . . 0.0 114.43 177.345 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.5 ' H ' HG22 ' A' ' 254' ' ' VAL . 34.2 tp . . . . . 0 C--O 1.25 1.116 0 C-N-CA 124.956 1.302 . . . . 0.0 111.726 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.545 ' C6 ' ' HE3' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.424 -2.451 1 O4'-C1'-N19 114.274 6.074 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.694 0 O4'-C1'-N19 112.137 3.937 . 0.258 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.523 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.713 2 C5'-C4'-C3' 109.252 -4.166 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.402 ' C5 ' ' CE1' ' A' ' 112' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.75 0 O5'-C5'-C4' 106.675 -2.518 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.417 " H4'" ' HB2' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.414 -3.288 1 C5'-C4'-C3' 107.857 -5.095 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.3 t . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 120.365 0.126 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -134.08 8.23 3.74 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.339 0.656 . . . . 0.0 111.129 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 53.4 24.81 4.15 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.065 0.946 . . . . 0.0 112.106 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -148.38 155.83 41.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.261 0.624 . . . . 0.0 109.569 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.4 -179.56 45.66 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -147.17 166.49 26.81 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.15 0.58 . . . . 0.0 110.307 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.9 ptt-85 -148.76 172.9 13.87 Favored 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 123.122 0.569 . . . . 0.0 110.979 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 t 52.05 48.4 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 123.966 0.906 . . . . 0.0 111.092 178.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -73.52 -179.89 3.73 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.177 0.513 . . . . 0.0 110.813 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.68 134.68 7.24 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.082 0.953 . . . . 0.0 110.487 173.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.21 157.52 43.43 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -172.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.9 t -102.75 150.45 23.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.076 174.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -85.63 3.74 39.48 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.652 0.381 . . . . 0.0 110.281 174.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -100.02 135.96 40.66 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.85 0.86 . . . . 0.0 109.413 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 p -149.75 144.41 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.816 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.446 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 14.7 t80 -92.2 144.42 25.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 m -132.69 130.03 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -141.37 148.3 19.96 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.409 ' HA2' " H4'" ' B' ' 1' ' ' ' C' . . . 101.94 37.43 3.41 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -175.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.6 mt -85.96 159.63 54.05 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -70.71 153.79 64.34 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.959 2.439 . . . . 0.0 108.968 172.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.03 3.19 4.13 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.884 3.056 . . . . 0.0 112.354 -178.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -94.0 -27.12 16.5 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.465 ' C ' HD12 ' A' ' 76' ' ' ILE . 2.3 pp -136.39 174.81 11.61 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-N 118.524 0.602 . . . . 0.0 110.252 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -163.39 5.8 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -145.41 -45.71 0.22 Allowed 'General case' 0 C--N 1.341 0.21 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -174.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -84.62 -34.14 23.17 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.622 0.646 . . . . 0.0 112.371 -172.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -73.45 -27.11 61.24 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.725 0.298 . . . . 0.0 110.509 -176.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.7 pt -88.01 -30.35 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 122.465 0.306 . . . . 0.0 110.916 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 56.8 m -71.75 -14.87 62.13 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.94 -22.07 17.64 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.5 m -88.2 -15.53 35.71 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.451 ' CE1' HD23 ' A' ' 137' ' ' LEU . 68.2 m-85 -123.29 10.21 9.25 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.852 0.751 . . . . 0.0 113.003 -174.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -83.63 -12.01 56.54 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.601 0.36 . . . . 0.0 111.945 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.493 ' HG3' ' CD2' ' A' ' 88' ' ' PHE . 15.9 ptm180 -72.79 -18.22 61.5 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.493 ' CD2' ' HG3' ' A' ' 87' ' ' ARG . 70.0 m-85 -105.61 1.84 27.7 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.339 0.256 . . . . 0.0 111.348 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.5 163.41 9.82 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.22 140.78 45.6 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.228 2.618 . . . . 0.0 110.237 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.513 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -153.04 166.15 33.33 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.257 0.551 . . . . 0.0 112.279 -177.87 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.8 pt -137.15 -179.95 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.597 173.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.0 p -132.4 157.75 43.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 O-C-N 122.283 -0.261 . . . . 0.0 110.349 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -148.32 161.72 40.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.296 0.569 . . . . 0.0 111.47 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.451 ' CZ2' ' HE3' ' A' ' 98' ' ' LYS . 27.7 p90 -157.1 158.75 31.26 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 105.539 -2.022 . . . . 0.0 105.539 169.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.589 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 59.8 Cg_endo -72.81 -10.05 24.46 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.494 1.463 . . . . 0.0 111.018 -169.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.589 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 17.1 m-70 -104.93 19.3 20.82 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.682 1.193 . . . . 0.0 110.444 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.536 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -36.39 -62.67 0.44 Allowed 'General case' 0 C--N 1.34 0.161 0 C-N-CA 125.571 1.549 . . . . 0.0 113.756 -171.133 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 55.81 167.44 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.02 0.928 . . . . 0.0 112.534 -173.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -137.42 11.42 2.99 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.808 -0.558 . . . . 0.0 111.373 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 85.8 p -141.9 -3.09 1.13 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -142.61 142.61 32.15 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.323 0.511 . . . . 0.0 111.029 -178.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.4 t 55.68 171.06 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.867 1.667 . . . . 0.0 114.545 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -138.33 -7.69 1.53 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.881 1.273 . . . . 0.0 110.326 176.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.28 59.47 2.0 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -175.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.38 -42.18 67.34 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.187 1.924 . . . . 0.0 113.455 175.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -64.39 163.66 25.89 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.293 2.662 . . . . 0.0 112.48 173.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -79.66 -29.82 41.03 Favored 'General case' 0 C--N 1.339 0.125 0 O-C-N 122.25 -0.281 . . . . 0.0 111.315 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 171.45 29.19 0.02 OUTLIER Glycine 0 CA--C 1.527 0.787 0 CA-C-O 119.833 -0.426 . . . . 0.0 112.264 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.412 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.0 OUTLIER -142.39 141.7 32.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.719 0.759 . . . . 0.0 110.18 -179.547 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.01 -179.1 7.19 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.985 0.514 . . . . 0.0 110.306 -176.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.471 ' CZ ' ' C6 ' ' B' ' 4' ' ' ' U' . 4.4 m-85 -129.24 121.12 26.93 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -176.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 mp -83.92 147.35 27.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.592 0.711 . . . . 0.0 111.292 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 mp -124.12 104.03 8.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -88.25 162.82 16.42 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.779 0.323 . . . . 0.0 110.249 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -90.26 -21.55 22.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.216 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -132.03 149.79 52.33 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.533 0.206 . . . . 0.0 111.534 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -77.49 -16.63 58.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.231 0.213 . . . . 0.0 110.629 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 59.0 m -93.64 -17.71 22.97 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 122.457 0.303 . . . . 0.0 111.305 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.0 m -70.59 -44.58 67.03 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.5 p -74.36 -15.66 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.997 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -78.3 -33.8 49.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 122.013 -0.429 . . . . 0.0 109.926 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.27 -36.74 61.17 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.25 0.477 . . . . 0.0 110.843 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.32 -40.18 93.41 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 57.5 mt -85.81 -9.93 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 O-C-N 121.663 -0.648 . . . . 0.0 111.893 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -107.66 -3.72 18.94 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.98 -0.45 . . . . 0.0 112.163 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -122.57 6.59 9.49 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 74.9 m -113.75 -172.94 2.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.399 0.545 . . . . 0.0 110.516 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.449 HD12 ' N ' ' A' ' 129' ' ' ILE . 3.2 mp -68.05 154.22 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.674 0.79 . . . . 0.0 108.904 -170.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -137.16 157.56 46.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -143.82 62.16 1.36 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.208 0.528 . . . . 0.0 110.895 175.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.2 t70 50.93 8.84 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.904 1.681 . . . . 0.0 115.534 171.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -179.51 -19.02 0.03 OUTLIER Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.558 -0.713 . . . . 0.0 111.895 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -129.94 162.67 28.1 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 117.642 0.721 . . . . 0.0 109.39 171.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.19 163.04 16.89 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -145.22 162.03 38.12 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.965 0.412 . . . . 0.0 111.186 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.451 HD23 ' CE1' ' A' ' 85' ' ' PHE . 56.4 tp -141.89 145.51 34.67 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 170.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 79.4 m -84.23 128.61 34.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.3 m -141.21 166.13 18.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 122.898 0.479 . . . . 0.0 110.616 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.0 t -65.91 149.4 50.27 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.2 t -151.64 91.33 3.82 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -176.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -55.24 -11.37 4.08 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.252 3.302 . . . . 0.0 115.645 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.401 HG23 ' CD1' ' A' ' 144' ' ' ILE . 5.5 t -95.98 -10.37 28.77 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.577 1.081 . . . . 0.0 111.353 178.115 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.654 HG22 ' H ' ' A' ' 145' ' ' LYS . 2.2 mm -132.96 -160.1 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.654 ' H ' HG22 ' A' ' 144' ' ' ILE . 49.9 mmtm -103.93 -23.42 13.36 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -163.04 152.58 15.35 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.981 1.313 . . . . 0.0 108.351 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.668 ' HE2' ' C6 ' ' B' ' 1' ' ' ' C' . 21.6 ttmt -153.64 120.21 2.89 Favored Pre-proline 0 N--CA 1.457 -0.083 0 CA-C-N 118.062 0.392 . . . . 0.0 110.865 177.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -64.74 127.93 19.86 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.162 2.575 . . . . 0.0 110.105 168.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.4 p -100.79 136.03 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -85.03 146.88 26.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.579 0.352 . . . . 0.0 110.513 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 40.0 mm -125.12 143.03 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.882 0.873 . . . . 0.0 109.422 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.95 96.92 2.69 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -176.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.01 172.15 16.68 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.451 3.434 . . . . 0.0 111.897 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -109.24 150.48 27.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.776 0.322 . . . . 0.0 111.285 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -116.42 155.16 29.03 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.611 0.764 . . . . 0.0 111.234 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.419 HD12 ' N ' ' A' ' 156' ' ' LEU . 6.9 mp -103.9 89.96 3.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -177.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 11.5 t -155.34 -36.25 0.09 Allowed 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -140.05 28.73 2.09 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.2 m -60.1 -35.92 76.3 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -154.24 161.51 41.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.78 0.432 . . . . 0.0 110.868 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -154.63 159.02 40.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.526 0.203 . . . . 0.0 110.62 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.9 m -138.95 149.98 23.45 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.016 0 C-N-CA 123.678 0.791 . . . . 0.0 109.585 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.2 mtm -137.83 8.71 2.8 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 -174.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -138.74 17.12 2.69 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.268 0.94 . . . . 0.0 112.936 -176.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.33 19.25 55.6 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 119.689 -0.506 . . . . 0.0 113.053 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 28.9 m 55.46 50.67 14.22 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 117.676 0.738 . . . . 0.0 112.327 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -62.11 165.75 7.83 Favored Pre-proline 0 CA--C 1.531 0.212 0 C-N-CA 123.748 0.819 . . . . 0.0 110.106 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.75 137.2 27.32 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.89 2.394 . . . . 0.0 110.534 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.442 HD11 ' HB1' ' A' ' 221' ' ' ALA . 12.8 tp -132.34 151.08 52.01 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 122.682 0.393 . . . . 0.0 110.483 -170.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -147.7 140.66 14.93 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.901 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.54 -21.6 47.07 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.569 2.846 . . . . 0.0 114.091 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -85.3 6.37 26.54 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.519 0.6 . . . . 0.0 110.787 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -125.03 28.14 6.49 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 31.4 m -129.66 152.29 49.33 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.088 -173.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.3 tt -123.95 148.21 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 C-N-CA 123.366 0.666 . . . . 0.0 109.288 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.473 ' CD1' ' N6 ' ' B' ' 5' ' ' ' A' . 10.1 t80 -114.42 144.18 43.73 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 13.7 m -135.97 130.13 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 122.87 0.468 . . . . 0.0 110.056 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -132.26 164.62 23.8 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 87.37 16.93 59.69 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -175.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 28.3 m -64.52 151.05 92.55 Favored Pre-proline 0 CA--C 1.53 0.181 0 C-N-CA 122.464 0.305 . . . . 0.0 111.257 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -75.83 -174.97 2.24 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.954 3.103 . . . . 0.0 110.065 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -56.03 -50.86 84.89 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.545 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.83 141.73 21.83 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.15 1.9 . . . . 0.0 110.928 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.675 ' CD1' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -148.02 -75.99 0.18 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.799 178.219 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.675 ' H ' ' CD1' ' A' ' 184' ' ' LEU . 5.8 ptm180 49.75 132.48 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 128.445 2.698 . . . . 0.0 115.073 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.87 -20.19 65.87 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 121.721 -0.612 . . . . 0.0 112.302 -175.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 96.7 t -67.91 -58.32 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-N 117.817 0.28 . . . . 0.0 111.187 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -82.73 -19.44 37.93 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.263 -0.273 . . . . 0.0 111.268 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.9 tp -70.09 -35.91 74.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.66 -35.47 57.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 122.387 -0.196 . . . . 0.0 111.406 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 23.5 mmt -69.78 -38.49 76.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -175.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 45.6 mt -71.85 -43.64 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.548 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -61.64 -21.27 64.25 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 118.31 0.505 . . . . 0.0 111.34 173.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.66 -11.58 36.58 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.659 0.663 . . . . 0.0 112.158 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -96.44 -15.75 21.58 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 122.033 -0.417 . . . . 0.0 111.861 175.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.08 -21.84 10.33 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 118.155 0.434 . . . . 0.0 110.793 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -139.86 44.21 1.93 Allowed 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.175 0.59 . . . . 0.0 109.444 -178.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -42.47 135.93 3.74 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.168 0.889 . . . . 0.0 113.04 -174.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 131.45 12.59 2.0 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -176.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.404 HG22 ' CE2' ' A' ' 222' ' ' PHE . 49.1 t -70.03 148.42 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-N 117.541 0.671 . . . . 0.0 110.24 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 51.5 t -125.64 -29.99 3.11 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.896 177.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -155.48 152.72 29.27 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.58 0.229 . . . . 0.0 110.893 -175.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.4 160.17 42.56 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.385 0.674 . . . . 0.0 110.761 175.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -178.58 173.55 45.88 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 176.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 205' ' ' ILE . 3.4 mp -94.51 84.73 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 23.4 t70 53.66 -66.77 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -168.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 38.8 p 43.0 54.14 4.9 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -60.65 132.31 91.27 Favored Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.19 -14.78 14.79 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.43 3.42 . . . . 0.0 113.886 -173.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -91.83 -39.68 11.62 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.616 0.644 . . . . 0.0 110.211 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.42 -7.8 34.02 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 65.8 mttm 52.02 46.34 26.77 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 124.618 1.167 . . . . 0.0 111.675 174.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.93 154.5 43.51 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -175.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -83.58 173.21 9.69 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.918 3.079 . . . . 0.0 110.868 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.518 ' HA ' ' C4 ' ' B' ' 4' ' ' ' U' . 60.9 mttp -127.8 18.57 6.72 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.999 0.519 . . . . 0.0 111.621 176.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.07 10.27 56.03 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.886 -0.397 . . . . 0.0 112.27 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -134.91 148.7 50.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.45 0.625 . . . . 0.0 110.306 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -87.49 156.14 27.69 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 121.455 0.475 . . . . 0.0 113.146 -173.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -144.71 149.26 35.31 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 169.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 71.8 t -138.56 144.2 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.442 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -129.07 148.86 51.05 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.068 0.461 . . . . 0.0 110.39 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.404 ' CE2' HG22 ' A' ' 200' ' ' VAL . 69.0 m-85 -120.62 154.14 35.86 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.101 -173.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 67.3 p -90.22 7.74 36.61 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.284 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -134.96 136.69 42.43 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.665 0.786 . . . . 0.0 109.655 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -75.9 -16.95 59.95 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.0 tp60 -77.71 -36.82 50.6 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 23.7 m -78.57 -24.65 45.42 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.287 -0.258 . . . . 0.0 110.38 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.46 -49.94 69.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.0 pt -75.09 -16.34 15.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.07 0 CA-C-N 117.744 0.247 . . . . 0.0 111.522 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.79 -25.59 37.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.83 0.286 . . . . 0.0 111.006 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -82.57 -22.23 34.95 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 21.8 pt -108.92 20.88 5.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.004 0.522 . . . . 0.0 110.538 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.3 t -77.41 -9.58 58.95 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.874 0.47 . . . . 0.0 111.659 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -152.12 144.12 23.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -53.69 -29.32 38.43 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -126.38 119.9 28.48 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.849 0.357 . . . . 0.0 110.415 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.431 HG23 HD21 ' A' ' 239' ' ' LEU . 2.7 m -84.37 159.19 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.207 175.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.606 ' C ' HD22 ' A' ' 239' ' ' LEU . 3.6 mp0 -94.86 138.53 32.52 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.606 HD22 ' C ' ' A' ' 238' ' ' GLN . 2.5 mm? -129.83 14.39 5.85 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.908 -175.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.63 140.29 29.9 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -172.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -147.59 21.21 1.17 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.408 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.59 139.74 6.32 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 54.85 3.28 0.05 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.186 1.394 . . . . 0.0 113.426 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 62.0 mt -145.43 142.04 22.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 C-N-CA 124.23 1.012 . . . . 0.0 108.619 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -151.89 136.36 16.87 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 176.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -148.22 164.99 32.29 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.802 0.841 . . . . 0.0 109.62 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.57 155.92 38.31 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 8.5 p -155.88 152.32 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -82.68 143.58 30.85 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.2 m -116.73 153.82 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 121.631 0.729 . . . . 0.0 112.949 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.452 ' HD2' ' N6 ' ' B' ' 5' ' ' ' A' . 32.4 ttmt -151.24 141.43 14.53 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.833 174.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' PRO . . . . . 0.409 ' HD2' ' HG3' ' A' ' 251' ' ' LYS . 24.9 Cg_endo -58.23 136.99 78.24 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.61 2.207 . . . . 0.0 108.364 176.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -70.07 132.65 46.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.266 -173.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' VAL . . . . . 0.435 HG22 ' H ' ' A' ' 255' ' ' LEU . 0.3 OUTLIER 53.17 172.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 127.111 2.164 . . . . 0.0 113.91 178.078 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.435 ' H ' HG22 ' A' ' 254' ' ' VAL . 1.8 pt? . . . . . 0 C--O 1.25 1.085 0 CA-C-O 117.005 -1.474 . . . . 0.0 112.37 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.668 ' C6 ' ' HE2' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.421 -2.679 1 O4'-C1'-N19 112.305 4.105 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.201 0 C3'-C2'-C1' 104.799 3.665 . 0.639 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.446 ' C6 ' ' CE2' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.934 1 O4'-C1'-N19 112.948 4.748 . 0.155 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.518 ' C4 ' ' HA ' ' A' ' 215' ' ' LYS . . . . . . . . 0 O4'--C4' 1.421 -2.662 0 O4'-C1'-N19 111.595 3.395 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.473 ' N6 ' ' CD1' ' A' ' 176' ' ' PHE . . . . . . . . 0 O4'--C4' 1.417 -3.005 0 C5'-C4'-C3' 110.258 -3.494 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 111.271 0.101 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 58.0 t60 -147.85 161.57 41.02 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.981 0.513 . . . . 0.0 110.256 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -149.18 164.59 34.3 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 122.907 0.483 . . . . 0.0 110.818 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -77.0 166.8 22.84 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.827 0.451 . . . . 0.0 110.332 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.62 -164.36 20.9 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.69 157.92 45.65 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.377 0.671 . . . . 0.0 110.477 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? 53.22 30.2 9.58 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.138 0.575 . . . . 0.0 111.254 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.6 m -88.6 8.39 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 123.614 0.765 . . . . 0.0 111.904 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -70.98 157.45 38.18 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.987 0.422 . . . . 0.0 111.222 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.637 ' HD3' HD13 ' A' ' 156' ' ' LEU . 0.4 OUTLIER -87.77 157.55 19.0 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.202 0.601 . . . . 0.0 111.324 179.061 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.704 ' C ' HD11 ' A' ' 156' ' ' LEU . 26.1 m-85 -134.27 160.79 36.8 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 121.135 0.493 . . . . 0.0 111.121 -174.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -88.51 31.88 0.81 Allowed 'General case' 0 C--N 1.334 -0.068 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.597 ' HA ' ' CE1' ' A' ' 115' ' ' PHE . 99.0 mtt180 54.62 18.42 2.04 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.192 0.597 . . . . 0.0 112.299 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -146.25 133.48 20.55 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 m -139.94 161.97 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -95.59 143.06 27.2 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 169.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.7 m -131.39 118.52 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 172.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.58 138.96 14.68 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.481 -172.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.57 145.44 4.85 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.446 0.546 . . . . 0.0 114.386 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.7 tp -164.96 132.79 2.47 Favored Pre-proline 0 N--CA 1.453 -0.283 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 81.9 Cg_endo -77.19 156.04 33.34 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.937 1.758 . . . . 0.0 110.329 178.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 33.0 Cg_exo -62.43 0.78 1.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 124.544 3.496 . . . . 0.0 114.913 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -134.25 43.54 2.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.598 0.636 . . . . 0.0 111.552 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mt -141.32 151.5 19.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -135.99 -179.47 5.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.916 0.389 . . . . 0.0 111.595 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -45.76 -42.36 11.91 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.59 1.156 . . . . 0.0 112.075 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.94 -29.57 62.09 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.192 0.451 . . . . 0.0 111.92 -173.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -80.79 -29.83 36.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 122.29 -0.256 . . . . 0.0 110.823 -172.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.2 pt -86.41 -26.02 6.27 Favored 'Isoleucine or valine' 0 C--N 1.338 0.078 0 O-C-N 121.782 -0.574 . . . . 0.0 109.899 173.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 61.7 m -70.24 -14.15 62.49 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 172.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.26 -21.97 16.95 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.393 0.277 . . . . 0.0 111.606 173.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.4 m -77.06 -21.56 54.26 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.255 0.479 . . . . 0.0 111.885 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -111.89 4.57 18.36 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 117.825 0.284 . . . . 0.0 111.649 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -71.64 -5.9 37.0 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.966 -0.459 . . . . 0.0 111.964 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.4 tpt85 -67.1 -10.0 45.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.189 0.996 . . . . 0.0 110.627 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -126.56 33.03 5.06 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.47 0.308 . . . . 0.0 111.464 -174.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.68 178.45 38.07 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.948 -0.461 . . . . 0.0 111.948 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.38 141.74 35.81 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.882 3.055 . . . . 0.0 111.305 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.44 173.48 14.83 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.811 0.844 . . . . 0.0 110.088 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.89 167.27 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.147 -177.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.29 148.37 29.9 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -150.91 163.96 37.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.108 0.48 . . . . 0.0 110.827 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.512 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 33.7 p90 -153.5 162.98 25.22 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 176.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.512 ' HD2' ' HB2' ' A' ' 95' ' ' TRP . 40.3 Cg_endo -73.59 -10.19 23.39 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.644 2.896 . . . . 0.0 110.923 -169.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.461 ' ND1' ' HG2' ' A' ' 96' ' ' PRO . 51.4 m80 -106.06 18.75 21.59 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.295 1.038 . . . . 0.0 111.257 -178.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -48.91 151.44 1.24 Allowed 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.895 0.878 . . . . 0.0 113.154 -176.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.82 169.99 16.55 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.008 0.923 . . . . 0.0 110.319 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -105.92 -3.85 21.32 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.978 0.511 . . . . 0.0 110.896 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.7 t -78.06 160.03 28.35 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.656 0.383 . . . . 0.0 111.212 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -66.96 161.38 24.33 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.567 0.747 . . . . 0.0 110.592 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.1 m 55.02 53.17 10.67 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.501 0.72 . . . . 0.0 111.652 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -49.68 133.49 21.18 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.927 0.891 . . . . 0.0 110.519 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -158.62 131.51 4.54 Favored Pre-proline 0 N--CA 1.453 -0.313 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -71.1 158.54 54.79 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.73 2.953 . . . . 0.0 110.686 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.76 -15.63 4.69 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 124.667 3.578 . . . . 0.0 115.977 -178.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -142.76 -58.18 0.44 Allowed 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.288 0.949 . . . . 0.0 111.979 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 154.53 21.98 0.04 OUTLIER Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.831 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.411 ' CE1' " H4'" ' B' ' 2' ' ' ' U' . 1.0 OUTLIER -113.93 142.53 46.01 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.968 1.384 . . . . 0.0 108.238 177.335 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.27 176.86 9.24 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.085 0.402 . . . . 0.0 111.754 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -142.95 137.15 29.2 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -177.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.77 148.7 23.11 Favored 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -174.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.2 mp -130.66 147.37 52.33 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.911 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.597 ' CE1' ' HA ' ' A' ' 65' ' ' ARG . 3.4 p90 -158.93 178.84 9.64 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.289 0.636 . . . . 0.0 109.297 175.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -107.76 -21.03 13.02 Favored 'General case' 0 N--CA 1.456 -0.128 0 O-C-N 122.187 -0.32 . . . . 0.0 111.782 -174.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -129.71 144.19 51.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.863 0.363 . . . . 0.0 111.335 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -74.68 -14.9 60.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.707 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 76.7 p -70.92 -21.65 62.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.354 -0.216 . . . . 0.0 110.902 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.4 t -75.35 -40.83 57.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.431 ' HB ' ' CZ ' ' A' ' 115' ' ' PHE . 4.7 p -82.8 -23.8 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -67.67 -37.83 82.9 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.108 -0.37 . . . . 0.0 110.004 177.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.4 -35.9 30.19 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.97 -18.25 60.41 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.58 0.627 . . . . 0.0 110.985 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.0 mt -93.82 -23.71 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 117.948 0.34 . . . . 0.0 110.748 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -83.94 -13.68 52.81 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.793 -0.567 . . . . 0.0 111.63 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -124.87 46.38 2.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.056 0.543 . . . . 0.0 111.125 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 18.6 p -137.75 -176.55 4.46 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 44.1 mt -86.29 154.98 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 125.168 1.387 . . . . 0.0 108.32 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.55 156.98 47.49 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.124 -0.36 . . . . 0.0 110.729 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.24 -176.64 5.37 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -42.75 -25.9 0.11 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -169.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.33 14.04 0.13 Allowed Glycine 0 CA--C 1.528 0.87 0 CA-C-N 119.163 0.892 . . . . 0.0 112.844 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -145.0 170.97 15.13 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 117.784 0.792 . . . . 0.0 111.05 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 75.1 mt -108.01 166.63 10.58 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -149.87 155.74 40.57 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.79 0.328 . . . . 0.0 110.739 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.6 mp -143.75 160.67 40.33 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 36.9 t -87.85 156.64 19.28 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.78 165.08 30.74 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-O 120.846 0.355 . . . . 0.0 111.109 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.4 t -115.62 179.33 4.0 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.562 0.745 . . . . 0.0 109.728 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.541 ' HB3' ' HD2' ' A' ' 142' ' ' PRO . 5.7 m 61.48 -172.77 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.321 0.648 . . . . 0.0 110.143 -176.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 97.4 Cg_endo -74.07 135.96 21.75 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.703 1.602 . . . . 0.0 111.423 -169.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.7 m -147.29 42.85 1.11 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.619 0.768 . . . . 0.0 109.206 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 144' ' ' ILE . 3.2 mp 63.4 -62.2 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.753 1.621 . . . . 0.0 111.167 -173.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -151.99 -62.09 0.17 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 174.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -160.55 130.46 5.15 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.897 0.479 . . . . 0.0 110.404 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.657 ' HD3' ' C6 ' ' B' ' 1' ' ' ' C' . 37.3 mttp -151.13 103.05 2.97 Favored Pre-proline 0 CA--C 1.53 0.174 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.97 135.29 58.3 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.402 2.735 . . . . 0.0 111.02 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.9 p -90.45 133.28 32.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -100.75 154.53 18.54 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -174.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.9 mm -131.08 147.64 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.946 0.898 . . . . 0.0 110.71 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -160.59 99.49 1.36 Allowed Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.009 0.524 . . . . 0.0 110.138 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.84 174.18 3.2 Favored 'Trans proline' 0 CA--C 1.531 0.356 1 C-N-CA 125.788 4.325 . . . . 0.0 115.969 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -108.18 156.48 19.28 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.539 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -102.58 125.22 49.23 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.515 0.674 . . . . 0.0 111.102 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.707 ' H ' ' CD1' ' A' ' 156' ' ' LEU . 1.9 mp -67.19 -19.77 65.61 Favored 'General case' 0 C--O 1.23 0.041 0 C-N-CA 125.102 1.361 . . . . 0.0 114.22 -172.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 81.1 p -87.11 -4.93 59.17 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -167.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -146.37 27.71 1.12 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.564 1.074 . . . . 0.0 113.318 -176.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.4 m -72.02 -20.98 61.61 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.8 -0.562 . . . . 0.0 112.377 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -150.49 155.36 39.34 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 122.801 0.44 . . . . 0.0 110.949 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -150.09 162.12 41.03 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 10.9 p -149.19 149.81 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.9 ttm -123.02 22.13 9.64 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -170.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -158.43 -41.16 0.06 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.22 10.26 59.2 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.723 173.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.5 t -141.79 -24.2 0.7 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.573 1.186 . . . . 0.0 114.163 -176.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 24.0 mm100 -80.32 130.51 65.25 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 119.625 1.102 . . . . 0.0 110.615 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 167' ' ' GLN . 32.4 Cg_exo -61.11 159.49 29.97 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.667 2.912 . . . . 0.0 111.457 173.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.7 mt -108.71 154.36 22.14 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.514 0.326 . . . . 0.0 110.122 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -151.58 138.44 11.96 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.51 -14.09 42.38 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.143 2.562 . . . . 0.0 113.182 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -86.32 -6.6 58.92 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.711 0.687 . . . . 0.0 110.491 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -125.65 15.71 8.14 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.665 0.386 . . . . 0.0 111.355 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 46.4 m -119.5 143.64 47.45 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 121.131 0.491 . . . . 0.0 110.905 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.47 148.7 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.088 -177.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -115.96 151.9 34.51 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.47 111.44 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.291 0.637 . . . . 0.0 109.911 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -82.92 126.58 7.54 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 118.2 -110.87 2.05 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.4 p 36.68 63.95 2.69 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.407 0.683 . . . . 0.0 111.573 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.22 176.75 3.66 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.251 3.301 . . . . 0.0 112.731 -174.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.435 ' N ' ' CD ' ' A' ' 183' ' ' PRO . 9.8 ptm180 -59.81 -21.14 0.71 Allowed Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -173.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 182' ' ' ARG . 46.9 Cg_exo -60.35 -12.1 18.98 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.926 1.751 . . . . 0.0 112.882 172.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 89.2 mt -104.71 174.24 5.96 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.976 0.51 . . . . 0.0 110.605 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -152.46 153.33 33.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.244 1.017 . . . . 0.0 109.376 -170.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.21 -26.37 65.69 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.27 -48.68 80.31 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 CA-C-N 118.418 0.554 . . . . 0.0 111.291 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -84.17 -20.8 31.79 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.94 -40.13 79.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 174.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.04 -38.08 78.93 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 122.323 -0.235 . . . . 0.0 111.567 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 24.4 mmt -69.45 -32.47 71.44 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.235 -0.29 . . . . 0.0 111.069 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 88.7 mt -71.8 -32.19 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.2 mmt -73.18 -23.23 60.39 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.943 -0.473 . . . . 0.0 110.642 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -82.19 -23.59 35.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 122.146 -0.346 . . . . 0.0 111.213 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -86.14 -19.58 29.91 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.94 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -116.25 -16.16 10.96 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -133.33 19.04 3.99 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -173.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.03 -144.68 38.34 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -70.72 113.36 4.76 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 112.256 -0.338 . . . . 0.0 112.256 -174.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 40.4 t -98.51 154.41 3.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 C-N-CA 124.143 0.977 . . . . 0.0 108.614 174.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.7 p -114.79 -31.45 6.13 Favored 'General case' 0 C--O 1.227 -0.084 0 CA-C-N 118.397 0.544 . . . . 0.0 111.324 175.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -148.19 144.44 27.73 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-N 118.492 0.587 . . . . 0.0 110.589 175.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -159.29 147.52 17.75 Favored 'General case' 0 N--CA 1.458 -0.03 0 CA-C-O 120.851 0.358 . . . . 0.0 111.075 177.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 163.41 -158.94 31.48 Favored Glycine 0 CA--C 1.522 0.481 0 O-C-N 121.924 -0.485 . . . . 0.0 112.289 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 44.0 mm -96.14 140.99 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -66.36 139.03 58.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.98 0.419 . . . . 0.0 110.8 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 55.0 p -136.31 155.7 49.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.277 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -80.88 126.59 77.28 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 171.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.2 -10.56 17.75 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.842 3.695 . . . . 0.0 113.405 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -103.73 -27.37 12.31 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.731 0.696 . . . . 0.0 110.398 -177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 81.7 mt -105.08 -7.34 19.21 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.775 0.43 . . . . 0.0 110.894 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm 53.06 40.74 31.7 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.048 0.939 . . . . 0.0 112.443 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.424 ' CE1' ' HB2' ' A' ' 65' ' ' ARG . 21.2 m-85 -127.82 155.55 77.23 Favored Pre-proline 0 N--CA 1.467 0.425 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.558 -175.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.7 146.56 92.37 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.272 1.982 . . . . 0.0 110.735 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' LYS . . . . . 0.465 ' HZ2' ' HB3' ' A' ' 215' ' ' LYS . 0.0 OUTLIER -130.98 31.25 4.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.031 0.932 . . . . 0.0 109.557 -176.128 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.53 156.93 2.62 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.231 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 54.59 -175.42 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.6 0.76 . . . . 0.0 111.999 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -139.36 174.09 22.41 Favored Glycine 0 CA--C 1.521 0.466 0 O-C-N 121.734 -0.604 . . . . 0.0 111.96 -176.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -148.93 154.32 39.26 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 62.8 t -140.27 145.84 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.45 150.37 52.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.119 0.485 . . . . 0.0 110.936 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -131.54 159.97 36.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.112 -175.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 77.3 p -92.95 -5.76 50.01 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.261 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -124.35 144.39 50.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.105 0.562 . . . . 0.0 111.061 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -78.33 -9.61 59.33 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.095 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -82.92 -38.92 22.17 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.2 m -75.91 -26.49 57.01 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -64.24 -50.94 66.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 175.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.45 -14.23 16.49 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 CA-C-N 118.051 0.387 . . . . 0.0 111.309 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.47 -21.16 32.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 117.708 0.231 . . . . 0.0 111.065 175.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.56 -14.91 36.48 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.0 pt -119.31 23.78 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.315 0.646 . . . . 0.0 110.567 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 88.7 p -76.2 -20.12 57.78 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.222 0.609 . . . . 0.0 112.544 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -149.77 133.01 16.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -54.88 -37.53 66.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -175.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -122.01 116.61 24.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.154 0.434 . . . . 0.0 110.615 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.5 m -97.95 158.41 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.311 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -89.75 144.19 26.18 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.931 0.395 . . . . 0.0 110.727 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.0 mp -138.22 98.73 3.68 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -138.54 76.19 1.56 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.928 -172.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -137.24 152.18 49.54 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 66.71 25.27 72.91 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 63.06 21.85 13.11 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.284 1.034 . . . . 0.0 112.21 -175.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 68.7 mt -92.34 163.99 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -152.43 110.02 3.6 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -146.1 164.11 33.21 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.824 0.45 . . . . 0.0 110.841 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.01 157.8 44.32 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 123.818 0.847 . . . . 0.0 109.188 178.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.58 149.54 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -87.42 121.87 30.42 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.4 m -95.6 150.45 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 CA-C-N 118.139 0.427 . . . . 0.0 111.286 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.483 ' HG3' ' H61' ' B' ' 5' ' ' ' A' . 0.0 OUTLIER -158.27 160.21 29.74 Favored Pre-proline 0 N--CA 1.457 -0.096 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 171.024 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.03 135.18 69.21 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.725 2.283 . . . . 0.0 109.139 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -73.64 112.92 10.2 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 119.221 -0.992 . . . . 0.0 111.421 -176.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.6 p 44.25 34.81 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.554 1.542 . . . . 0.0 113.051 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 60.4 tp . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.187 -1.387 . . . . 0.0 110.433 -178.209 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.657 ' C6 ' ' HD3' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.411 -3.492 0 O5'-C5'-C4' 113.577 2.412 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . 0.417 " C5'" " H4'" ' B' ' 1' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.416 -3.066 2 O4'-C1'-N19 113.871 5.671 OUTLIER-DELTA 0.0 OUTLIER '7D dist 0b' 0.0 . . . . . . . . . . 4 4 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.184 1 O4'-C1'-N19 113.236 5.036 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.494 " C1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.416 -3.062 0 C5'-C4'-C3' 110.409 -3.394 . 0.01 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.483 ' H61' ' HG3' ' A' ' 251' ' ' LYS . . . . . . . . 0 O4'--C4' 1.414 -3.275 0 O4'-C1'-N19 111.671 3.471 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 120.688 0.28 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -149.69 164.84 34.12 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.153 0.581 . . . . 0.0 110.523 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.53 12.22 1.91 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.109 0.564 . . . . 0.0 111.496 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -140.58 173.07 11.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.317 0.647 . . . . 0.0 111.002 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.11 -179.52 52.83 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -147.76 171.52 15.55 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.173 0.589 . . . . 0.0 110.556 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.3 ttp85 -136.2 -19.02 1.5 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.889 0.476 . . . . 0.0 111.385 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.3 p -153.52 153.58 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 122.905 0.482 . . . . 0.0 109.915 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -146.16 152.81 39.85 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.25 148.82 37.35 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 122.356 -0.215 . . . . 0.0 110.927 -178.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -166.2 164.98 17.82 Favored 'General case' 0 CA--C 1.52 -0.193 0 O-C-N 123.552 0.533 . . . . 0.0 109.699 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.5 t -108.37 156.95 18.84 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 171.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.553 ' H ' ' CD ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -76.6 26.77 0.13 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.497 0.719 . . . . 0.0 112.086 179.235 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.432 ' HE3' ' CD1' ' A' ' 154' ' ' TRP . 47.7 pttt -136.44 141.61 43.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.048 0.939 . . . . 0.0 109.627 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 m -147.25 160.87 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.055 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.767 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.461 ' CZ ' ' C6 ' ' B' ' 3' ' ' ' U' . 3.4 t80 -100.49 143.43 30.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.44 HG11 HD13 ' A' ' 113' ' ' LEU . 3.2 m -134.2 132.66 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 173.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.21 -163.59 9.57 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.3 21.37 66.28 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.001 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.676 HD23 ' H ' ' A' ' 72' ' ' LEU . 2.1 pt? -118.44 150.02 47.16 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 118.179 0.989 . . . . 0.0 109.954 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.4 168.98 21.97 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 124.09 3.194 . . . . 0.0 113.706 -169.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -83.36 0.31 9.55 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 124.116 3.211 . . . . 0.0 111.65 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -100.89 11.47 39.52 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -173.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.444 ' C ' HD12 ' A' ' 76' ' ' ILE . 1.9 pp -122.39 177.65 3.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -142.65 -175.58 4.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.921 0.391 . . . . 0.0 111.578 -175.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -50.03 -31.88 14.04 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.356 1.062 . . . . 0.0 112.258 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -71.45 -29.77 65.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 117.894 0.316 . . . . 0.0 111.542 -176.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -82.21 -31.78 30.15 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 122.184 -0.323 . . . . 0.0 110.42 -174.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 66.0 mt -77.49 -42.42 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.2 m -66.9 -22.97 65.95 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.67 -18.3 28.2 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.9 m -77.57 -27.61 51.51 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 118.424 0.557 . . . . 0.0 111.685 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.41 ' CZ ' HD11 ' A' ' 151' ' ' ILE . 74.6 m-85 -120.98 12.71 11.24 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.49 -18.05 64.44 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.293 0.497 . . . . 0.0 112.249 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -75.6 -10.18 59.22 Favored 'General case' 0 C--N 1.338 0.093 0 O-C-N 122.033 -0.417 . . . . 0.0 111.944 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -103.8 23.21 13.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.559 0.344 . . . . 0.0 111.319 -176.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.93 179.21 31.81 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.59 150.2 68.95 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.369 2.713 . . . . 0.0 110.772 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.417 HD23 ' N ' ' A' ' 91' ' ' LEU . 0.6 OUTLIER -162.77 164.6 26.18 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.02 -170.141 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.63 164.55 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.752 174.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -129.58 151.05 35.24 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -143.23 159.07 43.0 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.487 0.66 . . . . 0.0 112.02 -174.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.499 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 30.2 p90 -151.88 159.52 32.96 Favored Pre-proline 0 N--CA 1.452 -0.349 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 170.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.535 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 94.2 Cg_endo -65.68 -13.99 42.55 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 123.525 2.816 . . . . 0.0 112.505 -169.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.535 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 21.0 m170 -106.59 13.72 27.9 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.066 0.546 . . . . 0.0 111.549 -176.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.7 tptm -49.81 151.51 1.78 Allowed 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.844 0.858 . . . . 0.0 112.739 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -146.4 165.67 28.64 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.587 0.755 . . . . 0.0 110.487 -177.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -86.23 -9.76 55.92 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.932 0.493 . . . . 0.0 110.382 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 94.5 p -82.19 -178.19 6.93 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.601 0.76 . . . . 0.0 110.986 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -74.78 15.06 0.41 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.504 0.721 . . . . 0.0 111.559 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.8 m -77.93 58.64 1.97 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.595 0.758 . . . . 0.0 110.635 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -75.16 24.29 0.1 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.144 0.977 . . . . 0.0 112.191 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -118.62 123.2 29.33 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 118.132 0.424 . . . . 0.0 110.75 -175.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.94 166.68 8.26 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.343 3.362 . . . . 0.0 111.728 173.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.73 -17.12 47.99 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.493 2.795 . . . . 0.0 112.227 176.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -141.16 -69.96 0.37 Allowed 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 175.78 -17.02 0.04 OUTLIER Glycine 0 CA--C 1.526 0.735 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.101 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.472 ' HA ' HD21 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -76.05 150.12 37.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.025 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.69 -176.7 5.61 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.961 0.41 . . . . 0.0 111.427 -174.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -140.27 128.82 22.85 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.44 HD13 HG11 ' A' ' 69' ' ' VAL . 10.6 mp -89.98 149.54 22.52 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.656 0.741 . . . . 0.0 112.372 -177.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.2 mp -113.09 138.6 49.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -134.62 170.64 15.5 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.047 0.539 . . . . 0.0 110.388 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -101.87 -24.17 14.06 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.705 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -135.83 153.57 51.46 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -75.48 -15.51 60.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.735 171.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 m -78.91 -20.04 50.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 176.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.6 m -76.87 -42.3 40.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.7 m -74.15 -20.18 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -72.1 -41.33 67.4 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.71 -34.52 62.62 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 122.168 -0.333 . . . . 0.0 111.557 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 pp -77.41 -17.9 57.73 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.372 0.533 . . . . 0.0 111.613 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.9 mt -95.46 -17.48 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 122.39 0.276 . . . . 0.0 111.014 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -99.41 -11.2 21.36 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.864 -0.523 . . . . 0.0 112.273 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -114.84 29.34 8.09 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.811 0.444 . . . . 0.0 111.921 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 17.6 p -137.41 -173.8 3.58 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.994 0.426 . . . . 0.0 111.647 -176.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.2 mm -84.67 160.53 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 124.596 1.158 . . . . 0.0 109.427 -175.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -132.23 158.45 41.75 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.681 0.276 . . . . 0.0 110.821 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.3 74.52 1.33 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.436 0.636 . . . . 0.0 110.671 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 51.97 9.39 0.09 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.16 -9.87 0.06 OUTLIER Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.115 0.87 . . . . 0.0 113.289 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.6 pttt -146.34 178.25 8.39 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 174.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.6 mp -125.33 169.69 12.07 Favored 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -171.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 0.3 OUTLIER -140.87 156.01 46.2 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.591 -175.744 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.4 tp -137.06 142.89 42.41 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 47.4 t -82.97 132.58 35.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.518 0.599 . . . . 0.0 109.99 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 19.9 m -137.38 -10.42 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.4 m 46.3 46.1 13.41 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.531 0.732 . . . . 0.0 112.786 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.407 ' HB3' ' HD2' ' A' ' 142' ' ' PRO . 18.7 m -57.17 156.15 15.18 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.399 0.68 . . . . 0.0 111.785 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 97.1 Cg_endo -72.13 20.08 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 125.008 3.805 . . . . 0.0 114.19 -176.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.42 HG22 HG12 ' A' ' 144' ' ' ILE . 21.7 m -133.13 138.62 46.71 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.42 HG12 HG22 ' A' ' 143' ' ' THR . 0.9 OUTLIER 55.31 -149.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -170.352 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -139.12 145.7 39.76 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.449 0.568 . . . . 0.0 110.554 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 49.62 39.46 17.36 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.417 1.087 . . . . 0.0 112.969 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.498 ' HE2' ' C6 ' ' B' ' 1' ' ' ' C' . 2.6 tppp? -55.63 118.27 18.8 Favored Pre-proline 0 CA--C 1.53 0.195 0 C-N-CA 123.637 0.775 . . . . 0.0 111.964 -177.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.44 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 25.8 Cg_endo -93.8 129.53 0.66 Allowed 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 124.252 3.301 . . . . 0.0 109.765 169.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.3 131.53 38.18 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -89.23 151.15 22.3 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.605 0.762 . . . . 0.0 111.503 -173.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.41 HD11 ' CZ ' ' A' ' 85' ' ' PHE . 48.5 mm -134.94 144.48 34.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 123.967 0.907 . . . . 0.0 111.344 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.0 ttp85 -152.57 116.11 2.89 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 168.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.59 165.01 33.45 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.877 3.051 . . . . 0.0 111.908 177.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.432 ' CD1' ' HE3' ' A' ' 66' ' ' LYS . 34.5 t-105 -100.66 152.5 20.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.351 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -104.98 153.75 21.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.676 0.791 . . . . 0.0 112.209 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.3 mp -94.63 -2.56 51.13 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -172.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.4 m -79.52 -10.38 59.79 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -173.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -136.17 -110.44 0.2 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.733 0.697 . . . . 0.0 111.738 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 m 64.03 -33.4 0.14 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.541 1.937 . . . . 0.0 113.951 -173.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -153.49 151.82 30.27 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.101 0.56 . . . . 0.0 110.07 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -157.63 153.84 27.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.58 152.68 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 121.887 -0.508 . . . . 0.0 109.744 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 71.4 mtm -128.96 29.92 5.13 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -159.72 -44.5 0.05 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.54 3.93 59.68 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.102 -0.832 . . . . 0.0 113.635 174.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.3 m -138.53 -0.8 1.93 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -176.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -79.17 141.36 57.9 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 120.076 1.307 . . . . 0.0 110.261 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.11 153.21 41.08 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.369 2.713 . . . . 0.0 108.815 173.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 63.9 mt -121.46 150.12 42.04 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.631 0.253 . . . . 0.0 110.961 -177.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -144.22 139.02 15.37 Favored Pre-proline 0 N--CA 1.456 -0.157 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -68.34 -9.23 25.3 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.681 2.921 . . . . 0.0 112.613 -173.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -88.5 -1.68 58.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.715 0.406 . . . . 0.0 110.771 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -128.44 33.2 4.72 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.891 0.476 . . . . 0.0 109.733 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 11.5 m -126.14 153.45 44.55 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.077 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.6 tt -121.84 151.61 25.43 Favored 'Isoleucine or valine' 0 C--O 1.229 0.024 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -116.36 148.22 40.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 172.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.39 117.71 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.504 ' HA2' ' CB ' ' A' ' 217' ' ' ALA . . . -119.83 159.65 14.86 Favored Glycine 0 C--N 1.336 0.564 0 O-C-N 123.202 0.314 . . . . 0.0 113.586 -171.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.84 24.77 12.57 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.24 107.57 57.79 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 117.197 0.498 . . . . 0.0 110.969 -176.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.88 -33.61 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.759 2.306 . . . . 0.0 112.66 176.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.724 ' H ' ' CD ' ' A' ' 183' ' ' PRO . 71.7 mtt180 -149.81 -38.12 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -177.178 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.724 ' CD ' ' H ' ' A' ' 182' ' ' ARG . 51.8 Cg_exo -59.29 -168.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 124.029 3.153 . . . . 0.0 114.857 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 48.0 mt 65.35 -53.65 0.34 Allowed 'General case' 0 C--O 1.23 0.064 0 C-N-CA 126.963 2.105 . . . . 0.0 114.224 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 54.18 -163.43 0.11 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.947 0.794 . . . . 0.0 109.382 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -103.85 -37.2 7.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.964 -0.46 . . . . 0.0 110.806 172.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 69.0 t -67.16 -56.45 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 C-N-CA 122.391 0.276 . . . . 0.0 111.183 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -74.34 -22.29 59.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.856 -0.156 . . . . 0.0 110.961 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.6 tp -68.47 -35.94 78.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.39 -28.75 61.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.311 -0.243 . . . . 0.0 111.346 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 26.3 mmt -70.7 -35.2 72.64 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 117.704 0.229 . . . . 0.0 111.614 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.62 -32.17 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 O-C-N 121.64 -0.663 . . . . 0.0 109.683 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.6 mmt -76.66 -15.82 59.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 121.897 -0.502 . . . . 0.0 111.894 -177.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -97.9 -24.31 15.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.697 0.681 . . . . 0.0 111.553 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -86.43 -16.36 37.42 Favored 'General case' 0 C--N 1.34 0.165 0 O-C-N 121.872 -0.517 . . . . 0.0 112.334 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -117.49 -20.19 9.15 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.355 0.525 . . . . 0.0 111.082 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -140.03 42.65 1.94 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.928 0.491 . . . . 0.0 109.752 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.51 137.15 4.38 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.032 0.825 . . . . 0.0 112.782 -175.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 122.7 1.38 9.85 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.48 157.16 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 123.837 0.855 . . . . 0.0 109.889 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.9 p -129.41 -32.15 1.99 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -147.15 152.0 37.71 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.217 0.917 . . . . 0.0 111.891 -177.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -149.6 160.91 43.1 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.481 0.312 . . . . 0.0 111.176 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 168.39 -170.21 42.01 Favored Glycine 0 C--N 1.336 0.534 0 O-C-N 121.909 -0.494 . . . . 0.0 112.122 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.9 mp -105.08 146.02 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -65.81 117.88 8.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.552 0.215 . . . . 0.0 110.434 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 76.4 p -140.49 162.59 34.99 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 122.759 0.424 . . . . 0.0 110.266 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -115.98 130.75 24.16 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.28 -1.98 10.97 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 124.811 3.674 . . . . 0.0 114.335 -170.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -68.0 -32.42 72.79 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 119.025 0.829 . . . . 0.0 110.104 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.31 8.33 1.19 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.512 0.725 . . . . 0.0 109.853 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt 53.03 39.89 30.26 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.219 1.008 . . . . 0.0 111.434 -174.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -94.25 151.92 39.86 Favored Pre-proline 0 N--CA 1.455 -0.178 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.719 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.9 141.93 37.95 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.559 2.173 . . . . 0.0 110.821 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.67 14.67 6.48 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.867 0.867 . . . . 0.0 109.92 -178.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 165.69 -165.09 37.78 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.504 ' CB ' ' HA2' ' A' ' 178' ' ' GLY . . . -86.08 -160.21 0.53 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.349 1.06 . . . . 0.0 110.829 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -74.56 158.87 51.92 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 122.189 -0.32 . . . . 0.0 112.777 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.06 153.26 38.69 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 50.1 t -145.27 146.12 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.06 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.39 145.33 50.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.547 0.339 . . . . 0.0 110.405 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -128.84 -23.09 3.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.312 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 46.0 m 56.28 25.18 9.01 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -178.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -128.05 151.84 48.69 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -73.43 -30.99 63.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -176.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -85.12 -39.83 17.46 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 111.373 0.138 . . . . 0.0 111.373 -172.387 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 65.7 p -77.54 -23.07 50.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.16 -0.337 . . . . 0.0 110.249 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -67.6 -52.75 34.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 175.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 32.7 pt -73.08 -18.04 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.63 -29.38 30.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.159 0.436 . . . . 0.0 111.491 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -77.62 -23.77 49.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.931 0.332 . . . . 0.0 111.691 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.9 pt -108.89 25.14 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.525 0.73 . . . . 0.0 110.561 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.0 t -77.06 -12.51 59.95 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.136 0.574 . . . . 0.0 112.12 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -152.67 140.83 20.41 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -55.3 -30.26 59.84 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -128.15 130.24 47.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.295 0.569 . . . . 0.0 111.135 177.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.2 m -100.8 177.34 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.294 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -109.01 138.66 45.0 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.451 0.3 . . . . 0.0 110.346 172.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.2 mp -134.76 84.41 2.1 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -119.55 -66.93 1.02 Allowed 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -172.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 48.34 24.14 0.67 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -174.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 168.95 -151.28 17.47 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -80.3 6.18 12.71 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.022 0.529 . . . . 0.0 111.717 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ILE . . . . . 0.431 ' N ' HD12 ' A' ' 244' ' ' ILE . 1.8 mp -71.53 157.05 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.597 0.759 . . . . 0.0 108.971 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -141.58 25.63 1.99 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.906 0.384 . . . . 0.0 111.257 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' LYS . . . . . 0.425 ' H ' HG22 ' A' ' 244' ' ' ILE . 99.1 mttt -90.12 154.73 19.56 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.128 0.571 . . . . 0.0 111.093 -177.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -160.26 -179.93 8.14 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.61 157.94 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.854 0.862 . . . . 0.0 110.187 -174.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -85.19 129.48 34.8 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 122.678 0.391 . . . . 0.0 110.009 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -100.28 158.23 3.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.432 ' HE3' ' HB3' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -159.0 156.95 27.65 Favored Pre-proline 0 N--CA 1.456 -0.135 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.677 169.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.31 146.0 96.11 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.844 2.363 . . . . 0.0 109.863 174.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -79.83 166.03 22.12 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.489 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.7 152.84 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 123.059 0.544 . . . . 0.0 110.245 -171.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 62.2 tp . . . . . 0 C--O 1.251 1.149 0 CA-C-O 117.158 -1.401 . . . . 0.0 109.973 179.267 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.498 ' C6 ' ' HE2' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.921 1 O4'-C1'-N19 112.871 4.671 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.829 0 O4'-C1'-N19 111.842 3.642 . 0.271 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.461 ' C6 ' ' CZ ' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.756 1 O4'-C1'-N19 113.034 4.834 . 0.053 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.44 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 C5'-C4'-C3' 111.287 -2.809 . 0.063 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.47 H5'' ' C8 ' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.107 0 P-O3'-C3' 122.915 2.679 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 77.6 p . . . . . 0 N--CA 1.475 0.805 0 CA-C-O 120.418 0.152 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -138.39 10.26 2.73 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.097 0.559 . . . . 0.0 111.614 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -138.6 167.89 20.96 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 123.464 0.706 . . . . 0.0 110.241 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -141.52 177.91 7.81 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.285 0.634 . . . . 0.0 110.781 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.84 11.06 74.56 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 112.14 -0.384 . . . . 0.0 112.14 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -70.29 168.94 14.82 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.467 0.633 . . . . 0.0 111.618 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -137.11 145.54 44.0 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.185 0.594 . . . . 0.0 109.731 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.9 t -131.2 150.86 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 123.538 0.735 . . . . 0.0 109.475 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -77.15 149.88 35.59 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 111.465 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.9 31.14 0.71 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.456 1.102 . . . . 0.0 113.49 -174.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.586 ' HA ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -142.22 -153.13 0.44 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -174.662 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.2 m 64.75 5.89 3.02 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 126.133 1.773 . . . . 0.0 113.069 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -65.03 118.49 9.2 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 173.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 63.47 143.58 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.767 1.227 . . . . 0.0 111.071 -168.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -156.11 146.43 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.337 -172.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.494 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 9.3 t80 -89.69 140.01 30.0 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 p -118.76 117.88 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.482 ' HA2' ' CZ ' ' A' ' 68' ' ' PHE . . . -89.45 125.1 7.67 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 116.348 -0.387 . . . . 0.0 113.141 -170.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.37 146.67 11.1 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.222 0.915 . . . . 0.0 112.522 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.6 tp -153.94 122.62 3.09 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.17 164.07 31.71 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.217 2.611 . . . . 0.0 111.781 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.15 175.43 9.24 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.39 3.393 . . . . 0.0 111.426 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.1 t70 60.9 -85.86 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.237 0.615 . . . . 0.0 112.332 -175.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.0 pt -56.38 157.24 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 121.278 0.561 . . . . 0.0 111.333 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -149.63 -121.76 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.029 0.531 . . . . 0.0 110.256 -177.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -54.07 -22.9 11.97 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.091 1.357 . . . . 0.0 111.974 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -77.83 -36.96 49.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -173.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -86.41 -30.42 22.12 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.911 -0.493 . . . . 0.0 111.343 -173.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.8 pt -78.57 -33.3 16.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 O-C-N 121.935 -0.478 . . . . 0.0 109.968 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.3 m -70.47 -23.74 62.74 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 175.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.32 -17.07 40.76 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.4 m -76.66 -37.4 56.29 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.557 0.617 . . . . 0.0 111.695 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.455 ' CZ ' HD11 ' A' ' 151' ' ' ILE . 81.2 m-85 -108.25 6.66 26.82 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -176.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.89 -18.34 64.09 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.709 0.404 . . . . 0.0 110.941 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -72.09 -8.92 57.37 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.557 0.743 . . . . 0.0 112.031 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -110.23 5.72 22.02 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.335 0.254 . . . . 0.0 111.427 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.78 177.58 15.11 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -70.5 150.79 64.26 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.69 2.927 . . . . 0.0 110.835 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.421 HD23 ' N ' ' A' ' 91' ' ' LEU . 0.5 OUTLIER -164.53 164.41 21.76 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.747 -170.771 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 pt -142.22 170.82 11.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.295 174.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.09 155.15 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 122.449 0.299 . . . . 0.0 110.351 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -153.25 170.27 21.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.67 0.271 . . . . 0.0 111.608 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 33.7 p90 -159.27 158.14 28.03 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.421 ' HG3' " H1'" ' B' ' 4' ' ' ' U' . 34.6 Cg_endo -75.36 -9.18 20.18 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.892 1.728 . . . . 0.0 110.74 -169.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -95.37 6.71 48.29 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.723 0.809 . . . . 0.0 111.349 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -50.19 152.02 1.87 Allowed 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.778 0.831 . . . . 0.0 112.911 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.37 161.6 37.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.088 -177.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -142.24 152.33 42.96 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.162 0.585 . . . . 0.0 110.37 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 93.3 p 47.51 19.13 0.13 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.964 1.705 . . . . 0.0 115.106 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -152.94 -35.82 0.11 Allowed 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 118.348 0.522 . . . . 0.0 111.16 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.6 m -149.09 156.68 42.57 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 123.399 0.68 . . . . 0.0 110.025 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -153.78 22.7 0.52 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.766 0.426 . . . . 0.0 111.052 178.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -139.17 125.5 12.43 Favored Pre-proline 0 N--CA 1.451 -0.406 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.72 164.82 33.81 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.716 3.61 . . . . 0.0 111.675 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.1 -26.06 65.62 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.955 3.103 . . . . 0.0 112.873 -178.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -152.28 -38.72 0.11 Allowed 'General case' 0 C--O 1.227 -0.112 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.48 123.12 3.2 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 168.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.515 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 14.3 m-85 -147.77 143.12 27.31 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 167.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.35 172.89 12.31 Favored 'General case' 0 C--N 1.335 -0.057 0 CA-C-N 119.896 1.225 . . . . 0.0 113.489 -169.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.4 ' CE1' ' C5 ' ' B' ' 4' ' ' ' U' . 1.3 m-85 -136.08 125.47 24.95 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.218 0.607 . . . . 0.0 109.515 -177.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 mp -84.8 141.97 30.11 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.345 0.593 . . . . 0.0 110.72 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.7 mp -104.99 136.48 44.38 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -140.28 163.93 31.45 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.049 0.539 . . . . 0.0 110.68 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -123.53 -29.36 3.78 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.087 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -102.23 159.91 14.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.827 0.346 . . . . 0.0 111.53 -175.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -111.29 5.0 19.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.236 -178.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.8 p -105.3 -22.22 13.09 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.904 0.482 . . . . 0.0 110.921 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 76.8 p -76.16 -31.43 58.54 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.84 -22.26 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 173.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -80.29 -36.92 33.73 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -174.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.87 -35.11 62.32 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 119.684 -0.198 . . . . 0.0 111.52 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -80.42 -18.51 48.62 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.313 0.506 . . . . 0.0 111.916 -176.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.1 mt -97.8 -14.47 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 117.843 0.292 . . . . 0.0 110.557 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -91.91 -16.54 26.5 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.312 -0.868 . . . . 0.0 111.238 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -108.74 26.9 10.01 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.457 0.703 . . . . 0.0 111.794 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 136' ' ' TYR . 17.2 p -124.98 166.77 15.74 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.043 0.537 . . . . 0.0 111.105 -176.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.56 172.4 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -137.31 157.95 45.49 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.021 0.438 . . . . 0.0 111.558 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.52 -172.7 4.09 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -30.1 -39.57 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.1 1.76 . . . . 0.0 115.253 -173.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.0 15.72 0.15 Allowed Glycine 0 CA--C 1.527 0.814 0 CA-C-N 118.595 0.634 . . . . 0.0 112.089 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -141.16 177.35 8.14 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 117.577 0.688 . . . . 0.0 110.56 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.22 170.76 9.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.439 0.696 . . . . 0.0 110.186 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.431 ' O ' ' HB2' ' A' ' 128' ' ' CYS . 6.3 m-85 -146.76 151.59 37.42 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.857 0.463 . . . . 0.0 111.084 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 45.4 tp -132.46 145.73 51.4 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 170.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 85.0 m -80.33 141.88 35.02 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.745 -0.597 . . . . 0.0 110.893 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.2 175.43 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.324 0.65 . . . . 0.0 109.681 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.8 m -138.51 117.32 12.33 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 122.674 0.39 . . . . 0.0 110.759 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.479 ' HB3' ' HD2' ' A' ' 142' ' ' PRO . 52.7 m -155.21 162.15 27.89 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.688 1.195 . . . . 0.0 108.828 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 60.7 Cg_endo -66.1 -15.72 49.56 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.203 2.602 . . . . 0.0 114.088 -175.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.6 m -105.12 -2.93 23.67 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.44 0.564 . . . . 0.0 110.169 175.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.2 mp -98.97 -52.42 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.177 0.591 . . . . 0.0 111.026 -172.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 87.6 tttt 58.2 -57.96 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.729 1.612 . . . . 0.0 113.194 -172.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -149.83 12.72 0.79 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.391 1.076 . . . . 0.0 110.678 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.521 ' HD2' ' C6 ' ' B' ' 1' ' ' ' C' . 14.0 tttm -67.99 137.38 92.18 Favored Pre-proline 0 C--N 1.338 0.1 0 C-N-CA 123.607 0.763 . . . . 0.0 111.532 -177.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.428 ' HG2' ' CE1' ' A' ' 136' ' ' TYR . 37.8 Cg_endo -86.96 146.79 7.91 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 123.685 2.923 . . . . 0.0 110.632 168.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.9 p -98.88 142.37 14.94 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -83.37 158.78 22.01 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.786 0.721 . . . . 0.0 112.464 -174.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.455 HD11 ' CZ ' ' A' ' 85' ' ' PHE . 29.6 mm -137.13 142.79 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.051 1.341 . . . . 0.0 108.759 177.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 44.8 ttt-85 -146.08 88.52 6.31 Favored Pre-proline 0 CA--C 1.529 0.152 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.78 145.37 72.42 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.495 3.463 . . . . 0.0 112.857 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -92.86 153.02 19.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 173.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -119.48 134.1 55.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.653 0.739 . . . . 0.0 110.883 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.586 HD13 ' HA ' ' A' ' 63' ' ' TYR . 4.7 mp -87.87 8.21 27.13 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.473 -169.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.7 t -91.1 -12.65 34.95 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -175.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -135.51 20.12 3.35 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -175.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.6 m -69.89 -20.98 63.36 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.433 0.56 . . . . 0.0 112.448 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -158.19 158.09 33.91 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.275 0.488 . . . . 0.0 111.04 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -158.35 157.34 32.2 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.987 0.422 . . . . 0.0 111.054 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.0 m -140.35 149.34 21.69 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 C-N-CA 124.353 1.061 . . . . 0.0 109.722 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 58.3 mtm -140.62 10.42 2.25 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -140.3 16.64 2.41 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.243 0.929 . . . . 0.0 112.971 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 91.09 22.8 31.54 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.519 -0.6 . . . . 0.0 113.016 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.4 m 56.29 47.03 20.02 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 117.722 0.761 . . . . 0.0 112.544 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -61.88 158.21 44.82 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 123.259 0.624 . . . . 0.0 110.602 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.0 154.54 69.67 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.184 2.589 . . . . 0.0 110.67 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 61.2 mt -135.57 167.67 20.68 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.605 0.762 . . . . 0.0 110.666 -173.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -141.49 149.57 54.71 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.01 -19.84 57.72 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.217 2.611 . . . . 0.0 112.516 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -88.1 5.93 38.78 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.46 0.704 . . . . 0.0 110.837 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -131.07 18.96 4.97 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.903 0.481 . . . . 0.0 110.875 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 24.2 m -126.35 139.9 52.93 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.88 0.371 . . . . 0.0 111.153 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.7 tt -112.0 149.2 14.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.913 -177.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -116.15 148.73 40.03 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.19 139.01 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 122.632 0.373 . . . . 0.0 110.207 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -148.48 173.56 28.42 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.67 20.96 62.68 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -174.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.0 m -56.38 142.48 68.55 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 122.751 0.42 . . . . 0.0 110.372 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.06 -49.39 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.944 2.429 . . . . 0.0 112.21 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.412 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 41.7 ttm180 -161.11 -59.2 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.435 -0.793 . . . . 0.0 111.257 176.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 182' ' ' ARG . 77.3 Cg_endo -76.01 156.53 38.57 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.871 2.381 . . . . 0.0 111.394 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.59 0.68 0.11 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.155 0.582 . . . . 0.0 112.296 175.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ARG . . . . . 0.423 ' HG2' ' H ' ' A' ' 188' ' ' GLU . 16.7 ttp-105 -28.46 120.56 0.12 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.864 1.666 . . . . 0.0 111.582 175.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.4 -21.14 63.79 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 94.3 t -67.21 -50.16 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 118.154 0.434 . . . . 0.0 110.62 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 185' ' ' ARG . 59.6 mt-10 -84.87 -22.57 29.34 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.61 -0.144 . . . . 0.0 110.61 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.94 -30.91 68.41 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -83.4 -31.6 26.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 119.503 -0.284 . . . . 0.0 111.713 -177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.3 mmt -70.46 -37.05 74.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.318 0.508 . . . . 0.0 109.656 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.408 HG21 ' HA ' ' A' ' 239' ' ' LEU . 64.5 mt -72.55 -40.42 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.6 mmt -63.39 -25.37 68.26 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.941 -0.474 . . . . 0.0 110.929 172.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.59 -18.13 49.22 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.105 0.411 . . . . 0.0 111.836 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -98.53 -16.21 19.24 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.59 -13.11 11.53 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.184 0.902 . . . . 0.0 113.221 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -135.9 26.59 3.3 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.839 0.745 . . . . 0.0 112.657 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 76.18 -150.55 39.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -76.27 141.29 26.69 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -174.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.84 143.89 31.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 124.248 1.019 . . . . 0.0 108.56 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 61.4 m -109.48 -33.53 6.78 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -151.9 149.77 29.32 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.0 0.428 . . . . 0.0 110.964 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.28 155.61 40.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.465 0.706 . . . . 0.0 109.143 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.85 -174.97 47.27 Favored Glycine 0 C--N 1.333 0.363 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.2 mm -104.95 145.01 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -54.91 118.23 4.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.013 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 214' ' ' PRO . 12.2 p -144.23 158.94 43.45 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.63 0.372 . . . . 0.0 110.267 -176.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -135.1 135.54 23.06 Favored Pre-proline 0 N--CA 1.455 -0.216 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.68 -5.97 15.04 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.225 3.283 . . . . 0.0 112.824 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -73.74 -39.63 64.11 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.311 0.505 . . . . 0.0 110.688 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.11 0.68 12.41 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.35 0.66 . . . . 0.0 109.602 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm 48.26 59.35 4.35 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.281 1.032 . . . . 0.0 111.386 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -133.49 147.33 64.29 Favored Pre-proline 0 CA--C 1.529 0.149 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -176.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.413 ' HA ' HG22 ' A' ' 207' ' ' THR . 43.7 Cg_endo -81.96 165.65 17.27 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 124.238 3.292 . . . . 0.0 110.546 174.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -125.63 23.25 7.44 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 61.59 13.33 37.79 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 119.373 -0.682 . . . . 0.0 114.684 170.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -132.81 146.09 51.53 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 118.235 1.017 . . . . 0.0 109.569 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -93.18 162.31 25.92 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 121.445 0.469 . . . . 0.0 113.326 -172.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -149.64 145.21 26.62 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 173.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 95.2 t -136.57 147.77 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -133.51 154.03 51.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.396 0.617 . . . . 0.0 111.33 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -132.22 154.95 49.09 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.05 -176.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.9 m -97.3 10.08 40.53 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 173.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -132.17 134.22 45.14 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.631 0.773 . . . . 0.0 109.799 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -72.92 -12.86 61.12 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 116.859 -0.155 . . . . 0.0 111.145 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -82.1 -39.04 23.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.9 m -75.06 -28.95 60.57 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -64.52 -51.78 61.16 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 119.649 -0.215 . . . . 0.0 110.568 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.3 pt -71.42 -14.71 17.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 CA-C-N 118.111 0.414 . . . . 0.0 111.181 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.03 -22.01 33.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.799 0.272 . . . . 0.0 110.734 175.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -87.99 -27.84 21.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.5 pt -103.41 24.85 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 122.917 0.487 . . . . 0.0 110.547 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 86.6 p -75.15 -18.07 60.28 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.172 0.589 . . . . 0.0 111.96 -177.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.98 146.04 23.66 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -55.15 -31.4 61.29 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -123.05 121.94 37.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.899 0.381 . . . . 0.0 110.489 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.441 ' H ' HG22 ' A' ' 237' ' ' VAL . 1.8 m -82.68 153.98 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.594 172.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.566 ' C ' HD22 ' A' ' 239' ' ' LEU . 9.8 mp0 -95.62 140.58 30.24 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.566 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.0 mm? -127.82 27.23 5.76 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -91.96 136.52 33.1 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.909 0.484 . . . . 0.0 112.138 -171.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -148.71 19.26 1.02 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.918 177.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 84.79 138.54 4.2 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -176.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 55.86 7.39 0.27 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.389 1.076 . . . . 0.0 112.63 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.4 mt -142.71 141.61 27.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 C-N-CA 124.046 0.938 . . . . 0.0 108.991 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -157.41 123.97 4.95 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -144.34 161.27 39.4 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.98 155.21 36.51 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.0 p -154.92 151.43 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -84.97 126.71 33.75 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.5 m -102.03 158.52 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.23 157.43 27.49 Favored Pre-proline 0 N--CA 1.456 -0.148 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.733 169.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.86 130.73 41.43 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.55 2.167 . . . . 0.0 107.733 171.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -71.56 110.34 6.08 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.462 -172.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 8.6 p 45.2 34.87 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.473 1.509 . . . . 0.0 112.751 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 62.9 tp . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.107 -1.425 . . . . 0.0 110.357 -177.711 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.521 ' C6 ' ' HD2' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.415 -3.128 1 C5'-C4'-C3' 107.874 -5.084 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . 0.465 ' O2 ' " H2'" ' B' ' 2' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.774 2 C3'-C2'-C1' 105.947 4.941 OUTLIER-DELTA 0.061 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.515 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.421 -2.638 1 O4'-C1'-N19 113.849 5.649 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.421 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.422 -2.623 0 O4'-C1'-N19 111.215 3.015 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.438 ' N3 ' " H2'" ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.459 0 O3'-P-O5' 99.647 -2.291 . 0.013 4a . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -142.3 163.32 33.17 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.089 0.556 . . . . 0.0 110.481 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -82.24 163.77 21.64 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.832 0.453 . . . . 0.0 110.538 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -142.53 179.83 6.73 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.574 0.75 . . . . 0.0 110.45 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.32 -149.94 23.24 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 58' ' ' GLU . 2.4 pm0 -61.6 156.71 19.14 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.214 0.605 . . . . 0.0 112.013 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -100.77 -10.25 20.97 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.17 0.588 . . . . 0.0 111.864 -177.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.48 160.2 31.43 Favored 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 122.93 0.492 . . . . 0.0 110.866 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -97.72 171.68 8.17 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.4 0.68 . . . . 0.0 110.228 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.0 ppt_? -127.76 156.12 42.94 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.359 0.664 . . . . 0.0 110.789 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.448 ' CD1' ' HA ' ' A' ' 155' ' ' ASN . 54.1 m-85 -168.96 -172.98 1.69 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -169.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.8 t -141.01 36.37 1.75 Allowed 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.02 -0.425 . . . . 0.0 112.04 173.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.78 36.36 2.73 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.329 1.451 . . . . 0.0 114.487 176.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.4 pttm -141.71 153.48 44.68 Favored 'General case' 0 N--CA 1.46 0.064 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 171.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 p -153.54 146.29 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-O 120.62 0.247 . . . . 0.0 111.025 -176.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -89.41 144.15 26.28 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.78 115.0 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.724 0.773 . . . . 0.0 109.315 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.23 -165.17 37.4 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.87 -104.67 1.51 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.1 tp 54.97 101.5 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 125.366 1.466 . . . . 0.0 112.547 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -67.2 148.23 80.22 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.905 1.737 . . . . 0.0 108.572 174.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.8 20.14 0.63 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.883 3.055 . . . . 0.0 112.574 -174.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -138.5 28.72 2.44 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.1 pt -133.66 175.55 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 119.012 0.824 . . . . 0.0 109.049 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -138.17 -175.97 4.29 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -49.88 -34.88 21.52 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.764 1.226 . . . . 0.0 112.261 -175.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -72.15 -29.85 64.43 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -175.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -79.13 -36.95 39.74 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -174.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.5 mt -73.72 -39.31 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 90.0 m -65.31 -22.94 66.9 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.1 -17.89 28.35 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -79.55 -26.72 41.35 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.383 0.538 . . . . 0.0 112.363 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -114.47 10.2 16.89 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -59.41 -19.83 50.27 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -172.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -73.63 -11.89 60.57 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.22 0.464 . . . . 0.0 112.236 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -99.46 16.44 23.19 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.45 0.3 . . . . 0.0 111.713 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.03 -175.33 29.7 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.95 137.28 37.45 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.49 2.793 . . . . 0.0 110.536 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.9 pp -160.25 166.69 29.1 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.519 0.728 . . . . 0.0 109.909 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mt -136.01 164.78 31.15 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.44 147.06 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -148.36 166.98 26.42 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -174.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -156.51 159.15 31.58 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 176.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.471 ' HG3' " H1'" ' B' ' 4' ' ' ' U' . 63.8 Cg_endo -71.36 -10.89 27.83 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.482 2.788 . . . . 0.0 110.976 -171.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.442 ' ND1' ' HG2' ' A' ' 96' ' ' PRO . 39.0 m80 -100.28 17.09 22.27 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.955 0.902 . . . . 0.0 111.39 -178.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -54.02 160.56 1.47 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.004 0.922 . . . . 0.0 112.987 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.83 167.34 19.07 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.079 0.952 . . . . 0.0 110.499 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -143.73 150.12 38.16 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.274 0.63 . . . . 0.0 109.804 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.5 m 53.13 23.6 3.14 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.711 0.804 . . . . 0.0 112.503 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -150.88 162.86 39.98 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.719 0.808 . . . . 0.0 109.381 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.0 m -62.41 161.66 11.34 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.744 0.418 . . . . 0.0 110.683 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -131.39 135.68 47.4 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.038 0.447 . . . . 0.0 111.097 -177.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -159.79 99.01 1.5 Allowed Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.17 146.8 32.49 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.637 2.891 . . . . 0.0 111.946 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 109' ' ' GLY . 48.9 Cg_endo -80.3 -166.71 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.633 3.555 . . . . 0.0 109.217 172.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -75.93 33.7 0.12 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.874 0.368 . . . . 0.0 110.568 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 107' ' ' PRO . . . -80.28 9.32 48.74 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.562 0.601 . . . . 0.0 111.703 178.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.457 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 3.1 m-85 54.89 -177.25 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.068 0.547 . . . . 0.0 111.29 -175.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.54 175.38 12.38 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 121.356 -0.84 . . . . 0.0 112.672 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -139.59 143.49 37.32 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.9 mp -102.78 149.2 24.71 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-O 121.387 0.613 . . . . 0.0 112.267 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.9 mp -107.9 143.11 36.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.362 -1.29 . . . . 0.0 107.658 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -139.44 154.41 47.76 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.136 0.494 . . . . 0.0 110.346 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -101.18 -23.86 14.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.139 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -111.93 153.38 26.82 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.257 0.223 . . . . 0.0 110.438 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -97.58 1.71 49.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.559 0.219 . . . . 0.0 111.086 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.3 t -115.08 -13.93 11.82 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.509 0.724 . . . . 0.0 110.884 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.5 m -68.27 -32.53 72.76 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 121.507 -0.746 . . . . 0.0 109.227 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.78 -22.93 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -80.56 -26.37 38.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.832 -0.543 . . . . 0.0 109.639 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.51 -36.28 68.32 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.926 -0.484 . . . . 0.0 110.569 176.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -79.51 -16.3 56.26 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.312 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.51 HD11 ' HB3' ' A' ' 153' ' ' PRO . 97.0 mt -94.17 -10.77 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 122.439 0.295 . . . . 0.0 110.85 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -108.19 -10.72 15.36 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.709 -0.619 . . . . 0.0 112.225 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -116.37 42.2 2.46 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.482 0.713 . . . . 0.0 110.293 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 136' ' ' TYR . 31.1 p -142.67 174.97 10.17 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.45 0.7 . . . . 0.0 110.974 -172.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.95 165.89 2.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.02 157.27 44.56 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.995 0.426 . . . . 0.0 111.613 177.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -143.08 75.82 1.5 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.436 0.636 . . . . 0.0 109.654 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.7 t70 54.52 12.45 0.54 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.196 1.399 . . . . 0.0 114.703 175.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 154.71 -8.73 0.36 Allowed Glycine 0 CA--C 1.528 0.888 0 O-C-N 121.526 -0.734 . . . . 0.0 113.384 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -129.78 171.04 13.11 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 118.136 0.968 . . . . 0.0 109.328 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -122.44 164.95 17.12 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -170.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.433 ' O ' ' HB2' ' A' ' 128' ' ' CYS . 9.7 m-85 -143.69 150.36 38.57 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.028 176.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.8 mp -127.21 159.47 34.2 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.2 p -94.08 128.58 40.54 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.931 -0.48 . . . . 0.0 111.067 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.4 m -148.43 166.12 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 123.651 0.78 . . . . 0.0 109.838 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.8 m -96.68 155.4 16.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.615 0.366 . . . . 0.0 110.738 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.4 m -146.35 144.49 21.27 Favored Pre-proline 0 CA--C 1.528 0.132 0 C-N-CA 123.338 0.655 . . . . 0.0 109.436 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.86 -14.52 13.79 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.41 2.74 . . . . 0.0 111.338 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.4 m -76.71 -24.53 53.1 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 123.934 0.893 . . . . 0.0 110.668 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.417 HG22 ' H ' ' A' ' 145' ' ' LYS . 0.2 OUTLIER -137.83 -172.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.371 1.068 . . . . 0.0 108.804 -170.712 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.417 ' H ' HG22 ' A' ' 144' ' ' ILE . 22.1 ptmt -91.41 -23.38 20.05 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 169.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -165.42 154.04 11.79 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.087 1.355 . . . . 0.0 108.462 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.505 ' HE2' ' C6 ' ' B' ' 1' ' ' ' C' . 22.2 ttmt -151.13 117.69 3.29 Favored Pre-proline 0 N--CA 1.457 -0.083 0 CA-C-N 118.276 0.489 . . . . 0.0 111.139 175.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.402 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 38.4 Cg_exo -63.8 120.53 7.94 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 122.295 1.997 . . . . 0.0 108.654 168.023 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.6 p -84.25 132.0 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.1 tm0? -90.3 147.69 23.35 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.38 0.272 . . . . 0.0 110.787 -170.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 26.4 mm -135.18 142.76 39.03 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 C-N-CA 123.006 0.522 . . . . 0.0 111.501 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.437 ' HD2' ' C4 ' ' B' ' 3' ' ' ' U' . 72.1 mtt180 -144.33 106.83 4.79 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 173.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.51 ' HB3' HD11 ' A' ' 125' ' ' ILE . 84.1 Cg_endo -71.43 161.03 46.86 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.826 3.017 . . . . 0.0 113.79 -176.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -93.92 94.5 8.51 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.448 ' HA ' ' CD1' ' A' ' 63' ' ' TYR . 3.3 m120 -69.31 0.84 4.41 Favored 'General case' 0 C--O 1.228 -0.054 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -168.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.538 HD23 ' H ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -156.09 175.85 13.43 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.499 1.5 . . . . 0.0 114.464 -169.192 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 54.4 m -108.49 24.6 12.8 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.904 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.538 ' H ' HD23 ' A' ' 156' ' ' LEU . 80.5 m-20 -94.84 31.72 1.78 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.408 0.283 . . . . 0.0 110.497 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 m -75.47 -20.02 59.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -153.29 154.01 33.76 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.06 0.391 . . . . 0.0 111.356 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -157.88 153.25 26.01 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.935 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.8 m -139.21 155.75 26.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 122.803 0.441 . . . . 0.0 110.254 177.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 64.1 mtm -135.23 28.19 3.43 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.318 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -155.37 168.72 26.18 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -77.65 41.03 1.86 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.672 0.653 . . . . 0.0 112.793 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.9 m 55.89 60.56 3.19 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 117.414 0.607 . . . . 0.0 111.51 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -63.43 161.72 31.77 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 123.532 0.733 . . . . 0.0 109.745 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -56.01 124.02 15.26 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.518 2.145 . . . . 0.0 109.396 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.5 tp -127.07 138.31 53.18 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.748 0.819 . . . . 0.0 110.391 -171.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -144.78 156.3 55.87 Favored Pre-proline 0 N--CA 1.454 -0.261 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.63 -12.42 31.21 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.877 2.385 . . . . 0.0 111.203 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -83.61 -5.03 59.07 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.665 0.786 . . . . 0.0 111.563 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -118.35 24.51 10.9 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.853 0.461 . . . . 0.0 110.127 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 44.8 m -122.09 154.0 37.92 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.603 0.361 . . . . 0.0 111.001 -174.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.61 146.24 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -99.3 129.06 45.49 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.431 HG12 HG21 ' A' ' 248' ' ' VAL . 45.5 t -104.8 78.66 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 125.02 1.328 . . . . 0.0 108.447 -177.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.451 ' HA2' ' CB ' ' A' ' 217' ' ' ALA . . . -96.09 153.42 20.55 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 116.355 -0.384 . . . . 0.0 113.44 -174.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 109.21 11.79 21.31 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.9 m -73.63 152.88 89.54 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 117.255 0.527 . . . . 0.0 110.298 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.32 -45.9 2.42 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.63 2.22 . . . . 0.0 110.099 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.531 ' HB3' ' CD ' ' A' ' 183' ' ' PRO . 29.5 ttp-105 -159.8 -75.32 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 118.019 -0.991 . . . . 0.0 108.664 172.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 182' ' ' ARG . 14.4 Cg_endo -87.66 177.11 3.78 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.765 2.31 . . . . 0.0 109.81 169.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 184' ' ' LEU . 19.3 tp -136.58 -0.34 2.4 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 169.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 57.53 95.38 0.02 OUTLIER 'General case' 0 C--N 1.341 0.217 0 C-N-CA 126.941 2.096 . . . . 0.0 111.702 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.89 -27.44 63.29 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -173.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 62.5 t -62.8 -56.41 17.7 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 CA-C-N 118.515 0.598 . . . . 0.0 111.183 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -82.46 -23.03 34.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 122.454 -0.153 . . . . 0.0 110.721 -175.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.88 -38.87 66.82 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.52 -37.56 74.15 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 121.923 -0.486 . . . . 0.0 110.426 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.2 mmt -68.33 -35.64 78.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.376 -0.202 . . . . 0.0 110.818 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.41 HG21 ' HA ' ' A' ' 239' ' ' LEU . 56.5 mt -76.95 -35.95 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 117.594 0.179 . . . . 0.0 111.317 -176.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.3 mmt -64.56 -23.43 67.26 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.891 -0.505 . . . . 0.0 109.998 172.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -78.68 -24.26 45.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.022 0.374 . . . . 0.0 110.735 174.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -83.43 -17.7 41.24 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 119.129 -0.462 . . . . 0.0 112.134 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -118.48 -17.07 9.46 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -177.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -133.24 19.03 4.02 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -174.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.19 -144.41 37.64 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -69.3 118.38 8.56 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 60.2 t -109.3 142.35 22.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 124.08 0.952 . . . . 0.0 108.612 174.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 42.9 t -99.9 -39.78 8.0 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.687 0.221 . . . . 0.0 110.84 -178.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -150.09 146.29 26.85 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.727 0.298 . . . . 0.0 110.964 -176.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -154.49 153.04 30.83 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.312 0.645 . . . . 0.0 109.844 175.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 162.75 -158.25 30.42 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.651 -0.579 . . . . 0.0 111.651 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ILE . . . . . 0.454 ' HA ' ' HA2' ' A' ' 218' ' ' GLY . 48.8 mm -108.51 145.33 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -60.3 102.68 0.18 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 40.7 p -145.51 166.76 24.75 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.944 0.498 . . . . 0.0 109.802 -176.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -138.26 131.61 16.51 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -80.11 -16.42 11.12 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.458 3.439 . . . . 0.0 113.587 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -91.12 -31.65 16.15 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.527 0.603 . . . . 0.0 110.476 -176.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.04 -1.88 30.76 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.208 0.603 . . . . 0.0 110.291 176.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 49.86 45.2 25.1 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.103 0.961 . . . . 0.0 112.551 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.37 155.25 53.93 Favored Pre-proline 0 CA--C 1.528 0.104 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -84.41 153.85 12.21 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.411 2.741 . . . . 0.0 109.586 170.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.58 6.59 6.25 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.856 0.463 . . . . 0.0 110.502 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 165.46 -163.07 36.35 Favored Glycine 0 CA--C 1.524 0.609 0 O-C-N 121.919 -0.488 . . . . 0.0 112.08 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' ALA . . . . . 0.451 ' CB ' ' HA2' ' A' ' 178' ' ' GLY . . . -80.09 -162.36 0.44 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.223 1.009 . . . . 0.0 111.401 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 205' ' ' ILE . . . -71.05 166.58 52.31 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 116.427 -0.351 . . . . 0.0 112.97 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -155.56 154.68 32.09 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 87.6 t -140.6 147.09 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -137.56 154.04 49.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.355 0.597 . . . . 0.0 111.846 -177.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -129.48 158.25 39.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.035 -173.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 34.3 m -84.58 -10.49 57.34 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.311 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -124.67 149.15 47.48 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.166 0.587 . . . . 0.0 111.03 -174.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -78.07 -16.33 58.12 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.92 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -80.87 -35.42 32.69 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 15.1 m -77.51 -26.89 51.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -64.59 -48.03 76.48 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.629 0.372 . . . . 0.0 110.481 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 35.5 pt -72.95 -24.49 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 CA-C-N 117.937 0.335 . . . . 0.0 111.039 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -73.62 -24.72 60.06 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.018 0.372 . . . . 0.0 110.804 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -83.74 -8.52 59.24 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.4 pt -120.0 19.42 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 123.035 0.534 . . . . 0.0 110.791 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 21.1 m -89.32 -11.51 43.2 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.899 0.48 . . . . 0.0 112.129 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -142.41 122.94 14.09 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -50.75 -41.14 56.33 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -115.44 107.29 15.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.098 0.408 . . . . 0.0 111.104 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 237' ' ' VAL . 10.6 m -67.24 151.21 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.418 172.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.461 ' C ' HD22 ' A' ' 239' ' ' LEU . 0.3 OUTLIER -100.23 139.93 35.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.276 0.56 . . . . 0.0 109.678 174.043 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.461 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.1 mm? -118.94 21.41 12.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.522 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -84.04 121.85 27.98 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.709 0.803 . . . . 0.0 112.041 -170.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -147.58 24.68 1.09 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.36 142.47 7.58 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 56.22 10.86 0.68 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.259 1.024 . . . . 0.0 112.85 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.7 mt -140.87 142.29 30.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 C-N-CA 123.742 0.817 . . . . 0.0 109.213 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -142.8 18.56 1.98 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.542 0.337 . . . . 0.0 111.343 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -55.36 151.36 10.07 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 124.2 1.0 . . . . 0.0 111.385 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.61 154.21 37.1 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.826 1.25 . . . . 0.0 108.975 176.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' VAL . . . . . 0.431 HG21 HG12 ' A' ' 177' ' ' VAL . 7.2 p -161.12 158.32 2.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -89.66 150.28 22.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.463 0.305 . . . . 0.0 111.739 -175.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.2 m -118.69 155.98 20.72 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-O 120.775 0.322 . . . . 0.0 111.683 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.45 157.56 30.18 Favored Pre-proline 0 CA--C 1.528 0.118 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.73 137.6 74.63 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.349 2.033 . . . . 0.0 108.578 173.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -72.08 120.81 18.21 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 119.04 -1.064 . . . . 0.0 112.009 -175.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.7 p 42.84 42.48 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 126.17 1.788 . . . . 0.0 113.403 172.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.418 ' C ' HD22 ' A' ' 255' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.098 -0.953 . . . . 0.0 112.085 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.505 ' C6 ' ' HE2' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.947 1 O4'-C1'-N19 112.788 4.588 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.837 2 O4'-C1'-N19 112.935 4.735 . 0.673 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.457 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.416 -3.111 1 O4'-C1'-N19 113.176 4.976 . 0.01 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.471 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.42 -2.777 0 O4'-C4'-C3' 109.619 2.942 . 0.073 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.552 H5'' ' C8 ' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -3.001 0 C3'-C2'-C1' 104.159 2.955 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 110.872 -0.047 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -133.19 4.79 3.77 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.896 0.479 . . . . 0.0 111.841 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 51.53 41.15 28.34 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.793 0.837 . . . . 0.0 111.954 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -66.39 -10.99 49.05 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 122.023 -0.423 . . . . 0.0 111.489 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.03 -9.65 86.79 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 119.58 -0.567 . . . . 0.0 111.739 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.556 ' HG2' ' H ' ' A' ' 59' ' ' ARG . 21.0 tt0 57.31 -175.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.261 1.024 . . . . 0.0 111.798 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.556 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 30.9 ttt180 -135.99 171.78 13.97 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.317 0.647 . . . . 0.0 109.752 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.493 ' H ' ' HG2' ' A' ' 59' ' ' ARG . 73.6 t -54.46 122.61 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 123.554 0.741 . . . . 0.0 110.125 177.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -160.36 149.55 17.32 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? 57.19 -80.66 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.439 1.496 . . . . 0.0 112.064 -173.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 53.85 172.16 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -175.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.3 t -107.46 21.47 17.42 Favored 'General case' 0 C--O 1.23 0.043 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.652 -173.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.484 ' HA ' ' CE1' ' A' ' 115' ' ' PHE . 96.4 mtt180 54.23 20.87 2.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.507 0.723 . . . . 0.0 112.784 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -145.96 146.87 31.19 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.074 0.549 . . . . 0.0 110.73 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -139.07 153.5 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.468 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 6.8 t80 -88.44 142.68 27.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 170.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.505 HG11 HD13 ' A' ' 113' ' ' LEU . 3.6 m -129.28 100.61 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.994 0.902 . . . . 0.0 109.017 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.26 -174.77 50.3 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.504 ' HA2' " H4'" ' B' ' 1' ' ' ' C' . . . 77.26 11.24 85.71 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.715 -0.491 . . . . 0.0 112.72 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.0 tp -67.87 127.04 93.33 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 118.112 0.956 . . . . 0.0 110.965 -177.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.31 163.25 30.34 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.581 2.854 . . . . 0.0 110.257 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -83.64 3.17 7.87 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.123 3.215 . . . . 0.0 113.666 -173.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -129.67 22.41 5.46 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -170.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.0 pt -124.2 171.08 13.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 118.791 0.723 . . . . 0.0 109.958 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -140.35 -173.88 3.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.128 0.49 . . . . 0.0 112.201 -173.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -51.33 -29.41 15.09 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.317 1.447 . . . . 0.0 113.091 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.78 -32.28 35.51 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.501 0.591 . . . . 0.0 111.585 -175.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -76.81 -39.25 52.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.374 0.131 . . . . 0.0 110.848 -173.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.417 ' H ' HG12 ' A' ' 81' ' ' ILE . 5.0 pt -83.95 -36.15 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 119.652 -0.213 . . . . 0.0 110.971 -177.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.8 m -65.54 -26.52 67.93 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.01 -22.58 31.29 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.647 -0.216 . . . . 0.0 111.408 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 m -78.58 -12.88 60.04 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.213 0.461 . . . . 0.0 112.099 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -118.45 4.44 11.78 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.175 0.443 . . . . 0.0 112.145 175.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 47.9 tpt85 -67.8 -18.55 64.89 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -72.05 -5.34 34.51 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.415 0.552 . . . . 0.0 112.398 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -106.67 6.3 29.65 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.449 0.3 . . . . 0.0 111.619 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.31 179.59 17.54 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.57 134.89 25.16 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.548 2.832 . . . . 0.0 110.662 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.0 pp -159.85 164.93 33.21 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.919 0.888 . . . . 0.0 109.753 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.4 mm -128.45 163.79 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.17 153.67 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -145.47 157.07 44.07 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.214 0.53 . . . . 0.0 111.049 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.454 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 44.8 p90 -156.5 158.77 31.57 Favored Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 169.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.48 ' HG3' " C1'" ' B' ' 4' ' ' ' U' . 38.4 Cg_endo -74.15 -10.62 22.79 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.389 2.726 . . . . 0.0 110.459 -169.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.454 ' ND1' ' HG2' ' A' ' 96' ' ' PRO . 31.9 m80 -103.88 10.4 36.4 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.157 0.983 . . . . 0.0 110.927 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.493 ' HA ' ' HE3' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -63.92 -24.2 67.64 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.866 0.866 . . . . 0.0 110.927 -178.748 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 49.34 -151.76 0.15 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.736 0.814 . . . . 0.0 111.473 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -77.37 39.88 0.27 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.642 0.777 . . . . 0.0 111.036 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.7 t 57.41 27.5 13.98 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.882 0.873 . . . . 0.0 111.775 -177.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -88.11 11.52 15.99 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.561 0.744 . . . . 0.0 112.095 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.2 t -130.05 143.75 50.96 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.074 0.55 . . . . 0.0 110.211 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -142.28 14.92 2.03 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.379 0.672 . . . . 0.0 111.107 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -151.9 71.99 7.95 Favored Pre-proline 0 CA--C 1.532 0.265 0 O-C-N 122.017 -0.427 . . . . 0.0 110.139 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.93 156.72 47.79 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.478 2.785 . . . . 0.0 111.352 -178.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -77.68 -173.47 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 124.409 3.406 . . . . 0.0 110.027 175.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -75.62 37.54 0.14 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.975 0.51 . . . . 0.0 111.524 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -70.94 8.17 4.84 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 123.714 0.673 . . . . 0.0 112.165 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.599 ' CE1' " H4'" ' B' ' 2' ' ' ' U' . 3.1 m-85 60.64 166.12 0.08 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.324 0.65 . . . . 0.0 111.757 -177.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.82 175.34 9.9 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 121.153 -0.967 . . . . 0.0 113.126 -171.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.417 ' CE1' ' C4 ' ' B' ' 4' ' ' ' U' . 0.7 OUTLIER -145.95 141.71 28.0 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.702 0.801 . . . . 0.0 109.504 -178.01 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.505 HD13 HG11 ' A' ' 69' ' ' VAL . 9.0 mp -98.94 144.89 27.61 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.23 139.15 52.35 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.484 ' CE1' ' HA ' ' A' ' 65' ' ' ARG . 8.1 p90 -152.19 177.4 10.57 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -117.69 -30.36 5.48 Favored 'General case' 0 CA--C 1.521 -0.148 0 O-C-N 122.188 -0.32 . . . . 0.0 110.88 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -93.31 124.72 37.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -69.15 -19.36 64.01 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.73 0.3 . . . . 0.0 110.324 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.9 m -77.02 -13.27 59.98 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.854 0.462 . . . . 0.0 111.245 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.3 t -75.53 -38.28 59.46 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.9 p -83.64 -21.54 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -67.08 -40.16 86.94 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.28 -37.99 60.62 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.64 -20.47 59.88 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.536 0.607 . . . . 0.0 111.708 -176.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.412 HD11 ' HG3' ' A' ' 153' ' ' PRO . 76.8 mt -92.07 -22.55 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 118.014 0.37 . . . . 0.0 111.437 176.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -91.24 -12.65 34.6 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.889 -0.507 . . . . 0.0 112.225 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -127.04 46.0 2.59 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.885 0.474 . . . . 0.0 111.458 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 27.6 p -139.42 -177.9 5.14 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.775 0.43 . . . . 0.0 111.57 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 129' ' ' ILE . 2.9 mp -81.8 159.86 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -139.9 160.52 39.73 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.819 -0.551 . . . . 0.0 112.324 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -143.56 176.69 9.01 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -61.34 3.34 0.12 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -171.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.6 1.89 0.06 OUTLIER Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.006 -0.885 . . . . 0.0 114.0 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -154.1 177.02 11.54 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.713 1.256 . . . . 0.0 110.642 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -116.34 163.33 16.18 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.449 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 6.3 m-85 -139.46 148.16 42.33 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.009 0.433 . . . . 0.0 112.008 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.6 mp -139.56 -171.02 3.05 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 172.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 72.1 m -133.61 162.51 31.73 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.82 0.736 . . . . 0.0 112.138 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.09 167.72 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.674 1.19 . . . . 0.0 109.403 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.7 m -119.47 11.92 12.26 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -170.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.518 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 6.1 t -141.68 32.6 0.16 Allowed Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 176.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 141' ' ' SER . 85.5 Cg_endo -71.28 172.16 14.62 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.631 2.888 . . . . 0.0 113.533 -174.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.9 t -79.89 -20.54 45.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.728 0.811 . . . . 0.0 112.727 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.8 mm -117.21 165.1 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -62.82 121.1 12.62 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 57.5 159.47 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.875 1.27 . . . . 0.0 112.582 -172.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.05 108.53 1.41 Allowed Pre-proline 0 CA--C 1.522 -0.129 0 O-C-N 121.679 -0.638 . . . . 0.0 110.66 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.449 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 58.9 Cg_endo -79.77 139.92 14.31 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.636 2.224 . . . . 0.0 108.506 169.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.6 m -124.3 144.85 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.046 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -85.38 158.74 20.17 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 43.4 mm -133.32 140.73 46.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.586 1.154 . . . . 0.0 108.943 172.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -154.92 91.84 2.91 Favored Pre-proline 0 CA--C 1.535 0.375 0 O-C-N 123.345 0.403 . . . . 0.0 110.244 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.412 ' HG3' HD11 ' A' ' 125' ' ' ILE . 36.7 Cg_exo -61.23 169.93 5.72 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 124.758 3.639 . . . . 0.0 114.853 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' TRP . . . . . 0.434 ' CD2' ' HG2' ' A' ' 214' ' ' PRO . 19.6 t-105 -113.73 141.5 47.18 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.786 174.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -118.22 153.22 34.25 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.703 0.801 . . . . 0.0 110.957 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.66 12.45 16.84 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -170.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.4 t -75.51 -24.0 56.79 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -173.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -143.97 29.55 1.34 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.499 0.59 . . . . 0.0 112.578 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 49.3 m -65.51 -22.24 66.7 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.848 -0.532 . . . . 0.0 112.122 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -153.66 157.42 39.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.782 0.433 . . . . 0.0 110.851 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -155.82 152.83 28.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.33 150.3 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 O-C-N 121.935 -0.478 . . . . 0.0 109.85 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 65.2 mtm -125.14 18.9 8.35 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.252 0.221 . . . . 0.0 111.568 -175.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -154.38 -48.52 0.09 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 67.97 11.09 60.27 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 119.115 -0.825 . . . . 0.0 114.296 172.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 61.3 p -141.08 -16.51 0.85 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -176.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -82.9 139.18 42.99 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 119.548 1.067 . . . . 0.0 110.926 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -62.92 156.18 55.81 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.675 2.917 . . . . 0.0 112.238 174.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.5 mp -120.32 162.23 19.8 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.519 0.728 . . . . 0.0 110.719 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -150.01 138.79 12.64 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.17 -11.24 31.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.26 2.64 . . . . 0.0 113.322 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.2 6.14 46.29 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.558 0.617 . . . . 0.0 110.174 175.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -128.28 25.08 5.85 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.93 0.492 . . . . 0.0 110.832 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.7 m -123.75 144.48 49.66 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.77 0.319 . . . . 0.0 110.549 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.5 tt -118.8 151.25 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 123.076 0.55 . . . . 0.0 110.726 -173.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.498 ' CZ ' ' N7 ' ' B' ' 5' ' ' ' A' . 7.8 t80 -109.61 143.43 39.34 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 172.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.1 m -139.72 134.39 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 122.974 0.509 . . . . 0.0 109.664 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -150.09 -177.74 24.36 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 -176.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.65 7.19 84.71 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.93 128.37 86.69 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -79.55 -34.5 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.842 2.361 . . . . 0.0 114.376 -172.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.641 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 71.4 ttp85 -160.92 -38.32 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 116.841 2.163 . . . . 0.0 116.841 -174.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.641 ' HD2' ' H ' ' A' ' 182' ' ' ARG . 84.8 Cg_endo -76.98 -45.76 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 121.609 1.61 . . . . 0.0 113.989 -169.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 30.2 -106.74 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.734 1.214 . . . . 0.0 112.858 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 64.47 136.39 0.02 OUTLIER 'General case' 0 C--N 1.343 0.284 0 C-N-CA 126.222 1.809 . . . . 0.0 112.488 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.15 -32.13 56.1 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.005 -0.434 . . . . 0.0 112.022 -175.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.44 -54.18 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-N 117.674 0.215 . . . . 0.0 111.155 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -75.4 -23.54 57.06 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.68 -173.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 51.8 tp -72.98 -30.49 63.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.02 -41.38 35.97 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 122.171 -0.331 . . . . 0.0 111.768 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 17.3 ptp -75.08 -26.48 59.37 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.217 -0.302 . . . . 0.0 110.713 -177.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.5 mt -72.04 -37.74 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.1 mmt -72.68 -15.75 61.69 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.969 -0.457 . . . . 0.0 110.076 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -89.65 -17.72 27.86 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.862 0.301 . . . . 0.0 110.95 175.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -88.83 -18.27 28.01 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 119.341 -0.362 . . . . 0.0 111.874 177.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.36 -24.86 8.22 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.284 0.493 . . . . 0.0 111.377 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -140.01 47.7 1.81 Allowed 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.794 0.438 . . . . 0.0 110.501 -175.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.13 136.12 4.33 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 123.276 0.465 . . . . 0.0 112.097 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 128.55 8.96 3.75 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -174.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' VAL . . . . . 0.414 HG22 ' CE2' ' A' ' 222' ' ' PHE . 53.9 t -66.08 147.94 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 123.65 0.78 . . . . 0.0 110.146 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.2 p -118.24 -37.45 3.35 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 119.504 -0.284 . . . . 0.0 111.49 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -157.43 153.06 26.56 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.775 0.261 . . . . 0.0 110.936 -172.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -147.99 162.04 40.14 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.308 0.575 . . . . 0.0 111.839 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 178.0 -178.36 48.49 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 8.5 tp -87.73 155.59 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ASP . . . . . 0.446 ' HA ' ' CZ ' ' A' ' 219' ' ' ARG . 15.0 p-10 -70.76 38.68 0.05 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.2 t -74.2 152.4 39.78 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.105 -0.372 . . . . 0.0 110.325 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -134.18 146.23 58.81 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 122.604 0.362 . . . . 0.0 110.31 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.01 -7.43 18.23 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 124.533 3.489 . . . . 0.0 111.989 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.24 40.55 0.49 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.952 0.501 . . . . 0.0 110.347 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 51.68 21.94 1.49 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.263 1.825 . . . . 0.0 114.316 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -86.74 -24.15 25.23 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 119.24 -0.41 . . . . 0.0 110.261 174.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.52 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 37.6 m-85 56.28 -169.6 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.624 -0.703 . . . . 0.0 109.811 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.52 ' CD ' ' HB3' ' A' ' 213' ' ' TYR . 52.0 Cg_exo -56.15 151.2 44.35 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.063 1.842 . . . . 0.0 113.102 -177.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -120.9 25.1 9.87 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.739 0.415 . . . . 0.0 110.485 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.66 12.28 73.83 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.28 -0.733 . . . . 0.0 114.152 171.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -132.2 155.03 48.97 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.236 1.018 . . . . 0.0 110.64 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -97.68 160.23 21.04 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 121.45 0.472 . . . . 0.0 112.998 -173.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ARG . . . . . 0.446 ' CZ ' ' HA ' ' A' ' 206' ' ' ASP . 4.0 ptp85 -142.83 147.31 35.22 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 172.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 3.5 p -150.08 150.42 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.25 150.62 43.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.535 0.734 . . . . 0.0 111.175 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.414 ' CE2' HG22 ' A' ' 200' ' ' VAL . 74.8 m-85 -125.96 149.26 48.91 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.47 0.708 . . . . 0.0 110.816 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 69.1 m -82.05 -0.52 44.78 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 122.257 0.223 . . . . 0.0 110.879 173.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -132.68 133.66 43.82 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.01 0.524 . . . . 0.0 109.943 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -73.34 -21.95 60.42 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -70.42 -38.8 74.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.6 m -76.66 -25.05 53.3 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.239 -0.288 . . . . 0.0 110.239 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -69.21 -51.24 39.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 41.9 pt -69.48 -17.33 21.43 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 118.095 0.407 . . . . 0.0 110.969 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.04 -28.48 39.3 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.48 -17.06 49.99 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 13.5 pt -113.92 24.54 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 123.331 0.653 . . . . 0.0 110.329 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -81.0 -9.89 59.78 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.268 0.627 . . . . 0.0 111.669 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.45 141.78 20.6 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -56.23 -35.47 67.4 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.283 0.233 . . . . 0.0 111.403 -177.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -126.15 114.66 18.65 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.08 0.467 . . . . 0.0 110.306 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 28.7 m -97.81 161.22 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.888 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' GLN . . . . . 0.499 ' CD ' ' H ' ' A' ' 238' ' ' GLN . 0.1 OUTLIER -87.19 142.23 28.06 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.028 0.442 . . . . 0.0 109.833 176.39 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.432 HD12 ' C ' ' A' ' 238' ' ' GLN . 7.2 mp -117.47 19.2 14.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.667 0.746 . . . . 0.0 109.62 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -55.13 138.83 43.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.243 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -146.09 18.25 1.4 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.472 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 88.08 -9.53 74.41 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 123.703 0.668 . . . . 0.0 111.817 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -141.74 10.31 2.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.64 0.776 . . . . 0.0 110.884 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 35.5 mm -133.54 153.9 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.587 0.755 . . . . 0.0 109.71 -174.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -146.96 12.44 1.1 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.695 0.398 . . . . 0.0 111.019 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -80.11 173.51 12.52 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 123.579 0.752 . . . . 0.0 112.191 -172.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.6 163.01 31.56 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.818 1.247 . . . . 0.0 109.565 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 5.7 p -149.07 150.42 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -85.51 132.46 34.19 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -117.32 155.19 19.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -175.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -157.73 160.31 30.15 Favored Pre-proline 0 C--O 1.232 0.142 0 CA-C-O 119.548 -0.263 . . . . 0.0 110.548 168.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.48 124.8 14.88 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.244 1.962 . . . . 0.0 107.323 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -66.16 117.96 9.21 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.911 -169.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.7 p 45.76 29.01 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.914 1.686 . . . . 0.0 113.292 174.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 1.9 tm? . . . . . 0 C--O 1.252 1.187 0 CA-C-O 117.726 -1.131 . . . . 0.0 109.656 -179.901 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' ' C' . . . . . 0.504 " H4'" ' HA2' ' A' ' 71' ' ' GLY . . . . . . . . 0 O4'--C4' 1.419 -2.802 1 O4'-C1'-N19 113.572 5.372 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ' U' . . . . . 0.599 " H4'" ' CE1' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.415 -3.205 1 C3'-C2'-C1' 105.818 4.798 OUTLIER-DELTA 0.058 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.513 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.41 -3.557 3 O4'-C1'-N19 113.548 5.348 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ' U' . . . . . 0.48 " C1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.418 -2.909 0 O4'-C4'-C3' 109.695 2.996 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ' A' . . . . . 0.498 ' N7 ' ' CZ ' ' A' ' 176' ' ' PHE . . . . . . . . 0 O4'--C4' 1.415 -3.147 0 P-O3'-C3' 123.336 3.03 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.176 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -158.61 164.88 35.61 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 121.156 0.503 . . . . 0.0 110.543 -173.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.7 t -88.7 165.6 14.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.195 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.33 10.95 6.02 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.824 176.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -128.15 141.53 51.45 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 124.148 0.979 . . . . 0.0 109.977 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.63 134.58 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.613 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -79.63 140.68 37.03 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 3.3 m -127.63 114.48 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 173.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.9 163.12 25.55 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.368 -172.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.65 22.24 76.63 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 119.174 -0.792 . . . . 0.0 113.42 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.0 tp -47.11 123.38 8.14 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 118.629 1.214 . . . . 0.0 107.846 173.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.67 157.53 39.94 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.705 2.27 . . . . 0.0 111.823 -172.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.34 173.39 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.42 3.414 . . . . 0.0 112.873 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.9 t70 64.88 -78.94 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.6 pt -61.7 162.01 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 118.683 0.674 . . . . 0.0 111.699 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -143.54 -156.01 0.65 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.38 -174.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -43.09 -32.68 0.73 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.642 1.977 . . . . 0.0 114.847 -173.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -78.6 -34.74 46.54 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.615 1.098 . . . . 0.0 112.139 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -77.52 -27.92 51.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.149 -0.345 . . . . 0.0 110.51 -174.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 25.9 pt -84.26 -27.03 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 O-C-N 122.067 -0.396 . . . . 0.0 110.398 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.4 m -73.22 -12.97 61.05 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.16 -17.42 17.41 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.0 m -82.78 -42.51 17.85 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.93 0.787 . . . . 0.0 112.237 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -90.01 1.61 56.11 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -68.38 -14.64 63.14 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.838 0.455 . . . . 0.0 111.953 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -69.8 -10.0 56.76 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.014 0.525 . . . . 0.0 111.555 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -112.89 17.24 19.11 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.832 0.453 . . . . 0.0 110.46 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.54 167.89 21.03 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.78 146.45 72.51 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.448 2.765 . . . . 0.0 110.507 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.5 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -149.94 166.67 28.91 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.0 0.429 . . . . 0.0 111.646 -178.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.9 pt -135.14 166.63 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.201 175.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.66 148.39 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 CA-C-O 120.722 0.296 . . . . 0.0 110.484 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -150.32 165.02 34.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.935 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.524 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 42.1 p90 -154.76 164.05 22.29 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.631 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 43.3 Cg_endo -73.04 -13.58 26.16 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 123.117 2.545 . . . . 0.0 110.927 -169.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.631 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 63.7 m-70 -101.75 7.48 41.85 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.763 0.825 . . . . 0.0 111.102 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.9 tptt -62.23 148.5 44.58 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.945 0.498 . . . . 0.0 110.395 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.291 0 C-N-CA 123.08 0.552 . . . . 0.0 111.117 -177.972 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.619 0 CA-C-O 119.53 -0.594 . . . . 0.0 113.7 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.76 147.59 31.08 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.168 0.984 . . . . 0.0 109.254 172.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.89 175.91 11.59 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 122.61 0.364 . . . . 0.0 110.931 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -136.1 129.39 31.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -90.32 149.18 22.43 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.549 0.69 . . . . 0.0 111.785 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.82 145.58 41.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.158 -1.383 . . . . 0.0 107.297 171.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -134.11 165.88 24.05 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 110.956 -176.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -105.03 -31.48 9.17 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.236 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -121.24 150.48 41.29 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.862 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -87.32 -5.83 58.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.322 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.2 p -93.72 -15.19 25.48 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.665 0.386 . . . . 0.0 111.437 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 75.3 m -73.19 -36.12 66.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 122.019 -0.426 . . . . 0.0 110.769 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.01 -20.43 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -77.42 -38.54 49.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.0 -35.97 66.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.257 0.48 . . . . 0.0 111.584 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -78.84 -15.59 58.18 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.199 0.454 . . . . 0.0 111.705 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.5 mt -99.33 -15.44 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 122.354 0.262 . . . . 0.0 111.209 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -103.34 -9.31 19.58 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.593 -0.692 . . . . 0.0 112.641 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -115.99 29.9 7.69 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.848 0.459 . . . . 0.0 111.96 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 32.0 p -140.48 -176.26 4.57 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.774 0.43 . . . . 0.0 111.659 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 32.2 mm -79.14 156.05 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 124.629 1.172 . . . . 0.0 109.007 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -138.84 155.5 48.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 111.972 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -144.15 70.77 1.3 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.374 0.607 . . . . 0.0 110.066 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 p30 47.44 12.92 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.72 2.008 . . . . 0.0 116.228 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 175.5 -20.47 0.05 OUTLIER Glycine 0 CA--C 1.526 0.779 0 CA-C-N 118.578 0.626 . . . . 0.0 112.446 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -134.63 170.96 15.02 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 117.759 0.779 . . . . 0.0 109.555 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 150' ' ' GLN . 4.6 mp -130.63 173.33 11.0 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.897 -176.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -139.75 147.69 41.21 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.2 mp -133.84 164.0 28.24 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 170.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.7 m -101.98 150.49 23.17 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.205 0.602 . . . . 0.0 110.659 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.6 m -142.6 -4.76 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.3 m 48.53 43.94 20.45 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.515 0.726 . . . . 0.0 112.842 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.6 p -73.55 153.62 89.71 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.71 8.95 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.635 1 C-N-CA 125.58 4.186 . . . . 0.0 117.296 -175.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.0 m -96.28 -18.42 20.02 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.677 1.126 . . . . 0.0 110.069 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.533 ' N ' HD12 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -165.62 -172.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.342 1.457 . . . . 0.0 108.405 -171.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -69.5 -32.79 71.87 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.019 -0.426 . . . . 0.0 109.984 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.49 ' C ' HD13 ' A' ' 144' ' ' ILE . 24.3 t70 -162.95 153.15 16.17 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.266 0.626 . . . . 0.0 111.0 176.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.19 106.87 48.48 Favored Pre-proline 0 N--CA 1.457 -0.107 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 174.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -63.46 91.92 0.16 Allowed 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.866 2.378 . . . . 0.0 109.026 168.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.8 m -80.2 141.75 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.428 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 72.2 mt-30 -93.18 159.71 15.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.647 -177.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 50.0 mm -129.88 141.44 46.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.115 0.966 . . . . 0.0 109.761 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.29 101.62 1.54 Allowed Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.67 164.16 30.68 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.971 3.114 . . . . 0.0 111.91 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -88.08 148.7 24.35 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -109.28 150.31 28.15 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.851 0.46 . . . . 0.0 111.247 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.5 mp -96.74 78.1 2.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.128 0.571 . . . . 0.0 110.461 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.9 t -155.11 -32.66 0.1 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -134.56 28.06 3.66 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.2 m -60.71 -31.59 70.87 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.167 -0.333 . . . . 0.0 111.679 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -158.3 163.05 37.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.922 0.489 . . . . 0.0 110.877 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -156.1 156.61 34.6 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.494 0.318 . . . . 0.0 110.539 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.2 m -137.53 152.42 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 C-N-CA 123.273 0.629 . . . . 0.0 110.14 175.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 18.2 ttp -130.13 14.68 5.69 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.224 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -148.57 -170.95 3.74 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -73.02 25.77 0.8 Allowed Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.682 0.658 . . . . 0.0 112.949 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 44.7 m 53.67 52.17 13.69 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 117.945 0.873 . . . . 0.0 111.645 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -59.3 156.55 28.83 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 122.963 0.505 . . . . 0.0 110.349 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.15 140.64 60.52 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.179 2.586 . . . . 0.0 111.758 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 74.9 mt -114.38 153.61 29.54 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.777 0.431 . . . . 0.0 110.549 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -145.37 156.03 53.73 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.77 -5.76 17.57 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.033 2.488 . . . . 0.0 111.011 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -98.76 4.44 47.73 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.522 1.129 . . . . 0.0 111.455 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -129.01 16.6 6.22 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 122.693 0.397 . . . . 0.0 111.577 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 25.7 m -127.69 140.75 51.88 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.027 0.441 . . . . 0.0 112.018 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.9 tt -116.98 149.43 19.23 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.293 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -107.24 150.32 26.78 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 97.4 t -135.52 124.57 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 123.489 0.715 . . . . 0.0 109.278 -175.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -141.23 166.1 26.14 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 120.983 0.213 . . . . 0.0 112.585 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.6 17.79 61.35 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -170.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.0 m -72.19 154.85 92.08 Favored Pre-proline 0 CA--C 1.529 0.155 0 C-N-CA 122.965 0.506 . . . . 0.0 112.332 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.09 177.8 7.75 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.945 3.097 . . . . 0.0 108.963 169.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -66.39 -52.96 33.62 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.449 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.1 149.68 19.98 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.522 2.148 . . . . 0.0 111.069 175.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 43.1 mt -146.94 -43.54 0.18 Allowed 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 122.883 0.473 . . . . 0.0 110.964 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 52.76 102.71 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.43 1.492 . . . . 0.0 111.662 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -56.32 -24.28 42.62 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 30.9 t -63.27 -49.75 81.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 CA-C-N 117.979 0.354 . . . . 0.0 110.636 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -82.82 -21.12 34.57 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.814 -0.176 . . . . 0.0 110.773 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 40.7 tp -67.22 -37.31 83.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.68 -33.11 47.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.817 -0.135 . . . . 0.0 111.147 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.0 mmt -69.05 -37.17 78.42 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 117.873 0.306 . . . . 0.0 110.293 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.475 ' CG2' ' HA ' ' A' ' 239' ' ' LEU . 46.5 mt -69.6 -48.47 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 122.186 0.195 . . . . 0.0 110.535 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -58.94 -22.29 59.7 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.045 0.384 . . . . 0.0 111.453 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -84.18 -20.72 31.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.595 0.634 . . . . 0.0 111.546 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -89.32 -16.04 32.01 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 119.287 -0.387 . . . . 0.0 111.733 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -113.53 -18.36 11.97 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.36 0.527 . . . . 0.0 112.309 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -138.97 -30.37 0.74 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.851 0.75 . . . . 0.0 112.782 -177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.16 -177.92 18.57 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 68.99 11.66 63.81 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.586 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 15.6 t -69.09 149.11 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 118.323 1.061 . . . . 0.0 110.282 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 48.5 t -131.65 -35.3 1.29 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.163 0.185 . . . . 0.0 111.31 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -148.31 149.33 31.64 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.22 156.2 38.06 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.135 0.574 . . . . 0.0 109.803 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 169.39 -175.8 43.56 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.9 143.33 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -54.54 133.95 46.3 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.903 -0.135 . . . . 0.0 111.13 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 22.2 p -141.36 167.55 21.89 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 122.739 0.416 . . . . 0.0 110.363 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -129.34 131.51 23.69 Favored Pre-proline 0 N--CA 1.453 -0.299 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -80.19 -12.73 12.87 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.917 3.745 . . . . 0.0 113.728 -174.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -97.23 -27.06 14.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.701 0.682 . . . . 0.0 110.672 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 94.1 mt -108.75 -0.39 20.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.267 0.627 . . . . 0.0 110.534 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 46.59 48.41 14.24 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.707 1.203 . . . . 0.0 112.496 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.03 153.98 50.07 Favored Pre-proline 0 CA--C 1.53 0.182 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -176.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.85 153.92 29.71 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.78 2.32 . . . . 0.0 110.754 173.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -117.58 25.05 10.68 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.566 0.746 . . . . 0.0 110.563 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 68.01 -170.71 36.67 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -176.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 52.38 -166.51 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 117.521 0.661 . . . . 0.0 110.96 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -155.82 173.47 33.85 Favored Glycine 0 C--N 1.333 0.397 0 O-C-N 121.146 -0.972 . . . . 0.0 112.281 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -142.44 155.13 45.06 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 66.7 t -139.12 143.14 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.44 150.51 49.61 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.908 0.385 . . . . 0.0 110.197 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -125.81 152.72 45.06 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.899 -174.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 68.7 p -86.05 4.69 36.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.258 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -138.14 141.24 40.15 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.108 0.563 . . . . 0.0 110.448 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -75.13 -13.16 60.44 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.757 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -81.59 -37.48 27.59 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 20.0 m -75.58 -27.1 58.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -66.88 -51.8 51.08 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.448 -0.205 . . . . 0.0 110.448 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.0 pt -69.98 -15.67 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-N 118.002 0.365 . . . . 0.0 111.038 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.97 -23.91 35.8 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.786 0.267 . . . . 0.0 110.686 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -84.34 -31.34 24.87 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.705 0.229 . . . . 0.0 111.579 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.5 pt -98.77 24.57 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 122.621 0.368 . . . . 0.0 110.236 174.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.9 t -77.94 -17.7 56.92 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.024 0.53 . . . . 0.0 111.547 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.06 143.58 22.62 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -54.69 -32.29 59.17 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 122.716 0.406 . . . . 0.0 111.781 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -118.01 108.55 15.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.914 0.388 . . . . 0.0 110.195 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.53 HG23 HD21 ' A' ' 239' ' ' LEU . 2.4 m -78.03 161.3 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.599 176.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.61 ' C ' HD22 ' A' ' 239' ' ' LEU . 7.4 mp0 -93.55 135.77 34.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.61 HD22 ' C ' ' A' ' 238' ' ' GLN . 2.7 mm? -123.3 28.03 7.26 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.795 0.331 . . . . 0.0 110.72 -175.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -76.5 147.37 37.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.643 0.377 . . . . 0.0 110.964 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -149.49 16.89 0.91 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.652 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 83.94 125.72 1.22 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -173.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 53.49 15.74 0.78 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.196 0.998 . . . . 0.0 113.128 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 73.6 mt -140.7 148.67 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.987 0.915 . . . . 0.0 109.241 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -158.8 134.42 8.73 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -144.91 166.19 25.98 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 124.492 1.117 . . . . 0.0 108.34 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.75 150.92 33.94 Favored 'General case' 0 CA--C 1.523 -0.061 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.5 p -158.97 157.13 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -82.81 145.16 29.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.088 0.555 . . . . 0.0 110.835 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.11 161.37 29.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 112.503 0.556 . . . . 0.0 112.503 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.57 159.29 25.83 Favored Pre-proline 0 N--CA 1.455 -0.176 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.911 170.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.09 135.98 73.89 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.559 2.173 . . . . 0.0 109.038 173.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -69.89 146.38 51.3 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.964 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.451 -0.382 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.922 -176.265 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.4 ppt_? . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 110.692 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -155.48 169.23 24.74 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.092 -171.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.6 t -89.73 19.97 4.37 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 54.13 18.94 1.92 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.578 0.751 . . . . 0.0 112.256 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -145.38 146.27 31.5 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.151 0.58 . . . . 0.0 109.866 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.36 142.05 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.208 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -90.26 139.35 30.74 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.462 HG12 ' CD1' ' A' ' 151' ' ' ILE . 5.5 m -125.72 99.04 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 122.033 0.92 . . . . 0.0 108.765 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.03 164.59 31.21 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.529 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.47 24.09 77.27 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 122.618 -0.342 . . . . 0.0 112.649 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.1 tp -60.41 128.67 88.31 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 69.4 Cg_endo -69.72 131.02 20.42 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.886 1.724 . . . . 0.0 110.015 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 35.9 Cg_exo -64.45 -8.48 17.15 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.735 2.957 . . . . 0.0 114.627 -176.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -88.07 -0.65 57.31 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -173.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.404 HD12 ' C ' ' A' ' 76' ' ' ILE . 2.1 pp -136.67 -173.29 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.091 0 CA-C-N 118.636 0.653 . . . . 0.0 111.014 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -139.73 -166.78 2.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.541 0.736 . . . . 0.0 111.004 -175.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -45.93 -31.42 2.18 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.462 1.505 . . . . 0.0 113.213 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -65.94 -36.6 83.79 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -73.48 -38.17 65.51 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 122.095 -0.378 . . . . 0.0 110.403 -172.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.5 pt -84.05 -27.46 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 O-C-N 122.101 -0.374 . . . . 0.0 111.436 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 90.9 m -69.97 -16.41 63.19 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.14 -19.43 18.66 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.0 m -79.46 -26.68 41.68 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.902 0.774 . . . . 0.0 112.962 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -113.26 10.16 18.46 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.134 0.424 . . . . 0.0 111.743 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -68.9 -19.89 64.23 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 122.827 0.451 . . . . 0.0 111.762 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -72.18 -12.1 61.03 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.526 0.33 . . . . 0.0 111.102 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -105.2 20.5 18.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.744 0.418 . . . . 0.0 110.283 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.34 170.71 31.99 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.78 144.57 59.87 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.211 2.607 . . . . 0.0 110.425 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.511 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -149.61 168.33 23.86 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.862 0.363 . . . . 0.0 111.256 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.2 pt -140.53 166.49 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.46 149.73 24.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 121.147 0.498 . . . . 0.0 110.717 -176.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -147.18 163.32 36.71 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.222 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.409 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 28.8 p90 -158.62 161.75 27.85 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 174.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.563 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 32.8 Cg_endo -74.34 -9.59 21.8 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.5 2.134 . . . . 0.0 110.568 -170.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.563 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 8.2 m-70 -100.79 17.82 21.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.52 1.128 . . . . 0.0 110.98 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -50.15 146.1 5.29 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.322 0.649 . . . . 0.0 112.625 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.367 0 C-N-CA 124.495 1.118 . . . . 0.0 110.814 -177.164 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.66 0 N-CA-C 112.154 -0.379 . . . . 0.0 112.154 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -141.42 145.66 35.59 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 117.799 0.799 . . . . 0.0 108.884 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.06 176.79 10.81 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.598 0.359 . . . . 0.0 110.875 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -139.54 126.97 21.5 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.5 mp -89.58 151.04 22.13 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.32 0.581 . . . . 0.0 111.524 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 mp -114.11 139.59 49.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -136.78 175.62 9.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.508 0.723 . . . . 0.0 109.946 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -115.95 -23.43 8.56 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 122.92 0.488 . . . . 0.0 111.783 -175.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -141.49 160.88 39.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.868 0.366 . . . . 0.0 111.228 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -82.14 -14.61 55.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.271 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 41.4 m -79.02 -16.96 56.14 Favored 'General case' 0 C--O 1.231 0.093 0 O-C-N 122.277 -0.265 . . . . 0.0 111.112 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 73.1 m -79.62 -42.73 24.28 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.331 -0.23 . . . . 0.0 110.599 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.96 -22.34 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -75.89 -33.63 59.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.87 -36.9 59.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 117.967 0.349 . . . . 0.0 111.086 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 pp -78.86 -14.6 59.15 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 117.993 0.36 . . . . 0.0 111.43 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.8 mt -98.76 -17.16 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 122.328 0.251 . . . . 0.0 111.43 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -100.55 -10.78 20.68 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.879 -0.513 . . . . 0.0 112.131 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -120.22 30.25 7.08 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.053 0.541 . . . . 0.0 111.719 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 23.4 p -127.55 -174.83 3.28 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.241 0.616 . . . . 0.0 111.216 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 43.2 mm -87.76 161.31 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.023 0.929 . . . . 0.0 109.074 -176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -127.14 154.25 44.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.611 0.243 . . . . 0.0 110.769 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -141.45 66.21 1.36 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.271 0.558 . . . . 0.0 110.402 176.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 52.31 9.57 0.1 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 172.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 171.11 -16.36 0.06 OUTLIER Glycine 0 CA--C 1.528 0.847 0 CA-C-N 118.59 0.632 . . . . 0.0 112.485 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -128.27 172.16 11.3 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-N 117.663 0.731 . . . . 0.0 109.726 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.8 161.63 15.25 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.343 0.257 . . . . 0.0 110.308 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.413 ' CE1' ' HG2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -139.86 150.64 44.88 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.087 0.555 . . . . 0.0 109.784 -178.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.8 tp -138.82 151.26 46.88 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 169.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 44.0 t -84.7 152.7 23.56 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -127.71 161.31 35.77 Favored 'Isoleucine or valine' 0 C--N 1.337 0.056 0 C-N-CA 122.972 0.509 . . . . 0.0 110.099 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 52.9 m -92.25 -13.94 29.68 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.3 m -142.9 65.25 15.78 Favored Pre-proline 0 CA--C 1.53 0.18 0 C-N-CA 123.073 0.549 . . . . 0.0 109.968 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -68.95 168.96 18.97 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.682 3.588 . . . . 0.0 111.849 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.422 ' HB ' ' CB ' ' A' ' 73' ' ' PRO . 13.4 t -84.31 160.31 20.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 174.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.9 mt 57.17 -108.49 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -148.85 132.24 16.6 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.465 0.706 . . . . 0.0 109.135 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.4 t0 41.79 78.78 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.754 1.222 . . . . 0.0 112.064 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 108.81 20.4 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 119.568 -0.253 . . . . 0.0 110.711 -174.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.413 ' HG2' ' CE1' ' A' ' 136' ' ' TYR . 91.1 Cg_endo -71.59 165.31 32.91 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.399 3.4 . . . . 0.0 112.348 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.4 p -114.92 140.38 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.0 tm0? -94.94 151.89 18.81 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.483 0.713 . . . . 0.0 110.913 -174.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.462 ' CD1' HG12 ' A' ' 69' ' ' VAL . 32.4 mm -134.87 142.02 41.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 C-N-CA 123.408 0.683 . . . . 0.0 111.147 -177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -156.76 113.92 2.01 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 169.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -77.39 171.44 17.65 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 124.44 3.427 . . . . 0.0 112.464 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 -100.18 140.22 34.72 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -107.84 152.43 24.41 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.481 0.657 . . . . 0.0 111.663 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.7 mp -87.57 65.01 8.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.423 0.689 . . . . 0.0 110.544 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.4 t -133.76 -25.23 1.67 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.692 0.397 . . . . 0.0 111.151 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -153.81 138.3 16.8 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 67.2 m -157.79 -45.43 0.06 Allowed 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 117.907 0.321 . . . . 0.0 110.405 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -160.63 163.44 32.57 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.934 0.493 . . . . 0.0 110.617 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -157.37 160.24 38.25 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.2 m -138.69 150.39 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.559 0.744 . . . . 0.0 110.136 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 52.7 mtm -132.29 29.96 4.25 Favored 'General case' 0 C--N 1.335 -0.055 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.925 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -151.71 162.34 41.18 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -77.96 29.85 1.83 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 123.563 0.602 . . . . 0.0 112.141 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 m 57.42 52.1 9.03 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -61.92 163.51 12.86 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -47.03 128.05 13.32 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.171 2.58 . . . . 0.0 111.512 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.0 tp -136.45 136.41 39.47 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.648 0.779 . . . . 0.0 110.153 -172.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -150.95 159.99 32.9 Favored Pre-proline 0 N--CA 1.455 -0.215 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.88 -14.72 14.74 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.531 2.821 . . . . 0.0 113.151 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -79.74 -6.62 57.61 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.831 0.452 . . . . 0.0 111.286 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -126.75 23.23 6.74 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 122.744 0.417 . . . . 0.0 110.457 175.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 27.7 m -122.08 148.77 44.45 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.922 0.392 . . . . 0.0 111.075 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.27 147.86 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 123.306 0.643 . . . . 0.0 109.416 -176.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -112.32 154.34 25.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 10.9 m -140.14 146.16 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.077 0.551 . . . . 0.0 110.515 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -150.71 170.79 30.54 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.04 12.42 84.4 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . 10.7 p -87.76 146.27 38.67 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 122.71 0.404 . . . . 0.0 111.009 -176.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 180' ' ' VAL . 53.1 Cg_exo -55.64 161.91 7.21 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.247 2.632 . . . . 0.0 111.734 171.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -47.52 78.74 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.511 -0.757 . . . . 0.0 112.474 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.47 60.29 7.75 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.061 2.507 . . . . 0.0 111.429 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.408 HD12 ' C ' ' A' ' 184' ' ' LEU . 4.1 pp -74.02 -10.91 60.11 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.981 -0.449 . . . . 0.0 111.972 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.15 80.48 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.489 1.516 . . . . 0.0 112.242 172.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.39 -28.85 46.33 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -171.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.87 -44.37 88.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.068 0 CA-C-N 118.774 0.715 . . . . 0.0 110.167 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -85.86 -18.23 33.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.056 -175.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 29.9 tp -73.26 -30.31 63.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.85 -35.38 57.55 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.7 mmt -67.97 -33.5 74.77 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.425 ' CG2' ' HA ' ' A' ' 239' ' ' LEU . 34.8 mt -71.55 -46.99 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 122.613 0.365 . . . . 0.0 110.704 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -61.27 -23.18 65.49 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.31 0.505 . . . . 0.0 110.699 174.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -82.69 -18.65 40.17 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.969 -0.457 . . . . 0.0 111.272 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -93.4 -11.94 31.03 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 119.114 -0.47 . . . . 0.0 111.963 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -114.6 -20.75 10.59 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 118.673 0.669 . . . . 0.0 111.972 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -137.06 -33.6 0.75 Allowed 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.519 0.6 . . . . 0.0 112.578 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 68.08 179.1 15.97 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 70.82 13.89 72.46 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.428 -0.651 . . . . 0.0 113.133 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.41 HG22 ' CE2' ' A' ' 222' ' ' PHE . 22.6 t -68.78 140.66 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 118.269 1.034 . . . . 0.0 109.944 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.5 p -120.84 -30.13 4.5 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -153.39 149.37 27.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.639 0.256 . . . . 0.0 110.671 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -157.12 158.12 35.78 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.305 0.642 . . . . 0.0 109.739 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 157.41 -172.52 34.81 Favored Glycine 0 C--N 1.335 0.528 0 N-CA-C 111.974 -0.45 . . . . 0.0 111.974 177.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 205' ' ' ILE . 4.2 mp -88.01 140.15 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 174.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -53.67 106.01 0.16 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 14.4 t -152.56 146.27 25.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.238 0.542 . . . . 0.0 112.233 -175.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -152.79 135.44 9.26 Favored Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 170.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -75.89 3.09 6.37 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.022 3.148 . . . . 0.0 111.413 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -77.83 -45.73 23.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.5 pp -161.26 6.59 0.07 Allowed 'General case' 0 C--N 1.341 0.21 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -138.05 -29.77 0.82 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.501 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 34.3 m-85 54.18 -166.77 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.596 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.501 ' CD ' ' HB3' ' A' ' 213' ' ' TYR . 91.8 Cg_endo -75.19 144.35 29.52 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 CA-C-N 121.935 1.727 . . . . 0.0 112.778 -170.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -90.26 -168.76 2.2 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.583 0.753 . . . . 0.0 110.064 175.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -96.35 5.24 65.07 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -137.38 150.49 47.73 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.205 0.602 . . . . 0.0 110.85 -175.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -104.35 173.4 21.25 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.971 -173.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -148.31 153.51 38.75 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 88.7 t -138.25 148.85 24.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -136.65 156.87 47.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.422 0.63 . . . . 0.0 111.381 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.41 ' CE2' HG22 ' A' ' 200' ' ' VAL . 81.5 m-85 -132.25 153.23 50.85 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.561 -175.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.1 p -84.63 0.48 50.04 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.956 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -132.83 141.18 48.32 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.068 0.547 . . . . 0.0 110.362 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.3 pm0 -74.41 -7.27 52.36 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.369 0.268 . . . . 0.0 111.268 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -83.52 -40.62 18.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 25.5 m -75.51 -24.98 56.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -63.91 -50.75 67.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -73.71 -11.78 14.91 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 CA-C-N 118.09 0.405 . . . . 0.0 111.144 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.43 -17.05 33.13 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.588 0.176 . . . . 0.0 111.149 174.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.76 -12.34 29.36 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 11.3 pt -120.39 23.25 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.354 0.662 . . . . 0.0 110.313 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.2 p -76.79 -19.03 58.05 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.23 0.612 . . . . 0.0 111.721 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.3 144.33 22.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -57.61 -31.61 66.4 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -122.94 110.14 15.01 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.466 HG23 HD21 ' A' ' 239' ' ' LEU . 4.0 m -82.36 154.89 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.205 175.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.533 ' C ' HD22 ' A' ' 239' ' ' LEU . 24.8 mm100 -84.07 138.45 33.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 173.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.533 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.1 mm? -120.88 36.77 4.49 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -81.63 147.29 29.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.945 0.402 . . . . 0.0 111.887 -173.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -136.48 16.33 3.16 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.27 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 85.55 -15.36 46.7 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.006 0.813 . . . . 0.0 112.523 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -140.68 1.83 1.75 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.707 0.753 . . . . 0.0 110.786 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.6 mt -141.18 153.45 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 123.751 0.82 . . . . 0.0 109.335 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -148.02 135.3 20.49 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -145.34 169.38 18.39 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 125.023 1.329 . . . . 0.0 108.415 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . 0.456 ' HA ' HD23 ' A' ' 239' ' ' LEU . 0.1 OUTLIER -150.15 151.65 33.46 Favored 'General case' 0 CA--C 1.523 -0.059 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.47 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 11.4 p -155.17 153.73 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -83.35 124.09 30.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.5 m -102.98 159.0 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.67 159.01 27.91 Favored Pre-proline 0 CA--C 1.528 0.113 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.665 169.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.33 142.72 94.95 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.769 2.312 . . . . 0.0 110.124 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -83.83 166.79 17.65 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.997 0.427 . . . . 0.0 110.641 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 N--CA 1.454 -0.262 0 C-N-CA 123.282 0.633 . . . . 0.0 110.142 -170.894 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.431 ' HG3' ' H ' ' A' ' 63' ' ' TYR . 12.9 tpt180 . . . . . 0 CA--C 1.531 0.246 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.431 ' H ' ' HG3' ' A' ' 62' ' ' ARG . 15.6 m-85 -132.66 148.95 52.35 Favored 'General case' 0 N--CA 1.458 -0.044 0 CA-C-O 120.743 0.306 . . . . 0.0 111.106 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.2 m -88.41 24.86 1.81 Allowed 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.244 0.618 . . . . 0.0 111.847 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.19 28.02 6.61 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 122.867 0.467 . . . . 0.0 109.995 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -135.29 137.85 42.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.292 1.037 . . . . 0.0 110.447 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.4 p -151.39 137.96 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.732 174.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.427 ' CZ ' ' CA ' ' A' ' 70' ' ' GLY . 11.0 t80 -87.12 143.09 27.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.5 p -128.5 85.59 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 121.979 0.895 . . . . 0.0 108.96 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.427 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -80.84 165.05 47.18 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.094 -177.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 73.43 9.16 77.32 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 119.77 -0.461 . . . . 0.0 113.17 177.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.6 tp -49.47 137.08 16.9 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.477 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 58.3 Cg_endo -66.0 136.57 45.24 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.959 1.773 . . . . 0.0 109.535 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 31.8 Cg_exo -61.55 14.03 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 124.195 3.263 . . . . 0.0 115.593 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -140.55 32.31 1.86 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.961 0.801 . . . . 0.0 112.067 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.77 155.18 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -120.42 -178.45 3.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.443 0.697 . . . . 0.0 111.0 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -53.37 -31.48 44.9 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.753 0.821 . . . . 0.0 112.738 -175.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -78.18 -33.77 49.94 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -173.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -77.49 -24.98 50.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.867 -0.52 . . . . 0.0 110.583 -173.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.5 mt -80.53 -40.55 19.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.8 m -68.02 -8.71 39.83 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.593 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.43 -19.73 14.31 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 172.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.5 m -74.98 -26.96 59.96 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 118.856 0.753 . . . . 0.0 112.535 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -122.25 17.4 10.68 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -70.81 -17.08 62.77 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -80.62 4.94 16.96 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.044 -0.41 . . . . 0.0 111.79 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -116.66 24.87 10.98 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.566 0.346 . . . . 0.0 110.751 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.64 173.62 30.81 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.16 151.66 72.49 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.492 2.795 . . . . 0.0 110.846 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.464 ' N ' HD23 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -161.06 161.96 31.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.482 -170.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.9 pt -140.37 161.91 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.8 173.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.69 151.67 33.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -145.36 160.7 41.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.532 0.682 . . . . 0.0 112.299 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.418 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 30.3 p90 -155.75 158.77 31.86 Favored Pre-proline 0 N--CA 1.451 -0.386 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 169.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.632 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 28.5 Cg_endo -74.7 -7.98 19.93 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.447 2.765 . . . . 0.0 110.628 -169.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.632 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 75.4 m-70 -105.37 18.06 22.9 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.381 1.073 . . . . 0.0 111.182 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -50.86 155.04 1.26 Allowed 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.96 0.904 . . . . 0.0 112.387 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.279 0 C-N-CA 123.403 0.681 . . . . 0.0 111.1 -176.148 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.632 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -141.39 145.64 35.6 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.299 0.55 . . . . 0.0 110.625 175.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.5 -177.36 6.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.438 0.695 . . . . 0.0 109.72 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -144.21 144.23 31.43 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -97.56 146.01 25.69 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.407 0.622 . . . . 0.0 111.099 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.23 144.95 40.77 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -136.35 171.91 13.79 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.815 0.34 . . . . 0.0 111.088 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -108.39 -26.18 10.61 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.016 0.527 . . . . 0.0 109.969 -177.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -135.24 155.03 51.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.32 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -85.15 -11.34 55.29 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.069 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.4 m -81.29 -19.03 43.84 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.212 0.205 . . . . 0.0 111.235 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.3 m -76.2 -43.14 43.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.571 0.224 . . . . 0.0 110.846 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.4 ' HA ' HD12 ' A' ' 124' ' ' LEU . 8.6 p -75.74 -19.5 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -77.02 -29.03 55.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.06 -44.71 46.08 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 119.067 -0.492 . . . . 0.0 111.94 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.555 HD22 ' C ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -73.41 -29.51 62.64 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 118.325 -1.35 . . . . 0.0 110.567 -179.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.419 ' HA ' ' SG ' ' A' ' 128' ' ' CYS . 79.1 mt -78.42 -15.7 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 118.387 0.54 . . . . 0.0 111.111 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -92.09 -13.65 30.47 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.016 -0.427 . . . . 0.0 110.894 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -113.72 1.82 15.0 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.419 ' SG ' ' HA ' ' A' ' 125' ' ' ILE . 18.5 p -96.7 -176.07 3.49 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.159 0.504 . . . . 0.0 111.177 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.6 mm -81.66 155.91 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.534 1.134 . . . . 0.0 108.513 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -136.95 145.83 44.69 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.623 0.249 . . . . 0.0 110.375 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.99 176.18 9.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -57.66 -1.89 0.12 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -169.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -159.2 0.16 0.08 OUTLIER Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.415 1.007 . . . . 0.0 114.73 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -163.91 174.03 11.97 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.121 1.46 . . . . 0.0 111.6 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 135' ' ' LEU . 2.5 mm? -117.68 161.75 19.16 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.884 0.874 . . . . 0.0 109.706 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 83.2 m-85 -144.63 158.22 43.86 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 176.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.4 tp -125.3 145.57 49.95 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 168.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 80.3 m -100.16 119.29 38.11 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.001 -0.437 . . . . 0.0 110.653 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.9 m -148.2 159.49 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.597 0.759 . . . . 0.0 110.17 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.2 p -91.11 160.38 15.6 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 97.0 p -150.58 163.78 22.8 Favored Pre-proline 0 N--CA 1.454 -0.265 0 O-C-N 122.112 -0.367 . . . . 0.0 111.895 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -66.35 -10.06 26.17 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.213 2.609 . . . . 0.0 112.641 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.417 HG22 ' CD1' ' A' ' 144' ' ' ILE . 54.8 m -93.59 -45.46 7.72 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.099 0.56 . . . . 0.0 110.741 -176.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.451 HG13 ' HE3' ' A' ' 147' ' ' LYS . 5.1 mm -135.51 158.21 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 C-N-CA 123.446 0.698 . . . . 0.0 109.22 -173.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -62.11 -24.31 67.06 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.974 -0.454 . . . . 0.0 109.971 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -157.35 141.05 15.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.244 1.018 . . . . 0.0 108.882 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.451 ' HE3' HG13 ' A' ' 144' ' ' ILE . 5.3 tppp? -132.46 115.51 14.86 Favored Pre-proline 0 N--CA 1.455 -0.182 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.414 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 89.7 Cg_endo -74.33 96.52 0.97 Allowed 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.409 2.073 . . . . 0.0 106.814 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.0 p -78.04 132.22 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -85.1 153.18 22.86 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.062 0.545 . . . . 0.0 110.67 -173.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.4 mm -136.98 143.35 35.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 123.505 0.722 . . . . 0.0 110.262 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 54.3 ttp85 -154.06 113.0 2.5 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 169.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.46 172.82 15.36 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.42 3.413 . . . . 0.0 112.655 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 19.7 t-105 -122.41 140.27 52.89 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.092 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.477 ' C ' HD12 ' A' ' 156' ' ' LEU . 17.9 m120 -125.93 168.76 13.45 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.358 0.599 . . . . 0.0 111.021 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 155' ' ' ASN . 4.7 mp -104.59 99.01 8.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.373 -169.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.2 t -156.76 -32.97 0.08 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.999 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -138.86 26.25 2.5 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.7 m -70.14 -26.53 63.99 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -153.65 160.05 42.26 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.962 0.505 . . . . 0.0 110.941 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -154.69 162.34 41.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.455 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 1.6 p -154.04 147.46 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 122.63 0.372 . . . . 0.0 110.916 -175.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 66.2 mtm -140.79 22.51 2.29 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -147.21 13.07 1.09 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.947 0.794 . . . . 0.0 112.762 -174.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 83.33 23.05 55.56 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 121.77 -0.581 . . . . 0.0 112.848 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 31.6 m 56.91 44.14 23.59 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -65.71 159.31 69.61 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.72 147.31 31.91 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.725 2.95 . . . . 0.0 112.42 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 58.8 mt -118.57 161.95 19.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.481 0.713 . . . . 0.0 110.309 -176.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 171' ' ' PRO . 13.7 t70 -149.74 140.42 14.08 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 170' ' ' ASP . 50.1 Cg_exo -56.76 -21.88 42.06 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.336 2.691 . . . . 0.0 113.777 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -83.86 -3.26 57.76 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.276 0.489 . . . . 0.0 110.826 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.88 22.4 7.43 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 122.81 0.444 . . . . 0.0 110.86 175.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.6 m -127.26 146.57 50.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.69 0.281 . . . . 0.0 110.803 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 175' ' ' ILE . 9.7 tt -123.21 149.14 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 123.087 0.555 . . . . 0.0 110.551 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.449 ' CD1' ' HD3' ' A' ' 251' ' ' LYS . 5.4 t80 -111.28 143.74 41.57 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 172.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 8.6 m -138.99 136.71 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -145.43 171.45 26.48 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 77.86 11.18 85.67 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.6 p -67.22 146.41 98.9 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 122.728 0.411 . . . . 0.0 110.236 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.08 170.44 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.946 3.097 . . . . 0.0 112.789 173.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -55.08 -47.57 98.2 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.226 -0.892 . . . . 0.0 112.751 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.94 136.48 18.6 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.934 1.756 . . . . 0.0 110.375 173.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.653 ' CD1' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -145.7 -70.53 0.26 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 119.175 -0.441 . . . . 0.0 111.644 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.653 ' H ' ' CD1' ' A' ' 184' ' ' LEU . 81.3 mtp180 58.5 133.62 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.366 1.866 . . . . 0.0 112.912 -175.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.62 -26.3 64.36 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.557 -0.715 . . . . 0.0 110.076 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 51.1 t -68.73 -47.68 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-O 120.761 0.315 . . . . 0.0 110.662 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -81.05 -25.4 37.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.65 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 46.2 tp -71.67 -31.39 66.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.82 -34.59 45.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.284 -0.26 . . . . 0.0 111.317 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 23.3 mmt -68.99 -36.23 77.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 76.6 mt -72.45 -36.0 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.1 mmt -74.08 -14.88 61.05 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 122.09 -0.381 . . . . 0.0 110.194 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -95.19 -15.09 23.53 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 117.993 0.36 . . . . 0.0 110.978 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.31 -17.46 28.9 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.677 0.391 . . . . 0.0 111.339 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -118.12 -23.81 7.23 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 117.987 0.358 . . . . 0.0 111.215 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -139.89 45.21 1.9 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.688 0.395 . . . . 0.0 110.338 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -41.45 134.06 3.28 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.937 0.779 . . . . 0.0 112.618 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 132.07 6.77 3.07 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -175.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.422 HG22 ' CE2' ' A' ' 222' ' ' PHE . 46.5 t -65.59 147.39 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 123.335 0.654 . . . . 0.0 110.611 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 21.9 p -123.91 -28.84 3.74 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 119.216 -0.421 . . . . 0.0 112.121 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -154.19 154.42 33.49 Favored 'General case' 0 N--CA 1.458 -0.06 0 CA-C-N 118.626 0.648 . . . . 0.0 110.785 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.32 158.91 44.67 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.683 0.393 . . . . 0.0 110.57 175.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -177.29 177.66 48.29 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.6 mm -102.09 92.32 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.507 ' HB3' ' H ' ' A' ' 215' ' ' LYS . 27.7 t70 51.68 -58.3 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -169.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 69.3 p 46.04 71.5 0.29 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.552 0.741 . . . . 0.0 112.933 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -78.39 128.04 79.08 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.44 -6.91 20.02 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 124.294 3.329 . . . . 0.0 114.521 -174.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -73.36 -27.16 61.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.966 1.257 . . . . 0.0 111.575 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 78.0 mt -145.33 8.24 1.18 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.851 0.86 . . . . 0.0 110.592 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 54.02 50.08 17.47 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.745 0.818 . . . . 0.0 110.801 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -131.27 152.88 81.33 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 123.378 0.671 . . . . 0.0 110.228 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -84.77 140.52 8.11 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.741 2.294 . . . . 0.0 112.458 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . 0.507 ' H ' ' HB3' ' A' ' 206' ' ' ASP . 37.4 mtmm -98.87 26.81 5.41 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 168.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.77 171.48 14.81 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 60.62 153.67 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.656 1.183 . . . . 0.0 113.746 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -88.19 160.63 30.91 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.58 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -149.55 150.28 32.01 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 60.2 t -142.49 149.93 18.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.06 148.8 50.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.422 ' CE2' HG22 ' A' ' 200' ' ' VAL . 82.0 m-85 -123.22 153.24 40.39 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.895 -175.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 86.7 p -88.66 -0.74 57.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.637 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -130.84 144.67 51.63 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.798 0.439 . . . . 0.0 111.164 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 39.8 tp60 -74.27 -16.01 60.96 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.546 0.339 . . . . 0.0 110.195 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -85.21 -38.26 19.16 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 19.1 m -68.84 -29.65 68.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -66.98 -53.61 29.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.525 0.33 . . . . 0.0 110.944 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.6 pp -69.91 -12.26 15.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.08 0 CA-C-N 118.304 0.502 . . . . 0.0 111.686 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.79 -27.37 22.34 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.012 0.369 . . . . 0.0 111.102 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -82.92 -24.68 32.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.7 pt -108.67 27.22 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 123.153 0.581 . . . . 0.0 110.277 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.5 t -77.82 -15.34 59.15 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.299 0.639 . . . . 0.0 112.218 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -155.35 145.0 21.27 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -57.88 -32.45 67.71 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -124.49 111.84 16.18 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 30.0 m -98.2 159.27 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.55 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -81.88 143.14 31.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.4 mp -130.41 103.95 6.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -135.83 146.61 47.68 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.151 -177.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -146.91 8.64 0.97 Allowed 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.647 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.62 -139.25 5.48 Favored Glycine 0 C--N 1.336 0.537 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -175.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.82 4.34 14.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.986 0.393 . . . . 0.0 112.041 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 76.7 mt -104.2 136.28 38.2 Favored 'Isoleucine or valine' 0 C--N 1.338 0.106 0 C-N-CA 123.185 0.594 . . . . 0.0 110.541 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . 0.446 ' CG ' HH12 ' A' ' 247' ' ' ARG . 25.4 t70 -122.78 139.88 53.52 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.044 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -144.26 160.68 40.58 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.121 0.968 . . . . 0.0 109.851 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . 0.446 HH12 ' CG ' ' A' ' 245' ' ' ASP . 0.1 OUTLIER -134.81 160.43 38.24 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.195 0.598 . . . . 0.0 109.695 178.205 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.23 151.39 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -79.98 138.54 37.09 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -122.03 152.59 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.449 ' HD3' ' CD1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -159.03 158.62 29.05 Favored Pre-proline 0 C--O 1.231 0.13 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.775 169.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.52 141.2 90.51 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.177 2.585 . . . . 0.0 110.526 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -74.72 146.99 41.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.139 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -173.707 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.131 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -148.18 155.93 41.98 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.972 0.415 . . . . 0.0 111.159 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -91.14 22.77 3.58 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.412 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 53.86 21.95 3.04 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.633 0.773 . . . . 0.0 111.755 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -136.73 135.92 38.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.805 0.842 . . . . 0.0 109.525 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.11 137.91 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.314 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CZ ' ' CA ' ' A' ' 70' ' ' GLY . 7.9 t80 -81.61 140.43 34.44 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.0 96.54 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 122.02 0.914 . . . . 0.0 108.661 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.516 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -97.73 -171.43 32.98 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.831 -177.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.78 33.08 76.38 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-O 119.43 -0.65 . . . . 0.0 111.864 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 72' ' ' LEU . 43.6 mt -100.92 135.45 19.99 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 118.201 1.001 . . . . 0.0 110.649 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.488 ' HD2' HG21 ' A' ' 76' ' ' ILE . 60.1 Cg_endo -65.3 171.41 9.22 Favored 'Trans proline' 0 N--CA 1.459 -0.532 1 C-N-CA 125.577 4.185 . . . . 0.0 113.23 -178.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.62 9.32 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.463 1 C-N-CA 126.161 4.574 . . . . 0.0 116.391 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -138.66 -114.56 0.15 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.488 HG21 ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER 44.6 67.91 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 122.623 1.201 . . . . 0.0 111.738 172.012 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -70.68 -176.22 1.25 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -46.48 -33.13 3.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.89 1.676 . . . . 0.0 113.382 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -80.17 -29.74 38.77 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.187 -0.32 . . . . 0.0 111.852 -173.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -78.81 -30.64 45.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.256 -0.278 . . . . 0.0 110.758 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 61.0 mt -74.01 -40.67 52.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.6 m -65.37 -22.0 66.75 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.654 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.91 -17.97 26.99 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -79.33 -25.73 42.26 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.723 0.692 . . . . 0.0 112.03 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -122.09 18.56 10.82 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -71.75 -20.28 61.91 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -75.76 -5.95 48.26 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 122.111 -0.368 . . . . 0.0 111.93 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -108.38 21.8 16.82 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.692 0.397 . . . . 0.0 110.301 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.81 165.17 32.9 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.469 -1.053 . . . . 0.0 110.469 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.98 141.29 93.9 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.532 2.822 . . . . 0.0 112.148 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.513 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -151.24 167.93 26.29 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.713 0.405 . . . . 0.0 110.697 177.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 mt -134.19 163.92 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.7 p -126.8 150.16 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -152.15 165.91 33.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -170.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.475 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 4.7 p90 -147.32 159.81 41.07 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 169.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.595 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 79.6 Cg_endo -64.51 -18.72 63.85 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 124.133 3.222 . . . . 0.0 111.912 -168.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.595 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 3.2 p80 -118.63 21.64 12.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.008 0.923 . . . . 0.0 111.396 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HA ' ' HE2' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -58.59 115.71 3.21 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 173.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.246 0 C-N-CA 123.09 0.556 . . . . 0.0 109.953 179.553 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.703 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -69.82 139.54 53.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.548 0.674 . . . . 0.0 109.907 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -157.47 -162.42 1.19 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.607 0.763 . . . . 0.0 110.177 -170.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -137.18 141.31 42.16 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 122.59 0.356 . . . . 0.0 110.133 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.3 mp -96.84 149.51 21.77 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 mp -108.32 140.7 41.21 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 173.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -135.46 170.57 15.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.901 0.381 . . . . 0.0 110.559 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -111.25 -27.15 8.81 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.839 0.456 . . . . 0.0 110.487 -175.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -137.01 155.78 49.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.477 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -79.03 -18.86 52.82 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.487 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.9 m -77.9 -18.7 55.86 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.492 0.317 . . . . 0.0 111.528 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 63.3 m -75.36 -47.11 29.14 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.823 0.344 . . . . 0.0 110.678 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.4 p -76.78 -16.83 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -74.69 -32.69 62.27 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.46 -35.92 60.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.376 -0.345 . . . . 0.0 111.455 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 pp -76.38 -22.3 54.98 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.803 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.4 mt -87.27 -17.76 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 O-C-N 122.285 -0.259 . . . . 0.0 111.335 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -103.43 -5.87 22.45 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -122.9 10.26 9.5 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.8 m -122.76 -177.16 3.57 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.655 0.382 . . . . 0.0 110.456 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 38.2 mm -75.97 161.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 124.147 0.979 . . . . 0.0 110.136 -171.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -135.42 162.46 32.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.79 0.329 . . . . 0.0 110.722 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -140.22 77.4 1.61 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.318 0.58 . . . . 0.0 110.631 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 55.42 9.66 0.4 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 157.22 -10.92 0.26 Allowed Glycine 0 CA--C 1.526 0.745 0 CA-C-N 118.568 0.622 . . . . 0.0 113.053 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 134' ' ' LYS . 1.6 mppt? -124.08 176.51 6.33 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.22 160.55 19.6 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -172.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.35 161.87 39.4 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.405 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 27.2 tp -142.13 142.21 32.73 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 168.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 46.0 t -92.19 128.24 37.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.311 0.505 . . . . 0.0 110.866 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.2 m -145.83 172.04 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.879 0.871 . . . . 0.0 110.307 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.9 p -72.9 172.25 11.24 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.018 0.527 . . . . 0.0 110.127 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.9 t -140.3 137.03 17.34 Favored Pre-proline 0 N--CA 1.457 -0.123 0 O-C-N 122.177 -0.327 . . . . 0.0 111.777 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -80.74 -6.14 13.32 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 124.309 3.339 . . . . 0.0 112.662 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.465 HG23 HG12 ' A' ' 144' ' ' ILE . 3.8 t -125.38 -24.12 4.0 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.936 0.789 . . . . 0.0 112.458 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.638 HG22 ' H ' ' A' ' 145' ' ' LYS . 5.0 mm -124.09 -175.85 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.638 ' H ' HG22 ' A' ' 144' ' ' ILE . 54.4 mtmt -78.59 -21.33 48.73 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.684 -0.635 . . . . 0.0 111.356 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -158.9 166.45 31.83 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.62 0.768 . . . . 0.0 109.884 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.426 ' HB2' ' HZ3' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -151.23 119.37 3.4 Favored Pre-proline 0 N--CA 1.458 -0.071 0 O-C-N 122.192 -0.317 . . . . 0.0 110.987 178.246 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -81.08 101.87 1.31 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.617 2.212 . . . . 0.0 107.847 168.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.2 p -74.2 134.66 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -92.63 150.81 20.47 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.312 0.645 . . . . 0.0 110.785 -171.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 34.5 mm -137.32 141.19 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 122.545 0.338 . . . . 0.0 111.649 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -149.44 107.83 3.34 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 122.995 0.518 . . . . 0.0 109.649 174.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.36 165.0 31.65 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.744 2.963 . . . . 0.0 112.257 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -106.9 135.67 48.05 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-O 120.44 0.162 . . . . 0.0 110.678 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -102.26 156.41 17.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.693 0.797 . . . . 0.0 112.397 -175.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.6 mp -102.98 91.51 4.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 42.8 t -156.36 -32.85 0.09 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -141.67 31.65 1.65 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.1 m -71.15 -18.26 62.51 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -153.52 159.36 42.21 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.098 0.559 . . . . 0.0 110.664 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -153.35 153.2 32.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 17.3 t -130.76 141.0 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 33.1 ttm -127.92 -3.23 5.84 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.541 0.201 . . . . 0.0 111.541 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -159.69 -58.65 0.06 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.06 6.85 10.8 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.178 -0.79 . . . . 0.0 114.113 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 51.5 p -88.72 -11.79 44.12 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.853 1.326 . . . . 0.0 112.486 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -135.68 150.76 72.83 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 118.351 0.523 . . . . 0.0 111.479 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -70.43 167.76 24.39 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.196 3.264 . . . . 0.0 111.656 -177.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.3 mt -107.25 160.48 15.57 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.454 0.701 . . . . 0.0 110.762 -175.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -151.41 142.95 15.68 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.0 -22.23 54.11 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.199 2.599 . . . . 0.0 113.648 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.6 mtp-105 -83.85 -2.97 57.49 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 122.942 0.497 . . . . 0.0 111.179 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -127.99 19.06 6.57 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.75 0.42 . . . . 0.0 111.095 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 21.1 m -127.42 140.75 51.96 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.541 0.21 . . . . 0.0 110.684 -177.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 9.7 tt -110.24 150.25 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.032 0 C-N-CA 123.015 0.526 . . . . 0.0 110.158 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -112.16 144.27 41.82 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 96.6 t -136.57 132.48 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -176.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -159.01 179.62 34.51 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 112.131 -0.387 . . . . 0.0 112.131 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 79.94 10.59 85.45 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.3 p -67.85 146.24 98.26 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 123.083 0.553 . . . . 0.0 109.911 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -53.66 -58.32 1.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.053 2.502 . . . . 0.0 113.657 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.426 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 25.7 mmm-85 -151.58 -68.01 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.319 -0.848 . . . . 0.0 112.312 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 182' ' ' ARG . 50.1 Cg_endo -79.23 162.89 25.41 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.083 2.522 . . . . 0.0 112.135 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.3 mp -136.89 -49.97 0.64 Allowed 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 122.967 0.507 . . . . 0.0 109.633 173.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 47.9 102.83 0.0 OUTLIER 'General case' 0 C--N 1.341 0.207 0 C-N-CA 126.391 1.876 . . . . 0.0 112.829 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.54 -24.42 55.98 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 78.7 t -68.66 -51.76 42.64 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 CA-C-N 118.019 0.372 . . . . 0.0 110.866 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -84.51 -21.78 30.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 121.272 -0.171 . . . . 0.0 110.809 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 57.3 tp -68.01 -33.2 74.16 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.401 ' HB2' ' CB ' ' A' ' 203' ' ' ALA . . . -78.33 -36.18 46.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.407 -0.183 . . . . 0.0 111.361 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 25.2 mmt -70.02 -36.82 75.37 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 83.2 mt -70.0 -33.16 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.1 mmt -77.7 -9.78 59.17 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.119 -0.363 . . . . 0.0 111.024 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -109.53 -2.26 17.72 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.416 0.553 . . . . 0.0 112.448 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -108.08 -17.0 14.15 Favored 'General case' 0 C--N 1.34 0.193 0 O-C-N 121.969 -0.457 . . . . 0.0 111.454 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.47 -17.89 11.63 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.922 0.328 . . . . 0.0 110.554 175.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -142.69 40.39 1.55 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.188 0.595 . . . . 0.0 109.997 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -40.17 134.96 2.13 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.547 1.07 . . . . 0.0 113.502 -174.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 137.67 14.23 0.8 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.472 0.558 . . . . 0.0 112.046 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 42.4 t -73.73 149.2 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.244 1.022 . . . . 0.0 111.364 -176.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 25.7 p -124.85 -27.56 3.6 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.576 0.35 . . . . 0.0 111.014 175.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -155.15 156.82 36.43 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.655 0.264 . . . . 0.0 110.739 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.401 ' CB ' ' HB2' ' A' ' 190' ' ' ALA . . . -154.22 157.87 39.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.276 0.63 . . . . 0.0 109.977 176.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.43 -178.53 48.32 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.1 mm -95.35 143.51 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -59.67 122.71 14.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 16.9 p -141.73 163.41 32.99 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.119 0.485 . . . . 0.0 110.806 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -132.07 128.05 21.27 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 123.58 0.752 . . . . 0.0 109.16 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -80.31 -6.4 13.78 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 124.576 3.518 . . . . 0.0 113.196 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -92.79 -58.36 2.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.819 0.736 . . . . 0.0 111.459 -173.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -160.78 -5.06 0.05 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -96.24 -15.44 22.0 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 119.722 1.146 . . . . 0.0 113.117 -174.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.517 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 55.6 m-85 50.98 -146.89 0.01 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 117.219 -1.372 . . . . 0.0 110.044 177.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.517 ' CD ' ' HB3' ' A' ' 213' ' ' TYR . 89.4 Cg_endo -72.06 150.33 54.07 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 CA-C-N 123.178 2.171 . . . . 0.0 112.405 -173.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -105.81 13.85 28.99 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.7 0.8 . . . . 0.0 112.158 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 68.15 14.54 66.29 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.615 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -133.07 154.66 50.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 117.908 0.854 . . . . 0.0 109.867 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -100.7 162.28 18.63 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 121.064 0.258 . . . . 0.0 112.537 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -151.04 146.64 26.33 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 94.9 t -141.44 145.82 24.18 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.059 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.98 142.62 51.0 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 110.86 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -118.76 156.54 29.2 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.638 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.7 m -84.19 -5.63 59.28 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.209 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -130.02 148.27 51.86 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.073 0.397 . . . . 0.0 111.919 -172.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -74.98 -15.45 60.66 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -84.98 -37.89 19.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 18.6 m -73.07 -28.04 62.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -67.91 -54.62 17.38 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.444 0.298 . . . . 0.0 110.531 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.1 pt -69.58 -14.84 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 CA-C-N 118.108 0.413 . . . . 0.0 111.345 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.66 -28.06 28.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.833 0.288 . . . . 0.0 110.794 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -82.89 -27.2 30.86 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.858 0.299 . . . . 0.0 111.759 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.2 pt -105.77 29.07 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.127 0.571 . . . . 0.0 110.181 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 21.9 t -78.38 -11.06 59.92 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.085 0.554 . . . . 0.0 111.925 -176.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -158.06 145.29 18.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -59.05 -29.91 67.65 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 122.416 0.287 . . . . 0.0 111.139 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -123.19 118.79 28.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.8 m -107.52 156.55 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.006 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -81.5 144.3 31.44 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.989 0.423 . . . . 0.0 110.275 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.99 105.86 7.67 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -133.25 147.42 51.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.216 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -144.62 11.87 1.47 Allowed 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.168 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.95 -140.16 5.91 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -175.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.65 14.8 1.94 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.961 0.504 . . . . 0.0 111.984 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 73.5 mt -116.57 141.42 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 123.619 0.768 . . . . 0.0 110.582 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -129.54 146.62 51.34 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.978 0.418 . . . . 0.0 111.548 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -144.39 163.99 32.15 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 124.582 1.153 . . . . 0.0 109.137 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.08 153.87 50.46 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.367 0.667 . . . . 0.0 109.709 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 12.1 p -154.53 157.87 4.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -85.11 138.47 32.38 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.476 -0.14 . . . . 0.0 110.757 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -121.28 159.75 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.06 0 CA-C-O 120.795 0.331 . . . . 0.0 111.527 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.41 159.9 26.12 Favored Pre-proline 0 N--CA 1.455 -0.187 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 171.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.3 131.69 46.43 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.726 2.284 . . . . 0.0 108.217 171.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -73.42 112.22 9.29 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.526 -173.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 CA--C 1.534 0.34 0 C-N-CA 125.534 1.534 . . . . 0.0 112.769 175.007 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -154.14 157.36 38.77 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 122.57 0.348 . . . . 0.0 110.823 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.8 t -94.25 -179.25 4.87 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.377 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.53 ' HA ' ' CE2' ' A' ' 115' ' ' PHE . 95.1 mtt180 -90.99 27.36 1.85 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.592 0.757 . . . . 0.0 111.305 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.563 ' HE2' ' CD1' ' A' ' 154' ' ' TRP . 16.5 pttm -146.93 141.78 26.87 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.02 0.928 . . . . 0.0 111.154 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 p -148.81 148.16 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.245 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.416 ' CZ ' ' CA ' ' A' ' 70' ' ' GLY . 6.4 t80 -100.57 143.08 31.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 171.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.403 HG11 HD13 ' A' ' 113' ' ' LEU . 2.7 m -127.31 103.7 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.927 0.87 . . . . 0.0 108.853 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.416 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -93.77 -164.03 36.59 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.13 13.82 29.52 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 119.461 -0.633 . . . . 0.0 112.708 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 72' ' ' LEU . 27.0 mt -79.67 146.06 64.12 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 118.72 1.26 . . . . 0.0 109.676 177.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 97.2 Cg_endo -76.68 161.23 34.02 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 124.355 3.37 . . . . 0.0 110.375 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 33.1 Cg_exo -62.84 -11.61 25.08 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.777 2.985 . . . . 0.0 113.222 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -95.85 -39.47 9.81 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.4 mt -54.34 145.28 4.51 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 CA-C-O 121.735 0.779 . . . . 0.0 112.155 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -146.28 -170.45 3.5 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.768 1.227 . . . . 0.0 109.324 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -51.64 -27.0 10.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.604 0.762 . . . . 0.0 112.663 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -76.92 -45.02 29.35 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.721 -0.612 . . . . 0.0 111.446 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -78.4 -26.32 46.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.18 -173.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.411 ' CG2' HD11 ' A' ' 113' ' ' LEU . 84.6 mt -74.62 -47.27 39.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 87.4 m -67.94 -12.84 61.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.006 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.25 -15.11 20.97 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.6 m -82.38 -29.13 31.06 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.957 0.799 . . . . 0.0 112.032 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -118.46 14.64 13.73 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -66.32 -20.83 66.2 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.06 -0.4 . . . . 0.0 111.808 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -73.6 -5.1 38.26 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.512 0.325 . . . . 0.0 111.805 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -112.12 20.47 16.82 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.642 0.377 . . . . 0.0 111.083 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.23 176.2 25.35 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.92 154.29 67.25 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.677 2.918 . . . . 0.0 110.869 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -164.54 162.09 21.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.187 -170.202 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.2 pt -140.91 167.59 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.276 173.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.7 p -134.69 155.54 38.74 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -150.32 165.29 33.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.992 0.425 . . . . 0.0 111.651 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.443 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 41.4 p90 -159.83 162.8 24.12 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 172.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.538 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 26.0 Cg_endo -75.51 -15.53 19.61 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.198 1.932 . . . . 0.0 110.513 -168.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.538 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 24.4 m-70 -91.41 2.17 56.6 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.653 0.781 . . . . 0.0 110.872 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -63.33 149.02 46.74 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 122.966 0.507 . . . . 0.0 110.765 -176.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.346 0 C-N-CA 123.707 0.803 . . . . 0.0 109.943 -178.715 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.918 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.472 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -63.28 138.47 58.54 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.269 1.534 . . . . 0.0 110.854 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -156.53 -170.24 3.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.85 -169.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -130.36 129.94 43.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.167 0.587 . . . . 0.0 109.49 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.411 HD11 ' CG2' ' A' ' 81' ' ' ILE . 10.7 mp -86.79 142.98 27.72 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.744 0.783 . . . . 0.0 111.816 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.57 138.08 51.09 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 113.262 -1.79 . . . . 0.0 107.106 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 29.3 p90 -159.83 166.0 31.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.64 -20.51 5.95 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -174.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -79.07 -14.11 59.35 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -169.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 52.95 14.48 0.46 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.4 m -128.38 -12.47 5.03 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.211 0.605 . . . . 0.0 110.956 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.2 t -69.23 -34.69 75.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.477 HG11 ' CZ ' ' A' ' 115' ' ' PHE . 30.7 m -71.73 -26.23 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-N 116.857 -0.156 . . . . 0.0 111.007 177.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -70.63 -40.55 73.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -77.65 -32.41 53.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -82.56 -12.57 57.64 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 119.003 0.819 . . . . 0.0 111.587 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.467 HG23 HD13 ' A' ' 135' ' ' LEU . 61.4 mt -101.09 -19.81 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 O-C-N 122.174 -0.329 . . . . 0.0 110.745 178.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -101.84 -10.31 19.99 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -117.98 5.58 12.12 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 53.8 m -119.79 -159.92 0.8 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' A' ' 136' ' ' TYR . 75.5 mt -79.48 145.81 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.046 0.538 . . . . 0.0 109.756 -172.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -140.18 137.26 34.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -152.65 -175.61 5.37 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.077 0.465 . . . . 0.0 111.573 178.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -61.18 108.72 0.95 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.581 0.705 . . . . 0.0 111.444 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.44 -3.69 66.7 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.009 -0.996 . . . . 0.0 115.051 171.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -156.54 166.9 32.09 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.962 1.381 . . . . 0.0 111.829 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.467 HD13 HG23 ' A' ' 125' ' ' ILE . 28.6 mt -129.46 160.49 32.99 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 124.324 1.05 . . . . 0.0 109.151 -174.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 149' ' ' VAL . 75.4 m-85 -147.87 170.28 17.99 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 177.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.405 HD12 ' H ' ' A' ' 138' ' ' CYS . 43.6 tp -146.31 147.06 30.97 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.397 -1.274 . . . . 0.0 107.695 170.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . 0.405 ' H ' HD12 ' A' ' 137' ' ' LEU . 70.9 m -84.29 138.38 32.95 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.983 0.421 . . . . 0.0 112.105 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.3 p -160.74 149.25 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.817 1.247 . . . . 0.0 107.986 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.7 t -122.29 144.7 48.84 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 118.249 0.477 . . . . 0.0 111.304 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.6 m -152.55 167.7 12.8 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.292 0.637 . . . . 0.0 110.945 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -59.12 24.57 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.71 1 C-N-CA 126.097 4.531 . . . . 0.0 117.604 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.7 m -117.38 -28.28 6.16 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 119.82 1.191 . . . . 0.0 109.843 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.443 HG12 ' HE3' ' A' ' 147' ' ' LYS . 0.5 OUTLIER -165.32 166.52 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.321 1.049 . . . . 0.0 110.455 -171.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -84.42 101.78 12.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 170.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.0 t70 61.44 144.83 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.268 1.427 . . . . 0.0 113.523 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.443 ' HE3' HG12 ' A' ' 144' ' ' ILE . 27.6 ttmt -152.95 116.13 2.81 Favored Pre-proline 0 N--CA 1.455 -0.181 0 C-N-CA 124.232 1.013 . . . . 0.0 109.204 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.465 ' HB2' ' CD2' ' A' ' 136' ' ' TYR . 76.6 Cg_exo -54.94 125.08 17.96 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 124.416 3.411 . . . . 0.0 113.229 174.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 38.3 t -73.42 140.53 17.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 170.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.47 82.65 2.5 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.748 1.158 . . . . 0.0 110.284 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.9 mm -69.92 139.58 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.732 0.813 . . . . 0.0 112.313 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -155.14 105.28 2.25 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.834 172.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.56 164.97 29.75 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 124.123 3.216 . . . . 0.0 112.213 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.563 ' CD1' ' HE2' ' A' ' 66' ' ' LYS . 69.9 t-105 -86.16 145.75 26.87 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 175.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -105.83 152.25 23.48 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.108 0.48 . . . . 0.0 111.126 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.17 36.01 0.81 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.704 0.802 . . . . 0.0 111.715 -175.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.5 t -101.47 -30.5 11.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.097 -0.377 . . . . 0.0 110.771 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -159.93 144.92 15.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.9 m -152.4 -29.99 0.15 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.248 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -153.47 154.87 35.22 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.005 0.922 . . . . 0.0 109.431 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -157.1 155.57 31.3 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.603 0.24 . . . . 0.0 110.501 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.4 p -153.38 148.56 13.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -109.52 13.52 23.94 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -160.34 -47.56 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.532 0.606 . . . . 0.0 111.054 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.52 6.97 59.97 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.364 -0.686 . . . . 0.0 113.42 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.8 t -138.38 -2.6 1.79 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.285 1.043 . . . . 0.0 113.739 -177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -73.72 154.84 89.31 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 118.988 0.813 . . . . 0.0 109.958 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -53.79 140.93 66.93 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.239 2.626 . . . . 0.0 110.366 173.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 39.6 tp -150.25 135.29 17.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.535 0.207 . . . . 0.0 110.801 -175.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -148.68 155.36 41.5 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.089 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -65.31 -21.39 61.48 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.408 2.739 . . . . 0.0 111.897 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -85.27 3.86 37.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.89 0.876 . . . . 0.0 111.907 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -120.13 23.7 10.84 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.015 0.526 . . . . 0.0 109.715 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 17.0 m -117.17 146.38 43.24 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.016 0.436 . . . . 0.0 111.691 -173.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.4 tt -119.69 147.64 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.294 0.638 . . . . 0.0 109.735 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.4 ' HB2' ' CD1' ' A' ' 253' ' ' TYR . 6.3 t80 -105.24 136.5 44.65 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 99.5 t -130.9 113.31 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -141.91 -179.75 19.2 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 112.34 -0.304 . . . . 0.0 112.34 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.0 12.94 62.96 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -174.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.54 153.91 94.72 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -64.61 -68.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.027 2.485 . . . . 0.0 110.609 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.5 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 94.7 mtt-85 -146.59 -60.27 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.127 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' A' ' 182' ' ' ARG . 44.0 Cg_endo -80.09 162.28 23.25 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.904 2.403 . . . . 0.0 111.293 174.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.421 HD23 ' N ' ' A' ' 184' ' ' LEU . 2.1 pt? -159.49 -26.94 0.07 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.403 0.681 . . . . 0.0 110.87 173.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 51.87 115.49 0.0 OUTLIER 'General case' 0 C--N 1.342 0.251 0 C-N-CA 127.686 2.394 . . . . 0.0 114.475 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.74 -29.18 69.95 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.6 t -69.73 -49.61 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-N 117.902 0.319 . . . . 0.0 111.043 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -80.84 -21.72 40.52 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 122.345 -0.222 . . . . 0.0 110.929 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 33.7 tp -70.11 -33.61 72.07 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.433 ' HB2' ' CB ' ' A' ' 203' ' ' ALA . . . -77.21 -35.25 55.78 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.4 mmt -69.17 -35.31 76.16 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 66.1 mt -69.75 -34.08 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.2 mmt -74.13 -17.42 60.93 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.859 -0.526 . . . . 0.0 111.009 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -90.5 -17.42 27.1 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.062 0.392 . . . . 0.0 111.965 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -100.37 -28.3 13.02 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 118.719 0.691 . . . . 0.0 112.777 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.37 -9.17 23.84 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.62 0.646 . . . . 0.0 111.592 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -141.7 -44.59 0.35 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.03 0.377 . . . . 0.0 111.102 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 70.3 162.11 3.85 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 86.55 13.17 68.17 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 222' ' ' PHE . 10.7 p -88.46 164.61 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.164 0.986 . . . . 0.0 109.3 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 41.7 t -139.84 -62.16 0.52 Allowed 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.067 -0.395 . . . . 0.0 111.356 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -108.32 151.07 26.48 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.128 0.49 . . . . 0.0 112.24 -172.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' A' ' 190' ' ' ALA . . . -152.36 163.64 39.07 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.434 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 175.04 -179.06 46.56 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 41.3 mm -92.34 138.08 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -59.22 118.57 6.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 24.9 p -144.73 153.59 41.85 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -116.95 130.32 24.68 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -78.68 -11.51 15.43 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 124.529 3.486 . . . . 0.0 112.393 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -101.32 -9.91 20.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.645 0.378 . . . . 0.0 111.335 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -118.23 -3.59 11.02 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.557 0.743 . . . . 0.0 109.477 171.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 49.35 36.64 10.03 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.924 0.89 . . . . 0.0 112.377 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.21 162.16 51.44 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -90.66 -179.07 1.52 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 124.502 3.468 . . . . 0.0 111.388 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -121.97 7.43 9.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.263 0.625 . . . . 0.0 111.339 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.01 13.48 66.77 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.92 -0.378 . . . . 0.0 112.851 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -146.54 164.54 32.24 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.503 0.651 . . . . 0.0 110.241 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -103.11 165.14 15.89 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 121.003 0.224 . . . . 0.0 112.941 -174.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -145.6 145.86 31.14 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 94.7 t -138.72 147.32 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.11 145.19 51.23 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.251 0.548 . . . . 0.0 111.344 -177.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 200' ' ' VAL . 9.9 m-85 -120.07 161.95 20.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.369 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 92.0 p -98.48 8.59 44.68 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -131.02 140.45 50.1 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.831 0.453 . . . . 0.0 110.213 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -75.06 -19.03 60.18 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -80.61 -38.21 29.73 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 25.1 m -75.77 -25.38 56.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -67.36 -50.34 60.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -73.66 -11.12 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-N 117.969 0.349 . . . . 0.0 111.176 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.63 -21.26 25.41 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 119.722 -0.18 . . . . 0.0 110.808 174.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -87.5 -27.3 22.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.965 0.348 . . . . 0.0 111.868 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 8.4 pt -105.38 28.75 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.162 0.585 . . . . 0.0 110.262 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.2 p -74.99 -17.0 60.6 Favored 'General case' 0 C--N 1.334 -0.079 0 C-N-CA 123.406 0.682 . . . . 0.0 112.112 -176.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -156.96 145.01 19.35 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -176.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -59.72 -30.56 68.9 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 122.406 0.282 . . . . 0.0 111.324 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -122.61 121.73 37.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 29.6 m -111.93 160.54 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.412 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -86.76 144.94 26.84 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.971 0.415 . . . . 0.0 110.138 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.4 mp -132.86 104.07 6.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -130.64 149.69 52.18 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.193 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -146.9 20.41 1.27 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.149 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.61 129.46 2.96 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -173.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 53.89 16.7 1.13 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.28 1.032 . . . . 0.0 113.121 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 76.2 mt -139.99 146.22 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.789 0.836 . . . . 0.0 109.601 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -156.32 129.61 8.12 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -148.55 162.27 39.99 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.493 0.717 . . . . 0.0 110.981 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.84 155.93 43.34 Favored 'General case' 0 C--N 1.338 0.068 0 C-N-CA 124.001 0.92 . . . . 0.0 109.388 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.4 p -156.8 156.72 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -86.06 138.76 31.71 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.19 158.94 32.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.103 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.63 161.86 24.13 Favored Pre-proline 0 N--CA 1.455 -0.197 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.338 169.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.93 132.63 50.82 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.589 2.193 . . . . 0.0 108.861 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . 0.4 ' CD1' ' HB2' ' A' ' 176' ' ' PHE . 3.2 t80 -78.11 167.49 21.34 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.242 -177.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.456 -0.17 0 C-N-CA 123.748 0.819 . . . . 0.0 111.106 -172.098 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.527 0.072 0 CA-C-O 121.075 0.465 . . . . 0.0 111.698 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -154.6 164.33 38.88 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.369 -174.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.9 t -96.0 165.51 12.22 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.584 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.89 11.01 2.88 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -123.33 139.79 53.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 p -155.59 151.08 10.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.79 -172.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -96.79 142.12 29.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 174.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 m -131.85 130.75 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.63 151.67 18.62 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 112.052 -0.419 . . . . 0.0 112.052 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.48 19.51 37.96 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.654 -0.526 . . . . 0.0 113.029 176.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 pp -80.93 153.3 72.49 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 118.556 1.178 . . . . 0.0 109.114 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.58 144.76 17.92 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.076 2.517 . . . . 0.0 112.46 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -80.55 -4.65 13.05 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 124.057 3.172 . . . . 0.0 111.461 174.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -73.79 -6.3 46.13 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -176.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.404 HD12 ' C ' ' A' ' 76' ' ' ILE . 1.9 pp -141.68 -169.45 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -132.32 -170.62 2.46 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.918 0.487 . . . . 0.0 111.445 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -46.46 -30.3 2.12 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.461 1.504 . . . . 0.0 113.003 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.19 -34.23 77.08 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.399 0.545 . . . . 0.0 112.267 -176.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -80.26 -40.68 26.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.068 -0.395 . . . . 0.0 110.308 -174.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.7 pp -76.75 -23.76 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.366 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 78.3 m -70.84 -30.79 67.3 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.79 -16.95 60.03 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.056 -0.402 . . . . 0.0 110.8 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.7 m -86.28 -24.22 26.03 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -117.88 -18.18 9.59 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -176.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -68.26 -8.92 43.61 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.283 0.947 . . . . 0.0 112.176 -174.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -67.48 -6.7 20.75 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.983 -0.448 . . . . 0.0 111.617 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -111.98 -1.26 15.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.59 0.356 . . . . 0.0 111.545 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.41 165.73 11.43 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -68.17 137.31 40.14 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.368 2.712 . . . . 0.0 110.006 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.407 ' C ' HD12 ' A' ' 91' ' ' LEU . 3.3 pp -160.09 174.47 14.25 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.833 -174.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.17 174.7 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.087 178.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.63 159.41 43.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 CA-C-O 120.777 0.322 . . . . 0.0 111.019 -177.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -150.87 160.62 43.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.41 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.456 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 38.8 p90 -160.23 159.24 26.59 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.645 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 17.5 Cg_endo -75.97 -8.76 19.15 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.119 2.546 . . . . 0.0 109.71 -169.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.645 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 23.3 m-70 -102.08 11.42 38.41 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.472 1.109 . . . . 0.0 111.614 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -53.51 159.05 1.58 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 123.95 0.9 . . . . 0.0 113.11 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.327 0 C-N-CA 124.086 0.955 . . . . 0.0 110.212 -178.419 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.684 0 CA-C-O 119.748 -0.473 . . . . 0.0 113.026 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.59 147.36 34.27 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.035 0.918 . . . . 0.0 109.717 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.6 -177.26 6.24 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.077 0.551 . . . . 0.0 110.44 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -133.6 129.62 37.21 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -177.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mp -92.16 145.62 24.36 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.568 0.699 . . . . 0.0 111.997 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -115.21 136.2 53.36 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -128.51 177.91 6.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.442 0.697 . . . . 0.0 110.881 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -115.79 -32.28 5.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.079 0.552 . . . . 0.0 110.249 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -130.85 155.07 47.34 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.154 0.502 . . . . 0.0 111.523 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -81.52 -14.23 57.16 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.671 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.0 m -79.53 -14.9 58.55 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.173 -0.329 . . . . 0.0 111.034 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 52.8 m -79.93 -39.55 30.06 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.324 -0.235 . . . . 0.0 111.022 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.83 -19.3 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -79.71 -33.12 41.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.8 -34.57 57.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.072 0.396 . . . . 0.0 111.114 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.0 pp -79.86 -19.92 47.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.425 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 54.0 mt -92.66 -20.98 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 117.904 0.32 . . . . 0.0 111.328 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -95.43 -14.78 23.49 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.825 -0.547 . . . . 0.0 111.922 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -111.07 26.35 10.8 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.157 0.583 . . . . 0.0 111.418 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 16.7 p -130.73 -173.89 3.21 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.985 0.421 . . . . 0.0 111.771 -176.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 129' ' ' ILE . 2.0 mp -86.49 155.54 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -128.78 152.45 48.44 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -139.6 67.6 1.38 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.405 0.621 . . . . 0.0 110.411 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 51.88 14.74 0.33 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 172.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 163.49 -14.16 0.1 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-N 118.671 0.669 . . . . 0.0 112.807 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -131.58 169.63 15.85 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 117.597 0.698 . . . . 0.0 109.319 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.71 162.74 14.15 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.401 0.143 . . . . 0.0 110.879 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.445 ' CE1' ' HG2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -143.31 136.96 28.46 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.3 mp -125.08 132.51 53.14 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 25.0 p -81.51 131.77 35.29 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.944 0.402 . . . . 0.0 112.036 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.0 m -153.25 173.58 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.298 1.439 . . . . 0.0 108.23 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.9 t -146.25 132.65 19.63 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.956 -0.465 . . . . 0.0 111.963 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.469 ' H ' ' HB ' ' A' ' 144' ' ' ILE . 15.1 m -158.65 172.69 5.81 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 125.996 1.718 . . . . 0.0 107.969 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.423 ' CD ' ' HB3' ' A' ' 141' ' ' SER . 62.2 Cg_exo -53.71 -40.31 80.26 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.623 2.882 . . . . 0.0 115.7 -172.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.8 m -91.82 -13.32 31.62 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.053 0.842 . . . . 0.0 110.816 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.497 ' CD1' ' HE3' ' A' ' 147' ' ' LYS . 37.5 mm -86.79 -37.6 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 122.769 0.428 . . . . 0.0 110.661 -171.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 59.0 mttm 46.07 51.6 10.82 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.613 0.365 . . . . 0.0 111.537 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 64.31 17.61 10.84 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.497 ' HE3' ' CD1' ' A' ' 144' ' ' ILE . 18.4 pttp -82.56 154.47 68.59 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 119.206 0.912 . . . . 0.0 109.749 174.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.445 ' HG2' ' CE1' ' A' ' 136' ' ' TYR . 90.0 Cg_endo -76.97 161.4 32.99 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.91 2.407 . . . . 0.0 112.625 172.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.6 m -114.7 151.45 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -98.13 149.96 21.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -169.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.3 mm -131.64 146.82 32.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 124.762 1.225 . . . . 0.0 110.612 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 60.4 ttp85 -158.1 101.59 1.75 Allowed Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 122.653 0.381 . . . . 0.0 110.275 172.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.58 170.79 5.13 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 124.594 3.529 . . . . 0.0 114.334 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -95.3 159.73 14.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.499 175.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.411 ' C ' HD12 ' A' ' 156' ' ' LEU . 10.0 p30 -102.03 158.67 15.99 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.036 0.534 . . . . 0.0 112.013 -176.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.411 HD12 ' C ' ' A' ' 155' ' ' ASN . 8.3 mp -108.15 36.4 2.8 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.688 0.795 . . . . 0.0 111.562 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.6 t -137.15 -24.53 1.09 Allowed 'General case' 0 C--N 1.34 0.158 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -174.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -136.26 35.98 2.76 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.649 1.113 . . . . 0.0 113.53 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.6 m -74.02 -23.64 59.45 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.951 -0.468 . . . . 0.0 112.198 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -155.35 161.73 40.99 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 117.98 0.354 . . . . 0.0 111.395 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -155.72 153.62 30.22 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.021 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.4 m -140.3 155.91 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 121.249 0.547 . . . . 0.0 112.001 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 70.5 mtm -137.53 27.57 2.78 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.244 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -155.0 171.66 19.38 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -174.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -73.27 24.74 0.88 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 123.509 0.576 . . . . 0.0 112.411 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 31.6 m 56.07 46.93 20.72 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 117.451 0.626 . . . . 0.0 112.431 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -61.1 157.79 39.91 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -53.31 148.76 31.58 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.776 2.984 . . . . 0.0 112.684 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 53.9 mt -118.06 163.34 16.76 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.623 0.769 . . . . 0.0 110.049 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -148.7 141.44 15.27 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.49 -22.01 48.73 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.438 2.759 . . . . 0.0 114.164 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -89.21 5.24 45.68 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.302 0.501 . . . . 0.0 110.948 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -130.06 18.42 5.52 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.877 0.471 . . . . 0.0 110.618 175.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 18.8 m -127.83 143.05 51.13 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.727 0.299 . . . . 0.0 110.851 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.8 tt -116.89 149.71 19.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 123.152 0.581 . . . . 0.0 110.795 -174.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.449 ' CD1' ' CE1' ' A' ' 253' ' ' TYR . 8.4 t80 -106.74 144.46 33.36 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 172.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 62.1 t -133.83 122.05 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -131.12 153.1 20.2 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.832 -0.223 . . . . 0.0 112.686 -176.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.81 39.53 4.61 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -171.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 26.9 m -118.1 54.72 1.97 Allowed Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.03 -11.63 27.44 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.71 2.273 . . . . 0.0 112.061 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.656 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 0.0 OUTLIER -139.7 -37.75 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.656 ' HD2' ' H ' ' A' ' 182' ' ' ARG . 38.9 Cg_endo -83.57 22.16 0.96 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.807 2.338 . . . . 0.0 112.867 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.607 ' H ' HD23 ' A' ' 184' ' ' LEU . 1.6 pt? -80.61 -138.87 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.037 0.535 . . . . 0.0 112.062 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.428 ' H ' ' HG ' ' A' ' 184' ' ' LEU . 45.3 ttm-85 71.2 126.42 0.03 OUTLIER 'General case' 0 C--N 1.338 0.103 0 C-N-CA 125.881 1.672 . . . . 0.0 110.551 -172.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.57 -28.5 69.68 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 64.2 t -68.7 -48.07 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 CA-C-N 117.921 0.328 . . . . 0.0 110.757 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -77.96 -31.12 50.68 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 58.6 tp -73.14 -33.87 65.77 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.401 0.28 . . . . 0.0 110.37 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.27 -37.36 60.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.078 -0.389 . . . . 0.0 111.413 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 26.2 mmt -69.4 -40.59 77.27 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.5 mt -65.15 -36.95 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.2 mmt -73.05 -18.89 61.28 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.109 -0.37 . . . . 0.0 111.219 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -93.08 -13.52 28.45 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.436 0.562 . . . . 0.0 112.124 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -93.45 -19.66 21.06 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.392 0.542 . . . . 0.0 111.897 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.6 -19.14 10.7 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 118.273 0.488 . . . . 0.0 111.482 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -140.4 42.56 1.9 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.15 137.5 3.8 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 123.71 0.672 . . . . 0.0 112.331 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 124.85 9.81 5.09 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 58.5 t -69.61 144.78 13.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 117.47 0.635 . . . . 0.0 110.345 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 15.2 p -120.22 -32.62 4.1 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.124 0.169 . . . . 0.0 111.196 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -146.29 142.05 27.93 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -148.58 157.75 43.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 170.62 -167.27 40.43 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.43 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 43.5 mm -97.1 139.94 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -58.03 122.41 12.98 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.385 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.7 t -155.38 149.04 25.25 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -119.49 139.8 28.33 Favored Pre-proline 0 N--CA 1.455 -0.186 0 C-N-CA 122.726 0.41 . . . . 0.0 110.208 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -77.4 -8.58 17.34 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 124.223 3.282 . . . . 0.0 112.498 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.6 -22.4 62.56 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.44 0.564 . . . . 0.0 111.116 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.5 mt -140.38 5.87 2.08 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.146 0.978 . . . . 0.0 110.095 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt 49.22 40.46 18.01 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.896 1.279 . . . . 0.0 112.522 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -125.19 139.04 32.82 Favored Pre-proline 0 C--O 1.231 0.119 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.56 166.52 23.84 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 122.719 2.28 . . . . 0.0 111.383 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -120.27 24.2 10.53 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 64.5 15.89 60.01 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.605 -0.553 . . . . 0.0 114.109 170.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -131.01 161.94 30.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 117.877 0.838 . . . . 0.0 110.128 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -100.63 159.09 19.19 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 112.174 -0.37 . . . . 0.0 112.174 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -153.63 148.51 26.56 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 3.9 p -150.2 148.06 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -126.28 147.7 49.65 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.109 0.564 . . . . 0.0 110.186 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -119.41 155.29 32.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.183 -174.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 57.6 m -83.19 1.56 40.01 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.21 172.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -135.9 131.11 34.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.102 0.561 . . . . 0.0 110.192 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -73.2 -12.34 60.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.4 tp60 -76.24 -38.42 56.35 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 42.1 m -74.19 -30.29 62.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -64.3 -52.11 60.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.643 -0.217 . . . . 0.0 110.586 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.39 -14.65 17.94 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 CA-C-N 118.248 0.476 . . . . 0.0 111.355 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.39 -21.86 32.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 117.78 0.263 . . . . 0.0 110.382 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.21 -8.3 42.75 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 3.5 pt -125.16 40.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 118.781 0.718 . . . . 0.0 111.572 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 32.4 m -131.14 3.99 4.38 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -129.57 10.83 5.69 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 45.39 -89.61 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -83.64 90.34 7.26 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.482 HG23 ' CD1' ' A' ' 239' ' ' LEU . 3.8 m -81.94 140.9 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.684 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 247' ' ' ARG . 34.4 mt-30 -78.31 -12.71 60.02 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.109 0.964 . . . . 0.0 112.791 -174.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.482 ' CD1' HG23 ' A' ' 237' ' ' VAL . 10.3 mp 55.94 -77.13 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.947 0.899 . . . . 0.0 112.7 -175.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 58.49 132.09 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.172 1.789 . . . . 0.0 114.374 -177.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . 0.424 ' H ' HG22 ' A' ' 244' ' ' ILE . 7.4 t60 -160.83 129.17 4.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 58.79 34.74 78.94 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 64.35 17.9 11.02 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.033 1.333 . . . . 0.0 113.876 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.424 HG22 ' H ' ' A' ' 241' ' ' HIS . 3.9 tt -83.79 177.71 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 173.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -145.46 139.42 26.84 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -142.58 174.09 10.95 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . 0.449 ' HD3' ' HA ' ' A' ' 238' ' ' GLN . 0.5 OUTLIER -146.73 144.91 29.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.175 0.443 . . . . 0.0 110.631 173.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.8 p -158.91 154.6 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.31 144.51 25.25 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.357 0.263 . . . . 0.0 110.374 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 13.6 m -126.63 157.97 37.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 120.837 0.351 . . . . 0.0 111.123 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.95 162.28 24.77 Favored Pre-proline 0 N--CA 1.455 -0.225 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 173.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.57 133.38 57.64 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.733 2.289 . . . . 0.0 108.897 173.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . 0.449 ' CE1' ' CD1' ' A' ' 176' ' ' PHE . 2.0 t80 -75.5 166.88 22.91 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.927 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.456 -0.168 0 C-N-CA 123.934 0.894 . . . . 0.0 110.961 -171.169 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.449 ' HD3' ' H ' ' A' ' 63' ' ' TYR . 14.4 tpp180 . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 120.664 0.268 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.449 ' H ' ' HD3' ' A' ' 62' ' ' ARG . 8.1 m-85 -117.84 -173.87 2.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.396 -174.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.1 t -123.66 166.03 16.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.265 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 41.7 ptt85 -77.67 37.28 0.22 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.772 0.829 . . . . 0.0 112.096 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -138.91 135.58 34.59 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.143 0.977 . . . . 0.0 110.473 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -146.64 158.66 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.519 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.1 t80 -91.8 140.43 29.7 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 169.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.2 p -127.6 125.37 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.95 148.82 18.3 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 -169.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.07 108.99 0.04 OUTLIER Glycine 0 CA--C 1.524 0.646 0 C-N-CA 125.793 1.663 . . . . 0.0 114.369 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.2 mt -141.59 145.74 38.71 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 123.881 0.872 . . . . 0.0 108.675 172.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -76.78 172.65 15.82 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.702 2.935 . . . . 0.0 110.098 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.9 172.95 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.026 3.151 . . . . 0.0 113.103 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.2 t70 61.18 -91.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.2 pt -56.12 132.28 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.886 0.85 . . . . 0.0 112.121 -176.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -170.2 155.95 5.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.644 1.178 . . . . 0.0 108.003 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 61.65 -51.62 0.13 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.749 1.62 . . . . 0.0 114.046 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -80.87 -35.18 33.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.05 0.841 . . . . 0.0 111.567 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -76.02 -28.31 57.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.282 -0.261 . . . . 0.0 110.769 -174.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.6 pt -81.99 -27.17 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 O-C-N 121.978 -0.451 . . . . 0.0 110.067 173.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.413 ' HA ' HD21 ' A' ' 91' ' ' LEU . 94.4 m -72.8 -12.45 61.0 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.09 -19.53 16.45 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 173.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.9 m -76.78 -34.74 57.99 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.546 0.612 . . . . 0.0 111.921 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -105.41 7.07 33.04 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -65.18 -18.03 64.97 Favored 'General case' 0 CA--C 1.526 0.037 0 C-N-CA 122.767 0.427 . . . . 0.0 110.946 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -69.71 -12.21 61.45 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.362 0.665 . . . . 0.0 110.877 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -111.98 16.62 20.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.951 0.5 . . . . 0.0 109.939 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.51 163.12 30.41 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.63 148.57 63.7 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.63 2.887 . . . . 0.0 112.37 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.484 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -147.92 169.17 20.43 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.615 0.366 . . . . 0.0 111.048 179.128 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 pt -137.55 175.38 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.738 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.9 p -152.51 156.26 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 122.369 -0.207 . . . . 0.0 110.758 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -155.79 172.19 18.75 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.923 0.392 . . . . 0.0 111.127 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -160.14 162.65 23.76 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.468 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 68.1 Cg_endo -71.12 -16.96 31.88 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 CA-C-N 121.334 1.512 . . . . 0.0 110.468 -171.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.468 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 2.1 m-70 -88.38 1.34 54.87 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.848 0.859 . . . . 0.0 111.137 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.498 ' HE3' ' HA ' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -63.51 -29.11 70.43 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.718 0.807 . . . . 0.0 111.128 -176.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.299 0 C-N-CA 123.883 0.873 . . . . 0.0 112.894 179.292 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.105 0 CA-C-O 118.604 -1.109 . . . . 0.0 115.61 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -88.71 151.48 22.4 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 120.22 2.01 . . . . 0.0 108.906 174.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.68 -175.66 5.46 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.66 0.267 . . . . 0.0 110.964 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -132.19 118.57 19.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.8 tt -100.47 139.71 35.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.192 0.52 . . . . 0.0 111.515 -168.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.6 mp -119.9 153.46 35.85 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.976 -172.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -139.79 -176.26 4.51 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.359 1.064 . . . . 0.0 109.702 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -111.29 -26.66 9.04 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 122.634 0.373 . . . . 0.0 110.906 -176.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -140.63 161.71 37.11 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.5 0.32 . . . . 0.0 111.293 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -79.09 -13.41 59.77 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.424 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.5 p -75.04 -22.48 58.4 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.127 0.421 . . . . 0.0 110.523 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 57.0 m -79.25 -40.67 30.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.49 -0.131 . . . . 0.0 110.935 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.9 m -73.36 -20.21 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -72.64 -37.68 67.94 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.66 -32.48 62.25 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 119.329 -0.367 . . . . 0.0 111.735 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -82.07 -14.27 56.09 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.689 0.677 . . . . 0.0 111.933 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.6 mt -95.93 -20.9 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 122.008 -0.432 . . . . 0.0 110.258 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -101.84 -8.7 21.4 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -120.86 9.98 10.79 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 34.7 m -125.94 -178.53 4.32 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.191 0.596 . . . . 0.0 109.643 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -80.17 163.53 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 O-C-N 121.737 -0.602 . . . . 0.0 111.32 -170.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -143.44 157.62 44.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.541 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -146.84 173.29 12.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.76 3.94 0.32 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -171.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -148.22 -9.36 0.19 Allowed Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.016 -0.88 . . . . 0.0 114.224 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.42 ' HE2' ' CE2' ' A' ' 136' ' ' TYR . 24.8 pttm -167.14 -171.33 1.73 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.79 1.295 . . . . 0.0 110.963 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.28 170.22 10.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.077 0.951 . . . . 0.0 110.171 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.42 ' CE2' ' HE2' ' A' ' 134' ' ' LYS . 22.4 m-85 -150.64 165.05 34.56 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.992 0.425 . . . . 0.0 111.65 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.9 tp -141.37 134.61 29.43 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 167.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.2 p -78.21 141.42 38.62 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.1 m -141.05 162.77 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 122.882 0.473 . . . . 0.0 110.419 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.1 m -86.14 10.45 14.44 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.007 0.523 . . . . 0.0 110.978 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.0 t -67.08 118.87 59.81 Favored Pre-proline 0 N--CA 1.454 -0.271 0 C-N-CA 123.658 0.783 . . . . 0.0 110.478 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -79.83 113.02 2.97 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.4 2.733 . . . . 0.0 110.799 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.601 ' C ' ' H ' ' A' ' 145' ' ' LYS . 25.8 m -117.89 63.94 0.75 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.3 mp 64.38 -22.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.185 1.394 . . . . 0.0 110.889 -171.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.601 ' H ' ' C ' ' A' ' 143' ' ' THR . 39.2 ttpt -156.66 159.23 38.23 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 127.248 2.219 . . . . 0.0 106.025 169.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.58 139.83 58.48 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.68 0.673 . . . . 0.0 110.426 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -151.35 157.3 35.03 Favored Pre-proline 0 CA--C 1.529 0.153 0 C-N-CA 122.341 0.257 . . . . 0.0 111.203 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -79.41 163.29 24.69 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.808 3.005 . . . . 0.0 111.308 171.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.9 m -107.64 150.88 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.105 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -85.84 153.02 22.54 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 117.616 0.189 . . . . 0.0 111.081 -174.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.8 mm -137.63 143.27 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.802 0.841 . . . . 0.0 110.075 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -155.55 101.67 2.2 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -77.01 164.15 30.02 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.861 3.041 . . . . 0.0 112.218 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -97.99 150.01 21.83 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 46.2 p-10 -117.05 155.9 28.44 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.524 0.678 . . . . 0.0 111.955 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.3 mp -94.95 74.74 3.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.755 -175.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.2 t -141.35 -40.52 0.38 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.926 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -153.68 135.87 14.84 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.6 m -149.29 -30.15 0.25 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.252 0.221 . . . . 0.0 111.286 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -151.42 160.03 43.94 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.622 0.769 . . . . 0.0 109.815 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -149.85 158.55 44.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.5 t -130.63 138.4 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 51.6 tpp -100.34 -10.47 21.21 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -174.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -158.62 -47.39 0.06 Allowed 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.833 -0.542 . . . . 0.0 110.628 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.66 4.98 62.88 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.227 -0.763 . . . . 0.0 114.412 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.6 t -129.71 -13.8 4.16 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.726 1.263 . . . . 0.0 112.092 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -87.09 159.73 50.57 Favored Pre-proline 0 CA--C 1.533 0.294 0 O-C-N 122.066 -0.396 . . . . 0.0 110.464 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.65 163.59 6.84 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 124.278 3.318 . . . . 0.0 113.792 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.25 128.76 21.32 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -148.4 124.96 5.39 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-O 119.305 -0.379 . . . . 0.0 110.0 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -55.11 -20.17 23.08 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.617 2.878 . . . . 0.0 113.599 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -81.03 -3.25 51.18 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.123 0.419 . . . . 0.0 111.04 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -127.01 28.7 5.74 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 51.3 m -121.08 145.22 48.03 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.9 tt -115.9 149.52 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 123.085 0.554 . . . . 0.0 110.154 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.483 ' HB2' ' CD1' ' A' ' 253' ' ' TYR . 6.8 t80 -108.4 143.99 36.58 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 97.2 t -137.78 124.2 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -175.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -132.53 162.6 24.09 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 112.413 -0.275 . . . . 0.0 112.413 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.62 16.26 58.75 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -172.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.9 m -71.47 152.3 93.95 Favored Pre-proline 0 N--CA 1.456 -0.174 0 C-N-CA 122.706 0.402 . . . . 0.0 111.563 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -76.83 171.81 17.33 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 124.001 3.134 . . . . 0.0 109.965 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 48.5 tpt85 -73.51 -48.35 7.01 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -80.02 32.38 0.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.417 2.745 . . . . 0.0 112.634 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -61.37 -33.08 73.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.537 0.608 . . . . 0.0 112.319 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 54.23 122.01 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.704 2.002 . . . . 0.0 113.941 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.25 -29.06 70.17 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.777 -0.577 . . . . 0.0 111.783 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 65.7 t -68.36 -48.35 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 122.295 0.238 . . . . 0.0 111.167 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -82.89 -20.87 34.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.9 -0.137 . . . . 0.0 110.923 -174.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 42.1 tp -71.51 -33.24 69.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' A' ' 203' ' ' ALA . . . -74.45 -37.07 63.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.324 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 25.7 mmt -70.74 -34.04 71.45 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 62.4 mt -68.91 -37.31 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -71.58 -21.95 61.8 Favored 'General case' 0 N--CA 1.457 -0.106 0 O-C-N 121.856 -0.528 . . . . 0.0 110.339 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -86.7 -13.28 45.86 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 122.115 -0.366 . . . . 0.0 111.526 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -98.62 -21.21 16.58 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.36 -13.5 14.86 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.55 0.613 . . . . 0.0 111.954 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -140.44 -34.77 0.52 Allowed 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 118.673 0.67 . . . . 0.0 112.367 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.33 -178.33 18.12 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 69.6 10.96 64.67 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 119.411 -0.661 . . . . 0.0 112.899 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 22.1 t -72.77 147.02 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 118.248 1.024 . . . . 0.0 109.958 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.8 p -128.9 -24.97 2.86 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 119.625 -0.226 . . . . 0.0 111.455 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -150.46 149.98 30.71 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.007 0.367 . . . . 0.0 110.758 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 190' ' ' ALA . . . -160.92 156.38 24.84 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.92 0.488 . . . . 0.0 110.332 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 158.55 -165.22 33.89 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.448 ' N ' HD12 ' A' ' 205' ' ' ILE . 3.1 mp -100.65 130.58 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -56.2 114.91 2.16 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 89.6 m -143.71 157.48 44.36 Favored 'General case' 0 N--CA 1.458 -0.075 0 O-C-N 123.441 0.463 . . . . 0.0 110.279 -172.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -135.85 132.51 19.46 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.882 0.873 . . . . 0.0 108.916 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -80.86 -6.97 13.37 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 124.202 3.268 . . . . 0.0 114.558 -172.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -112.06 -41.02 4.05 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.993 1.27 . . . . 0.0 114.239 -172.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.5 pp -161.12 -15.88 0.05 OUTLIER 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -88.49 -26.51 22.02 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.759 1.163 . . . . 0.0 111.691 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.517 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 29.7 m-85 56.5 -178.7 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.83 0.852 . . . . 0.0 113.215 172.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.517 ' CD ' ' HB3' ' A' ' 213' ' ' TYR . 77.4 Cg_exo -54.26 153.16 22.81 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.026 2.484 . . . . 0.0 112.864 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -104.61 5.7 33.93 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.918 0.887 . . . . 0.0 111.169 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 66.81 10.67 55.97 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 112.19 -0.364 . . . . 0.0 112.19 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -141.39 149.2 40.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.262 0.625 . . . . 0.0 110.341 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -92.32 166.25 29.37 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.813 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -147.24 150.98 35.92 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 62.0 t -142.19 142.01 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.88 145.72 48.92 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -123.52 151.98 42.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.638 -176.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 54.4 m -84.25 2.8 38.3 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.075 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -137.82 138.13 38.86 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.955 0.502 . . . . 0.0 110.082 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -74.4 -14.9 60.92 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.4 tp60 -76.82 -38.44 53.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 31.7 m -75.16 -26.48 59.13 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -67.44 -50.33 59.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 119.545 -0.265 . . . . 0.0 110.37 176.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -72.32 -12.66 15.99 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 CA-C-N 118.163 0.438 . . . . 0.0 111.158 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.07 -23.55 28.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 174.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -85.94 -23.05 27.1 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 11.5 pt -106.6 25.25 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 C-N-CA 122.859 0.464 . . . . 0.0 110.311 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -79.64 -13.26 59.62 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.074 0.549 . . . . 0.0 112.033 -175.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -156.6 143.72 18.85 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -55.65 -36.07 66.64 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.692 0.397 . . . . 0.0 111.558 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -115.79 105.68 12.98 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 18.0 m -88.5 160.04 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.425 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -84.97 139.85 31.5 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.802 0.334 . . . . 0.0 110.249 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.49 104.2 6.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 172.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -137.67 153.0 49.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.371 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -146.51 20.08 1.34 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.187 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.29 130.17 3.01 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 52.85 17.82 0.94 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.425 1.09 . . . . 0.0 112.933 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 76.1 mt -140.52 149.33 21.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 123.97 0.908 . . . . 0.0 109.296 -178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -153.74 133.4 12.97 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -145.32 161.25 40.05 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.254 1.022 . . . . 0.0 109.025 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.86 155.17 44.73 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 123.361 0.664 . . . . 0.0 109.826 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.3 p -158.38 159.22 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 122.961 0.505 . . . . 0.0 109.981 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -83.68 141.35 31.55 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.112 0.565 . . . . 0.0 110.831 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.88 162.54 31.32 Favored 'Isoleucine or valine' 0 C--N 1.338 0.092 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.82 158.92 29.58 Favored Pre-proline 0 N--CA 1.455 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.823 170.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.76 134.74 62.5 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.461 2.108 . . . . 0.0 108.087 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . 0.483 ' CD1' ' HB2' ' A' ' 176' ' ' PHE . 0.7 OUTLIER -77.01 170.51 16.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.192 -175.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 CA--C 1.529 0.161 0 C-N-CA 123.669 0.788 . . . . 0.0 110.829 -170.43 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.131 0 CA-C-O 120.767 0.317 . . . . 0.0 111.717 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -156.95 170.66 22.01 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.544 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.1 t -95.89 165.45 12.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.401 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -84.72 9.44 13.99 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.836 0.454 . . . . 0.0 111.005 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -128.83 141.46 51.29 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 121.14 0.495 . . . . 0.0 110.168 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 p -147.8 147.86 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.306 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -87.04 145.14 26.59 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 177.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.9 p -128.63 122.91 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -110.27 175.03 18.02 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-O 121.307 0.393 . . . . 0.0 112.175 -175.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.45 29.75 74.34 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.379 -0.41 . . . . 0.0 113.39 171.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.1 mt -69.15 142.44 92.85 Favored Pre-proline 0 N--CA 1.45 -0.462 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.11 174.88 11.69 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.233 2.622 . . . . 0.0 109.567 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -54.74 -9.38 1.79 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 124.742 3.628 . . . . 0.0 114.32 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 77' ' ' ASP . 9.9 m-20 -125.5 -123.46 0.25 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER 63.55 -25.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 75' ' ' ASP . 4.2 p-10 39.26 -113.88 0.15 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.563 1.545 . . . . 0.0 113.114 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -127.27 -19.85 4.21 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.104 0.961 . . . . 0.0 110.487 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -80.95 -46.58 14.93 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.845 -0.535 . . . . 0.0 112.036 -174.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -68.03 -34.05 75.75 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.631 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.7 pt -84.25 -29.87 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 O-C-N 122.052 -0.405 . . . . 0.0 111.21 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 97.2 m -70.71 -12.93 61.86 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.49 0.586 . . . . 0.0 109.42 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.91 -15.45 15.14 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.6 m -82.18 -36.68 27.09 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.025 0.83 . . . . 0.0 112.461 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -98.08 1.56 47.77 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.4 ttt85 -78.43 -4.91 50.72 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -77.03 -11.09 59.76 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.737 0.415 . . . . 0.0 111.762 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -108.03 -19.12 13.61 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.443 0.297 . . . . 0.0 110.629 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.92 161.0 10.93 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.45 140.18 93.57 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.387 2.725 . . . . 0.0 111.906 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.532 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -151.77 164.53 36.81 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.274 0.23 . . . . 0.0 111.582 178.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 93' ' ' VAL . 26.8 mm -134.48 164.08 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.403 ' N ' HG22 ' A' ' 92' ' ' ILE . 7.5 p -128.24 146.44 33.74 Favored 'Isoleucine or valine' 0 C--O 1.23 0.079 0 CA-C-N 118.324 0.511 . . . . 0.0 110.243 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -150.0 166.78 28.65 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.085 0.469 . . . . 0.0 110.781 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.479 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 17.1 p90 -148.4 160.37 36.78 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.651 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 69.6 Cg_endo -70.0 -8.94 24.86 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 124.467 3.445 . . . . 0.0 111.72 -170.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.651 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 60.2 m-70 -101.47 5.15 41.84 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.091 0.556 . . . . 0.0 112.16 -176.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.412 ' HG3' ' CD1' ' A' ' 95' ' ' TRP . 50.9 mtpt -70.17 161.22 30.66 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 121.659 0.742 . . . . 0.0 112.113 -177.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.458 0 C-N-CA 124.829 1.251 . . . . 0.0 111.04 -175.56 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.615 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.31 148.65 33.66 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.346 1.073 . . . . 0.0 110.149 176.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.45 -176.46 5.6 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.965 0.506 . . . . 0.0 110.606 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -139.26 136.93 35.45 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -103.01 149.93 24.06 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 mp -111.23 143.01 42.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 171.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -130.62 162.87 28.39 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.202 0.525 . . . . 0.0 111.072 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -100.84 -32.3 10.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.693 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -113.53 151.51 31.47 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -88.65 -11.84 44.17 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.871 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.8 m -102.45 -7.02 22.29 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 122.932 0.493 . . . . 0.0 111.029 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.8 t -71.67 -35.14 70.22 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.0 m -73.71 -25.23 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -77.01 -29.5 55.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.405 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.5 -36.67 57.65 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.497 0.589 . . . . 0.0 110.899 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -76.72 -18.37 58.54 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.778 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.405 HG23 HD22 ' A' ' 135' ' ' LEU . 35.8 mt -91.97 -18.72 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 122.377 0.271 . . . . 0.0 111.203 177.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -100.98 -10.02 20.94 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.534 -0.728 . . . . 0.0 112.514 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.56 14.63 13.63 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 73.2 m -132.79 -171.38 2.65 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.959 0.345 . . . . 0.0 111.846 -175.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.46 ' N ' HD12 ' A' ' 129' ' ' ILE . 3.5 mp -74.97 154.67 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.296 1.038 . . . . 0.0 109.159 -171.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 135' ' ' LEU . 12.7 pt-20 -133.24 161.64 33.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.494 0.188 . . . . 0.0 111.178 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.46 177.41 9.07 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -46.36 -24.74 0.53 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -169.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -153.67 5.2 0.34 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-N 119.184 0.902 . . . . 0.0 113.384 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -146.06 -171.75 3.78 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 117.949 0.874 . . . . 0.0 109.127 -175.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.405 HD22 HG23 ' A' ' 125' ' ' ILE . 4.5 mp -134.89 166.54 22.77 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.376 -0.202 . . . . 0.0 111.116 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 149' ' ' VAL . 17.4 m-85 -138.1 156.45 47.76 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.155 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.2 mp -134.04 157.45 46.07 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 73.5 m -100.28 135.11 42.21 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.182 0.447 . . . . 0.0 110.721 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.9 m -144.12 164.46 14.26 Favored 'Isoleucine or valine' 0 C--N 1.338 0.067 0 C-N-CA 123.694 0.798 . . . . 0.0 109.923 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.4 t -70.63 151.41 45.01 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 120.54 0.209 . . . . 0.0 110.559 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.3 t -156.02 139.05 10.77 Favored Pre-proline 0 N--CA 1.456 -0.151 0 C-N-CA 122.646 0.379 . . . . 0.0 110.408 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -79.13 -0.08 10.45 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.55 3.5 . . . . 0.0 114.046 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.443 ' HB ' HD13 ' A' ' 144' ' ' ILE . 49.2 m -93.97 -10.99 31.84 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.077 0.853 . . . . 0.0 108.998 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.443 HD13 ' HB ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -154.97 -155.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 126.94 2.096 . . . . 0.0 106.668 -174.083 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -94.71 -36.94 11.52 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -162.07 154.63 19.76 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.896 1.279 . . . . 0.0 108.296 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 148' ' ' PRO . 23.4 ttpp -143.5 138.6 15.56 Favored Pre-proline 0 CA--C 1.528 0.114 0 CA-C-N 118.171 0.441 . . . . 0.0 112.088 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 147' ' ' LYS . 46.8 Cg_exo -59.58 140.32 93.29 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.596 2.864 . . . . 0.0 111.678 169.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 33.0 m -126.33 143.07 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -87.74 150.74 23.41 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.9 mm -129.24 143.45 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 124.807 1.243 . . . . 0.0 110.419 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 47.8 ttp85 -159.13 97.68 1.65 Allowed Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -62.99 167.21 12.63 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 124.12 3.213 . . . . 0.0 113.497 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -87.2 147.37 25.62 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 172.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -107.35 147.95 29.67 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.349 0.595 . . . . 0.0 111.743 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 156' ' ' LEU . 6.3 mp -98.42 93.54 6.23 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 t -158.18 -39.76 0.06 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.475 ' CG ' ' HE ' ' A' ' 185' ' ' ARG . 16.0 m-20 -143.91 39.58 1.36 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.3 m -67.53 -19.41 65.29 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -155.83 160.03 39.88 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.303 0.641 . . . . 0.0 110.835 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -154.11 151.88 29.78 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.09 143.39 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . 0.466 ' SD ' ' HB1' ' A' ' 190' ' ' ALA . 90.0 mtp -129.41 3.19 5.1 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -175.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -156.17 -40.93 0.08 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.766 0.712 . . . . 0.0 112.322 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 155.81 12.14 0.06 OUTLIER Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.428 -0.651 . . . . 0.0 112.886 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.0 m 54.59 56.4 6.83 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 117.981 0.89 . . . . 0.0 112.167 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -57.8 159.41 10.06 Favored Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -59.45 145.44 97.94 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.692 2.261 . . . . 0.0 109.72 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 72.0 mt -121.09 166.84 13.34 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.101 0.477 . . . . 0.0 112.211 -171.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -141.3 155.35 67.84 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.26 -6.83 20.04 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.142 2.561 . . . . 0.0 111.026 -176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -101.96 5.56 40.83 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.107 0.963 . . . . 0.0 111.464 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -129.33 14.72 6.13 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.798 0.439 . . . . 0.0 111.088 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.6 m -132.45 142.56 49.3 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.178 0.191 . . . . 0.0 111.086 -174.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.4 tt -112.04 152.01 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 123.219 0.607 . . . . 0.0 110.343 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -121.16 143.23 49.22 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 35.3 m -139.01 149.68 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-O 120.663 0.268 . . . . 0.0 110.704 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -146.0 165.92 28.04 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 79.14 20.85 69.0 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -173.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 19.4 m -61.06 153.27 67.47 Favored Pre-proline 0 CA--C 1.529 0.171 0 C-N-CA 122.9 0.48 . . . . 0.0 111.956 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.14 168.76 21.14 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.755 2.97 . . . . 0.0 109.563 173.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -65.6 -47.44 67.38 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -173.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.52 -51.75 0.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 121.617 1.545 . . . . 0.0 112.254 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.1 tp 50.7 -72.48 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.537 1.935 . . . . 0.0 114.548 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.475 ' HE ' ' CG ' ' A' ' 158' ' ' ASP . 63.2 mtp180 61.97 127.66 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 127.521 2.328 . . . . 0.0 112.43 -174.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.46 -22.96 66.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.397 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 59.0 t -72.56 -47.83 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 122.341 0.256 . . . . 0.0 110.638 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -80.65 -32.89 36.03 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 55.6 tp -66.26 -34.0 77.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.468 ' HB2' ' CB ' ' A' ' 203' ' ' ALA . . . -86.73 -25.32 24.77 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -175.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 20.7 mmt -70.6 -33.83 71.49 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.4 mt -72.55 -39.76 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 20.1 mmt -60.08 -24.76 64.85 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 119.231 -0.414 . . . . 0.0 111.605 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -88.25 -20.17 25.83 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.923 0.783 . . . . 0.0 111.412 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.19 -18.73 33.18 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.871 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.38 -23.96 7.58 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 118.147 0.43 . . . . 0.0 111.042 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -135.29 45.3 2.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.893 0.477 . . . . 0.0 110.024 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -45.12 138.36 5.79 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.431 0.539 . . . . 0.0 112.117 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 123.52 9.87 5.72 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 222' ' ' PHE . 5.2 p -71.02 160.46 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.847 0.859 . . . . 0.0 110.555 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 52.4 t -134.91 -35.64 0.85 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.638 0.606 . . . . 0.0 112.638 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -150.74 155.82 40.06 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.763 0.256 . . . . 0.0 110.766 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . 0.468 ' CB ' ' HB2' ' A' ' 190' ' ' ALA . . . -154.2 159.42 41.35 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.025 0.441 . . . . 0.0 110.181 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 175.22 -175.67 47.17 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.7 mm -97.46 144.68 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -60.74 123.38 17.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 52.5 p -134.97 140.48 45.73 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -85.08 128.03 61.83 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -76.47 -10.88 18.94 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.263 3.309 . . . . 0.0 112.565 -174.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -69.23 -29.68 67.68 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.428 0.291 . . . . 0.0 110.53 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.13 6.71 1.76 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.453 0.701 . . . . 0.0 111.592 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 51.81 48.65 22.39 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.198 1.399 . . . . 0.0 113.904 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -123.15 152.18 63.17 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.965 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.55 171.72 16.58 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 124.206 3.271 . . . . 0.0 112.639 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 12.9 ttmt -134.69 19.31 3.56 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.68 0.792 . . . . 0.0 111.38 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 63.0 16.57 57.59 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 119.61 -0.55 . . . . 0.0 113.535 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -130.34 155.27 46.63 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.877 0.838 . . . . 0.0 109.982 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -105.98 160.56 14.7 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 112.426 -0.27 . . . . 0.0 112.426 -175.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -151.03 144.94 25.2 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 99.6 t -140.01 148.34 22.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -130.2 147.51 51.93 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.722 0.296 . . . . 0.0 110.845 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 200' ' ' VAL . 14.0 m-85 -128.05 156.7 42.35 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.598 -176.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 74.1 m -77.84 -7.58 56.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -131.87 145.76 51.72 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.101 0.409 . . . . 0.0 111.085 -176.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -71.78 -22.55 61.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -70.22 -38.21 75.19 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 17.9 m -72.35 -29.91 64.24 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -70.09 -51.6 30.49 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 119.622 -0.228 . . . . 0.0 111.118 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.7 pt -69.11 -15.74 20.02 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 CA-C-N 118.289 0.495 . . . . 0.0 110.735 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.18 -27.52 29.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.17 -25.61 36.69 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 8.1 pt -105.09 24.98 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.022 0.529 . . . . 0.0 110.44 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -78.86 -11.38 59.99 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.247 0.619 . . . . 0.0 111.932 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.55 143.0 21.68 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -56.26 -33.23 65.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.778 0.431 . . . . 0.0 111.989 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -123.62 114.63 20.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.04 0.448 . . . . 0.0 110.633 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.5 m -87.55 147.61 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.136 173.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -83.21 134.12 34.98 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -121.61 21.25 10.93 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -66.86 149.35 50.71 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -147.0 8.58 0.95 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.624 0.25 . . . . 0.0 111.313 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 163.31 -137.36 4.74 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -176.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -74.63 -4.79 39.28 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.98 0.39 . . . . 0.0 110.502 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 244' ' ' ILE . 1.9 mp -87.2 153.54 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.034 0.934 . . . . 0.0 108.963 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -134.68 135.73 42.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.893 0.378 . . . . 0.0 110.603 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -145.39 147.67 32.5 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.442 1.097 . . . . 0.0 109.199 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 161.63 42.33 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.271 0.628 . . . . 0.0 109.504 177.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.0 p -154.59 152.16 9.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -88.76 128.4 35.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.469 ' C ' ' HE2' ' A' ' 251' ' ' LYS . 1.5 m -104.56 156.34 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -174.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.469 ' HE2' ' C ' ' A' ' 250' ' ' VAL . 0.0 OUTLIER -156.15 158.48 31.6 Favored Pre-proline 0 N--CA 1.456 -0.147 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.891 170.205 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.91 140.56 92.28 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.777 2.318 . . . . 0.0 109.917 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -91.49 175.82 6.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.924 0.392 . . . . 0.0 110.505 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.451 -0.393 0 C-N-CA 123.375 0.67 . . . . 0.0 109.846 -170.859 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.801 0.334 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.413 ' HA ' ' HG ' ' A' ' 156' ' ' LEU . 0.3 OUTLIER -147.59 171.35 15.72 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.569 177.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.9 t -89.22 169.0 11.82 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.507 0.723 . . . . 0.0 111.666 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 49.1 ptt85 -77.42 5.57 8.56 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.709 0.804 . . . . 0.0 111.118 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -108.21 130.89 55.13 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.336 -0.986 . . . . 0.0 108.336 174.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.1 p -150.54 146.44 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.458 -170.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.427 ' CZ ' ' HA3' ' A' ' 70' ' ' GLY . 8.3 t80 -83.25 135.57 34.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.9 t -137.75 78.16 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 110' ' ' TYR . . . -120.28 159.62 15.11 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.946 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.45 5.92 33.86 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.579 ' H ' HD23 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -73.69 173.4 6.36 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 171.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 72' ' ' LEU . 50.2 Cg_endo -80.9 155.51 20.22 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 CA-C-N 120.677 1.277 . . . . 0.0 110.292 -174.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 27.0 Cg_exo -64.95 13.39 0.1 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.92 3.08 . . . . 0.0 112.755 173.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 73' ' ' PRO . 12.2 m-20 -134.29 26.82 3.82 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -172.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 mt -123.93 152.05 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -126.11 -176.19 3.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.286 0.634 . . . . 0.0 110.933 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -51.4 -23.76 4.16 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.367 1.067 . . . . 0.0 113.139 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -79.64 -37.44 36.04 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.715 0.688 . . . . 0.0 112.472 -175.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -84.7 -25.45 28.37 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.41 0.55 . . . . 0.0 110.671 -174.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 52.9 mt -75.03 -42.71 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.9 m -66.51 -26.24 67.07 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.44 -20.77 46.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.234 -0.291 . . . . 0.0 111.541 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 m -85.34 -25.05 27.36 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.561 ' CE1' HD23 ' A' ' 137' ' ' LEU . 87.6 m-85 -117.58 1.98 12.31 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -174.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -80.6 -2.73 47.6 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.095 0.861 . . . . 0.0 112.09 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.529 ' HG3' ' CD2' ' A' ' 88' ' ' PHE . 12.7 ptp180 -77.12 -7.46 55.82 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.439 0.696 . . . . 0.0 112.149 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.529 ' CD2' ' HG3' ' A' ' 87' ' ' ARG . 71.3 m-85 -121.73 2.72 10.07 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.394 0.277 . . . . 0.0 111.699 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.45 162.37 9.31 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.0 139.24 46.4 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.072 2.515 . . . . 0.0 110.759 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.502 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -155.59 169.77 23.54 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.845 0.458 . . . . 0.0 111.333 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.5 pt -135.98 163.02 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 172.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.9 149.69 20.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -154.29 171.76 18.73 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.1 0.952 . . . . 0.0 112.494 -175.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.422 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 2.9 p90 -146.73 158.28 46.24 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 174.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.611 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 74.3 Cg_endo -63.14 -14.72 43.52 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 124.023 3.149 . . . . 0.0 112.996 -168.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.611 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 3.3 m170 -105.68 -34.29 7.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.927 0.331 . . . . 0.0 111.087 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 98' ' ' LYS . 12.0 tptm 42.04 27.98 0.09 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.063 1.745 . . . . 0.0 113.634 -174.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.384 0 C-N-CA 124.585 1.154 . . . . 0.0 112.914 179.52 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.977 0 CA-C-O 119.923 -0.376 . . . . 0.0 113.853 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.457 ' HA ' ' HA2' ' A' ' 70' ' ' GLY . 0.4 OUTLIER -145.17 134.25 22.67 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 118.545 1.173 . . . . 0.0 111.079 170.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.31 -169.25 3.33 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.627 1.171 . . . . 0.0 109.37 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -134.8 151.02 50.6 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -176.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mp -108.24 151.04 26.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.585 0.707 . . . . 0.0 112.004 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.9 99.69 6.05 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -84.28 156.65 21.86 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.822 0.344 . . . . 0.0 110.232 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -86.35 -29.0 23.3 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.208 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -128.08 156.64 42.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -80.23 -19.86 45.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.218 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.0 m -90.44 -16.14 29.56 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.699 0.4 . . . . 0.0 111.14 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 18.8 m -72.67 -41.36 65.47 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.57 -13.97 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.849 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -78.4 -35.31 47.29 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.062 -0.398 . . . . 0.0 110.028 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.26 -37.5 57.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 117.83 0.287 . . . . 0.0 111.122 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.404 ' CD1' HG13 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -66.01 -38.16 87.75 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.415 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.404 HG13 ' CD1' ' A' ' 124' ' ' LEU . 52.3 mt -85.1 -10.73 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 121.422 -0.799 . . . . 0.0 111.925 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -102.26 -5.14 24.64 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.805 -0.559 . . . . 0.0 112.038 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -126.6 6.68 6.84 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 81.6 m -112.78 -179.48 3.67 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.865 0.757 . . . . 0.0 111.066 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.472 ' N ' HD12 ' A' ' 129' ' ' ILE . 3.0 mp -68.72 147.98 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -171.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -130.69 151.91 50.62 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.545 0.212 . . . . 0.0 111.096 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.41 67.5 1.36 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.303 0.573 . . . . 0.0 110.26 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 52.72 12.23 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.45 -18.81 0.09 OUTLIER Glycine 0 CA--C 1.526 0.77 0 CA-C-N 118.682 0.673 . . . . 0.0 112.386 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -127.03 174.31 8.98 Favored 'General case' 0 C--N 1.338 0.07 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.4 167.95 20.1 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.032 0.378 . . . . 0.0 111.583 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.475 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 31.9 m-85 -139.09 159.17 42.78 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.795 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.561 HD23 ' CE1' ' A' ' 85' ' ' PHE . 54.8 tp -150.47 158.58 44.32 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 169.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 84.7 m -95.26 167.97 11.03 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.891 -0.506 . . . . 0.0 111.954 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.15 164.78 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.933 0.893 . . . . 0.0 109.838 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.1 m -104.48 2.37 30.91 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.442 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 45.3 m -133.86 48.34 3.18 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 118.294 0.497 . . . . 0.0 111.546 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 141' ' ' SER . 62.0 Cg_endo -65.03 155.22 69.43 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.172 3.248 . . . . 0.0 111.905 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.805 HG23 HG13 ' A' ' 144' ' ' ILE . 14.8 t -89.12 -9.98 49.02 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.031 0.533 . . . . 0.0 111.513 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.805 HG13 HG23 ' A' ' 143' ' ' THR . 64.7 mt -141.23 175.01 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -176.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.474 ' H ' HG22 ' A' ' 144' ' ' ILE . 1.7 tmmt? -56.85 -24.82 54.17 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.998 -0.439 . . . . 0.0 111.284 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -141.97 150.3 41.2 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.873 0.869 . . . . 0.0 109.631 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.477 ' HE2' HG22 ' A' ' 143' ' ' THR . 0.1 OUTLIER -158.95 70.0 3.5 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 122.703 0.401 . . . . 0.0 110.02 174.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.475 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 72.1 Cg_endo -68.76 124.0 11.03 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.077 1.851 . . . . 0.0 109.115 175.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.7 140.33 16.13 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -91.67 153.06 19.93 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.734 0.414 . . . . 0.0 110.857 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.9 mm -126.6 136.26 61.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.342 0.657 . . . . 0.0 110.303 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -147.83 96.85 4.01 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -78.7 165.07 25.17 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.614 2.876 . . . . 0.0 110.828 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.45 ' CD2' ' HG2' ' A' ' 214' ' ' PRO . 47.1 t-105 -82.15 111.41 18.24 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 121.9 -0.5 . . . . 0.0 111.001 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -70.62 148.91 47.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.413 ' HG ' ' HA ' ' A' ' 63' ' ' TYR . 35.7 mt -119.14 101.34 7.93 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.201 0.524 . . . . 0.0 111.076 -169.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.7 t -164.85 -32.23 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.737 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -140.5 42.47 1.88 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.384 0.274 . . . . 0.0 111.332 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.6 t -66.57 -32.46 73.81 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -176.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -151.44 158.27 43.45 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.004 0.522 . . . . 0.0 110.49 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.43 ' CD2' ' HA ' ' A' ' 187' ' ' VAL . 58.3 t80 -156.24 153.42 29.13 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.4 p -144.73 149.25 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 67.5 mtm -117.16 13.43 14.7 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -173.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -160.55 -41.63 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.32 7.4 38.87 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.302 -0.721 . . . . 0.0 113.335 175.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.9 m -133.72 -0.23 3.19 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -86.81 150.31 50.17 Favored Pre-proline 0 CA--C 1.529 0.148 0 CA-C-N 119.839 1.2 . . . . 0.0 110.448 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.36 148.64 49.26 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.093 2.529 . . . . 0.0 109.659 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 77.1 mt -133.75 152.27 51.83 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.161 0.584 . . . . 0.0 109.871 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -145.29 153.28 52.17 Favored Pre-proline 0 N--CA 1.455 -0.186 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -59.19 -20.12 53.18 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.318 2.679 . . . . 0.0 112.353 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.9 6.56 38.73 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.418 0.687 . . . . 0.0 110.741 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -129.72 19.42 5.63 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 122.833 0.453 . . . . 0.0 110.455 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 30.2 m -125.12 139.92 53.35 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.72 0.295 . . . . 0.0 111.133 -175.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.8 tt -110.92 150.78 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.17 0.588 . . . . 0.0 109.77 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -120.43 140.48 51.3 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.7 m -135.92 142.16 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -156.05 -173.86 25.15 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 118.454 0.57 . . . . 0.0 113.05 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 76.05 28.75 59.9 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.1 146.84 53.69 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.811 0.306 . . . . 0.0 111.24 -171.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.414 ' C ' ' HD2' ' A' ' 183' ' ' PRO . 73.4 Cg_endo -68.28 -172.35 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.536 2.824 . . . . 0.0 110.158 169.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.48 ' N ' ' CD ' ' A' ' 183' ' ' PRO . 0.0 OUTLIER -95.35 5.31 0.06 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 117.737 2.495 . . . . 0.0 117.737 -172.247 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 182' ' ' ARG . 66.4 Cg_endo -76.17 6.19 4.05 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 122.505 1.93 . . . . 0.0 112.64 -175.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 57.4 mt -64.49 -35.79 82.09 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.513 0.597 . . . . 0.0 110.881 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 59.36 125.11 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.091 1.356 . . . . 0.0 112.162 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.6 -30.17 70.51 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.548 -0.72 . . . . 0.0 111.56 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.43 ' HA ' ' CD2' ' A' ' 161' ' ' PHE . 54.3 t -67.74 -50.85 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 120.609 0.242 . . . . 0.0 110.847 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -79.53 -24.97 41.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.482 -0.137 . . . . 0.0 110.781 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.1 tp -67.2 -34.55 77.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.09 -35.88 59.16 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.212 -0.305 . . . . 0.0 111.473 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 57.7 mtt -73.11 -33.73 65.74 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.324 -0.235 . . . . 0.0 111.083 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.436 HG21 ' HA ' ' A' ' 239' ' ' LEU . 72.2 mt -78.11 -39.53 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 121.151 -0.219 . . . . 0.0 110.683 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.3 mmt -63.14 -26.44 68.82 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.592 0.633 . . . . 0.0 110.513 172.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -85.42 -16.92 38.16 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.816 -0.552 . . . . 0.0 111.677 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.63 -18.27 22.37 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.239 -0.41 . . . . 0.0 111.574 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -114.03 -14.49 12.4 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -137.62 -29.96 0.85 Allowed 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.651 0.659 . . . . 0.0 112.211 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.86 -176.47 25.25 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 71.42 7.54 64.35 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.372 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.462 HG22 ' CE2' ' A' ' 222' ' ' PHE . 22.0 t -77.2 151.24 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 CA-C-N 118.127 0.963 . . . . 0.0 110.108 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 44.3 t -133.12 -42.86 0.88 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 119.619 -0.229 . . . . 0.0 110.949 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -136.66 150.59 48.58 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -173.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.06 163.36 39.99 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.255 0.55 . . . . 0.0 111.988 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -178.34 169.46 41.16 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.1 mm -94.0 93.76 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 38.0 t70 41.61 -84.43 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -169.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.48 ' H ' ' HA ' ' A' ' 214' ' ' PRO . 16.2 m 52.79 50.46 18.03 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.444 0.64 . . . . 0.0 111.016 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.24 140.6 88.0 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.739 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -81.33 -16.18 9.68 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 124.263 3.309 . . . . 0.0 113.575 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -100.21 -36.66 9.22 Favored 'General case' 0 C--N 1.338 0.069 0 CA-C-N 118.613 0.642 . . . . 0.0 110.979 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.94 -3.89 53.72 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt 56.17 115.2 0.01 OUTLIER 'General case' 0 C--N 1.34 0.155 0 C-N-CA 126.798 2.039 . . . . 0.0 113.492 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.44 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 70.7 m-85 65.34 170.05 0.1 Allowed Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.338 1.055 . . . . 0.0 111.566 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.48 ' HA ' ' H ' ' A' ' 207' ' ' THR . 50.8 Cg_exo -56.62 163.07 7.46 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.701 2.934 . . . . 0.0 115.486 -170.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -123.63 35.09 4.92 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.556 176.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 64.35 26.06 70.36 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -145.12 164.94 29.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.527 0.731 . . . . 0.0 110.169 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -116.32 164.65 12.27 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -146.83 149.97 34.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 93.5 t -141.23 144.16 26.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -125.33 143.49 50.94 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.213 0.53 . . . . 0.0 110.336 -178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.462 ' CE2' HG22 ' A' ' 200' ' ' VAL . 55.4 m-85 -117.47 152.78 34.33 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.639 -175.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 71.1 p -84.36 2.24 41.39 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.77 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -137.42 139.13 40.49 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.325 0.65 . . . . 0.0 110.316 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 11.8 tm0? -73.98 -22.01 59.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -71.37 -38.95 71.51 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.5 m -73.25 -29.49 62.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -66.0 -48.93 69.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.635 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.4 pp -72.93 -10.7 14.22 Favored 'Isoleucine or valine' 0 C--N 1.338 0.084 0 CA-C-N 118.515 0.598 . . . . 0.0 111.139 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.42 -23.94 27.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 117.602 0.183 . . . . 0.0 110.52 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -85.01 -23.92 28.44 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 10.4 pt -102.98 26.27 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 123.092 0.557 . . . . 0.0 110.474 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.2 t -90.9 2.52 56.12 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.537 0.735 . . . . 0.0 111.564 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -139.83 -156.68 0.7 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -128.65 -35.76 1.89 Allowed 'General case' 0 C--O 1.227 -0.106 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -127.88 104.54 7.87 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.9 m -64.32 149.76 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.763 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.526 ' C ' HD22 ' A' ' 239' ' ' LEU . 17.8 mm-40 -91.36 138.2 31.76 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.526 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.2 mm? -127.52 22.64 6.42 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -87.85 133.97 33.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.244 0.618 . . . . 0.0 111.69 -172.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -147.09 22.9 1.2 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.885 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.7 135.82 4.89 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 54.13 7.54 0.13 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.05 1.34 . . . . 0.0 113.82 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.4 mt -144.54 142.63 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 C-N-CA 123.486 0.715 . . . . 0.0 109.292 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -150.99 138.07 19.18 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -144.37 161.42 39.02 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -155.55 158.28 38.18 Favored 'General case' 0 N--CA 1.46 0.054 0 CA-C-N 118.117 0.417 . . . . 0.0 110.221 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 12.7 p -158.66 152.21 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -86.13 126.72 34.42 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.46 ' C ' ' HE2' ' A' ' 251' ' ' LYS . 4.3 m -97.46 155.01 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.46 ' HE2' ' C ' ' A' ' 250' ' ' VAL . 0.0 OUTLIER -155.48 157.47 31.62 Favored Pre-proline 0 C--O 1.231 0.103 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.591 170.151 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.01 138.23 84.9 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.816 2.344 . . . . 0.0 109.336 173.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -92.11 170.02 10.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.447 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.453 -0.3 0 C-N-CA 123.273 0.629 . . . . 0.0 110.128 -169.771 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 121.139 0.495 . . . . 0.0 111.298 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -97.05 161.26 13.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.3 t -92.25 27.86 2.08 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.129 0.972 . . . . 0.0 113.471 -169.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 54.34 23.52 4.45 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.373 0.533 . . . . 0.0 111.052 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -146.0 138.16 25.28 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.479 0.712 . . . . 0.0 109.945 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.7 m -138.91 152.36 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.921 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.467 ' CZ ' ' HA3' ' A' ' 70' ' ' GLY . 19.1 t80 -84.03 148.41 26.87 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.69 73.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 122.251 1.025 . . . . 0.0 109.028 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.467 ' HA3' ' CZ ' ' A' ' 68' ' ' PHE . . . -78.19 144.63 28.64 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.47 23.44 60.55 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-O 119.203 -0.776 . . . . 0.0 113.569 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 pp -62.04 148.92 87.59 Favored Pre-proline 0 CA--C 1.531 0.22 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 172.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 66.1 Cg_endo -66.15 143.82 72.92 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 121.585 1.524 . . . . 0.0 110.499 -169.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 31.2 Cg_exo -61.83 174.37 2.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.106 2.538 . . . . 0.0 113.669 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.8 t70 63.36 5.71 2.15 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.434 ' C ' HD12 ' A' ' 76' ' ' ILE . 2.5 pp -134.01 171.41 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 171.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -143.31 -25.58 0.59 Allowed 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -154.25 -35.15 0.1 Allowed 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 119.199 0.908 . . . . 0.0 112.547 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -67.7 -45.7 74.39 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.716 0.689 . . . . 0.0 111.529 -175.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -72.34 -35.56 68.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.879 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.4 pt -83.89 -36.65 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 O-C-N 122.163 -0.336 . . . . 0.0 111.869 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 95.9 m -71.99 -15.41 62.06 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.44 0.564 . . . . 0.0 109.565 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.73 -21.29 20.05 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 172.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -84.2 -19.19 34.44 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.433 ' HB2' ' CD1' ' A' ' 91' ' ' LEU . 34.6 m-85 -113.02 5.84 17.39 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.338 0.517 . . . . 0.0 111.208 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -65.25 -21.75 66.78 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 123.811 0.845 . . . . 0.0 111.972 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -72.17 -3.37 22.97 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -113.06 15.48 19.55 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.467 0.307 . . . . 0.0 111.648 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.27 177.6 20.37 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.31 150.44 70.96 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.557 2.838 . . . . 0.0 110.675 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.433 ' CD1' ' HB2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -163.15 163.29 25.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.178 -169.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pt -142.71 168.11 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.017 172.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.9 p -128.34 157.0 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -148.05 155.88 42.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.002 0.429 . . . . 0.0 110.87 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.42 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 45.8 p90 -157.11 154.4 26.04 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 169.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.658 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 31.1 Cg_endo -75.61 -10.28 20.18 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.075 3.183 . . . . 0.0 110.77 -169.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.658 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 69.5 m-70 -102.37 9.92 39.44 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.872 0.869 . . . . 0.0 111.022 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.449 ' HE3' ' HA ' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -61.35 143.44 55.74 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.809 0.844 . . . . 0.0 109.914 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.224 0 C-N-CA 123.381 0.673 . . . . 0.0 110.118 179.813 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.817 0 CA-C-O 119.748 -0.473 . . . . 0.0 113.099 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.1 m-30 -104.05 130.13 51.72 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.702 1.251 . . . . 0.0 108.543 172.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.98 -176.46 5.77 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.217 0.462 . . . . 0.0 110.657 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -141.62 144.35 34.14 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.773 0.429 . . . . 0.0 110.322 -176.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -102.08 146.89 27.28 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.378 0.609 . . . . 0.0 111.769 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.4 mp -114.27 137.72 51.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -131.1 175.2 9.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.381 0.672 . . . . 0.0 110.004 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -115.6 -32.56 5.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.454 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -114.66 149.21 37.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.066 0.46 . . . . 0.0 111.327 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -77.97 -17.6 56.97 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.02 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.8 t -83.43 -16.39 45.99 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.264 -0.272 . . . . 0.0 111.476 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 67.5 m -74.93 -43.45 54.08 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.911 -0.493 . . . . 0.0 111.492 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 m -71.04 -22.99 23.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -80.29 -35.65 35.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.88 -33.02 65.79 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 119.442 -0.314 . . . . 0.0 111.382 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -80.26 -23.37 40.84 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.462 0.574 . . . . 0.0 110.955 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 54.5 mt -89.56 -20.91 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -100.98 -13.84 18.11 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.568 0.622 . . . . 0.0 112.619 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -108.62 11.07 26.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.06 0.391 . . . . 0.0 111.97 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 72.4 m -129.74 -166.41 1.66 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.852 0.461 . . . . 0.0 111.259 -176.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 129' ' ' ILE . 3.8 mp -80.71 152.15 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 123.806 0.842 . . . . 0.0 109.353 -171.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -144.35 158.74 43.58 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.658 176.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 134' ' ' LYS . 1.9 pt-20 -145.62 174.79 10.88 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 175.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -59.8 -5.25 0.88 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -170.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -153.42 0.34 0.21 Allowed Glycine 0 CA--C 1.528 0.878 0 CA-C-N 119.164 0.893 . . . . 0.0 114.02 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.478 ' H ' ' HG3' ' A' ' 131' ' ' GLU . 3.4 mppt? -151.6 167.01 29.44 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 118.441 1.12 . . . . 0.0 110.618 -176.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -115.8 156.46 26.0 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -144.76 156.09 43.88 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.6 mp -135.55 164.02 28.78 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 169.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.2 m -108.13 141.09 40.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.76 150.4 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 C-N-CA 122.953 0.501 . . . . 0.0 110.344 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.9 m -66.63 161.76 22.57 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 122.902 0.481 . . . . 0.0 110.192 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.3 t -151.39 148.5 22.41 Favored Pre-proline 0 N--CA 1.455 -0.177 0 O-C-N 121.894 -0.504 . . . . 0.0 111.711 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -80.05 -7.76 14.23 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.768 2.979 . . . . 0.0 111.231 169.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 45.7 m -102.09 -32.69 10.01 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.872 0.869 . . . . 0.0 110.792 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 3.7 mm -140.09 170.81 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 124.191 0.996 . . . . 0.0 108.936 -175.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -70.16 -23.76 63.04 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -159.61 149.16 18.3 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.859 0.864 . . . . 0.0 109.912 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.12 106.72 28.21 Favored Pre-proline 0 C--N 1.337 0.051 0 C-N-CA 123.269 0.627 . . . . 0.0 109.59 178.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.84 96.82 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.226 2.618 . . . . 0.0 109.193 169.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.8 p -84.98 137.96 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.24 146.77 24.78 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.22 0.608 . . . . 0.0 110.977 -173.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 37.4 mm -130.85 146.18 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 123.158 0.583 . . . . 0.0 111.218 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -148.37 109.76 3.66 Favored Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.85 165.11 26.97 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.51 2.806 . . . . 0.0 111.377 177.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -105.89 126.27 51.98 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 174.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -96.52 132.62 41.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.495 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -92.6 118.13 30.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.767 0.794 . . . . 0.0 110.899 -178.222 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 34.5 t -172.62 -31.83 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.146 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -122.3 21.87 10.23 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.092 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 23.7 m -64.56 -27.77 69.18 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -160.4 160.95 32.88 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.569 0.348 . . . . 0.0 111.387 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.437 ' CD2' ' HA ' ' A' ' 187' ' ' VAL . 12.9 t80 -155.87 161.59 40.56 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.8 0.333 . . . . 0.0 110.711 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.9 m -136.95 148.76 26.36 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 C-N-CA 124.493 1.117 . . . . 0.0 109.878 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 29.3 mtm -139.49 12.31 2.54 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -137.88 24.07 2.84 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.041 0.837 . . . . 0.0 112.383 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 89.07 24.45 31.96 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 119.639 -0.534 . . . . 0.0 111.938 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 98.0 p 48.4 45.26 20.64 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -61.94 156.9 54.51 Favored Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -65.9 151.02 85.23 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.718 2.279 . . . . 0.0 110.688 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.481 HD12 ' HB1' ' A' ' 221' ' ' ALA . 3.0 mm? -108.66 172.49 6.81 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 121.259 0.552 . . . . 0.0 110.625 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -149.61 139.79 13.57 Favored Pre-proline 0 N--CA 1.452 -0.325 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.967 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.34 -12.19 31.79 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.213 2.608 . . . . 0.0 113.42 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -89.9 0.26 57.17 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.811 0.732 . . . . 0.0 110.383 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -127.01 25.11 6.3 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 122.959 0.504 . . . . 0.0 110.918 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 23.8 m -127.74 140.25 52.18 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.969 0.414 . . . . 0.0 111.486 -175.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.6 tt -113.24 150.23 15.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 C-N-CA 123.539 0.736 . . . . 0.0 109.726 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.445 ' CD1' ' CE1' ' A' ' 253' ' ' TYR . 10.9 t80 -109.55 147.82 32.31 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 48.1 t -137.13 138.72 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.317 0.647 . . . . 0.0 109.294 -175.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -141.89 146.84 18.17 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 112.065 -0.414 . . . . 0.0 112.065 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.42 15.23 48.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -172.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.6 m -70.04 146.7 95.28 Favored Pre-proline 0 C--O 1.231 0.108 0 CA-C-N 117.188 0.494 . . . . 0.0 111.298 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -79.64 160.0 25.09 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.579 2.853 . . . . 0.0 108.293 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.83 -43.81 6.6 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.903 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.29 20.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.118 3.212 . . . . 0.0 115.087 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.84 -27.63 69.01 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.511 1.05 . . . . 0.0 112.445 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 56.92 106.74 0.01 OUTLIER 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.602 1.561 . . . . 0.0 112.612 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.32 -23.2 47.18 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.437 ' HA ' ' CD2' ' A' ' 161' ' ' PHE . 41.8 t -68.27 -55.16 17.36 Favored 'Isoleucine or valine' 0 C--N 1.337 0.064 0 CA-C-N 118.691 0.678 . . . . 0.0 110.819 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.13 -20.09 38.71 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.363 -0.211 . . . . 0.0 110.977 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.06 -33.82 63.82 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.34 -35.29 63.6 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.789 -0.569 . . . . 0.0 110.538 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.4 mmt -69.1 -33.31 73.3 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 57.7 mt -75.31 -41.83 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -63.97 -20.71 66.08 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.07 0.395 . . . . 0.0 110.899 173.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -86.1 -20.46 28.68 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.586 0.63 . . . . 0.0 111.287 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -89.3 -16.45 31.1 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -115.75 -22.39 9.16 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.172 0.442 . . . . 0.0 110.909 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -137.78 43.79 2.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.201 0.6 . . . . 0.0 109.801 -176.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -46.14 138.66 7.18 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 123.654 0.645 . . . . 0.0 112.549 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 120.46 12.03 6.38 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -175.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 9.1 p -77.69 161.09 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.952 0.901 . . . . 0.0 110.598 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 47.9 t -135.98 -27.16 1.13 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -153.22 140.88 19.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 117.83 0.286 . . . . 0.0 110.896 -173.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.37 157.5 43.12 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.569 0.347 . . . . 0.0 110.716 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 161.76 -161.33 33.18 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 44.9 mm -102.4 138.39 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -59.58 138.28 57.76 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.532 0.206 . . . . 0.0 110.577 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 26.5 p -141.73 160.01 41.05 Favored 'General case' 0 N--CA 1.458 -0.052 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.179 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -111.74 130.19 23.42 Favored Pre-proline 0 N--CA 1.455 -0.197 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -80.25 -17.07 10.59 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.385 3.39 . . . . 0.0 113.813 -174.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -88.61 -31.75 18.43 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.549 0.613 . . . . 0.0 110.95 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.53 -2.78 15.37 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.114 0.566 . . . . 0.0 110.478 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 62.6 mttp 48.12 61.89 2.77 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.043 1.337 . . . . 0.0 112.734 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -147.32 151.61 40.74 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 122.292 0.237 . . . . 0.0 111.105 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -82.54 155.92 16.22 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.347 2.698 . . . . 0.0 112.577 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -93.42 1.38 56.89 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.147 0.979 . . . . 0.0 109.492 173.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 65.86 7.74 37.62 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.19 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -117.86 146.16 44.09 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 117.462 0.631 . . . . 0.0 109.738 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -84.76 151.04 25.9 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 121.319 0.4 . . . . 0.0 112.547 -173.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.82 142.91 24.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 171.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.8 t -134.75 144.48 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.481 ' HB1' HD12 ' A' ' 169' ' ' LEU . . . -133.03 149.02 52.22 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.026 0.441 . . . . 0.0 110.056 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -126.13 153.66 44.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.481 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 63.2 p -84.15 4.51 30.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.732 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -134.98 136.68 42.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.391 0.677 . . . . 0.0 109.796 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -73.86 -20.28 60.47 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -70.99 -35.82 72.25 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 17.3 m -75.19 -29.96 60.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -66.93 -50.03 63.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.793 -0.146 . . . . 0.0 110.927 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.9 pt -70.09 -17.99 21.38 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 CA-C-N 118.061 0.392 . . . . 0.0 110.741 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.01 -24.55 37.86 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 117.582 0.174 . . . . 0.0 110.851 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.72 -31.06 32.25 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.981 0.355 . . . . 0.0 111.666 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.4 pt -95.78 23.54 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 122.712 0.405 . . . . 0.0 110.324 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.3 t -84.3 -13.81 51.44 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.004 0.522 . . . . 0.0 111.518 -176.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -149.62 135.81 18.97 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -53.54 -37.36 62.78 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.966 0.506 . . . . 0.0 112.019 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -113.84 105.06 12.82 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.905 0.383 . . . . 0.0 110.56 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.4 HG23 HD21 ' A' ' 239' ' ' LEU . 1.4 m -65.44 154.53 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.959 174.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.519 ' C ' HD22 ' A' ' 239' ' ' LEU . 44.3 mm-40 -95.23 130.55 41.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.519 HD22 ' C ' ' A' ' 238' ' ' GLN . 2.3 mm? -124.04 17.98 9.24 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.991 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -89.86 118.77 29.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -170.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -149.36 141.04 23.51 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 173.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.16 -131.61 50.11 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -98.98 7.5 45.94 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.942 0.497 . . . . 0.0 111.462 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.45 ' N ' HD12 ' A' ' 244' ' ' ILE . 1.9 mp -88.1 149.41 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 122.841 0.456 . . . . 0.0 109.952 -177.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -150.82 127.89 11.15 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -145.6 157.41 43.98 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.405 1.082 . . . . 0.0 108.652 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -153.36 152.02 30.61 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.9 p -159.93 158.49 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -85.86 145.61 27.11 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.363 0.665 . . . . 0.0 111.183 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.56 161.63 27.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.1 159.25 26.89 Favored Pre-proline 0 N--CA 1.455 -0.198 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.087 169.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.49 133.78 59.1 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.3 2.0 . . . . 0.0 108.731 173.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . 0.445 ' CE1' ' CD1' ' A' ' 176' ' ' PHE . 1.1 t80 -73.99 159.9 32.08 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.389 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.456 -0.163 0 C-N-CA 123.918 0.887 . . . . 0.0 111.331 -170.441 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 . . . . . 0 N--CA 1.456 -0.16 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -117.69 159.16 23.42 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t -98.18 174.43 6.53 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.506 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -77.5 30.0 0.15 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.159 0.584 . . . . 0.0 110.992 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -143.3 144.03 31.94 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.195 0.598 . . . . 0.0 110.701 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.0 m -141.66 155.0 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.801 176.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.409 ' CZ ' ' CA ' ' A' ' 70' ' ' GLY . 2.4 t80 -94.97 129.54 41.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 169.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 p -108.7 93.07 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 122.203 1.001 . . . . 0.0 108.455 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.409 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -86.49 155.81 28.58 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.005 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.76 26.86 73.71 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-O 119.045 -0.864 . . . . 0.0 113.912 171.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 pp -75.23 144.95 79.45 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 118.981 1.391 . . . . 0.0 108.208 173.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 39.9 Cg_endo -62.22 120.07 7.47 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.822 2.348 . . . . 0.0 110.343 -172.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 85.8 Cg_exo -54.84 -11.38 3.47 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.666 3.577 . . . . 0.0 115.238 -178.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -82.89 -7.65 59.64 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.416 0.553 . . . . 0.0 112.307 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.439 ' C ' HD12 ' A' ' 76' ' ' ILE . 2.2 pp -142.98 168.81 12.99 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -165.12 179.7 6.19 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 45.27 -99.42 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.144 1.777 . . . . 0.0 114.339 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -58.1 -28.32 64.52 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -80.38 -24.28 39.86 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.204 0.456 . . . . 0.0 110.29 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.1 mt -76.29 -46.05 33.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.1 m -63.25 -21.13 66.04 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.752 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.16 -18.37 24.58 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.1 m -79.15 -27.05 42.72 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.765 0.711 . . . . 0.0 112.139 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -114.99 11.87 16.6 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -64.85 -20.34 66.36 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.828 0.451 . . . . 0.0 112.189 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -75.24 -0.26 18.9 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -115.59 -4.48 12.24 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 141.86 177.34 16.89 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.24 146.05 50.27 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.475 2.784 . . . . 0.0 110.246 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.415 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -162.37 161.41 27.4 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.965 -169.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.9 mm -138.35 160.53 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.63 144.2 34.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -150.46 167.23 27.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.303 0.573 . . . . 0.0 110.826 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.431 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 35.7 p90 -157.77 162.74 26.6 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 175.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.562 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 39.2 Cg_endo -75.28 -15.64 20.03 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.304 2.002 . . . . 0.0 110.527 -169.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.562 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 20.8 m-70 -89.54 -0.49 57.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.829 0.851 . . . . 0.0 111.18 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.15 110.29 4.47 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.813 0.845 . . . . 0.0 109.108 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.305 0 C-N-CA 122.557 0.343 . . . . 0.0 111.049 -179.201 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.641 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.39 150.55 35.89 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.338 0.569 . . . . 0.0 109.494 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.93 -175.03 5.23 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.762 0.425 . . . . 0.0 110.344 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -137.93 142.45 40.56 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.8 151.38 25.8 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -113.82 146.45 39.94 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 169.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -134.69 168.11 19.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.873 0.469 . . . . 0.0 110.578 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -103.83 -25.31 13.13 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.572 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -122.38 152.54 40.09 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -84.36 -15.01 47.93 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.759 176.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.3 t -90.52 -14.95 31.63 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.707 0.403 . . . . 0.0 110.635 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.4 m -75.49 -39.34 58.68 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 122.037 -0.414 . . . . 0.0 110.078 177.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.2 -22.15 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -77.87 -29.9 50.59 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.71 -35.29 45.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.656 0.207 . . . . 0.0 111.148 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 pp -80.11 -16.31 55.25 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.252 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 79.5 mt -96.39 -17.4 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 122.282 0.233 . . . . 0.0 111.084 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -100.43 -10.95 20.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.464 0.574 . . . . 0.0 112.478 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -119.74 44.87 2.28 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.074 0.55 . . . . 0.0 110.825 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 31.4 p -141.48 179.92 6.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.741 0.416 . . . . 0.0 111.904 -175.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.462 ' N ' HD12 ' A' ' 129' ' ' ILE . 2.7 mp -82.71 157.5 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -123.67 157.3 34.15 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.948 0.404 . . . . 0.0 111.199 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.98 -179.07 6.37 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -41.29 -23.44 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -161.04 4.82 0.09 OUTLIER Glycine 0 CA--C 1.529 0.946 0 CA-C-N 119.491 1.041 . . . . 0.0 113.47 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -146.28 -170.53 3.52 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.598 1.199 . . . . 0.0 111.096 -173.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -115.99 165.29 13.29 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.074 0.55 . . . . 0.0 111.815 -174.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -143.88 147.49 34.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.267 0.627 . . . . 0.0 109.404 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.6 mp -128.38 159.94 33.77 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 170.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.4 p -91.4 149.84 21.53 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 122.082 -0.386 . . . . 0.0 110.907 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.4 m -144.43 174.11 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 123.391 0.676 . . . . 0.0 109.944 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.4 p -67.71 -14.13 62.69 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.687 0.395 . . . . 0.0 111.669 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.425 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 39.0 t 47.24 57.38 17.62 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.313 1.045 . . . . 0.0 113.561 174.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 141' ' ' SER . 31.5 Cg_exo -61.9 -9.41 14.18 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.922 2.414 . . . . 0.0 113.945 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.442 HG21 ' HD2' ' A' ' 74' ' ' PRO . 55.3 m -82.37 -27.98 31.8 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.5 0.591 . . . . 0.0 109.6 178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.475 HD12 ' HD3' ' A' ' 147' ' ' LYS . 4.4 mt -150.31 -122.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -170.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -147.47 122.21 9.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.803 0.441 . . . . 0.0 110.311 174.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.6 t70 47.18 32.78 2.18 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 172.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.475 ' HD3' HD12 ' A' ' 144' ' ' ILE . 14.0 pttp -82.94 148.56 57.31 Favored Pre-proline 0 C--N 1.34 0.186 0 CA-C-N 119.786 1.176 . . . . 0.0 110.017 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -83.5 168.27 12.98 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.667 2.911 . . . . 0.0 112.245 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.9 m -128.3 146.78 33.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.501 HE21 ' C ' ' A' ' 150' ' ' GLN . 0.0 OUTLIER -93.02 149.52 21.16 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.601 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 45.0 mm -122.49 144.65 31.13 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 C-N-CA 124.246 1.018 . . . . 0.0 109.646 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.83 100.25 3.09 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.39 162.27 40.62 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.777 2.984 . . . . 0.0 111.799 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -89.82 149.54 22.63 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.935 -0.12 . . . . 0.0 110.799 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -109.04 115.23 29.66 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.768 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -83.85 12.09 6.61 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -169.634 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.2 t -96.2 -1.79 47.56 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -173.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -144.5 20.33 1.69 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.0 m -64.82 -21.06 66.71 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -175.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -153.74 156.29 37.5 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 118.014 0.37 . . . . 0.0 110.854 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -158.17 150.56 22.15 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.37 151.82 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 O-C-N 121.944 -0.473 . . . . 0.0 110.174 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 64.2 mtm -127.84 24.7 6.05 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 122.366 0.266 . . . . 0.0 111.409 -175.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -158.94 -49.91 0.06 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 64.95 11.64 51.67 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.98 -0.9 . . . . 0.0 113.939 172.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 26.3 t -138.75 -27.63 0.83 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.776 1.288 . . . . 0.0 114.332 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -77.08 147.34 76.68 Favored Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 119.115 0.871 . . . . 0.0 111.03 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.43 157.42 40.96 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.909 3.073 . . . . 0.0 110.969 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 10.6 mp -118.48 161.93 19.19 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.688 0.795 . . . . 0.0 109.85 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -137.5 152.89 73.87 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.68 -0.19 9.03 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.603 2.869 . . . . 0.0 111.432 -176.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -114.99 7.97 15.69 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 124.206 1.002 . . . . 0.0 111.494 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -123.33 19.72 9.74 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.825 0.45 . . . . 0.0 111.39 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.0 m -115.6 139.53 50.02 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.759 0.314 . . . . 0.0 111.079 -175.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.5 tt -118.32 149.57 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 C-N-CA 123.178 0.591 . . . . 0.0 109.934 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -109.97 147.28 33.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.2 t -134.9 132.25 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -177.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -152.39 167.16 31.33 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 87.1 11.82 69.13 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -170.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.8 m -65.93 156.21 84.49 Favored Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 122.919 0.488 . . . . 0.0 111.272 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -72.76 -171.98 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.941 3.094 . . . . 0.0 109.857 174.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -54.26 -50.92 82.07 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.874 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.42 139.32 23.12 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.143 1.895 . . . . 0.0 110.221 173.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.0 12.66 0.5 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 -42.14 140.07 1.21 Allowed 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.125 0.97 . . . . 0.0 112.209 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.47 -17.77 62.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.746 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.75 -50.45 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-O 120.699 0.285 . . . . 0.0 110.294 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -83.77 -25.93 30.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.562 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 26.0 tp -69.81 -32.97 71.71 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.68 -32.2 36.07 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 122.335 -0.228 . . . . 0.0 111.268 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.3 mmt -68.66 -31.58 70.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.6 mt -79.01 -33.26 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 O-C-N 122.231 -0.293 . . . . 0.0 110.49 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.7 mmt -73.36 -19.42 61.01 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.534 0.606 . . . . 0.0 109.984 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -83.62 -24.93 31.22 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.371 0.268 . . . . 0.0 111.224 175.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -87.76 -16.93 32.82 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -117.19 -17.01 10.34 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -134.68 23.06 3.64 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -173.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 73.87 -144.41 33.71 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 175.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -72.44 123.51 9.21 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 112.145 -0.382 . . . . 0.0 112.145 -173.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 90.8 t -111.57 137.74 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 124.745 1.218 . . . . 0.0 108.027 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.9 p -92.76 -41.44 10.13 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 118.364 0.529 . . . . 0.0 111.902 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -156.61 155.64 32.17 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.144 0.429 . . . . 0.0 111.676 -171.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -149.7 159.6 44.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.33 0.586 . . . . 0.0 111.006 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -174.67 170.48 43.6 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.7 mp -82.42 148.92 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -57.99 119.03 6.04 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 22.6 p -138.35 158.64 43.88 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -117.07 131.96 23.71 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.61 -16.1 15.07 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 124.503 3.469 . . . . 0.0 114.47 -172.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -110.97 -25.14 9.97 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.334 0.97 . . . . 0.0 111.381 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -86.86 -10.2 53.98 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 169.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 49.89 45.81 24.71 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.647 1.179 . . . . 0.0 111.839 175.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.32 156.22 39.66 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -80.69 157.25 21.47 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.527 2.818 . . . . 0.0 111.2 174.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 35.2 mtmm -119.11 21.55 12.27 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.595 0.758 . . . . 0.0 111.04 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.23 -178.15 31.08 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 55.34 -173.98 0.05 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.334 0.567 . . . . 0.0 111.869 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -140.92 168.79 25.18 Favored Glycine 0 CA--C 1.524 0.632 0 O-C-N 121.608 -0.682 . . . . 0.0 112.979 -177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -146.58 149.8 34.26 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 97.1 t -136.68 151.09 27.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -124.38 145.72 49.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.916 0.486 . . . . 0.0 111.355 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -122.38 151.23 41.41 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.697 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 62.9 p -91.96 -0.64 57.49 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 116.78 -0.191 . . . . 0.0 111.242 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -132.5 144.83 50.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.901 0.48 . . . . 0.0 110.243 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -80.12 -9.36 59.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.244 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -85.09 -42.18 15.04 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 34.8 p -74.63 -24.6 58.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -68.45 -48.81 63.56 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 119.639 -0.22 . . . . 0.0 110.993 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.6 pp -71.95 -12.46 15.91 Favored 'Isoleucine or valine' 0 C--N 1.338 0.066 0 CA-C-N 118.372 0.533 . . . . 0.0 110.991 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.96 -27.83 30.22 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 173.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.59 -27.23 34.37 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.7 pt -106.92 29.58 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.039 0.536 . . . . 0.0 110.372 174.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.8 t -78.35 -14.57 59.34 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.29 0.636 . . . . 0.0 111.813 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -155.79 144.08 20.05 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -60.2 -33.12 71.8 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.409 -0.329 . . . . 0.0 111.584 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -119.67 116.26 25.62 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.738 0.304 . . . . 0.0 110.42 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -108.62 159.4 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.333 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -86.6 143.82 27.47 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.949 0.404 . . . . 0.0 111.155 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.85 103.97 6.09 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 173.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -135.44 153.31 51.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.226 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -138.73 11.88 2.7 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.123 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 175.17 -134.45 2.74 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -76.54 12.49 1.25 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.096 0.558 . . . . 0.0 111.381 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.1 mt -66.91 157.97 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.41 1.084 . . . . 0.0 110.112 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -145.82 21.02 1.46 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -67.87 160.48 28.35 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.054 0.542 . . . . 0.0 111.986 -173.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.16 161.99 35.4 Favored 'General case' 0 C--N 1.337 0.065 0 C-N-CA 124.353 1.061 . . . . 0.0 110.229 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.4 p -153.8 156.61 5.17 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -89.32 138.47 31.41 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 117.671 0.214 . . . . 0.0 110.624 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.97 158.46 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-O 120.828 0.347 . . . . 0.0 111.233 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.02 159.25 24.78 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 171.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.81 140.21 92.1 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.629 2.219 . . . . 0.0 109.78 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -78.41 168.24 20.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.244 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.4 p . . . . . 0 N--CA 1.452 -0.372 0 C-N-CA 123.067 0.547 . . . . 0.0 110.319 -170.548 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -75.33 170.83 15.32 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.153 0.501 . . . . 0.0 112.304 177.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.4 t -100.38 27.45 5.72 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -168.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.517 ' HA ' ' CE2' ' A' ' 115' ' ' PHE . 0.0 OUTLIER 55.33 17.41 2.1 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.122 0.419 . . . . 0.0 111.155 -176.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -147.82 140.24 24.47 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.247 0.619 . . . . 0.0 111.632 -177.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.5 m -136.06 148.52 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.704 169.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -85.22 140.45 30.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 174.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.9 p -122.98 98.55 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 121.779 0.8 . . . . 0.0 108.906 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.36 169.49 51.34 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.41 26.76 71.92 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 119.226 -0.763 . . . . 0.0 113.901 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.457 ' HB3' ' H ' ' A' ' 110' ' ' TYR . 18.5 tp -63.0 122.18 73.46 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 119.626 1.713 . . . . 0.0 107.352 173.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.65 170.07 20.86 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.164 2.576 . . . . 0.0 111.537 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.46 179.06 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 124.357 3.371 . . . . 0.0 112.753 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 61.45 -79.7 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.411 ' C ' HD12 ' A' ' 76' ' ' ILE . 2.3 pp -65.2 164.8 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 118.288 0.494 . . . . 0.0 111.539 -177.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -146.88 -24.67 0.41 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -154.28 -36.69 0.1 Allowed 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -174.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -67.48 -39.99 85.25 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.006 0.366 . . . . 0.0 111.944 -173.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -74.48 -35.33 63.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.179 -0.326 . . . . 0.0 111.37 -172.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.7 pt -83.91 -28.03 7.34 Favored 'Isoleucine or valine' 0 C--O 1.23 0.041 0 O-C-N 122.145 -0.347 . . . . 0.0 110.967 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.0 m -79.77 -5.63 55.68 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.15 -14.13 14.99 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 171.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 m -95.14 -17.79 21.49 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -120.65 0.74 10.49 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.374 0.534 . . . . 0.0 111.986 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.0 tpt85 -70.38 -21.4 62.87 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 122.716 0.406 . . . . 0.0 110.831 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -69.15 -5.71 24.16 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.674 0.789 . . . . 0.0 111.947 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -112.68 -13.34 13.27 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.239 0.215 . . . . 0.0 111.427 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.5 168.6 18.81 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -70.9 149.14 59.1 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.294 2.663 . . . . 0.0 110.804 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.404 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -164.77 158.73 17.86 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -170.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.489 HG22 ' H ' ' A' ' 93' ' ' VAL . 12.2 mm -136.86 173.17 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 171.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.489 ' H ' HG22 ' A' ' 92' ' ' ILE . 7.3 p -137.6 156.03 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 118.445 0.566 . . . . 0.0 110.606 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -149.18 164.24 35.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.542 0.337 . . . . 0.0 111.039 -175.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.461 ' CZ2' ' HE3' ' A' ' 98' ' ' LYS . 24.2 p90 -155.46 156.32 30.75 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.684 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 25.5 Cg_endo -75.42 -11.66 20.72 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 124.026 3.151 . . . . 0.0 110.683 -169.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.684 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 89.9 m-70 -105.52 5.94 31.87 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.847 0.859 . . . . 0.0 111.363 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.461 ' HE3' ' CZ2' ' A' ' 95' ' ' TRP . 68.8 tttt -64.65 157.84 26.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.717 0.807 . . . . 0.0 112.568 -176.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.258 0 C-N-CA 125.037 1.335 . . . . 0.0 113.303 -178.795 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.778 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.457 ' H ' ' HB3' ' A' ' 72' ' ' LEU . 0.0 OUTLIER 60.54 147.7 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 113.859 -1.171 . . . . 0.0 113.991 -177.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.49 -173.45 3.99 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.185 0.594 . . . . 0.0 110.043 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.35 134.0 26.78 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.424 ' C ' HD12 ' A' ' 114' ' ' LEU . 10.6 mp -91.19 149.64 21.7 Favored 'General case' 0 CA--C 1.522 -0.108 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -176.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.424 HD12 ' C ' ' A' ' 113' ' ' LEU . 9.8 mp -118.59 144.69 45.95 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 173.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.517 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.7 p90 -158.93 177.35 11.25 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -117.89 -12.74 10.12 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -129.29 142.66 50.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.973 0.416 . . . . 0.0 112.03 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -80.76 -6.05 57.97 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.831 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 75.1 p -82.73 -19.26 38.28 Favored 'General case' 0 N--CA 1.457 -0.113 0 O-C-N 122.137 -0.352 . . . . 0.0 111.075 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.5 t -72.58 -44.27 62.27 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.0 m -70.84 -26.2 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -69.94 -41.6 74.35 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.764 -0.585 . . . . 0.0 110.702 -176.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.54 -36.6 60.44 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.04 0.382 . . . . 0.0 111.792 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -76.86 -15.37 59.73 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.06 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 77.3 mt -95.42 -17.32 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.336 0.254 . . . . 0.0 110.467 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -90.84 -14.92 30.91 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.608 -0.682 . . . . 0.0 111.121 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.29 46.32 1.82 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.491 0.717 . . . . 0.0 111.437 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 22.5 p -138.27 176.7 8.47 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 39.5 mm -92.88 164.35 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 125.363 1.465 . . . . 0.0 108.351 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -133.46 150.63 51.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.778 0.323 . . . . 0.0 110.836 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.16 -179.86 5.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 175.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -55.84 -4.76 0.12 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -171.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -170.17 14.03 0.05 OUTLIER Glycine 0 CA--C 1.527 0.831 0 CA-C-N 118.854 0.752 . . . . 0.0 113.137 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' A' ' 134' ' ' LYS . 21.4 ttmt -157.89 -178.05 7.02 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.596 1.198 . . . . 0.0 111.23 -174.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 150' ' ' GLN . 67.2 mt -112.24 169.56 8.78 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.078 0.551 . . . . 0.0 110.972 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.472 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 0.3 OUTLIER -145.81 139.53 26.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.27 0.628 . . . . 0.0 109.717 179.126 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.0 mp -136.8 149.71 47.91 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.346 0.521 . . . . 0.0 110.069 170.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.3 p -71.1 154.57 41.64 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.9 p -148.77 7.34 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 O-C-N 122.402 -0.187 . . . . 0.0 111.479 -177.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.2 m 53.16 46.99 25.44 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.847 -0.533 . . . . 0.0 110.799 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.9 t -47.6 139.83 8.27 Favored Pre-proline 0 CA--C 1.53 0.199 0 C-N-CA 124.351 1.06 . . . . 0.0 112.234 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -80.1 -15.14 11.79 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 124.142 3.228 . . . . 0.0 113.854 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.7 t -89.47 -24.0 21.95 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.841 1.201 . . . . 0.0 111.657 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.49 HG22 ' H ' ' A' ' 145' ' ' LYS . 2.4 mm -121.63 -174.95 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.49 ' H ' HG22 ' A' ' 144' ' ' ILE . 63.9 pttt -69.97 -32.67 71.0 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.346 -0.846 . . . . 0.0 109.139 171.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -165.58 150.14 8.59 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.781 1.633 . . . . 0.0 107.187 170.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.85 105.49 2.49 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.472 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 78.1 Cg_exo -53.39 145.11 47.17 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.031 3.154 . . . . 0.0 113.905 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.4 m -116.72 148.61 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.059 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 25.3 mp0 -82.03 157.33 24.21 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -174.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.0 mm -136.59 142.37 38.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.379 0.672 . . . . 0.0 109.36 171.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.6 ttp85 -157.66 104.4 1.8 Allowed Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 171.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -60.72 167.17 8.84 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 124.507 3.471 . . . . 0.0 114.819 175.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -111.1 136.43 50.15 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.348 171.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -103.18 150.12 23.99 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.478 0.711 . . . . 0.0 112.455 -176.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.6 mp -94.47 97.7 10.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.466 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.9 t -156.09 -33.1 0.09 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.803 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -138.78 22.36 2.67 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.7 m -68.62 -25.04 64.65 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -175.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -153.67 159.62 42.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.239 0.616 . . . . 0.0 110.518 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -151.77 154.26 35.91 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.6 t -136.42 144.29 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -174.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 63.8 mtm -141.74 15.36 2.14 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -151.38 10.79 0.59 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.336 0.516 . . . . 0.0 112.062 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.94 12.25 84.1 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 121.764 -0.585 . . . . 0.0 111.931 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.5 m 52.89 73.17 0.37 Allowed 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -70.85 173.55 4.65 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -54.44 133.97 59.07 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.208 1.938 . . . . 0.0 112.073 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.4 mp -106.66 160.87 15.12 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 123.603 0.761 . . . . 0.0 109.904 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -150.08 145.04 18.2 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.3 -20.84 33.78 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.425 2.75 . . . . 0.0 114.176 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -91.1 2.93 55.96 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.457 0.571 . . . . 0.0 111.126 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -131.07 15.96 5.14 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.655 0.382 . . . . 0.0 111.117 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 18.7 m -128.08 140.17 52.1 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 120.713 0.292 . . . . 0.0 110.805 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.4 tt -113.28 150.57 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 C-N-CA 123.204 0.602 . . . . 0.0 109.992 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -120.84 153.16 37.5 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 18.0 m -141.68 151.74 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.792 0.437 . . . . 0.0 110.422 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -164.34 171.48 39.87 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.47 11.04 80.95 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 11.9 p -63.26 138.62 97.39 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.18 -52.89 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.502 2.135 . . . . 0.0 112.218 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.428 ' H ' ' CD ' ' A' ' 183' ' ' PRO . 24.5 tpt180 -162.78 -47.24 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.331 -0.842 . . . . 0.0 113.066 176.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.428 ' CD ' ' H ' ' A' ' 182' ' ' ARG . 16.3 Cg_exo -71.38 140.93 37.75 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.747 2.298 . . . . 0.0 111.778 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.696 ' CD1' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -151.88 -87.12 0.07 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 119.151 -0.452 . . . . 0.0 111.463 176.514 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.696 ' H ' ' CD1' ' A' ' 184' ' ' LEU . 71.2 mtp180 59.38 126.48 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 126.393 1.877 . . . . 0.0 112.181 -173.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.5 -20.23 65.42 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.896 -0.503 . . . . 0.0 110.364 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 68.1 t -69.43 -54.01 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 122.434 0.294 . . . . 0.0 110.616 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -81.71 -23.38 36.81 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.341 -0.224 . . . . 0.0 111.054 -174.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 53.1 tp -71.0 -33.6 70.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -79.49 -33.45 42.2 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.4 mmt -69.83 -38.63 76.61 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.877 0.308 . . . . 0.0 110.304 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 94.1 mt -73.1 -37.32 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.6 mmt -67.07 -20.08 65.76 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.975 -0.453 . . . . 0.0 110.695 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -86.3 -19.88 29.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.872 0.306 . . . . 0.0 111.784 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -96.58 -14.34 22.29 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.0 -13.45 10.02 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -136.66 21.22 3.1 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 81.83 -150.14 29.09 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 122.141 -0.349 . . . . 0.0 112.252 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.19 121.81 5.98 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 123.086 0.374 . . . . 0.0 112.221 -171.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 90.9 t -100.49 147.19 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 124.242 1.017 . . . . 0.0 109.612 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 46.7 t -102.12 -43.73 5.66 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -159.7 158.42 31.33 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.37 0.129 . . . . 0.0 111.105 -170.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -152.88 156.97 39.97 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.849 0.46 . . . . 0.0 110.648 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -178.16 -176.05 45.8 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 42.8 mm -113.58 90.81 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 14.1 t70 56.72 -63.57 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -169.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 55.3 p 45.67 56.41 5.88 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.87 130.59 94.89 Favored Pre-proline 0 N--CA 1.453 -0.307 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -78.32 -14.58 14.67 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.517 3.478 . . . . 0.0 113.681 -173.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -94.65 -36.82 11.61 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 118.643 0.656 . . . . 0.0 110.317 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 94.3 mt -96.44 -7.39 35.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.867 0.467 . . . . 0.0 109.925 176.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 50.16 44.55 26.07 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.792 1.237 . . . . 0.0 111.87 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.99 155.53 62.33 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -174.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -84.74 177.83 5.28 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 123.807 3.005 . . . . 0.0 111.073 174.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -138.73 22.81 2.67 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.113 0.565 . . . . 0.0 110.862 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 62.72 8.24 20.01 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.63 -0.539 . . . . 0.0 113.677 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -128.58 141.04 51.49 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.952 0.876 . . . . 0.0 109.274 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -86.16 161.64 34.55 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-O 121.526 0.515 . . . . 0.0 113.942 -171.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -149.53 148.51 29.47 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.9 t -141.64 154.82 19.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -135.69 150.48 49.59 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.619 0.247 . . . . 0.0 110.61 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -124.66 154.57 40.57 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 66.5 p -86.02 3.01 44.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.156 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -139.3 140.53 37.61 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.32 0.648 . . . . 0.0 110.005 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -74.2 -19.68 60.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.395 -0.191 . . . . 0.0 110.661 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -71.64 -37.0 70.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 44.2 m -72.49 -30.26 64.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -69.25 -49.97 51.31 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 119.484 -0.293 . . . . 0.0 111.041 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 41.8 pt -68.16 -18.31 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.032 0 CA-C-N 118.43 0.559 . . . . 0.0 110.79 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.55 -25.63 35.69 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -84.95 -23.23 28.87 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.6 pt -105.23 25.75 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 122.734 0.414 . . . . 0.0 110.833 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 20.0 t -84.54 -9.4 58.36 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.12 0.568 . . . . 0.0 112.271 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -156.65 143.97 18.98 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 249' ' ' GLU . 10.1 ptp180 -60.04 -52.57 64.81 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.214 -175.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -93.05 115.79 28.44 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.374 0.988 . . . . 0.0 110.139 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 237' ' ' VAL . 0.6 OUTLIER -83.52 147.24 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 171.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -81.99 127.19 32.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.84 17.25 6.82 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -84.15 130.34 34.85 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.165 0.586 . . . . 0.0 112.26 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -152.49 143.41 22.99 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 61.85 -144.31 48.93 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -177.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.1 8.73 31.27 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.086 0.554 . . . . 0.0 111.669 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 66.7 mt -96.62 153.81 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 123.442 0.697 . . . . 0.0 110.264 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -130.52 133.95 46.66 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -145.37 145.37 31.15 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 124.502 1.121 . . . . 0.0 108.576 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -158.93 155.31 27.4 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.29 0.636 . . . . 0.0 109.622 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 8.7 p -157.6 154.31 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 235' ' ' ARG . 42.8 mt-10 -94.13 136.4 34.46 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 117.786 0.266 . . . . 0.0 110.64 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.4 m -101.72 161.34 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.01 159.61 29.28 Favored Pre-proline 0 N--CA 1.454 -0.226 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.776 169.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.2 136.66 76.39 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.796 2.33 . . . . 0.0 109.27 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -87.28 167.55 13.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.052 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.451 -0.384 0 C-N-CA 123.626 0.771 . . . . 0.0 110.018 -170.455 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 . . . . . 0 N--CA 1.458 -0.026 0 CA-C-O 120.988 0.423 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -151.19 157.03 42.13 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.225 -171.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.0 t -94.01 161.24 14.37 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 50.1 mtm105 -81.96 24.32 0.64 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.32 0.248 . . . . 0.0 110.894 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -140.27 138.15 34.77 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.698 0.399 . . . . 0.0 110.804 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.36 155.78 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.866 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.414 ' CZ ' ' HA2' ' A' ' 70' ' ' GLY . 5.8 t80 -86.97 139.04 30.99 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 171.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.23 115.48 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 174.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.414 ' HA2' ' CZ ' ' A' ' 68' ' ' PHE . . . -79.73 137.98 19.55 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.47 -175.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.49 158.61 6.17 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 121.985 0.77 . . . . 0.0 114.69 173.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.5 tp -160.09 126.37 2.44 Favored Pre-proline 0 N--CA 1.451 -0.385 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.465 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 98.0 Cg_endo -73.74 142.23 31.84 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.622 1.548 . . . . 0.0 109.12 -178.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 32.1 Cg_exo -61.54 -3.23 3.2 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.93 3.087 . . . . 0.0 115.165 -174.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -99.88 -21.27 15.77 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.432 ' C ' HD12 ' A' ' 76' ' ' ILE . 1.8 pp -133.36 -171.89 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 119.459 1.027 . . . . 0.0 111.203 -177.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -136.68 -163.24 1.38 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.465 0.706 . . . . 0.0 112.291 -172.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -40.62 -31.08 0.14 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.853 2.061 . . . . 0.0 113.459 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -64.61 -30.26 71.28 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -175.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -80.04 -33.99 38.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.083 -0.386 . . . . 0.0 111.133 -173.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.4 mt -73.78 -36.19 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 33.5 m -68.75 -21.77 64.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.76 -13.23 27.64 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.4 m -84.75 -29.54 25.41 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.285 0.493 . . . . 0.0 112.022 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -110.49 5.15 21.08 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -176.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.6 tpt85 -67.96 -14.0 62.62 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.973 -0.454 . . . . 0.0 110.365 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -64.78 -15.72 62.03 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.813 1.245 . . . . 0.0 111.81 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -120.83 -5.95 9.62 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.917 0.339 . . . . 0.0 111.917 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.04 163.82 10.31 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -57.93 139.04 88.97 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.141 2.56 . . . . 0.0 111.342 177.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.516 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -150.38 167.5 26.87 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.066 0.46 . . . . 0.0 111.096 178.229 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 pt -138.08 163.68 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.5 p -132.66 145.04 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -154.04 171.37 19.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.081 0.467 . . . . 0.0 110.395 -174.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.4 ' CH2' ' HE3' ' A' ' 98' ' ' LYS . 18.8 p90 -155.14 163.04 25.87 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 174.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.487 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 89.8 Cg_endo -71.31 -7.44 21.32 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 CA-C-N 121.232 1.476 . . . . 0.0 110.844 -170.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.487 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 3.4 m-70 -99.73 2.81 44.57 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.726 0.811 . . . . 0.0 111.491 -177.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.4 ' HE3' ' CH2' ' A' ' 95' ' ' TRP . 12.4 tptm -54.6 158.24 2.62 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.054 0.942 . . . . 0.0 112.693 -178.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.214 0 C-N-CA 124.078 0.951 . . . . 0.0 110.918 179.635 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.83 0 CA-C-O 119.364 -0.686 . . . . 0.0 114.173 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.75 153.61 45.95 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.519 1.159 . . . . 0.0 108.888 174.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.18 -178.63 6.74 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.274 0.488 . . . . 0.0 111.972 -174.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -141.11 140.51 34.16 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.5 mp -96.32 148.91 22.27 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 118.497 0.59 . . . . 0.0 112.326 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.9 mp -115.52 142.28 46.93 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 170.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -131.7 167.8 18.86 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.404 0.621 . . . . 0.0 111.93 -174.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -109.28 -29.85 8.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.932 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -121.8 153.17 38.66 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -85.97 -17.84 34.24 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.176 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.7 t -85.76 -17.67 35.19 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.128 -0.358 . . . . 0.0 110.198 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 41.9 t -72.36 -39.5 68.03 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.31 -26.71 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -71.05 -34.91 71.7 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.971 -0.455 . . . . 0.0 110.311 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -77.97 -35.17 50.55 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 122.176 -0.328 . . . . 0.0 111.654 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 pp -78.91 -16.7 56.66 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.43 0.559 . . . . 0.0 111.458 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.4 mt -92.33 -22.7 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 122.254 0.222 . . . . 0.0 110.454 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -97.9 -10.21 24.98 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -117.56 35.04 4.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.175 0.59 . . . . 0.0 111.269 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 26.8 p -136.76 -179.59 5.78 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.906 0.482 . . . . 0.0 111.331 -176.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.1 mm -87.4 159.44 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 124.391 1.077 . . . . 0.0 109.018 -177.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.65 154.79 43.56 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.759 0.314 . . . . 0.0 110.791 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -146.39 85.11 1.64 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.516 0.675 . . . . 0.0 110.753 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 55.43 0.13 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.22 -12.18 0.07 OUTLIER Glycine 0 CA--C 1.527 0.841 0 CA-C-N 119.568 1.076 . . . . 0.0 114.072 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.1 170.84 15.06 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 118.195 0.998 . . . . 0.0 109.609 177.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.97 166.05 10.65 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -172.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.406 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -142.39 139.49 31.71 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.891 -177.52 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.1 tp -124.55 128.72 49.36 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 48.9 t -77.03 139.48 40.06 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.1 m -137.65 -0.97 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.116 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 29.7 t 45.68 60.38 3.15 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.265 0.626 . . . . 0.0 111.116 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 142' ' ' PRO . 75.2 m -56.96 150.48 38.79 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.941 -175.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 141' ' ' SER . 19.8 Cg_exo -67.82 11.91 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.795 2.996 . . . . 0.0 114.907 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.743 HG23 HG13 ' A' ' 144' ' ' ILE . 15.1 t -121.23 -15.39 8.17 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.595 1.089 . . . . 0.0 111.832 -174.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.743 HG13 HG23 ' A' ' 143' ' ' THR . 0.6 OUTLIER -168.25 -176.44 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 125.178 1.391 . . . . 0.0 109.635 -177.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -120.74 16.74 11.91 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.739 0.816 . . . . 0.0 110.953 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -141.38 34.35 1.67 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -173.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 50.2 mttp -129.16 80.1 73.16 Favored Pre-proline 0 C--N 1.34 0.179 0 CA-C-N 118.927 0.785 . . . . 0.0 111.193 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.406 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 19.8 Cg_exo -67.69 145.56 70.02 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.908 2.405 . . . . 0.0 108.765 169.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.8 m -75.65 133.92 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -86.27 150.28 24.47 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 26.3 mm -130.17 137.36 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 C-N-CA 122.743 0.417 . . . . 0.0 110.646 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -141.45 92.19 8.28 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.53 162.87 34.89 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 124.174 3.25 . . . . 0.0 112.742 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -93.47 142.69 27.04 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 172.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -101.52 157.1 17.06 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.219 0.533 . . . . 0.0 110.489 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 156' ' ' LEU . 8.5 mp -90.33 178.99 5.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.518 0.675 . . . . 0.0 111.402 -176.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.7 m 65.12 4.43 2.56 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.501 1.92 . . . . 0.0 116.115 176.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 52.9 p30 -135.58 12.65 3.46 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 120.345 1.43 . . . . 0.0 113.317 172.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.8 m -66.13 -32.46 73.91 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -152.84 161.27 42.76 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 122.817 0.447 . . . . 0.0 111.015 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -152.97 152.89 31.94 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.956 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.97 140.66 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 28.3 ttp -132.44 13.7 4.55 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -159.66 -57.75 0.06 Allowed 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 61.33 11.64 28.18 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.409 -0.662 . . . . 0.0 113.54 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.4 t -109.36 -4.28 16.51 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.174 0.987 . . . . 0.0 112.184 -175.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -124.38 136.74 28.1 Favored Pre-proline 0 CA--C 1.531 0.218 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -68.3 160.52 48.62 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.146 2.564 . . . . 0.0 110.049 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 46.7 mt -113.04 153.31 28.31 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.51 0.324 . . . . 0.0 110.769 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -145.0 150.56 46.19 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.95 -5.43 13.43 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.442 2.761 . . . . 0.0 112.017 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -93.87 -1.22 55.13 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.028 0.531 . . . . 0.0 110.757 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.07 20.81 4.08 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.585 0.354 . . . . 0.0 111.444 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 13.6 m -119.99 143.17 48.18 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-O 120.987 0.422 . . . . 0.0 111.395 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.9 tt -113.05 141.3 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -106.92 152.36 24.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 76.1 t -137.97 144.98 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 123.633 0.773 . . . . 0.0 108.965 -173.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -148.02 149.55 21.64 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 112.04 -0.424 . . . . 0.0 112.04 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.4 22.1 54.97 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -172.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.6 m -60.94 144.91 89.86 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 116.913 0.356 . . . . 0.0 111.32 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.05 157.76 42.38 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.1 2.533 . . . . 0.0 108.715 170.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.419 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 10.7 tpt180 -66.73 -46.66 56.42 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.74 -176.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 182' ' ' ARG . 45.1 Cg_endo -78.48 27.08 0.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.452 2.768 . . . . 0.0 113.025 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.6 tp -64.96 -43.56 92.26 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.117 0.871 . . . . 0.0 110.38 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.427 ' HG2' ' H ' ' A' ' 187' ' ' VAL . 59.7 ttm-85 59.35 129.64 0.01 OUTLIER 'General case' 0 C--N 1.341 0.223 0 C-N-CA 126.11 1.764 . . . . 0.0 112.955 179.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.86 -25.69 68.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 121.554 -0.716 . . . . 0.0 111.474 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.427 ' H ' ' HG2' ' A' ' 185' ' ' ARG . 24.2 t -72.14 -47.85 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-O 120.662 0.268 . . . . 0.0 110.453 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -79.86 -24.64 41.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -176.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.8 tp -69.0 -33.85 74.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.78 -32.8 46.63 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.263 -0.273 . . . . 0.0 111.552 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.8 mmt -71.4 -35.99 71.23 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 122.305 -0.247 . . . . 0.0 110.475 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 71.5 mt -78.16 -40.51 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 22.5 mmt -60.67 -28.19 68.4 Favored 'General case' 0 C--N 1.334 -0.078 0 O-C-N 121.941 -0.474 . . . . 0.0 111.342 173.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -82.38 -21.51 35.83 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.419 0.554 . . . . 0.0 111.088 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.11 -19.69 26.67 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -110.1 -16.9 13.69 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.563 0.62 . . . . 0.0 111.875 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -135.1 -41.64 0.73 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.377 0.535 . . . . 0.0 111.587 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 69.19 162.76 3.08 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 121.474 0.486 . . . . 0.0 112.615 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 87.07 15.47 62.65 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 174.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.4 p -77.5 162.4 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.0 0.92 . . . . 0.0 110.597 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 51.5 t -137.28 -31.82 0.8 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -150.63 155.03 38.58 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.084 0.402 . . . . 0.0 111.814 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -156.27 156.85 34.76 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.346 0.658 . . . . 0.0 110.518 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 176.51 177.6 45.62 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.417 ' HA ' ' HA2' ' A' ' 218' ' ' GLY . 44.6 mm -103.83 87.05 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 26.2 t70 47.39 -86.85 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.927 -169.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.659 ' H ' ' HA ' ' A' ' 214' ' ' PRO . 12.6 m 49.72 65.16 1.49 Allowed 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.315 0.646 . . . . 0.0 111.091 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -59.75 133.46 89.27 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.74 -17.27 14.19 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 124.629 3.553 . . . . 0.0 114.282 -171.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -104.87 0.06 27.6 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.865 0.757 . . . . 0.0 111.282 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 97.5 mt -122.2 -13.21 8.16 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.807 0.843 . . . . 0.0 109.942 172.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt 52.97 38.11 26.29 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.534 1.134 . . . . 0.0 111.507 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -140.55 145.21 39.6 Favored Pre-proline 0 N--CA 1.461 0.12 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.659 ' HA ' ' H ' ' A' ' 207' ' ' THR . 64.6 Cg_endo -77.98 174.64 12.22 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.818 3.012 . . . . 0.0 110.769 173.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -132.16 21.07 4.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.417 0.687 . . . . 0.0 110.318 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 62.67 16.04 55.08 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 119.844 -0.42 . . . . 0.0 112.426 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -135.9 149.42 48.96 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.255 0.622 . . . . 0.0 110.273 -176.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 205' ' ' ILE . . . -95.11 162.0 23.66 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 116.629 -0.259 . . . . 0.0 112.773 -175.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -155.2 148.49 24.92 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 171.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.35 147.23 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -131.53 144.83 51.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.831 0.348 . . . . 0.0 110.301 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -128.88 165.66 20.59 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.027 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 78.5 p -94.66 -1.44 53.13 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -125.69 147.67 49.28 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 121.146 0.498 . . . . 0.0 111.62 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -78.5 -18.13 55.24 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.035 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -78.73 -37.14 42.15 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 58.6 p -80.14 -23.58 41.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -64.87 -41.67 95.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.722 0.409 . . . . 0.0 110.701 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.2 pt -84.21 -16.3 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 118.04 0.382 . . . . 0.0 111.592 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.66 -30.87 26.5 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 117.981 0.355 . . . . 0.0 110.86 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -77.04 -15.81 59.48 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.653 0.206 . . . . 0.0 111.38 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.409 ' HA ' HG21 ' A' ' 250' ' ' VAL . 1.6 pp -117.79 24.51 4.78 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 C-N-CA 123.133 0.573 . . . . 0.0 110.523 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.0 t -77.53 -9.19 58.77 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.005 0.522 . . . . 0.0 111.037 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -152.29 145.66 24.79 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -56.84 -28.9 62.26 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.6 0.36 . . . . 0.0 111.664 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -121.7 122.19 39.01 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 237' ' ' VAL . 2.4 m -82.79 151.85 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 C-N-CA 122.882 0.473 . . . . 0.0 109.961 174.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.521 ' C ' HD22 ' A' ' 239' ' ' LEU . 11.1 mp0 -94.98 138.42 32.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.521 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.5 mm? -125.37 22.61 7.72 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.091 -175.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -88.3 132.37 34.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.851 0.46 . . . . 0.0 112.137 -172.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -150.18 12.42 0.75 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.206 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 176.19 -143.8 6.68 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 243' ' ' GLU . 0.4 OUTLIER -81.4 3.35 24.79 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.708 0.403 . . . . 0.0 111.273 178.163 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 77.1 mt -99.95 148.74 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.64 0.776 . . . . 0.0 109.719 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -147.57 140.86 25.24 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.755 0.312 . . . . 0.0 110.199 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -142.92 154.43 44.07 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.69 151.44 30.55 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.1 p -161.72 158.42 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -83.26 144.93 29.41 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.197 0.599 . . . . 0.0 111.206 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 232' ' ' ILE . 2.1 m -123.75 163.72 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 252' ' ' PRO . 0.0 OUTLIER -157.29 156.37 29.11 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.089 170.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 251' ' ' LYS . 96.8 Cg_endo -73.06 39.21 0.44 Allowed 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 125.052 3.835 . . . . 0.0 111.754 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 43.96 43.87 5.63 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.326 1.45 . . . . 0.0 111.331 -174.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 CA--C 1.537 0.48 0 C-N-CA 125.732 1.613 . . . . 0.0 113.723 177.533 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.401 ' N ' ' HD3' ' A' ' 62' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.115 0 N-CA-C 111.481 0.178 . . . . 0.0 111.481 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -153.33 159.34 42.46 Favored 'General case' 0 C--O 1.23 0.046 0 O-C-N 123.495 0.497 . . . . 0.0 110.219 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.9 t -93.26 20.56 6.88 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.168 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 70.1 mtm-85 55.97 21.03 4.64 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.423 0.689 . . . . 0.0 112.314 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -146.9 144.51 29.31 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.014 0.526 . . . . 0.0 110.068 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.2 m -138.34 152.39 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.155 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -88.63 140.9 28.99 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 170.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 113' ' ' LEU . 1.5 m -134.61 138.47 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.57 -170.83 12.22 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -176.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 76.48 5.58 82.68 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.456 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.0 mt -70.86 148.79 94.88 Favored Pre-proline 0 N--CA 1.454 -0.245 0 CA-C-N 118.655 1.227 . . . . 0.0 108.823 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -62.38 160.53 31.0 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.328 2.019 . . . . 0.0 110.735 -177.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.64 -10.61 0.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 125.094 3.863 . . . . 0.0 114.781 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 76' ' ' ILE . 5.8 p-10 -105.0 -96.06 0.33 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 118.946 -0.55 . . . . 0.0 109.805 175.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.424 ' H ' ' CG ' ' A' ' 75' ' ' ASP . 3.1 tp 55.79 163.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -158.47 -179.28 7.94 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.863 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -59.14 -32.58 69.99 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.85 0.86 . . . . 0.0 112.633 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -91.09 -23.36 20.34 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 118.702 0.683 . . . . 0.0 112.629 -170.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -80.83 -27.16 36.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.3 mt -78.43 -40.53 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 97.0 m -63.31 -22.6 66.98 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.05 -21.25 24.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -72.94 -26.44 61.39 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.509 0.595 . . . . 0.0 111.88 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.519 ' CZ ' HD11 ' A' ' 151' ' ' ILE . 55.5 m-85 -124.31 13.17 8.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -17.29 64.39 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.992 -0.442 . . . . 0.0 111.269 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -68.41 -11.46 59.69 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.138 0.975 . . . . 0.0 111.466 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -123.61 36.15 4.69 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -173.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.1 175.46 34.74 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.11 151.83 61.74 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.9 3.066 . . . . 0.0 111.278 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.452 ' N ' HD23 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -166.89 163.34 16.19 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.872 -170.205 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.3 pt -141.42 169.55 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.0 p -135.38 150.12 29.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -152.91 174.11 14.52 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.419 0.628 . . . . 0.0 111.396 -177.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -160.41 157.94 24.89 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.505 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 37.8 Cg_endo -75.77 -17.97 17.49 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.237 1.958 . . . . 0.0 110.885 -169.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.505 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 22.6 m-70 -84.78 -7.57 59.15 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.561 0.744 . . . . 0.0 110.833 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -71.05 170.35 13.04 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.664 1.186 . . . . 0.0 112.997 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.297 0 C-N-CA 124.508 1.123 . . . . 0.0 109.655 178.07 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.599 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -129.13 140.59 51.48 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.51 -177.44 6.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.526 0.33 . . . . 0.0 110.591 -174.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -141.77 134.14 28.04 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.538 HD13 HG11 ' A' ' 69' ' ' VAL . 11.2 mp -92.28 150.83 20.64 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.245 0.545 . . . . 0.0 111.582 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.99 137.53 51.9 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 173.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -130.34 166.11 21.09 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.882 0.372 . . . . 0.0 111.117 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -113.03 -31.95 6.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.275 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -117.74 149.1 41.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.037 0.446 . . . . 0.0 111.074 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -83.91 -16.92 42.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.218 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.8 p -86.43 -17.61 33.85 Favored 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 122.16 -0.338 . . . . 0.0 111.549 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.3 m -71.94 -47.01 55.46 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.004 0.43 . . . . 0.0 110.584 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.428 ' HA ' HD12 ' A' ' 124' ' ' LEU . 5.0 p -72.58 -20.22 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.042 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -75.27 -32.28 61.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.66 -44.49 56.64 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.547 HD22 ' C ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -72.98 -28.79 62.6 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 118.388 -1.325 . . . . 0.0 110.994 -178.367 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 83.4 mt -80.54 -16.65 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 118.292 0.496 . . . . 0.0 110.928 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -86.14 -17.83 33.91 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.731 -0.606 . . . . 0.0 110.364 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -112.11 14.12 20.67 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 20.0 p -98.99 171.56 7.96 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.168 0.508 . . . . 0.0 112.251 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 130' ' ' GLU . 39.9 mm -90.17 167.96 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 125.522 1.529 . . . . 0.0 108.472 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.414 ' N ' HG22 ' A' ' 129' ' ' ILE . 42.2 mt-10 -124.33 152.87 42.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.021 0.439 . . . . 0.0 112.004 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -145.61 -174.37 4.38 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 172.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.75 98.11 0.09 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.909 0.385 . . . . 0.0 111.342 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 78.06 -2.15 66.45 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.25 -0.75 . . . . 0.0 114.258 175.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -137.89 173.94 11.1 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.569 1.184 . . . . 0.0 110.372 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -110.19 174.8 5.7 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.479 0.712 . . . . 0.0 109.527 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -144.07 149.21 36.26 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.2 0.6 . . . . 0.0 109.582 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.8 tp -132.22 146.32 51.93 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 169.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.1 m -89.25 133.72 34.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.793 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.1 p -156.18 154.11 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 124.32 1.048 . . . . 0.0 108.403 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.4 p -85.7 150.41 24.62 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.142 -0.349 . . . . 0.0 110.28 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.7 p -138.44 146.29 50.45 Favored Pre-proline 0 N--CA 1.456 -0.172 0 O-C-N 122.278 -0.264 . . . . 0.0 110.442 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.12 -8.85 20.3 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.214 2.609 . . . . 0.0 112.902 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.42 HG23 HG12 ' A' ' 144' ' ' ILE . 1.9 t -90.74 -18.21 25.38 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.239 0.927 . . . . 0.0 111.179 178.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.597 HG22 ' H ' ' A' ' 145' ' ' LYS . 2.3 mm -134.05 -144.72 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.597 ' H ' HG22 ' A' ' 144' ' ' ILE . 75.8 mmtt -119.41 -14.02 9.21 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.058 0.943 . . . . 0.0 109.158 169.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -156.99 157.35 34.57 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.612 1.165 . . . . 0.0 109.4 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.47 112.04 2.41 Favored Pre-proline 0 N--CA 1.457 -0.077 0 C-N-CA 122.54 0.336 . . . . 0.0 110.921 178.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.508 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 23.9 Cg_exo -67.68 133.98 31.32 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.894 2.396 . . . . 0.0 108.929 167.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.6 m -121.23 138.29 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 118.299 0.5 . . . . 0.0 110.354 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -74.56 154.77 38.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.519 HD11 ' CZ ' ' A' ' 85' ' ' PHE . 44.2 mm -138.55 141.32 37.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 124.886 1.274 . . . . 0.0 108.918 171.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.9 ttp85 -156.44 109.96 2.03 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 170.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -76.34 164.42 30.93 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.917 3.078 . . . . 0.0 111.356 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.413 ' CG ' ' HG3' ' A' ' 214' ' ' PRO . 55.0 t-105 -100.44 144.84 28.96 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.595 0.235 . . . . 0.0 111.209 176.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -107.02 156.85 18.31 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.494 0.718 . . . . 0.0 111.718 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.0 mp -100.89 15.41 28.61 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.091 0.556 . . . . 0.0 111.598 -175.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.4 t -90.86 -28.53 18.09 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -174.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -140.33 25.07 2.27 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.63 0.65 . . . . 0.0 112.631 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.0 t -70.74 -16.42 62.77 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -155.07 159.9 40.6 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.041 0.536 . . . . 0.0 110.524 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -156.86 156.74 33.67 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.587 0.232 . . . . 0.0 111.0 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.9 m -137.49 151.5 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 C-N-CA 123.152 0.581 . . . . 0.0 110.327 175.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 16.1 ttp -135.34 19.15 3.38 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.555 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -151.93 -179.66 7.67 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.86 18.75 0.61 Allowed Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.372 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.0 t 54.6 50.46 15.92 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 117.736 0.768 . . . . 0.0 111.895 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -64.36 160.07 53.49 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 122.926 0.49 . . . . 0.0 109.962 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -52.19 147.55 27.38 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.72 2.947 . . . . 0.0 112.355 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 68.8 mt -122.09 162.04 21.97 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.357 0.663 . . . . 0.0 110.995 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -143.92 150.25 48.95 Favored Pre-proline 0 CA--C 1.529 0.168 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -68.28 -10.83 30.14 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.957 2.438 . . . . 0.0 111.508 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.78 2.48 56.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.149 0.58 . . . . 0.0 110.496 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -126.17 18.04 7.74 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.674 0.39 . . . . 0.0 111.09 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 16.4 m -127.55 139.74 52.58 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.722 0.296 . . . . 0.0 111.019 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.1 tt -111.62 152.07 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 C-N-CA 123.16 0.584 . . . . 0.0 110.474 -176.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.404 ' CD1' ' CE1' ' A' ' 253' ' ' TYR . 6.3 t80 -114.68 143.84 44.39 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.8 m -140.92 132.36 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 122.611 0.364 . . . . 0.0 110.287 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -142.44 179.95 19.8 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.99 10.12 83.37 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -171.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 28.9 m -72.82 155.42 90.71 Favored Pre-proline 0 N--CA 1.455 -0.177 0 C-N-CA 122.904 0.481 . . . . 0.0 110.891 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.74 -172.6 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.756 2.971 . . . . 0.0 109.785 175.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -55.8 -48.4 96.67 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.213 -0.898 . . . . 0.0 112.236 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.59 138.75 17.5 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.223 1.949 . . . . 0.0 110.939 174.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.413 ' N ' HD23 ' A' ' 184' ' ' LEU . 2.4 pt? -155.52 16.32 0.39 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.371 0.668 . . . . 0.0 111.448 178.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -42.71 142.1 0.93 Allowed 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.963 1.305 . . . . 0.0 112.334 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.73 -21.57 61.74 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -171.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.5 t -60.75 -52.13 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-N 118.306 0.503 . . . . 0.0 110.838 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -83.54 -20.09 34.5 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.387 -0.196 . . . . 0.0 110.798 -175.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 25.2 tp -73.85 -32.9 63.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -77.63 -39.31 45.69 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 117.563 0.165 . . . . 0.0 111.046 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 25.5 mmt -64.88 -49.81 69.02 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -177.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.8 mt -65.87 -34.57 71.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -178.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.4 tpp -74.23 -13.09 60.73 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 122.469 -0.145 . . . . 0.0 110.966 -178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -102.26 -12.61 17.85 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.029 -0.42 . . . . 0.0 112.032 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -92.4 -18.06 23.78 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.241 0.473 . . . . 0.0 111.369 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.47 -20.79 10.63 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.18 0.445 . . . . 0.0 111.036 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -141.05 46.83 1.73 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.958 0.503 . . . . 0.0 109.97 -177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.55 136.79 4.57 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.016 0.817 . . . . 0.0 113.395 -175.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 135.8 7.15 1.88 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.123 0.868 . . . . 0.0 111.747 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 40.9 t -72.31 149.3 9.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 117.617 0.709 . . . . 0.0 110.903 -177.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 23.5 p -134.2 -23.04 1.73 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -151.17 150.94 31.23 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -149.67 155.23 39.87 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.429 0.692 . . . . 0.0 109.285 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -177.27 -176.32 45.27 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 30.4 mm -100.23 152.81 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 9.8 t70 -53.34 132.03 38.6 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 33.4 p -144.2 167.66 21.9 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 122.584 0.353 . . . . 0.0 110.518 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . 0.479 ' HA ' ' HD3' ' A' ' 209' ' ' PRO . 12.6 t70 -132.97 136.57 27.87 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 119.392 -0.337 . . . . 0.0 110.212 174.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 208' ' ' ASP . 22.1 Cg_exo -68.61 -9.35 25.86 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 124.532 3.488 . . . . 0.0 115.809 -172.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.27 -26.24 68.41 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 119.737 1.153 . . . . 0.0 110.92 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 19.3 tp -150.35 3.83 0.51 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.971 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 55.11 39.67 31.58 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.208 1.003 . . . . 0.0 110.605 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -100.08 146.2 31.52 Favored Pre-proline 0 N--CA 1.457 -0.083 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.373 -176.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.413 ' HG3' ' CG ' ' A' ' 154' ' ' TRP . 30.7 Cg_endo -82.1 164.91 17.32 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.289 2.659 . . . . 0.0 113.465 -177.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -128.39 -174.64 3.28 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.921 1.289 . . . . 0.0 108.372 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -71.45 164.25 53.98 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.0 173.47 0.07 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -135.21 177.38 19.41 Favored Glycine 0 CA--C 1.525 0.718 0 O-C-N 121.97 -0.457 . . . . 0.0 112.553 -173.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.02 155.18 42.03 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.173 0.511 . . . . 0.0 111.077 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 63.6 t -139.45 145.88 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.61 148.19 46.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.854 0.359 . . . . 0.0 110.274 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -122.79 150.24 43.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.416 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 68.5 m -83.32 2.6 35.41 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 111.389 0.144 . . . . 0.0 111.389 175.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -131.19 138.9 49.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.775 0.43 . . . . 0.0 110.559 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . 0.473 ' CD ' ' H ' ' A' ' 225' ' ' GLN . 0.0 OUTLIER -75.45 -12.83 60.32 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 176.601 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 -82.35 -37.11 26.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 19.9 m -73.26 -29.04 62.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -67.17 -53.04 34.11 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 119.687 -0.196 . . . . 0.0 110.749 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.2 pt -69.56 -16.59 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 CA-C-N 118.126 0.421 . . . . 0.0 111.092 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.9 -24.7 33.03 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.713 0.233 . . . . 0.0 110.821 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.74 -21.52 26.53 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.1 pt -110.43 27.49 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.071 0.548 . . . . 0.0 110.345 174.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 20.4 t -80.68 -9.99 59.76 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.257 0.623 . . . . 0.0 112.065 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -158.3 145.12 17.63 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 55.7 ttm-85 -57.06 -32.63 66.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.562 0.345 . . . . 0.0 111.665 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -122.54 115.92 23.01 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 23.5 m -99.36 161.3 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.119 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -85.18 142.34 29.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 110.463 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.31 105.44 7.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 173.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -131.73 148.01 52.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.434 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -141.76 20.62 2.16 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.452 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 95.75 131.04 6.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 54.73 4.31 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.52 1.528 . . . . 0.0 114.7 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.2 mt -145.09 136.33 20.12 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 CA-C-N 118.702 0.683 . . . . 0.0 109.937 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -129.16 147.44 51.01 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.825 0.345 . . . . 0.0 111.367 173.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -144.9 170.52 15.98 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.612 1.165 . . . . 0.0 109.648 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.88 160.41 39.37 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.635 0.774 . . . . 0.0 110.303 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.0 p -152.23 152.11 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -85.84 126.88 34.38 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.05 157.7 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 CA-C-O 121.039 0.447 . . . . 0.0 111.84 -176.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.46 158.41 27.82 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.57 169.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.64 133.28 57.02 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.564 2.176 . . . . 0.0 107.884 172.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . 0.404 ' CE1' ' CD1' ' A' ' 176' ' ' PHE . 2.3 t80 -75.28 118.88 18.68 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.087 -173.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.534 0.335 0 C-N-CA 127.434 2.293 . . . . 0.0 114.43 177.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.749 0.309 . . . . 0.0 110.487 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.21 157.52 43.43 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -172.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.9 t -102.75 150.45 23.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.076 174.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -85.63 3.74 39.48 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.652 0.381 . . . . 0.0 110.281 174.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -100.02 135.96 40.66 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.85 0.86 . . . . 0.0 109.413 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 p -149.75 144.41 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.816 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -92.2 144.42 25.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 m -132.69 130.03 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -141.37 148.3 19.96 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.94 37.43 3.41 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -175.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.6 mt -85.96 159.63 54.05 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -70.71 153.79 64.34 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.959 2.439 . . . . 0.0 108.968 172.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.03 3.19 4.13 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.884 3.056 . . . . 0.0 112.354 -178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -94.0 -27.12 16.5 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.465 HD12 ' C ' ' A' ' 76' ' ' ILE . 2.3 pp -136.39 174.81 11.61 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-N 118.524 0.602 . . . . 0.0 110.252 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -163.39 5.8 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -145.41 -45.71 0.22 Allowed 'General case' 0 C--N 1.341 0.21 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -174.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -84.62 -34.14 23.17 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.622 0.646 . . . . 0.0 112.371 -172.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -73.45 -27.11 61.24 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.725 0.298 . . . . 0.0 110.509 -176.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.7 pt -88.01 -30.35 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 122.465 0.306 . . . . 0.0 110.916 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 56.8 m -71.75 -14.87 62.13 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.94 -22.07 17.64 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.5 m -88.2 -15.53 35.71 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.451 ' CE1' HD23 ' A' ' 137' ' ' LEU . 68.2 m-85 -123.29 10.21 9.25 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.852 0.751 . . . . 0.0 113.003 -174.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -83.63 -12.01 56.54 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.601 0.36 . . . . 0.0 111.945 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.493 ' HG3' ' CD2' ' A' ' 88' ' ' PHE . 15.9 ptm180 -72.79 -18.22 61.5 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.493 ' CD2' ' HG3' ' A' ' 87' ' ' ARG . 70.0 m-85 -105.61 1.84 27.7 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.339 0.256 . . . . 0.0 111.348 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.5 163.41 9.82 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.22 140.78 45.6 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.228 2.618 . . . . 0.0 110.237 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.513 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -153.04 166.15 33.33 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.257 0.551 . . . . 0.0 112.279 -177.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.8 pt -137.15 -179.95 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.597 173.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.0 p -132.4 157.75 43.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 O-C-N 122.283 -0.261 . . . . 0.0 110.349 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -148.32 161.72 40.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.296 0.569 . . . . 0.0 111.47 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.451 ' CZ2' ' HE3' ' A' ' 98' ' ' LYS . 27.7 p90 -157.1 158.75 31.26 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 105.539 -2.022 . . . . 0.0 105.539 169.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.589 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 59.8 Cg_endo -72.81 -10.05 24.46 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.494 1.463 . . . . 0.0 111.018 -169.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.589 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 17.1 m-70 -104.93 19.3 20.82 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.682 1.193 . . . . 0.0 110.444 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -36.39 -62.67 0.44 Allowed 'General case' 0 C--N 1.34 0.161 0 C-N-CA 125.571 1.549 . . . . 0.0 113.756 -171.133 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 124.02 0.928 . . . . 0.0 112.534 -173.613 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.787 0 CA-C-O 119.833 -0.426 . . . . 0.0 112.264 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.39 141.7 32.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.719 0.759 . . . . 0.0 110.18 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.01 -179.1 7.19 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.985 0.514 . . . . 0.0 110.306 -176.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -129.24 121.12 26.93 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -176.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 mp -83.92 147.35 27.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.592 0.711 . . . . 0.0 111.292 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 mp -124.12 104.03 8.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -88.25 162.82 16.42 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.779 0.323 . . . . 0.0 110.249 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -90.26 -21.55 22.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.216 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -132.03 149.79 52.33 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.533 0.206 . . . . 0.0 111.534 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -77.49 -16.63 58.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.231 0.213 . . . . 0.0 110.629 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 59.0 m -93.64 -17.71 22.97 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 122.457 0.303 . . . . 0.0 111.305 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.0 m -70.59 -44.58 67.03 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.5 p -74.36 -15.66 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.997 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -78.3 -33.8 49.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 122.013 -0.429 . . . . 0.0 109.926 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.27 -36.74 61.17 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.25 0.477 . . . . 0.0 110.843 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.32 -40.18 93.41 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 57.5 mt -85.81 -9.93 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 O-C-N 121.663 -0.648 . . . . 0.0 111.893 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -107.66 -3.72 18.94 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.98 -0.45 . . . . 0.0 112.163 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -122.57 6.59 9.49 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 74.9 m -113.75 -172.94 2.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.399 0.545 . . . . 0.0 110.516 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 129' ' ' ILE . 3.2 mp -68.05 154.22 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.674 0.79 . . . . 0.0 108.904 -170.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -137.16 157.56 46.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -143.82 62.16 1.36 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.208 0.528 . . . . 0.0 110.895 175.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.2 t70 50.93 8.84 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.904 1.681 . . . . 0.0 115.534 171.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -179.51 -19.02 0.03 OUTLIER Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.558 -0.713 . . . . 0.0 111.895 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -129.94 162.67 28.1 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 117.642 0.721 . . . . 0.0 109.39 171.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.19 163.04 16.89 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -145.22 162.03 38.12 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.965 0.412 . . . . 0.0 111.186 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.451 HD23 ' CE1' ' A' ' 85' ' ' PHE . 56.4 tp -141.89 145.51 34.67 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 170.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 79.4 m -84.23 128.61 34.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.3 m -141.21 166.13 18.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 122.898 0.479 . . . . 0.0 110.616 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.0 t -65.91 149.4 50.27 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.2 t -151.64 91.33 3.82 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -176.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -55.24 -11.37 4.08 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.252 3.302 . . . . 0.0 115.645 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.401 HG23 ' CD1' ' A' ' 144' ' ' ILE . 5.5 t -95.98 -10.37 28.77 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.577 1.081 . . . . 0.0 111.353 178.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.654 HG22 ' H ' ' A' ' 145' ' ' LYS . 2.2 mm -132.96 -160.1 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.654 ' H ' HG22 ' A' ' 144' ' ' ILE . 49.9 mmtm -103.93 -23.42 13.36 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -163.04 152.58 15.35 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.981 1.313 . . . . 0.0 108.351 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 21.6 ttmt -153.64 120.21 2.89 Favored Pre-proline 0 N--CA 1.457 -0.083 0 CA-C-N 118.062 0.392 . . . . 0.0 110.865 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -64.74 127.93 19.86 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.162 2.575 . . . . 0.0 110.105 168.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.4 p -100.79 136.03 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -85.03 146.88 26.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.579 0.352 . . . . 0.0 110.513 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 40.0 mm -125.12 143.03 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.882 0.873 . . . . 0.0 109.422 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.95 96.92 2.69 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -176.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.01 172.15 16.68 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.451 3.434 . . . . 0.0 111.897 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -109.24 150.48 27.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.776 0.322 . . . . 0.0 111.285 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -116.42 155.16 29.03 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.611 0.764 . . . . 0.0 111.234 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 156' ' ' LEU . 6.9 mp -103.9 89.96 3.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -177.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 11.5 t -155.34 -36.25 0.09 Allowed 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -140.05 28.73 2.09 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.2 m -60.1 -35.92 76.3 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -154.24 161.51 41.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.78 0.432 . . . . 0.0 110.868 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -154.63 159.02 40.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.526 0.203 . . . . 0.0 110.62 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.9 m -138.95 149.98 23.45 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.016 0 C-N-CA 123.678 0.791 . . . . 0.0 109.585 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.2 mtm -137.83 8.71 2.8 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 -174.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -138.74 17.12 2.69 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.268 0.94 . . . . 0.0 112.936 -176.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.33 19.25 55.6 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 119.689 -0.506 . . . . 0.0 113.053 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 28.9 m 55.46 50.67 14.22 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 117.676 0.738 . . . . 0.0 112.327 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -62.11 165.75 7.83 Favored Pre-proline 0 CA--C 1.531 0.212 0 C-N-CA 123.748 0.819 . . . . 0.0 110.106 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.75 137.2 27.32 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.89 2.394 . . . . 0.0 110.534 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.442 HD11 ' HB1' ' A' ' 221' ' ' ALA . 12.8 tp -132.34 151.08 52.01 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 122.682 0.393 . . . . 0.0 110.483 -170.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -147.7 140.66 14.93 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.901 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.54 -21.6 47.07 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.569 2.846 . . . . 0.0 114.091 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -85.3 6.37 26.54 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.519 0.6 . . . . 0.0 110.787 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -125.03 28.14 6.49 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 31.4 m -129.66 152.29 49.33 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.088 -173.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.3 tt -123.95 148.21 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 C-N-CA 123.366 0.666 . . . . 0.0 109.288 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -114.42 144.18 43.73 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 13.7 m -135.97 130.13 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 122.87 0.468 . . . . 0.0 110.056 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -132.26 164.62 23.8 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 87.37 16.93 59.69 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -175.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 28.3 m -64.52 151.05 92.55 Favored Pre-proline 0 CA--C 1.53 0.181 0 C-N-CA 122.464 0.305 . . . . 0.0 111.257 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -75.83 -174.97 2.24 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.954 3.103 . . . . 0.0 110.065 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -56.03 -50.86 84.89 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.545 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.83 141.73 21.83 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.15 1.9 . . . . 0.0 110.928 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.675 ' CD1' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -148.02 -75.99 0.18 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.799 178.219 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.675 ' H ' ' CD1' ' A' ' 184' ' ' LEU . 5.8 ptm180 49.75 132.48 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 128.445 2.698 . . . . 0.0 115.073 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.87 -20.19 65.87 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 121.721 -0.612 . . . . 0.0 112.302 -175.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 96.7 t -67.91 -58.32 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-N 117.817 0.28 . . . . 0.0 111.187 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -82.73 -19.44 37.93 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.263 -0.273 . . . . 0.0 111.268 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.9 tp -70.09 -35.91 74.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.66 -35.47 57.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 122.387 -0.196 . . . . 0.0 111.406 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 23.5 mmt -69.78 -38.49 76.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -175.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 45.6 mt -71.85 -43.64 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.548 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -61.64 -21.27 64.25 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 118.31 0.505 . . . . 0.0 111.34 173.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.66 -11.58 36.58 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.659 0.663 . . . . 0.0 112.158 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -96.44 -15.75 21.58 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 122.033 -0.417 . . . . 0.0 111.861 175.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.08 -21.84 10.33 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 118.155 0.434 . . . . 0.0 110.793 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -139.86 44.21 1.93 Allowed 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.175 0.59 . . . . 0.0 109.444 -178.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -42.47 135.93 3.74 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.168 0.889 . . . . 0.0 113.04 -174.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 131.45 12.59 2.0 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -176.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.404 HG22 ' CE2' ' A' ' 222' ' ' PHE . 49.1 t -70.03 148.42 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-N 117.541 0.671 . . . . 0.0 110.24 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 51.5 t -125.64 -29.99 3.11 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.896 177.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -155.48 152.72 29.27 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.58 0.229 . . . . 0.0 110.893 -175.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.4 160.17 42.56 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.385 0.674 . . . . 0.0 110.761 175.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -178.58 173.55 45.88 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 176.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.464 HD12 ' N ' ' A' ' 205' ' ' ILE . 3.4 mp -94.51 84.73 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 23.4 t70 53.66 -66.77 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -168.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 38.8 p 43.0 54.14 4.9 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -60.65 132.31 91.27 Favored Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.19 -14.78 14.79 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.43 3.42 . . . . 0.0 113.886 -173.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -91.83 -39.68 11.62 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.616 0.644 . . . . 0.0 110.211 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.42 -7.8 34.02 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 65.8 mttm 52.02 46.34 26.77 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 124.618 1.167 . . . . 0.0 111.675 174.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.93 154.5 43.51 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -175.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -83.58 173.21 9.69 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.918 3.079 . . . . 0.0 110.868 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -127.8 18.57 6.72 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.999 0.519 . . . . 0.0 111.621 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.07 10.27 56.03 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.886 -0.397 . . . . 0.0 112.27 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -134.91 148.7 50.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.45 0.625 . . . . 0.0 110.306 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -87.49 156.14 27.69 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 121.455 0.475 . . . . 0.0 113.146 -173.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -144.71 149.26 35.31 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 169.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 71.8 t -138.56 144.2 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.442 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -129.07 148.86 51.05 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.068 0.461 . . . . 0.0 110.39 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.404 ' CE2' HG22 ' A' ' 200' ' ' VAL . 69.0 m-85 -120.62 154.14 35.86 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.101 -173.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 67.3 p -90.22 7.74 36.61 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.284 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -134.96 136.69 42.43 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.665 0.786 . . . . 0.0 109.655 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -75.9 -16.95 59.95 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.0 tp60 -77.71 -36.82 50.6 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 23.7 m -78.57 -24.65 45.42 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.287 -0.258 . . . . 0.0 110.38 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.46 -49.94 69.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.0 pt -75.09 -16.34 15.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.07 0 CA-C-N 117.744 0.247 . . . . 0.0 111.522 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.79 -25.59 37.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.83 0.286 . . . . 0.0 111.006 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -82.57 -22.23 34.95 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 21.8 pt -108.92 20.88 5.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.004 0.522 . . . . 0.0 110.538 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.3 t -77.41 -9.58 58.95 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.874 0.47 . . . . 0.0 111.659 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -152.12 144.12 23.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -53.69 -29.32 38.43 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -126.38 119.9 28.48 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.849 0.357 . . . . 0.0 110.415 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.431 HG23 HD21 ' A' ' 239' ' ' LEU . 2.7 m -84.37 159.19 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.207 175.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.606 ' C ' HD22 ' A' ' 239' ' ' LEU . 3.6 mp0 -94.86 138.53 32.52 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.606 HD22 ' C ' ' A' ' 238' ' ' GLN . 2.5 mm? -129.83 14.39 5.85 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.908 -175.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.63 140.29 29.9 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -172.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -147.59 21.21 1.17 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.408 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.59 139.74 6.32 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 54.85 3.28 0.05 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.186 1.394 . . . . 0.0 113.426 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 62.0 mt -145.43 142.04 22.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 C-N-CA 124.23 1.012 . . . . 0.0 108.619 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -151.89 136.36 16.87 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 176.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -148.22 164.99 32.29 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.802 0.841 . . . . 0.0 109.62 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.57 155.92 38.31 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 8.5 p -155.88 152.32 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -82.68 143.58 30.85 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.2 m -116.73 153.82 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 121.631 0.729 . . . . 0.0 112.949 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 251' ' ' LYS . 32.4 ttmt -151.24 141.43 14.53 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.833 174.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . 0.409 ' HD2' ' HG3' ' A' ' 251' ' ' LYS . 24.9 Cg_endo -58.23 136.99 78.24 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.61 2.207 . . . . 0.0 108.364 176.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -70.07 132.65 46.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.266 -173.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.466 0 C-N-CA 127.111 2.164 . . . . 0.0 113.91 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.637 ' HD3' HD13 ' A' ' 156' ' ' LEU . 0.4 OUTLIER . . . . . 0 CA--C 1.53 0.182 0 CA-C-O 120.53 0.205 . . . . 0.0 111.324 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.704 ' C ' HD11 ' A' ' 156' ' ' LEU . 26.1 m-85 -134.27 160.79 36.8 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 121.135 0.493 . . . . 0.0 111.121 -174.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -88.51 31.88 0.81 Allowed 'General case' 0 C--N 1.334 -0.068 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.597 ' HA ' ' CE1' ' A' ' 115' ' ' PHE . 99.0 mtt180 54.62 18.42 2.04 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.192 0.597 . . . . 0.0 112.299 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -146.25 133.48 20.55 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 m -139.94 161.97 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -95.59 143.06 27.2 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 169.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.7 m -131.39 118.52 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 172.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.58 138.96 14.68 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.481 -172.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.57 145.44 4.85 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.446 0.546 . . . . 0.0 114.386 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.7 tp -164.96 132.79 2.47 Favored Pre-proline 0 N--CA 1.453 -0.283 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 81.9 Cg_endo -77.19 156.04 33.34 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.937 1.758 . . . . 0.0 110.329 178.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 33.0 Cg_exo -62.43 0.78 1.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 124.544 3.496 . . . . 0.0 114.913 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -134.25 43.54 2.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.598 0.636 . . . . 0.0 111.552 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mt -141.32 151.5 19.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -135.99 -179.47 5.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.916 0.389 . . . . 0.0 111.595 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -45.76 -42.36 11.91 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.59 1.156 . . . . 0.0 112.075 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.94 -29.57 62.09 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.192 0.451 . . . . 0.0 111.92 -173.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -80.79 -29.83 36.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 122.29 -0.256 . . . . 0.0 110.823 -172.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.2 pt -86.41 -26.02 6.27 Favored 'Isoleucine or valine' 0 C--N 1.338 0.078 0 O-C-N 121.782 -0.574 . . . . 0.0 109.899 173.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 61.7 m -70.24 -14.15 62.49 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 172.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.26 -21.97 16.95 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.393 0.277 . . . . 0.0 111.606 173.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.4 m -77.06 -21.56 54.26 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.255 0.479 . . . . 0.0 111.885 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -111.89 4.57 18.36 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 117.825 0.284 . . . . 0.0 111.649 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -71.64 -5.9 37.0 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.966 -0.459 . . . . 0.0 111.964 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.4 tpt85 -67.1 -10.0 45.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.189 0.996 . . . . 0.0 110.627 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -126.56 33.03 5.06 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.47 0.308 . . . . 0.0 111.464 -174.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.68 178.45 38.07 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.948 -0.461 . . . . 0.0 111.948 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.38 141.74 35.81 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.882 3.055 . . . . 0.0 111.305 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.44 173.48 14.83 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.811 0.844 . . . . 0.0 110.088 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.89 167.27 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.147 -177.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.29 148.37 29.9 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -150.91 163.96 37.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.108 0.48 . . . . 0.0 110.827 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.512 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 33.7 p90 -153.5 162.98 25.22 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 176.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.649 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 40.3 Cg_endo -73.59 -10.19 23.39 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.644 2.896 . . . . 0.0 110.923 -169.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.649 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 74.4 m-70 -106.06 18.75 21.59 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.295 1.038 . . . . 0.0 111.257 -178.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -48.91 151.44 1.24 Allowed 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.895 0.878 . . . . 0.0 113.154 -176.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.302 0 C-N-CA 124.008 0.923 . . . . 0.0 110.319 -176.749 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.828 0 CA-C-O 119.332 -0.704 . . . . 0.0 113.831 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -113.93 142.53 46.01 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.968 1.384 . . . . 0.0 108.238 177.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.27 176.86 9.24 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.085 0.402 . . . . 0.0 111.754 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -142.95 137.15 29.2 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -177.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.77 148.7 23.11 Favored 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -174.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.2 mp -130.66 147.37 52.33 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.911 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.597 ' CE1' ' HA ' ' A' ' 65' ' ' ARG . 3.4 p90 -158.93 178.84 9.64 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.289 0.636 . . . . 0.0 109.297 175.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -107.76 -21.03 13.02 Favored 'General case' 0 N--CA 1.456 -0.128 0 O-C-N 122.187 -0.32 . . . . 0.0 111.782 -174.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -129.71 144.19 51.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.863 0.363 . . . . 0.0 111.335 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -74.68 -14.9 60.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.707 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 76.7 p -70.92 -21.65 62.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.354 -0.216 . . . . 0.0 110.902 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.4 t -75.35 -40.83 57.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.431 ' HB ' ' CZ ' ' A' ' 115' ' ' PHE . 4.7 p -82.8 -23.8 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -67.67 -37.83 82.9 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.108 -0.37 . . . . 0.0 110.004 177.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.4 -35.9 30.19 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.97 -18.25 60.41 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.58 0.627 . . . . 0.0 110.985 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.0 mt -93.82 -23.71 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 117.948 0.34 . . . . 0.0 110.748 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -83.94 -13.68 52.81 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.793 -0.567 . . . . 0.0 111.63 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -124.87 46.38 2.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.056 0.543 . . . . 0.0 111.125 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 18.6 p -137.75 -176.55 4.46 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 44.1 mt -86.29 154.98 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 125.168 1.387 . . . . 0.0 108.32 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.55 156.98 47.49 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.124 -0.36 . . . . 0.0 110.729 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.24 -176.64 5.37 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -42.75 -25.9 0.11 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -169.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.33 14.04 0.13 Allowed Glycine 0 CA--C 1.528 0.87 0 CA-C-N 119.163 0.892 . . . . 0.0 112.844 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -145.0 170.97 15.13 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 117.784 0.792 . . . . 0.0 111.05 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 75.1 mt -108.01 166.63 10.58 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -149.87 155.74 40.57 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.79 0.328 . . . . 0.0 110.739 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.6 mp -143.75 160.67 40.33 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 36.9 t -87.85 156.64 19.28 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.78 165.08 30.74 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-O 120.846 0.355 . . . . 0.0 111.109 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.4 t -115.62 179.33 4.0 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.562 0.745 . . . . 0.0 109.728 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.541 ' HB3' ' HD2' ' A' ' 142' ' ' PRO . 5.7 m 61.48 -172.77 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.321 0.648 . . . . 0.0 110.143 -176.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 97.4 Cg_endo -74.07 135.96 21.75 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.703 1.602 . . . . 0.0 111.423 -169.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.7 m -147.29 42.85 1.11 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.619 0.768 . . . . 0.0 109.206 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 144' ' ' ILE . 3.2 mp 63.4 -62.2 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.753 1.621 . . . . 0.0 111.167 -173.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -151.99 -62.09 0.17 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 174.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -160.55 130.46 5.15 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.897 0.479 . . . . 0.0 110.404 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 37.3 mttp -151.13 103.05 2.97 Favored Pre-proline 0 CA--C 1.53 0.174 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.97 135.29 58.3 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.402 2.735 . . . . 0.0 111.02 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.9 p -90.45 133.28 32.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -100.75 154.53 18.54 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -174.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.9 mm -131.08 147.64 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.946 0.898 . . . . 0.0 110.71 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -160.59 99.49 1.36 Allowed Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.009 0.524 . . . . 0.0 110.138 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.84 174.18 3.2 Favored 'Trans proline' 0 CA--C 1.531 0.356 1 C-N-CA 125.788 4.325 . . . . 0.0 115.969 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -108.18 156.48 19.28 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.539 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -102.58 125.22 49.23 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.515 0.674 . . . . 0.0 111.102 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.707 ' CD1' ' H ' ' A' ' 156' ' ' LEU . 1.9 mp -67.19 -19.77 65.61 Favored 'General case' 0 C--O 1.23 0.041 0 C-N-CA 125.102 1.361 . . . . 0.0 114.22 -172.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 81.1 p -87.11 -4.93 59.17 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -167.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -146.37 27.71 1.12 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.564 1.074 . . . . 0.0 113.318 -176.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.4 m -72.02 -20.98 61.61 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.8 -0.562 . . . . 0.0 112.377 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -150.49 155.36 39.34 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 122.801 0.44 . . . . 0.0 110.949 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -150.09 162.12 41.03 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 10.9 p -149.19 149.81 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.9 ttm -123.02 22.13 9.64 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -170.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -158.43 -41.16 0.06 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.22 10.26 59.2 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.723 173.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.5 t -141.79 -24.2 0.7 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.573 1.186 . . . . 0.0 114.163 -176.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 24.0 mm100 -80.32 130.51 65.25 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 119.625 1.102 . . . . 0.0 110.615 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 167' ' ' GLN . 32.4 Cg_exo -61.11 159.49 29.97 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.667 2.912 . . . . 0.0 111.457 173.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.7 mt -108.71 154.36 22.14 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.514 0.326 . . . . 0.0 110.122 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -151.58 138.44 11.96 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.51 -14.09 42.38 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.143 2.562 . . . . 0.0 113.182 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -86.32 -6.6 58.92 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.711 0.687 . . . . 0.0 110.491 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -125.65 15.71 8.14 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.665 0.386 . . . . 0.0 111.355 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 46.4 m -119.5 143.64 47.45 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 121.131 0.491 . . . . 0.0 110.905 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.47 148.7 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.088 -177.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -115.96 151.9 34.51 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.47 111.44 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.291 0.637 . . . . 0.0 109.911 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -82.92 126.58 7.54 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 118.2 -110.87 2.05 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.4 p 36.68 63.95 2.69 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.407 0.683 . . . . 0.0 111.573 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.22 176.75 3.66 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.251 3.301 . . . . 0.0 112.731 -174.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.435 ' N ' ' CD ' ' A' ' 183' ' ' PRO . 9.8 ptm180 -59.81 -21.14 0.71 Allowed Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -173.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 182' ' ' ARG . 46.9 Cg_exo -60.35 -12.1 18.98 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.926 1.751 . . . . 0.0 112.882 172.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 89.2 mt -104.71 174.24 5.96 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.976 0.51 . . . . 0.0 110.605 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -152.46 153.33 33.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.244 1.017 . . . . 0.0 109.376 -170.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.21 -26.37 65.69 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.27 -48.68 80.31 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 CA-C-N 118.418 0.554 . . . . 0.0 111.291 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -84.17 -20.8 31.79 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.94 -40.13 79.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 174.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.04 -38.08 78.93 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 122.323 -0.235 . . . . 0.0 111.567 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 24.4 mmt -69.45 -32.47 71.44 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.235 -0.29 . . . . 0.0 111.069 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 88.7 mt -71.8 -32.19 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.2 mmt -73.18 -23.23 60.39 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.943 -0.473 . . . . 0.0 110.642 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -82.19 -23.59 35.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 122.146 -0.346 . . . . 0.0 111.213 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -86.14 -19.58 29.91 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.94 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -116.25 -16.16 10.96 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -133.33 19.04 3.99 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -173.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.03 -144.68 38.34 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -70.72 113.36 4.76 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 112.256 -0.338 . . . . 0.0 112.256 -174.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 40.4 t -98.51 154.41 3.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 C-N-CA 124.143 0.977 . . . . 0.0 108.614 174.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.7 p -114.79 -31.45 6.13 Favored 'General case' 0 C--O 1.227 -0.084 0 CA-C-N 118.397 0.544 . . . . 0.0 111.324 175.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -148.19 144.44 27.73 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-N 118.492 0.587 . . . . 0.0 110.589 175.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -159.29 147.52 17.75 Favored 'General case' 0 N--CA 1.458 -0.03 0 CA-C-O 120.851 0.358 . . . . 0.0 111.075 177.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 163.41 -158.94 31.48 Favored Glycine 0 CA--C 1.522 0.481 0 O-C-N 121.924 -0.485 . . . . 0.0 112.289 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 44.0 mm -96.14 140.99 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -66.36 139.03 58.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.98 0.419 . . . . 0.0 110.8 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 55.0 p -136.31 155.7 49.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.277 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -80.88 126.59 77.28 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 171.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.2 -10.56 17.75 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.842 3.695 . . . . 0.0 113.405 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -103.73 -27.37 12.31 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.731 0.696 . . . . 0.0 110.398 -177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 81.7 mt -105.08 -7.34 19.21 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.775 0.43 . . . . 0.0 110.894 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm 53.06 40.74 31.7 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.048 0.939 . . . . 0.0 112.443 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.424 ' CE1' ' HB2' ' A' ' 65' ' ' ARG . 21.2 m-85 -127.82 155.55 77.23 Favored Pre-proline 0 N--CA 1.467 0.425 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.558 -175.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.7 146.56 92.37 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.272 1.982 . . . . 0.0 110.735 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.98 31.25 4.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.031 0.932 . . . . 0.0 109.557 -176.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.53 156.93 2.62 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.231 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 54.59 -175.42 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.6 0.76 . . . . 0.0 111.999 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -139.36 174.09 22.41 Favored Glycine 0 CA--C 1.521 0.466 0 O-C-N 121.734 -0.604 . . . . 0.0 111.96 -176.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -148.93 154.32 39.26 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 62.8 t -140.27 145.84 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.45 150.37 52.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.119 0.485 . . . . 0.0 110.936 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -131.54 159.97 36.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.112 -175.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 77.3 p -92.95 -5.76 50.01 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.261 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -124.35 144.39 50.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.105 0.562 . . . . 0.0 111.061 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -78.33 -9.61 59.33 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.095 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -82.92 -38.92 22.17 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.2 m -75.91 -26.49 57.01 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -64.24 -50.94 66.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 175.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.45 -14.23 16.49 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 CA-C-N 118.051 0.387 . . . . 0.0 111.309 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.47 -21.16 32.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 117.708 0.231 . . . . 0.0 111.065 175.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.56 -14.91 36.48 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.0 pt -119.31 23.78 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.315 0.646 . . . . 0.0 110.567 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 88.7 p -76.2 -20.12 57.78 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.222 0.609 . . . . 0.0 112.544 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -149.77 133.01 16.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -54.88 -37.53 66.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -175.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -122.01 116.61 24.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.154 0.434 . . . . 0.0 110.615 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.5 m -97.95 158.41 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.311 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -89.75 144.19 26.18 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.931 0.395 . . . . 0.0 110.727 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.0 mp -138.22 98.73 3.68 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -138.54 76.19 1.56 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.928 -172.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -137.24 152.18 49.54 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 66.71 25.27 72.91 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 63.06 21.85 13.11 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.284 1.034 . . . . 0.0 112.21 -175.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 68.7 mt -92.34 163.99 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -152.43 110.02 3.6 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -146.1 164.11 33.21 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.824 0.45 . . . . 0.0 110.841 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.01 157.8 44.32 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 123.818 0.847 . . . . 0.0 109.188 178.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.58 149.54 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -87.42 121.87 30.42 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.4 m -95.6 150.45 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 CA-C-N 118.139 0.427 . . . . 0.0 111.286 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.27 160.21 29.74 Favored Pre-proline 0 N--CA 1.457 -0.096 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 171.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.03 135.18 69.21 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.725 2.283 . . . . 0.0 109.139 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -73.64 112.92 10.2 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 119.221 -0.992 . . . . 0.0 111.421 -176.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 CA--C 1.536 0.408 0 C-N-CA 125.554 1.542 . . . . 0.0 113.051 174.091 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.293 0.092 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -166.2 164.98 17.82 Favored 'General case' 0 CA--C 1.52 -0.193 0 O-C-N 123.552 0.533 . . . . 0.0 109.699 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.5 t -108.37 156.95 18.84 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 171.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.553 ' CD ' ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -76.6 26.77 0.13 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.497 0.719 . . . . 0.0 112.086 179.235 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.432 ' HE3' ' CD1' ' A' ' 154' ' ' TRP . 47.7 pttt -136.44 141.61 43.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.048 0.939 . . . . 0.0 109.627 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 m -147.25 160.87 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.055 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.767 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -100.49 143.43 30.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.44 HG11 HD13 ' A' ' 113' ' ' LEU . 3.2 m -134.2 132.66 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 173.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.21 -163.59 9.57 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.3 21.37 66.28 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.001 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.676 ' H ' HD23 ' A' ' 72' ' ' LEU . 2.1 pt? -118.44 150.02 47.16 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 118.179 0.989 . . . . 0.0 109.954 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.4 168.98 21.97 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 124.09 3.194 . . . . 0.0 113.706 -169.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -83.36 0.31 9.55 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 124.116 3.211 . . . . 0.0 111.65 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -100.89 11.47 39.52 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -173.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.444 HD12 ' C ' ' A' ' 76' ' ' ILE . 1.9 pp -122.39 177.65 3.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -142.65 -175.58 4.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.921 0.391 . . . . 0.0 111.578 -175.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -50.03 -31.88 14.04 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.356 1.062 . . . . 0.0 112.258 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -71.45 -29.77 65.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 117.894 0.316 . . . . 0.0 111.542 -176.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -82.21 -31.78 30.15 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 122.184 -0.323 . . . . 0.0 110.42 -174.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 66.0 mt -77.49 -42.42 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.2 m -66.9 -22.97 65.95 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.67 -18.3 28.2 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.9 m -77.57 -27.61 51.51 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 118.424 0.557 . . . . 0.0 111.685 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.41 ' CZ ' HD11 ' A' ' 151' ' ' ILE . 74.6 m-85 -120.98 12.71 11.24 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.49 -18.05 64.44 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.293 0.497 . . . . 0.0 112.249 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -75.6 -10.18 59.22 Favored 'General case' 0 C--N 1.338 0.093 0 O-C-N 122.033 -0.417 . . . . 0.0 111.944 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -103.8 23.21 13.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.559 0.344 . . . . 0.0 111.319 -176.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.93 179.21 31.81 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.59 150.2 68.95 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.369 2.713 . . . . 0.0 110.772 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.417 ' N ' HD23 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -162.77 164.6 26.18 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.02 -170.141 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.63 164.55 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.752 174.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -129.58 151.05 35.24 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -143.23 159.07 43.0 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.487 0.66 . . . . 0.0 112.02 -174.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.499 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 30.2 p90 -151.88 159.52 32.96 Favored Pre-proline 0 N--CA 1.452 -0.349 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 170.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.535 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 94.2 Cg_endo -65.68 -13.99 42.55 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 123.525 2.816 . . . . 0.0 112.505 -169.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.535 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 21.0 m170 -106.59 13.72 27.9 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.066 0.546 . . . . 0.0 111.549 -176.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.7 tptm -49.81 151.51 1.78 Allowed 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.844 0.858 . . . . 0.0 112.739 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.301 0 C-N-CA 123.587 0.755 . . . . 0.0 110.487 -177.749 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.735 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.101 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.472 ' HA ' HD21 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -76.05 150.12 37.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.025 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.69 -176.7 5.61 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.961 0.41 . . . . 0.0 111.427 -174.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -140.27 128.82 22.85 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.44 HD13 HG11 ' A' ' 69' ' ' VAL . 10.6 mp -89.98 149.54 22.52 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.656 0.741 . . . . 0.0 112.372 -177.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.2 mp -113.09 138.6 49.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -134.62 170.64 15.5 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.047 0.539 . . . . 0.0 110.388 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -101.87 -24.17 14.06 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.705 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -135.83 153.57 51.46 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -75.48 -15.51 60.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.735 171.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 m -78.91 -20.04 50.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 176.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.6 m -76.87 -42.3 40.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.7 m -74.15 -20.18 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -72.1 -41.33 67.4 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.71 -34.52 62.62 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 122.168 -0.333 . . . . 0.0 111.557 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 pp -77.41 -17.9 57.73 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.372 0.533 . . . . 0.0 111.613 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.9 mt -95.46 -17.48 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 122.39 0.276 . . . . 0.0 111.014 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -99.41 -11.2 21.36 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.864 -0.523 . . . . 0.0 112.273 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -114.84 29.34 8.09 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.811 0.444 . . . . 0.0 111.921 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 17.6 p -137.41 -173.8 3.58 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.994 0.426 . . . . 0.0 111.647 -176.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.2 mm -84.67 160.53 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 124.596 1.158 . . . . 0.0 109.427 -175.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -132.23 158.45 41.75 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.681 0.276 . . . . 0.0 110.821 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.3 74.52 1.33 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.436 0.636 . . . . 0.0 110.671 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 51.97 9.39 0.09 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.16 -9.87 0.06 OUTLIER Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.115 0.87 . . . . 0.0 113.289 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.6 pttt -146.34 178.25 8.39 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 174.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.6 mp -125.33 169.69 12.07 Favored 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -171.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 0.3 OUTLIER -140.87 156.01 46.2 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.591 -175.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.4 tp -137.06 142.89 42.41 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 47.4 t -82.97 132.58 35.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.518 0.599 . . . . 0.0 109.99 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 19.9 m -137.38 -10.42 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.4 m 46.3 46.1 13.41 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.531 0.732 . . . . 0.0 112.786 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.407 ' HB3' ' HD2' ' A' ' 142' ' ' PRO . 18.7 m -57.17 156.15 15.18 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.399 0.68 . . . . 0.0 111.785 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 97.1 Cg_endo -72.13 20.08 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 125.008 3.805 . . . . 0.0 114.19 -176.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.42 HG22 HG12 ' A' ' 144' ' ' ILE . 21.7 m -133.13 138.62 46.71 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.42 HG12 HG22 ' A' ' 143' ' ' THR . 0.9 OUTLIER 55.31 -149.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -170.352 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -139.12 145.7 39.76 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.449 0.568 . . . . 0.0 110.554 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 49.62 39.46 17.36 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.417 1.087 . . . . 0.0 112.969 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -55.63 118.27 18.8 Favored Pre-proline 0 CA--C 1.53 0.195 0 C-N-CA 123.637 0.775 . . . . 0.0 111.964 -177.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.44 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 25.8 Cg_endo -93.8 129.53 0.66 Allowed 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 124.252 3.301 . . . . 0.0 109.765 169.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.3 131.53 38.18 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -89.23 151.15 22.3 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.605 0.762 . . . . 0.0 111.503 -173.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.41 HD11 ' CZ ' ' A' ' 85' ' ' PHE . 48.5 mm -134.94 144.48 34.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 123.967 0.907 . . . . 0.0 111.344 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.0 ttp85 -152.57 116.11 2.89 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 168.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.59 165.01 33.45 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.877 3.051 . . . . 0.0 111.908 177.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.432 ' CD1' ' HE3' ' A' ' 66' ' ' LYS . 34.5 t-105 -100.66 152.5 20.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.351 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -104.98 153.75 21.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.676 0.791 . . . . 0.0 112.209 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.3 mp -94.63 -2.56 51.13 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -172.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.4 m -79.52 -10.38 59.79 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -173.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -136.17 -110.44 0.2 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.733 0.697 . . . . 0.0 111.738 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 m 64.03 -33.4 0.14 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.541 1.937 . . . . 0.0 113.951 -173.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -153.49 151.82 30.27 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.101 0.56 . . . . 0.0 110.07 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -157.63 153.84 27.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.58 152.68 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 121.887 -0.508 . . . . 0.0 109.744 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 71.4 mtm -128.96 29.92 5.13 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -159.72 -44.5 0.05 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.54 3.93 59.68 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.102 -0.832 . . . . 0.0 113.635 174.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.3 m -138.53 -0.8 1.93 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -176.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -79.17 141.36 57.9 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 120.076 1.307 . . . . 0.0 110.261 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.11 153.21 41.08 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.369 2.713 . . . . 0.0 108.815 173.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 63.9 mt -121.46 150.12 42.04 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.631 0.253 . . . . 0.0 110.961 -177.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -144.22 139.02 15.37 Favored Pre-proline 0 N--CA 1.456 -0.157 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -68.34 -9.23 25.3 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.681 2.921 . . . . 0.0 112.613 -173.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -88.5 -1.68 58.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.715 0.406 . . . . 0.0 110.771 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -128.44 33.2 4.72 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.891 0.476 . . . . 0.0 109.733 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 11.5 m -126.14 153.45 44.55 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.077 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.6 tt -121.84 151.61 25.43 Favored 'Isoleucine or valine' 0 C--O 1.229 0.024 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -116.36 148.22 40.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 172.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.39 117.71 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.504 ' HA2' ' CB ' ' A' ' 217' ' ' ALA . . . -119.83 159.65 14.86 Favored Glycine 0 C--N 1.336 0.564 0 O-C-N 123.202 0.314 . . . . 0.0 113.586 -171.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.84 24.77 12.57 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.24 107.57 57.79 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 117.197 0.498 . . . . 0.0 110.969 -176.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.88 -33.61 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.759 2.306 . . . . 0.0 112.66 176.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.724 ' H ' ' CD ' ' A' ' 183' ' ' PRO . 71.7 mtt180 -149.81 -38.12 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -177.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.724 ' CD ' ' H ' ' A' ' 182' ' ' ARG . 51.8 Cg_exo -59.29 -168.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 124.029 3.153 . . . . 0.0 114.857 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 48.0 mt 65.35 -53.65 0.34 Allowed 'General case' 0 C--O 1.23 0.064 0 C-N-CA 126.963 2.105 . . . . 0.0 114.224 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 54.18 -163.43 0.11 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.947 0.794 . . . . 0.0 109.382 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -103.85 -37.2 7.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.964 -0.46 . . . . 0.0 110.806 172.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 69.0 t -67.16 -56.45 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 C-N-CA 122.391 0.276 . . . . 0.0 111.183 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -74.34 -22.29 59.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.856 -0.156 . . . . 0.0 110.961 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.6 tp -68.47 -35.94 78.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.39 -28.75 61.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.311 -0.243 . . . . 0.0 111.346 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 26.3 mmt -70.7 -35.2 72.64 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 117.704 0.229 . . . . 0.0 111.614 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.62 -32.17 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 O-C-N 121.64 -0.663 . . . . 0.0 109.683 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.6 mmt -76.66 -15.82 59.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 121.897 -0.502 . . . . 0.0 111.894 -177.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -97.9 -24.31 15.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.697 0.681 . . . . 0.0 111.553 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -86.43 -16.36 37.42 Favored 'General case' 0 C--N 1.34 0.165 0 O-C-N 121.872 -0.517 . . . . 0.0 112.334 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -117.49 -20.19 9.15 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.355 0.525 . . . . 0.0 111.082 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -140.03 42.65 1.94 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.928 0.491 . . . . 0.0 109.752 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.51 137.15 4.38 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.032 0.825 . . . . 0.0 112.782 -175.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 122.7 1.38 9.85 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.48 157.16 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 123.837 0.855 . . . . 0.0 109.889 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.9 p -129.41 -32.15 1.99 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -147.15 152.0 37.71 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.217 0.917 . . . . 0.0 111.891 -177.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -149.6 160.91 43.1 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.481 0.312 . . . . 0.0 111.176 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 168.39 -170.21 42.01 Favored Glycine 0 C--N 1.336 0.534 0 O-C-N 121.909 -0.494 . . . . 0.0 112.122 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.9 mp -105.08 146.02 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -65.81 117.88 8.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.552 0.215 . . . . 0.0 110.434 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 76.4 p -140.49 162.59 34.99 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 122.759 0.424 . . . . 0.0 110.266 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -115.98 130.75 24.16 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.28 -1.98 10.97 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 124.811 3.674 . . . . 0.0 114.335 -170.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -68.0 -32.42 72.79 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 119.025 0.829 . . . . 0.0 110.104 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.31 8.33 1.19 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.512 0.725 . . . . 0.0 109.853 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt 53.03 39.89 30.26 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.219 1.008 . . . . 0.0 111.434 -174.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -94.25 151.92 39.86 Favored Pre-proline 0 N--CA 1.455 -0.178 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.719 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.9 141.93 37.95 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.559 2.173 . . . . 0.0 110.821 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.67 14.67 6.48 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.867 0.867 . . . . 0.0 109.92 -178.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 165.69 -165.09 37.78 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.504 ' CB ' ' HA2' ' A' ' 178' ' ' GLY . . . -86.08 -160.21 0.53 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.349 1.06 . . . . 0.0 110.829 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -74.56 158.87 51.92 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 122.189 -0.32 . . . . 0.0 112.777 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.06 153.26 38.69 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 50.1 t -145.27 146.12 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.06 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.39 145.33 50.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.547 0.339 . . . . 0.0 110.405 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -128.84 -23.09 3.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.312 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 46.0 m 56.28 25.18 9.01 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -178.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -128.05 151.84 48.69 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -73.43 -30.99 63.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -176.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -85.12 -39.83 17.46 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 111.373 0.138 . . . . 0.0 111.373 -172.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 65.7 p -77.54 -23.07 50.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.16 -0.337 . . . . 0.0 110.249 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -67.6 -52.75 34.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 175.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 32.7 pt -73.08 -18.04 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.63 -29.38 30.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.159 0.436 . . . . 0.0 111.491 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -77.62 -23.77 49.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.931 0.332 . . . . 0.0 111.691 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.9 pt -108.89 25.14 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.525 0.73 . . . . 0.0 110.561 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.0 t -77.06 -12.51 59.95 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.136 0.574 . . . . 0.0 112.12 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -152.67 140.83 20.41 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -55.3 -30.26 59.84 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -128.15 130.24 47.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.295 0.569 . . . . 0.0 111.135 177.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.2 m -100.8 177.34 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.294 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -109.01 138.66 45.0 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.451 0.3 . . . . 0.0 110.346 172.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.2 mp -134.76 84.41 2.1 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -119.55 -66.93 1.02 Allowed 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -172.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 48.34 24.14 0.67 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -174.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 168.95 -151.28 17.47 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -80.3 6.18 12.71 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.022 0.529 . . . . 0.0 111.717 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 244' ' ' ILE . 1.8 mp -71.53 157.05 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.597 0.759 . . . . 0.0 108.971 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -141.58 25.63 1.99 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.906 0.384 . . . . 0.0 111.257 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . 0.425 ' H ' HG22 ' A' ' 244' ' ' ILE . 99.1 mttt -90.12 154.73 19.56 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.128 0.571 . . . . 0.0 111.093 -177.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -160.26 -179.93 8.14 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.61 157.94 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.854 0.862 . . . . 0.0 110.187 -174.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -85.19 129.48 34.8 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 122.678 0.391 . . . . 0.0 110.009 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -100.28 158.23 3.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.432 ' HE3' ' HB3' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -159.0 156.95 27.65 Favored Pre-proline 0 N--CA 1.456 -0.135 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.677 169.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.31 146.0 96.11 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.844 2.363 . . . . 0.0 109.863 174.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -79.83 166.03 22.12 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.489 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.452 -0.37 0 C-N-CA 123.059 0.544 . . . . 0.0 110.245 -171.23 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.274 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.586 ' HA ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -142.22 -153.13 0.44 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -174.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.2 m 64.75 5.89 3.02 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 126.133 1.773 . . . . 0.0 113.069 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -65.03 118.49 9.2 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 173.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 63.47 143.58 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.767 1.227 . . . . 0.0 111.071 -168.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -156.11 146.43 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.337 -172.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.482 ' CZ ' ' HA2' ' A' ' 70' ' ' GLY . 9.3 t80 -89.69 140.01 30.0 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 p -118.76 117.88 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.482 ' HA2' ' CZ ' ' A' ' 68' ' ' PHE . . . -89.45 125.1 7.67 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 116.348 -0.387 . . . . 0.0 113.141 -170.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.37 146.67 11.1 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.222 0.915 . . . . 0.0 112.522 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.6 tp -153.94 122.62 3.09 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.17 164.07 31.71 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.217 2.611 . . . . 0.0 111.781 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.15 175.43 9.24 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.39 3.393 . . . . 0.0 111.426 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.1 t70 60.9 -85.86 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.237 0.615 . . . . 0.0 112.332 -175.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.0 pt -56.38 157.24 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 121.278 0.561 . . . . 0.0 111.333 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -149.63 -121.76 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.029 0.531 . . . . 0.0 110.256 -177.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -54.07 -22.9 11.97 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.091 1.357 . . . . 0.0 111.974 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -77.83 -36.96 49.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -173.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -86.41 -30.42 22.12 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.911 -0.493 . . . . 0.0 111.343 -173.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.8 pt -78.57 -33.3 16.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 O-C-N 121.935 -0.478 . . . . 0.0 109.968 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.3 m -70.47 -23.74 62.74 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 175.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.32 -17.07 40.76 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.4 m -76.66 -37.4 56.29 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.557 0.617 . . . . 0.0 111.695 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.455 ' CZ ' HD11 ' A' ' 151' ' ' ILE . 81.2 m-85 -108.25 6.66 26.82 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -176.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.89 -18.34 64.09 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.709 0.404 . . . . 0.0 110.941 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -72.09 -8.92 57.37 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.557 0.743 . . . . 0.0 112.031 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -110.23 5.72 22.02 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.335 0.254 . . . . 0.0 111.427 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.78 177.58 15.11 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -70.5 150.79 64.26 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.69 2.927 . . . . 0.0 110.835 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.421 ' N ' HD23 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -164.53 164.41 21.76 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.747 -170.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 pt -142.22 170.82 11.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.295 174.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.09 155.15 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 122.449 0.299 . . . . 0.0 110.351 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -153.25 170.27 21.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.67 0.271 . . . . 0.0 111.608 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 33.7 p90 -159.27 158.14 28.03 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -75.36 -9.18 20.18 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.892 1.728 . . . . 0.0 110.74 -169.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -95.37 6.71 48.29 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.723 0.809 . . . . 0.0 111.349 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -50.19 152.02 1.87 Allowed 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.778 0.831 . . . . 0.0 112.911 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.336 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.088 -177.153 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.566 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -147.77 143.12 27.31 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 167.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.35 172.89 12.31 Favored 'General case' 0 C--N 1.335 -0.057 0 CA-C-N 119.896 1.225 . . . . 0.0 113.489 -169.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -136.08 125.47 24.95 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.218 0.607 . . . . 0.0 109.515 -177.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 mp -84.8 141.97 30.11 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.345 0.593 . . . . 0.0 110.72 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.7 mp -104.99 136.48 44.38 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -140.28 163.93 31.45 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.049 0.539 . . . . 0.0 110.68 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -123.53 -29.36 3.78 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.087 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -102.23 159.91 14.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.827 0.346 . . . . 0.0 111.53 -175.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -111.29 5.0 19.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.236 -178.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.8 p -105.3 -22.22 13.09 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.904 0.482 . . . . 0.0 110.921 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 76.8 p -76.16 -31.43 58.54 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.84 -22.26 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 173.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -80.29 -36.92 33.73 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -174.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.87 -35.11 62.32 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 119.684 -0.198 . . . . 0.0 111.52 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -80.42 -18.51 48.62 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.313 0.506 . . . . 0.0 111.916 -176.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.1 mt -97.8 -14.47 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 117.843 0.292 . . . . 0.0 110.557 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -91.91 -16.54 26.5 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.312 -0.868 . . . . 0.0 111.238 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -108.74 26.9 10.01 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.457 0.703 . . . . 0.0 111.794 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 136' ' ' TYR . 17.2 p -124.98 166.77 15.74 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.043 0.537 . . . . 0.0 111.105 -176.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.56 172.4 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -137.31 157.95 45.49 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.021 0.438 . . . . 0.0 111.558 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.52 -172.7 4.09 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -30.1 -39.57 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.1 1.76 . . . . 0.0 115.253 -173.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.0 15.72 0.15 Allowed Glycine 0 CA--C 1.527 0.814 0 CA-C-N 118.595 0.634 . . . . 0.0 112.089 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -141.16 177.35 8.14 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 117.577 0.688 . . . . 0.0 110.56 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.22 170.76 9.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.439 0.696 . . . . 0.0 110.186 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.431 ' O ' ' HB2' ' A' ' 128' ' ' CYS . 6.3 m-85 -146.76 151.59 37.42 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.857 0.463 . . . . 0.0 111.084 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 45.4 tp -132.46 145.73 51.4 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 170.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 85.0 m -80.33 141.88 35.02 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.745 -0.597 . . . . 0.0 110.893 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.2 175.43 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.324 0.65 . . . . 0.0 109.681 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.8 m -138.51 117.32 12.33 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 122.674 0.39 . . . . 0.0 110.759 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.479 ' HB3' ' HD2' ' A' ' 142' ' ' PRO . 52.7 m -155.21 162.15 27.89 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.688 1.195 . . . . 0.0 108.828 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 60.7 Cg_endo -66.1 -15.72 49.56 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.203 2.602 . . . . 0.0 114.088 -175.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.6 m -105.12 -2.93 23.67 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.44 0.564 . . . . 0.0 110.169 175.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.2 mp -98.97 -52.42 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.177 0.591 . . . . 0.0 111.026 -172.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 87.6 tttt 58.2 -57.96 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.729 1.612 . . . . 0.0 113.194 -172.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -149.83 12.72 0.79 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.391 1.076 . . . . 0.0 110.678 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 14.0 tttm -67.99 137.38 92.18 Favored Pre-proline 0 C--N 1.338 0.1 0 C-N-CA 123.607 0.763 . . . . 0.0 111.532 -177.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.428 ' HG2' ' CE1' ' A' ' 136' ' ' TYR . 37.8 Cg_endo -86.96 146.79 7.91 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 123.685 2.923 . . . . 0.0 110.632 168.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.9 p -98.88 142.37 14.94 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -83.37 158.78 22.01 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.786 0.721 . . . . 0.0 112.464 -174.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.455 HD11 ' CZ ' ' A' ' 85' ' ' PHE . 29.6 mm -137.13 142.79 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.051 1.341 . . . . 0.0 108.759 177.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 44.8 ttt-85 -146.08 88.52 6.31 Favored Pre-proline 0 CA--C 1.529 0.152 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.78 145.37 72.42 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.495 3.463 . . . . 0.0 112.857 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -92.86 153.02 19.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 173.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -119.48 134.1 55.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.653 0.739 . . . . 0.0 110.883 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.586 HD13 ' HA ' ' A' ' 63' ' ' TYR . 4.7 mp -87.87 8.21 27.13 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.473 -169.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.7 t -91.1 -12.65 34.95 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -175.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -135.51 20.12 3.35 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -175.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.6 m -69.89 -20.98 63.36 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.433 0.56 . . . . 0.0 112.448 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -158.19 158.09 33.91 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.275 0.488 . . . . 0.0 111.04 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -158.35 157.34 32.2 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.987 0.422 . . . . 0.0 111.054 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.0 m -140.35 149.34 21.69 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 C-N-CA 124.353 1.061 . . . . 0.0 109.722 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 58.3 mtm -140.62 10.42 2.25 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -140.3 16.64 2.41 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.243 0.929 . . . . 0.0 112.971 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 91.09 22.8 31.54 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.519 -0.6 . . . . 0.0 113.016 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.4 m 56.29 47.03 20.02 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 117.722 0.761 . . . . 0.0 112.544 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -61.88 158.21 44.82 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 123.259 0.624 . . . . 0.0 110.602 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.0 154.54 69.67 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.184 2.589 . . . . 0.0 110.67 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 61.2 mt -135.57 167.67 20.68 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.605 0.762 . . . . 0.0 110.666 -173.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -141.49 149.57 54.71 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.01 -19.84 57.72 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.217 2.611 . . . . 0.0 112.516 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -88.1 5.93 38.78 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.46 0.704 . . . . 0.0 110.837 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -131.07 18.96 4.97 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.903 0.481 . . . . 0.0 110.875 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 24.2 m -126.35 139.9 52.93 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.88 0.371 . . . . 0.0 111.153 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.7 tt -112.0 149.2 14.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.913 -177.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -116.15 148.73 40.03 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.19 139.01 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 122.632 0.373 . . . . 0.0 110.207 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -148.48 173.56 28.42 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.67 20.96 62.68 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -174.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.0 m -56.38 142.48 68.55 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 122.751 0.42 . . . . 0.0 110.372 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.06 -49.39 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.944 2.429 . . . . 0.0 112.21 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.412 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 41.7 ttm180 -161.11 -59.2 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.435 -0.793 . . . . 0.0 111.257 176.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 182' ' ' ARG . 77.3 Cg_endo -76.01 156.53 38.57 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.871 2.381 . . . . 0.0 111.394 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.59 0.68 0.11 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.155 0.582 . . . . 0.0 112.296 175.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . 0.423 ' HG2' ' H ' ' A' ' 188' ' ' GLU . 16.7 ttp-105 -28.46 120.56 0.12 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.864 1.666 . . . . 0.0 111.582 175.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.4 -21.14 63.79 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 94.3 t -67.21 -50.16 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 118.154 0.434 . . . . 0.0 110.62 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 185' ' ' ARG . 59.6 mt-10 -84.87 -22.57 29.34 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.61 -0.144 . . . . 0.0 110.61 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.94 -30.91 68.41 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -83.4 -31.6 26.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 119.503 -0.284 . . . . 0.0 111.713 -177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.3 mmt -70.46 -37.05 74.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.318 0.508 . . . . 0.0 109.656 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.408 HG21 ' HA ' ' A' ' 239' ' ' LEU . 64.5 mt -72.55 -40.42 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.6 mmt -63.39 -25.37 68.26 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.941 -0.474 . . . . 0.0 110.929 172.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.59 -18.13 49.22 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.105 0.411 . . . . 0.0 111.836 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -98.53 -16.21 19.24 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.59 -13.11 11.53 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.184 0.902 . . . . 0.0 113.221 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -135.9 26.59 3.3 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.839 0.745 . . . . 0.0 112.657 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 76.18 -150.55 39.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -76.27 141.29 26.69 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -174.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.84 143.89 31.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 124.248 1.019 . . . . 0.0 108.56 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 61.4 m -109.48 -33.53 6.78 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -151.9 149.77 29.32 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.0 0.428 . . . . 0.0 110.964 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.28 155.61 40.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.465 0.706 . . . . 0.0 109.143 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.85 -174.97 47.27 Favored Glycine 0 C--N 1.333 0.363 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.2 mm -104.95 145.01 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -54.91 118.23 4.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.013 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 214' ' ' PRO . 12.2 p -144.23 158.94 43.45 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.63 0.372 . . . . 0.0 110.267 -176.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -135.1 135.54 23.06 Favored Pre-proline 0 N--CA 1.455 -0.216 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.68 -5.97 15.04 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.225 3.283 . . . . 0.0 112.824 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -73.74 -39.63 64.11 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.311 0.505 . . . . 0.0 110.688 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.11 0.68 12.41 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.35 0.66 . . . . 0.0 109.602 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm 48.26 59.35 4.35 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.281 1.032 . . . . 0.0 111.386 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -133.49 147.33 64.29 Favored Pre-proline 0 CA--C 1.529 0.149 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -176.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.413 ' HA ' HG22 ' A' ' 207' ' ' THR . 43.7 Cg_endo -81.96 165.65 17.27 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 124.238 3.292 . . . . 0.0 110.546 174.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -125.63 23.25 7.44 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 61.59 13.33 37.79 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 119.373 -0.682 . . . . 0.0 114.684 170.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -132.81 146.09 51.53 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 118.235 1.017 . . . . 0.0 109.569 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -93.18 162.31 25.92 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 121.445 0.469 . . . . 0.0 113.326 -172.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -149.64 145.21 26.62 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 173.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 95.2 t -136.57 147.77 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -133.51 154.03 51.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.396 0.617 . . . . 0.0 111.33 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -132.22 154.95 49.09 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.05 -176.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.9 m -97.3 10.08 40.53 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 173.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -132.17 134.22 45.14 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.631 0.773 . . . . 0.0 109.799 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -72.92 -12.86 61.12 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 116.859 -0.155 . . . . 0.0 111.145 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -82.1 -39.04 23.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.9 m -75.06 -28.95 60.57 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -64.52 -51.78 61.16 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 119.649 -0.215 . . . . 0.0 110.568 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.3 pt -71.42 -14.71 17.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 CA-C-N 118.111 0.414 . . . . 0.0 111.181 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.03 -22.01 33.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.799 0.272 . . . . 0.0 110.734 175.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -87.99 -27.84 21.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.5 pt -103.41 24.85 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 122.917 0.487 . . . . 0.0 110.547 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 86.6 p -75.15 -18.07 60.28 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.172 0.589 . . . . 0.0 111.96 -177.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.98 146.04 23.66 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -55.15 -31.4 61.29 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -123.05 121.94 37.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.899 0.381 . . . . 0.0 110.489 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.441 ' H ' HG22 ' A' ' 237' ' ' VAL . 1.8 m -82.68 153.98 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.594 172.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.566 ' C ' HD22 ' A' ' 239' ' ' LEU . 9.8 mp0 -95.62 140.58 30.24 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.566 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.0 mm? -127.82 27.23 5.76 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -91.96 136.52 33.1 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.909 0.484 . . . . 0.0 112.138 -171.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -148.71 19.26 1.02 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.918 177.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 84.79 138.54 4.2 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -176.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 55.86 7.39 0.27 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.389 1.076 . . . . 0.0 112.63 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.4 mt -142.71 141.61 27.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 C-N-CA 124.046 0.938 . . . . 0.0 108.991 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -157.41 123.97 4.95 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -144.34 161.27 39.4 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.98 155.21 36.51 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.0 p -154.92 151.43 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -84.97 126.71 33.75 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.5 m -102.03 158.52 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.23 157.43 27.49 Favored Pre-proline 0 N--CA 1.456 -0.148 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.733 169.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.86 130.73 41.43 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.55 2.167 . . . . 0.0 107.733 171.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -71.56 110.34 6.08 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.462 -172.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 8.6 p . . . . . 0 CA--C 1.534 0.363 0 C-N-CA 125.473 1.509 . . . . 0.0 112.751 174.929 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.0 ppt_? . . . . . 0 CA--C 1.528 0.132 0 CA-C-O 120.68 0.276 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.448 ' CD1' ' HA ' ' A' ' 155' ' ' ASN . 54.1 m-85 -168.96 -172.98 1.69 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -169.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.8 t -141.01 36.37 1.75 Allowed 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.02 -0.425 . . . . 0.0 112.04 173.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.78 36.36 2.73 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.329 1.451 . . . . 0.0 114.487 176.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.4 pttm -141.71 153.48 44.68 Favored 'General case' 0 N--CA 1.46 0.064 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 171.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 p -153.54 146.29 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-O 120.62 0.247 . . . . 0.0 111.025 -176.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -89.41 144.15 26.28 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.78 115.0 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.724 0.773 . . . . 0.0 109.315 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.23 -165.17 37.4 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.87 -104.67 1.51 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.1 tp 54.97 101.5 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 125.366 1.466 . . . . 0.0 112.547 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -67.2 148.23 80.22 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.905 1.737 . . . . 0.0 108.572 174.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.8 20.14 0.63 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.883 3.055 . . . . 0.0 112.574 -174.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -138.5 28.72 2.44 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.1 pt -133.66 175.55 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 119.012 0.824 . . . . 0.0 109.049 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -138.17 -175.97 4.29 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -49.88 -34.88 21.52 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.764 1.226 . . . . 0.0 112.261 -175.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -72.15 -29.85 64.43 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -175.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -79.13 -36.95 39.74 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -174.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.5 mt -73.72 -39.31 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 90.0 m -65.31 -22.94 66.9 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.1 -17.89 28.35 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -79.55 -26.72 41.35 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.383 0.538 . . . . 0.0 112.363 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -114.47 10.2 16.89 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -59.41 -19.83 50.27 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -172.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -73.63 -11.89 60.57 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.22 0.464 . . . . 0.0 112.236 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -99.46 16.44 23.19 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.45 0.3 . . . . 0.0 111.713 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.03 -175.33 29.7 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.95 137.28 37.45 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.49 2.793 . . . . 0.0 110.536 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.9 pp -160.25 166.69 29.1 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.519 0.728 . . . . 0.0 109.909 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mt -136.01 164.78 31.15 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.44 147.06 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -148.36 166.98 26.42 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -174.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -156.51 159.15 31.58 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 176.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.642 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 63.8 Cg_endo -71.36 -10.89 27.83 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.482 2.788 . . . . 0.0 110.976 -171.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.642 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 54.0 m-70 -100.28 17.09 22.27 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.955 0.902 . . . . 0.0 111.39 -178.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -54.02 160.56 1.47 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.004 0.922 . . . . 0.0 112.987 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.223 0 C-N-CA 124.079 0.952 . . . . 0.0 110.499 -178.02 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.892 0 N-CA-C 111.703 -0.559 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 54.89 -177.25 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.068 0.547 . . . . 0.0 111.29 -175.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.54 175.38 12.38 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 121.356 -0.84 . . . . 0.0 112.672 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -139.59 143.49 37.32 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.9 mp -102.78 149.2 24.71 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-O 121.387 0.613 . . . . 0.0 112.267 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.9 mp -107.9 143.11 36.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.362 -1.29 . . . . 0.0 107.658 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -139.44 154.41 47.76 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.136 0.494 . . . . 0.0 110.346 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -101.18 -23.86 14.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.139 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -111.93 153.38 26.82 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.257 0.223 . . . . 0.0 110.438 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -97.58 1.71 49.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.559 0.219 . . . . 0.0 111.086 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.3 t -115.08 -13.93 11.82 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.509 0.724 . . . . 0.0 110.884 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.5 m -68.27 -32.53 72.76 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 121.507 -0.746 . . . . 0.0 109.227 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.78 -22.93 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -80.56 -26.37 38.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.832 -0.543 . . . . 0.0 109.639 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.51 -36.28 68.32 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.926 -0.484 . . . . 0.0 110.569 176.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -79.51 -16.3 56.26 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.312 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.51 HD11 ' HB3' ' A' ' 153' ' ' PRO . 97.0 mt -94.17 -10.77 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 122.439 0.295 . . . . 0.0 110.85 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -108.19 -10.72 15.36 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.709 -0.619 . . . . 0.0 112.225 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -116.37 42.2 2.46 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.482 0.713 . . . . 0.0 110.293 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 136' ' ' TYR . 31.1 p -142.67 174.97 10.17 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.45 0.7 . . . . 0.0 110.974 -172.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.95 165.89 2.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.02 157.27 44.56 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.995 0.426 . . . . 0.0 111.613 177.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -143.08 75.82 1.5 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.436 0.636 . . . . 0.0 109.654 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.7 t70 54.52 12.45 0.54 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.196 1.399 . . . . 0.0 114.703 175.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 154.71 -8.73 0.36 Allowed Glycine 0 CA--C 1.528 0.888 0 O-C-N 121.526 -0.734 . . . . 0.0 113.384 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -129.78 171.04 13.11 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 118.136 0.968 . . . . 0.0 109.328 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -122.44 164.95 17.12 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -170.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.433 ' O ' ' HB2' ' A' ' 128' ' ' CYS . 9.7 m-85 -143.69 150.36 38.57 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.028 176.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.8 mp -127.21 159.47 34.2 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.2 p -94.08 128.58 40.54 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.931 -0.48 . . . . 0.0 111.067 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.4 m -148.43 166.12 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 123.651 0.78 . . . . 0.0 109.838 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.8 m -96.68 155.4 16.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.615 0.366 . . . . 0.0 110.738 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.4 m -146.35 144.49 21.27 Favored Pre-proline 0 CA--C 1.528 0.132 0 C-N-CA 123.338 0.655 . . . . 0.0 109.436 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.86 -14.52 13.79 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.41 2.74 . . . . 0.0 111.338 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.4 m -76.71 -24.53 53.1 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 123.934 0.893 . . . . 0.0 110.668 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.417 HG22 ' H ' ' A' ' 145' ' ' LYS . 0.2 OUTLIER -137.83 -172.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.371 1.068 . . . . 0.0 108.804 -170.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.417 ' H ' HG22 ' A' ' 144' ' ' ILE . 22.1 ptmt -91.41 -23.38 20.05 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 169.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -165.42 154.04 11.79 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.087 1.355 . . . . 0.0 108.462 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' A' ' 147' ' ' LYS . 22.2 ttmt -151.13 117.69 3.29 Favored Pre-proline 0 N--CA 1.457 -0.083 0 CA-C-N 118.276 0.489 . . . . 0.0 111.139 175.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.402 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 38.4 Cg_exo -63.8 120.53 7.94 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 122.295 1.997 . . . . 0.0 108.654 168.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.6 p -84.25 132.0 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.1 tm0? -90.3 147.69 23.35 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.38 0.272 . . . . 0.0 110.787 -170.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 26.4 mm -135.18 142.76 39.03 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 C-N-CA 123.006 0.522 . . . . 0.0 111.501 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -144.33 106.83 4.79 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 173.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.51 ' HB3' HD11 ' A' ' 125' ' ' ILE . 84.1 Cg_endo -71.43 161.03 46.86 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.826 3.017 . . . . 0.0 113.79 -176.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -93.92 94.5 8.51 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.448 ' HA ' ' CD1' ' A' ' 63' ' ' TYR . 3.3 m120 -69.31 0.84 4.41 Favored 'General case' 0 C--O 1.228 -0.054 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -168.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.538 HD23 ' H ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -156.09 175.85 13.43 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.499 1.5 . . . . 0.0 114.464 -169.192 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 54.4 m -108.49 24.6 12.8 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.904 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.538 ' H ' HD23 ' A' ' 156' ' ' LEU . 80.5 m-20 -94.84 31.72 1.78 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.408 0.283 . . . . 0.0 110.497 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 m -75.47 -20.02 59.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -153.29 154.01 33.76 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.06 0.391 . . . . 0.0 111.356 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -157.88 153.25 26.01 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.935 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.8 m -139.21 155.75 26.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 122.803 0.441 . . . . 0.0 110.254 177.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 64.1 mtm -135.23 28.19 3.43 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.318 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -155.37 168.72 26.18 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -77.65 41.03 1.86 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.672 0.653 . . . . 0.0 112.793 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.9 m 55.89 60.56 3.19 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 117.414 0.607 . . . . 0.0 111.51 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -63.43 161.72 31.77 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 123.532 0.733 . . . . 0.0 109.745 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -56.01 124.02 15.26 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.518 2.145 . . . . 0.0 109.396 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.5 tp -127.07 138.31 53.18 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.748 0.819 . . . . 0.0 110.391 -171.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -144.78 156.3 55.87 Favored Pre-proline 0 N--CA 1.454 -0.261 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.63 -12.42 31.21 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.877 2.385 . . . . 0.0 111.203 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -83.61 -5.03 59.07 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.665 0.786 . . . . 0.0 111.563 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -118.35 24.51 10.9 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.853 0.461 . . . . 0.0 110.127 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 44.8 m -122.09 154.0 37.92 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.603 0.361 . . . . 0.0 111.001 -174.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.61 146.24 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -99.3 129.06 45.49 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.431 HG12 HG21 ' A' ' 248' ' ' VAL . 45.5 t -104.8 78.66 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 125.02 1.328 . . . . 0.0 108.447 -177.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.451 ' HA2' ' CB ' ' A' ' 217' ' ' ALA . . . -96.09 153.42 20.55 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 116.355 -0.384 . . . . 0.0 113.44 -174.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 109.21 11.79 21.31 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.9 m -73.63 152.88 89.54 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 117.255 0.527 . . . . 0.0 110.298 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.32 -45.9 2.42 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.63 2.22 . . . . 0.0 110.099 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.531 ' HB3' ' CD ' ' A' ' 183' ' ' PRO . 29.5 ttp-105 -159.8 -75.32 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 118.019 -0.991 . . . . 0.0 108.664 172.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 182' ' ' ARG . 14.4 Cg_endo -87.66 177.11 3.78 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.765 2.31 . . . . 0.0 109.81 169.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 184' ' ' LEU . 19.3 tp -136.58 -0.34 2.4 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 169.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 57.53 95.38 0.02 OUTLIER 'General case' 0 C--N 1.341 0.217 0 C-N-CA 126.941 2.096 . . . . 0.0 111.702 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.89 -27.44 63.29 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -173.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 62.5 t -62.8 -56.41 17.7 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 CA-C-N 118.515 0.598 . . . . 0.0 111.183 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -82.46 -23.03 34.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 122.454 -0.153 . . . . 0.0 110.721 -175.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.88 -38.87 66.82 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.52 -37.56 74.15 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 121.923 -0.486 . . . . 0.0 110.426 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.2 mmt -68.33 -35.64 78.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.376 -0.202 . . . . 0.0 110.818 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.41 HG21 ' HA ' ' A' ' 239' ' ' LEU . 56.5 mt -76.95 -35.95 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 117.594 0.179 . . . . 0.0 111.317 -176.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.3 mmt -64.56 -23.43 67.26 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.891 -0.505 . . . . 0.0 109.998 172.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -78.68 -24.26 45.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.022 0.374 . . . . 0.0 110.735 174.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -83.43 -17.7 41.24 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 119.129 -0.462 . . . . 0.0 112.134 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -118.48 -17.07 9.46 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -177.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -133.24 19.03 4.02 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -174.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.19 -144.41 37.64 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -69.3 118.38 8.56 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 60.2 t -109.3 142.35 22.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 124.08 0.952 . . . . 0.0 108.612 174.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 42.9 t -99.9 -39.78 8.0 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.687 0.221 . . . . 0.0 110.84 -178.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -150.09 146.29 26.85 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.727 0.298 . . . . 0.0 110.964 -176.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -154.49 153.04 30.83 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.312 0.645 . . . . 0.0 109.844 175.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 162.75 -158.25 30.42 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.651 -0.579 . . . . 0.0 111.651 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . 0.454 ' HA ' ' HA2' ' A' ' 218' ' ' GLY . 48.8 mm -108.51 145.33 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -60.3 102.68 0.18 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 40.7 p -145.51 166.76 24.75 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.944 0.498 . . . . 0.0 109.802 -176.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -138.26 131.61 16.51 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -80.11 -16.42 11.12 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.458 3.439 . . . . 0.0 113.587 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -91.12 -31.65 16.15 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.527 0.603 . . . . 0.0 110.476 -176.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.04 -1.88 30.76 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.208 0.603 . . . . 0.0 110.291 176.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 49.86 45.2 25.1 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.103 0.961 . . . . 0.0 112.551 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.37 155.25 53.93 Favored Pre-proline 0 CA--C 1.528 0.104 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -84.41 153.85 12.21 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.411 2.741 . . . . 0.0 109.586 170.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.58 6.59 6.25 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.856 0.463 . . . . 0.0 110.502 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 165.46 -163.07 36.35 Favored Glycine 0 CA--C 1.524 0.609 0 O-C-N 121.919 -0.488 . . . . 0.0 112.08 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . 0.451 ' CB ' ' HA2' ' A' ' 178' ' ' GLY . . . -80.09 -162.36 0.44 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.223 1.009 . . . . 0.0 111.401 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 205' ' ' ILE . . . -71.05 166.58 52.31 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 116.427 -0.351 . . . . 0.0 112.97 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -155.56 154.68 32.09 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 87.6 t -140.6 147.09 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -137.56 154.04 49.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.355 0.597 . . . . 0.0 111.846 -177.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -129.48 158.25 39.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.035 -173.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 34.3 m -84.58 -10.49 57.34 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.311 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -124.67 149.15 47.48 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.166 0.587 . . . . 0.0 111.03 -174.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -78.07 -16.33 58.12 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.92 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -80.87 -35.42 32.69 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 15.1 m -77.51 -26.89 51.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -64.59 -48.03 76.48 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.629 0.372 . . . . 0.0 110.481 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 35.5 pt -72.95 -24.49 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 CA-C-N 117.937 0.335 . . . . 0.0 111.039 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -73.62 -24.72 60.06 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.018 0.372 . . . . 0.0 110.804 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -83.74 -8.52 59.24 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.4 pt -120.0 19.42 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 123.035 0.534 . . . . 0.0 110.791 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 21.1 m -89.32 -11.51 43.2 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.899 0.48 . . . . 0.0 112.129 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -142.41 122.94 14.09 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -50.75 -41.14 56.33 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -115.44 107.29 15.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.098 0.408 . . . . 0.0 111.104 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 237' ' ' VAL . 10.6 m -67.24 151.21 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.418 172.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.461 ' C ' HD22 ' A' ' 239' ' ' LEU . 0.3 OUTLIER -100.23 139.93 35.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.276 0.56 . . . . 0.0 109.678 174.043 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.461 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.1 mm? -118.94 21.41 12.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.522 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -84.04 121.85 27.98 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.709 0.803 . . . . 0.0 112.041 -170.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -147.58 24.68 1.09 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.36 142.47 7.58 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 56.22 10.86 0.68 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.259 1.024 . . . . 0.0 112.85 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.7 mt -140.87 142.29 30.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 C-N-CA 123.742 0.817 . . . . 0.0 109.213 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -142.8 18.56 1.98 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.542 0.337 . . . . 0.0 111.343 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -55.36 151.36 10.07 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 124.2 1.0 . . . . 0.0 111.385 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.61 154.21 37.1 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.826 1.25 . . . . 0.0 108.975 176.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . 0.431 HG21 HG12 ' A' ' 177' ' ' VAL . 7.2 p -161.12 158.32 2.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -89.66 150.28 22.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.463 0.305 . . . . 0.0 111.739 -175.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.2 m -118.69 155.98 20.72 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-O 120.775 0.322 . . . . 0.0 111.683 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.45 157.56 30.18 Favored Pre-proline 0 CA--C 1.528 0.118 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.73 137.6 74.63 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.349 2.033 . . . . 0.0 108.578 173.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -72.08 120.81 18.21 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 119.04 -1.064 . . . . 0.0 112.009 -175.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 CA--C 1.533 0.309 0 C-N-CA 126.17 1.788 . . . . 0.0 113.403 172.994 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? . . . . . 0 CA--C 1.531 0.217 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 53.85 172.16 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -175.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.3 t -107.46 21.47 17.42 Favored 'General case' 0 C--O 1.23 0.043 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.652 -173.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.484 ' HA ' ' CE1' ' A' ' 115' ' ' PHE . 96.4 mtt180 54.23 20.87 2.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.507 0.723 . . . . 0.0 112.784 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -145.96 146.87 31.19 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.074 0.549 . . . . 0.0 110.73 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -139.07 153.5 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.468 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -88.44 142.68 27.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 170.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.505 HG11 HD13 ' A' ' 113' ' ' LEU . 3.6 m -129.28 100.61 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.994 0.902 . . . . 0.0 109.017 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.26 -174.77 50.3 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 77.26 11.24 85.71 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.715 -0.491 . . . . 0.0 112.72 178.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.0 tp -67.87 127.04 93.33 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 118.112 0.956 . . . . 0.0 110.965 -177.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.31 163.25 30.34 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.581 2.854 . . . . 0.0 110.257 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -83.64 3.17 7.87 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.123 3.215 . . . . 0.0 113.666 -173.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -129.67 22.41 5.46 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -170.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.0 pt -124.2 171.08 13.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 118.791 0.723 . . . . 0.0 109.958 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -140.35 -173.88 3.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.128 0.49 . . . . 0.0 112.201 -173.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -51.33 -29.41 15.09 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.317 1.447 . . . . 0.0 113.091 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.78 -32.28 35.51 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.501 0.591 . . . . 0.0 111.585 -175.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -76.81 -39.25 52.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.374 0.131 . . . . 0.0 110.848 -173.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.417 ' H ' HG12 ' A' ' 81' ' ' ILE . 5.0 pt -83.95 -36.15 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 119.652 -0.213 . . . . 0.0 110.971 -177.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.8 m -65.54 -26.52 67.93 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.01 -22.58 31.29 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.647 -0.216 . . . . 0.0 111.408 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 m -78.58 -12.88 60.04 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.213 0.461 . . . . 0.0 112.099 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -118.45 4.44 11.78 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.175 0.443 . . . . 0.0 112.145 175.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 47.9 tpt85 -67.8 -18.55 64.89 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -72.05 -5.34 34.51 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.415 0.552 . . . . 0.0 112.398 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -106.67 6.3 29.65 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.449 0.3 . . . . 0.0 111.619 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.31 179.59 17.54 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.57 134.89 25.16 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.548 2.832 . . . . 0.0 110.662 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.0 pp -159.85 164.93 33.21 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.919 0.888 . . . . 0.0 109.753 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.4 mm -128.45 163.79 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.17 153.67 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -145.47 157.07 44.07 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.214 0.53 . . . . 0.0 111.049 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.454 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 44.8 p90 -156.5 158.77 31.57 Favored Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 169.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.654 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 38.4 Cg_endo -74.15 -10.62 22.79 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.389 2.726 . . . . 0.0 110.459 -169.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.654 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 50.1 m-70 -103.88 10.4 36.4 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.157 0.983 . . . . 0.0 110.927 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -63.92 -24.2 67.64 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.866 0.866 . . . . 0.0 110.927 -178.748 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.255 0 C-N-CA 123.736 0.814 . . . . 0.0 111.473 178.719 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.99 0 CA-C-O 119.656 -0.525 . . . . 0.0 112.165 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 60.64 166.12 0.08 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.324 0.65 . . . . 0.0 111.757 -177.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.82 175.34 9.9 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 121.153 -0.967 . . . . 0.0 113.126 -171.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -145.95 141.71 28.0 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.702 0.801 . . . . 0.0 109.504 -178.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.505 HD13 HG11 ' A' ' 69' ' ' VAL . 9.0 mp -98.94 144.89 27.61 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.23 139.15 52.35 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.484 ' CE1' ' HA ' ' A' ' 65' ' ' ARG . 8.1 p90 -152.19 177.4 10.57 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -117.69 -30.36 5.48 Favored 'General case' 0 CA--C 1.521 -0.148 0 O-C-N 122.188 -0.32 . . . . 0.0 110.88 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -93.31 124.72 37.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -69.15 -19.36 64.01 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.73 0.3 . . . . 0.0 110.324 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.9 m -77.02 -13.27 59.98 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.854 0.462 . . . . 0.0 111.245 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.3 t -75.53 -38.28 59.46 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.9 p -83.64 -21.54 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -67.08 -40.16 86.94 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.28 -37.99 60.62 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.64 -20.47 59.88 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.536 0.607 . . . . 0.0 111.708 -176.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.412 HD11 ' HG3' ' A' ' 153' ' ' PRO . 76.8 mt -92.07 -22.55 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 118.014 0.37 . . . . 0.0 111.437 176.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -91.24 -12.65 34.6 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.889 -0.507 . . . . 0.0 112.225 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -127.04 46.0 2.59 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.885 0.474 . . . . 0.0 111.458 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 27.6 p -139.42 -177.9 5.14 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.775 0.43 . . . . 0.0 111.57 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.471 ' N ' HD12 ' A' ' 129' ' ' ILE . 2.9 mp -81.8 159.86 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -139.9 160.52 39.73 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.819 -0.551 . . . . 0.0 112.324 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -143.56 176.69 9.01 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -61.34 3.34 0.12 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -171.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.6 1.89 0.06 OUTLIER Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.006 -0.885 . . . . 0.0 114.0 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -154.1 177.02 11.54 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.713 1.256 . . . . 0.0 110.642 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -116.34 163.33 16.18 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.449 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 6.3 m-85 -139.46 148.16 42.33 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.009 0.433 . . . . 0.0 112.008 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.6 mp -139.56 -171.02 3.05 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 172.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 72.1 m -133.61 162.51 31.73 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.82 0.736 . . . . 0.0 112.138 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.09 167.72 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.674 1.19 . . . . 0.0 109.403 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.7 m -119.47 11.92 12.26 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -170.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.518 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 6.1 t -141.68 32.6 0.16 Allowed Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 176.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 141' ' ' SER . 85.5 Cg_endo -71.28 172.16 14.62 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.631 2.888 . . . . 0.0 113.533 -174.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.9 t -79.89 -20.54 45.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.728 0.811 . . . . 0.0 112.727 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.8 mm -117.21 165.1 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -62.82 121.1 12.62 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 57.5 159.47 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.875 1.27 . . . . 0.0 112.582 -172.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.05 108.53 1.41 Allowed Pre-proline 0 CA--C 1.522 -0.129 0 O-C-N 121.679 -0.638 . . . . 0.0 110.66 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.449 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 58.9 Cg_endo -79.77 139.92 14.31 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.636 2.224 . . . . 0.0 108.506 169.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.6 m -124.3 144.85 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.046 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -85.38 158.74 20.17 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 43.4 mm -133.32 140.73 46.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.586 1.154 . . . . 0.0 108.943 172.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -154.92 91.84 2.91 Favored Pre-proline 0 CA--C 1.535 0.375 0 O-C-N 123.345 0.403 . . . . 0.0 110.244 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.412 ' HG3' HD11 ' A' ' 125' ' ' ILE . 36.7 Cg_exo -61.23 169.93 5.72 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 124.758 3.639 . . . . 0.0 114.853 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' TRP . . . . . 0.434 ' CD2' ' HG2' ' A' ' 214' ' ' PRO . 19.6 t-105 -113.73 141.5 47.18 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.786 174.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -118.22 153.22 34.25 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.703 0.801 . . . . 0.0 110.957 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.66 12.45 16.84 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -170.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.4 t -75.51 -24.0 56.79 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -173.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -143.97 29.55 1.34 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.499 0.59 . . . . 0.0 112.578 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 49.3 m -65.51 -22.24 66.7 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.848 -0.532 . . . . 0.0 112.122 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -153.66 157.42 39.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.782 0.433 . . . . 0.0 110.851 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -155.82 152.83 28.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.33 150.3 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 O-C-N 121.935 -0.478 . . . . 0.0 109.85 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 65.2 mtm -125.14 18.9 8.35 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.252 0.221 . . . . 0.0 111.568 -175.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -154.38 -48.52 0.09 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 67.97 11.09 60.27 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 119.115 -0.825 . . . . 0.0 114.296 172.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 61.3 p -141.08 -16.51 0.85 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -176.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -82.9 139.18 42.99 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 119.548 1.067 . . . . 0.0 110.926 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -62.92 156.18 55.81 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.675 2.917 . . . . 0.0 112.238 174.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.5 mp -120.32 162.23 19.8 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.519 0.728 . . . . 0.0 110.719 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -150.01 138.79 12.64 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.17 -11.24 31.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.26 2.64 . . . . 0.0 113.322 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.2 6.14 46.29 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.558 0.617 . . . . 0.0 110.174 175.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -128.28 25.08 5.85 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.93 0.492 . . . . 0.0 110.832 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.7 m -123.75 144.48 49.66 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.77 0.319 . . . . 0.0 110.549 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.5 tt -118.8 151.25 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 123.076 0.55 . . . . 0.0 110.726 -173.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -109.61 143.43 39.34 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 172.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.1 m -139.72 134.39 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 122.974 0.509 . . . . 0.0 109.664 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -150.09 -177.74 24.36 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 -176.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.65 7.19 84.71 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.93 128.37 86.69 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -79.55 -34.5 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.842 2.361 . . . . 0.0 114.376 -172.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ARG . . . . . 0.641 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 71.4 ttp85 -160.92 -38.32 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 116.841 2.163 . . . . 0.0 116.841 -174.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.641 ' HD2' ' H ' ' A' ' 182' ' ' ARG . 84.8 Cg_endo -76.98 -45.76 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 121.609 1.61 . . . . 0.0 113.989 -169.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 30.2 -106.74 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.734 1.214 . . . . 0.0 112.858 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 64.47 136.39 0.02 OUTLIER 'General case' 0 C--N 1.343 0.284 0 C-N-CA 126.222 1.809 . . . . 0.0 112.488 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.15 -32.13 56.1 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.005 -0.434 . . . . 0.0 112.022 -175.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.44 -54.18 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-N 117.674 0.215 . . . . 0.0 111.155 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -75.4 -23.54 57.06 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.68 -173.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 51.8 tp -72.98 -30.49 63.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.02 -41.38 35.97 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 122.171 -0.331 . . . . 0.0 111.768 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 17.3 ptp -75.08 -26.48 59.37 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.217 -0.302 . . . . 0.0 110.713 -177.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.5 mt -72.04 -37.74 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.1 mmt -72.68 -15.75 61.69 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.969 -0.457 . . . . 0.0 110.076 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -89.65 -17.72 27.86 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.862 0.301 . . . . 0.0 110.95 175.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -88.83 -18.27 28.01 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 119.341 -0.362 . . . . 0.0 111.874 177.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.36 -24.86 8.22 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.284 0.493 . . . . 0.0 111.377 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -140.01 47.7 1.81 Allowed 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.794 0.438 . . . . 0.0 110.501 -175.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.13 136.12 4.33 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 123.276 0.465 . . . . 0.0 112.097 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 128.55 8.96 3.75 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -174.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' VAL . . . . . 0.414 HG22 ' CE2' ' A' ' 222' ' ' PHE . 53.9 t -66.08 147.94 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 123.65 0.78 . . . . 0.0 110.146 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.2 p -118.24 -37.45 3.35 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 119.504 -0.284 . . . . 0.0 111.49 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -157.43 153.06 26.56 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.775 0.261 . . . . 0.0 110.936 -172.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -147.99 162.04 40.14 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.308 0.575 . . . . 0.0 111.839 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 178.0 -178.36 48.49 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 8.5 tp -87.73 155.59 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ASP . . . . . 0.446 ' HA ' ' CZ ' ' A' ' 219' ' ' ARG . 15.0 p-10 -70.76 38.68 0.05 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.2 t -74.2 152.4 39.78 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.105 -0.372 . . . . 0.0 110.325 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -134.18 146.23 58.81 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 122.604 0.362 . . . . 0.0 110.31 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.01 -7.43 18.23 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 124.533 3.489 . . . . 0.0 111.989 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.24 40.55 0.49 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.952 0.501 . . . . 0.0 110.347 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 51.68 21.94 1.49 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.263 1.825 . . . . 0.0 114.316 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -86.74 -24.15 25.23 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 119.24 -0.41 . . . . 0.0 110.261 174.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.52 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 37.6 m-85 56.28 -169.6 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.624 -0.703 . . . . 0.0 109.811 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.52 ' CD ' ' HB3' ' A' ' 213' ' ' TYR . 52.0 Cg_exo -56.15 151.2 44.35 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.063 1.842 . . . . 0.0 113.102 -177.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -120.9 25.1 9.87 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.739 0.415 . . . . 0.0 110.485 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.66 12.28 73.83 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.28 -0.733 . . . . 0.0 114.152 171.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -132.2 155.03 48.97 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.236 1.018 . . . . 0.0 110.64 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -97.68 160.23 21.04 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 121.45 0.472 . . . . 0.0 112.998 -173.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' ARG . . . . . 0.446 ' CZ ' ' HA ' ' A' ' 206' ' ' ASP . 4.0 ptp85 -142.83 147.31 35.22 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 172.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 3.5 p -150.08 150.42 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.25 150.62 43.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.535 0.734 . . . . 0.0 111.175 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.414 ' CE2' HG22 ' A' ' 200' ' ' VAL . 74.8 m-85 -125.96 149.26 48.91 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.47 0.708 . . . . 0.0 110.816 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 69.1 m -82.05 -0.52 44.78 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 122.257 0.223 . . . . 0.0 110.879 173.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -132.68 133.66 43.82 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.01 0.524 . . . . 0.0 109.943 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -73.34 -21.95 60.42 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -70.42 -38.8 74.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.6 m -76.66 -25.05 53.3 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.239 -0.288 . . . . 0.0 110.239 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -69.21 -51.24 39.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 41.9 pt -69.48 -17.33 21.43 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 118.095 0.407 . . . . 0.0 110.969 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.04 -28.48 39.3 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.48 -17.06 49.99 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 13.5 pt -113.92 24.54 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 123.331 0.653 . . . . 0.0 110.329 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -81.0 -9.89 59.78 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.268 0.627 . . . . 0.0 111.669 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.45 141.78 20.6 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -56.23 -35.47 67.4 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.283 0.233 . . . . 0.0 111.403 -177.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -126.15 114.66 18.65 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.08 0.467 . . . . 0.0 110.306 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 28.7 m -97.81 161.22 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.888 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' GLN . . . . . 0.499 ' H ' ' CD ' ' A' ' 238' ' ' GLN . 0.1 OUTLIER -87.19 142.23 28.06 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.028 0.442 . . . . 0.0 109.833 176.39 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.432 HD12 ' C ' ' A' ' 238' ' ' GLN . 7.2 mp -117.47 19.2 14.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.667 0.746 . . . . 0.0 109.62 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -55.13 138.83 43.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.243 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -146.09 18.25 1.4 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.472 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 88.08 -9.53 74.41 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 123.703 0.668 . . . . 0.0 111.817 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -141.74 10.31 2.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.64 0.776 . . . . 0.0 110.884 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 35.5 mm -133.54 153.9 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.587 0.755 . . . . 0.0 109.71 -174.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -146.96 12.44 1.1 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.695 0.398 . . . . 0.0 111.019 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -80.11 173.51 12.52 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 123.579 0.752 . . . . 0.0 112.191 -172.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.6 163.01 31.56 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.818 1.247 . . . . 0.0 109.565 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 5.7 p -149.07 150.42 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -85.51 132.46 34.19 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -117.32 155.19 19.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -175.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -157.73 160.31 30.15 Favored Pre-proline 0 C--O 1.232 0.142 0 CA-C-O 119.548 -0.263 . . . . 0.0 110.548 168.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.48 124.8 14.88 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.244 1.962 . . . . 0.0 107.323 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -66.16 117.96 9.21 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.911 -169.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 CA--C 1.535 0.387 0 C-N-CA 125.914 1.686 . . . . 0.0 113.292 174.56 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.1 m . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 120.455 0.169 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.5 t60 -146.83 169.51 18.95 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.232 0.613 . . . . 0.0 109.905 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -142.22 166.89 23.46 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.954 0.502 . . . . 0.0 111.134 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -128.5 19.19 6.28 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.535 0.734 . . . . 0.0 111.624 -178.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -61.92 166.97 16.95 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 57.39 10.81 1.0 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.379 1.072 . . . . 0.0 113.222 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 77.3 mtp85 -136.21 -1.85 2.34 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.297 0.639 . . . . 0.0 111.753 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 31.2 m -135.47 12.53 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 C-N-CA 123.302 0.641 . . . . 0.0 111.24 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -117.2 11.39 14.1 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 123.581 0.752 . . . . 0.0 111.629 -177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.5 ' HD3' ' H ' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -80.7 141.47 34.84 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -158.61 164.88 35.61 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-O 121.156 0.503 . . . . 0.0 110.543 -173.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.7 t -88.7 165.6 14.64 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.195 178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -82.33 10.95 6.02 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.824 176.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -128.15 141.53 51.45 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 124.148 0.979 . . . . 0.0 109.977 177.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 p -145.63 134.58 17.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.613 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.455 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 7.8 t80 -79.63 140.68 37.03 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 150' ' ' GLN . 3.3 m -127.63 114.48 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 173.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -93.9 163.12 25.55 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.368 -172.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 69.65 22.24 76.63 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-O 119.174 -0.792 . . . . 0.0 113.42 174.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 17.0 tp -47.11 123.38 8.14 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 118.629 1.214 . . . . 0.0 107.846 173.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -75.67 157.53 39.94 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.705 2.27 . . . . 0.0 111.823 -172.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.34 173.39 1.45 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 124.42 3.414 . . . . 0.0 112.873 173.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.9 t70 64.88 -78.94 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.6 pt -61.7 162.01 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.131 0 CA-C-N 118.683 0.674 . . . . 0.0 111.699 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -143.54 -156.01 0.65 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.38 -174.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -43.09 -32.68 0.73 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.642 1.977 . . . . 0.0 114.847 -173.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -78.6 -34.74 46.54 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 119.615 1.098 . . . . 0.0 112.139 -174.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -77.52 -27.92 51.85 Favored 'General case' 0 N--CA 1.454 -0.259 0 O-C-N 122.149 -0.345 . . . . 0.0 110.51 -174.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 25.9 pt -84.26 -27.03 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 O-C-N 122.067 -0.396 . . . . 0.0 110.398 176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.4 m -73.22 -12.97 61.05 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 174.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.16 -17.42 17.41 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 172.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.0 m -82.78 -42.51 17.85 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 118.93 0.787 . . . . 0.0 112.237 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -90.01 1.61 56.11 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -68.38 -14.64 63.14 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.838 0.455 . . . . 0.0 111.953 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -69.8 -10.0 56.76 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.014 0.525 . . . . 0.0 111.555 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -112.89 17.24 19.11 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.832 0.453 . . . . 0.0 110.46 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 108.54 167.89 21.03 Favored Glycine 0 CA--C 1.528 0.848 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.78 146.45 72.51 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.448 2.765 . . . . 0.0 110.507 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.5 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -149.94 166.67 28.91 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-O 121.0 0.429 . . . . 0.0 111.646 -178.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 10.9 pt -135.14 166.63 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.201 175.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -139.66 148.39 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.087 0 CA-C-O 120.722 0.296 . . . . 0.0 110.484 -176.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -150.32 165.02 34.29 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.935 -177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.524 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 42.1 p90 -154.76 164.05 22.29 Favored Pre-proline 0 CA--C 1.538 0.486 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 175.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.631 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 43.3 Cg_endo -73.04 -13.58 26.16 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 123.117 2.545 . . . . 0.0 110.927 -169.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.631 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 63.7 m-70 -101.75 7.48 41.85 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.763 0.825 . . . . 0.0 111.102 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 18.9 tptt -62.23 148.5 44.58 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.945 0.498 . . . . 0.0 110.395 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -148.43 166.58 27.69 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.08 0.552 . . . . 0.0 111.117 -177.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -89.47 9.2 27.35 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.212 0.605 . . . . 0.0 110.947 177.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 84.4 p -79.02 -0.57 31.78 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.398 0.679 . . . . 0.0 112.044 -178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt 52.76 31.7 10.92 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.817 0.847 . . . . 0.0 112.346 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.1 t -82.09 -25.48 34.46 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.133 0.173 . . . . 0.0 110.974 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 53.02 -171.42 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.764 1.225 . . . . 0.0 113.422 179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 48.9 t80 57.48 110.54 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.419 0 C-N-CA 126.435 1.894 . . . . 0.0 113.975 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -56.9 166.81 3.56 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 124.373 3.382 . . . . 0.0 112.778 175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_exo -47.98 -29.85 12.73 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 124.892 3.728 . . . . 0.0 115.633 -177.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -151.35 -68.23 0.18 Allowed 'General case' 0 C--N 1.34 0.156 0 CA-C-N 119.239 0.927 . . . . 0.0 111.649 177.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.73 41.34 0.14 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.7 -171.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -146.76 147.59 31.08 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 118.168 0.984 . . . . 0.0 109.254 172.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.89 175.91 11.59 Favored 'General case' 0 CA--C 1.528 0.125 0 C-N-CA 122.61 0.364 . . . . 0.0 110.931 -177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -136.1 129.39 31.78 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -90.32 149.18 22.43 Favored 'General case' 0 CA--C 1.521 -0.144 0 CA-C-O 121.549 0.69 . . . . 0.0 111.785 -178.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.2 mp -114.82 145.58 41.99 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.158 -1.383 . . . . 0.0 107.297 171.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -134.11 165.88 24.05 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.967 0.413 . . . . 0.0 110.956 -176.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -105.03 -31.48 9.17 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.236 -176.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -121.24 150.48 41.29 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.862 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -87.32 -5.83 58.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.322 -176.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.2 p -93.72 -15.19 25.48 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.665 0.386 . . . . 0.0 111.437 178.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 75.3 m -73.19 -36.12 66.49 Favored 'General case' 0 N--CA 1.455 -0.211 0 O-C-N 122.019 -0.426 . . . . 0.0 110.769 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.01 -20.43 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.0 tp60 -77.42 -38.54 49.4 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -176.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.0 -35.97 66.93 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.257 0.48 . . . . 0.0 111.584 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.6 pp -78.84 -15.59 58.18 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.199 0.454 . . . . 0.0 111.705 -177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.5 mt -99.33 -15.44 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 122.354 0.262 . . . . 0.0 111.209 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -103.34 -9.31 19.58 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.593 -0.692 . . . . 0.0 112.641 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -115.99 29.9 7.69 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.848 0.459 . . . . 0.0 111.96 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 32.0 p -140.48 -176.26 4.57 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.774 0.43 . . . . 0.0 111.659 -176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 32.2 mm -79.14 156.05 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.105 0 C-N-CA 124.629 1.172 . . . . 0.0 109.007 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -138.84 155.5 48.07 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.988 0.423 . . . . 0.0 111.972 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -144.15 70.77 1.3 Allowed 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.374 0.607 . . . . 0.0 110.066 176.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.4 p30 47.44 12.92 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.72 2.008 . . . . 0.0 116.228 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 175.5 -20.47 0.05 OUTLIER Glycine 0 CA--C 1.526 0.779 0 CA-C-N 118.578 0.626 . . . . 0.0 112.446 178.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -134.63 170.96 15.02 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 117.759 0.779 . . . . 0.0 109.555 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 150' ' ' GLN . 4.6 mp -130.63 173.33 11.0 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 119.242 -0.409 . . . . 0.0 110.897 -176.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -139.75 147.69 41.21 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.2 mp -133.84 164.0 28.24 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 170.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 82.7 m -101.98 150.49 23.17 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.205 0.602 . . . . 0.0 110.659 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.6 m -142.6 -4.76 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.3 m 48.53 43.94 20.45 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.515 0.726 . . . . 0.0 112.842 178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 70.6 p -73.55 153.62 89.71 Favored Pre-proline 0 CA--C 1.534 0.355 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -174.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -62.71 8.95 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.635 1 C-N-CA 125.58 4.186 . . . . 0.0 117.296 -175.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 47.0 m -96.28 -18.42 20.02 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.677 1.126 . . . . 0.0 110.069 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.533 ' N ' HD12 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -165.62 -172.28 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 125.342 1.457 . . . . 0.0 108.405 -171.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -69.5 -32.79 71.87 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.019 -0.426 . . . . 0.0 109.984 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.49 ' C ' HD13 ' A' ' 144' ' ' ILE . 24.3 t70 -162.95 153.15 16.17 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.266 0.626 . . . . 0.0 111.0 176.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.472 ' HE3' " O5'" ' B' ' 1' ' ' ' C' . 0.0 OUTLIER -116.19 106.87 48.48 Favored Pre-proline 0 N--CA 1.457 -0.107 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 174.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.407 ' HD2' ' C2 ' ' B' ' 1' ' ' ' C' . 35.5 Cg_exo -63.46 91.92 0.16 Allowed 'Trans proline' 0 N--CA 1.447 -1.231 0 C-N-CA 122.866 2.378 . . . . 0.0 109.026 168.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.8 m -80.2 141.75 14.85 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.197 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.428 ' O ' ' HA ' ' A' ' 69' ' ' VAL . 72.2 mt-30 -93.18 159.71 15.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.864 -0.334 . . . . 0.0 111.647 -177.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 50.0 mm -129.88 141.44 46.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 124.115 0.966 . . . . 0.0 109.761 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.29 101.62 1.54 Allowed Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.67 164.16 30.68 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.971 3.114 . . . . 0.0 111.91 -177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -88.08 148.7 24.35 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -109.28 150.31 28.15 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.851 0.46 . . . . 0.0 111.247 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.5 mp -96.74 78.1 2.89 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.128 0.571 . . . . 0.0 110.461 -175.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.9 t -155.11 -32.66 0.1 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 113.084 0.772 . . . . 0.0 113.084 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -134.56 28.06 3.66 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -174.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.2 m -60.71 -31.59 70.87 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 122.167 -0.333 . . . . 0.0 111.679 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -158.3 163.05 37.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.922 0.489 . . . . 0.0 110.877 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -156.1 156.61 34.6 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.494 0.318 . . . . 0.0 110.539 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.2 m -137.53 152.42 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.084 0 C-N-CA 123.273 0.629 . . . . 0.0 110.14 175.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 18.2 ttp -130.13 14.68 5.69 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.224 -176.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -148.57 -170.95 3.74 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -73.02 25.77 0.8 Allowed Glycine 0 CA--C 1.53 0.998 0 C-N-CA 123.682 0.658 . . . . 0.0 112.949 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 44.7 m 53.67 52.17 13.69 Favored 'General case' 0 C--N 1.34 0.161 0 CA-C-N 117.945 0.873 . . . . 0.0 111.645 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -59.3 156.55 28.83 Favored Pre-proline 0 CA--C 1.531 0.246 0 C-N-CA 122.963 0.505 . . . . 0.0 110.349 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -53.15 140.64 60.52 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.179 2.586 . . . . 0.0 111.758 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 74.9 mt -114.38 153.61 29.54 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 122.777 0.431 . . . . 0.0 110.549 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -145.37 156.03 53.73 Favored Pre-proline 0 N--CA 1.455 -0.221 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -70.77 -5.76 17.57 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 123.033 2.488 . . . . 0.0 111.011 -177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 33.0 ptt180 -98.76 4.44 47.73 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 124.522 1.129 . . . . 0.0 111.455 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -129.01 16.6 6.22 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 122.693 0.397 . . . . 0.0 111.577 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 25.7 m -127.69 140.75 51.88 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-O 121.027 0.441 . . . . 0.0 112.018 -173.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.9 tt -116.98 149.43 19.23 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.293 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -107.24 150.32 26.78 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 97.4 t -135.52 124.57 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 123.489 0.715 . . . . 0.0 109.278 -175.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -141.23 166.1 26.14 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 120.983 0.213 . . . . 0.0 112.585 -177.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.6 17.79 61.35 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -170.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.0 m -72.19 154.85 92.08 Favored Pre-proline 0 CA--C 1.529 0.155 0 C-N-CA 122.965 0.506 . . . . 0.0 112.332 -176.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.09 177.8 7.75 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 123.945 3.097 . . . . 0.0 108.963 169.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 93.4 mtm-85 -66.39 -52.96 33.62 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-O 118.303 -0.856 . . . . 0.0 112.449 -176.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.1 149.68 19.98 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.522 2.148 . . . . 0.0 111.069 175.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 43.1 mt -146.94 -43.54 0.18 Allowed 'General case' 0 N--CA 1.461 0.112 0 C-N-CA 122.883 0.473 . . . . 0.0 110.964 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 52.76 102.71 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.43 1.492 . . . . 0.0 111.662 -175.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -56.32 -24.28 42.62 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.724 0.638 . . . . 0.0 112.724 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 30.9 t -63.27 -49.75 81.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 CA-C-N 117.979 0.354 . . . . 0.0 110.636 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -82.82 -21.12 34.57 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 116.814 -0.176 . . . . 0.0 110.773 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 40.7 tp -67.22 -37.31 83.38 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.68 -33.11 47.25 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 119.817 -0.135 . . . . 0.0 111.147 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.0 mmt -69.05 -37.17 78.42 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-N 117.873 0.306 . . . . 0.0 110.293 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.475 ' CG2' ' HA ' ' A' ' 239' ' ' LEU . 46.5 mt -69.6 -48.47 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 122.186 0.195 . . . . 0.0 110.535 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -58.94 -22.29 59.7 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 118.045 0.384 . . . . 0.0 111.453 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -84.18 -20.72 31.9 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 118.595 0.634 . . . . 0.0 111.546 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -89.32 -16.04 32.01 Favored 'General case' 0 CA--C 1.528 0.1 0 CA-C-O 119.287 -0.387 . . . . 0.0 111.733 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -113.53 -18.36 11.97 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.36 0.527 . . . . 0.0 112.309 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -138.97 -30.37 0.74 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.851 0.75 . . . . 0.0 112.782 -177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.16 -177.92 18.57 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 68.99 11.66 63.81 Favored Glycine 0 CA--C 1.529 0.934 0 CA-C-O 119.484 -0.62 . . . . 0.0 113.586 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 15.6 t -69.09 149.11 11.27 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-N 118.323 1.061 . . . . 0.0 110.282 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 48.5 t -131.65 -35.3 1.29 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.163 0.185 . . . . 0.0 111.31 178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -148.31 149.33 31.64 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.22 156.2 38.06 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.135 0.574 . . . . 0.0 109.803 176.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 169.39 -175.8 43.56 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.8 mp -88.9 143.33 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -54.54 133.95 46.3 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-N 116.903 -0.135 . . . . 0.0 111.13 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 22.2 p -141.36 167.55 21.89 Favored 'General case' 0 C--O 1.231 0.102 0 C-N-CA 122.739 0.416 . . . . 0.0 110.363 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -129.34 131.51 23.69 Favored Pre-proline 0 N--CA 1.453 -0.299 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -80.19 -12.73 12.87 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.917 3.745 . . . . 0.0 113.728 -174.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -97.23 -27.06 14.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-N 118.701 0.682 . . . . 0.0 110.672 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 94.1 mt -108.75 -0.39 20.01 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.267 0.627 . . . . 0.0 110.534 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 46.59 48.41 14.24 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.707 1.203 . . . . 0.0 112.496 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -146.03 153.98 50.07 Favored Pre-proline 0 CA--C 1.53 0.182 0 N-CA-C 111.932 0.345 . . . . 0.0 111.932 -176.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.85 153.92 29.71 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.78 2.32 . . . . 0.0 110.754 173.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -117.58 25.05 10.68 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.566 0.746 . . . . 0.0 110.563 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.41 ' HA3' ' C5 ' ' B' ' 4' ' ' ' U' . . . 68.01 -170.71 36.67 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -176.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 52.38 -166.51 0.06 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 117.521 0.661 . . . . 0.0 110.96 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -155.82 173.47 33.85 Favored Glycine 0 C--N 1.333 0.397 0 O-C-N 121.146 -0.972 . . . . 0.0 112.281 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 5.6 ptp180 -142.44 155.13 45.06 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 66.7 t -139.12 143.14 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.44 150.51 49.61 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 120.908 0.385 . . . . 0.0 110.197 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -125.81 152.72 45.06 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.899 -174.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 68.7 p -86.05 4.69 36.9 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.258 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -138.14 141.24 40.15 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.108 0.563 . . . . 0.0 110.448 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -75.13 -13.16 60.44 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.757 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 38.1 tp60 -81.59 -37.48 27.59 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 20.0 m -75.58 -27.1 58.44 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -66.88 -51.8 51.08 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.448 -0.205 . . . . 0.0 110.448 176.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.0 pt -69.98 -15.67 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.074 0 CA-C-N 118.002 0.365 . . . . 0.0 111.038 -179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.97 -23.91 35.8 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 117.786 0.267 . . . . 0.0 110.686 175.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -84.34 -31.34 24.87 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.705 0.229 . . . . 0.0 111.579 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 7.5 pt -98.77 24.57 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 122.621 0.368 . . . . 0.0 110.236 174.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.9 t -77.94 -17.7 56.92 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.024 0.53 . . . . 0.0 111.547 -177.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.06 143.58 22.62 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -54.69 -32.29 59.17 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 122.716 0.406 . . . . 0.0 111.781 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -118.01 108.55 15.38 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.914 0.388 . . . . 0.0 110.195 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.53 HG23 HD21 ' A' ' 239' ' ' LEU . 2.4 m -78.03 161.3 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.132 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.599 176.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.61 ' C ' HD22 ' A' ' 239' ' ' LEU . 7.4 mp0 -93.55 135.77 34.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.61 HD22 ' C ' ' A' ' 238' ' ' GLN . 2.7 mm? -123.3 28.03 7.26 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.795 0.331 . . . . 0.0 110.72 -175.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -76.5 147.37 37.85 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 122.643 0.377 . . . . 0.0 110.964 -175.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -149.49 16.89 0.91 Allowed 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.652 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 83.94 125.72 1.22 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 -173.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 53.49 15.74 0.78 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.196 0.998 . . . . 0.0 113.128 -176.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 73.6 mt -140.7 148.67 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 123.987 0.915 . . . . 0.0 109.241 -178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -158.8 134.42 8.73 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.77 -0.456 . . . . 0.0 109.77 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -144.91 166.19 25.98 Favored 'General case' 0 N--CA 1.457 -0.094 0 C-N-CA 124.492 1.117 . . . . 0.0 108.34 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.75 150.92 33.94 Favored 'General case' 0 CA--C 1.523 -0.061 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 175.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.5 p -158.97 157.13 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 110.252 -0.277 . . . . 0.0 110.252 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -82.81 145.16 29.65 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.088 0.555 . . . . 0.0 110.835 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.5 m -125.11 161.37 29.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.148 0 N-CA-C 112.503 0.556 . . . . 0.0 112.503 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.57 159.29 25.83 Favored Pre-proline 0 N--CA 1.455 -0.176 0 CA-C-N 115.318 -0.856 . . . . 0.0 108.911 170.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.09 135.98 73.89 Favored 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 122.559 2.173 . . . . 0.0 109.038 173.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -69.89 146.38 51.3 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.964 -177.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.5 p -154.3 146.21 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.922 -176.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 C--O 1.251 1.176 0 CA-C-O 117.776 -1.107 . . . . 0.0 110.926 -179.809 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.472 " O5'" ' HE3' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.898 1 O4'-C1'-N19 113.936 5.736 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.171 2 C3'-C2'-C1' 105.735 4.706 OUTLIER-DELTA 0.378 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.455 ' C6 ' ' CE2' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.417 -3.02 2 O4'-C1'-N19 114.191 5.991 . 0.0 OUTLIER gamma 0.0 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.5 " C1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.417 -2.965 0 C5'-C4'-C3' 110.825 -3.117 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.54 ' C8 ' H5'' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.059 0 O4'-C1'-N19 111.445 3.245 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 50.5 p . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 120.0 -0.048 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -146.26 162.31 38.37 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.283 0.633 . . . . 0.0 110.075 179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -137.68 164.79 27.97 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.708 0.803 . . . . 0.0 110.188 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -142.09 161.13 38.78 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 122.823 0.449 . . . . 0.0 110.882 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.89 -173.88 47.9 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.713 -0.555 . . . . 0.0 111.713 179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -138.79 152.77 48.18 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 123.626 0.771 . . . . 0.0 109.231 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.7 mmt-85 -137.76 166.99 22.64 Favored 'General case' 0 C--O 1.228 -0.042 0 C-N-CA 123.365 0.666 . . . . 0.0 110.116 -177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.5 m -128.26 9.6 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 123.034 0.534 . . . . 0.0 111.49 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -81.93 -8.65 59.69 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 122.729 0.412 . . . . 0.0 111.195 -179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.4 ppt_? -86.95 145.93 26.34 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.861 0.362 . . . . 0.0 110.692 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -155.48 169.23 24.74 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.092 -171.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.6 t -89.73 19.97 4.37 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 54.13 18.94 1.92 Allowed 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.578 0.751 . . . . 0.0 112.256 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -145.38 146.27 31.5 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.151 0.58 . . . . 0.0 109.866 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.6 p -145.36 142.05 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.208 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.497 ' CZ ' ' C6 ' ' B' ' 3' ' ' ' U' . 3.7 t80 -90.26 139.35 30.74 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.462 HG12 ' CD1' ' A' ' 151' ' ' ILE . 5.5 m -125.72 99.04 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 122.033 0.92 . . . . 0.0 108.765 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.03 164.59 31.21 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.529 -177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.47 24.09 77.27 Favored Glycine 0 CA--C 1.528 0.905 0 O-C-N 122.618 -0.342 . . . . 0.0 112.649 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 19.1 tp -60.41 128.67 88.31 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 173.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 69.4 Cg_endo -69.72 131.02 20.42 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 121.886 1.724 . . . . 0.0 110.015 -178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 35.9 Cg_exo -64.45 -8.48 17.15 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 123.735 2.957 . . . . 0.0 114.627 -176.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -88.07 -0.65 57.31 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -173.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.404 HD12 ' C ' ' A' ' 76' ' ' ILE . 2.1 pp -136.67 -173.29 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.091 0 CA-C-N 118.636 0.653 . . . . 0.0 111.014 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -139.73 -166.78 2.14 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.541 0.736 . . . . 0.0 111.004 -175.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -45.93 -31.42 2.18 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 125.462 1.505 . . . . 0.0 113.213 -177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -65.94 -36.6 83.79 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -174.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -73.48 -38.17 65.51 Favored 'General case' 0 N--CA 1.452 -0.355 0 O-C-N 122.095 -0.378 . . . . 0.0 110.403 -172.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.5 pt -84.05 -27.46 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 O-C-N 122.101 -0.374 . . . . 0.0 111.436 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 90.9 m -69.97 -16.41 63.19 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 175.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.14 -19.43 18.66 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.413 0.523 . . . . 0.0 112.413 173.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.0 m -79.46 -26.68 41.68 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 118.902 0.774 . . . . 0.0 112.962 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -113.26 10.16 18.46 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.134 0.424 . . . . 0.0 111.743 -177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 69.6 ttp85 -68.9 -19.89 64.23 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 122.827 0.451 . . . . 0.0 111.762 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -72.18 -12.1 61.03 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.526 0.33 . . . . 0.0 111.102 178.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -105.2 20.5 18.76 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.744 0.418 . . . . 0.0 110.283 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.34 170.71 31.99 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -174.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -68.78 144.57 59.87 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.211 2.607 . . . . 0.0 110.425 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.511 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -149.61 168.33 23.86 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-O 120.862 0.363 . . . . 0.0 111.256 179.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 9.2 pt -140.53 166.49 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -138.46 149.73 24.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-O 121.147 0.498 . . . . 0.0 110.717 -176.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -147.18 163.32 36.71 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.222 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.409 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 28.8 p90 -158.62 161.75 27.85 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 174.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.563 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 32.8 Cg_endo -74.34 -9.59 21.8 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.5 2.134 . . . . 0.0 110.568 -170.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.563 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 8.2 m-70 -100.79 17.82 21.04 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.52 1.128 . . . . 0.0 110.98 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.2 tptt -50.15 146.1 5.29 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.322 0.649 . . . . 0.0 112.625 -172.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -108.42 -172.24 2.02 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.495 1.118 . . . . 0.0 110.814 -177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -68.35 -178.99 1.19 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.32 0.648 . . . . 0.0 110.536 176.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 36.9 m -70.24 9.12 0.63 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.087 0.555 . . . . 0.0 111.712 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -147.6 160.97 42.06 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.305 1.042 . . . . 0.0 110.052 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.3 t 52.97 32.45 12.73 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.589 0.756 . . . . 0.0 112.811 179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -80.01 138.57 37.07 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.6 0.36 . . . . 0.0 111.146 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -153.14 150.46 23.97 Favored Pre-proline 0 N--CA 1.453 -0.28 0 C-N-CA 124.096 0.958 . . . . 0.0 109.296 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -62.86 156.62 52.79 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 124.28 3.32 . . . . 0.0 111.976 175.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.66 -29.09 16.43 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.784 2.989 . . . . 0.0 112.149 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.407 ' HD3' ' C ' ' A' ' 108' ' ' LYS . 4.4 tmtm? -156.74 -68.53 0.1 Allowed 'General case' 0 CA--C 1.521 -0.151 0 C-N-CA 123.419 0.687 . . . . 0.0 109.454 176.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -177.3 31.5 0.07 OUTLIER Glycine 0 CA--C 1.525 0.66 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.154 -172.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.436 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.4 OUTLIER -141.42 145.66 35.59 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 117.799 0.799 . . . . 0.0 108.884 174.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.06 176.79 10.81 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 122.598 0.359 . . . . 0.0 110.875 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.495 ' CE1' ' C5 ' ' B' ' 4' ' ' ' U' . 1.6 m-85 -139.54 126.97 21.5 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -177.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.5 mp -89.58 151.04 22.13 Favored 'General case' 0 CA--C 1.522 -0.121 0 CA-C-O 121.32 0.581 . . . . 0.0 111.524 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.6 mp -114.11 139.59 49.19 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -136.78 175.62 9.45 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.508 0.723 . . . . 0.0 109.946 -177.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -115.95 -23.43 8.56 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 122.92 0.488 . . . . 0.0 111.783 -175.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -141.49 160.88 39.23 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.868 0.366 . . . . 0.0 111.228 -176.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -82.14 -14.61 55.43 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.271 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 41.4 m -79.02 -16.96 56.14 Favored 'General case' 0 C--O 1.231 0.093 0 O-C-N 122.277 -0.265 . . . . 0.0 111.112 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 73.1 m -79.62 -42.73 24.28 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.331 -0.23 . . . . 0.0 110.599 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.96 -22.34 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -75.89 -33.63 59.95 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.87 -36.9 59.38 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 117.967 0.349 . . . . 0.0 111.086 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 pp -78.86 -14.6 59.15 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 117.993 0.36 . . . . 0.0 111.43 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 61.8 mt -98.76 -17.16 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 122.328 0.251 . . . . 0.0 111.43 177.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -100.55 -10.78 20.68 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.879 -0.513 . . . . 0.0 112.131 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -120.22 30.25 7.08 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.053 0.541 . . . . 0.0 111.719 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 23.4 p -127.55 -174.83 3.28 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.241 0.616 . . . . 0.0 111.216 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 43.2 mm -87.76 161.31 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 124.023 0.929 . . . . 0.0 109.074 -176.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -127.14 154.25 44.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 120.611 0.243 . . . . 0.0 110.769 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -141.45 66.21 1.36 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.271 0.558 . . . . 0.0 110.402 176.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 52.31 9.57 0.1 Allowed 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 172.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 171.11 -16.36 0.06 OUTLIER Glycine 0 CA--C 1.528 0.847 0 CA-C-N 118.59 0.632 . . . . 0.0 112.485 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -128.27 172.16 11.3 Favored 'General case' 0 C--O 1.23 0.063 0 CA-C-N 117.663 0.731 . . . . 0.0 109.726 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.8 161.63 15.25 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.343 0.257 . . . . 0.0 110.308 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.413 ' CE1' ' HG2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -139.86 150.64 44.88 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.087 0.555 . . . . 0.0 109.784 -178.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 29.8 tp -138.82 151.26 46.88 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 169.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 44.0 t -84.7 152.7 23.56 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -127.71 161.31 35.77 Favored 'Isoleucine or valine' 0 C--N 1.337 0.056 0 C-N-CA 122.972 0.509 . . . . 0.0 110.099 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 52.9 m -92.25 -13.94 29.68 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 67.3 m -142.9 65.25 15.78 Favored Pre-proline 0 CA--C 1.53 0.18 0 C-N-CA 123.073 0.549 . . . . 0.0 109.968 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -68.95 168.96 18.97 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 124.682 3.588 . . . . 0.0 111.849 -179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.422 ' HB ' ' CB ' ' A' ' 73' ' ' PRO . 13.4 t -84.31 160.31 20.74 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 174.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.9 mt 57.17 -108.49 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -148.85 132.24 16.6 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.465 0.706 . . . . 0.0 109.135 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.4 t0 41.79 78.78 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.754 1.222 . . . . 0.0 112.064 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.8 108.81 20.4 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-O 119.568 -0.253 . . . . 0.0 110.711 -174.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.413 ' HG2' ' CE1' ' A' ' 136' ' ' TYR . 91.1 Cg_endo -71.59 165.31 32.91 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.399 3.4 . . . . 0.0 112.348 -178.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.4 p -114.92 140.38 36.38 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.084 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.0 tm0? -94.94 151.89 18.81 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.483 0.713 . . . . 0.0 110.913 -174.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.462 ' CD1' HG12 ' A' ' 69' ' ' VAL . 32.4 mm -134.87 142.02 41.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.202 0 C-N-CA 123.408 0.683 . . . . 0.0 111.147 -177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 62.9 ttp85 -156.76 113.92 2.01 Favored Pre-proline 0 CA--C 1.536 0.415 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 169.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -77.39 171.44 17.65 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 124.44 3.427 . . . . 0.0 112.464 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 -100.18 140.22 34.72 Favored 'General case' 0 C--N 1.341 0.207 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 173.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 47.6 p-10 -107.84 152.43 24.41 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-O 121.481 0.657 . . . . 0.0 111.663 -176.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.7 mp -87.57 65.01 8.38 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.423 0.689 . . . . 0.0 110.544 -177.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.4 t -133.76 -25.23 1.67 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.692 0.397 . . . . 0.0 111.151 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -153.81 138.3 16.8 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 67.2 m -157.79 -45.43 0.06 Allowed 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 117.907 0.321 . . . . 0.0 110.405 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -160.63 163.44 32.57 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 122.934 0.493 . . . . 0.0 110.617 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -157.37 160.24 38.25 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.807 0.337 . . . . 0.0 110.642 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 12.2 m -138.69 150.39 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 C-N-CA 123.559 0.744 . . . . 0.0 110.136 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 52.7 mtm -132.29 29.96 4.25 Favored 'General case' 0 C--N 1.335 -0.055 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.925 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -151.71 162.34 41.18 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -175.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -77.96 29.85 1.83 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 123.563 0.602 . . . . 0.0 112.141 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 37.4 m 57.42 52.1 9.03 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -61.92 163.51 12.86 Favored Pre-proline 0 CA--C 1.533 0.297 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -47.03 128.05 13.32 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 123.171 2.58 . . . . 0.0 111.512 -178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.0 tp -136.45 136.41 39.47 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.648 0.779 . . . . 0.0 110.153 -172.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -150.95 159.99 32.9 Favored Pre-proline 0 N--CA 1.455 -0.215 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 -178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.88 -14.72 14.74 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 123.531 2.821 . . . . 0.0 113.151 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -79.74 -6.62 57.61 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.831 0.452 . . . . 0.0 111.286 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -126.75 23.23 6.74 Favored 'General case' 0 C--N 1.338 0.1 0 C-N-CA 122.744 0.417 . . . . 0.0 110.457 175.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 27.7 m -122.08 148.77 44.45 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.922 0.392 . . . . 0.0 111.075 -175.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.27 147.86 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 C-N-CA 123.306 0.643 . . . . 0.0 109.416 -176.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -112.32 154.34 25.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 10.9 m -140.14 146.16 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.077 0.551 . . . . 0.0 110.515 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -150.71 170.79 30.54 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 111.754 -0.538 . . . . 0.0 111.754 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 78.04 12.42 84.4 Favored Glycine 0 CA--C 1.529 0.916 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -174.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . 10.7 p -87.76 146.27 38.67 Favored Pre-proline 0 CA--C 1.53 0.198 0 C-N-CA 122.71 0.404 . . . . 0.0 111.009 -176.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 180' ' ' VAL . 53.1 Cg_exo -55.64 161.91 7.21 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.247 2.632 . . . . 0.0 111.734 171.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.18 -47.52 78.74 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-O 118.511 -0.757 . . . . 0.0 112.474 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.47 60.29 7.75 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.061 2.507 . . . . 0.0 111.429 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.408 ' C ' HD12 ' A' ' 184' ' ' LEU . 4.1 pp -74.02 -10.91 60.11 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.981 -0.449 . . . . 0.0 111.972 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.15 80.48 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.489 1.516 . . . . 0.0 112.242 172.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -54.39 -28.85 46.33 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -171.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.87 -44.37 88.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.068 0 CA-C-N 118.774 0.715 . . . . 0.0 110.167 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -85.86 -18.23 33.4 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.056 -175.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 29.9 tp -73.26 -30.31 63.35 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.85 -35.38 57.55 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.7 mmt -67.97 -33.5 74.77 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.425 ' CG2' ' HA ' ' A' ' 239' ' ' LEU . 34.8 mt -71.55 -46.99 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 C-N-CA 122.613 0.365 . . . . 0.0 110.704 -177.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.5 mmt -61.27 -23.18 65.49 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 118.31 0.505 . . . . 0.0 110.699 174.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -82.69 -18.65 40.17 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.969 -0.457 . . . . 0.0 111.272 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? -93.4 -11.94 31.03 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 119.114 -0.47 . . . . 0.0 111.963 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -114.6 -20.75 10.59 Favored 'General case' 0 N--CA 1.461 0.084 0 CA-C-N 118.673 0.669 . . . . 0.0 111.972 178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -137.06 -33.6 0.75 Allowed 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.519 0.6 . . . . 0.0 112.578 -176.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 68.08 179.1 15.97 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 -178.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 70.82 13.89 72.46 Favored Glycine 0 CA--C 1.527 0.839 0 CA-C-O 119.428 -0.651 . . . . 0.0 113.133 176.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.41 HG22 ' CE2' ' A' ' 222' ' ' PHE . 22.6 t -68.78 140.66 18.56 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 118.269 1.034 . . . . 0.0 109.944 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.5 p -120.84 -30.13 4.5 Favored 'General case' 0 N--CA 1.457 -0.1 0 N-CA-C 111.586 0.217 . . . . 0.0 111.586 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -153.39 149.37 27.74 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 120.639 0.256 . . . . 0.0 110.671 -177.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -157.12 158.12 35.78 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 123.305 0.642 . . . . 0.0 109.739 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 157.41 -172.52 34.81 Favored Glycine 0 C--N 1.335 0.528 0 N-CA-C 111.974 -0.45 . . . . 0.0 111.974 177.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 205' ' ' ILE . 4.2 mp -88.01 140.15 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 174.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -53.67 106.01 0.16 Allowed 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 14.4 t -152.56 146.27 25.08 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.238 0.542 . . . . 0.0 112.233 -175.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -152.79 135.44 9.26 Favored Pre-proline 0 N--CA 1.454 -0.262 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 170.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -75.89 3.09 6.37 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.022 3.148 . . . . 0.0 111.413 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -77.83 -45.73 23.53 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -175.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.5 pp -161.26 6.59 0.07 Allowed 'General case' 0 C--N 1.341 0.21 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -138.05 -29.77 0.82 Allowed 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 -177.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.501 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 34.3 m-85 54.18 -166.77 0.01 OUTLIER Pre-proline 0 CA--C 1.546 0.797 0 CA-C-O 118.328 -0.844 . . . . 0.0 109.596 -174.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.501 ' CD ' ' HB3' ' A' ' 213' ' ' TYR . 91.8 Cg_endo -75.19 144.35 29.52 Favored 'Trans proline' 0 N--CA 1.454 -0.816 0 CA-C-N 121.935 1.727 . . . . 0.0 112.778 -170.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.472 ' HA ' ' C4 ' ' B' ' 4' ' ' ' U' . 88.3 mttt -90.26 -168.76 2.2 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.583 0.753 . . . . 0.0 110.064 175.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.408 ' N ' ' C5 ' ' B' ' 4' ' ' ' U' . . . -96.35 5.24 65.07 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -137.38 150.49 47.73 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.205 0.602 . . . . 0.0 110.85 -175.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -104.35 173.4 21.25 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.971 -173.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -148.31 153.51 38.75 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 88.7 t -138.25 148.85 24.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -136.65 156.87 47.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 121.422 0.63 . . . . 0.0 111.381 -177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.41 ' CE2' HG22 ' A' ' 200' ' ' VAL . 81.5 m-85 -132.25 153.23 50.85 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.561 -175.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.1 p -84.63 0.48 50.04 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.956 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -132.83 141.18 48.32 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.068 0.547 . . . . 0.0 110.362 -179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.3 pm0 -74.41 -7.27 52.36 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.369 0.268 . . . . 0.0 111.268 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.7 tp60 -83.52 -40.62 18.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 25.5 m -75.51 -24.98 56.9 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -63.91 -50.75 67.51 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 174.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -73.71 -11.78 14.91 Favored 'Isoleucine or valine' 0 C--N 1.338 0.075 0 CA-C-N 118.09 0.405 . . . . 0.0 111.144 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.43 -17.05 33.13 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.588 0.176 . . . . 0.0 111.149 174.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.76 -12.34 29.36 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 11.3 pt -120.39 23.25 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 123.354 0.662 . . . . 0.0 110.313 174.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.2 p -76.79 -19.03 58.05 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.23 0.612 . . . . 0.0 111.721 -178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.3 144.33 22.92 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -176.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -57.61 -31.61 66.4 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -177.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -122.94 110.14 15.01 Favored 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.466 HG23 HD21 ' A' ' 239' ' ' LEU . 4.0 m -82.36 154.89 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.205 175.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.533 ' C ' HD22 ' A' ' 239' ' ' LEU . 24.8 mm100 -84.07 138.45 33.05 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 173.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.533 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.1 mm? -120.88 36.77 4.49 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -81.63 147.29 29.64 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.945 0.402 . . . . 0.0 111.887 -173.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -136.48 16.33 3.16 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.27 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 85.55 -15.36 46.7 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.006 0.813 . . . . 0.0 112.523 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -140.68 1.83 1.75 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.707 0.753 . . . . 0.0 110.786 178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.6 mt -141.18 153.45 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 C-N-CA 123.751 0.82 . . . . 0.0 109.335 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -148.02 135.3 20.49 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 174.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -145.34 169.38 18.39 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 125.023 1.329 . . . . 0.0 108.415 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . 0.456 ' HA ' HD23 ' A' ' 239' ' ' LEU . 0.1 OUTLIER -150.15 151.65 33.46 Favored 'General case' 0 CA--C 1.523 -0.059 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 175.47 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 11.4 p -155.17 153.73 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -83.35 124.09 30.28 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.5 m -102.98 159.0 4.66 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.119 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -177.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.547 ' HG3' ' H61' ' B' ' 5' ' ' ' A' . 0.0 OUTLIER -159.67 159.01 27.91 Favored Pre-proline 0 CA--C 1.528 0.113 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.665 169.45 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.33 142.72 94.95 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.769 2.312 . . . . 0.0 110.124 176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -83.83 166.79 17.65 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-O 120.997 0.427 . . . . 0.0 110.641 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 6.7 p -151.78 155.37 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 123.282 0.633 . . . . 0.0 110.142 -170.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 61.8 tp . . . . . 0 C--O 1.249 1.035 0 CA-C-O 117.245 -1.359 . . . . 0.0 110.064 179.56 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.42 -2.77 1 C5'-C4'-C3' 108.76 -4.493 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.94 1 C3'-C2'-C1' 105.15 4.056 . 0.095 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.497 ' C6 ' ' CZ ' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.421 -2.691 2 O4'-C1'-N19 114.062 5.862 OUTLIER-DELTA 0.308 4b . 0.0 . . . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.495 ' C5 ' ' CE1' ' A' ' 112' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.732 0 C5'-C4'-C3' 111.32 -2.787 . 0.0 OUTLIER '7D dist 4b' 0.0 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.547 ' H61' ' HG3' ' A' ' 251' ' ' LYS . . . . . . . . 0 O4'--C4' 1.412 -3.395 1 C5'-C4'-C3' 108.711 -4.526 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 120.487 0.184 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 48.0 p-80 -145.93 14.21 1.33 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 122.944 0.498 . . . . 0.0 111.243 179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -138.87 168.86 18.89 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.723 0.809 . . . . 0.0 110.485 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -142.15 157.25 45.09 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.887 0.475 . . . . 0.0 109.803 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.87 167.83 27.75 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.783 -0.527 . . . . 0.0 111.783 -178.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -153.67 154.74 34.71 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 123.277 0.631 . . . . 0.0 109.682 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -138.42 120.75 15.92 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 122.765 0.426 . . . . 0.0 109.914 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 66.2 t -149.2 127.45 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 175.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -158.35 170.99 20.99 Favored 'General case' 0 N--CA 1.456 -0.162 0 CA-C-O 120.703 0.287 . . . . 0.0 110.687 178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.431 ' HG3' ' H ' ' A' ' 63' ' ' TYR . 12.9 tpt180 -130.42 174.34 9.96 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.737 0.815 . . . . 0.0 109.257 -177.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.431 ' H ' ' HG3' ' A' ' 62' ' ' ARG . 15.6 m-85 -132.66 148.95 52.35 Favored 'General case' 0 N--CA 1.458 -0.044 0 CA-C-O 120.743 0.306 . . . . 0.0 111.106 -174.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.2 m -88.41 24.86 1.81 Allowed 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.244 0.618 . . . . 0.0 111.847 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 53.19 28.02 6.61 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 122.867 0.467 . . . . 0.0 109.995 -174.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 21.1 tptm -135.29 137.85 42.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.292 1.037 . . . . 0.0 110.447 -173.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.4 p -151.39 137.96 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.732 174.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.498 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 11.0 t80 -87.12 143.09 27.46 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.5 p -128.5 85.59 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 121.979 0.895 . . . . 0.0 108.96 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.427 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -80.84 165.05 47.18 Favored Glycine 0 C--N 1.335 0.517 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.094 -177.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.526 ' HA2' " H4'" ' B' ' 1' ' ' ' C' . . . 73.43 9.16 77.32 Favored Glycine 0 CA--C 1.526 0.761 0 CA-C-O 119.77 -0.461 . . . . 0.0 113.17 177.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 14.6 tp -49.47 137.08 16.9 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 173.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.477 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 58.3 Cg_endo -66.0 136.57 45.24 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.959 1.773 . . . . 0.0 109.535 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 31.8 Cg_exo -61.55 14.03 0.05 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 124.195 3.263 . . . . 0.0 115.593 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -140.55 32.31 1.86 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.961 0.801 . . . . 0.0 112.067 -177.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.77 155.18 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 176.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -120.42 -178.45 3.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.443 0.697 . . . . 0.0 111.0 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -53.37 -31.48 44.9 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.753 0.821 . . . . 0.0 112.738 -175.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -78.18 -33.77 49.94 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -173.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -77.49 -24.98 50.04 Favored 'General case' 0 CA--C 1.533 0.296 0 O-C-N 121.867 -0.52 . . . . 0.0 110.583 -173.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.5 mt -80.53 -40.55 19.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 51.8 m -68.02 -8.71 39.83 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 115.85 -0.613 . . . . 0.0 109.593 177.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -103.43 -19.73 14.31 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 172.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.5 m -74.98 -26.96 59.96 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-N 118.856 0.753 . . . . 0.0 112.535 179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -122.25 17.4 10.68 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -70.81 -17.08 62.77 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 -173.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -80.62 4.94 16.96 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.044 -0.41 . . . . 0.0 111.79 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -116.66 24.87 10.98 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.566 0.346 . . . . 0.0 110.751 -178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.64 173.62 30.81 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.782 -0.927 . . . . 0.0 110.782 -177.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.16 151.66 72.49 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.492 2.795 . . . . 0.0 110.846 -178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.464 ' N ' HD23 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -161.06 161.96 31.5 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.482 -170.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 8.9 pt -140.37 161.91 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 CA-C-N 115.36 -0.836 . . . . 0.0 108.8 173.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.6 p -126.69 151.67 33.62 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -145.36 160.7 41.14 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.532 0.682 . . . . 0.0 112.299 -173.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.418 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 30.3 p90 -155.75 158.77 31.86 Favored Pre-proline 0 N--CA 1.451 -0.386 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 169.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.632 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 28.5 Cg_endo -74.7 -7.98 19.93 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.447 2.765 . . . . 0.0 110.628 -169.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.632 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 75.4 m-70 -105.37 18.06 22.9 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.381 1.073 . . . . 0.0 111.182 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -50.86 155.04 1.26 Allowed 'General case' 0 C--N 1.341 0.215 0 C-N-CA 123.96 0.904 . . . . 0.0 112.387 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -136.74 169.47 17.69 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.403 0.681 . . . . 0.0 111.1 -176.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -141.23 150.81 43.13 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.36 0.664 . . . . 0.0 109.544 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 39.6 m 55.56 18.63 2.82 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.737 0.815 . . . . 0.0 112.767 -176.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -142.46 170.92 14.8 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.429 1.092 . . . . 0.0 109.438 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 78.3 p -67.63 159.4 30.01 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.685 0.278 . . . . 0.0 110.727 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -98.02 142.36 29.83 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 122.651 0.38 . . . . 0.0 110.903 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -159.19 115.82 1.61 Allowed Pre-proline 0 N--CA 1.454 -0.264 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 175.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -79.69 158.29 24.91 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 123.933 3.089 . . . . 0.0 110.815 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.14 133.63 31.4 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 123.378 2.719 . . . . 0.0 110.305 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.6 tptm 40.03 -93.3 0.01 OUTLIER 'General case' 0 C--N 1.341 0.215 0 C-N-CA 125.574 1.55 . . . . 0.0 111.917 -177.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -157.87 40.13 0.53 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.024 -1.23 . . . . 0.0 110.024 -172.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.459 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.0 OUTLIER -141.39 145.64 35.6 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.299 0.55 . . . . 0.0 110.625 175.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.5 -177.36 6.17 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.438 0.695 . . . . 0.0 109.72 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -144.21 144.23 31.43 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -97.56 146.01 25.69 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-O 121.407 0.622 . . . . 0.0 111.099 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.5 mp -112.23 144.95 40.77 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.2 m-85 -136.35 171.91 13.79 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.815 0.34 . . . . 0.0 111.088 -175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -108.39 -26.18 10.61 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.016 0.527 . . . . 0.0 109.969 -177.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -135.24 155.03 51.33 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.32 -178.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -85.15 -11.34 55.29 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.069 -177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 48.4 m -81.29 -19.03 43.84 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 122.212 0.205 . . . . 0.0 111.235 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.3 m -76.2 -43.14 43.79 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.571 0.224 . . . . 0.0 110.846 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.4 ' HA ' HD12 ' A' ' 124' ' ' LEU . 8.6 p -75.74 -19.5 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 15.7 tp60 -77.02 -29.03 55.19 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.06 -44.71 46.08 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 119.067 -0.492 . . . . 0.0 111.94 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.555 HD22 ' C ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -73.41 -29.51 62.64 Favored 'General case' 0 C--N 1.342 0.252 0 C-N-CA 118.325 -1.35 . . . . 0.0 110.567 -179.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.419 ' HA ' ' SG ' ' A' ' 128' ' ' CYS . 79.1 mt -78.42 -15.7 13.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 118.387 0.54 . . . . 0.0 111.111 178.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -92.09 -13.65 30.47 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.016 -0.427 . . . . 0.0 110.894 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -113.72 1.82 15.0 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.419 ' SG ' ' HA ' ' A' ' 125' ' ' ILE . 18.5 p -96.7 -176.07 3.49 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 121.159 0.504 . . . . 0.0 111.177 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 22.6 mm -81.66 155.91 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 124.534 1.134 . . . . 0.0 108.513 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -136.95 145.83 44.69 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 120.623 0.249 . . . . 0.0 110.375 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.99 176.18 9.28 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 174.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -57.66 -1.89 0.12 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -169.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -159.2 0.16 0.08 OUTLIER Glycine 0 CA--C 1.529 0.929 0 CA-C-N 119.415 1.007 . . . . 0.0 114.73 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -163.91 174.03 11.97 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.121 1.46 . . . . 0.0 111.6 -176.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.405 HD22 ' N ' ' A' ' 135' ' ' LEU . 2.5 mm? -117.68 161.75 19.16 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.884 0.874 . . . . 0.0 109.706 -178.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 83.2 m-85 -144.63 158.22 43.86 Favored 'General case' 0 C--N 1.34 0.158 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 176.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.4 tp -125.3 145.57 49.95 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 168.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 80.3 m -100.16 119.29 38.11 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.001 -0.437 . . . . 0.0 110.653 -177.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.9 m -148.2 159.49 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 C-N-CA 123.597 0.759 . . . . 0.0 110.17 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.2 p -91.11 160.38 15.6 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 173.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 97.0 p -150.58 163.78 22.8 Favored Pre-proline 0 N--CA 1.454 -0.265 0 O-C-N 122.112 -0.367 . . . . 0.0 111.895 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -66.35 -10.06 26.17 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 123.213 2.609 . . . . 0.0 112.641 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.417 HG22 ' CD1' ' A' ' 144' ' ' ILE . 54.8 m -93.59 -45.46 7.72 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 123.099 0.56 . . . . 0.0 110.741 -176.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.451 HG13 ' HE3' ' A' ' 147' ' ' LYS . 5.1 mm -135.51 158.21 39.94 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.091 0 C-N-CA 123.446 0.698 . . . . 0.0 109.22 -173.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.5 mttp -62.11 -24.31 67.06 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 121.974 -0.454 . . . . 0.0 109.971 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -157.35 141.05 15.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.244 1.018 . . . . 0.0 108.882 174.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.451 ' HE3' HG13 ' A' ' 144' ' ' ILE . 5.3 tppp? -132.46 115.51 14.86 Favored Pre-proline 0 N--CA 1.455 -0.182 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.414 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 89.7 Cg_endo -74.33 96.52 0.97 Allowed 'Trans proline' 0 N--CA 1.445 -1.341 0 C-N-CA 122.409 2.073 . . . . 0.0 106.814 169.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 14.0 p -78.04 132.22 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -85.1 153.18 22.86 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.062 0.545 . . . . 0.0 110.67 -173.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.4 mm -136.98 143.35 35.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 C-N-CA 123.505 0.722 . . . . 0.0 110.262 177.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 54.3 ttp85 -154.06 113.0 2.5 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 169.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.46 172.82 15.36 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 124.42 3.413 . . . . 0.0 112.655 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 19.7 t-105 -122.41 140.27 52.89 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.092 174.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.477 ' C ' HD12 ' A' ' 156' ' ' LEU . 17.9 m120 -125.93 168.76 13.45 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-O 121.358 0.599 . . . . 0.0 111.021 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 155' ' ' ASN . 4.7 mp -104.59 99.01 8.68 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.373 -169.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.2 t -156.76 -32.97 0.08 Allowed 'General case' 0 N--CA 1.456 -0.169 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.999 176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -138.86 26.25 2.5 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.527 0.195 . . . . 0.0 111.527 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.7 m -70.14 -26.53 63.99 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -153.65 160.05 42.26 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 122.962 0.505 . . . . 0.0 110.941 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -154.69 162.34 41.17 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.455 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 1.6 p -154.04 147.46 13.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 122.63 0.372 . . . . 0.0 110.916 -175.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 66.2 mtm -140.79 22.51 2.29 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -147.21 13.07 1.09 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.947 0.794 . . . . 0.0 112.762 -174.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 83.33 23.05 55.56 Favored Glycine 0 CA--C 1.527 0.796 0 O-C-N 121.77 -0.581 . . . . 0.0 112.848 178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 31.6 m 56.91 44.14 23.59 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 113.039 0.755 . . . . 0.0 113.039 177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -65.71 159.31 69.61 Favored Pre-proline 0 CA--C 1.531 0.235 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 177.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -52.72 147.31 31.91 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.725 2.95 . . . . 0.0 112.42 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 58.8 mt -118.57 161.95 19.2 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.481 0.713 . . . . 0.0 110.309 -176.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 171' ' ' PRO . 13.7 t70 -149.74 140.42 14.08 Favored Pre-proline 0 CA--C 1.533 0.306 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 170' ' ' ASP . 50.1 Cg_exo -56.76 -21.88 42.06 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.336 2.691 . . . . 0.0 113.777 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -83.86 -3.26 57.76 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 118.276 0.489 . . . . 0.0 110.826 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.88 22.4 7.43 Favored 'General case' 0 C--N 1.339 0.135 0 C-N-CA 122.81 0.444 . . . . 0.0 110.86 175.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.6 m -127.26 146.57 50.38 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.69 0.281 . . . . 0.0 110.803 -176.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.417 HD13 HG21 ' A' ' 175' ' ' ILE . 9.7 tt -123.21 149.14 26.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 123.087 0.555 . . . . 0.0 110.551 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.449 ' CD1' ' HD3' ' A' ' 251' ' ' LYS . 5.4 t80 -111.28 143.74 41.57 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 172.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 8.6 m -138.99 136.71 42.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 177.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -145.43 171.45 26.48 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 111.923 -0.471 . . . . 0.0 111.923 -176.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 77.86 11.18 85.67 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -175.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.6 p -67.22 146.41 98.9 Favored Pre-proline 0 CA--C 1.534 0.349 0 C-N-CA 122.728 0.411 . . . . 0.0 110.236 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -54.08 170.44 0.49 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.946 3.097 . . . . 0.0 112.789 173.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -55.08 -47.57 98.2 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-O 118.226 -0.892 . . . . 0.0 112.751 -176.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.94 136.48 18.6 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.934 1.756 . . . . 0.0 110.375 173.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.653 ' CD1' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -145.7 -70.53 0.26 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 119.175 -0.441 . . . . 0.0 111.644 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.653 ' H ' ' CD1' ' A' ' 184' ' ' LEU . 81.3 mtp180 58.5 133.62 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 126.366 1.866 . . . . 0.0 112.912 -175.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.62 -26.3 64.36 Favored 'General case' 0 CA--C 1.528 0.123 0 O-C-N 121.557 -0.715 . . . . 0.0 110.076 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 51.1 t -68.73 -47.68 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 CA-C-O 120.761 0.315 . . . . 0.0 110.662 178.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 33.7 mm-40 -81.05 -25.4 37.13 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.65 -174.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 46.2 tp -71.67 -31.39 66.74 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.82 -34.59 45.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.284 -0.26 . . . . 0.0 111.317 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 23.3 mmt -68.99 -36.23 77.6 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 76.6 mt -72.45 -36.0 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 110.052 -0.351 . . . . 0.0 110.052 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.1 mmt -74.08 -14.88 61.05 Favored 'General case' 0 N--CA 1.454 -0.275 0 O-C-N 122.09 -0.381 . . . . 0.0 110.194 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -95.19 -15.09 23.53 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 117.993 0.36 . . . . 0.0 110.978 175.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.31 -17.46 28.9 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.677 0.391 . . . . 0.0 111.339 176.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -118.12 -23.81 7.23 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 117.987 0.358 . . . . 0.0 111.215 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -139.89 45.21 1.9 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 122.688 0.395 . . . . 0.0 110.338 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -41.45 134.06 3.28 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 123.937 0.779 . . . . 0.0 112.618 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 132.07 6.77 3.07 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -175.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.422 HG22 ' CE2' ' A' ' 222' ' ' PHE . 46.5 t -65.59 147.39 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.108 0 C-N-CA 123.335 0.654 . . . . 0.0 110.611 -179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 21.9 p -123.91 -28.84 3.74 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 119.216 -0.421 . . . . 0.0 112.121 176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -154.19 154.42 33.49 Favored 'General case' 0 N--CA 1.458 -0.06 0 CA-C-N 118.626 0.648 . . . . 0.0 110.785 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.32 158.91 44.67 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.683 0.393 . . . . 0.0 110.57 175.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -177.29 177.66 48.29 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 111.529 -0.629 . . . . 0.0 111.529 177.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.6 mm -102.09 92.32 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.507 ' HB3' ' H ' ' A' ' 215' ' ' LYS . 27.7 t70 51.68 -58.3 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -169.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 69.3 p 46.04 71.5 0.29 Allowed 'General case' 0 N--CA 1.463 0.197 0 C-N-CA 123.552 0.741 . . . . 0.0 112.933 175.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -78.39 128.04 79.08 Favored Pre-proline 0 N--CA 1.454 -0.273 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.44 -6.91 20.02 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 124.294 3.329 . . . . 0.0 114.521 -174.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -73.36 -27.16 61.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.966 1.257 . . . . 0.0 111.575 -177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 78.0 mt -145.33 8.24 1.18 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.851 0.86 . . . . 0.0 110.592 177.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt 54.02 50.08 17.47 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.745 0.818 . . . . 0.0 110.801 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -131.27 152.88 81.33 Favored Pre-proline 0 N--CA 1.455 -0.211 0 C-N-CA 123.378 0.671 . . . . 0.0 110.228 -177.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -84.77 140.52 8.11 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 122.741 2.294 . . . . 0.0 112.458 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.507 ' H ' ' HB3' ' A' ' 206' ' ' ASP . 37.4 mtmm -98.87 26.81 5.41 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 168.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.77 171.48 14.81 Favored Glycine 0 CA--C 1.525 0.696 0 N-CA-C 111.447 -0.661 . . . . 0.0 111.447 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 60.62 153.67 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.656 1.183 . . . . 0.0 113.746 -178.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -88.19 160.63 30.91 Favored Glycine 0 CA--C 1.525 0.685 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.58 -174.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -149.55 150.28 32.01 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 60.2 t -142.49 149.93 18.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.06 148.8 50.12 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.422 ' CE2' HG22 ' A' ' 200' ' ' VAL . 82.0 m-85 -123.22 153.24 40.39 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.895 -175.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 86.7 p -88.66 -0.74 57.59 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.637 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 -130.84 144.67 51.63 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.798 0.439 . . . . 0.0 111.164 -177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 39.8 tp60 -74.27 -16.01 60.96 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 122.546 0.339 . . . . 0.0 110.195 178.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 20.8 tm0? -85.21 -38.26 19.16 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 19.1 m -68.84 -29.65 68.02 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -66.98 -53.61 29.89 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.525 0.33 . . . . 0.0 110.944 177.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.6 pp -69.91 -12.26 15.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.08 0 CA-C-N 118.304 0.502 . . . . 0.0 111.686 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.79 -27.37 22.34 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.012 0.369 . . . . 0.0 111.102 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -82.92 -24.68 32.99 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.7 pt -108.67 27.22 1.99 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 123.153 0.581 . . . . 0.0 110.277 175.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.5 t -77.82 -15.34 59.15 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.299 0.639 . . . . 0.0 112.218 -176.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -155.35 145.0 21.27 Favored 'General case' 0 N--CA 1.458 -0.056 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -57.88 -32.45 67.71 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -124.49 111.84 16.18 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 30.0 m -98.2 159.27 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.166 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.55 178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -81.88 143.14 31.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.4 mp -130.41 103.95 6.97 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 173.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -135.83 146.61 47.68 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.151 -177.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -146.91 8.64 0.97 Allowed 'General case' 0 N--CA 1.456 -0.137 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.647 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.62 -139.25 5.48 Favored Glycine 0 C--N 1.336 0.537 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -175.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -78.82 4.34 14.27 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.986 0.393 . . . . 0.0 112.041 179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 76.7 mt -104.2 136.28 38.2 Favored 'Isoleucine or valine' 0 C--N 1.338 0.106 0 C-N-CA 123.185 0.594 . . . . 0.0 110.541 -178.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . 0.446 ' CG ' HH12 ' A' ' 247' ' ' ARG . 25.4 t70 -122.78 139.88 53.52 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.044 177.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 59.8 mtpt -144.26 160.68 40.58 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.121 0.968 . . . . 0.0 109.851 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . 0.446 HH12 ' CG ' ' A' ' 245' ' ' ASP . 0.1 OUTLIER -134.81 160.43 38.24 Favored 'General case' 0 N--CA 1.461 0.093 0 C-N-CA 123.195 0.598 . . . . 0.0 109.695 178.205 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.23 151.39 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -79.98 138.54 37.09 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 175.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -122.03 152.59 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.471 ' HG3' ' H61' ' B' ' 5' ' ' ' A' . 0.0 OUTLIER -159.03 158.62 29.05 Favored Pre-proline 0 C--O 1.231 0.13 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.775 169.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.52 141.2 90.51 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.177 2.585 . . . . 0.0 110.526 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -74.72 146.99 41.79 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.139 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 14.7 p -158.35 165.88 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -173.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 78.5 mt . . . . . 0 C--O 1.251 1.151 0 C-N-CA 124.342 1.057 . . . . 0.0 111.087 -175.815 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.526 " H4'" ' HA2' ' A' ' 71' ' ' GLY . . . . . . . . 0 O4'--C4' 1.419 -2.872 1 O4'-C1'-N19 112.92 4.72 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.913 0 C3'-C2'-C1' 104.598 3.442 . 0.332 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.498 ' C6 ' ' CE2' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.738 1 O4'-C1'-N19 112.793 4.593 . 0.376 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.472 " C1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.42 -2.761 0 O4'-C4'-C3' 109.343 2.745 . 0.096 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.503 ' C8 ' H5'' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.415 -3.134 0 P-O3'-C3' 123.321 3.017 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 24.8 t . . . . . 0 N--CA 1.474 0.76 0 CA-C-O 120.329 0.109 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -149.47 165.15 33.02 Favored 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 123.039 0.536 . . . . 0.0 110.537 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -138.51 167.32 22.18 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.326 0.65 . . . . 0.0 110.249 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -110.49 161.67 15.45 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.286 0.634 . . . . 0.0 109.887 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -68.27 160.38 51.04 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -150.38 154.51 37.91 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.115 0.566 . . . . 0.0 109.82 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 84.5 mtt85 -135.46 162.89 31.37 Favored 'General case' 0 C--N 1.339 0.117 0 C-N-CA 123.366 0.667 . . . . 0.0 110.373 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.0 m 49.77 -178.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 C-N-CA 126.366 1.866 . . . . 0.0 113.42 -177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -134.65 162.03 33.45 Favored 'General case' 0 N--CA 1.457 -0.118 0 CA-C-O 121.293 0.568 . . . . 0.0 111.545 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.16 150.6 24.72 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.37 1.068 . . . . 0.0 110.024 177.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.1 m-85 -148.18 155.93 41.98 Favored 'General case' 0 N--CA 1.457 -0.116 0 CA-C-O 120.972 0.415 . . . . 0.0 111.159 -175.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -91.14 22.77 3.58 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.412 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 53.86 21.95 3.04 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.633 0.773 . . . . 0.0 111.755 -176.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -136.73 135.92 38.54 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.805 0.842 . . . . 0.0 109.525 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.6 p -142.11 137.91 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.314 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CZ ' ' CA ' ' A' ' 70' ' ' GLY . 7.9 t80 -81.61 140.43 34.44 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.06 -0.718 . . . . 0.0 109.06 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.3 p -120.0 96.54 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-O 122.02 0.914 . . . . 0.0 108.661 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.516 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -97.73 -171.43 32.98 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.831 -177.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 59.78 33.08 76.38 Favored Glycine 0 CA--C 1.525 0.719 0 CA-C-O 119.43 -0.65 . . . . 0.0 111.864 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 72' ' ' LEU . 43.6 mt -100.92 135.45 19.99 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 118.201 1.001 . . . . 0.0 110.649 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.488 ' HD2' HG21 ' A' ' 76' ' ' ILE . 60.1 Cg_endo -65.3 171.41 9.22 Favored 'Trans proline' 0 N--CA 1.459 -0.532 1 C-N-CA 125.577 4.185 . . . . 0.0 113.23 -178.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.62 9.32 0.06 OUTLIER 'Trans proline' 0 CA--C 1.533 0.463 1 C-N-CA 126.161 4.574 . . . . 0.0 116.391 -177.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -138.66 -114.56 0.15 Allowed 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.488 HG21 ' HD2' ' A' ' 73' ' ' PRO . 0.1 OUTLIER 44.6 67.91 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 CA-C-O 122.623 1.201 . . . . 0.0 111.738 172.012 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -70.68 -176.22 1.25 Allowed 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -46.48 -33.13 3.77 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.89 1.676 . . . . 0.0 113.382 -176.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -80.17 -29.74 38.77 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.187 -0.32 . . . . 0.0 111.852 -173.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -78.81 -30.64 45.49 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 122.256 -0.278 . . . . 0.0 110.758 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 61.0 mt -74.01 -40.67 52.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 72.6 m -65.37 -22.0 66.75 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.654 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.91 -17.97 26.99 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 67.5 m -79.33 -25.73 42.26 Favored 'General case' 0 C--N 1.339 0.147 0 CA-C-N 118.723 0.692 . . . . 0.0 112.03 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -122.09 18.56 10.82 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 -176.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -71.75 -20.28 61.91 Favored 'General case' 0 N--CA 1.461 0.118 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -75.76 -5.95 48.26 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 122.111 -0.368 . . . . 0.0 111.93 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -108.38 21.8 16.82 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.692 0.397 . . . . 0.0 110.301 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 96.81 165.17 32.9 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.469 -1.053 . . . . 0.0 110.469 -176.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.98 141.29 93.9 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.532 2.822 . . . . 0.0 112.148 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.513 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -151.24 167.93 26.29 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.713 0.405 . . . . 0.0 110.697 177.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 mt -134.19 163.92 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.7 p -126.8 150.16 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 175.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -152.15 165.91 33.33 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -170.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.475 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 4.7 p90 -147.32 159.81 41.07 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 169.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.595 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 79.6 Cg_endo -64.51 -18.72 63.85 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 124.133 3.222 . . . . 0.0 111.912 -168.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.595 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 3.2 p80 -118.63 21.64 12.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.008 0.923 . . . . 0.0 111.396 -177.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.607 ' HE2' ' HA ' ' A' ' 98' ' ' LYS . 0.3 OUTLIER -58.59 115.71 3.21 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 173.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -154.19 167.33 30.23 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.09 0.556 . . . . 0.0 109.953 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -76.23 -8.58 57.38 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 122.069 0.148 . . . . 0.0 110.875 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 78.5 p -86.24 -4.86 59.25 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 123.249 0.62 . . . . 0.0 111.158 177.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -128.12 9.42 6.24 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.777 0.831 . . . . 0.0 110.817 178.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 9.6 t 56.07 -170.35 0.08 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.059 0.944 . . . . 0.0 112.066 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -87.87 22.96 2.16 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.936 0.894 . . . . 0.0 111.173 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -102.35 121.83 48.7 Favored Pre-proline 0 N--CA 1.451 -0.405 0 C-N-CA 123.491 0.716 . . . . 0.0 110.088 -176.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -59.52 163.38 13.01 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 124.593 3.529 . . . . 0.0 112.522 176.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -60.96 -24.08 78.72 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.489 2.793 . . . . 0.0 111.595 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -153.41 -51.8 0.1 Allowed 'General case' 0 C--O 1.227 -0.095 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 170.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 174.21 -38.42 0.12 Allowed Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.41 ' CE1' H5'' ' B' ' 3' ' ' ' U' . 0.6 OUTLIER -69.82 139.54 53.17 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.548 0.674 . . . . 0.0 109.907 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -157.47 -162.42 1.19 Allowed 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.607 0.763 . . . . 0.0 110.177 -170.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -137.18 141.31 42.16 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 122.59 0.356 . . . . 0.0 110.133 -177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.3 mp -96.84 149.51 21.77 Favored 'General case' 0 N--CA 1.456 -0.127 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 8.9 mp -108.32 140.7 41.21 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 173.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -135.46 170.57 15.74 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-O 120.901 0.381 . . . . 0.0 110.559 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.3 mt-30 -111.25 -27.15 8.81 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.839 0.456 . . . . 0.0 110.487 -175.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -137.01 155.78 49.26 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.477 -178.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -79.03 -18.86 52.82 Favored 'General case' 0 N--CA 1.455 -0.205 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.487 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 45.9 m -77.9 -18.7 55.86 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 122.492 0.317 . . . . 0.0 111.528 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 63.3 m -75.36 -47.11 29.14 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.823 0.344 . . . . 0.0 110.678 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.4 p -76.78 -16.83 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.9 tp60 -74.69 -32.69 62.27 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 175.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.46 -35.92 60.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.376 -0.345 . . . . 0.0 111.455 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.4 pp -76.38 -22.3 54.98 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 120.065 -0.654 . . . . 0.0 110.803 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 48.4 mt -87.27 -17.76 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 O-C-N 122.285 -0.259 . . . . 0.0 111.335 176.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -103.43 -5.87 22.45 Favored 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.362 0.505 . . . . 0.0 112.362 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -122.9 10.26 9.5 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 61.8 m -122.76 -177.16 3.57 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 122.655 0.382 . . . . 0.0 110.456 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 38.2 mm -75.97 161.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 C-N-CA 124.147 0.979 . . . . 0.0 110.136 -171.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -135.42 162.46 32.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 120.79 0.329 . . . . 0.0 110.722 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -140.22 77.4 1.61 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.318 0.58 . . . . 0.0 110.631 -179.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 55.42 9.66 0.4 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 115.079 1.511 . . . . 0.0 115.079 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 157.22 -10.92 0.26 Allowed Glycine 0 CA--C 1.526 0.745 0 CA-C-N 118.568 0.622 . . . . 0.0 113.053 177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 134' ' ' LYS . 1.6 mppt? -124.08 176.51 6.33 Favored 'General case' 0 C--N 1.338 0.092 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -115.22 160.55 19.6 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -172.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -146.35 161.87 39.4 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 114.762 -1.108 . . . . 0.0 108.405 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 27.2 tp -142.13 142.21 32.73 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 168.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 46.0 t -92.19 128.24 37.96 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 118.311 0.505 . . . . 0.0 110.866 -178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.2 m -145.83 172.04 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.879 0.871 . . . . 0.0 110.307 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.9 p -72.9 172.25 11.24 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.018 0.527 . . . . 0.0 110.127 176.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.9 t -140.3 137.03 17.34 Favored Pre-proline 0 N--CA 1.457 -0.123 0 O-C-N 122.177 -0.327 . . . . 0.0 111.777 -177.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -80.74 -6.14 13.32 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 124.309 3.339 . . . . 0.0 112.662 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.465 HG23 HG12 ' A' ' 144' ' ' ILE . 3.8 t -125.38 -24.12 4.0 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.936 0.789 . . . . 0.0 112.458 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.638 HG22 ' H ' ' A' ' 145' ' ' LYS . 5.0 mm -124.09 -175.85 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.638 ' H ' HG22 ' A' ' 144' ' ' ILE . 54.4 mtmt -78.59 -21.33 48.73 Favored 'General case' 0 CA--C 1.53 0.192 0 O-C-N 121.684 -0.635 . . . . 0.0 111.356 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -158.9 166.45 31.83 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.62 0.768 . . . . 0.0 109.884 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.426 ' HB2' ' HZ3' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -151.23 119.37 3.4 Favored Pre-proline 0 N--CA 1.458 -0.071 0 O-C-N 122.192 -0.317 . . . . 0.0 110.987 178.246 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -81.08 101.87 1.31 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 122.617 2.212 . . . . 0.0 107.847 168.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.2 p -74.2 134.66 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.054 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -92.63 150.81 20.47 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.312 0.645 . . . . 0.0 110.785 -171.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 34.5 mm -137.32 141.19 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 C-N-CA 122.545 0.338 . . . . 0.0 111.649 -176.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 83.4 mtt85 -149.44 107.83 3.34 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 122.995 0.518 . . . . 0.0 109.649 174.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -75.36 165.0 31.65 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.744 2.963 . . . . 0.0 112.257 177.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -106.9 135.67 48.05 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-O 120.44 0.162 . . . . 0.0 110.678 173.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 40.7 p-10 -102.26 156.41 17.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.693 0.797 . . . . 0.0 112.397 -175.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.6 mp -102.98 91.51 4.16 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 42.8 t -156.36 -32.85 0.09 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -141.67 31.65 1.65 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -176.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.1 m -71.15 -18.26 62.51 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -153.52 159.36 42.21 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 123.098 0.559 . . . . 0.0 110.664 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -153.35 153.2 32.13 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 17.3 t -130.76 141.0 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 33.1 ttm -127.92 -3.23 5.84 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 111.541 0.201 . . . . 0.0 111.541 -177.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -159.69 -58.65 0.06 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 62.06 6.85 10.8 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.178 -0.79 . . . . 0.0 114.113 175.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 51.5 p -88.72 -11.79 44.12 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 118.853 1.326 . . . . 0.0 112.486 -175.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -135.68 150.76 72.83 Favored Pre-proline 0 CA--C 1.53 0.205 0 CA-C-N 118.351 0.523 . . . . 0.0 111.479 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -70.43 167.76 24.39 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 124.196 3.264 . . . . 0.0 111.656 -177.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.3 mt -107.25 160.48 15.57 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.454 0.701 . . . . 0.0 110.762 -175.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -151.41 142.95 15.68 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -58.0 -22.23 54.11 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.199 2.599 . . . . 0.0 113.648 -178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 16.6 mtp-105 -83.85 -2.97 57.49 Favored 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 122.942 0.497 . . . . 0.0 111.179 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -127.99 19.06 6.57 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.75 0.42 . . . . 0.0 111.095 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 21.1 m -127.42 140.75 51.96 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 120.541 0.21 . . . . 0.0 110.684 -177.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 9.7 tt -110.24 150.25 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.032 0 C-N-CA 123.015 0.526 . . . . 0.0 110.158 -177.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -112.16 144.27 41.82 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 96.6 t -136.57 132.48 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -176.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -159.01 179.62 34.51 Favored Glycine 0 CA--C 1.523 0.569 0 N-CA-C 112.131 -0.387 . . . . 0.0 112.131 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 79.94 10.59 85.45 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 -175.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.3 p -67.85 146.24 98.26 Favored Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 123.083 0.553 . . . . 0.0 109.911 -179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -53.66 -58.32 1.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 123.053 2.502 . . . . 0.0 113.657 -178.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.426 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 25.7 mmm-85 -151.58 -68.01 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.373 0 CA-C-O 118.319 -0.848 . . . . 0.0 112.312 -179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 182' ' ' ARG . 50.1 Cg_endo -79.23 162.89 25.41 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 123.083 2.522 . . . . 0.0 112.135 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 5.3 mp -136.89 -49.97 0.64 Allowed 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 122.967 0.507 . . . . 0.0 109.633 173.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 63.7 ttt180 47.9 102.83 0.0 OUTLIER 'General case' 0 C--N 1.341 0.207 0 C-N-CA 126.391 1.876 . . . . 0.0 112.829 -177.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.54 -24.42 55.98 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -175.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 78.7 t -68.66 -51.76 42.64 Favored 'Isoleucine or valine' 0 C--N 1.338 0.079 0 CA-C-N 118.019 0.372 . . . . 0.0 110.866 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -84.51 -21.78 30.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 121.272 -0.171 . . . . 0.0 110.809 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 57.3 tp -68.01 -33.2 74.16 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 175.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.401 ' HB2' ' CB ' ' A' ' 203' ' ' ALA . . . -78.33 -36.18 46.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 122.407 -0.183 . . . . 0.0 111.361 -178.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 25.2 mmt -70.02 -36.82 75.37 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -178.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 83.2 mt -70.0 -33.16 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.1 mmt -77.7 -9.78 59.17 Favored 'General case' 0 N--CA 1.454 -0.238 0 O-C-N 122.119 -0.363 . . . . 0.0 111.024 176.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -109.53 -2.26 17.72 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.416 0.553 . . . . 0.0 112.448 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -108.08 -17.0 14.15 Favored 'General case' 0 C--N 1.34 0.193 0 O-C-N 121.969 -0.457 . . . . 0.0 111.454 175.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.47 -17.89 11.63 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 117.922 0.328 . . . . 0.0 110.554 175.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -142.69 40.39 1.55 Allowed 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 123.188 0.595 . . . . 0.0 109.997 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -40.17 134.96 2.13 Favored Glycine 0 C--N 1.34 0.771 0 C-N-CA 124.547 1.07 . . . . 0.0 113.502 -174.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 137.67 14.23 0.8 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.472 0.558 . . . . 0.0 112.046 -177.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 42.4 t -73.73 149.2 8.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-N 118.244 1.022 . . . . 0.0 111.364 -176.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 25.7 p -124.85 -27.56 3.6 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.576 0.35 . . . . 0.0 111.014 175.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -155.15 156.82 36.43 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.655 0.264 . . . . 0.0 110.739 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.401 ' CB ' ' HB2' ' A' ' 190' ' ' ALA . . . -154.22 157.87 39.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 123.276 0.63 . . . . 0.0 109.977 176.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.43 -178.53 48.32 Favored Glycine 0 N--CA 1.451 -0.334 0 N-CA-C 111.532 -0.627 . . . . 0.0 111.532 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.1 mm -95.35 143.51 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 175.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -59.67 122.71 14.81 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 16.9 p -141.73 163.41 32.99 Favored 'General case' 0 N--CA 1.456 -0.14 0 CA-C-O 121.119 0.485 . . . . 0.0 110.806 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -132.07 128.05 21.27 Favored Pre-proline 0 N--CA 1.452 -0.328 0 C-N-CA 123.58 0.752 . . . . 0.0 109.16 177.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -80.31 -6.4 13.78 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 124.576 3.518 . . . . 0.0 113.196 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -92.79 -58.36 2.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-N 118.819 0.736 . . . . 0.0 111.459 -173.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -160.78 -5.06 0.05 Allowed 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -96.24 -15.44 22.0 Favored 'General case' 0 C--N 1.338 0.075 0 CA-C-N 119.722 1.146 . . . . 0.0 113.117 -174.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.517 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 55.6 m-85 50.98 -146.89 0.01 OUTLIER Pre-proline 0 CA--C 1.544 0.75 0 CA-C-O 117.219 -1.372 . . . . 0.0 110.044 177.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.517 ' CD ' ' HB3' ' A' ' 213' ' ' TYR . 89.4 Cg_endo -72.06 150.33 54.07 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 CA-C-N 123.178 2.171 . . . . 0.0 112.405 -173.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -105.81 13.85 28.99 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.7 0.8 . . . . 0.0 112.158 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 68.15 14.54 66.29 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.695 -0.503 . . . . 0.0 113.615 174.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -133.07 154.66 50.36 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 117.908 0.854 . . . . 0.0 109.867 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -100.7 162.28 18.63 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 121.064 0.258 . . . . 0.0 112.537 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 33.6 ptt180 -151.04 146.64 26.33 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 94.9 t -141.44 145.82 24.18 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.059 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.98 142.62 51.0 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.826 0.346 . . . . 0.0 110.86 -176.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -118.76 156.54 29.2 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.638 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.7 m -84.19 -5.63 59.28 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.209 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 41.3 m-20 -130.02 148.27 51.86 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 118.073 0.397 . . . . 0.0 111.919 -172.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -74.98 -15.45 60.66 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -84.98 -37.89 19.93 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 18.6 m -73.07 -28.04 62.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -67.91 -54.62 17.38 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.444 0.298 . . . . 0.0 110.531 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.1 pt -69.58 -14.84 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 CA-C-N 118.108 0.413 . . . . 0.0 111.345 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.66 -28.06 28.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.833 0.288 . . . . 0.0 110.794 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -82.89 -27.2 30.86 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 117.858 0.299 . . . . 0.0 111.759 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.2 pt -105.77 29.07 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 C-N-CA 123.127 0.571 . . . . 0.0 110.181 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 21.9 t -78.38 -11.06 59.92 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.085 0.554 . . . . 0.0 111.925 -176.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -158.06 145.29 18.07 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -59.05 -29.91 67.65 Favored 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 122.416 0.287 . . . . 0.0 111.139 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -123.19 118.79 28.45 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.8 m -107.52 156.55 7.96 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.006 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -81.5 144.3 31.44 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.989 0.423 . . . . 0.0 110.275 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.5 mp -131.99 105.86 7.67 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -133.25 147.42 51.95 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.216 -177.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -144.62 11.87 1.47 Allowed 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.168 178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 169.95 -140.16 5.91 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -175.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -80.65 14.8 1.94 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 122.961 0.504 . . . . 0.0 111.984 178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 73.5 mt -116.57 141.42 34.58 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 C-N-CA 123.619 0.768 . . . . 0.0 110.582 -176.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -129.54 146.62 51.34 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.978 0.418 . . . . 0.0 111.548 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -144.39 163.99 32.15 Favored 'General case' 0 N--CA 1.457 -0.091 0 C-N-CA 124.582 1.153 . . . . 0.0 109.137 176.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.08 153.87 50.46 Favored 'General case' 0 C--O 1.232 0.132 0 C-N-CA 123.367 0.667 . . . . 0.0 109.709 178.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 12.1 p -154.53 157.87 4.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -85.11 138.47 32.38 Favored 'General case' 0 N--CA 1.455 -0.196 0 O-C-N 122.476 -0.14 . . . . 0.0 110.757 -178.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -121.28 159.75 23.09 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.06 0 CA-C-O 120.795 0.331 . . . . 0.0 111.527 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.41 159.9 26.12 Favored Pre-proline 0 N--CA 1.455 -0.187 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 171.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.3 131.69 46.43 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.726 2.284 . . . . 0.0 108.217 171.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -73.42 112.22 9.29 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 119.446 -0.902 . . . . 0.0 111.526 -173.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 8.2 p 45.3 35.39 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.534 1.534 . . . . 0.0 112.769 175.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 63.0 tp . . . . . 0 C--O 1.25 1.106 0 CA-C-O 117.622 -1.18 . . . . 0.0 110.417 -178.004 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.812 1 O4'-C1'-N19 113.599 5.399 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.647 1 O4'-C1'-N19 113.096 4.896 . 0.382 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.479 " O4'" ' CZ ' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.415 -3.186 0 O4'-C1'-N19 111.927 3.727 . 0.597 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.471 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.417 -2.999 0 C5'-C4'-C3' 111.822 -2.452 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.847 1 C5'-C4'-C3' 108.457 -4.695 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.7 p . . . . . 0 N--CA 1.474 0.748 0 CA-C-O 120.583 0.23 . . . . 0.0 110.827 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 62.7 t60 -148.54 161.01 42.52 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.157 0.583 . . . . 0.0 110.105 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -148.58 163.03 38.46 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.047 0.539 . . . . 0.0 110.911 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -96.39 37.91 1.23 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.355 0.662 . . . . 0.0 111.153 -177.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -162.46 -179.12 36.86 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -151.44 167.83 26.76 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.333 0.653 . . . . 0.0 110.447 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 22.6 tpp180 -147.55 148.71 31.45 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 122.857 0.463 . . . . 0.0 110.115 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.9 p -149.68 154.61 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 123.564 0.745 . . . . 0.0 109.313 178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -89.57 161.62 16.08 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.659 0.384 . . . . 0.0 110.938 -178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.4 ' H ' ' HD3' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -149.63 145.26 26.66 Favored 'General case' 0 C--O 1.231 0.098 0 C-N-CA 123.325 0.65 . . . . 0.0 110.128 -179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -154.14 157.36 38.77 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 122.57 0.348 . . . . 0.0 110.823 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.8 t -94.25 -179.25 4.87 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.377 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.53 ' HA ' ' CE2' ' A' ' 115' ' ' PHE . 95.1 mtt180 -90.99 27.36 1.85 Allowed 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.592 0.757 . . . . 0.0 111.305 -178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.563 ' HE2' ' CD1' ' A' ' 154' ' ' TRP . 16.5 pttm -146.93 141.78 26.87 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 124.02 0.928 . . . . 0.0 111.154 -177.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 p -148.81 148.16 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.245 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.434 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 6.4 t80 -100.57 143.08 31.17 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 171.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.403 HG11 HD13 ' A' ' 113' ' ' LEU . 2.7 m -127.31 103.7 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-O 121.927 0.87 . . . . 0.0 108.853 176.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.416 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -93.77 -164.03 36.59 Favored Glycine 0 C--N 1.335 0.49 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 60.13 13.82 29.52 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-O 119.461 -0.633 . . . . 0.0 112.708 175.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 72' ' ' LEU . 27.0 mt -79.67 146.06 64.12 Favored Pre-proline 0 N--CA 1.453 -0.302 0 CA-C-N 118.72 1.26 . . . . 0.0 109.676 177.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 97.2 Cg_endo -76.68 161.23 34.02 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 124.355 3.37 . . . . 0.0 110.375 178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 33.1 Cg_exo -62.84 -11.61 25.08 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 123.777 2.985 . . . . 0.0 113.222 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -95.85 -39.47 9.81 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.4 mt -54.34 145.28 4.51 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 CA-C-O 121.735 0.779 . . . . 0.0 112.155 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -146.28 -170.45 3.5 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.768 1.227 . . . . 0.0 109.324 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -51.64 -27.0 10.1 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.604 0.762 . . . . 0.0 112.663 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -76.92 -45.02 29.35 Favored 'General case' 0 N--CA 1.454 -0.226 0 O-C-N 121.721 -0.612 . . . . 0.0 111.446 -178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 40.3 mm-40 -78.4 -26.32 46.39 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.18 -173.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.411 ' CG2' HD11 ' A' ' 113' ' ' LEU . 84.6 mt -74.62 -47.27 39.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 87.4 m -67.94 -12.84 61.5 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.006 179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.25 -15.11 20.97 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 173.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.6 m -82.38 -29.13 31.06 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 118.957 0.799 . . . . 0.0 112.032 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -118.46 14.64 13.73 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -66.32 -20.83 66.2 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 122.06 -0.4 . . . . 0.0 111.808 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.3 ptp180 -73.6 -5.1 38.26 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 122.512 0.325 . . . . 0.0 111.805 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -112.12 20.47 16.82 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 122.642 0.377 . . . . 0.0 111.083 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.23 176.2 25.35 Favored Glycine 0 CA--C 1.527 0.841 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.92 154.29 67.25 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.677 2.918 . . . . 0.0 110.869 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.479 ' N ' HD23 ' A' ' 91' ' ' LEU . 0.7 OUTLIER -164.54 162.09 21.54 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.187 -170.202 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.2 pt -140.91 167.59 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.276 173.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 6.7 p -134.69 155.54 38.74 Favored 'Isoleucine or valine' 0 C--O 1.23 0.045 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -150.32 165.29 33.48 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.992 0.425 . . . . 0.0 111.651 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.443 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 41.4 p90 -159.83 162.8 24.12 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 172.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.538 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 26.0 Cg_endo -75.51 -15.53 19.61 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.198 1.932 . . . . 0.0 110.513 -168.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.538 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 24.4 m-70 -91.41 2.17 56.6 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.653 0.781 . . . . 0.0 110.872 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.1 tptt -63.33 149.02 46.74 Favored 'General case' 0 C--N 1.341 0.229 0 C-N-CA 122.966 0.507 . . . . 0.0 110.765 -176.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -149.5 179.11 8.22 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.707 0.803 . . . . 0.0 109.943 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -76.25 6.56 5.32 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.729 0.411 . . . . 0.0 111.12 176.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.4 t -72.17 166.22 22.8 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 123.604 0.761 . . . . 0.0 110.952 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -129.11 17.51 6.1 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.881 0.873 . . . . 0.0 110.571 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.6 m -77.84 -6.67 54.96 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 122.993 0.517 . . . . 0.0 112.368 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 51.68 -157.32 0.13 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.97 0.908 . . . . 0.0 112.588 179.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 54.72 86.41 0.17 Allowed Pre-proline 0 CA--C 1.533 0.315 0 C-N-CA 125.685 1.594 . . . . 0.0 113.544 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.16 171.82 2.09 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 124.449 3.433 . . . . 0.0 111.016 171.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_exo -46.96 -38.59 23.96 Favored 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 123.778 2.986 . . . . 0.0 113.801 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 110' ' ' TYR . 42.6 tttp -155.99 22.09 0.38 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.829 0.451 . . . . 0.0 110.568 173.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 89.29 -35.87 3.61 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 118.885 -0.953 . . . . 0.0 113.472 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 108' ' ' LYS . 0.3 OUTLIER -63.28 138.47 58.54 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.269 1.534 . . . . 0.0 110.854 -179.556 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -156.53 -170.24 3.27 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.85 -169.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -130.36 129.94 43.77 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.167 0.587 . . . . 0.0 109.49 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.411 HD11 ' CG2' ' A' ' 81' ' ' ILE . 10.7 mp -86.79 142.98 27.72 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.744 0.783 . . . . 0.0 111.816 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -114.57 138.08 51.09 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 113.262 -1.79 . . . . 0.0 107.106 177.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 29.3 p90 -159.83 166.0 31.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -122.64 -20.51 5.95 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -174.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -79.07 -14.11 59.35 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -169.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 52.95 14.48 0.46 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 39.4 m -128.38 -12.47 5.03 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.211 0.605 . . . . 0.0 110.956 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 33.2 t -69.23 -34.69 75.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.477 HG11 ' CZ ' ' A' ' 115' ' ' PHE . 30.7 m -71.73 -26.23 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-N 116.857 -0.156 . . . . 0.0 111.007 177.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 -70.63 -40.55 73.04 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -77.65 -32.41 53.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -82.56 -12.57 57.64 Favored 'General case' 0 C--N 1.338 0.106 0 CA-C-N 119.003 0.819 . . . . 0.0 111.587 -178.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.467 HG23 HD13 ' A' ' 135' ' ' LEU . 61.4 mt -101.09 -19.81 5.78 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 O-C-N 122.174 -0.329 . . . . 0.0 110.745 178.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -101.84 -10.31 19.99 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -117.98 5.58 12.12 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 53.8 m -119.79 -159.92 0.8 Allowed 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.419 ' HB ' ' HB2' ' A' ' 136' ' ' TYR . 75.5 mt -79.48 145.81 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.046 0.538 . . . . 0.0 109.756 -172.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -140.18 137.26 34.22 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 176.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -152.65 -175.61 5.37 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.077 0.465 . . . . 0.0 111.573 178.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -61.18 108.72 0.95 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.581 0.705 . . . . 0.0 111.444 -177.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.44 -3.69 66.7 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-N 115.009 -0.996 . . . . 0.0 115.051 171.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.3 pttt -156.54 166.9 32.09 Favored 'General case' 0 CA--C 1.527 0.084 0 CA-C-N 118.962 1.381 . . . . 0.0 111.829 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.467 HD13 HG23 ' A' ' 125' ' ' ILE . 28.6 mt -129.46 160.49 32.99 Favored 'General case' 0 N--CA 1.457 -0.08 0 C-N-CA 124.324 1.05 . . . . 0.0 109.151 -174.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.497 ' HA ' ' O ' ' A' ' 149' ' ' VAL . 75.4 m-85 -147.87 170.28 17.99 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 177.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.405 HD12 ' H ' ' A' ' 138' ' ' CYS . 43.6 tp -146.31 147.06 30.97 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 114.397 -1.274 . . . . 0.0 107.695 170.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . 0.405 ' H ' HD12 ' A' ' 137' ' ' LEU . 70.9 m -84.29 138.38 32.95 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.983 0.421 . . . . 0.0 112.105 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.3 p -160.74 149.25 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.817 1.247 . . . . 0.0 107.986 174.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.7 t -122.29 144.7 48.84 Favored 'General case' 0 C--O 1.231 0.084 0 CA-C-N 118.249 0.477 . . . . 0.0 111.304 -176.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.6 m -152.55 167.7 12.8 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.292 0.637 . . . . 0.0 110.945 -175.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -59.12 24.57 0.04 OUTLIER 'Trans proline' 0 CA--C 1.538 0.71 1 C-N-CA 126.097 4.531 . . . . 0.0 117.604 -177.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.7 m -117.38 -28.28 6.16 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 119.82 1.191 . . . . 0.0 109.843 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.443 HG12 ' HE3' ' A' ' 147' ' ' LYS . 0.5 OUTLIER -165.32 166.52 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 C-N-CA 124.321 1.049 . . . . 0.0 110.455 -171.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 65.8 mttp -84.42 101.78 12.27 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 170.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 36.0 t70 61.44 144.83 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.268 1.427 . . . . 0.0 113.523 -174.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.729 ' HE2' ' C6 ' ' B' ' 1' ' ' ' C' . 27.6 ttmt -152.95 116.13 2.81 Favored Pre-proline 0 N--CA 1.455 -0.181 0 C-N-CA 124.232 1.013 . . . . 0.0 109.204 176.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.465 ' HB2' ' CD2' ' A' ' 136' ' ' TYR . 76.6 Cg_exo -54.94 125.08 17.96 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 124.416 3.411 . . . . 0.0 113.229 174.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 38.3 t -73.42 140.53 17.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.365 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 170.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.47 82.65 2.5 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 119.748 1.158 . . . . 0.0 110.284 -178.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 47.9 mm -69.92 139.58 20.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.732 0.813 . . . . 0.0 112.313 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 61.6 ttp85 -155.14 105.28 2.25 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.834 172.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -76.56 164.97 29.75 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 124.123 3.216 . . . . 0.0 112.213 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.563 ' CD1' ' HE2' ' A' ' 66' ' ' LYS . 69.9 t-105 -86.16 145.75 26.87 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 175.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -105.83 152.25 23.48 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.108 0.48 . . . . 0.0 111.126 -176.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.17 36.01 0.81 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.704 0.802 . . . . 0.0 111.715 -175.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.5 t -101.47 -30.5 11.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.097 -0.377 . . . . 0.0 110.771 -177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -159.93 144.92 15.08 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 174.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 35.9 m -152.4 -29.99 0.15 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.248 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -153.47 154.87 35.22 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.005 0.922 . . . . 0.0 109.431 175.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -157.1 155.57 31.3 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-O 120.603 0.24 . . . . 0.0 110.501 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.4 p -153.38 148.56 13.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.145 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -109.52 13.52 23.94 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -177.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -160.34 -47.56 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.532 0.606 . . . . 0.0 111.054 -178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 70.52 6.97 59.97 Favored Glycine 0 CA--C 1.529 0.965 0 CA-C-O 119.364 -0.686 . . . . 0.0 113.42 177.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 10.8 t -138.38 -2.6 1.79 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 118.285 1.043 . . . . 0.0 113.739 -177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -73.72 154.84 89.31 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 118.988 0.813 . . . . 0.0 109.958 176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -53.79 140.93 66.93 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 123.239 2.626 . . . . 0.0 110.366 173.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 39.6 tp -150.25 135.29 17.78 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.535 0.207 . . . . 0.0 110.801 -175.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -148.68 155.36 41.5 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.089 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -65.31 -21.39 61.48 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.408 2.739 . . . . 0.0 111.897 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -85.27 3.86 37.58 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.89 0.876 . . . . 0.0 111.907 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -120.13 23.7 10.84 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.015 0.526 . . . . 0.0 109.715 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 17.0 m -117.17 146.38 43.24 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.016 0.436 . . . . 0.0 111.691 -173.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.4 tt -119.69 147.64 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.107 0 C-N-CA 123.294 0.638 . . . . 0.0 109.735 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.4 ' HB2' ' CD1' ' A' ' 253' ' ' TYR . 6.3 t80 -105.24 136.5 44.65 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 174.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 99.5 t -130.9 113.31 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -174.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -141.91 -179.75 19.2 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 112.34 -0.304 . . . . 0.0 112.34 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 89.0 12.94 62.96 Favored Glycine 0 CA--C 1.527 0.806 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -174.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.54 153.91 94.72 Favored Pre-proline 0 CA--C 1.53 0.189 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -64.61 -68.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.027 2.485 . . . . 0.0 110.609 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.5 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 94.7 mtt-85 -146.59 -60.27 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 118.538 -0.744 . . . . 0.0 110.127 174.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' A' ' 182' ' ' ARG . 44.0 Cg_endo -80.09 162.28 23.25 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.904 2.403 . . . . 0.0 111.293 174.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.421 HD23 ' N ' ' A' ' 184' ' ' LEU . 2.1 pt? -159.49 -26.94 0.07 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.403 0.681 . . . . 0.0 110.87 173.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 51.87 115.49 0.0 OUTLIER 'General case' 0 C--N 1.342 0.251 0 C-N-CA 127.686 2.394 . . . . 0.0 114.475 177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.74 -29.18 69.95 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -177.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 35.6 t -69.73 -49.61 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-N 117.902 0.319 . . . . 0.0 111.043 -177.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -80.84 -21.72 40.52 Favored 'General case' 0 N--CA 1.453 -0.32 0 O-C-N 122.345 -0.222 . . . . 0.0 110.929 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 33.7 tp -70.11 -33.61 72.07 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.433 ' HB2' ' CB ' ' A' ' 203' ' ' ALA . . . -77.21 -35.25 55.78 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -177.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.4 mmt -69.17 -35.31 76.16 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 66.1 mt -69.75 -34.08 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.2 mmt -74.13 -17.42 60.93 Favored 'General case' 0 CA--C 1.529 0.152 0 O-C-N 121.859 -0.526 . . . . 0.0 111.009 176.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -90.5 -17.42 27.1 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 118.062 0.392 . . . . 0.0 111.965 175.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -100.37 -28.3 13.02 Favored 'General case' 0 C--N 1.342 0.253 0 CA-C-N 118.719 0.691 . . . . 0.0 112.777 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -99.37 -9.17 23.84 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.62 0.646 . . . . 0.0 111.592 -178.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -141.7 -44.59 0.35 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-N 118.03 0.377 . . . . 0.0 111.102 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 70.3 162.11 3.85 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 86.55 13.17 68.17 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 176.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 222' ' ' PHE . 10.7 p -88.46 164.61 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 124.164 0.986 . . . . 0.0 109.3 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 41.7 t -139.84 -62.16 0.52 Allowed 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.067 -0.395 . . . . 0.0 111.356 178.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -108.32 151.07 26.48 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.128 0.49 . . . . 0.0 112.24 -172.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.433 ' CB ' ' HB2' ' A' ' 190' ' ' ALA . . . -152.36 163.64 39.07 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.434 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 175.04 -179.06 46.56 Favored Glycine 0 N--CA 1.45 -0.428 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 176.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 41.3 mm -92.34 138.08 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -59.22 118.57 6.07 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 24.9 p -144.73 153.59 41.85 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -116.95 130.32 24.68 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -78.68 -11.51 15.43 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 124.529 3.486 . . . . 0.0 112.393 -176.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -101.32 -9.91 20.76 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.645 0.378 . . . . 0.0 111.335 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -118.23 -3.59 11.02 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.557 0.743 . . . . 0.0 109.477 171.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt 49.35 36.64 10.03 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.924 0.89 . . . . 0.0 112.377 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.21 162.16 51.44 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -174.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -90.66 -179.07 1.52 Allowed 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 124.502 3.468 . . . . 0.0 111.388 -177.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 6.0 tppt? -121.97 7.43 9.82 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.263 0.625 . . . . 0.0 111.339 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 69.01 13.48 66.77 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.92 -0.378 . . . . 0.0 112.851 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -146.54 164.54 32.24 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 117.503 0.651 . . . . 0.0 110.241 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -103.11 165.14 15.89 Favored Glycine 0 CA--C 1.527 0.832 0 CA-C-O 121.003 0.224 . . . . 0.0 112.941 -174.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 24.7 ptt180 -145.6 145.86 31.14 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 176.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 94.7 t -138.72 147.32 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 -178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.11 145.19 51.23 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.251 0.548 . . . . 0.0 111.344 -177.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 200' ' ' VAL . 9.9 m-85 -120.07 161.95 20.11 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.369 -175.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 92.0 p -98.48 8.59 44.68 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -131.02 140.45 50.1 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.831 0.453 . . . . 0.0 110.213 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -75.06 -19.03 60.18 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.8 tp60 -80.61 -38.21 29.73 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 25.1 m -75.77 -25.38 56.41 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -67.36 -50.34 60.26 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 176.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -73.66 -11.12 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 CA-C-N 117.969 0.349 . . . . 0.0 111.176 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -87.63 -21.26 25.41 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 119.722 -0.18 . . . . 0.0 110.808 174.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -87.5 -27.3 22.73 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.965 0.348 . . . . 0.0 111.868 -179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 8.4 pt -105.38 28.75 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.162 0.585 . . . . 0.0 110.262 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 93.2 p -74.99 -17.0 60.6 Favored 'General case' 0 C--N 1.334 -0.079 0 C-N-CA 123.406 0.682 . . . . 0.0 112.112 -176.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -156.96 145.01 19.35 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -176.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -59.72 -30.56 68.9 Favored 'General case' 0 C--N 1.339 0.109 0 C-N-CA 122.406 0.282 . . . . 0.0 111.324 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -122.61 121.73 37.14 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 29.6 m -111.93 160.54 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.412 179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -86.76 144.94 26.84 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.971 0.415 . . . . 0.0 110.138 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.4 mp -132.86 104.07 6.4 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 173.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -130.64 149.69 52.18 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.193 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -146.9 20.41 1.27 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.149 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.61 129.46 2.96 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -173.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 53.89 16.7 1.13 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.28 1.032 . . . . 0.0 113.121 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 76.2 mt -139.99 146.22 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 123.789 0.836 . . . . 0.0 109.601 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -156.32 129.61 8.12 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -148.55 162.27 39.99 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 123.493 0.717 . . . . 0.0 110.981 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -127.84 155.93 43.34 Favored 'General case' 0 C--N 1.338 0.068 0 C-N-CA 124.001 0.92 . . . . 0.0 109.388 176.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.4 p -156.8 156.72 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -86.06 138.76 31.71 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -125.19 158.94 32.89 Favored 'Isoleucine or valine' 0 C--N 1.338 0.103 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.457 ' HG3' ' H61' ' B' ' 5' ' ' ' A' . 0.0 OUTLIER -160.63 161.86 24.13 Favored Pre-proline 0 N--CA 1.455 -0.197 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.338 169.412 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -57.93 132.63 50.82 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.589 2.193 . . . . 0.0 108.861 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . 0.4 ' CD1' ' HB2' ' A' ' 176' ' ' PHE . 3.2 t80 -78.11 167.49 21.34 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.242 -177.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 33.8 m -119.71 162.73 17.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 123.748 0.819 . . . . 0.0 111.106 -172.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 C--O 1.251 1.135 0 CA-C-O 117.209 -1.377 . . . . 0.0 108.998 -179.871 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.729 ' C6 ' ' HE2' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.422 -2.553 0 O4'-C1'-N19 112.183 3.983 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.665 1 O4'-C1'-N19 112.412 4.212 . 0.71 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.434 ' C6 ' ' CE2' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.416 -3.046 0 O4'-C1'-N19 111.635 3.435 . 0.413 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.43 " C4'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.418 -2.89 0 O5'-C5'-C4' 106.572 -2.592 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.457 ' H61' ' HG3' ' A' ' 251' ' ' LYS . . . . . . . . 0 O4'--C4' 1.411 -3.474 1 C5'-C4'-C3' 109.204 -4.197 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.4 m . . . . . 0 N--CA 1.475 0.822 0 CA-C-O 120.387 0.137 . . . . 0.0 110.802 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -131.8 7.24 4.39 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.125 0.57 . . . . 0.0 111.679 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 38.0 tp60 -147.59 152.42 37.9 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.133 0.573 . . . . 0.0 109.625 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -143.19 173.06 11.92 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.419 0.688 . . . . 0.0 110.707 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -159.87 5.1 0.11 Allowed Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.499 -0.612 . . . . 0.0 112.685 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 60.66 161.61 0.05 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.896 1.278 . . . . 0.0 112.823 -176.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -144.62 146.56 32.35 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 123.341 0.656 . . . . 0.0 109.905 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.1 t -138.81 153.28 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.83 0.852 . . . . 0.0 109.061 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -141.69 149.86 41.12 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.27 150.8 20.66 Favored 'General case' 0 CA--C 1.527 0.072 0 CA-C-O 121.075 0.465 . . . . 0.0 111.698 -177.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -154.6 164.33 38.88 Favored 'General case' 0 N--CA 1.457 -0.094 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.369 -174.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.9 t -96.0 165.51 12.22 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.584 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.89 11.01 2.88 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 174.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -123.33 139.79 53.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 p -155.59 151.08 10.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.79 -172.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -96.79 142.12 29.18 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 174.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.0 m -131.85 130.75 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 174.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -127.63 151.67 18.62 Favored Glycine 0 C--N 1.333 0.371 0 N-CA-C 112.052 -0.419 . . . . 0.0 112.052 -174.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 92.48 19.51 37.96 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 119.654 -0.526 . . . . 0.0 113.029 176.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.3 pp -80.93 153.3 72.49 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 118.556 1.178 . . . . 0.0 109.114 175.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.58 144.76 17.92 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.076 2.517 . . . . 0.0 112.46 -177.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -80.55 -4.65 13.05 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 124.057 3.172 . . . . 0.0 111.461 174.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -73.79 -6.3 46.13 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -176.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.404 HD12 ' C ' ' A' ' 76' ' ' ILE . 1.9 pp -141.68 -169.45 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.159 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -132.32 -170.62 2.46 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.918 0.487 . . . . 0.0 111.445 -177.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -46.46 -30.3 2.12 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.461 1.504 . . . . 0.0 113.003 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.19 -34.23 77.08 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.399 0.545 . . . . 0.0 112.267 -176.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.4 tm-20 -80.26 -40.68 26.49 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 122.068 -0.395 . . . . 0.0 110.308 -174.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.7 pp -76.75 -23.76 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.366 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 78.3 m -70.84 -30.79 67.3 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 173.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.79 -16.95 60.03 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 122.056 -0.402 . . . . 0.0 110.8 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 64.7 m -86.28 -24.22 26.03 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -117.88 -18.18 9.59 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -176.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -68.26 -8.92 43.61 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.283 0.947 . . . . 0.0 112.176 -174.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -67.48 -6.7 20.75 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.983 -0.448 . . . . 0.0 111.617 177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -111.98 -1.26 15.47 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 122.59 0.356 . . . . 0.0 111.545 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.41 165.73 11.43 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -68.17 137.31 40.14 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 123.368 2.712 . . . . 0.0 110.006 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.407 ' C ' HD12 ' A' ' 91' ' ' LEU . 3.3 pp -160.09 174.47 14.25 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.833 -174.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -147.17 174.7 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.087 178.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.9 p -131.63 159.41 43.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 CA-C-O 120.777 0.322 . . . . 0.0 111.019 -177.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -150.87 160.62 43.77 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.41 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.456 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 38.8 p90 -160.23 159.24 26.59 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 169.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.645 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 17.5 Cg_endo -75.97 -8.76 19.15 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.119 2.546 . . . . 0.0 109.71 -169.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.645 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 23.3 m-70 -102.08 11.42 38.41 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.472 1.109 . . . . 0.0 111.614 -177.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.9 tptm -53.51 159.05 1.58 Allowed 'General case' 0 C--N 1.343 0.317 0 C-N-CA 123.95 0.9 . . . . 0.0 113.11 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -136.43 168.51 19.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.086 0.955 . . . . 0.0 110.212 -178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -127.64 14.2 7.0 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.166 0.586 . . . . 0.0 111.187 -178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 24.5 m -78.8 36.42 0.27 Allowed 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.975 0.91 . . . . 0.0 111.861 -178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt 55.74 19.1 3.22 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.348 1.059 . . . . 0.0 112.276 -176.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.7 t -153.63 161.64 41.99 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.027 0.931 . . . . 0.0 108.873 178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -137.58 155.5 49.14 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 122.297 0.239 . . . . 0.0 110.425 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -156.09 126.75 3.47 Favored Pre-proline 0 N--CA 1.453 -0.324 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.68 159.92 41.76 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 123.838 3.026 . . . . 0.0 110.41 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.59 -28.73 44.74 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.273 2.649 . . . . 0.0 111.881 -178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 3.9 tmtm? -160.41 -54.23 0.05 Allowed 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.214 0.605 . . . . 0.0 109.532 176.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 176.16 34.77 0.05 OUTLIER Glycine 0 CA--C 1.525 0.684 0 C-N-CA 121.059 -0.591 . . . . 0.0 113.026 -176.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.511 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -143.59 147.36 34.27 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 118.035 0.918 . . . . 0.0 109.717 178.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.6 -177.26 6.24 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.077 0.551 . . . . 0.0 110.44 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.431 ' CE1' ' C4 ' ' B' ' 4' ' ' ' U' . 2.4 m-85 -133.6 129.62 37.21 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 -177.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 mp -92.16 145.62 24.36 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.568 0.699 . . . . 0.0 111.997 -177.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -115.21 136.2 53.36 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 175.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -128.51 177.91 6.67 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.442 0.697 . . . . 0.0 110.881 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -115.79 -32.28 5.52 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.079 0.552 . . . . 0.0 110.249 -177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -130.85 155.07 47.34 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 121.154 0.502 . . . . 0.0 111.523 -178.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -81.52 -14.23 57.16 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.671 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.0 m -79.53 -14.9 58.55 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.173 -0.329 . . . . 0.0 111.034 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 52.8 m -79.93 -39.55 30.06 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 122.324 -0.235 . . . . 0.0 111.022 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.83 -19.3 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.115 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -79.71 -33.12 41.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.8 -34.57 57.94 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.072 0.396 . . . . 0.0 111.114 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.0 pp -79.86 -19.92 47.19 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.425 -178.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 54.0 mt -92.66 -20.98 6.34 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 117.904 0.32 . . . . 0.0 111.328 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -95.43 -14.78 23.49 Favored 'General case' 0 CA--C 1.531 0.243 0 O-C-N 121.825 -0.547 . . . . 0.0 111.922 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -111.07 26.35 10.8 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.157 0.583 . . . . 0.0 111.418 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 16.7 p -130.73 -173.89 3.21 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-O 120.985 0.421 . . . . 0.0 111.771 -176.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.506 ' N ' HD12 ' A' ' 129' ' ' ILE . 2.0 mp -86.49 155.54 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -128.78 152.45 48.44 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -139.6 67.6 1.38 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.405 0.621 . . . . 0.0 110.411 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 51.88 14.74 0.33 Allowed 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 172.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 163.49 -14.16 0.1 Allowed Glycine 0 CA--C 1.525 0.698 0 CA-C-N 118.671 0.669 . . . . 0.0 112.807 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -131.58 169.63 15.85 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 117.597 0.698 . . . . 0.0 109.319 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -109.71 162.74 14.15 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.401 0.143 . . . . 0.0 110.879 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.445 ' CE1' ' HG2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -143.31 136.96 28.46 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.562 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 9.3 mp -125.08 132.51 53.14 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 175.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 25.0 p -81.51 131.77 35.29 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.944 0.402 . . . . 0.0 112.036 -175.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.0 m -153.25 173.58 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 125.298 1.439 . . . . 0.0 108.23 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 27.9 t -146.25 132.65 19.63 Favored 'General case' 0 CA--C 1.529 0.168 0 O-C-N 121.956 -0.465 . . . . 0.0 111.963 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.469 ' H ' ' HB ' ' A' ' 144' ' ' ILE . 15.1 m -158.65 172.69 5.81 Favored Pre-proline 0 CA--C 1.535 0.381 0 C-N-CA 125.996 1.718 . . . . 0.0 107.969 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.423 ' CD ' ' HB3' ' A' ' 141' ' ' SER . 62.2 Cg_exo -53.71 -40.31 80.26 Favored 'Trans proline' 0 CA--C 1.534 0.518 0 C-N-CA 123.623 2.882 . . . . 0.0 115.7 -172.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 97.8 m -91.82 -13.32 31.62 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.053 0.842 . . . . 0.0 110.816 178.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.497 ' CD1' ' HE3' ' A' ' 147' ' ' LYS . 37.5 mm -86.79 -37.6 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 122.769 0.428 . . . . 0.0 110.661 -171.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 59.0 mttm 46.07 51.6 10.82 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.613 0.365 . . . . 0.0 111.537 177.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 64.31 17.61 10.84 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.497 ' HE3' ' CD1' ' A' ' 144' ' ' ILE . 18.4 pttp -82.56 154.47 68.59 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 119.206 0.912 . . . . 0.0 109.749 174.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.445 ' HG2' ' CE1' ' A' ' 136' ' ' TYR . 90.0 Cg_endo -76.97 161.4 32.99 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.91 2.407 . . . . 0.0 112.625 172.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.6 m -114.7 151.45 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 10.1 tm0? -98.13 149.96 21.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -169.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.3 mm -131.64 146.82 32.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 C-N-CA 124.762 1.225 . . . . 0.0 110.612 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 60.4 ttp85 -158.1 101.59 1.75 Allowed Pre-proline 0 CA--C 1.536 0.433 0 C-N-CA 122.653 0.381 . . . . 0.0 110.275 172.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -61.58 170.79 5.13 Favored 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 124.594 3.529 . . . . 0.0 114.334 178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -95.3 159.73 14.87 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.499 175.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.411 ' C ' HD12 ' A' ' 156' ' ' LEU . 10.0 p30 -102.03 158.67 15.99 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.036 0.534 . . . . 0.0 112.013 -176.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.411 HD12 ' C ' ' A' ' 155' ' ' ASN . 8.3 mp -108.15 36.4 2.8 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.688 0.795 . . . . 0.0 111.562 -178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.6 t -137.15 -24.53 1.09 Allowed 'General case' 0 C--N 1.34 0.158 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -174.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -136.26 35.98 2.76 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.649 1.113 . . . . 0.0 113.53 -173.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 45.6 m -74.02 -23.64 59.45 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.951 -0.468 . . . . 0.0 112.198 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -155.35 161.73 40.99 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 117.98 0.354 . . . . 0.0 111.395 -178.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -155.72 153.62 30.22 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.021 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 7.4 m -140.3 155.91 23.85 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.123 0 CA-C-O 121.249 0.547 . . . . 0.0 112.001 178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 70.5 mtm -137.53 27.57 2.78 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.244 178.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -155.0 171.66 19.38 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 -174.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -73.27 24.74 0.88 Allowed Glycine 0 CA--C 1.53 1.03 0 C-N-CA 123.509 0.576 . . . . 0.0 112.411 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 31.6 m 56.07 46.93 20.72 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 117.451 0.626 . . . . 0.0 112.431 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -61.1 157.79 39.91 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -53.31 148.76 31.58 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.776 2.984 . . . . 0.0 112.684 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 53.9 mt -118.06 163.34 16.76 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.623 0.769 . . . . 0.0 110.049 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -148.7 141.44 15.27 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.49 -22.01 48.73 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 123.438 2.759 . . . . 0.0 114.164 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -89.21 5.24 45.68 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.302 0.501 . . . . 0.0 110.948 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -130.06 18.42 5.52 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.877 0.471 . . . . 0.0 110.618 175.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 18.8 m -127.83 143.05 51.13 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 120.727 0.299 . . . . 0.0 110.851 -176.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.8 tt -116.89 149.71 19.07 Favored 'Isoleucine or valine' 0 C--O 1.231 0.108 0 C-N-CA 123.152 0.581 . . . . 0.0 110.795 -174.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.449 ' CD1' ' CE1' ' A' ' 253' ' ' TYR . 8.4 t80 -106.74 144.46 33.36 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 172.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 62.1 t -133.83 122.05 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -131.12 153.1 20.2 Favored Glycine 0 C--N 1.337 0.596 0 C-N-CA 121.832 -0.223 . . . . 0.0 112.686 -176.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.81 39.53 4.61 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -171.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 26.9 m -118.1 54.72 1.97 Allowed Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -72.03 -11.63 27.44 Favored 'Trans proline' 0 N--CA 1.455 -0.744 0 C-N-CA 122.71 2.273 . . . . 0.0 112.061 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.656 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 0.0 OUTLIER -139.7 -37.75 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.443 0 N-CA-C 114.532 1.308 . . . . 0.0 114.532 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.656 ' HD2' ' H ' ' A' ' 182' ' ' ARG . 38.9 Cg_endo -83.57 22.16 0.96 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 122.807 2.338 . . . . 0.0 112.867 -177.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.607 ' H ' HD23 ' A' ' 184' ' ' LEU . 1.6 pt? -80.61 -138.87 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.037 0.535 . . . . 0.0 112.062 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.428 ' H ' ' HG ' ' A' ' 184' ' ' LEU . 45.3 ttm-85 71.2 126.42 0.03 OUTLIER 'General case' 0 C--N 1.338 0.103 0 C-N-CA 125.881 1.672 . . . . 0.0 110.551 -172.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.57 -28.5 69.68 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 64.2 t -68.7 -48.07 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.126 0 CA-C-N 117.921 0.328 . . . . 0.0 110.757 -179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -77.96 -31.12 50.68 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.218 -0.289 . . . . 0.0 110.218 -175.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 58.6 tp -73.14 -33.87 65.77 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 122.401 0.28 . . . . 0.0 110.37 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -75.27 -37.36 60.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.078 -0.389 . . . . 0.0 111.413 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 26.2 mmt -69.4 -40.59 77.27 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -177.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.5 mt -65.15 -36.95 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.101 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.2 mmt -73.05 -18.89 61.28 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.109 -0.37 . . . . 0.0 111.219 -179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -93.08 -13.52 28.45 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.436 0.562 . . . . 0.0 112.124 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -93.45 -19.66 21.06 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 118.392 0.542 . . . . 0.0 111.897 176.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.6 -19.14 10.7 Favored 'General case' 0 C--N 1.338 0.083 0 CA-C-N 118.273 0.488 . . . . 0.0 111.482 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -140.4 42.56 1.9 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -177.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.15 137.5 3.8 Favored Glycine 0 C--N 1.338 0.679 0 C-N-CA 123.71 0.672 . . . . 0.0 112.331 -176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 124.85 9.81 5.09 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.891 -0.884 . . . . 0.0 110.891 -175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 58.5 t -69.61 144.78 13.63 Favored 'Isoleucine or valine' 0 C--O 1.232 0.173 0 CA-C-N 117.47 0.635 . . . . 0.0 110.345 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 15.2 p -120.22 -32.62 4.1 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 122.124 0.169 . . . . 0.0 111.196 175.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 50.1 t80 -146.29 142.05 27.93 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -148.58 157.75 43.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 170.62 -167.27 40.43 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.43 177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 43.5 mm -97.1 139.94 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -58.03 122.41 12.98 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.385 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.7 t -155.38 149.04 25.25 Favored 'General case' 0 C--O 1.231 0.128 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 175.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -119.49 139.8 28.33 Favored Pre-proline 0 N--CA 1.455 -0.186 0 C-N-CA 122.726 0.41 . . . . 0.0 110.208 -178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -77.4 -8.58 17.34 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 124.223 3.282 . . . . 0.0 112.498 -176.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -70.6 -22.4 62.56 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.44 0.564 . . . . 0.0 111.116 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 89.5 mt -140.38 5.87 2.08 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.146 0.978 . . . . 0.0 110.095 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt 49.22 40.46 18.01 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.896 1.279 . . . . 0.0 112.522 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -125.19 139.04 32.82 Favored Pre-proline 0 C--O 1.231 0.119 0 N-CA-C 111.523 0.194 . . . . 0.0 111.523 -175.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.56 166.52 23.84 Favored 'Trans proline' 0 N--CA 1.447 -1.253 0 C-N-CA 122.719 2.28 . . . . 0.0 111.383 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.503 ' HA ' ' C4 ' ' B' ' 4' ' ' ' U' . 33.5 mtmm -120.27 24.2 10.53 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.538 0.57 . . . . 0.0 112.538 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 64.5 15.89 60.01 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 119.605 -0.553 . . . . 0.0 114.109 170.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -131.01 161.94 30.87 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 117.877 0.838 . . . . 0.0 110.128 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -100.63 159.09 19.19 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 112.174 -0.37 . . . . 0.0 112.174 -177.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -153.63 148.51 26.56 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 174.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 3.9 p -150.2 148.06 15.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -126.28 147.7 49.65 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.109 0.564 . . . . 0.0 110.186 -177.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -119.41 155.29 32.26 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.183 -174.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 57.6 m -83.19 1.56 40.01 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.21 172.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -135.9 131.11 34.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.102 0.561 . . . . 0.0 110.192 -178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -73.2 -12.34 60.84 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.4 tp60 -76.24 -38.42 56.35 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 42.1 m -74.19 -30.29 62.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 16.6 t80 -64.3 -52.11 60.13 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 119.643 -0.217 . . . . 0.0 110.586 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.39 -14.65 17.94 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 CA-C-N 118.248 0.476 . . . . 0.0 111.355 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.39 -21.86 32.91 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 117.78 0.263 . . . . 0.0 110.382 176.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -93.21 -8.3 42.75 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.232 0.827 . . . . 0.0 113.232 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 3.5 pt -125.16 40.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 118.781 0.718 . . . . 0.0 111.572 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 32.4 m -131.14 3.99 4.38 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -129.57 10.83 5.69 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 45.39 -89.61 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 -177.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -83.64 90.34 7.26 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.482 HG23 ' CD1' ' A' ' 239' ' ' LEU . 3.8 m -81.94 140.9 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.684 -179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.449 ' HA ' ' HD3' ' A' ' 247' ' ' ARG . 34.4 mt-30 -78.31 -12.71 60.02 Favored 'General case' 0 N--CA 1.462 0.144 0 C-N-CA 124.109 0.964 . . . . 0.0 112.791 -174.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.482 ' CD1' HG23 ' A' ' 237' ' ' VAL . 10.3 mp 55.94 -77.13 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.947 0.899 . . . . 0.0 112.7 -175.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 58.49 132.09 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.172 1.789 . . . . 0.0 114.374 -177.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . 0.424 ' H ' HG22 ' A' ' 244' ' ' ILE . 7.4 t60 -160.83 129.17 4.53 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 58.79 34.74 78.94 Favored Glycine 0 CA--C 1.531 1.035 0 N-CA-C 110.448 -1.061 . . . . 0.0 110.448 -177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 64.35 17.9 11.02 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.033 1.333 . . . . 0.0 113.876 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.424 HG22 ' H ' ' A' ' 241' ' ' HIS . 3.9 tt -83.79 177.71 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 173.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -145.46 139.42 26.84 Favored 'General case' 0 C--O 1.23 0.078 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -142.58 174.09 10.95 Favored 'General case' 0 CA--C 1.521 -0.145 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . 0.449 ' HD3' ' HA ' ' A' ' 238' ' ' GLN . 0.5 OUTLIER -146.73 144.91 29.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.175 0.443 . . . . 0.0 110.631 173.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 14.8 p -158.91 154.6 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -93.31 144.51 25.25 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.357 0.263 . . . . 0.0 110.374 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 13.6 m -126.63 157.97 37.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-O 120.837 0.351 . . . . 0.0 111.123 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.95 162.28 24.77 Favored Pre-proline 0 N--CA 1.455 -0.225 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 173.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -56.57 133.38 57.64 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.733 2.289 . . . . 0.0 108.897 173.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . 0.449 ' CE1' ' CD1' ' A' ' 176' ' ' PHE . 2.0 t80 -75.5 166.88 22.91 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.927 -178.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 33.0 m -119.89 163.94 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 C-N-CA 123.934 0.894 . . . . 0.0 110.961 -171.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 2.1 tm? . . . . . 0 C--O 1.251 1.173 0 CA-C-O 117.582 -1.199 . . . . 0.0 109.093 179.903 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.417 -3.027 1 C5'-C4'-C3' 108.148 -4.901 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.915 2 C3'-C2'-C1' 105.809 4.788 OUTLIER-DELTA 0.06 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.511 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.72 2 O4'-C1'-N19 113.677 5.477 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.503 ' C4 ' ' HA ' ' A' ' 215' ' ' LYS . . . . . . . . 0 O4'--C4' 1.419 -2.85 1 C5'-C4'-C3' 108.999 -4.334 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.468 " H4'" ' HB2' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.41 -3.618 0 C5'-C4'-C3' 110.363 -3.425 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 25.4 t . . . . . 0 N--CA 1.474 0.773 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.459 ' CG ' ' H ' ' A' ' 55' ' ' GLN . 9.5 t60 57.78 178.46 0.06 Allowed 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.502 1.121 . . . . 0.0 112.293 -177.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.459 ' H ' ' CG ' ' A' ' 54' ' ' HIS . 21.7 pt20 -144.97 165.23 28.76 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.034 0.533 . . . . 0.0 110.759 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -107.92 19.08 20.5 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.338 0.655 . . . . 0.0 110.948 -178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 76.65 4.91 82.38 Favored Glycine 0 CA--C 1.528 0.844 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 53.86 20.98 2.55 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.578 1.151 . . . . 0.0 113.11 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -145.94 144.92 30.46 Favored 'General case' 0 C--N 1.338 0.097 0 C-N-CA 123.236 0.614 . . . . 0.0 109.408 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.6 p -145.45 160.92 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.137 0 C-N-CA 123.217 0.607 . . . . 0.0 110.188 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -133.3 153.05 51.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.449 ' HD3' ' H ' ' A' ' 63' ' ' TYR . 14.4 tpp180 -118.22 154.02 32.92 Favored 'General case' 0 N--CA 1.457 -0.111 0 C-N-CA 122.527 0.331 . . . . 0.0 110.623 -176.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.449 ' H ' ' HD3' ' A' ' 62' ' ' ARG . 8.1 m-85 -117.84 -173.87 2.52 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.396 -174.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 29.1 t -123.66 166.03 16.2 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.265 175.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 41.7 ptt85 -77.67 37.28 0.22 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.772 0.829 . . . . 0.0 112.096 -177.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 pttm -138.91 135.58 34.59 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.143 0.977 . . . . 0.0 110.473 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.3 m -146.64 158.66 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.519 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.449 ' CZ ' ' C6 ' ' B' ' 3' ' ' ' U' . 5.1 t80 -91.8 140.43 29.7 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 169.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.2 p -127.6 125.37 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -118.95 148.82 18.3 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 114.562 0.585 . . . . 0.0 114.562 -169.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.07 108.99 0.04 OUTLIER Glycine 0 CA--C 1.524 0.646 0 C-N-CA 125.793 1.663 . . . . 0.0 114.369 169.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.2 mt -141.59 145.74 38.71 Favored Pre-proline 0 N--CA 1.454 -0.231 0 C-N-CA 123.881 0.872 . . . . 0.0 108.675 172.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -76.78 172.65 15.82 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.702 2.935 . . . . 0.0 110.098 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.9 172.95 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.026 3.151 . . . . 0.0 113.103 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.2 t70 61.18 -91.81 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 34.2 pt -56.12 132.28 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-O 121.886 0.85 . . . . 0.0 112.121 -176.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -170.2 155.95 5.61 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 124.644 1.178 . . . . 0.0 108.003 176.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 61.65 -51.62 0.13 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.749 1.62 . . . . 0.0 114.046 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -80.87 -35.18 33.03 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.05 0.841 . . . . 0.0 111.567 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.3 tm-20 -76.02 -28.31 57.69 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 122.282 -0.261 . . . . 0.0 110.769 -174.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.6 pt -81.99 -27.17 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.09 0 O-C-N 121.978 -0.451 . . . . 0.0 110.067 173.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.413 ' HA ' HD21 ' A' ' 91' ' ' LEU . 94.4 m -72.8 -12.45 61.0 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.09 -19.53 16.45 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 173.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.9 m -76.78 -34.74 57.99 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.546 0.612 . . . . 0.0 111.921 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -105.41 7.07 33.04 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -65.18 -18.03 64.97 Favored 'General case' 0 CA--C 1.526 0.037 0 C-N-CA 122.767 0.427 . . . . 0.0 110.946 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -69.71 -12.21 61.45 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 123.362 0.665 . . . . 0.0 110.877 176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -111.98 16.62 20.22 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.951 0.5 . . . . 0.0 109.939 178.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.51 163.12 30.41 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -175.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.63 148.57 63.7 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.63 2.887 . . . . 0.0 112.37 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.484 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -147.92 169.17 20.43 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.615 0.366 . . . . 0.0 111.048 179.128 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.2 pt -137.55 175.38 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.738 -179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.9 p -152.51 156.26 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 O-C-N 122.369 -0.207 . . . . 0.0 110.758 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -155.79 172.19 18.75 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.923 0.392 . . . . 0.0 111.127 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 34.4 p90 -160.14 162.65 23.76 Favored Pre-proline 0 CA--C 1.534 0.354 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.478 ' HB2' " H4'" ' B' ' 5' ' ' ' A' . 68.1 Cg_endo -71.12 -16.96 31.88 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 CA-C-N 121.334 1.512 . . . . 0.0 110.468 -171.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.468 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 2.1 m-70 -88.38 1.34 54.87 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.848 0.859 . . . . 0.0 111.137 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.498 ' HA ' ' HE3' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -63.51 -29.11 70.43 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.718 0.807 . . . . 0.0 111.128 -176.064 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 50.0 27.03 2.26 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.883 0.873 . . . . 0.0 112.894 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 53.17 23.96 3.38 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.707 0.803 . . . . 0.0 112.116 -176.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.7 t -101.72 165.84 11.0 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.785 0.834 . . . . 0.0 111.17 -177.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.656 ' HA ' ' HE2' ' A' ' 102' ' ' LYS . 0.6 OUTLIER -86.83 4.69 40.11 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.692 0.797 . . . . 0.0 110.709 -179.421 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 80.0 p -58.89 162.82 3.84 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.689 0.795 . . . . 0.0 111.935 -178.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -126.25 166.58 16.84 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.219 0.607 . . . . 0.0 111.502 -177.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.432 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 60.9 t80 56.18 102.33 0.03 OUTLIER Pre-proline 0 CA--C 1.532 0.277 0 C-N-CA 126.975 2.11 . . . . 0.0 113.679 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 105' ' ' PHE . 69.9 Cg_endo -70.75 167.6 25.26 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.58 2.853 . . . . 0.0 109.467 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -45.36 -25.96 2.34 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 124.835 3.69 . . . . 0.0 116.486 -172.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.501 ' HB3' ' CE2' ' A' ' 110' ' ' TYR . 3.6 tmtm? -151.26 22.37 0.74 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.396 0.998 . . . . 0.0 112.144 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.54 2.17 87.51 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-O 118.604 -1.109 . . . . 0.0 115.61 172.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.517 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -88.71 151.48 22.4 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 120.22 2.01 . . . . 0.0 108.906 174.503 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.68 -175.66 5.46 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.66 0.267 . . . . 0.0 110.964 -177.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -132.19 118.57 19.72 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.8 tt -100.47 139.71 35.77 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.192 0.52 . . . . 0.0 111.515 -168.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.6 mp -119.9 153.46 35.85 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.976 -172.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -139.79 -176.26 4.51 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.359 1.064 . . . . 0.0 109.702 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 12.8 mp0 -111.29 -26.66 9.04 Favored 'General case' 0 C--N 1.339 0.12 0 C-N-CA 122.634 0.373 . . . . 0.0 110.906 -176.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -140.63 161.71 37.11 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 122.5 0.32 . . . . 0.0 111.293 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -79.09 -13.41 59.77 Favored 'General case' 0 CA--C 1.528 0.124 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.424 179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 65.5 p -75.04 -22.48 58.4 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 118.127 0.421 . . . . 0.0 110.523 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 57.0 m -79.25 -40.67 30.02 Favored 'General case' 0 N--CA 1.453 -0.305 0 O-C-N 122.49 -0.131 . . . . 0.0 110.935 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.9 m -73.36 -20.21 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 175.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -72.64 -37.68 67.94 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.66 -32.48 62.25 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 119.329 -0.367 . . . . 0.0 111.735 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -82.07 -14.27 56.09 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.689 0.677 . . . . 0.0 111.933 -178.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 94.6 mt -95.93 -20.9 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 122.008 -0.432 . . . . 0.0 110.258 176.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -101.84 -8.7 21.4 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -120.86 9.98 10.79 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 34.7 m -125.94 -178.53 4.32 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.191 0.596 . . . . 0.0 109.643 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.405 ' HB ' ' HB2' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -80.17 163.53 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 O-C-N 121.737 -0.602 . . . . 0.0 111.32 -170.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -143.44 157.62 44.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.541 176.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -146.84 173.29 12.53 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -63.76 3.94 0.32 Allowed 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -171.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -148.22 -9.36 0.19 Allowed Glycine 0 CA--C 1.529 0.935 0 CA-C-O 119.016 -0.88 . . . . 0.0 114.224 178.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.42 ' HE2' ' CE2' ' A' ' 136' ' ' TYR . 24.8 pttm -167.14 -171.33 1.73 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 118.79 1.295 . . . . 0.0 110.963 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 77.7 mt -123.28 170.22 10.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.077 0.951 . . . . 0.0 110.171 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.42 ' CE2' ' HE2' ' A' ' 134' ' ' LYS . 22.4 m-85 -150.64 165.05 34.56 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.992 0.425 . . . . 0.0 111.65 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 21.9 tp -141.37 134.61 29.43 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 167.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.2 p -78.21 141.42 38.62 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.1 m -141.05 162.77 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 C-N-CA 122.882 0.473 . . . . 0.0 110.419 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 40.1 m -86.14 10.45 14.44 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.007 0.523 . . . . 0.0 110.978 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 47.0 t -67.08 118.87 59.81 Favored Pre-proline 0 N--CA 1.454 -0.271 0 C-N-CA 123.658 0.783 . . . . 0.0 110.478 -178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -79.83 113.02 2.97 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.4 2.733 . . . . 0.0 110.799 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.601 ' C ' ' H ' ' A' ' 145' ' ' LYS . 25.8 m -117.89 63.94 0.75 Allowed 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 178.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.3 mp 64.38 -22.22 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 125.185 1.394 . . . . 0.0 110.889 -171.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.601 ' H ' ' C ' ' A' ' 143' ' ' THR . 39.2 ttpt -156.66 159.23 38.23 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 127.248 2.219 . . . . 0.0 106.025 169.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -65.58 139.83 58.48 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.68 0.673 . . . . 0.0 110.426 -179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -151.35 157.3 35.03 Favored Pre-proline 0 CA--C 1.529 0.153 0 C-N-CA 122.341 0.257 . . . . 0.0 111.203 179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -79.41 163.29 24.69 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.808 3.005 . . . . 0.0 111.308 171.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 22.9 m -107.64 150.88 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.105 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 175.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -85.84 153.02 22.54 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 117.616 0.189 . . . . 0.0 111.081 -174.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 25.8 mm -137.63 143.27 34.31 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.802 0.841 . . . . 0.0 110.075 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -155.55 101.67 2.2 Favored Pre-proline 0 CA--C 1.533 0.299 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 176.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -77.01 164.15 30.02 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.861 3.041 . . . . 0.0 112.218 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 30.9 t-105 -97.99 150.01 21.83 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 171.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 46.2 p-10 -117.05 155.9 28.44 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 121.524 0.678 . . . . 0.0 111.955 -176.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 7.3 mp -94.95 74.74 3.53 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.755 -175.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.2 t -141.35 -40.52 0.38 Allowed 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.926 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -153.68 135.87 14.84 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 22.6 m -149.29 -30.15 0.25 Allowed 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 122.252 0.221 . . . . 0.0 111.286 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -151.42 160.03 43.94 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 123.622 0.769 . . . . 0.0 109.815 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -149.85 158.55 44.28 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.5 t -130.63 138.4 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.085 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 51.6 tpp -100.34 -10.47 21.21 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 112.08 0.4 . . . . 0.0 112.08 -174.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -158.62 -47.39 0.06 Allowed 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.833 -0.542 . . . . 0.0 110.628 -177.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.66 4.98 62.88 Favored Glycine 0 CA--C 1.53 1.01 0 CA-C-O 119.227 -0.763 . . . . 0.0 114.412 174.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.6 t -129.71 -13.8 4.16 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 118.726 1.263 . . . . 0.0 112.092 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -87.09 159.73 50.57 Favored Pre-proline 0 CA--C 1.533 0.294 0 O-C-N 122.066 -0.396 . . . . 0.0 110.464 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.65 163.59 6.84 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 124.278 3.318 . . . . 0.0 113.792 -177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -141.25 128.76 21.32 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -148.4 124.96 5.39 Favored Pre-proline 0 CA--C 1.53 0.204 0 CA-C-O 119.305 -0.379 . . . . 0.0 110.0 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -55.11 -20.17 23.08 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.617 2.878 . . . . 0.0 113.599 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -81.03 -3.25 51.18 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 118.123 0.419 . . . . 0.0 111.04 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 7.9 mptt -127.01 28.7 5.74 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 51.3 m -121.08 145.22 48.03 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 -178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.9 tt -115.9 149.52 18.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 C-N-CA 123.085 0.554 . . . . 0.0 110.154 -176.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.483 ' HB2' ' CD1' ' A' ' 253' ' ' TYR . 6.8 t80 -108.4 143.99 36.58 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 97.2 t -137.78 124.2 27.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 -175.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -132.53 162.6 24.09 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 112.413 -0.275 . . . . 0.0 112.413 -178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 88.62 16.26 58.75 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -172.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.9 m -71.47 152.3 93.95 Favored Pre-proline 0 N--CA 1.456 -0.174 0 C-N-CA 122.706 0.402 . . . . 0.0 111.563 -178.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -76.83 171.81 17.33 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 124.001 3.134 . . . . 0.0 109.965 173.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 48.5 tpt85 -73.51 -48.35 7.01 Favored Pre-proline 0 CA--C 1.533 0.316 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -80.02 32.38 0.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.417 2.745 . . . . 0.0 112.634 178.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -61.37 -33.08 73.05 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 118.537 0.608 . . . . 0.0 112.319 -176.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 54.23 122.01 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.704 2.002 . . . . 0.0 113.941 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.25 -29.06 70.17 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 121.777 -0.577 . . . . 0.0 111.783 -177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 65.7 t -68.36 -48.35 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 C-N-CA 122.295 0.238 . . . . 0.0 111.167 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -82.89 -20.87 34.64 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 116.9 -0.137 . . . . 0.0 110.923 -174.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 42.1 tp -71.51 -33.24 69.05 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 175.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.432 ' HB2' ' HB3' ' A' ' 203' ' ' ALA . . . -74.45 -37.07 63.36 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.324 -178.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 25.7 mmt -70.74 -34.04 71.45 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 62.4 mt -68.91 -37.31 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -71.58 -21.95 61.8 Favored 'General case' 0 N--CA 1.457 -0.106 0 O-C-N 121.856 -0.528 . . . . 0.0 110.339 177.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -86.7 -13.28 45.86 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 122.115 -0.366 . . . . 0.0 111.526 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -98.62 -21.21 16.58 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 177.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -108.36 -13.5 14.86 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 118.55 0.613 . . . . 0.0 111.954 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -140.44 -34.77 0.52 Allowed 'General case' 0 N--CA 1.457 -0.11 0 CA-C-N 118.673 0.67 . . . . 0.0 112.367 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.33 -178.33 18.12 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 69.6 10.96 64.67 Favored Glycine 0 CA--C 1.529 0.911 0 CA-C-O 119.411 -0.661 . . . . 0.0 112.899 177.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 22.1 t -72.77 147.02 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 CA-C-N 118.248 1.024 . . . . 0.0 109.958 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.8 p -128.9 -24.97 2.86 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 119.625 -0.226 . . . . 0.0 111.455 175.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -150.46 149.98 30.71 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.007 0.367 . . . . 0.0 110.758 177.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 190' ' ' ALA . . . -160.92 156.38 24.84 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 122.92 0.488 . . . . 0.0 110.332 177.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 158.55 -165.22 33.89 Favored Glycine 0 C--N 1.335 0.485 0 N-CA-C 111.306 -0.718 . . . . 0.0 111.306 177.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 205' ' ' ILE . 3.1 mp -100.65 130.58 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 177.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -56.2 114.91 2.16 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 89.6 m -143.71 157.48 44.36 Favored 'General case' 0 N--CA 1.458 -0.075 0 O-C-N 123.441 0.463 . . . . 0.0 110.279 -172.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -135.85 132.51 19.46 Favored Pre-proline 0 N--CA 1.452 -0.369 0 C-N-CA 123.882 0.873 . . . . 0.0 108.916 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -80.86 -6.97 13.37 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 124.202 3.268 . . . . 0.0 114.558 -172.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -112.06 -41.02 4.05 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 119.993 1.27 . . . . 0.0 114.239 -172.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.5 pp -161.12 -15.88 0.05 OUTLIER 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 178.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -88.49 -26.51 22.02 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-N 119.759 1.163 . . . . 0.0 111.691 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.517 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 29.7 m-85 56.5 -178.7 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 123.83 0.852 . . . . 0.0 113.215 172.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.517 ' CD ' ' HB3' ' A' ' 213' ' ' TYR . 77.4 Cg_exo -54.26 153.16 22.81 Favored 'Trans proline' 0 N--CA 1.453 -0.856 0 C-N-CA 123.026 2.484 . . . . 0.0 112.864 -178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -104.61 5.7 33.93 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.918 0.887 . . . . 0.0 111.169 -178.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 66.81 10.67 55.97 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 112.19 -0.364 . . . . 0.0 112.19 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -141.39 149.2 40.77 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.262 0.625 . . . . 0.0 110.341 -177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -92.32 166.25 29.37 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.813 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -147.24 150.98 35.92 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 174.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 62.0 t -142.19 142.01 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.88 145.72 48.92 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -123.52 151.98 42.24 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.638 -176.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 54.4 m -84.25 2.8 38.3 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.075 176.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -137.82 138.13 38.86 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.955 0.502 . . . . 0.0 110.082 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -74.4 -14.9 60.92 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.4 tp60 -76.82 -38.44 53.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 31.7 m -75.16 -26.48 59.13 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 178.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -67.44 -50.33 59.79 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 119.545 -0.265 . . . . 0.0 110.37 176.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.5 pp -72.32 -12.66 15.99 Favored 'Isoleucine or valine' 0 C--N 1.339 0.116 0 CA-C-N 118.163 0.438 . . . . 0.0 111.158 -178.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.07 -23.55 28.5 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 174.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -85.94 -23.05 27.1 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 11.5 pt -106.6 25.25 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.165 0 C-N-CA 122.859 0.464 . . . . 0.0 110.311 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -79.64 -13.26 59.62 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.074 0.549 . . . . 0.0 112.033 -175.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -156.6 143.72 18.85 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -55.65 -36.07 66.64 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 122.692 0.397 . . . . 0.0 111.558 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -115.79 105.68 12.98 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 177.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 18.0 m -88.5 160.04 2.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.177 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.425 178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -84.97 139.85 31.5 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-O 120.802 0.334 . . . . 0.0 110.249 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.1 mp -132.49 104.2 6.57 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 172.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -137.67 153.0 49.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.371 -176.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -146.51 20.08 1.34 Allowed 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.187 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.29 130.17 3.01 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -174.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 52.85 17.82 0.94 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.425 1.09 . . . . 0.0 112.933 -177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 76.1 mt -140.52 149.33 21.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 C-N-CA 123.97 0.908 . . . . 0.0 109.296 -178.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -153.74 133.4 12.97 Favored 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 177.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -145.32 161.25 40.05 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 124.254 1.022 . . . . 0.0 109.025 179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.86 155.17 44.73 Favored 'General case' 0 N--CA 1.46 0.071 0 C-N-CA 123.361 0.664 . . . . 0.0 109.826 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.3 p -158.38 159.22 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 122.961 0.505 . . . . 0.0 109.981 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -83.68 141.35 31.55 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.112 0.565 . . . . 0.0 110.831 -178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.88 162.54 31.32 Favored 'Isoleucine or valine' 0 C--N 1.338 0.092 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.82 158.92 29.58 Favored Pre-proline 0 N--CA 1.455 -0.215 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.823 170.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -58.76 134.74 62.5 Favored 'Trans proline' 0 N--CA 1.451 -1.006 0 C-N-CA 122.461 2.108 . . . . 0.0 108.087 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . 0.483 ' CD1' ' HB2' ' A' ' 176' ' ' PHE . 0.7 OUTLIER -77.01 170.51 16.38 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 119.508 -0.877 . . . . 0.0 111.192 -175.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 32.9 m -125.51 163.58 26.37 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 123.669 0.788 . . . . 0.0 110.829 -170.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 3.9 tt . . . . . 0 C--O 1.251 1.157 0 CA-C-O 117.228 -1.368 . . . . 0.0 109.255 -179.825 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.418 -2.916 0 C5'-C4'-C3' 110.108 -3.595 . 0.0 '__' . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . 0.411 " H4'" ' CE1' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.416 -3.056 2 O4'-C1'-N19 113.123 4.923 OUTLIER-DELTA 0.165 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.517 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.709 1 O4'-C1'-N19 112.363 4.163 . 0.054 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.417 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.421 -2.705 0 O5'-C5'-C4' 106.03 -2.978 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.478 " H4'" ' HB2' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.415 -3.164 0 C5'-C4'-C3' 112.045 -2.303 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 N--CA 1.475 0.779 0 N-CA-C 110.522 -0.177 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -140.54 161.59 37.38 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.341 0.657 . . . . 0.0 110.402 -178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -78.01 159.93 28.46 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 122.537 0.335 . . . . 0.0 110.578 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -88.23 -4.62 58.69 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 122.514 0.325 . . . . 0.0 111.283 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.92 -175.24 46.3 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 178.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -136.05 165.95 24.5 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 123.077 0.551 . . . . 0.0 110.562 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.17 166.71 22.95 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.046 0.538 . . . . 0.0 111.664 -178.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 m 47.54 28.8 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 125.405 1.482 . . . . 0.0 113.473 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -65.68 147.68 52.99 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.64 154.09 21.93 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-O 120.767 0.317 . . . . 0.0 111.717 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -156.95 170.66 22.01 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.544 -176.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.1 t -95.89 165.45 12.27 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.401 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -84.72 9.44 13.99 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 122.836 0.454 . . . . 0.0 111.005 177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -128.83 141.46 51.29 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-O 121.14 0.495 . . . . 0.0 110.168 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.9 p -147.8 147.86 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.306 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.532 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 8.1 t80 -87.04 145.14 26.59 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.9 p -128.63 122.91 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 171.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -110.27 175.03 18.02 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-O 121.307 0.393 . . . . 0.0 112.175 -175.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 62.45 29.75 74.34 Favored Glycine 0 CA--C 1.526 0.763 0 CA-C-N 115.379 -0.41 . . . . 0.0 113.39 171.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 51.1 mt -69.15 142.44 92.85 Favored Pre-proline 0 N--CA 1.45 -0.462 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -74.11 174.88 11.69 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.233 2.622 . . . . 0.0 109.567 -179.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_exo -54.74 -9.38 1.79 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 124.742 3.628 . . . . 0.0 114.32 -178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 77' ' ' ASP . 9.9 m-20 -125.5 -123.46 0.25 Allowed 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER 63.55 -25.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -176.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 75' ' ' ASP . 4.2 p-10 39.26 -113.88 0.15 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.563 1.545 . . . . 0.0 113.114 174.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -127.27 -19.85 4.21 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.104 0.961 . . . . 0.0 110.487 -176.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -80.95 -46.58 14.93 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.845 -0.535 . . . . 0.0 112.036 -174.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -68.03 -34.05 75.75 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.631 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.7 pt -84.25 -29.87 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 O-C-N 122.052 -0.405 . . . . 0.0 111.21 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 97.2 m -70.71 -12.93 61.86 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 118.49 0.586 . . . . 0.0 109.42 175.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -104.91 -15.45 15.14 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.6 m -82.18 -36.68 27.09 Favored 'General case' 0 C--N 1.341 0.207 0 CA-C-N 119.025 0.83 . . . . 0.0 112.461 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -98.08 1.56 47.77 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.4 ttt85 -78.43 -4.91 50.72 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -174.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -77.03 -11.09 59.76 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.737 0.415 . . . . 0.0 111.762 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -108.03 -19.12 13.61 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.443 0.297 . . . . 0.0 110.629 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.92 161.0 10.93 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.45 140.18 93.57 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.387 2.725 . . . . 0.0 111.906 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.532 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -151.77 164.53 36.81 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 122.274 0.23 . . . . 0.0 111.582 178.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.403 HG22 ' N ' ' A' ' 93' ' ' VAL . 26.8 mm -134.48 164.08 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.403 ' N ' HG22 ' A' ' 92' ' ' ILE . 7.5 p -128.24 146.44 33.74 Favored 'Isoleucine or valine' 0 C--O 1.23 0.079 0 CA-C-N 118.324 0.511 . . . . 0.0 110.243 177.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -150.0 166.78 28.65 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.085 0.469 . . . . 0.0 110.781 -177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.479 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 17.1 p90 -148.4 160.37 36.78 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.651 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 69.6 Cg_endo -70.0 -8.94 24.86 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 124.467 3.445 . . . . 0.0 111.72 -170.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.651 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 60.2 m-70 -101.47 5.15 41.84 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.091 0.556 . . . . 0.0 112.16 -176.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.412 ' HG3' ' CD1' ' A' ' 95' ' ' TRP . 50.9 mtpt -70.17 161.22 30.66 Favored 'General case' 0 C--N 1.34 0.182 0 CA-C-O 121.659 0.742 . . . . 0.0 112.113 -177.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -101.04 36.31 2.0 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.829 1.251 . . . . 0.0 111.04 -175.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 59.21 14.3 3.5 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.74 0.816 . . . . 0.0 111.228 -173.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.6 t -155.54 173.91 16.02 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.764 1.226 . . . . 0.0 108.284 178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -64.06 150.98 44.26 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-O 120.77 0.319 . . . . 0.0 110.778 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 23.2 t -149.69 -8.19 0.32 Allowed 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.251 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 56.8 177.84 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.435 1.094 . . . . 0.0 112.716 -177.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 44.72 77.85 0.43 Allowed Pre-proline 0 CA--C 1.534 0.34 0 C-N-CA 124.815 1.246 . . . . 0.0 113.138 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -68.99 162.23 42.52 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 123.588 2.859 . . . . 0.0 110.583 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -47.83 128.82 16.69 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.342 3.361 . . . . 0.0 113.02 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.5 tmtm? 44.05 -83.42 0.0 OUTLIER 'General case' 0 C--N 1.34 0.177 0 C-N-CA 126.904 2.082 . . . . 0.0 112.629 -178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -165.82 34.75 0.24 Allowed Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -174.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.533 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -145.31 148.65 33.66 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 118.346 1.073 . . . . 0.0 110.149 176.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.45 -176.46 5.6 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 122.965 0.506 . . . . 0.0 110.606 -176.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -139.26 136.93 35.45 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -177.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -103.01 149.93 24.06 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -175.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 mp -111.23 143.01 42.67 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 171.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -130.62 162.87 28.39 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 121.202 0.525 . . . . 0.0 111.072 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -100.84 -32.3 10.74 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.693 -178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -113.53 151.51 31.47 Favored 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 111.906 0.335 . . . . 0.0 111.906 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 48.1 tt0 -88.65 -11.84 44.17 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.871 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 49.8 m -102.45 -7.02 22.29 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 122.932 0.493 . . . . 0.0 111.029 176.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 40.8 t -71.67 -35.14 70.22 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 19.0 m -73.71 -25.23 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -77.01 -29.5 55.42 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.405 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.5 -36.67 57.65 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 118.497 0.589 . . . . 0.0 110.899 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -76.72 -18.37 58.54 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.778 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.405 HG23 HD22 ' A' ' 135' ' ' LEU . 35.8 mt -91.97 -18.72 7.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 122.377 0.271 . . . . 0.0 111.203 177.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -100.98 -10.02 20.94 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 121.534 -0.728 . . . . 0.0 112.514 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.56 14.63 13.63 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 73.2 m -132.79 -171.38 2.65 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.959 0.345 . . . . 0.0 111.846 -175.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.46 ' N ' HD12 ' A' ' 129' ' ' ILE . 3.5 mp -74.97 154.67 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 124.296 1.038 . . . . 0.0 109.159 -171.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 135' ' ' LEU . 12.7 pt-20 -133.24 161.64 33.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.494 0.188 . . . . 0.0 111.178 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.46 177.41 9.07 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 177.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -46.36 -24.74 0.53 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -169.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -153.67 5.2 0.34 Allowed Glycine 0 CA--C 1.527 0.808 0 CA-C-N 119.184 0.902 . . . . 0.0 113.384 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.1 mppt? -146.06 -171.75 3.78 Favored 'General case' 0 C--N 1.34 0.162 0 CA-C-N 117.949 0.874 . . . . 0.0 109.127 -175.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.405 HD22 HG23 ' A' ' 125' ' ' ILE . 4.5 mp -134.89 166.54 22.77 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 122.376 -0.202 . . . . 0.0 111.116 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 149' ' ' VAL . 17.4 m-85 -138.1 156.45 47.76 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.155 -178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.2 mp -134.04 157.45 46.07 Favored 'General case' 0 C--N 1.339 0.127 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 170.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 73.5 m -100.28 135.11 42.21 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.182 0.447 . . . . 0.0 110.721 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.9 m -144.12 164.46 14.26 Favored 'Isoleucine or valine' 0 C--N 1.338 0.067 0 C-N-CA 123.694 0.798 . . . . 0.0 109.923 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.4 t -70.63 151.41 45.01 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 120.54 0.209 . . . . 0.0 110.559 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.3 t -156.02 139.05 10.77 Favored Pre-proline 0 N--CA 1.456 -0.151 0 C-N-CA 122.646 0.379 . . . . 0.0 110.408 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -79.13 -0.08 10.45 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 124.55 3.5 . . . . 0.0 114.046 176.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.443 ' HB ' HD13 ' A' ' 144' ' ' ILE . 49.2 m -93.97 -10.99 31.84 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.077 0.853 . . . . 0.0 108.998 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.443 HD13 ' HB ' ' A' ' 143' ' ' THR . 0.0 OUTLIER -154.97 -155.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 126.94 2.096 . . . . 0.0 106.668 -174.083 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -94.71 -36.94 11.52 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 169.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -162.07 154.63 19.76 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.896 1.279 . . . . 0.0 108.296 175.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.45 ' HD2' ' N1 ' ' B' ' 1' ' ' ' C' . 23.4 ttpp -143.5 138.6 15.56 Favored Pre-proline 0 CA--C 1.528 0.114 0 CA-C-N 118.171 0.441 . . . . 0.0 112.088 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 147' ' ' LYS . 46.8 Cg_exo -59.58 140.32 93.29 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.596 2.864 . . . . 0.0 111.678 169.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 136' ' ' TYR . 33.0 m -126.33 143.07 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -87.74 150.74 23.41 Favored 'General case' 0 CA--C 1.529 0.136 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -172.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.9 mm -129.24 143.45 41.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 124.807 1.243 . . . . 0.0 110.419 176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 47.8 ttp85 -159.13 97.68 1.65 Allowed Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -62.99 167.21 12.63 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 124.12 3.213 . . . . 0.0 113.497 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -87.2 147.37 25.62 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 172.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 37.4 p-10 -107.35 147.95 29.67 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.349 0.595 . . . . 0.0 111.743 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 156' ' ' LEU . 6.3 mp -98.42 93.54 6.23 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -177.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 47.1 t -158.18 -39.76 0.06 Allowed 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.475 ' CG ' ' HE ' ' A' ' 185' ' ' ARG . 16.0 m-20 -143.91 39.58 1.36 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -174.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.3 m -67.53 -19.41 65.29 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -155.83 160.03 39.88 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.303 0.641 . . . . 0.0 110.835 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -154.11 151.88 29.78 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 21.2 t -128.09 143.39 41.03 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.085 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . 0.466 ' SD ' ' HB1' ' A' ' 190' ' ' ALA . 90.0 mtp -129.41 3.19 5.1 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -175.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -156.17 -40.93 0.08 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 118.766 0.712 . . . . 0.0 112.322 178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 155.81 12.14 0.06 OUTLIER Glycine 0 CA--C 1.528 0.884 0 CA-C-O 119.428 -0.651 . . . . 0.0 112.886 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 46.0 m 54.59 56.4 6.83 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 117.981 0.89 . . . . 0.0 112.167 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -57.8 159.41 10.06 Favored Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -59.45 145.44 97.94 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.692 2.261 . . . . 0.0 109.72 176.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 72.0 mt -121.09 166.84 13.34 Favored 'General case' 0 C--O 1.231 0.097 0 CA-C-O 121.101 0.477 . . . . 0.0 112.211 -171.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -141.3 155.35 67.84 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.26 -6.83 20.04 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.142 2.561 . . . . 0.0 111.026 -176.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -101.96 5.56 40.83 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.107 0.963 . . . . 0.0 111.464 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -129.33 14.72 6.13 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 122.798 0.439 . . . . 0.0 111.088 176.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.6 m -132.45 142.56 49.3 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 122.178 0.191 . . . . 0.0 111.086 -174.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.4 tt -112.04 152.01 13.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 123.219 0.607 . . . . 0.0 110.343 -177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 25.1 t80 -121.16 143.23 49.22 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 175.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 35.3 m -139.01 149.68 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 CA-C-O 120.663 0.268 . . . . 0.0 110.704 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -146.0 165.92 28.04 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.221 -0.752 . . . . 0.0 111.221 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 79.14 20.85 69.0 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -173.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 19.4 m -61.06 153.27 67.47 Favored Pre-proline 0 CA--C 1.529 0.171 0 C-N-CA 122.9 0.48 . . . . 0.0 111.956 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.14 168.76 21.14 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.755 2.97 . . . . 0.0 109.563 173.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -65.6 -47.44 67.38 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -173.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -72.52 -51.75 0.19 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 121.617 1.545 . . . . 0.0 112.254 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 38.1 tp 50.7 -72.48 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 126.537 1.935 . . . . 0.0 114.548 -177.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.475 ' HE ' ' CG ' ' A' ' 158' ' ' ASP . 63.2 mtp180 61.97 127.66 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 127.521 2.328 . . . . 0.0 112.43 -174.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.46 -22.96 66.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.397 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 59.0 t -72.56 -47.83 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 122.341 0.256 . . . . 0.0 110.638 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -80.65 -32.89 36.03 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 110.213 -0.292 . . . . 0.0 110.213 -175.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 55.6 tp -66.26 -34.0 77.02 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.468 ' HB2' ' CB ' ' A' ' 203' ' ' ALA . . . -86.73 -25.32 24.77 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -175.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 20.7 mmt -70.6 -33.83 71.49 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.4 mt -72.55 -39.76 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 20.1 mmt -60.08 -24.76 64.85 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 119.231 -0.414 . . . . 0.0 111.605 174.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -88.25 -20.17 25.83 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.923 0.783 . . . . 0.0 111.412 177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.19 -18.73 33.18 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 119.176 -0.44 . . . . 0.0 111.871 -179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.38 -23.96 7.58 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 118.147 0.43 . . . . 0.0 111.042 177.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -135.29 45.3 2.5 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 122.893 0.477 . . . . 0.0 110.024 -175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -45.12 138.36 5.79 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 123.431 0.539 . . . . 0.0 112.117 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 123.52 9.87 5.72 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -175.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.406 ' HA ' ' HA ' ' A' ' 222' ' ' PHE . 5.2 p -71.02 160.46 5.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 123.847 0.859 . . . . 0.0 110.555 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 52.4 t -134.91 -35.64 0.85 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 112.638 0.606 . . . . 0.0 112.638 -177.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -150.74 155.82 40.06 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.763 0.256 . . . . 0.0 110.766 -176.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . 0.468 ' CB ' ' HB2' ' A' ' 190' ' ' ALA . . . -154.2 159.42 41.35 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.025 0.441 . . . . 0.0 110.181 177.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 175.22 -175.67 47.17 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.7 mm -97.46 144.68 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -60.74 123.38 17.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 52.5 p -134.97 140.48 45.73 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -85.08 128.03 61.83 Favored Pre-proline 0 N--CA 1.451 -0.387 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -76.47 -10.88 18.94 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 124.263 3.309 . . . . 0.0 112.565 -174.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 31.2 tp10 -69.23 -29.68 67.68 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 122.428 0.291 . . . . 0.0 110.53 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.13 6.71 1.76 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.453 0.701 . . . . 0.0 111.592 -178.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 51.81 48.65 22.39 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.198 1.399 . . . . 0.0 113.904 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -123.15 152.18 63.17 Favored Pre-proline 0 N--CA 1.467 0.395 0 CA-C-O 119.379 -0.343 . . . . 0.0 110.965 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -72.55 171.72 16.58 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 124.206 3.271 . . . . 0.0 112.639 -176.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 12.9 ttmt -134.69 19.31 3.56 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.68 0.792 . . . . 0.0 111.38 178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 63.0 16.57 57.59 Favored Glycine 0 CA--C 1.53 1.013 0 CA-C-O 119.61 -0.55 . . . . 0.0 113.535 176.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -130.34 155.27 46.63 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 117.877 0.838 . . . . 0.0 109.982 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -105.98 160.56 14.7 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 112.426 -0.27 . . . . 0.0 112.426 -175.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -151.03 144.94 25.2 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 174.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 99.6 t -140.01 148.34 22.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -130.2 147.51 51.93 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.722 0.296 . . . . 0.0 110.845 -177.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 200' ' ' VAL . 14.0 m-85 -128.05 156.7 42.35 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.598 -176.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 74.1 m -77.84 -7.58 56.86 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -131.87 145.76 51.72 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 118.101 0.409 . . . . 0.0 111.085 -176.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -71.78 -22.55 61.57 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -70.22 -38.21 75.19 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 17.9 m -72.35 -29.91 64.24 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -70.09 -51.6 30.49 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 119.622 -0.228 . . . . 0.0 111.118 178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.7 pt -69.11 -15.74 20.02 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 CA-C-N 118.289 0.495 . . . . 0.0 110.735 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.18 -27.52 29.97 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 176.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.17 -25.61 36.69 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 8.1 pt -105.09 24.98 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 123.022 0.529 . . . . 0.0 110.44 175.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -78.86 -11.38 59.99 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.247 0.619 . . . . 0.0 111.932 -177.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.55 143.0 21.68 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 57.6 ttm-85 -56.26 -33.23 65.25 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.778 0.431 . . . . 0.0 111.989 -178.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -123.62 114.63 20.26 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.04 0.448 . . . . 0.0 110.633 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.5 m -87.55 147.61 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.136 173.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 12.2 mp0 -83.21 134.12 34.98 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -121.61 21.25 10.93 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 82.3 mt-30 -66.86 149.35 50.71 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -147.0 8.58 0.95 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.624 0.25 . . . . 0.0 111.313 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 163.31 -137.36 4.74 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -176.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 14.7 mp0 -74.63 -4.79 39.28 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.98 0.39 . . . . 0.0 110.502 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.437 HD12 ' N ' ' A' ' 244' ' ' ILE . 1.9 mp -87.2 153.54 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 124.034 0.934 . . . . 0.0 108.963 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -134.68 135.73 42.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.893 0.378 . . . . 0.0 110.603 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -145.39 147.67 32.5 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.442 1.097 . . . . 0.0 109.199 -177.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.99 161.63 42.33 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.271 0.628 . . . . 0.0 109.504 177.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.0 p -154.59 152.16 9.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 175.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -88.76 128.4 35.63 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.469 ' C ' ' HE2' ' A' ' 251' ' ' LYS . 1.5 m -104.56 156.34 5.88 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.125 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 -174.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.469 ' HE2' ' C ' ' A' ' 250' ' ' VAL . 0.0 OUTLIER -156.15 158.48 31.6 Favored Pre-proline 0 N--CA 1.456 -0.147 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.891 170.205 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.91 140.56 92.28 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.777 2.318 . . . . 0.0 109.917 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -91.49 175.82 6.78 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.924 0.392 . . . . 0.0 110.505 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.1 p -151.11 152.8 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 123.375 0.67 . . . . 0.0 109.846 -170.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.612 ' H ' HD23 ' A' ' 255' ' ' LEU . 1.9 pt? . . . . . 0 C--O 1.252 1.188 0 CA-C-O 116.823 -1.56 . . . . 0.0 112.256 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.45 ' N1 ' ' HD2' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.93 1 C5'-C4'-C3' 109.002 -4.332 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.414 -3.221 0 C5'-C4'-C3' 110.514 -3.324 . 0.01 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.533 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.418 -2.948 1 O4'-C1'-N19 113.277 5.077 . 0.356 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.5 " C1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.417 -3.031 0 O4'-C4'-C3' 109.863 3.116 . 0.01 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.476 ' C8 ' H5'' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.414 -3.289 0 P-O3'-C3' 123.01 2.758 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.2 p . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 119.876 -0.106 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -138.15 167.3 22.11 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.28 0.632 . . . . 0.0 110.619 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -143.58 164.81 29.33 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.331 0.653 . . . . 0.0 110.36 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -76.28 160.37 29.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 120.897 0.379 . . . . 0.0 110.723 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -155.28 8.54 0.32 Allowed Glycine 0 CA--C 1.528 0.872 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -82.14 0.51 40.47 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 117.55 0.675 . . . . 0.0 111.749 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -144.07 150.56 38.35 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.673 0.789 . . . . 0.0 109.442 179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 p -148.39 156.15 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.367 0.667 . . . . 0.0 109.654 179.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -129.73 166.44 19.85 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.333 0.653 . . . . 0.0 109.881 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -135.91 124.45 23.6 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 120.801 0.334 . . . . 0.0 110.461 -178.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.413 ' HA ' ' HG ' ' A' ' 156' ' ' LEU . 0.3 OUTLIER -147.59 171.35 15.72 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.569 177.493 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.9 t -89.22 169.0 11.82 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.507 0.723 . . . . 0.0 111.666 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 49.1 ptt85 -77.42 5.57 8.56 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.709 0.804 . . . . 0.0 111.118 176.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -108.21 130.89 55.13 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.336 -0.986 . . . . 0.0 108.336 174.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.1 p -150.54 146.44 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.458 -170.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.427 ' CZ ' ' HA3' ' A' ' 70' ' ' GLY . 8.3 t80 -83.25 135.57 34.71 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 173.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 75.9 t -137.75 78.16 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -176.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.457 ' HA2' ' HA ' ' A' ' 110' ' ' TYR . . . -120.28 159.62 15.11 Favored Glycine 0 C--N 1.335 0.508 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.946 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 107.45 5.92 33.86 Favored Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.178 -0.769 . . . . 0.0 111.178 -176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.579 ' H ' HD23 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -73.69 173.4 6.36 Favored Pre-proline 0 CA--C 1.537 0.477 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 171.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 72' ' ' LEU . 50.2 Cg_endo -80.9 155.51 20.22 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 CA-C-N 120.677 1.277 . . . . 0.0 110.292 -174.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 27.0 Cg_exo -64.95 13.39 0.1 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.92 3.08 . . . . 0.0 112.755 173.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 73' ' ' PRO . 12.2 m-20 -134.29 26.82 3.82 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -172.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 mt -123.93 152.05 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -126.11 -176.19 3.57 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.286 0.634 . . . . 0.0 110.933 -178.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -51.4 -23.76 4.16 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.367 1.067 . . . . 0.0 113.139 -175.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -79.64 -37.44 36.04 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.715 0.688 . . . . 0.0 112.472 -175.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -84.7 -25.45 28.37 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.41 0.55 . . . . 0.0 110.671 -174.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 52.9 mt -75.03 -42.71 45.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 176.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.9 m -66.51 -26.24 67.07 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.44 -20.77 46.68 Favored 'General case' 0 N--CA 1.453 -0.294 0 O-C-N 122.234 -0.291 . . . . 0.0 111.541 178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 m -85.34 -25.05 27.36 Favored 'General case' 0 CA--C 1.527 0.076 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.561 ' CE1' HD23 ' A' ' 137' ' ' LEU . 87.6 m-85 -117.58 1.98 12.31 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -174.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 37.6 ptt180 -80.6 -2.73 47.6 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.095 0.861 . . . . 0.0 112.09 177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.529 ' HG3' ' CD2' ' A' ' 88' ' ' PHE . 12.7 ptp180 -77.12 -7.46 55.82 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 123.439 0.696 . . . . 0.0 112.149 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.529 ' CD2' ' HG3' ' A' ' 87' ' ' ARG . 71.3 m-85 -121.73 2.72 10.07 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.394 0.277 . . . . 0.0 111.699 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.45 162.37 9.31 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.0 139.24 46.4 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.072 2.515 . . . . 0.0 110.759 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.502 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -155.59 169.77 23.54 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.845 0.458 . . . . 0.0 111.333 -179.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 36.5 pt -135.98 163.02 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 172.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.4 p -117.9 149.69 20.2 Favored 'Isoleucine or valine' 0 C--O 1.231 0.118 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 177.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -154.29 171.76 18.73 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 122.1 0.952 . . . . 0.0 112.494 -175.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.422 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 2.9 p90 -146.73 158.28 46.24 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 174.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.611 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 74.3 Cg_endo -63.14 -14.72 43.52 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 124.023 3.149 . . . . 0.0 112.996 -168.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.611 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 3.3 m170 -105.68 -34.29 7.77 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 117.927 0.331 . . . . 0.0 111.087 -176.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 98' ' ' LYS . 12.0 tptm 42.04 27.98 0.09 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.063 1.745 . . . . 0.0 113.634 -174.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 53.13 -169.24 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.585 1.154 . . . . 0.0 112.914 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -83.84 26.68 0.69 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.621 0.769 . . . . 0.0 111.104 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 30.6 m 59.43 24.19 12.8 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.985 0.914 . . . . 0.0 112.699 -175.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -113.77 3.73 15.65 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.446 0.699 . . . . 0.0 111.162 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.8 p -150.13 167.96 25.32 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 123.211 0.604 . . . . 0.0 110.358 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -141.41 33.0 1.67 Allowed 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.5 0.72 . . . . 0.0 110.897 -176.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -129.54 125.54 22.43 Favored Pre-proline 0 N--CA 1.45 -0.475 0 C-N-CA 124.21 1.004 . . . . 0.0 108.885 -175.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -73.21 157.7 49.87 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.169 3.246 . . . . 0.0 111.144 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -71.06 -16.07 32.19 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.839 3.026 . . . . 0.0 112.827 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.673 ' CD ' ' H ' ' A' ' 109' ' ' GLY . 1.9 tmtm? -154.46 169.99 22.45 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.673 ' H ' ' CD ' ' A' ' 108' ' ' LYS . . . -71.69 34.27 0.59 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 125.923 1.725 . . . . 0.0 113.853 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.457 ' HA ' ' HA2' ' A' ' 70' ' ' GLY . 0.4 OUTLIER -145.17 134.25 22.67 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 118.545 1.173 . . . . 0.0 111.079 170.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.31 -169.25 3.33 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.627 1.171 . . . . 0.0 109.37 -175.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.509 ' CE1' ' C5 ' ' B' ' 4' ' ' ' U' . 1.9 m-85 -134.8 151.02 50.6 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -176.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mp -108.24 151.04 26.48 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.585 0.707 . . . . 0.0 112.004 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.9 99.69 6.05 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -84.28 156.65 21.86 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.822 0.344 . . . . 0.0 110.232 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 24.0 mm100 -86.35 -29.0 23.3 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.208 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -128.08 156.64 42.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -80.23 -19.86 45.94 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.218 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 63.0 m -90.44 -16.14 29.56 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 122.699 0.4 . . . . 0.0 111.14 177.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 18.8 m -72.67 -41.36 65.47 Favored 'General case' 0 CA--C 1.522 -0.13 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.7 p -76.57 -13.97 14.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.849 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.1 tp60 -78.4 -35.31 47.29 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 122.062 -0.398 . . . . 0.0 110.028 178.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.26 -37.5 57.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 117.83 0.287 . . . . 0.0 111.122 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.404 ' CD1' HG13 ' A' ' 125' ' ' ILE . 0.2 OUTLIER -66.01 -38.16 87.75 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.415 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.404 HG13 ' CD1' ' A' ' 124' ' ' LEU . 52.3 mt -85.1 -10.73 11.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 O-C-N 121.422 -0.799 . . . . 0.0 111.925 -177.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -102.26 -5.14 24.64 Favored 'General case' 0 CA--C 1.532 0.265 0 O-C-N 121.805 -0.559 . . . . 0.0 112.038 175.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -126.6 6.68 6.84 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 -177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 81.6 m -112.78 -179.48 3.67 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.865 0.757 . . . . 0.0 111.066 177.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.472 ' N ' HD12 ' A' ' 129' ' ' ILE . 3.0 mp -68.72 147.98 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -171.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -130.69 151.91 50.62 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.545 0.212 . . . . 0.0 111.096 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -140.41 67.5 1.36 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.303 0.573 . . . . 0.0 110.26 179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 52.72 12.23 0.25 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 115.538 1.681 . . . . 0.0 115.538 172.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.45 -18.81 0.09 OUTLIER Glycine 0 CA--C 1.526 0.77 0 CA-C-N 118.682 0.673 . . . . 0.0 112.386 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.0 mppt? -127.03 174.31 8.98 Favored 'General case' 0 C--N 1.338 0.07 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 5.2 mp -135.4 167.95 20.1 Favored 'General case' 0 CA--C 1.527 0.085 0 CA-C-N 118.032 0.378 . . . . 0.0 111.583 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.475 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 31.9 m-85 -139.09 159.17 42.78 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.795 178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.561 HD23 ' CE1' ' A' ' 85' ' ' PHE . 54.8 tp -150.47 158.58 44.32 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 169.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 84.7 m -95.26 167.97 11.03 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.891 -0.506 . . . . 0.0 111.954 -177.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.15 164.78 33.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 C-N-CA 123.933 0.893 . . . . 0.0 109.838 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 32.1 m -104.48 2.37 30.91 Favored 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.442 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 45.3 m -133.86 48.34 3.18 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 118.294 0.497 . . . . 0.0 111.546 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.442 ' CD ' ' N ' ' A' ' 141' ' ' SER . 62.0 Cg_endo -65.03 155.22 69.43 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 124.172 3.248 . . . . 0.0 111.905 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.805 HG23 HG13 ' A' ' 144' ' ' ILE . 14.8 t -89.12 -9.98 49.02 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.031 0.533 . . . . 0.0 111.513 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.805 HG13 HG23 ' A' ' 143' ' ' THR . 64.7 mt -141.23 175.01 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -176.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.474 ' H ' HG22 ' A' ' 144' ' ' ILE . 1.7 tmmt? -56.85 -24.82 54.17 Favored 'General case' 0 CA--C 1.534 0.348 0 O-C-N 121.998 -0.439 . . . . 0.0 111.284 -176.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -141.97 150.3 41.2 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 123.873 0.869 . . . . 0.0 109.631 173.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.477 ' HE2' HG22 ' A' ' 143' ' ' THR . 0.1 OUTLIER -158.95 70.0 3.5 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 122.703 0.401 . . . . 0.0 110.02 174.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.475 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 72.1 Cg_endo -68.76 124.0 11.03 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.077 1.851 . . . . 0.0 109.115 175.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.4 p -90.7 140.33 16.13 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -91.67 153.06 19.93 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 122.734 0.414 . . . . 0.0 110.857 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 30.9 mm -126.6 136.26 61.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 123.342 0.657 . . . . 0.0 110.303 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 86.0 mtt180 -147.83 96.85 4.01 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 176.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -78.7 165.07 25.17 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.614 2.876 . . . . 0.0 110.828 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.45 ' CD2' ' HG2' ' A' ' 214' ' ' PRO . 47.1 t-105 -82.15 111.41 18.24 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 121.9 -0.5 . . . . 0.0 111.001 177.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 17.9 p30 -70.62 148.91 47.59 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 175.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.413 ' HG ' ' HA ' ' A' ' 63' ' ' TYR . 35.7 mt -119.14 101.34 7.93 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.201 0.524 . . . . 0.0 111.076 -169.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 22.7 t -164.85 -32.23 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.161 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.737 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -140.5 42.47 1.88 Allowed 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.384 0.274 . . . . 0.0 111.332 -178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.6 t -66.57 -32.46 73.81 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -176.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -151.44 158.27 43.45 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.004 0.522 . . . . 0.0 110.49 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.43 ' CD2' ' HA ' ' A' ' 187' ' ' VAL . 58.3 t80 -156.24 153.42 29.13 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.4 p -144.73 149.25 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 67.5 mtm -117.16 13.43 14.7 Favored 'General case' 0 N--CA 1.457 -0.081 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -173.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -160.55 -41.63 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.32 7.4 38.87 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 119.302 -0.721 . . . . 0.0 113.335 175.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.9 m -133.72 -0.23 3.19 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -175.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 90.7 mm-40 -86.81 150.31 50.17 Favored Pre-proline 0 CA--C 1.529 0.148 0 CA-C-N 119.839 1.2 . . . . 0.0 110.448 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.36 148.64 49.26 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 123.093 2.529 . . . . 0.0 109.659 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 77.1 mt -133.75 152.27 51.83 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.161 0.584 . . . . 0.0 109.871 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -145.29 153.28 52.17 Favored Pre-proline 0 N--CA 1.455 -0.186 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -59.19 -20.12 53.18 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.318 2.679 . . . . 0.0 112.353 175.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.9 6.56 38.73 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.418 0.687 . . . . 0.0 110.741 177.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -129.72 19.42 5.63 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 122.833 0.453 . . . . 0.0 110.455 178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 30.2 m -125.12 139.92 53.35 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.72 0.295 . . . . 0.0 111.133 -175.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.8 tt -110.92 150.78 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.139 0 C-N-CA 123.17 0.588 . . . . 0.0 109.77 -178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -120.43 140.48 51.3 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 175.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 23.7 m -135.92 142.16 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -156.05 -173.86 25.15 Favored Glycine 0 CA--C 1.525 0.692 0 CA-C-N 118.454 0.57 . . . . 0.0 113.05 -175.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 76.05 28.75 59.9 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.16 -1.176 . . . . 0.0 110.16 -175.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.1 146.84 53.69 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.811 0.306 . . . . 0.0 111.24 -171.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.414 ' C ' ' HD2' ' A' ' 183' ' ' PRO . 73.4 Cg_endo -68.28 -172.35 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.536 2.824 . . . . 0.0 110.158 169.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.48 ' N ' ' CD ' ' A' ' 183' ' ' PRO . 0.0 OUTLIER -95.35 5.31 0.06 OUTLIER Pre-proline 0 CA--C 1.539 0.529 0 N-CA-C 117.737 2.495 . . . . 0.0 117.737 -172.247 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 182' ' ' ARG . 66.4 Cg_endo -76.17 6.19 4.05 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 122.505 1.93 . . . . 0.0 112.64 -175.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 57.4 mt -64.49 -35.79 82.09 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 118.513 0.597 . . . . 0.0 110.881 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 59.36 125.11 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.091 1.356 . . . . 0.0 112.162 -177.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -61.6 -30.17 70.51 Favored 'General case' 0 CA--C 1.529 0.139 0 O-C-N 121.548 -0.72 . . . . 0.0 111.56 -176.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.43 ' HA ' ' CD2' ' A' ' 161' ' ' PHE . 54.3 t -67.74 -50.85 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 CA-C-O 120.609 0.242 . . . . 0.0 110.847 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 77.0 mt-10 -79.53 -24.97 41.84 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 122.482 -0.137 . . . . 0.0 110.781 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.1 tp -67.2 -34.55 77.74 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.09 -35.88 59.16 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 122.212 -0.305 . . . . 0.0 111.473 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 57.7 mtt -73.11 -33.73 65.74 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 122.324 -0.235 . . . . 0.0 111.083 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.436 HG21 ' HA ' ' A' ' 239' ' ' LEU . 72.2 mt -78.11 -39.53 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 121.151 -0.219 . . . . 0.0 110.683 -176.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 24.3 mmt -63.14 -26.44 68.82 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 118.592 0.633 . . . . 0.0 110.513 172.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -85.42 -16.92 38.16 Favored 'General case' 0 N--CA 1.454 -0.27 0 O-C-N 121.816 -0.552 . . . . 0.0 111.677 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.63 -18.27 22.37 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.239 -0.41 . . . . 0.0 111.574 178.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -114.03 -14.49 12.4 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.389 0.514 . . . . 0.0 112.389 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -137.62 -29.96 0.85 Allowed 'General case' 0 C--N 1.339 0.116 0 CA-C-N 118.651 0.659 . . . . 0.0 112.211 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 67.86 -176.47 25.25 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 71.42 7.54 64.35 Favored Glycine 0 CA--C 1.527 0.8 0 CA-C-O 119.577 -0.568 . . . . 0.0 113.372 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.462 HG22 ' CE2' ' A' ' 222' ' ' PHE . 22.0 t -77.2 151.24 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 CA-C-N 118.127 0.963 . . . . 0.0 110.108 -178.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 44.3 t -133.12 -42.86 0.88 Allowed 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 119.619 -0.229 . . . . 0.0 110.949 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -136.66 150.59 48.58 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -173.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.06 163.36 39.99 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-O 121.255 0.55 . . . . 0.0 111.988 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -178.34 169.46 41.16 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.1 mm -94.0 93.76 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 38.0 t70 41.61 -84.43 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -169.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.48 ' H ' ' HA ' ' A' ' 214' ' ' PRO . 16.2 m 52.79 50.46 18.03 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-O 121.444 0.64 . . . . 0.0 111.016 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.24 140.6 88.0 Favored Pre-proline 0 N--CA 1.452 -0.355 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.739 -178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -81.33 -16.18 9.68 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 124.263 3.309 . . . . 0.0 113.575 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -100.21 -36.66 9.22 Favored 'General case' 0 C--N 1.338 0.069 0 CA-C-N 118.613 0.642 . . . . 0.0 110.979 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -92.94 -3.89 53.72 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt 56.17 115.2 0.01 OUTLIER 'General case' 0 C--N 1.34 0.155 0 C-N-CA 126.798 2.039 . . . . 0.0 113.492 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.44 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 70.7 m-85 65.34 170.05 0.1 Allowed Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.338 1.055 . . . . 0.0 111.566 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.48 ' HA ' ' H ' ' A' ' 207' ' ' THR . 50.8 Cg_exo -56.62 163.07 7.46 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.701 2.934 . . . . 0.0 115.486 -170.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.542 ' HA ' ' C4 ' ' B' ' 4' ' ' ' U' . 36.9 mtmm -123.63 35.09 4.92 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.556 176.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 64.35 26.06 70.36 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -145.12 164.94 29.72 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 123.527 0.731 . . . . 0.0 110.169 -173.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -116.32 164.65 12.27 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -146.83 149.97 34.36 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 93.5 t -141.23 144.16 26.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -125.33 143.49 50.94 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.213 0.53 . . . . 0.0 110.336 -178.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.462 ' CE2' HG22 ' A' ' 200' ' ' VAL . 55.4 m-85 -117.47 152.78 34.33 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.639 -175.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 71.1 p -84.36 2.24 41.39 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.645 -0.252 . . . . 0.0 110.77 175.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -137.42 139.13 40.49 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 123.325 0.65 . . . . 0.0 110.316 179.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 11.8 tm0? -73.98 -22.01 59.78 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -71.37 -38.95 71.51 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.5 m -73.25 -29.49 62.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -66.0 -48.93 69.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.635 176.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.4 pp -72.93 -10.7 14.22 Favored 'Isoleucine or valine' 0 C--N 1.338 0.084 0 CA-C-N 118.515 0.598 . . . . 0.0 111.139 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -85.42 -23.94 27.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 117.602 0.183 . . . . 0.0 110.52 173.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -85.01 -23.92 28.44 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 10.4 pt -102.98 26.27 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 123.092 0.557 . . . . 0.0 110.474 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.2 t -90.9 2.52 56.12 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.537 0.735 . . . . 0.0 111.564 -176.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -139.83 -156.68 0.7 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 80.3 ttt180 -128.65 -35.76 1.89 Allowed 'General case' 0 C--O 1.227 -0.106 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -127.88 104.54 7.87 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 1.9 m -64.32 149.76 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.763 176.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.526 ' C ' HD22 ' A' ' 239' ' ' LEU . 17.8 mm-40 -91.36 138.2 31.76 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.526 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.2 mm? -127.52 22.64 6.42 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -177.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -87.85 133.97 33.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.244 0.618 . . . . 0.0 111.69 -172.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -147.09 22.9 1.2 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.885 177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.7 135.82 4.89 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 54.13 7.54 0.13 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.05 1.34 . . . . 0.0 113.82 -177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.4 mt -144.54 142.63 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 C-N-CA 123.486 0.715 . . . . 0.0 109.292 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -150.99 138.07 19.18 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 175.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -144.37 161.42 39.02 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -155.55 158.28 38.18 Favored 'General case' 0 N--CA 1.46 0.054 0 CA-C-N 118.117 0.417 . . . . 0.0 110.221 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 12.7 p -158.66 152.21 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 174.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -86.13 126.72 34.42 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.46 ' C ' ' HE2' ' A' ' 251' ' ' LYS . 4.3 m -97.46 155.01 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.148 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.46 ' HE2' ' C ' ' A' ' 250' ' ' VAL . 0.0 OUTLIER -155.48 157.47 31.62 Favored Pre-proline 0 C--O 1.231 0.103 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.591 170.151 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -58.01 138.23 84.9 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.816 2.344 . . . . 0.0 109.336 173.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -92.11 170.02 10.17 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.447 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.8 p -150.53 153.81 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 123.273 0.629 . . . . 0.0 110.128 -169.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 4.6 tt . . . . . 0 C--O 1.25 1.122 0 CA-C-O 117.733 -1.127 . . . . 0.0 108.923 178.937 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.422 -2.573 1 O4'-C1'-N19 114.456 6.256 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.86 0 C3'-C2'-C1' 105.065 3.961 . 0.141 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.406 ' C6 ' ' CE2' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.417 -3.01 1 O4'-C1'-N19 112.622 4.422 . 0.195 0b . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.542 ' C4 ' ' HA ' ' A' ' 215' ' ' LYS . . . . . . . . 0 O4'--C4' 1.42 -2.769 0 C5'-C4'-C3' 111.071 -2.952 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.41 " H2'" ' N3 ' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.414 -3.254 0 C5'-C4'-C3' 111.283 -2.811 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 44.7 m . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 120.594 0.235 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -148.58 154.02 39.17 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.916 0.487 . . . . 0.0 110.436 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -143.16 154.38 43.83 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.621 0.768 . . . . 0.0 109.597 178.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -96.94 -7.57 32.87 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 122.407 0.283 . . . . 0.0 111.625 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -80.99 151.29 31.63 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.126 -0.789 . . . . 0.0 111.126 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -155.41 -27.0 0.11 Allowed 'General case' 0 CA--C 1.531 0.242 0 O-C-N 122.66 -0.318 . . . . 0.0 111.362 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -139.8 19.74 2.49 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 122.788 0.435 . . . . 0.0 111.826 -173.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.7 9.95 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -174.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.43 -1.73 2.82 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.996 0.518 . . . . 0.0 111.878 179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.82 67.67 5.67 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.647 0.779 . . . . 0.0 111.298 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -97.05 161.26 13.91 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -176.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.3 t -92.25 27.86 2.08 Favored 'General case' 0 C--O 1.23 0.076 0 C-N-CA 124.129 0.972 . . . . 0.0 113.471 -169.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 19.5 mtp-105 54.34 23.52 4.45 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.373 0.533 . . . . 0.0 111.052 -177.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -146.0 138.16 25.28 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.479 0.712 . . . . 0.0 109.945 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.7 m -138.91 152.36 24.23 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.921 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.467 ' CZ ' ' HA3' ' A' ' 70' ' ' GLY . 19.1 t80 -84.03 148.41 26.87 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.1 p -134.69 73.82 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-O 122.251 1.025 . . . . 0.0 109.028 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.467 ' HA3' ' CZ ' ' A' ' 68' ' ' PHE . . . -78.19 144.63 28.64 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.47 23.44 60.55 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-O 119.203 -0.776 . . . . 0.0 113.569 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.7 pp -62.04 148.92 87.59 Favored Pre-proline 0 CA--C 1.531 0.22 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 172.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 66.1 Cg_endo -66.15 143.82 72.92 Favored 'Trans proline' 0 N--CA 1.447 -1.228 0 C-N-CA 121.585 1.524 . . . . 0.0 110.499 -169.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 31.2 Cg_exo -61.83 174.37 2.39 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 123.106 2.538 . . . . 0.0 113.669 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.8 t70 63.36 5.71 2.15 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.285 1.587 . . . . 0.0 115.285 175.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.434 HD12 ' C ' ' A' ' 76' ' ' ILE . 2.5 pp -134.01 171.41 17.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 171.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -143.31 -25.58 0.59 Allowed 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -177.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -154.25 -35.15 0.1 Allowed 'General case' 0 CA--C 1.528 0.113 0 CA-C-N 119.199 0.908 . . . . 0.0 112.547 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -67.7 -45.7 74.39 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.716 0.689 . . . . 0.0 111.529 -175.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -72.34 -35.56 68.58 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.879 -173.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.4 pt -83.89 -36.65 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 O-C-N 122.163 -0.336 . . . . 0.0 111.869 -176.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 95.9 m -71.99 -15.41 62.06 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.44 0.564 . . . . 0.0 109.565 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.73 -21.29 20.05 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 172.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.1 m -84.2 -19.19 34.44 Favored 'General case' 0 C--N 1.34 0.195 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.433 ' HB2' ' CD1' ' A' ' 91' ' ' LEU . 34.6 m-85 -113.02 5.84 17.39 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.338 0.517 . . . . 0.0 111.208 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.5 tpp180 -65.25 -21.75 66.78 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 123.811 0.845 . . . . 0.0 111.972 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -72.17 -3.37 22.97 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -113.06 15.48 19.55 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 122.467 0.307 . . . . 0.0 111.648 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 111.27 177.6 20.37 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.31 150.44 70.96 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.557 2.838 . . . . 0.0 110.675 -179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.433 ' CD1' ' HB2' ' A' ' 85' ' ' PHE . 0.6 OUTLIER -163.15 163.29 25.72 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.178 -169.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.2 pt -142.71 168.11 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.017 172.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.9 p -128.34 157.0 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -148.05 155.88 42.0 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 121.002 0.429 . . . . 0.0 110.87 -177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.42 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 45.8 p90 -157.11 154.4 26.04 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 169.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.658 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 31.1 Cg_endo -75.61 -10.28 20.18 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.075 3.183 . . . . 0.0 110.77 -169.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.658 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 69.5 m-70 -102.37 9.92 39.44 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.872 0.869 . . . . 0.0 111.022 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.449 ' HA ' ' HE3' ' A' ' 98' ' ' LYS . 0.7 OUTLIER -61.35 143.44 55.74 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.809 0.844 . . . . 0.0 109.914 179.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -146.21 172.55 13.29 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.381 0.673 . . . . 0.0 110.118 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.5 mm-40 -80.38 0.98 30.86 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 122.679 0.392 . . . . 0.0 111.664 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 82.0 p -81.16 165.88 21.15 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 122.991 0.516 . . . . 0.0 111.234 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -95.61 41.91 1.1 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.37 0.668 . . . . 0.0 110.592 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.7 p -75.56 169.93 17.13 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.071 0.548 . . . . 0.0 111.287 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -137.95 170.55 15.86 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.335 0.654 . . . . 0.0 110.373 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.41 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 14.2 t80 52.6 94.21 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 125.533 1.533 . . . . 0.0 113.6 177.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 105' ' ' PHE . 76.6 Cg_endo -71.85 164.65 34.99 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.425 2.75 . . . . 0.0 109.105 175.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_exo -43.41 107.02 0.08 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 124.272 3.315 . . . . 0.0 113.196 -175.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.3 tptt 47.14 21.23 0.16 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.15 1.78 . . . . 0.0 113.632 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 78.01 33.98 39.32 Favored Glycine 0 CA--C 1.527 0.817 0 O-C-N 121.187 -0.946 . . . . 0.0 113.099 177.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.602 ' CE1' " H4'" ' B' ' 2' ' ' ' U' . 1.1 m-30 -104.05 130.13 51.72 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.702 1.251 . . . . 0.0 108.543 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.98 -176.46 5.77 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 118.217 0.462 . . . . 0.0 110.657 178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -141.62 144.35 34.14 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.773 0.429 . . . . 0.0 110.322 -176.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -102.08 146.89 27.28 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.378 0.609 . . . . 0.0 111.769 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.4 mp -114.27 137.72 51.42 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 171.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -131.1 175.2 9.29 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.381 0.672 . . . . 0.0 110.004 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 -115.6 -32.56 5.5 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.454 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -114.66 149.21 37.07 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.066 0.46 . . . . 0.0 111.327 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -77.97 -17.6 56.97 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.02 -179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 24.8 t -83.43 -16.39 45.99 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.264 -0.272 . . . . 0.0 111.476 -178.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 67.5 m -74.93 -43.45 54.08 Favored 'General case' 0 N--CA 1.455 -0.178 0 O-C-N 121.911 -0.493 . . . . 0.0 111.492 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 27.6 m -71.04 -22.99 23.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -80.29 -35.65 35.51 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 -176.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.88 -33.02 65.79 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 119.442 -0.314 . . . . 0.0 111.382 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.3 pp -80.26 -23.37 40.84 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.462 0.574 . . . . 0.0 110.955 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 54.5 mt -89.56 -20.91 6.94 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 111.668 0.248 . . . . 0.0 111.668 178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -100.98 -13.84 18.11 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 118.568 0.622 . . . . 0.0 112.619 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -108.62 11.07 26.85 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.06 0.391 . . . . 0.0 111.97 -179.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 72.4 m -129.74 -166.41 1.66 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.852 0.461 . . . . 0.0 111.259 -176.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 129' ' ' ILE . 3.8 mp -80.71 152.15 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 C-N-CA 123.806 0.842 . . . . 0.0 109.353 -171.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -144.35 158.74 43.58 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.658 176.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 134' ' ' LYS . 1.9 pt-20 -145.62 174.79 10.88 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 175.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -59.8 -5.25 0.88 Allowed 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 -170.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -153.42 0.34 0.21 Allowed Glycine 0 CA--C 1.528 0.878 0 CA-C-N 119.164 0.893 . . . . 0.0 114.02 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.478 ' H ' ' HG3' ' A' ' 131' ' ' GLU . 3.4 mppt? -151.6 167.01 29.44 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 118.441 1.12 . . . . 0.0 110.618 -176.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -115.8 156.46 26.0 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -144.76 156.09 43.88 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.6 mp -135.55 164.02 28.78 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 169.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.2 m -108.13 141.09 40.37 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.76 150.4 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 C-N-CA 122.953 0.501 . . . . 0.0 110.344 -178.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.9 m -66.63 161.76 22.57 Favored 'General case' 0 N--CA 1.457 -0.113 0 C-N-CA 122.902 0.481 . . . . 0.0 110.192 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 31.3 t -151.39 148.5 22.41 Favored Pre-proline 0 N--CA 1.455 -0.177 0 O-C-N 121.894 -0.504 . . . . 0.0 111.711 -176.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -80.05 -7.76 14.23 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 123.768 2.979 . . . . 0.0 111.231 169.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 45.7 m -102.09 -32.69 10.01 Favored 'General case' 0 N--CA 1.462 0.155 0 C-N-CA 123.872 0.869 . . . . 0.0 110.792 -178.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 3.7 mm -140.09 170.81 14.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 124.191 0.996 . . . . 0.0 108.936 -175.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.7 mptp? -70.16 -23.76 63.04 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 171.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -159.61 149.16 18.3 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.859 0.864 . . . . 0.0 109.912 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.438 ' HD2' " O4'" ' B' ' 1' ' ' ' C' . 0.0 OUTLIER -125.12 106.72 28.21 Favored Pre-proline 0 C--N 1.337 0.051 0 C-N-CA 123.269 0.627 . . . . 0.0 109.59 178.354 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.84 96.82 0.14 Allowed 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 123.226 2.618 . . . . 0.0 109.193 169.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.8 p -84.98 137.96 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -97.24 146.77 24.78 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.22 0.608 . . . . 0.0 110.977 -173.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 37.4 mm -130.85 146.18 34.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 123.158 0.583 . . . . 0.0 111.218 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -148.37 109.76 3.66 Favored Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 172.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -77.85 165.11 26.97 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.51 2.806 . . . . 0.0 111.377 177.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 42.8 t-105 -105.89 126.27 51.98 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 174.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -96.52 132.62 41.91 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 173.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.495 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -92.6 118.13 30.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.767 0.794 . . . . 0.0 110.899 -178.222 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 34.5 t -172.62 -31.83 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 114.842 -1.072 . . . . 0.0 109.146 177.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -122.3 21.87 10.23 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.225 -0.443 . . . . 0.0 112.092 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 23.7 m -64.56 -27.77 69.18 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -176.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -160.4 160.95 32.88 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 122.569 0.348 . . . . 0.0 111.387 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.437 ' CD2' ' HA ' ' A' ' 187' ' ' VAL . 12.9 t80 -155.87 161.59 40.56 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.8 0.333 . . . . 0.0 110.711 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.9 m -136.95 148.76 26.36 Favored 'Isoleucine or valine' 0 C--N 1.338 0.077 0 C-N-CA 124.493 1.117 . . . . 0.0 109.878 -179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 29.3 mtm -139.49 12.31 2.54 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -177.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -137.88 24.07 2.84 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 119.041 0.837 . . . . 0.0 112.383 -176.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 89.07 24.45 31.96 Favored Glycine 0 CA--C 1.527 0.828 0 CA-C-O 119.639 -0.534 . . . . 0.0 111.938 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 98.0 p 48.4 45.26 20.64 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.7 mm-40 -61.94 156.9 54.51 Favored Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -65.9 151.02 85.23 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.718 2.279 . . . . 0.0 110.688 178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.481 HD12 ' HB1' ' A' ' 221' ' ' ALA . 3.0 mm? -108.66 172.49 6.81 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-O 121.259 0.552 . . . . 0.0 110.625 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -149.61 139.79 13.57 Favored Pre-proline 0 N--CA 1.452 -0.325 0 CA-C-N 115.276 -0.874 . . . . 0.0 108.967 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.34 -12.19 31.79 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 123.213 2.608 . . . . 0.0 113.42 -177.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -89.9 0.26 57.17 Favored 'General case' 0 C--N 1.341 0.206 0 CA-C-N 118.811 0.732 . . . . 0.0 110.383 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -127.01 25.11 6.3 Favored 'General case' 0 C--N 1.339 0.11 0 C-N-CA 122.959 0.504 . . . . 0.0 110.918 176.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 23.8 m -127.74 140.25 52.18 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.969 0.414 . . . . 0.0 111.486 -175.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.6 tt -113.24 150.23 15.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.086 0 C-N-CA 123.539 0.736 . . . . 0.0 109.726 -177.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.445 ' CD1' ' CE1' ' A' ' 253' ' ' TYR . 10.9 t80 -109.55 147.82 32.31 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 175.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 48.1 t -137.13 138.72 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.317 0.647 . . . . 0.0 109.294 -175.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -141.89 146.84 18.17 Favored Glycine 0 C--N 1.336 0.557 0 N-CA-C 112.065 -0.414 . . . . 0.0 112.065 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 94.42 15.23 48.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.964 -0.854 . . . . 0.0 110.964 -172.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.6 m -70.04 146.7 95.28 Favored Pre-proline 0 C--O 1.231 0.108 0 CA-C-N 117.188 0.494 . . . . 0.0 111.298 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -79.64 160.0 25.09 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.579 2.853 . . . . 0.0 108.293 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.83 -43.81 6.6 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.903 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -65.29 20.94 0.08 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 124.118 3.212 . . . . 0.0 115.087 177.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -64.84 -27.63 69.01 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 119.511 1.05 . . . . 0.0 112.445 -175.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 56.92 106.74 0.01 OUTLIER 'General case' 0 C--N 1.342 0.252 0 C-N-CA 125.602 1.561 . . . . 0.0 112.612 176.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.32 -23.2 47.18 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.437 ' HA ' ' CD2' ' A' ' 161' ' ' PHE . 41.8 t -68.27 -55.16 17.36 Favored 'Isoleucine or valine' 0 C--N 1.337 0.064 0 CA-C-N 118.691 0.678 . . . . 0.0 110.819 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -82.13 -20.09 38.71 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.363 -0.211 . . . . 0.0 110.977 -176.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -74.06 -33.82 63.82 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 176.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.34 -35.29 63.6 Favored 'General case' 0 N--CA 1.453 -0.321 0 O-C-N 121.789 -0.569 . . . . 0.0 110.538 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.4 mmt -69.1 -33.31 73.3 Favored 'General case' 0 N--CA 1.457 -0.086 0 N-CA-C 110.506 -0.183 . . . . 0.0 110.506 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 57.7 mt -75.31 -41.83 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 -177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.4 mmt -63.97 -20.71 66.08 Favored 'General case' 0 N--CA 1.456 -0.153 0 CA-C-N 118.07 0.395 . . . . 0.0 110.899 173.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -86.1 -20.46 28.68 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.586 0.63 . . . . 0.0 111.287 176.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -89.3 -16.45 31.1 Favored 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -115.75 -22.39 9.16 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 118.172 0.442 . . . . 0.0 110.909 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -137.78 43.79 2.24 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.201 0.6 . . . . 0.0 109.801 -176.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -46.14 138.66 7.18 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 123.654 0.645 . . . . 0.0 112.549 -175.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 120.46 12.03 6.38 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 -175.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 9.1 p -77.69 161.09 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 123.952 0.901 . . . . 0.0 110.598 -178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 47.9 t -135.98 -27.16 1.13 Allowed 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -153.22 140.88 19.95 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 117.83 0.286 . . . . 0.0 110.896 -173.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.37 157.5 43.12 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 122.569 0.347 . . . . 0.0 110.716 177.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 161.76 -161.33 33.18 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.726 -0.55 . . . . 0.0 111.726 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 44.9 mm -102.4 138.39 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 177.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -59.58 138.28 57.76 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.532 0.206 . . . . 0.0 110.577 178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 26.5 p -141.73 160.01 41.05 Favored 'General case' 0 N--CA 1.458 -0.052 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.179 -177.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -111.74 130.19 23.42 Favored Pre-proline 0 N--CA 1.455 -0.197 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 174.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -80.25 -17.07 10.59 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 124.385 3.39 . . . . 0.0 113.813 -174.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -88.61 -31.75 18.43 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 118.549 0.613 . . . . 0.0 110.95 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.53 -2.78 15.37 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.114 0.566 . . . . 0.0 110.478 177.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 62.6 mttp 48.12 61.89 2.77 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.043 1.337 . . . . 0.0 112.734 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -147.32 151.61 40.74 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 122.292 0.237 . . . . 0.0 111.105 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -82.54 155.92 16.22 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.347 2.698 . . . . 0.0 112.577 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -93.42 1.38 56.89 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.147 0.979 . . . . 0.0 109.492 173.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 65.86 7.74 37.62 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-O 119.839 -0.423 . . . . 0.0 113.19 177.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -117.86 146.16 44.09 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 117.462 0.631 . . . . 0.0 109.738 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -84.76 151.04 25.9 Favored Glycine 0 CA--C 1.523 0.586 0 CA-C-O 121.319 0.4 . . . . 0.0 112.547 -173.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.82 142.91 24.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 171.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.8 t -134.75 144.48 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.481 ' HB1' HD12 ' A' ' 169' ' ' LEU . . . -133.03 149.02 52.22 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 121.026 0.441 . . . . 0.0 110.056 -178.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -126.13 153.66 44.24 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.481 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 63.2 p -84.15 4.51 30.15 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.732 176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -134.98 136.68 42.39 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 123.391 0.677 . . . . 0.0 109.796 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -73.86 -20.28 60.47 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.5 tp60 -70.99 -35.82 72.25 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 17.3 m -75.19 -29.96 60.51 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -66.93 -50.03 63.66 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.793 -0.146 . . . . 0.0 110.927 177.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 46.9 pt -70.09 -17.99 21.38 Favored 'Isoleucine or valine' 0 C--N 1.338 0.093 0 CA-C-N 118.061 0.392 . . . . 0.0 110.741 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.01 -24.55 37.86 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 117.582 0.174 . . . . 0.0 110.851 175.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.72 -31.06 32.25 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.981 0.355 . . . . 0.0 111.666 -178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.4 pt -95.78 23.54 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 122.712 0.405 . . . . 0.0 110.324 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.3 t -84.3 -13.81 51.44 Favored 'General case' 0 CA--C 1.528 0.126 0 C-N-CA 123.004 0.522 . . . . 0.0 111.518 -176.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -149.62 135.81 18.97 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -53.54 -37.36 62.78 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.966 0.506 . . . . 0.0 112.019 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -113.84 105.06 12.82 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.905 0.383 . . . . 0.0 110.56 178.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.4 HG23 HD21 ' A' ' 239' ' ' LEU . 1.4 m -65.44 154.53 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.133 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.959 174.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.519 ' C ' HD22 ' A' ' 239' ' ' LEU . 44.3 mm-40 -95.23 130.55 41.93 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.519 HD22 ' C ' ' A' ' 238' ' ' GLN . 2.3 mm? -124.04 17.98 9.24 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.991 -178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -89.86 118.77 29.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -170.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 50.2 m80 -149.36 141.04 23.51 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 173.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 60.16 -131.61 50.11 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -176.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -98.98 7.5 45.94 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 122.942 0.497 . . . . 0.0 111.462 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.45 HD12 ' N ' ' A' ' 244' ' ' ILE . 1.9 mp -88.1 149.41 4.07 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 122.841 0.456 . . . . 0.0 109.952 -177.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -150.82 127.89 11.15 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -145.6 157.41 43.98 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 124.405 1.082 . . . . 0.0 108.652 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -153.36 152.02 30.61 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.9 p -159.93 158.49 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -85.86 145.61 27.11 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.363 0.665 . . . . 0.0 111.183 -177.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.56 161.63 27.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.104 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.1 159.25 26.89 Favored Pre-proline 0 N--CA 1.455 -0.198 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.087 169.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -57.49 133.78 59.1 Favored 'Trans proline' 0 N--CA 1.45 -1.067 0 C-N-CA 122.3 2.0 . . . . 0.0 108.731 173.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . 0.445 ' CE1' ' CD1' ' A' ' 176' ' ' PHE . 1.1 t80 -73.99 159.9 32.08 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.389 -176.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 34.0 m -107.24 165.05 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 C-N-CA 123.918 0.887 . . . . 0.0 111.331 -170.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 3.9 tt . . . . . 0 C--O 1.251 1.152 0 CA-C-O 117.167 -1.397 . . . . 0.0 109.235 -178.314 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.438 " O4'" ' HD2' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.419 -2.795 1 O4'-C1'-N19 114.423 6.223 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . 0.602 " H4'" ' CE1' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.414 -3.229 1 C3'-C2'-C1' 105.714 4.683 OUTLIER-DELTA 0.193 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.404 " O4'" ' CZ ' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.414 -3.264 2 O4'-C1'-N19 113.932 5.732 OUTLIER-DELTA 0.0 OUTLIER . 0.0 . . . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.455 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.419 -2.847 0 O4'-C4'-C3' 109.07 2.55 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.462 " H4'" ' HB2' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.414 -3.259 0 P-O3'-C3' 123.437 3.114 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.1 m . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 120.164 0.031 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 95.9 m-70 -133.48 5.92 3.76 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.038 0.535 . . . . 0.0 111.801 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -99.2 2.66 45.96 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.186 0.594 . . . . 0.0 110.698 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -139.39 174.91 10.03 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.725 0.81 . . . . 0.0 110.56 -179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.8 10.13 85.49 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -140.27 153.09 46.39 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.466 0.706 . . . . 0.0 109.782 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.5 tmm_? -72.78 136.85 45.53 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 122.695 0.398 . . . . 0.0 110.402 -177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.5 m -141.06 172.28 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 C-N-CA 123.889 0.876 . . . . 0.0 109.934 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -129.82 168.75 16.1 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 123.185 0.594 . . . . 0.0 109.887 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 26.7 tpt180 -124.96 161.35 26.87 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 122.876 0.47 . . . . 0.0 109.861 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -117.69 159.16 23.42 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -173.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.7 t -98.18 174.43 6.53 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.506 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 45.6 mtm105 -77.5 30.0 0.15 Allowed 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.159 0.584 . . . . 0.0 110.992 178.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -143.3 144.03 31.94 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.195 0.598 . . . . 0.0 110.701 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.0 m -141.66 155.0 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.081 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.801 176.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.409 ' CZ ' ' CA ' ' A' ' 70' ' ' GLY . 2.4 t80 -94.97 129.54 41.99 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 107.402 -1.332 . . . . 0.0 107.402 169.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.1 p -108.7 93.07 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 122.203 1.001 . . . . 0.0 108.455 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.409 ' CA ' ' CZ ' ' A' ' 68' ' ' PHE . . . -86.49 155.81 28.58 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.18 -0.918 . . . . 0.0 111.005 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 67.76 26.86 73.71 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-O 119.045 -0.864 . . . . 0.0 113.912 171.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.4 pp -75.23 144.95 79.45 Favored Pre-proline 0 N--CA 1.453 -0.277 0 CA-C-N 118.981 1.391 . . . . 0.0 108.208 173.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 39.9 Cg_endo -62.22 120.07 7.47 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.822 2.348 . . . . 0.0 110.343 -172.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 85.8 Cg_exo -54.84 -11.38 3.47 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 124.666 3.577 . . . . 0.0 115.238 -178.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -82.89 -7.65 59.64 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 118.416 0.553 . . . . 0.0 112.307 -176.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.439 ' C ' HD12 ' A' ' 76' ' ' ILE . 2.2 pp -142.98 168.81 12.99 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -165.12 179.7 6.19 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 45.27 -99.42 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 126.144 1.777 . . . . 0.0 114.339 177.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -58.1 -28.32 64.52 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -80.38 -24.28 39.86 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.204 0.456 . . . . 0.0 110.29 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.1 mt -76.29 -46.05 33.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 177.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.1 m -63.25 -21.13 66.04 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.752 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.16 -18.37 24.58 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.1 m -79.15 -27.05 42.72 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.765 0.711 . . . . 0.0 112.139 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -114.99 11.87 16.6 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -178.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -64.85 -20.34 66.36 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.828 0.451 . . . . 0.0 112.189 -176.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.6 ptp180 -75.24 -0.26 18.9 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -115.59 -4.48 12.24 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 141.86 177.34 16.89 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -71.24 146.05 50.27 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.475 2.784 . . . . 0.0 110.246 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.415 ' CD2' ' N ' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -162.37 161.41 27.4 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.965 -169.744 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 21.9 mm -138.35 160.53 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 174.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.63 144.2 34.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -150.46 167.23 27.77 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.303 0.573 . . . . 0.0 110.826 -176.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.431 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 35.7 p90 -157.77 162.74 26.6 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 175.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.562 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 39.2 Cg_endo -75.28 -15.64 20.03 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.304 2.002 . . . . 0.0 110.527 -169.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.562 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 20.8 m-70 -89.54 -0.49 57.54 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.829 0.851 . . . . 0.0 111.18 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.15 110.29 4.47 Favored 'General case' 0 C--N 1.339 0.13 0 C-N-CA 123.813 0.845 . . . . 0.0 109.108 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -156.51 161.24 40.03 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.557 0.343 . . . . 0.0 111.049 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 58.88 -5.78 0.06 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.842 1.657 . . . . 0.0 114.262 177.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 10.0 t 54.8 27.31 8.72 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.816 0.847 . . . . 0.0 112.684 -178.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.5 mttp -129.38 17.11 5.99 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.367 0.667 . . . . 0.0 111.696 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 35.5 t -135.27 146.15 48.26 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 123.075 0.55 . . . . 0.0 109.611 177.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -142.72 -1.06 1.15 Allowed 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -174.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.514 ' N ' ' CD ' ' A' ' 106' ' ' PRO . 83.6 m-85 -136.54 29.05 0.13 Allowed Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.514 ' CD ' ' N ' ' A' ' 105' ' ' PHE . 46.8 Cg_endo -66.33 -29.91 45.57 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 CA-C-N 120.839 1.335 . . . . 0.0 114.457 177.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -81.19 168.41 16.92 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 CA-C-N 122.321 1.865 . . . . 0.0 110.29 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -79.42 -50.22 11.14 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.73 36.77 0.11 Allowed Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 -175.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.474 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.0 OUTLIER -146.39 150.55 35.89 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 117.338 0.569 . . . . 0.0 109.494 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.93 -175.03 5.23 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 122.762 0.425 . . . . 0.0 110.344 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -137.93 142.45 40.56 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 -178.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.4 mp -107.8 151.38 25.8 Favored 'General case' 0 CA--C 1.522 -0.099 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.9 mp -113.82 146.45 39.94 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 169.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -134.69 168.11 19.62 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.873 0.469 . . . . 0.0 110.578 -178.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -103.83 -25.31 13.13 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.572 -178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -122.38 152.54 40.09 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -84.36 -15.01 47.93 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.759 176.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 23.3 t -90.52 -14.95 31.63 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 122.707 0.403 . . . . 0.0 110.635 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 58.4 m -75.49 -39.34 58.68 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 122.037 -0.414 . . . . 0.0 110.078 177.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.1 m -72.2 -22.15 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -77.87 -29.9 50.59 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.71 -35.29 45.16 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.656 0.207 . . . . 0.0 111.148 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.1 pp -80.11 -16.31 55.25 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.252 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 79.5 mt -96.39 -17.4 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 C-N-CA 122.282 0.233 . . . . 0.0 111.084 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -100.43 -10.95 20.62 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.464 0.574 . . . . 0.0 112.478 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -119.74 44.87 2.28 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 123.074 0.55 . . . . 0.0 110.825 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 31.4 p -141.48 179.92 6.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.741 0.416 . . . . 0.0 111.904 -175.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.462 ' N ' HD12 ' A' ' 129' ' ' ILE . 2.7 mp -82.71 157.5 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -123.67 157.3 34.15 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-O 120.948 0.404 . . . . 0.0 111.199 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -144.98 -179.07 6.37 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 175.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -41.29 -23.44 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 -169.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -161.04 4.82 0.09 OUTLIER Glycine 0 CA--C 1.529 0.946 0 CA-C-N 119.491 1.041 . . . . 0.0 113.47 175.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -146.28 -170.53 3.52 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.598 1.199 . . . . 0.0 111.096 -173.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -115.99 165.29 13.29 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.074 0.55 . . . . 0.0 111.815 -174.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -143.88 147.49 34.11 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.267 0.627 . . . . 0.0 109.404 175.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.6 mp -128.38 159.94 33.77 Favored 'General case' 0 N--CA 1.462 0.168 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 170.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.4 p -91.4 149.84 21.53 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 122.082 -0.386 . . . . 0.0 110.907 178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 28.4 m -144.43 174.11 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 C-N-CA 123.391 0.676 . . . . 0.0 109.944 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 77.4 p -67.71 -14.13 62.69 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 122.687 0.395 . . . . 0.0 111.669 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.425 ' N ' ' HD3' ' A' ' 142' ' ' PRO . 39.0 t 47.24 57.38 17.62 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 124.313 1.045 . . . . 0.0 113.561 174.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 141' ' ' SER . 31.5 Cg_exo -61.9 -9.41 14.18 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.922 2.414 . . . . 0.0 113.945 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.442 HG21 ' HD2' ' A' ' 74' ' ' PRO . 55.3 m -82.37 -27.98 31.8 Favored 'General case' 0 C--N 1.34 0.179 0 CA-C-N 118.5 0.591 . . . . 0.0 109.6 178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.475 HD12 ' HD3' ' A' ' 147' ' ' LYS . 4.4 mt -150.31 -122.5 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -170.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -147.47 122.21 9.9 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.803 0.441 . . . . 0.0 110.311 174.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 24.6 t70 47.18 32.78 2.18 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 172.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.475 ' HD3' HD12 ' A' ' 144' ' ' ILE . 14.0 pttp -82.94 148.56 57.31 Favored Pre-proline 0 C--N 1.34 0.186 0 CA-C-N 119.786 1.176 . . . . 0.0 110.017 176.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -83.5 168.27 12.98 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.667 2.911 . . . . 0.0 112.245 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.9 m -128.3 146.78 33.25 Favored 'Isoleucine or valine' 0 C--N 1.339 0.142 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.501 HE21 ' C ' ' A' ' 150' ' ' GLN . 0.0 OUTLIER -93.02 149.52 21.16 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -171.601 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 45.0 mm -122.49 144.65 31.13 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 C-N-CA 124.246 1.018 . . . . 0.0 109.646 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.83 100.25 3.09 Favored Pre-proline 0 CA--C 1.529 0.167 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -178.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -73.39 162.27 40.62 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.777 2.984 . . . . 0.0 111.799 -178.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 70.0 t-105 -89.82 149.54 22.63 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 116.935 -0.12 . . . . 0.0 110.799 175.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -109.04 115.23 29.66 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 175.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.768 ' H ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -83.85 12.09 6.61 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -169.634 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 9.2 t -96.2 -1.79 47.56 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 112.743 0.646 . . . . 0.0 112.743 -173.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -144.5 20.33 1.69 Allowed 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.0 m -64.82 -21.06 66.71 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -175.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -153.74 156.29 37.5 Favored 'General case' 0 N--CA 1.456 -0.125 0 CA-C-N 118.014 0.37 . . . . 0.0 110.854 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -158.17 150.56 22.15 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.1 p -142.37 151.82 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.083 0 O-C-N 121.944 -0.473 . . . . 0.0 110.174 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 64.2 mtm -127.84 24.7 6.05 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 122.366 0.266 . . . . 0.0 111.409 -175.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -158.94 -49.91 0.06 Allowed 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 64.95 11.64 51.67 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.98 -0.9 . . . . 0.0 113.939 172.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 26.3 t -138.75 -27.63 0.83 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 118.776 1.288 . . . . 0.0 114.332 -175.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 22.5 mm100 -77.08 147.34 76.68 Favored Pre-proline 0 CA--C 1.529 0.157 0 CA-C-N 119.115 0.871 . . . . 0.0 111.03 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -75.43 157.42 40.96 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.909 3.073 . . . . 0.0 110.969 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 10.6 mp -118.48 161.93 19.19 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.688 0.795 . . . . 0.0 109.85 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -137.5 152.89 73.87 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -73.68 -0.19 9.03 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.603 2.869 . . . . 0.0 111.432 -176.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 40.9 ptt85 -114.99 7.97 15.69 Favored 'General case' 0 N--CA 1.456 -0.129 0 C-N-CA 124.206 1.002 . . . . 0.0 111.494 -178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -123.33 19.72 9.74 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.825 0.45 . . . . 0.0 111.39 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 26.0 m -115.6 139.53 50.02 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.759 0.314 . . . . 0.0 111.079 -175.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.5 tt -118.32 149.57 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.043 0 C-N-CA 123.178 0.591 . . . . 0.0 109.934 -176.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -109.97 147.28 33.76 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 173.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 73.2 t -134.9 132.25 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -177.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -152.39 167.16 31.33 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 112.27 -0.332 . . . . 0.0 112.27 -177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 87.1 11.82 69.13 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -170.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 17.8 m -65.93 156.21 84.49 Favored Pre-proline 0 CA--C 1.531 0.213 0 C-N-CA 122.919 0.488 . . . . 0.0 111.272 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -72.76 -171.98 0.87 Allowed 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 123.941 3.094 . . . . 0.0 109.857 174.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 5.9 tmm_? -54.26 -50.92 82.07 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-O 118.371 -0.823 . . . . 0.0 111.874 -177.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -75.42 139.32 23.12 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 C-N-CA 122.143 1.895 . . . . 0.0 110.221 173.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.0 12.66 0.5 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 6.0 ptp85 -42.14 140.07 1.21 Allowed 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.125 0.97 . . . . 0.0 112.209 177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.47 -17.77 62.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.746 -176.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.75 -50.45 75.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.092 0 CA-C-O 120.699 0.285 . . . . 0.0 110.294 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -83.77 -25.93 30.07 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.797 -0.183 . . . . 0.0 110.562 -176.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 26.0 tp -69.81 -32.97 71.71 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -80.68 -32.2 36.07 Favored 'General case' 0 N--CA 1.451 -0.375 0 O-C-N 122.335 -0.228 . . . . 0.0 111.268 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.3 mmt -68.66 -31.58 70.8 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.6 mt -79.01 -33.26 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 O-C-N 122.231 -0.293 . . . . 0.0 110.49 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.7 mmt -73.36 -19.42 61.01 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.534 0.606 . . . . 0.0 109.984 176.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -83.62 -24.93 31.22 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 122.371 0.268 . . . . 0.0 111.224 175.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -87.76 -16.93 32.82 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -117.19 -17.01 10.34 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -134.68 23.06 3.64 Favored 'General case' 0 C--O 1.231 0.102 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -173.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 73.87 -144.41 33.71 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 175.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -72.44 123.51 9.21 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 112.145 -0.382 . . . . 0.0 112.145 -173.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 90.8 t -111.57 137.74 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.107 0 C-N-CA 124.745 1.218 . . . . 0.0 108.027 173.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.9 p -92.76 -41.44 10.13 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 118.364 0.529 . . . . 0.0 111.902 -177.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -156.61 155.64 32.17 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.144 0.429 . . . . 0.0 111.676 -171.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -149.7 159.6 44.21 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.33 0.586 . . . . 0.0 111.006 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -174.67 170.48 43.6 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 111.625 -0.59 . . . . 0.0 111.625 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.7 mp -82.42 148.92 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.964 -1.495 . . . . 0.0 106.964 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -57.99 119.03 6.04 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 22.6 p -138.35 158.64 43.88 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -117.07 131.96 23.71 Favored Pre-proline 0 N--CA 1.454 -0.274 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -77.61 -16.1 15.07 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 124.503 3.469 . . . . 0.0 114.47 -172.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -110.97 -25.14 9.97 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.334 0.97 . . . . 0.0 111.381 -178.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -86.86 -10.2 53.98 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 169.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm 49.89 45.81 24.71 Favored 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.647 1.179 . . . . 0.0 111.839 175.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.32 156.22 39.66 Favored Pre-proline 0 CA--C 1.532 0.272 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -80.69 157.25 21.47 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.527 2.818 . . . . 0.0 111.2 174.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.41 ' HA ' ' N3 ' ' B' ' 4' ' ' ' U' . 35.2 mtmm -119.11 21.55 12.27 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.595 0.758 . . . . 0.0 111.04 177.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 70.23 -178.15 31.08 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 110.164 -1.175 . . . . 0.0 110.164 -176.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 55.34 -173.98 0.05 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.334 0.567 . . . . 0.0 111.869 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -140.92 168.79 25.18 Favored Glycine 0 CA--C 1.524 0.632 0 O-C-N 121.608 -0.682 . . . . 0.0 112.979 -177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -146.58 149.8 34.26 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 97.1 t -136.68 151.09 27.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -178.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -124.38 145.72 49.29 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 122.916 0.486 . . . . 0.0 111.355 -177.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -122.38 151.23 41.41 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.697 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 62.9 p -91.96 -0.64 57.49 Favored 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 116.78 -0.191 . . . . 0.0 111.242 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -132.5 144.83 50.71 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 122.901 0.48 . . . . 0.0 110.243 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -80.12 -9.36 59.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.244 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.0 tp60 -85.09 -42.18 15.04 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 34.8 p -74.63 -24.6 58.86 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -68.45 -48.81 63.56 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 119.639 -0.22 . . . . 0.0 110.993 175.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.6 pp -71.95 -12.46 15.91 Favored 'Isoleucine or valine' 0 C--N 1.338 0.066 0 CA-C-N 118.372 0.533 . . . . 0.0 110.991 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.96 -27.83 30.22 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 110.349 -0.241 . . . . 0.0 110.349 173.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.59 -27.23 34.37 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.7 pt -106.92 29.58 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.039 0.536 . . . . 0.0 110.372 174.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.8 t -78.35 -14.57 59.34 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.29 0.636 . . . . 0.0 111.813 -177.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -155.79 144.08 20.05 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 54.9 ttm-85 -60.2 -33.12 71.8 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 119.409 -0.329 . . . . 0.0 111.584 -178.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -119.67 116.26 25.62 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.738 0.304 . . . . 0.0 110.42 178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 34.8 m -108.62 159.4 8.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.333 178.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -86.6 143.82 27.47 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 120.949 0.404 . . . . 0.0 111.155 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.5 mp -133.85 103.97 6.09 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 173.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -135.44 153.31 51.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.226 -174.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 4.5 m-70 -138.73 11.88 2.7 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.123 174.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 175.17 -134.45 2.74 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -175.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -76.54 12.49 1.25 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.096 0.558 . . . . 0.0 111.381 177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.1 mt -66.91 157.97 5.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 124.41 1.084 . . . . 0.0 110.112 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -145.82 21.02 1.46 Allowed 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -176.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -67.87 160.48 28.35 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.054 0.542 . . . . 0.0 111.986 -173.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.16 161.99 35.4 Favored 'General case' 0 C--N 1.337 0.065 0 C-N-CA 124.353 1.061 . . . . 0.0 110.229 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.4 p -153.8 156.61 5.17 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.092 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -89.32 138.47 31.41 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 117.671 0.214 . . . . 0.0 110.624 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.97 158.46 21.82 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.101 0 CA-C-O 120.828 0.347 . . . . 0.0 111.233 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.424 ' HG3' ' H61' ' B' ' 5' ' ' ' A' . 0.0 OUTLIER -161.02 159.25 24.78 Favored Pre-proline 0 N--CA 1.454 -0.225 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 171.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -59.81 140.21 92.1 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.629 2.219 . . . . 0.0 109.78 174.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -78.41 168.24 20.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.244 179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.4 p -149.7 153.27 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 123.067 0.547 . . . . 0.0 110.319 -170.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.403 ' H ' HD23 ' A' ' 255' ' ' LEU . 2.0 pt? . . . . . 0 C--O 1.251 1.14 0 CA-C-O 116.995 -1.478 . . . . 0.0 111.203 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.45 ' C5 ' ' CD1' ' A' ' 144' ' ' ILE . . . . . . . . 0 O4'--C4' 1.425 -2.324 5 O4'-C1'-N19 115.888 7.688 OUTLIER-DELTA 0.0 '__' . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . 0.446 ' C6 ' ' P ' ' B' ' 2' ' ' ' U' . . . . . . . . 0 P--O5' 1.622 2.877 0 O4'-C1'-N19 111.896 3.696 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.474 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.425 -2.336 2 O4'-C1'-N19 113.477 5.277 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.41 ' N3 ' ' HA ' ' A' ' 215' ' ' LYS . . . . . . . . 0 O4'--C4' 1.419 -2.792 0 O5'-C5'-C4' 106.319 -2.772 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.424 ' H61' ' HG3' ' A' ' 251' ' ' LYS . . . . . . . . 0 O4'--C4' 1.414 -3.233 1 C5'-C4'-C3' 108.399 -4.734 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 43.1 m . . . . . 0 N--CA 1.475 0.776 0 CA-C-O 120.45 0.167 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.9 p80 -146.34 169.04 19.65 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.216 0.606 . . . . 0.0 110.437 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.457 ' CD ' ' H ' ' A' ' 55' ' ' GLN . 0.1 OUTLIER -94.67 10.78 33.58 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.261 0.624 . . . . 0.0 112.567 -175.909 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -105.45 9.63 33.54 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 122.883 0.473 . . . . 0.0 111.278 179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -71.55 172.04 46.07 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 123.049 0.357 . . . . 0.0 112.36 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -147.56 159.76 43.39 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.487 0.715 . . . . 0.0 109.352 -179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -65.71 -23.76 66.83 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 122.873 0.469 . . . . 0.0 111.485 -178.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.4 m -143.74 157.56 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.048 0 C-N-CA 123.865 0.866 . . . . 0.0 109.569 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.461 ' HB3' ' CE2' ' A' ' 63' ' ' TYR . 14.4 mp0 -91.2 6.96 43.05 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 122.292 0.237 . . . . 0.0 111.428 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.89 37.6 3.74 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 125.236 1.414 . . . . 0.0 114.479 175.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.461 ' CE2' ' HB3' ' A' ' 61' ' ' GLU . 29.7 m-85 -75.33 170.83 15.32 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.153 0.501 . . . . 0.0 112.304 177.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.4 t -100.38 27.45 5.72 Favored 'General case' 0 C--N 1.338 0.066 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -168.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.517 ' HA ' ' CE2' ' A' ' 115' ' ' PHE . 0.0 OUTLIER 55.33 17.41 2.1 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.122 0.419 . . . . 0.0 111.155 -176.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -147.82 140.24 24.47 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.247 0.619 . . . . 0.0 111.632 -177.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.5 m -136.06 148.52 27.65 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.095 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.704 169.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.422 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 4.3 t80 -85.22 140.45 30.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 174.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.9 p -122.98 98.55 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 121.779 0.8 . . . . 0.0 108.906 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -81.36 169.49 51.34 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.41 26.76 71.92 Favored Glycine 0 CA--C 1.526 0.739 0 CA-C-O 119.226 -0.763 . . . . 0.0 113.901 175.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.457 ' HB3' ' H ' ' A' ' 110' ' ' TYR . 18.5 tp -63.0 122.18 73.46 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 119.626 1.713 . . . . 0.0 107.352 173.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -73.65 170.07 20.86 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 123.164 2.576 . . . . 0.0 111.537 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.46 179.06 0.51 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 124.357 3.371 . . . . 0.0 112.753 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 61.45 -79.7 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.411 HD12 ' C ' ' A' ' 76' ' ' ILE . 2.3 pp -65.2 164.8 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 CA-C-N 118.288 0.494 . . . . 0.0 111.539 -177.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -146.88 -24.67 0.41 Allowed 'General case' 0 CA--C 1.529 0.167 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -154.28 -36.69 0.1 Allowed 'General case' 0 N--CA 1.457 -0.109 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -174.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -67.48 -39.99 85.25 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.006 0.366 . . . . 0.0 111.944 -173.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -74.48 -35.33 63.25 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.179 -0.326 . . . . 0.0 111.37 -172.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 19.7 pt -83.91 -28.03 7.34 Favored 'Isoleucine or valine' 0 C--O 1.23 0.041 0 O-C-N 122.145 -0.347 . . . . 0.0 110.967 179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.0 m -79.77 -5.63 55.68 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.15 -14.13 14.99 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 171.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.6 m -95.14 -17.79 21.49 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -120.65 0.74 10.49 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 118.374 0.534 . . . . 0.0 111.986 -178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 52.0 tpt85 -70.38 -21.4 62.87 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 122.716 0.406 . . . . 0.0 110.831 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -69.15 -5.71 24.16 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.674 0.789 . . . . 0.0 111.947 178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -112.68 -13.34 13.27 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 122.239 0.215 . . . . 0.0 111.427 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 155.5 168.6 18.81 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -70.9 149.14 59.1 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 123.294 2.663 . . . . 0.0 110.804 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.404 ' N ' ' CD2' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -164.77 158.73 17.86 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -170.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.489 HG22 ' H ' ' A' ' 93' ' ' VAL . 12.2 mm -136.86 173.17 13.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 171.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.489 ' H ' HG22 ' A' ' 92' ' ' ILE . 7.3 p -137.6 156.03 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 118.445 0.566 . . . . 0.0 110.606 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -149.18 164.24 35.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 122.542 0.337 . . . . 0.0 111.039 -175.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.461 ' CZ2' ' HE3' ' A' ' 98' ' ' LYS . 24.2 p90 -155.46 156.32 30.75 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 171.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.684 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 25.5 Cg_endo -75.42 -11.66 20.72 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 124.026 3.151 . . . . 0.0 110.683 -169.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.684 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 89.9 m-70 -105.52 5.94 31.87 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.847 0.859 . . . . 0.0 111.363 -177.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.461 ' HE3' ' CZ2' ' A' ' 95' ' ' TRP . 68.8 tttt -64.65 157.84 26.09 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.717 0.807 . . . . 0.0 112.568 -176.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 60.45 173.38 0.09 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.037 1.335 . . . . 0.0 113.303 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 53.54 82.77 0.08 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.797 1.239 . . . . 0.0 111.796 -178.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 17.9 m 56.72 19.66 4.53 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.554 1.142 . . . . 0.0 113.908 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -134.8 26.84 3.64 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.412 0.685 . . . . 0.0 110.893 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.2 m -86.61 163.49 17.39 Favored 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 123.085 0.554 . . . . 0.0 111.037 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 26.6 t80 57.16 9.59 0.7 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.925 1.29 . . . . 0.0 114.129 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.422 ' CD1' ' HD2' ' A' ' 106' ' ' PRO . 44.2 t80 -162.3 130.0 2.72 Favored Pre-proline 0 CA--C 1.534 0.349 0 O-C-N 121.567 -0.708 . . . . 0.0 109.85 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.422 ' HD2' ' CD1' ' A' ' 105' ' ' PHE . 83.2 Cg_endo -73.84 168.35 25.0 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 124.094 3.196 . . . . 0.0 109.945 175.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -62.21 -28.18 79.09 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.71 2.273 . . . . 0.0 111.099 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -162.14 -41.83 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 171.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 176.54 -163.81 33.15 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 110.176 -1.169 . . . . 0.0 110.176 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.457 ' H ' ' HB3' ' A' ' 72' ' ' LEU . 0.0 OUTLIER 60.54 147.7 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 113.859 -1.171 . . . . 0.0 113.991 -177.411 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.49 -173.45 3.99 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.185 0.594 . . . . 0.0 110.043 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -142.35 134.0 26.78 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.424 ' C ' HD12 ' A' ' 114' ' ' LEU . 10.6 mp -91.19 149.64 21.7 Favored 'General case' 0 CA--C 1.522 -0.108 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -176.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.424 HD12 ' C ' ' A' ' 113' ' ' LEU . 9.8 mp -118.59 144.69 45.95 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 173.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.517 ' CE2' ' HA ' ' A' ' 65' ' ' ARG . 12.7 p90 -158.93 177.35 11.25 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -117.89 -12.74 10.12 Favored 'General case' 0 C--O 1.23 0.074 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -129.29 142.66 50.77 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 120.973 0.416 . . . . 0.0 112.03 -174.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -80.76 -6.05 57.97 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.831 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 75.1 p -82.73 -19.26 38.28 Favored 'General case' 0 N--CA 1.457 -0.113 0 O-C-N 122.137 -0.352 . . . . 0.0 111.075 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.5 t -72.58 -44.27 62.27 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.0 m -70.84 -26.2 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 177.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -69.94 -41.6 74.35 Favored 'General case' 0 N--CA 1.454 -0.267 0 O-C-N 121.764 -0.585 . . . . 0.0 110.702 -176.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.54 -36.6 60.44 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 118.04 0.382 . . . . 0.0 111.792 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 1.2 pp -76.86 -15.37 59.73 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 120.361 -0.535 . . . . 0.0 111.06 -178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 77.3 mt -95.42 -17.32 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 122.336 0.254 . . . . 0.0 110.467 176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -90.84 -14.92 30.91 Favored 'General case' 0 CA--C 1.532 0.259 0 O-C-N 121.608 -0.682 . . . . 0.0 111.121 177.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -118.29 46.32 1.82 Allowed 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.491 0.717 . . . . 0.0 111.437 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 22.5 p -138.27 176.7 8.47 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 112.767 0.655 . . . . 0.0 112.767 -176.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 39.5 mm -92.88 164.35 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.129 0 C-N-CA 125.363 1.465 . . . . 0.0 108.351 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -133.46 150.63 51.74 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.778 0.323 . . . . 0.0 110.836 -179.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -130.16 -179.86 5.48 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 175.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -55.84 -4.76 0.12 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.792 1.404 . . . . 0.0 114.792 -171.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -170.17 14.03 0.05 OUTLIER Glycine 0 CA--C 1.527 0.831 0 CA-C-N 118.854 0.752 . . . . 0.0 113.137 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.432 ' HE3' ' HB2' ' A' ' 134' ' ' LYS . 21.4 ttmt -157.89 -178.05 7.02 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 118.596 1.198 . . . . 0.0 111.23 -174.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.42 ' O ' ' HA ' ' A' ' 150' ' ' GLN . 67.2 mt -112.24 169.56 8.78 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.078 0.551 . . . . 0.0 110.972 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.472 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 0.3 OUTLIER -145.81 139.53 26.45 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.27 0.628 . . . . 0.0 109.717 179.126 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.0 mp -136.8 149.71 47.91 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 118.346 0.521 . . . . 0.0 110.069 170.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 26.3 p -71.1 154.57 41.64 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 176.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 8.9 p -148.77 7.34 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 O-C-N 122.402 -0.187 . . . . 0.0 111.479 -177.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.2 m 53.16 46.99 25.44 Favored 'General case' 0 CA--C 1.529 0.165 0 O-C-N 121.847 -0.533 . . . . 0.0 110.799 -177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 28.9 t -47.6 139.83 8.27 Favored Pre-proline 0 CA--C 1.53 0.199 0 C-N-CA 124.351 1.06 . . . . 0.0 112.234 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -80.1 -15.14 11.79 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 124.142 3.228 . . . . 0.0 113.854 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.7 t -89.47 -24.0 21.95 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 119.841 1.201 . . . . 0.0 111.657 -177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.49 HG22 ' H ' ' A' ' 145' ' ' LYS . 2.4 mm -121.63 -174.95 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.077 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.49 ' H ' HG22 ' A' ' 144' ' ' ILE . 63.9 pttt -69.97 -32.67 71.0 Favored 'General case' 0 CA--C 1.53 0.196 0 O-C-N 121.346 -0.846 . . . . 0.0 109.139 171.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -165.58 150.14 8.59 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 125.781 1.633 . . . . 0.0 107.187 170.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.85 105.49 2.49 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 -177.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.472 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 78.1 Cg_exo -53.39 145.11 47.17 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 124.031 3.154 . . . . 0.0 113.905 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 6.4 m -116.72 148.61 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.059 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . 0.42 ' HA ' ' O ' ' A' ' 135' ' ' LEU . 25.3 mp0 -82.03 157.33 24.21 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -174.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 28.0 mm -136.59 142.37 38.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.138 0 C-N-CA 123.379 0.672 . . . . 0.0 109.36 171.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.6 ttp85 -157.66 104.4 1.8 Allowed Pre-proline 0 CA--C 1.533 0.322 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 171.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -60.72 167.17 8.84 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 124.507 3.471 . . . . 0.0 114.819 175.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 11.7 t-105 -111.1 136.43 50.15 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.348 171.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 33.1 p-10 -103.18 150.12 23.99 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.478 0.711 . . . . 0.0 112.455 -176.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.6 mp -94.47 97.7 10.35 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.466 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 23.9 t -156.09 -33.1 0.09 Allowed 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.803 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -138.78 22.36 2.67 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.7 m -68.62 -25.04 64.65 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -175.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -153.67 159.62 42.11 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.239 0.616 . . . . 0.0 110.518 -178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -151.77 154.26 35.91 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 177.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 8.6 t -136.42 144.29 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.069 0 N-CA-C 110.394 -0.224 . . . . 0.0 110.394 -174.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 63.8 mtm -141.74 15.36 2.14 Favored 'General case' 0 CA--C 1.529 0.154 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 178.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -151.38 10.79 0.59 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.336 0.516 . . . . 0.0 112.062 -177.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 75.94 12.25 84.1 Favored Glycine 0 CA--C 1.529 0.936 0 O-C-N 121.764 -0.585 . . . . 0.0 111.931 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.5 m 52.89 73.17 0.37 Allowed 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -70.85 173.55 4.65 Favored Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -54.44 133.97 59.07 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.208 1.938 . . . . 0.0 112.073 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.4 mp -106.66 160.87 15.12 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 123.603 0.761 . . . . 0.0 109.904 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -150.08 145.04 18.2 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.3 -20.84 33.78 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.425 2.75 . . . . 0.0 114.176 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -91.1 2.93 55.96 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 118.457 0.571 . . . . 0.0 111.126 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -131.07 15.96 5.14 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 122.655 0.382 . . . . 0.0 111.117 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 18.7 m -128.08 140.17 52.1 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 120.713 0.292 . . . . 0.0 110.805 -176.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.4 tt -113.28 150.57 15.35 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 C-N-CA 123.204 0.602 . . . . 0.0 109.992 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -120.84 153.16 37.5 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 18.0 m -141.68 151.74 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 122.792 0.437 . . . . 0.0 110.422 179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -164.34 171.48 39.87 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.196 -0.761 . . . . 0.0 111.196 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.47 11.04 80.95 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 -176.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 11.9 p -63.26 138.62 97.39 Favored Pre-proline 0 CA--C 1.533 0.307 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -66.18 -52.89 0.75 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.502 2.135 . . . . 0.0 112.218 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.428 ' H ' ' CD ' ' A' ' 183' ' ' PRO . 24.5 tpt180 -162.78 -47.24 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.318 0 CA-C-O 118.331 -0.842 . . . . 0.0 113.066 176.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.428 ' CD ' ' H ' ' A' ' 182' ' ' ARG . 16.3 Cg_exo -71.38 140.93 37.75 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.747 2.298 . . . . 0.0 111.778 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.696 ' CD1' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -151.88 -87.12 0.07 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 119.151 -0.452 . . . . 0.0 111.463 176.514 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.696 ' H ' ' CD1' ' A' ' 184' ' ' LEU . 71.2 mtp180 59.38 126.48 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.126 0 C-N-CA 126.393 1.877 . . . . 0.0 112.181 -173.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.5 -20.23 65.42 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 121.896 -0.503 . . . . 0.0 110.364 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 68.1 t -69.43 -54.01 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 122.434 0.294 . . . . 0.0 110.616 179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -81.71 -23.38 36.81 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.341 -0.224 . . . . 0.0 111.054 -174.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 53.1 tp -71.0 -33.6 70.54 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -79.49 -33.45 42.2 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 22.4 mmt -69.83 -38.63 76.61 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 117.877 0.308 . . . . 0.0 110.304 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 94.1 mt -73.1 -37.32 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.6 mmt -67.07 -20.08 65.76 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.975 -0.453 . . . . 0.0 110.695 174.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -86.3 -19.88 29.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 117.872 0.306 . . . . 0.0 111.784 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -96.58 -14.34 22.29 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.0 -13.45 10.02 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -136.66 21.22 3.1 Favored 'General case' 0 C--N 1.338 0.09 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -175.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 81.83 -150.14 29.09 Favored Glycine 0 CA--C 1.526 0.768 0 O-C-N 122.141 -0.349 . . . . 0.0 112.252 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.19 121.81 5.98 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 123.086 0.374 . . . . 0.0 112.221 -171.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 90.9 t -100.49 147.19 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 C-N-CA 124.242 1.017 . . . . 0.0 109.612 177.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 46.7 t -102.12 -43.73 5.66 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -159.7 158.42 31.33 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.37 0.129 . . . . 0.0 111.105 -170.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -152.88 156.97 39.97 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.849 0.46 . . . . 0.0 110.648 177.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -178.16 -176.05 45.8 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 42.8 mm -113.58 90.81 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 14.1 t70 56.72 -63.57 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -169.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 55.3 p 45.67 56.41 5.88 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -64.87 130.59 94.89 Favored Pre-proline 0 N--CA 1.453 -0.307 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 176.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -78.32 -14.58 14.67 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 124.517 3.478 . . . . 0.0 113.681 -173.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -94.65 -36.82 11.61 Favored 'General case' 0 N--CA 1.457 -0.108 0 CA-C-N 118.643 0.656 . . . . 0.0 110.317 -177.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 94.3 mt -96.44 -7.39 35.01 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 122.867 0.467 . . . . 0.0 109.925 176.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 65.6 mttm 50.16 44.55 26.07 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.792 1.237 . . . . 0.0 111.87 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.99 155.53 62.33 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -174.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -84.74 177.83 5.28 Favored 'Trans proline' 0 N--CA 1.45 -1.056 0 C-N-CA 123.807 3.005 . . . . 0.0 111.073 174.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 13.4 ttmt -138.73 22.81 2.67 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.113 0.565 . . . . 0.0 110.862 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 62.72 8.24 20.01 Favored Glycine 0 CA--C 1.53 1.015 0 CA-C-O 119.63 -0.539 . . . . 0.0 113.677 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -128.58 141.04 51.49 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.952 0.876 . . . . 0.0 109.274 -179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -86.16 161.64 34.55 Favored Glycine 0 CA--C 1.525 0.713 0 CA-C-O 121.526 0.515 . . . . 0.0 113.942 -171.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -149.53 148.51 29.47 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 173.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.9 t -141.64 154.82 19.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -135.69 150.48 49.59 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.619 0.247 . . . . 0.0 110.61 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -124.66 154.57 40.57 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.862 -177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 66.5 p -86.02 3.01 44.19 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.156 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -139.3 140.53 37.61 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.32 0.648 . . . . 0.0 110.005 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -74.2 -19.68 60.45 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.395 -0.191 . . . . 0.0 110.661 178.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -71.64 -37.0 70.91 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 44.2 m -72.49 -30.26 64.37 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -69.25 -49.97 51.31 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 119.484 -0.293 . . . . 0.0 111.041 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 41.8 pt -68.16 -18.31 23.33 Favored 'Isoleucine or valine' 0 CA--C 1.526 0.032 0 CA-C-N 118.43 0.559 . . . . 0.0 110.79 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -81.55 -25.63 35.69 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 110.524 -0.176 . . . . 0.0 110.524 175.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -84.95 -23.23 28.87 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.6 pt -105.23 25.75 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 122.734 0.414 . . . . 0.0 110.833 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 20.0 t -84.54 -9.4 58.36 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.12 0.568 . . . . 0.0 112.271 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -156.65 143.97 18.98 Favored 'General case' 0 C--O 1.231 0.085 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' A' ' 249' ' ' GLU . 10.1 ptp180 -60.04 -52.57 64.81 Favored 'General case' 0 C--O 1.225 -0.224 0 CA-C-O 118.749 -0.643 . . . . 0.0 112.214 -175.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -93.05 115.79 28.44 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 119.374 0.988 . . . . 0.0 110.139 -178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.408 HG22 ' H ' ' A' ' 237' ' ' VAL . 0.6 OUTLIER -83.52 147.24 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.13 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 171.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -81.99 127.19 32.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -127.84 17.25 6.82 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -84.15 130.34 34.85 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.165 0.586 . . . . 0.0 112.26 -174.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -152.49 143.41 22.99 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 61.85 -144.31 48.93 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -177.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -90.1 8.73 31.27 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.086 0.554 . . . . 0.0 111.669 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 66.7 mt -96.62 153.81 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 123.442 0.697 . . . . 0.0 110.264 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -130.52 133.95 46.66 Favored 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -145.37 145.37 31.15 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 124.502 1.121 . . . . 0.0 108.576 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -158.93 155.31 27.4 Favored 'General case' 0 C--O 1.231 0.082 0 C-N-CA 123.29 0.636 . . . . 0.0 109.622 176.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 8.7 p -157.6 154.31 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 174.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.443 ' HA ' ' O ' ' A' ' 235' ' ' ARG . 42.8 mt-10 -94.13 136.4 34.46 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 117.786 0.266 . . . . 0.0 110.64 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.4 m -101.72 161.34 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.158 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -175.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.432 ' HG3' ' H61' ' B' ' 5' ' ' ' A' . 0.0 OUTLIER -159.01 159.61 29.28 Favored Pre-proline 0 N--CA 1.454 -0.226 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.776 169.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.2 136.66 76.39 Favored 'Trans proline' 0 N--CA 1.451 -0.993 0 C-N-CA 122.796 2.33 . . . . 0.0 109.27 173.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -87.28 167.55 13.99 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 120.09 -0.644 . . . . 0.0 111.052 -178.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.3 p -153.44 149.44 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 C-N-CA 123.626 0.771 . . . . 0.0 110.018 -170.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 89.7 mt . . . . . 0 C--O 1.253 1.253 0 CA-C-O 117.568 -1.206 . . . . 0.0 109.625 178.866 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.683 2 O4'-C1'-N19 113.141 4.941 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.804 1 O4'-C1'-N19 112.653 4.453 . 0.36 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.422 ' C6 ' ' CE2' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.423 -2.5 1 O4'-C1'-N19 113.887 5.687 . 0.01 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.43 " C1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.418 -2.902 0 C5'-C4'-C3' 109.595 -3.937 . 0.0 OUTLIER beta 0.0 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.432 ' H61' ' HG3' ' A' ' 251' ' ' LYS . . . . . . . . 0 O4'--C4' 1.411 -3.521 0 O4'-C1'-N19 110.847 2.647 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.1 m . . . . . 0 N--CA 1.475 0.805 0 CA-C-O 120.347 0.118 . . . . 0.0 111.013 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 53.25 30.48 10.08 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.04 0.936 . . . . 0.0 113.189 178.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -73.56 161.85 29.89 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.723 0.297 . . . . 0.0 110.817 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.4 p-10 -135.6 14.59 3.42 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.402 0.681 . . . . 0.0 111.483 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -73.74 -171.74 24.04 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -127.39 162.55 26.07 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 123.149 0.58 . . . . 0.0 110.515 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -93.86 171.5 8.83 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-O 121.151 0.5 . . . . 0.0 111.451 -178.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.1 p -68.57 158.73 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.816 0.847 . . . . 0.0 110.535 178.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -126.09 153.94 43.78 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.489 0.715 . . . . 0.0 109.46 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -122.75 164.8 17.67 Favored 'General case' 0 C--N 1.337 0.063 0 C-N-CA 123.051 0.54 . . . . 0.0 111.238 -176.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -151.19 157.03 42.13 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.225 -171.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 36.0 t -94.01 161.24 14.37 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 176.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 50.1 mtm105 -81.96 24.32 0.64 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 122.32 0.248 . . . . 0.0 110.894 178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -140.27 138.15 34.77 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.698 0.399 . . . . 0.0 110.804 177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.2 m -144.36 155.78 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.098 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.866 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.419 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 5.8 t80 -86.97 139.04 30.99 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 171.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.23 115.48 47.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 174.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.414 ' HA2' ' CZ ' ' A' ' 68' ' ' PHE . . . -79.73 137.98 19.55 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.47 -175.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.49 158.61 6.17 Favored Glycine 0 CA--C 1.525 0.709 0 CA-C-O 121.985 0.77 . . . . 0.0 114.69 173.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.5 tp -160.09 126.37 2.44 Favored Pre-proline 0 N--CA 1.451 -0.385 0 N-CA-C 105.671 -1.974 . . . . 0.0 105.671 176.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.465 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 98.0 Cg_endo -73.74 142.23 31.84 Favored 'Trans proline' 0 N--CA 1.449 -1.144 0 C-N-CA 121.622 1.548 . . . . 0.0 109.12 -178.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 32.1 Cg_exo -61.54 -3.23 3.2 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.93 3.087 . . . . 0.0 115.165 -174.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -99.88 -21.27 15.77 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -172.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.432 HD12 ' C ' ' A' ' 76' ' ' ILE . 1.8 pp -133.36 -171.89 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 119.459 1.027 . . . . 0.0 111.203 -177.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -136.68 -163.24 1.38 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.465 0.706 . . . . 0.0 112.291 -172.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -40.62 -31.08 0.14 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 126.853 2.061 . . . . 0.0 113.459 178.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -64.61 -30.26 71.28 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -175.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -80.04 -33.99 38.65 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.083 -0.386 . . . . 0.0 111.133 -173.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.4 mt -73.78 -36.19 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 33.5 m -68.75 -21.77 64.34 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.76 -13.23 27.64 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 176.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.4 m -84.75 -29.54 25.41 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 118.285 0.493 . . . . 0.0 112.022 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -110.49 5.15 21.08 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -176.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 48.6 tpt85 -67.96 -14.0 62.62 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.973 -0.454 . . . . 0.0 110.365 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 50.2 tpt85 -64.78 -15.72 62.03 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.813 1.245 . . . . 0.0 111.81 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -120.83 -5.95 9.62 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.917 0.339 . . . . 0.0 111.917 -176.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 145.04 163.82 10.31 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -57.93 139.04 88.97 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.141 2.56 . . . . 0.0 111.342 177.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.516 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -150.38 167.5 26.87 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.066 0.46 . . . . 0.0 111.096 178.229 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 pt -138.08 163.68 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.5 p -132.66 145.04 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.088 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -154.04 171.37 19.18 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.081 0.467 . . . . 0.0 110.395 -174.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.4 ' CH2' ' HE3' ' A' ' 98' ' ' LYS . 18.8 p90 -155.14 163.04 25.87 Favored Pre-proline 0 CA--C 1.536 0.423 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 174.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.487 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 89.8 Cg_endo -71.31 -7.44 21.32 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 CA-C-N 121.232 1.476 . . . . 0.0 110.844 -170.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.487 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 3.4 m-70 -99.73 2.81 44.57 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.726 0.811 . . . . 0.0 111.491 -177.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.4 ' HE3' ' CH2' ' A' ' 95' ' ' TRP . 12.4 tptm -54.6 158.24 2.62 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 124.054 0.942 . . . . 0.0 112.693 -178.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -126.47 18.32 7.52 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.078 0.951 . . . . 0.0 110.918 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 59.95 -25.08 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.99 2.116 . . . . 0.0 115.394 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.0 t -163.07 -21.36 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.162 0.892 . . . . 0.0 112.143 178.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -87.71 1.17 54.49 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -175.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.2 m -141.37 149.62 41.35 Favored 'General case' 0 N--CA 1.458 -0.073 0 CA-C-N 118.063 0.392 . . . . 0.0 110.849 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -137.44 -2.91 1.95 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.789 0.835 . . . . 0.0 111.331 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 91.9 m-85 -126.51 127.76 24.48 Favored Pre-proline 0 N--CA 1.453 -0.316 0 CA-C-N 118.03 0.377 . . . . 0.0 110.324 -175.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 105' ' ' PHE . 39.1 Cg_exo -59.76 165.76 9.42 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.917 3.078 . . . . 0.0 111.512 171.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -52.05 -24.39 19.58 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 124.039 3.159 . . . . 0.0 113.734 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -146.98 -61.31 0.29 Allowed 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.149 0.432 . . . . 0.0 110.643 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.02 42.55 0.04 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 120.282 -0.961 . . . . 0.0 114.173 -177.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.542 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.1 OUTLIER -140.75 153.61 45.95 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.519 1.159 . . . . 0.0 108.888 174.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.18 -178.63 6.74 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.274 0.488 . . . . 0.0 111.972 -174.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -141.11 140.51 34.16 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 9.5 mp -96.32 148.91 22.27 Favored 'General case' 0 CA--C 1.521 -0.138 0 CA-C-N 118.497 0.59 . . . . 0.0 112.326 -178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 5.9 mp -115.52 142.28 46.93 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 170.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -131.7 167.8 18.86 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 121.404 0.621 . . . . 0.0 111.93 -174.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 25.2 mm100 -109.28 -29.85 8.28 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.932 -178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -121.8 153.17 38.66 Favored 'General case' 0 CA--C 1.528 0.108 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -85.97 -17.84 34.24 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.176 176.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.7 t -85.76 -17.67 35.19 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.128 -0.358 . . . . 0.0 110.198 176.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 41.9 t -72.36 -39.5 68.03 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.31 -26.71 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -71.05 -34.91 71.7 Favored 'General case' 0 N--CA 1.453 -0.304 0 O-C-N 121.971 -0.455 . . . . 0.0 110.311 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -77.97 -35.17 50.55 Favored 'General case' 0 N--CA 1.45 -0.429 0 O-C-N 122.176 -0.328 . . . . 0.0 111.654 -178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.3 pp -78.91 -16.7 56.66 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.43 0.559 . . . . 0.0 111.458 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.4 mt -92.33 -22.7 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 122.254 0.222 . . . . 0.0 110.454 177.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -97.9 -10.21 24.98 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -117.56 35.04 4.85 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.175 0.59 . . . . 0.0 111.269 -179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 26.8 p -136.76 -179.59 5.78 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 122.906 0.482 . . . . 0.0 111.331 -176.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 35.1 mm -87.4 159.44 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 124.391 1.077 . . . . 0.0 109.018 -177.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.65 154.79 43.56 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.759 0.314 . . . . 0.0 110.791 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -146.39 85.11 1.64 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.516 0.675 . . . . 0.0 110.753 -178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 55.43 0.13 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 116.192 1.923 . . . . 0.0 116.192 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.22 -12.18 0.07 OUTLIER Glycine 0 CA--C 1.527 0.841 0 CA-C-N 119.568 1.076 . . . . 0.0 114.072 176.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.1 170.84 15.06 Favored 'General case' 0 N--CA 1.458 -0.071 0 CA-C-N 118.195 0.998 . . . . 0.0 109.609 177.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.97 166.05 10.65 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -172.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.406 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -142.39 139.49 31.71 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.891 -177.52 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.1 tp -124.55 128.72 49.36 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 170.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 48.9 t -77.03 139.48 40.06 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.1 m -137.65 -0.97 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.116 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 29.7 t 45.68 60.38 3.15 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.265 0.626 . . . . 0.0 111.116 -179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 142' ' ' PRO . 75.2 m -56.96 150.48 38.79 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.941 -175.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 141' ' ' SER . 19.8 Cg_exo -67.82 11.91 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 123.795 2.996 . . . . 0.0 114.907 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.743 HG23 HG13 ' A' ' 144' ' ' ILE . 15.1 t -121.23 -15.39 8.17 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.595 1.089 . . . . 0.0 111.832 -174.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.743 HG13 HG23 ' A' ' 143' ' ' THR . 0.6 OUTLIER -168.25 -176.44 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 C-N-CA 125.178 1.391 . . . . 0.0 109.635 -177.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -120.74 16.74 11.91 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.739 0.816 . . . . 0.0 110.953 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -141.38 34.35 1.67 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.189 1.181 . . . . 0.0 114.189 -173.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.638 ' CD ' " H2'" ' B' ' 1' ' ' ' C' . 50.2 mttp -129.16 80.1 73.16 Favored Pre-proline 0 C--N 1.34 0.179 0 CA-C-N 118.927 0.785 . . . . 0.0 111.193 177.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.406 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 19.8 Cg_exo -67.69 145.56 70.02 Favored 'Trans proline' 0 N--CA 1.451 -0.991 0 C-N-CA 122.908 2.405 . . . . 0.0 108.765 169.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 33.8 m -75.65 133.92 30.28 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.172 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -86.27 150.28 24.47 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 26.3 mm -130.17 137.36 56.61 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 C-N-CA 122.743 0.417 . . . . 0.0 110.646 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -141.45 92.19 8.28 Favored Pre-proline 0 CA--C 1.532 0.252 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 175.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -66.53 162.87 34.89 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 124.174 3.25 . . . . 0.0 112.742 -179.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -93.47 142.69 27.04 Favored 'General case' 0 CA--C 1.528 0.132 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 172.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -101.52 157.1 17.06 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 121.219 0.533 . . . . 0.0 110.489 178.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 156' ' ' LEU . 8.5 mp -90.33 178.99 5.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.518 0.675 . . . . 0.0 111.402 -176.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.7 m 65.12 4.43 2.56 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.501 1.92 . . . . 0.0 116.115 176.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 52.9 p30 -135.58 12.65 3.46 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 120.345 1.43 . . . . 0.0 113.317 172.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.8 m -66.13 -32.46 73.91 Favored 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -152.84 161.27 42.76 Favored 'General case' 0 N--CA 1.456 -0.143 0 C-N-CA 122.817 0.447 . . . . 0.0 111.015 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -152.97 152.89 31.94 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.956 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.9 t -127.97 140.66 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.125 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 28.3 ttp -132.44 13.7 4.55 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -177.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -159.66 -57.75 0.06 Allowed 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 177.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 61.33 11.64 28.18 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-O 119.409 -0.662 . . . . 0.0 113.54 175.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 12.4 t -109.36 -4.28 16.51 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.174 0.987 . . . . 0.0 112.184 -175.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -124.38 136.74 28.1 Favored Pre-proline 0 CA--C 1.531 0.218 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -68.3 160.52 48.62 Favored 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.146 2.564 . . . . 0.0 110.049 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 46.7 mt -113.04 153.31 28.31 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.51 0.324 . . . . 0.0 110.769 -175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -145.0 150.56 46.19 Favored Pre-proline 0 C--O 1.232 0.147 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -66.95 -5.43 13.43 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 123.442 2.761 . . . . 0.0 112.017 -178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? -93.87 -1.22 55.13 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.028 0.531 . . . . 0.0 110.757 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -133.07 20.81 4.08 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 122.585 0.354 . . . . 0.0 111.444 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 13.6 m -119.99 143.17 48.18 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-O 120.987 0.422 . . . . 0.0 111.395 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.9 tt -113.05 141.3 29.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 178.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -106.92 152.36 24.03 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 76.1 t -137.97 144.98 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 123.633 0.773 . . . . 0.0 108.965 -173.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -148.02 149.55 21.64 Favored Glycine 0 C--N 1.335 0.493 0 N-CA-C 112.04 -0.424 . . . . 0.0 112.04 -178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.4 22.1 54.97 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -172.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 24.6 m -60.94 144.91 89.86 Favored Pre-proline 0 CA--C 1.53 0.191 0 CA-C-N 116.913 0.356 . . . . 0.0 111.32 -177.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.05 157.76 42.38 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 C-N-CA 123.1 2.533 . . . . 0.0 108.715 170.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.419 ' N ' ' HD2' ' A' ' 183' ' ' PRO . 10.7 tpt180 -66.73 -46.66 56.42 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.74 -176.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 182' ' ' ARG . 45.1 Cg_endo -78.48 27.08 0.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.452 2.768 . . . . 0.0 113.025 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 36.6 tp -64.96 -43.56 92.26 Favored 'General case' 0 C--N 1.34 0.16 0 CA-C-N 119.117 0.871 . . . . 0.0 110.38 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.427 ' HG2' ' H ' ' A' ' 187' ' ' VAL . 59.7 ttm-85 59.35 129.64 0.01 OUTLIER 'General case' 0 C--N 1.341 0.223 0 C-N-CA 126.11 1.764 . . . . 0.0 112.955 179.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.86 -25.69 68.01 Favored 'General case' 0 N--CA 1.455 -0.204 0 O-C-N 121.554 -0.716 . . . . 0.0 111.474 -177.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.427 ' H ' ' HG2' ' A' ' 185' ' ' ARG . 24.2 t -72.14 -47.85 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 CA-C-O 120.662 0.268 . . . . 0.0 110.453 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -79.86 -24.64 41.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 -176.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.8 tp -69.0 -33.85 74.33 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.78 -32.8 46.63 Favored 'General case' 0 N--CA 1.454 -0.272 0 O-C-N 122.263 -0.273 . . . . 0.0 111.552 -178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.8 mmt -71.4 -35.99 71.23 Favored 'General case' 0 N--CA 1.457 -0.114 0 O-C-N 122.305 -0.247 . . . . 0.0 110.475 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 71.5 mt -78.16 -40.51 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 22.5 mmt -60.67 -28.19 68.4 Favored 'General case' 0 C--N 1.334 -0.078 0 O-C-N 121.941 -0.474 . . . . 0.0 111.342 173.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -82.38 -21.51 35.83 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.419 0.554 . . . . 0.0 111.088 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.11 -19.69 26.67 Favored 'General case' 0 CA--C 1.528 0.119 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -110.1 -16.9 13.69 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.563 0.62 . . . . 0.0 111.875 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 50.7 m-85 -135.1 -41.64 0.73 Allowed 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 118.377 0.535 . . . . 0.0 111.587 -177.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 69.19 162.76 3.08 Favored Glycine 0 CA--C 1.527 0.814 0 CA-C-O 121.474 0.486 . . . . 0.0 112.615 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 87.07 15.47 62.65 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 174.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 3.4 p -77.5 162.4 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.0 0.92 . . . . 0.0 110.597 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 51.5 t -137.28 -31.82 0.8 Allowed 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -150.63 155.03 38.58 Favored 'General case' 0 N--CA 1.457 -0.124 0 CA-C-N 118.084 0.402 . . . . 0.0 111.814 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -156.27 156.85 34.76 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 123.346 0.658 . . . . 0.0 110.518 177.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 176.51 177.6 45.62 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.417 ' HA ' ' HA2' ' A' ' 218' ' ' GLY . 44.6 mm -103.83 87.05 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 177.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 26.2 t70 47.39 -86.85 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.927 -169.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.659 ' H ' ' HA ' ' A' ' 214' ' ' PRO . 12.6 m 49.72 65.16 1.49 Allowed 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 123.315 0.646 . . . . 0.0 111.091 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -59.75 133.46 89.27 Favored Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.74 -17.27 14.19 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 124.629 3.553 . . . . 0.0 114.282 -171.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -104.87 0.06 27.6 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 118.865 0.757 . . . . 0.0 111.282 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 97.5 mt -122.2 -13.21 8.16 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.807 0.843 . . . . 0.0 109.942 172.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt 52.97 38.11 26.29 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.534 1.134 . . . . 0.0 111.507 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -140.55 145.21 39.6 Favored Pre-proline 0 N--CA 1.461 0.12 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -175.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.659 ' HA ' ' H ' ' A' ' 207' ' ' THR . 64.6 Cg_endo -77.98 174.64 12.22 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.818 3.012 . . . . 0.0 110.769 173.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -132.16 21.07 4.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.417 0.687 . . . . 0.0 110.318 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 62.67 16.04 55.08 Favored Glycine 0 CA--C 1.529 0.957 0 CA-C-O 119.844 -0.42 . . . . 0.0 112.426 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -135.9 149.42 48.96 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.255 0.622 . . . . 0.0 110.273 -176.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.417 ' HA2' ' HA ' ' A' ' 205' ' ' ILE . . . -95.11 162.0 23.66 Favored Glycine 0 CA--C 1.524 0.641 0 CA-C-N 116.629 -0.259 . . . . 0.0 112.773 -175.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -155.2 148.49 24.92 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.109 -0.701 . . . . 0.0 109.109 171.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 48.4 t -140.35 147.23 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -131.53 144.83 51.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.831 0.348 . . . . 0.0 110.301 -177.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -128.88 165.66 20.59 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.027 -176.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 78.5 p -94.66 -1.44 53.13 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -125.69 147.67 49.28 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 121.146 0.498 . . . . 0.0 111.62 -177.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 15.1 tm0? -78.5 -18.13 55.24 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.035 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -78.73 -37.14 42.15 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 -178.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 58.6 p -80.14 -23.58 41.03 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 178.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -64.87 -41.67 95.48 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 122.722 0.409 . . . . 0.0 110.701 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 40.2 pt -84.21 -16.3 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 CA-C-N 118.04 0.382 . . . . 0.0 111.592 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.66 -30.87 26.5 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 117.981 0.355 . . . . 0.0 110.86 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -77.04 -15.81 59.48 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 117.653 0.206 . . . . 0.0 111.38 -179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.409 ' HA ' HG21 ' A' ' 250' ' ' VAL . 1.6 pp -117.79 24.51 4.78 Favored 'Isoleucine or valine' 0 C--N 1.339 0.122 0 C-N-CA 123.133 0.573 . . . . 0.0 110.523 177.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.0 t -77.53 -9.19 58.77 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 123.005 0.522 . . . . 0.0 111.037 -176.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -152.29 145.66 24.79 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 77.6 ttt180 -56.84 -28.9 62.26 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 122.6 0.36 . . . . 0.0 111.664 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -121.7 122.19 39.01 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 237' ' ' VAL . 2.4 m -82.79 151.85 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 C-N-CA 122.882 0.473 . . . . 0.0 109.961 174.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.521 ' C ' HD22 ' A' ' 239' ' ' LEU . 11.1 mp0 -94.98 138.42 32.74 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 176.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.521 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.5 mm? -125.37 22.61 7.72 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.091 -175.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -88.3 132.37 34.43 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 122.851 0.46 . . . . 0.0 112.137 -172.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 14.3 m80 -150.18 12.42 0.75 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.206 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 176.19 -143.8 6.68 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 -177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 243' ' ' GLU . 0.4 OUTLIER -81.4 3.35 24.79 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.708 0.403 . . . . 0.0 111.273 178.163 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 77.1 mt -99.95 148.74 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.64 0.776 . . . . 0.0 109.719 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -147.57 140.86 25.24 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.755 0.312 . . . . 0.0 110.199 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -142.92 154.43 44.07 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -152.69 151.44 30.55 Favored 'General case' 0 N--CA 1.462 0.147 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.1 p -161.72 158.42 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 110.243 -0.28 . . . . 0.0 110.243 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -83.26 144.93 29.41 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.197 0.599 . . . . 0.0 111.206 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.409 HG21 ' HA ' ' A' ' 232' ' ' ILE . 2.1 m -123.75 163.72 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -177.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.406 ' HB2' ' HD2' ' A' ' 252' ' ' PRO . 0.0 OUTLIER -157.29 156.37 29.11 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.089 170.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . 0.406 ' HD2' ' HB2' ' A' ' 251' ' ' LYS . 96.8 Cg_endo -73.06 39.21 0.44 Allowed 'Trans proline' 0 CA--C 1.533 0.456 0 C-N-CA 125.052 3.835 . . . . 0.0 111.754 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 43.96 43.87 5.63 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 125.326 1.45 . . . . 0.0 111.331 -174.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 9.8 p 49.73 18.75 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.732 1.613 . . . . 0.0 113.723 177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 C--O 1.252 1.218 0 C-N-CA 126.497 1.919 . . . . 0.0 114.237 178.274 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.638 " H2'" ' CD ' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.417 -2.977 0 C4'-C3'-C2' 99.638 -3.062 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.836 1 O4'-C1'-N19 113.969 5.769 . 0.128 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.542 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.422 -2.592 1 O4'-C1'-N19 113.33 5.13 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.417 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.422 -2.581 0 O4'-C1'-N19 111.664 3.464 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.447 " H2'" ' N3 ' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.422 -2.576 0 O5'-C5'-C4' 113.286 2.204 . 0.07 4a . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 N--CA 1.475 0.815 0 N-CA-C 111.308 0.114 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -140.73 7.61 2.1 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.139 0.575 . . . . 0.0 111.05 -179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -74.97 162.19 28.81 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.342 0.657 . . . . 0.0 110.416 -179.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -143.83 142.93 31.1 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.984 0.514 . . . . 0.0 109.821 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -84.08 -4.35 88.43 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.904 -0.478 . . . . 0.0 111.904 179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -119.59 167.69 11.75 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.474 0.71 . . . . 0.0 110.806 -178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -139.85 168.51 19.64 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.522 0.729 . . . . 0.0 110.877 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.6 t 63.43 146.3 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 125.762 1.625 . . . . 0.0 112.345 -176.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -134.22 160.8 36.76 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.409 0.683 . . . . 0.0 110.266 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.401 ' N ' ' HD3' ' A' ' 62' ' ' ARG . 0.1 OUTLIER -62.65 142.2 58.18 Favored 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 123.067 0.547 . . . . 0.0 111.481 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -153.33 159.34 42.46 Favored 'General case' 0 C--O 1.23 0.046 0 O-C-N 123.495 0.497 . . . . 0.0 110.219 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.9 t -93.26 20.56 6.88 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.168 -177.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 70.1 mtm-85 55.97 21.03 4.64 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.423 0.689 . . . . 0.0 112.314 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.1 ttpt -146.9 144.51 29.31 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.014 0.526 . . . . 0.0 110.068 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.2 m -138.34 152.39 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.155 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.434 ' CZ ' ' C6 ' ' B' ' 3' ' ' ' U' . 2.9 t80 -88.63 140.9 28.99 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 170.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 113' ' ' LEU . 1.5 m -134.61 138.47 49.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 173.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.57 -170.83 12.22 Favored Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -176.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.431 ' HA2' " H4'" ' B' ' 1' ' ' ' C' . . . 76.48 5.58 82.68 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.456 178.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 26.0 mt -70.86 148.79 94.88 Favored Pre-proline 0 N--CA 1.454 -0.245 0 CA-C-N 118.655 1.227 . . . . 0.0 108.823 179.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -62.38 160.53 31.0 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.328 2.019 . . . . 0.0 110.735 -177.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.64 -10.61 0.96 Allowed 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 125.094 3.863 . . . . 0.0 114.781 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 76' ' ' ILE . 5.8 p-10 -105.0 -96.06 0.33 Allowed 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 118.946 -0.55 . . . . 0.0 109.805 175.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.424 ' H ' ' CG ' ' A' ' 75' ' ' ASP . 3.1 tp 55.79 163.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -158.47 -179.28 7.94 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.863 178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -59.14 -32.58 69.99 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.85 0.86 . . . . 0.0 112.633 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -91.09 -23.36 20.34 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 118.702 0.683 . . . . 0.0 112.629 -170.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -80.83 -27.16 36.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.3 mt -78.43 -40.53 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 174.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 97.0 m -63.31 -22.6 66.98 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.05 -21.25 24.85 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 73.3 m -72.94 -26.44 61.39 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.509 0.595 . . . . 0.0 111.88 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.519 ' CZ ' HD11 ' A' ' 151' ' ' ILE . 55.5 m-85 -124.31 13.17 8.88 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -177.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.3 -17.29 64.39 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.992 -0.442 . . . . 0.0 111.269 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -68.41 -11.46 59.69 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 124.138 0.975 . . . . 0.0 111.466 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -123.61 36.15 4.69 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -173.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.1 175.46 34.74 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.682 -0.567 . . . . 0.0 111.682 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -71.11 151.83 61.74 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.9 3.066 . . . . 0.0 111.278 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.452 ' N ' HD23 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -166.89 163.34 16.19 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.872 -170.205 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 26.3 pt -141.42 169.55 14.34 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 172.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.0 p -135.38 150.12 29.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 -179.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -152.91 174.11 14.52 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.419 0.628 . . . . 0.0 111.396 -177.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 23.7 p90 -160.41 157.94 24.89 Favored Pre-proline 0 CA--C 1.533 0.289 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.505 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 37.8 Cg_endo -75.77 -17.97 17.49 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.237 1.958 . . . . 0.0 110.885 -169.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.505 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 22.6 m-70 -84.78 -7.57 59.15 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 123.561 0.744 . . . . 0.0 110.833 -178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 70.5 tttt -71.05 170.35 13.04 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 124.664 1.186 . . . . 0.0 112.997 -175.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -124.61 167.0 15.1 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.508 1.123 . . . . 0.0 109.655 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -88.77 -7.76 55.66 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.6 t -155.02 17.2 0.43 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 118.214 0.461 . . . . 0.0 112.166 -178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.9 tptp -144.62 144.16 31.13 Favored 'General case' 0 C--N 1.339 0.146 0 O-C-N 121.719 -0.613 . . . . 0.0 111.705 -175.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 70.9 m 58.01 163.2 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.844 1.658 . . . . 0.0 114.762 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -142.9 10.97 1.8 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.762 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -106.22 116.05 60.04 Favored Pre-proline 0 CA--C 1.531 0.225 0 C-N-CA 123.846 0.858 . . . . 0.0 110.983 -172.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -60.13 159.79 24.97 Favored 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 124.093 3.195 . . . . 0.0 111.7 172.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.74 -32.2 35.63 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 124.25 3.3 . . . . 0.0 114.788 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.4 tptm -159.29 -59.62 0.07 Allowed 'General case' 0 C--N 1.34 0.162 0 CA-C-N 118.505 0.593 . . . . 0.0 111.752 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -179.89 23.02 0.04 OUTLIER Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.868 -0.493 . . . . 0.0 111.868 -174.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.523 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.2 OUTLIER -129.13 140.59 51.48 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.199 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.51 -177.44 6.48 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 122.526 0.33 . . . . 0.0 110.591 -174.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.402 ' CE1' ' C5 ' ' B' ' 4' ' ' ' U' . 1.2 m-85 -141.77 134.14 28.04 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.217 -0.661 . . . . 0.0 109.217 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.538 HD13 HG11 ' A' ' 69' ' ' VAL . 11.2 mp -92.28 150.83 20.64 Favored 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.245 0.545 . . . . 0.0 111.582 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.99 137.53 51.9 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 173.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -130.34 166.11 21.09 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 120.882 0.372 . . . . 0.0 111.117 -176.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -113.03 -31.95 6.51 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.275 -177.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -117.74 149.1 41.32 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.037 0.446 . . . . 0.0 111.074 -178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -83.91 -16.92 42.49 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.218 -177.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.8 p -86.43 -17.61 33.85 Favored 'General case' 0 N--CA 1.456 -0.134 0 O-C-N 122.16 -0.338 . . . . 0.0 111.549 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 37.3 m -71.94 -47.01 55.46 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 121.004 0.43 . . . . 0.0 110.584 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.428 ' HA ' HD12 ' A' ' 124' ' ' LEU . 5.0 p -72.58 -20.22 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.042 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -75.27 -32.28 61.0 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -73.66 -44.49 56.64 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.547 HD22 ' C ' ' A' ' 124' ' ' LEU . 0.0 OUTLIER -72.98 -28.79 62.6 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 118.388 -1.325 . . . . 0.0 110.994 -178.367 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 83.4 mt -80.54 -16.65 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 118.292 0.496 . . . . 0.0 110.928 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -86.14 -17.83 33.91 Favored 'General case' 0 CA--C 1.532 0.256 0 O-C-N 121.731 -0.606 . . . . 0.0 110.364 174.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -112.11 14.12 20.67 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 20.0 p -98.99 171.56 7.96 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.168 0.508 . . . . 0.0 112.251 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 130' ' ' GLU . 39.9 mm -90.17 167.96 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 C-N-CA 125.522 1.529 . . . . 0.0 108.472 179.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.414 ' N ' HG22 ' A' ' 129' ' ' ILE . 42.2 mt-10 -124.33 152.87 42.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.021 0.439 . . . . 0.0 112.004 -178.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -145.61 -174.37 4.38 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 172.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -61.75 98.11 0.09 Allowed 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.909 0.385 . . . . 0.0 111.342 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 78.06 -2.15 66.45 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.25 -0.75 . . . . 0.0 114.258 175.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 3.7 mppt? -137.89 173.94 11.1 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 118.569 1.184 . . . . 0.0 110.372 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -110.19 174.8 5.7 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.479 0.712 . . . . 0.0 109.527 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.508 ' CE1' ' HB2' ' A' ' 148' ' ' PRO . 0.1 OUTLIER -144.07 149.21 36.26 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.2 0.6 . . . . 0.0 109.582 179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 46.8 tp -132.22 146.32 51.93 Favored 'General case' 0 N--CA 1.461 0.113 0 N-CA-C 108.725 -0.842 . . . . 0.0 108.725 169.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 76.1 m -89.25 133.72 34.34 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 120.864 0.364 . . . . 0.0 110.793 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.1 p -156.18 154.11 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 124.32 1.048 . . . . 0.0 108.403 178.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.4 p -85.7 150.41 24.62 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 122.142 -0.349 . . . . 0.0 110.28 178.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 88.7 p -138.44 146.29 50.45 Favored Pre-proline 0 N--CA 1.456 -0.172 0 O-C-N 122.278 -0.264 . . . . 0.0 110.442 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.12 -8.85 20.3 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 123.214 2.609 . . . . 0.0 112.902 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.42 HG23 HG12 ' A' ' 144' ' ' ILE . 1.9 t -90.74 -18.21 25.38 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 119.239 0.927 . . . . 0.0 111.179 178.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.597 HG22 ' H ' ' A' ' 145' ' ' LYS . 2.3 mm -134.05 -144.72 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.597 ' H ' HG22 ' A' ' 144' ' ' ILE . 75.8 mmtt -119.41 -14.02 9.21 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.058 0.943 . . . . 0.0 109.158 169.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -156.99 157.35 34.57 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.612 1.165 . . . . 0.0 109.4 177.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.545 ' HE3' ' C6 ' ' B' ' 1' ' ' ' C' . 0.0 OUTLIER -154.47 112.04 2.41 Favored Pre-proline 0 N--CA 1.457 -0.077 0 C-N-CA 122.54 0.336 . . . . 0.0 110.921 178.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.508 ' HB2' ' CE1' ' A' ' 136' ' ' TYR . 23.9 Cg_exo -67.68 133.98 31.32 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.894 2.396 . . . . 0.0 108.929 167.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.6 m -121.23 138.29 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.149 0 CA-C-N 118.299 0.5 . . . . 0.0 110.354 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 19.3 mp0 -74.56 154.77 38.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 112.502 0.556 . . . . 0.0 112.502 -176.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.519 HD11 ' CZ ' ' A' ' 85' ' ' PHE . 44.2 mm -138.55 141.32 37.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.081 0 C-N-CA 124.886 1.274 . . . . 0.0 108.918 171.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.9 ttp85 -156.44 109.96 2.03 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 170.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -76.34 164.42 30.93 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 123.917 3.078 . . . . 0.0 111.356 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.413 ' CG ' ' HG3' ' A' ' 214' ' ' PRO . 55.0 t-105 -100.44 144.84 28.96 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.595 0.235 . . . . 0.0 111.209 176.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -107.02 156.85 18.31 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.494 0.718 . . . . 0.0 111.718 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.0 mp -100.89 15.41 28.61 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.091 0.556 . . . . 0.0 111.598 -175.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 24.4 t -90.86 -28.53 18.09 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -174.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -140.33 25.07 2.27 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.63 0.65 . . . . 0.0 112.631 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 9.0 t -70.74 -16.42 62.77 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -155.07 159.9 40.6 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 123.041 0.536 . . . . 0.0 110.524 179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -156.86 156.74 33.67 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-O 120.587 0.232 . . . . 0.0 111.0 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.9 m -137.49 151.5 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 C-N-CA 123.152 0.581 . . . . 0.0 110.327 175.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 16.1 ttp -135.34 19.15 3.38 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.555 -178.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -151.93 -179.66 7.67 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.86 18.75 0.61 Allowed Glycine 0 CA--C 1.53 1.027 0 CA-C-O 119.696 -0.502 . . . . 0.0 113.372 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 9.0 t 54.6 50.46 15.92 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 117.736 0.768 . . . . 0.0 111.895 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -64.36 160.07 53.49 Favored Pre-proline 0 CA--C 1.533 0.309 0 C-N-CA 122.926 0.49 . . . . 0.0 109.962 177.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -52.19 147.55 27.38 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 123.72 2.947 . . . . 0.0 112.355 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 68.8 mt -122.09 162.04 21.97 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.357 0.663 . . . . 0.0 110.995 -175.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -143.92 150.25 48.95 Favored Pre-proline 0 CA--C 1.529 0.168 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -68.28 -10.83 30.14 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.957 2.438 . . . . 0.0 111.508 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.78 2.48 56.02 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.149 0.58 . . . . 0.0 110.496 174.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -126.17 18.04 7.74 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 122.674 0.39 . . . . 0.0 111.09 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 16.4 m -127.55 139.74 52.58 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.722 0.296 . . . . 0.0 111.019 -175.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.1 tt -111.62 152.07 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.094 0 C-N-CA 123.16 0.584 . . . . 0.0 110.474 -176.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.404 ' CD1' ' CE1' ' A' ' 253' ' ' TYR . 6.3 t80 -114.68 143.84 44.39 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 173.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.8 m -140.92 132.36 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 C-N-CA 122.611 0.364 . . . . 0.0 110.287 -179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -142.44 179.95 19.8 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 111.976 -0.45 . . . . 0.0 111.976 -176.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.99 10.12 83.37 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -171.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 28.9 m -72.82 155.42 90.71 Favored Pre-proline 0 N--CA 1.455 -0.177 0 C-N-CA 122.904 0.481 . . . . 0.0 110.891 -179.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -72.74 -172.6 0.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.756 2.971 . . . . 0.0 109.785 175.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -55.8 -48.4 96.67 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-O 118.213 -0.898 . . . . 0.0 112.236 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -77.59 138.75 17.5 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.223 1.949 . . . . 0.0 110.939 174.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 184' ' ' LEU . 2.4 pt? -155.52 16.32 0.39 Allowed 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.371 0.668 . . . . 0.0 111.448 178.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 2.5 ptm180 -42.71 142.1 0.93 Allowed 'General case' 0 CA--C 1.528 0.1 0 C-N-CA 124.963 1.305 . . . . 0.0 112.334 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.73 -21.57 61.74 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -171.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 58.5 t -60.75 -52.13 65.08 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 CA-C-N 118.306 0.503 . . . . 0.0 110.838 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -83.54 -20.09 34.5 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 122.387 -0.196 . . . . 0.0 110.798 -175.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 25.2 tp -73.85 -32.9 63.87 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -77.63 -39.31 45.69 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 117.563 0.165 . . . . 0.0 111.046 -179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 25.5 mmt -64.88 -49.81 69.02 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -177.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.8 mt -65.87 -34.57 71.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -178.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.4 tpp -74.23 -13.09 60.73 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 122.469 -0.145 . . . . 0.0 110.966 -178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -102.26 -12.61 17.85 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 122.029 -0.42 . . . . 0.0 112.032 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -92.4 -18.06 23.78 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 118.241 0.473 . . . . 0.0 111.369 176.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.47 -20.79 10.63 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 118.18 0.445 . . . . 0.0 111.036 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -141.05 46.83 1.73 Allowed 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.958 0.503 . . . . 0.0 109.97 -177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.55 136.79 4.57 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.016 0.817 . . . . 0.0 113.395 -175.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 135.8 7.15 1.88 Allowed Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.123 0.868 . . . . 0.0 111.747 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 40.9 t -72.31 149.3 9.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 CA-C-N 117.617 0.709 . . . . 0.0 110.903 -177.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 23.5 p -134.2 -23.04 1.73 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -151.17 150.94 31.23 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 110.186 -0.302 . . . . 0.0 110.186 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -149.67 155.23 39.87 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.429 0.692 . . . . 0.0 109.285 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -177.27 -176.32 45.27 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 179.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 30.4 mm -100.23 152.81 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 214' ' ' PRO . 9.8 t70 -53.34 132.03 38.6 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 33.4 p -144.2 167.66 21.9 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 122.584 0.353 . . . . 0.0 110.518 178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . 0.479 ' HA ' ' HD3' ' A' ' 209' ' ' PRO . 12.6 t70 -132.97 136.57 27.87 Favored Pre-proline 0 C--O 1.235 0.291 0 CA-C-O 119.392 -0.337 . . . . 0.0 110.212 174.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 208' ' ' ASP . 22.1 Cg_exo -68.61 -9.35 25.86 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 124.532 3.488 . . . . 0.0 115.809 -172.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -64.27 -26.24 68.41 Favored 'General case' 0 C--N 1.338 0.091 0 CA-C-N 119.737 1.153 . . . . 0.0 110.92 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 19.3 tp -150.35 3.83 0.51 Allowed 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.971 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 95.6 mttt 55.11 39.67 31.58 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.208 1.003 . . . . 0.0 110.605 -175.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -100.08 146.2 31.52 Favored Pre-proline 0 N--CA 1.457 -0.083 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.373 -176.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.413 ' HG3' ' CG ' ' A' ' 154' ' ' TRP . 30.7 Cg_endo -82.1 164.91 17.32 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.289 2.659 . . . . 0.0 113.465 -177.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -128.39 -174.64 3.28 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.921 1.289 . . . . 0.0 108.372 169.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -71.45 164.25 53.98 Favored Glycine 0 CA--C 1.526 0.774 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 59.0 173.47 0.07 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -135.21 177.38 19.41 Favored Glycine 0 CA--C 1.525 0.718 0 O-C-N 121.97 -0.457 . . . . 0.0 112.553 -173.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.02 155.18 42.03 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 121.173 0.511 . . . . 0.0 111.077 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 63.6 t -139.45 145.88 26.38 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.61 148.19 46.64 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 120.854 0.359 . . . . 0.0 110.274 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -122.79 150.24 43.07 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.416 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 68.5 m -83.32 2.6 35.41 Favored 'General case' 0 N--CA 1.456 -0.14 0 N-CA-C 111.389 0.144 . . . . 0.0 111.389 175.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -131.19 138.9 49.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 122.775 0.43 . . . . 0.0 110.559 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.473 ' H ' ' CD ' ' A' ' 225' ' ' GLN . 0.0 OUTLIER -75.45 -12.83 60.32 Favored 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 110.457 -0.201 . . . . 0.0 110.457 176.601 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.3 tp60 -82.35 -37.11 26.14 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 19.9 m -73.26 -29.04 62.48 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -67.17 -53.04 34.11 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 119.687 -0.196 . . . . 0.0 110.749 177.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.2 pt -69.56 -16.59 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.07 0 CA-C-N 118.126 0.421 . . . . 0.0 111.092 -178.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.9 -24.7 33.03 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 117.713 0.233 . . . . 0.0 110.821 176.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -86.74 -21.52 26.53 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 -179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.1 pt -110.43 27.49 2.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 123.071 0.548 . . . . 0.0 110.345 174.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 20.4 t -80.68 -9.99 59.76 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.257 0.623 . . . . 0.0 112.065 -177.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -158.3 145.12 17.63 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 55.7 ttm-85 -57.06 -32.63 66.42 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.562 0.345 . . . . 0.0 111.665 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -122.54 115.92 23.01 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 177.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 23.5 m -99.36 161.3 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.159 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.119 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 4.3 mp0 -85.18 142.34 29.52 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 121.163 0.506 . . . . 0.0 110.463 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.3 mp -131.31 105.44 7.64 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 173.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -131.73 148.01 52.55 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.434 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -141.76 20.62 2.16 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.452 177.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 95.75 131.04 6.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 -177.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 54.73 4.31 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.52 1.528 . . . . 0.0 114.7 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 64.2 mt -145.09 136.33 20.12 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 CA-C-N 118.702 0.683 . . . . 0.0 109.937 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -129.16 147.44 51.01 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.825 0.345 . . . . 0.0 111.367 173.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -144.9 170.52 15.98 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 124.612 1.165 . . . . 0.0 109.648 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.88 160.41 39.37 Favored 'General case' 0 C--O 1.231 0.115 0 C-N-CA 123.635 0.774 . . . . 0.0 110.303 179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 10.0 p -152.23 152.11 11.14 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.08 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -85.84 126.88 34.38 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -109.05 157.7 9.19 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.127 0 CA-C-O 121.039 0.447 . . . . 0.0 111.84 -176.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.46 158.41 27.82 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.57 169.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -56.64 133.28 57.02 Favored 'Trans proline' 0 N--CA 1.448 -1.166 0 C-N-CA 122.564 2.176 . . . . 0.0 107.884 172.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . 0.404 ' CE1' ' CD1' ' A' ' 176' ' ' PHE . 2.3 t80 -75.28 118.88 18.68 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 118.991 -1.084 . . . . 0.0 111.087 -173.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.5 HG22 ' H ' ' A' ' 255' ' ' LEU . 0.8 OUTLIER 53.7 168.77 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 C-N-CA 127.434 2.293 . . . . 0.0 114.43 177.345 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.5 ' H ' HG22 ' A' ' 254' ' ' VAL . 34.2 tp . . . . . 0 C--O 1.25 1.116 0 C-N-CA 124.956 1.302 . . . . 0.0 111.726 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.545 ' C6 ' ' HE3' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.424 -2.451 1 O4'-C1'-N19 114.274 6.074 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.421 -2.694 0 O4'-C1'-N19 112.137 3.937 . 0.258 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.523 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.42 -2.713 2 C5'-C4'-C3' 109.252 -4.166 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.402 ' C5 ' ' CE1' ' A' ' 112' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.75 0 O5'-C5'-C4' 106.675 -2.518 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.417 " H4'" ' HB2' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.414 -3.288 1 C5'-C4'-C3' 107.857 -5.095 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 31.3 t . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 120.365 0.126 . . . . 0.0 110.699 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -134.08 8.23 3.74 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.339 0.656 . . . . 0.0 111.129 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 53.4 24.81 4.15 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.065 0.946 . . . . 0.0 112.106 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -148.38 155.83 41.73 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.261 0.624 . . . . 0.0 109.569 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 174.4 -179.56 45.66 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -147.17 166.49 26.81 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.15 0.58 . . . . 0.0 110.307 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.9 ptt-85 -148.76 172.9 13.87 Favored 'General case' 0 CA--C 1.527 0.078 0 C-N-CA 123.122 0.569 . . . . 0.0 110.979 -178.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 t 52.05 48.4 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 123.966 0.906 . . . . 0.0 111.092 178.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -73.52 -179.89 3.73 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.177 0.513 . . . . 0.0 110.813 177.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.68 134.68 7.24 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.082 0.953 . . . . 0.0 110.487 173.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -149.21 157.52 43.43 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -172.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 33.9 t -102.75 150.45 23.45 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.076 174.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 27.9 ptt-85 -85.63 3.74 39.48 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.652 0.381 . . . . 0.0 110.281 174.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -100.02 135.96 40.66 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.85 0.86 . . . . 0.0 109.413 175.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 p -149.75 144.41 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.816 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.446 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 14.7 t80 -92.2 144.42 25.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 175.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 3.7 m -132.69 130.03 58.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -141.37 148.3 19.96 Favored Glycine 0 C--N 1.332 0.334 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 -175.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.409 ' HA2' " H4'" ' B' ' 1' ' ' ' C' . . . 101.94 37.43 3.41 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -175.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 68.6 mt -85.96 159.63 54.05 Favored Pre-proline 0 N--CA 1.453 -0.321 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 171.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -70.71 153.79 64.34 Favored 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 122.959 2.439 . . . . 0.0 108.968 172.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.03 3.19 4.13 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.884 3.056 . . . . 0.0 112.354 -178.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -94.0 -27.12 16.5 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -176.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.465 HD12 ' C ' ' A' ' 76' ' ' ILE . 2.3 pp -136.39 174.81 11.61 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 CA-C-N 118.524 0.602 . . . . 0.0 110.252 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -163.39 5.8 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 177.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -145.41 -45.71 0.22 Allowed 'General case' 0 C--N 1.341 0.21 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -174.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -84.62 -34.14 23.17 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-N 118.622 0.646 . . . . 0.0 112.371 -172.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -73.45 -27.11 61.24 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 120.725 0.298 . . . . 0.0 110.509 -176.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 16.7 pt -88.01 -30.35 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.198 0 C-N-CA 122.465 0.306 . . . . 0.0 110.916 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 56.8 m -71.75 -14.87 62.13 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 175.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.94 -22.07 17.64 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.5 m -88.2 -15.53 35.71 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.451 ' CE1' HD23 ' A' ' 137' ' ' LEU . 68.2 m-85 -123.29 10.21 9.25 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 118.852 0.751 . . . . 0.0 113.003 -174.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 54.6 ttp180 -83.63 -12.01 56.54 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 122.601 0.36 . . . . 0.0 111.945 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.493 ' HG3' ' CD2' ' A' ' 88' ' ' PHE . 15.9 ptm180 -72.79 -18.22 61.5 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.493 ' CD2' ' HG3' ' A' ' 87' ' ' ARG . 70.0 m-85 -105.61 1.84 27.7 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 122.339 0.256 . . . . 0.0 111.348 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.5 163.41 9.82 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.22 140.78 45.6 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.228 2.618 . . . . 0.0 110.237 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.513 HD22 ' C ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -153.04 166.15 33.33 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.257 0.551 . . . . 0.0 112.279 -177.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 18.8 pt -137.15 -179.95 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.597 173.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.0 p -132.4 157.75 43.13 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.121 0 O-C-N 122.283 -0.261 . . . . 0.0 110.349 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -148.32 161.72 40.97 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.296 0.569 . . . . 0.0 111.47 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.451 ' CZ2' ' HE3' ' A' ' 98' ' ' LYS . 27.7 p90 -157.1 158.75 31.26 Favored Pre-proline 0 CA--C 1.534 0.342 0 N-CA-C 105.539 -2.022 . . . . 0.0 105.539 169.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.589 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 59.8 Cg_endo -72.81 -10.05 24.46 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.494 1.463 . . . . 0.0 111.018 -169.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.589 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 17.1 m-70 -104.93 19.3 20.82 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.682 1.193 . . . . 0.0 110.444 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' A' ' 98' ' ' LYS . 0.4 OUTLIER -36.39 -62.67 0.44 Allowed 'General case' 0 C--N 1.34 0.161 0 C-N-CA 125.571 1.549 . . . . 0.0 113.756 -171.133 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 55.81 167.44 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.02 0.928 . . . . 0.0 112.534 -173.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -137.42 11.42 2.99 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.808 -0.558 . . . . 0.0 111.373 -178.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 85.8 p -141.9 -3.09 1.13 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -178.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -142.61 142.61 32.15 Favored 'General case' 0 C--N 1.34 0.168 0 CA-C-N 118.323 0.511 . . . . 0.0 111.029 -178.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.4 t 55.68 171.06 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 125.867 1.667 . . . . 0.0 114.545 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 -138.33 -7.69 1.53 Allowed 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.881 1.273 . . . . 0.0 110.326 176.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -156.28 59.47 2.0 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 -175.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.38 -42.18 67.34 Favored 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.187 1.924 . . . . 0.0 113.455 175.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -64.39 163.66 25.89 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.293 2.662 . . . . 0.0 112.48 173.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -79.66 -29.82 41.03 Favored 'General case' 0 C--N 1.339 0.125 0 O-C-N 122.25 -0.281 . . . . 0.0 111.315 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 171.45 29.19 0.02 OUTLIER Glycine 0 CA--C 1.527 0.787 0 CA-C-O 119.833 -0.426 . . . . 0.0 112.264 -176.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.412 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 0.0 OUTLIER -142.39 141.7 32.32 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 117.719 0.759 . . . . 0.0 110.18 -179.547 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -152.01 -179.1 7.19 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.985 0.514 . . . . 0.0 110.306 -176.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.471 ' CZ ' ' C6 ' ' B' ' 4' ' ' ' U' . 4.4 m-85 -129.24 121.12 26.93 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -176.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.3 mp -83.92 147.35 27.55 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 121.592 0.711 . . . . 0.0 111.292 -179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 1.3 mp -124.12 104.03 8.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -88.25 162.82 16.42 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-O 120.779 0.323 . . . . 0.0 110.249 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -90.26 -21.55 22.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.216 179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -132.03 149.79 52.33 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.533 0.206 . . . . 0.0 111.534 177.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -77.49 -16.63 58.62 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.231 0.213 . . . . 0.0 110.629 178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 59.0 m -93.64 -17.71 22.97 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 122.457 0.303 . . . . 0.0 111.305 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 30.0 m -70.59 -44.58 67.03 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 176.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 12.5 p -74.36 -15.66 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.997 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 19.1 tp60 -78.3 -33.8 49.13 Favored 'General case' 0 N--CA 1.452 -0.359 0 O-C-N 122.013 -0.429 . . . . 0.0 109.926 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.27 -36.74 61.17 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.25 0.477 . . . . 0.0 110.843 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.32 -40.18 93.41 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 57.5 mt -85.81 -9.93 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 O-C-N 121.663 -0.648 . . . . 0.0 111.893 -175.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -107.66 -3.72 18.94 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.98 -0.45 . . . . 0.0 112.163 177.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -122.57 6.59 9.49 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.165 0.802 . . . . 0.0 113.165 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 74.9 m -113.75 -172.94 2.18 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.399 0.545 . . . . 0.0 110.516 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 129' ' ' ILE . 3.2 mp -68.05 154.22 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 123.674 0.79 . . . . 0.0 108.904 -170.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -137.16 157.56 46.4 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -143.82 62.16 1.36 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 121.208 0.528 . . . . 0.0 110.895 175.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.2 t70 50.93 8.84 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.904 1.681 . . . . 0.0 115.534 171.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -179.51 -19.02 0.03 OUTLIER Glycine 0 CA--C 1.525 0.661 0 O-C-N 121.558 -0.713 . . . . 0.0 111.895 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 48.7 mmtm -129.94 162.67 28.1 Favored 'General case' 0 CA--C 1.521 -0.135 0 CA-C-N 117.642 0.721 . . . . 0.0 109.39 171.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -117.19 163.04 16.89 Favored 'General case' 0 N--CA 1.457 -0.111 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -145.22 162.03 38.12 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.965 0.412 . . . . 0.0 111.186 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.451 HD23 ' CE1' ' A' ' 85' ' ' PHE . 56.4 tp -141.89 145.51 34.67 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 170.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 79.4 m -84.23 128.61 34.67 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 177.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 33.3 m -141.21 166.13 18.41 Favored 'Isoleucine or valine' 0 C--O 1.231 0.1 0 C-N-CA 122.898 0.479 . . . . 0.0 110.616 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 35.0 t -65.91 149.4 50.27 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.894 -0.409 . . . . 0.0 109.894 178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 33.2 t -151.64 91.33 3.82 Favored Pre-proline 0 N--CA 1.452 -0.329 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 -176.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -55.24 -11.37 4.08 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 124.252 3.302 . . . . 0.0 115.645 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.401 HG23 ' CD1' ' A' ' 144' ' ' ILE . 5.5 t -95.98 -10.37 28.77 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 119.577 1.081 . . . . 0.0 111.353 178.115 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.654 HG22 ' H ' ' A' ' 145' ' ' LYS . 2.2 mm -132.96 -160.1 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -179.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.654 ' H ' HG22 ' A' ' 144' ' ' ILE . 49.9 mmtm -103.93 -23.42 13.36 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -163.04 152.58 15.35 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.981 1.313 . . . . 0.0 108.351 175.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.668 ' HE2' ' C6 ' ' B' ' 1' ' ' ' C' . 21.6 ttmt -153.64 120.21 2.89 Favored Pre-proline 0 N--CA 1.457 -0.083 0 CA-C-N 118.062 0.392 . . . . 0.0 110.865 177.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -64.74 127.93 19.86 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.162 2.575 . . . . 0.0 110.105 168.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.4 p -100.79 136.03 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 175.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -85.03 146.88 26.95 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.579 0.352 . . . . 0.0 110.513 -176.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 40.0 mm -125.12 143.03 40.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.882 0.873 . . . . 0.0 109.422 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.95 96.92 2.69 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -176.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -77.01 172.15 16.68 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 124.451 3.434 . . . . 0.0 111.897 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -109.24 150.48 27.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.776 0.322 . . . . 0.0 111.285 176.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -116.42 155.16 29.03 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.611 0.764 . . . . 0.0 111.234 -177.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.419 ' N ' HD12 ' A' ' 156' ' ' LEU . 6.9 mp -103.9 89.96 3.47 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 -177.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 11.5 t -155.34 -36.25 0.09 Allowed 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -140.05 28.73 2.09 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 29.2 m -60.1 -35.92 76.3 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -154.24 161.51 41.77 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.78 0.432 . . . . 0.0 110.868 -178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 12.9 t80 -154.63 159.02 40.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 120.526 0.203 . . . . 0.0 110.62 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.9 m -138.95 149.98 23.45 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.016 0 C-N-CA 123.678 0.791 . . . . 0.0 109.585 178.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 34.2 mtm -137.83 8.71 2.8 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 -174.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -138.74 17.12 2.69 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.268 0.94 . . . . 0.0 112.936 -176.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 87.33 19.25 55.6 Favored Glycine 0 CA--C 1.527 0.836 0 CA-C-O 119.689 -0.506 . . . . 0.0 113.053 177.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 28.9 m 55.46 50.67 14.22 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 117.676 0.738 . . . . 0.0 112.327 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 62.0 mm-40 -62.11 165.75 7.83 Favored Pre-proline 0 CA--C 1.531 0.212 0 C-N-CA 123.748 0.819 . . . . 0.0 110.106 177.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -48.75 137.2 27.32 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.89 2.394 . . . . 0.0 110.534 175.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.442 HD11 ' HB1' ' A' ' 221' ' ' ALA . 12.8 tp -132.34 151.08 52.01 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 122.682 0.393 . . . . 0.0 110.483 -170.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -147.7 140.66 14.93 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-O 119.235 -0.412 . . . . 0.0 110.901 -177.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -57.54 -21.6 47.07 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 123.569 2.846 . . . . 0.0 114.091 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -85.3 6.37 26.54 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.519 0.6 . . . . 0.0 110.787 179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -125.03 28.14 6.49 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 175.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 31.4 m -129.66 152.29 49.33 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.088 -173.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.3 tt -123.95 148.21 28.15 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.081 0 C-N-CA 123.366 0.666 . . . . 0.0 109.288 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.473 ' CD1' ' N6 ' ' B' ' 5' ' ' ' A' . 10.1 t80 -114.42 144.18 43.73 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 173.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 13.7 m -135.97 130.13 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 122.87 0.468 . . . . 0.0 110.056 177.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -132.26 164.62 23.8 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.824 -0.51 . . . . 0.0 111.824 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 87.37 16.93 59.69 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 111.019 -0.832 . . . . 0.0 111.019 -175.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 28.3 m -64.52 151.05 92.55 Favored Pre-proline 0 CA--C 1.53 0.181 0 C-N-CA 122.464 0.305 . . . . 0.0 111.257 -179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -75.83 -174.97 2.24 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.954 3.103 . . . . 0.0 110.065 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -56.03 -50.86 84.89 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-O 118.244 -0.884 . . . . 0.0 112.545 -177.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -76.83 141.73 21.83 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.15 1.9 . . . . 0.0 110.928 176.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.675 ' CD1' ' H ' ' A' ' 185' ' ' ARG . 0.3 OUTLIER -148.02 -75.99 0.18 Allowed 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 118.94 -0.552 . . . . 0.0 110.799 178.219 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.675 ' H ' ' CD1' ' A' ' 184' ' ' LEU . 5.8 ptm180 49.75 132.48 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 128.445 2.698 . . . . 0.0 115.073 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.87 -20.19 65.87 Favored 'General case' 0 N--CA 1.456 -0.17 0 O-C-N 121.721 -0.612 . . . . 0.0 112.302 -175.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 96.7 t -67.91 -58.32 6.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-N 117.817 0.28 . . . . 0.0 111.187 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -82.73 -19.44 37.93 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 122.263 -0.273 . . . . 0.0 111.268 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 56.9 tp -70.09 -35.91 74.52 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 175.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -76.66 -35.47 57.94 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 122.387 -0.196 . . . . 0.0 111.406 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 23.5 mmt -69.78 -38.49 76.71 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -175.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 45.6 mt -71.85 -43.64 68.76 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-O 119.545 -0.264 . . . . 0.0 110.548 -176.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.6 mmt -61.64 -21.27 64.25 Favored 'General case' 0 C--O 1.227 -0.131 0 CA-C-N 118.31 0.505 . . . . 0.0 111.34 173.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -91.66 -11.58 36.58 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 118.659 0.663 . . . . 0.0 112.158 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -96.44 -15.75 21.58 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 122.033 -0.417 . . . . 0.0 111.861 175.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.08 -21.84 10.33 Favored 'General case' 0 CA--C 1.527 0.088 0 CA-C-N 118.155 0.434 . . . . 0.0 110.793 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -139.86 44.21 1.93 Allowed 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.175 0.59 . . . . 0.0 109.444 -178.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -42.47 135.93 3.74 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.168 0.889 . . . . 0.0 113.04 -174.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 131.45 12.59 2.0 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -176.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.404 HG22 ' CE2' ' A' ' 222' ' ' PHE . 49.1 t -70.03 148.42 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-N 117.541 0.671 . . . . 0.0 110.24 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 51.5 t -125.64 -29.99 3.11 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.896 177.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -155.48 152.72 29.27 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 120.58 0.229 . . . . 0.0 110.893 -175.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -153.4 160.17 42.56 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.385 0.674 . . . . 0.0 110.761 175.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -178.58 173.55 45.88 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.578 -0.609 . . . . 0.0 111.578 176.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.464 HD12 ' N ' ' A' ' 205' ' ' ILE . 3.4 mp -94.51 84.73 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 23.4 t70 53.66 -66.77 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -168.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 38.8 p 43.0 54.14 4.9 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 178.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -60.65 132.31 91.27 Favored Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.19 -14.78 14.79 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 124.43 3.42 . . . . 0.0 113.886 -173.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -91.83 -39.68 11.62 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 118.616 0.644 . . . . 0.0 110.211 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -96.42 -7.8 34.02 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 65.8 mttm 52.02 46.34 26.77 Favored 'General case' 0 C--N 1.338 0.095 0 C-N-CA 124.618 1.167 . . . . 0.0 111.675 174.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -147.93 154.5 43.51 Favored Pre-proline 0 CA--C 1.531 0.238 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -175.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -83.58 173.21 9.69 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 123.918 3.079 . . . . 0.0 110.868 173.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.518 ' HA ' ' C4 ' ' B' ' 4' ' ' ' U' . 60.9 mttp -127.8 18.57 6.72 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.999 0.519 . . . . 0.0 111.621 176.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 67.07 10.27 56.03 Favored Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.886 -0.397 . . . . 0.0 112.27 -179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -134.91 148.7 50.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.45 0.625 . . . . 0.0 110.306 -178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -87.49 156.14 27.69 Favored Glycine 0 CA--C 1.524 0.62 0 CA-C-O 121.455 0.475 . . . . 0.0 113.146 -173.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 32.4 ptt180 -144.71 149.26 35.31 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 169.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 71.8 t -138.56 144.2 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.442 ' HB1' HD11 ' A' ' 169' ' ' LEU . . . -129.07 148.86 51.05 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.068 0.461 . . . . 0.0 110.39 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.404 ' CE2' HG22 ' A' ' 200' ' ' VAL . 69.0 m-85 -120.62 154.14 35.86 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.101 -173.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 67.3 p -90.22 7.74 36.61 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.284 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 21.7 m-80 -134.96 136.69 42.43 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.665 0.786 . . . . 0.0 109.655 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -75.9 -16.95 59.95 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.0 tp60 -77.71 -36.82 50.6 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 23.7 m -78.57 -24.65 45.42 Favored 'General case' 0 N--CA 1.455 -0.201 0 O-C-N 122.287 -0.258 . . . . 0.0 110.38 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -64.46 -49.94 69.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 175.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.0 pt -75.09 -16.34 15.99 Favored 'Isoleucine or valine' 0 C--N 1.338 0.07 0 CA-C-N 117.744 0.247 . . . . 0.0 111.522 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.79 -25.59 37.76 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 117.83 0.286 . . . . 0.0 111.006 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -82.57 -22.23 34.95 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 111.806 0.298 . . . . 0.0 111.806 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 21.8 pt -108.92 20.88 5.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 C-N-CA 123.004 0.522 . . . . 0.0 110.538 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.3 t -77.41 -9.58 58.95 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.874 0.47 . . . . 0.0 111.659 -177.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -152.12 144.12 23.79 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -53.69 -29.32 38.43 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -126.38 119.9 28.48 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.849 0.357 . . . . 0.0 110.415 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.431 HG23 HD21 ' A' ' 239' ' ' LEU . 2.7 m -84.37 159.19 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.146 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.207 175.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.606 ' C ' HD22 ' A' ' 239' ' ' LEU . 3.6 mp0 -94.86 138.53 32.52 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.606 HD22 ' C ' ' A' ' 238' ' ' GLN . 2.5 mm? -129.83 14.39 5.85 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.908 -175.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.63 140.29 29.9 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 112.108 0.41 . . . . 0.0 112.108 -172.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -147.59 21.21 1.17 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.408 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.59 139.74 6.32 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 54.85 3.28 0.05 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.186 1.394 . . . . 0.0 113.426 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 62.0 mt -145.43 142.04 22.33 Favored 'Isoleucine or valine' 0 C--N 1.338 0.1 0 C-N-CA 124.23 1.012 . . . . 0.0 108.619 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -151.89 136.36 16.87 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 176.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -148.22 164.99 32.29 Favored 'General case' 0 C--N 1.338 0.091 0 C-N-CA 123.802 0.841 . . . . 0.0 109.62 179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.57 155.92 38.31 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 173.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 8.5 p -155.88 152.32 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -82.68 143.58 30.85 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 2.2 m -116.73 153.82 18.39 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 121.631 0.729 . . . . 0.0 112.949 -175.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.452 ' HD2' ' N6 ' ' B' ' 5' ' ' ' A' . 32.4 ttmt -151.24 141.43 14.53 Favored Pre-proline 0 N--CA 1.446 -0.67 0 CA-C-N 114.484 -1.235 . . . . 0.0 108.833 174.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . 0.409 ' HD2' ' HG3' ' A' ' 251' ' ' LYS . 24.9 Cg_endo -58.23 136.99 78.24 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.61 2.207 . . . . 0.0 108.364 176.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -70.07 132.65 46.18 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 119.42 -0.912 . . . . 0.0 111.266 -173.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . 0.435 HG22 ' H ' ' A' ' 255' ' ' LEU . 0.3 OUTLIER 53.17 172.41 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 127.111 2.164 . . . . 0.0 113.91 178.078 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.435 ' H ' HG22 ' A' ' 254' ' ' VAL . 1.8 pt? . . . . . 0 C--O 1.25 1.085 0 CA-C-O 117.005 -1.474 . . . . 0.0 112.37 -176.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.668 ' C6 ' ' HE2' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.421 -2.679 1 O4'-C1'-N19 112.305 4.105 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.201 0 C3'-C2'-C1' 104.799 3.665 . 0.639 0b . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.446 ' C6 ' ' CE2' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.418 -2.934 1 O4'-C1'-N19 112.948 4.748 . 0.155 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.518 ' C4 ' ' HA ' ' A' ' 215' ' ' LYS . . . . . . . . 0 O4'--C4' 1.421 -2.662 0 O4'-C1'-N19 111.595 3.395 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.473 ' N6 ' ' CD1' ' A' ' 176' ' ' PHE . . . . . . . . 0 O4'--C4' 1.417 -3.005 0 C5'-C4'-C3' 110.258 -3.494 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 111.271 0.101 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 58.0 t60 -147.85 161.57 41.02 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 122.981 0.513 . . . . 0.0 110.256 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -149.18 164.59 34.3 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 122.907 0.483 . . . . 0.0 110.818 -178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -77.0 166.8 22.84 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.827 0.451 . . . . 0.0 110.332 179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.62 -164.36 20.9 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.69 157.92 45.65 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 123.377 0.671 . . . . 0.0 110.477 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? 53.22 30.2 9.58 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.138 0.575 . . . . 0.0 111.254 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 32.6 m -88.6 8.39 2.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 123.614 0.765 . . . . 0.0 111.904 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 17.3 mp0 -70.98 157.45 38.18 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.987 0.422 . . . . 0.0 111.222 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.637 ' HD3' HD13 ' A' ' 156' ' ' LEU . 0.4 OUTLIER -87.77 157.55 19.0 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 123.202 0.601 . . . . 0.0 111.324 179.061 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.704 ' C ' HD11 ' A' ' 156' ' ' LEU . 26.1 m-85 -134.27 160.79 36.8 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-O 121.135 0.493 . . . . 0.0 111.121 -174.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -88.51 31.88 0.81 Allowed 'General case' 0 C--N 1.334 -0.068 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.597 ' HA ' ' CE1' ' A' ' 115' ' ' PHE . 99.0 mtt180 54.62 18.42 2.04 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.192 0.597 . . . . 0.0 112.299 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 2.0 tmtm? -146.25 133.48 20.55 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -177.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 m -139.94 161.97 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -95.59 143.06 27.2 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 169.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.7 m -131.39 118.52 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 172.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -90.58 138.96 14.68 Favored Glycine 0 C--N 1.334 0.449 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.481 -172.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 81.57 145.44 4.85 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 123.446 0.546 . . . . 0.0 114.386 173.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.7 tp -164.96 132.79 2.47 Favored Pre-proline 0 N--CA 1.453 -0.283 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.435 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . 81.9 Cg_endo -77.19 156.04 33.34 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.937 1.758 . . . . 0.0 110.329 178.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 73' ' ' PRO . 33.0 Cg_exo -62.43 0.78 1.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 124.544 3.496 . . . . 0.0 114.913 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -134.25 43.54 2.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 118.598 0.636 . . . . 0.0 111.552 -175.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.0 mt -141.32 151.5 19.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -135.99 -179.47 5.68 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-O 120.916 0.389 . . . . 0.0 111.595 -177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -45.76 -42.36 11.91 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.59 1.156 . . . . 0.0 112.075 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -73.94 -29.57 62.09 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 118.192 0.451 . . . . 0.0 111.92 -173.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -80.79 -29.83 36.05 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 122.29 -0.256 . . . . 0.0 110.823 -172.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.2 pt -86.41 -26.02 6.27 Favored 'Isoleucine or valine' 0 C--N 1.338 0.078 0 O-C-N 121.782 -0.574 . . . . 0.0 109.899 173.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 61.7 m -70.24 -14.15 62.49 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 172.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -97.26 -21.97 16.95 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.393 0.277 . . . . 0.0 111.606 173.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 69.4 m -77.06 -21.56 54.26 Favored 'General case' 0 C--N 1.34 0.177 0 CA-C-N 118.255 0.479 . . . . 0.0 111.885 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -111.89 4.57 18.36 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 117.825 0.284 . . . . 0.0 111.649 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -71.64 -5.9 37.0 Favored 'General case' 0 N--CA 1.463 0.189 0 O-C-N 121.966 -0.459 . . . . 0.0 111.964 -176.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 49.4 tpt85 -67.1 -10.0 45.49 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.189 0.996 . . . . 0.0 110.627 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -126.56 33.03 5.06 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.47 0.308 . . . . 0.0 111.464 -174.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.68 178.45 38.07 Favored Glycine 0 CA--C 1.529 0.92 0 N-CA-C 111.948 -0.461 . . . . 0.0 111.948 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -72.38 141.74 35.81 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.882 3.055 . . . . 0.0 111.305 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -161.44 173.48 14.83 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.811 0.844 . . . . 0.0 110.088 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.89 167.27 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.147 -177.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.29 148.37 29.9 Favored 'Isoleucine or valine' 0 C--O 1.23 0.069 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -150.91 163.96 37.45 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.108 0.48 . . . . 0.0 110.827 -177.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.512 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 33.7 p90 -153.5 162.98 25.22 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 176.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.649 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 40.3 Cg_endo -73.59 -10.19 23.39 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.644 2.896 . . . . 0.0 110.923 -169.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.649 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 74.4 m-70 -106.06 18.75 21.59 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.295 1.038 . . . . 0.0 111.257 -178.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.6 tptm -48.91 151.44 1.24 Allowed 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.895 0.878 . . . . 0.0 113.154 -176.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -141.82 169.99 16.55 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.008 0.923 . . . . 0.0 110.319 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -105.92 -3.85 21.32 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 122.978 0.511 . . . . 0.0 110.896 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.7 t -78.06 160.03 28.35 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.656 0.383 . . . . 0.0 111.212 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -66.96 161.38 24.33 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.567 0.747 . . . . 0.0 110.592 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.1 m 55.02 53.17 10.67 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 123.501 0.72 . . . . 0.0 111.652 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -49.68 133.49 21.18 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.927 0.891 . . . . 0.0 110.519 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -158.62 131.51 4.54 Favored Pre-proline 0 N--CA 1.453 -0.313 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -71.1 158.54 54.79 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.73 2.953 . . . . 0.0 110.686 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -52.76 -15.63 4.69 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 124.667 3.578 . . . . 0.0 115.977 -178.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -142.76 -58.18 0.44 Allowed 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.288 0.949 . . . . 0.0 111.979 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 154.53 21.98 0.04 OUTLIER Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.324 -0.941 . . . . 0.0 113.831 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.411 ' CE1' " H4'" ' B' ' 2' ' ' ' U' . 1.0 OUTLIER -113.93 142.53 46.01 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 118.968 1.384 . . . . 0.0 108.238 177.335 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -145.27 176.86 9.24 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 118.085 0.402 . . . . 0.0 111.754 -173.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -142.95 137.15 29.2 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -177.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.77 148.7 23.11 Favored 'General case' 0 N--CA 1.461 0.103 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -174.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 4.2 mp -130.66 147.37 52.33 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.911 178.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.597 ' CE1' ' HA ' ' A' ' 65' ' ' ARG . 3.4 p90 -158.93 178.84 9.64 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.289 0.636 . . . . 0.0 109.297 175.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 21.9 mp0 -107.76 -21.03 13.02 Favored 'General case' 0 N--CA 1.456 -0.128 0 O-C-N 122.187 -0.32 . . . . 0.0 111.782 -174.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 -129.71 144.19 51.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.863 0.363 . . . . 0.0 111.335 -175.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.5 mp0 -74.68 -14.9 60.8 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.707 -178.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 76.7 p -70.92 -21.65 62.34 Favored 'General case' 0 N--CA 1.453 -0.276 0 O-C-N 122.354 -0.216 . . . . 0.0 110.902 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 36.4 t -75.35 -40.83 57.77 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.431 ' HB ' ' CZ ' ' A' ' 115' ' ' PHE . 4.7 p -82.8 -23.8 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.114 0 N-CA-C 110.469 -0.197 . . . . 0.0 110.469 179.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 20.4 tp60 -67.67 -37.83 82.9 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.108 -0.37 . . . . 0.0 110.004 177.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -81.4 -35.9 30.19 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.97 -18.25 60.41 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.58 0.627 . . . . 0.0 110.985 -177.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 44.0 mt -93.82 -23.71 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 117.948 0.34 . . . . 0.0 110.748 175.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -83.94 -13.68 52.81 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.793 -0.567 . . . . 0.0 111.63 179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -124.87 46.38 2.34 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.056 0.543 . . . . 0.0 111.125 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 18.6 p -137.75 -176.55 4.46 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -177.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 44.1 mt -86.29 154.98 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 125.168 1.387 . . . . 0.0 108.32 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -137.55 156.98 47.49 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 122.124 -0.36 . . . . 0.0 110.729 175.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -148.24 -176.64 5.37 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 178.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -42.75 -25.9 0.11 Allowed 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -169.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.33 14.04 0.13 Allowed Glycine 0 CA--C 1.528 0.87 0 CA-C-N 119.163 0.892 . . . . 0.0 112.844 178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -145.0 170.97 15.13 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 117.784 0.792 . . . . 0.0 111.05 -175.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 75.1 mt -108.01 166.63 10.58 Favored 'General case' 0 N--CA 1.456 -0.129 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 175.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -149.87 155.74 40.57 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.79 0.328 . . . . 0.0 110.739 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 5.6 mp -143.75 160.67 40.33 Favored 'General case' 0 CA--C 1.529 0.143 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 173.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 36.9 t -87.85 156.64 19.28 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 175.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.1 m -129.78 165.08 30.74 Favored 'Isoleucine or valine' 0 C--O 1.23 0.078 0 CA-C-O 120.846 0.355 . . . . 0.0 111.109 -179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.4 t -115.62 179.33 4.0 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.562 0.745 . . . . 0.0 109.728 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.541 ' HB3' ' HD2' ' A' ' 142' ' ' PRO . 5.7 m 61.48 -172.77 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 123.321 0.648 . . . . 0.0 110.143 -176.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 97.4 Cg_endo -74.07 135.96 21.75 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.703 1.602 . . . . 0.0 111.423 -169.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.7 m -147.29 42.85 1.11 Allowed 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.619 0.768 . . . . 0.0 109.206 -177.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 144' ' ' ILE . 3.2 mp 63.4 -62.2 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.753 1.621 . . . . 0.0 111.167 -173.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -151.99 -62.09 0.17 Allowed 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 174.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -160.55 130.46 5.15 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 122.897 0.479 . . . . 0.0 110.404 173.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.657 ' HD3' ' C6 ' ' B' ' 1' ' ' ' C' . 37.3 mttp -151.13 103.05 2.97 Favored Pre-proline 0 CA--C 1.53 0.174 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 176.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.97 135.29 58.3 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.402 2.735 . . . . 0.0 111.02 173.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.9 p -90.45 133.28 32.78 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -100.75 154.53 18.54 Favored 'General case' 0 N--CA 1.457 -0.121 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 -174.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 18.9 mm -131.08 147.64 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.946 0.898 . . . . 0.0 110.71 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -160.59 99.49 1.36 Allowed Pre-proline 0 CA--C 1.539 0.527 0 C-N-CA 123.009 0.524 . . . . 0.0 110.138 173.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.84 174.18 3.2 Favored 'Trans proline' 0 CA--C 1.531 0.356 1 C-N-CA 125.788 4.325 . . . . 0.0 115.969 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -108.18 156.48 19.28 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.539 177.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -102.58 125.22 49.23 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.515 0.674 . . . . 0.0 111.102 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.707 ' H ' ' CD1' ' A' ' 156' ' ' LEU . 1.9 mp -67.19 -19.77 65.61 Favored 'General case' 0 C--O 1.23 0.041 0 C-N-CA 125.102 1.361 . . . . 0.0 114.22 -172.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 81.1 p -87.11 -4.93 59.17 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -167.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -146.37 27.71 1.12 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.564 1.074 . . . . 0.0 113.318 -176.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.4 m -72.02 -20.98 61.61 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.8 -0.562 . . . . 0.0 112.377 -177.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -150.49 155.36 39.34 Favored 'General case' 0 C--O 1.231 0.096 0 C-N-CA 122.801 0.44 . . . . 0.0 110.949 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -150.09 162.12 41.03 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 10.9 p -149.19 149.81 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 177.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 30.9 ttm -123.02 22.13 9.64 Favored 'General case' 0 N--CA 1.456 -0.126 0 N-CA-C 111.844 0.313 . . . . 0.0 111.844 -170.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -158.43 -41.16 0.06 Allowed 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 68.22 10.26 59.2 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 119.172 -0.793 . . . . 0.0 113.723 173.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 20.5 t -141.79 -24.2 0.7 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.573 1.186 . . . . 0.0 114.163 -176.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 168' ' ' PRO . 24.0 mm100 -80.32 130.51 65.25 Favored Pre-proline 0 CA--C 1.532 0.272 0 CA-C-N 119.625 1.102 . . . . 0.0 110.615 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 167' ' ' GLN . 32.4 Cg_exo -61.11 159.49 29.97 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.667 2.912 . . . . 0.0 111.457 173.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.7 mt -108.71 154.36 22.14 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 122.514 0.326 . . . . 0.0 110.122 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -151.58 138.44 11.96 Favored Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -64.51 -14.09 42.38 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.143 2.562 . . . . 0.0 113.182 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -86.32 -6.6 58.92 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 118.711 0.687 . . . . 0.0 110.491 176.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -125.65 15.71 8.14 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 122.665 0.386 . . . . 0.0 111.355 175.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 46.4 m -119.5 143.64 47.45 Favored 'General case' 0 N--CA 1.457 -0.09 0 CA-C-O 121.131 0.491 . . . . 0.0 110.905 -177.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -122.47 148.7 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.088 -177.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -115.96 151.9 34.51 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.47 111.44 14.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.141 0 C-N-CA 123.291 0.637 . . . . 0.0 109.911 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -82.92 126.58 7.54 Favored Glycine 0 C--N 1.335 0.52 0 N-CA-C 111.599 -0.6 . . . . 0.0 111.599 -176.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 118.2 -110.87 2.05 Favored Glycine 0 CA--C 1.522 0.526 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -173.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.4 p 36.68 63.95 2.69 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.407 0.683 . . . . 0.0 111.573 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.22 176.75 3.66 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 124.251 3.301 . . . . 0.0 112.731 -174.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.435 ' N ' ' CD ' ' A' ' 183' ' ' PRO . 9.8 ptm180 -59.81 -21.14 0.71 Allowed Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 -173.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 182' ' ' ARG . 46.9 Cg_exo -60.35 -12.1 18.98 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 121.926 1.751 . . . . 0.0 112.882 172.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 89.2 mt -104.71 174.24 5.96 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 122.976 0.51 . . . . 0.0 110.605 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 4.2 ptm180 -152.46 153.33 33.3 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.244 1.017 . . . . 0.0 109.376 -170.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.21 -26.37 65.69 Favored 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -173.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 57.9 t -66.27 -48.68 80.31 Favored 'Isoleucine or valine' 0 C--N 1.338 0.099 0 CA-C-N 118.418 0.554 . . . . 0.0 111.291 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -84.17 -20.8 31.79 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.622 -0.14 . . . . 0.0 110.622 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -68.94 -40.13 79.17 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 174.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -69.04 -38.08 78.93 Favored 'General case' 0 N--CA 1.453 -0.315 0 O-C-N 122.323 -0.235 . . . . 0.0 111.567 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 24.4 mmt -69.45 -32.47 71.44 Favored 'General case' 0 N--CA 1.455 -0.184 0 O-C-N 122.235 -0.29 . . . . 0.0 111.069 -177.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 88.7 mt -71.8 -32.19 43.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.2 mmt -73.18 -23.23 60.39 Favored 'General case' 0 N--CA 1.454 -0.233 0 O-C-N 121.943 -0.473 . . . . 0.0 110.642 178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -82.19 -23.59 35.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 122.146 -0.346 . . . . 0.0 111.213 176.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -86.14 -19.58 29.91 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 119.023 -0.513 . . . . 0.0 111.94 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -116.25 -16.16 10.96 Favored 'General case' 0 CA--C 1.529 0.163 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -133.33 19.04 3.99 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 113.651 0.982 . . . . 0.0 113.651 -173.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.03 -144.68 38.34 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 175.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -70.72 113.36 4.76 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 112.256 -0.338 . . . . 0.0 112.256 -174.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 40.4 t -98.51 154.41 3.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 C-N-CA 124.143 0.977 . . . . 0.0 108.614 174.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 27.7 p -114.79 -31.45 6.13 Favored 'General case' 0 C--O 1.227 -0.084 0 CA-C-N 118.397 0.544 . . . . 0.0 111.324 175.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -148.19 144.44 27.73 Favored 'General case' 0 C--N 1.338 0.066 0 CA-C-N 118.492 0.587 . . . . 0.0 110.589 175.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -159.29 147.52 17.75 Favored 'General case' 0 N--CA 1.458 -0.03 0 CA-C-O 120.851 0.358 . . . . 0.0 111.075 177.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 163.41 -158.94 31.48 Favored Glycine 0 CA--C 1.522 0.481 0 O-C-N 121.924 -0.485 . . . . 0.0 112.289 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 44.0 mm -96.14 140.99 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -66.36 139.03 58.0 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.98 0.419 . . . . 0.0 110.8 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 55.0 p -136.31 155.7 49.71 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.277 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -80.88 126.59 77.28 Favored Pre-proline 0 N--CA 1.449 -0.504 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 171.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.2 -10.56 17.75 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 124.842 3.695 . . . . 0.0 113.405 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -103.73 -27.37 12.31 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 118.731 0.696 . . . . 0.0 110.398 -177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 81.7 mt -105.08 -7.34 19.21 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.775 0.43 . . . . 0.0 110.894 178.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 46.7 mmtm 53.06 40.74 31.7 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.048 0.939 . . . . 0.0 112.443 -179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.424 ' CE1' ' HB2' ' A' ' 65' ' ' ARG . 21.2 m-85 -127.82 155.55 77.23 Favored Pre-proline 0 N--CA 1.467 0.425 0 CA-C-O 118.958 -0.544 . . . . 0.0 110.558 -175.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -63.7 146.56 92.37 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.272 1.982 . . . . 0.0 110.735 178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . 0.465 ' HZ2' ' HB3' ' A' ' 215' ' ' LYS . 0.0 OUTLIER -130.98 31.25 4.49 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.031 0.932 . . . . 0.0 109.557 -176.128 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.53 156.93 2.62 Favored Glycine 0 C--N 1.335 0.521 0 CA-C-N 115.551 -0.75 . . . . 0.0 113.231 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . 54.59 -175.42 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.6 0.76 . . . . 0.0 111.999 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -139.36 174.09 22.41 Favored Glycine 0 CA--C 1.521 0.466 0 O-C-N 121.734 -0.604 . . . . 0.0 111.96 -176.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -148.93 154.32 39.26 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 62.8 t -140.27 145.84 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -132.45 150.37 52.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.119 0.485 . . . . 0.0 110.936 -177.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -131.54 159.97 36.62 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.112 -175.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 77.3 p -92.95 -5.76 50.01 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.261 175.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -124.35 144.39 50.05 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 123.105 0.562 . . . . 0.0 111.061 -176.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -78.33 -9.61 59.33 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.095 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -82.92 -38.92 22.17 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.2 m -75.91 -26.49 57.01 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 177.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -64.24 -50.94 66.02 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 175.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 2.6 pp -73.45 -14.23 16.49 Favored 'Isoleucine or valine' 0 C--N 1.338 0.104 0 CA-C-N 118.051 0.387 . . . . 0.0 111.309 -178.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.47 -21.16 32.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 117.708 0.231 . . . . 0.0 111.065 175.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -88.56 -14.91 36.48 Favored 'General case' 0 CA--C 1.532 0.265 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.0 pt -119.31 23.78 4.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.315 0.646 . . . . 0.0 110.567 176.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 88.7 p -76.2 -20.12 57.78 Favored 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.222 0.609 . . . . 0.0 112.544 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -149.77 133.01 16.4 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 -176.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -54.88 -37.53 66.39 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -175.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 56.1 m-85 -122.01 116.61 24.61 Favored 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 118.154 0.434 . . . . 0.0 110.615 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 27.5 m -97.95 158.41 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.311 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -89.75 144.19 26.18 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 120.931 0.395 . . . . 0.0 110.727 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 5.0 mp -138.22 98.73 3.68 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -138.54 76.19 1.56 Allowed 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.928 -172.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -137.24 152.18 49.54 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 66.71 25.27 72.91 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.343 -0.703 . . . . 0.0 111.343 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 63.06 21.85 13.11 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.284 1.034 . . . . 0.0 112.21 -175.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 68.7 mt -92.34 163.99 2.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 175.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -152.43 110.02 3.6 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -146.1 164.11 33.21 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 122.824 0.45 . . . . 0.0 110.841 -179.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.01 157.8 44.32 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 123.818 0.847 . . . . 0.0 109.188 178.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.58 149.54 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -87.42 121.87 30.42 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.4 m -95.6 150.45 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.103 0 CA-C-N 118.139 0.427 . . . . 0.0 111.286 -178.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.483 ' HG3' ' H61' ' B' ' 5' ' ' ' A' . 0.0 OUTLIER -158.27 160.21 29.74 Favored Pre-proline 0 N--CA 1.457 -0.096 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 171.024 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -57.03 135.18 69.21 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.725 2.283 . . . . 0.0 109.139 175.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -73.64 112.92 10.2 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 119.221 -0.992 . . . . 0.0 111.421 -176.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.6 p 44.25 34.81 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 125.554 1.542 . . . . 0.0 113.051 174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 60.4 tp . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.187 -1.387 . . . . 0.0 110.433 -178.209 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.657 ' C6 ' ' HD3' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.411 -3.492 0 O5'-C5'-C4' 113.577 2.412 . 0.0 '__' . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . 0.417 " C5'" " H4'" ' B' ' 1' ' ' ' C' . . . . . . . . 0 O4'--C4' 1.416 -3.066 2 O4'-C1'-N19 113.871 5.671 OUTLIER-DELTA 0.0 OUTLIER '7D dist 0b' 0.0 . . . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.415 -3.184 1 O4'-C1'-N19 113.236 5.036 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.494 " C1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.416 -3.062 0 C5'-C4'-C3' 110.409 -3.394 . 0.01 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.483 ' H61' ' HG3' ' A' ' 251' ' ' LYS . . . . . . . . 0 O4'--C4' 1.414 -3.275 0 O4'-C1'-N19 111.671 3.471 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 49.9 m . . . . . 0 N--CA 1.474 0.744 0 CA-C-O 120.688 0.28 . . . . 0.0 110.455 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 52.1 p-80 -149.69 164.84 34.12 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 123.153 0.581 . . . . 0.0 110.523 -178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.53 12.22 1.91 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.109 0.564 . . . . 0.0 111.496 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -140.58 173.07 11.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.317 0.647 . . . . 0.0 111.002 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 79.11 -179.52 52.83 Favored Glycine 0 CA--C 1.526 0.779 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -147.76 171.52 15.55 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 123.173 0.589 . . . . 0.0 110.556 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 72.3 ttp85 -136.2 -19.02 1.5 Allowed 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.889 0.476 . . . . 0.0 111.385 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.3 p -153.52 153.58 8.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 122.905 0.482 . . . . 0.0 109.915 -179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -146.16 152.81 39.85 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -76.25 148.82 37.35 Favored 'General case' 0 N--CA 1.457 -0.088 0 O-C-N 122.356 -0.215 . . . . 0.0 110.927 -178.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -166.2 164.98 17.82 Favored 'General case' 0 CA--C 1.52 -0.193 0 O-C-N 123.552 0.533 . . . . 0.0 109.699 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.5 t -108.37 156.95 18.84 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 171.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.553 ' CD ' ' H ' ' A' ' 65' ' ' ARG . 0.0 OUTLIER -76.6 26.77 0.13 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.497 0.719 . . . . 0.0 112.086 179.235 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.432 ' HE3' ' CD1' ' A' ' 154' ' ' TRP . 47.7 pttt -136.44 141.61 43.58 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.048 0.939 . . . . 0.0 109.627 -179.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 m -147.25 160.87 8.51 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.055 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.767 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.461 ' CZ ' ' C6 ' ' B' ' 3' ' ' ' U' . 3.4 t80 -100.49 143.43 30.68 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 169.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.44 HG11 HD13 ' A' ' 113' ' ' LEU . 3.2 m -134.2 132.66 55.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 173.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -140.21 -163.59 9.57 Favored Glycine 0 C--N 1.333 0.377 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 -176.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.3 21.37 66.28 Favored Glycine 0 CA--C 1.529 0.956 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.001 178.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.676 ' H ' HD23 ' A' ' 72' ' ' LEU . 2.1 pt? -118.44 150.02 47.16 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 118.179 0.989 . . . . 0.0 109.954 177.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -77.4 168.98 21.97 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 124.09 3.194 . . . . 0.0 113.706 -169.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -83.36 0.31 9.55 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 124.116 3.211 . . . . 0.0 111.65 178.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -100.89 11.47 39.52 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -173.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.444 HD12 ' C ' ' A' ' 76' ' ' ILE . 1.9 pp -122.39 177.65 3.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -142.65 -175.58 4.53 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-O 120.921 0.391 . . . . 0.0 111.578 -175.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -50.03 -31.88 14.04 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.356 1.062 . . . . 0.0 112.258 -178.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -71.45 -29.77 65.25 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 117.894 0.316 . . . . 0.0 111.542 -176.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -82.21 -31.78 30.15 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 122.184 -0.323 . . . . 0.0 110.42 -174.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 66.0 mt -77.49 -42.42 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.2 m -66.9 -22.97 65.95 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.67 -18.3 28.2 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.9 m -77.57 -27.61 51.51 Favored 'General case' 0 N--CA 1.461 0.111 0 CA-C-N 118.424 0.557 . . . . 0.0 111.685 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.41 ' CZ ' HD11 ' A' ' 151' ' ' ILE . 74.6 m-85 -120.98 12.71 11.24 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.49 -18.05 64.44 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.293 0.497 . . . . 0.0 112.249 -176.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -75.6 -10.18 59.22 Favored 'General case' 0 C--N 1.338 0.093 0 O-C-N 122.033 -0.417 . . . . 0.0 111.944 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -103.8 23.21 13.16 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 122.559 0.344 . . . . 0.0 111.319 -176.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.93 179.21 31.81 Favored Glycine 0 CA--C 1.527 0.823 0 N-CA-C 110.821 -0.911 . . . . 0.0 110.821 -177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.59 150.2 68.95 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 123.369 2.713 . . . . 0.0 110.772 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.417 ' N ' HD23 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -162.77 164.6 26.18 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.02 -170.141 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -145.63 164.55 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.752 174.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -129.58 151.05 35.24 Favored 'Isoleucine or valine' 0 C--O 1.23 0.07 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -143.23 159.07 43.0 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.487 0.66 . . . . 0.0 112.02 -174.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.499 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 30.2 p90 -151.88 159.52 32.96 Favored Pre-proline 0 N--CA 1.452 -0.349 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 170.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.535 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 94.2 Cg_endo -65.68 -13.99 42.55 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 123.525 2.816 . . . . 0.0 112.505 -169.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.535 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 21.0 m170 -106.59 13.72 27.9 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.066 0.546 . . . . 0.0 111.549 -176.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.7 tptm -49.81 151.51 1.78 Allowed 'General case' 0 C--N 1.34 0.174 0 C-N-CA 123.844 0.858 . . . . 0.0 112.739 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -146.4 165.67 28.64 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.587 0.755 . . . . 0.0 110.487 -177.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -86.23 -9.76 55.92 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.932 0.493 . . . . 0.0 110.382 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 94.5 p -82.19 -178.19 6.93 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 123.601 0.76 . . . . 0.0 110.986 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -74.78 15.06 0.41 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.504 0.721 . . . . 0.0 111.559 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 61.8 m -77.93 58.64 1.97 Allowed 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.595 0.758 . . . . 0.0 110.635 178.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -75.16 24.29 0.1 Allowed 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.144 0.977 . . . . 0.0 112.191 -178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -118.62 123.2 29.33 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 118.132 0.424 . . . . 0.0 110.75 -175.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.94 166.68 8.26 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 124.343 3.362 . . . . 0.0 111.728 173.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -60.73 -17.12 47.99 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.493 2.795 . . . . 0.0 112.227 176.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 4.8 tmtm? -141.16 -69.96 0.37 Allowed 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 172.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 175.78 -17.02 0.04 OUTLIER Glycine 0 CA--C 1.526 0.735 0 CA-C-O 119.592 -0.56 . . . . 0.0 112.101 -179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.472 ' HA ' HD21 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -76.05 150.12 37.38 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.025 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.69 -176.7 5.61 Favored 'General case' 0 N--CA 1.456 -0.161 0 CA-C-O 120.961 0.41 . . . . 0.0 111.427 -174.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -140.27 128.82 22.85 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.44 HD13 HG11 ' A' ' 69' ' ' VAL . 10.6 mp -89.98 149.54 22.52 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-O 121.656 0.741 . . . . 0.0 112.372 -177.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.2 mp -113.09 138.6 49.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -134.62 170.64 15.5 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.047 0.539 . . . . 0.0 110.388 -177.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -101.87 -24.17 14.06 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.705 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -135.83 153.57 51.46 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 23.2 mp0 -75.48 -15.51 60.4 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.735 171.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 36.0 m -78.91 -20.04 50.34 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 176.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.6 m -76.87 -42.3 40.43 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.7 m -74.15 -20.18 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.108 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -72.1 -41.33 67.4 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 -179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.71 -34.52 62.62 Favored 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 122.168 -0.333 . . . . 0.0 111.557 -178.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.5 pp -77.41 -17.9 57.73 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 118.372 0.533 . . . . 0.0 111.613 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 65.9 mt -95.46 -17.48 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 122.39 0.276 . . . . 0.0 111.014 178.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -99.41 -11.2 21.36 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.864 -0.523 . . . . 0.0 112.273 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -114.84 29.34 8.09 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 122.811 0.444 . . . . 0.0 111.921 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 17.6 p -137.41 -173.8 3.58 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.994 0.426 . . . . 0.0 111.647 -176.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.2 mm -84.67 160.53 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.167 0 C-N-CA 124.596 1.158 . . . . 0.0 109.427 -175.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -132.23 158.45 41.75 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.681 0.276 . . . . 0.0 110.821 177.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.3 74.52 1.33 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.436 0.636 . . . . 0.0 110.671 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 51.97 9.39 0.09 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 170.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 167.16 -9.87 0.06 OUTLIER Glycine 0 CA--C 1.527 0.794 0 CA-C-N 119.115 0.87 . . . . 0.0 113.289 178.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 36.6 pttt -146.34 178.25 8.39 Favored 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 174.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 4.6 mp -125.33 169.69 12.07 Favored 'General case' 0 CA--C 1.527 0.089 0 N-CA-C 113.275 0.842 . . . . 0.0 113.275 -171.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.44 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 0.3 OUTLIER -140.87 156.01 46.2 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.591 -175.744 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 48.4 tp -137.06 142.89 42.41 Favored 'General case' 0 CA--C 1.528 0.127 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 169.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 47.4 t -82.97 132.58 35.14 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.518 0.599 . . . . 0.0 109.99 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 19.9 m -137.38 -10.42 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -178.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 45.4 m 46.3 46.1 13.41 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.531 0.732 . . . . 0.0 112.786 176.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.407 ' HB3' ' HD2' ' A' ' 142' ' ' PRO . 18.7 m -57.17 156.15 15.18 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.399 0.68 . . . . 0.0 111.785 -178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.407 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 97.1 Cg_endo -72.13 20.08 0.29 Allowed 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 125.008 3.805 . . . . 0.0 114.19 -176.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.42 HG22 HG12 ' A' ' 144' ' ' ILE . 21.7 m -133.13 138.62 46.71 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.42 HG12 HG22 ' A' ' 143' ' ' THR . 0.9 OUTLIER 55.31 -149.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -170.352 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -139.12 145.7 39.76 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.449 0.568 . . . . 0.0 110.554 178.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 49.62 39.46 17.36 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.417 1.087 . . . . 0.0 112.969 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.498 ' HE2' ' C6 ' ' B' ' 1' ' ' ' C' . 2.6 tppp? -55.63 118.27 18.8 Favored Pre-proline 0 CA--C 1.53 0.195 0 C-N-CA 123.637 0.775 . . . . 0.0 111.964 -177.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.44 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 25.8 Cg_endo -93.8 129.53 0.66 Allowed 'Trans proline' 0 N--CA 1.445 -1.345 0 C-N-CA 124.252 3.301 . . . . 0.0 109.765 169.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 7.4 p -91.3 131.53 38.18 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -89.23 151.15 22.3 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.605 0.762 . . . . 0.0 111.503 -173.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.41 HD11 ' CZ ' ' A' ' 85' ' ' PHE . 48.5 mm -134.94 144.48 34.49 Favored 'Isoleucine or valine' 0 C--N 1.34 0.165 0 C-N-CA 123.967 0.907 . . . . 0.0 111.344 -177.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 59.0 ttp85 -152.57 116.11 2.89 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 168.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -73.59 165.01 33.45 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.877 3.051 . . . . 0.0 111.908 177.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.432 ' CD1' ' HE3' ' A' ' 66' ' ' LYS . 34.5 t-105 -100.66 152.5 20.37 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.351 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 49.4 p-10 -104.98 153.75 21.01 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.676 0.791 . . . . 0.0 112.209 -176.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.3 mp -94.63 -2.56 51.13 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 113.688 0.995 . . . . 0.0 113.688 -172.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 27.4 m -79.52 -10.38 59.79 Favored 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -173.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -136.17 -110.44 0.2 Allowed 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.733 0.697 . . . . 0.0 111.738 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 m 64.03 -33.4 0.14 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.541 1.937 . . . . 0.0 113.951 -173.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -153.49 151.82 30.27 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.101 0.56 . . . . 0.0 110.07 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -157.63 153.84 27.45 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 9.8 p -152.58 152.68 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 121.887 -0.508 . . . . 0.0 109.744 -177.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 71.4 mtm -128.96 29.92 5.13 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 111.583 0.216 . . . . 0.0 111.583 -176.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -159.72 -44.5 0.05 Allowed 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 72.54 3.93 59.68 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-O 119.102 -0.832 . . . . 0.0 113.635 174.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.3 m -138.53 -0.8 1.93 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -176.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -79.17 141.36 57.9 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 120.076 1.307 . . . . 0.0 110.261 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -75.11 153.21 41.08 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.369 2.713 . . . . 0.0 108.815 173.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 63.9 mt -121.46 150.12 42.04 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.631 0.253 . . . . 0.0 110.961 -177.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -144.22 139.02 15.37 Favored Pre-proline 0 N--CA 1.456 -0.157 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -68.34 -9.23 25.3 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.681 2.921 . . . . 0.0 112.613 -173.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -88.5 -1.68 58.19 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.715 0.406 . . . . 0.0 110.771 177.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -128.44 33.2 4.72 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 122.891 0.476 . . . . 0.0 109.733 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 11.5 m -126.14 153.45 44.55 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.077 -176.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 8.6 tt -121.84 151.61 25.43 Favored 'Isoleucine or valine' 0 C--O 1.229 0.024 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -116.36 148.22 40.83 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 172.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.39 117.71 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.504 ' HA2' ' CB ' ' A' ' 217' ' ' ALA . . . -119.83 159.65 14.86 Favored Glycine 0 C--N 1.336 0.564 0 O-C-N 123.202 0.314 . . . . 0.0 113.586 -171.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 96.84 24.77 12.57 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.7 p -104.24 107.57 57.79 Favored Pre-proline 0 CA--C 1.535 0.37 0 CA-C-N 117.197 0.498 . . . . 0.0 110.969 -176.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.88 -33.61 1.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.759 2.306 . . . . 0.0 112.66 176.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.724 ' H ' ' CD ' ' A' ' 183' ' ' PRO . 71.7 mtt180 -149.81 -38.12 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -177.178 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.724 ' CD ' ' H ' ' A' ' 182' ' ' ARG . 51.8 Cg_exo -59.29 -168.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 124.029 3.153 . . . . 0.0 114.857 -178.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 48.0 mt 65.35 -53.65 0.34 Allowed 'General case' 0 C--O 1.23 0.064 0 C-N-CA 126.963 2.105 . . . . 0.0 114.224 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 54.18 -163.43 0.11 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.947 0.794 . . . . 0.0 109.382 -173.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -103.85 -37.2 7.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 O-C-N 121.964 -0.46 . . . . 0.0 110.806 172.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 69.0 t -67.16 -56.45 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.078 0 C-N-CA 122.391 0.276 . . . . 0.0 111.183 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -74.34 -22.29 59.29 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 116.856 -0.156 . . . . 0.0 110.961 -173.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 63.6 tp -68.47 -35.94 78.27 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.39 -28.75 61.23 Favored 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 122.311 -0.243 . . . . 0.0 111.346 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 26.3 mmt -70.7 -35.2 72.64 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 117.704 0.229 . . . . 0.0 111.614 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 1.7 mp -76.62 -32.17 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 O-C-N 121.64 -0.663 . . . . 0.0 109.683 177.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.6 mmt -76.66 -15.82 59.71 Favored 'General case' 0 N--CA 1.453 -0.275 0 O-C-N 121.897 -0.502 . . . . 0.0 111.894 -177.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -97.9 -24.31 15.46 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 118.697 0.681 . . . . 0.0 111.553 176.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -86.43 -16.36 37.42 Favored 'General case' 0 C--N 1.34 0.165 0 O-C-N 121.872 -0.517 . . . . 0.0 112.334 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -117.49 -20.19 9.15 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 118.355 0.525 . . . . 0.0 111.082 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -140.03 42.65 1.94 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 122.928 0.491 . . . . 0.0 109.752 -176.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.51 137.15 4.38 Favored Glycine 0 CA--C 1.524 0.648 0 C-N-CA 124.032 0.825 . . . . 0.0 112.782 -175.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 122.7 1.38 9.85 Favored Glycine 0 CA--C 1.527 0.781 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 -176.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 9.8 p -65.48 157.16 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 C-N-CA 123.837 0.855 . . . . 0.0 109.889 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.9 p -129.41 -32.15 1.99 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -147.15 152.0 37.71 Favored 'General case' 0 C--N 1.339 0.113 0 CA-C-N 119.217 0.917 . . . . 0.0 111.891 -177.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -149.6 160.91 43.1 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 122.481 0.312 . . . . 0.0 111.176 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 168.39 -170.21 42.01 Favored Glycine 0 C--N 1.336 0.534 0 O-C-N 121.909 -0.494 . . . . 0.0 112.122 176.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 1.9 mp -105.08 146.02 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 176.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -65.81 117.88 8.86 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 120.552 0.215 . . . . 0.0 110.434 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 76.4 p -140.49 162.59 34.99 Favored 'General case' 0 C--O 1.231 0.092 0 C-N-CA 122.759 0.424 . . . . 0.0 110.266 -179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -115.98 130.75 24.16 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.28 -1.98 10.97 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 124.811 3.674 . . . . 0.0 114.335 -170.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -68.0 -32.42 72.79 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 119.025 0.829 . . . . 0.0 110.104 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.31 8.33 1.19 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.512 0.725 . . . . 0.0 109.853 177.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt 53.03 39.89 30.26 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.219 1.008 . . . . 0.0 111.434 -174.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -94.25 151.92 39.86 Favored Pre-proline 0 N--CA 1.455 -0.178 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.719 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -71.9 141.93 37.95 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.559 2.173 . . . . 0.0 110.821 -177.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.67 14.67 6.48 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 123.867 0.867 . . . . 0.0 109.92 -178.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 165.69 -165.09 37.78 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.39 -0.684 . . . . 0.0 111.39 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.504 ' CB ' ' HA2' ' A' ' 178' ' ' GLY . . . -86.08 -160.21 0.53 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.349 1.06 . . . . 0.0 110.829 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -74.56 158.87 51.92 Favored Glycine 0 CA--C 1.529 0.944 0 O-C-N 122.189 -0.32 . . . . 0.0 112.777 -177.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.06 153.26 38.69 Favored 'General case' 0 CA--C 1.528 0.097 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 177.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 50.1 t -145.27 146.12 20.03 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.06 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -127.39 145.33 50.85 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 122.547 0.339 . . . . 0.0 110.405 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -128.84 -23.09 3.14 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.312 -177.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 46.0 m 56.28 25.18 9.01 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -178.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -128.05 151.84 48.69 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 173.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -73.43 -30.99 63.58 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 111.571 0.212 . . . . 0.0 111.571 -176.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -85.12 -39.83 17.46 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 111.373 0.138 . . . . 0.0 111.373 -172.387 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 65.7 p -77.54 -23.07 50.18 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 122.16 -0.337 . . . . 0.0 110.249 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -67.6 -52.75 34.69 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 175.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 32.7 pt -73.08 -18.04 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.086 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -82.63 -29.38 30.12 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 118.159 0.436 . . . . 0.0 111.491 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -77.62 -23.77 49.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.931 0.332 . . . . 0.0 111.691 -177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 9.9 pt -108.89 25.14 2.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.525 0.73 . . . . 0.0 110.561 177.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 23.0 t -77.06 -12.51 59.95 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.136 0.574 . . . . 0.0 112.12 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -152.67 140.83 20.41 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -55.3 -30.26 59.84 Favored 'General case' 0 CA--C 1.527 0.07 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -177.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -128.15 130.24 47.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 121.295 0.569 . . . . 0.0 111.135 177.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 4.2 m -100.8 177.34 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.294 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . . . . . . . . . 22.2 mm100 -109.01 138.66 45.0 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 122.451 0.3 . . . . 0.0 110.346 172.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.2 mp -134.76 84.41 2.1 Favored 'General case' 0 N--CA 1.456 -0.15 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 176.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -119.55 -66.93 1.02 Allowed 'General case' 0 N--CA 1.455 -0.192 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -172.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 48.34 24.14 0.67 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -174.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 168.95 -151.28 17.47 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.627 -0.989 . . . . 0.0 110.627 -176.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -80.3 6.18 12.71 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.022 0.529 . . . . 0.0 111.717 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 244' ' ' ILE . 1.8 mp -71.53 157.05 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.597 0.759 . . . . 0.0 108.971 179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -141.58 25.63 1.99 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 120.906 0.384 . . . . 0.0 111.257 -178.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . 0.425 ' H ' HG22 ' A' ' 244' ' ' ILE . 99.1 mttt -90.12 154.73 19.56 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 123.128 0.571 . . . . 0.0 111.093 -177.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 14.8 ptt180 -160.26 -179.93 8.14 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 172.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 13.8 p -138.61 157.94 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 123.854 0.862 . . . . 0.0 110.187 -174.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -85.19 129.48 34.8 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 122.678 0.391 . . . . 0.0 110.009 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -100.28 158.23 3.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.134 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -176.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.432 ' HE3' ' HB3' ' A' ' 251' ' ' LYS . 0.0 OUTLIER -159.0 156.95 27.65 Favored Pre-proline 0 N--CA 1.456 -0.135 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.677 169.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -59.31 146.0 96.11 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.844 2.363 . . . . 0.0 109.863 174.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -79.83 166.03 22.12 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.489 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.1 p -151.7 152.84 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 123.059 0.544 . . . . 0.0 110.245 -171.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 62.2 tp . . . . . 0 C--O 1.251 1.149 0 CA-C-O 117.158 -1.401 . . . . 0.0 109.973 179.267 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.498 ' C6 ' ' HE2' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.921 1 O4'-C1'-N19 112.871 4.671 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.829 0 O4'-C1'-N19 111.842 3.642 . 0.271 4b . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.461 ' C6 ' ' CZ ' ' A' ' 68' ' ' PHE . . . . . . . . 0 O4'--C4' 1.42 -2.756 1 O4'-C1'-N19 113.034 4.834 . 0.053 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.44 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.421 -2.654 0 C5'-C4'-C3' 111.287 -2.809 . 0.063 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.47 ' C8 ' H5'' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.416 -3.107 0 P-O3'-C3' 122.915 2.679 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 77.6 p . . . . . 0 N--CA 1.475 0.805 0 CA-C-O 120.418 0.152 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -138.39 10.26 2.73 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.097 0.559 . . . . 0.0 111.614 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -138.6 167.89 20.96 Favored 'General case' 0 N--CA 1.457 -0.095 0 C-N-CA 123.464 0.706 . . . . 0.0 110.241 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.6 p-10 -141.52 177.91 7.81 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.285 0.634 . . . . 0.0 110.781 -179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 85.84 11.06 74.56 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 112.14 -0.384 . . . . 0.0 112.14 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -70.29 168.94 14.82 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 117.467 0.633 . . . . 0.0 111.618 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.5 tmt_? -137.11 145.54 44.0 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.185 0.594 . . . . 0.0 109.731 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 48.9 t -131.2 150.86 34.89 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 123.538 0.735 . . . . 0.0 109.475 -178.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -77.15 149.88 35.59 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-O 120.881 0.372 . . . . 0.0 111.465 -176.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.9 31.14 0.71 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.456 1.102 . . . . 0.0 113.49 -174.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.586 ' HA ' HD13 ' A' ' 156' ' ' LEU . 0.0 OUTLIER -142.22 -153.13 0.44 Allowed 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -174.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.2 m 64.75 5.89 3.02 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 126.133 1.773 . . . . 0.0 113.069 -179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -65.03 118.49 9.2 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.596 -2.002 . . . . 0.0 105.596 173.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.6 mptt 63.47 143.58 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.767 1.227 . . . . 0.0 111.071 -168.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -156.11 146.43 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.337 -172.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.494 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 9.3 t80 -89.69 140.01 30.0 Favored 'General case' 0 CA--C 1.527 0.094 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 6.1 p -118.76 117.88 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.482 ' HA2' ' CZ ' ' A' ' 68' ' ' PHE . . . -89.45 125.1 7.67 Favored Glycine 0 C--N 1.335 0.486 0 CA-C-N 116.348 -0.387 . . . . 0.0 113.141 -170.191 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 87.37 146.67 11.1 Favored Glycine 0 CA--C 1.526 0.75 0 C-N-CA 124.222 0.915 . . . . 0.0 112.522 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 22.6 tp -153.94 122.62 3.09 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -67.17 164.07 31.71 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.217 2.611 . . . . 0.0 111.781 176.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.15 175.43 9.24 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 124.39 3.393 . . . . 0.0 111.426 178.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 37.1 t70 60.9 -85.86 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.237 0.615 . . . . 0.0 112.332 -175.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 16.0 pt -56.38 157.24 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-O 121.278 0.561 . . . . 0.0 111.333 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -149.63 -121.76 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.029 0.531 . . . . 0.0 110.256 -177.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -54.07 -22.9 11.97 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.091 1.357 . . . . 0.0 111.974 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -77.83 -36.96 49.54 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -173.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -86.41 -30.42 22.12 Favored 'General case' 0 N--CA 1.456 -0.173 0 O-C-N 121.911 -0.493 . . . . 0.0 111.343 -173.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 15.8 pt -78.57 -33.3 16.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 O-C-N 121.935 -0.478 . . . . 0.0 109.968 177.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 91.3 m -70.47 -23.74 62.74 Favored 'General case' 0 CA--C 1.528 0.096 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 175.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.32 -17.07 40.76 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 112.025 0.379 . . . . 0.0 112.025 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.4 m -76.66 -37.4 56.29 Favored 'General case' 0 C--N 1.339 0.152 0 CA-C-N 118.557 0.617 . . . . 0.0 111.695 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.455 ' CZ ' HD11 ' A' ' 151' ' ' ILE . 81.2 m-85 -108.25 6.66 26.82 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 112.821 0.675 . . . . 0.0 112.821 -176.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.89 -18.34 64.09 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 122.709 0.404 . . . . 0.0 110.941 178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -72.09 -8.92 57.37 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.557 0.743 . . . . 0.0 112.031 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -110.23 5.72 22.02 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.335 0.254 . . . . 0.0 111.427 -179.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 123.78 177.58 15.11 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -70.5 150.79 64.26 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.69 2.927 . . . . 0.0 110.835 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.421 ' N ' HD23 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -164.53 164.41 21.76 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.747 -170.771 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.6 pt -142.22 170.82 11.57 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.295 174.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.7 p -143.09 155.15 17.07 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.131 0 C-N-CA 122.449 0.299 . . . . 0.0 110.351 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -153.25 170.27 21.0 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-O 120.67 0.271 . . . . 0.0 111.608 -176.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 33.7 p90 -159.27 158.14 28.03 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 169.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.421 ' HG3' " H1'" ' B' ' 4' ' ' ' U' . 34.6 Cg_endo -75.36 -9.18 20.18 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.892 1.728 . . . . 0.0 110.74 -169.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -95.37 6.71 48.29 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.723 0.809 . . . . 0.0 111.349 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.4 tptm -50.19 152.02 1.87 Allowed 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.778 0.831 . . . . 0.0 112.911 -176.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -143.37 161.6 37.92 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.088 -177.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -142.24 152.33 42.96 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.162 0.585 . . . . 0.0 110.37 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 93.3 p 47.51 19.13 0.13 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.964 1.705 . . . . 0.0 115.106 176.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -152.94 -35.82 0.11 Allowed 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 118.348 0.522 . . . . 0.0 111.16 178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.6 m -149.09 156.68 42.57 Favored 'General case' 0 N--CA 1.457 -0.079 0 C-N-CA 123.399 0.68 . . . . 0.0 110.025 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -153.78 22.7 0.52 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 122.766 0.426 . . . . 0.0 111.052 178.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -139.17 125.5 12.43 Favored Pre-proline 0 N--CA 1.451 -0.406 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -175.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.72 164.82 33.81 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 124.716 3.61 . . . . 0.0 111.675 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -64.1 -26.06 65.62 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.955 3.103 . . . . 0.0 112.873 -178.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -152.28 -38.72 0.11 Allowed 'General case' 0 C--O 1.227 -0.112 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 173.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 92.48 123.12 3.2 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 116.5 1.36 . . . . 0.0 116.5 168.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.515 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 14.3 m-85 -147.77 143.12 27.31 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 102.582 -3.118 . . . . 0.0 102.582 167.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.35 172.89 12.31 Favored 'General case' 0 C--N 1.335 -0.057 0 CA-C-N 119.896 1.225 . . . . 0.0 113.489 -169.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.4 ' CE1' ' C5 ' ' B' ' 4' ' ' ' U' . 1.3 m-85 -136.08 125.47 24.95 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.218 0.607 . . . . 0.0 109.515 -177.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.8 mp -84.8 141.97 30.11 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 121.345 0.593 . . . . 0.0 110.72 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.7 mp -104.99 136.48 44.38 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -140.28 163.93 31.45 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 123.049 0.539 . . . . 0.0 110.68 -175.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -123.53 -29.36 3.78 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.087 -177.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -102.23 159.91 14.99 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 120.827 0.346 . . . . 0.0 111.53 -175.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -111.29 5.0 19.55 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.236 -178.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 77.8 p -105.3 -22.22 13.09 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.904 0.482 . . . . 0.0 110.921 176.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 76.8 p -76.16 -31.43 58.54 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.5 m -66.84 -22.26 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 173.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -80.29 -36.92 33.73 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -174.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -74.87 -35.11 62.32 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 119.684 -0.198 . . . . 0.0 111.52 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -80.42 -18.51 48.62 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.313 0.506 . . . . 0.0 111.916 -176.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.1 mt -97.8 -14.47 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 117.843 0.292 . . . . 0.0 110.557 177.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -91.91 -16.54 26.5 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.312 -0.868 . . . . 0.0 111.238 175.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -108.74 26.9 10.01 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.457 0.703 . . . . 0.0 111.794 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 136' ' ' TYR . 17.2 p -124.98 166.77 15.74 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.043 0.537 . . . . 0.0 111.105 -176.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.56 172.4 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.339 0.113 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -137.31 157.95 45.49 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.021 0.438 . . . . 0.0 111.558 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.52 -172.7 4.09 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -30.1 -39.57 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.1 1.76 . . . . 0.0 115.253 -173.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.0 15.72 0.15 Allowed Glycine 0 CA--C 1.527 0.814 0 CA-C-N 118.595 0.634 . . . . 0.0 112.089 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -141.16 177.35 8.14 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-N 117.577 0.688 . . . . 0.0 110.56 -173.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -120.22 170.76 9.03 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.439 0.696 . . . . 0.0 110.186 -177.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.431 ' O ' ' HB2' ' A' ' 128' ' ' CYS . 6.3 m-85 -146.76 151.59 37.42 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.857 0.463 . . . . 0.0 111.084 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 45.4 tp -132.46 145.73 51.4 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 170.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 85.0 m -80.33 141.88 35.02 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.745 -0.597 . . . . 0.0 110.893 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.5 m -142.2 175.43 4.82 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.324 0.65 . . . . 0.0 109.681 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 54.8 m -138.51 117.32 12.33 Favored 'General case' 0 C--N 1.339 0.114 0 C-N-CA 122.674 0.39 . . . . 0.0 110.759 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.479 ' HB3' ' HD2' ' A' ' 142' ' ' PRO . 52.7 m -155.21 162.15 27.89 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 124.688 1.195 . . . . 0.0 108.828 -177.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 141' ' ' SER . 60.7 Cg_endo -66.1 -15.72 49.56 Favored 'Trans proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.203 2.602 . . . . 0.0 114.088 -175.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 88.6 m -105.12 -2.93 23.67 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 118.44 0.564 . . . . 0.0 110.169 175.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.2 mp -98.97 -52.42 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 123.177 0.591 . . . . 0.0 111.026 -172.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 87.6 tttt 58.2 -57.96 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.729 1.612 . . . . 0.0 113.194 -172.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -149.83 12.72 0.79 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.391 1.076 . . . . 0.0 110.678 178.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.521 ' HD2' ' C6 ' ' B' ' 1' ' ' ' C' . 14.0 tttm -67.99 137.38 92.18 Favored Pre-proline 0 C--N 1.338 0.1 0 C-N-CA 123.607 0.763 . . . . 0.0 111.532 -177.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.428 ' HG2' ' CE1' ' A' ' 136' ' ' TYR . 37.8 Cg_endo -86.96 146.79 7.91 Favored 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 123.685 2.923 . . . . 0.0 110.632 168.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.9 p -98.88 142.37 14.94 Favored 'Isoleucine or valine' 0 C--N 1.337 0.06 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 175.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -83.37 158.78 22.01 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 118.786 0.721 . . . . 0.0 112.464 -174.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.455 HD11 ' CZ ' ' A' ' 85' ' ' PHE . 29.6 mm -137.13 142.79 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.051 1.341 . . . . 0.0 108.759 177.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 44.8 ttt-85 -146.08 88.52 6.31 Favored Pre-proline 0 CA--C 1.529 0.152 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.78 145.37 72.42 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 124.495 3.463 . . . . 0.0 112.857 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 47.3 t-105 -92.86 153.02 19.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 173.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -119.48 134.1 55.38 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.653 0.739 . . . . 0.0 110.883 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.586 HD13 ' HA ' ' A' ' 63' ' ' TYR . 4.7 mp -87.87 8.21 27.13 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.473 -169.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 10.7 t -91.1 -12.65 34.95 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 -175.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -135.51 20.12 3.35 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -175.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 33.6 m -69.89 -20.98 63.36 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.433 0.56 . . . . 0.0 112.448 -176.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -158.19 158.09 33.91 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 118.275 0.488 . . . . 0.0 111.04 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -158.35 157.34 32.2 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.987 0.422 . . . . 0.0 111.054 179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.0 m -140.35 149.34 21.69 Favored 'Isoleucine or valine' 0 C--O 1.23 0.059 0 C-N-CA 124.353 1.061 . . . . 0.0 109.722 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 58.3 mtm -140.62 10.42 2.25 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -177.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -140.3 16.64 2.41 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 119.243 0.929 . . . . 0.0 112.971 -176.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 91.09 22.8 31.54 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-O 119.519 -0.6 . . . . 0.0 113.016 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 19.4 m 56.29 47.03 20.02 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 117.722 0.761 . . . . 0.0 112.544 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -61.88 158.21 44.82 Favored Pre-proline 0 CA--C 1.532 0.251 0 C-N-CA 123.259 0.624 . . . . 0.0 110.602 179.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.0 154.54 69.67 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.184 2.589 . . . . 0.0 110.67 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 61.2 mt -135.57 167.67 20.68 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.605 0.762 . . . . 0.0 110.666 -173.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -141.49 149.57 54.71 Favored Pre-proline 0 CA--C 1.531 0.227 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -60.01 -19.84 57.72 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 123.217 2.611 . . . . 0.0 112.516 177.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -88.1 5.93 38.78 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 123.46 0.704 . . . . 0.0 110.837 178.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -131.07 18.96 4.97 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 122.903 0.481 . . . . 0.0 110.875 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 24.2 m -126.35 139.9 52.93 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.88 0.371 . . . . 0.0 111.153 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.7 tt -112.0 149.2 14.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.913 -177.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -116.15 148.73 40.03 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 174.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.19 139.01 33.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 C-N-CA 122.632 0.373 . . . . 0.0 110.207 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -148.48 173.56 28.42 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 -178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.67 20.96 62.68 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -174.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.0 m -56.38 142.48 68.55 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 122.751 0.42 . . . . 0.0 110.372 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.06 -49.39 0.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.944 2.429 . . . . 0.0 112.21 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.412 ' HB3' ' HD3' ' A' ' 183' ' ' PRO . 41.7 ttm180 -161.11 -59.2 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.292 0 CA-C-O 118.435 -0.793 . . . . 0.0 111.257 176.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.412 ' HD3' ' HB3' ' A' ' 182' ' ' ARG . 77.3 Cg_endo -76.01 156.53 38.57 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.871 2.381 . . . . 0.0 111.394 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -157.59 0.68 0.11 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.155 0.582 . . . . 0.0 112.296 175.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . 0.423 ' HG2' ' H ' ' A' ' 188' ' ' GLU . 16.7 ttp-105 -28.46 120.56 0.12 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 125.864 1.666 . . . . 0.0 111.582 175.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.4 -21.14 63.79 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -174.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 94.3 t -67.21 -50.16 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 CA-C-N 118.154 0.434 . . . . 0.0 110.62 -179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.423 ' H ' ' HG2' ' A' ' 185' ' ' ARG . 59.6 mt-10 -84.87 -22.57 29.34 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 110.61 -0.144 . . . . 0.0 110.61 -176.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.94 -30.91 68.41 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 175.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -83.4 -31.6 26.59 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 119.503 -0.284 . . . . 0.0 111.713 -177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.3 mmt -70.46 -37.05 74.25 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 118.318 0.508 . . . . 0.0 109.656 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.408 HG21 ' HA ' ' A' ' 239' ' ' LEU . 64.5 mt -72.55 -40.42 62.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 -178.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 23.6 mmt -63.39 -25.37 68.26 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 121.941 -0.474 . . . . 0.0 110.929 172.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -80.59 -18.13 49.22 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 118.105 0.411 . . . . 0.0 111.836 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -98.53 -16.21 19.24 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.59 -13.11 11.53 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 119.184 0.902 . . . . 0.0 113.221 -177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -135.9 26.59 3.3 Favored 'General case' 0 C--N 1.338 0.101 0 CA-C-N 118.839 0.745 . . . . 0.0 112.657 -175.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 76.18 -150.55 39.07 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.796 -0.922 . . . . 0.0 110.796 178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -76.27 141.29 26.69 Favored Glycine 0 CA--C 1.523 0.539 0 N-CA-C 111.76 -0.536 . . . . 0.0 111.76 -174.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 41.0 t -120.84 143.89 31.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 124.248 1.019 . . . . 0.0 108.56 174.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 61.4 m -109.48 -33.53 6.78 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -176.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -151.9 149.77 29.32 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.0 0.428 . . . . 0.0 110.964 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -150.28 155.61 40.01 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.465 0.706 . . . . 0.0 109.143 175.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 177.85 -174.97 47.27 Favored Glycine 0 C--N 1.333 0.363 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 45.2 mm -104.95 145.01 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -54.91 118.23 4.1 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.013 177.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.413 HG22 ' HA ' ' A' ' 214' ' ' PRO . 12.2 p -144.23 158.94 43.45 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.63 0.372 . . . . 0.0 110.267 -176.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -135.1 135.54 23.06 Favored Pre-proline 0 N--CA 1.455 -0.216 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 174.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.68 -5.97 15.04 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 124.225 3.283 . . . . 0.0 112.824 -175.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -73.74 -39.63 64.11 Favored 'General case' 0 N--CA 1.456 -0.149 0 CA-C-N 118.311 0.505 . . . . 0.0 110.688 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.11 0.68 12.41 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.35 0.66 . . . . 0.0 109.602 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm 48.26 59.35 4.35 Favored 'General case' 0 N--CA 1.462 0.16 0 C-N-CA 124.281 1.032 . . . . 0.0 111.386 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -133.49 147.33 64.29 Favored Pre-proline 0 CA--C 1.529 0.149 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -176.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.413 ' HA ' HG22 ' A' ' 207' ' ' THR . 43.7 Cg_endo -81.96 165.65 17.27 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 124.238 3.292 . . . . 0.0 110.546 174.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -125.63 23.25 7.44 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 61.59 13.33 37.79 Favored Glycine 0 CA--C 1.528 0.879 0 CA-C-O 119.373 -0.682 . . . . 0.0 114.684 170.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -132.81 146.09 51.53 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 118.235 1.017 . . . . 0.0 109.569 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -93.18 162.31 25.92 Favored Glycine 0 CA--C 1.525 0.662 0 CA-C-O 121.445 0.469 . . . . 0.0 113.326 -172.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -149.64 145.21 26.62 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 173.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 95.2 t -136.57 147.77 27.39 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.167 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -133.51 154.03 51.16 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 121.396 0.617 . . . . 0.0 111.33 -176.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -132.22 154.95 49.09 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.05 -176.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 73.9 m -97.3 10.08 40.53 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 173.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -132.17 134.22 45.14 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.631 0.773 . . . . 0.0 109.799 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -72.92 -12.86 61.12 Favored 'General case' 0 N--CA 1.456 -0.126 0 CA-C-N 116.859 -0.155 . . . . 0.0 111.145 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 -82.1 -39.04 23.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 21.9 m -75.06 -28.95 60.57 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -64.52 -51.78 61.16 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-O 119.649 -0.215 . . . . 0.0 110.568 177.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.3 pt -71.42 -14.71 17.96 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 CA-C-N 118.111 0.414 . . . . 0.0 111.181 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -83.03 -22.01 33.68 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 117.799 0.272 . . . . 0.0 110.734 175.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -87.99 -27.84 21.82 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 5.5 pt -103.41 24.85 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 122.917 0.487 . . . . 0.0 110.547 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 86.6 p -75.15 -18.07 60.28 Favored 'General case' 0 C--O 1.231 0.112 0 C-N-CA 123.172 0.589 . . . . 0.0 111.96 -177.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.98 146.04 23.66 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -176.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -55.15 -31.4 61.29 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -123.05 121.94 37.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 120.899 0.381 . . . . 0.0 110.489 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.441 ' H ' HG22 ' A' ' 237' ' ' VAL . 1.8 m -82.68 153.98 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.594 172.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.566 ' C ' HD22 ' A' ' 239' ' ' LEU . 9.8 mp0 -95.62 140.58 30.24 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.566 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.0 mm? -127.82 27.23 5.76 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -175.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -91.96 136.52 33.1 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 122.909 0.484 . . . . 0.0 112.138 -171.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -148.71 19.26 1.02 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.918 177.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 84.79 138.54 4.2 Favored Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -176.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 55.86 7.39 0.27 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.389 1.076 . . . . 0.0 112.63 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.4 mt -142.71 141.61 27.27 Favored 'Isoleucine or valine' 0 C--N 1.339 0.146 0 C-N-CA 124.046 0.938 . . . . 0.0 108.991 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -157.41 123.97 4.95 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -144.34 161.27 39.4 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.98 155.21 36.51 Favored 'General case' 0 C--N 1.334 -0.107 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 9.0 p -154.92 151.43 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 177.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -84.97 126.71 33.75 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.5 m -102.03 158.52 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.162 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.23 157.43 27.49 Favored Pre-proline 0 N--CA 1.456 -0.148 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.733 169.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -56.86 130.73 41.43 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.55 2.167 . . . . 0.0 107.733 171.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -71.56 110.34 6.08 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 119.032 -1.067 . . . . 0.0 111.462 -172.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 8.6 p 45.2 34.87 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 125.473 1.509 . . . . 0.0 112.751 174.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 62.9 tp . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.107 -1.425 . . . . 0.0 110.357 -177.711 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.521 ' C6 ' ' HD2' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.415 -3.128 1 C5'-C4'-C3' 107.874 -5.084 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . 0.465 ' O2 ' " H2'" ' B' ' 2' ' ' ' U' . . . . . . . . 0 O4'--C4' 1.42 -2.774 2 C3'-C2'-C1' 105.947 4.941 OUTLIER-DELTA 0.061 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.515 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.421 -2.638 1 O4'-C1'-N19 113.849 5.649 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.421 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.422 -2.623 0 O4'-C1'-N19 111.215 3.015 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.438 " H2'" ' N3 ' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.423 -2.459 0 O3'-P-O5' 99.647 -2.291 . 0.013 4a . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.2 t . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -142.3 163.32 33.17 Favored 'General case' 0 CA--C 1.528 0.118 0 C-N-CA 123.089 0.556 . . . . 0.0 110.481 -178.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -82.24 163.77 21.64 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 122.832 0.453 . . . . 0.0 110.538 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 52.8 p-10 -142.53 179.83 6.73 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.574 0.75 . . . . 0.0 110.45 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 86.32 -149.94 23.24 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.425 ' CD ' ' H ' ' A' ' 58' ' ' GLU . 2.4 pm0 -61.6 156.71 19.14 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.214 0.605 . . . . 0.0 112.013 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -100.77 -10.25 20.97 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.17 0.588 . . . . 0.0 111.864 -177.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 33.3 m -138.48 160.2 31.43 Favored 'Isoleucine or valine' 0 C--N 1.338 0.098 0 C-N-CA 122.93 0.492 . . . . 0.0 110.866 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -97.72 171.68 8.17 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.4 0.68 . . . . 0.0 110.228 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.0 ppt_? -127.76 156.12 42.94 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 123.359 0.664 . . . . 0.0 110.789 178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.448 ' CD1' ' HA ' ' A' ' 155' ' ' ASN . 54.1 m-85 -168.96 -172.98 1.69 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -169.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.8 t -141.01 36.37 1.75 Allowed 'General case' 0 CA--C 1.531 0.229 0 O-C-N 122.02 -0.425 . . . . 0.0 112.04 173.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 45.78 36.36 2.73 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.329 1.451 . . . . 0.0 114.487 176.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.4 pttm -141.71 153.48 44.68 Favored 'General case' 0 N--CA 1.46 0.064 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 171.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 p -153.54 146.29 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 CA-C-O 120.62 0.247 . . . . 0.0 111.025 -176.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -89.41 144.15 26.28 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 175.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.78 115.0 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.724 0.773 . . . . 0.0 109.315 176.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -83.23 -165.17 37.4 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 -179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 71.87 -104.67 1.51 Allowed Glycine 0 CA--C 1.524 0.599 0 N-CA-C 110.429 -1.068 . . . . 0.0 110.429 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 53.1 tp 54.97 101.5 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.217 0 C-N-CA 125.366 1.466 . . . . 0.0 112.547 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -67.2 148.23 80.22 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 121.905 1.737 . . . . 0.0 108.572 174.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -76.8 20.14 0.63 Allowed 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.883 3.055 . . . . 0.0 112.574 -174.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -138.5 28.72 2.44 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 40.1 pt -133.66 175.55 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 119.012 0.824 . . . . 0.0 109.049 175.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -138.17 -175.97 4.29 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -176.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -49.88 -34.88 21.52 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.764 1.226 . . . . 0.0 112.261 -175.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -72.15 -29.85 64.43 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -175.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -79.13 -36.95 39.74 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -174.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 45.5 mt -73.72 -39.31 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 90.0 m -65.31 -22.94 66.9 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.1 -17.89 28.35 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.1 m -79.55 -26.72 41.35 Favored 'General case' 0 C--N 1.34 0.167 0 CA-C-N 118.383 0.538 . . . . 0.0 112.363 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -114.47 10.2 16.89 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 22.3 tpt180 -59.41 -19.83 50.27 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -172.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -73.63 -11.89 60.57 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 118.22 0.464 . . . . 0.0 112.236 -178.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -99.46 16.44 23.19 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.45 0.3 . . . . 0.0 111.713 -177.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.03 -175.33 29.7 Favored Glycine 0 CA--C 1.528 0.87 0 N-CA-C 111.244 -0.742 . . . . 0.0 111.244 179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.95 137.28 37.45 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 123.49 2.793 . . . . 0.0 110.536 -179.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.9 pp -160.25 166.69 29.1 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.519 0.728 . . . . 0.0 109.909 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mt -136.01 164.78 31.15 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.12 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.44 147.06 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 174.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -148.36 166.98 26.42 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -174.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 26.7 p90 -156.51 159.15 31.58 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 176.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.642 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 63.8 Cg_endo -71.36 -10.89 27.83 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.482 2.788 . . . . 0.0 110.976 -171.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.642 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 54.0 m-70 -100.28 17.09 22.27 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.955 0.902 . . . . 0.0 111.39 -178.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.4 tptm -54.02 160.56 1.47 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 124.004 0.922 . . . . 0.0 112.987 -178.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -130.83 167.34 19.07 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.079 0.952 . . . . 0.0 110.499 -178.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -143.73 150.12 38.16 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.274 0.63 . . . . 0.0 109.804 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.5 m 53.13 23.6 3.14 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.711 0.804 . . . . 0.0 112.503 -177.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -150.88 162.86 39.98 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.719 0.808 . . . . 0.0 109.381 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.0 m -62.41 161.66 11.34 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 122.744 0.418 . . . . 0.0 110.683 178.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -131.39 135.68 47.4 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.038 0.447 . . . . 0.0 111.097 -177.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -159.79 99.01 1.5 Allowed Pre-proline 0 CA--C 1.532 0.285 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.17 146.8 32.49 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.637 2.891 . . . . 0.0 111.946 -177.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 109' ' ' GLY . 48.9 Cg_endo -80.3 -166.71 0.43 Allowed 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.633 3.555 . . . . 0.0 109.217 172.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -75.93 33.7 0.12 Allowed 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 120.874 0.368 . . . . 0.0 110.568 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.426 ' H ' ' C ' ' A' ' 107' ' ' PRO . . . -80.28 9.32 48.74 Favored Glycine 0 CA--C 1.528 0.892 0 C-N-CA 123.562 0.601 . . . . 0.0 111.703 178.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.457 ' CD2' " H4'" ' B' ' 3' ' ' ' U' . 3.1 m-85 54.89 -177.25 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.068 0.547 . . . . 0.0 111.29 -175.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.54 175.38 12.38 Favored 'General case' 0 N--CA 1.456 -0.137 0 O-C-N 121.356 -0.84 . . . . 0.0 112.672 -176.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -139.59 143.49 37.32 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.9 mp -102.78 149.2 24.71 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-O 121.387 0.613 . . . . 0.0 112.267 -177.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 7.9 mp -107.9 143.11 36.98 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 114.362 -1.29 . . . . 0.0 107.658 176.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -139.44 154.41 47.76 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.136 0.494 . . . . 0.0 110.346 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 47.8 mm-40 -101.18 -23.86 14.37 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.139 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -111.93 153.38 26.82 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 122.257 0.223 . . . . 0.0 110.438 178.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -97.58 1.71 49.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.559 0.219 . . . . 0.0 111.086 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 21.3 t -115.08 -13.93 11.82 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.509 0.724 . . . . 0.0 110.884 176.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 38.5 m -68.27 -32.53 72.76 Favored 'General case' 0 C--O 1.231 0.129 0 O-C-N 121.507 -0.746 . . . . 0.0 109.227 174.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.1 m -67.78 -22.93 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -80.56 -26.37 38.03 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.832 -0.543 . . . . 0.0 109.639 -178.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -72.51 -36.28 68.32 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 121.926 -0.484 . . . . 0.0 110.569 176.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.8 pp -79.51 -16.3 56.26 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.312 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.51 HD11 ' HB3' ' A' ' 153' ' ' PRO . 97.0 mt -94.17 -10.77 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 C-N-CA 122.439 0.295 . . . . 0.0 110.85 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -108.19 -10.72 15.36 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.709 -0.619 . . . . 0.0 112.225 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -116.37 42.2 2.46 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.482 0.713 . . . . 0.0 110.293 179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 136' ' ' TYR . 31.1 p -142.67 174.97 10.17 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 123.45 0.7 . . . . 0.0 110.974 -172.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.95 165.89 2.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.186 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 177.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -132.02 157.27 44.56 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 120.995 0.426 . . . . 0.0 111.613 177.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -143.08 75.82 1.5 Allowed 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.436 0.636 . . . . 0.0 109.654 178.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.7 t70 54.52 12.45 0.54 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.196 1.399 . . . . 0.0 114.703 175.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 154.71 -8.73 0.36 Allowed Glycine 0 CA--C 1.528 0.888 0 O-C-N 121.526 -0.734 . . . . 0.0 113.384 177.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -129.78 171.04 13.11 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 118.136 0.968 . . . . 0.0 109.328 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -122.44 164.95 17.12 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -170.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.433 ' O ' ' HB2' ' A' ' 128' ' ' CYS . 9.7 m-85 -143.69 150.36 38.57 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.028 176.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 6.8 mp -127.21 159.47 34.2 Favored 'General case' 0 C--O 1.227 -0.087 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 169.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 24.2 p -94.08 128.58 40.54 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 121.931 -0.48 . . . . 0.0 111.067 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 34.4 m -148.43 166.12 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 C-N-CA 123.651 0.78 . . . . 0.0 109.838 178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 49.8 m -96.68 155.4 16.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 122.615 0.366 . . . . 0.0 110.738 178.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.4 m -146.35 144.49 21.27 Favored Pre-proline 0 CA--C 1.528 0.132 0 C-N-CA 123.338 0.655 . . . . 0.0 109.436 178.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -78.86 -14.52 13.79 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.41 2.74 . . . . 0.0 111.338 176.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 19.4 m -76.71 -24.53 53.1 Favored 'General case' 0 C--O 1.231 0.106 0 C-N-CA 123.934 0.893 . . . . 0.0 110.668 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.417 HG22 ' H ' ' A' ' 145' ' ' LYS . 0.2 OUTLIER -137.83 -172.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.371 1.068 . . . . 0.0 108.804 -170.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.417 ' H ' HG22 ' A' ' 144' ' ' ILE . 22.1 ptmt -91.41 -23.38 20.05 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 169.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -165.42 154.04 11.79 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.087 1.355 . . . . 0.0 108.462 177.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.505 ' HE2' ' C6 ' ' B' ' 1' ' ' ' C' . 22.2 ttmt -151.13 117.69 3.29 Favored Pre-proline 0 N--CA 1.457 -0.083 0 CA-C-N 118.276 0.489 . . . . 0.0 111.139 175.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.402 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 38.4 Cg_exo -63.8 120.53 7.94 Favored 'Trans proline' 0 N--CA 1.446 -1.284 0 C-N-CA 122.295 1.997 . . . . 0.0 108.654 168.023 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 10.6 p -84.25 132.0 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 13.1 tm0? -90.3 147.69 23.35 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.38 0.272 . . . . 0.0 110.787 -170.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 26.4 mm -135.18 142.76 39.03 Favored 'Isoleucine or valine' 0 C--N 1.338 0.085 0 C-N-CA 123.006 0.522 . . . . 0.0 111.501 -176.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.437 ' HD2' ' C4 ' ' B' ' 3' ' ' ' U' . 72.1 mtt180 -144.33 106.83 4.79 Favored Pre-proline 0 CA--C 1.534 0.334 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 173.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.51 ' HB3' HD11 ' A' ' 125' ' ' ILE . 84.1 Cg_endo -71.43 161.03 46.86 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 123.826 3.017 . . . . 0.0 113.79 -176.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -93.92 94.5 8.51 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.448 ' HA ' ' CD1' ' A' ' 63' ' ' TYR . 3.3 m120 -69.31 0.84 4.41 Favored 'General case' 0 C--O 1.228 -0.054 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -168.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.538 HD23 ' H ' ' A' ' 158' ' ' ASP . 0.0 OUTLIER -156.09 175.85 13.43 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.499 1.5 . . . . 0.0 114.464 -169.192 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 54.4 m -108.49 24.6 12.8 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 113.948 -1.478 . . . . 0.0 109.904 177.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.538 ' H ' HD23 ' A' ' 156' ' ' LEU . 80.5 m-20 -94.84 31.72 1.78 Allowed 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 122.408 0.283 . . . . 0.0 110.497 -177.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 m -75.47 -20.02 59.07 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 -175.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -153.29 154.01 33.76 Favored 'General case' 0 N--CA 1.456 -0.131 0 CA-C-N 118.06 0.391 . . . . 0.0 111.356 -178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -157.88 153.25 26.01 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.935 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.8 m -139.21 155.75 26.67 Favored 'Isoleucine or valine' 0 C--O 1.231 0.08 0 C-N-CA 122.803 0.441 . . . . 0.0 110.254 177.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 64.1 mtm -135.23 28.19 3.43 Favored 'General case' 0 CA--C 1.527 0.094 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.318 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -155.37 168.72 26.18 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -77.65 41.03 1.86 Allowed Glycine 0 CA--C 1.529 0.949 0 C-N-CA 123.672 0.653 . . . . 0.0 112.793 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 41.9 m 55.89 60.56 3.19 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-N 117.414 0.607 . . . . 0.0 111.51 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 58.4 mm-40 -63.43 161.72 31.77 Favored Pre-proline 0 CA--C 1.53 0.201 0 C-N-CA 123.532 0.733 . . . . 0.0 109.745 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -56.01 124.02 15.26 Favored 'Trans proline' 0 N--CA 1.452 -0.926 0 C-N-CA 122.518 2.145 . . . . 0.0 109.396 177.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.5 tp -127.07 138.31 53.18 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.748 0.819 . . . . 0.0 110.391 -171.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -144.78 156.3 55.87 Favored Pre-proline 0 N--CA 1.454 -0.261 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -70.63 -12.42 31.21 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.877 2.385 . . . . 0.0 111.203 -176.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -83.61 -5.03 59.07 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 123.665 0.786 . . . . 0.0 111.563 178.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -118.35 24.51 10.9 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 122.853 0.461 . . . . 0.0 110.127 174.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 44.8 m -122.09 154.0 37.92 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 122.603 0.361 . . . . 0.0 111.001 -174.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.61 146.24 34.47 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -99.3 129.06 45.49 Favored 'General case' 0 C--N 1.339 0.131 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.431 HG12 HG21 ' A' ' 248' ' ' VAL . 45.5 t -104.8 78.66 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 C-N-CA 125.02 1.328 . . . . 0.0 108.447 -177.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.451 ' HA2' ' CB ' ' A' ' 217' ' ' ALA . . . -96.09 153.42 20.55 Favored Glycine 0 C--N 1.335 0.496 0 CA-C-N 116.355 -0.384 . . . . 0.0 113.44 -174.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 109.21 11.79 21.31 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.9 m -73.63 152.88 89.54 Favored Pre-proline 0 N--CA 1.455 -0.205 0 CA-C-N 117.255 0.527 . . . . 0.0 110.298 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.32 -45.9 2.42 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.63 2.22 . . . . 0.0 110.099 177.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.531 ' HB3' ' CD ' ' A' ' 183' ' ' PRO . 29.5 ttp-105 -159.8 -75.32 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.369 0 CA-C-O 118.019 -0.991 . . . . 0.0 108.664 172.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 182' ' ' ARG . 14.4 Cg_endo -87.66 177.11 3.78 Favored 'Trans proline' 0 N--CA 1.451 -1.028 0 C-N-CA 122.765 2.31 . . . . 0.0 109.81 169.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 184' ' ' LEU . 19.3 tp -136.58 -0.34 2.4 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 169.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 42.9 ttt180 57.53 95.38 0.02 OUTLIER 'General case' 0 C--N 1.341 0.217 0 C-N-CA 126.941 2.096 . . . . 0.0 111.702 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -57.89 -27.44 63.29 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -173.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 62.5 t -62.8 -56.41 17.7 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 CA-C-N 118.515 0.598 . . . . 0.0 111.183 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -82.46 -23.03 34.94 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 122.454 -0.153 . . . . 0.0 110.721 -175.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.88 -38.87 66.82 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -70.52 -37.56 74.15 Favored 'General case' 0 N--CA 1.451 -0.425 0 O-C-N 121.923 -0.486 . . . . 0.0 110.426 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 21.2 mmt -68.33 -35.64 78.09 Favored 'General case' 0 N--CA 1.452 -0.347 0 O-C-N 122.376 -0.202 . . . . 0.0 110.818 -176.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.41 HG21 ' HA ' ' A' ' 239' ' ' LEU . 56.5 mt -76.95 -35.95 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 117.594 0.179 . . . . 0.0 111.317 -176.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 25.3 mmt -64.56 -23.43 67.26 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 121.891 -0.505 . . . . 0.0 109.998 172.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -78.68 -24.26 45.19 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 118.022 0.374 . . . . 0.0 110.735 174.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -83.43 -17.7 41.24 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 119.129 -0.462 . . . . 0.0 112.134 178.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -118.48 -17.07 9.46 Favored 'General case' 0 C--N 1.341 0.234 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -177.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -133.24 19.03 4.02 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 -174.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 71.19 -144.41 37.64 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.995 -0.442 . . . . 0.0 111.995 175.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -69.3 118.38 8.56 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.969 -0.452 . . . . 0.0 111.969 -174.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . . . . . . . . . 60.2 t -109.3 142.35 22.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 C-N-CA 124.08 0.952 . . . . 0.0 108.612 174.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 42.9 t -99.9 -39.78 8.0 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 117.687 0.221 . . . . 0.0 110.84 -178.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 28.6 t80 -150.09 146.29 26.85 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.727 0.298 . . . . 0.0 110.964 -176.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -154.49 153.04 30.83 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.312 0.645 . . . . 0.0 109.844 175.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 162.75 -158.25 30.42 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.651 -0.579 . . . . 0.0 111.651 178.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . 0.454 ' HA ' ' HA2' ' A' ' 218' ' ' GLY . 48.8 mm -108.51 145.33 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -60.3 102.68 0.18 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 40.7 p -145.51 166.76 24.75 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 122.944 0.498 . . . . 0.0 109.802 -176.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -138.26 131.61 16.51 Favored Pre-proline 0 CA--C 1.531 0.248 0 N-CA-C 109.611 -0.515 . . . . 0.0 109.611 176.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -80.11 -16.42 11.12 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 124.458 3.439 . . . . 0.0 113.587 -175.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -91.12 -31.65 16.15 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 118.527 0.603 . . . . 0.0 110.476 -176.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.04 -1.88 30.76 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.208 0.603 . . . . 0.0 110.291 176.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 49.86 45.2 25.1 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.103 0.961 . . . . 0.0 112.551 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.37 155.25 53.93 Favored Pre-proline 0 CA--C 1.528 0.104 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -176.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -84.41 153.85 12.21 Favored 'Trans proline' 0 N--CA 1.447 -1.248 0 C-N-CA 123.411 2.741 . . . . 0.0 109.586 170.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.58 6.59 6.25 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 122.856 0.463 . . . . 0.0 110.502 -178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 165.46 -163.07 36.35 Favored Glycine 0 CA--C 1.524 0.609 0 O-C-N 121.919 -0.488 . . . . 0.0 112.08 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . 0.451 ' CB ' ' HA2' ' A' ' 178' ' ' GLY . . . -80.09 -162.36 0.44 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.223 1.009 . . . . 0.0 111.401 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 205' ' ' ILE . . . -71.05 166.58 52.31 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 116.427 -0.351 . . . . 0.0 112.97 -178.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -155.56 154.68 32.09 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 175.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 87.6 t -140.6 147.09 23.36 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.128 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -137.56 154.04 49.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.355 0.597 . . . . 0.0 111.846 -177.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -129.48 158.25 39.72 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.035 -173.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 34.3 m -84.58 -10.49 57.34 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.311 177.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -124.67 149.15 47.48 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.166 0.587 . . . . 0.0 111.03 -174.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -78.07 -16.33 58.12 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.92 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 22.3 tm0? -80.87 -35.42 32.69 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 15.1 m -77.51 -26.89 51.56 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -64.59 -48.03 76.48 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.629 0.372 . . . . 0.0 110.481 176.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 35.5 pt -72.95 -24.49 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 CA-C-N 117.937 0.335 . . . . 0.0 111.039 -179.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -73.62 -24.72 60.06 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 118.018 0.372 . . . . 0.0 110.804 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -83.74 -8.52 59.24 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 15.4 pt -120.0 19.42 6.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 123.035 0.534 . . . . 0.0 110.791 176.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 21.1 m -89.32 -11.51 43.2 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 122.899 0.48 . . . . 0.0 112.129 -179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -142.41 122.94 14.09 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -50.75 -41.14 56.33 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -177.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -115.44 107.29 15.0 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.098 0.408 . . . . 0.0 111.104 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 237' ' ' VAL . 10.6 m -67.24 151.21 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.418 172.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.461 ' C ' HD22 ' A' ' 239' ' ' LEU . 0.3 OUTLIER -100.23 139.93 35.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.276 0.56 . . . . 0.0 109.678 174.043 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.461 HD22 ' C ' ' A' ' 238' ' ' GLN . 3.1 mm? -118.94 21.41 12.42 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.953 -1.021 . . . . 0.0 108.522 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 59.2 mt-30 -84.04 121.85 27.98 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.709 0.803 . . . . 0.0 112.041 -170.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -147.58 24.68 1.09 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 175.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 87.36 142.47 7.58 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -174.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 56.22 10.86 0.68 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.259 1.024 . . . . 0.0 112.85 -176.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 67.7 mt -140.87 142.29 30.37 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 C-N-CA 123.742 0.817 . . . . 0.0 109.213 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -142.8 18.56 1.98 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 122.542 0.337 . . . . 0.0 111.343 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -55.36 151.36 10.07 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 124.2 1.0 . . . . 0.0 111.385 -175.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.61 154.21 37.1 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 124.826 1.25 . . . . 0.0 108.975 176.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . 0.431 HG21 HG12 ' A' ' 177' ' ' VAL . 7.2 p -161.12 158.32 2.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -89.66 150.28 22.42 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.463 0.305 . . . . 0.0 111.739 -175.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 3.2 m -118.69 155.98 20.72 Favored 'Isoleucine or valine' 0 C--N 1.339 0.114 0 CA-C-O 120.775 0.322 . . . . 0.0 111.683 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.45 157.56 30.18 Favored Pre-proline 0 CA--C 1.528 0.118 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 173.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.73 137.6 74.63 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 122.349 2.033 . . . . 0.0 108.578 173.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 34.4 t80 -72.08 120.81 18.21 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 119.04 -1.064 . . . . 0.0 112.009 -175.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 7.7 p 42.84 42.48 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 126.17 1.788 . . . . 0.0 113.403 172.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.418 HD22 ' C ' ' A' ' 255' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.098 -0.953 . . . . 0.0 112.085 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.505 ' C6 ' ' HE2' ' A' ' 147' ' ' LYS . . . . . . . . 0 O4'--C4' 1.418 -2.947 1 O4'-C1'-N19 112.788 4.588 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O4'--C4' 1.419 -2.837 2 O4'-C1'-N19 112.935 4.735 . 0.673 0b . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.457 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.416 -3.111 1 O4'-C1'-N19 113.176 4.976 . 0.01 4b . 0.0 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.471 " H1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.42 -2.777 0 O4'-C4'-C3' 109.619 2.942 . 0.073 4b . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.552 ' C8 ' H5'' ' B' ' 5' ' ' ' A' . . . . . . . . 0 O4'--C4' 1.417 -3.001 0 C3'-C2'-C1' 104.159 2.955 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 110.872 -0.047 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -133.19 4.79 3.77 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 122.896 0.479 . . . . 0.0 111.841 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 51.53 41.15 28.34 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.793 0.837 . . . . 0.0 111.954 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -66.39 -10.99 49.05 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 122.023 -0.423 . . . . 0.0 111.489 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -78.03 -9.65 86.79 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-O 119.58 -0.567 . . . . 0.0 111.739 177.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.556 ' HG2' ' H ' ' A' ' 59' ' ' ARG . 21.0 tt0 57.31 -175.89 0.07 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.261 1.024 . . . . 0.0 111.798 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.556 ' H ' ' HG2' ' A' ' 58' ' ' GLU . 30.9 ttt180 -135.99 171.78 13.97 Favored 'General case' 0 C--O 1.231 0.089 0 C-N-CA 123.317 0.647 . . . . 0.0 109.752 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.493 ' H ' ' HG2' ' A' ' 59' ' ' ARG . 73.6 t -54.46 122.61 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 123.554 0.741 . . . . 0.0 110.125 177.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -160.36 149.55 17.32 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? 57.19 -80.66 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.439 1.496 . . . . 0.0 112.064 -173.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.8 m-30 53.85 172.16 0.02 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -175.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.3 t -107.46 21.47 17.42 Favored 'General case' 0 C--O 1.23 0.043 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.652 -173.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.484 ' HA ' ' CE1' ' A' ' 115' ' ' PHE . 96.4 mtt180 54.23 20.87 2.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.507 0.723 . . . . 0.0 112.784 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -145.96 146.87 31.19 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.074 0.549 . . . . 0.0 110.73 178.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.4 m -139.07 153.5 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.468 177.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CE2' ' C6 ' ' B' ' 3' ' ' ' U' . 6.8 t80 -88.44 142.68 27.52 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 170.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.505 HG11 HD13 ' A' ' 113' ' ' LEU . 3.6 m -129.28 100.61 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-O 121.994 0.902 . . . . 0.0 109.017 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . -85.26 -174.77 50.3 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.504 ' HA2' " H4'" ' B' ' 1' ' ' ' C' . . . 77.26 11.24 85.71 Favored Glycine 0 CA--C 1.53 1.006 0 CA-C-O 119.715 -0.491 . . . . 0.0 112.72 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 16.0 tp -67.87 127.04 93.33 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 118.112 0.956 . . . . 0.0 110.965 -177.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.31 163.25 30.34 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 123.581 2.854 . . . . 0.0 110.257 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -83.64 3.17 7.87 Favored 'Trans proline' 0 N--CA 1.455 -0.757 0 C-N-CA 124.123 3.215 . . . . 0.0 113.666 -173.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -129.67 22.41 5.46 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -170.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.0 pt -124.2 171.08 13.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 118.791 0.723 . . . . 0.0 109.958 175.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -140.35 -173.88 3.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.128 0.49 . . . . 0.0 112.201 -173.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -51.33 -29.41 15.09 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 125.317 1.447 . . . . 0.0 113.091 -175.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -80.78 -32.28 35.51 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 118.501 0.591 . . . . 0.0 111.585 -175.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -76.81 -39.25 52.04 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.374 0.131 . . . . 0.0 110.848 -173.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.417 ' H ' HG12 ' A' ' 81' ' ' ILE . 5.0 pt -83.95 -36.15 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 119.652 -0.213 . . . . 0.0 110.971 -177.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.8 m -65.54 -26.52 67.93 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 177.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.01 -22.58 31.29 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 119.647 -0.216 . . . . 0.0 111.408 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.7 m -78.58 -12.88 60.04 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.213 0.461 . . . . 0.0 112.099 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -118.45 4.44 11.78 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 118.175 0.443 . . . . 0.0 112.145 175.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 47.9 tpt85 -67.8 -18.55 64.89 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -173.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 -72.05 -5.34 34.51 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 118.415 0.552 . . . . 0.0 112.398 -176.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -106.67 6.3 29.65 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 122.449 0.3 . . . . 0.0 111.619 -178.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 117.31 179.59 17.54 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 110.707 -0.957 . . . . 0.0 110.707 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -71.57 134.89 25.16 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.548 2.832 . . . . 0.0 110.662 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.0 pp -159.85 164.93 33.21 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.919 0.888 . . . . 0.0 109.753 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 13.4 mm -128.45 163.79 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.17 153.67 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.153 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 175.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -145.47 157.07 44.07 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.214 0.53 . . . . 0.0 111.049 -175.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.454 ' HB2' ' HD2' ' A' ' 96' ' ' PRO . 44.8 p90 -156.5 158.77 31.57 Favored Pre-proline 0 N--CA 1.452 -0.342 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 169.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.654 ' HG2' ' CD2' ' A' ' 97' ' ' HIS . 38.4 Cg_endo -74.15 -10.62 22.79 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.389 2.726 . . . . 0.0 110.459 -169.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.654 ' CD2' ' HG2' ' A' ' 96' ' ' PRO . 50.1 m-70 -103.88 10.4 36.4 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.157 0.983 . . . . 0.0 110.927 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.493 ' HA ' ' HE3' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -63.92 -24.2 67.64 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 123.866 0.866 . . . . 0.0 110.927 -178.748 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . 49.34 -151.76 0.15 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.736 0.814 . . . . 0.0 111.473 178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -77.37 39.88 0.27 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.642 0.777 . . . . 0.0 111.036 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 7.7 t 57.41 27.5 13.98 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.882 0.873 . . . . 0.0 111.775 -177.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -88.11 11.52 15.99 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.561 0.744 . . . . 0.0 112.095 -179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.2 t -130.05 143.75 50.96 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 123.074 0.55 . . . . 0.0 110.211 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -142.28 14.92 2.03 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.379 0.672 . . . . 0.0 111.107 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 48.3 t80 -151.9 71.99 7.95 Favored Pre-proline 0 CA--C 1.532 0.265 0 O-C-N 122.017 -0.427 . . . . 0.0 110.139 178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -73.93 156.72 47.79 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.478 2.785 . . . . 0.0 111.352 -178.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -77.68 -173.47 1.82 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 124.409 3.406 . . . . 0.0 110.027 175.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -75.62 37.54 0.14 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.975 0.51 . . . . 0.0 111.524 177.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -70.94 8.17 4.84 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 123.714 0.673 . . . . 0.0 112.165 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.599 ' CE1' " H4'" ' B' ' 2' ' ' ' U' . 3.1 m-85 60.64 166.12 0.08 Allowed 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.324 0.65 . . . . 0.0 111.757 -177.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.82 175.34 9.9 Favored 'General case' 0 C--N 1.34 0.185 0 O-C-N 121.153 -0.967 . . . . 0.0 113.126 -171.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.417 ' CE1' ' C4 ' ' B' ' 4' ' ' ' U' . 0.7 OUTLIER -145.95 141.71 28.0 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.702 0.801 . . . . 0.0 109.504 -178.01 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.505 HD13 HG11 ' A' ' 69' ' ' VAL . 9.0 mp -98.94 144.89 27.61 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -178.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.23 139.15 52.35 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 174.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.484 ' CE1' ' HA ' ' A' ' 65' ' ' ARG . 8.1 p90 -152.19 177.4 10.57 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 51.8 mm-40 -117.69 -30.36 5.48 Favored 'General case' 0 CA--C 1.521 -0.148 0 O-C-N 122.188 -0.32 . . . . 0.0 110.88 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 24.9 m-20 -93.31 124.72 37.5 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -69.15 -19.36 64.01 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.73 0.3 . . . . 0.0 110.324 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.9 m -77.02 -13.27 59.98 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 122.854 0.462 . . . . 0.0 111.245 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 35.3 t -75.53 -38.28 59.46 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.9 p -83.64 -21.54 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 110.418 -0.216 . . . . 0.0 110.418 178.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLN . . . . . . . . . . . . . 11.7 tp60 -67.08 -40.16 86.94 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 174.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -75.28 -37.99 60.62 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.2 pp -74.64 -20.47 59.88 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 118.536 0.607 . . . . 0.0 111.708 -176.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.412 HD11 ' HG3' ' A' ' 153' ' ' PRO . 76.8 mt -92.07 -22.55 5.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 118.014 0.37 . . . . 0.0 111.437 176.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -91.24 -12.65 34.6 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 121.889 -0.507 . . . . 0.0 112.225 -177.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -127.04 46.0 2.59 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.885 0.474 . . . . 0.0 111.458 -178.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' CYS . . . . . . . . . . . . . 27.6 p -139.42 -177.9 5.14 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.775 0.43 . . . . 0.0 111.57 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.471 ' N ' HD12 ' A' ' 129' ' ' ILE . 2.9 mp -81.8 159.86 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -139.9 160.52 39.73 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.819 -0.551 . . . . 0.0 112.324 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -143.56 176.69 9.01 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 173.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -61.34 3.34 0.12 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -171.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.6 1.89 0.06 OUTLIER Glycine 0 CA--C 1.528 0.9 0 CA-C-O 119.006 -0.885 . . . . 0.0 114.0 177.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -154.1 177.02 11.54 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-N 118.713 1.256 . . . . 0.0 110.642 -175.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -116.34 163.33 16.18 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 174.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.449 ' CD1' ' HB2' ' A' ' 148' ' ' PRO . 6.3 m-85 -139.46 148.16 42.33 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.009 0.433 . . . . 0.0 112.008 -178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 4.6 mp -139.56 -171.02 3.05 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 172.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' CYS . . . . . . . . . . . . . 72.1 m -133.61 162.51 31.73 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.82 0.736 . . . . 0.0 112.138 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 27.1 m -127.09 167.72 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 124.674 1.19 . . . . 0.0 109.403 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.7 m -119.47 11.92 12.26 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -170.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.518 ' N ' ' CD ' ' A' ' 142' ' ' PRO . 6.1 t -141.68 32.6 0.16 Allowed Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 176.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' A' ' 141' ' ' SER . 85.5 Cg_endo -71.28 172.16 14.62 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.631 2.888 . . . . 0.0 113.533 -174.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.9 t -79.89 -20.54 45.62 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.728 0.811 . . . . 0.0 112.727 -177.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.8 mm -117.21 165.1 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.131 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -62.82 121.1 12.62 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 57.5 159.47 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.875 1.27 . . . . 0.0 112.582 -172.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -160.05 108.53 1.41 Allowed Pre-proline 0 CA--C 1.522 -0.129 0 O-C-N 121.679 -0.638 . . . . 0.0 110.66 178.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.449 ' HB2' ' CD1' ' A' ' 136' ' ' TYR . 58.9 Cg_endo -79.77 139.92 14.31 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.636 2.224 . . . . 0.0 108.506 169.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 13.6 m -124.3 144.85 32.7 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.046 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -85.38 158.74 20.17 Favored 'General case' 0 C--O 1.227 -0.083 0 N-CA-C 111.811 0.3 . . . . 0.0 111.811 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . . . . . . . . . 43.4 mm -133.32 140.73 46.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 C-N-CA 124.586 1.154 . . . . 0.0 108.943 172.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 65.1 ttt-85 -154.92 91.84 2.91 Favored Pre-proline 0 CA--C 1.535 0.375 0 O-C-N 123.345 0.403 . . . . 0.0 110.244 -178.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.412 ' HG3' HD11 ' A' ' 125' ' ' ILE . 36.7 Cg_exo -61.23 169.93 5.72 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 124.758 3.639 . . . . 0.0 114.853 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . 0.434 ' CD2' ' HG2' ' A' ' 214' ' ' PRO . 19.6 t-105 -113.73 141.5 47.18 Favored 'General case' 0 C--N 1.341 0.219 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.786 174.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -118.22 153.22 34.25 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.703 0.801 . . . . 0.0 110.957 179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 8.7 mp -89.66 12.45 16.84 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 -170.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 15.4 t -75.51 -24.0 56.79 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -173.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -143.97 29.55 1.34 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 118.499 0.59 . . . . 0.0 112.578 -178.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 49.3 m -65.51 -22.24 66.7 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.848 -0.532 . . . . 0.0 112.122 -178.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -153.66 157.42 39.57 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 122.782 0.433 . . . . 0.0 110.851 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -155.82 152.83 28.88 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 5.8 p -143.33 150.3 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 O-C-N 121.935 -0.478 . . . . 0.0 109.85 -178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' MET . . . . . . . . . . . . . 65.2 mtm -125.14 18.9 8.35 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 122.252 0.221 . . . . 0.0 111.568 -175.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -154.38 -48.52 0.09 Allowed 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 67.97 11.09 60.27 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 119.115 -0.825 . . . . 0.0 114.296 172.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 61.3 p -141.08 -16.51 0.85 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 -176.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -82.9 139.18 42.99 Favored Pre-proline 0 CA--C 1.532 0.269 0 CA-C-N 119.548 1.067 . . . . 0.0 110.926 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -62.92 156.18 55.81 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.675 2.917 . . . . 0.0 112.238 174.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.5 mp -120.32 162.23 19.8 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 123.519 0.728 . . . . 0.0 110.719 178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -150.01 138.79 12.64 Favored Pre-proline 0 CA--C 1.533 0.323 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.17 -11.24 31.39 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.26 2.64 . . . . 0.0 113.322 -174.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.2 6.14 46.29 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.558 0.617 . . . . 0.0 110.174 175.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -128.28 25.08 5.85 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.93 0.492 . . . . 0.0 110.832 175.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.7 m -123.75 144.48 49.66 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-O 120.77 0.319 . . . . 0.0 110.549 -178.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.5 tt -118.8 151.25 20.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.118 0 C-N-CA 123.076 0.55 . . . . 0.0 110.726 -173.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.498 ' CZ ' ' N7 ' ' B' ' 5' ' ' ' A' . 7.8 t80 -109.61 143.43 39.34 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 172.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 4.1 m -139.72 134.39 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 C-N-CA 122.974 0.509 . . . . 0.0 109.664 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -150.09 -177.74 24.36 Favored Glycine 0 CA--C 1.526 0.777 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 -176.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.65 7.19 84.71 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 111.013 -0.835 . . . . 0.0 111.013 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 7.4 p -73.93 128.37 86.69 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -79.55 -34.5 1.01 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.842 2.361 . . . . 0.0 114.376 -172.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.641 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 71.4 ttp85 -160.92 -38.32 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 116.841 2.163 . . . . 0.0 116.841 -174.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.641 ' HD2' ' H ' ' A' ' 182' ' ' ARG . 84.8 Cg_endo -76.98 -45.76 0.16 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-N 121.609 1.61 . . . . 0.0 113.989 -169.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 30.2 -106.74 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.734 1.214 . . . . 0.0 112.858 -176.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 64.47 136.39 0.02 OUTLIER 'General case' 0 C--N 1.343 0.284 0 C-N-CA 126.222 1.809 . . . . 0.0 112.488 -177.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -77.15 -32.13 56.1 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 122.005 -0.434 . . . . 0.0 112.022 -175.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 79.1 t -64.44 -54.18 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.196 0 CA-C-N 117.674 0.215 . . . . 0.0 111.155 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -75.4 -23.54 57.06 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.68 -173.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 51.8 tp -72.98 -30.49 63.86 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -78.02 -41.38 35.97 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 122.171 -0.331 . . . . 0.0 111.768 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 17.3 ptp -75.08 -26.48 59.37 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 122.217 -0.302 . . . . 0.0 110.713 -177.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 44.5 mt -72.04 -37.74 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.144 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 26.1 mmt -72.68 -15.75 61.69 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.969 -0.457 . . . . 0.0 110.076 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -89.65 -17.72 27.86 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.862 0.301 . . . . 0.0 110.95 175.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -88.83 -18.27 28.01 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-O 119.341 -0.362 . . . . 0.0 111.874 177.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.36 -24.86 8.22 Favored 'General case' 0 C--N 1.338 0.105 0 CA-C-N 118.284 0.493 . . . . 0.0 111.377 176.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -140.01 47.7 1.81 Allowed 'General case' 0 C--O 1.231 0.116 0 C-N-CA 122.794 0.438 . . . . 0.0 110.501 -175.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -43.13 136.12 4.33 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 123.276 0.465 . . . . 0.0 112.097 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 128.55 8.96 3.75 Favored Glycine 0 CA--C 1.53 0.97 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 -174.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' VAL . . . . . 0.414 HG22 ' CE2' ' A' ' 222' ' ' PHE . 53.9 t -66.08 147.94 12.34 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 C-N-CA 123.65 0.78 . . . . 0.0 110.146 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 24.2 p -118.24 -37.45 3.35 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 119.504 -0.284 . . . . 0.0 111.49 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -157.43 153.06 26.56 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 117.775 0.261 . . . . 0.0 110.936 -172.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ALA . . . . . . . . . . . . . . . -147.99 162.04 40.14 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 121.308 0.575 . . . . 0.0 111.839 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 178.0 -178.36 48.49 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ILE . . . . . . . . . . . . . 8.5 tp -87.73 155.59 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ASP . . . . . 0.446 ' HA ' ' CZ ' ' A' ' 219' ' ' ARG . 15.0 p-10 -70.76 38.68 0.05 Allowed 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 10.2 t -74.2 152.4 39.78 Favored 'General case' 0 N--CA 1.455 -0.208 0 O-C-N 122.105 -0.372 . . . . 0.0 110.325 176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -134.18 146.23 58.81 Favored Pre-proline 0 CA--C 1.532 0.273 0 C-N-CA 122.604 0.362 . . . . 0.0 110.31 -178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -76.01 -7.43 18.23 Favored 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 124.533 3.489 . . . . 0.0 111.989 -176.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -80.24 40.55 0.49 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 122.952 0.501 . . . . 0.0 110.347 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 51.68 21.94 1.49 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.263 1.825 . . . . 0.0 114.316 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -86.74 -24.15 25.23 Favored 'General case' 0 C--O 1.231 0.118 0 CA-C-O 119.24 -0.41 . . . . 0.0 110.261 174.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.52 ' HB3' ' CD ' ' A' ' 214' ' ' PRO . 37.6 m-85 56.28 -169.6 0.01 OUTLIER Pre-proline 0 CA--C 1.543 0.704 0 CA-C-O 118.624 -0.703 . . . . 0.0 109.811 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.52 ' CD ' ' HB3' ' A' ' 213' ' ' TYR . 52.0 Cg_exo -56.15 151.2 44.35 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.063 1.842 . . . . 0.0 113.102 -177.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -120.9 25.1 9.87 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 122.739 0.415 . . . . 0.0 110.485 175.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 71.66 12.28 73.83 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 119.28 -0.733 . . . . 0.0 114.152 171.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -132.2 155.03 48.97 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 118.236 1.018 . . . . 0.0 110.64 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -97.68 160.23 21.04 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-O 121.45 0.472 . . . . 0.0 112.998 -173.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . 0.446 ' CZ ' ' HA ' ' A' ' 206' ' ' ASP . 4.0 ptp85 -142.83 147.31 35.22 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 172.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 3.5 p -150.08 150.42 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -123.25 150.62 43.23 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.535 0.734 . . . . 0.0 111.175 -173.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.414 ' CE2' HG22 ' A' ' 200' ' ' VAL . 74.8 m-85 -125.96 149.26 48.91 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.47 0.708 . . . . 0.0 110.816 -177.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 69.1 m -82.05 -0.52 44.78 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 122.257 0.223 . . . . 0.0 110.879 173.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -132.68 133.66 43.82 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.01 0.524 . . . . 0.0 109.943 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -73.34 -21.95 60.42 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 36.5 tp60 -70.42 -38.8 74.64 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 38.6 m -76.66 -25.05 53.3 Favored 'General case' 0 N--CA 1.455 -0.183 0 O-C-N 122.239 -0.288 . . . . 0.0 110.239 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -69.21 -51.24 39.79 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 176.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 41.9 pt -69.48 -17.33 21.43 Favored 'Isoleucine or valine' 0 C--N 1.338 0.101 0 CA-C-N 118.095 0.407 . . . . 0.0 110.969 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . . . . -80.04 -28.48 39.3 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 176.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -81.48 -17.06 49.99 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 13.5 pt -113.92 24.54 4.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 123.331 0.653 . . . . 0.0 110.329 174.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 22.9 t -81.0 -9.89 59.78 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.268 0.627 . . . . 0.0 111.669 -177.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -153.45 141.78 20.6 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -56.23 -35.47 67.4 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 122.283 0.233 . . . . 0.0 111.403 -177.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -126.15 114.66 18.65 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-O 121.08 0.467 . . . . 0.0 110.306 178.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 28.7 m -97.81 161.22 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.888 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' GLN . . . . . 0.499 ' CD ' ' H ' ' A' ' 238' ' ' GLN . 0.1 OUTLIER -87.19 142.23 28.06 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-O 121.028 0.442 . . . . 0.0 109.833 176.39 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.432 HD12 ' C ' ' A' ' 238' ' ' GLN . 7.2 mp -117.47 19.2 14.1 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-O 121.667 0.746 . . . . 0.0 109.62 -179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -55.13 138.83 43.59 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.243 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -146.09 18.25 1.4 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.472 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . 88.08 -9.53 74.41 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 123.703 0.668 . . . . 0.0 111.817 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -141.74 10.31 2.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.64 0.776 . . . . 0.0 110.884 178.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ILE . . . . . . . . . . . . . 35.5 mm -133.54 153.9 37.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 123.587 0.755 . . . . 0.0 109.71 -174.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -146.96 12.44 1.1 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.695 0.398 . . . . 0.0 111.019 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -80.11 173.51 12.52 Favored 'General case' 0 N--CA 1.457 -0.085 0 C-N-CA 123.579 0.752 . . . . 0.0 112.191 -172.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.6 163.01 31.56 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 124.818 1.247 . . . . 0.0 109.565 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' VAL . . . . . . . . . . . . . 5.7 p -149.07 150.42 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -85.51 132.46 34.19 Favored 'General case' 0 N--CA 1.456 -0.152 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -117.32 155.19 19.02 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -175.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 11.1 ptpt -157.73 160.31 30.15 Favored Pre-proline 0 C--O 1.232 0.142 0 CA-C-O 119.548 -0.263 . . . . 0.0 110.548 168.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -62.48 124.8 14.88 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.244 1.962 . . . . 0.0 107.323 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -66.16 117.96 9.21 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 119.921 -0.712 . . . . 0.0 111.911 -169.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' VAL . . . . . . . . . . . . . 5.7 p 45.76 29.01 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 125.914 1.686 . . . . 0.0 113.292 174.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 1.9 tm? . . . . . 0 C--O 1.252 1.187 0 CA-C-O 117.726 -1.131 . . . . 0.0 109.656 -179.901 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' ' C' . . . . . 0.504 " H4'" ' HA2' ' A' ' 71' ' ' GLY . . . . . . . . 0 O4'--C4' 1.419 -2.802 1 O4'-C1'-N19 113.572 5.372 . 0.0 '__' . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ' U' . . . . . 0.599 " H4'" ' CE1' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.415 -3.205 1 C3'-C2'-C1' 105.818 4.798 OUTLIER-DELTA 0.058 0b . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.513 " H4'" ' CD2' ' A' ' 110' ' ' TYR . . . . . . . . 0 O4'--C4' 1.41 -3.557 3 O4'-C1'-N19 113.548 5.348 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ' U' . . . . . 0.48 " C1'" ' HG3' ' A' ' 96' ' ' PRO . . . . . . . . 0 O4'--C4' 1.418 -2.909 0 O4'-C4'-C3' 109.695 2.996 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ' A' . . . . . 0.498 ' N7 ' ' CZ ' ' A' ' 176' ' ' PHE . . . . . . . . 0 O4'--C4' 1.415 -3.147 0 P-O3'-C3' 123.336 3.03 . 0.0 OUTLIER . 0.0 . . . . . . . . . . 2 2 . 1 stop_ save_